data_1jbh_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1jbh _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo . . . . . 0 CA--C 1.563 1.967 0 N-CA-C 114.658 0.984 . . . . 0.0 114.658 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 33.0 m -78.73 125.84 38.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -166.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -75.67 97.49 3.82 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.026 -1.046 . . . . 0.0 112.532 -176.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -72.76 1.22 8.9 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 117.981 2.586 . . . . 0.0 117.981 -178.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -51.84 109.51 0.37 Allowed 'General case' 0 CA--C 1.566 1.594 0 N-CA-C 115.716 1.747 . . . . 0.0 115.716 -176.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 161.24 179.05 35.72 Favored Glycine 0 N--CA 1.484 1.894 0 CA-C-O 122.666 1.148 . . . . 0.0 115.94 -178.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -110.92 126.09 54.36 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 114.052 -1.074 . . . . 0.0 108.541 172.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 49.7 m95 -128.94 125.09 36.75 Favored 'General case' 0 CA--C 1.566 1.578 0 C-N-CA 123.358 0.663 . . . . 0.0 109.46 -167.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 16.7 ptpt -89.78 143.95 26.37 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.857 -1.152 . . . . 0.0 112.933 174.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.414 ' SD ' ' HD2' ' A' ' 38' ' ' PRO . 49.1 ttm -75.99 127.87 33.87 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.845 -1.16 . . . . 0.0 112.585 174.25 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 88.7 mt -87.06 -49.91 7.0 Favored 'General case' 0 CA--C 1.568 1.639 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 171.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 91.9 p -143.46 142.04 31.03 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 119.428 1.013 . . . . 0.0 113.368 -170.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.41 ' OD1' ' SD ' ' A' ' 10' ' ' MET . 2.3 m120 -117.99 93.42 4.13 Favored 'General case' 0 CA--C 1.565 1.527 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 -177.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -77.18 -70.23 0.48 Allowed 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 115.585 1.698 . . . . 0.0 115.585 -165.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -119.08 44.56 2.3 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.907 0.861 . . . . 0.0 111.237 175.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -72.38 -37.53 68.72 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 114.894 1.442 . . . . 0.0 114.894 175.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -50.02 -54.08 22.51 Favored 'General case' 0 CA--C 1.574 1.889 0 N-CA-C 115.288 1.588 . . . . 0.0 115.288 166.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -71.62 -36.94 70.93 Favored 'General case' 0 CA--C 1.574 1.881 0 N-CA-C 115.978 1.844 . . . . 0.0 115.978 175.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -55.09 -49.54 71.44 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 114.84 1.422 . . . . 0.0 114.84 165.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 78.7 mt -60.96 -39.91 91.33 Favored 'General case' 0 CA--C 1.574 1.889 0 N-CA-C 114.819 1.414 . . . . 0.0 114.819 169.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 26.9 ttm180 -51.52 -51.73 52.8 Favored 'General case' 0 N--CA 1.502 2.173 0 N-CA-C 115.467 1.654 . . . . 0.0 115.467 163.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.51 -27.7 62.78 Favored 'General case' 0 CA--C 1.567 1.635 0 N-CA-C 117.908 2.559 . . . . 0.0 117.908 167.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 95.8 mt -81.52 10.92 5.1 Favored 'General case' 0 CA--C 1.573 1.837 0 N-CA-C 115.614 1.709 . . . . 0.0 115.614 167.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.541 ' N ' ' HD2' ' A' ' 24' ' ' ASP 0.252 0.9 OUTLIER 64.03 40.0 7.47 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 115.434 1.642 . . . . 0.0 115.434 -175.429 . . . . . . . . 4 4 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 89.0 t -100.15 151.0 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 CA-C-O 122.379 1.085 . . . . 0.0 110.645 -178.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 9.7 p-10 -74.12 154.39 39.16 Favored 'General case' 0 CA--C 1.568 1.656 0 N-CA-C 115.59 1.7 . . . . 0.0 115.59 -179.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 45.9 t -54.58 -45.72 71.72 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.345 0 N-CA-C 115.059 1.503 . . . . 0.0 115.059 -176.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.33 -47.98 83.41 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 115.922 1.823 . . . . 0.0 115.922 176.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.77 -49.89 75.96 Favored 'General case' 0 CA--C 1.571 1.75 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 168.02 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 56.3 mtp180 -48.55 -55.47 11.0 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 116.302 1.964 . . . . 0.0 116.302 167.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 35.8 tptt -59.32 -50.78 72.67 Favored 'General case' 0 CA--C 1.564 1.504 0 N-CA-C 115.471 1.656 . . . . 0.0 115.471 176.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 22.2 mt -67.86 -45.69 83.64 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.806 0 CA-C-O 118.03 -0.986 . . . . 0.0 112.286 177.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -57.9 -39.89 79.0 Favored 'General case' 0 CA--C 1.565 1.548 0 N-CA-C 117.229 2.307 . . . . 0.0 117.229 170.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -65.94 -28.67 69.09 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 116.411 2.004 . . . . 0.0 116.411 166.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 80.4 mt -72.99 -37.17 67.1 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 115.727 1.751 . . . . 0.0 115.727 165.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 44.2 mt -68.74 141.48 55.23 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 119.45 1.023 . . . . 0.0 113.711 -175.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 39.2 mmtm -112.54 78.99 2.89 Favored Pre-proline 0 CA--C 1.575 1.91 0 CA-C-O 118.411 -0.804 . . . . 0.0 109.934 177.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.414 ' HD2' ' SD ' ' A' ' 10' ' ' MET . 74.1 Cg_endo -75.34 168.4 24.68 Favored 'Trans proline' 0 CA--C 1.562 1.895 0 C-N-CA 122.528 2.152 . . . . 0.0 115.708 -176.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -108.58 127.36 53.88 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.664 -174.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 38.7 mttp -97.6 113.95 25.77 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.563 -0.71 . . . . 0.0 109.651 172.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -98.69 108.26 20.9 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 165.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.3 mp -96.97 120.05 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 177.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 75.4 t -99.67 101.85 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 166.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -104.59 114.02 27.97 Favored 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 123.469 0.708 . . . . 0.0 110.927 -178.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -123.7 74.48 1.27 Allowed 'General case' 0 CA--C 1.569 1.685 0 C-N-CA 123.843 0.857 . . . . 0.0 110.493 177.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.76 -100.37 1.45 Allowed Glycine 0 N--CA 1.489 2.229 0 O-C-N 121.48 -0.762 . . . . 0.0 114.063 177.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -85.22 -33.84 22.14 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 115.218 1.562 . . . . 0.0 115.218 162.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -78.16 114.15 16.78 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-N 120.682 1.583 . . . . 0.0 112.11 -174.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 48.2 ttm -128.29 118.63 23.6 Favored 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 123.43 0.692 . . . . 0.0 109.644 -175.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 52.4 mt -107.02 103.33 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 176.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 73.2 mt -90.39 99.53 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 175.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 70.5 mtt85 -89.42 95.96 10.5 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.467 -0.771 . . . . 0.0 110.673 178.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 49.5 m -88.29 105.08 17.32 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 177.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 12.2 mt -106.01 113.9 27.72 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 123.684 0.793 . . . . 0.0 109.213 -163.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 9.1 t -139.68 155.91 47.11 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.856 0.836 . . . . 0.0 112.434 -166.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 26.9 m -61.57 -40.74 95.83 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 115.745 1.757 . . . . 0.0 115.745 178.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -69.04 -58.13 4.51 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 114.699 1.37 . . . . 0.0 114.699 171.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 26.4 tpt180 -152.15 135.67 16.09 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-N 118.516 0.598 . . . . 0.0 109.863 175.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -73.98 112.42 10.09 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.776 -0.577 . . . . 0.0 109.706 163.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 52.8 t80 -79.29 -61.68 1.93 Allowed 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -167.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.334 49.7 mt 74.5 97.64 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 C-N-CA 123.932 0.893 . . . . 0.0 111.91 167.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 89.0 mtp -100.18 99.42 10.11 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.486 -0.759 . . . . 0.0 109.352 172.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -98.71 114.45 26.97 Favored 'General case' 0 CA--C 1.563 1.479 0 C-N-CA 124.013 0.925 . . . . 0.0 111.663 177.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -156.55 157.17 34.89 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 -168.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 66.1 mt-30 -100.28 127.16 46.63 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.581 -0.7 . . . . 0.0 110.481 165.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 37.3 t -63.53 123.5 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 C-N-CA 124.103 0.961 . . . . 0.0 110.503 178.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 107.67 -43.28 1.73 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 116.199 1.24 . . . . 0.0 116.199 -158.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 76.1 mttt -86.72 152.57 22.42 Favored 'General case' 0 CA--C 1.568 1.642 0 CA-C-N 118.612 1.206 . . . . 0.0 113.489 -172.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -107.92 117.92 35.39 Favored 'General case' 0 CA--C 1.569 1.674 0 C-N-CA 123.469 0.707 . . . . 0.0 111.469 -173.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 8.8 p90 -127.28 151.57 48.57 Favored 'General case' 0 N--CA 1.501 2.108 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 -171.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -80.43 123.89 28.43 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.015 -1.678 . . . . 0.0 114.81 -176.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 . . . . . 0 N--CA 1.502 2.136 0 N-CA-C 115.696 1.739 . . . . 0.0 115.696 177.501 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 99.2 m . . . . . 0 CA--C 1.56 1.328 0 CA-C-O 121.227 0.536 . . . . 0.0 111.033 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -79.51 94.83 5.68 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 122.999 1.38 . . . . 0.0 110.255 -170.04 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 99.5 m -100.0 118.02 35.5 Favored 'General case' 0 N--CA 1.48 1.036 0 O-C-N 121.292 -0.88 . . . . 0.0 110.372 -153.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 25.0 m -112.74 122.53 47.95 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-N 115.102 -0.954 . . . . 0.0 108.504 -174.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 20.7 t -113.26 127.77 70.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 -177.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 60.9 p -131.36 159.21 38.63 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 122.223 1.011 . . . . 0.0 112.609 -175.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 55.5 m95 -92.13 113.76 26.12 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.782 -0.574 . . . . 0.0 110.605 171.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -92.71 73.22 4.99 Favored 'General case' 0 CA--C 1.566 1.58 0 C-N-CA 123.253 0.621 . . . . 0.0 110.291 171.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.05 -94.56 0.18 Allowed Glycine 0 N--CA 1.489 2.187 0 N-CA-C 114.637 0.615 . . . . 0.0 114.637 -171.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -85.39 -38.37 18.79 Favored 'General case' 0 CA--C 1.569 1.676 0 N-CA-C 115.405 1.631 . . . . 0.0 115.405 171.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -93.31 154.65 17.87 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 119.163 0.892 . . . . 0.0 112.733 -167.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 18.5 tp -99.16 109.68 22.34 Favored 'General case' 0 CA--C 1.564 1.504 0 O-C-N 121.04 -1.037 . . . . 0.0 110.273 178.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 31.7 mm-40 -97.48 122.61 40.74 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 123.862 0.865 . . . . 0.0 111.3 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 41.7 t -114.6 131.39 56.71 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.38 0.672 . . . . 0.0 111.609 175.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 15.0 p -117.03 123.59 72.02 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.699 0 C-N-CA 123.174 0.59 . . . . 0.0 109.579 170.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -98.73 97.05 8.34 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 124.033 0.933 . . . . 0.0 109.277 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 30.4 mmtp -81.31 119.72 24.02 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 -168.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -174.3 -121.38 0.62 Allowed Glycine 0 N--CA 1.484 1.861 0 O-C-N 121.994 -0.441 . . . . 0.0 112.425 171.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -87.05 -32.51 19.94 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 116.619 2.081 . . . . 0.0 116.619 -178.497 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 50.7 mttp -89.57 135.73 33.43 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 120.711 1.596 . . . . 0.0 112.756 -165.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -81.09 102.83 10.5 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.742 0.782 . . . . 0.0 112.989 -164.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 82.35 41.75 9.02 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 117.308 1.683 . . . . 0.0 117.308 -168.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 46.9 ttt180 -84.8 118.46 24.48 Favored 'General case' 0 CA--C 1.564 1.503 0 CA-C-N 118.857 1.329 . . . . 0.0 111.121 175.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 170.84 -165.55 38.75 Favored Glycine 0 N--CA 1.484 1.861 0 N-CA-C 114.827 0.691 . . . . 0.0 114.827 -178.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 28.9 p-90 -157.43 157.13 33.4 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 114.6 1.333 . . . . 0.0 114.6 176.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 25.5 m -120.25 122.37 40.74 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 171.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -119.72 133.89 55.44 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 123.187 0.595 . . . . 0.0 111.834 -178.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 19.0 p90 -149.1 174.45 12.32 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 178.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 55.5 mt -116.46 133.13 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.212 -0.93 . . . . 0.0 108.988 176.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -112.13 90.19 3.27 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 123.773 0.829 . . . . 0.0 109.092 163.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 64.49 -104.66 0.95 Allowed Glycine 0 N--CA 1.492 2.4 0 N-CA-C 115.754 1.062 . . . . 0.0 115.754 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 57.3 p30 -84.13 -2.02 56.04 Favored 'General case' 0 CA--C 1.571 1.775 0 N-CA-C 117.86 2.541 . . . . 0.0 117.86 166.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -118.47 135.9 54.11 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-N 120.657 1.572 . . . . 0.0 112.424 -168.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 12.4 tp -94.38 120.91 35.33 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 123.73 0.812 . . . . 0.0 108.969 174.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 37.3 m80 -109.99 120.1 41.4 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -176.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 42.3 tp -121.51 121.53 37.69 Favored 'General case' 0 CA--C 1.56 1.35 0 C-N-CA 123.576 0.75 . . . . 0.0 109.543 -176.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -107.97 117.89 35.32 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.878 -0.513 . . . . 0.0 109.679 168.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 66.9 mtm -110.46 127.41 55.12 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-N 118.61 0.641 . . . . 0.0 111.1 -178.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 69.1 mtp180 -110.88 144.66 39.56 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -179.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -159.36 131.18 6.36 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.187 0.595 . . . . 0.0 111.153 166.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 59.0 38.07 24.32 Favored 'General case' 0 N--CA 1.507 2.402 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 -173.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 75.75 -26.21 1.4 Allowed Glycine 0 CA--C 1.559 2.827 0 N-CA-C 119.597 2.599 . . . . 0.0 119.597 -160.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 86.8 t -81.02 122.79 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 CA-C-N 119.392 1.596 . . . . 0.0 110.571 -163.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 24.1 m -100.9 120.95 40.9 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 122.909 0.484 . . . . 0.0 111.489 -176.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 44.1 t -88.34 139.45 30.48 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.306 0.643 . . . . 0.0 112.242 160.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 44.8 mtpt -109.51 126.2 53.28 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 168.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -123.03 126.14 46.55 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 123.742 0.817 . . . . 0.0 109.543 174.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 72.8 t -109.1 132.57 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 179.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -122.18 153.07 39.27 Favored 'General case' 0 CA--C 1.565 1.558 0 C-N-CA 124.541 1.136 . . . . 0.0 111.442 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 8.9 tmtt? -120.87 136.88 54.82 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.199 -0.938 . . . . 0.0 111.607 175.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -72.5 120.49 18.19 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 33.4 m -101.49 -43.75 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 N-CA-C 113.194 0.812 . . . . 0.0 113.194 174.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 53.7 t-80 . . . . . 0 N--CA 1.485 1.317 0 CA-C-N 119.75 1.159 . . . . 0.0 108.124 168.472 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo . . . . . 0 CA--C 1.566 2.114 0 N-CA-C 115.356 1.252 . . . . 0.0 115.356 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 25.9 m -81.2 140.04 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.468 -0.77 . . . . 0.0 112.56 177.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.422 ' HD2' ' N ' ' A' ' 3' ' ' ASP . 1.0 OUTLIER -82.5 100.51 10.13 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.514 -1.366 . . . . 0.0 111.459 175.355 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -72.72 -2.24 19.5 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 118.307 2.706 . . . . 0.0 118.307 177.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -56.29 112.27 1.19 Allowed 'General case' 0 CA--C 1.567 1.601 0 N-CA-C 115.945 1.831 . . . . 0.0 115.945 -172.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 155.46 -161.89 30.78 Favored Glycine 0 N--CA 1.486 1.996 0 N-CA-C 115.7 1.04 . . . . 0.0 115.7 178.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -124.13 127.83 48.37 Favored 'General case' 0 CA--C 1.564 1.498 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 -179.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 61.4 m95 -129.0 125.26 37.0 Favored 'General case' 0 CA--C 1.566 1.567 0 C-N-CA 123.273 0.629 . . . . 0.0 109.489 -166.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 24.8 pttm -96.17 141.19 29.83 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.089 -1.007 . . . . 0.0 112.903 177.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.445 ' SD ' ' HD2' ' A' ' 38' ' ' PRO . 32.8 ttm -68.89 125.89 28.04 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-N 120.044 1.293 . . . . 0.0 113.264 176.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 91.9 mt -85.87 -53.97 4.79 Favored 'General case' 0 CA--C 1.565 1.552 0 C-N-CA 123.387 0.675 . . . . 0.0 112.798 166.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 92.7 p -142.88 150.53 39.96 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 119.243 0.929 . . . . 0.0 112.838 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 24.1 p30 -125.92 84.65 2.3 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-O 122.235 1.017 . . . . 0.0 110.665 178.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -93.8 119.07 32.27 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.825 -1.172 . . . . 0.0 110.656 -163.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.281 32.1 t30 62.96 24.45 14.56 Favored 'General case' 0 N--CA 1.503 2.186 0 N-CA-C 116.617 2.08 . . . . 0.0 116.617 -169.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -69.27 -44.68 71.39 Favored 'General case' 0 CA--C 1.567 1.619 0 N-CA-C 115.223 1.564 . . . . 0.0 115.223 178.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -55.99 -39.91 72.53 Favored 'General case' 0 N--CA 1.504 2.257 0 N-CA-C 117.412 2.375 . . . . 0.0 117.412 169.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -65.38 -43.05 91.93 Favored 'General case' 0 CA--C 1.573 1.854 0 CA-C-N 120.252 1.387 . . . . 0.0 114.639 169.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -57.35 -47.83 80.59 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 115.31 1.596 . . . . 0.0 115.31 166.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 90.0 mt -58.25 -43.55 87.92 Favored 'General case' 0 CA--C 1.57 1.744 0 N-CA-C 114.633 1.346 . . . . 0.0 114.633 169.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.25 -49.2 72.63 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 115.639 1.718 . . . . 0.0 115.639 166.475 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.49 -21.25 9.51 Favored 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 118.507 2.78 . . . . 0.0 118.507 163.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 95.9 mt -91.9 15.87 12.19 Favored 'General case' 0 CA--C 1.576 1.959 0 N-CA-C 114.867 1.432 . . . . 0.0 114.867 166.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.536 ' N ' ' HD2' ' A' ' 24' ' ' ASP . 2.3 m-20 60.41 42.72 14.22 Favored 'General case' 0 N--CA 1.502 2.138 0 N-CA-C 116.149 1.907 . . . . 0.0 116.149 -175.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 91.3 t -93.62 140.05 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.091 -1.006 . . . . 0.0 110.179 -179.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 15.1 p30 -65.37 155.59 34.87 Favored 'General case' 0 CA--C 1.572 1.803 0 N-CA-C 115.188 1.551 . . . . 0.0 115.188 171.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 61.6 t -57.78 -41.32 79.38 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.251 0 N-CA-C 114.668 1.358 . . . . 0.0 114.668 179.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.72 -50.73 72.24 Favored 'General case' 0 CA--C 1.565 1.534 0 N-CA-C 116.163 1.912 . . . . 0.0 116.163 172.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 6.1 tt -67.2 -39.08 86.28 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-N 120.637 1.562 . . . . 0.0 115.13 170.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 53.3 mtp180 -49.17 -42.42 39.74 Favored 'General case' 0 N--CA 1.502 2.128 0 N-CA-C 116.551 2.056 . . . . 0.0 116.551 163.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -72.77 -52.15 16.2 Favored 'General case' 0 CA--C 1.567 1.623 0 CA-C-O 118.284 -0.865 . . . . 0.0 113.324 167.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 5.6 mt -80.74 58.16 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.587 2.397 0 CA-C-N 121.107 1.776 . . . . 0.0 111.761 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -172.79 -51.95 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 126.187 1.795 . . . . 0.0 110.415 -178.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -66.53 -36.52 82.88 Favored 'General case' 0 CA--C 1.568 1.655 0 N-CA-C 116.0 1.852 . . . . 0.0 116.0 164.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 91.9 mt -74.53 -30.49 61.79 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 176.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.6 pp -84.27 149.63 25.96 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 119.408 1.004 . . . . 0.0 111.971 167.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp -104.67 94.74 7.68 Favored Pre-proline 0 CA--C 1.57 1.749 0 CA-C-O 118.091 -0.957 . . . . 0.0 108.492 174.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.445 ' HD2' ' SD ' ' A' ' 10' ' ' MET . 88.9 Cg_endo -75.27 172.71 15.82 Favored 'Trans proline' 0 CA--C 1.562 1.911 0 C-N-CA 122.642 2.228 . . . . 0.0 114.694 -175.263 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -123.95 130.56 52.79 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.663 -171.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 57.2 mttm -98.46 112.67 24.61 Favored 'General case' 0 N--CA 1.485 1.315 0 O-C-N 121.441 -0.787 . . . . 0.0 109.808 177.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -97.09 110.06 22.68 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 166.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 64.8 mt -105.7 116.66 49.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -174.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 63.2 t -99.25 98.75 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 169.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -100.63 115.71 30.84 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 123.725 0.81 . . . . 0.0 110.848 -178.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -125.6 72.95 1.29 Allowed 'General case' 0 CA--C 1.568 1.659 0 O-C-N 121.647 -0.658 . . . . 0.0 111.186 176.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 70.92 -93.52 0.49 Allowed Glycine 0 N--CA 1.49 2.24 0 O-C-N 121.468 -0.77 . . . . 0.0 114.879 178.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -88.2 -38.57 15.18 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 115.307 1.595 . . . . 0.0 115.307 164.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 20.8 t-160 -80.62 110.27 15.95 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 121.218 1.826 . . . . 0.0 111.717 -176.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 45.6 ttm -126.29 121.82 33.73 Favored 'General case' 0 CA--C 1.556 1.2 0 C-N-CA 123.448 0.699 . . . . 0.0 109.733 -172.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 4.6 mp -112.04 97.06 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 -179.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 73.3 mt -89.77 101.59 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 176.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -91.58 98.03 11.41 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.597 -0.689 . . . . 0.0 109.78 -179.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 18.9 m -87.38 104.76 16.74 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 178.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 18.0 mt -103.22 116.66 32.88 Favored 'General case' 0 CA--C 1.557 1.241 0 CA-C-N 115.417 -0.811 . . . . 0.0 109.991 -162.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 31.3 t -128.91 143.64 50.95 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 123.929 0.892 . . . . 0.0 110.535 -177.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.4 m -77.64 49.22 0.73 Allowed 'General case' 0 CA--C 1.586 2.353 0 O-C-N 121.256 -0.902 . . . . 0.0 113.159 171.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -172.53 -66.43 0.02 OUTLIER 'General case' 0 CA--C 1.566 1.587 0 C-N-CA 125.762 1.625 . . . . 0.0 109.082 -179.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -134.34 101.64 5.07 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-N 119.306 0.957 . . . . 0.0 110.299 -174.04 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 -83.15 139.72 33.01 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.515 -0.74 . . . . 0.0 112.6 -178.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -128.56 100.69 5.85 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.41 0.624 . . . . 0.0 109.726 -178.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.6 mt -100.23 112.8 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 -179.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 24.6 mmm -96.05 91.56 6.02 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 175.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -96.55 101.97 13.67 Favored 'General case' 0 CA--C 1.561 1.389 0 C-N-CA 123.977 0.911 . . . . 0.0 111.793 178.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -145.73 151.98 38.86 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 -166.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 23.6 mp0 -93.31 122.44 35.72 Favored 'General case' 0 CA--C 1.566 1.585 0 O-C-N 121.672 -0.643 . . . . 0.0 110.043 166.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 49.0 t -63.57 126.77 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 C-N-CA 123.912 0.885 . . . . 0.0 110.834 177.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 102.28 -38.2 3.31 Favored Glycine 0 CA--C 1.552 2.344 0 N-CA-C 116.752 1.461 . . . . 0.0 116.752 -162.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 11.2 mmpt? -88.34 134.34 33.84 Favored 'General case' 0 CA--C 1.564 1.503 0 CA-C-N 118.981 1.39 . . . . 0.0 112.254 -175.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -88.47 119.87 29.32 Favored 'General case' 0 CA--C 1.566 1.577 0 O-C-N 121.706 -0.622 . . . . 0.0 112.391 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 33.0 p90 -120.07 157.74 28.31 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 113.753 1.019 . . . . 0.0 113.753 -172.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.39 132.17 36.32 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.726 -1.234 . . . . 0.0 113.786 177.448 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 . . . . . 0 N--CA 1.496 1.849 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 168.145 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 95.8 m . . . . . 0 CA--C 1.563 1.461 0 CA-C-O 122.14 0.972 . . . . 0.0 112.238 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -88.09 101.99 14.34 Favored 'General case' 0 CA--C 1.56 1.332 0 C-N-CA 124.486 1.115 . . . . 0.0 110.046 -178.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 87.8 m -97.07 108.78 21.58 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.549 -0.719 . . . . 0.0 111.516 -170.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 53.8 m -91.82 131.62 37.03 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 164.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.4 t -116.76 136.33 54.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 171.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 68.2 m -150.17 148.57 29.1 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.141 -1.599 . . . . 0.0 113.029 -175.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 75.3 m95 -81.23 130.95 35.25 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.906 -1.121 . . . . 0.0 112.99 178.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -137.47 79.38 1.74 Allowed 'General case' 0 CA--C 1.569 1.688 0 C-N-CA 123.425 0.69 . . . . 0.0 110.344 178.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 64.23 76.97 0.25 Allowed Glycine 0 N--CA 1.497 2.71 0 N-CA-C 117.317 1.687 . . . . 0.0 117.317 170.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . 0.265 6.9 m-20 63.57 2.14 1.18 Allowed 'General case' 0 N--CA 1.505 2.286 0 N-CA-C 117.855 2.539 . . . . 0.0 117.855 -167.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 72.5 mttt -134.2 135.63 43.15 Favored 'General case' 0 N--CA 1.485 1.278 0 O-C-N 121.113 -0.992 . . . . 0.0 109.807 -168.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 22.0 tp -95.37 108.78 20.99 Favored 'General case' 0 CA--C 1.56 1.357 0 O-C-N 121.428 -0.795 . . . . 0.0 109.958 178.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 21.0 mm100 -86.46 141.05 29.39 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.371 0.669 . . . . 0.0 111.639 176.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 41.0 t -133.71 135.76 44.23 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.381 0.672 . . . . 0.0 111.329 175.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.7 p -127.99 116.92 44.47 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.647 0 C-N-CA 123.145 0.578 . . . . 0.0 109.576 174.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -93.36 100.46 12.78 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 124.118 0.967 . . . . 0.0 109.93 176.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -91.92 121.11 33.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.437 -0.789 . . . . 0.0 111.72 -169.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 167.81 -105.44 0.23 Allowed Glycine 0 N--CA 1.486 1.979 0 O-C-N 121.319 -0.863 . . . . 0.0 113.995 172.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -85.79 -46.98 10.16 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 115.091 1.515 . . . . 0.0 115.091 -172.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 48.9 mmtm -78.62 134.04 37.22 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 119.688 1.131 . . . . 0.0 112.433 179.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -88.5 109.33 19.96 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.017 -168.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 76.95 41.12 23.66 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 117.47 1.748 . . . . 0.0 117.47 -167.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 53.8 ttt180 -86.2 117.25 24.9 Favored 'General case' 0 CA--C 1.563 1.47 0 CA-C-N 118.316 1.058 . . . . 0.0 110.704 177.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -172.5 -178.45 42.64 Favored Glycine 0 N--CA 1.484 1.872 0 CA-C-O 122.071 0.817 . . . . 0.0 115.093 -176.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 28.3 p-90 -154.94 158.55 39.43 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 172.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 55.6 m -123.75 120.36 32.46 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 170.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -114.13 132.44 56.07 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 123.196 0.598 . . . . 0.0 111.922 179.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 16.4 p90 -148.4 173.07 13.46 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.215 -0.928 . . . . 0.0 113.088 177.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 73.9 mt -114.24 133.66 59.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.226 -0.921 . . . . 0.0 110.052 174.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -111.65 88.98 2.93 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 123.729 0.812 . . . . 0.0 108.895 162.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 65.35 -104.99 1.08 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 115.832 1.093 . . . . 0.0 115.832 -178.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -85.88 -8.34 58.11 Favored 'General case' 0 CA--C 1.571 1.788 0 N-CA-C 117.591 2.441 . . . . 0.0 117.591 168.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 86.9 mt-10 -105.08 135.46 46.39 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 120.316 1.416 . . . . 0.0 112.316 -175.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 15.5 tp -91.79 121.94 33.88 Favored 'General case' 0 CA--C 1.563 1.45 0 C-N-CA 123.861 0.864 . . . . 0.0 109.38 167.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 47.4 m80 -109.52 120.89 43.89 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -179.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 48.3 tp -120.5 116.57 25.67 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.444 0.698 . . . . 0.0 109.677 179.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -98.19 127.9 44.38 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.764 -0.585 . . . . 0.0 109.898 167.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 69.1 mtm -122.85 129.82 52.12 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-N 118.355 0.525 . . . . 0.0 111.241 -175.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 71.9 mtm-85 -117.9 139.32 51.3 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 123.588 0.755 . . . . 0.0 111.233 -174.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -161.75 131.65 4.77 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.68 -0.637 . . . . 0.0 111.279 170.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 55.7 39.09 30.83 Favored 'General case' 0 N--CA 1.507 2.397 0 N-CA-C 115.444 1.646 . . . . 0.0 115.444 -175.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 72.84 -11.76 4.29 Favored Glycine 0 CA--C 1.557 2.682 0 N-CA-C 120.302 2.881 . . . . 0.0 120.302 -163.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 88.1 t -89.28 123.54 41.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 CA-C-N 120.291 2.045 . . . . 0.0 109.608 -171.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 34.7 m -102.77 123.99 47.47 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.302 0.572 . . . . 0.0 111.169 177.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 21.1 t -100.92 146.64 27.11 Favored 'General case' 0 CA--C 1.563 1.462 0 C-N-CA 123.921 0.888 . . . . 0.0 112.079 165.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 7.6 mtpm? -118.49 110.66 17.67 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.669 -0.644 . . . . 0.0 109.541 174.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -103.48 130.09 50.77 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.502 -0.749 . . . . 0.0 110.817 174.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 44.2 t -113.86 129.91 68.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 176.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -123.67 150.86 43.73 Favored 'General case' 0 CA--C 1.567 1.62 0 C-N-CA 124.729 1.211 . . . . 0.0 110.071 179.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.7 tmtt? -122.47 140.95 52.15 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.556 -1.34 . . . . 0.0 111.484 177.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 66.0 tttt -71.08 117.75 12.99 Favored 'General case' 0 CA--C 1.565 1.556 0 N-CA-C 113.523 0.934 . . . . 0.0 113.523 -177.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 5.5 m -82.59 -34.57 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.273 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 168.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 44.6 t-80 . . . . . 0 N--CA 1.484 1.255 0 C-N-CA 125.04 1.336 . . . . 0.0 113.305 175.505 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo . . . . . 0 CA--C 1.56 1.82 0 N-CA-C 114.98 1.108 . . . . 0.0 114.98 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 1.8 t -79.05 146.04 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 CA-C-O 121.701 0.763 . . . . 0.0 110.906 -174.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -72.04 97.03 1.82 Allowed 'General case' 0 CA--C 1.568 1.651 0 O-C-N 120.79 -1.194 . . . . 0.0 111.618 173.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 4.5 m-30 -77.92 3.74 13.8 Favored 'General case' 0 CA--C 1.581 2.151 0 N-CA-C 116.471 2.026 . . . . 0.0 116.471 179.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -60.4 111.02 1.41 Allowed 'General case' 0 CA--C 1.564 1.488 0 C-N-CA 125.339 1.456 . . . . 0.0 114.688 -178.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 165.2 177.21 37.48 Favored Glycine 0 N--CA 1.484 1.887 0 N-CA-C 116.319 1.287 . . . . 0.0 116.319 -179.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -108.11 122.35 46.71 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 114.35 -0.925 . . . . 0.0 108.781 173.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 83.7 m95 -120.77 120.18 34.89 Favored 'General case' 0 CA--C 1.562 1.412 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -167.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 62.1 pttt -88.92 136.5 32.98 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.348 -0.845 . . . . 0.0 112.588 176.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 56.3 ttm -77.19 123.47 26.47 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 121.914 0.864 . . . . 0.0 112.139 179.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 84.0 mt -90.97 -60.16 1.98 Allowed 'General case' 0 CA--C 1.565 1.527 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.757 175.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 67.4 p -130.0 119.29 22.93 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.721 -0.612 . . . . 0.0 110.746 176.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -98.01 93.39 6.28 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 123.252 0.621 . . . . 0.0 109.794 165.227 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -97.12 125.26 41.49 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.66 0.784 . . . . 0.0 110.462 -169.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.269 49.2 t30 64.97 15.59 10.06 Favored 'General case' 0 N--CA 1.504 2.272 0 N-CA-C 117.061 2.245 . . . . 0.0 117.061 -172.142 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -61.01 -41.21 96.11 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 116.234 1.939 . . . . 0.0 116.234 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.543 ' HE2' ' NZ ' ' A' ' 31' ' ' LYS . 2.9 mp0 -51.52 -44.78 62.7 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 115.602 1.704 . . . . 0.0 115.602 166.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -68.81 -41.35 78.77 Favored 'General case' 0 CA--C 1.573 1.836 0 N-CA-C 115.228 1.566 . . . . 0.0 115.228 174.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 48.7 t80 -55.27 -49.26 72.52 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 114.47 1.285 . . . . 0.0 114.47 165.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 97.5 mt -61.0 -40.64 94.31 Favored 'General case' 0 CA--C 1.575 1.922 0 N-CA-C 115.001 1.482 . . . . 0.0 115.001 170.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 49.5 ttp180 -53.86 -49.94 67.37 Favored 'General case' 0 N--CA 1.501 2.11 0 N-CA-C 115.647 1.721 . . . . 0.0 115.647 165.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.67 -15.97 9.32 Favored 'General case' 0 CA--C 1.57 1.742 0 N-CA-C 118.409 2.744 . . . . 0.0 118.409 165.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 99.3 mt -98.56 23.48 8.55 Favored 'General case' 0 CA--C 1.575 1.926 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 163.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 69.39 15.16 8.44 Favored 'General case' 0 N--CA 1.507 2.382 0 N-CA-C 117.482 2.401 . . . . 0.0 117.482 -179.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 67.5 t -87.81 141.88 13.71 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.863 0 O-C-N 120.061 -1.65 . . . . 0.0 110.414 -170.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -73.46 155.02 39.69 Favored 'General case' 0 CA--C 1.569 1.687 0 N-CA-C 115.714 1.746 . . . . 0.0 115.714 -177.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 74.6 t -50.88 -45.83 28.79 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.502 0 N-CA-C 115.715 1.746 . . . . 0.0 115.715 -178.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.03 -49.41 77.75 Favored 'General case' 0 CA--C 1.564 1.5 0 N-CA-C 115.434 1.642 . . . . 0.0 115.434 173.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.8 tt -64.49 -44.58 90.5 Favored 'General case' 0 CA--C 1.572 1.794 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 171.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 74.9 mtp180 -45.15 -54.45 6.83 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 115.911 1.819 . . . . 0.0 115.911 164.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.543 ' NZ ' ' HE2' ' A' ' 17' ' ' GLU . 73.0 mmtt -71.84 -37.96 70.21 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 115.461 1.652 . . . . 0.0 115.461 174.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . 0.25 69.2 mt -62.51 -50.2 80.77 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 CA-C-N 121.116 1.78 . . . . 0.0 112.171 173.19 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -56.93 -42.24 79.65 Favored 'General case' 0 CA--C 1.568 1.67 0 N-CA-C 117.772 2.508 . . . . 0.0 117.772 170.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -53.85 -46.09 71.14 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 117.01 2.226 . . . . 0.0 117.01 163.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 92.6 mt -80.56 -18.29 48.81 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 116.025 1.861 . . . . 0.0 116.025 179.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 18.5 mt -73.46 -37.44 65.8 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 115.789 1.774 . . . . 0.0 115.789 173.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 65.5 mmtt 64.76 65.54 1.01 Allowed Pre-proline 0 CA--C 1.577 1.99 0 C-N-CA 124.546 1.139 . . . . 0.0 112.122 -178.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -71.45 135.0 25.59 Favored 'Trans proline' 0 CA--C 1.562 1.913 0 CA-C-N 122.486 1.924 . . . . 0.0 114.765 -165.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.489 ' N ' ' HD2' ' A' ' 39' ' ' ASP . 1.2 m-20 -86.67 130.53 34.45 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.832 -0.543 . . . . 0.0 111.897 -175.364 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 47.9 mttp -93.26 112.72 24.73 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.191 -0.943 . . . . 0.0 110.181 -179.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -94.59 109.44 21.36 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.388 -0.82 . . . . 0.0 109.034 164.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 97.6 mt -102.49 116.35 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 -175.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 54.0 t -98.16 95.95 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 168.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -93.86 108.5 20.28 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 123.876 0.87 . . . . 0.0 110.558 -179.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -113.94 69.31 0.7 Allowed 'General case' 0 CA--C 1.569 1.689 0 O-C-N 121.637 -0.664 . . . . 0.0 111.061 175.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 70.09 -85.39 0.31 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 115.798 1.079 . . . . 0.0 115.798 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -94.65 -40.04 10.02 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 114.903 1.446 . . . . 0.0 114.903 163.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 20.7 t-160 -79.08 107.19 11.66 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 121.216 1.825 . . . . 0.0 111.243 -175.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 41.1 ttm -118.24 120.5 37.85 Favored 'General case' 0 CA--C 1.553 1.064 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -173.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 5.0 mp -106.13 100.49 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 16.4 mm -87.07 101.3 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 176.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -94.71 97.93 10.42 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 18.3 m -91.94 100.39 13.06 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 -176.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 19.9 mt -99.8 132.85 44.89 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-O 121.812 0.815 . . . . 0.0 112.189 -156.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 28.3 t -151.6 145.72 25.31 Favored 'General case' 0 CA--C 1.562 1.425 0 C-N-CA 123.452 0.701 . . . . 0.0 110.97 -176.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.6 t -77.48 54.12 1.13 Allowed 'General case' 0 N--CA 1.505 2.291 0 O-C-N 120.639 -1.288 . . . . 0.0 114.077 165.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -173.2 -67.04 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 124.983 1.313 . . . . 0.0 109.169 -168.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.06 103.83 4.37 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.379 -0.826 . . . . 0.0 110.014 -179.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -88.48 119.54 29.02 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.738 -0.601 . . . . 0.0 110.357 178.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 51.8 m-85 -107.59 110.11 21.91 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 121.336 0.589 . . . . 0.0 110.573 -175.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 25.0 mm -105.95 104.48 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 N-CA-C 108.11 -1.071 . . . . 0.0 108.11 -174.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 11.4 mmm -99.11 90.71 4.69 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.523 -0.735 . . . . 0.0 109.27 175.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -93.35 111.55 23.24 Favored 'General case' 0 CA--C 1.561 1.386 0 C-N-CA 123.429 0.692 . . . . 0.0 111.385 175.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 11.9 p90 -147.13 148.31 31.45 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.831 0.824 . . . . 0.0 112.849 -170.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 23.8 mp0 -87.6 117.15 26.21 Favored 'General case' 0 CA--C 1.561 1.368 0 O-C-N 121.621 -0.674 . . . . 0.0 109.999 168.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 44.0 t -66.99 113.04 2.7 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.794 0 C-N-CA 124.159 0.984 . . . . 0.0 109.609 175.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 123.22 -48.68 0.94 Allowed Glycine 0 CA--C 1.549 2.213 0 N-CA-C 115.14 0.816 . . . . 0.0 115.14 -156.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 58.4 mttm -86.59 151.77 23.17 Favored 'General case' 0 CA--C 1.568 1.66 0 CA-C-N 118.493 1.146 . . . . 0.0 113.476 -175.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -96.8 107.22 19.66 Favored 'General case' 0 CA--C 1.568 1.643 0 C-N-CA 123.275 0.63 . . . . 0.0 110.425 173.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 15.6 p90 -106.92 142.32 36.73 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 113.639 0.978 . . . . 0.0 113.639 -171.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -76.9 110.55 11.61 Favored 'General case' 0 CA--C 1.568 1.669 0 N-CA-C 114.411 1.263 . . . . 0.0 114.411 179.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 . . . . . 0 N--CA 1.497 1.888 0 O-C-N 120.96 -1.087 . . . . 0.0 113.262 173.365 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 72.6 m . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 121.055 0.455 . . . . 0.0 110.05 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 82.5 mmm -79.48 95.75 5.89 Favored 'General case' 0 CA--C 1.563 1.454 0 CA-C-O 121.98 0.895 . . . . 0.0 109.338 170.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 37.8 m -102.65 117.11 33.95 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.114 0.566 . . . . 0.0 110.698 -160.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 92.3 m -95.16 122.43 37.83 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 173.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 22.1 t -109.97 135.79 47.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 170.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 58.0 m -148.55 147.27 28.85 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.265 -1.522 . . . . 0.0 112.481 -176.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 59.9 m95 -79.41 109.06 13.41 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.255 -0.903 . . . . 0.0 111.095 174.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -86.73 76.21 9.53 Favored 'General case' 0 CA--C 1.566 1.572 0 C-N-CA 123.813 0.845 . . . . 0.0 110.429 172.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 64.72 -99.53 0.36 Allowed Glycine 0 N--CA 1.489 2.199 0 N-CA-C 114.433 0.533 . . . . 0.0 114.433 -169.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -84.4 -32.85 23.92 Favored 'General case' 0 CA--C 1.574 1.88 0 N-CA-C 115.705 1.743 . . . . 0.0 115.705 170.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 48.9 mtpt -94.1 150.14 20.6 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 124.125 0.97 . . . . 0.0 112.011 -168.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 24.0 tp -98.46 109.7 22.41 Favored 'General case' 0 CA--C 1.563 1.464 0 O-C-N 120.329 -1.482 . . . . 0.0 110.345 177.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 31.8 mm-40 -96.65 146.4 24.89 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 123.383 0.673 . . . . 0.0 111.909 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 42.6 t -138.74 131.27 28.87 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.316 0.646 . . . . 0.0 111.527 176.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.9 p -113.81 122.01 67.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 166.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -101.95 75.02 1.5 Allowed 'General case' 0 CA--C 1.567 1.609 0 C-N-CA 123.461 0.704 . . . . 0.0 110.299 -178.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -91.17 129.68 37.14 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.011 -1.056 . . . . 0.0 113.427 -170.164 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 164.81 -94.1 0.11 Allowed Glycine 0 N--CA 1.487 2.084 0 O-C-N 121.335 -0.853 . . . . 0.0 112.477 177.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -72.2 -46.67 55.28 Favored 'General case' 0 CA--C 1.572 1.815 0 N-CA-C 115.614 1.709 . . . . 0.0 115.614 178.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -101.26 143.31 31.49 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 119.362 0.983 . . . . 0.0 112.945 -175.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -76.5 155.9 33.41 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.774 -0.579 . . . . 0.0 112.241 165.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 61.95 12.6 36.83 Favored Glycine 0 N--CA 1.497 2.757 0 N-CA-C 120.488 2.955 . . . . 0.0 120.488 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 36.8 ttt180 -88.16 129.11 35.42 Favored 'General case' 0 CA--C 1.564 1.511 0 CA-C-N 119.082 1.441 . . . . 0.0 112.591 -172.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 178.32 -173.27 45.73 Favored Glycine 0 N--CA 1.486 1.972 0 CA-C-O 121.707 0.615 . . . . 0.0 114.052 -175.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . 0.277 44.2 p-90 -159.43 156.8 29.0 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 171.469 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 58.9 m -129.56 119.13 23.15 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 176.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 16.2 tt0 -122.98 131.58 53.78 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 123.277 0.631 . . . . 0.0 112.202 -174.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 21.8 p90 -148.71 169.12 21.12 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.379 -0.826 . . . . 0.0 112.302 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 96.4 mt -115.53 145.26 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.22 0 CA-C-O 122.998 1.38 . . . . 0.0 111.062 177.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -136.65 90.58 2.56 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 71.42 -111.8 3.84 Favored Glycine 0 N--CA 1.49 2.269 0 O-C-N 121.983 -0.448 . . . . 0.0 114.158 -174.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 16.5 p-10 -94.66 15.36 18.38 Favored 'General case' 0 CA--C 1.576 1.975 0 N-CA-C 116.585 2.069 . . . . 0.0 116.585 167.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -120.65 136.54 54.81 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-N 120.177 1.353 . . . . 0.0 111.946 -171.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 8.6 tp -97.34 123.09 41.04 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 171.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 36.4 m80 -111.65 121.58 45.49 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 -176.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 50.7 tp -128.48 120.78 27.48 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.618 0.767 . . . . 0.0 109.963 -172.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -105.55 113.83 27.64 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.511 -0.743 . . . . 0.0 109.038 170.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' MET . . . . . 0.425 ' HB2' ' SG ' ' A' ' 126' ' ' CYS . 63.1 mtm -106.85 131.9 53.42 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-N 118.891 0.769 . . . . 0.0 111.438 -178.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? -114.76 140.88 48.54 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.784 0.834 . . . . 0.0 111.445 -171.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -156.07 129.37 8.18 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 123.207 0.603 . . . . 0.0 111.111 170.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . 0.265 8.7 mm-40 64.8 -0.32 1.02 Allowed 'General case' 0 N--CA 1.504 2.254 0 N-CA-C 118.135 2.643 . . . . 0.0 118.135 -176.252 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 109.69 -24.4 19.74 Favored Glycine 0 CA--C 1.554 2.531 0 N-CA-C 117.096 1.598 . . . . 0.0 117.096 -156.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 93.6 t -78.1 127.71 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 CA-C-N 119.857 1.829 . . . . 0.0 110.115 177.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 45.6 m -106.86 124.67 49.96 Favored 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 123.032 0.533 . . . . 0.0 110.118 173.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . 0.425 ' SG ' ' HB2' ' A' ' 119' ' ' MET . 19.3 p -107.14 142.08 37.38 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-O 121.701 0.762 . . . . 0.0 112.424 168.047 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 60.1 mttp -114.76 111.14 20.8 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.666 -0.646 . . . . 0.0 109.36 -168.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 82.9 mt-30 -105.35 123.84 48.54 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 123.403 0.681 . . . . 0.0 111.178 178.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 79.1 t -111.27 131.47 62.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 176.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -121.67 164.04 18.0 Favored 'General case' 0 CA--C 1.567 1.608 0 CA-C-N 115.113 -0.949 . . . . 0.0 111.474 -178.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 29.3 ttmt -130.57 142.82 50.46 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.065 -1.022 . . . . 0.0 111.984 165.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 59.8 tttt -76.31 120.15 21.17 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.49 -0.756 . . . . 0.0 112.882 -176.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 32.8 m -97.21 -43.41 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.112 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 174.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 72.0 t60 . . . . . 0 N--CA 1.485 1.302 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 169.235 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo . . . . . 0 CA--C 1.561 1.868 0 N-CA-C 115.375 1.26 . . . . 0.0 115.375 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 31.6 m -80.08 156.48 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 CA-C-O 121.934 0.873 . . . . 0.0 112.761 176.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -77.74 113.17 15.33 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.124 -0.985 . . . . 0.0 112.759 176.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -90.28 7.95 35.73 Favored 'General case' 0 CA--C 1.576 1.966 0 N-CA-C 115.389 1.626 . . . . 0.0 115.389 173.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 62.6 m-80 -67.02 110.19 3.28 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 120.262 1.392 . . . . 0.0 113.077 -176.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 169.63 173.81 37.45 Favored Glycine 0 N--CA 1.478 1.441 0 N-CA-C 116.638 1.415 . . . . 0.0 116.638 -177.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 19.5 t80 -104.19 124.53 49.29 Favored 'General case' 0 CA--C 1.563 1.48 0 CA-C-N 113.675 -1.262 . . . . 0.0 108.516 168.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 82.4 m95 -120.82 122.71 40.89 Favored 'General case' 0 CA--C 1.561 1.394 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -169.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -96.08 135.51 37.76 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.579 -0.701 . . . . 0.0 111.449 178.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 53.6 ttm -71.93 124.34 24.67 Favored 'General case' 0 CA--C 1.565 1.524 0 CA-C-O 122.079 0.942 . . . . 0.0 113.058 -178.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 97.5 mt -81.99 -50.14 9.47 Favored 'General case' 0 CA--C 1.567 1.615 0 CA-C-N 115.191 -0.913 . . . . 0.0 112.292 168.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 89.7 p -149.92 126.79 11.1 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 118.727 0.694 . . . . 0.0 111.751 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -99.69 108.77 21.2 Favored 'General case' 0 N--CA 1.494 1.767 0 C-N-CA 122.944 0.497 . . . . 0.0 110.889 162.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -112.26 125.57 54.31 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.503 -0.748 . . . . 0.0 109.803 -172.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.258 5.3 t30 63.53 27.84 15.13 Favored 'General case' 0 N--CA 1.507 2.414 0 N-CA-C 116.325 1.972 . . . . 0.0 116.325 -174.146 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -70.39 -44.97 66.92 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 114.436 1.273 . . . . 0.0 114.436 174.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.68 ' HE2' ' NZ ' ' A' ' 31' ' ' LYS . 30.0 mt-10 -53.43 -51.96 60.96 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 116.813 2.153 . . . . 0.0 116.813 174.269 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.266 1.5 pm0 -76.89 -25.89 53.56 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 116.394 1.998 . . . . 0.0 116.394 178.328 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 38.6 t80 -54.84 -49.56 70.79 Favored 'General case' 0 N--CA 1.498 1.967 0 CA-C-N 120.797 1.635 . . . . 0.0 114.481 154.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 68.8 mt -61.98 -35.35 78.24 Favored 'General case' 0 CA--C 1.576 1.965 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 170.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 8.7 ttm180 -56.99 -48.1 79.26 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-N 120.415 1.462 . . . . 0.0 114.645 162.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.74 -13.53 24.14 Favored 'General case' 0 CA--C 1.569 1.703 0 N-CA-C 118.414 2.746 . . . . 0.0 118.414 168.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 48.0 mt -90.15 -1.38 57.94 Favored 'General case' 0 CA--C 1.573 1.845 0 N-CA-C 116.071 1.878 . . . . 0.0 116.071 162.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.277 51.6 m-20 63.02 46.54 4.69 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 115.411 1.634 . . . . 0.0 115.411 -166.48 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 98.7 t -95.26 135.23 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 174.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 5.5 p-10 -64.3 152.08 42.05 Favored 'General case' 0 CA--C 1.566 1.592 0 N-CA-C 115.192 1.552 . . . . 0.0 115.192 178.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.438 HG23 HH11 ' A' ' 30' ' ' ARG 0.262 38.5 t -58.84 -35.47 56.27 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.224 0 N-CA-C 115.719 1.748 . . . . 0.0 115.719 -172.257 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.8 -50.93 69.16 Favored 'General case' 0 CA--C 1.567 1.62 0 N-CA-C 115.969 1.841 . . . . 0.0 115.969 166.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -71.45 -28.41 63.95 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 116.697 2.11 . . . . 0.0 116.697 171.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.438 HH11 HG23 ' A' ' 27' ' ' VAL . 54.2 mtp180 -55.83 -53.53 55.62 Favored 'General case' 0 N--CA 1.498 1.959 0 CA-C-N 120.824 1.647 . . . . 0.0 114.135 162.229 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.68 ' NZ ' ' HE2' ' A' ' 17' ' ' GLU . 48.1 mmtm -64.39 -49.99 69.43 Favored 'General case' 0 CA--C 1.566 1.596 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 170.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 11.9 mt -77.38 62.12 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.323 0 CA-C-O 123.493 1.615 . . . . 0.0 110.974 175.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -176.03 -53.59 0.01 OUTLIER 'General case' 0 CA--C 1.558 1.28 0 C-N-CA 126.752 2.021 . . . . 0.0 110.044 -177.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -71.52 -35.51 70.73 Favored 'General case' 0 CA--C 1.567 1.619 0 N-CA-C 116.04 1.867 . . . . 0.0 116.04 167.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 92.9 mt -71.85 -35.3 69.81 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 115.153 1.538 . . . . 0.0 115.153 177.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.9 pp -88.71 148.94 23.73 Favored 'General case' 0 CA--C 1.566 1.57 0 CA-C-N 118.671 0.669 . . . . 0.0 111.084 169.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 29.0 mmtp -103.94 93.98 5.96 Favored Pre-proline 0 CA--C 1.573 1.827 0 CA-C-O 117.813 -1.089 . . . . 0.0 109.764 178.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -73.82 160.39 43.59 Favored 'Trans proline' 0 CA--C 1.566 2.09 0 C-N-CA 122.49 2.126 . . . . 0.0 115.489 -175.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -104.2 141.96 35.34 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.508 -0.745 . . . . 0.0 110.795 -179.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 41.8 mttp -102.9 115.38 30.48 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.857 -1.152 . . . . 0.0 109.742 171.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -95.36 110.37 22.4 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 163.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 78.7 mt -106.8 128.33 61.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -177.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 93.1 t -106.27 118.41 53.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 106.026 -1.842 . . . . 0.0 106.026 163.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -111.95 113.51 25.86 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 124.147 0.979 . . . . 0.0 109.197 175.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -120.19 68.83 0.85 Allowed 'General case' 0 CA--C 1.567 1.613 0 O-C-N 121.339 -0.85 . . . . 0.0 110.334 174.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.65 -97.39 0.7 Allowed Glycine 0 N--CA 1.488 2.164 0 N-CA-C 114.672 0.629 . . . . 0.0 114.672 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -85.07 -40.45 16.8 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 115.314 1.598 . . . . 0.0 115.314 165.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 18.7 t-160 -77.41 119.97 21.76 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 120.899 1.681 . . . . 0.0 111.781 -178.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.42 ' SD ' HD23 ' A' ' 93' ' ' LEU . 46.5 ttm -133.9 133.98 42.11 Favored 'General case' 0 CA--C 1.557 1.231 0 CA-C-O 121.488 0.661 . . . . 0.0 110.674 -173.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 33.6 mt -118.56 107.76 22.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 24.8 mm -94.24 100.23 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 176.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 68.4 mtt85 -93.85 100.57 12.73 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.135 -0.978 . . . . 0.0 109.201 178.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 16.6 m -88.46 102.12 14.59 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 178.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 48.0 mt -97.78 112.23 24.21 Favored 'General case' 0 CA--C 1.556 1.209 0 C-N-CA 123.841 0.856 . . . . 0.0 109.286 -165.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 46.0 t -130.18 143.48 50.81 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.972 -171.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.1 m -78.96 56.42 1.95 Allowed 'General case' 0 CA--C 1.579 2.089 0 CA-C-O 122.036 0.922 . . . . 0.0 112.715 175.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -168.99 -67.93 0.02 OUTLIER 'General case' 0 CA--C 1.567 1.598 0 C-N-CA 124.999 1.32 . . . . 0.0 109.267 -179.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 32.3 tpt180 -135.78 115.72 13.17 Favored 'General case' 0 CA--C 1.565 1.55 0 C-N-CA 123.777 0.831 . . . . 0.0 109.193 173.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 71.9 m-80 -83.63 125.05 31.43 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.685 -0.634 . . . . 0.0 111.501 178.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 86.2 t80 -110.87 105.99 14.99 Favored 'General case' 0 CA--C 1.567 1.602 0 C-N-CA 123.24 0.616 . . . . 0.0 110.744 -169.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.8 mp -93.38 115.35 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 178.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -107.31 90.98 3.47 Favored 'General case' 0 CA--C 1.568 1.64 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 175.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -102.4 119.6 39.08 Favored 'General case' 0 CA--C 1.565 1.551 0 C-N-CA 124.159 0.984 . . . . 0.0 112.633 -175.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -157.72 154.79 28.81 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 114.784 1.401 . . . . 0.0 114.784 -166.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 25.2 mp0 -92.82 121.7 34.46 Favored 'General case' 0 CA--C 1.564 1.486 0 O-C-N 121.577 -0.702 . . . . 0.0 110.553 166.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 40.0 t -66.25 121.7 15.83 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.808 0 C-N-CA 124.218 1.007 . . . . 0.0 109.915 174.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 117.2 -42.45 1.85 Allowed Glycine 0 CA--C 1.55 2.236 0 N-CA-C 115.729 1.052 . . . . 0.0 115.729 -160.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 55.9 mttm -82.64 144.78 30.05 Favored 'General case' 0 CA--C 1.566 1.564 0 CA-C-N 118.916 1.358 . . . . 0.0 113.557 -174.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -90.95 97.8 11.4 Favored 'General case' 0 CA--C 1.566 1.588 0 CA-C-O 121.349 0.595 . . . . 0.0 110.014 167.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -107.54 151.7 25.23 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 123.999 0.92 . . . . 0.0 113.083 -169.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -77.1 135.36 38.58 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.693 -1.254 . . . . 0.0 112.918 169.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 . . . . . 0 N--CA 1.497 1.919 0 O-C-N 121.428 -0.795 . . . . 0.0 112.886 175.278 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 72.8 m . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.835 0.35 . . . . 0.0 111.856 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 23.5 mmt -68.63 96.16 0.7 Allowed 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 124.576 1.15 . . . . 0.0 111.579 -177.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 89.6 m -111.59 118.09 34.73 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 -162.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 93.8 m -101.85 118.94 37.95 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 176.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.424 HG21 ' SG ' ' A' ' 95' ' ' CYS . 57.1 t -108.73 124.93 65.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 171.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 57.9 m -130.57 151.54 50.93 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 121.935 0.874 . . . . 0.0 111.529 -177.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 28.1 m95 -83.66 116.66 22.74 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.992 -1.067 . . . . 0.0 112.726 176.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -103.77 65.79 0.83 Allowed 'General case' 0 CA--C 1.572 1.805 0 C-N-CA 123.428 0.691 . . . . 0.0 109.909 162.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 58.28 -114.59 5.99 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 115.538 0.975 . . . . 0.0 115.538 -172.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -61.42 -28.22 69.11 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 116.934 2.198 . . . . 0.0 116.934 168.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 63.5 mttm -93.69 120.96 34.61 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-O 122.097 0.951 . . . . 0.0 110.583 -178.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.42 HD23 ' SD ' ' A' ' 49' ' ' MET . 34.7 tp -86.79 107.11 18.14 Favored 'General case' 0 CA--C 1.564 1.515 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 168.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -98.59 132.64 43.84 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 123.27 0.628 . . . . 0.0 111.544 -172.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . 0.424 ' SG ' HG21 ' A' ' 86' ' ' VAL . 35.4 t -128.33 134.97 48.99 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.158 0.583 . . . . 0.0 111.728 -179.243 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.9 p -115.82 128.91 72.93 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.792 0 C-N-CA 123.151 0.581 . . . . 0.0 109.758 164.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -106.15 108.2 19.59 Favored 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 123.548 0.739 . . . . 0.0 110.4 -178.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 62.1 mttm -101.08 118.45 37.03 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.042 -1.036 . . . . 0.0 110.814 -174.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -178.91 -60.78 0.07 OUTLIER Glycine 0 N--CA 1.491 2.348 0 N-CA-C 116.546 1.379 . . . . 0.0 116.546 -177.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -125.18 -58.76 1.44 Allowed 'General case' 0 N--CA 1.497 1.893 0 CA-C-N 117.872 0.836 . . . . 0.0 111.938 173.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 41.9 mmtm -87.72 151.51 22.86 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-O 122.189 0.995 . . . . 0.0 113.509 -161.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -73.48 -68.92 0.46 Allowed 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 -169.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -78.35 51.46 3.63 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 116.804 1.482 . . . . 0.0 116.804 171.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 21.2 ttt180 -98.35 118.59 35.36 Favored 'General case' 0 CA--C 1.563 1.461 0 CA-C-N 118.659 1.23 . . . . 0.0 114.041 -169.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 177.46 -165.05 34.6 Favored Glycine 0 N--CA 1.482 1.756 0 CA-C-O 121.844 0.691 . . . . 0.0 114.554 178.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 53.2 p-90 -157.81 152.9 25.61 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 173.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 56.6 m -125.59 118.07 24.92 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 174.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -118.6 125.51 49.93 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 123.021 0.528 . . . . 0.0 111.77 -178.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 17.0 p90 -140.62 170.63 15.42 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.491 -0.755 . . . . 0.0 112.631 178.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 77.4 mt -117.57 135.85 56.63 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.031 -1.043 . . . . 0.0 110.006 176.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -121.52 95.81 4.83 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 173.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 71.93 -109.77 2.95 Favored Glycine 0 N--CA 1.491 2.312 0 O-C-N 121.619 -0.675 . . . . 0.0 114.11 -176.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -110.17 38.42 2.43 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 114.338 1.236 . . . . 0.0 114.338 165.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 82.8 mt-10 -132.62 136.17 46.35 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-N 118.891 0.768 . . . . 0.0 111.199 178.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 20.8 tp -90.75 124.71 35.33 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 123.354 0.662 . . . . 0.0 109.785 173.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 51.5 m80 -113.68 117.52 31.79 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 179.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 51.4 tp -126.53 120.02 28.6 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.884 0.873 . . . . 0.0 109.445 -171.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -111.54 110.03 20.26 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 109.389 -0.596 . . . . 0.0 109.389 173.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 71.9 mtm -104.41 127.13 52.03 Favored 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 123.492 0.717 . . . . 0.0 111.028 -179.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 36.9 mtp-105 -114.04 145.58 41.39 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.377 -0.827 . . . . 0.0 112.659 -175.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -149.88 138.91 21.11 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.705 -0.622 . . . . 0.0 112.002 163.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . 0.287 6.0 mm-40 69.58 -76.19 0.06 Allowed 'General case' 0 N--CA 1.503 2.215 0 C-N-CA 124.326 1.05 . . . . 0.0 112.884 -177.436 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -159.78 46.42 0.42 Allowed Glycine 0 CA--C 1.553 2.408 0 CA-C-N 116.042 -0.526 . . . . 0.0 113.202 153.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 72.1 t -133.93 121.8 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 -163.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 16.2 m -101.97 120.91 41.17 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -173.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 26.7 t -84.73 125.5 32.59 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.657 -0.652 . . . . 0.0 111.821 160.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 28.5 mtmm -111.7 109.05 18.72 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 -173.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -117.95 130.6 56.31 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.613 -0.679 . . . . 0.0 111.565 -172.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 39.7 t -116.97 129.25 73.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 N-CA-C 107.969 -1.122 . . . . 0.0 107.969 179.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -122.0 157.55 31.09 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 123.479 0.712 . . . . 0.0 110.71 173.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 75.4 tttt -114.56 141.29 47.93 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.332 -0.855 . . . . 0.0 112.06 172.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 33.9 tttm -76.41 118.04 18.69 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.605 -0.684 . . . . 0.0 112.758 -178.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 33.6 m -103.38 -35.36 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.2 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 175.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 81.7 t60 . . . . . 0 N--CA 1.484 1.239 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 169.063 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo . . . . . 0 CA--C 1.564 1.975 0 N-CA-C 116.175 1.567 . . . . 0.0 116.175 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 34.3 m -69.88 156.65 7.04 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.854 0 CA-C-O 122.216 1.008 . . . . 0.0 113.399 172.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -87.43 116.5 25.58 Favored 'General case' 0 CA--C 1.56 1.334 0 O-C-N 121.129 -0.982 . . . . 0.0 111.249 169.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 11.1 m-30 -80.07 0.95 29.74 Favored 'General case' 0 CA--C 1.578 2.052 0 N-CA-C 115.504 1.668 . . . . 0.0 115.504 163.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 43.7 m-20 -53.01 113.16 1.01 Allowed 'General case' 0 N--CA 1.493 1.689 0 CA-C-N 120.665 1.575 . . . . 0.0 115.044 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 159.92 173.31 28.27 Favored Glycine 0 N--CA 1.481 1.7 0 CA-C-O 122.378 0.988 . . . . 0.0 115.272 -175.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -104.87 126.5 52.01 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 170.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 65.5 m95 -124.37 122.77 38.62 Favored 'General case' 0 CA--C 1.565 1.522 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 -169.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 21.7 pttp -96.35 138.35 34.08 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.555 -0.716 . . . . 0.0 112.054 -178.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 54.9 ttm -69.71 127.82 34.29 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 119.594 1.088 . . . . 0.0 113.91 -178.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 98.2 mt -87.52 -50.69 6.36 Favored 'General case' 0 CA--C 1.567 1.621 0 CA-C-N 115.291 -0.868 . . . . 0.0 112.757 167.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 80.7 p -144.86 144.6 31.2 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 118.984 0.811 . . . . 0.0 112.188 176.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -114.72 101.75 9.37 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.519 0.676 . . . . 0.0 109.745 164.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -101.84 121.67 42.54 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 123.858 0.863 . . . . 0.0 109.691 -171.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.264 27.9 t30 66.51 22.34 10.64 Favored 'General case' 0 N--CA 1.504 2.264 0 N-CA-C 116.971 2.212 . . . . 0.0 116.971 -174.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -66.28 -40.44 90.08 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 116.055 1.872 . . . . 0.0 116.055 177.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -58.45 -41.09 84.36 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 116.074 1.879 . . . . 0.0 116.074 170.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -65.85 -43.0 89.78 Favored 'General case' 0 CA--C 1.571 1.774 0 N-CA-C 114.724 1.379 . . . . 0.0 114.724 170.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -56.87 -47.2 80.98 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 115.137 1.532 . . . . 0.0 115.137 167.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 84.2 mt -61.1 -42.69 98.98 Favored 'General case' 0 CA--C 1.574 1.893 0 N-CA-C 114.618 1.34 . . . . 0.0 114.618 169.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 48.1 ttp180 -53.11 -47.55 68.53 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 115.395 1.628 . . . . 0.0 115.395 164.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.12 -22.71 61.29 Favored 'General case' 0 CA--C 1.568 1.641 0 N-CA-C 118.239 2.681 . . . . 0.0 118.239 166.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 98.5 mt -88.39 11.56 16.53 Favored 'General case' 0 CA--C 1.573 1.849 0 N-CA-C 115.46 1.652 . . . . 0.0 115.46 164.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.25 10.7 m-20 61.34 40.7 13.92 Favored 'General case' 0 CA--C 1.576 1.964 0 N-CA-C 115.493 1.664 . . . . 0.0 115.493 -175.443 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 91.2 t -94.88 141.89 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.191 -0.943 . . . . 0.0 109.931 -176.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 14.0 p30 -64.48 154.44 35.86 Favored 'General case' 0 CA--C 1.572 1.812 0 N-CA-C 115.82 1.785 . . . . 0.0 115.82 178.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 96.8 t -58.63 -40.84 80.45 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.276 0 N-CA-C 115.127 1.528 . . . . 0.0 115.127 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.58 -50.3 72.34 Favored 'General case' 0 CA--C 1.567 1.631 0 N-CA-C 116.029 1.863 . . . . 0.0 116.029 171.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -71.65 -34.65 69.93 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 115.322 1.601 . . . . 0.0 115.322 172.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 74.3 mtp180 -50.68 -41.71 55.99 Favored 'General case' 0 N--CA 1.503 2.197 0 N-CA-C 116.131 1.9 . . . . 0.0 116.131 160.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp -71.48 -54.05 11.89 Favored 'General case' 0 CA--C 1.567 1.621 0 O-C-N 120.96 -1.088 . . . . 0.0 113.574 166.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 12.0 mt -77.98 60.44 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.509 2.484 0 CA-C-N 120.923 1.692 . . . . 0.0 111.708 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -179.45 -47.29 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 126.701 2.0 . . . . 0.0 110.969 -174.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -64.49 -45.45 87.26 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 115.99 1.848 . . . . 0.0 115.99 158.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 65.2 mt -78.02 -24.94 47.69 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 115.645 1.72 . . . . 0.0 115.645 -175.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.9 pp -96.0 134.61 38.82 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 162.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 62.4 pttt -98.91 102.06 14.09 Favored Pre-proline 0 CA--C 1.574 1.896 0 CA-C-O 117.906 -1.045 . . . . 0.0 110.644 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -73.61 166.03 30.83 Favored 'Trans proline' 0 CA--C 1.565 2.041 0 CA-C-N 123.101 2.143 . . . . 0.0 115.77 -173.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -110.69 136.27 50.02 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.621 -0.674 . . . . 0.0 110.345 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 43.0 mttp -100.51 116.58 32.79 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 120.918 -1.114 . . . . 0.0 109.851 176.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -101.46 109.29 21.08 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 167.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.1 mp -96.06 127.12 48.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 178.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 74.7 t -110.21 106.55 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 164.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -103.69 105.69 15.99 Favored 'General case' 0 CA--C 1.565 1.535 0 C-N-CA 124.361 1.064 . . . . 0.0 109.222 177.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -125.97 87.42 2.68 Favored 'General case' 0 CA--C 1.565 1.532 0 C-N-CA 123.509 0.724 . . . . 0.0 110.061 -176.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 57.36 72.03 0.65 Allowed Glycine 0 N--CA 1.496 2.662 0 N-CA-C 117.106 1.602 . . . . 0.0 117.106 175.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.471 0.6 OUTLIER 65.26 -33.8 0.17 Allowed 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 118.476 2.769 . . . . 0.0 118.476 -166.473 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 15.6 t-160 -73.69 114.78 12.35 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-N 120.62 1.555 . . . . 0.0 111.471 172.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 44.7 ttm -123.35 124.18 42.37 Favored 'General case' 0 CA--C 1.557 1.227 0 C-N-CA 123.707 0.803 . . . . 0.0 109.646 -175.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 43.2 mt -108.46 104.4 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 178.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 17.0 mm -90.39 98.29 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 176.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -90.39 100.82 13.58 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.225 -0.922 . . . . 0.0 109.2 -176.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 28.6 m -88.55 104.49 16.87 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 43.7 mt -103.2 117.38 34.4 Favored 'General case' 0 CA--C 1.557 1.225 0 C-N-CA 123.852 0.861 . . . . 0.0 109.499 -163.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 43.7 t -128.58 143.03 50.88 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.063 0.945 . . . . 0.0 110.453 -165.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . 0.253 12.7 t -77.34 50.83 0.81 Allowed 'General case' 0 N--CA 1.503 2.191 0 N-CA-C 114.55 1.315 . . . . 0.0 114.55 168.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -167.26 -68.64 0.03 OUTLIER 'General case' 0 CA--C 1.568 1.639 0 C-N-CA 125.537 1.535 . . . . 0.0 108.057 -178.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 33.5 ttm105 -151.19 123.14 8.14 Favored 'General case' 0 CA--C 1.565 1.551 0 CA-C-N 118.959 0.8 . . . . 0.0 110.322 -179.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -80.16 139.44 36.79 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 -178.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -114.0 107.36 15.57 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.745 -0.597 . . . . 0.0 109.465 177.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 43.9 mm -100.51 106.5 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -171.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 1.2 mmm -96.24 87.32 4.47 Favored 'General case' 0 CA--C 1.564 1.493 0 CA-C-O 121.638 0.732 . . . . 0.0 110.207 -176.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -100.01 116.99 33.35 Favored 'General case' 0 CA--C 1.562 1.41 0 C-N-CA 123.928 0.891 . . . . 0.0 112.282 -175.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -155.59 153.54 30.28 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 -168.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -95.09 122.95 38.29 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.507 -0.746 . . . . 0.0 111.425 166.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 31.7 t -65.46 121.85 15.29 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.831 0 C-N-CA 124.169 0.987 . . . . 0.0 110.538 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 105.54 -34.57 5.67 Favored Glycine 0 CA--C 1.552 2.389 0 N-CA-C 116.955 1.542 . . . . 0.0 116.955 -162.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 52.4 mttp -95.55 122.96 38.84 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 119.265 1.532 . . . . 0.0 111.454 -171.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -78.9 116.52 19.28 Favored 'General case' 0 CA--C 1.569 1.697 0 O-C-N 121.491 -0.756 . . . . 0.0 112.587 -178.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -124.71 147.83 48.38 Favored 'General case' 0 N--CA 1.496 1.828 0 C-N-CA 123.787 0.835 . . . . 0.0 112.346 -170.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -68.29 127.18 32.01 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 119.91 -1.744 . . . . 0.0 113.92 172.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 . . . . . 0 N--CA 1.5 2.056 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 176.956 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 84.5 m . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 121.235 0.54 . . . . 0.0 111.211 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 79.1 mmm -72.21 103.4 3.33 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 121.979 0.895 . . . . 0.0 110.398 -174.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 85.8 m -107.76 113.6 26.97 Favored 'General case' 0 N--CA 1.48 1.038 0 O-C-N 121.162 -0.961 . . . . 0.0 110.07 -159.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 40.5 m -98.57 121.37 40.42 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 170.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.512 HG21 ' SG ' ' A' ' 95' ' ' CYS . 20.2 t -109.21 126.36 66.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 170.304 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 58.3 m -133.22 144.41 49.78 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 123.627 0.771 . . . . 0.0 111.323 -176.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 8.2 m95 -83.88 122.55 28.87 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.821 -1.174 . . . . 0.0 113.656 179.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -108.58 65.7 0.63 Allowed 'General case' 0 CA--C 1.576 1.964 0 C-N-CA 123.485 0.714 . . . . 0.0 110.424 163.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 67.65 -94.61 0.29 Allowed Glycine 0 N--CA 1.493 2.477 0 N-CA-C 116.322 1.289 . . . . 0.0 116.322 178.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -82.47 -30.52 29.92 Favored 'General case' 0 CA--C 1.573 1.857 0 N-CA-C 115.34 1.607 . . . . 0.0 115.34 165.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 33.8 mtpt -96.24 116.38 28.92 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-N 119.853 1.206 . . . . 0.0 110.434 -171.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 33.6 tp -86.96 110.8 20.27 Favored 'General case' 0 CA--C 1.564 1.509 0 O-C-N 120.992 -1.068 . . . . 0.0 109.711 174.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 18.2 mm100 -103.05 126.01 50.04 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.863 0.865 . . . . 0.0 110.226 -167.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . 0.512 ' SG ' HG21 ' A' ' 86' ' ' VAL . 41.0 t -127.6 129.11 46.7 Favored 'General case' 0 N--CA 1.481 1.083 0 O-C-N 121.822 -0.549 . . . . 0.0 111.417 -175.028 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 12.0 p -109.5 127.59 66.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 162.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -103.93 75.98 1.33 Allowed 'General case' 0 CA--C 1.57 1.712 0 C-N-CA 123.805 0.842 . . . . 0.0 109.263 175.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 15.7 ptpt -84.44 143.91 29.1 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 114.586 1.328 . . . . 0.0 114.586 -166.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 161.66 -114.15 0.59 Allowed Glycine 0 N--CA 1.484 1.884 0 O-C-N 121.663 -0.648 . . . . 0.0 111.949 172.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -80.33 -36.08 34.71 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 115.655 1.724 . . . . 0.0 115.655 175.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 9.4 tppt? -77.02 114.68 16.09 Favored 'General case' 0 CA--C 1.567 1.605 0 CA-C-N 119.559 1.072 . . . . 0.0 111.58 -177.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -74.17 119.46 18.41 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.418 -0.801 . . . . 0.0 112.854 -169.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 68.48 40.83 86.34 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 118.594 2.197 . . . . 0.0 118.594 -172.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 45.7 ttt180 -92.0 130.22 37.79 Favored 'General case' 0 CA--C 1.566 1.572 0 CA-C-N 118.514 1.157 . . . . 0.0 111.854 179.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 179.73 -168.52 38.98 Favored Glycine 0 N--CA 1.484 1.859 0 CA-C-O 122.368 0.982 . . . . 0.0 114.021 175.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 58.2 p-90 -156.62 153.3 28.37 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 122.214 1.007 . . . . 0.0 112.989 174.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 39.8 m -129.71 117.72 20.75 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 176.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -121.29 129.2 53.01 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 123.247 0.619 . . . . 0.0 111.621 -174.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 17.8 p90 -146.78 163.63 35.37 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.025 -1.047 . . . . 0.0 113.339 -174.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 76.0 mt -106.52 143.39 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.298 0 CA-C-O 123.224 1.488 . . . . 0.0 111.654 178.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -137.06 84.97 2.1 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 178.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 72.39 -110.04 3.04 Favored Glycine 0 N--CA 1.489 2.208 0 CA-C-N 116.025 -0.534 . . . . 0.0 114.415 -174.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 55.6 p30 -88.9 7.22 35.5 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 117.473 2.397 . . . . 0.0 117.473 169.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -124.07 137.93 54.51 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-N 120.085 1.311 . . . . 0.0 112.754 -166.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 26.4 tp -97.01 118.65 33.88 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 123.947 0.899 . . . . 0.0 108.984 172.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 34.1 m80 -107.83 123.29 48.35 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.926 0.89 . . . . 0.0 108.977 -176.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 45.4 tp -123.17 121.14 35.21 Favored 'General case' 0 CA--C 1.559 1.323 0 C-N-CA 123.82 0.848 . . . . 0.0 110.004 -172.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.474 ' HE2' ' NZ ' ' A' ' 127' ' ' LYS . 40.7 mt-10 -102.13 114.66 28.98 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.594 -0.691 . . . . 0.0 109.296 166.034 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 73.5 mtm -103.89 126.85 51.31 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-N 118.557 0.617 . . . . 0.0 110.582 175.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 87.0 mtm180 -120.0 134.43 55.25 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 123.837 0.855 . . . . 0.0 110.471 -167.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -162.53 137.22 6.71 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.372 -0.83 . . . . 0.0 112.236 173.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . 0.328 12.1 mt-10 48.68 43.83 20.94 Favored 'General case' 0 N--CA 1.504 2.265 0 N-CA-C 116.156 1.91 . . . . 0.0 116.156 -178.197 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 65.71 26.24 71.99 Favored Glycine 0 CA--C 1.552 2.363 0 N-CA-C 120.609 3.004 . . . . 0.0 120.609 -167.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 87.6 t -130.83 128.36 62.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 CA-C-N 119.605 1.703 . . . . 0.0 109.202 -175.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 52.4 m -106.07 126.11 51.81 Favored 'General case' 0 N--CA 1.496 1.834 0 C-N-CA 123.284 0.634 . . . . 0.0 111.267 176.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 9.2 t -96.67 128.65 43.81 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.698 0.799 . . . . 0.0 111.542 162.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.474 ' NZ ' ' HE2' ' A' ' 118' ' ' GLU . 47.0 mttp -102.02 111.1 23.25 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 121.427 0.632 . . . . 0.0 110.536 176.102 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 64.2 mt-30 -108.98 126.74 53.42 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.693 0.797 . . . . 0.0 110.767 176.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 47.7 t -114.27 132.0 64.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -126.87 149.6 49.67 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 123.742 0.817 . . . . 0.0 111.329 178.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 75.4 tttt -111.33 140.18 46.11 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.374 -0.829 . . . . 0.0 112.164 175.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 73.0 tttt -74.19 122.93 23.55 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.448 -0.782 . . . . 0.0 113.07 -178.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 31.7 m -109.32 -42.31 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 175.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 50.2 t-80 . . . . . 0 N--CA 1.485 1.309 0 CA-C-N 119.712 1.142 . . . . 0.0 108.268 167.782 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo . . . . . 0 CA--C 1.565 2.028 0 N-CA-C 117.35 2.019 . . . . 0.0 117.35 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 27.6 m -108.98 175.42 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 CA-C-O 122.666 1.222 . . . . 0.0 112.719 174.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -78.14 96.74 5.24 Favored 'General case' 0 CA--C 1.568 1.643 0 O-C-N 120.874 -1.141 . . . . 0.0 113.287 -172.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -78.14 -0.22 27.4 Favored 'General case' 0 N--CA 1.501 2.116 0 N-CA-C 116.334 1.976 . . . . 0.0 116.334 169.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -60.24 116.07 3.97 Favored 'General case' 0 CA--C 1.563 1.47 0 C-N-CA 125.826 1.65 . . . . 0.0 114.343 179.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 163.44 177.99 36.77 Favored Glycine 0 N--CA 1.484 1.879 0 N-CA-C 116.743 1.457 . . . . 0.0 116.743 177.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -106.57 120.07 40.96 Favored 'General case' 0 CA--C 1.563 1.459 0 CA-C-N 113.961 -1.12 . . . . 0.0 108.536 170.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 64.5 m95 -120.03 124.98 47.22 Favored 'General case' 0 CA--C 1.565 1.547 0 C-N-CA 123.882 0.873 . . . . 0.0 108.766 -169.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -95.24 137.06 34.81 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.67 -1.269 . . . . 0.0 112.619 179.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 4.3 ttp -74.86 121.64 22.15 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 122.133 0.968 . . . . 0.0 112.773 179.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 93.4 mt -79.47 -54.65 5.71 Favored 'General case' 0 CA--C 1.566 1.592 0 CA-C-N 115.029 -0.987 . . . . 0.0 112.609 171.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 89.6 p -144.33 151.77 39.82 Favored 'General case' 0 CA--C 1.563 1.45 0 C-N-CA 123.717 0.807 . . . . 0.0 112.624 -173.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -122.64 133.49 54.52 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.43 0.634 . . . . 0.0 110.901 160.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -125.58 117.78 24.3 Favored 'General case' 0 CA--C 1.561 1.367 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 -179.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.292 31.3 t30 68.88 31.65 4.23 Favored 'General case' 0 CA--C 1.579 2.089 0 N-CA-C 117.082 2.253 . . . . 0.0 117.082 -175.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -71.8 -42.97 66.42 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 115.215 1.561 . . . . 0.0 115.215 175.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.479 ' HE2' ' NZ ' ' A' ' 31' ' ' LYS . 17.9 mt-10 -47.3 -47.33 25.37 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 116.442 2.015 . . . . 0.0 116.442 166.387 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -70.26 -38.62 75.15 Favored 'General case' 0 CA--C 1.57 1.736 0 N-CA-C 115.686 1.736 . . . . 0.0 115.686 176.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 81.5 t80 -55.41 -49.4 72.45 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-N 120.519 1.508 . . . . 0.0 114.201 165.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 79.8 mt -59.37 -43.01 92.91 Favored 'General case' 0 CA--C 1.574 1.895 0 N-CA-C 115.493 1.664 . . . . 0.0 115.493 169.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 36.4 ttp180 -51.2 -51.16 56.44 Favored 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 115.325 1.602 . . . . 0.0 115.325 165.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.87 -24.53 52.39 Favored 'General case' 0 CA--C 1.565 1.538 0 N-CA-C 118.364 2.728 . . . . 0.0 118.364 165.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 93.3 mt -87.18 8.91 21.87 Favored 'General case' 0 CA--C 1.575 1.912 0 N-CA-C 115.735 1.754 . . . . 0.0 115.735 167.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.256 25.8 m-20 67.24 41.46 2.52 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 -175.241 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 90.3 t -100.37 141.66 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 121.031 -1.043 . . . . 0.0 110.014 -178.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 12.1 p30 -68.68 159.89 31.28 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 115.887 1.81 . . . . 0.0 115.887 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 65.0 t -58.52 -46.2 89.9 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.256 0 N-CA-C 114.895 1.443 . . . . 0.0 114.895 -179.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.55 -47.4 84.36 Favored 'General case' 0 CA--C 1.57 1.717 0 N-CA-C 116.052 1.871 . . . . 0.0 116.052 173.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.49 -43.83 97.85 Favored 'General case' 0 CA--C 1.574 1.9 0 N-CA-C 114.873 1.434 . . . . 0.0 114.873 169.259 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 77.1 mtp180 -49.92 -50.92 44.55 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 115.569 1.692 . . . . 0.0 115.569 164.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.479 ' NZ ' ' HE2' ' A' ' 17' ' ' GLU . 12.2 mptt -54.95 -54.15 46.51 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 115.258 1.577 . . . . 0.0 115.258 168.183 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 34.9 mt -59.73 -53.2 51.71 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 CA-C-N 119.808 1.185 . . . . 0.0 113.162 178.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -61.94 -40.41 95.45 Favored 'General case' 0 CA--C 1.566 1.569 0 N-CA-C 117.529 2.418 . . . . 0.0 117.529 175.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -65.64 -32.08 73.45 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 116.003 1.853 . . . . 0.0 116.003 169.242 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 81.5 mt -72.79 -30.45 64.1 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 116.139 1.903 . . . . 0.0 116.139 170.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 38.6 mt -73.95 139.8 45.12 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 119.539 1.063 . . . . 0.0 113.547 -179.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -110.96 86.01 5.61 Favored Pre-proline 0 CA--C 1.572 1.826 0 CA-C-O 118.299 -0.858 . . . . 0.0 109.723 172.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -76.87 174.02 13.53 Favored 'Trans proline' 0 CA--C 1.563 1.926 0 C-N-CA 122.558 2.172 . . . . 0.0 115.67 -176.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -111.88 130.27 55.89 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.699 -0.625 . . . . 0.0 111.315 178.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 47.6 mttm -90.12 109.93 20.97 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.275 -0.891 . . . . 0.0 110.137 171.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -92.55 110.94 22.37 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 163.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 74.3 mt -109.03 118.35 56.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 107.475 -1.305 . . . . 0.0 107.475 -178.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 72.1 t -100.87 98.48 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 106.676 -1.602 . . . . 0.0 106.676 166.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -90.44 93.0 9.12 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.537 0.684 . . . . 0.0 109.731 174.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -100.33 70.58 1.52 Allowed 'General case' 0 CA--C 1.567 1.624 0 O-C-N 121.478 -0.764 . . . . 0.0 111.403 -177.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 53.56 67.46 2.13 Favored Glycine 0 N--CA 1.496 2.695 0 N-CA-C 117.64 1.816 . . . . 0.0 117.64 176.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.438 0.5 OUTLIER 61.0 8.22 1.82 Allowed 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 119.617 3.192 . . . . 0.0 119.617 -163.579 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 17.5 t-160 -107.48 106.56 17.01 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 121.276 1.853 . . . . 0.0 107.643 161.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 6.6 tpp -109.45 132.19 54.36 Favored 'General case' 0 CA--C 1.556 1.186 0 O-C-N 121.458 -0.776 . . . . 0.0 110.969 -172.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 47.1 mt -116.47 101.87 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 173.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 72.9 mt -99.13 116.31 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 178.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -115.86 103.39 10.59 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 70.4 m -88.42 112.62 23.12 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 172.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 24.0 mt -110.96 119.01 37.64 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.303 -158.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 36.1 t -130.76 153.53 48.93 Favored 'General case' 0 CA--C 1.56 1.346 0 C-N-CA 123.668 0.787 . . . . 0.0 110.529 173.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 70.2 p -80.98 62.32 4.92 Favored 'General case' 0 N--CA 1.504 2.247 0 O-C-N 120.636 -1.29 . . . . 0.0 111.633 163.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -174.06 -68.61 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 125.097 1.359 . . . . 0.0 108.985 -174.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 14.8 ttm180 -146.61 118.08 7.96 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 123.634 0.773 . . . . 0.0 109.103 -173.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -106.11 130.55 53.98 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 123.229 0.612 . . . . 0.0 110.588 -170.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 10.3 t80 -101.45 109.55 21.4 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.544 -0.722 . . . . 0.0 109.871 178.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 41.6 mm -116.67 117.47 55.58 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -169.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 25.4 mmm -126.6 97.54 5.06 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 123.226 0.61 . . . . 0.0 109.77 -175.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -104.84 103.7 13.34 Favored 'General case' 0 CA--C 1.563 1.463 0 C-N-CA 124.06 0.944 . . . . 0.0 111.875 177.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -151.49 154.24 36.17 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 -163.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 17.8 mp0 -84.57 126.53 33.4 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.11 -0.994 . . . . 0.0 111.08 164.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 15.1 t -69.06 114.15 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 174.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 124.88 -46.72 1.07 Allowed Glycine 0 N--CA 1.488 2.146 0 N-CA-C 115.807 1.083 . . . . 0.0 115.807 -160.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 34.9 mtmt -83.74 142.83 30.42 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 118.872 1.336 . . . . 0.0 113.861 -173.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -93.25 95.54 9.43 Favored 'General case' 0 CA--C 1.566 1.58 0 CA-C-O 121.321 0.582 . . . . 0.0 111.252 176.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -104.56 142.14 35.16 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 124.032 0.933 . . . . 0.0 113.058 -170.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -71.58 115.7 11.07 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.164 -1.585 . . . . 0.0 113.46 176.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 . . . . . 0 CA--C 1.564 1.508 0 O-C-N 121.397 -0.814 . . . . 0.0 109.423 165.501 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 72.5 m . . . . . 0 CA--C 1.559 1.31 0 CA-C-O 121.466 0.651 . . . . 0.0 110.866 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 2.4 tpt -75.58 98.66 4.06 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 122.195 0.998 . . . . 0.0 109.638 -176.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 65.3 m -104.72 110.26 22.51 Favored 'General case' 0 N--CA 1.48 1.059 0 O-C-N 121.695 -0.628 . . . . 0.0 110.065 -154.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 54.6 m -88.79 121.82 31.56 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 167.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 22.9 t -110.35 121.51 63.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 165.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 31.8 m -128.08 154.11 46.07 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 122.125 0.964 . . . . 0.0 111.545 -175.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 29.0 m95 -84.69 114.98 22.42 Favored 'General case' 0 CA--C 1.562 1.422 0 O-C-N 121.223 -0.923 . . . . 0.0 111.939 174.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -93.5 70.92 4.3 Favored 'General case' 0 CA--C 1.571 1.783 0 CA-C-O 121.539 0.685 . . . . 0.0 109.57 159.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 61.14 -114.72 6.96 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 114.901 0.72 . . . . 0.0 114.901 -168.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -64.87 -30.56 71.57 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 116.461 2.023 . . . . 0.0 116.461 166.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -86.87 127.81 35.04 Favored 'General case' 0 CA--C 1.561 1.384 0 CA-C-N 119.443 1.019 . . . . 0.0 111.256 -173.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 25.8 tp -92.28 106.56 18.54 Favored 'General case' 0 CA--C 1.566 1.562 0 O-C-N 121.378 -0.826 . . . . 0.0 109.097 176.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 -100.46 128.83 46.41 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 123.658 0.783 . . . . 0.0 111.132 -173.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 40.9 t -124.19 131.64 53.55 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.436 0.694 . . . . 0.0 111.975 -177.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.5 p -120.15 125.65 74.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 C-N-CA 122.979 0.511 . . . . 0.0 109.628 168.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -100.87 90.26 4.14 Favored 'General case' 0 CA--C 1.568 1.657 0 C-N-CA 124.092 0.957 . . . . 0.0 109.58 -176.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -84.88 122.47 29.21 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.66 -1.275 . . . . 0.0 113.525 -166.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -169.76 -130.64 1.23 Allowed Glycine 0 N--CA 1.485 1.947 0 O-C-N 121.593 -0.692 . . . . 0.0 112.157 171.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.68 -16.44 58.49 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 117.157 2.281 . . . . 0.0 117.157 176.165 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 16.7 ttmt -98.82 129.64 45.22 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 119.97 1.259 . . . . 0.0 111.561 -170.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -79.01 128.55 33.4 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.472 -0.767 . . . . 0.0 112.816 -172.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 66.61 34.1 86.53 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 118.975 2.35 . . . . 0.0 118.975 -176.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 36.7 ttt180 -85.92 124.36 32.3 Favored 'General case' 0 CA--C 1.565 1.527 0 CA-C-N 118.734 1.267 . . . . 0.0 111.577 -177.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -179.18 -168.96 39.03 Favored Glycine 0 N--CA 1.486 1.989 0 N-CA-C 115.687 1.035 . . . . 0.0 115.687 -177.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 41.8 p-90 -157.43 155.47 30.53 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.958 0.885 . . . . 0.0 112.898 170.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 97.5 m -126.16 120.47 30.2 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.344 -0.848 . . . . 0.0 108.712 176.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 16.8 tt0 -124.42 124.72 42.95 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.846 -0.534 . . . . 0.0 111.992 -175.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 14.0 p90 -143.17 163.02 34.04 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.079 -1.013 . . . . 0.0 113.227 -177.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 86.1 mt -107.92 133.94 51.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 CA-C-O 122.266 1.031 . . . . 0.0 110.652 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -120.71 85.34 2.38 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 124.525 1.13 . . . . 0.0 108.451 173.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 69.68 -108.06 2.34 Favored Glycine 0 N--CA 1.491 2.315 0 O-C-N 121.584 -0.697 . . . . 0.0 114.752 -175.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 31.6 p-10 -87.96 -5.16 58.68 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 117.427 2.38 . . . . 0.0 117.427 166.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -103.41 139.59 38.59 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-N 120.408 1.458 . . . . 0.0 112.368 -175.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 10.7 tp -101.46 122.08 43.12 Favored 'General case' 0 CA--C 1.562 1.417 0 C-N-CA 123.873 0.869 . . . . 0.0 108.957 169.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 36.9 m80 -109.27 119.87 40.81 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.533 0.733 . . . . 0.0 109.208 -175.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 20.0 tp -114.38 129.86 56.67 Favored 'General case' 0 CA--C 1.56 1.327 0 C-N-CA 123.737 0.815 . . . . 0.0 110.183 -178.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -119.16 108.7 14.99 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.936 -0.478 . . . . 0.0 110.003 169.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 76.8 mtm -97.82 127.49 43.8 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 123.62 0.768 . . . . 0.0 111.515 -176.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 78.7 mtm180 -118.14 135.2 54.37 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 123.329 0.651 . . . . 0.0 111.693 -167.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -160.23 132.89 6.46 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.26 -0.9 . . . . 0.0 111.515 170.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 33.8 mm-40 58.13 36.88 26.24 Favored 'General case' 0 N--CA 1.505 2.3 0 N-CA-C 115.361 1.615 . . . . 0.0 115.361 -177.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 72.9 -8.62 7.56 Favored Glycine 0 CA--C 1.556 2.603 0 N-CA-C 120.399 2.92 . . . . 0.0 120.399 -162.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 97.1 t -92.88 128.23 44.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 CA-C-N 120.137 1.969 . . . . 0.0 109.76 -171.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 37.8 m -105.9 124.25 49.28 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 122.73 0.412 . . . . 0.0 111.5 177.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 11.2 t -95.14 126.21 40.31 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.426 0.69 . . . . 0.0 111.234 162.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -103.4 121.1 42.09 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 123.381 0.672 . . . . 0.0 109.569 -179.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 20.0 mt-30 -126.64 134.24 50.8 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.588 -0.695 . . . . 0.0 111.227 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 57.1 t -115.24 131.07 68.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 -177.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -123.5 149.83 44.69 Favored 'General case' 0 CA--C 1.563 1.478 0 C-N-CA 124.72 1.208 . . . . 0.0 110.232 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 29.6 ttmt -123.61 141.08 52.36 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.789 -1.194 . . . . 0.0 112.153 175.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 70.8 tttt -73.84 123.4 24.13 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 -175.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . 0.255 34.5 m -107.86 -43.07 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 175.248 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 . . . . . 0 N--CA 1.487 1.414 0 CA-C-N 120.206 1.366 . . . . 0.0 108.312 167.011 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo . . . . . 0 CA--C 1.561 1.859 0 N-CA-C 115.405 1.271 . . . . 0.0 115.405 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 15.6 m -72.58 141.26 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 CA-C-O 121.936 0.874 . . . . 0.0 113.079 178.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -76.25 121.48 23.0 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 -176.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 8.6 m-30 -85.05 8.4 18.04 Favored 'General case' 0 CA--C 1.572 1.807 0 N-CA-C 115.647 1.721 . . . . 0.0 115.647 177.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 27.5 m120 -51.43 121.82 6.93 Favored 'General case' 0 N--CA 1.499 2.004 0 CA-C-N 121.496 1.953 . . . . 0.0 115.082 172.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 160.45 177.88 33.95 Favored Glycine 0 N--CA 1.481 1.685 0 CA-C-O 123.002 1.334 . . . . 0.0 116.031 174.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 14.8 t80 -110.74 128.84 55.89 Favored 'General case' 0 CA--C 1.564 1.491 0 CA-C-N 113.578 -1.311 . . . . 0.0 108.364 165.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 55.3 m95 -126.81 138.51 53.36 Favored 'General case' 0 CA--C 1.573 1.832 0 C-N-CA 123.733 0.813 . . . . 0.0 110.144 -167.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -112.11 137.05 50.71 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 120.678 -1.264 . . . . 0.0 112.633 178.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.455 ' SD ' ' HD2' ' A' ' 38' ' ' PRO . 1.9 ttt -75.0 123.45 25.18 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.454 -1.404 . . . . 0.0 114.281 -175.122 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 97.5 mt -85.92 -52.67 5.58 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 113.688 0.996 . . . . 0.0 113.688 176.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 83.3 p -142.36 148.25 37.61 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 123.671 0.788 . . . . 0.0 112.112 -176.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -126.75 116.73 21.38 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 123.107 0.563 . . . . 0.0 110.078 170.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -112.15 116.05 29.85 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 178.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.293 18.7 t30 69.71 25.47 5.14 Favored 'General case' 0 CA--C 1.579 2.096 0 N-CA-C 117.964 2.579 . . . . 0.0 117.964 177.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 15.7 t80 -63.41 -45.14 92.39 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 115.459 1.651 . . . . 0.0 115.459 170.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -54.68 -40.78 69.47 Favored 'General case' 0 CA--C 1.573 1.836 0 N-CA-C 117.868 2.544 . . . . 0.0 117.868 172.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -74.22 -40.72 62.26 Favored 'General case' 0 CA--C 1.571 1.775 0 N-CA-C 115.264 1.579 . . . . 0.0 115.264 171.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -49.06 -48.92 43.67 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 115.19 1.552 . . . . 0.0 115.19 162.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 88.5 mt -62.06 -40.19 94.94 Favored 'General case' 0 CA--C 1.573 1.835 0 N-CA-C 115.339 1.607 . . . . 0.0 115.339 169.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 46.9 ttp180 -54.0 -50.47 66.52 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 165.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.58 -21.52 53.34 Favored 'General case' 0 CA--C 1.567 1.622 0 N-CA-C 118.223 2.675 . . . . 0.0 118.223 167.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 37.7 mt -90.83 8.53 34.36 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 115.988 1.847 . . . . 0.0 115.988 168.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 69.84 32.94 3.01 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 115.141 1.534 . . . . 0.0 115.141 -177.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 70.3 t -95.36 144.08 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 120.666 -1.271 . . . . 0.0 110.623 -172.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -64.74 152.64 42.04 Favored 'General case' 0 CA--C 1.573 1.835 0 N-CA-C 116.213 1.931 . . . . 0.0 116.213 -176.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . 0.251 56.1 t -58.45 -42.47 84.37 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.156 0 N-CA-C 115.682 1.734 . . . . 0.0 115.682 -179.251 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.05 -51.3 70.65 Favored 'General case' 0 CA--C 1.57 1.72 0 N-CA-C 115.878 1.807 . . . . 0.0 115.878 173.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -54.28 -53.49 53.05 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 114.314 1.227 . . . . 0.0 114.314 166.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 56.3 mtp180 -47.52 -41.57 21.33 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 118.378 2.732 . . . . 0.0 118.378 171.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -75.73 -52.88 9.48 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 174.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 19.9 mt -63.33 -49.75 81.64 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 CA-C-N 119.251 0.932 . . . . 0.0 112.961 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.93 -33.07 74.88 Favored 'General case' 0 CA--C 1.568 1.664 0 N-CA-C 117.821 2.526 . . . . 0.0 117.821 175.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -69.14 -31.27 69.82 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 116.11 1.893 . . . . 0.0 116.11 165.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 79.9 mt -72.25 -36.49 69.08 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 116.075 1.88 . . . . 0.0 116.075 171.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . 0.293 2.5 pp -80.82 152.69 28.1 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-N 120.196 1.362 . . . . 0.0 114.545 -178.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 30.8 mmtp -111.07 99.29 42.54 Favored Pre-proline 0 CA--C 1.572 1.808 0 CA-C-O 118.348 -0.834 . . . . 0.0 108.818 176.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.455 ' HD2' ' SD ' ' A' ' 10' ' ' MET . 91.0 Cg_endo -77.92 176.92 9.42 Favored 'Trans proline' 0 CA--C 1.565 2.032 0 C-N-CA 122.948 2.432 . . . . 0.0 116.025 -175.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -109.98 163.45 13.55 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.969 0.89 . . . . 0.0 112.213 173.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.436 ' NZ ' ' HG1' ' A' ' 53' ' ' THR . 43.2 mttm -135.46 120.53 18.78 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.099 -1.001 . . . . 0.0 110.123 176.196 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.551 ' HE2' ' NH1' ' A' ' 52' ' ' ARG . 30.3 tt0 -100.57 118.57 37.0 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.422 -0.798 . . . . 0.0 109.656 163.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 78.6 mt -113.75 121.42 65.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 177.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 52.9 t -107.09 97.35 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 107.788 -1.189 . . . . 0.0 107.788 167.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -88.48 117.04 27.14 Favored 'General case' 0 CA--C 1.567 1.604 0 C-N-CA 123.454 0.701 . . . . 0.0 110.019 165.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -142.9 102.04 3.95 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.241 -0.912 . . . . 0.0 109.762 -179.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 56.8 62.36 6.45 Favored Glycine 0 N--CA 1.497 2.706 0 N-CA-C 117.409 1.724 . . . . 0.0 117.409 178.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.416 0.6 OUTLIER 59.97 -10.79 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 119.914 3.302 . . . . 0.0 119.914 -165.291 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 12.4 t-80 -88.4 121.93 31.33 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-N 121.192 1.814 . . . . 0.0 110.127 174.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 40.4 ttm -123.58 116.99 24.04 Favored 'General case' 0 CA--C 1.556 1.208 0 CA-C-O 121.553 0.692 . . . . 0.0 110.161 -174.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 27.6 mt -104.13 98.91 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 177.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 72.0 mt -94.23 111.76 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 178.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.551 ' NH1' ' HE2' ' A' ' 41' ' ' GLU . 41.9 mtt85 -110.27 101.79 10.5 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 178.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.436 ' HG1' ' NZ ' ' A' ' 40' ' ' LYS . 3.2 m -80.0 120.7 24.54 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 167.247 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 74.9 mt -124.39 118.21 26.19 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-O 121.649 0.738 . . . . 0.0 109.638 -164.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.47 -3.13 0.2 Allowed 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 117.018 2.229 . . . . 0.0 117.018 -178.191 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . 0.344 30.3 m 75.4 -62.97 0.43 Allowed 'General case' 0 N--CA 1.505 2.293 0 CA-C-N 121.556 1.98 . . . . 0.0 112.893 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -63.15 -44.44 95.51 Favored 'General case' 0 CA--C 1.571 1.778 0 N-CA-C 115.174 1.546 . . . . 0.0 115.174 165.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 31.4 ttt85 -128.16 130.77 48.59 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 120.081 1.309 . . . . 0.0 110.397 172.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -133.82 135.21 43.65 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.764 -0.585 . . . . 0.0 110.507 176.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -120.0 119.99 35.01 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 170.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 33.9 mm -112.4 104.88 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 174.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 94.4 mtp -110.74 98.71 7.8 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 -179.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -102.01 98.35 8.56 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 123.523 0.729 . . . . 0.0 110.136 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -142.78 156.78 45.03 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -168.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -94.7 131.26 40.7 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.105 -0.997 . . . . 0.0 110.824 166.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 22.0 t -66.85 113.3 2.84 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.776 0 C-N-CA 123.501 0.721 . . . . 0.0 109.978 -179.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 127.4 -55.45 0.75 Allowed Glycine 0 CA--C 1.548 2.109 0 CA-C-O 119.059 -0.856 . . . . 0.0 114.923 -158.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 13.9 pttt -75.76 145.58 40.69 Favored 'General case' 0 CA--C 1.567 1.627 0 N-CA-C 116.286 1.958 . . . . 0.0 116.286 -170.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -95.01 108.85 20.93 Favored 'General case' 0 CA--C 1.567 1.627 0 C-N-CA 123.172 0.589 . . . . 0.0 110.835 174.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -116.02 143.12 45.89 Favored 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 123.666 0.786 . . . . 0.0 112.819 -173.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -70.66 116.24 10.75 Favored 'General case' 0 CA--C 1.569 1.709 0 O-C-N 120.042 -1.661 . . . . 0.0 113.975 175.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.777 0 O-C-N 121.166 -0.959 . . . . 0.0 108.763 167.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 22.1 m . . . . . 0 CA--C 1.562 1.423 0 CA-C-O 122.208 1.004 . . . . 0.0 111.435 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 72.1 mmm -74.05 110.46 8.36 Favored 'General case' 0 CA--C 1.562 1.439 0 C-N-CA 123.744 0.818 . . . . 0.0 109.757 172.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 76.6 m -108.81 116.16 31.46 Favored 'General case' 0 N--CA 1.484 1.256 0 O-C-N 121.668 -0.645 . . . . 0.0 110.714 -161.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 89.8 m -104.68 125.81 51.15 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 176.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.425 HG23 ' SG ' ' A' ' 95' ' ' CYS . 15.4 t -117.85 119.24 60.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 177.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 56.8 m -140.56 150.18 43.35 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 123.341 0.656 . . . . 0.0 112.161 -174.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 90.7 m95 -79.27 119.74 22.76 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.462 -1.399 . . . . 0.0 112.847 177.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -93.55 78.52 4.34 Favored 'General case' 0 CA--C 1.567 1.616 0 O-C-N 121.631 -0.668 . . . . 0.0 109.295 163.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 67.65 -99.27 0.52 Allowed Glycine 0 N--CA 1.49 2.264 0 O-C-N 121.818 -0.551 . . . . 0.0 114.451 -171.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -102.95 -6.05 22.82 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 116.454 2.02 . . . . 0.0 116.454 170.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 35.8 mtmm -97.39 127.59 43.48 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-N 120.539 1.518 . . . . 0.0 110.026 176.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 22.3 tp -84.73 110.15 18.56 Favored 'General case' 0 CA--C 1.564 1.489 0 O-C-N 121.034 -1.041 . . . . 0.0 110.071 174.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -97.39 125.53 42.07 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.693 0.797 . . . . 0.0 110.841 -175.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . 0.425 ' SG ' HG23 ' A' ' 86' ' ' VAL . 39.4 t -114.03 124.33 51.87 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 123.284 0.633 . . . . 0.0 110.154 175.075 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.6 p -107.3 118.47 55.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 166.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -97.97 88.14 4.17 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 174.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -99.07 126.74 44.87 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.092 -1.005 . . . . 0.0 112.462 -174.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 166.39 -107.25 0.28 Allowed Glycine 0 N--CA 1.487 2.072 0 O-C-N 121.28 -0.887 . . . . 0.0 112.915 176.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -76.87 -10.22 59.22 Favored 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 117.764 2.505 . . . . 0.0 117.764 -177.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -122.94 142.84 50.37 Favored 'General case' 0 CA--C 1.566 1.563 0 CA-C-N 120.086 1.312 . . . . 0.0 111.294 177.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -81.79 144.32 31.16 Favored 'General case' 0 CA--C 1.563 1.467 0 O-C-N 121.491 -0.756 . . . . 0.0 111.565 173.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 57.63 23.96 51.4 Favored Glycine 0 N--CA 1.498 2.81 0 N-CA-C 120.854 3.102 . . . . 0.0 120.854 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 57.8 ttt180 -85.95 124.8 32.82 Favored 'General case' 0 CA--C 1.565 1.544 0 CA-C-N 118.501 1.151 . . . . 0.0 111.28 -178.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 178.25 -173.67 46.09 Favored Glycine 0 N--CA 1.488 2.119 0 O-C-N 121.341 -0.849 . . . . 0.0 114.852 -178.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . 0.25 16.8 p-90 -155.12 157.77 37.99 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 114.66 1.356 . . . . 0.0 114.66 171.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 31.8 m -123.77 123.7 41.06 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 123.831 0.852 . . . . 0.0 108.842 170.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -123.44 131.99 53.81 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 123.287 0.635 . . . . 0.0 111.882 -176.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 23.4 p90 -150.54 167.08 28.27 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.045 -1.034 . . . . 0.0 113.014 -179.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 89.3 mt -107.94 136.83 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.193 0 O-C-N 120.776 -1.202 . . . . 0.0 110.447 175.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -123.3 97.09 5.25 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 123.578 0.751 . . . . 0.0 109.701 164.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 76.97 -111.3 3.23 Favored Glycine 0 N--CA 1.491 2.316 0 O-C-N 121.275 -0.89 . . . . 0.0 113.9 -176.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -107.37 37.87 2.28 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 164.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -131.65 117.01 18.1 Favored 'General case' 0 CA--C 1.559 1.326 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 -168.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 17.2 tp -87.42 114.4 24.0 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-O 121.755 0.788 . . . . 0.0 109.914 172.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 48.9 m80 -102.66 120.09 39.96 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.972 0.909 . . . . 0.0 109.076 -177.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 49.5 tp -120.31 120.08 35.01 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 123.784 0.834 . . . . 0.0 109.833 -177.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -105.43 116.3 31.71 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.577 -0.702 . . . . 0.0 109.454 168.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 69.3 mtm -108.5 131.13 55.13 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 123.372 0.669 . . . . 0.0 111.023 -178.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 77.6 mtm-85 -115.16 143.87 44.56 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.534 -0.729 . . . . 0.0 111.411 -175.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -149.17 124.07 9.96 Favored 'General case' 0 N--CA 1.484 1.259 0 CA-C-O 121.456 0.646 . . . . 0.0 110.707 166.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 62.0 24.71 14.75 Favored 'General case' 0 CA--C 1.581 2.17 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 -172.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 88.33 -28.96 5.89 Favored Glycine 0 CA--C 1.557 2.694 0 N-CA-C 118.256 2.062 . . . . 0.0 118.256 -158.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 87.4 t -72.19 120.58 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 CA-C-N 119.644 1.722 . . . . 0.0 110.588 -173.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 29.4 m -102.12 123.74 46.5 Favored 'General case' 0 CA--C 1.566 1.573 0 CA-C-O 121.585 0.707 . . . . 0.0 111.484 -173.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 10.7 t -96.0 138.18 34.0 Favored 'General case' 0 CA--C 1.559 1.316 0 C-N-CA 124.3 1.04 . . . . 0.0 111.475 162.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 6.0 mtmt -118.07 124.14 47.36 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.333 -0.854 . . . . 0.0 110.051 179.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -127.24 134.45 50.08 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 123.593 0.757 . . . . 0.0 111.353 -177.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 38.0 t -116.68 132.39 66.52 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.439 ' CZ ' ' SD ' ' A' ' 10' ' ' MET . 38.3 m-85 -126.89 134.84 50.39 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.999 0.92 . . . . 0.0 111.062 -178.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 74.9 tttt -99.89 137.24 38.62 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.636 -1.29 . . . . 0.0 112.446 -179.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -71.56 118.82 14.86 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 179.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 26.8 m -104.04 -40.72 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 174.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 76.9 t60 . . . . . 0 C--O 1.253 1.273 0 CA-C-N 119.629 1.104 . . . . 0.0 108.416 166.275 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo . . . . . 0 CA--C 1.565 2.053 0 N-CA-C 117.061 1.908 . . . . 0.0 117.061 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.1 t -81.9 139.85 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.53 -0.731 . . . . 0.0 110.76 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -67.92 99.41 0.84 Allowed 'General case' 0 CA--C 1.569 1.674 0 O-C-N 121.109 -0.994 . . . . 0.0 113.35 167.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 10.6 m-30 -79.26 5.46 12.28 Favored 'General case' 0 CA--C 1.579 2.086 0 N-CA-C 116.364 1.987 . . . . 0.0 116.364 175.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -60.43 116.09 4.05 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 125.711 1.604 . . . . 0.0 114.616 -176.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 162.89 -177.9 38.8 Favored Glycine 0 N--CA 1.482 1.767 0 N-CA-C 116.646 1.419 . . . . 0.0 116.646 179.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 24.2 t80 -111.25 122.78 48.75 Favored 'General case' 0 CA--C 1.564 1.484 0 CA-C-N 113.514 -1.343 . . . . 0.0 108.138 170.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 83.1 m95 -122.43 125.82 46.64 Favored 'General case' 0 CA--C 1.564 1.497 0 C-N-CA 123.47 0.708 . . . . 0.0 109.93 -167.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -101.21 139.19 37.22 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.111 -0.993 . . . . 0.0 112.816 -179.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.473 ' SD ' ' HD2' ' A' ' 38' ' ' PRO . 42.0 ttm -67.1 126.12 28.19 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-N 120.241 1.382 . . . . 0.0 113.912 -179.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 91.3 mt -85.07 -55.54 4.0 Favored 'General case' 0 CA--C 1.567 1.611 0 CA-C-N 115.723 -0.672 . . . . 0.0 112.55 163.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 99.7 p -138.65 150.25 46.05 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 123.526 0.73 . . . . 0.0 112.773 -177.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -132.76 104.74 6.77 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.683 0.754 . . . . 0.0 109.453 165.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -108.0 124.77 50.66 Favored 'General case' 0 CA--C 1.56 1.357 0 C-N-CA 124.155 0.982 . . . . 0.0 109.487 -170.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.286 33.4 t30 64.87 24.3 12.74 Favored 'General case' 0 N--CA 1.502 2.165 0 N-CA-C 117.105 2.261 . . . . 0.0 117.105 -173.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -68.21 -45.02 74.45 Favored 'General case' 0 CA--C 1.569 1.68 0 N-CA-C 115.271 1.582 . . . . 0.0 115.271 176.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -43.36 -50.5 6.75 Favored 'General case' 0 N--CA 1.501 2.124 0 N-CA-C 117.319 2.341 . . . . 0.0 117.319 164.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -71.68 -38.45 70.61 Favored 'General case' 0 CA--C 1.571 1.752 0 N-CA-C 115.563 1.69 . . . . 0.0 115.563 177.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 73.0 t80 -53.98 -47.52 71.32 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 114.907 1.447 . . . . 0.0 114.907 162.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 72.6 mt -62.17 -42.0 98.85 Favored 'General case' 0 CA--C 1.574 1.871 0 N-CA-C 114.681 1.363 . . . . 0.0 114.681 171.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 26.1 ttt-85 -50.41 -50.74 51.01 Favored 'General case' 0 N--CA 1.501 2.118 0 N-CA-C 115.586 1.699 . . . . 0.0 115.586 163.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.25 -23.2 55.23 Favored 'General case' 0 CA--C 1.566 1.576 0 N-CA-C 118.181 2.66 . . . . 0.0 118.181 167.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 96.1 mt -88.95 13.83 11.9 Favored 'General case' 0 CA--C 1.574 1.901 0 N-CA-C 115.484 1.661 . . . . 0.0 115.484 165.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 60.29 40.59 17.57 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 115.984 1.846 . . . . 0.0 115.984 -174.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 88.9 t -93.65 137.83 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 120.99 -1.069 . . . . 0.0 109.185 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.5 p-10 -66.83 150.24 49.44 Favored 'General case' 0 CA--C 1.567 1.628 0 N-CA-C 115.19 1.552 . . . . 0.0 115.19 178.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 77.5 t -53.31 -41.23 43.01 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.291 0 N-CA-C 116.057 1.873 . . . . 0.0 116.057 -175.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.54 -49.19 78.75 Favored 'General case' 0 CA--C 1.568 1.635 0 N-CA-C 115.726 1.75 . . . . 0.0 115.726 170.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.6 tt -65.53 -41.86 92.62 Favored 'General case' 0 CA--C 1.574 1.887 0 N-CA-C 114.66 1.355 . . . . 0.0 114.66 171.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 74.8 mtp180 -46.85 -52.14 15.0 Favored 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 115.773 1.768 . . . . 0.0 115.773 164.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -65.71 -47.29 75.88 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 114.88 1.437 . . . . 0.0 114.88 171.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 61.4 mt -55.73 -57.98 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 CA-C-N 120.289 1.404 . . . . 0.0 112.766 175.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.27 -36.56 73.46 Favored 'General case' 0 CA--C 1.564 1.49 0 N-CA-C 118.409 2.744 . . . . 0.0 118.409 176.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -73.59 -30.71 63.17 Favored 'General case' 0 CA--C 1.57 1.724 0 N-CA-C 116.017 1.858 . . . . 0.0 116.017 171.051 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 73.8 mt -72.0 -33.54 68.18 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 116.001 1.852 . . . . 0.0 116.001 173.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.9 pp -78.94 150.64 32.02 Favored 'General case' 0 CA--C 1.566 1.588 0 N-CA-C 114.678 1.362 . . . . 0.0 114.678 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -109.52 94.06 15.4 Favored Pre-proline 0 CA--C 1.571 1.784 0 CA-C-O 118.286 -0.864 . . . . 0.0 108.797 176.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.473 ' HD2' ' SD ' ' A' ' 10' ' ' MET . 83.3 Cg_endo -78.44 171.07 17.45 Favored 'Trans proline' 0 CA--C 1.563 1.966 0 C-N-CA 122.806 2.337 . . . . 0.0 114.504 -178.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -116.61 127.7 54.71 Favored 'General case' 0 CA--C 1.56 1.359 0 CA-C-N 114.992 -1.003 . . . . 0.0 110.405 177.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 58.1 mttm -91.15 113.11 25.29 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.088 -1.007 . . . . 0.0 109.739 170.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -94.48 112.41 24.18 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 165.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 63.6 mt -110.86 119.35 59.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 -174.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 95.4 t -101.9 98.98 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 166.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -95.87 113.45 25.08 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 123.316 0.647 . . . . 0.0 110.028 175.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -116.2 64.59 0.7 Allowed 'General case' 0 CA--C 1.569 1.692 0 O-C-N 121.477 -0.765 . . . . 0.0 110.36 171.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 66.3 -97.95 0.35 Allowed Glycine 0 N--CA 1.487 2.07 0 N-CA-C 115.743 1.057 . . . . 0.0 115.743 -179.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -76.86 -41.84 42.43 Favored 'General case' 0 CA--C 1.565 1.541 0 N-CA-C 115.832 1.79 . . . . 0.0 115.832 169.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 13.1 t-160 -84.12 122.85 29.38 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 120.699 1.591 . . . . 0.0 111.429 175.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 8.6 ttp -137.93 131.34 30.75 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-O 122.116 0.96 . . . . 0.0 111.857 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 48.3 mt -115.24 107.84 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 73.1 mt -98.36 106.15 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 173.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 69.8 mtt180 -95.97 103.52 15.41 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.24 -0.912 . . . . 0.0 110.307 174.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 23.7 m -85.49 103.05 14.01 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 175.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.4 mt -104.5 118.32 36.32 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 124.104 0.962 . . . . 0.0 109.189 -166.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 47.1 t -118.84 161.67 19.77 Favored 'General case' 0 CA--C 1.556 1.183 0 CA-C-O 122.27 1.034 . . . . 0.0 111.181 -170.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 70.6 p -65.99 -19.76 65.97 Favored 'General case' 0 N--CA 1.5 2.025 0 N-CA-C 116.191 1.922 . . . . 0.0 116.191 161.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -78.08 -67.9 0.69 Allowed 'General case' 0 CA--C 1.569 1.679 0 CA-C-N 119.477 1.035 . . . . 0.0 112.185 169.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . 0.263 64.9 ttt180 -151.08 -117.15 0.04 OUTLIER 'General case' 0 CA--C 1.577 1.981 0 CA-C-N 120.516 1.507 . . . . 0.0 111.074 163.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 49.6 t-20 -164.48 138.44 5.27 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.178 -1.576 . . . . 0.0 109.237 -168.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 25.7 t80 -98.07 -55.4 2.79 Favored 'General case' 0 N--CA 1.5 2.054 0 N-CA-C 115.455 1.65 . . . . 0.0 115.455 -173.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.332 3.7 mp 62.02 92.7 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 -176.025 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 45.9 mmm -91.54 94.28 9.36 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.007 -1.058 . . . . 0.0 108.718 160.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.8 p30 -100.13 108.76 20.97 Favored 'General case' 0 CA--C 1.559 1.308 0 C-N-CA 123.954 0.902 . . . . 0.0 110.918 176.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 40.6 p90 -147.67 149.3 32.22 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-O 122.546 1.165 . . . . 0.0 114.029 -165.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 16.5 mm-40 -91.75 123.27 35.01 Favored 'General case' 0 CA--C 1.559 1.326 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.739 160.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 66.3 t -62.45 125.18 18.37 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.787 0 C-N-CA 124.109 0.964 . . . . 0.0 110.539 176.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 100.92 -36.66 4.03 Favored Glycine 0 CA--C 1.55 2.278 0 N-CA-C 117.075 1.59 . . . . 0.0 117.075 -167.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 84.5 mttt -81.21 129.88 34.78 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-N 119.775 1.788 . . . . 0.0 112.207 -176.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.58 ' HE2' ' NZ ' ' A' ' 98' ' ' LYS . 22.4 tt0 -88.93 103.69 16.26 Favored 'General case' 0 CA--C 1.566 1.578 0 O-C-N 121.789 -0.569 . . . . 0.0 111.668 -179.118 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -106.11 147.73 28.63 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -173.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.46 125.34 28.81 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.7 -1.25 . . . . 0.0 112.759 170.145 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 . . . . . 0 N--CA 1.5 2.045 0 CA-C-O 122.66 1.219 . . . . 0.0 113.487 174.85 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 89.2 m . . . . . 0 N--CA 1.489 1.502 0 N-CA-C 111.378 0.14 . . . . 0.0 111.378 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 2.7 mmt -70.83 99.19 1.69 Allowed 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 121.816 0.817 . . . . 0.0 111.123 176.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 64.7 m -114.47 111.37 21.3 Favored 'General case' 0 N--CA 1.483 1.186 0 O-C-N 121.648 -0.657 . . . . 0.0 110.541 -156.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 36.9 m -95.37 129.64 42.44 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 169.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.1 t -108.58 129.2 63.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 163.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 49.4 m -133.89 141.25 47.29 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.291 -0.88 . . . . 0.0 111.109 -175.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 42.6 m95 -78.29 107.74 11.12 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.66 -1.275 . . . . 0.0 110.859 169.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -85.61 74.92 10.2 Favored 'General case' 0 CA--C 1.568 1.645 0 O-C-N 121.362 -0.836 . . . . 0.0 109.822 168.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.95 -98.46 0.36 Allowed Glycine 0 N--CA 1.487 2.086 0 CA-C-N 116.18 -0.464 . . . . 0.0 114.133 -167.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -105.86 -4.05 21.18 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 116.378 1.992 . . . . 0.0 116.378 173.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 41.7 mtpt -103.36 124.98 49.71 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-N 120.327 1.421 . . . . 0.0 109.247 177.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 24.7 tp -84.79 107.48 16.99 Favored 'General case' 0 CA--C 1.563 1.458 0 O-C-N 120.858 -1.151 . . . . 0.0 110.493 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -96.54 131.25 43.35 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.704 0.802 . . . . 0.0 111.065 -175.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 53.8 t -122.67 136.87 55.0 Favored 'General case' 0 N--CA 1.484 1.269 0 O-C-N 121.645 -0.66 . . . . 0.0 111.693 175.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.7 p -127.08 119.46 52.94 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.637 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 171.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 19.2 mp0 -91.93 104.83 17.2 Favored 'General case' 0 CA--C 1.565 1.541 0 C-N-CA 124.001 0.921 . . . . 0.0 109.976 173.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.58 ' NZ ' ' HE2' ' A' ' 69' ' ' GLU . 94.7 mttt -91.26 131.44 36.77 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.161 -0.962 . . . . 0.0 112.442 -174.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 161.79 -98.37 0.16 Allowed Glycine 0 N--CA 1.485 1.92 0 O-C-N 121.949 -0.469 . . . . 0.0 112.854 168.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -77.41 -51.83 10.14 Favored 'General case' 0 CA--C 1.568 1.652 0 N-CA-C 115.649 1.722 . . . . 0.0 115.649 -177.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 58.3 mttm -99.31 143.03 30.04 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 122.613 1.197 . . . . 0.0 114.058 -160.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -83.95 97.33 9.19 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 122.144 0.973 . . . . 0.0 112.505 -166.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 82.31 41.48 9.23 Favored Glycine 0 N--CA 1.485 1.924 0 N-CA-C 117.443 1.737 . . . . 0.0 117.443 -168.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 64.0 ttt180 -77.25 113.01 14.56 Favored 'General case' 0 CA--C 1.566 1.594 0 CA-C-N 119.561 1.68 . . . . 0.0 110.41 164.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -169.3 177.79 42.77 Favored Glycine 0 N--CA 1.482 1.724 0 CA-C-O 122.184 0.88 . . . . 0.0 113.978 -177.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . 0.257 28.1 p-90 -152.13 158.47 42.99 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 171.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 33.5 m -129.14 118.64 22.77 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 176.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 -120.29 128.85 53.68 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 123.284 0.634 . . . . 0.0 111.79 -176.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 19.6 p90 -148.81 166.91 27.07 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.997 -1.064 . . . . 0.0 112.21 -179.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 96.2 mt -108.16 132.69 55.26 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.121 0 O-C-N 120.677 -1.264 . . . . 0.0 110.369 176.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -112.42 100.91 9.14 Favored 'General case' 0 CA--C 1.566 1.563 0 C-N-CA 123.796 0.838 . . . . 0.0 108.96 162.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 72.04 -109.51 2.85 Favored Glycine 0 N--CA 1.493 2.463 0 O-C-N 121.366 -0.833 . . . . 0.0 114.792 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -109.14 35.4 3.28 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 163.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -131.91 126.26 33.7 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.799 0.84 . . . . 0.0 109.53 -178.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 23.6 tp -88.6 118.45 28.26 Favored 'General case' 0 CA--C 1.56 1.363 0 C-N-CA 124.008 0.923 . . . . 0.0 109.954 173.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 44.8 m80 -105.47 120.83 42.6 Favored 'General case' 0 CA--C 1.56 1.328 0 C-N-CA 123.949 0.9 . . . . 0.0 108.972 -177.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 28.2 tp -119.38 123.81 45.04 Favored 'General case' 0 CA--C 1.561 1.397 0 C-N-CA 124.056 0.942 . . . . 0.0 109.798 -177.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -105.0 123.42 47.77 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.614 -0.679 . . . . 0.0 109.266 165.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 70.0 mtm -115.3 125.21 53.0 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-N 118.896 0.771 . . . . 0.0 110.659 178.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 69.3 mtp180 -112.89 144.64 42.1 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 123.169 0.588 . . . . 0.0 111.881 -178.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -156.89 129.76 7.73 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 123.079 0.551 . . . . 0.0 111.183 166.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 56.32 40.21 29.91 Favored 'General case' 0 N--CA 1.506 2.355 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 -172.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 77.47 -31.12 1.65 Allowed Glycine 0 CA--C 1.558 2.744 0 N-CA-C 119.536 2.575 . . . . 0.0 119.536 -160.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 90.0 t -77.87 123.39 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 CA-C-N 119.15 1.475 . . . . 0.0 111.114 -162.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 34.2 m -104.99 118.11 35.69 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 123.064 0.546 . . . . 0.0 111.629 -171.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 18.1 t -92.22 141.86 28.11 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.495 0.718 . . . . 0.0 112.006 163.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -117.75 118.16 31.3 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 123.348 0.659 . . . . 0.0 110.006 178.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 71.1 mt-30 -119.09 140.98 49.19 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 123.804 0.841 . . . . 0.0 111.695 179.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 25.0 t -128.46 132.56 67.91 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 177.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -126.64 139.86 52.85 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 123.584 0.754 . . . . 0.0 111.425 179.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 22.3 ttmt -99.49 139.73 34.71 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.881 -1.137 . . . . 0.0 112.67 178.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 73.7 tttt -73.66 118.83 17.08 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 178.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 34.2 m -103.03 -43.08 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 173.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 55.5 t-80 . . . . . 0 N--CA 1.484 1.266 0 CA-C-N 119.491 1.041 . . . . 0.0 108.259 168.079 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo . . . . . 0 CA--C 1.575 2.571 0 N-CA-C 114.039 0.746 . . . . 0.0 114.039 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 22.9 t -131.27 139.14 51.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 -175.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -76.89 107.53 9.29 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.641 -1.287 . . . . 0.0 110.76 163.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 15.9 m-30 -80.98 14.79 2.08 Favored 'General case' 0 CA--C 1.582 2.207 0 N-CA-C 115.905 1.817 . . . . 0.0 115.905 173.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -62.68 111.99 2.32 Favored 'General case' 0 CA--C 1.563 1.474 0 C-N-CA 125.667 1.587 . . . . 0.0 115.136 -172.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 161.09 -178.17 37.15 Favored Glycine 0 N--CA 1.486 1.984 0 N-CA-C 116.026 1.17 . . . . 0.0 116.026 178.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -106.29 123.64 48.37 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-N 114.917 -0.642 . . . . 0.0 109.468 174.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 80.6 m95 -121.55 122.08 38.9 Favored 'General case' 0 CA--C 1.561 1.391 0 C-N-CA 123.481 0.712 . . . . 0.0 109.329 -169.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -96.47 140.87 30.48 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.313 -0.867 . . . . 0.0 112.711 176.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 41.9 ttm -69.47 124.23 23.35 Favored 'General case' 0 CA--C 1.569 1.705 0 O-C-N 120.94 -1.1 . . . . 0.0 113.129 176.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 91.9 mt -82.68 -50.29 8.88 Favored 'General case' 0 CA--C 1.564 1.486 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 165.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.415 ' CB ' ' HE2' ' A' ' 14' ' ' GLU . 87.3 p -151.75 154.53 36.46 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 119.285 0.948 . . . . 0.0 113.274 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -127.37 105.6 8.63 Favored 'General case' 0 CA--C 1.568 1.673 0 C-N-CA 123.64 0.776 . . . . 0.0 110.632 174.354 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.415 ' HE2' ' CB ' ' A' ' 12' ' ' SER . 3.7 mp0 -96.19 129.78 43.41 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 124.608 1.163 . . . . 0.0 109.965 -174.429 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 34.3 t30 62.39 18.31 10.19 Favored 'General case' 0 N--CA 1.506 2.368 0 N-CA-C 117.048 2.24 . . . . 0.0 117.048 -179.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -65.59 -42.1 92.08 Favored 'General case' 0 CA--C 1.566 1.583 0 N-CA-C 115.832 1.79 . . . . 0.0 115.832 -178.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -58.37 -39.06 78.58 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 116.243 1.942 . . . . 0.0 116.243 168.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -66.19 -45.78 79.62 Favored 'General case' 0 CA--C 1.571 1.78 0 N-CA-C 114.849 1.426 . . . . 0.0 114.849 170.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -52.82 -48.82 66.7 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 115.121 1.526 . . . . 0.0 115.121 165.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 64.5 mt -62.46 -40.73 97.6 Favored 'General case' 0 CA--C 1.57 1.745 0 N-CA-C 114.746 1.387 . . . . 0.0 114.746 171.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 65.1 ttp85 -55.56 -46.68 77.14 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 115.229 1.566 . . . . 0.0 115.229 164.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.1 -18.85 39.09 Favored 'General case' 0 CA--C 1.569 1.681 0 N-CA-C 118.29 2.7 . . . . 0.0 118.29 164.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 92.3 mt -91.83 15.31 13.23 Favored 'General case' 0 CA--C 1.574 1.898 0 N-CA-C 115.265 1.58 . . . . 0.0 115.265 163.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.259 49.7 m-20 66.72 39.86 3.43 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 115.887 1.81 . . . . 0.0 115.887 -177.523 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 65.6 t -99.61 140.9 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 120.815 -1.178 . . . . 0.0 110.489 -177.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 8.3 p-10 -71.33 156.52 39.41 Favored 'General case' 0 CA--C 1.569 1.679 0 N-CA-C 115.265 1.579 . . . . 0.0 115.265 174.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 61.9 t -53.14 -44.95 53.38 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.373 0 N-CA-C 115.27 1.581 . . . . 0.0 115.27 -177.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.57 -49.2 78.49 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 116.101 1.889 . . . . 0.0 116.101 174.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 31.9 tp -65.8 -36.67 84.16 Favored 'General case' 0 CA--C 1.573 1.842 0 N-CA-C 115.777 1.769 . . . . 0.0 115.777 171.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 55.1 mtp180 -51.36 -52.55 44.67 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 115.394 1.627 . . . . 0.0 115.394 160.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -63.13 -43.29 98.78 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 115.679 1.733 . . . . 0.0 115.679 172.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 59.3 mt -55.76 -55.31 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.192 0 CA-C-N 120.276 1.398 . . . . 0.0 112.72 170.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.86 -43.53 94.62 Favored 'General case' 0 CA--C 1.566 1.573 0 N-CA-C 117.294 2.331 . . . . 0.0 117.294 173.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -53.91 -39.97 66.27 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 117.471 2.397 . . . . 0.0 117.471 167.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 80.7 mt -86.27 -13.21 47.39 Favored 'General case' 0 CA--C 1.572 1.815 0 N-CA-C 116.103 1.89 . . . . 0.0 116.103 175.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 37.9 mt -80.07 133.12 36.08 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-N 119.949 1.25 . . . . 0.0 111.314 169.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 29.1 mmtp -101.31 93.04 2.94 Favored Pre-proline 0 CA--C 1.571 1.755 0 CA-C-O 118.045 -0.978 . . . . 0.0 109.705 171.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -72.41 154.3 55.78 Favored 'Trans proline' 0 CA--C 1.563 1.943 0 CA-C-N 122.852 2.054 . . . . 0.0 114.739 177.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -112.3 127.5 56.0 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.685 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 45.8 mttp -95.42 110.06 22.15 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.508 -0.745 . . . . 0.0 109.854 177.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -95.48 104.77 16.68 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.379 -0.826 . . . . 0.0 108.825 166.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 76.0 mt -98.55 118.29 44.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 -173.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 83.4 t -109.86 95.86 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 107.289 -1.375 . . . . 0.0 107.289 176.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -96.34 114.0 25.64 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 123.567 0.747 . . . . 0.0 111.084 177.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -132.16 93.27 3.24 Favored 'General case' 0 CA--C 1.566 1.577 0 C-N-CA 123.401 0.68 . . . . 0.0 110.004 -178.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 53.67 63.68 4.89 Favored Glycine 0 N--CA 1.497 2.756 0 N-CA-C 118.569 2.188 . . . . 0.0 118.569 172.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.471 0.0 OUTLIER 76.71 -34.56 0.22 Allowed 'General case' 0 N--CA 1.501 2.077 0 N-CA-C 117.317 2.34 . . . . 0.0 117.317 -164.423 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 9.4 t-160 -82.4 108.97 16.23 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 120.923 1.692 . . . . 0.0 110.898 178.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 6.5 ttp -121.25 125.1 46.26 Favored 'General case' 0 CA--C 1.556 1.194 0 CA-C-O 122.147 0.975 . . . . 0.0 110.888 -176.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 4.4 mp -110.1 104.43 17.06 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.353 0 N-CA-C 106.53 -1.656 . . . . 0.0 106.53 -178.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 80.0 mt -89.33 96.09 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 174.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 93.1 mtt180 -84.9 97.27 9.67 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.656 -0.652 . . . . 0.0 110.038 -178.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 51.0 m -89.78 101.39 14.08 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.761 0.791 . . . . 0.0 109.312 -178.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 16.1 mt -102.94 120.93 41.5 Favored 'General case' 0 N--CA 1.485 1.312 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.033 -164.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 10.3 t -136.7 146.53 45.98 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.684 -0.635 . . . . 0.0 111.629 -178.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . 0.253 13.7 t -77.73 56.19 1.46 Allowed 'General case' 0 N--CA 1.503 2.181 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 172.179 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -168.81 -67.82 0.02 OUTLIER 'General case' 0 CA--C 1.567 1.623 0 C-N-CA 125.274 1.429 . . . . 0.0 108.517 -177.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 62.9 ttt-85 -136.67 124.75 22.93 Favored 'General case' 0 CA--C 1.565 1.521 0 CA-C-N 118.754 0.706 . . . . 0.0 109.517 172.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 44.1 t-20 -85.26 130.59 34.57 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.78 -0.575 . . . . 0.0 111.038 170.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -95.96 -75.02 0.54 Allowed 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 118.899 -0.572 . . . . 0.0 112.338 -175.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.331 38.5 mt 74.62 108.75 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 C-N-CA 124.261 1.025 . . . . 0.0 111.9 178.28 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 86.9 mtp -104.95 99.22 8.85 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.478 -0.764 . . . . 0.0 109.491 170.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.7 p30 -96.97 108.54 21.28 Favored 'General case' 0 CA--C 1.56 1.365 0 C-N-CA 124.064 0.946 . . . . 0.0 111.935 176.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 35.2 p90 -148.68 151.91 35.75 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-N 119.029 0.831 . . . . 0.0 113.103 -168.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 54.6 mt-30 -89.86 135.23 33.76 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.289 -0.882 . . . . 0.0 110.796 161.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 41.0 t -69.56 109.54 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.28 -0.888 . . . . 0.0 109.305 179.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 128.27 -50.49 0.89 Allowed Glycine 0 CA--C 1.548 2.122 0 CA-C-O 118.542 -1.143 . . . . 0.0 115.904 -162.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 15.3 ptpt -70.41 139.22 51.79 Favored 'General case' 0 CA--C 1.566 1.578 0 CA-C-N 119.8 1.8 . . . . 0.0 115.231 -173.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -97.71 97.42 9.0 Favored 'General case' 0 CA--C 1.566 1.578 0 C-N-CA 123.116 0.566 . . . . 0.0 110.135 175.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -103.92 130.67 51.55 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 -170.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -69.21 111.75 5.35 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.671 -1.268 . . . . 0.0 113.524 175.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 . . . . . 0 N--CA 1.491 1.577 0 O-C-N 121.22 -0.925 . . . . 0.0 110.683 -177.617 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 95.3 m . . . . . 0 N--CA 1.488 1.454 0 CA-C-O 122.416 1.103 . . . . 0.0 111.383 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 23.6 mtp -76.3 100.06 4.99 Favored 'General case' 0 CA--C 1.557 1.25 0 CA-C-O 122.434 1.111 . . . . 0.0 110.622 -170.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 88.5 m -103.23 112.89 25.97 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.329 -158.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 87.1 m -99.7 125.71 45.61 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 174.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 16.9 t -111.6 123.0 67.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 171.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 71.1 m -138.87 148.78 44.1 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.247 -0.908 . . . . 0.0 112.348 -175.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 10.9 m95 -82.79 122.76 28.61 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.68 -1.263 . . . . 0.0 113.694 -179.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -107.57 71.0 0.8 Allowed 'General case' 0 CA--C 1.572 1.815 0 C-N-CA 123.481 0.712 . . . . 0.0 109.737 160.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.24 -103.15 0.75 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 115.669 1.028 . . . . 0.0 115.669 -179.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.491 ' N ' ' HD2' ' A' ' 91' ' ' ASP . 1.1 m-20 -80.4 -25.17 39.22 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 116.322 1.971 . . . . 0.0 116.322 165.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -90.62 110.31 21.46 Favored 'General case' 0 N--CA 1.484 1.269 0 CA-C-N 119.861 1.21 . . . . 0.0 111.261 -179.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 32.7 tp -77.93 111.5 13.85 Favored 'General case' 0 CA--C 1.564 1.516 0 O-C-N 121.354 -0.841 . . . . 0.0 109.671 168.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 31.5 mm-40 -100.39 119.44 38.45 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.567 0.747 . . . . 0.0 110.862 -170.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 40.8 t -111.97 128.93 56.31 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.283 0.633 . . . . 0.0 111.068 175.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.1 p -126.83 121.04 57.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 CA-C-O 121.331 0.586 . . . . 0.0 109.845 174.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -100.79 98.8 9.28 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 124.018 0.927 . . . . 0.0 109.777 -174.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 55.4 mttp -90.84 118.06 29.95 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.337 -0.852 . . . . 0.0 112.238 -167.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 178.68 -118.95 0.63 Allowed Glycine 0 N--CA 1.486 2.008 0 O-C-N 121.137 -0.977 . . . . 0.0 113.624 172.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -75.74 -46.84 28.75 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 115.998 1.851 . . . . 0.0 115.998 -174.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 1.7 ttmp? -91.02 130.77 36.9 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 119.173 0.897 . . . . 0.0 112.081 -176.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -74.52 145.08 43.78 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -176.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 62.38 23.29 64.38 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 120.154 2.822 . . . . 0.0 120.154 -178.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 10.5 ttt85 -83.25 120.51 25.92 Favored 'General case' 0 CA--C 1.563 1.444 0 CA-C-N 119.165 1.483 . . . . 0.0 111.615 -179.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 172.99 -165.1 37.31 Favored Glycine 0 N--CA 1.484 1.865 0 CA-C-O 121.921 0.734 . . . . 0.0 114.605 -179.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 49.9 p-90 -157.14 158.09 35.69 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 114.341 1.237 . . . . 0.0 114.341 176.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 62.9 m -127.03 119.12 25.86 Favored 'General case' 0 CA--C 1.567 1.616 0 C-N-CA 124.117 0.967 . . . . 0.0 108.465 174.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -120.89 127.34 51.78 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.795 -0.566 . . . . 0.0 112.296 -175.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 23.6 p90 -142.76 169.75 16.99 Favored 'General case' 0 N--CA 1.499 1.977 0 C-N-CA 123.763 0.825 . . . . 0.0 112.978 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 94.5 mt -113.42 146.11 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.285 0 CA-C-O 123.145 1.45 . . . . 0.0 111.322 176.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -137.37 90.05 2.48 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 177.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 73.39 -119.35 6.59 Favored Glycine 0 N--CA 1.491 2.305 0 O-C-N 121.867 -0.521 . . . . 0.0 114.258 -172.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -91.16 11.44 23.26 Favored 'General case' 0 N--CA 1.5 2.045 0 N-CA-C 116.742 2.127 . . . . 0.0 116.742 165.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 75.8 mt-10 -111.29 138.29 47.95 Favored 'General case' 0 CA--C 1.56 1.34 0 CA-C-N 119.78 1.173 . . . . 0.0 111.999 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 10.4 tp -98.03 125.96 43.23 Favored 'General case' 0 CA--C 1.563 1.454 0 C-N-CA 123.902 0.881 . . . . 0.0 109.148 170.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 45.4 m80 -113.22 123.08 49.35 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.713 0.805 . . . . 0.0 109.126 -175.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 32.4 tp -122.59 122.26 38.43 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.596 0.758 . . . . 0.0 110.218 -174.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -100.51 117.15 34.06 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.715 -0.615 . . . . 0.0 109.589 164.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 74.3 mtm -105.09 125.93 51.52 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-N 118.782 0.719 . . . . 0.0 110.493 175.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 49.0 mtp180 -114.22 140.13 48.82 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.604 -0.685 . . . . 0.0 111.459 -174.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -151.51 126.75 9.91 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.787 -0.571 . . . . 0.0 110.616 167.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 61.72 28.92 17.87 Favored 'General case' 0 N--CA 1.504 2.232 0 N-CA-C 115.375 1.62 . . . . 0.0 115.375 -172.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 82.4 -27.6 3.62 Favored Glycine 0 CA--C 1.558 2.73 0 N-CA-C 118.693 2.237 . . . . 0.0 118.693 -158.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 96.4 t -73.8 119.38 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 CA-C-N 119.221 1.511 . . . . 0.0 110.416 -169.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 59.4 m -106.35 120.74 42.66 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.182 -169.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 6.6 t -97.31 122.8 40.75 Favored 'General case' 0 CA--C 1.558 1.28 0 C-N-CA 124.082 0.953 . . . . 0.0 111.528 170.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 85.6 mttt -96.19 119.62 35.02 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.824 -0.548 . . . . 0.0 110.059 176.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 18.2 mt-30 -119.68 123.4 43.73 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.706 -0.621 . . . . 0.0 110.686 -179.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 47.5 t -105.03 131.78 53.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 -177.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -126.17 149.08 49.24 Favored 'General case' 0 CA--C 1.563 1.455 0 C-N-CA 124.515 1.126 . . . . 0.0 110.511 -178.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 22.2 ttmt -118.62 141.0 49.01 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.94 -1.1 . . . . 0.0 112.002 175.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 61.6 tttt -74.87 126.43 30.93 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 179.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 33.3 m -107.09 -40.7 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 174.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 33.9 m170 . . . . . 0 C--O 1.255 1.354 0 CA-C-N 120.138 1.336 . . . . 0.0 108.784 -177.751 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo . . . . . 0 CA--C 1.575 2.531 0 N-CA-C 114.634 0.974 . . . . 0.0 114.634 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 18.1 m -144.95 153.64 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 120.595 -1.316 . . . . 0.0 110.393 -171.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -73.3 98.64 2.72 Favored 'General case' 0 CA--C 1.569 1.679 0 O-C-N 121.1 -1.0 . . . . 0.0 112.362 174.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 7.4 m-30 -78.95 -9.55 59.55 Favored 'General case' 0 CA--C 1.577 2.012 0 N-CA-C 115.471 1.656 . . . . 0.0 115.471 161.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -57.9 116.36 3.43 Favored 'General case' 0 CA--C 1.564 1.485 0 CA-C-N 120.837 1.653 . . . . 0.0 114.713 -176.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 152.62 -177.59 30.26 Favored Glycine 0 N--CA 1.486 2.028 0 CA-C-O 122.54 1.078 . . . . 0.0 115.711 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -105.42 123.35 47.72 Favored 'General case' 0 CA--C 1.562 1.434 0 CA-C-N 114.638 -0.781 . . . . 0.0 109.514 178.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 72.2 m95 -122.81 126.02 46.59 Favored 'General case' 0 CA--C 1.567 1.605 0 C-N-CA 123.364 0.666 . . . . 0.0 110.004 -170.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 62.2 pttt -95.06 140.16 30.4 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.244 -0.91 . . . . 0.0 113.167 177.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 50.4 ttm -69.73 129.69 40.29 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.638 -1.289 . . . . 0.0 113.626 174.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 87.4 mt -94.4 -58.27 2.25 Favored 'General case' 0 CA--C 1.567 1.611 0 CA-C-N 115.584 -0.735 . . . . 0.0 112.65 170.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 94.2 p -139.48 130.02 25.73 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 119.632 1.106 . . . . 0.0 113.431 -165.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -102.41 81.45 2.06 Favored 'General case' 0 CA--C 1.568 1.671 0 C-N-CA 123.871 0.868 . . . . 0.0 110.277 176.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -93.93 114.61 26.86 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.656 -1.278 . . . . 0.0 111.013 -170.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.272 22.2 t30 63.15 27.09 15.56 Favored 'General case' 0 N--CA 1.506 2.355 0 N-CA-C 116.801 2.148 . . . . 0.0 116.801 -171.138 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -69.94 -49.18 54.43 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 115.18 1.548 . . . . 0.0 115.18 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 90.0 mt-10 -61.35 -35.52 77.66 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 116.506 2.039 . . . . 0.0 116.506 174.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -63.69 -42.99 97.93 Favored 'General case' 0 CA--C 1.576 1.948 0 N-CA-C 115.187 1.551 . . . . 0.0 115.187 167.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 28.2 t80 -56.31 -50.68 70.74 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 115.041 1.496 . . . . 0.0 115.041 165.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.2 mt -61.3 -40.67 95.02 Favored 'General case' 0 CA--C 1.573 1.834 0 N-CA-C 115.191 1.552 . . . . 0.0 115.191 173.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 41.9 ttp85 -51.15 -50.66 58.49 Favored 'General case' 0 CA--C 1.575 1.904 0 N-CA-C 115.086 1.513 . . . . 0.0 115.086 162.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.74 -19.3 58.65 Favored 'General case' 0 CA--C 1.573 1.83 0 N-CA-C 118.462 2.764 . . . . 0.0 118.462 168.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 43.7 mt -86.51 2.08 49.24 Favored 'General case' 0 CA--C 1.572 1.79 0 N-CA-C 116.12 1.896 . . . . 0.0 116.12 165.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 61.04 46.66 8.05 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 115.126 1.528 . . . . 0.0 115.126 -169.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 99.0 t -93.95 135.04 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.403 -0.81 . . . . 0.0 108.838 176.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.0 p-10 -67.91 147.55 52.33 Favored 'General case' 0 CA--C 1.566 1.584 0 N-CA-C 115.504 1.668 . . . . 0.0 115.504 179.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 25.3 t -49.32 -44.98 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.327 0 N-CA-C 115.796 1.776 . . . . 0.0 115.796 -174.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.99 -46.19 88.75 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 116.3 1.963 . . . . 0.0 116.3 173.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.62 -43.69 96.12 Favored 'General case' 0 CA--C 1.572 1.794 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 168.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 27.5 mtm-85 -53.37 -41.1 65.53 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 116.516 2.043 . . . . 0.0 116.516 167.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -68.6 -54.9 13.63 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 168.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 63.1 mt -54.47 -51.62 47.88 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.303 0 CA-C-N 120.435 1.47 . . . . 0.0 113.841 178.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.78 -38.66 91.95 Favored 'General case' 0 CA--C 1.562 1.435 0 N-CA-C 117.642 2.46 . . . . 0.0 117.642 175.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 16.4 t30 -72.44 -30.33 64.49 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 116.395 1.998 . . . . 0.0 116.395 170.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 83.4 mt -75.05 -32.85 61.64 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 115.331 1.604 . . . . 0.0 115.331 172.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 93.6 mt -81.35 142.2 33.27 Favored 'General case' 0 CA--C 1.564 1.505 0 CA-C-N 119.384 0.993 . . . . 0.0 112.139 174.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -106.94 84.89 1.7 Allowed Pre-proline 0 CA--C 1.575 1.917 0 CA-C-O 118.248 -0.882 . . . . 0.0 109.947 175.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -72.94 166.27 30.5 Favored 'Trans proline' 0 CA--C 1.563 1.965 0 C-N-CA 122.537 2.158 . . . . 0.0 116.028 -178.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -111.25 138.83 47.21 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.214 -177.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 58.6 mttm -104.88 111.65 24.48 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.399 -0.813 . . . . 0.0 109.376 173.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 54.9 tt0 -98.74 102.87 14.74 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 171.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 61.3 mt -97.67 123.68 50.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.513 -0.742 . . . . 0.0 109.202 -169.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 88.4 t -102.48 101.93 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 166.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -104.2 108.19 19.45 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 123.706 0.803 . . . . 0.0 110.358 -179.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -112.56 72.32 0.77 Allowed 'General case' 0 CA--C 1.567 1.634 0 O-C-N 121.683 -0.636 . . . . 0.0 110.634 175.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 68.48 -95.65 0.39 Allowed Glycine 0 N--CA 1.489 2.21 0 N-CA-C 115.014 0.766 . . . . 0.0 115.014 -179.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -86.67 -37.09 18.34 Favored 'General case' 0 CA--C 1.566 1.574 0 N-CA-C 115.743 1.757 . . . . 0.0 115.743 166.077 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 20.8 t-160 -80.66 113.66 19.01 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 121.099 1.772 . . . . 0.0 111.463 -178.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 46.6 ttm -130.5 123.19 29.12 Favored 'General case' 0 CA--C 1.555 1.165 0 CA-C-O 121.386 0.612 . . . . 0.0 110.074 -169.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 54.5 mt -115.86 101.22 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 87.9 mt -89.79 90.67 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -77.59 99.01 5.59 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.303 -0.873 . . . . 0.0 110.715 -173.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 29.4 m -97.13 105.64 17.83 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-O 121.803 0.811 . . . . 0.0 109.016 -169.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 22.2 mt -109.49 117.17 33.3 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.991 0.917 . . . . 0.0 110.072 -159.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 19.2 t -133.87 146.55 50.69 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 123.154 0.582 . . . . 0.0 111.976 -174.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 43.5 p -79.92 61.66 3.89 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.122 -0.986 . . . . 0.0 112.631 172.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -169.95 -70.79 0.02 OUTLIER 'General case' 0 CA--C 1.569 1.693 0 C-N-CA 125.648 1.579 . . . . 0.0 107.513 178.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 32.1 mtt180 -139.8 131.5 27.35 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 123.803 0.841 . . . . 0.0 109.648 171.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -85.4 129.14 34.88 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.039 0.447 . . . . 0.0 111.027 176.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -91.35 -77.4 0.42 Allowed 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 123.146 0.579 . . . . 0.0 111.972 -172.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.36 14.9 mt 79.46 108.35 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 C-N-CA 124.216 1.006 . . . . 0.0 110.986 -179.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.76 95.74 6.85 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 123.513 0.725 . . . . 0.0 109.729 177.064 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -101.53 116.34 32.55 Favored 'General case' 0 CA--C 1.564 1.515 0 C-N-CA 124.228 1.011 . . . . 0.0 112.321 -175.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -157.91 156.44 31.33 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 115.07 1.507 . . . . 0.0 115.07 -171.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -104.23 119.24 38.52 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 123.474 0.709 . . . . 0.0 109.857 167.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 54.0 t -61.98 128.9 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 C-N-CA 123.936 0.894 . . . . 0.0 111.674 -178.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 99.74 -37.13 3.67 Favored Glycine 0 CA--C 1.55 2.279 0 N-CA-C 116.704 1.442 . . . . 0.0 116.704 -163.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 77.7 mttt -89.43 129.83 35.88 Favored 'General case' 0 CA--C 1.565 1.539 0 CA-C-N 118.88 1.34 . . . . 0.0 111.746 -172.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.617 ' HE2' ' NZ ' ' A' ' 98' ' ' LYS . 26.5 tt0 -81.84 106.61 13.9 Favored 'General case' 0 CA--C 1.567 1.615 0 O-C-N 121.321 -0.862 . . . . 0.0 111.771 178.119 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -109.88 148.89 30.72 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 123.856 0.862 . . . . 0.0 112.006 -175.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.62 124.09 23.04 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.2 -1.562 . . . . 0.0 111.73 168.15 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.496 1.84 0 CA-C-N 119.137 0.88 . . . . 0.0 111.612 -174.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 74.1 m . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 1.1 mmt -70.55 98.18 1.43 Allowed 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 122.216 1.008 . . . . 0.0 111.697 -176.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 95.5 m -112.36 114.53 27.31 Favored 'General case' 0 N--CA 1.481 1.115 0 O-C-N 121.51 -0.744 . . . . 0.0 110.452 -157.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 63.0 m -92.79 124.47 36.81 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 168.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.7 t -112.3 130.33 66.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 169.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 74.9 m -134.79 140.34 45.81 Favored 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 123.791 0.836 . . . . 0.0 111.989 -173.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 8.4 m95 -80.98 116.35 20.9 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.457 -1.402 . . . . 0.0 112.874 177.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 38.8 t0 -103.66 67.18 0.89 Allowed 'General case' 0 CA--C 1.576 1.95 0 C-N-CA 124.063 0.945 . . . . 0.0 110.189 164.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 68.08 -105.82 1.53 Allowed Glycine 0 N--CA 1.492 2.418 0 N-CA-C 115.641 1.016 . . . . 0.0 115.641 -179.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -72.87 -30.25 63.83 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 115.123 1.527 . . . . 0.0 115.123 163.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 24.0 mttt -92.78 110.59 22.03 Favored 'General case' 0 CA--C 1.557 1.221 0 CA-C-N 119.443 1.019 . . . . 0.0 111.62 -171.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 29.0 tp -82.07 105.57 13.28 Favored 'General case' 0 CA--C 1.563 1.479 0 O-C-N 120.47 -1.394 . . . . 0.0 110.164 171.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 11.2 mm100 -87.42 145.89 26.1 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 124.51 1.124 . . . . 0.0 110.721 -174.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 42.9 t -143.63 133.47 23.93 Favored 'General case' 0 N--CA 1.484 1.25 0 O-C-N 121.541 -0.724 . . . . 0.0 112.421 178.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.2 p -118.33 123.8 72.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 165.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -104.46 97.09 7.06 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 123.626 0.77 . . . . 0.0 109.427 -178.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.617 ' NZ ' ' HE2' ' A' ' 69' ' ' GLU . 92.5 mttt -83.42 111.43 19.03 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.761 -1.212 . . . . 0.0 111.425 -170.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 162.56 103.98 0.18 Allowed Glycine 0 N--CA 1.483 1.798 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.898 -172.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . 0.282 42.3 mt-10 69.61 -68.47 0.19 Allowed 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 116.142 1.904 . . . . 0.0 116.142 174.027 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -82.08 129.89 34.93 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 122.153 0.978 . . . . 0.0 111.242 -170.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -67.78 -45.97 73.3 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 116.096 1.887 . . . . 0.0 116.096 -162.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -101.68 54.52 0.78 Allowed Glycine 0 N--CA 1.49 2.286 0 CA-C-O 118.63 -1.095 . . . . 0.0 115.727 164.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.9 ttt-85 -85.25 116.88 23.85 Favored 'General case' 0 CA--C 1.565 1.543 0 CA-C-N 118.844 1.322 . . . . 0.0 112.062 -179.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 178.7 -173.24 45.58 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 115.139 0.816 . . . . 0.0 115.139 -174.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . 0.279 49.6 p-90 -155.48 167.89 28.92 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 123.338 1.542 . . . . 0.0 113.918 174.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 96.0 m -144.93 114.14 7.01 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.147 -1.596 . . . . 0.0 107.81 174.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 45.6 tt0 -114.67 127.56 55.83 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 123.566 0.746 . . . . 0.0 111.444 -173.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 9.6 p90 -148.34 154.85 40.54 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.706 -1.246 . . . . 0.0 113.679 -174.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 94.8 mt -98.84 133.98 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 O-C-N 120.793 -1.192 . . . . 0.0 110.823 176.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -120.09 91.79 3.62 Favored 'General case' 0 CA--C 1.567 1.618 0 C-N-CA 124.291 1.036 . . . . 0.0 108.387 162.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 69.36 -113.17 4.96 Favored Glycine 0 N--CA 1.492 2.402 0 O-C-N 121.238 -0.914 . . . . 0.0 114.927 -177.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -84.54 -8.75 58.81 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 117.423 2.379 . . . . 0.0 117.423 167.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 62.1 mt-10 -99.95 126.56 46.13 Favored 'General case' 0 CA--C 1.56 1.363 0 CA-C-N 120.549 1.522 . . . . 0.0 111.292 -176.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 21.2 tp -89.22 115.5 26.77 Favored 'General case' 0 CA--C 1.563 1.448 0 C-N-CA 124.224 1.01 . . . . 0.0 109.122 164.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 48.7 m80 -101.83 119.09 38.23 Favored 'General case' 0 CA--C 1.556 1.207 0 C-N-CA 123.979 0.911 . . . . 0.0 108.857 -178.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 42.7 tp -113.31 114.76 27.12 Favored 'General case' 0 CA--C 1.557 1.228 0 C-N-CA 123.677 0.791 . . . . 0.0 109.642 179.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -90.04 126.88 35.92 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.906 -0.496 . . . . 0.0 109.74 163.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 75.5 mtm -119.99 127.79 52.94 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-N 118.658 0.663 . . . . 0.0 110.297 176.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 88.0 mtm-85 -114.82 141.26 48.13 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 123.429 0.692 . . . . 0.0 111.326 -174.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -150.29 131.05 14.09 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.676 -0.64 . . . . 0.0 110.931 163.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 54.79 34.4 21.79 Favored 'General case' 0 N--CA 1.507 2.415 0 N-CA-C 116.169 1.914 . . . . 0.0 116.169 -172.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 76.43 -1.29 61.56 Favored Glycine 0 CA--C 1.557 2.709 0 N-CA-C 120.173 2.829 . . . . 0.0 120.173 -165.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 89.6 t -98.7 120.09 47.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 CA-C-N 120.453 2.126 . . . . 0.0 109.49 -173.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 30.7 m -102.88 120.9 41.44 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 123.243 0.617 . . . . 0.0 111.357 -172.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 33.5 t -92.32 140.34 29.7 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 123.384 0.674 . . . . 0.0 112.041 161.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 33.9 mtpt -104.24 114.94 29.53 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.6 -0.688 . . . . 0.0 110.564 164.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -104.48 124.27 48.97 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.334 0.654 . . . . 0.0 110.291 168.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 62.7 t -109.93 132.79 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -127.23 134.96 50.03 Favored 'General case' 0 CA--C 1.561 1.398 0 C-N-CA 124.104 0.962 . . . . 0.0 110.823 -177.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -103.57 137.38 41.72 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.837 -1.165 . . . . 0.0 112.493 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 71.4 tttt -71.35 125.79 27.93 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 177.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 27.7 m -116.24 -40.17 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.128 0 N-CA-C 114.058 1.133 . . . . 0.0 114.058 177.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 50.5 t60 . . . . . 0 N--CA 1.487 1.395 0 CA-C-N 120.47 1.487 . . . . 0.0 108.53 175.229 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo . . . . . 0 CA--C 1.557 1.658 0 CA-C-O 122.604 1.002 . . . . 0.0 113.919 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 27.6 m -78.38 155.16 5.06 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.687 0 CA-C-N 114.71 -1.132 . . . . 0.0 113.262 -174.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -68.93 100.93 1.27 Allowed 'General case' 0 CA--C 1.563 1.453 0 O-C-N 120.93 -1.106 . . . . 0.0 113.93 176.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 4.5 m-30 -70.61 -1.5 11.36 Favored 'General case' 0 CA--C 1.581 2.161 0 N-CA-C 116.871 2.175 . . . . 0.0 116.871 177.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -45.05 111.03 0.28 Allowed 'General case' 0 CA--C 1.566 1.569 0 N-CA-C 116.122 1.897 . . . . 0.0 116.122 173.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 165.96 175.85 36.76 Favored Glycine 0 N--CA 1.484 1.848 0 N-CA-C 116.313 1.285 . . . . 0.0 116.313 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 12.7 t80 -110.19 125.65 53.28 Favored 'General case' 0 CA--C 1.562 1.409 0 CA-C-N 113.952 -1.124 . . . . 0.0 108.657 173.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 82.3 m95 -124.67 127.4 47.24 Favored 'General case' 0 CA--C 1.565 1.539 0 C-N-CA 123.49 0.716 . . . . 0.0 109.982 -167.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -97.1 140.37 31.71 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.188 -0.945 . . . . 0.0 112.853 175.368 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 37.4 ttm -70.79 125.08 25.86 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.819 -1.176 . . . . 0.0 113.024 177.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 90.2 mt -84.62 -51.56 6.76 Favored 'General case' 0 CA--C 1.566 1.595 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 167.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 92.3 p -144.52 150.75 38.08 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 118.806 0.73 . . . . 0.0 112.2 177.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -125.84 114.11 18.13 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 123.13 0.572 . . . . 0.0 109.734 165.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -115.25 124.1 50.5 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 123.387 0.675 . . . . 0.0 109.651 -168.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.264 23.4 t30 62.16 25.26 15.11 Favored 'General case' 0 N--CA 1.504 2.251 0 N-CA-C 116.699 2.111 . . . . 0.0 116.699 -172.224 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -67.8 -43.5 79.51 Favored 'General case' 0 CA--C 1.567 1.633 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 175.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -45.96 -50.0 15.22 Favored 'General case' 0 N--CA 1.505 2.324 0 N-CA-C 116.433 2.012 . . . . 0.0 116.433 167.193 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -70.86 -41.01 71.95 Favored 'General case' 0 CA--C 1.57 1.747 0 N-CA-C 115.463 1.653 . . . . 0.0 115.463 178.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -50.84 -49.38 59.03 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 114.9 1.445 . . . . 0.0 114.9 160.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 81.2 mt -62.96 -39.5 94.84 Favored 'General case' 0 CA--C 1.574 1.877 0 N-CA-C 114.866 1.432 . . . . 0.0 114.866 173.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 69.0 ttp85 -52.45 -50.97 61.55 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 115.087 1.514 . . . . 0.0 115.087 164.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.54 -14.88 22.49 Favored 'General case' 0 CA--C 1.572 1.79 0 N-CA-C 118.545 2.794 . . . . 0.0 118.545 167.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 94.8 mt -97.36 16.48 19.95 Favored 'General case' 0 CA--C 1.57 1.742 0 N-CA-C 115.159 1.54 . . . . 0.0 115.159 164.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 60.74 45.37 10.14 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 115.547 1.684 . . . . 0.0 115.547 -177.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 98.0 t -99.83 138.24 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.22 -0.925 . . . . 0.0 109.794 -178.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 12.6 p30 -63.68 152.28 39.51 Favored 'General case' 0 CA--C 1.57 1.746 0 N-CA-C 115.112 1.523 . . . . 0.0 115.112 176.124 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . 0.251 78.8 t -58.62 -40.8 80.3 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.303 0 N-CA-C 115.307 1.595 . . . . 0.0 115.307 -177.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.26 -50.18 72.08 Favored 'General case' 0 CA--C 1.567 1.607 0 N-CA-C 115.953 1.834 . . . . 0.0 115.953 168.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 25.4 tp -66.9 -38.82 86.97 Favored 'General case' 0 CA--C 1.573 1.829 0 N-CA-C 116.052 1.871 . . . . 0.0 116.052 171.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 69.6 mtp180 -50.85 -47.87 60.19 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 115.303 1.594 . . . . 0.0 115.303 162.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -65.05 -54.42 30.49 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 170.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 61.6 mt -51.77 -55.66 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.246 0 CA-C-N 120.41 1.459 . . . . 0.0 113.172 175.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.23 -35.89 80.28 Favored 'General case' 0 CA--C 1.563 1.453 0 N-CA-C 118.352 2.723 . . . . 0.0 118.352 176.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -76.16 -33.43 59.37 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 116.018 1.859 . . . . 0.0 116.018 171.117 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 77.2 mt -72.85 -36.54 67.45 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 115.387 1.625 . . . . 0.0 115.387 178.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . 0.262 3.7 pp -93.92 151.94 19.21 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 119.327 0.967 . . . . 0.0 113.208 179.457 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 28.0 mmtp -108.42 93.37 11.48 Favored Pre-proline 0 CA--C 1.574 1.871 0 CA-C-O 118.078 -0.963 . . . . 0.0 110.03 -173.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -75.6 169.37 22.47 Favored 'Trans proline' 0 CA--C 1.565 2.043 0 C-N-CA 122.664 2.243 . . . . 0.0 115.605 -178.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -112.67 134.05 54.39 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-N 116.03 -0.532 . . . . 0.0 112.106 -177.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 23.5 mtpp -102.51 113.88 27.6 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.037 -1.04 . . . . 0.0 110.578 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -97.99 109.68 22.39 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.694 -0.629 . . . . 0.0 109.319 167.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 76.2 mt -102.42 120.56 52.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 -179.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 88.9 t -109.85 95.05 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 174.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -86.87 97.13 10.49 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 123.324 0.65 . . . . 0.0 110.362 173.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -102.27 70.46 1.18 Allowed 'General case' 0 CA--C 1.567 1.633 0 C-N-CA 123.556 0.742 . . . . 0.0 111.332 -178.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 57.94 65.8 3.27 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 117.368 1.707 . . . . 0.0 117.368 177.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.478 0.0 OUTLIER 82.07 -36.99 0.1 Allowed 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 116.473 2.027 . . . . 0.0 116.473 -165.235 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 12.3 t-160 -79.81 95.29 5.98 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-N 120.834 1.652 . . . . 0.0 110.513 175.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 4.1 ttp -104.6 119.52 39.19 Favored 'General case' 0 CA--C 1.552 1.052 0 CA-C-O 121.982 0.896 . . . . 0.0 110.094 -175.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 37.4 mt -106.32 101.16 12.05 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.479 0 N-CA-C 106.587 -1.634 . . . . 0.0 106.587 -178.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 88.1 mt -89.3 111.91 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 177.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 90.3 mtt180 -109.6 100.27 9.34 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -174.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 16.8 m -92.99 109.62 21.07 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 39.7 mt -102.64 123.62 46.69 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.349 0.66 . . . . 0.0 110.938 -159.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 10.2 t -151.01 160.51 43.88 Favored 'General case' 0 CA--C 1.571 1.763 0 CA-C-O 121.31 0.576 . . . . 0.0 112.474 -176.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.0 t -63.05 -36.07 82.35 Favored 'General case' 0 N--CA 1.504 2.235 0 N-CA-C 117.738 2.496 . . . . 0.0 117.738 175.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -76.48 -52.32 10.04 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 175.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.6 tmm_? -149.05 138.03 21.37 Favored 'General case' 0 CA--C 1.56 1.349 0 C-N-CA 124.212 1.005 . . . . 0.0 108.767 -178.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -102.06 114.93 29.48 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 174.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -87.54 121.42 29.96 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 122.862 0.465 . . . . 0.0 110.598 -173.204 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 43.2 mm -114.27 101.98 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 -177.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 76.5 mtp -95.28 90.53 5.88 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.126 -0.984 . . . . 0.0 109.132 169.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.6 p30 -95.15 108.17 20.27 Favored 'General case' 0 CA--C 1.561 1.376 0 C-N-CA 123.821 0.849 . . . . 0.0 111.82 178.045 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 29.4 p90 -147.77 142.88 27.1 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 113.844 1.054 . . . . 0.0 113.844 -169.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 17.1 mp0 -79.96 123.46 27.82 Favored 'General case' 0 CA--C 1.563 1.459 0 O-C-N 121.543 -0.723 . . . . 0.0 110.289 162.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 46.9 t -65.98 117.68 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 C-N-CA 123.315 0.646 . . . . 0.0 110.422 -179.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 115.44 -45.18 1.34 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 116.006 1.162 . . . . 0.0 116.006 -160.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -82.29 144.15 30.81 Favored 'General case' 0 CA--C 1.567 1.617 0 CA-C-N 118.802 1.301 . . . . 0.0 113.284 -173.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -95.14 111.56 23.38 Favored 'General case' 0 CA--C 1.564 1.504 0 O-C-N 121.76 -0.588 . . . . 0.0 111.481 176.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 22.8 p90 -106.94 142.74 36.07 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 123.33 0.652 . . . . 0.0 112.748 -177.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -71.13 114.2 8.95 Favored 'General case' 0 CA--C 1.567 1.622 0 O-C-N 120.358 -1.464 . . . . 0.0 112.177 170.719 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 . . . . . 0 CA--C 1.568 1.646 0 CA-C-O 122.125 0.965 . . . . 0.0 111.266 -175.904 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 93.5 m . . . . . 0 N--CA 1.488 1.447 0 CA-C-O 121.469 0.652 . . . . 0.0 111.24 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 80.6 mmm -71.61 103.73 3.11 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 121.714 0.768 . . . . 0.0 110.277 177.223 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 92.1 m -109.56 111.53 23.09 Favored 'General case' 0 N--CA 1.483 1.178 0 O-C-N 121.671 -0.643 . . . . 0.0 110.866 -159.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 95.1 m -94.71 128.24 41.25 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 170.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.9 t -116.41 129.66 72.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 172.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 58.2 m -149.09 157.12 43.14 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.423 -1.423 . . . . 0.0 113.316 -177.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 45.7 m95 -86.84 123.61 32.16 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.751 -1.218 . . . . 0.0 113.775 -174.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -109.35 73.3 0.84 Allowed 'General case' 0 CA--C 1.57 1.712 0 C-N-CA 124.064 0.946 . . . . 0.0 109.356 164.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.0 -125.14 29.68 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 114.637 0.615 . . . . 0.0 114.637 -172.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -61.12 -19.81 61.93 Favored 'General case' 0 N--CA 1.501 2.09 0 N-CA-C 116.526 2.047 . . . . 0.0 116.526 166.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 43.7 mttt -97.15 121.11 38.67 Favored 'General case' 0 CA--C 1.556 1.206 0 CA-C-N 119.554 1.07 . . . . 0.0 111.554 -174.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 24.3 tp -84.68 108.05 17.2 Favored 'General case' 0 CA--C 1.565 1.544 0 O-C-N 121.326 -0.859 . . . . 0.0 109.086 170.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -93.81 132.02 38.62 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.703 0.801 . . . . 0.0 111.036 -176.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 42.1 t -126.96 128.28 46.16 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.213 0.605 . . . . 0.0 111.315 178.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 12.7 p -109.8 118.12 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 168.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 55.7 mt-30 -99.42 73.69 1.87 Allowed 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 123.577 0.751 . . . . 0.0 109.813 178.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -83.96 134.13 34.67 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.577 -1.327 . . . . 0.0 113.781 -169.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 178.46 -85.03 0.07 OUTLIER Glycine 0 N--CA 1.485 1.932 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.955 -177.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -104.16 -58.25 1.91 Allowed 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 177.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -76.88 133.26 39.34 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 119.985 1.266 . . . . 0.0 112.07 -173.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -61.52 -54.73 39.34 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 116.171 1.915 . . . . 0.0 116.171 -167.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -98.67 53.42 1.11 Allowed Glycine 0 N--CA 1.489 2.177 0 N-CA-C 115.97 1.148 . . . . 0.0 115.97 169.223 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 25.7 ttt-85 -87.57 118.62 27.17 Favored 'General case' 0 CA--C 1.563 1.479 0 CA-C-N 118.685 1.243 . . . . 0.0 111.713 179.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 171.18 -168.9 42.02 Favored Glycine 0 N--CA 1.485 1.918 0 CA-C-O 121.892 0.718 . . . . 0.0 114.226 -179.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 38.5 p-90 -155.99 157.07 35.57 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 176.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 83.1 m -125.89 114.21 18.24 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 175.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 41.1 tt0 -117.57 123.01 45.19 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 123.413 0.685 . . . . 0.0 111.142 -175.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 12.5 p90 -144.36 148.58 34.9 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.966 -1.084 . . . . 0.0 113.229 -176.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 94.3 mt -97.3 135.87 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 CA-C-O 122.374 1.083 . . . . 0.0 110.374 177.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -122.9 87.21 2.71 Favored 'General case' 0 CA--C 1.563 1.445 0 CA-C-N 114.214 -1.357 . . . . 0.0 107.781 174.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 70.97 -105.25 1.58 Allowed Glycine 0 N--CA 1.491 2.323 0 O-C-N 121.488 -0.758 . . . . 0.0 114.714 -175.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 54.8 p30 -99.95 7.23 44.97 Favored 'General case' 0 CA--C 1.574 1.898 0 N-CA-C 116.868 2.173 . . . . 0.0 116.868 169.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -115.33 130.11 56.8 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-N 120.43 1.468 . . . . 0.0 111.694 -178.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 13.3 tp -90.94 115.56 28.06 Favored 'General case' 0 CA--C 1.561 1.384 0 C-N-CA 124.224 1.01 . . . . 0.0 109.356 170.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 43.4 m80 -102.31 122.45 44.27 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.873 0.869 . . . . 0.0 109.04 -178.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 49.3 tp -122.96 117.63 25.96 Favored 'General case' 0 CA--C 1.56 1.34 0 C-N-CA 123.701 0.801 . . . . 0.0 109.924 -174.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -104.77 107.87 19.05 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 169.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 68.5 mtm -100.18 128.5 46.24 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.881 -0.512 . . . . 0.0 110.682 178.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 68.5 mtp180 -115.03 143.45 45.17 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.656 -0.653 . . . . 0.0 111.868 -178.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -148.34 130.07 15.09 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.601 -0.687 . . . . 0.0 111.567 164.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 58.27 25.6 12.88 Favored 'General case' 0 N--CA 1.506 2.361 0 N-CA-C 115.716 1.746 . . . . 0.0 115.716 -167.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 90.37 -34.04 4.31 Favored Glycine 0 CA--C 1.557 2.685 0 N-CA-C 118.095 1.998 . . . . 0.0 118.095 -159.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 76.5 t -70.49 119.41 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 CA-C-N 119.276 1.538 . . . . 0.0 111.614 -165.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 21.0 m -95.13 123.36 38.58 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.166 0.507 . . . . 0.0 112.091 -173.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 10.4 t -94.03 130.87 40.0 Favored 'General case' 0 CA--C 1.561 1.383 0 C-N-CA 123.518 0.727 . . . . 0.0 110.99 159.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -108.36 111.63 23.65 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.558 -0.713 . . . . 0.0 109.45 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -111.46 132.07 54.75 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 123.612 0.765 . . . . 0.0 111.384 178.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 43.9 t -115.35 130.42 69.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 176.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -126.59 141.63 51.8 Favored 'General case' 0 CA--C 1.563 1.448 0 C-N-CA 124.232 1.013 . . . . 0.0 110.78 -178.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 10.3 tmtt? -110.46 139.7 45.42 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.966 -1.084 . . . . 0.0 112.288 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 37.0 tttp -73.68 117.23 15.21 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 113.464 0.913 . . . . 0.0 113.464 -177.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . 0.263 34.8 m -103.25 -39.28 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.152 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 174.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 38.2 t60 . . . . . 0 N--CA 1.486 1.344 0 CA-C-N 119.863 1.21 . . . . 0.0 107.956 163.654 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo . . . . . 0 CA--C 1.575 2.555 0 N-CA-C 114.877 1.068 . . . . 0.0 114.877 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -152.77 164.56 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 -178.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -87.85 104.67 16.81 Favored 'General case' 0 CA--C 1.567 1.612 0 O-C-N 119.89 -1.756 . . . . 0.0 111.308 167.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -88.73 3.52 50.59 Favored 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 115.808 1.781 . . . . 0.0 115.808 171.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 62.8 m-80 -65.22 114.63 4.83 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 120.93 1.695 . . . . 0.0 113.426 -178.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 168.33 169.04 31.28 Favored Glycine 0 N--CA 1.483 1.767 0 N-CA-C 116.113 1.205 . . . . 0.0 116.113 -176.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -103.19 128.07 50.29 Favored 'General case' 0 CA--C 1.565 1.52 0 CA-C-N 114.125 -1.037 . . . . 0.0 109.251 169.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 63.1 m95 -125.31 128.54 48.38 Favored 'General case' 0 CA--C 1.568 1.65 0 C-N-CA 123.663 0.785 . . . . 0.0 109.361 -170.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -92.73 147.5 22.81 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.753 -1.217 . . . . 0.0 112.831 171.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.413 ' SD ' ' HD2' ' A' ' 38' ' ' PRO . 42.7 ttm -72.64 130.52 40.76 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.723 -1.235 . . . . 0.0 112.528 171.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 83.3 mt -89.08 -53.24 4.67 Favored 'General case' 0 CA--C 1.568 1.636 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.622 163.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 87.3 p -140.4 151.67 45.12 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-N 119.175 0.898 . . . . 0.0 112.784 -176.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -128.75 112.71 14.48 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.744 -0.597 . . . . 0.0 110.21 166.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -110.91 122.93 49.11 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.911 0.885 . . . . 0.0 109.252 -172.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.263 27.1 t30 65.36 25.33 12.07 Favored 'General case' 0 N--CA 1.503 2.222 0 N-CA-C 116.901 2.186 . . . . 0.0 116.901 -175.358 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -68.09 -41.43 81.85 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 115.925 1.824 . . . . 0.0 115.925 178.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -58.52 -40.54 83.21 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 116.213 1.931 . . . . 0.0 116.213 170.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -69.63 -40.8 76.32 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 115.031 1.493 . . . . 0.0 115.031 174.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -51.39 -52.18 48.1 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 114.79 1.404 . . . . 0.0 114.79 161.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 75.0 mt -61.25 -40.46 94.15 Favored 'General case' 0 CA--C 1.573 1.851 0 N-CA-C 115.045 1.498 . . . . 0.0 115.045 172.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 45.7 ttp180 -53.95 -50.17 67.07 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 115.366 1.617 . . . . 0.0 115.366 164.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.63 -22.92 48.37 Favored 'General case' 0 CA--C 1.568 1.639 0 N-CA-C 118.172 2.656 . . . . 0.0 118.172 166.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 93.5 mt -85.83 11.84 10.37 Favored 'General case' 0 CA--C 1.574 1.88 0 N-CA-C 115.88 1.807 . . . . 0.0 115.88 165.02 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 60.69 35.82 19.67 Favored 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 115.951 1.834 . . . . 0.0 115.951 -172.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 97.5 t -96.44 138.62 21.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 120.797 -1.189 . . . . 0.0 109.119 -177.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 7.8 p-10 -67.01 154.35 41.41 Favored 'General case' 0 CA--C 1.567 1.615 0 N-CA-C 115.752 1.76 . . . . 0.0 115.752 -178.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 87.8 t -53.34 -43.65 51.93 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.349 0 N-CA-C 115.502 1.667 . . . . 0.0 115.502 -177.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.95 -47.36 83.14 Favored 'General case' 0 CA--C 1.567 1.608 0 N-CA-C 116.264 1.95 . . . . 0.0 116.264 172.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 31.2 tp -75.77 -26.32 57.26 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 116.477 2.028 . . . . 0.0 116.477 171.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 77.4 mtp180 -54.05 -52.65 60.2 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-N 120.695 1.589 . . . . 0.0 114.092 158.09 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 30.9 mmtp -63.38 -51.17 66.99 Favored 'General case' 0 CA--C 1.568 1.637 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 170.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 15.3 mt -78.42 60.98 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.408 0 CA-C-O 123.63 1.681 . . . . 0.0 111.166 178.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -177.07 -56.98 0.01 OUTLIER 'General case' 0 CA--C 1.562 1.429 0 C-N-CA 126.735 2.014 . . . . 0.0 109.139 -174.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -57.74 -42.69 84.46 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 116.504 2.038 . . . . 0.0 116.504 161.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 74.1 mt -79.31 -19.74 49.64 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 116.067 1.877 . . . . 0.0 116.067 -177.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.0 pp -101.91 141.91 34.03 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 118.988 0.813 . . . . 0.0 111.522 171.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 7.0 mtmp? -102.38 100.65 16.29 Favored Pre-proline 0 CA--C 1.572 1.811 0 CA-C-O 117.878 -1.058 . . . . 0.0 110.37 -177.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.413 ' HD2' ' SD ' ' A' ' 10' ' ' MET . 73.6 Cg_endo -75.76 170.18 20.72 Favored 'Trans proline' 0 CA--C 1.566 2.11 0 CA-C-N 122.85 2.054 . . . . 0.0 116.857 -175.09 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -102.52 154.45 19.09 Favored 'General case' 0 CA--C 1.566 1.558 0 CA-C-N 113.983 -1.462 . . . . 0.0 109.988 176.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 21.8 mtpp -128.46 114.06 16.31 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.807 -1.183 . . . . 0.0 109.227 171.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.475 ' HE2' ' NH1' ' A' ' 52' ' ' ARG . 35.1 tt0 -102.1 103.56 14.14 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 169.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 73.1 mt -98.24 124.72 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 -177.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 36.6 t -108.57 111.95 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 164.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -99.5 101.55 12.82 Favored 'General case' 0 CA--C 1.566 1.561 0 C-N-CA 123.943 0.897 . . . . 0.0 109.117 172.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -121.36 76.39 1.24 Allowed 'General case' 0 CA--C 1.567 1.627 0 C-N-CA 123.219 0.608 . . . . 0.0 111.409 -174.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 57.1 67.23 2.33 Favored Glycine 0 N--CA 1.497 2.723 0 N-CA-C 117.672 1.829 . . . . 0.0 117.672 171.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.488 0.0 OUTLIER 77.81 -43.53 0.4 Allowed 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 116.209 1.929 . . . . 0.0 116.209 -163.204 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 21.1 t-160 -73.56 109.26 6.93 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-N 120.797 1.635 . . . . 0.0 111.168 176.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 2.9 tpp -114.64 124.99 53.24 Favored 'General case' 0 CA--C 1.555 1.171 0 CA-C-O 122.045 0.926 . . . . 0.0 110.111 178.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 19.3 mt -108.63 103.86 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 N-CA-C 105.407 -2.072 . . . . 0.0 105.407 174.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 90.0 mt -93.41 95.16 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 172.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.475 ' NH1' ' HE2' ' A' ' 41' ' ' GLU . 63.1 mtt85 -82.68 94.66 7.62 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.345 -0.847 . . . . 0.0 110.003 177.02 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 34.1 m -84.8 109.29 17.97 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.137 -1.061 . . . . 0.0 108.137 172.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 15.3 mt -116.66 107.66 14.97 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 -164.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 36.7 p -116.45 155.5 28.47 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.349 0.66 . . . . 0.0 111.314 -173.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.3 t -68.35 4.16 1.43 Allowed 'General case' 0 CA--C 1.581 2.149 0 N-CA-C 117.992 2.59 . . . . 0.0 117.992 167.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -104.13 -58.86 1.82 Allowed 'General case' 0 CA--C 1.568 1.671 0 CA-C-N 119.619 1.099 . . . . 0.0 111.836 163.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 11.8 ptm180 -140.02 160.62 39.52 Favored 'General case' 0 CA--C 1.568 1.665 0 CA-C-O 122.56 1.172 . . . . 0.0 114.026 175.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -82.49 128.55 34.38 Favored 'General case' 0 CA--C 1.568 1.652 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.333 160.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -95.97 -66.91 0.88 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.592 -0.692 . . . . 0.0 110.92 178.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.359 58.6 mt 69.76 91.35 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 C-N-CA 124.563 1.145 . . . . 0.0 112.893 170.215 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 75.9 mtp -91.57 96.57 10.55 Favored 'General case' 0 CA--C 1.565 1.55 0 O-C-N 121.544 -0.723 . . . . 0.0 109.276 173.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -96.89 113.38 24.92 Favored 'General case' 0 CA--C 1.564 1.517 0 C-N-CA 123.893 0.877 . . . . 0.0 110.108 178.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -153.98 156.15 36.9 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -171.17 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 11.5 mp0 -91.62 126.27 36.65 Favored 'General case' 0 CA--C 1.564 1.505 0 O-C-N 121.403 -0.811 . . . . 0.0 110.286 163.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 41.5 t -67.41 114.69 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 C-N-CA 124.194 0.998 . . . . 0.0 109.381 174.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 119.88 -47.69 1.01 Allowed Glycine 0 N--CA 1.489 2.172 0 N-CA-C 115.58 0.992 . . . . 0.0 115.58 -160.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 85.1 mttt -79.75 141.01 36.72 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-N 118.743 1.272 . . . . 0.0 113.53 -173.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.591 ' HE2' ' NZ ' ' A' ' 98' ' ' LYS . 55.4 tt0 -100.83 100.79 11.49 Favored 'General case' 0 CA--C 1.565 1.532 0 C-N-CA 123.275 0.63 . . . . 0.0 111.164 -178.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -105.96 144.53 32.55 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 -168.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -73.43 103.69 4.17 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.691 -1.255 . . . . 0.0 111.735 173.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.571 1.767 0 N-CA-C 114.534 1.309 . . . . 0.0 114.534 -170.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 88.2 m . . . . . 0 CA--C 1.556 1.187 0 CA-C-O 121.533 0.682 . . . . 0.0 111.134 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 87.7 mmm -73.08 101.55 3.3 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-O 121.878 0.847 . . . . 0.0 110.751 -172.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 92.2 m -109.16 107.1 17.26 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.535 -158.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 64.6 m -92.8 128.68 38.75 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 172.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 18.2 t -112.55 130.67 65.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 167.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 39.5 m -150.74 155.89 40.19 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.589 -1.319 . . . . 0.0 112.853 -175.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 55.8 m95 -86.24 122.47 30.27 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.836 -1.165 . . . . 0.0 113.601 -175.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -102.54 67.03 0.99 Allowed 'General case' 0 CA--C 1.574 1.897 0 C-N-CA 123.286 0.634 . . . . 0.0 109.646 157.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 60.87 -104.17 0.62 Allowed Glycine 0 N--CA 1.492 2.387 0 N-CA-C 115.825 1.09 . . . . 0.0 115.825 -175.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -72.46 -27.78 62.52 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 116.357 1.984 . . . . 0.0 116.357 168.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -91.08 115.23 27.85 Favored 'General case' 0 N--CA 1.485 1.294 0 CA-C-N 119.505 1.048 . . . . 0.0 111.301 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 31.4 tp -80.22 110.38 15.59 Favored 'General case' 0 CA--C 1.565 1.555 0 O-C-N 121.401 -0.812 . . . . 0.0 109.207 167.022 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 30.4 mm-40 -101.07 126.05 47.73 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.713 0.805 . . . . 0.0 110.884 -170.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 40.4 t -118.05 128.9 55.21 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.592 0.757 . . . . 0.0 111.058 176.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.6 p -120.67 118.45 56.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 172.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 63.4 mt-30 -103.21 95.47 6.13 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 123.919 0.887 . . . . 0.0 109.339 -175.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.591 ' NZ ' ' HE2' ' A' ' 69' ' ' GLU . 81.4 mttt -85.23 119.98 26.21 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.749 -1.22 . . . . 0.0 112.373 -168.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 176.51 -101.55 0.16 Allowed Glycine 0 N--CA 1.486 2.004 0 O-C-N 121.458 -0.776 . . . . 0.0 114.0 170.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -86.99 -59.35 2.28 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 -173.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 12.3 mptt -75.26 129.81 38.06 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 122.551 1.167 . . . . 0.0 110.945 -179.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 -76.47 -38.16 55.79 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 116.659 2.096 . . . . 0.0 116.659 -157.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -106.18 56.25 0.51 Allowed Glycine 0 N--CA 1.49 2.249 0 CA-C-N 119.258 0.936 . . . . 0.0 114.81 162.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 35.9 ttt180 -87.44 122.06 30.68 Favored 'General case' 0 CA--C 1.567 1.597 0 CA-C-N 118.364 1.082 . . . . 0.0 112.573 -177.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 172.9 -167.1 39.87 Favored Glycine 0 CA--C 1.546 2.019 0 N-CA-C 114.991 0.757 . . . . 0.0 114.991 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . 0.254 34.7 p-90 -155.26 156.03 34.86 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 113.888 1.069 . . . . 0.0 113.888 170.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 91.1 m -127.74 118.43 23.77 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 176.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -122.66 121.23 35.9 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.743 -0.598 . . . . 0.0 111.728 -174.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 21.9 p90 -134.45 165.74 24.47 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.347 -0.846 . . . . 0.0 113.138 178.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 95.4 mt -110.12 132.55 58.12 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.135 -0.978 . . . . 0.0 109.819 175.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -114.47 91.98 3.81 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 123.979 0.912 . . . . 0.0 108.878 168.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 71.67 -106.49 1.92 Allowed Glycine 0 N--CA 1.491 2.328 0 O-C-N 121.463 -0.773 . . . . 0.0 114.732 -177.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -108.06 32.76 4.53 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 115.111 1.523 . . . . 0.0 115.111 165.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -129.33 131.46 46.9 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-N 119.073 0.851 . . . . 0.0 110.345 178.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 12.9 tp -95.83 122.08 38.23 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 121.675 0.75 . . . . 0.0 109.531 175.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 41.0 m80 -111.28 117.31 32.8 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -174.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 42.4 tp -119.81 118.71 31.54 Favored 'General case' 0 CA--C 1.561 1.399 0 C-N-CA 123.764 0.826 . . . . 0.0 110.051 -172.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -106.57 107.72 18.86 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.68 -0.638 . . . . 0.0 109.603 171.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 72.9 mtm -99.58 129.92 45.78 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 123.035 0.534 . . . . 0.0 111.072 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 73.4 mtp85 -117.68 141.85 47.91 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.548 -0.72 . . . . 0.0 112.515 -172.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -151.23 133.47 15.31 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 123.187 0.595 . . . . 0.0 111.274 165.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 59.3 20.82 9.01 Favored 'General case' 0 N--CA 1.509 2.484 0 N-CA-C 116.373 1.99 . . . . 0.0 116.373 -173.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 86.91 -18.61 34.42 Favored Glycine 0 CA--C 1.557 2.715 0 N-CA-C 119.018 2.367 . . . . 0.0 119.018 -159.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 87.4 t -81.31 121.27 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 CA-C-N 119.498 1.649 . . . . 0.0 109.869 -174.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 25.0 m -101.75 126.03 48.53 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.217 0.532 . . . . 0.0 111.812 -177.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 7.7 t -95.59 125.64 40.32 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.885 0.874 . . . . 0.0 110.919 162.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 51.7 mtpt -105.5 113.25 26.72 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 123.123 0.569 . . . . 0.0 109.815 -177.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 -114.28 136.56 52.83 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.516 -0.74 . . . . 0.0 111.652 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 62.6 t -116.98 130.31 72.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 178.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -124.78 149.87 46.91 Favored 'General case' 0 CA--C 1.565 1.536 0 C-N-CA 124.536 1.134 . . . . 0.0 110.696 -179.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 25.8 ttmt -119.7 141.95 48.93 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.028 -1.045 . . . . 0.0 112.293 175.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 36.5 tttm -74.68 128.56 35.84 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -177.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 29.2 m -111.73 -33.74 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 178.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 49.1 t-80 . . . . . 0 N--CA 1.485 1.292 0 CA-C-N 120.569 1.531 . . . . 0.0 109.112 174.215 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_endo . . . . . 0 CA--C 1.56 1.796 0 N-CA-C 115.017 1.122 . . . . 0.0 115.017 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 27.5 t -97.56 -98.31 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.57 1.712 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 -171.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -152.1 79.15 1.25 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.809 -1.182 . . . . 0.0 108.052 160.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -74.46 -11.34 60.21 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 116.514 2.042 . . . . 0.0 116.514 179.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -61.83 108.56 1.04 Allowed 'General case' 0 CA--C 1.563 1.473 0 C-N-CA 125.813 1.645 . . . . 0.0 114.02 -178.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 163.2 -179.27 38.48 Favored Glycine 0 N--CA 1.483 1.802 0 N-CA-C 116.453 1.341 . . . . 0.0 116.453 -179.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -106.92 128.3 54.19 Favored 'General case' 0 CA--C 1.564 1.505 0 CA-C-N 114.035 -1.082 . . . . 0.0 109.234 171.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 73.4 m95 -122.14 143.53 49.49 Favored 'General case' 0 CA--C 1.572 1.808 0 C-N-CA 123.964 0.905 . . . . 0.0 110.102 -169.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -111.67 140.39 46.34 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.035 -1.041 . . . . 0.0 112.306 173.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 50.0 ttm -72.08 125.11 26.45 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.099 -1.001 . . . . 0.0 112.93 176.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 86.4 mt -82.62 -47.87 11.59 Favored 'General case' 0 CA--C 1.567 1.609 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 166.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 80.0 p -148.74 147.96 29.44 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 123.496 0.718 . . . . 0.0 112.242 177.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -120.57 105.8 11.16 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 123.133 0.573 . . . . 0.0 109.535 164.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -101.44 125.48 48.08 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.418 -0.801 . . . . 0.0 109.911 -177.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.273 19.5 t30 64.89 18.91 11.69 Favored 'General case' 0 CA--C 1.583 2.213 0 N-CA-C 117.515 2.413 . . . . 0.0 117.515 -177.588 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -65.28 -47.85 75.22 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 115.516 1.673 . . . . 0.0 115.516 176.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -56.72 -35.32 68.42 Favored 'General case' 0 CA--C 1.576 1.97 0 N-CA-C 117.211 2.3 . . . . 0.0 117.211 172.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -68.4 -46.92 68.67 Favored 'General case' 0 CA--C 1.573 1.834 0 N-CA-C 114.79 1.404 . . . . 0.0 114.79 166.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -52.25 -46.98 66.0 Favored 'General case' 0 N--CA 1.501 2.088 0 N-CA-C 115.369 1.618 . . . . 0.0 115.369 167.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 93.1 mt -61.9 -39.86 93.43 Favored 'General case' 0 CA--C 1.573 1.864 0 N-CA-C 115.061 1.504 . . . . 0.0 115.061 170.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 67.4 ttp85 -56.87 -48.48 78.02 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 115.241 1.571 . . . . 0.0 115.241 164.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.2 -19.15 12.5 Favored 'General case' 0 CA--C 1.569 1.706 0 N-CA-C 118.21 2.671 . . . . 0.0 118.21 167.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 84.5 mt -95.22 3.71 54.31 Favored 'General case' 0 CA--C 1.569 1.694 0 N-CA-C 116.078 1.881 . . . . 0.0 116.078 167.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.566 ' HD2' ' NZ ' ' A' ' 101' ' ' LYS . 31.7 m-20 58.49 46.17 15.39 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 115.452 1.649 . . . . 0.0 115.452 -169.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 70.0 t -90.3 143.07 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.322 -0.861 . . . . 0.0 109.259 178.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -60.3 145.57 47.12 Favored 'General case' 0 CA--C 1.569 1.681 0 N-CA-C 115.556 1.687 . . . . 0.0 115.556 -176.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . 0.272 91.9 t -60.27 -36.01 65.84 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.168 0 N-CA-C 115.137 1.532 . . . . 0.0 115.137 -176.691 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.27 -55.03 38.33 Favored 'General case' 0 CA--C 1.566 1.584 0 N-CA-C 115.889 1.811 . . . . 0.0 115.889 167.256 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 5.5 tt -65.27 -39.6 92.82 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 115.565 1.691 . . . . 0.0 115.565 171.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 37.7 mtp-105 -46.84 -41.6 15.9 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 117.208 2.299 . . . . 0.0 117.208 165.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -74.67 -54.84 6.65 Favored 'General case' 0 CA--C 1.567 1.608 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 164.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 4.8 mt -80.89 60.78 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.585 2.296 0 CA-C-N 120.395 1.452 . . . . 0.0 111.61 -176.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -176.03 -51.71 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 126.392 1.877 . . . . 0.0 110.157 -176.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -63.23 -41.25 99.07 Favored 'General case' 0 CA--C 1.568 1.651 0 N-CA-C 115.76 1.763 . . . . 0.0 115.76 161.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 84.0 mt -75.03 -28.93 60.65 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 115.792 1.775 . . . . 0.0 115.792 178.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . 0.259 3.1 pp -91.0 152.12 20.8 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 119.462 1.028 . . . . 0.0 112.24 170.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 29.6 mmtp -108.23 91.71 8.52 Favored Pre-proline 0 CA--C 1.572 1.821 0 CA-C-O 118.064 -0.969 . . . . 0.0 109.341 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -77.22 175.73 10.98 Favored 'Trans proline' 0 CA--C 1.563 1.931 0 C-N-CA 122.384 2.056 . . . . 0.0 116.317 -172.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -107.92 155.87 19.83 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 114.985 -1.007 . . . . 0.0 112.392 178.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 40.9 mttp -121.02 119.64 33.09 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.663 -0.648 . . . . 0.0 109.382 169.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -96.73 111.01 23.35 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.463 -0.939 . . . . 0.0 108.463 162.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 74.3 mt -106.81 122.38 60.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 92.9 t -103.92 104.48 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 167.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -112.52 97.57 6.68 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 123.562 0.745 . . . . 0.0 111.159 -176.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -96.58 69.32 2.54 Favored 'General case' 0 CA--C 1.567 1.634 0 O-C-N 120.88 -1.138 . . . . 0.0 110.766 172.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 64.45 -89.7 0.09 OUTLIER Glycine 0 N--CA 1.491 2.328 0 N-CA-C 116.169 1.227 . . . . 0.0 116.169 -178.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.541 ' HD2' ' N ' ' A' ' 48' ' ' HIS . 5.8 p30 -81.84 -39.77 23.46 Favored 'General case' 0 CA--C 1.566 1.573 0 N-CA-C 115.91 1.819 . . . . 0.0 115.91 166.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.541 ' N ' ' HD2' ' A' ' 47' ' ' ASP . 11.7 t-160 -80.3 121.74 26.04 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 121.055 1.752 . . . . 0.0 111.893 -178.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 42.2 ttm -130.29 128.48 41.64 Favored 'General case' 0 CA--C 1.556 1.198 0 CA-C-O 121.597 0.713 . . . . 0.0 111.362 -177.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 46.7 mt -113.56 103.37 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 170.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 64.7 mt -92.88 98.8 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 174.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -86.46 98.89 11.28 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.333 -0.854 . . . . 0.0 109.967 174.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 31.9 m -83.57 109.91 17.8 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 172.075 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 53.5 mt -114.79 118.96 35.04 Favored 'General case' 0 CA--C 1.559 1.302 0 C-N-CA 124.005 0.922 . . . . 0.0 109.725 -164.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 9.7 p -133.62 155.42 49.71 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.256 0.55 . . . . 0.0 111.923 177.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 26.1 m -80.86 59.29 3.67 Favored 'General case' 0 N--CA 1.505 2.3 0 O-C-N 120.726 -1.234 . . . . 0.0 112.197 169.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -172.42 -64.53 0.02 OUTLIER 'General case' 0 CA--C 1.568 1.654 0 C-N-CA 125.509 1.524 . . . . 0.0 109.25 -179.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 65.5 ttt180 -138.93 140.3 38.26 Favored 'General case' 0 CA--C 1.568 1.639 0 CA-C-N 118.965 0.802 . . . . 0.0 110.81 175.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -110.28 137.7 47.65 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 123.338 0.655 . . . . 0.0 110.487 174.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -91.41 -74.92 0.49 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.657 -0.652 . . . . 0.0 111.375 178.545 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.363 54.3 mt 75.87 93.45 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 C-N-CA 124.368 1.067 . . . . 0.0 110.664 -177.207 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 81.1 mtp -100.29 99.56 10.24 Favored 'General case' 0 CA--C 1.561 1.37 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 174.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -101.32 113.35 26.34 Favored 'General case' 0 CA--C 1.565 1.52 0 C-N-CA 124.123 0.969 . . . . 0.0 111.614 178.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -157.77 158.32 35.04 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.154 -0.966 . . . . 0.0 113.224 -166.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 30.5 tt0 -95.38 130.6 42.11 Favored 'General case' 0 CA--C 1.564 1.485 0 O-C-N 121.123 -0.986 . . . . 0.0 110.822 160.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.3 t -65.25 117.31 5.64 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.813 0 C-N-CA 124.12 0.968 . . . . 0.0 109.535 170.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 115.25 -46.6 1.14 Allowed Glycine 0 CA--C 1.551 2.313 0 N-CA-C 115.667 1.027 . . . . 0.0 115.667 -159.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -82.77 154.49 24.73 Favored 'General case' 0 CA--C 1.567 1.633 0 CA-C-N 118.662 1.231 . . . . 0.0 113.729 -179.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -99.3 130.86 45.62 Favored 'General case' 0 CA--C 1.57 1.736 0 CA-C-O 121.928 0.871 . . . . 0.0 112.268 175.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -68.8 157.49 36.34 Favored 'General case' 0 CA--C 1.57 1.716 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 168.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -105.64 108.99 20.8 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.258 -0.901 . . . . 0.0 108.578 132.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 . . . . . 0 N--CA 1.496 1.861 0 O-C-N 120.832 -1.167 . . . . 0.0 110.325 172.447 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 44.9 m . . . . . 0 N--CA 1.487 1.412 0 CA-C-O 120.987 0.422 . . . . 0.0 111.175 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 4.9 mmt -75.32 74.51 2.42 Favored 'General case' 0 CA--C 1.567 1.62 0 CA-C-O 122.345 1.069 . . . . 0.0 111.241 169.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 100.0 m -93.0 130.21 38.65 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.03 -1.044 . . . . 0.0 109.824 -167.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 91.1 m -123.09 134.14 54.26 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 -178.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 16.1 t -120.64 138.23 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 178.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 59.2 m -147.57 150.8 35.16 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.215 -1.553 . . . . 0.0 113.056 -177.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 75.3 m95 -81.85 126.53 31.99 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.04 -1.037 . . . . 0.0 111.808 176.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -106.5 -21.67 13.0 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 118.145 2.646 . . . . 0.0 118.145 -167.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 159.8 -70.77 0.24 Allowed Glycine 0 N--CA 1.493 2.46 0 CA-C-N 121.296 1.862 . . . . 0.0 112.982 -172.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 34.4 m-20 -126.28 32.04 5.29 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 148.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -141.44 146.94 37.13 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.453 -1.404 . . . . 0.0 110.525 -165.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 35.8 tp -100.08 108.02 20.07 Favored 'General case' 0 CA--C 1.561 1.402 0 O-C-N 121.256 -0.903 . . . . 0.0 109.258 172.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 43.5 mm-40 -93.42 131.25 38.78 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 123.205 0.602 . . . . 0.0 111.535 -179.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 39.5 t -123.12 133.1 54.3 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.663 0.785 . . . . 0.0 111.063 173.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.2 p -115.4 127.41 72.98 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.683 0 C-N-CA 123.33 0.652 . . . . 0.0 109.343 169.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -105.6 91.32 3.71 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 124.096 0.958 . . . . 0.0 109.482 -176.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -90.35 126.51 35.89 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.753 -1.217 . . . . 0.0 112.035 -168.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 165.65 -95.16 0.12 Allowed Glycine 0 N--CA 1.489 2.167 0 O-C-N 121.017 -1.052 . . . . 0.0 114.122 172.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -75.05 -48.32 24.57 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 115.7 1.741 . . . . 0.0 115.7 -173.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.566 ' NZ ' ' HD2' ' A' ' 24' ' ' ASP . 43.6 mttp -115.88 151.47 35.25 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 122.488 1.137 . . . . 0.0 113.908 -168.645 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -75.68 153.52 37.09 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 54.44 36.32 57.89 Favored Glycine 0 N--CA 1.5 2.954 0 N-CA-C 119.949 2.74 . . . . 0.0 119.949 -178.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 32.3 ttt180 -100.53 116.06 31.59 Favored 'General case' 0 CA--C 1.563 1.45 0 C-N-CA 123.861 0.864 . . . . 0.0 111.177 -164.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 178.25 -170.64 42.84 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 115.336 0.894 . . . . 0.0 115.336 -178.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 37.3 p-90 -154.02 151.93 29.93 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 174.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 91.1 m -121.07 121.06 37.1 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.364 -0.835 . . . . 0.0 109.299 173.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -120.8 129.42 53.57 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 123.205 0.602 . . . . 0.0 112.087 -177.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 19.7 p90 -142.96 172.68 12.37 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.995 -1.066 . . . . 0.0 112.836 178.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 72.0 mt -119.86 132.04 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 O-C-N 121.07 -1.019 . . . . 0.0 109.989 175.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -110.19 89.74 3.11 Favored 'General case' 0 CA--C 1.567 1.611 0 C-N-CA 123.847 0.859 . . . . 0.0 108.77 165.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 68.6 -106.99 1.91 Allowed Glycine 0 N--CA 1.492 2.431 0 N-CA-C 115.75 1.06 . . . . 0.0 115.75 179.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 23.4 p-10 -87.79 0.31 55.94 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 117.248 2.314 . . . . 0.0 117.248 167.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -113.13 132.55 55.41 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-N 120.148 1.34 . . . . 0.0 112.116 -173.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 12.3 tp -93.98 124.71 38.17 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 123.726 0.811 . . . . 0.0 109.667 171.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 41.4 m80 -114.52 120.96 42.0 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 123.618 0.767 . . . . 0.0 109.078 -176.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 38.9 tp -122.99 121.67 36.65 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 123.742 0.817 . . . . 0.0 110.166 -175.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -106.35 113.65 27.3 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.601 -0.687 . . . . 0.0 109.957 169.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 66.9 mtm -105.94 127.99 53.51 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 123.164 0.586 . . . . 0.0 111.151 -178.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 73.4 mtm180 -119.14 134.11 55.39 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 124.064 0.945 . . . . 0.0 110.442 -169.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -156.78 129.42 7.64 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.27 -0.894 . . . . 0.0 111.697 170.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . 0.283 11.4 mt-10 52.55 44.77 29.67 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 115.843 1.794 . . . . 0.0 115.843 -177.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 68.41 12.53 63.81 Favored Glycine 0 CA--C 1.553 2.411 0 N-CA-C 120.713 3.045 . . . . 0.0 120.713 -167.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 92.6 t -113.88 124.96 71.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 CA-C-N 120.017 1.909 . . . . 0.0 108.516 -177.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 80.8 m -105.0 119.2 38.44 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 123.266 0.626 . . . . 0.0 110.389 179.079 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 12.6 t -88.71 138.13 31.69 Favored 'General case' 0 CA--C 1.56 1.363 0 C-N-CA 123.644 0.778 . . . . 0.0 111.735 161.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 48.1 mtpt -115.17 111.21 20.65 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.66 -0.65 . . . . 0.0 109.483 177.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -108.08 131.63 54.4 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 123.546 0.738 . . . . 0.0 111.169 176.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 51.6 t -116.58 131.52 68.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 176.15 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -123.08 153.69 39.58 Favored 'General case' 0 CA--C 1.565 1.522 0 C-N-CA 124.724 1.209 . . . . 0.0 110.628 178.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 26.6 ttmt -122.34 145.9 47.82 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.952 -1.092 . . . . 0.0 111.999 170.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 64.9 tttt -76.07 126.33 30.79 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -176.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 34.1 m -104.71 -43.42 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 174.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 68.5 t60 . . . . . 0 N--CA 1.486 1.34 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 168.46 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo . . . . . 0 CA--C 1.568 2.211 0 N-CA-C 118.475 2.452 . . . . 0.0 118.475 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.4 p -178.3 130.34 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 C-N-CA 124.714 1.206 . . . . 0.0 108.92 -174.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -83.68 107.16 15.94 Favored 'General case' 0 CA--C 1.565 1.531 0 O-C-N 121.049 -1.032 . . . . 0.0 112.128 170.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -80.73 1.46 30.17 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 117.578 2.436 . . . . 0.0 117.578 175.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -55.06 113.42 1.35 Allowed 'General case' 0 CA--C 1.567 1.627 0 N-CA-C 115.756 1.761 . . . . 0.0 115.756 -174.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 162.51 177.26 35.38 Favored Glycine 0 N--CA 1.486 2.025 0 N-CA-C 116.184 1.234 . . . . 0.0 116.184 178.191 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -106.16 131.98 52.77 Favored 'General case' 0 CA--C 1.566 1.589 0 CA-C-N 114.388 -0.906 . . . . 0.0 109.312 168.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 78.4 m95 -128.06 129.15 46.18 Favored 'General case' 0 CA--C 1.563 1.479 0 C-N-CA 123.945 0.898 . . . . 0.0 109.542 -167.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.96 143.72 26.54 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.027 -1.046 . . . . 0.0 112.204 169.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 52.1 ttm -75.59 124.64 27.56 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.874 -1.142 . . . . 0.0 112.302 173.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 95.1 mt -82.52 -51.78 7.47 Favored 'General case' 0 CA--C 1.567 1.628 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.473 166.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 91.3 p -139.61 144.63 37.81 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-N 118.955 0.798 . . . . 0.0 112.134 177.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -118.18 89.56 3.15 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 121.763 0.792 . . . . 0.0 109.145 163.366 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -96.27 121.04 37.63 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.857 0.863 . . . . 0.0 110.081 -167.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.269 27.7 t30 66.59 24.73 10.12 Favored 'General case' 0 N--CA 1.503 2.184 0 N-CA-C 116.651 2.093 . . . . 0.0 116.651 -171.368 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -68.34 -44.54 75.09 Favored 'General case' 0 CA--C 1.569 1.676 0 N-CA-C 115.579 1.696 . . . . 0.0 115.579 178.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -53.73 -44.35 69.83 Favored 'General case' 0 N--CA 1.503 2.176 0 N-CA-C 116.632 2.086 . . . . 0.0 116.632 168.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -63.25 -44.74 94.3 Favored 'General case' 0 CA--C 1.573 1.858 0 N-CA-C 114.765 1.395 . . . . 0.0 114.765 174.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 44.4 t80 -54.48 -50.56 67.48 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 115.0 1.482 . . . . 0.0 115.0 166.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 94.2 mt -63.61 -41.38 98.31 Favored 'General case' 0 CA--C 1.571 1.762 0 N-CA-C 115.142 1.534 . . . . 0.0 115.142 174.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 71.5 ttp85 -53.4 -50.63 64.74 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 115.173 1.545 . . . . 0.0 115.173 163.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.08 -16.11 17.44 Favored 'General case' 0 CA--C 1.568 1.665 0 N-CA-C 118.591 2.812 . . . . 0.0 118.591 168.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 35.4 mt -91.92 -0.66 57.5 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 115.919 1.822 . . . . 0.0 115.919 166.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 62.43 61.64 1.23 Allowed 'General case' 0 N--CA 1.494 1.77 0 CA-C-N 119.98 1.264 . . . . 0.0 113.392 -165.026 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 96.1 t -111.48 136.97 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 N-CA-C 107.767 -1.198 . . . . 0.0 107.767 170.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 14.3 p30 -64.02 157.47 25.09 Favored 'General case' 0 CA--C 1.57 1.749 0 N-CA-C 116.094 1.887 . . . . 0.0 116.094 -177.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 43.2 t -56.9 -43.87 81.18 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.301 0 N-CA-C 114.753 1.39 . . . . 0.0 114.753 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.63 -50.52 72.86 Favored 'General case' 0 CA--C 1.564 1.518 0 N-CA-C 115.741 1.756 . . . . 0.0 115.741 172.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.2 tt -69.9 -37.78 76.11 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 115.092 1.515 . . . . 0.0 115.092 172.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 69.9 mtp180 -46.78 -52.87 13.13 Favored 'General case' 0 N--CA 1.502 2.166 0 CA-C-N 121.21 1.823 . . . . 0.0 115.695 161.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -65.91 -50.07 65.77 Favored 'General case' 0 CA--C 1.565 1.532 0 N-CA-C 114.004 1.113 . . . . 0.0 114.004 170.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 9.8 mt -78.99 58.68 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.586 2.346 0 CA-C-N 120.952 1.705 . . . . 0.0 110.831 175.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -174.98 -47.21 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 126.425 1.89 . . . . 0.0 111.131 -178.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -76.2 -30.61 58.08 Favored 'General case' 0 CA--C 1.569 1.682 0 N-CA-C 115.794 1.776 . . . . 0.0 115.794 164.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 96.0 mt -76.56 -36.27 57.73 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 114.925 1.454 . . . . 0.0 114.925 177.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -100.2 148.21 24.88 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 118.759 0.709 . . . . 0.0 111.015 170.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 44.5 mmtm -103.09 95.86 7.25 Favored Pre-proline 0 CA--C 1.573 1.854 0 CA-C-O 117.707 -1.14 . . . . 0.0 110.105 -171.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -73.52 158.49 47.66 Favored 'Trans proline' 0 CA--C 1.564 1.998 0 CA-C-N 123.158 2.164 . . . . 0.0 115.898 -176.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -90.78 160.55 15.72 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-N 115.714 -0.675 . . . . 0.0 112.21 178.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 30.4 mttp -120.96 121.28 37.68 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.018 -1.052 . . . . 0.0 110.016 170.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -103.37 105.66 15.99 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 164.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 76.0 mt -97.85 116.83 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 87.0 t -102.12 93.79 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 173.017 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -93.12 94.13 8.67 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 123.163 0.585 . . . . 0.0 109.712 175.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -101.81 73.93 1.45 Allowed 'General case' 0 CA--C 1.566 1.594 0 O-C-N 121.632 -0.668 . . . . 0.0 110.877 -178.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 57.4 71.49 0.74 Allowed Glycine 0 N--CA 1.494 2.506 0 N-CA-C 116.909 1.524 . . . . 0.0 116.909 179.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.471 0.4 OUTLIER 70.2 -30.37 0.2 Allowed 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 118.257 2.688 . . . . 0.0 118.257 -166.499 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 21.9 t-160 -76.42 99.42 4.87 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-N 120.937 1.699 . . . . 0.0 110.543 170.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 3.8 ttp -116.7 119.06 34.28 Favored 'General case' 0 CA--C 1.552 1.054 0 CA-C-O 121.917 0.865 . . . . 0.0 110.08 -169.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 5.2 mp -107.02 106.91 21.52 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.422 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 -178.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 24.1 mm -88.97 99.58 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 177.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 65.4 mtt-85 -95.07 95.67 8.73 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.498 -0.751 . . . . 0.0 109.591 -179.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 16.3 m -82.6 115.87 21.75 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 169.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 45.9 mt -119.65 114.1 21.68 Favored 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 123.665 0.786 . . . . 0.0 109.04 -164.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.6 t -102.12 -67.13 0.88 Allowed 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -178.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . 0.317 8.8 t 160.47 -61.89 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.165 0 C-N-CA 126.884 2.074 . . . . 0.0 106.821 -171.627 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -77.25 -48.57 17.16 Favored 'General case' 0 CA--C 1.579 2.062 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 161.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 3.6 tpm_? -95.02 135.97 35.9 Favored 'General case' 0 CA--C 1.564 1.501 0 CA-C-O 122.434 1.111 . . . . 0.0 113.157 -170.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 47.1 m-80 -121.89 135.51 54.89 Favored 'General case' 0 CA--C 1.568 1.64 0 CA-C-N 114.625 -1.171 . . . . 0.0 108.574 164.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 20.6 m-30 -94.25 -61.0 1.6 Allowed 'General case' 0 N--CA 1.504 2.231 0 O-C-N 120.898 -1.126 . . . . 0.0 113.179 171.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.282 4.3 mm 64.0 57.21 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.429 0 CA-C-N 119.694 1.133 . . . . 0.0 113.606 175.559 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 66.7 mtp -79.61 104.7 10.39 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.007 -1.683 . . . . 0.0 109.69 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -116.56 108.65 16.24 Favored 'General case' 0 CA--C 1.56 1.354 0 C-N-CA 123.739 0.816 . . . . 0.0 110.807 -162.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 20.5 p90 -152.22 145.81 24.95 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -163.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 18.7 mp0 -82.46 124.85 30.44 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.333 -0.854 . . . . 0.0 110.332 159.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 26.0 t -65.88 121.4 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.57 -0.706 . . . . 0.0 110.581 178.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 116.24 -38.85 2.9 Favored Glycine 0 CA--C 1.55 2.26 0 N-CA-C 116.328 1.291 . . . . 0.0 116.328 -160.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -80.89 141.64 34.38 Favored 'General case' 0 CA--C 1.567 1.616 0 CA-C-N 119.397 1.599 . . . . 0.0 114.021 -172.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -96.11 102.35 14.14 Favored 'General case' 0 CA--C 1.568 1.641 0 C-N-CA 123.694 0.798 . . . . 0.0 109.896 171.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -115.41 146.64 41.42 Favored 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 123.883 0.873 . . . . 0.0 113.153 -169.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -70.1 120.77 16.3 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 119.955 -1.716 . . . . 0.0 113.263 171.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 . . . . . 0 N--CA 1.493 1.693 0 O-C-N 121.087 -1.008 . . . . 0.0 110.332 173.334 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 81.2 m . . . . . 0 N--CA 1.486 1.368 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 4.6 tpt -78.45 104.18 8.88 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-O 122.153 0.978 . . . . 0.0 110.16 -172.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 85.7 m -110.43 121.97 46.6 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.926 -155.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 91.7 m -113.44 119.68 38.42 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 -179.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.46 HG23 ' SG ' ' A' ' 95' ' ' CYS . 22.0 t -112.19 119.11 59.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 177.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 65.3 m -140.54 156.86 46.18 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 122.049 0.928 . . . . 0.0 112.513 -173.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 34.5 m95 -84.52 118.76 24.52 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.043 -1.035 . . . . 0.0 112.908 -178.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -99.23 75.25 1.99 Allowed 'General case' 0 CA--C 1.567 1.597 0 C-N-CA 123.494 0.718 . . . . 0.0 109.894 167.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 73.19 -104.97 1.66 Allowed Glycine 0 N--CA 1.487 2.092 0 O-C-N 121.544 -0.723 . . . . 0.0 112.7 -174.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -92.48 -18.19 23.52 Favored 'General case' 0 CA--C 1.573 1.832 0 N-CA-C 115.469 1.655 . . . . 0.0 115.469 167.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 78.7 mttt -91.46 137.59 32.24 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 121.111 1.778 . . . . 0.0 112.07 -174.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 22.8 tp -92.25 109.96 21.34 Favored 'General case' 0 CA--C 1.563 1.457 0 O-C-N 121.324 -0.86 . . . . 0.0 110.017 177.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -99.3 125.72 45.0 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.392 0.677 . . . . 0.0 111.411 -175.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . 0.46 ' SG ' HG23 ' A' ' 86' ' ' VAL . 46.1 t -116.89 131.86 56.85 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.725 0.81 . . . . 0.0 110.803 176.461 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 11.0 p -123.66 123.68 67.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 C-N-CA 122.791 0.437 . . . . 0.0 110.281 169.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 69.3 mt-30 -102.57 108.36 19.62 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 124.25 1.02 . . . . 0.0 110.71 -177.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -96.65 127.01 42.22 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 -169.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 167.62 -110.42 0.39 Allowed Glycine 0 N--CA 1.488 2.146 0 O-C-N 121.419 -0.801 . . . . 0.0 114.189 167.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -75.41 -43.16 51.42 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 115.614 1.709 . . . . 0.0 115.614 -176.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 37.4 mmtm -83.9 138.56 33.11 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-O 121.935 0.874 . . . . 0.0 112.713 179.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -78.77 148.09 33.09 Favored 'General case' 0 CA--C 1.566 1.585 0 CA-C-N 115.663 -0.699 . . . . 0.0 112.096 168.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 61.0 23.65 61.87 Favored Glycine 0 N--CA 1.498 2.774 0 N-CA-C 120.85 3.1 . . . . 0.0 120.85 178.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 46.5 ttt180 -87.5 118.25 26.84 Favored 'General case' 0 CA--C 1.564 1.498 0 CA-C-N 118.78 1.29 . . . . 0.0 111.792 -175.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -178.3 -172.18 42.43 Favored Glycine 0 N--CA 1.486 2.029 0 O-C-N 121.449 -0.782 . . . . 0.0 114.925 -175.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 41.8 p-90 -157.42 151.1 24.12 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 172.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 29.3 m -120.47 120.04 34.74 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 123.604 0.761 . . . . 0.0 109.192 173.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 22.6 tt0 -119.61 135.08 54.95 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 123.316 0.646 . . . . 0.0 112.489 -176.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 20.8 p90 -152.41 168.98 23.7 Favored 'General case' 0 N--CA 1.497 1.899 0 C-N-CA 123.792 0.837 . . . . 0.0 112.535 177.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 63.2 mt -113.65 133.42 59.66 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.168 0 O-C-N 120.557 -1.339 . . . . 0.0 110.119 172.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -107.66 90.36 3.28 Favored 'General case' 0 CA--C 1.566 1.596 0 C-N-CA 123.789 0.836 . . . . 0.0 109.313 164.102 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 70.29 -103.98 1.27 Allowed Glycine 0 N--CA 1.491 2.358 0 N-CA-C 115.388 0.915 . . . . 0.0 115.388 179.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 54.1 p30 -95.51 5.17 52.24 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 117.121 2.267 . . . . 0.0 117.121 167.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 77.6 mt-10 -115.33 133.96 55.55 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 120.321 1.419 . . . . 0.0 112.295 -176.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 11.1 tp -91.73 121.63 33.55 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 123.951 0.9 . . . . 0.0 109.357 173.145 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 39.2 m80 -111.72 119.39 38.47 Favored 'General case' 0 CA--C 1.559 1.3 0 C-N-CA 123.655 0.782 . . . . 0.0 108.939 -176.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 37.8 tp -124.8 121.62 35.1 Favored 'General case' 0 CA--C 1.562 1.437 0 C-N-CA 123.885 0.874 . . . . 0.0 109.618 -174.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -108.53 104.2 13.48 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 172.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 64.5 mtm -98.82 125.2 44.13 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.784 -0.572 . . . . 0.0 111.158 -177.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -107.74 142.36 37.86 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 123.443 0.697 . . . . 0.0 112.277 -175.132 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -152.98 124.73 7.81 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-O 121.635 0.731 . . . . 0.0 110.867 164.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . 0.311 13.8 mt-10 60.58 31.61 20.26 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 116.654 2.094 . . . . 0.0 116.654 -178.103 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 83.07 -15.21 34.23 Favored Glycine 0 CA--C 1.553 2.451 0 N-CA-C 119.167 2.427 . . . . 0.0 119.167 -162.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 86.2 t -86.93 122.97 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 CA-C-N 120.04 1.92 . . . . 0.0 109.516 -176.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 42.8 m -100.56 124.68 46.45 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 121.092 0.472 . . . . 0.0 111.198 176.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 16.1 t -89.72 127.48 35.95 Favored 'General case' 0 CA--C 1.559 1.312 0 C-N-CA 123.239 0.616 . . . . 0.0 111.241 160.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp -100.48 107.74 19.53 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 175.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 66.3 mt-30 -103.49 124.38 48.65 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.105 0.562 . . . . 0.0 110.361 175.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 58.1 t -112.08 130.99 64.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 175.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -124.65 155.45 39.15 Favored 'General case' 0 CA--C 1.566 1.575 0 C-N-CA 124.685 1.194 . . . . 0.0 110.763 -179.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -125.89 141.27 52.06 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.811 -1.18 . . . . 0.0 112.492 174.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 43.0 tttm -74.49 125.07 27.78 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 -174.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 35.8 m -108.55 -41.76 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 176.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 47.2 t-80 . . . . . 0 C--O 1.254 1.331 0 CA-C-N 119.932 1.242 . . . . 0.0 108.966 172.651 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo . . . . . 0 CA--C 1.564 2.006 0 N-CA-C 116.711 1.773 . . . . 0.0 116.711 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 32.8 m -76.83 146.26 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 CA-C-N 115.266 -0.879 . . . . 0.0 112.712 177.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -80.94 103.48 10.79 Favored 'General case' 0 CA--C 1.565 1.536 0 O-C-N 120.606 -1.308 . . . . 0.0 111.381 176.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 13.6 m-30 -70.43 -3.43 17.63 Favored 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 117.66 2.466 . . . . 0.0 117.66 172.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -46.5 114.28 0.79 Allowed 'General case' 0 CA--C 1.567 1.62 0 N-CA-C 116.575 2.065 . . . . 0.0 116.575 178.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 157.18 176.01 28.76 Favored Glycine 0 N--CA 1.487 2.08 0 N-CA-C 116.084 1.193 . . . . 0.0 116.084 -179.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -104.6 125.05 50.36 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 121.345 0.593 . . . . 0.0 109.514 172.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 68.5 m95 -123.33 124.66 43.45 Favored 'General case' 0 CA--C 1.568 1.659 0 C-N-CA 123.832 0.853 . . . . 0.0 109.11 -171.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 20.7 pttp -102.96 143.09 33.0 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 120.91 -1.119 . . . . 0.0 112.678 179.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.414 ' SD ' ' HD2' ' A' ' 38' ' ' PRO . 34.0 ttm -66.77 127.23 31.68 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.791 -1.193 . . . . 0.0 113.959 -179.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 93.7 mt -86.46 -55.41 3.9 Favored 'General case' 0 CA--C 1.566 1.595 0 C-N-CA 123.41 0.684 . . . . 0.0 112.467 163.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 88.1 p -139.53 149.5 43.98 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 119.023 0.828 . . . . 0.0 112.759 -177.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -124.49 110.88 15.04 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.07 0.548 . . . . 0.0 109.936 164.063 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -109.77 128.16 55.11 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.861 0.864 . . . . 0.0 109.362 -175.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.268 22.6 t30 64.57 23.02 12.79 Favored 'General case' 0 N--CA 1.504 2.229 0 N-CA-C 116.877 2.177 . . . . 0.0 116.877 -176.218 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -66.59 -45.65 78.54 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 115.471 1.656 . . . . 0.0 115.471 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -55.12 -41.42 71.68 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 116.298 1.962 . . . . 0.0 116.298 169.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -67.31 -41.24 85.66 Favored 'General case' 0 CA--C 1.573 1.835 0 N-CA-C 115.528 1.677 . . . . 0.0 115.528 174.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -53.98 -51.23 64.57 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 163.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.5 mt -63.41 -42.64 98.77 Favored 'General case' 0 CA--C 1.572 1.811 0 N-CA-C 114.641 1.348 . . . . 0.0 114.641 175.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 29.7 ttp85 -49.88 -49.65 48.7 Favored 'General case' 0 CA--C 1.575 1.938 0 N-CA-C 115.525 1.676 . . . . 0.0 115.525 161.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.04 -24.31 57.84 Favored 'General case' 0 CA--C 1.569 1.678 0 N-CA-C 117.709 2.485 . . . . 0.0 117.709 167.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 88.6 mt -83.52 1.61 41.04 Favored 'General case' 0 CA--C 1.572 1.823 0 N-CA-C 116.172 1.916 . . . . 0.0 116.172 166.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.268 20.8 m-20 64.1 48.36 3.02 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 114.834 1.42 . . . . 0.0 114.834 -168.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 92.6 t -96.58 142.42 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 CA-C-O 122.218 1.009 . . . . 0.0 109.429 175.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 7.5 p-10 -69.7 154.65 41.68 Favored 'General case' 0 CA--C 1.57 1.717 0 N-CA-C 115.305 1.594 . . . . 0.0 115.305 176.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 57.7 t -55.55 -41.24 62.96 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.303 0 N-CA-C 115.399 1.629 . . . . 0.0 115.399 -176.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.87 -49.42 76.32 Favored 'General case' 0 CA--C 1.567 1.598 0 N-CA-C 116.09 1.885 . . . . 0.0 116.09 173.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -62.02 -43.46 98.79 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 170.014 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 60.4 mtp180 -46.12 -53.59 10.09 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 116.201 1.926 . . . . 0.0 116.201 162.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 14.2 tptt -65.37 -47.99 74.49 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 115.603 1.705 . . . . 0.0 115.603 173.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 60.9 mt -55.26 -49.7 70.37 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.188 0 CA-C-N 119.806 1.185 . . . . 0.0 113.499 173.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.54 -42.05 92.36 Favored 'General case' 0 CA--C 1.565 1.529 0 N-CA-C 117.339 2.348 . . . . 0.0 117.339 173.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -59.65 -39.87 85.83 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 116.487 2.032 . . . . 0.0 116.487 168.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 89.9 mt -83.06 -16.21 47.88 Favored 'General case' 0 CA--C 1.569 1.681 0 N-CA-C 116.302 1.964 . . . . 0.0 116.302 179.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 69.4 mt -85.43 147.94 26.24 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 120.093 1.315 . . . . 0.0 112.342 171.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -105.21 87.42 1.99 Allowed Pre-proline 0 CA--C 1.574 1.873 0 CA-C-O 118.154 -0.926 . . . . 0.0 109.489 172.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.417 ' C ' ' HD2' ' A' ' 39' ' ' ASP . 60.5 Cg_endo -69.92 174.78 9.14 Favored 'Trans proline' 0 CA--C 1.564 1.992 0 C-N-CA 122.538 2.159 . . . . 0.0 115.423 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.417 ' HD2' ' C ' ' A' ' 38' ' ' PRO . 66.9 m-20 -130.36 136.27 48.91 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.545 -1.347 . . . . 0.0 110.806 -176.524 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 50.2 mttp -103.48 111.65 24.2 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.582 -0.699 . . . . 0.0 109.696 174.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -96.84 101.29 12.85 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 166.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 65.3 mt -93.93 119.15 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -173.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 75.8 t -109.83 95.32 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 177.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -99.31 118.46 36.03 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 123.751 0.82 . . . . 0.0 110.329 178.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -133.58 66.38 1.55 Allowed 'General case' 0 CA--C 1.569 1.696 0 O-C-N 121.51 -0.744 . . . . 0.0 111.867 -178.212 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 72.15 81.39 0.34 Allowed Glycine 0 N--CA 1.493 2.448 0 N-CA-C 115.274 0.87 . . . . 0.0 115.274 174.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.458 0.2 OUTLIER 65.66 -41.59 0.34 Allowed 'General case' 0 N--CA 1.502 2.141 0 N-CA-C 117.861 2.541 . . . . 0.0 117.861 -167.903 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 14.3 t-80 -70.55 120.47 16.23 Favored 'General case' 0 CA--C 1.562 1.416 0 O-C-N 120.984 -1.073 . . . . 0.0 111.595 168.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 17.5 ttp -136.87 125.35 23.52 Favored 'General case' 0 CA--C 1.555 1.163 0 CA-C-O 121.841 0.829 . . . . 0.0 110.522 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 23.0 mt -104.43 107.62 22.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 174.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 83.0 mt -86.67 99.71 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 168.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -85.05 93.07 8.52 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.51 -0.744 . . . . 0.0 109.863 -178.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 80.7 m -87.84 102.29 14.55 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 -177.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 17.6 mt -105.84 121.22 43.61 Favored 'General case' 0 CA--C 1.557 1.241 0 CA-C-N 114.514 -1.221 . . . . 0.0 109.365 -164.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 27.1 t -132.57 143.96 50.07 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.38 0.672 . . . . 0.0 110.528 -178.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 21.6 m -56.05 -34.77 66.21 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 116.123 1.898 . . . . 0.0 116.123 175.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -79.93 -58.64 3.07 Favored 'General case' 0 CA--C 1.569 1.693 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 175.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 11.9 tpt180 -151.7 127.18 10.04 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-N 119.824 1.193 . . . . 0.0 110.887 177.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -76.86 145.14 38.53 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 177.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -95.92 -67.96 0.82 Allowed 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 118.714 -0.66 . . . . 0.0 112.186 178.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.273 11.4 mm 72.52 96.76 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 C-N-CA 124.128 0.971 . . . . 0.0 111.716 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 82.2 mtp -96.25 98.71 10.51 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.02 -1.05 . . . . 0.0 109.568 173.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -100.66 110.57 22.7 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 123.659 0.784 . . . . 0.0 110.183 -179.118 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -150.52 157.45 43.02 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 114.527 1.306 . . . . 0.0 114.527 -167.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -101.08 138.03 38.65 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.586 -0.696 . . . . 0.0 110.312 160.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 92.5 t -67.77 128.18 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.289 -0.882 . . . . 0.0 110.995 -177.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 91.25 -45.7 2.82 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 116.518 1.367 . . . . 0.0 116.518 -165.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 16.7 tttp -67.29 122.49 17.99 Favored 'General case' 0 CA--C 1.571 1.78 0 C-N-CA 125.37 1.468 . . . . 0.0 113.051 178.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -84.43 114.93 22.26 Favored 'General case' 0 CA--C 1.567 1.6 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.888 -176.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -113.17 139.83 48.43 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -169.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -76.97 112.67 13.85 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.154 -0.966 . . . . 0.0 112.496 177.12 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 . . . . . 0 N--CA 1.487 1.392 0 C-N-CA 123.232 0.613 . . . . 0.0 110.334 175.541 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 73.7 m . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 120.931 0.395 . . . . 0.0 111.802 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 15.5 mtp -80.46 98.11 7.4 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-O 121.655 0.74 . . . . 0.0 110.919 177.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 91.2 m -101.46 125.35 48.09 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.658 -0.651 . . . . 0.0 110.7 -167.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 85.3 m -106.3 122.94 47.24 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 176.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 20.6 t -116.19 121.61 67.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 179.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 58.4 m -128.64 139.19 52.38 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 123.829 0.852 . . . . 0.0 111.221 -173.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 2.9 m95 -81.49 122.34 27.41 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.845 -1.16 . . . . 0.0 113.69 179.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -112.32 67.93 0.66 Allowed 'General case' 0 CA--C 1.577 1.996 0 C-N-CA 123.382 0.673 . . . . 0.0 110.632 164.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 69.96 -102.82 1.04 Allowed Glycine 0 N--CA 1.495 2.584 0 N-CA-C 115.968 1.147 . . . . 0.0 115.968 177.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -75.47 -28.93 59.44 Favored 'General case' 0 CA--C 1.574 1.878 0 N-CA-C 115.206 1.558 . . . . 0.0 115.206 162.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 29.8 mtpt -98.87 107.42 19.85 Favored 'General case' 0 N--CA 1.484 1.263 0 CA-C-N 119.469 1.031 . . . . 0.0 110.56 -167.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 30.4 tp -80.75 111.06 16.84 Favored 'General case' 0 CA--C 1.563 1.473 0 O-C-N 120.729 -1.232 . . . . 0.0 109.844 173.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 -97.55 126.94 43.13 Favored 'General case' 0 CA--C 1.558 1.272 0 C-N-CA 124.011 0.925 . . . . 0.0 110.961 -174.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 41.9 t -127.48 133.88 49.86 Favored 'General case' 0 N--CA 1.481 1.108 0 O-C-N 121.674 -0.641 . . . . 0.0 111.831 -178.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 12.2 p -118.78 128.92 75.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 C-N-CA 123.068 0.547 . . . . 0.0 109.78 168.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -99.96 104.28 15.89 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 123.47 0.708 . . . . 0.0 109.753 178.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -91.25 119.79 31.61 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.059 -1.026 . . . . 0.0 110.676 -173.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -174.41 -70.33 0.05 OUTLIER Glycine 0 N--CA 1.489 2.172 0 N-CA-C 116.022 1.169 . . . . 0.0 116.022 -175.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -138.27 -60.45 0.62 Allowed 'General case' 0 N--CA 1.498 1.963 0 CA-C-N 117.755 0.777 . . . . 0.0 111.952 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -72.74 133.04 44.38 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-O 122.231 1.015 . . . . 0.0 111.704 -173.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -68.73 -56.83 6.84 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 115.392 1.627 . . . . 0.0 115.392 -160.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -83.68 44.11 3.26 Favored Glycine 0 CA--C 1.55 2.226 0 N-CA-C 117.728 1.851 . . . . 0.0 117.728 166.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 25.1 ttt180 -85.95 119.04 25.83 Favored 'General case' 0 CA--C 1.566 1.587 0 CA-C-N 119.674 1.737 . . . . 0.0 113.366 -176.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 175.0 -165.84 37.18 Favored Glycine 0 N--CA 1.485 1.906 0 CA-C-O 122.01 0.783 . . . . 0.0 114.73 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 45.3 p-90 -155.66 152.94 29.26 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 172.065 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 81.8 m -119.73 121.38 39.06 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 169.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -121.0 128.52 52.78 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.604 -0.685 . . . . 0.0 111.578 -177.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 16.4 p90 -148.04 155.32 41.36 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.797 -1.19 . . . . 0.0 113.587 -176.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 94.8 mt -94.35 134.46 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.033 -1.042 . . . . 0.0 110.382 174.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -118.4 94.9 4.65 Favored 'General case' 0 CA--C 1.566 1.574 0 CA-C-N 114.897 -1.047 . . . . 0.0 108.441 159.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 69.11 -108.03 2.32 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 115.619 1.008 . . . . 0.0 115.619 -179.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 55.5 p30 -90.18 2.42 55.38 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 117.407 2.373 . . . . 0.0 117.407 168.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -121.24 130.15 53.53 Favored 'General case' 0 N--CA 1.486 1.329 0 CA-C-N 119.827 1.194 . . . . 0.0 111.663 -168.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 18.4 tp -91.64 113.63 25.95 Favored 'General case' 0 CA--C 1.562 1.409 0 C-N-CA 124.424 1.089 . . . . 0.0 109.451 172.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 41.6 m80 -101.16 124.79 47.41 Favored 'General case' 0 CA--C 1.561 1.399 0 C-N-CA 124.33 1.052 . . . . 0.0 108.842 -177.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 43.6 tp -124.99 120.27 31.09 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.824 0.85 . . . . 0.0 110.332 -171.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -105.06 107.02 17.78 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.711 -0.618 . . . . 0.0 109.686 170.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 72.1 mtm -97.72 124.58 42.12 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-N 118.58 0.627 . . . . 0.0 111.131 179.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 84.7 mtm180 -111.55 139.45 46.98 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 123.866 0.866 . . . . 0.0 110.926 -171.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -147.28 132.46 18.36 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.095 -1.003 . . . . 0.0 112.968 167.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . 0.344 24.7 mt-10 65.61 -73.36 0.07 Allowed 'General case' 0 N--CA 1.502 2.126 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 -173.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -160.2 50.3 0.37 Allowed Glycine 0 CA--C 1.552 2.386 0 C-N-CA 123.862 0.744 . . . . 0.0 112.259 157.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 69.0 t -139.96 122.92 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 -163.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 31.3 m -105.47 123.06 47.26 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 122.996 0.518 . . . . 0.0 111.588 -173.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 44.6 t -88.61 128.98 35.59 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.561 -0.712 . . . . 0.0 111.261 159.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -105.39 110.75 23.22 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -179.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 16.4 mt-30 -118.07 139.08 51.74 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 123.559 0.744 . . . . 0.0 111.491 -176.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 33.9 t -122.93 131.79 72.61 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 O-C-N 121.478 -0.764 . . . . 0.0 109.042 -178.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -126.48 138.72 53.54 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 124.146 0.978 . . . . 0.0 110.521 -179.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 76.8 tttt -106.89 140.45 39.69 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.643 -1.286 . . . . 0.0 112.654 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 61.8 tttt -73.63 120.74 19.65 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -179.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 35.9 m -104.92 -41.27 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 175.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 52.8 t-80 . . . . . 0 N--CA 1.486 1.354 0 CA-C-N 119.715 1.143 . . . . 0.0 108.143 168.361 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo . . . . . 0 CA--C 1.561 1.846 0 N-CA-C 116.367 1.641 . . . . 0.0 116.367 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 29.1 m -78.78 160.88 4.39 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.929 0 CA-C-O 122.399 1.095 . . . . 0.0 113.405 -177.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -90.99 107.1 18.98 Favored 'General case' 0 CA--C 1.565 1.547 0 O-C-N 121.015 -1.053 . . . . 0.0 112.373 -175.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 6.5 m-30 -83.64 -2.2 55.61 Favored 'General case' 0 CA--C 1.577 1.981 0 N-CA-C 116.152 1.908 . . . . 0.0 116.152 171.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 51.1 m-80 -58.52 114.05 2.28 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-N 121.612 2.006 . . . . 0.0 114.22 -178.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 160.05 -178.03 36.28 Favored Glycine 0 N--CA 1.483 1.833 0 CA-C-O 122.623 1.124 . . . . 0.0 115.896 -177.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 12.7 t80 -113.36 119.43 37.61 Favored 'General case' 0 CA--C 1.565 1.533 0 CA-C-N 114.222 -0.989 . . . . 0.0 108.875 178.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 77.2 m95 -123.01 124.37 42.99 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 123.541 0.737 . . . . 0.0 110.182 -165.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 64.1 pttt -98.68 136.81 38.21 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 120.501 -1.374 . . . . 0.0 113.4 -179.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 11.0 ttp -72.09 125.34 27.02 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-N 119.395 0.998 . . . . 0.0 112.901 177.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 78.6 mt -94.69 -56.29 2.83 Favored 'General case' 0 CA--C 1.564 1.503 0 CA-C-N 115.068 -0.969 . . . . 0.0 112.927 178.119 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 92.4 p -141.54 124.12 15.9 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.724 0.81 . . . . 0.0 110.227 -170.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -113.77 119.12 36.28 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 121.343 0.592 . . . . 0.0 111.327 175.107 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -114.37 126.84 55.45 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.81 0.844 . . . . 0.0 109.148 -176.054 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.265 19.0 t30 66.76 22.17 10.37 Favored 'General case' 0 CA--C 1.582 2.185 0 N-CA-C 116.911 2.189 . . . . 0.0 116.911 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -68.39 -43.39 77.39 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 115.382 1.623 . . . . 0.0 115.382 178.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -53.54 -44.86 69.55 Favored 'General case' 0 N--CA 1.501 2.108 0 N-CA-C 116.348 1.981 . . . . 0.0 116.348 167.006 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -65.64 -43.93 87.96 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 115.103 1.519 . . . . 0.0 115.103 175.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -53.44 -49.04 68.2 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 164.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 77.7 mt -63.47 -42.72 98.6 Favored 'General case' 0 CA--C 1.571 1.759 0 N-CA-C 114.539 1.311 . . . . 0.0 114.539 172.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 69.5 ttp85 -54.34 -46.19 72.88 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 115.696 1.739 . . . . 0.0 115.696 166.297 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.98 -31.83 65.45 Favored 'General case' 0 CA--C 1.567 1.63 0 N-CA-C 116.632 2.086 . . . . 0.0 116.632 164.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 82.2 mt -85.88 30.43 0.66 Allowed 'General case' 0 CA--C 1.572 1.818 0 N-CA-C 114.506 1.298 . . . . 0.0 114.506 167.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 64.54 17.98 11.14 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 117.023 2.231 . . . . 0.0 117.023 175.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 94.8 t -88.17 142.41 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 120.504 -1.373 . . . . 0.0 110.932 -168.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 7.8 p-10 -71.9 156.96 38.69 Favored 'General case' 0 CA--C 1.569 1.677 0 N-CA-C 115.363 1.616 . . . . 0.0 115.363 177.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 49.0 t -53.97 -42.71 55.35 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.407 0 N-CA-C 115.203 1.557 . . . . 0.0 115.203 -176.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.03 -52.4 65.53 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 115.871 1.804 . . . . 0.0 115.871 173.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -59.47 -42.27 91.64 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 115.934 1.827 . . . . 0.0 115.934 169.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 54.0 mtp180 -51.68 -57.53 8.95 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 164.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -59.63 -47.34 85.98 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 115.054 1.502 . . . . 0.0 115.054 175.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 64.7 mt -56.05 -57.06 9.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 CA-C-N 119.622 1.101 . . . . 0.0 112.675 172.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.0 -44.1 91.6 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 117.704 2.483 . . . . 0.0 117.704 176.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -67.61 -27.64 67.07 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 116.375 1.991 . . . . 0.0 116.375 172.289 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 88.5 mt -79.81 -31.45 40.66 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 115.686 1.735 . . . . 0.0 115.686 171.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . 0.272 4.1 pp -80.72 145.79 31.37 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-N 120.148 1.34 . . . . 0.0 114.486 -178.344 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -114.29 93.37 31.02 Favored Pre-proline 0 CA--C 1.573 1.843 0 CA-C-O 118.368 -0.825 . . . . 0.0 108.841 -177.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -81.19 166.93 18.15 Favored 'Trans proline' 0 CA--C 1.56 1.817 0 C-N-CA 122.969 2.446 . . . . 0.0 115.083 -174.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -106.0 118.65 37.17 Favored 'General case' 0 N--CA 1.487 1.379 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.303 173.128 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.451 ' NZ ' ' HG1' ' A' ' 53' ' ' THR . 35.4 mttp -83.33 107.08 15.61 Favored 'General case' 0 N--CA 1.485 1.284 0 O-C-N 121.302 -0.874 . . . . 0.0 110.331 169.508 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -91.33 113.18 25.37 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 164.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 82.7 mt -108.9 122.94 64.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 -177.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 91.3 t -108.3 102.47 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 169.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 42.7 tt0 -98.69 100.55 11.78 Favored 'General case' 0 CA--C 1.565 1.54 0 C-N-CA 123.825 0.85 . . . . 0.0 110.031 175.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -93.91 74.01 4.17 Favored 'General case' 0 CA--C 1.57 1.737 0 O-C-N 121.438 -0.789 . . . . 0.0 110.228 168.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 65.03 -99.0 0.32 Allowed Glycine 0 N--CA 1.492 2.374 0 N-CA-C 115.053 0.781 . . . . 0.0 115.053 -174.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -83.26 -31.36 26.99 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 116.406 2.002 . . . . 0.0 116.406 165.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 22.6 t-160 -80.19 108.72 14.02 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 121.228 1.831 . . . . 0.0 110.915 -177.2 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 45.2 ttm -118.75 123.6 45.23 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 123.511 0.724 . . . . 0.0 110.046 -172.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 35.9 mt -107.36 106.14 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 175.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 33.9 mm -90.7 108.67 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 174.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 67.2 mtt85 -105.66 100.09 9.67 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.654 -0.654 . . . . 0.0 109.464 173.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.451 ' HG1' ' NZ ' ' A' ' 40' ' ' LYS . 59.1 m -89.9 102.74 15.44 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 176.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 15.2 mt -101.08 125.05 47.67 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.367 0.667 . . . . 0.0 111.132 -160.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.4 t -147.88 156.61 42.88 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 122.009 0.909 . . . . 0.0 111.126 179.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 25.2 m -59.57 -38.7 81.83 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 115.3 1.593 . . . . 0.0 115.3 171.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 35.5 t80 -74.54 -53.24 9.83 Favored 'General case' 0 CA--C 1.572 1.82 0 N-CA-C 114.733 1.382 . . . . 0.0 114.733 174.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 71.2 ttt180 -142.85 130.15 21.01 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 119.526 1.057 . . . . 0.0 110.274 174.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 71.5 m-80 -93.5 117.29 29.9 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 166.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 75.6 t80 -105.01 105.43 15.47 Favored 'General case' 0 CA--C 1.566 1.59 0 C-N-CA 123.28 0.632 . . . . 0.0 111.087 -172.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.9 mp -99.19 121.53 49.9 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.833 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -178.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 95.9 mtp -115.39 103.37 10.72 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.568 -0.707 . . . . 0.0 109.369 167.259 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -101.22 112.92 25.54 Favored 'General case' 0 CA--C 1.566 1.577 0 C-N-CA 124.163 0.985 . . . . 0.0 111.806 177.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -153.74 154.28 33.76 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 115.047 1.499 . . . . 0.0 115.047 -166.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 28.0 mp0 -89.24 121.62 31.71 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.445 -0.784 . . . . 0.0 110.671 167.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 37.3 t -66.85 116.11 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 C-N-CA 123.785 0.834 . . . . 0.0 109.512 172.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 121.55 -46.31 1.13 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 115.589 0.996 . . . . 0.0 115.589 -158.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -84.34 145.75 28.08 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 118.726 1.263 . . . . 0.0 113.297 -174.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -91.9 100.34 13.03 Favored 'General case' 0 CA--C 1.568 1.638 0 O-C-N 121.788 -0.57 . . . . 0.0 110.895 173.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -107.63 145.7 32.96 Favored 'General case' 0 N--CA 1.495 1.813 0 C-N-CA 124.073 0.949 . . . . 0.0 113.429 -169.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -68.57 118.79 12.05 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.234 -1.541 . . . . 0.0 114.133 176.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 . . . . . 0 N--CA 1.493 1.697 0 CA-C-O 122.448 1.118 . . . . 0.0 109.672 163.012 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 99.4 m . . . . . 0 N--CA 1.487 1.394 0 CA-C-O 121.77 0.795 . . . . 0.0 112.151 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 3.9 tpt -78.78 107.28 11.37 Favored 'General case' 0 CA--C 1.563 1.472 0 CA-C-O 122.211 1.005 . . . . 0.0 109.822 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 90.4 m -111.8 115.91 29.83 Favored 'General case' 0 N--CA 1.484 1.227 0 O-C-N 121.545 -0.722 . . . . 0.0 110.737 -152.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 50.3 m -89.96 123.53 33.96 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 168.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 59.7 t -108.87 131.8 58.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 166.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 58.7 m -143.36 150.94 39.84 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.771 -1.205 . . . . 0.0 112.676 -175.205 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 20.5 m95 -86.24 120.25 27.39 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 -178.001 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -105.23 62.76 0.69 Allowed 'General case' 0 CA--C 1.58 2.099 0 C-N-CA 123.871 0.868 . . . . 0.0 110.405 158.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 64.5 -98.99 0.3 Allowed Glycine 0 N--CA 1.496 2.634 0 N-CA-C 116.978 1.551 . . . . 0.0 116.978 178.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -68.96 -35.99 77.39 Favored 'General case' 0 CA--C 1.574 1.886 0 N-CA-C 115.121 1.526 . . . . 0.0 115.121 165.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -92.4 124.34 36.38 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.906 0.883 . . . . 0.0 112.073 -176.199 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 22.0 tp -89.99 108.69 19.87 Favored 'General case' 0 CA--C 1.564 1.491 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 166.087 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 30.3 mm-40 -97.95 130.82 44.79 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.709 0.804 . . . . 0.0 110.991 -172.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 42.4 t -127.67 127.92 44.57 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.015 0.526 . . . . 0.0 111.711 -175.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.6 p -115.07 115.21 48.75 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.625 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 169.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -93.59 94.95 8.91 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 123.628 0.771 . . . . 0.0 109.124 179.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 64.8 mttm -88.43 109.39 19.98 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.123 -0.986 . . . . 0.0 112.075 -169.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -179.83 85.37 0.07 OUTLIER Glycine 0 N--CA 1.484 1.871 0 CA-C-N 116.1 -0.5 . . . . 0.0 113.174 177.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . 0.271 29.1 tt0 70.35 -55.25 0.62 Allowed 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 116.697 2.11 . . . . 0.0 116.697 178.692 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.0 mmmp? -72.94 141.5 47.82 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 114.798 1.407 . . . . 0.0 114.798 -166.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -80.69 94.68 6.41 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.98 0.895 . . . . 0.0 112.526 -164.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 77.37 46.0 10.58 Favored Glycine 0 N--CA 1.486 1.988 0 N-CA-C 117.208 1.643 . . . . 0.0 117.208 -173.317 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 14.8 ttm180 -77.56 121.51 24.0 Favored 'General case' 0 CA--C 1.568 1.654 0 CA-C-N 118.546 1.173 . . . . 0.0 110.725 167.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 177.37 -171.74 44.51 Favored Glycine 0 N--CA 1.486 2.012 0 O-C-N 121.502 -0.749 . . . . 0.0 114.874 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 51.7 p-90 -157.96 154.04 27.13 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 114.125 1.157 . . . . 0.0 114.125 178.095 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 74.1 m -121.95 116.95 25.27 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 171.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 19.2 tt0 -115.7 126.73 54.48 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 123.398 0.679 . . . . 0.0 110.682 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 14.1 p90 -147.18 157.32 43.56 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.685 -1.259 . . . . 0.0 114.089 -175.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 95.8 mt -100.82 128.8 52.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.434 -0.791 . . . . 0.0 110.038 175.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -112.33 100.03 8.48 Favored 'General case' 0 CA--C 1.567 1.611 0 CA-C-N 114.697 -1.138 . . . . 0.0 108.543 160.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 70.53 -106.58 1.89 Allowed Glycine 0 N--CA 1.494 2.5 0 N-CA-C 115.442 0.937 . . . . 0.0 115.442 -179.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -112.43 33.7 4.76 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 114.767 1.395 . . . . 0.0 114.767 162.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -125.7 127.52 46.37 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 124.058 0.943 . . . . 0.0 109.707 177.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 17.0 tp -93.09 115.55 28.19 Favored 'General case' 0 CA--C 1.563 1.461 0 CA-C-O 122.097 0.951 . . . . 0.0 109.412 173.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 48.1 m80 -102.6 123.81 47.0 Favored 'General case' 0 CA--C 1.558 1.253 0 C-N-CA 124.17 0.988 . . . . 0.0 108.878 -176.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 43.3 tp -124.56 118.52 26.76 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.508 0.723 . . . . 0.0 109.654 -172.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 82.1 mt-10 -114.05 110.65 20.37 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.75 -0.594 . . . . 0.0 109.764 173.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 68.0 mtm -105.77 125.25 50.77 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 123.591 0.756 . . . . 0.0 110.755 -174.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 54.6 mtp180 -111.22 142.97 42.73 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.584 -0.697 . . . . 0.0 112.338 -177.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -156.52 133.05 10.09 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 123.08 0.552 . . . . 0.0 110.898 161.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 60.7 34.93 19.85 Favored 'General case' 0 N--CA 1.509 2.478 0 N-CA-C 115.339 1.607 . . . . 0.0 115.339 -168.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 67.35 -0.81 7.86 Favored Glycine 0 CA--C 1.561 2.913 0 N-CA-C 119.984 2.753 . . . . 0.0 119.984 -159.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 75.2 t -95.51 114.14 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 CA-C-N 120.81 2.305 . . . . 0.0 109.446 -167.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 25.0 m -94.63 118.63 32.0 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 123.094 0.557 . . . . 0.0 111.295 -173.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 13.9 t -91.6 124.65 35.91 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.306 0.642 . . . . 0.0 111.238 162.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -108.55 115.5 30.21 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.192 0.597 . . . . 0.0 109.659 -175.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -124.22 135.43 53.43 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.636 -0.665 . . . . 0.0 111.854 -174.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 61.7 t -112.97 131.62 64.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -125.34 145.13 50.17 Favored 'General case' 0 CA--C 1.563 1.463 0 C-N-CA 124.844 1.258 . . . . 0.0 109.778 179.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 30.3 ttmt -120.25 140.61 50.94 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.651 -1.281 . . . . 0.0 112.804 179.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 54.5 tttt -74.97 115.81 15.0 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -177.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 35.0 m -97.21 -40.73 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 174.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 79.5 t60 . . . . . 0 N--CA 1.486 1.343 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 164.628 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_exo . . . . . 0 CA--C 1.561 1.871 0 N-CA-C 116.563 1.717 . . . . 0.0 116.563 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 22.0 m -107.01 176.43 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 CA-C-O 122.248 1.023 . . . . 0.0 112.067 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -79.19 82.21 5.37 Favored 'General case' 0 CA--C 1.569 1.676 0 O-C-N 120.158 -1.589 . . . . 0.0 113.862 -171.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -73.41 -11.71 60.56 Favored 'General case' 0 CA--C 1.576 1.97 0 N-CA-C 115.614 1.709 . . . . 0.0 115.614 167.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -45.78 121.96 3.45 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 115.793 1.775 . . . . 0.0 115.793 168.007 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 154.84 174.39 24.74 Favored Glycine 0 N--CA 1.484 1.876 0 N-CA-C 115.976 1.15 . . . . 0.0 115.976 175.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 17.3 t80 -103.28 121.2 42.22 Favored 'General case' 0 CA--C 1.563 1.449 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 167.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 70.4 m95 -120.39 121.5 38.69 Favored 'General case' 0 CA--C 1.562 1.434 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 -170.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 63.7 pttt -89.47 137.74 32.07 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.249 -0.907 . . . . 0.0 112.169 177.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 51.3 ttm -73.38 121.84 21.11 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 122.092 0.949 . . . . 0.0 112.423 176.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 89.6 mt -81.79 -48.13 12.0 Favored 'General case' 0 CA--C 1.568 1.66 0 CA-C-N 115.242 -0.89 . . . . 0.0 113.157 167.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 88.6 p -136.55 146.29 45.99 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 119.225 0.92 . . . . 0.0 112.873 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 20.9 p30 -124.45 81.72 1.97 Allowed 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 121.694 0.759 . . . . 0.0 110.709 167.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -94.72 125.56 39.45 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.138 -0.976 . . . . 0.0 111.56 -167.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.257 51.2 t30 59.15 25.16 13.63 Favored 'General case' 0 N--CA 1.503 2.183 0 N-CA-C 116.968 2.21 . . . . 0.0 116.968 -170.453 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -66.97 -40.47 87.47 Favored 'General case' 0 CA--C 1.568 1.643 0 N-CA-C 114.969 1.47 . . . . 0.0 114.969 172.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -52.93 -53.42 49.79 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 115.484 1.661 . . . . 0.0 115.484 172.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.516 ' HE2' ' NH2' ' A' ' 21' ' ' ARG . 11.9 tp10 -72.08 -37.01 69.69 Favored 'General case' 0 CA--C 1.566 1.565 0 N-CA-C 115.796 1.776 . . . . 0.0 115.796 176.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 61.3 t80 -50.2 -49.96 51.0 Favored 'General case' 0 N--CA 1.499 2.02 0 CA-C-N 120.526 1.512 . . . . 0.0 114.859 161.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 93.9 mt -62.57 -41.47 98.94 Favored 'General case' 0 CA--C 1.57 1.734 0 N-CA-C 115.51 1.67 . . . . 0.0 115.51 171.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.516 ' NH2' ' HE2' ' A' ' 18' ' ' GLU . 35.2 ttp180 -62.07 -44.85 95.78 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 115.091 1.515 . . . . 0.0 115.091 169.563 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -49.82 -28.96 7.09 Favored 'General case' 0 CA--C 1.571 1.781 0 N-CA-C 118.234 2.679 . . . . 0.0 118.234 162.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 91.0 mt -86.97 0.68 54.72 Favored 'General case' 0 CA--C 1.569 1.7 0 N-CA-C 116.45 2.019 . . . . 0.0 116.45 168.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 62.32 39.07 12.68 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 115.458 1.651 . . . . 0.0 115.458 -169.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 86.1 t -92.88 140.25 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 CA-C-O 122.195 0.997 . . . . 0.0 109.02 178.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.8 p-10 -67.0 146.05 54.77 Favored 'General case' 0 CA--C 1.567 1.613 0 N-CA-C 116.287 1.958 . . . . 0.0 116.287 -170.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 58.5 t -59.57 -38.75 77.02 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.162 0 N-CA-C 115.622 1.712 . . . . 0.0 115.622 -173.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.12 -38.95 84.58 Favored 'General case' 0 CA--C 1.569 1.711 0 N-CA-C 116.412 2.005 . . . . 0.0 116.412 169.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 6.1 tt -65.49 -50.67 64.45 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-N 119.318 0.963 . . . . 0.0 113.553 165.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 35.2 mtp-105 -47.62 -50.35 24.63 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 116.263 1.949 . . . . 0.0 116.263 172.203 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -70.91 -36.29 72.62 Favored 'General case' 0 CA--C 1.564 1.493 0 N-CA-C 115.239 1.57 . . . . 0.0 115.239 174.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 41.0 mt -71.99 -55.78 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.22 0 CA-C-N 122.334 2.334 . . . . 0.0 110.559 174.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -61.14 -23.3 65.43 Favored 'General case' 0 CA--C 1.565 1.54 0 N-CA-C 119.255 3.057 . . . . 0.0 119.255 176.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -75.28 -47.59 27.21 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 115.454 1.65 . . . . 0.0 115.454 160.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 97.4 mt -75.25 -25.56 58.14 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 116.29 1.959 . . . . 0.0 116.29 -175.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . 0.25 1.4 pp -96.34 149.89 21.19 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 119.444 1.02 . . . . 0.0 110.397 158.327 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -107.06 92.32 7.6 Favored Pre-proline 0 CA--C 1.574 1.873 0 CA-C-O 117.78 -1.105 . . . . 0.0 109.222 -176.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -72.04 155.85 56.67 Favored 'Trans proline' 0 CA--C 1.562 1.901 0 C-N-CA 122.535 2.157 . . . . 0.0 116.739 -170.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -101.14 136.22 41.34 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.926 -170.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 60.8 mttm -96.02 112.1 23.93 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.123 -0.986 . . . . 0.0 110.19 174.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -94.5 108.13 20.08 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 163.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 78.0 mt -103.07 117.14 48.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 -175.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 91.1 t -100.18 93.75 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 173.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -95.31 97.17 9.65 Favored 'General case' 0 CA--C 1.566 1.568 0 CA-C-O 121.395 0.617 . . . . 0.0 110.831 176.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -89.97 79.23 6.61 Favored 'General case' 0 CA--C 1.568 1.666 0 O-C-N 121.275 -0.89 . . . . 0.0 109.815 167.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 65.94 -102.66 0.73 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 114.897 0.719 . . . . 0.0 114.897 -174.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -86.07 -23.29 26.77 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 116.531 2.048 . . . . 0.0 116.531 165.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 18.5 t-160 -78.9 108.89 12.69 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 121.602 2.001 . . . . 0.0 111.148 178.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 47.1 ttm -117.64 121.08 39.94 Favored 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 123.676 0.79 . . . . 0.0 109.932 -174.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 29.6 mt -107.41 101.94 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 173.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 78.8 mt -88.89 100.63 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 177.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 62.6 mtt180 -94.5 98.48 10.88 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.774 -0.579 . . . . 0.0 110.251 -179.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 11.4 m -87.6 107.92 18.83 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 177.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 13.5 mt -108.96 120.35 42.26 Favored 'General case' 0 CA--C 1.558 1.273 0 C-N-CA 123.478 0.711 . . . . 0.0 110.486 -160.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 38.7 t -116.45 -93.41 0.5 Allowed 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.147 0.579 . . . . 0.0 110.624 177.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 52.8 m 176.83 -62.18 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.033 0 C-N-CA 126.618 1.967 . . . . 0.0 106.015 -170.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -72.89 -48.63 35.61 Favored 'General case' 0 CA--C 1.573 1.838 0 N-CA-C 115.935 1.828 . . . . 0.0 115.935 176.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 42.7 tpt85 -139.08 124.64 19.44 Favored 'General case' 0 CA--C 1.564 1.492 0 CA-C-N 118.995 0.816 . . . . 0.0 109.755 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -83.46 173.72 11.25 Favored 'General case' 0 CA--C 1.569 1.69 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 169.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -112.9 -76.24 0.59 Allowed 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.337 -0.852 . . . . 0.0 110.196 170.012 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.374 58.5 mt 70.5 85.51 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.127 0 C-N-CA 124.5 1.12 . . . . 0.0 111.678 173.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 94.4 mtp -102.05 102.64 13.16 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.5 p30 -99.96 110.44 22.77 Favored 'General case' 0 CA--C 1.562 1.434 0 C-N-CA 123.899 0.88 . . . . 0.0 112.554 -178.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -155.04 148.78 25.48 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 -168.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 23.1 mp0 -82.65 125.76 31.57 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.219 -0.926 . . . . 0.0 110.667 160.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 13.1 t -66.17 123.34 18.94 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.91 0 O-C-N 121.31 -0.869 . . . . 0.0 110.142 176.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 115.81 -44.26 1.51 Allowed Glycine 0 CA--C 1.55 2.253 0 N-CA-C 115.597 0.999 . . . . 0.0 115.597 -157.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 83.8 mttt -83.6 146.62 28.19 Favored 'General case' 0 CA--C 1.566 1.593 0 CA-C-N 118.822 1.311 . . . . 0.0 114.18 -172.237 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -91.05 103.71 16.38 Favored 'General case' 0 CA--C 1.564 1.51 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.995 167.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 11.1 p90 -102.72 145.49 29.63 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -171.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -78.81 124.67 28.45 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 177.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 . . . . . 0 N--CA 1.487 1.385 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 169.655 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 73.3 m . . . . . 0 CA--C 1.557 1.213 0 CA-C-O 121.713 0.768 . . . . 0.0 111.835 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 12.4 mmt -88.82 90.13 8.28 Favored 'General case' 0 CA--C 1.56 1.33 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 173.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 86.0 m -92.78 122.41 35.14 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.166 -0.958 . . . . 0.0 110.265 -174.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 58.5 m -110.04 122.73 48.26 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.477 HG21 ' SG ' ' A' ' 95' ' ' CYS . 17.8 t -118.0 128.09 75.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 92.0 p -130.6 166.58 20.33 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 122.506 1.146 . . . . 0.0 113.256 -176.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 68.5 m95 -97.19 129.67 44.52 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.615 -0.678 . . . . 0.0 111.932 175.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -126.49 81.84 2.03 Favored 'General case' 0 CA--C 1.567 1.597 0 C-N-CA 123.668 0.787 . . . . 0.0 109.647 177.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 63.21 17.44 59.24 Favored Glycine 0 N--CA 1.496 2.69 0 N-CA-C 121.74 3.456 . . . . 0.0 121.74 172.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . 0.269 0.8 OUTLIER 126.33 -45.41 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.472 0 C-N-CA 127.374 2.269 . . . . 0.0 111.087 -159.543 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 64.3 mttm -77.7 142.21 38.91 Favored 'General case' 0 CA--C 1.562 1.408 0 C-N-CA 123.68 0.792 . . . . 0.0 111.937 -176.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 25.7 tp -97.62 104.1 16.09 Favored 'General case' 0 CA--C 1.564 1.514 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 172.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 32.9 mm-40 -92.57 142.69 27.12 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 123.332 0.653 . . . . 0.0 111.831 -177.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . 0.477 ' SG ' HG21 ' A' ' 86' ' ' VAL . 49.3 t -139.64 136.88 34.78 Favored 'General case' 0 N--CA 1.484 1.238 0 O-C-N 121.441 -0.787 . . . . 0.0 112.127 -178.67 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.7 p -114.78 129.25 71.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 C-N-CA 123.203 0.601 . . . . 0.0 109.506 162.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -105.95 75.55 1.12 Allowed 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 123.593 0.757 . . . . 0.0 109.687 179.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -86.92 141.07 29.01 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.487 -1.383 . . . . 0.0 113.388 -173.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 135.69 -66.93 0.55 Allowed Glycine 0 N--CA 1.491 2.312 0 O-C-N 121.73 -0.606 . . . . 0.0 113.957 -171.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -79.54 -53.54 6.77 Favored 'General case' 0 CA--C 1.57 1.739 0 N-CA-C 115.335 1.606 . . . . 0.0 115.335 -175.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 45.1 mmtm -133.12 160.61 36.72 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-N 119.903 1.228 . . . . 0.0 114.313 -166.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -77.04 137.9 39.25 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.43 175.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 61.6 35.8 91.68 Favored Glycine 0 N--CA 1.496 2.652 0 N-CA-C 118.785 2.274 . . . . 0.0 118.785 -176.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 46.1 ttt180 -96.93 123.95 40.77 Favored 'General case' 0 CA--C 1.561 1.395 0 CA-C-N 118.16 0.98 . . . . 0.0 112.59 -170.095 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 179.92 -169.13 39.81 Favored Glycine 0 N--CA 1.483 1.776 0 CA-C-O 122.129 0.849 . . . . 0.0 114.847 176.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 43.4 p-90 -155.1 156.27 35.51 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 175.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 49.2 m -125.29 118.71 26.56 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 173.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 -118.52 129.81 55.57 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 123.345 0.658 . . . . 0.0 111.07 -178.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 15.3 p90 -150.34 156.72 42.05 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.761 -1.212 . . . . 0.0 113.396 -175.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 73.8 mt -101.44 141.76 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.186 0 CA-C-O 122.697 1.237 . . . . 0.0 111.346 -176.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -139.7 88.25 2.23 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 123.997 0.919 . . . . 0.0 109.12 -177.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 72.29 -112.61 4.1 Favored Glycine 0 N--CA 1.49 2.257 0 CA-C-N 115.87 -0.605 . . . . 0.0 113.755 -173.021 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 54.8 p30 -92.28 7.35 43.11 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 116.78 2.141 . . . . 0.0 116.78 164.034 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -107.87 146.76 31.87 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-N 120.519 1.509 . . . . 0.0 112.526 -174.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 13.8 tp -108.01 118.98 38.17 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 169.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 34.1 m80 -106.51 124.24 49.3 Favored 'General case' 0 CA--C 1.559 1.326 0 C-N-CA 123.713 0.805 . . . . 0.0 109.202 -175.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 20.1 tp -120.49 130.29 54.22 Favored 'General case' 0 CA--C 1.561 1.374 0 C-N-CA 123.8 0.84 . . . . 0.0 109.736 -176.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -117.76 114.51 23.42 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.567 -0.708 . . . . 0.0 109.532 166.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 68.2 mtm -106.81 125.0 50.44 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 123.368 0.667 . . . . 0.0 110.923 -178.224 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 72.7 mtp85 -111.6 140.93 45.81 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 123.381 0.673 . . . . 0.0 112.299 -176.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -159.22 135.18 8.81 Favored 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 123.301 0.64 . . . . 0.0 111.876 167.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 60.5 21.7 11.41 Favored 'General case' 0 N--CA 1.506 2.351 0 N-CA-C 115.963 1.838 . . . . 0.0 115.963 -170.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 82.88 -12.47 48.64 Favored Glycine 0 CA--C 1.56 2.858 0 N-CA-C 119.29 2.476 . . . . 0.0 119.29 -158.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 92.3 t -89.11 123.6 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 CA-C-N 120.015 1.908 . . . . 0.0 109.825 -171.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 24.1 m -101.16 120.81 40.78 Favored 'General case' 0 N--CA 1.494 1.773 0 C-N-CA 122.922 0.489 . . . . 0.0 112.092 -178.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 13.3 t -90.64 125.86 35.78 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.576 0.75 . . . . 0.0 111.655 162.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -107.86 113.57 26.89 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -177.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 14.4 mt-30 -121.51 126.97 50.5 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.431 -0.793 . . . . 0.0 110.882 -174.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 58.1 t -110.83 132.87 58.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -179.083 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -124.84 152.7 43.61 Favored 'General case' 0 CA--C 1.563 1.468 0 C-N-CA 124.307 1.043 . . . . 0.0 110.866 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -120.3 139.24 53.02 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.263 -0.898 . . . . 0.0 111.899 174.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 73.3 tttt -73.14 120.32 18.61 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.452 -0.78 . . . . 0.0 112.795 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . 0.253 34.7 m -105.81 -40.18 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 173.743 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 44.6 t60 . . . . . 0 N--CA 1.486 1.365 0 CA-C-N 119.988 1.267 . . . . 0.0 108.192 165.686 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo . . . . . 0 CA--C 1.564 2.008 0 N-CA-C 115.813 1.428 . . . . 0.0 115.813 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 19.0 m -76.52 152.63 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 CA-C-O 122.302 1.049 . . . . 0.0 112.307 165.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -76.74 118.08 19.0 Favored 'General case' 0 CA--C 1.565 1.545 0 O-C-N 121.242 -0.911 . . . . 0.0 113.383 178.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 6.2 m-30 -84.77 8.47 17.07 Favored 'General case' 0 CA--C 1.579 2.065 0 N-CA-C 115.57 1.693 . . . . 0.0 115.57 169.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -57.59 111.99 1.29 Allowed 'General case' 0 CA--C 1.564 1.499 0 N-CA-C 114.916 1.45 . . . . 0.0 114.916 -179.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 164.24 173.29 32.74 Favored Glycine 0 N--CA 1.484 1.862 0 N-CA-C 115.944 1.138 . . . . 0.0 115.944 -178.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -102.69 120.58 40.82 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-N 114.648 -0.776 . . . . 0.0 108.974 172.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 75.6 m95 -119.14 118.64 31.91 Favored 'General case' 0 CA--C 1.566 1.58 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -170.048 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 59.9 pttt -102.72 141.49 35.45 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.144 -0.972 . . . . 0.0 112.76 -176.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 45.6 ttm -66.05 124.78 23.49 Favored 'General case' 0 CA--C 1.569 1.689 0 N-CA-C 115.188 1.551 . . . . 0.0 115.188 -175.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 94.9 mt -88.32 -49.93 6.65 Favored 'General case' 0 CA--C 1.569 1.675 0 CA-C-N 115.128 -0.942 . . . . 0.0 112.986 164.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 87.0 p -136.6 149.56 48.09 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-N 119.143 0.883 . . . . 0.0 112.848 -178.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -135.7 87.24 2.3 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 123.671 0.789 . . . . 0.0 110.175 172.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -98.27 132.7 43.54 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.543 0.737 . . . . 0.0 110.872 -175.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.271 41.5 t30 62.75 17.08 9.53 Favored 'General case' 0 N--CA 1.503 2.203 0 N-CA-C 117.588 2.44 . . . . 0.0 117.588 179.757 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -62.4 -46.39 88.83 Favored 'General case' 0 CA--C 1.565 1.551 0 N-CA-C 115.764 1.764 . . . . 0.0 115.764 177.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -61.47 -38.93 89.04 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 116.764 2.135 . . . . 0.0 116.764 173.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -65.5 -41.43 93.21 Favored 'General case' 0 CA--C 1.572 1.825 0 CA-C-N 120.684 1.583 . . . . 0.0 114.924 168.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 39.4 t80 -55.0 -50.32 69.3 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 114.754 1.39 . . . . 0.0 114.754 166.048 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 91.9 mt -61.87 -43.4 98.91 Favored 'General case' 0 CA--C 1.571 1.775 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 171.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 20.4 ttm180 -53.12 -47.55 68.58 Favored 'General case' 0 CA--C 1.578 2.037 0 CA-C-N 120.746 1.612 . . . . 0.0 114.896 164.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.46 -19.11 45.19 Favored 'General case' 0 CA--C 1.568 1.647 0 N-CA-C 118.317 2.71 . . . . 0.0 118.317 166.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 95.4 mt -92.73 12.55 23.03 Favored 'General case' 0 CA--C 1.572 1.815 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 164.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 61.25 45.6 8.68 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 115.21 1.559 . . . . 0.0 115.21 -174.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 57.4 t -96.85 143.37 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 CA-C-O 122.388 1.09 . . . . 0.0 110.123 -176.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 -71.46 152.74 42.8 Favored 'General case' 0 CA--C 1.569 1.676 0 N-CA-C 115.022 1.49 . . . . 0.0 115.022 177.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 57.8 t -57.37 -41.1 77.8 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.166 0 N-CA-C 115.14 1.533 . . . . 0.0 115.14 -176.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.09 -49.32 78.31 Favored 'General case' 0 CA--C 1.567 1.624 0 N-CA-C 116.296 1.961 . . . . 0.0 116.296 174.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -59.55 -48.19 82.61 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 114.136 1.162 . . . . 0.0 114.136 168.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 53.2 mtp180 -50.82 -45.42 59.47 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 117.444 2.387 . . . . 0.0 117.444 168.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -72.5 -51.7 18.91 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-N 119.978 1.263 . . . . 0.0 113.807 172.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 45.2 mt -58.72 -51.5 71.24 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.23 0 CA-C-N 120.498 1.499 . . . . 0.0 113.293 178.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.83 -35.77 82.19 Favored 'General case' 0 CA--C 1.563 1.477 0 N-CA-C 117.76 2.504 . . . . 0.0 117.76 175.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -74.33 -30.82 62.19 Favored 'General case' 0 CA--C 1.571 1.777 0 N-CA-C 116.357 1.984 . . . . 0.0 116.357 169.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 79.4 mt -73.02 -34.38 66.31 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 115.209 1.559 . . . . 0.0 115.209 169.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 81.9 mt -72.5 152.81 41.69 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 119.318 0.963 . . . . 0.0 112.574 169.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -102.65 89.52 1.83 Allowed Pre-proline 0 CA--C 1.57 1.72 0 CA-C-O 118.234 -0.889 . . . . 0.0 109.339 167.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -70.16 168.67 21.42 Favored 'Trans proline' 0 CA--C 1.563 1.964 0 C-N-CA 122.47 2.114 . . . . 0.0 115.399 -179.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -131.95 128.6 38.81 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.905 -169.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -99.79 109.11 21.55 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.161 -0.962 . . . . 0.0 109.822 177.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -93.76 102.74 14.89 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 169.15 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 92.2 mt -94.91 121.38 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -172.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 96.0 t -112.1 93.2 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 107.067 -1.456 . . . . 0.0 107.067 176.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -89.69 115.97 27.45 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 123.72 0.808 . . . . 0.0 110.556 176.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -135.62 70.51 1.43 Allowed 'General case' 0 CA--C 1.569 1.682 0 C-N-CA 123.212 0.605 . . . . 0.0 110.811 -173.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 61.98 81.62 0.09 OUTLIER Glycine 0 N--CA 1.495 2.627 0 N-CA-C 116.488 1.355 . . . . 0.0 116.488 173.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.452 1.1 p30 63.85 -39.02 0.2 Allowed 'General case' 0 N--CA 1.504 2.225 0 N-CA-C 118.332 2.716 . . . . 0.0 118.332 -165.181 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 12.4 t-80 -79.15 121.64 25.26 Favored 'General case' 0 CA--C 1.56 1.346 0 CA-C-N 120.157 1.344 . . . . 0.0 111.406 173.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 11.3 ttp -134.6 129.51 35.07 Favored 'General case' 0 CA--C 1.556 1.204 0 CA-C-O 122.08 0.943 . . . . 0.0 110.979 -179.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 4.4 mp -105.06 113.57 42.45 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.377 0 N-CA-C 107.081 -1.452 . . . . 0.0 107.081 174.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 24.5 mm -89.04 93.57 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 167.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -80.18 96.68 6.63 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.146 -0.971 . . . . 0.0 109.733 -179.036 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 26.3 m -90.24 100.85 13.6 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 -175.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 23.6 mt -105.86 135.13 47.85 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 124.214 1.006 . . . . 0.0 110.491 -164.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 12.5 p -144.26 156.36 44.24 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.136 -0.978 . . . . 0.0 112.597 177.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.6 m -77.75 61.08 2.35 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 120.742 -1.223 . . . . 0.0 112.316 172.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -177.14 -67.55 0.01 OUTLIER 'General case' 0 CA--C 1.568 1.657 0 C-N-CA 126.013 1.725 . . . . 0.0 107.946 -174.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 56.7 ttt85 -144.76 140.94 28.84 Favored 'General case' 0 CA--C 1.565 1.528 0 CA-C-O 121.784 0.802 . . . . 0.0 110.217 177.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -105.18 119.43 39.03 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 175.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 19.3 t80 -81.75 -57.73 3.31 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 114.074 1.139 . . . . 0.0 114.074 -172.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.272 10.4 mm 76.2 95.97 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 C-N-CA 124.071 0.949 . . . . 0.0 111.798 172.395 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 91.1 mtp -97.52 94.2 6.88 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.994 -1.066 . . . . 0.0 109.628 173.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.9 p30 -96.19 111.29 23.39 Favored 'General case' 0 CA--C 1.561 1.38 0 C-N-CA 124.069 0.948 . . . . 0.0 112.136 179.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 20.4 p90 -150.38 158.57 44.31 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 -168.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -95.22 134.19 38.25 Favored 'General case' 0 CA--C 1.563 1.47 0 O-C-N 121.464 -0.773 . . . . 0.0 110.938 164.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 36.4 t -72.53 122.92 26.09 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.807 0 C-N-CA 123.845 0.858 . . . . 0.0 109.431 178.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 104.74 -48.55 0.98 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 115.56 0.984 . . . . 0.0 115.56 -163.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 26.2 tptp -65.14 133.48 51.66 Favored 'General case' 0 CA--C 1.567 1.618 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 176.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -92.48 110.19 21.6 Favored 'General case' 0 CA--C 1.569 1.709 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.139 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -118.99 134.44 55.19 Favored 'General case' 0 N--CA 1.498 1.947 0 C-N-CA 124.092 0.957 . . . . 0.0 112.664 -169.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -73.41 131.78 42.23 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.248 -1.532 . . . . 0.0 114.245 178.704 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 . . . . . 0 N--CA 1.5 2.068 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 176.819 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 97.8 m . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 121.384 0.611 . . . . 0.0 110.626 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 33.7 mtp -71.2 105.37 3.4 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-O 122.305 1.05 . . . . 0.0 111.799 -179.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 53.8 m -106.13 119.2 38.61 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.638 -161.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 87.6 m -94.79 124.68 38.98 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 166.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 57.8 t -105.45 135.95 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 167.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 52.4 m -147.5 146.88 29.66 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.286 -1.509 . . . . 0.0 112.528 -177.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 47.1 m95 -83.94 119.03 24.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.177 -0.952 . . . . 0.0 112.782 178.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -96.13 71.55 2.86 Favored 'General case' 0 CA--C 1.573 1.849 0 C-N-CA 123.061 0.544 . . . . 0.0 109.569 157.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 62.65 -102.83 0.54 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 115.653 1.021 . . . . 0.0 115.653 -175.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -80.77 -22.29 40.26 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 116.312 1.967 . . . . 0.0 116.312 169.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 61.2 mtpt -92.92 121.83 34.67 Favored 'General case' 0 CA--C 1.56 1.349 0 CA-C-N 119.547 1.067 . . . . 0.0 110.499 -177.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 33.0 tp -89.17 106.98 18.79 Favored 'General case' 0 CA--C 1.564 1.492 0 O-C-N 121.407 -0.808 . . . . 0.0 109.345 174.099 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 -96.59 137.21 36.01 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.724 0.81 . . . . 0.0 111.349 -175.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 40.7 t -134.17 128.35 33.86 Favored 'General case' 0 N--CA 1.483 1.189 0 O-C-N 121.732 -0.605 . . . . 0.0 111.742 -177.056 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 11.1 p -122.47 124.1 70.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 C-N-CA 123.284 0.634 . . . . 0.0 109.84 176.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -102.66 106.85 17.57 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 123.855 0.862 . . . . 0.0 110.385 -176.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -101.85 124.12 46.94 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.289 -0.882 . . . . 0.0 111.666 -169.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 177.49 -62.17 0.09 OUTLIER Glycine 0 N--CA 1.494 2.541 0 N-CA-C 117.388 1.715 . . . . 0.0 117.388 178.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -134.12 -58.41 0.85 Allowed 'General case' 0 N--CA 1.496 1.836 0 CA-C-N 117.529 0.664 . . . . 0.0 112.151 178.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 53.8 mttm -79.37 139.78 37.65 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 114.374 1.25 . . . . 0.0 114.374 -176.042 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -80.33 146.98 31.3 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-N 114.638 -1.165 . . . . 0.0 112.705 175.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 65.04 20.3 66.76 Favored Glycine 0 N--CA 1.495 2.59 0 N-CA-C 119.802 2.681 . . . . 0.0 119.802 -173.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 26.6 ttt180 -84.36 118.17 24.06 Favored 'General case' 0 CA--C 1.566 1.577 0 CA-C-N 118.91 1.355 . . . . 0.0 111.654 -177.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 179.29 -171.77 43.7 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 115.298 0.879 . . . . 0.0 115.298 -174.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . 0.259 39.9 p-90 -156.49 155.0 31.24 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 170.647 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 84.7 m -128.06 116.55 20.18 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 177.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -120.26 126.98 51.93 Favored 'General case' 0 N--CA 1.495 1.821 0 C-N-CA 123.545 0.738 . . . . 0.0 111.537 -174.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 16.3 p90 -148.61 155.38 41.0 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 120.893 -1.13 . . . . 0.0 113.364 -178.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 90.7 mt -98.1 132.96 41.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.02 -1.05 . . . . 0.0 110.291 177.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -118.79 94.04 4.31 Favored 'General case' 0 CA--C 1.566 1.594 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 162.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 69.07 -112.38 4.52 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 115.396 0.919 . . . . 0.0 115.396 -178.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 16.0 p30 -85.96 -2.42 58.27 Favored 'General case' 0 CA--C 1.572 1.827 0 N-CA-C 117.139 2.274 . . . . 0.0 117.139 166.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 88.2 mt-10 -109.93 128.95 55.69 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-N 120.646 1.566 . . . . 0.0 111.712 -174.142 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 12.2 tp -90.59 116.03 28.17 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.962 0.905 . . . . 0.0 109.421 167.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 57.7 m80 -99.9 122.45 42.84 Favored 'General case' 0 CA--C 1.559 1.295 0 C-N-CA 123.936 0.895 . . . . 0.0 109.422 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 47.6 tp -123.96 119.65 30.21 Favored 'General case' 0 CA--C 1.561 1.368 0 C-N-CA 123.974 0.909 . . . . 0.0 109.878 -174.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -108.74 106.62 16.73 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 171.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 62.0 mtm -99.72 125.83 45.67 Favored 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 123.043 0.537 . . . . 0.0 111.05 -178.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 71.5 mtm180 -114.56 139.41 49.61 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 123.629 0.772 . . . . 0.0 111.551 -168.114 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -155.64 124.6 6.11 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.583 -0.698 . . . . 0.0 110.798 168.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 60.55 36.21 19.95 Favored 'General case' 0 N--CA 1.505 2.32 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 -178.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 78.64 -22.39 3.36 Favored Glycine 0 CA--C 1.554 2.524 0 N-CA-C 119.3 2.48 . . . . 0.0 119.3 -162.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 85.7 t -80.15 120.83 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 CA-C-N 119.886 1.843 . . . . 0.0 110.091 -171.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 57.0 m -103.74 118.22 36.2 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 122.923 0.489 . . . . 0.0 111.015 -179.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 37.7 t -84.74 127.79 34.28 Favored 'General case' 0 CA--C 1.559 1.291 0 C-N-CA 123.115 0.566 . . . . 0.0 111.953 162.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 38.2 mtmm -106.21 109.39 21.31 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -179.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -114.69 133.19 56.07 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 123.674 0.79 . . . . 0.0 111.14 179.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 44.7 t -118.06 131.3 71.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 177.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -125.96 138.26 53.75 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 123.328 0.651 . . . . 0.0 111.656 -179.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 29.0 tptp -96.39 137.25 35.74 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.156 -0.965 . . . . 0.0 112.623 178.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 73.1 tttt -70.73 123.6 22.31 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 174.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 24.4 m -107.0 -42.67 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.13 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 173.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 32.8 m80 . . . . . 0 C--O 1.254 1.293 0 CA-C-N 119.601 1.091 . . . . 0.0 108.683 179.256 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo . . . . . 0 CA--C 1.561 1.849 0 N-CA-C 115.728 1.395 . . . . 0.0 115.728 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 33.0 m -75.37 152.91 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 CA-C-O 122.305 1.05 . . . . 0.0 113.121 177.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -71.93 113.53 9.06 Favored 'General case' 0 CA--C 1.56 1.365 0 O-C-N 121.328 -0.857 . . . . 0.0 112.212 172.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 6.0 m-30 -77.02 6.38 6.44 Favored 'General case' 0 CA--C 1.582 2.173 0 N-CA-C 116.188 1.922 . . . . 0.0 116.188 173.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -53.51 111.42 0.71 Allowed 'General case' 0 CA--C 1.565 1.532 0 C-N-CA 126.376 1.87 . . . . 0.0 115.597 -178.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 163.1 178.18 36.68 Favored Glycine 0 N--CA 1.482 1.759 0 CA-C-O 123.01 1.339 . . . . 0.0 116.104 177.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -107.76 124.6 50.27 Favored 'General case' 0 CA--C 1.563 1.46 0 CA-C-N 113.869 -1.165 . . . . 0.0 109.088 175.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -118.92 140.92 49.18 Favored 'General case' 0 CA--C 1.569 1.674 0 C-N-CA 123.9 0.88 . . . . 0.0 110.357 -168.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -115.6 133.04 56.42 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.165 -0.959 . . . . 0.0 111.841 176.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 53.9 ttm -71.61 123.83 23.37 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.096 -1.002 . . . . 0.0 113.562 -177.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 94.9 mt -81.19 -53.18 6.6 Favored 'General case' 0 CA--C 1.567 1.626 0 CA-C-N 115.307 -0.861 . . . . 0.0 112.466 169.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 92.4 p -145.65 124.8 12.89 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.662 0.785 . . . . 0.0 111.106 -175.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -103.19 96.21 6.63 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.92 0.867 . . . . 0.0 110.527 166.047 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.578 ' HE2' ' NZ ' ' A' ' 127' ' ' LYS . 24.4 tt0 -99.24 127.05 45.18 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 124.007 0.923 . . . . 0.0 109.592 -171.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 5.9 t30 66.32 23.16 10.76 Favored 'General case' 0 N--CA 1.508 2.443 0 N-CA-C 116.794 2.146 . . . . 0.0 116.794 -174.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -69.08 -46.96 66.47 Favored 'General case' 0 CA--C 1.568 1.656 0 N-CA-C 115.034 1.494 . . . . 0.0 115.034 178.135 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -42.09 -54.42 3.59 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 118.091 2.626 . . . . 0.0 118.091 167.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.28 8.5 pt-20 -75.67 -31.3 59.69 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 116.612 2.079 . . . . 0.0 116.612 176.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 79.5 t80 -55.4 -48.4 74.41 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-N 120.36 1.437 . . . . 0.0 114.569 160.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 69.3 mt -60.82 -40.97 94.75 Favored 'General case' 0 CA--C 1.574 1.898 0 N-CA-C 114.887 1.439 . . . . 0.0 114.887 170.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 37.6 ttm-85 -51.73 -50.84 59.77 Favored 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 115.262 1.578 . . . . 0.0 115.262 163.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.32 -25.37 59.24 Favored 'General case' 0 CA--C 1.566 1.574 0 N-CA-C 117.87 2.544 . . . . 0.0 117.87 168.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 97.0 mt -87.58 9.81 19.96 Favored 'General case' 0 CA--C 1.573 1.864 0 N-CA-C 115.656 1.724 . . . . 0.0 115.656 168.243 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 60.54 43.91 12.36 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 115.606 1.706 . . . . 0.0 115.606 -172.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 95.4 t -93.9 138.7 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.193 -0.942 . . . . 0.0 109.231 177.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 13.1 p30 -63.79 150.38 44.78 Favored 'General case' 0 CA--C 1.57 1.731 0 N-CA-C 115.251 1.575 . . . . 0.0 115.251 178.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 88.8 t -56.41 -40.24 66.01 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.22 0 N-CA-C 115.522 1.675 . . . . 0.0 115.522 -177.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.5 -53.69 55.35 Favored 'General case' 0 CA--C 1.568 1.672 0 N-CA-C 115.739 1.755 . . . . 0.0 115.739 169.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 28.9 tp -63.39 -38.28 90.52 Favored 'General case' 0 CA--C 1.571 1.781 0 N-CA-C 116.175 1.917 . . . . 0.0 116.175 171.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 34.6 mtp-105 -49.76 -52.05 34.58 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 115.801 1.778 . . . . 0.0 115.801 163.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -64.15 -49.09 73.49 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 114.547 1.314 . . . . 0.0 114.547 172.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 64.6 mt -58.49 -51.98 65.02 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 CA-C-N 119.996 1.271 . . . . 0.0 113.152 176.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.01 -35.82 81.97 Favored 'General case' 0 CA--C 1.563 1.47 0 N-CA-C 117.682 2.475 . . . . 0.0 117.682 175.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -72.23 -31.02 65.45 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 116.049 1.87 . . . . 0.0 116.049 168.115 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 78.3 mt -73.46 -35.15 65.67 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 115.317 1.599 . . . . 0.0 115.317 171.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 86.6 mt -83.22 143.68 30.29 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 119.069 0.85 . . . . 0.0 111.858 175.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 29.9 mmtp -106.05 88.36 3.01 Favored Pre-proline 0 CA--C 1.574 1.903 0 CA-C-O 117.982 -1.009 . . . . 0.0 109.641 176.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -73.18 166.41 30.04 Favored 'Trans proline' 0 CA--C 1.564 1.981 0 C-N-CA 122.45 2.1 . . . . 0.0 116.089 -175.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -98.74 155.7 17.21 Favored 'General case' 0 N--CA 1.488 1.425 0 CA-C-O 121.824 0.821 . . . . 0.0 112.373 177.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 65.2 mttt -117.4 121.14 40.27 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.508 -0.745 . . . . 0.0 109.357 164.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -94.61 109.77 21.66 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.104 -0.997 . . . . 0.0 108.594 161.17 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 68.3 mt -102.32 118.76 49.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 N-CA-C 107.424 -1.325 . . . . 0.0 107.424 179.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 57.3 t -111.35 95.43 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 172.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -88.32 97.87 11.28 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 123.519 0.728 . . . . 0.0 110.298 173.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -114.94 88.92 2.97 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 123.452 0.701 . . . . 0.0 109.973 -176.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 57.98 67.68 2.08 Favored Glycine 0 N--CA 1.495 2.607 0 N-CA-C 116.631 1.412 . . . . 0.0 116.631 178.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.477 0.6 OUTLIER 64.26 -25.46 0.08 Allowed 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 119.183 3.031 . . . . 0.0 119.183 -165.08 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 15.7 t-160 -78.09 109.48 12.21 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 121.284 1.856 . . . . 0.0 111.156 174.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 46.3 ttm -110.19 114.06 27.24 Favored 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 123.729 0.812 . . . . 0.0 109.496 -175.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 49.7 mt -100.15 102.59 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 175.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 59.1 mt -95.92 104.73 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 175.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 89.3 mtt180 -90.65 103.52 16.21 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.648 -0.658 . . . . 0.0 109.276 175.036 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 22.1 m -87.36 101.42 13.54 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 5.9 mt -111.96 118.48 35.59 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 124.009 0.924 . . . . 0.0 110.093 -163.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.1 t -99.08 -78.43 0.5 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.45 -0.781 . . . . 0.0 112.614 178.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.7 t 178.58 -61.58 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 125.699 1.6 . . . . 0.0 107.444 -170.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 7.9 p90 -83.89 -41.37 17.5 Favored 'General case' 0 CA--C 1.573 1.865 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 163.082 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 42.1 ttt85 -109.43 143.16 39.4 Favored 'General case' 0 CA--C 1.565 1.537 0 C-N-CA 124.124 0.97 . . . . 0.0 112.083 -168.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 46.1 t-20 -135.4 131.73 36.65 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 123.383 0.673 . . . . 0.0 110.096 175.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 9.2 t80 -124.78 110.24 14.07 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 172.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 87.1 mt -102.29 112.42 35.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -176.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 27.0 mmm -95.83 94.81 7.87 Favored 'General case' 0 CA--C 1.56 1.359 0 C-N-CA 123.628 0.771 . . . . 0.0 109.238 174.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.1 p30 -101.29 100.38 10.89 Favored 'General case' 0 CA--C 1.561 1.377 0 C-N-CA 123.725 0.81 . . . . 0.0 111.616 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -143.96 150.83 38.92 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -166.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -90.44 125.19 35.48 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.977 -1.077 . . . . 0.0 111.81 169.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 17.2 t -68.84 119.03 14.0 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.735 0 C-N-CA 123.858 0.863 . . . . 0.0 110.043 179.208 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 111.7 -43.49 1.71 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 115.778 1.071 . . . . 0.0 115.778 -160.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 51.2 mttm -83.71 143.87 29.74 Favored 'General case' 0 CA--C 1.567 1.608 0 CA-C-N 118.884 1.342 . . . . 0.0 113.41 -175.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.617 ' HE2' ' NZ ' ' A' ' 98' ' ' LYS . 19.1 tt0 -92.04 121.07 33.26 Favored 'General case' 0 CA--C 1.567 1.615 0 O-C-N 121.882 -0.511 . . . . 0.0 111.277 172.727 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 22.5 p90 -120.63 152.25 38.41 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 123.777 0.831 . . . . 0.0 112.668 -176.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -74.2 120.37 19.67 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.183 -1.573 . . . . 0.0 112.181 167.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 . . . . . 0 N--CA 1.492 1.67 0 O-C-N 121.326 -0.859 . . . . 0.0 111.077 169.868 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 85.6 m . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 121.723 0.773 . . . . 0.0 111.741 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 8.9 tpt -79.01 108.67 12.67 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.879 -1.138 . . . . 0.0 110.743 -178.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 97.4 m -119.71 114.57 22.38 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.146 -0.971 . . . . 0.0 111.069 -151.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 52.7 m -92.07 129.95 37.91 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 165.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.6 t -113.43 129.08 69.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 163.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 52.2 m -149.04 156.8 42.77 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.587 -1.32 . . . . 0.0 112.843 -175.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 72.8 m95 -82.23 115.39 21.29 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.89 -1.131 . . . . 0.0 112.308 179.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -84.83 72.99 10.7 Favored 'General case' 0 CA--C 1.569 1.709 0 O-C-N 121.382 -0.824 . . . . 0.0 109.869 163.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 69.42 -98.51 0.59 Allowed Glycine 0 N--CA 1.488 2.125 0 O-C-N 122.188 -0.32 . . . . 0.0 113.646 -167.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -99.95 -14.63 18.62 Favored 'General case' 0 CA--C 1.575 1.916 0 N-CA-C 116.393 1.997 . . . . 0.0 116.393 169.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 48.7 mtpt -92.82 127.33 38.29 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-N 120.407 1.458 . . . . 0.0 110.236 -176.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 26.0 tp -85.03 105.86 16.1 Favored 'General case' 0 CA--C 1.563 1.462 0 O-C-N 120.739 -1.226 . . . . 0.0 110.562 -177.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 29.5 mm-40 -95.16 129.34 42.3 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 123.369 0.668 . . . . 0.0 111.478 -177.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 41.4 t -116.35 128.34 55.45 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.666 0.786 . . . . 0.0 110.896 173.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.6 p -118.76 116.72 52.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 173.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 68.7 mt-30 -104.18 98.01 7.88 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 123.84 0.856 . . . . 0.0 109.079 -173.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.617 ' NZ ' ' HE2' ' A' ' 69' ' ' GLU . 92.7 mttt -91.49 134.89 34.26 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.424 -0.797 . . . . 0.0 113.074 -164.275 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 160.43 -109.89 0.42 Allowed Glycine 0 N--CA 1.486 2.009 0 O-C-N 121.504 -0.748 . . . . 0.0 113.526 165.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -84.63 -39.08 19.08 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 115.906 1.817 . . . . 0.0 115.906 -175.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 17.8 ttmm -88.6 129.07 35.57 Favored 'General case' 0 CA--C 1.564 1.504 0 CA-C-N 119.5 1.046 . . . . 0.0 112.315 -175.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -76.16 134.13 40.02 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -172.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 61.93 32.97 83.94 Favored Glycine 0 N--CA 1.496 2.637 0 N-CA-C 119.622 2.609 . . . . 0.0 119.622 -177.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 3.9 ttt85 -86.97 119.77 27.53 Favored 'General case' 0 CA--C 1.564 1.515 0 CA-C-N 118.863 1.331 . . . . 0.0 111.264 -179.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -178.62 -171.83 42.32 Favored Glycine 0 N--CA 1.483 1.804 0 CA-C-O 122.102 0.834 . . . . 0.0 114.366 179.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 47.7 p-90 -156.08 156.24 33.98 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 175.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 29.4 m -127.96 119.65 25.95 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 177.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -122.72 131.49 53.81 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 -176.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 23.9 p90 -148.87 160.66 43.04 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.202 -0.937 . . . . 0.0 112.184 -179.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 96.1 mt -109.09 135.04 49.2 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.182 0 O-C-N 120.722 -1.236 . . . . 0.0 110.637 178.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -122.51 94.52 4.31 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 124.417 1.087 . . . . 0.0 108.156 176.293 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 73.11 -109.56 2.85 Favored Glycine 0 N--CA 1.491 2.34 0 O-C-N 121.494 -0.754 . . . . 0.0 114.024 -174.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -111.55 37.3 2.94 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 114.514 1.301 . . . . 0.0 114.514 164.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 81.3 mt-10 -130.72 130.66 44.09 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.709 0.804 . . . . 0.0 110.642 178.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 15.5 tp -90.85 118.09 29.98 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 123.892 0.877 . . . . 0.0 109.526 173.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 43.1 m80 -106.39 118.76 37.48 Favored 'General case' 0 CA--C 1.559 1.294 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -178.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 46.8 tp -122.24 124.53 44.02 Favored 'General case' 0 CA--C 1.559 1.301 0 C-N-CA 124.078 0.951 . . . . 0.0 109.572 -173.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 77.5 mt-10 -114.03 109.89 19.18 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.547 -0.72 . . . . 0.0 109.661 170.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 68.7 mtm -101.64 127.2 48.49 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 123.336 0.654 . . . . 0.0 110.858 -177.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 54.2 mtp85 -116.83 137.62 52.08 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 123.416 0.687 . . . . 0.0 110.932 -171.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -157.18 129.38 7.29 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.562 -0.711 . . . . 0.0 111.278 170.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . 0.276 22.6 mt-10 57.57 38.37 27.87 Favored 'General case' 0 N--CA 1.502 2.15 0 N-CA-C 115.77 1.767 . . . . 0.0 115.77 -176.256 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 69.14 9.26 60.05 Favored Glycine 0 CA--C 1.555 2.586 0 N-CA-C 120.365 2.906 . . . . 0.0 120.365 -164.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 95.0 t -111.59 125.54 68.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 CA-C-N 119.989 1.894 . . . . 0.0 108.972 -174.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 41.7 m -106.73 123.24 47.85 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 123.137 0.575 . . . . 0.0 111.168 -176.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 22.1 t -94.27 124.2 38.14 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.541 0.736 . . . . 0.0 111.513 164.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.578 ' NZ ' ' HE2' ' A' ' 14' ' ' GLU . 48.5 mtpt -99.02 114.74 27.56 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 123.38 0.672 . . . . 0.0 109.65 177.773 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 20.2 mt-30 -119.78 123.59 44.09 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 123.35 0.66 . . . . 0.0 110.729 -178.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 43.8 t -112.91 130.49 66.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -123.97 147.45 47.74 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 123.595 0.758 . . . . 0.0 110.909 177.327 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -107.02 143.5 35.03 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.222 -0.924 . . . . 0.0 112.24 174.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 64.9 tttt -77.08 124.65 28.1 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 -177.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 27.7 m -110.86 -40.22 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 178.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 47.6 t-80 . . . . . 0 N--CA 1.486 1.373 0 CA-C-N 120.474 1.488 . . . . 0.0 108.488 174.824 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo . . . . . 0 CA--C 1.574 2.496 0 N-CA-C 115.867 1.449 . . . . 0.0 115.867 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 16.9 t -151.0 132.06 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 -172.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -75.78 90.09 2.88 Favored 'General case' 0 CA--C 1.569 1.698 0 O-C-N 121.193 -0.942 . . . . 0.0 111.76 172.065 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 10.6 m-30 -70.36 -1.38 10.4 Favored 'General case' 0 CA--C 1.58 2.119 0 N-CA-C 117.834 2.531 . . . . 0.0 117.834 176.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -51.96 123.61 10.8 Favored 'General case' 0 CA--C 1.566 1.594 0 N-CA-C 115.668 1.729 . . . . 0.0 115.668 177.382 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 163.21 176.93 35.73 Favored Glycine 0 N--CA 1.486 1.995 0 N-CA-C 116.153 1.221 . . . . 0.0 116.153 178.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -111.58 121.0 43.97 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 171.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 78.9 m95 -124.71 126.11 45.17 Favored 'General case' 0 CA--C 1.566 1.594 0 C-N-CA 123.297 0.639 . . . . 0.0 110.591 -165.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -96.62 138.97 33.39 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 120.673 -1.267 . . . . 0.0 113.215 177.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 6.5 ttp -74.68 128.41 35.49 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.683 -1.261 . . . . 0.0 114.207 -178.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 91.0 mt -90.39 -50.05 6.18 Favored 'General case' 0 CA--C 1.567 1.617 0 N-CA-C 113.874 1.065 . . . . 0.0 113.874 172.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 91.3 p -139.98 154.81 47.27 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -175.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 24.7 p30 -135.77 81.36 1.88 Allowed 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 124.133 0.973 . . . . 0.0 111.092 173.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -88.67 119.58 29.27 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.102 -0.999 . . . . 0.0 110.144 -174.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.273 41.9 t30 67.95 21.68 8.84 Favored 'General case' 0 N--CA 1.504 2.251 0 N-CA-C 116.821 2.156 . . . . 0.0 116.821 -175.533 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -69.29 -47.14 65.41 Favored 'General case' 0 CA--C 1.568 1.666 0 N-CA-C 115.795 1.776 . . . . 0.0 115.795 178.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -46.48 -44.41 17.55 Favored 'General case' 0 N--CA 1.502 2.173 0 N-CA-C 117.534 2.42 . . . . 0.0 117.534 165.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -69.44 -44.79 70.57 Favored 'General case' 0 CA--C 1.57 1.731 0 N-CA-C 114.992 1.479 . . . . 0.0 114.992 172.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -52.94 -47.35 68.14 Favored 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 115.123 1.527 . . . . 0.0 115.123 166.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.7 mt -61.14 -41.63 97.08 Favored 'General case' 0 CA--C 1.571 1.782 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 169.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 44.2 ttp85 -56.62 -45.52 81.47 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 115.36 1.615 . . . . 0.0 115.36 166.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.12 -25.1 60.98 Favored 'General case' 0 CA--C 1.567 1.606 0 N-CA-C 117.827 2.528 . . . . 0.0 117.827 165.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 98.1 mt -89.39 21.79 3.19 Favored 'General case' 0 CA--C 1.573 1.836 0 N-CA-C 115.23 1.567 . . . . 0.0 115.23 164.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.486 ' HD2' ' NZ ' ' A' ' 101' ' ' LYS . 11.7 m-20 66.9 16.39 10.36 Favored 'General case' 0 N--CA 1.504 2.236 0 N-CA-C 116.682 2.104 . . . . 0.0 116.682 179.551 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 91.4 t -82.03 136.35 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 120.223 -1.548 . . . . 0.0 110.215 -167.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 13.7 p30 -62.06 152.86 31.45 Favored 'General case' 0 CA--C 1.57 1.727 0 N-CA-C 115.208 1.559 . . . . 0.0 115.208 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 91.5 t -58.7 -38.4 71.53 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.153 0 N-CA-C 115.219 1.563 . . . . 0.0 115.219 -176.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.12 -55.98 27.64 Favored 'General case' 0 CA--C 1.569 1.687 0 N-CA-C 115.448 1.647 . . . . 0.0 115.448 167.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -56.52 -43.29 79.65 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 116.275 1.954 . . . . 0.0 116.275 169.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 37.3 mtp-105 -52.07 -53.06 46.85 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 116.017 1.858 . . . . 0.0 116.017 168.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -66.75 -47.75 71.27 Favored 'General case' 0 CA--C 1.567 1.629 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 174.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 66.1 mt -55.34 -54.87 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 CA-C-N 120.047 1.294 . . . . 0.0 113.266 174.042 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.84 -38.02 89.13 Favored 'General case' 0 CA--C 1.564 1.514 0 N-CA-C 117.635 2.457 . . . . 0.0 117.635 176.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -74.16 -24.11 59.35 Favored 'General case' 0 CA--C 1.571 1.759 0 N-CA-C 116.138 1.903 . . . . 0.0 116.138 171.265 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 73.6 mt -73.2 -37.79 66.34 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 115.405 1.631 . . . . 0.0 115.405 168.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.5 pp -84.28 143.92 29.23 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 119.597 1.089 . . . . 0.0 113.923 -178.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm -104.53 101.88 30.58 Favored Pre-proline 0 CA--C 1.572 1.818 0 CA-C-O 117.954 -1.022 . . . . 0.0 109.348 174.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -82.26 172.12 11.96 Favored 'Trans proline' 0 CA--C 1.564 2.014 0 C-N-CA 122.805 2.337 . . . . 0.0 114.778 -176.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -109.2 118.97 38.11 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.278 176.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 52.6 mttm -85.38 108.3 17.78 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.073 -1.017 . . . . 0.0 109.895 172.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -91.89 108.06 19.65 Favored 'General case' 0 CA--C 1.559 1.302 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 164.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 84.9 mt -97.6 114.15 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 -179.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 98.0 t -101.06 97.72 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 168.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -95.66 99.63 11.46 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 123.673 0.789 . . . . 0.0 109.727 175.328 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -106.64 75.25 1.05 Allowed 'General case' 0 CA--C 1.567 1.612 0 C-N-CA 123.557 0.743 . . . . 0.0 110.563 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 57.61 68.24 1.8 Allowed Glycine 0 N--CA 1.494 2.552 0 N-CA-C 117.628 1.811 . . . . 0.0 117.628 177.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.494 0.0 OUTLIER 81.99 -39.24 0.12 Allowed 'General case' 0 N--CA 1.501 2.108 0 N-CA-C 115.837 1.792 . . . . 0.0 115.837 -165.358 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 21.8 t-160 -74.32 100.49 3.77 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 120.677 1.58 . . . . 0.0 111.183 177.327 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 42.5 ttm -113.14 111.26 21.8 Favored 'General case' 0 CA--C 1.552 1.031 0 CA-C-O 121.665 0.745 . . . . 0.0 109.137 -170.191 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 51.8 mt -102.79 103.12 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 -175.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 26.0 mm -89.22 93.72 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 -178.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 61.1 mtt85 -90.45 97.38 11.15 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.232 -0.918 . . . . 0.0 110.099 178.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 14.3 m -89.41 99.19 12.24 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 15.1 mt -93.77 117.36 29.99 Favored 'General case' 0 N--CA 1.484 1.266 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.594 -162.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 42.2 t -133.11 141.27 48.09 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.849 0.859 . . . . 0.0 110.752 -159.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 13.1 t -74.09 39.35 0.11 Allowed 'General case' 0 CA--C 1.581 2.144 0 N-CA-C 116.701 2.112 . . . . 0.0 116.701 172.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -159.52 -65.29 0.08 Allowed 'General case' 0 CA--C 1.567 1.621 0 C-N-CA 124.676 1.19 . . . . 0.0 109.92 178.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 53.4 ttm-85 -140.09 117.52 11.42 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 123.625 0.77 . . . . 0.0 108.942 174.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 72.0 m-80 -76.77 126.99 31.92 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.785 -0.572 . . . . 0.0 111.993 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 40.9 t80 -106.47 100.28 9.82 Favored 'General case' 0 CA--C 1.567 1.606 0 O-C-N 121.645 -0.66 . . . . 0.0 110.724 -172.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 4.1 mp -95.36 111.22 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 C-N-CA 123.73 0.812 . . . . 0.0 109.051 178.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -103.55 94.83 5.67 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 123.413 0.685 . . . . 0.0 109.621 176.672 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -100.38 118.07 35.87 Favored 'General case' 0 CA--C 1.564 1.486 0 C-N-CA 123.913 0.885 . . . . 0.0 112.805 -174.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -155.15 143.2 20.11 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 -170.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 17.9 mp0 -85.18 116.17 23.39 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.441 -0.787 . . . . 0.0 110.376 166.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 41.2 t -65.08 117.54 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 C-N-CA 123.769 0.828 . . . . 0.0 110.047 177.242 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 118.61 -54.68 0.61 Allowed Glycine 0 N--CA 1.488 2.139 0 N-CA-C 114.675 0.63 . . . . 0.0 114.675 -159.049 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 5.9 mtmp? -80.79 148.02 30.21 Favored 'General case' 0 CA--C 1.566 1.586 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 -173.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -98.78 124.13 43.45 Favored 'General case' 0 CA--C 1.568 1.665 0 C-N-CA 123.183 0.593 . . . . 0.0 111.78 178.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 9.0 p90 -135.76 145.63 46.79 Favored 'General case' 0 N--CA 1.498 1.967 0 C-N-CA 123.837 0.855 . . . . 0.0 112.024 -171.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -79.15 128.29 33.1 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 119.54 -1.975 . . . . 0.0 113.64 177.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 . . . . . 0 N--CA 1.493 1.677 0 CA-C-O 122.238 1.018 . . . . 0.0 112.079 173.267 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 73.0 m . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 121.922 0.868 . . . . 0.0 113.038 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 7.2 tpt -75.88 111.13 10.92 Favored 'General case' 0 CA--C 1.56 1.331 0 CA-C-O 122.175 0.988 . . . . 0.0 110.522 -170.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 93.8 m -120.61 120.61 36.27 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 115.377 -0.828 . . . . 0.0 110.399 -153.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 50.9 m -105.79 125.29 50.82 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 171.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.454 HG21 ' SG ' ' A' ' 95' ' ' CYS . 20.4 t -104.61 130.8 54.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 165.794 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 58.7 m -149.94 152.35 34.85 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.455 -1.403 . . . . 0.0 112.871 -178.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 52.3 m95 -83.78 118.96 24.26 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.939 -1.1 . . . . 0.0 113.544 -176.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -94.13 67.38 3.61 Favored 'General case' 0 CA--C 1.572 1.819 0 O-C-N 121.594 -0.691 . . . . 0.0 110.101 159.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 67.09 -102.63 0.81 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 114.798 0.679 . . . . 0.0 114.798 -176.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -80.81 -23.22 39.38 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 116.523 2.045 . . . . 0.0 116.523 169.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 60.1 mtpt -98.77 116.15 30.36 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 119.317 0.962 . . . . 0.0 110.182 -174.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 29.2 tp -82.83 109.47 16.99 Favored 'General case' 0 CA--C 1.564 1.485 0 O-C-N 121.277 -0.89 . . . . 0.0 110.057 175.438 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 -97.78 131.93 43.85 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.644 0.778 . . . . 0.0 111.538 -174.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . 0.454 ' SG ' HG21 ' A' ' 86' ' ' VAL . 44.9 t -122.26 128.92 51.71 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.341 0.657 . . . . 0.0 110.744 175.208 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.1 p -110.69 127.6 67.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 166.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -109.05 88.62 2.77 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 123.453 0.701 . . . . 0.0 109.665 175.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 12.0 ptmm? -97.22 145.19 26.3 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 114.309 1.225 . . . . 0.0 114.309 -172.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 159.75 -97.52 0.16 Allowed Glycine 0 N--CA 1.488 2.133 0 O-C-N 121.282 -0.886 . . . . 0.0 112.626 173.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -75.2 -47.16 29.63 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 115.125 1.528 . . . . 0.0 115.125 173.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.486 ' NZ ' ' HD2' ' A' ' 24' ' ' ASP . 1.6 ttmp? -103.51 131.79 50.33 Favored 'General case' 0 CA--C 1.561 1.38 0 C-N-CA 123.636 0.774 . . . . 0.0 111.77 -161.796 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -77.87 160.38 28.32 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -179.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 56.57 21.43 35.08 Favored Glycine 0 N--CA 1.498 2.774 0 N-CA-C 120.722 3.049 . . . . 0.0 120.722 -179.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 45.1 ttt180 -96.02 123.21 39.53 Favored 'General case' 0 CA--C 1.563 1.459 0 CA-C-N 118.481 1.14 . . . . 0.0 112.42 -168.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 173.39 -169.78 42.9 Favored Glycine 0 N--CA 1.484 1.887 0 CA-C-O 121.949 0.75 . . . . 0.0 114.558 -176.327 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . 0.253 41.5 p-90 -156.82 157.17 34.47 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 113.804 1.038 . . . . 0.0 113.804 173.536 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 34.5 m -129.63 118.57 22.17 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 123.782 0.833 . . . . 0.0 108.765 176.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 -121.42 130.15 53.42 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.743 -0.598 . . . . 0.0 112.434 -175.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 25.4 p90 -144.66 164.86 29.7 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.251 -0.906 . . . . 0.0 112.059 176.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 96.3 mt -109.79 127.82 66.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 120.915 -1.116 . . . . 0.0 109.789 175.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -102.02 84.54 2.53 Favored 'General case' 0 CA--C 1.567 1.616 0 C-N-CA 123.997 0.919 . . . . 0.0 109.185 163.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 64.84 -98.06 0.28 Allowed Glycine 0 N--CA 1.493 2.442 0 N-CA-C 116.452 1.341 . . . . 0.0 116.452 -179.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 41.1 p30 -88.94 -5.46 57.96 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 117.36 2.356 . . . . 0.0 117.36 167.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -114.63 125.53 53.87 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-N 120.874 1.67 . . . . 0.0 111.529 -172.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 14.2 tp -86.26 115.13 23.61 Favored 'General case' 0 CA--C 1.563 1.474 0 C-N-CA 123.869 0.867 . . . . 0.0 109.472 169.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 51.8 m80 -102.42 121.09 41.65 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.651 0.78 . . . . 0.0 109.029 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 53.6 tp -121.16 119.41 32.28 Favored 'General case' 0 CA--C 1.562 1.433 0 C-N-CA 123.714 0.806 . . . . 0.0 110.005 -176.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -100.19 116.55 32.45 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 168.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 71.9 mtm -109.76 124.97 52.19 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 118.974 0.806 . . . . 0.0 110.977 -178.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 87.4 mtm180 -112.3 137.13 50.86 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 123.963 0.905 . . . . 0.0 110.809 -171.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -154.03 129.97 10.21 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.372 -0.83 . . . . 0.0 111.344 168.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . 0.273 7.9 mm-40 64.05 9.19 4.47 Favored 'General case' 0 N--CA 1.502 2.125 0 N-CA-C 117.59 2.441 . . . . 0.0 117.59 -175.303 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 99.88 -19.08 54.74 Favored Glycine 0 CA--C 1.556 2.615 0 N-CA-C 117.792 1.877 . . . . 0.0 117.792 -157.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 96.8 t -83.86 124.27 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 CA-C-N 119.7 1.75 . . . . 0.0 109.77 -177.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 47.9 m -103.74 119.73 39.51 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 121.108 0.48 . . . . 0.0 111.205 176.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 8.8 t -88.94 136.45 33.0 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.656 0.783 . . . . 0.0 112.075 162.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -111.23 114.93 28.5 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.718 -0.614 . . . . 0.0 109.832 176.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -113.81 140.38 48.36 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.857 0.863 . . . . 0.0 111.545 176.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 34.5 t -123.06 134.84 65.0 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 177.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -130.24 132.56 46.01 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 123.878 0.871 . . . . 0.0 111.215 -177.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 20.2 tptm -98.06 136.11 38.78 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.997 -1.065 . . . . 0.0 112.161 -178.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 67.7 tttt -74.5 118.33 17.33 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.522 -0.737 . . . . 0.0 112.777 179.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . 0.254 35.0 m -102.85 -40.79 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 175.067 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 67.0 t60 . . . . . 0 N--CA 1.486 1.351 0 CA-C-N 119.838 1.199 . . . . 0.0 107.95 164.212 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 67.5 mtt . . . . . 0 CA--C 1.572 1.793 0 CA-C-O 117.852 -1.071 . . . . 0.0 109.792 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.64 130.0 16.44 Favored 'Trans proline' 0 CA--C 1.563 1.967 0 C-N-CA 122.881 2.387 . . . . 0.0 114.658 -175.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 33.0 m -78.73 125.84 38.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -166.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -75.67 97.49 3.82 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.026 -1.046 . . . . 0.0 112.532 -176.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -72.76 1.22 8.9 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 117.981 2.586 . . . . 0.0 117.981 -178.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -51.84 109.51 0.37 Allowed 'General case' 0 CA--C 1.566 1.594 0 N-CA-C 115.716 1.747 . . . . 0.0 115.716 -176.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 161.24 179.05 35.72 Favored Glycine 0 N--CA 1.484 1.894 0 CA-C-O 122.666 1.148 . . . . 0.0 115.94 -178.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -110.92 126.09 54.36 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 114.052 -1.074 . . . . 0.0 108.541 172.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 49.7 m95 -128.94 125.09 36.75 Favored 'General case' 0 CA--C 1.566 1.578 0 C-N-CA 123.358 0.663 . . . . 0.0 109.46 -167.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 16.7 ptpt -89.78 143.95 26.37 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.857 -1.152 . . . . 0.0 112.933 174.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.414 ' SD ' ' HD2' ' A' ' 38' ' ' PRO . 49.1 ttm -75.99 127.87 33.87 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.845 -1.16 . . . . 0.0 112.585 174.25 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 88.7 mt -87.06 -49.91 7.0 Favored 'General case' 0 CA--C 1.568 1.639 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 171.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 91.9 p -143.46 142.04 31.03 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 119.428 1.013 . . . . 0.0 113.368 -170.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.41 ' OD1' ' SD ' ' A' ' 10' ' ' MET . 2.3 m120 -117.99 93.42 4.13 Favored 'General case' 0 CA--C 1.565 1.527 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 -177.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -77.18 -70.23 0.48 Allowed 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 115.585 1.698 . . . . 0.0 115.585 -165.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -119.08 44.56 2.3 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.907 0.861 . . . . 0.0 111.237 175.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -72.38 -37.53 68.72 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 114.894 1.442 . . . . 0.0 114.894 175.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -50.02 -54.08 22.51 Favored 'General case' 0 CA--C 1.574 1.889 0 N-CA-C 115.288 1.588 . . . . 0.0 115.288 166.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -71.62 -36.94 70.93 Favored 'General case' 0 CA--C 1.574 1.881 0 N-CA-C 115.978 1.844 . . . . 0.0 115.978 175.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -55.09 -49.54 71.44 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 114.84 1.422 . . . . 0.0 114.84 165.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 78.7 mt -60.96 -39.91 91.33 Favored 'General case' 0 CA--C 1.574 1.889 0 N-CA-C 114.819 1.414 . . . . 0.0 114.819 169.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 26.9 ttm180 -51.52 -51.73 52.8 Favored 'General case' 0 N--CA 1.502 2.173 0 N-CA-C 115.467 1.654 . . . . 0.0 115.467 163.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.51 -27.7 62.78 Favored 'General case' 0 CA--C 1.567 1.635 0 N-CA-C 117.908 2.559 . . . . 0.0 117.908 167.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 95.8 mt -81.52 10.92 5.1 Favored 'General case' 0 CA--C 1.573 1.837 0 N-CA-C 115.614 1.709 . . . . 0.0 115.614 167.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.541 ' N ' ' HD2' ' A' ' 24' ' ' ASP 0.252 0.9 OUTLIER 64.03 40.0 7.47 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 115.434 1.642 . . . . 0.0 115.434 -175.429 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 89.0 t -100.15 151.0 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 CA-C-O 122.379 1.085 . . . . 0.0 110.645 -178.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 9.7 p-10 -74.12 154.39 39.16 Favored 'General case' 0 CA--C 1.568 1.656 0 N-CA-C 115.59 1.7 . . . . 0.0 115.59 -179.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 45.9 t -54.58 -45.72 71.72 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.345 0 N-CA-C 115.059 1.503 . . . . 0.0 115.059 -176.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.33 -47.98 83.41 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 115.922 1.823 . . . . 0.0 115.922 176.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.77 -49.89 75.96 Favored 'General case' 0 CA--C 1.571 1.75 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 168.02 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 56.3 mtp180 -48.55 -55.47 11.0 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 116.302 1.964 . . . . 0.0 116.302 167.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 35.8 tptt -59.32 -50.78 72.67 Favored 'General case' 0 CA--C 1.564 1.504 0 N-CA-C 115.471 1.656 . . . . 0.0 115.471 176.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 22.2 mt -67.86 -45.69 83.64 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.806 0 CA-C-O 118.03 -0.986 . . . . 0.0 112.286 177.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -57.9 -39.89 79.0 Favored 'General case' 0 CA--C 1.565 1.548 0 N-CA-C 117.229 2.307 . . . . 0.0 117.229 170.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -65.94 -28.67 69.09 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 116.411 2.004 . . . . 0.0 116.411 166.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 80.4 mt -72.99 -37.17 67.1 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 115.727 1.751 . . . . 0.0 115.727 165.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 44.2 mt -68.74 141.48 55.23 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 119.45 1.023 . . . . 0.0 113.711 -175.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 39.2 mmtm -112.54 78.99 2.89 Favored Pre-proline 0 CA--C 1.575 1.91 0 CA-C-O 118.411 -0.804 . . . . 0.0 109.934 177.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.414 ' HD2' ' SD ' ' A' ' 10' ' ' MET . 74.1 Cg_endo -75.34 168.4 24.68 Favored 'Trans proline' 0 CA--C 1.562 1.895 0 C-N-CA 122.528 2.152 . . . . 0.0 115.708 -176.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -108.58 127.36 53.88 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.664 -174.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 38.7 mttp -97.6 113.95 25.77 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.563 -0.71 . . . . 0.0 109.651 172.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -98.69 108.26 20.9 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 165.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.3 mp -96.97 120.05 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 177.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 75.4 t -99.67 101.85 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 166.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -104.59 114.02 27.97 Favored 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 123.469 0.708 . . . . 0.0 110.927 -178.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -123.7 74.48 1.27 Allowed 'General case' 0 CA--C 1.569 1.685 0 C-N-CA 123.843 0.857 . . . . 0.0 110.493 177.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.76 -100.37 1.45 Allowed Glycine 0 N--CA 1.489 2.229 0 O-C-N 121.48 -0.762 . . . . 0.0 114.063 177.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -85.22 -33.84 22.14 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 115.218 1.562 . . . . 0.0 115.218 162.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -78.16 114.15 16.78 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-N 120.682 1.583 . . . . 0.0 112.11 -174.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 48.2 ttm -128.29 118.63 23.6 Favored 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 123.43 0.692 . . . . 0.0 109.644 -175.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 52.4 mt -107.02 103.33 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 176.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 73.2 mt -90.39 99.53 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 175.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 70.5 mtt85 -89.42 95.96 10.5 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.467 -0.771 . . . . 0.0 110.673 178.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 49.5 m -88.29 105.08 17.32 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 177.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 12.2 mt -106.01 113.9 27.72 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 123.684 0.793 . . . . 0.0 109.213 -163.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 9.1 t -139.68 155.91 47.11 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.856 0.836 . . . . 0.0 112.434 -166.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 26.9 m -61.57 -40.74 95.83 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 115.745 1.757 . . . . 0.0 115.745 178.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -69.04 -58.13 4.51 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 114.699 1.37 . . . . 0.0 114.699 171.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 26.4 tpt180 -152.15 135.67 16.09 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-N 118.516 0.598 . . . . 0.0 109.863 175.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -73.98 112.42 10.09 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.776 -0.577 . . . . 0.0 109.706 163.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 52.8 t80 -79.29 -61.68 1.93 Allowed 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -167.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.334 49.7 mt 74.5 97.64 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 C-N-CA 123.932 0.893 . . . . 0.0 111.91 167.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 89.0 mtp -100.18 99.42 10.11 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.486 -0.759 . . . . 0.0 109.352 172.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -98.71 114.45 26.97 Favored 'General case' 0 CA--C 1.563 1.479 0 C-N-CA 124.013 0.925 . . . . 0.0 111.663 177.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -156.55 157.17 34.89 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 -168.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 66.1 mt-30 -100.28 127.16 46.63 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.581 -0.7 . . . . 0.0 110.481 165.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 37.3 t -63.53 123.5 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 C-N-CA 124.103 0.961 . . . . 0.0 110.503 178.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 107.67 -43.28 1.73 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 116.199 1.24 . . . . 0.0 116.199 -158.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 76.1 mttt -86.72 152.57 22.42 Favored 'General case' 0 CA--C 1.568 1.642 0 CA-C-N 118.612 1.206 . . . . 0.0 113.489 -172.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -107.92 117.92 35.39 Favored 'General case' 0 CA--C 1.569 1.674 0 C-N-CA 123.469 0.707 . . . . 0.0 111.469 -173.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 8.8 p90 -127.28 151.57 48.57 Favored 'General case' 0 N--CA 1.501 2.108 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 -171.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -80.43 123.89 28.43 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.015 -1.678 . . . . 0.0 114.81 -176.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -85.65 53.1 2.65 Favored 'General case' 0 N--CA 1.502 2.136 0 N-CA-C 115.696 1.739 . . . . 0.0 115.696 177.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 19.2 p30 -83.68 75.19 10.08 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.134 -1.604 . . . . 0.0 112.378 167.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 95.1 mt -127.64 129.96 48.13 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.633 0.73 . . . . 0.0 109.933 -175.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 67.4 p -83.5 59.84 5.32 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 115.472 1.656 . . . . 0.0 115.472 -163.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -153.38 -70.56 0.01 OUTLIER Glycine 0 N--CA 1.491 2.339 0 O-C-N 120.697 -1.252 . . . . 0.0 115.325 -177.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 50.5 mm -77.19 -60.12 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 C-N-CA 123.291 0.636 . . . . 0.0 111.939 -176.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.461 ' HD2' ' NZ ' ' A' ' 101' ' ' LYS . 41.6 t0 -152.94 107.03 3.1 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-N 119.544 1.066 . . . . 0.0 108.219 167.479 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -81.33 87.45 6.14 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.383 -0.823 . . . . 0.0 112.971 -172.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 7.4 ptm180 -165.27 141.23 5.41 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 123.509 0.724 . . . . 0.0 110.044 -177.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 57.5 mtmt -73.3 80.88 1.35 Allowed 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 114.807 1.41 . . . . 0.0 114.807 -167.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 99.2 m -89.48 126.61 35.65 Favored 'General case' 0 CA--C 1.56 1.328 0 O-C-N 121.814 -0.554 . . . . 0.0 111.033 173.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -79.51 94.83 5.68 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 122.999 1.38 . . . . 0.0 110.255 -170.04 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 99.5 m -100.0 118.02 35.5 Favored 'General case' 0 N--CA 1.48 1.036 0 O-C-N 121.292 -0.88 . . . . 0.0 110.372 -153.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 25.0 m -112.74 122.53 47.95 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-N 115.102 -0.954 . . . . 0.0 108.504 -174.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 20.7 t -113.26 127.77 70.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 -177.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 60.9 p -131.36 159.21 38.63 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 122.223 1.011 . . . . 0.0 112.609 -175.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 55.5 m95 -92.13 113.76 26.12 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.782 -0.574 . . . . 0.0 110.605 171.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -92.71 73.22 4.99 Favored 'General case' 0 CA--C 1.566 1.58 0 C-N-CA 123.253 0.621 . . . . 0.0 110.291 171.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.05 -94.56 0.18 Allowed Glycine 0 N--CA 1.489 2.187 0 N-CA-C 114.637 0.615 . . . . 0.0 114.637 -171.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -85.39 -38.37 18.79 Favored 'General case' 0 CA--C 1.569 1.676 0 N-CA-C 115.405 1.631 . . . . 0.0 115.405 171.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -93.31 154.65 17.87 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 119.163 0.892 . . . . 0.0 112.733 -167.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 18.5 tp -99.16 109.68 22.34 Favored 'General case' 0 CA--C 1.564 1.504 0 O-C-N 121.04 -1.037 . . . . 0.0 110.273 178.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 31.7 mm-40 -97.48 122.61 40.74 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 123.862 0.865 . . . . 0.0 111.3 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 41.7 t -114.6 131.39 56.71 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.38 0.672 . . . . 0.0 111.609 175.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 15.0 p -117.03 123.59 72.02 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.699 0 C-N-CA 123.174 0.59 . . . . 0.0 109.579 170.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -98.73 97.05 8.34 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 124.033 0.933 . . . . 0.0 109.277 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 30.4 mmtp -81.31 119.72 24.02 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 -168.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -174.3 -121.38 0.62 Allowed Glycine 0 N--CA 1.484 1.861 0 O-C-N 121.994 -0.441 . . . . 0.0 112.425 171.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -87.05 -32.51 19.94 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 116.619 2.081 . . . . 0.0 116.619 -178.497 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.461 ' NZ ' ' HD2' ' A' ' 78' ' ' ASP . 50.7 mttp -89.57 135.73 33.43 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 120.711 1.596 . . . . 0.0 112.756 -165.481 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -81.09 102.83 10.5 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.742 0.782 . . . . 0.0 112.989 -164.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 82.35 41.75 9.02 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 117.308 1.683 . . . . 0.0 117.308 -168.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 46.9 ttt180 -84.8 118.46 24.48 Favored 'General case' 0 CA--C 1.564 1.503 0 CA-C-N 118.857 1.329 . . . . 0.0 111.121 175.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 170.84 -165.55 38.75 Favored Glycine 0 N--CA 1.484 1.861 0 N-CA-C 114.827 0.691 . . . . 0.0 114.827 -178.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 28.9 p-90 -157.43 157.13 33.4 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 114.6 1.333 . . . . 0.0 114.6 176.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 25.5 m -120.25 122.37 40.74 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 171.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -119.72 133.89 55.44 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 123.187 0.595 . . . . 0.0 111.834 -178.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 19.0 p90 -149.1 174.45 12.32 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 178.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 55.5 mt -116.46 133.13 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.212 -0.93 . . . . 0.0 108.988 176.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -112.13 90.19 3.27 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 123.773 0.829 . . . . 0.0 109.092 163.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 64.49 -104.66 0.95 Allowed Glycine 0 N--CA 1.492 2.4 0 N-CA-C 115.754 1.062 . . . . 0.0 115.754 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 57.3 p30 -84.13 -2.02 56.04 Favored 'General case' 0 CA--C 1.571 1.775 0 N-CA-C 117.86 2.541 . . . . 0.0 117.86 166.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -118.47 135.9 54.11 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-N 120.657 1.572 . . . . 0.0 112.424 -168.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 12.4 tp -94.38 120.91 35.33 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 123.73 0.812 . . . . 0.0 108.969 174.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 37.3 m80 -109.99 120.1 41.4 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -176.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 42.3 tp -121.51 121.53 37.69 Favored 'General case' 0 CA--C 1.56 1.35 0 C-N-CA 123.576 0.75 . . . . 0.0 109.543 -176.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -107.97 117.89 35.32 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.878 -0.513 . . . . 0.0 109.679 168.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 66.9 mtm -110.46 127.41 55.12 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-N 118.61 0.641 . . . . 0.0 111.1 -178.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 69.1 mtp180 -110.88 144.66 39.56 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -179.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -159.36 131.18 6.36 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.187 0.595 . . . . 0.0 111.153 166.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 59.0 38.07 24.32 Favored 'General case' 0 N--CA 1.507 2.402 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 -173.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 75.75 -26.21 1.4 Allowed Glycine 0 CA--C 1.559 2.827 0 N-CA-C 119.597 2.599 . . . . 0.0 119.597 -160.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 86.8 t -81.02 122.79 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 CA-C-N 119.392 1.596 . . . . 0.0 110.571 -163.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 24.1 m -100.9 120.95 40.9 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 122.909 0.484 . . . . 0.0 111.489 -176.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 44.1 t -88.34 139.45 30.48 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.306 0.643 . . . . 0.0 112.242 160.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 44.8 mtpt -109.51 126.2 53.28 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 168.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -123.03 126.14 46.55 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 123.742 0.817 . . . . 0.0 109.543 174.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 72.8 t -109.1 132.57 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 179.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -122.18 153.07 39.27 Favored 'General case' 0 CA--C 1.565 1.558 0 C-N-CA 124.541 1.136 . . . . 0.0 111.442 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 8.9 tmtt? -120.87 136.88 54.82 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.199 -0.938 . . . . 0.0 111.607 175.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -72.5 120.49 18.19 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 33.4 m -101.49 -43.75 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 N-CA-C 113.194 0.812 . . . . 0.0 113.194 174.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 53.7 t-80 . . . . . 0 N--CA 1.485 1.317 0 CA-C-N 119.75 1.159 . . . . 0.0 108.124 168.472 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 1.8 mpt? . . . . . 0 CA--C 1.569 1.696 0 CA-C-O 117.92 -1.038 . . . . 0.0 109.601 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -84.66 147.53 10.93 Favored 'Trans proline' 0 CA--C 1.566 2.114 0 C-N-CA 122.472 2.114 . . . . 0.0 115.356 -177.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 25.9 m -81.2 140.04 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.468 -0.77 . . . . 0.0 112.56 177.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.422 ' HD2' ' N ' ' A' ' 3' ' ' ASP . 1.0 OUTLIER -82.5 100.51 10.13 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.514 -1.366 . . . . 0.0 111.459 175.355 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -72.72 -2.24 19.5 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 118.307 2.706 . . . . 0.0 118.307 177.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -56.29 112.27 1.19 Allowed 'General case' 0 CA--C 1.567 1.601 0 N-CA-C 115.945 1.831 . . . . 0.0 115.945 -172.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 155.46 -161.89 30.78 Favored Glycine 0 N--CA 1.486 1.996 0 N-CA-C 115.7 1.04 . . . . 0.0 115.7 178.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -124.13 127.83 48.37 Favored 'General case' 0 CA--C 1.564 1.498 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 -179.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 61.4 m95 -129.0 125.26 37.0 Favored 'General case' 0 CA--C 1.566 1.567 0 C-N-CA 123.273 0.629 . . . . 0.0 109.489 -166.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 24.8 pttm -96.17 141.19 29.83 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.089 -1.007 . . . . 0.0 112.903 177.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.445 ' SD ' ' HD2' ' A' ' 38' ' ' PRO . 32.8 ttm -68.89 125.89 28.04 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-N 120.044 1.293 . . . . 0.0 113.264 176.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 91.9 mt -85.87 -53.97 4.79 Favored 'General case' 0 CA--C 1.565 1.552 0 C-N-CA 123.387 0.675 . . . . 0.0 112.798 166.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 92.7 p -142.88 150.53 39.96 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 119.243 0.929 . . . . 0.0 112.838 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 24.1 p30 -125.92 84.65 2.3 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-O 122.235 1.017 . . . . 0.0 110.665 178.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -93.8 119.07 32.27 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.825 -1.172 . . . . 0.0 110.656 -163.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.281 32.1 t30 62.96 24.45 14.56 Favored 'General case' 0 N--CA 1.503 2.186 0 N-CA-C 116.617 2.08 . . . . 0.0 116.617 -169.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -69.27 -44.68 71.39 Favored 'General case' 0 CA--C 1.567 1.619 0 N-CA-C 115.223 1.564 . . . . 0.0 115.223 178.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -55.99 -39.91 72.53 Favored 'General case' 0 N--CA 1.504 2.257 0 N-CA-C 117.412 2.375 . . . . 0.0 117.412 169.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -65.38 -43.05 91.93 Favored 'General case' 0 CA--C 1.573 1.854 0 CA-C-N 120.252 1.387 . . . . 0.0 114.639 169.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -57.35 -47.83 80.59 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 115.31 1.596 . . . . 0.0 115.31 166.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 90.0 mt -58.25 -43.55 87.92 Favored 'General case' 0 CA--C 1.57 1.744 0 N-CA-C 114.633 1.346 . . . . 0.0 114.633 169.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.25 -49.2 72.63 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 115.639 1.718 . . . . 0.0 115.639 166.475 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.49 -21.25 9.51 Favored 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 118.507 2.78 . . . . 0.0 118.507 163.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 95.9 mt -91.9 15.87 12.19 Favored 'General case' 0 CA--C 1.576 1.959 0 N-CA-C 114.867 1.432 . . . . 0.0 114.867 166.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.536 ' N ' ' HD2' ' A' ' 24' ' ' ASP . 2.3 m-20 60.41 42.72 14.22 Favored 'General case' 0 N--CA 1.502 2.138 0 N-CA-C 116.149 1.907 . . . . 0.0 116.149 -175.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 91.3 t -93.62 140.05 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.091 -1.006 . . . . 0.0 110.179 -179.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 15.1 p30 -65.37 155.59 34.87 Favored 'General case' 0 CA--C 1.572 1.803 0 N-CA-C 115.188 1.551 . . . . 0.0 115.188 171.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 61.6 t -57.78 -41.32 79.38 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.251 0 N-CA-C 114.668 1.358 . . . . 0.0 114.668 179.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.72 -50.73 72.24 Favored 'General case' 0 CA--C 1.565 1.534 0 N-CA-C 116.163 1.912 . . . . 0.0 116.163 172.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 6.1 tt -67.2 -39.08 86.28 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-N 120.637 1.562 . . . . 0.0 115.13 170.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 53.3 mtp180 -49.17 -42.42 39.74 Favored 'General case' 0 N--CA 1.502 2.128 0 N-CA-C 116.551 2.056 . . . . 0.0 116.551 163.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -72.77 -52.15 16.2 Favored 'General case' 0 CA--C 1.567 1.623 0 CA-C-O 118.284 -0.865 . . . . 0.0 113.324 167.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 5.6 mt -80.74 58.16 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.587 2.397 0 CA-C-N 121.107 1.776 . . . . 0.0 111.761 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -172.79 -51.95 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 126.187 1.795 . . . . 0.0 110.415 -178.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -66.53 -36.52 82.88 Favored 'General case' 0 CA--C 1.568 1.655 0 N-CA-C 116.0 1.852 . . . . 0.0 116.0 164.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 91.9 mt -74.53 -30.49 61.79 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 176.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.6 pp -84.27 149.63 25.96 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 119.408 1.004 . . . . 0.0 111.971 167.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp -104.67 94.74 7.68 Favored Pre-proline 0 CA--C 1.57 1.749 0 CA-C-O 118.091 -0.957 . . . . 0.0 108.492 174.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.445 ' HD2' ' SD ' ' A' ' 10' ' ' MET . 88.9 Cg_endo -75.27 172.71 15.82 Favored 'Trans proline' 0 CA--C 1.562 1.911 0 C-N-CA 122.642 2.228 . . . . 0.0 114.694 -175.263 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -123.95 130.56 52.79 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.663 -171.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 57.2 mttm -98.46 112.67 24.61 Favored 'General case' 0 N--CA 1.485 1.315 0 O-C-N 121.441 -0.787 . . . . 0.0 109.808 177.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -97.09 110.06 22.68 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 166.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 64.8 mt -105.7 116.66 49.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -174.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 63.2 t -99.25 98.75 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 169.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -100.63 115.71 30.84 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 123.725 0.81 . . . . 0.0 110.848 -178.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -125.6 72.95 1.29 Allowed 'General case' 0 CA--C 1.568 1.659 0 O-C-N 121.647 -0.658 . . . . 0.0 111.186 176.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 70.92 -93.52 0.49 Allowed Glycine 0 N--CA 1.49 2.24 0 O-C-N 121.468 -0.77 . . . . 0.0 114.879 178.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -88.2 -38.57 15.18 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 115.307 1.595 . . . . 0.0 115.307 164.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 20.8 t-160 -80.62 110.27 15.95 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 121.218 1.826 . . . . 0.0 111.717 -176.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 45.6 ttm -126.29 121.82 33.73 Favored 'General case' 0 CA--C 1.556 1.2 0 C-N-CA 123.448 0.699 . . . . 0.0 109.733 -172.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 4.6 mp -112.04 97.06 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 -179.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 73.3 mt -89.77 101.59 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 176.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -91.58 98.03 11.41 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.597 -0.689 . . . . 0.0 109.78 -179.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 18.9 m -87.38 104.76 16.74 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 178.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 18.0 mt -103.22 116.66 32.88 Favored 'General case' 0 CA--C 1.557 1.241 0 CA-C-N 115.417 -0.811 . . . . 0.0 109.991 -162.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 31.3 t -128.91 143.64 50.95 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 123.929 0.892 . . . . 0.0 110.535 -177.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.4 m -77.64 49.22 0.73 Allowed 'General case' 0 CA--C 1.586 2.353 0 O-C-N 121.256 -0.902 . . . . 0.0 113.159 171.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -172.53 -66.43 0.02 OUTLIER 'General case' 0 CA--C 1.566 1.587 0 C-N-CA 125.762 1.625 . . . . 0.0 109.082 -179.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -134.34 101.64 5.07 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-N 119.306 0.957 . . . . 0.0 110.299 -174.04 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 -83.15 139.72 33.01 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.515 -0.74 . . . . 0.0 112.6 -178.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -128.56 100.69 5.85 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.41 0.624 . . . . 0.0 109.726 -178.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.6 mt -100.23 112.8 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 -179.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 24.6 mmm -96.05 91.56 6.02 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 175.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -96.55 101.97 13.67 Favored 'General case' 0 CA--C 1.561 1.389 0 C-N-CA 123.977 0.911 . . . . 0.0 111.793 178.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -145.73 151.98 38.86 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 -166.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 23.6 mp0 -93.31 122.44 35.72 Favored 'General case' 0 CA--C 1.566 1.585 0 O-C-N 121.672 -0.643 . . . . 0.0 110.043 166.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 49.0 t -63.57 126.77 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 C-N-CA 123.912 0.885 . . . . 0.0 110.834 177.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 102.28 -38.2 3.31 Favored Glycine 0 CA--C 1.552 2.344 0 N-CA-C 116.752 1.461 . . . . 0.0 116.752 -162.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 11.2 mmpt? -88.34 134.34 33.84 Favored 'General case' 0 CA--C 1.564 1.503 0 CA-C-N 118.981 1.39 . . . . 0.0 112.254 -175.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -88.47 119.87 29.32 Favored 'General case' 0 CA--C 1.566 1.577 0 O-C-N 121.706 -0.622 . . . . 0.0 112.391 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 33.0 p90 -120.07 157.74 28.31 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 113.753 1.019 . . . . 0.0 113.753 -172.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.39 132.17 36.32 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.726 -1.234 . . . . 0.0 113.786 177.448 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -71.63 -66.05 0.68 Allowed 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 168.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . 0.373 35.6 t0 69.49 -123.6 0.12 Allowed 'General case' 0 CA--C 1.571 1.765 0 C-N-CA 124.588 1.155 . . . . 0.0 113.143 175.487 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 5.9 tt -85.38 88.14 7.47 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-N 120.101 1.318 . . . . 0.0 109.759 -177.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 74.8 p -87.32 -13.48 43.49 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 117.146 2.276 . . . . 0.0 117.146 -174.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 82.79 -44.0 3.18 Favored Glycine 0 N--CA 1.495 2.607 0 CA-C-N 120.834 1.652 . . . . 0.0 116.56 -166.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 3.6 mp -83.55 -75.0 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.576 1.947 0 C-N-CA 124.493 1.117 . . . . 0.0 109.454 177.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.446 ' HD2' ' NZ ' ' A' ' 101' ' ' LYS . 7.1 t0 -89.4 -43.56 10.8 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 115.279 1.585 . . . . 0.0 115.279 -174.033 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.0 t70 64.58 73.09 0.43 Allowed 'General case' 0 CA--C 1.572 1.804 0 C-N-CA 124.444 1.098 . . . . 0.0 113.899 -171.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -155.9 141.94 18.21 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.562 -0.711 . . . . 0.0 112.157 177.241 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -77.99 73.59 4.55 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.147 -0.97 . . . . 0.0 113.132 177.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 95.8 m -92.48 142.47 27.38 Favored 'General case' 0 CA--C 1.563 1.461 0 CA-C-O 122.14 0.972 . . . . 0.0 112.238 176.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -88.09 101.99 14.34 Favored 'General case' 0 CA--C 1.56 1.332 0 C-N-CA 124.486 1.115 . . . . 0.0 110.046 -178.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 87.8 m -97.07 108.78 21.58 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.549 -0.719 . . . . 0.0 111.516 -170.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 53.8 m -91.82 131.62 37.03 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 164.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.4 t -116.76 136.33 54.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 171.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 68.2 m -150.17 148.57 29.1 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.141 -1.599 . . . . 0.0 113.029 -175.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 75.3 m95 -81.23 130.95 35.25 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.906 -1.121 . . . . 0.0 112.99 178.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -137.47 79.38 1.74 Allowed 'General case' 0 CA--C 1.569 1.688 0 C-N-CA 123.425 0.69 . . . . 0.0 110.344 178.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 64.23 76.97 0.25 Allowed Glycine 0 N--CA 1.497 2.71 0 N-CA-C 117.317 1.687 . . . . 0.0 117.317 170.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . 0.265 6.9 m-20 63.57 2.14 1.18 Allowed 'General case' 0 N--CA 1.505 2.286 0 N-CA-C 117.855 2.539 . . . . 0.0 117.855 -167.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 72.5 mttt -134.2 135.63 43.15 Favored 'General case' 0 N--CA 1.485 1.278 0 O-C-N 121.113 -0.992 . . . . 0.0 109.807 -168.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 22.0 tp -95.37 108.78 20.99 Favored 'General case' 0 CA--C 1.56 1.357 0 O-C-N 121.428 -0.795 . . . . 0.0 109.958 178.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 21.0 mm100 -86.46 141.05 29.39 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.371 0.669 . . . . 0.0 111.639 176.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 41.0 t -133.71 135.76 44.23 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.381 0.672 . . . . 0.0 111.329 175.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.7 p -127.99 116.92 44.47 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.647 0 C-N-CA 123.145 0.578 . . . . 0.0 109.576 174.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -93.36 100.46 12.78 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 124.118 0.967 . . . . 0.0 109.93 176.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -91.92 121.11 33.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.437 -0.789 . . . . 0.0 111.72 -169.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 167.81 -105.44 0.23 Allowed Glycine 0 N--CA 1.486 1.979 0 O-C-N 121.319 -0.863 . . . . 0.0 113.995 172.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -85.79 -46.98 10.16 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 115.091 1.515 . . . . 0.0 115.091 -172.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.446 ' NZ ' ' HD2' ' A' ' 78' ' ' ASP . 48.9 mmtm -78.62 134.04 37.22 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 119.688 1.131 . . . . 0.0 112.433 179.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -88.5 109.33 19.96 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.017 -168.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 76.95 41.12 23.66 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 117.47 1.748 . . . . 0.0 117.47 -167.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 53.8 ttt180 -86.2 117.25 24.9 Favored 'General case' 0 CA--C 1.563 1.47 0 CA-C-N 118.316 1.058 . . . . 0.0 110.704 177.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -172.5 -178.45 42.64 Favored Glycine 0 N--CA 1.484 1.872 0 CA-C-O 122.071 0.817 . . . . 0.0 115.093 -176.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 28.3 p-90 -154.94 158.55 39.43 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 172.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 55.6 m -123.75 120.36 32.46 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 170.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -114.13 132.44 56.07 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 123.196 0.598 . . . . 0.0 111.922 179.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 16.4 p90 -148.4 173.07 13.46 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.215 -0.928 . . . . 0.0 113.088 177.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 73.9 mt -114.24 133.66 59.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.226 -0.921 . . . . 0.0 110.052 174.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -111.65 88.98 2.93 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 123.729 0.812 . . . . 0.0 108.895 162.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 65.35 -104.99 1.08 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 115.832 1.093 . . . . 0.0 115.832 -178.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -85.88 -8.34 58.11 Favored 'General case' 0 CA--C 1.571 1.788 0 N-CA-C 117.591 2.441 . . . . 0.0 117.591 168.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 86.9 mt-10 -105.08 135.46 46.39 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 120.316 1.416 . . . . 0.0 112.316 -175.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 15.5 tp -91.79 121.94 33.88 Favored 'General case' 0 CA--C 1.563 1.45 0 C-N-CA 123.861 0.864 . . . . 0.0 109.38 167.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 47.4 m80 -109.52 120.89 43.89 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -179.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 48.3 tp -120.5 116.57 25.67 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.444 0.698 . . . . 0.0 109.677 179.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -98.19 127.9 44.38 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.764 -0.585 . . . . 0.0 109.898 167.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 69.1 mtm -122.85 129.82 52.12 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-N 118.355 0.525 . . . . 0.0 111.241 -175.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 71.9 mtm-85 -117.9 139.32 51.3 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 123.588 0.755 . . . . 0.0 111.233 -174.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -161.75 131.65 4.77 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.68 -0.637 . . . . 0.0 111.279 170.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 55.7 39.09 30.83 Favored 'General case' 0 N--CA 1.507 2.397 0 N-CA-C 115.444 1.646 . . . . 0.0 115.444 -175.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 72.84 -11.76 4.29 Favored Glycine 0 CA--C 1.557 2.682 0 N-CA-C 120.302 2.881 . . . . 0.0 120.302 -163.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 88.1 t -89.28 123.54 41.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 CA-C-N 120.291 2.045 . . . . 0.0 109.608 -171.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 34.7 m -102.77 123.99 47.47 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.302 0.572 . . . . 0.0 111.169 177.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 21.1 t -100.92 146.64 27.11 Favored 'General case' 0 CA--C 1.563 1.462 0 C-N-CA 123.921 0.888 . . . . 0.0 112.079 165.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 7.6 mtpm? -118.49 110.66 17.67 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.669 -0.644 . . . . 0.0 109.541 174.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -103.48 130.09 50.77 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.502 -0.749 . . . . 0.0 110.817 174.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 44.2 t -113.86 129.91 68.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 176.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -123.67 150.86 43.73 Favored 'General case' 0 CA--C 1.567 1.62 0 C-N-CA 124.729 1.211 . . . . 0.0 110.071 179.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.7 tmtt? -122.47 140.95 52.15 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.556 -1.34 . . . . 0.0 111.484 177.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 66.0 tttt -71.08 117.75 12.99 Favored 'General case' 0 CA--C 1.565 1.556 0 N-CA-C 113.523 0.934 . . . . 0.0 113.523 -177.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 5.5 m -82.59 -34.57 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.273 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 168.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 44.6 t-80 . . . . . 0 N--CA 1.484 1.255 0 C-N-CA 125.04 1.336 . . . . 0.0 113.305 175.505 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 66.1 mtt . . . . . 0 CA--C 1.57 1.718 0 CA-C-O 118.123 -0.942 . . . . 0.0 109.532 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -73.58 139.21 27.98 Favored 'Trans proline' 0 CA--C 1.56 1.82 0 C-N-CA 122.54 2.16 . . . . 0.0 114.98 -174.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 1.8 t -79.05 146.04 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 CA-C-O 121.701 0.763 . . . . 0.0 110.906 -174.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -72.04 97.03 1.82 Allowed 'General case' 0 CA--C 1.568 1.651 0 O-C-N 120.79 -1.194 . . . . 0.0 111.618 173.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 4.5 m-30 -77.92 3.74 13.8 Favored 'General case' 0 CA--C 1.581 2.151 0 N-CA-C 116.471 2.026 . . . . 0.0 116.471 179.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -60.4 111.02 1.41 Allowed 'General case' 0 CA--C 1.564 1.488 0 C-N-CA 125.339 1.456 . . . . 0.0 114.688 -178.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 165.2 177.21 37.48 Favored Glycine 0 N--CA 1.484 1.887 0 N-CA-C 116.319 1.287 . . . . 0.0 116.319 -179.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -108.11 122.35 46.71 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 114.35 -0.925 . . . . 0.0 108.781 173.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 83.7 m95 -120.77 120.18 34.89 Favored 'General case' 0 CA--C 1.562 1.412 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -167.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 62.1 pttt -88.92 136.5 32.98 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.348 -0.845 . . . . 0.0 112.588 176.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 56.3 ttm -77.19 123.47 26.47 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 121.914 0.864 . . . . 0.0 112.139 179.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 84.0 mt -90.97 -60.16 1.98 Allowed 'General case' 0 CA--C 1.565 1.527 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.757 175.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 67.4 p -130.0 119.29 22.93 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.721 -0.612 . . . . 0.0 110.746 176.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -98.01 93.39 6.28 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 123.252 0.621 . . . . 0.0 109.794 165.227 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -97.12 125.26 41.49 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.66 0.784 . . . . 0.0 110.462 -169.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.269 49.2 t30 64.97 15.59 10.06 Favored 'General case' 0 N--CA 1.504 2.272 0 N-CA-C 117.061 2.245 . . . . 0.0 117.061 -172.142 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -61.01 -41.21 96.11 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 116.234 1.939 . . . . 0.0 116.234 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.543 ' HE2' ' NZ ' ' A' ' 31' ' ' LYS . 2.9 mp0 -51.52 -44.78 62.7 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 115.602 1.704 . . . . 0.0 115.602 166.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -68.81 -41.35 78.77 Favored 'General case' 0 CA--C 1.573 1.836 0 N-CA-C 115.228 1.566 . . . . 0.0 115.228 174.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 48.7 t80 -55.27 -49.26 72.52 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 114.47 1.285 . . . . 0.0 114.47 165.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 97.5 mt -61.0 -40.64 94.31 Favored 'General case' 0 CA--C 1.575 1.922 0 N-CA-C 115.001 1.482 . . . . 0.0 115.001 170.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 49.5 ttp180 -53.86 -49.94 67.37 Favored 'General case' 0 N--CA 1.501 2.11 0 N-CA-C 115.647 1.721 . . . . 0.0 115.647 165.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.67 -15.97 9.32 Favored 'General case' 0 CA--C 1.57 1.742 0 N-CA-C 118.409 2.744 . . . . 0.0 118.409 165.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 99.3 mt -98.56 23.48 8.55 Favored 'General case' 0 CA--C 1.575 1.926 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 163.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 69.39 15.16 8.44 Favored 'General case' 0 N--CA 1.507 2.382 0 N-CA-C 117.482 2.401 . . . . 0.0 117.482 -179.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 67.5 t -87.81 141.88 13.71 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.863 0 O-C-N 120.061 -1.65 . . . . 0.0 110.414 -170.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -73.46 155.02 39.69 Favored 'General case' 0 CA--C 1.569 1.687 0 N-CA-C 115.714 1.746 . . . . 0.0 115.714 -177.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 74.6 t -50.88 -45.83 28.79 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.502 0 N-CA-C 115.715 1.746 . . . . 0.0 115.715 -178.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.03 -49.41 77.75 Favored 'General case' 0 CA--C 1.564 1.5 0 N-CA-C 115.434 1.642 . . . . 0.0 115.434 173.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.8 tt -64.49 -44.58 90.5 Favored 'General case' 0 CA--C 1.572 1.794 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 171.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 74.9 mtp180 -45.15 -54.45 6.83 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 115.911 1.819 . . . . 0.0 115.911 164.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.543 ' NZ ' ' HE2' ' A' ' 17' ' ' GLU . 73.0 mmtt -71.84 -37.96 70.21 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 115.461 1.652 . . . . 0.0 115.461 174.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . 0.25 69.2 mt -62.51 -50.2 80.77 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 CA-C-N 121.116 1.78 . . . . 0.0 112.171 173.19 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -56.93 -42.24 79.65 Favored 'General case' 0 CA--C 1.568 1.67 0 N-CA-C 117.772 2.508 . . . . 0.0 117.772 170.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -53.85 -46.09 71.14 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 117.01 2.226 . . . . 0.0 117.01 163.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 92.6 mt -80.56 -18.29 48.81 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 116.025 1.861 . . . . 0.0 116.025 179.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 18.5 mt -73.46 -37.44 65.8 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 115.789 1.774 . . . . 0.0 115.789 173.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 65.5 mmtt 64.76 65.54 1.01 Allowed Pre-proline 0 CA--C 1.577 1.99 0 C-N-CA 124.546 1.139 . . . . 0.0 112.122 -178.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -71.45 135.0 25.59 Favored 'Trans proline' 0 CA--C 1.562 1.913 0 CA-C-N 122.486 1.924 . . . . 0.0 114.765 -165.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.489 ' N ' ' HD2' ' A' ' 39' ' ' ASP . 1.2 m-20 -86.67 130.53 34.45 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.832 -0.543 . . . . 0.0 111.897 -175.364 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 47.9 mttp -93.26 112.72 24.73 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.191 -0.943 . . . . 0.0 110.181 -179.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -94.59 109.44 21.36 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.388 -0.82 . . . . 0.0 109.034 164.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 97.6 mt -102.49 116.35 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 -175.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 54.0 t -98.16 95.95 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 168.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -93.86 108.5 20.28 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 123.876 0.87 . . . . 0.0 110.558 -179.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -113.94 69.31 0.7 Allowed 'General case' 0 CA--C 1.569 1.689 0 O-C-N 121.637 -0.664 . . . . 0.0 111.061 175.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 70.09 -85.39 0.31 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 115.798 1.079 . . . . 0.0 115.798 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -94.65 -40.04 10.02 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 114.903 1.446 . . . . 0.0 114.903 163.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 20.7 t-160 -79.08 107.19 11.66 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 121.216 1.825 . . . . 0.0 111.243 -175.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 41.1 ttm -118.24 120.5 37.85 Favored 'General case' 0 CA--C 1.553 1.064 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -173.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 5.0 mp -106.13 100.49 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 16.4 mm -87.07 101.3 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 176.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -94.71 97.93 10.42 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 18.3 m -91.94 100.39 13.06 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 -176.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 19.9 mt -99.8 132.85 44.89 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-O 121.812 0.815 . . . . 0.0 112.189 -156.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 28.3 t -151.6 145.72 25.31 Favored 'General case' 0 CA--C 1.562 1.425 0 C-N-CA 123.452 0.701 . . . . 0.0 110.97 -176.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.6 t -77.48 54.12 1.13 Allowed 'General case' 0 N--CA 1.505 2.291 0 O-C-N 120.639 -1.288 . . . . 0.0 114.077 165.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -173.2 -67.04 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 124.983 1.313 . . . . 0.0 109.169 -168.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.06 103.83 4.37 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.379 -0.826 . . . . 0.0 110.014 -179.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -88.48 119.54 29.02 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.738 -0.601 . . . . 0.0 110.357 178.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 51.8 m-85 -107.59 110.11 21.91 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 121.336 0.589 . . . . 0.0 110.573 -175.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 25.0 mm -105.95 104.48 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 N-CA-C 108.11 -1.071 . . . . 0.0 108.11 -174.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 11.4 mmm -99.11 90.71 4.69 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.523 -0.735 . . . . 0.0 109.27 175.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -93.35 111.55 23.24 Favored 'General case' 0 CA--C 1.561 1.386 0 C-N-CA 123.429 0.692 . . . . 0.0 111.385 175.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 11.9 p90 -147.13 148.31 31.45 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.831 0.824 . . . . 0.0 112.849 -170.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 23.8 mp0 -87.6 117.15 26.21 Favored 'General case' 0 CA--C 1.561 1.368 0 O-C-N 121.621 -0.674 . . . . 0.0 109.999 168.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 44.0 t -66.99 113.04 2.7 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.794 0 C-N-CA 124.159 0.984 . . . . 0.0 109.609 175.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 123.22 -48.68 0.94 Allowed Glycine 0 CA--C 1.549 2.213 0 N-CA-C 115.14 0.816 . . . . 0.0 115.14 -156.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 58.4 mttm -86.59 151.77 23.17 Favored 'General case' 0 CA--C 1.568 1.66 0 CA-C-N 118.493 1.146 . . . . 0.0 113.476 -175.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -96.8 107.22 19.66 Favored 'General case' 0 CA--C 1.568 1.643 0 C-N-CA 123.275 0.63 . . . . 0.0 110.425 173.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 15.6 p90 -106.92 142.32 36.73 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 113.639 0.978 . . . . 0.0 113.639 -171.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -76.9 110.55 11.61 Favored 'General case' 0 CA--C 1.568 1.669 0 N-CA-C 114.411 1.263 . . . . 0.0 114.411 179.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -81.08 62.0 4.87 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.96 -1.087 . . . . 0.0 113.262 173.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -84.2 -44.21 14.16 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.877 -1.139 . . . . 0.0 113.86 164.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -103.99 -54.87 2.47 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-N 119.113 0.87 . . . . 0.0 112.058 169.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 48.3 p -79.75 84.99 5.48 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-N 119.682 1.128 . . . . 0.0 113.239 -172.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -177.09 161.97 29.89 Favored Glycine 0 N--CA 1.488 2.119 0 O-C-N 121.349 -0.845 . . . . 0.0 114.935 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 2.6 mp -66.64 -61.48 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.292 0 C-N-CA 123.555 0.742 . . . . 0.0 111.842 -175.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -104.17 93.21 4.71 Favored 'General case' 0 CA--C 1.561 1.392 0 O-C-N 120.895 -1.128 . . . . 0.0 108.065 155.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -75.45 63.65 1.49 Allowed 'General case' 0 CA--C 1.573 1.851 0 N-CA-C 115.929 1.826 . . . . 0.0 115.929 -173.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 76.3 mtt180 -108.11 52.01 0.73 Allowed 'General case' 0 CA--C 1.575 1.935 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -177.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . 0.254 62.1 mttp 61.88 81.6 0.19 Allowed 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 115.453 1.649 . . . . 0.0 115.453 175.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 72.6 m -121.6 127.89 51.37 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.363 0.665 . . . . 0.0 110.05 166.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 82.5 mmm -79.48 95.75 5.89 Favored 'General case' 0 CA--C 1.563 1.454 0 CA-C-O 121.98 0.895 . . . . 0.0 109.338 170.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 37.8 m -102.65 117.11 33.95 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.114 0.566 . . . . 0.0 110.698 -160.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 92.3 m -95.16 122.43 37.83 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 173.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 22.1 t -109.97 135.79 47.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 170.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 58.0 m -148.55 147.27 28.85 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.265 -1.522 . . . . 0.0 112.481 -176.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 59.9 m95 -79.41 109.06 13.41 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.255 -0.903 . . . . 0.0 111.095 174.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -86.73 76.21 9.53 Favored 'General case' 0 CA--C 1.566 1.572 0 C-N-CA 123.813 0.845 . . . . 0.0 110.429 172.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 64.72 -99.53 0.36 Allowed Glycine 0 N--CA 1.489 2.199 0 N-CA-C 114.433 0.533 . . . . 0.0 114.433 -169.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -84.4 -32.85 23.92 Favored 'General case' 0 CA--C 1.574 1.88 0 N-CA-C 115.705 1.743 . . . . 0.0 115.705 170.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 48.9 mtpt -94.1 150.14 20.6 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 124.125 0.97 . . . . 0.0 112.011 -168.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 24.0 tp -98.46 109.7 22.41 Favored 'General case' 0 CA--C 1.563 1.464 0 O-C-N 120.329 -1.482 . . . . 0.0 110.345 177.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 31.8 mm-40 -96.65 146.4 24.89 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 123.383 0.673 . . . . 0.0 111.909 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 42.6 t -138.74 131.27 28.87 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.316 0.646 . . . . 0.0 111.527 176.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.9 p -113.81 122.01 67.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 166.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -101.95 75.02 1.5 Allowed 'General case' 0 CA--C 1.567 1.609 0 C-N-CA 123.461 0.704 . . . . 0.0 110.299 -178.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -91.17 129.68 37.14 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.011 -1.056 . . . . 0.0 113.427 -170.164 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 164.81 -94.1 0.11 Allowed Glycine 0 N--CA 1.487 2.084 0 O-C-N 121.335 -0.853 . . . . 0.0 112.477 177.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -72.2 -46.67 55.28 Favored 'General case' 0 CA--C 1.572 1.815 0 N-CA-C 115.614 1.709 . . . . 0.0 115.614 178.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -101.26 143.31 31.49 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 119.362 0.983 . . . . 0.0 112.945 -175.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -76.5 155.9 33.41 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.774 -0.579 . . . . 0.0 112.241 165.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 61.95 12.6 36.83 Favored Glycine 0 N--CA 1.497 2.757 0 N-CA-C 120.488 2.955 . . . . 0.0 120.488 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 36.8 ttt180 -88.16 129.11 35.42 Favored 'General case' 0 CA--C 1.564 1.511 0 CA-C-N 119.082 1.441 . . . . 0.0 112.591 -172.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 178.32 -173.27 45.73 Favored Glycine 0 N--CA 1.486 1.972 0 CA-C-O 121.707 0.615 . . . . 0.0 114.052 -175.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . 0.277 44.2 p-90 -159.43 156.8 29.0 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 171.469 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 58.9 m -129.56 119.13 23.15 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 176.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 16.2 tt0 -122.98 131.58 53.78 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 123.277 0.631 . . . . 0.0 112.202 -174.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 21.8 p90 -148.71 169.12 21.12 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.379 -0.826 . . . . 0.0 112.302 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 96.4 mt -115.53 145.26 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.22 0 CA-C-O 122.998 1.38 . . . . 0.0 111.062 177.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -136.65 90.58 2.56 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 71.42 -111.8 3.84 Favored Glycine 0 N--CA 1.49 2.269 0 O-C-N 121.983 -0.448 . . . . 0.0 114.158 -174.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 16.5 p-10 -94.66 15.36 18.38 Favored 'General case' 0 CA--C 1.576 1.975 0 N-CA-C 116.585 2.069 . . . . 0.0 116.585 167.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -120.65 136.54 54.81 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-N 120.177 1.353 . . . . 0.0 111.946 -171.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 8.6 tp -97.34 123.09 41.04 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 171.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 36.4 m80 -111.65 121.58 45.49 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 -176.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 50.7 tp -128.48 120.78 27.48 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.618 0.767 . . . . 0.0 109.963 -172.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -105.55 113.83 27.64 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.511 -0.743 . . . . 0.0 109.038 170.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' MET . . . . . 0.425 ' HB2' ' SG ' ' A' ' 126' ' ' CYS . 63.1 mtm -106.85 131.9 53.42 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-N 118.891 0.769 . . . . 0.0 111.438 -178.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? -114.76 140.88 48.54 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.784 0.834 . . . . 0.0 111.445 -171.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -156.07 129.37 8.18 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 123.207 0.603 . . . . 0.0 111.111 170.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . 0.265 8.7 mm-40 64.8 -0.32 1.02 Allowed 'General case' 0 N--CA 1.504 2.254 0 N-CA-C 118.135 2.643 . . . . 0.0 118.135 -176.252 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 109.69 -24.4 19.74 Favored Glycine 0 CA--C 1.554 2.531 0 N-CA-C 117.096 1.598 . . . . 0.0 117.096 -156.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 93.6 t -78.1 127.71 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 CA-C-N 119.857 1.829 . . . . 0.0 110.115 177.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 45.6 m -106.86 124.67 49.96 Favored 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 123.032 0.533 . . . . 0.0 110.118 173.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . 0.425 ' SG ' ' HB2' ' A' ' 119' ' ' MET . 19.3 p -107.14 142.08 37.38 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-O 121.701 0.762 . . . . 0.0 112.424 168.047 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 60.1 mttp -114.76 111.14 20.8 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.666 -0.646 . . . . 0.0 109.36 -168.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 82.9 mt-30 -105.35 123.84 48.54 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 123.403 0.681 . . . . 0.0 111.178 178.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 79.1 t -111.27 131.47 62.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 176.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -121.67 164.04 18.0 Favored 'General case' 0 CA--C 1.567 1.608 0 CA-C-N 115.113 -0.949 . . . . 0.0 111.474 -178.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 29.3 ttmt -130.57 142.82 50.46 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.065 -1.022 . . . . 0.0 111.984 165.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 59.8 tttt -76.31 120.15 21.17 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.49 -0.756 . . . . 0.0 112.882 -176.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 32.8 m -97.21 -43.41 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.112 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 174.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 72.0 t60 . . . . . 0 N--CA 1.485 1.302 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 169.235 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 81.6 mtp . . . . . 0 CA--C 1.57 1.75 0 CA-C-O 118.33 -0.843 . . . . 0.0 110.238 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -84.17 136.91 7.0 Favored 'Trans proline' 0 CA--C 1.561 1.868 0 C-N-CA 122.301 2.0 . . . . 0.0 115.375 -176.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 31.6 m -80.08 156.48 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 CA-C-O 121.934 0.873 . . . . 0.0 112.761 176.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -77.74 113.17 15.33 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.124 -0.985 . . . . 0.0 112.759 176.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -90.28 7.95 35.73 Favored 'General case' 0 CA--C 1.576 1.966 0 N-CA-C 115.389 1.626 . . . . 0.0 115.389 173.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 62.6 m-80 -67.02 110.19 3.28 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 120.262 1.392 . . . . 0.0 113.077 -176.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 169.63 173.81 37.45 Favored Glycine 0 N--CA 1.478 1.441 0 N-CA-C 116.638 1.415 . . . . 0.0 116.638 -177.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 19.5 t80 -104.19 124.53 49.29 Favored 'General case' 0 CA--C 1.563 1.48 0 CA-C-N 113.675 -1.262 . . . . 0.0 108.516 168.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 82.4 m95 -120.82 122.71 40.89 Favored 'General case' 0 CA--C 1.561 1.394 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -169.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -96.08 135.51 37.76 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.579 -0.701 . . . . 0.0 111.449 178.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 53.6 ttm -71.93 124.34 24.67 Favored 'General case' 0 CA--C 1.565 1.524 0 CA-C-O 122.079 0.942 . . . . 0.0 113.058 -178.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 97.5 mt -81.99 -50.14 9.47 Favored 'General case' 0 CA--C 1.567 1.615 0 CA-C-N 115.191 -0.913 . . . . 0.0 112.292 168.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 89.7 p -149.92 126.79 11.1 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 118.727 0.694 . . . . 0.0 111.751 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -99.69 108.77 21.2 Favored 'General case' 0 N--CA 1.494 1.767 0 C-N-CA 122.944 0.497 . . . . 0.0 110.889 162.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -112.26 125.57 54.31 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.503 -0.748 . . . . 0.0 109.803 -172.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.258 5.3 t30 63.53 27.84 15.13 Favored 'General case' 0 N--CA 1.507 2.414 0 N-CA-C 116.325 1.972 . . . . 0.0 116.325 -174.146 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -70.39 -44.97 66.92 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 114.436 1.273 . . . . 0.0 114.436 174.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.68 ' HE2' ' NZ ' ' A' ' 31' ' ' LYS . 30.0 mt-10 -53.43 -51.96 60.96 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 116.813 2.153 . . . . 0.0 116.813 174.269 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.266 1.5 pm0 -76.89 -25.89 53.56 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 116.394 1.998 . . . . 0.0 116.394 178.328 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 38.6 t80 -54.84 -49.56 70.79 Favored 'General case' 0 N--CA 1.498 1.967 0 CA-C-N 120.797 1.635 . . . . 0.0 114.481 154.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 68.8 mt -61.98 -35.35 78.24 Favored 'General case' 0 CA--C 1.576 1.965 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 170.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 8.7 ttm180 -56.99 -48.1 79.26 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-N 120.415 1.462 . . . . 0.0 114.645 162.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.74 -13.53 24.14 Favored 'General case' 0 CA--C 1.569 1.703 0 N-CA-C 118.414 2.746 . . . . 0.0 118.414 168.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 48.0 mt -90.15 -1.38 57.94 Favored 'General case' 0 CA--C 1.573 1.845 0 N-CA-C 116.071 1.878 . . . . 0.0 116.071 162.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.277 51.6 m-20 63.02 46.54 4.69 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 115.411 1.634 . . . . 0.0 115.411 -166.48 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 98.7 t -95.26 135.23 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 174.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 5.5 p-10 -64.3 152.08 42.05 Favored 'General case' 0 CA--C 1.566 1.592 0 N-CA-C 115.192 1.552 . . . . 0.0 115.192 178.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.438 HG23 HH11 ' A' ' 30' ' ' ARG 0.262 38.5 t -58.84 -35.47 56.27 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.224 0 N-CA-C 115.719 1.748 . . . . 0.0 115.719 -172.257 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.8 -50.93 69.16 Favored 'General case' 0 CA--C 1.567 1.62 0 N-CA-C 115.969 1.841 . . . . 0.0 115.969 166.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -71.45 -28.41 63.95 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 116.697 2.11 . . . . 0.0 116.697 171.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.438 HH11 HG23 ' A' ' 27' ' ' VAL . 54.2 mtp180 -55.83 -53.53 55.62 Favored 'General case' 0 N--CA 1.498 1.959 0 CA-C-N 120.824 1.647 . . . . 0.0 114.135 162.229 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.68 ' NZ ' ' HE2' ' A' ' 17' ' ' GLU . 48.1 mmtm -64.39 -49.99 69.43 Favored 'General case' 0 CA--C 1.566 1.596 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 170.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 11.9 mt -77.38 62.12 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.323 0 CA-C-O 123.493 1.615 . . . . 0.0 110.974 175.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -176.03 -53.59 0.01 OUTLIER 'General case' 0 CA--C 1.558 1.28 0 C-N-CA 126.752 2.021 . . . . 0.0 110.044 -177.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -71.52 -35.51 70.73 Favored 'General case' 0 CA--C 1.567 1.619 0 N-CA-C 116.04 1.867 . . . . 0.0 116.04 167.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 92.9 mt -71.85 -35.3 69.81 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 115.153 1.538 . . . . 0.0 115.153 177.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.9 pp -88.71 148.94 23.73 Favored 'General case' 0 CA--C 1.566 1.57 0 CA-C-N 118.671 0.669 . . . . 0.0 111.084 169.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 29.0 mmtp -103.94 93.98 5.96 Favored Pre-proline 0 CA--C 1.573 1.827 0 CA-C-O 117.813 -1.089 . . . . 0.0 109.764 178.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -73.82 160.39 43.59 Favored 'Trans proline' 0 CA--C 1.566 2.09 0 C-N-CA 122.49 2.126 . . . . 0.0 115.489 -175.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -104.2 141.96 35.34 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.508 -0.745 . . . . 0.0 110.795 -179.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 41.8 mttp -102.9 115.38 30.48 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.857 -1.152 . . . . 0.0 109.742 171.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -95.36 110.37 22.4 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 163.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 78.7 mt -106.8 128.33 61.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -177.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 93.1 t -106.27 118.41 53.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 106.026 -1.842 . . . . 0.0 106.026 163.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -111.95 113.51 25.86 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 124.147 0.979 . . . . 0.0 109.197 175.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -120.19 68.83 0.85 Allowed 'General case' 0 CA--C 1.567 1.613 0 O-C-N 121.339 -0.85 . . . . 0.0 110.334 174.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.65 -97.39 0.7 Allowed Glycine 0 N--CA 1.488 2.164 0 N-CA-C 114.672 0.629 . . . . 0.0 114.672 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -85.07 -40.45 16.8 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 115.314 1.598 . . . . 0.0 115.314 165.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 18.7 t-160 -77.41 119.97 21.76 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 120.899 1.681 . . . . 0.0 111.781 -178.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.42 ' SD ' HD23 ' A' ' 93' ' ' LEU . 46.5 ttm -133.9 133.98 42.11 Favored 'General case' 0 CA--C 1.557 1.231 0 CA-C-O 121.488 0.661 . . . . 0.0 110.674 -173.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 33.6 mt -118.56 107.76 22.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 24.8 mm -94.24 100.23 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 176.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 68.4 mtt85 -93.85 100.57 12.73 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.135 -0.978 . . . . 0.0 109.201 178.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 16.6 m -88.46 102.12 14.59 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 178.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 48.0 mt -97.78 112.23 24.21 Favored 'General case' 0 CA--C 1.556 1.209 0 C-N-CA 123.841 0.856 . . . . 0.0 109.286 -165.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 46.0 t -130.18 143.48 50.81 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.972 -171.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.1 m -78.96 56.42 1.95 Allowed 'General case' 0 CA--C 1.579 2.089 0 CA-C-O 122.036 0.922 . . . . 0.0 112.715 175.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -168.99 -67.93 0.02 OUTLIER 'General case' 0 CA--C 1.567 1.598 0 C-N-CA 124.999 1.32 . . . . 0.0 109.267 -179.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 32.3 tpt180 -135.78 115.72 13.17 Favored 'General case' 0 CA--C 1.565 1.55 0 C-N-CA 123.777 0.831 . . . . 0.0 109.193 173.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 71.9 m-80 -83.63 125.05 31.43 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.685 -0.634 . . . . 0.0 111.501 178.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 86.2 t80 -110.87 105.99 14.99 Favored 'General case' 0 CA--C 1.567 1.602 0 C-N-CA 123.24 0.616 . . . . 0.0 110.744 -169.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.8 mp -93.38 115.35 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 178.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -107.31 90.98 3.47 Favored 'General case' 0 CA--C 1.568 1.64 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 175.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -102.4 119.6 39.08 Favored 'General case' 0 CA--C 1.565 1.551 0 C-N-CA 124.159 0.984 . . . . 0.0 112.633 -175.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -157.72 154.79 28.81 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 114.784 1.401 . . . . 0.0 114.784 -166.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 25.2 mp0 -92.82 121.7 34.46 Favored 'General case' 0 CA--C 1.564 1.486 0 O-C-N 121.577 -0.702 . . . . 0.0 110.553 166.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 40.0 t -66.25 121.7 15.83 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.808 0 C-N-CA 124.218 1.007 . . . . 0.0 109.915 174.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 117.2 -42.45 1.85 Allowed Glycine 0 CA--C 1.55 2.236 0 N-CA-C 115.729 1.052 . . . . 0.0 115.729 -160.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 55.9 mttm -82.64 144.78 30.05 Favored 'General case' 0 CA--C 1.566 1.564 0 CA-C-N 118.916 1.358 . . . . 0.0 113.557 -174.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -90.95 97.8 11.4 Favored 'General case' 0 CA--C 1.566 1.588 0 CA-C-O 121.349 0.595 . . . . 0.0 110.014 167.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -107.54 151.7 25.23 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 123.999 0.92 . . . . 0.0 113.083 -169.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -77.1 135.36 38.58 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.693 -1.254 . . . . 0.0 112.918 169.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -70.98 -69.23 0.38 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.428 -0.795 . . . . 0.0 112.886 175.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 19.0 t70 59.93 55.2 3.92 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 116.854 2.168 . . . . 0.0 116.854 168.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -156.01 158.14 37.34 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.271 -0.893 . . . . 0.0 111.322 177.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 41.0 m -75.63 99.05 4.2 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.759 -1.213 . . . . 0.0 110.735 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 151.87 142.92 3.59 Favored Glycine 0 CA--C 1.547 2.077 0 C-N-CA 123.304 0.478 . . . . 0.0 112.3 -175.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . 0.492 1.3 tp 70.04 -71.57 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.318 0 C-N-CA 124.25 1.02 . . . . 0.0 113.548 -173.185 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -156.96 120.39 4.16 Favored 'General case' 0 CA--C 1.567 1.597 0 N-CA-C 105.343 -2.095 . . . . 0.0 105.343 168.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -74.76 80.5 2.07 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 113.904 1.075 . . . . 0.0 113.904 -176.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 27.1 tpt180 -154.37 151.95 29.64 Favored 'General case' 0 CA--C 1.563 1.481 0 CA-C-O 122.276 1.036 . . . . 0.0 110.722 -170.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 58.1 mtmt -72.48 71.22 0.93 Allowed 'General case' 0 CA--C 1.577 1.985 0 O-C-N 121.153 -0.967 . . . . 0.0 112.8 166.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 72.8 m -87.61 118.63 27.23 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.139 -0.976 . . . . 0.0 111.856 -174.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 23.5 mmt -68.63 96.16 0.7 Allowed 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 124.576 1.15 . . . . 0.0 111.579 -177.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 89.6 m -111.59 118.09 34.73 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 -162.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 93.8 m -101.85 118.94 37.95 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 176.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.424 HG21 ' SG ' ' A' ' 95' ' ' CYS . 57.1 t -108.73 124.93 65.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 171.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 57.9 m -130.57 151.54 50.93 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 121.935 0.874 . . . . 0.0 111.529 -177.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 28.1 m95 -83.66 116.66 22.74 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.992 -1.067 . . . . 0.0 112.726 176.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -103.77 65.79 0.83 Allowed 'General case' 0 CA--C 1.572 1.805 0 C-N-CA 123.428 0.691 . . . . 0.0 109.909 162.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 58.28 -114.59 5.99 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 115.538 0.975 . . . . 0.0 115.538 -172.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -61.42 -28.22 69.11 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 116.934 2.198 . . . . 0.0 116.934 168.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 63.5 mttm -93.69 120.96 34.61 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-O 122.097 0.951 . . . . 0.0 110.583 -178.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.42 HD23 ' SD ' ' A' ' 49' ' ' MET . 34.7 tp -86.79 107.11 18.14 Favored 'General case' 0 CA--C 1.564 1.515 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 168.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -98.59 132.64 43.84 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 123.27 0.628 . . . . 0.0 111.544 -172.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . 0.424 ' SG ' HG21 ' A' ' 86' ' ' VAL . 35.4 t -128.33 134.97 48.99 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.158 0.583 . . . . 0.0 111.728 -179.243 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.9 p -115.82 128.91 72.93 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.792 0 C-N-CA 123.151 0.581 . . . . 0.0 109.758 164.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -106.15 108.2 19.59 Favored 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 123.548 0.739 . . . . 0.0 110.4 -178.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 62.1 mttm -101.08 118.45 37.03 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.042 -1.036 . . . . 0.0 110.814 -174.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -178.91 -60.78 0.07 OUTLIER Glycine 0 N--CA 1.491 2.348 0 N-CA-C 116.546 1.379 . . . . 0.0 116.546 -177.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -125.18 -58.76 1.44 Allowed 'General case' 0 N--CA 1.497 1.893 0 CA-C-N 117.872 0.836 . . . . 0.0 111.938 173.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 41.9 mmtm -87.72 151.51 22.86 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-O 122.189 0.995 . . . . 0.0 113.509 -161.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -73.48 -68.92 0.46 Allowed 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 -169.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -78.35 51.46 3.63 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 116.804 1.482 . . . . 0.0 116.804 171.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 21.2 ttt180 -98.35 118.59 35.36 Favored 'General case' 0 CA--C 1.563 1.461 0 CA-C-N 118.659 1.23 . . . . 0.0 114.041 -169.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 177.46 -165.05 34.6 Favored Glycine 0 N--CA 1.482 1.756 0 CA-C-O 121.844 0.691 . . . . 0.0 114.554 178.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 53.2 p-90 -157.81 152.9 25.61 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 173.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 56.6 m -125.59 118.07 24.92 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 174.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -118.6 125.51 49.93 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 123.021 0.528 . . . . 0.0 111.77 -178.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 17.0 p90 -140.62 170.63 15.42 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.491 -0.755 . . . . 0.0 112.631 178.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 77.4 mt -117.57 135.85 56.63 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.031 -1.043 . . . . 0.0 110.006 176.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -121.52 95.81 4.83 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 173.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 71.93 -109.77 2.95 Favored Glycine 0 N--CA 1.491 2.312 0 O-C-N 121.619 -0.675 . . . . 0.0 114.11 -176.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -110.17 38.42 2.43 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 114.338 1.236 . . . . 0.0 114.338 165.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 82.8 mt-10 -132.62 136.17 46.35 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-N 118.891 0.768 . . . . 0.0 111.199 178.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 20.8 tp -90.75 124.71 35.33 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 123.354 0.662 . . . . 0.0 109.785 173.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 51.5 m80 -113.68 117.52 31.79 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 179.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 51.4 tp -126.53 120.02 28.6 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.884 0.873 . . . . 0.0 109.445 -171.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -111.54 110.03 20.26 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 109.389 -0.596 . . . . 0.0 109.389 173.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 71.9 mtm -104.41 127.13 52.03 Favored 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 123.492 0.717 . . . . 0.0 111.028 -179.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 36.9 mtp-105 -114.04 145.58 41.39 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.377 -0.827 . . . . 0.0 112.659 -175.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -149.88 138.91 21.11 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.705 -0.622 . . . . 0.0 112.002 163.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . 0.287 6.0 mm-40 69.58 -76.19 0.06 Allowed 'General case' 0 N--CA 1.503 2.215 0 C-N-CA 124.326 1.05 . . . . 0.0 112.884 -177.436 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -159.78 46.42 0.42 Allowed Glycine 0 CA--C 1.553 2.408 0 CA-C-N 116.042 -0.526 . . . . 0.0 113.202 153.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 72.1 t -133.93 121.8 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 -163.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 16.2 m -101.97 120.91 41.17 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -173.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 26.7 t -84.73 125.5 32.59 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.657 -0.652 . . . . 0.0 111.821 160.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 28.5 mtmm -111.7 109.05 18.72 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 -173.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -117.95 130.6 56.31 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.613 -0.679 . . . . 0.0 111.565 -172.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 39.7 t -116.97 129.25 73.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 N-CA-C 107.969 -1.122 . . . . 0.0 107.969 179.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -122.0 157.55 31.09 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 123.479 0.712 . . . . 0.0 110.71 173.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 75.4 tttt -114.56 141.29 47.93 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.332 -0.855 . . . . 0.0 112.06 172.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 33.9 tttm -76.41 118.04 18.69 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.605 -0.684 . . . . 0.0 112.758 -178.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 33.6 m -103.38 -35.36 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.2 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 175.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 81.7 t60 . . . . . 0 N--CA 1.484 1.239 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 169.063 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 62.8 mtt . . . . . 0 CA--C 1.572 1.806 0 CA-C-O 118.583 -0.722 . . . . 0.0 112.074 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -73.98 168.76 24.01 Favored 'Trans proline' 0 CA--C 1.564 1.975 0 C-N-CA 122.445 2.097 . . . . 0.0 116.175 176.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 34.3 m -69.88 156.65 7.04 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.854 0 CA-C-O 122.216 1.008 . . . . 0.0 113.399 172.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -87.43 116.5 25.58 Favored 'General case' 0 CA--C 1.56 1.334 0 O-C-N 121.129 -0.982 . . . . 0.0 111.249 169.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 11.1 m-30 -80.07 0.95 29.74 Favored 'General case' 0 CA--C 1.578 2.052 0 N-CA-C 115.504 1.668 . . . . 0.0 115.504 163.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 43.7 m-20 -53.01 113.16 1.01 Allowed 'General case' 0 N--CA 1.493 1.689 0 CA-C-N 120.665 1.575 . . . . 0.0 115.044 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 159.92 173.31 28.27 Favored Glycine 0 N--CA 1.481 1.7 0 CA-C-O 122.378 0.988 . . . . 0.0 115.272 -175.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -104.87 126.5 52.01 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 170.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 65.5 m95 -124.37 122.77 38.62 Favored 'General case' 0 CA--C 1.565 1.522 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 -169.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 21.7 pttp -96.35 138.35 34.08 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.555 -0.716 . . . . 0.0 112.054 -178.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 54.9 ttm -69.71 127.82 34.29 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 119.594 1.088 . . . . 0.0 113.91 -178.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 98.2 mt -87.52 -50.69 6.36 Favored 'General case' 0 CA--C 1.567 1.621 0 CA-C-N 115.291 -0.868 . . . . 0.0 112.757 167.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 80.7 p -144.86 144.6 31.2 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 118.984 0.811 . . . . 0.0 112.188 176.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -114.72 101.75 9.37 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.519 0.676 . . . . 0.0 109.745 164.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -101.84 121.67 42.54 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 123.858 0.863 . . . . 0.0 109.691 -171.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.264 27.9 t30 66.51 22.34 10.64 Favored 'General case' 0 N--CA 1.504 2.264 0 N-CA-C 116.971 2.212 . . . . 0.0 116.971 -174.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -66.28 -40.44 90.08 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 116.055 1.872 . . . . 0.0 116.055 177.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -58.45 -41.09 84.36 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 116.074 1.879 . . . . 0.0 116.074 170.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -65.85 -43.0 89.78 Favored 'General case' 0 CA--C 1.571 1.774 0 N-CA-C 114.724 1.379 . . . . 0.0 114.724 170.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -56.87 -47.2 80.98 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 115.137 1.532 . . . . 0.0 115.137 167.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 84.2 mt -61.1 -42.69 98.98 Favored 'General case' 0 CA--C 1.574 1.893 0 N-CA-C 114.618 1.34 . . . . 0.0 114.618 169.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 48.1 ttp180 -53.11 -47.55 68.53 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 115.395 1.628 . . . . 0.0 115.395 164.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.12 -22.71 61.29 Favored 'General case' 0 CA--C 1.568 1.641 0 N-CA-C 118.239 2.681 . . . . 0.0 118.239 166.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 98.5 mt -88.39 11.56 16.53 Favored 'General case' 0 CA--C 1.573 1.849 0 N-CA-C 115.46 1.652 . . . . 0.0 115.46 164.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.25 10.7 m-20 61.34 40.7 13.92 Favored 'General case' 0 CA--C 1.576 1.964 0 N-CA-C 115.493 1.664 . . . . 0.0 115.493 -175.443 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 91.2 t -94.88 141.89 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.191 -0.943 . . . . 0.0 109.931 -176.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 14.0 p30 -64.48 154.44 35.86 Favored 'General case' 0 CA--C 1.572 1.812 0 N-CA-C 115.82 1.785 . . . . 0.0 115.82 178.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 96.8 t -58.63 -40.84 80.45 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.276 0 N-CA-C 115.127 1.528 . . . . 0.0 115.127 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.58 -50.3 72.34 Favored 'General case' 0 CA--C 1.567 1.631 0 N-CA-C 116.029 1.863 . . . . 0.0 116.029 171.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -71.65 -34.65 69.93 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 115.322 1.601 . . . . 0.0 115.322 172.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 74.3 mtp180 -50.68 -41.71 55.99 Favored 'General case' 0 N--CA 1.503 2.197 0 N-CA-C 116.131 1.9 . . . . 0.0 116.131 160.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp -71.48 -54.05 11.89 Favored 'General case' 0 CA--C 1.567 1.621 0 O-C-N 120.96 -1.088 . . . . 0.0 113.574 166.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 12.0 mt -77.98 60.44 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.509 2.484 0 CA-C-N 120.923 1.692 . . . . 0.0 111.708 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -179.45 -47.29 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 126.701 2.0 . . . . 0.0 110.969 -174.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -64.49 -45.45 87.26 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 115.99 1.848 . . . . 0.0 115.99 158.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 65.2 mt -78.02 -24.94 47.69 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 115.645 1.72 . . . . 0.0 115.645 -175.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.9 pp -96.0 134.61 38.82 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 162.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 62.4 pttt -98.91 102.06 14.09 Favored Pre-proline 0 CA--C 1.574 1.896 0 CA-C-O 117.906 -1.045 . . . . 0.0 110.644 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -73.61 166.03 30.83 Favored 'Trans proline' 0 CA--C 1.565 2.041 0 CA-C-N 123.101 2.143 . . . . 0.0 115.77 -173.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -110.69 136.27 50.02 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.621 -0.674 . . . . 0.0 110.345 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 43.0 mttp -100.51 116.58 32.79 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 120.918 -1.114 . . . . 0.0 109.851 176.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -101.46 109.29 21.08 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 167.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.1 mp -96.06 127.12 48.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 178.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 74.7 t -110.21 106.55 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 164.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -103.69 105.69 15.99 Favored 'General case' 0 CA--C 1.565 1.535 0 C-N-CA 124.361 1.064 . . . . 0.0 109.222 177.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -125.97 87.42 2.68 Favored 'General case' 0 CA--C 1.565 1.532 0 C-N-CA 123.509 0.724 . . . . 0.0 110.061 -176.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 57.36 72.03 0.65 Allowed Glycine 0 N--CA 1.496 2.662 0 N-CA-C 117.106 1.602 . . . . 0.0 117.106 175.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.471 0.6 OUTLIER 65.26 -33.8 0.17 Allowed 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 118.476 2.769 . . . . 0.0 118.476 -166.473 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 15.6 t-160 -73.69 114.78 12.35 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-N 120.62 1.555 . . . . 0.0 111.471 172.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 44.7 ttm -123.35 124.18 42.37 Favored 'General case' 0 CA--C 1.557 1.227 0 C-N-CA 123.707 0.803 . . . . 0.0 109.646 -175.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 43.2 mt -108.46 104.4 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 178.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 17.0 mm -90.39 98.29 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 176.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -90.39 100.82 13.58 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.225 -0.922 . . . . 0.0 109.2 -176.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 28.6 m -88.55 104.49 16.87 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 43.7 mt -103.2 117.38 34.4 Favored 'General case' 0 CA--C 1.557 1.225 0 C-N-CA 123.852 0.861 . . . . 0.0 109.499 -163.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 43.7 t -128.58 143.03 50.88 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.063 0.945 . . . . 0.0 110.453 -165.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . 0.253 12.7 t -77.34 50.83 0.81 Allowed 'General case' 0 N--CA 1.503 2.191 0 N-CA-C 114.55 1.315 . . . . 0.0 114.55 168.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -167.26 -68.64 0.03 OUTLIER 'General case' 0 CA--C 1.568 1.639 0 C-N-CA 125.537 1.535 . . . . 0.0 108.057 -178.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 33.5 ttm105 -151.19 123.14 8.14 Favored 'General case' 0 CA--C 1.565 1.551 0 CA-C-N 118.959 0.8 . . . . 0.0 110.322 -179.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -80.16 139.44 36.79 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 -178.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -114.0 107.36 15.57 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.745 -0.597 . . . . 0.0 109.465 177.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 43.9 mm -100.51 106.5 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -171.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 1.2 mmm -96.24 87.32 4.47 Favored 'General case' 0 CA--C 1.564 1.493 0 CA-C-O 121.638 0.732 . . . . 0.0 110.207 -176.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -100.01 116.99 33.35 Favored 'General case' 0 CA--C 1.562 1.41 0 C-N-CA 123.928 0.891 . . . . 0.0 112.282 -175.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -155.59 153.54 30.28 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 -168.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -95.09 122.95 38.29 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.507 -0.746 . . . . 0.0 111.425 166.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 31.7 t -65.46 121.85 15.29 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.831 0 C-N-CA 124.169 0.987 . . . . 0.0 110.538 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 105.54 -34.57 5.67 Favored Glycine 0 CA--C 1.552 2.389 0 N-CA-C 116.955 1.542 . . . . 0.0 116.955 -162.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 52.4 mttp -95.55 122.96 38.84 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 119.265 1.532 . . . . 0.0 111.454 -171.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -78.9 116.52 19.28 Favored 'General case' 0 CA--C 1.569 1.697 0 O-C-N 121.491 -0.756 . . . . 0.0 112.587 -178.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -124.71 147.83 48.38 Favored 'General case' 0 N--CA 1.496 1.828 0 C-N-CA 123.787 0.835 . . . . 0.0 112.346 -170.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -68.29 127.18 32.01 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 119.91 -1.744 . . . . 0.0 113.92 172.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -77.03 61.15 1.94 Allowed 'General case' 0 N--CA 1.5 2.056 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 176.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -90.59 74.41 6.75 Favored 'General case' 0 CA--C 1.568 1.667 0 O-C-N 120.481 -1.387 . . . . 0.0 111.69 -174.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 92.3 mt -125.29 140.06 53.16 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 121.573 0.702 . . . . 0.0 110.897 -174.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 34.4 p -92.64 98.34 11.37 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.899 -1.126 . . . . 0.0 111.284 -175.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 173.21 -76.54 0.09 OUTLIER Glycine 0 N--CA 1.486 1.976 0 N-CA-C 115.663 1.025 . . . . 0.0 115.663 173.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 49.6 mm -74.33 -65.98 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 CA-C-N 117.413 0.606 . . . . 0.0 112.144 -173.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -108.74 -52.2 2.79 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-N 119.276 0.944 . . . . 0.0 113.354 174.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.271 13.9 t70 63.34 66.11 0.73 Allowed 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 114.452 1.278 . . . . 0.0 114.452 -171.329 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 19.6 ttp85 -147.2 141.03 25.77 Favored 'General case' 0 CA--C 1.562 1.426 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 173.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? -75.16 71.84 2.21 Favored 'General case' 0 CA--C 1.572 1.805 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 -172.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 84.5 m -87.13 122.74 31.35 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.585 -0.697 . . . . 0.0 111.211 -178.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 79.1 mmm -72.21 103.4 3.33 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 121.979 0.895 . . . . 0.0 110.398 -174.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 85.8 m -107.76 113.6 26.97 Favored 'General case' 0 N--CA 1.48 1.038 0 O-C-N 121.162 -0.961 . . . . 0.0 110.07 -159.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 40.5 m -98.57 121.37 40.42 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 170.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.512 HG21 ' SG ' ' A' ' 95' ' ' CYS . 20.2 t -109.21 126.36 66.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 170.304 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 58.3 m -133.22 144.41 49.78 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 123.627 0.771 . . . . 0.0 111.323 -176.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 8.2 m95 -83.88 122.55 28.87 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.821 -1.174 . . . . 0.0 113.656 179.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -108.58 65.7 0.63 Allowed 'General case' 0 CA--C 1.576 1.964 0 C-N-CA 123.485 0.714 . . . . 0.0 110.424 163.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 67.65 -94.61 0.29 Allowed Glycine 0 N--CA 1.493 2.477 0 N-CA-C 116.322 1.289 . . . . 0.0 116.322 178.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -82.47 -30.52 29.92 Favored 'General case' 0 CA--C 1.573 1.857 0 N-CA-C 115.34 1.607 . . . . 0.0 115.34 165.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 33.8 mtpt -96.24 116.38 28.92 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-N 119.853 1.206 . . . . 0.0 110.434 -171.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 33.6 tp -86.96 110.8 20.27 Favored 'General case' 0 CA--C 1.564 1.509 0 O-C-N 120.992 -1.068 . . . . 0.0 109.711 174.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 18.2 mm100 -103.05 126.01 50.04 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.863 0.865 . . . . 0.0 110.226 -167.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . 0.512 ' SG ' HG21 ' A' ' 86' ' ' VAL . 41.0 t -127.6 129.11 46.7 Favored 'General case' 0 N--CA 1.481 1.083 0 O-C-N 121.822 -0.549 . . . . 0.0 111.417 -175.028 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 12.0 p -109.5 127.59 66.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 162.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -103.93 75.98 1.33 Allowed 'General case' 0 CA--C 1.57 1.712 0 C-N-CA 123.805 0.842 . . . . 0.0 109.263 175.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 15.7 ptpt -84.44 143.91 29.1 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 114.586 1.328 . . . . 0.0 114.586 -166.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 161.66 -114.15 0.59 Allowed Glycine 0 N--CA 1.484 1.884 0 O-C-N 121.663 -0.648 . . . . 0.0 111.949 172.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -80.33 -36.08 34.71 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 115.655 1.724 . . . . 0.0 115.655 175.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 9.4 tppt? -77.02 114.68 16.09 Favored 'General case' 0 CA--C 1.567 1.605 0 CA-C-N 119.559 1.072 . . . . 0.0 111.58 -177.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -74.17 119.46 18.41 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.418 -0.801 . . . . 0.0 112.854 -169.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 68.48 40.83 86.34 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 118.594 2.197 . . . . 0.0 118.594 -172.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 45.7 ttt180 -92.0 130.22 37.79 Favored 'General case' 0 CA--C 1.566 1.572 0 CA-C-N 118.514 1.157 . . . . 0.0 111.854 179.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 179.73 -168.52 38.98 Favored Glycine 0 N--CA 1.484 1.859 0 CA-C-O 122.368 0.982 . . . . 0.0 114.021 175.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 58.2 p-90 -156.62 153.3 28.37 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 122.214 1.007 . . . . 0.0 112.989 174.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 39.8 m -129.71 117.72 20.75 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 176.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -121.29 129.2 53.01 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 123.247 0.619 . . . . 0.0 111.621 -174.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 17.8 p90 -146.78 163.63 35.37 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.025 -1.047 . . . . 0.0 113.339 -174.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 76.0 mt -106.52 143.39 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.298 0 CA-C-O 123.224 1.488 . . . . 0.0 111.654 178.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -137.06 84.97 2.1 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 178.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 72.39 -110.04 3.04 Favored Glycine 0 N--CA 1.489 2.208 0 CA-C-N 116.025 -0.534 . . . . 0.0 114.415 -174.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 55.6 p30 -88.9 7.22 35.5 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 117.473 2.397 . . . . 0.0 117.473 169.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -124.07 137.93 54.51 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-N 120.085 1.311 . . . . 0.0 112.754 -166.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 26.4 tp -97.01 118.65 33.88 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 123.947 0.899 . . . . 0.0 108.984 172.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 34.1 m80 -107.83 123.29 48.35 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.926 0.89 . . . . 0.0 108.977 -176.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 45.4 tp -123.17 121.14 35.21 Favored 'General case' 0 CA--C 1.559 1.323 0 C-N-CA 123.82 0.848 . . . . 0.0 110.004 -172.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.474 ' HE2' ' NZ ' ' A' ' 127' ' ' LYS . 40.7 mt-10 -102.13 114.66 28.98 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.594 -0.691 . . . . 0.0 109.296 166.034 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 73.5 mtm -103.89 126.85 51.31 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-N 118.557 0.617 . . . . 0.0 110.582 175.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 87.0 mtm180 -120.0 134.43 55.25 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 123.837 0.855 . . . . 0.0 110.471 -167.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -162.53 137.22 6.71 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.372 -0.83 . . . . 0.0 112.236 173.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . 0.328 12.1 mt-10 48.68 43.83 20.94 Favored 'General case' 0 N--CA 1.504 2.265 0 N-CA-C 116.156 1.91 . . . . 0.0 116.156 -178.197 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 65.71 26.24 71.99 Favored Glycine 0 CA--C 1.552 2.363 0 N-CA-C 120.609 3.004 . . . . 0.0 120.609 -167.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 87.6 t -130.83 128.36 62.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 CA-C-N 119.605 1.703 . . . . 0.0 109.202 -175.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 52.4 m -106.07 126.11 51.81 Favored 'General case' 0 N--CA 1.496 1.834 0 C-N-CA 123.284 0.634 . . . . 0.0 111.267 176.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 9.2 t -96.67 128.65 43.81 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.698 0.799 . . . . 0.0 111.542 162.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.474 ' NZ ' ' HE2' ' A' ' 118' ' ' GLU . 47.0 mttp -102.02 111.1 23.25 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 121.427 0.632 . . . . 0.0 110.536 176.102 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 64.2 mt-30 -108.98 126.74 53.42 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.693 0.797 . . . . 0.0 110.767 176.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 47.7 t -114.27 132.0 64.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -126.87 149.6 49.67 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 123.742 0.817 . . . . 0.0 111.329 178.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 75.4 tttt -111.33 140.18 46.11 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.374 -0.829 . . . . 0.0 112.164 175.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 73.0 tttt -74.19 122.93 23.55 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.448 -0.782 . . . . 0.0 113.07 -178.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 31.7 m -109.32 -42.31 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 175.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 50.2 t-80 . . . . . 0 N--CA 1.485 1.309 0 CA-C-N 119.712 1.142 . . . . 0.0 108.268 167.782 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 72.3 mtm . . . . . 0 CA--C 1.575 1.928 0 CA-C-O 118.525 -0.75 . . . . 0.0 110.924 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -89.98 163.17 4.92 Favored 'Trans proline' 0 CA--C 1.565 2.028 0 N-CA-C 117.35 2.019 . . . . 0.0 117.35 -173.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 27.6 m -108.98 175.42 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 CA-C-O 122.666 1.222 . . . . 0.0 112.719 174.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -78.14 96.74 5.24 Favored 'General case' 0 CA--C 1.568 1.643 0 O-C-N 120.874 -1.141 . . . . 0.0 113.287 -172.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -78.14 -0.22 27.4 Favored 'General case' 0 N--CA 1.501 2.116 0 N-CA-C 116.334 1.976 . . . . 0.0 116.334 169.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -60.24 116.07 3.97 Favored 'General case' 0 CA--C 1.563 1.47 0 C-N-CA 125.826 1.65 . . . . 0.0 114.343 179.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 163.44 177.99 36.77 Favored Glycine 0 N--CA 1.484 1.879 0 N-CA-C 116.743 1.457 . . . . 0.0 116.743 177.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -106.57 120.07 40.96 Favored 'General case' 0 CA--C 1.563 1.459 0 CA-C-N 113.961 -1.12 . . . . 0.0 108.536 170.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 64.5 m95 -120.03 124.98 47.22 Favored 'General case' 0 CA--C 1.565 1.547 0 C-N-CA 123.882 0.873 . . . . 0.0 108.766 -169.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -95.24 137.06 34.81 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.67 -1.269 . . . . 0.0 112.619 179.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 4.3 ttp -74.86 121.64 22.15 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 122.133 0.968 . . . . 0.0 112.773 179.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 93.4 mt -79.47 -54.65 5.71 Favored 'General case' 0 CA--C 1.566 1.592 0 CA-C-N 115.029 -0.987 . . . . 0.0 112.609 171.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 89.6 p -144.33 151.77 39.82 Favored 'General case' 0 CA--C 1.563 1.45 0 C-N-CA 123.717 0.807 . . . . 0.0 112.624 -173.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -122.64 133.49 54.52 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.43 0.634 . . . . 0.0 110.901 160.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -125.58 117.78 24.3 Favored 'General case' 0 CA--C 1.561 1.367 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 -179.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.292 31.3 t30 68.88 31.65 4.23 Favored 'General case' 0 CA--C 1.579 2.089 0 N-CA-C 117.082 2.253 . . . . 0.0 117.082 -175.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -71.8 -42.97 66.42 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 115.215 1.561 . . . . 0.0 115.215 175.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.479 ' HE2' ' NZ ' ' A' ' 31' ' ' LYS . 17.9 mt-10 -47.3 -47.33 25.37 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 116.442 2.015 . . . . 0.0 116.442 166.387 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -70.26 -38.62 75.15 Favored 'General case' 0 CA--C 1.57 1.736 0 N-CA-C 115.686 1.736 . . . . 0.0 115.686 176.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 81.5 t80 -55.41 -49.4 72.45 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-N 120.519 1.508 . . . . 0.0 114.201 165.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 79.8 mt -59.37 -43.01 92.91 Favored 'General case' 0 CA--C 1.574 1.895 0 N-CA-C 115.493 1.664 . . . . 0.0 115.493 169.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 36.4 ttp180 -51.2 -51.16 56.44 Favored 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 115.325 1.602 . . . . 0.0 115.325 165.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.87 -24.53 52.39 Favored 'General case' 0 CA--C 1.565 1.538 0 N-CA-C 118.364 2.728 . . . . 0.0 118.364 165.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 93.3 mt -87.18 8.91 21.87 Favored 'General case' 0 CA--C 1.575 1.912 0 N-CA-C 115.735 1.754 . . . . 0.0 115.735 167.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.256 25.8 m-20 67.24 41.46 2.52 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 -175.241 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 90.3 t -100.37 141.66 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 121.031 -1.043 . . . . 0.0 110.014 -178.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 12.1 p30 -68.68 159.89 31.28 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 115.887 1.81 . . . . 0.0 115.887 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 65.0 t -58.52 -46.2 89.9 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.256 0 N-CA-C 114.895 1.443 . . . . 0.0 114.895 -179.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.55 -47.4 84.36 Favored 'General case' 0 CA--C 1.57 1.717 0 N-CA-C 116.052 1.871 . . . . 0.0 116.052 173.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.49 -43.83 97.85 Favored 'General case' 0 CA--C 1.574 1.9 0 N-CA-C 114.873 1.434 . . . . 0.0 114.873 169.259 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 77.1 mtp180 -49.92 -50.92 44.55 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 115.569 1.692 . . . . 0.0 115.569 164.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.479 ' NZ ' ' HE2' ' A' ' 17' ' ' GLU . 12.2 mptt -54.95 -54.15 46.51 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 115.258 1.577 . . . . 0.0 115.258 168.183 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 34.9 mt -59.73 -53.2 51.71 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 CA-C-N 119.808 1.185 . . . . 0.0 113.162 178.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -61.94 -40.41 95.45 Favored 'General case' 0 CA--C 1.566 1.569 0 N-CA-C 117.529 2.418 . . . . 0.0 117.529 175.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -65.64 -32.08 73.45 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 116.003 1.853 . . . . 0.0 116.003 169.242 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 81.5 mt -72.79 -30.45 64.1 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 116.139 1.903 . . . . 0.0 116.139 170.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 38.6 mt -73.95 139.8 45.12 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 119.539 1.063 . . . . 0.0 113.547 -179.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -110.96 86.01 5.61 Favored Pre-proline 0 CA--C 1.572 1.826 0 CA-C-O 118.299 -0.858 . . . . 0.0 109.723 172.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -76.87 174.02 13.53 Favored 'Trans proline' 0 CA--C 1.563 1.926 0 C-N-CA 122.558 2.172 . . . . 0.0 115.67 -176.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -111.88 130.27 55.89 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.699 -0.625 . . . . 0.0 111.315 178.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 47.6 mttm -90.12 109.93 20.97 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.275 -0.891 . . . . 0.0 110.137 171.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -92.55 110.94 22.37 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 163.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 74.3 mt -109.03 118.35 56.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 107.475 -1.305 . . . . 0.0 107.475 -178.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 72.1 t -100.87 98.48 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 106.676 -1.602 . . . . 0.0 106.676 166.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -90.44 93.0 9.12 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.537 0.684 . . . . 0.0 109.731 174.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -100.33 70.58 1.52 Allowed 'General case' 0 CA--C 1.567 1.624 0 O-C-N 121.478 -0.764 . . . . 0.0 111.403 -177.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 53.56 67.46 2.13 Favored Glycine 0 N--CA 1.496 2.695 0 N-CA-C 117.64 1.816 . . . . 0.0 117.64 176.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.438 0.5 OUTLIER 61.0 8.22 1.82 Allowed 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 119.617 3.192 . . . . 0.0 119.617 -163.579 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 17.5 t-160 -107.48 106.56 17.01 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 121.276 1.853 . . . . 0.0 107.643 161.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 6.6 tpp -109.45 132.19 54.36 Favored 'General case' 0 CA--C 1.556 1.186 0 O-C-N 121.458 -0.776 . . . . 0.0 110.969 -172.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 47.1 mt -116.47 101.87 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 173.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 72.9 mt -99.13 116.31 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 178.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -115.86 103.39 10.59 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 70.4 m -88.42 112.62 23.12 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 172.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 24.0 mt -110.96 119.01 37.64 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.303 -158.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 36.1 t -130.76 153.53 48.93 Favored 'General case' 0 CA--C 1.56 1.346 0 C-N-CA 123.668 0.787 . . . . 0.0 110.529 173.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 70.2 p -80.98 62.32 4.92 Favored 'General case' 0 N--CA 1.504 2.247 0 O-C-N 120.636 -1.29 . . . . 0.0 111.633 163.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -174.06 -68.61 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 125.097 1.359 . . . . 0.0 108.985 -174.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 14.8 ttm180 -146.61 118.08 7.96 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 123.634 0.773 . . . . 0.0 109.103 -173.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -106.11 130.55 53.98 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 123.229 0.612 . . . . 0.0 110.588 -170.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 10.3 t80 -101.45 109.55 21.4 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.544 -0.722 . . . . 0.0 109.871 178.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 41.6 mm -116.67 117.47 55.58 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -169.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 25.4 mmm -126.6 97.54 5.06 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 123.226 0.61 . . . . 0.0 109.77 -175.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -104.84 103.7 13.34 Favored 'General case' 0 CA--C 1.563 1.463 0 C-N-CA 124.06 0.944 . . . . 0.0 111.875 177.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -151.49 154.24 36.17 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 -163.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 17.8 mp0 -84.57 126.53 33.4 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.11 -0.994 . . . . 0.0 111.08 164.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 15.1 t -69.06 114.15 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 174.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 124.88 -46.72 1.07 Allowed Glycine 0 N--CA 1.488 2.146 0 N-CA-C 115.807 1.083 . . . . 0.0 115.807 -160.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 34.9 mtmt -83.74 142.83 30.42 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 118.872 1.336 . . . . 0.0 113.861 -173.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -93.25 95.54 9.43 Favored 'General case' 0 CA--C 1.566 1.58 0 CA-C-O 121.321 0.582 . . . . 0.0 111.252 176.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -104.56 142.14 35.16 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 124.032 0.933 . . . . 0.0 113.058 -170.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -71.58 115.7 11.07 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.164 -1.585 . . . . 0.0 113.46 176.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -81.97 100.34 9.63 Favored 'General case' 0 CA--C 1.564 1.508 0 O-C-N 121.397 -0.814 . . . . 0.0 109.423 165.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -109.2 92.23 3.97 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 123.736 0.815 . . . . 0.0 110.601 179.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . 0.278 2.2 tt 57.16 74.98 0.39 Allowed 'General case' 0 N--CA 1.498 1.968 0 C-N-CA 124.783 1.233 . . . . 0.0 113.906 -170.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 28.5 m -90.06 3.62 52.72 Favored 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 116.095 1.887 . . . . 0.0 116.095 -173.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 138.84 -73.55 0.41 Allowed Glycine 0 N--CA 1.487 2.037 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 -164.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 47.3 mm -86.28 173.55 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.587 2.396 0 CA-C-O 122.3 1.048 . . . . 0.0 109.801 164.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 -67.04 68.74 0.07 Allowed 'General case' 0 CA--C 1.576 1.965 0 N-CA-C 117.404 2.372 . . . . 0.0 117.404 -177.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -83.95 98.85 10.03 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.048 -1.033 . . . . 0.0 110.486 171.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 -89.57 78.03 7.12 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.065 -1.022 . . . . 0.0 111.648 -178.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . 0.254 52.2 mtmt 54.81 57.25 5.83 Favored 'General case' 0 N--CA 1.5 2.072 0 N-CA-C 115.711 1.745 . . . . 0.0 115.711 -173.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 72.5 m -86.07 113.9 22.51 Favored 'General case' 0 CA--C 1.559 1.31 0 O-C-N 121.082 -1.011 . . . . 0.0 110.866 178.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 2.4 tpt -75.58 98.66 4.06 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 122.195 0.998 . . . . 0.0 109.638 -176.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 65.3 m -104.72 110.26 22.51 Favored 'General case' 0 N--CA 1.48 1.059 0 O-C-N 121.695 -0.628 . . . . 0.0 110.065 -154.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 54.6 m -88.79 121.82 31.56 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 167.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 22.9 t -110.35 121.51 63.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 165.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 31.8 m -128.08 154.11 46.07 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 122.125 0.964 . . . . 0.0 111.545 -175.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 29.0 m95 -84.69 114.98 22.42 Favored 'General case' 0 CA--C 1.562 1.422 0 O-C-N 121.223 -0.923 . . . . 0.0 111.939 174.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -93.5 70.92 4.3 Favored 'General case' 0 CA--C 1.571 1.783 0 CA-C-O 121.539 0.685 . . . . 0.0 109.57 159.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 61.14 -114.72 6.96 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 114.901 0.72 . . . . 0.0 114.901 -168.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -64.87 -30.56 71.57 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 116.461 2.023 . . . . 0.0 116.461 166.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -86.87 127.81 35.04 Favored 'General case' 0 CA--C 1.561 1.384 0 CA-C-N 119.443 1.019 . . . . 0.0 111.256 -173.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 25.8 tp -92.28 106.56 18.54 Favored 'General case' 0 CA--C 1.566 1.562 0 O-C-N 121.378 -0.826 . . . . 0.0 109.097 176.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 -100.46 128.83 46.41 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 123.658 0.783 . . . . 0.0 111.132 -173.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 40.9 t -124.19 131.64 53.55 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.436 0.694 . . . . 0.0 111.975 -177.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.5 p -120.15 125.65 74.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 C-N-CA 122.979 0.511 . . . . 0.0 109.628 168.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -100.87 90.26 4.14 Favored 'General case' 0 CA--C 1.568 1.657 0 C-N-CA 124.092 0.957 . . . . 0.0 109.58 -176.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -84.88 122.47 29.21 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.66 -1.275 . . . . 0.0 113.525 -166.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -169.76 -130.64 1.23 Allowed Glycine 0 N--CA 1.485 1.947 0 O-C-N 121.593 -0.692 . . . . 0.0 112.157 171.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.68 -16.44 58.49 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 117.157 2.281 . . . . 0.0 117.157 176.165 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 16.7 ttmt -98.82 129.64 45.22 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 119.97 1.259 . . . . 0.0 111.561 -170.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -79.01 128.55 33.4 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.472 -0.767 . . . . 0.0 112.816 -172.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 66.61 34.1 86.53 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 118.975 2.35 . . . . 0.0 118.975 -176.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 36.7 ttt180 -85.92 124.36 32.3 Favored 'General case' 0 CA--C 1.565 1.527 0 CA-C-N 118.734 1.267 . . . . 0.0 111.577 -177.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -179.18 -168.96 39.03 Favored Glycine 0 N--CA 1.486 1.989 0 N-CA-C 115.687 1.035 . . . . 0.0 115.687 -177.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 41.8 p-90 -157.43 155.47 30.53 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.958 0.885 . . . . 0.0 112.898 170.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 97.5 m -126.16 120.47 30.2 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.344 -0.848 . . . . 0.0 108.712 176.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 16.8 tt0 -124.42 124.72 42.95 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.846 -0.534 . . . . 0.0 111.992 -175.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 14.0 p90 -143.17 163.02 34.04 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.079 -1.013 . . . . 0.0 113.227 -177.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 86.1 mt -107.92 133.94 51.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 CA-C-O 122.266 1.031 . . . . 0.0 110.652 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -120.71 85.34 2.38 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 124.525 1.13 . . . . 0.0 108.451 173.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 69.68 -108.06 2.34 Favored Glycine 0 N--CA 1.491 2.315 0 O-C-N 121.584 -0.697 . . . . 0.0 114.752 -175.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 31.6 p-10 -87.96 -5.16 58.68 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 117.427 2.38 . . . . 0.0 117.427 166.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -103.41 139.59 38.59 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-N 120.408 1.458 . . . . 0.0 112.368 -175.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 10.7 tp -101.46 122.08 43.12 Favored 'General case' 0 CA--C 1.562 1.417 0 C-N-CA 123.873 0.869 . . . . 0.0 108.957 169.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 36.9 m80 -109.27 119.87 40.81 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.533 0.733 . . . . 0.0 109.208 -175.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 20.0 tp -114.38 129.86 56.67 Favored 'General case' 0 CA--C 1.56 1.327 0 C-N-CA 123.737 0.815 . . . . 0.0 110.183 -178.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -119.16 108.7 14.99 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.936 -0.478 . . . . 0.0 110.003 169.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 76.8 mtm -97.82 127.49 43.8 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 123.62 0.768 . . . . 0.0 111.515 -176.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 78.7 mtm180 -118.14 135.2 54.37 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 123.329 0.651 . . . . 0.0 111.693 -167.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -160.23 132.89 6.46 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.26 -0.9 . . . . 0.0 111.515 170.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 33.8 mm-40 58.13 36.88 26.24 Favored 'General case' 0 N--CA 1.505 2.3 0 N-CA-C 115.361 1.615 . . . . 0.0 115.361 -177.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 72.9 -8.62 7.56 Favored Glycine 0 CA--C 1.556 2.603 0 N-CA-C 120.399 2.92 . . . . 0.0 120.399 -162.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 97.1 t -92.88 128.23 44.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 CA-C-N 120.137 1.969 . . . . 0.0 109.76 -171.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 37.8 m -105.9 124.25 49.28 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 122.73 0.412 . . . . 0.0 111.5 177.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 11.2 t -95.14 126.21 40.31 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.426 0.69 . . . . 0.0 111.234 162.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -103.4 121.1 42.09 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 123.381 0.672 . . . . 0.0 109.569 -179.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 20.0 mt-30 -126.64 134.24 50.8 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.588 -0.695 . . . . 0.0 111.227 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 57.1 t -115.24 131.07 68.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 -177.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -123.5 149.83 44.69 Favored 'General case' 0 CA--C 1.563 1.478 0 C-N-CA 124.72 1.208 . . . . 0.0 110.232 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 29.6 ttmt -123.61 141.08 52.36 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.789 -1.194 . . . . 0.0 112.153 175.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 70.8 tttt -73.84 123.4 24.13 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 -175.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . 0.255 34.5 m -107.86 -43.07 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 175.248 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 . . . . . 0 N--CA 1.487 1.414 0 CA-C-N 120.206 1.366 . . . . 0.0 108.312 167.011 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 26.6 ttt . . . . . 0 CA--C 1.571 1.78 0 CA-C-O 118.269 -0.872 . . . . 0.0 109.871 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -75.71 134.51 16.75 Favored 'Trans proline' 0 CA--C 1.561 1.859 0 C-N-CA 122.507 2.138 . . . . 0.0 115.405 -173.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 15.6 m -72.58 141.26 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 CA-C-O 121.936 0.874 . . . . 0.0 113.079 178.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -76.25 121.48 23.0 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 -176.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 8.6 m-30 -85.05 8.4 18.04 Favored 'General case' 0 CA--C 1.572 1.807 0 N-CA-C 115.647 1.721 . . . . 0.0 115.647 177.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 27.5 m120 -51.43 121.82 6.93 Favored 'General case' 0 N--CA 1.499 2.004 0 CA-C-N 121.496 1.953 . . . . 0.0 115.082 172.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 160.45 177.88 33.95 Favored Glycine 0 N--CA 1.481 1.685 0 CA-C-O 123.002 1.334 . . . . 0.0 116.031 174.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 14.8 t80 -110.74 128.84 55.89 Favored 'General case' 0 CA--C 1.564 1.491 0 CA-C-N 113.578 -1.311 . . . . 0.0 108.364 165.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 55.3 m95 -126.81 138.51 53.36 Favored 'General case' 0 CA--C 1.573 1.832 0 C-N-CA 123.733 0.813 . . . . 0.0 110.144 -167.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -112.11 137.05 50.71 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 120.678 -1.264 . . . . 0.0 112.633 178.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.455 ' SD ' ' HD2' ' A' ' 38' ' ' PRO . 1.9 ttt -75.0 123.45 25.18 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.454 -1.404 . . . . 0.0 114.281 -175.122 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 97.5 mt -85.92 -52.67 5.58 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 113.688 0.996 . . . . 0.0 113.688 176.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 83.3 p -142.36 148.25 37.61 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 123.671 0.788 . . . . 0.0 112.112 -176.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -126.75 116.73 21.38 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 123.107 0.563 . . . . 0.0 110.078 170.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -112.15 116.05 29.85 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 178.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.293 18.7 t30 69.71 25.47 5.14 Favored 'General case' 0 CA--C 1.579 2.096 0 N-CA-C 117.964 2.579 . . . . 0.0 117.964 177.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 15.7 t80 -63.41 -45.14 92.39 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 115.459 1.651 . . . . 0.0 115.459 170.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -54.68 -40.78 69.47 Favored 'General case' 0 CA--C 1.573 1.836 0 N-CA-C 117.868 2.544 . . . . 0.0 117.868 172.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -74.22 -40.72 62.26 Favored 'General case' 0 CA--C 1.571 1.775 0 N-CA-C 115.264 1.579 . . . . 0.0 115.264 171.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -49.06 -48.92 43.67 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 115.19 1.552 . . . . 0.0 115.19 162.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 88.5 mt -62.06 -40.19 94.94 Favored 'General case' 0 CA--C 1.573 1.835 0 N-CA-C 115.339 1.607 . . . . 0.0 115.339 169.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 46.9 ttp180 -54.0 -50.47 66.52 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 165.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.58 -21.52 53.34 Favored 'General case' 0 CA--C 1.567 1.622 0 N-CA-C 118.223 2.675 . . . . 0.0 118.223 167.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 37.7 mt -90.83 8.53 34.36 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 115.988 1.847 . . . . 0.0 115.988 168.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 69.84 32.94 3.01 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 115.141 1.534 . . . . 0.0 115.141 -177.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 70.3 t -95.36 144.08 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 120.666 -1.271 . . . . 0.0 110.623 -172.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -64.74 152.64 42.04 Favored 'General case' 0 CA--C 1.573 1.835 0 N-CA-C 116.213 1.931 . . . . 0.0 116.213 -176.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . 0.251 56.1 t -58.45 -42.47 84.37 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.156 0 N-CA-C 115.682 1.734 . . . . 0.0 115.682 -179.251 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.05 -51.3 70.65 Favored 'General case' 0 CA--C 1.57 1.72 0 N-CA-C 115.878 1.807 . . . . 0.0 115.878 173.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -54.28 -53.49 53.05 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 114.314 1.227 . . . . 0.0 114.314 166.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 56.3 mtp180 -47.52 -41.57 21.33 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 118.378 2.732 . . . . 0.0 118.378 171.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -75.73 -52.88 9.48 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 174.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 19.9 mt -63.33 -49.75 81.64 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 CA-C-N 119.251 0.932 . . . . 0.0 112.961 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.93 -33.07 74.88 Favored 'General case' 0 CA--C 1.568 1.664 0 N-CA-C 117.821 2.526 . . . . 0.0 117.821 175.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -69.14 -31.27 69.82 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 116.11 1.893 . . . . 0.0 116.11 165.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 79.9 mt -72.25 -36.49 69.08 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 116.075 1.88 . . . . 0.0 116.075 171.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . 0.293 2.5 pp -80.82 152.69 28.1 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-N 120.196 1.362 . . . . 0.0 114.545 -178.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 30.8 mmtp -111.07 99.29 42.54 Favored Pre-proline 0 CA--C 1.572 1.808 0 CA-C-O 118.348 -0.834 . . . . 0.0 108.818 176.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.455 ' HD2' ' SD ' ' A' ' 10' ' ' MET . 91.0 Cg_endo -77.92 176.92 9.42 Favored 'Trans proline' 0 CA--C 1.565 2.032 0 C-N-CA 122.948 2.432 . . . . 0.0 116.025 -175.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -109.98 163.45 13.55 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.969 0.89 . . . . 0.0 112.213 173.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.436 ' NZ ' ' HG1' ' A' ' 53' ' ' THR . 43.2 mttm -135.46 120.53 18.78 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.099 -1.001 . . . . 0.0 110.123 176.196 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.551 ' HE2' ' NH1' ' A' ' 52' ' ' ARG . 30.3 tt0 -100.57 118.57 37.0 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.422 -0.798 . . . . 0.0 109.656 163.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 78.6 mt -113.75 121.42 65.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 177.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 52.9 t -107.09 97.35 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 107.788 -1.189 . . . . 0.0 107.788 167.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -88.48 117.04 27.14 Favored 'General case' 0 CA--C 1.567 1.604 0 C-N-CA 123.454 0.701 . . . . 0.0 110.019 165.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -142.9 102.04 3.95 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.241 -0.912 . . . . 0.0 109.762 -179.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 56.8 62.36 6.45 Favored Glycine 0 N--CA 1.497 2.706 0 N-CA-C 117.409 1.724 . . . . 0.0 117.409 178.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.416 0.6 OUTLIER 59.97 -10.79 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 119.914 3.302 . . . . 0.0 119.914 -165.291 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 12.4 t-80 -88.4 121.93 31.33 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-N 121.192 1.814 . . . . 0.0 110.127 174.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 40.4 ttm -123.58 116.99 24.04 Favored 'General case' 0 CA--C 1.556 1.208 0 CA-C-O 121.553 0.692 . . . . 0.0 110.161 -174.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 27.6 mt -104.13 98.91 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 177.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 72.0 mt -94.23 111.76 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 178.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.551 ' NH1' ' HE2' ' A' ' 41' ' ' GLU . 41.9 mtt85 -110.27 101.79 10.5 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 178.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.436 ' HG1' ' NZ ' ' A' ' 40' ' ' LYS . 3.2 m -80.0 120.7 24.54 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 167.247 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 74.9 mt -124.39 118.21 26.19 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-O 121.649 0.738 . . . . 0.0 109.638 -164.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.47 -3.13 0.2 Allowed 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 117.018 2.229 . . . . 0.0 117.018 -178.191 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . 0.344 30.3 m 75.4 -62.97 0.43 Allowed 'General case' 0 N--CA 1.505 2.293 0 CA-C-N 121.556 1.98 . . . . 0.0 112.893 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -63.15 -44.44 95.51 Favored 'General case' 0 CA--C 1.571 1.778 0 N-CA-C 115.174 1.546 . . . . 0.0 115.174 165.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 31.4 ttt85 -128.16 130.77 48.59 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 120.081 1.309 . . . . 0.0 110.397 172.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -133.82 135.21 43.65 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.764 -0.585 . . . . 0.0 110.507 176.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -120.0 119.99 35.01 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 170.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 33.9 mm -112.4 104.88 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 174.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 94.4 mtp -110.74 98.71 7.8 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 -179.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -102.01 98.35 8.56 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 123.523 0.729 . . . . 0.0 110.136 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -142.78 156.78 45.03 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -168.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -94.7 131.26 40.7 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.105 -0.997 . . . . 0.0 110.824 166.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 22.0 t -66.85 113.3 2.84 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.776 0 C-N-CA 123.501 0.721 . . . . 0.0 109.978 -179.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 127.4 -55.45 0.75 Allowed Glycine 0 CA--C 1.548 2.109 0 CA-C-O 119.059 -0.856 . . . . 0.0 114.923 -158.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 13.9 pttt -75.76 145.58 40.69 Favored 'General case' 0 CA--C 1.567 1.627 0 N-CA-C 116.286 1.958 . . . . 0.0 116.286 -170.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -95.01 108.85 20.93 Favored 'General case' 0 CA--C 1.567 1.627 0 C-N-CA 123.172 0.589 . . . . 0.0 110.835 174.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -116.02 143.12 45.89 Favored 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 123.666 0.786 . . . . 0.0 112.819 -173.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -70.66 116.24 10.75 Favored 'General case' 0 CA--C 1.569 1.709 0 O-C-N 120.042 -1.661 . . . . 0.0 113.975 175.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -71.62 99.85 2.17 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.166 -0.959 . . . . 0.0 108.763 167.316 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . 0.28 3.4 p30 -119.27 -159.75 0.78 Allowed 'General case' 0 CA--C 1.568 1.647 0 N-CA-C 113.369 0.878 . . . . 0.0 113.369 -156.132 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 72.5 mt 55.33 60.0 3.63 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 -171.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . 0.438 4.1 t 55.58 -1.7 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.222 0 N-CA-C 120.696 3.591 . . . . 0.0 120.696 -165.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 88.91 146.26 12.75 Favored Glycine 0 N--CA 1.487 2.079 0 CA-C-N 120.774 1.624 . . . . 0.0 115.453 -174.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 31.7 mt -90.05 -56.48 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.175 0 O-C-N 122.104 -0.645 . . . . 0.0 111.06 178.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -87.94 -66.99 0.86 Allowed 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 119.962 1.255 . . . . 0.0 113.173 171.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -99.07 -101.88 0.22 Allowed 'General case' 0 CA--C 1.566 1.587 0 CA-C-N 119.445 1.02 . . . . 0.0 110.401 175.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . 0.282 39.6 ttt85 -140.83 -124.43 0.1 Allowed 'General case' 0 CA--C 1.567 1.633 0 CA-C-N 119.935 1.243 . . . . 0.0 110.081 -176.126 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -106.33 121.68 44.72 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 120.644 1.565 . . . . 0.0 111.974 -168.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 22.1 m -134.96 132.03 37.91 Favored 'General case' 0 CA--C 1.562 1.423 0 CA-C-O 122.208 1.004 . . . . 0.0 111.435 177.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 72.1 mmm -74.05 110.46 8.36 Favored 'General case' 0 CA--C 1.562 1.439 0 C-N-CA 123.744 0.818 . . . . 0.0 109.757 172.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 76.6 m -108.81 116.16 31.46 Favored 'General case' 0 N--CA 1.484 1.256 0 O-C-N 121.668 -0.645 . . . . 0.0 110.714 -161.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 89.8 m -104.68 125.81 51.15 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 176.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.425 HG23 ' SG ' ' A' ' 95' ' ' CYS . 15.4 t -117.85 119.24 60.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 177.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 56.8 m -140.56 150.18 43.35 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 123.341 0.656 . . . . 0.0 112.161 -174.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 90.7 m95 -79.27 119.74 22.76 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.462 -1.399 . . . . 0.0 112.847 177.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -93.55 78.52 4.34 Favored 'General case' 0 CA--C 1.567 1.616 0 O-C-N 121.631 -0.668 . . . . 0.0 109.295 163.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 67.65 -99.27 0.52 Allowed Glycine 0 N--CA 1.49 2.264 0 O-C-N 121.818 -0.551 . . . . 0.0 114.451 -171.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -102.95 -6.05 22.82 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 116.454 2.02 . . . . 0.0 116.454 170.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 35.8 mtmm -97.39 127.59 43.48 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-N 120.539 1.518 . . . . 0.0 110.026 176.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 22.3 tp -84.73 110.15 18.56 Favored 'General case' 0 CA--C 1.564 1.489 0 O-C-N 121.034 -1.041 . . . . 0.0 110.071 174.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -97.39 125.53 42.07 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.693 0.797 . . . . 0.0 110.841 -175.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . 0.425 ' SG ' HG23 ' A' ' 86' ' ' VAL . 39.4 t -114.03 124.33 51.87 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 123.284 0.633 . . . . 0.0 110.154 175.075 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.6 p -107.3 118.47 55.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 166.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -97.97 88.14 4.17 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 174.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -99.07 126.74 44.87 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.092 -1.005 . . . . 0.0 112.462 -174.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 166.39 -107.25 0.28 Allowed Glycine 0 N--CA 1.487 2.072 0 O-C-N 121.28 -0.887 . . . . 0.0 112.915 176.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -76.87 -10.22 59.22 Favored 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 117.764 2.505 . . . . 0.0 117.764 -177.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -122.94 142.84 50.37 Favored 'General case' 0 CA--C 1.566 1.563 0 CA-C-N 120.086 1.312 . . . . 0.0 111.294 177.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -81.79 144.32 31.16 Favored 'General case' 0 CA--C 1.563 1.467 0 O-C-N 121.491 -0.756 . . . . 0.0 111.565 173.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 57.63 23.96 51.4 Favored Glycine 0 N--CA 1.498 2.81 0 N-CA-C 120.854 3.102 . . . . 0.0 120.854 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 57.8 ttt180 -85.95 124.8 32.82 Favored 'General case' 0 CA--C 1.565 1.544 0 CA-C-N 118.501 1.151 . . . . 0.0 111.28 -178.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 178.25 -173.67 46.09 Favored Glycine 0 N--CA 1.488 2.119 0 O-C-N 121.341 -0.849 . . . . 0.0 114.852 -178.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . 0.25 16.8 p-90 -155.12 157.77 37.99 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 114.66 1.356 . . . . 0.0 114.66 171.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 31.8 m -123.77 123.7 41.06 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 123.831 0.852 . . . . 0.0 108.842 170.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -123.44 131.99 53.81 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 123.287 0.635 . . . . 0.0 111.882 -176.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 23.4 p90 -150.54 167.08 28.27 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.045 -1.034 . . . . 0.0 113.014 -179.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 89.3 mt -107.94 136.83 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.193 0 O-C-N 120.776 -1.202 . . . . 0.0 110.447 175.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -123.3 97.09 5.25 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 123.578 0.751 . . . . 0.0 109.701 164.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 76.97 -111.3 3.23 Favored Glycine 0 N--CA 1.491 2.316 0 O-C-N 121.275 -0.89 . . . . 0.0 113.9 -176.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -107.37 37.87 2.28 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 164.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -131.65 117.01 18.1 Favored 'General case' 0 CA--C 1.559 1.326 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 -168.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 17.2 tp -87.42 114.4 24.0 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-O 121.755 0.788 . . . . 0.0 109.914 172.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 48.9 m80 -102.66 120.09 39.96 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.972 0.909 . . . . 0.0 109.076 -177.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 49.5 tp -120.31 120.08 35.01 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 123.784 0.834 . . . . 0.0 109.833 -177.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -105.43 116.3 31.71 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.577 -0.702 . . . . 0.0 109.454 168.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 69.3 mtm -108.5 131.13 55.13 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 123.372 0.669 . . . . 0.0 111.023 -178.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 77.6 mtm-85 -115.16 143.87 44.56 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.534 -0.729 . . . . 0.0 111.411 -175.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -149.17 124.07 9.96 Favored 'General case' 0 N--CA 1.484 1.259 0 CA-C-O 121.456 0.646 . . . . 0.0 110.707 166.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 62.0 24.71 14.75 Favored 'General case' 0 CA--C 1.581 2.17 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 -172.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 88.33 -28.96 5.89 Favored Glycine 0 CA--C 1.557 2.694 0 N-CA-C 118.256 2.062 . . . . 0.0 118.256 -158.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 87.4 t -72.19 120.58 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 CA-C-N 119.644 1.722 . . . . 0.0 110.588 -173.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 29.4 m -102.12 123.74 46.5 Favored 'General case' 0 CA--C 1.566 1.573 0 CA-C-O 121.585 0.707 . . . . 0.0 111.484 -173.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 10.7 t -96.0 138.18 34.0 Favored 'General case' 0 CA--C 1.559 1.316 0 C-N-CA 124.3 1.04 . . . . 0.0 111.475 162.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 6.0 mtmt -118.07 124.14 47.36 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.333 -0.854 . . . . 0.0 110.051 179.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -127.24 134.45 50.08 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 123.593 0.757 . . . . 0.0 111.353 -177.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 38.0 t -116.68 132.39 66.52 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.439 ' CZ ' ' SD ' ' A' ' 10' ' ' MET . 38.3 m-85 -126.89 134.84 50.39 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.999 0.92 . . . . 0.0 111.062 -178.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 74.9 tttt -99.89 137.24 38.62 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.636 -1.29 . . . . 0.0 112.446 -179.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -71.56 118.82 14.86 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 179.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 26.8 m -104.04 -40.72 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 174.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 76.9 t60 . . . . . 0 C--O 1.253 1.273 0 CA-C-N 119.629 1.104 . . . . 0.0 108.416 166.275 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.57 1.747 0 CA-C-O 117.636 -1.174 . . . . 0.0 109.382 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -78.78 168.12 21.41 Favored 'Trans proline' 0 CA--C 1.565 2.053 0 C-N-CA 122.555 2.17 . . . . 0.0 117.061 -172.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.1 t -81.9 139.85 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.53 -0.731 . . . . 0.0 110.76 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -67.92 99.41 0.84 Allowed 'General case' 0 CA--C 1.569 1.674 0 O-C-N 121.109 -0.994 . . . . 0.0 113.35 167.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 10.6 m-30 -79.26 5.46 12.28 Favored 'General case' 0 CA--C 1.579 2.086 0 N-CA-C 116.364 1.987 . . . . 0.0 116.364 175.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -60.43 116.09 4.05 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 125.711 1.604 . . . . 0.0 114.616 -176.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 162.89 -177.9 38.8 Favored Glycine 0 N--CA 1.482 1.767 0 N-CA-C 116.646 1.419 . . . . 0.0 116.646 179.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 24.2 t80 -111.25 122.78 48.75 Favored 'General case' 0 CA--C 1.564 1.484 0 CA-C-N 113.514 -1.343 . . . . 0.0 108.138 170.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 83.1 m95 -122.43 125.82 46.64 Favored 'General case' 0 CA--C 1.564 1.497 0 C-N-CA 123.47 0.708 . . . . 0.0 109.93 -167.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -101.21 139.19 37.22 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.111 -0.993 . . . . 0.0 112.816 -179.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.473 ' SD ' ' HD2' ' A' ' 38' ' ' PRO . 42.0 ttm -67.1 126.12 28.19 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-N 120.241 1.382 . . . . 0.0 113.912 -179.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 91.3 mt -85.07 -55.54 4.0 Favored 'General case' 0 CA--C 1.567 1.611 0 CA-C-N 115.723 -0.672 . . . . 0.0 112.55 163.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 99.7 p -138.65 150.25 46.05 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 123.526 0.73 . . . . 0.0 112.773 -177.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -132.76 104.74 6.77 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.683 0.754 . . . . 0.0 109.453 165.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -108.0 124.77 50.66 Favored 'General case' 0 CA--C 1.56 1.357 0 C-N-CA 124.155 0.982 . . . . 0.0 109.487 -170.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.286 33.4 t30 64.87 24.3 12.74 Favored 'General case' 0 N--CA 1.502 2.165 0 N-CA-C 117.105 2.261 . . . . 0.0 117.105 -173.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -68.21 -45.02 74.45 Favored 'General case' 0 CA--C 1.569 1.68 0 N-CA-C 115.271 1.582 . . . . 0.0 115.271 176.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -43.36 -50.5 6.75 Favored 'General case' 0 N--CA 1.501 2.124 0 N-CA-C 117.319 2.341 . . . . 0.0 117.319 164.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -71.68 -38.45 70.61 Favored 'General case' 0 CA--C 1.571 1.752 0 N-CA-C 115.563 1.69 . . . . 0.0 115.563 177.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 73.0 t80 -53.98 -47.52 71.32 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 114.907 1.447 . . . . 0.0 114.907 162.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 72.6 mt -62.17 -42.0 98.85 Favored 'General case' 0 CA--C 1.574 1.871 0 N-CA-C 114.681 1.363 . . . . 0.0 114.681 171.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 26.1 ttt-85 -50.41 -50.74 51.01 Favored 'General case' 0 N--CA 1.501 2.118 0 N-CA-C 115.586 1.699 . . . . 0.0 115.586 163.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.25 -23.2 55.23 Favored 'General case' 0 CA--C 1.566 1.576 0 N-CA-C 118.181 2.66 . . . . 0.0 118.181 167.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 96.1 mt -88.95 13.83 11.9 Favored 'General case' 0 CA--C 1.574 1.901 0 N-CA-C 115.484 1.661 . . . . 0.0 115.484 165.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 60.29 40.59 17.57 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 115.984 1.846 . . . . 0.0 115.984 -174.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 88.9 t -93.65 137.83 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 120.99 -1.069 . . . . 0.0 109.185 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.5 p-10 -66.83 150.24 49.44 Favored 'General case' 0 CA--C 1.567 1.628 0 N-CA-C 115.19 1.552 . . . . 0.0 115.19 178.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 77.5 t -53.31 -41.23 43.01 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.291 0 N-CA-C 116.057 1.873 . . . . 0.0 116.057 -175.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.54 -49.19 78.75 Favored 'General case' 0 CA--C 1.568 1.635 0 N-CA-C 115.726 1.75 . . . . 0.0 115.726 170.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.6 tt -65.53 -41.86 92.62 Favored 'General case' 0 CA--C 1.574 1.887 0 N-CA-C 114.66 1.355 . . . . 0.0 114.66 171.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 74.8 mtp180 -46.85 -52.14 15.0 Favored 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 115.773 1.768 . . . . 0.0 115.773 164.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -65.71 -47.29 75.88 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 114.88 1.437 . . . . 0.0 114.88 171.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 61.4 mt -55.73 -57.98 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 CA-C-N 120.289 1.404 . . . . 0.0 112.766 175.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.27 -36.56 73.46 Favored 'General case' 0 CA--C 1.564 1.49 0 N-CA-C 118.409 2.744 . . . . 0.0 118.409 176.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -73.59 -30.71 63.17 Favored 'General case' 0 CA--C 1.57 1.724 0 N-CA-C 116.017 1.858 . . . . 0.0 116.017 171.051 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 73.8 mt -72.0 -33.54 68.18 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 116.001 1.852 . . . . 0.0 116.001 173.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.9 pp -78.94 150.64 32.02 Favored 'General case' 0 CA--C 1.566 1.588 0 N-CA-C 114.678 1.362 . . . . 0.0 114.678 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -109.52 94.06 15.4 Favored Pre-proline 0 CA--C 1.571 1.784 0 CA-C-O 118.286 -0.864 . . . . 0.0 108.797 176.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.473 ' HD2' ' SD ' ' A' ' 10' ' ' MET . 83.3 Cg_endo -78.44 171.07 17.45 Favored 'Trans proline' 0 CA--C 1.563 1.966 0 C-N-CA 122.806 2.337 . . . . 0.0 114.504 -178.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -116.61 127.7 54.71 Favored 'General case' 0 CA--C 1.56 1.359 0 CA-C-N 114.992 -1.003 . . . . 0.0 110.405 177.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 58.1 mttm -91.15 113.11 25.29 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.088 -1.007 . . . . 0.0 109.739 170.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -94.48 112.41 24.18 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 165.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 63.6 mt -110.86 119.35 59.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 -174.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 95.4 t -101.9 98.98 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 166.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -95.87 113.45 25.08 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 123.316 0.647 . . . . 0.0 110.028 175.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -116.2 64.59 0.7 Allowed 'General case' 0 CA--C 1.569 1.692 0 O-C-N 121.477 -0.765 . . . . 0.0 110.36 171.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 66.3 -97.95 0.35 Allowed Glycine 0 N--CA 1.487 2.07 0 N-CA-C 115.743 1.057 . . . . 0.0 115.743 -179.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -76.86 -41.84 42.43 Favored 'General case' 0 CA--C 1.565 1.541 0 N-CA-C 115.832 1.79 . . . . 0.0 115.832 169.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 13.1 t-160 -84.12 122.85 29.38 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 120.699 1.591 . . . . 0.0 111.429 175.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 8.6 ttp -137.93 131.34 30.75 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-O 122.116 0.96 . . . . 0.0 111.857 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 48.3 mt -115.24 107.84 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 73.1 mt -98.36 106.15 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 173.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 69.8 mtt180 -95.97 103.52 15.41 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.24 -0.912 . . . . 0.0 110.307 174.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 23.7 m -85.49 103.05 14.01 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 175.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.4 mt -104.5 118.32 36.32 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 124.104 0.962 . . . . 0.0 109.189 -166.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 47.1 t -118.84 161.67 19.77 Favored 'General case' 0 CA--C 1.556 1.183 0 CA-C-O 122.27 1.034 . . . . 0.0 111.181 -170.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 70.6 p -65.99 -19.76 65.97 Favored 'General case' 0 N--CA 1.5 2.025 0 N-CA-C 116.191 1.922 . . . . 0.0 116.191 161.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -78.08 -67.9 0.69 Allowed 'General case' 0 CA--C 1.569 1.679 0 CA-C-N 119.477 1.035 . . . . 0.0 112.185 169.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . 0.263 64.9 ttt180 -151.08 -117.15 0.04 OUTLIER 'General case' 0 CA--C 1.577 1.981 0 CA-C-N 120.516 1.507 . . . . 0.0 111.074 163.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 49.6 t-20 -164.48 138.44 5.27 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.178 -1.576 . . . . 0.0 109.237 -168.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 25.7 t80 -98.07 -55.4 2.79 Favored 'General case' 0 N--CA 1.5 2.054 0 N-CA-C 115.455 1.65 . . . . 0.0 115.455 -173.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.332 3.7 mp 62.02 92.7 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 -176.025 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 45.9 mmm -91.54 94.28 9.36 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.007 -1.058 . . . . 0.0 108.718 160.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.8 p30 -100.13 108.76 20.97 Favored 'General case' 0 CA--C 1.559 1.308 0 C-N-CA 123.954 0.902 . . . . 0.0 110.918 176.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 40.6 p90 -147.67 149.3 32.22 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-O 122.546 1.165 . . . . 0.0 114.029 -165.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 16.5 mm-40 -91.75 123.27 35.01 Favored 'General case' 0 CA--C 1.559 1.326 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.739 160.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 66.3 t -62.45 125.18 18.37 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.787 0 C-N-CA 124.109 0.964 . . . . 0.0 110.539 176.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 100.92 -36.66 4.03 Favored Glycine 0 CA--C 1.55 2.278 0 N-CA-C 117.075 1.59 . . . . 0.0 117.075 -167.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 84.5 mttt -81.21 129.88 34.78 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-N 119.775 1.788 . . . . 0.0 112.207 -176.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.58 ' HE2' ' NZ ' ' A' ' 98' ' ' LYS . 22.4 tt0 -88.93 103.69 16.26 Favored 'General case' 0 CA--C 1.566 1.578 0 O-C-N 121.789 -0.569 . . . . 0.0 111.668 -179.118 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -106.11 147.73 28.63 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -173.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.46 125.34 28.81 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.7 -1.25 . . . . 0.0 112.759 170.145 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -76.41 68.34 2.74 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 122.66 1.219 . . . . 0.0 113.487 174.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -81.85 104.53 12.29 Favored 'General case' 0 CA--C 1.564 1.505 0 O-C-N 120.644 -1.285 . . . . 0.0 112.258 -169.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.7 tp 69.57 49.25 0.57 Allowed 'General case' 0 N--CA 1.503 2.202 0 N-CA-C 114.586 1.328 . . . . 0.0 114.586 178.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 12.4 t -93.95 -8.13 40.96 Favored 'General case' 0 N--CA 1.5 2.073 0 N-CA-C 118.716 2.858 . . . . 0.0 118.716 -171.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 90.24 165.04 40.28 Favored Glycine 0 CA--C 1.552 2.384 0 CA-C-N 121.122 1.783 . . . . 0.0 115.811 -169.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . 0.43 1.7 mp 68.79 -87.58 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.351 0 C-N-CA 124.387 1.075 . . . . 0.0 111.294 176.4 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -78.64 -40.87 32.97 Favored 'General case' 0 CA--C 1.57 1.723 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 163.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.6 t70 58.12 58.18 3.66 Favored 'General case' 0 CA--C 1.572 1.825 0 N-CA-C 115.289 1.589 . . . . 0.0 115.289 176.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.1 ttp85 -148.26 144.35 27.59 Favored 'General case' 0 CA--C 1.565 1.545 0 C-N-CA 123.212 0.605 . . . . 0.0 110.059 -169.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 61.3 mtpt -71.28 82.14 0.75 Allowed 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -177.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 89.2 m -93.27 127.11 38.73 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 123.128 0.571 . . . . 0.0 111.378 178.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 2.7 mmt -70.83 99.19 1.69 Allowed 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 121.816 0.817 . . . . 0.0 111.123 176.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 64.7 m -114.47 111.37 21.3 Favored 'General case' 0 N--CA 1.483 1.186 0 O-C-N 121.648 -0.657 . . . . 0.0 110.541 -156.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 36.9 m -95.37 129.64 42.44 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 169.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.1 t -108.58 129.2 63.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 163.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 49.4 m -133.89 141.25 47.29 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.291 -0.88 . . . . 0.0 111.109 -175.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 42.6 m95 -78.29 107.74 11.12 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.66 -1.275 . . . . 0.0 110.859 169.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -85.61 74.92 10.2 Favored 'General case' 0 CA--C 1.568 1.645 0 O-C-N 121.362 -0.836 . . . . 0.0 109.822 168.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.95 -98.46 0.36 Allowed Glycine 0 N--CA 1.487 2.086 0 CA-C-N 116.18 -0.464 . . . . 0.0 114.133 -167.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -105.86 -4.05 21.18 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 116.378 1.992 . . . . 0.0 116.378 173.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 41.7 mtpt -103.36 124.98 49.71 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-N 120.327 1.421 . . . . 0.0 109.247 177.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 24.7 tp -84.79 107.48 16.99 Favored 'General case' 0 CA--C 1.563 1.458 0 O-C-N 120.858 -1.151 . . . . 0.0 110.493 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -96.54 131.25 43.35 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.704 0.802 . . . . 0.0 111.065 -175.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 53.8 t -122.67 136.87 55.0 Favored 'General case' 0 N--CA 1.484 1.269 0 O-C-N 121.645 -0.66 . . . . 0.0 111.693 175.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.7 p -127.08 119.46 52.94 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.637 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 171.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 19.2 mp0 -91.93 104.83 17.2 Favored 'General case' 0 CA--C 1.565 1.541 0 C-N-CA 124.001 0.921 . . . . 0.0 109.976 173.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.58 ' NZ ' ' HE2' ' A' ' 69' ' ' GLU . 94.7 mttt -91.26 131.44 36.77 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.161 -0.962 . . . . 0.0 112.442 -174.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 161.79 -98.37 0.16 Allowed Glycine 0 N--CA 1.485 1.92 0 O-C-N 121.949 -0.469 . . . . 0.0 112.854 168.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -77.41 -51.83 10.14 Favored 'General case' 0 CA--C 1.568 1.652 0 N-CA-C 115.649 1.722 . . . . 0.0 115.649 -177.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 58.3 mttm -99.31 143.03 30.04 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 122.613 1.197 . . . . 0.0 114.058 -160.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -83.95 97.33 9.19 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 122.144 0.973 . . . . 0.0 112.505 -166.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 82.31 41.48 9.23 Favored Glycine 0 N--CA 1.485 1.924 0 N-CA-C 117.443 1.737 . . . . 0.0 117.443 -168.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 64.0 ttt180 -77.25 113.01 14.56 Favored 'General case' 0 CA--C 1.566 1.594 0 CA-C-N 119.561 1.68 . . . . 0.0 110.41 164.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -169.3 177.79 42.77 Favored Glycine 0 N--CA 1.482 1.724 0 CA-C-O 122.184 0.88 . . . . 0.0 113.978 -177.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . 0.257 28.1 p-90 -152.13 158.47 42.99 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 171.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 33.5 m -129.14 118.64 22.77 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 176.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 -120.29 128.85 53.68 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 123.284 0.634 . . . . 0.0 111.79 -176.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 19.6 p90 -148.81 166.91 27.07 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.997 -1.064 . . . . 0.0 112.21 -179.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 96.2 mt -108.16 132.69 55.26 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.121 0 O-C-N 120.677 -1.264 . . . . 0.0 110.369 176.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -112.42 100.91 9.14 Favored 'General case' 0 CA--C 1.566 1.563 0 C-N-CA 123.796 0.838 . . . . 0.0 108.96 162.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 72.04 -109.51 2.85 Favored Glycine 0 N--CA 1.493 2.463 0 O-C-N 121.366 -0.833 . . . . 0.0 114.792 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -109.14 35.4 3.28 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 163.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -131.91 126.26 33.7 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.799 0.84 . . . . 0.0 109.53 -178.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 23.6 tp -88.6 118.45 28.26 Favored 'General case' 0 CA--C 1.56 1.363 0 C-N-CA 124.008 0.923 . . . . 0.0 109.954 173.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 44.8 m80 -105.47 120.83 42.6 Favored 'General case' 0 CA--C 1.56 1.328 0 C-N-CA 123.949 0.9 . . . . 0.0 108.972 -177.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 28.2 tp -119.38 123.81 45.04 Favored 'General case' 0 CA--C 1.561 1.397 0 C-N-CA 124.056 0.942 . . . . 0.0 109.798 -177.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -105.0 123.42 47.77 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.614 -0.679 . . . . 0.0 109.266 165.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 70.0 mtm -115.3 125.21 53.0 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-N 118.896 0.771 . . . . 0.0 110.659 178.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 69.3 mtp180 -112.89 144.64 42.1 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 123.169 0.588 . . . . 0.0 111.881 -178.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -156.89 129.76 7.73 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 123.079 0.551 . . . . 0.0 111.183 166.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 56.32 40.21 29.91 Favored 'General case' 0 N--CA 1.506 2.355 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 -172.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 77.47 -31.12 1.65 Allowed Glycine 0 CA--C 1.558 2.744 0 N-CA-C 119.536 2.575 . . . . 0.0 119.536 -160.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 90.0 t -77.87 123.39 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 CA-C-N 119.15 1.475 . . . . 0.0 111.114 -162.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 34.2 m -104.99 118.11 35.69 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 123.064 0.546 . . . . 0.0 111.629 -171.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 18.1 t -92.22 141.86 28.11 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.495 0.718 . . . . 0.0 112.006 163.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -117.75 118.16 31.3 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 123.348 0.659 . . . . 0.0 110.006 178.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 71.1 mt-30 -119.09 140.98 49.19 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 123.804 0.841 . . . . 0.0 111.695 179.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 25.0 t -128.46 132.56 67.91 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 177.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -126.64 139.86 52.85 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 123.584 0.754 . . . . 0.0 111.425 179.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 22.3 ttmt -99.49 139.73 34.71 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.881 -1.137 . . . . 0.0 112.67 178.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 73.7 tttt -73.66 118.83 17.08 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 178.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 34.2 m -103.03 -43.08 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 173.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 55.5 t-80 . . . . . 0 N--CA 1.484 1.266 0 CA-C-N 119.491 1.041 . . . . 0.0 108.259 168.079 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 26.7 ptt? . . . . . 0 CA--C 1.575 1.936 0 N-CA-C 113.7 1.0 . . . . 0.0 113.7 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -80.72 -137.97 0.02 OUTLIER 'Trans proline' 0 CA--C 1.575 2.571 0 C-N-CA 122.355 2.037 . . . . 0.0 114.039 173.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 22.9 t -131.27 139.14 51.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 -175.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -76.89 107.53 9.29 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.641 -1.287 . . . . 0.0 110.76 163.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 15.9 m-30 -80.98 14.79 2.08 Favored 'General case' 0 CA--C 1.582 2.207 0 N-CA-C 115.905 1.817 . . . . 0.0 115.905 173.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -62.68 111.99 2.32 Favored 'General case' 0 CA--C 1.563 1.474 0 C-N-CA 125.667 1.587 . . . . 0.0 115.136 -172.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 161.09 -178.17 37.15 Favored Glycine 0 N--CA 1.486 1.984 0 N-CA-C 116.026 1.17 . . . . 0.0 116.026 178.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -106.29 123.64 48.37 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-N 114.917 -0.642 . . . . 0.0 109.468 174.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 80.6 m95 -121.55 122.08 38.9 Favored 'General case' 0 CA--C 1.561 1.391 0 C-N-CA 123.481 0.712 . . . . 0.0 109.329 -169.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -96.47 140.87 30.48 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.313 -0.867 . . . . 0.0 112.711 176.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 41.9 ttm -69.47 124.23 23.35 Favored 'General case' 0 CA--C 1.569 1.705 0 O-C-N 120.94 -1.1 . . . . 0.0 113.129 176.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 91.9 mt -82.68 -50.29 8.88 Favored 'General case' 0 CA--C 1.564 1.486 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 165.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.415 ' CB ' ' HE2' ' A' ' 14' ' ' GLU . 87.3 p -151.75 154.53 36.46 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 119.285 0.948 . . . . 0.0 113.274 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -127.37 105.6 8.63 Favored 'General case' 0 CA--C 1.568 1.673 0 C-N-CA 123.64 0.776 . . . . 0.0 110.632 174.354 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.415 ' HE2' ' CB ' ' A' ' 12' ' ' SER . 3.7 mp0 -96.19 129.78 43.41 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 124.608 1.163 . . . . 0.0 109.965 -174.429 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 34.3 t30 62.39 18.31 10.19 Favored 'General case' 0 N--CA 1.506 2.368 0 N-CA-C 117.048 2.24 . . . . 0.0 117.048 -179.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -65.59 -42.1 92.08 Favored 'General case' 0 CA--C 1.566 1.583 0 N-CA-C 115.832 1.79 . . . . 0.0 115.832 -178.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -58.37 -39.06 78.58 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 116.243 1.942 . . . . 0.0 116.243 168.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -66.19 -45.78 79.62 Favored 'General case' 0 CA--C 1.571 1.78 0 N-CA-C 114.849 1.426 . . . . 0.0 114.849 170.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -52.82 -48.82 66.7 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 115.121 1.526 . . . . 0.0 115.121 165.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 64.5 mt -62.46 -40.73 97.6 Favored 'General case' 0 CA--C 1.57 1.745 0 N-CA-C 114.746 1.387 . . . . 0.0 114.746 171.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 65.1 ttp85 -55.56 -46.68 77.14 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 115.229 1.566 . . . . 0.0 115.229 164.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.1 -18.85 39.09 Favored 'General case' 0 CA--C 1.569 1.681 0 N-CA-C 118.29 2.7 . . . . 0.0 118.29 164.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 92.3 mt -91.83 15.31 13.23 Favored 'General case' 0 CA--C 1.574 1.898 0 N-CA-C 115.265 1.58 . . . . 0.0 115.265 163.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.259 49.7 m-20 66.72 39.86 3.43 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 115.887 1.81 . . . . 0.0 115.887 -177.523 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 65.6 t -99.61 140.9 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 120.815 -1.178 . . . . 0.0 110.489 -177.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 8.3 p-10 -71.33 156.52 39.41 Favored 'General case' 0 CA--C 1.569 1.679 0 N-CA-C 115.265 1.579 . . . . 0.0 115.265 174.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 61.9 t -53.14 -44.95 53.38 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.373 0 N-CA-C 115.27 1.581 . . . . 0.0 115.27 -177.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.57 -49.2 78.49 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 116.101 1.889 . . . . 0.0 116.101 174.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 31.9 tp -65.8 -36.67 84.16 Favored 'General case' 0 CA--C 1.573 1.842 0 N-CA-C 115.777 1.769 . . . . 0.0 115.777 171.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 55.1 mtp180 -51.36 -52.55 44.67 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 115.394 1.627 . . . . 0.0 115.394 160.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -63.13 -43.29 98.78 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 115.679 1.733 . . . . 0.0 115.679 172.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 59.3 mt -55.76 -55.31 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.192 0 CA-C-N 120.276 1.398 . . . . 0.0 112.72 170.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.86 -43.53 94.62 Favored 'General case' 0 CA--C 1.566 1.573 0 N-CA-C 117.294 2.331 . . . . 0.0 117.294 173.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -53.91 -39.97 66.27 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 117.471 2.397 . . . . 0.0 117.471 167.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 80.7 mt -86.27 -13.21 47.39 Favored 'General case' 0 CA--C 1.572 1.815 0 N-CA-C 116.103 1.89 . . . . 0.0 116.103 175.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 37.9 mt -80.07 133.12 36.08 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-N 119.949 1.25 . . . . 0.0 111.314 169.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 29.1 mmtp -101.31 93.04 2.94 Favored Pre-proline 0 CA--C 1.571 1.755 0 CA-C-O 118.045 -0.978 . . . . 0.0 109.705 171.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -72.41 154.3 55.78 Favored 'Trans proline' 0 CA--C 1.563 1.943 0 CA-C-N 122.852 2.054 . . . . 0.0 114.739 177.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -112.3 127.5 56.0 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.685 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 45.8 mttp -95.42 110.06 22.15 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.508 -0.745 . . . . 0.0 109.854 177.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -95.48 104.77 16.68 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.379 -0.826 . . . . 0.0 108.825 166.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 76.0 mt -98.55 118.29 44.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 -173.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 83.4 t -109.86 95.86 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 107.289 -1.375 . . . . 0.0 107.289 176.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -96.34 114.0 25.64 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 123.567 0.747 . . . . 0.0 111.084 177.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -132.16 93.27 3.24 Favored 'General case' 0 CA--C 1.566 1.577 0 C-N-CA 123.401 0.68 . . . . 0.0 110.004 -178.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 53.67 63.68 4.89 Favored Glycine 0 N--CA 1.497 2.756 0 N-CA-C 118.569 2.188 . . . . 0.0 118.569 172.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.471 0.0 OUTLIER 76.71 -34.56 0.22 Allowed 'General case' 0 N--CA 1.501 2.077 0 N-CA-C 117.317 2.34 . . . . 0.0 117.317 -164.423 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 9.4 t-160 -82.4 108.97 16.23 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 120.923 1.692 . . . . 0.0 110.898 178.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 6.5 ttp -121.25 125.1 46.26 Favored 'General case' 0 CA--C 1.556 1.194 0 CA-C-O 122.147 0.975 . . . . 0.0 110.888 -176.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 4.4 mp -110.1 104.43 17.06 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.353 0 N-CA-C 106.53 -1.656 . . . . 0.0 106.53 -178.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 80.0 mt -89.33 96.09 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 174.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 93.1 mtt180 -84.9 97.27 9.67 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.656 -0.652 . . . . 0.0 110.038 -178.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 51.0 m -89.78 101.39 14.08 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.761 0.791 . . . . 0.0 109.312 -178.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 16.1 mt -102.94 120.93 41.5 Favored 'General case' 0 N--CA 1.485 1.312 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.033 -164.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 10.3 t -136.7 146.53 45.98 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.684 -0.635 . . . . 0.0 111.629 -178.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . 0.253 13.7 t -77.73 56.19 1.46 Allowed 'General case' 0 N--CA 1.503 2.181 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 172.179 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -168.81 -67.82 0.02 OUTLIER 'General case' 0 CA--C 1.567 1.623 0 C-N-CA 125.274 1.429 . . . . 0.0 108.517 -177.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 62.9 ttt-85 -136.67 124.75 22.93 Favored 'General case' 0 CA--C 1.565 1.521 0 CA-C-N 118.754 0.706 . . . . 0.0 109.517 172.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 44.1 t-20 -85.26 130.59 34.57 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.78 -0.575 . . . . 0.0 111.038 170.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -95.96 -75.02 0.54 Allowed 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 118.899 -0.572 . . . . 0.0 112.338 -175.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.331 38.5 mt 74.62 108.75 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 C-N-CA 124.261 1.025 . . . . 0.0 111.9 178.28 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 86.9 mtp -104.95 99.22 8.85 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.478 -0.764 . . . . 0.0 109.491 170.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.7 p30 -96.97 108.54 21.28 Favored 'General case' 0 CA--C 1.56 1.365 0 C-N-CA 124.064 0.946 . . . . 0.0 111.935 176.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 35.2 p90 -148.68 151.91 35.75 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-N 119.029 0.831 . . . . 0.0 113.103 -168.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 54.6 mt-30 -89.86 135.23 33.76 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.289 -0.882 . . . . 0.0 110.796 161.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 41.0 t -69.56 109.54 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.28 -0.888 . . . . 0.0 109.305 179.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 128.27 -50.49 0.89 Allowed Glycine 0 CA--C 1.548 2.122 0 CA-C-O 118.542 -1.143 . . . . 0.0 115.904 -162.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 15.3 ptpt -70.41 139.22 51.79 Favored 'General case' 0 CA--C 1.566 1.578 0 CA-C-N 119.8 1.8 . . . . 0.0 115.231 -173.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -97.71 97.42 9.0 Favored 'General case' 0 CA--C 1.566 1.578 0 C-N-CA 123.116 0.566 . . . . 0.0 110.135 175.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -103.92 130.67 51.55 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 -170.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -69.21 111.75 5.35 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.671 -1.268 . . . . 0.0 113.524 175.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -81.88 92.83 6.77 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.22 -0.925 . . . . 0.0 110.683 -177.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.2 p30 -120.06 114.52 22.11 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 123.632 0.773 . . . . 0.0 111.702 -172.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . 0.291 12.0 tp 62.55 51.78 3.12 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 115.098 1.518 . . . . 0.0 115.098 -172.434 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 97.1 m -162.59 100.67 1.04 Allowed 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 106.139 -1.8 . . . . 0.0 106.139 177.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 122.36 -146.71 16.87 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 115.258 0.863 . . . . 0.0 115.258 177.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . 0.251 5.2 mp -108.83 -87.01 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 -175.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -85.08 65.63 9.33 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 120.266 1.394 . . . . 0.0 111.147 171.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.265 2.4 p30 -78.45 -70.79 0.47 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.38 -0.825 . . . . 0.0 112.523 -172.075 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . 0.252 6.6 tpm_? 53.27 36.95 24.04 Favored 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 118.635 2.828 . . . . 0.0 118.635 160.264 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . 0.261 99.6 mttt 60.44 40.23 17.49 Favored 'General case' 0 N--CA 1.501 2.099 0 N-CA-C 115.84 1.793 . . . . 0.0 115.84 -171.625 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 95.3 m -78.98 116.21 19.15 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.441 -1.412 . . . . 0.0 111.383 178.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 23.6 mtp -76.3 100.06 4.99 Favored 'General case' 0 CA--C 1.557 1.25 0 CA-C-O 122.434 1.111 . . . . 0.0 110.622 -170.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 88.5 m -103.23 112.89 25.97 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.329 -158.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 87.1 m -99.7 125.71 45.61 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 174.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 16.9 t -111.6 123.0 67.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 171.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 71.1 m -138.87 148.78 44.1 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.247 -0.908 . . . . 0.0 112.348 -175.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 10.9 m95 -82.79 122.76 28.61 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.68 -1.263 . . . . 0.0 113.694 -179.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -107.57 71.0 0.8 Allowed 'General case' 0 CA--C 1.572 1.815 0 C-N-CA 123.481 0.712 . . . . 0.0 109.737 160.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.24 -103.15 0.75 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 115.669 1.028 . . . . 0.0 115.669 -179.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.491 ' N ' ' HD2' ' A' ' 91' ' ' ASP . 1.1 m-20 -80.4 -25.17 39.22 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 116.322 1.971 . . . . 0.0 116.322 165.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -90.62 110.31 21.46 Favored 'General case' 0 N--CA 1.484 1.269 0 CA-C-N 119.861 1.21 . . . . 0.0 111.261 -179.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 32.7 tp -77.93 111.5 13.85 Favored 'General case' 0 CA--C 1.564 1.516 0 O-C-N 121.354 -0.841 . . . . 0.0 109.671 168.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 31.5 mm-40 -100.39 119.44 38.45 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.567 0.747 . . . . 0.0 110.862 -170.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 40.8 t -111.97 128.93 56.31 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.283 0.633 . . . . 0.0 111.068 175.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.1 p -126.83 121.04 57.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 CA-C-O 121.331 0.586 . . . . 0.0 109.845 174.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -100.79 98.8 9.28 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 124.018 0.927 . . . . 0.0 109.777 -174.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 55.4 mttp -90.84 118.06 29.95 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.337 -0.852 . . . . 0.0 112.238 -167.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 178.68 -118.95 0.63 Allowed Glycine 0 N--CA 1.486 2.008 0 O-C-N 121.137 -0.977 . . . . 0.0 113.624 172.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -75.74 -46.84 28.75 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 115.998 1.851 . . . . 0.0 115.998 -174.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 1.7 ttmp? -91.02 130.77 36.9 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 119.173 0.897 . . . . 0.0 112.081 -176.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -74.52 145.08 43.78 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -176.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 62.38 23.29 64.38 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 120.154 2.822 . . . . 0.0 120.154 -178.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 10.5 ttt85 -83.25 120.51 25.92 Favored 'General case' 0 CA--C 1.563 1.444 0 CA-C-N 119.165 1.483 . . . . 0.0 111.615 -179.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 172.99 -165.1 37.31 Favored Glycine 0 N--CA 1.484 1.865 0 CA-C-O 121.921 0.734 . . . . 0.0 114.605 -179.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 49.9 p-90 -157.14 158.09 35.69 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 114.341 1.237 . . . . 0.0 114.341 176.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 62.9 m -127.03 119.12 25.86 Favored 'General case' 0 CA--C 1.567 1.616 0 C-N-CA 124.117 0.967 . . . . 0.0 108.465 174.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -120.89 127.34 51.78 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.795 -0.566 . . . . 0.0 112.296 -175.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 23.6 p90 -142.76 169.75 16.99 Favored 'General case' 0 N--CA 1.499 1.977 0 C-N-CA 123.763 0.825 . . . . 0.0 112.978 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 94.5 mt -113.42 146.11 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.285 0 CA-C-O 123.145 1.45 . . . . 0.0 111.322 176.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -137.37 90.05 2.48 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 177.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 73.39 -119.35 6.59 Favored Glycine 0 N--CA 1.491 2.305 0 O-C-N 121.867 -0.521 . . . . 0.0 114.258 -172.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -91.16 11.44 23.26 Favored 'General case' 0 N--CA 1.5 2.045 0 N-CA-C 116.742 2.127 . . . . 0.0 116.742 165.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 75.8 mt-10 -111.29 138.29 47.95 Favored 'General case' 0 CA--C 1.56 1.34 0 CA-C-N 119.78 1.173 . . . . 0.0 111.999 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 10.4 tp -98.03 125.96 43.23 Favored 'General case' 0 CA--C 1.563 1.454 0 C-N-CA 123.902 0.881 . . . . 0.0 109.148 170.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 45.4 m80 -113.22 123.08 49.35 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.713 0.805 . . . . 0.0 109.126 -175.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 32.4 tp -122.59 122.26 38.43 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.596 0.758 . . . . 0.0 110.218 -174.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -100.51 117.15 34.06 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.715 -0.615 . . . . 0.0 109.589 164.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 74.3 mtm -105.09 125.93 51.52 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-N 118.782 0.719 . . . . 0.0 110.493 175.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 49.0 mtp180 -114.22 140.13 48.82 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.604 -0.685 . . . . 0.0 111.459 -174.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -151.51 126.75 9.91 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.787 -0.571 . . . . 0.0 110.616 167.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 61.72 28.92 17.87 Favored 'General case' 0 N--CA 1.504 2.232 0 N-CA-C 115.375 1.62 . . . . 0.0 115.375 -172.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 82.4 -27.6 3.62 Favored Glycine 0 CA--C 1.558 2.73 0 N-CA-C 118.693 2.237 . . . . 0.0 118.693 -158.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 96.4 t -73.8 119.38 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 CA-C-N 119.221 1.511 . . . . 0.0 110.416 -169.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 59.4 m -106.35 120.74 42.66 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.182 -169.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 6.6 t -97.31 122.8 40.75 Favored 'General case' 0 CA--C 1.558 1.28 0 C-N-CA 124.082 0.953 . . . . 0.0 111.528 170.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 85.6 mttt -96.19 119.62 35.02 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.824 -0.548 . . . . 0.0 110.059 176.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 18.2 mt-30 -119.68 123.4 43.73 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.706 -0.621 . . . . 0.0 110.686 -179.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 47.5 t -105.03 131.78 53.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 -177.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -126.17 149.08 49.24 Favored 'General case' 0 CA--C 1.563 1.455 0 C-N-CA 124.515 1.126 . . . . 0.0 110.511 -178.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 22.2 ttmt -118.62 141.0 49.01 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.94 -1.1 . . . . 0.0 112.002 175.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 61.6 tttt -74.87 126.43 30.93 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 179.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 33.3 m -107.09 -40.7 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 174.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 33.9 m170 . . . . . 0 C--O 1.255 1.354 0 CA-C-N 120.138 1.336 . . . . 0.0 108.784 -177.751 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.576 1.978 0 N-CA-C 113.834 1.05 . . . . 0.0 113.834 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -78.15 -122.12 0.01 OUTLIER 'Trans proline' 0 CA--C 1.575 2.531 0 C-N-CA 122.612 2.208 . . . . 0.0 114.634 -178.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 18.1 m -144.95 153.64 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 120.595 -1.316 . . . . 0.0 110.393 -171.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -73.3 98.64 2.72 Favored 'General case' 0 CA--C 1.569 1.679 0 O-C-N 121.1 -1.0 . . . . 0.0 112.362 174.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 7.4 m-30 -78.95 -9.55 59.55 Favored 'General case' 0 CA--C 1.577 2.012 0 N-CA-C 115.471 1.656 . . . . 0.0 115.471 161.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -57.9 116.36 3.43 Favored 'General case' 0 CA--C 1.564 1.485 0 CA-C-N 120.837 1.653 . . . . 0.0 114.713 -176.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 152.62 -177.59 30.26 Favored Glycine 0 N--CA 1.486 2.028 0 CA-C-O 122.54 1.078 . . . . 0.0 115.711 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -105.42 123.35 47.72 Favored 'General case' 0 CA--C 1.562 1.434 0 CA-C-N 114.638 -0.781 . . . . 0.0 109.514 178.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 72.2 m95 -122.81 126.02 46.59 Favored 'General case' 0 CA--C 1.567 1.605 0 C-N-CA 123.364 0.666 . . . . 0.0 110.004 -170.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 62.2 pttt -95.06 140.16 30.4 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.244 -0.91 . . . . 0.0 113.167 177.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 50.4 ttm -69.73 129.69 40.29 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.638 -1.289 . . . . 0.0 113.626 174.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 87.4 mt -94.4 -58.27 2.25 Favored 'General case' 0 CA--C 1.567 1.611 0 CA-C-N 115.584 -0.735 . . . . 0.0 112.65 170.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 94.2 p -139.48 130.02 25.73 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 119.632 1.106 . . . . 0.0 113.431 -165.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -102.41 81.45 2.06 Favored 'General case' 0 CA--C 1.568 1.671 0 C-N-CA 123.871 0.868 . . . . 0.0 110.277 176.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -93.93 114.61 26.86 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.656 -1.278 . . . . 0.0 111.013 -170.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.272 22.2 t30 63.15 27.09 15.56 Favored 'General case' 0 N--CA 1.506 2.355 0 N-CA-C 116.801 2.148 . . . . 0.0 116.801 -171.138 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -69.94 -49.18 54.43 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 115.18 1.548 . . . . 0.0 115.18 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 90.0 mt-10 -61.35 -35.52 77.66 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 116.506 2.039 . . . . 0.0 116.506 174.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -63.69 -42.99 97.93 Favored 'General case' 0 CA--C 1.576 1.948 0 N-CA-C 115.187 1.551 . . . . 0.0 115.187 167.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 28.2 t80 -56.31 -50.68 70.74 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 115.041 1.496 . . . . 0.0 115.041 165.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.2 mt -61.3 -40.67 95.02 Favored 'General case' 0 CA--C 1.573 1.834 0 N-CA-C 115.191 1.552 . . . . 0.0 115.191 173.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 41.9 ttp85 -51.15 -50.66 58.49 Favored 'General case' 0 CA--C 1.575 1.904 0 N-CA-C 115.086 1.513 . . . . 0.0 115.086 162.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.74 -19.3 58.65 Favored 'General case' 0 CA--C 1.573 1.83 0 N-CA-C 118.462 2.764 . . . . 0.0 118.462 168.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 43.7 mt -86.51 2.08 49.24 Favored 'General case' 0 CA--C 1.572 1.79 0 N-CA-C 116.12 1.896 . . . . 0.0 116.12 165.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 61.04 46.66 8.05 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 115.126 1.528 . . . . 0.0 115.126 -169.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 99.0 t -93.95 135.04 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.403 -0.81 . . . . 0.0 108.838 176.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.0 p-10 -67.91 147.55 52.33 Favored 'General case' 0 CA--C 1.566 1.584 0 N-CA-C 115.504 1.668 . . . . 0.0 115.504 179.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 25.3 t -49.32 -44.98 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.327 0 N-CA-C 115.796 1.776 . . . . 0.0 115.796 -174.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.99 -46.19 88.75 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 116.3 1.963 . . . . 0.0 116.3 173.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.62 -43.69 96.12 Favored 'General case' 0 CA--C 1.572 1.794 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 168.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 27.5 mtm-85 -53.37 -41.1 65.53 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 116.516 2.043 . . . . 0.0 116.516 167.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -68.6 -54.9 13.63 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 168.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 63.1 mt -54.47 -51.62 47.88 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.303 0 CA-C-N 120.435 1.47 . . . . 0.0 113.841 178.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.78 -38.66 91.95 Favored 'General case' 0 CA--C 1.562 1.435 0 N-CA-C 117.642 2.46 . . . . 0.0 117.642 175.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 16.4 t30 -72.44 -30.33 64.49 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 116.395 1.998 . . . . 0.0 116.395 170.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 83.4 mt -75.05 -32.85 61.64 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 115.331 1.604 . . . . 0.0 115.331 172.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 93.6 mt -81.35 142.2 33.27 Favored 'General case' 0 CA--C 1.564 1.505 0 CA-C-N 119.384 0.993 . . . . 0.0 112.139 174.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -106.94 84.89 1.7 Allowed Pre-proline 0 CA--C 1.575 1.917 0 CA-C-O 118.248 -0.882 . . . . 0.0 109.947 175.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -72.94 166.27 30.5 Favored 'Trans proline' 0 CA--C 1.563 1.965 0 C-N-CA 122.537 2.158 . . . . 0.0 116.028 -178.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -111.25 138.83 47.21 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.214 -177.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 58.6 mttm -104.88 111.65 24.48 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.399 -0.813 . . . . 0.0 109.376 173.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 54.9 tt0 -98.74 102.87 14.74 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 171.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 61.3 mt -97.67 123.68 50.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.513 -0.742 . . . . 0.0 109.202 -169.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 88.4 t -102.48 101.93 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 166.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -104.2 108.19 19.45 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 123.706 0.803 . . . . 0.0 110.358 -179.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -112.56 72.32 0.77 Allowed 'General case' 0 CA--C 1.567 1.634 0 O-C-N 121.683 -0.636 . . . . 0.0 110.634 175.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 68.48 -95.65 0.39 Allowed Glycine 0 N--CA 1.489 2.21 0 N-CA-C 115.014 0.766 . . . . 0.0 115.014 -179.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -86.67 -37.09 18.34 Favored 'General case' 0 CA--C 1.566 1.574 0 N-CA-C 115.743 1.757 . . . . 0.0 115.743 166.077 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 20.8 t-160 -80.66 113.66 19.01 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 121.099 1.772 . . . . 0.0 111.463 -178.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 46.6 ttm -130.5 123.19 29.12 Favored 'General case' 0 CA--C 1.555 1.165 0 CA-C-O 121.386 0.612 . . . . 0.0 110.074 -169.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 54.5 mt -115.86 101.22 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 87.9 mt -89.79 90.67 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -77.59 99.01 5.59 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.303 -0.873 . . . . 0.0 110.715 -173.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 29.4 m -97.13 105.64 17.83 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-O 121.803 0.811 . . . . 0.0 109.016 -169.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 22.2 mt -109.49 117.17 33.3 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.991 0.917 . . . . 0.0 110.072 -159.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 19.2 t -133.87 146.55 50.69 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 123.154 0.582 . . . . 0.0 111.976 -174.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 43.5 p -79.92 61.66 3.89 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.122 -0.986 . . . . 0.0 112.631 172.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -169.95 -70.79 0.02 OUTLIER 'General case' 0 CA--C 1.569 1.693 0 C-N-CA 125.648 1.579 . . . . 0.0 107.513 178.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 32.1 mtt180 -139.8 131.5 27.35 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 123.803 0.841 . . . . 0.0 109.648 171.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -85.4 129.14 34.88 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.039 0.447 . . . . 0.0 111.027 176.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -91.35 -77.4 0.42 Allowed 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 123.146 0.579 . . . . 0.0 111.972 -172.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.36 14.9 mt 79.46 108.35 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 C-N-CA 124.216 1.006 . . . . 0.0 110.986 -179.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.76 95.74 6.85 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 123.513 0.725 . . . . 0.0 109.729 177.064 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -101.53 116.34 32.55 Favored 'General case' 0 CA--C 1.564 1.515 0 C-N-CA 124.228 1.011 . . . . 0.0 112.321 -175.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -157.91 156.44 31.33 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 115.07 1.507 . . . . 0.0 115.07 -171.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -104.23 119.24 38.52 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 123.474 0.709 . . . . 0.0 109.857 167.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 54.0 t -61.98 128.9 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 C-N-CA 123.936 0.894 . . . . 0.0 111.674 -178.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 99.74 -37.13 3.67 Favored Glycine 0 CA--C 1.55 2.279 0 N-CA-C 116.704 1.442 . . . . 0.0 116.704 -163.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 77.7 mttt -89.43 129.83 35.88 Favored 'General case' 0 CA--C 1.565 1.539 0 CA-C-N 118.88 1.34 . . . . 0.0 111.746 -172.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.617 ' HE2' ' NZ ' ' A' ' 98' ' ' LYS . 26.5 tt0 -81.84 106.61 13.9 Favored 'General case' 0 CA--C 1.567 1.615 0 O-C-N 121.321 -0.862 . . . . 0.0 111.771 178.119 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -109.88 148.89 30.72 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 123.856 0.862 . . . . 0.0 112.006 -175.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.62 124.09 23.04 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.2 -1.562 . . . . 0.0 111.73 168.15 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -74.13 89.9 2.01 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-N 119.137 0.88 . . . . 0.0 111.612 -174.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -86.3 166.37 15.7 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 117.708 2.485 . . . . 0.0 117.708 -139.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . 0.338 2.9 tt 74.79 -76.54 0.06 Allowed 'General case' 0 N--CA 1.499 1.994 0 C-N-CA 124.87 1.268 . . . . 0.0 112.135 -176.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 39.0 p -128.18 -47.33 1.34 Allowed 'General case' 0 N--CA 1.5 2.036 0 C-N-CA 124.345 1.058 . . . . 0.0 111.565 168.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 101.4 -127.12 9.13 Favored Glycine 0 CA--C 1.54 1.626 0 C-N-CA 123.695 0.664 . . . . 0.0 111.467 -177.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 54.1 mt -84.6 -59.74 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 CA-C-O 119.15 -0.452 . . . . 0.0 110.449 172.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . 0.252 26.5 t70 -100.21 -91.9 0.29 Allowed 'General case' 0 CA--C 1.568 1.652 0 CA-C-O 118.052 -0.975 . . . . 0.0 109.453 172.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -154.2 71.29 0.84 Allowed 'General case' 0 N--CA 1.498 1.964 0 CA-C-N 121.118 1.781 . . . . 0.0 112.399 178.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.14 134.2 3.44 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.226 -0.921 . . . . 0.0 110.46 174.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 72.1 mttt -85.66 93.25 8.79 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.38 -0.825 . . . . 0.0 111.155 -176.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 74.1 m -92.47 135.21 34.24 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 -167.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 1.1 mmt -70.55 98.18 1.43 Allowed 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 122.216 1.008 . . . . 0.0 111.697 -176.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 95.5 m -112.36 114.53 27.31 Favored 'General case' 0 N--CA 1.481 1.115 0 O-C-N 121.51 -0.744 . . . . 0.0 110.452 -157.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 63.0 m -92.79 124.47 36.81 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 168.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.7 t -112.3 130.33 66.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 169.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 74.9 m -134.79 140.34 45.81 Favored 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 123.791 0.836 . . . . 0.0 111.989 -173.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 8.4 m95 -80.98 116.35 20.9 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.457 -1.402 . . . . 0.0 112.874 177.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 38.8 t0 -103.66 67.18 0.89 Allowed 'General case' 0 CA--C 1.576 1.95 0 C-N-CA 124.063 0.945 . . . . 0.0 110.189 164.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 68.08 -105.82 1.53 Allowed Glycine 0 N--CA 1.492 2.418 0 N-CA-C 115.641 1.016 . . . . 0.0 115.641 -179.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -72.87 -30.25 63.83 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 115.123 1.527 . . . . 0.0 115.123 163.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 24.0 mttt -92.78 110.59 22.03 Favored 'General case' 0 CA--C 1.557 1.221 0 CA-C-N 119.443 1.019 . . . . 0.0 111.62 -171.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 29.0 tp -82.07 105.57 13.28 Favored 'General case' 0 CA--C 1.563 1.479 0 O-C-N 120.47 -1.394 . . . . 0.0 110.164 171.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 11.2 mm100 -87.42 145.89 26.1 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 124.51 1.124 . . . . 0.0 110.721 -174.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 42.9 t -143.63 133.47 23.93 Favored 'General case' 0 N--CA 1.484 1.25 0 O-C-N 121.541 -0.724 . . . . 0.0 112.421 178.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.2 p -118.33 123.8 72.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 165.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -104.46 97.09 7.06 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 123.626 0.77 . . . . 0.0 109.427 -178.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.617 ' NZ ' ' HE2' ' A' ' 69' ' ' GLU . 92.5 mttt -83.42 111.43 19.03 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.761 -1.212 . . . . 0.0 111.425 -170.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 162.56 103.98 0.18 Allowed Glycine 0 N--CA 1.483 1.798 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.898 -172.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . 0.282 42.3 mt-10 69.61 -68.47 0.19 Allowed 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 116.142 1.904 . . . . 0.0 116.142 174.027 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -82.08 129.89 34.93 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 122.153 0.978 . . . . 0.0 111.242 -170.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -67.78 -45.97 73.3 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 116.096 1.887 . . . . 0.0 116.096 -162.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -101.68 54.52 0.78 Allowed Glycine 0 N--CA 1.49 2.286 0 CA-C-O 118.63 -1.095 . . . . 0.0 115.727 164.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.9 ttt-85 -85.25 116.88 23.85 Favored 'General case' 0 CA--C 1.565 1.543 0 CA-C-N 118.844 1.322 . . . . 0.0 112.062 -179.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 178.7 -173.24 45.58 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 115.139 0.816 . . . . 0.0 115.139 -174.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . 0.279 49.6 p-90 -155.48 167.89 28.92 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 123.338 1.542 . . . . 0.0 113.918 174.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 96.0 m -144.93 114.14 7.01 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.147 -1.596 . . . . 0.0 107.81 174.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 45.6 tt0 -114.67 127.56 55.83 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 123.566 0.746 . . . . 0.0 111.444 -173.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 9.6 p90 -148.34 154.85 40.54 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.706 -1.246 . . . . 0.0 113.679 -174.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 94.8 mt -98.84 133.98 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 O-C-N 120.793 -1.192 . . . . 0.0 110.823 176.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -120.09 91.79 3.62 Favored 'General case' 0 CA--C 1.567 1.618 0 C-N-CA 124.291 1.036 . . . . 0.0 108.387 162.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 69.36 -113.17 4.96 Favored Glycine 0 N--CA 1.492 2.402 0 O-C-N 121.238 -0.914 . . . . 0.0 114.927 -177.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -84.54 -8.75 58.81 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 117.423 2.379 . . . . 0.0 117.423 167.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 62.1 mt-10 -99.95 126.56 46.13 Favored 'General case' 0 CA--C 1.56 1.363 0 CA-C-N 120.549 1.522 . . . . 0.0 111.292 -176.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 21.2 tp -89.22 115.5 26.77 Favored 'General case' 0 CA--C 1.563 1.448 0 C-N-CA 124.224 1.01 . . . . 0.0 109.122 164.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 48.7 m80 -101.83 119.09 38.23 Favored 'General case' 0 CA--C 1.556 1.207 0 C-N-CA 123.979 0.911 . . . . 0.0 108.857 -178.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 42.7 tp -113.31 114.76 27.12 Favored 'General case' 0 CA--C 1.557 1.228 0 C-N-CA 123.677 0.791 . . . . 0.0 109.642 179.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -90.04 126.88 35.92 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.906 -0.496 . . . . 0.0 109.74 163.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 75.5 mtm -119.99 127.79 52.94 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-N 118.658 0.663 . . . . 0.0 110.297 176.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 88.0 mtm-85 -114.82 141.26 48.13 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 123.429 0.692 . . . . 0.0 111.326 -174.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -150.29 131.05 14.09 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.676 -0.64 . . . . 0.0 110.931 163.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 54.79 34.4 21.79 Favored 'General case' 0 N--CA 1.507 2.415 0 N-CA-C 116.169 1.914 . . . . 0.0 116.169 -172.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 76.43 -1.29 61.56 Favored Glycine 0 CA--C 1.557 2.709 0 N-CA-C 120.173 2.829 . . . . 0.0 120.173 -165.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 89.6 t -98.7 120.09 47.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 CA-C-N 120.453 2.126 . . . . 0.0 109.49 -173.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 30.7 m -102.88 120.9 41.44 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 123.243 0.617 . . . . 0.0 111.357 -172.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 33.5 t -92.32 140.34 29.7 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 123.384 0.674 . . . . 0.0 112.041 161.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 33.9 mtpt -104.24 114.94 29.53 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.6 -0.688 . . . . 0.0 110.564 164.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -104.48 124.27 48.97 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.334 0.654 . . . . 0.0 110.291 168.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 62.7 t -109.93 132.79 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -127.23 134.96 50.03 Favored 'General case' 0 CA--C 1.561 1.398 0 C-N-CA 124.104 0.962 . . . . 0.0 110.823 -177.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -103.57 137.38 41.72 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.837 -1.165 . . . . 0.0 112.493 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 71.4 tttt -71.35 125.79 27.93 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 177.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 27.7 m -116.24 -40.17 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.128 0 N-CA-C 114.058 1.133 . . . . 0.0 114.058 177.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 50.5 t60 . . . . . 0 N--CA 1.487 1.395 0 CA-C-N 120.47 1.487 . . . . 0.0 108.53 175.229 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 CA--C 1.571 1.781 0 CA-C-O 118.201 -0.904 . . . . 0.0 109.671 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -79.93 105.86 1.86 Allowed 'Trans proline' 0 C--N 1.371 1.727 0 C-N-CA 122.395 2.063 . . . . 0.0 113.919 -177.005 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 27.6 m -78.38 155.16 5.06 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.687 0 CA-C-N 114.71 -1.132 . . . . 0.0 113.262 -174.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -68.93 100.93 1.27 Allowed 'General case' 0 CA--C 1.563 1.453 0 O-C-N 120.93 -1.106 . . . . 0.0 113.93 176.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 4.5 m-30 -70.61 -1.5 11.36 Favored 'General case' 0 CA--C 1.581 2.161 0 N-CA-C 116.871 2.175 . . . . 0.0 116.871 177.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -45.05 111.03 0.28 Allowed 'General case' 0 CA--C 1.566 1.569 0 N-CA-C 116.122 1.897 . . . . 0.0 116.122 173.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 165.96 175.85 36.76 Favored Glycine 0 N--CA 1.484 1.848 0 N-CA-C 116.313 1.285 . . . . 0.0 116.313 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 12.7 t80 -110.19 125.65 53.28 Favored 'General case' 0 CA--C 1.562 1.409 0 CA-C-N 113.952 -1.124 . . . . 0.0 108.657 173.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 82.3 m95 -124.67 127.4 47.24 Favored 'General case' 0 CA--C 1.565 1.539 0 C-N-CA 123.49 0.716 . . . . 0.0 109.982 -167.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -97.1 140.37 31.71 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.188 -0.945 . . . . 0.0 112.853 175.368 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 37.4 ttm -70.79 125.08 25.86 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.819 -1.176 . . . . 0.0 113.024 177.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 90.2 mt -84.62 -51.56 6.76 Favored 'General case' 0 CA--C 1.566 1.595 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 167.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 92.3 p -144.52 150.75 38.08 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 118.806 0.73 . . . . 0.0 112.2 177.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -125.84 114.11 18.13 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 123.13 0.572 . . . . 0.0 109.734 165.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -115.25 124.1 50.5 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 123.387 0.675 . . . . 0.0 109.651 -168.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.264 23.4 t30 62.16 25.26 15.11 Favored 'General case' 0 N--CA 1.504 2.251 0 N-CA-C 116.699 2.111 . . . . 0.0 116.699 -172.224 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -67.8 -43.5 79.51 Favored 'General case' 0 CA--C 1.567 1.633 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 175.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -45.96 -50.0 15.22 Favored 'General case' 0 N--CA 1.505 2.324 0 N-CA-C 116.433 2.012 . . . . 0.0 116.433 167.193 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -70.86 -41.01 71.95 Favored 'General case' 0 CA--C 1.57 1.747 0 N-CA-C 115.463 1.653 . . . . 0.0 115.463 178.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -50.84 -49.38 59.03 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 114.9 1.445 . . . . 0.0 114.9 160.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 81.2 mt -62.96 -39.5 94.84 Favored 'General case' 0 CA--C 1.574 1.877 0 N-CA-C 114.866 1.432 . . . . 0.0 114.866 173.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 69.0 ttp85 -52.45 -50.97 61.55 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 115.087 1.514 . . . . 0.0 115.087 164.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.54 -14.88 22.49 Favored 'General case' 0 CA--C 1.572 1.79 0 N-CA-C 118.545 2.794 . . . . 0.0 118.545 167.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 94.8 mt -97.36 16.48 19.95 Favored 'General case' 0 CA--C 1.57 1.742 0 N-CA-C 115.159 1.54 . . . . 0.0 115.159 164.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 60.74 45.37 10.14 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 115.547 1.684 . . . . 0.0 115.547 -177.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 98.0 t -99.83 138.24 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.22 -0.925 . . . . 0.0 109.794 -178.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 12.6 p30 -63.68 152.28 39.51 Favored 'General case' 0 CA--C 1.57 1.746 0 N-CA-C 115.112 1.523 . . . . 0.0 115.112 176.124 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . 0.251 78.8 t -58.62 -40.8 80.3 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.303 0 N-CA-C 115.307 1.595 . . . . 0.0 115.307 -177.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.26 -50.18 72.08 Favored 'General case' 0 CA--C 1.567 1.607 0 N-CA-C 115.953 1.834 . . . . 0.0 115.953 168.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 25.4 tp -66.9 -38.82 86.97 Favored 'General case' 0 CA--C 1.573 1.829 0 N-CA-C 116.052 1.871 . . . . 0.0 116.052 171.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 69.6 mtp180 -50.85 -47.87 60.19 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 115.303 1.594 . . . . 0.0 115.303 162.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -65.05 -54.42 30.49 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 170.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 61.6 mt -51.77 -55.66 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.246 0 CA-C-N 120.41 1.459 . . . . 0.0 113.172 175.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.23 -35.89 80.28 Favored 'General case' 0 CA--C 1.563 1.453 0 N-CA-C 118.352 2.723 . . . . 0.0 118.352 176.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -76.16 -33.43 59.37 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 116.018 1.859 . . . . 0.0 116.018 171.117 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 77.2 mt -72.85 -36.54 67.45 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 115.387 1.625 . . . . 0.0 115.387 178.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . 0.262 3.7 pp -93.92 151.94 19.21 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 119.327 0.967 . . . . 0.0 113.208 179.457 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 28.0 mmtp -108.42 93.37 11.48 Favored Pre-proline 0 CA--C 1.574 1.871 0 CA-C-O 118.078 -0.963 . . . . 0.0 110.03 -173.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -75.6 169.37 22.47 Favored 'Trans proline' 0 CA--C 1.565 2.043 0 C-N-CA 122.664 2.243 . . . . 0.0 115.605 -178.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -112.67 134.05 54.39 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-N 116.03 -0.532 . . . . 0.0 112.106 -177.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 23.5 mtpp -102.51 113.88 27.6 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.037 -1.04 . . . . 0.0 110.578 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -97.99 109.68 22.39 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.694 -0.629 . . . . 0.0 109.319 167.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 76.2 mt -102.42 120.56 52.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 -179.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 88.9 t -109.85 95.05 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 174.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -86.87 97.13 10.49 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 123.324 0.65 . . . . 0.0 110.362 173.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -102.27 70.46 1.18 Allowed 'General case' 0 CA--C 1.567 1.633 0 C-N-CA 123.556 0.742 . . . . 0.0 111.332 -178.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 57.94 65.8 3.27 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 117.368 1.707 . . . . 0.0 117.368 177.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.478 0.0 OUTLIER 82.07 -36.99 0.1 Allowed 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 116.473 2.027 . . . . 0.0 116.473 -165.235 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 12.3 t-160 -79.81 95.29 5.98 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-N 120.834 1.652 . . . . 0.0 110.513 175.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 4.1 ttp -104.6 119.52 39.19 Favored 'General case' 0 CA--C 1.552 1.052 0 CA-C-O 121.982 0.896 . . . . 0.0 110.094 -175.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 37.4 mt -106.32 101.16 12.05 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.479 0 N-CA-C 106.587 -1.634 . . . . 0.0 106.587 -178.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 88.1 mt -89.3 111.91 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 177.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 90.3 mtt180 -109.6 100.27 9.34 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -174.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 16.8 m -92.99 109.62 21.07 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 39.7 mt -102.64 123.62 46.69 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.349 0.66 . . . . 0.0 110.938 -159.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 10.2 t -151.01 160.51 43.88 Favored 'General case' 0 CA--C 1.571 1.763 0 CA-C-O 121.31 0.576 . . . . 0.0 112.474 -176.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.0 t -63.05 -36.07 82.35 Favored 'General case' 0 N--CA 1.504 2.235 0 N-CA-C 117.738 2.496 . . . . 0.0 117.738 175.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -76.48 -52.32 10.04 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 175.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.6 tmm_? -149.05 138.03 21.37 Favored 'General case' 0 CA--C 1.56 1.349 0 C-N-CA 124.212 1.005 . . . . 0.0 108.767 -178.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -102.06 114.93 29.48 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 174.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -87.54 121.42 29.96 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 122.862 0.465 . . . . 0.0 110.598 -173.204 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 43.2 mm -114.27 101.98 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 -177.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 76.5 mtp -95.28 90.53 5.88 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.126 -0.984 . . . . 0.0 109.132 169.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.6 p30 -95.15 108.17 20.27 Favored 'General case' 0 CA--C 1.561 1.376 0 C-N-CA 123.821 0.849 . . . . 0.0 111.82 178.045 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 29.4 p90 -147.77 142.88 27.1 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 113.844 1.054 . . . . 0.0 113.844 -169.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 17.1 mp0 -79.96 123.46 27.82 Favored 'General case' 0 CA--C 1.563 1.459 0 O-C-N 121.543 -0.723 . . . . 0.0 110.289 162.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 46.9 t -65.98 117.68 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 C-N-CA 123.315 0.646 . . . . 0.0 110.422 -179.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 115.44 -45.18 1.34 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 116.006 1.162 . . . . 0.0 116.006 -160.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -82.29 144.15 30.81 Favored 'General case' 0 CA--C 1.567 1.617 0 CA-C-N 118.802 1.301 . . . . 0.0 113.284 -173.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -95.14 111.56 23.38 Favored 'General case' 0 CA--C 1.564 1.504 0 O-C-N 121.76 -0.588 . . . . 0.0 111.481 176.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 22.8 p90 -106.94 142.74 36.07 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 123.33 0.652 . . . . 0.0 112.748 -177.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -71.13 114.2 8.95 Favored 'General case' 0 CA--C 1.567 1.622 0 O-C-N 120.358 -1.464 . . . . 0.0 112.177 170.719 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -79.85 80.33 6.26 Favored 'General case' 0 CA--C 1.568 1.646 0 CA-C-O 122.125 0.965 . . . . 0.0 111.266 -175.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -112.18 -38.9 4.6 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 124.033 0.933 . . . . 0.0 113.479 176.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.1 pp -69.53 102.33 1.8 Allowed 'General case' 0 CA--C 1.567 1.608 0 CA-C-N 120.308 1.413 . . . . 0.0 111.768 173.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . 0.254 30.4 p 74.45 122.0 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.014 0 C-N-CA 124.308 1.043 . . . . 0.0 112.911 -177.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -140.41 177.38 20.76 Favored Glycine 0 N--CA 1.49 2.259 0 CA-C-O 122.353 0.974 . . . . 0.0 115.078 -179.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 50.2 mm -82.71 -79.69 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 170.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 40.6 t0 -87.48 167.03 14.34 Favored 'General case' 0 CA--C 1.575 1.918 0 CA-C-O 121.818 0.818 . . . . 0.0 110.089 152.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -75.83 78.57 2.75 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.318 -1.489 . . . . 0.0 112.191 177.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 8.0 tpm_? -136.02 114.44 11.71 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.692 0.797 . . . . 0.0 109.357 -170.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 55.5 mtmt -74.87 127.92 34.35 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 123.127 0.571 . . . . 0.0 111.981 178.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 93.5 m -136.69 124.69 22.82 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 121.469 0.652 . . . . 0.0 111.24 179.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 80.6 mmm -71.61 103.73 3.11 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 121.714 0.768 . . . . 0.0 110.277 177.223 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 92.1 m -109.56 111.53 23.09 Favored 'General case' 0 N--CA 1.483 1.178 0 O-C-N 121.671 -0.643 . . . . 0.0 110.866 -159.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 95.1 m -94.71 128.24 41.25 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 170.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.9 t -116.41 129.66 72.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 172.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 58.2 m -149.09 157.12 43.14 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.423 -1.423 . . . . 0.0 113.316 -177.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 45.7 m95 -86.84 123.61 32.16 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.751 -1.218 . . . . 0.0 113.775 -174.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -109.35 73.3 0.84 Allowed 'General case' 0 CA--C 1.57 1.712 0 C-N-CA 124.064 0.946 . . . . 0.0 109.356 164.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.0 -125.14 29.68 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 114.637 0.615 . . . . 0.0 114.637 -172.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -61.12 -19.81 61.93 Favored 'General case' 0 N--CA 1.501 2.09 0 N-CA-C 116.526 2.047 . . . . 0.0 116.526 166.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 43.7 mttt -97.15 121.11 38.67 Favored 'General case' 0 CA--C 1.556 1.206 0 CA-C-N 119.554 1.07 . . . . 0.0 111.554 -174.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 24.3 tp -84.68 108.05 17.2 Favored 'General case' 0 CA--C 1.565 1.544 0 O-C-N 121.326 -0.859 . . . . 0.0 109.086 170.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -93.81 132.02 38.62 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.703 0.801 . . . . 0.0 111.036 -176.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 42.1 t -126.96 128.28 46.16 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.213 0.605 . . . . 0.0 111.315 178.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 12.7 p -109.8 118.12 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 168.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 55.7 mt-30 -99.42 73.69 1.87 Allowed 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 123.577 0.751 . . . . 0.0 109.813 178.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -83.96 134.13 34.67 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.577 -1.327 . . . . 0.0 113.781 -169.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 178.46 -85.03 0.07 OUTLIER Glycine 0 N--CA 1.485 1.932 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.955 -177.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -104.16 -58.25 1.91 Allowed 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 177.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -76.88 133.26 39.34 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 119.985 1.266 . . . . 0.0 112.07 -173.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -61.52 -54.73 39.34 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 116.171 1.915 . . . . 0.0 116.171 -167.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -98.67 53.42 1.11 Allowed Glycine 0 N--CA 1.489 2.177 0 N-CA-C 115.97 1.148 . . . . 0.0 115.97 169.223 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 25.7 ttt-85 -87.57 118.62 27.17 Favored 'General case' 0 CA--C 1.563 1.479 0 CA-C-N 118.685 1.243 . . . . 0.0 111.713 179.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 171.18 -168.9 42.02 Favored Glycine 0 N--CA 1.485 1.918 0 CA-C-O 121.892 0.718 . . . . 0.0 114.226 -179.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 38.5 p-90 -155.99 157.07 35.57 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 176.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 83.1 m -125.89 114.21 18.24 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 175.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 41.1 tt0 -117.57 123.01 45.19 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 123.413 0.685 . . . . 0.0 111.142 -175.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 12.5 p90 -144.36 148.58 34.9 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.966 -1.084 . . . . 0.0 113.229 -176.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 94.3 mt -97.3 135.87 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 CA-C-O 122.374 1.083 . . . . 0.0 110.374 177.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -122.9 87.21 2.71 Favored 'General case' 0 CA--C 1.563 1.445 0 CA-C-N 114.214 -1.357 . . . . 0.0 107.781 174.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 70.97 -105.25 1.58 Allowed Glycine 0 N--CA 1.491 2.323 0 O-C-N 121.488 -0.758 . . . . 0.0 114.714 -175.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 54.8 p30 -99.95 7.23 44.97 Favored 'General case' 0 CA--C 1.574 1.898 0 N-CA-C 116.868 2.173 . . . . 0.0 116.868 169.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -115.33 130.11 56.8 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-N 120.43 1.468 . . . . 0.0 111.694 -178.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 13.3 tp -90.94 115.56 28.06 Favored 'General case' 0 CA--C 1.561 1.384 0 C-N-CA 124.224 1.01 . . . . 0.0 109.356 170.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 43.4 m80 -102.31 122.45 44.27 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.873 0.869 . . . . 0.0 109.04 -178.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 49.3 tp -122.96 117.63 25.96 Favored 'General case' 0 CA--C 1.56 1.34 0 C-N-CA 123.701 0.801 . . . . 0.0 109.924 -174.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -104.77 107.87 19.05 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 169.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 68.5 mtm -100.18 128.5 46.24 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.881 -0.512 . . . . 0.0 110.682 178.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 68.5 mtp180 -115.03 143.45 45.17 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.656 -0.653 . . . . 0.0 111.868 -178.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -148.34 130.07 15.09 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.601 -0.687 . . . . 0.0 111.567 164.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 58.27 25.6 12.88 Favored 'General case' 0 N--CA 1.506 2.361 0 N-CA-C 115.716 1.746 . . . . 0.0 115.716 -167.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 90.37 -34.04 4.31 Favored Glycine 0 CA--C 1.557 2.685 0 N-CA-C 118.095 1.998 . . . . 0.0 118.095 -159.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 76.5 t -70.49 119.41 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 CA-C-N 119.276 1.538 . . . . 0.0 111.614 -165.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 21.0 m -95.13 123.36 38.58 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.166 0.507 . . . . 0.0 112.091 -173.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 10.4 t -94.03 130.87 40.0 Favored 'General case' 0 CA--C 1.561 1.383 0 C-N-CA 123.518 0.727 . . . . 0.0 110.99 159.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -108.36 111.63 23.65 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.558 -0.713 . . . . 0.0 109.45 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -111.46 132.07 54.75 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 123.612 0.765 . . . . 0.0 111.384 178.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 43.9 t -115.35 130.42 69.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 176.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -126.59 141.63 51.8 Favored 'General case' 0 CA--C 1.563 1.448 0 C-N-CA 124.232 1.013 . . . . 0.0 110.78 -178.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 10.3 tmtt? -110.46 139.7 45.42 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.966 -1.084 . . . . 0.0 112.288 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 37.0 tttp -73.68 117.23 15.21 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 113.464 0.913 . . . . 0.0 113.464 -177.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . 0.263 34.8 m -103.25 -39.28 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.152 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 174.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 38.2 t60 . . . . . 0 N--CA 1.486 1.344 0 CA-C-N 119.863 1.21 . . . . 0.0 107.956 163.654 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 56.7 mtm . . . . . 0 CA--C 1.575 1.921 0 CA-C-O 118.559 -0.734 . . . . 0.0 112.633 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -72.28 -99.07 0.01 OUTLIER 'Trans proline' 0 CA--C 1.575 2.555 0 C-N-CA 122.906 2.404 . . . . 0.0 114.877 179.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -152.77 164.56 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 -178.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -87.85 104.67 16.81 Favored 'General case' 0 CA--C 1.567 1.612 0 O-C-N 119.89 -1.756 . . . . 0.0 111.308 167.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -88.73 3.52 50.59 Favored 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 115.808 1.781 . . . . 0.0 115.808 171.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 62.8 m-80 -65.22 114.63 4.83 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 120.93 1.695 . . . . 0.0 113.426 -178.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 168.33 169.04 31.28 Favored Glycine 0 N--CA 1.483 1.767 0 N-CA-C 116.113 1.205 . . . . 0.0 116.113 -176.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -103.19 128.07 50.29 Favored 'General case' 0 CA--C 1.565 1.52 0 CA-C-N 114.125 -1.037 . . . . 0.0 109.251 169.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 63.1 m95 -125.31 128.54 48.38 Favored 'General case' 0 CA--C 1.568 1.65 0 C-N-CA 123.663 0.785 . . . . 0.0 109.361 -170.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -92.73 147.5 22.81 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.753 -1.217 . . . . 0.0 112.831 171.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.413 ' SD ' ' HD2' ' A' ' 38' ' ' PRO . 42.7 ttm -72.64 130.52 40.76 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.723 -1.235 . . . . 0.0 112.528 171.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 83.3 mt -89.08 -53.24 4.67 Favored 'General case' 0 CA--C 1.568 1.636 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.622 163.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 87.3 p -140.4 151.67 45.12 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-N 119.175 0.898 . . . . 0.0 112.784 -176.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -128.75 112.71 14.48 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.744 -0.597 . . . . 0.0 110.21 166.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -110.91 122.93 49.11 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.911 0.885 . . . . 0.0 109.252 -172.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.263 27.1 t30 65.36 25.33 12.07 Favored 'General case' 0 N--CA 1.503 2.222 0 N-CA-C 116.901 2.186 . . . . 0.0 116.901 -175.358 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -68.09 -41.43 81.85 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 115.925 1.824 . . . . 0.0 115.925 178.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -58.52 -40.54 83.21 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 116.213 1.931 . . . . 0.0 116.213 170.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -69.63 -40.8 76.32 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 115.031 1.493 . . . . 0.0 115.031 174.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -51.39 -52.18 48.1 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 114.79 1.404 . . . . 0.0 114.79 161.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 75.0 mt -61.25 -40.46 94.15 Favored 'General case' 0 CA--C 1.573 1.851 0 N-CA-C 115.045 1.498 . . . . 0.0 115.045 172.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 45.7 ttp180 -53.95 -50.17 67.07 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 115.366 1.617 . . . . 0.0 115.366 164.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.63 -22.92 48.37 Favored 'General case' 0 CA--C 1.568 1.639 0 N-CA-C 118.172 2.656 . . . . 0.0 118.172 166.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 93.5 mt -85.83 11.84 10.37 Favored 'General case' 0 CA--C 1.574 1.88 0 N-CA-C 115.88 1.807 . . . . 0.0 115.88 165.02 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 60.69 35.82 19.67 Favored 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 115.951 1.834 . . . . 0.0 115.951 -172.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 97.5 t -96.44 138.62 21.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 120.797 -1.189 . . . . 0.0 109.119 -177.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 7.8 p-10 -67.01 154.35 41.41 Favored 'General case' 0 CA--C 1.567 1.615 0 N-CA-C 115.752 1.76 . . . . 0.0 115.752 -178.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 87.8 t -53.34 -43.65 51.93 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.349 0 N-CA-C 115.502 1.667 . . . . 0.0 115.502 -177.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.95 -47.36 83.14 Favored 'General case' 0 CA--C 1.567 1.608 0 N-CA-C 116.264 1.95 . . . . 0.0 116.264 172.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 31.2 tp -75.77 -26.32 57.26 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 116.477 2.028 . . . . 0.0 116.477 171.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 77.4 mtp180 -54.05 -52.65 60.2 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-N 120.695 1.589 . . . . 0.0 114.092 158.09 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 30.9 mmtp -63.38 -51.17 66.99 Favored 'General case' 0 CA--C 1.568 1.637 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 170.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 15.3 mt -78.42 60.98 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.408 0 CA-C-O 123.63 1.681 . . . . 0.0 111.166 178.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -177.07 -56.98 0.01 OUTLIER 'General case' 0 CA--C 1.562 1.429 0 C-N-CA 126.735 2.014 . . . . 0.0 109.139 -174.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -57.74 -42.69 84.46 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 116.504 2.038 . . . . 0.0 116.504 161.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 74.1 mt -79.31 -19.74 49.64 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 116.067 1.877 . . . . 0.0 116.067 -177.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.0 pp -101.91 141.91 34.03 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 118.988 0.813 . . . . 0.0 111.522 171.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 7.0 mtmp? -102.38 100.65 16.29 Favored Pre-proline 0 CA--C 1.572 1.811 0 CA-C-O 117.878 -1.058 . . . . 0.0 110.37 -177.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.413 ' HD2' ' SD ' ' A' ' 10' ' ' MET . 73.6 Cg_endo -75.76 170.18 20.72 Favored 'Trans proline' 0 CA--C 1.566 2.11 0 CA-C-N 122.85 2.054 . . . . 0.0 116.857 -175.09 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -102.52 154.45 19.09 Favored 'General case' 0 CA--C 1.566 1.558 0 CA-C-N 113.983 -1.462 . . . . 0.0 109.988 176.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 21.8 mtpp -128.46 114.06 16.31 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.807 -1.183 . . . . 0.0 109.227 171.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.475 ' HE2' ' NH1' ' A' ' 52' ' ' ARG . 35.1 tt0 -102.1 103.56 14.14 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 169.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 73.1 mt -98.24 124.72 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 -177.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 36.6 t -108.57 111.95 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 164.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -99.5 101.55 12.82 Favored 'General case' 0 CA--C 1.566 1.561 0 C-N-CA 123.943 0.897 . . . . 0.0 109.117 172.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -121.36 76.39 1.24 Allowed 'General case' 0 CA--C 1.567 1.627 0 C-N-CA 123.219 0.608 . . . . 0.0 111.409 -174.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 57.1 67.23 2.33 Favored Glycine 0 N--CA 1.497 2.723 0 N-CA-C 117.672 1.829 . . . . 0.0 117.672 171.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.488 0.0 OUTLIER 77.81 -43.53 0.4 Allowed 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 116.209 1.929 . . . . 0.0 116.209 -163.204 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 21.1 t-160 -73.56 109.26 6.93 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-N 120.797 1.635 . . . . 0.0 111.168 176.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 2.9 tpp -114.64 124.99 53.24 Favored 'General case' 0 CA--C 1.555 1.171 0 CA-C-O 122.045 0.926 . . . . 0.0 110.111 178.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 19.3 mt -108.63 103.86 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 N-CA-C 105.407 -2.072 . . . . 0.0 105.407 174.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 90.0 mt -93.41 95.16 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 172.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.475 ' NH1' ' HE2' ' A' ' 41' ' ' GLU . 63.1 mtt85 -82.68 94.66 7.62 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.345 -0.847 . . . . 0.0 110.003 177.02 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 34.1 m -84.8 109.29 17.97 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.137 -1.061 . . . . 0.0 108.137 172.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 15.3 mt -116.66 107.66 14.97 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 -164.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 36.7 p -116.45 155.5 28.47 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.349 0.66 . . . . 0.0 111.314 -173.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.3 t -68.35 4.16 1.43 Allowed 'General case' 0 CA--C 1.581 2.149 0 N-CA-C 117.992 2.59 . . . . 0.0 117.992 167.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -104.13 -58.86 1.82 Allowed 'General case' 0 CA--C 1.568 1.671 0 CA-C-N 119.619 1.099 . . . . 0.0 111.836 163.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 11.8 ptm180 -140.02 160.62 39.52 Favored 'General case' 0 CA--C 1.568 1.665 0 CA-C-O 122.56 1.172 . . . . 0.0 114.026 175.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -82.49 128.55 34.38 Favored 'General case' 0 CA--C 1.568 1.652 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.333 160.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -95.97 -66.91 0.88 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.592 -0.692 . . . . 0.0 110.92 178.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.359 58.6 mt 69.76 91.35 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 C-N-CA 124.563 1.145 . . . . 0.0 112.893 170.215 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 75.9 mtp -91.57 96.57 10.55 Favored 'General case' 0 CA--C 1.565 1.55 0 O-C-N 121.544 -0.723 . . . . 0.0 109.276 173.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -96.89 113.38 24.92 Favored 'General case' 0 CA--C 1.564 1.517 0 C-N-CA 123.893 0.877 . . . . 0.0 110.108 178.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -153.98 156.15 36.9 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -171.17 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 11.5 mp0 -91.62 126.27 36.65 Favored 'General case' 0 CA--C 1.564 1.505 0 O-C-N 121.403 -0.811 . . . . 0.0 110.286 163.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 41.5 t -67.41 114.69 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 C-N-CA 124.194 0.998 . . . . 0.0 109.381 174.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 119.88 -47.69 1.01 Allowed Glycine 0 N--CA 1.489 2.172 0 N-CA-C 115.58 0.992 . . . . 0.0 115.58 -160.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 85.1 mttt -79.75 141.01 36.72 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-N 118.743 1.272 . . . . 0.0 113.53 -173.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.591 ' HE2' ' NZ ' ' A' ' 98' ' ' LYS . 55.4 tt0 -100.83 100.79 11.49 Favored 'General case' 0 CA--C 1.565 1.532 0 C-N-CA 123.275 0.63 . . . . 0.0 111.164 -178.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -105.96 144.53 32.55 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 -168.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -73.43 103.69 4.17 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.691 -1.255 . . . . 0.0 111.735 173.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -85.41 66.1 9.52 Favored 'General case' 0 CA--C 1.571 1.767 0 N-CA-C 114.534 1.309 . . . . 0.0 114.534 -170.747 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -77.37 -52.19 9.57 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 115.176 1.547 . . . . 0.0 115.176 -177.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 93.7 mt -81.2 -162.31 0.49 Allowed 'General case' 0 CA--C 1.576 1.953 0 CA-C-N 119.591 1.087 . . . . 0.0 111.907 177.088 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . 0.381 22.6 m 67.91 37.48 3.09 Favored 'General case' 0 N--CA 1.507 2.407 0 N-CA-C 115.489 1.663 . . . . 0.0 115.489 178.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 62.9 -128.25 39.91 Favored Glycine 0 N--CA 1.489 2.224 0 O-C-N 120.204 -1.56 . . . . 0.0 116.25 175.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . 0.513 0.0 OUTLIER 58.32 -83.84 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 N-CA-C 115.82 1.785 . . . . 0.0 115.82 171.169 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.674 ' HD2' ' NZ ' ' A' ' 101' ' ' LYS . 65.5 t0 -158.37 99.21 1.6 Allowed 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 105.041 -2.207 . . . . 0.0 105.041 170.211 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -74.65 83.85 2.08 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 115.021 1.489 . . . . 0.0 115.021 -160.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.538 ' NH1' ' HE2' ' A' ' 100' ' ' GLU . 86.6 mtt-85 -145.34 149.04 34.07 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 124.615 1.166 . . . . 0.0 108.73 -171.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 57.2 mtmt -74.44 73.91 1.9 Allowed 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.362 -1.461 . . . . 0.0 114.362 -177.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 88.2 m -94.54 126.59 39.92 Favored 'General case' 0 CA--C 1.556 1.187 0 O-C-N 121.446 -0.784 . . . . 0.0 111.134 -179.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 87.7 mmm -73.08 101.55 3.3 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-O 121.878 0.847 . . . . 0.0 110.751 -172.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 92.2 m -109.16 107.1 17.26 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.535 -158.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 64.6 m -92.8 128.68 38.75 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 172.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 18.2 t -112.55 130.67 65.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 167.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 39.5 m -150.74 155.89 40.19 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.589 -1.319 . . . . 0.0 112.853 -175.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 55.8 m95 -86.24 122.47 30.27 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.836 -1.165 . . . . 0.0 113.601 -175.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -102.54 67.03 0.99 Allowed 'General case' 0 CA--C 1.574 1.897 0 C-N-CA 123.286 0.634 . . . . 0.0 109.646 157.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 60.87 -104.17 0.62 Allowed Glycine 0 N--CA 1.492 2.387 0 N-CA-C 115.825 1.09 . . . . 0.0 115.825 -175.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -72.46 -27.78 62.52 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 116.357 1.984 . . . . 0.0 116.357 168.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -91.08 115.23 27.85 Favored 'General case' 0 N--CA 1.485 1.294 0 CA-C-N 119.505 1.048 . . . . 0.0 111.301 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 31.4 tp -80.22 110.38 15.59 Favored 'General case' 0 CA--C 1.565 1.555 0 O-C-N 121.401 -0.812 . . . . 0.0 109.207 167.022 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 30.4 mm-40 -101.07 126.05 47.73 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.713 0.805 . . . . 0.0 110.884 -170.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 40.4 t -118.05 128.9 55.21 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.592 0.757 . . . . 0.0 111.058 176.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.6 p -120.67 118.45 56.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 172.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 63.4 mt-30 -103.21 95.47 6.13 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 123.919 0.887 . . . . 0.0 109.339 -175.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.591 ' NZ ' ' HE2' ' A' ' 69' ' ' GLU . 81.4 mttt -85.23 119.98 26.21 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.749 -1.22 . . . . 0.0 112.373 -168.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 176.51 -101.55 0.16 Allowed Glycine 0 N--CA 1.486 2.004 0 O-C-N 121.458 -0.776 . . . . 0.0 114.0 170.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.538 ' HE2' ' NH1' ' A' ' 80' ' ' ARG . 25.2 tt0 -86.99 -59.35 2.28 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 -173.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.674 ' NZ ' ' HD2' ' A' ' 78' ' ' ASP . 12.3 mptt -75.26 129.81 38.06 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 122.551 1.167 . . . . 0.0 110.945 -179.068 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 -76.47 -38.16 55.79 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 116.659 2.096 . . . . 0.0 116.659 -157.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -106.18 56.25 0.51 Allowed Glycine 0 N--CA 1.49 2.249 0 CA-C-N 119.258 0.936 . . . . 0.0 114.81 162.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 35.9 ttt180 -87.44 122.06 30.68 Favored 'General case' 0 CA--C 1.567 1.597 0 CA-C-N 118.364 1.082 . . . . 0.0 112.573 -177.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 172.9 -167.1 39.87 Favored Glycine 0 CA--C 1.546 2.019 0 N-CA-C 114.991 0.757 . . . . 0.0 114.991 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . 0.254 34.7 p-90 -155.26 156.03 34.86 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 113.888 1.069 . . . . 0.0 113.888 170.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 91.1 m -127.74 118.43 23.77 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 176.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -122.66 121.23 35.9 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.743 -0.598 . . . . 0.0 111.728 -174.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 21.9 p90 -134.45 165.74 24.47 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.347 -0.846 . . . . 0.0 113.138 178.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 95.4 mt -110.12 132.55 58.12 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.135 -0.978 . . . . 0.0 109.819 175.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -114.47 91.98 3.81 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 123.979 0.912 . . . . 0.0 108.878 168.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 71.67 -106.49 1.92 Allowed Glycine 0 N--CA 1.491 2.328 0 O-C-N 121.463 -0.773 . . . . 0.0 114.732 -177.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -108.06 32.76 4.53 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 115.111 1.523 . . . . 0.0 115.111 165.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -129.33 131.46 46.9 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-N 119.073 0.851 . . . . 0.0 110.345 178.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 12.9 tp -95.83 122.08 38.23 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 121.675 0.75 . . . . 0.0 109.531 175.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 41.0 m80 -111.28 117.31 32.8 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -174.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 42.4 tp -119.81 118.71 31.54 Favored 'General case' 0 CA--C 1.561 1.399 0 C-N-CA 123.764 0.826 . . . . 0.0 110.051 -172.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -106.57 107.72 18.86 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.68 -0.638 . . . . 0.0 109.603 171.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 72.9 mtm -99.58 129.92 45.78 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 123.035 0.534 . . . . 0.0 111.072 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 73.4 mtp85 -117.68 141.85 47.91 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.548 -0.72 . . . . 0.0 112.515 -172.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -151.23 133.47 15.31 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 123.187 0.595 . . . . 0.0 111.274 165.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 59.3 20.82 9.01 Favored 'General case' 0 N--CA 1.509 2.484 0 N-CA-C 116.373 1.99 . . . . 0.0 116.373 -173.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 86.91 -18.61 34.42 Favored Glycine 0 CA--C 1.557 2.715 0 N-CA-C 119.018 2.367 . . . . 0.0 119.018 -159.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 87.4 t -81.31 121.27 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 CA-C-N 119.498 1.649 . . . . 0.0 109.869 -174.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 25.0 m -101.75 126.03 48.53 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.217 0.532 . . . . 0.0 111.812 -177.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 7.7 t -95.59 125.64 40.32 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.885 0.874 . . . . 0.0 110.919 162.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 51.7 mtpt -105.5 113.25 26.72 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 123.123 0.569 . . . . 0.0 109.815 -177.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 -114.28 136.56 52.83 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.516 -0.74 . . . . 0.0 111.652 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 62.6 t -116.98 130.31 72.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 178.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -124.78 149.87 46.91 Favored 'General case' 0 CA--C 1.565 1.536 0 C-N-CA 124.536 1.134 . . . . 0.0 110.696 -179.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 25.8 ttmt -119.7 141.95 48.93 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.028 -1.045 . . . . 0.0 112.293 175.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 36.5 tttm -74.68 128.56 35.84 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -177.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 29.2 m -111.73 -33.74 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 178.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 49.1 t-80 . . . . . 0 N--CA 1.485 1.292 0 CA-C-N 120.569 1.531 . . . . 0.0 109.112 174.215 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 59.8 mtt . . . . . 0 CA--C 1.569 1.675 0 CA-C-O 118.508 -0.758 . . . . 0.0 111.936 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_endo -67.72 128.82 18.63 Favored 'Trans proline' 0 CA--C 1.56 1.796 0 C-N-CA 122.467 2.112 . . . . 0.0 115.017 171.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 27.5 t -97.56 -98.31 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.57 1.712 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 -171.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -152.1 79.15 1.25 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.809 -1.182 . . . . 0.0 108.052 160.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -74.46 -11.34 60.21 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 116.514 2.042 . . . . 0.0 116.514 179.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -61.83 108.56 1.04 Allowed 'General case' 0 CA--C 1.563 1.473 0 C-N-CA 125.813 1.645 . . . . 0.0 114.02 -178.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 163.2 -179.27 38.48 Favored Glycine 0 N--CA 1.483 1.802 0 N-CA-C 116.453 1.341 . . . . 0.0 116.453 -179.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -106.92 128.3 54.19 Favored 'General case' 0 CA--C 1.564 1.505 0 CA-C-N 114.035 -1.082 . . . . 0.0 109.234 171.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 73.4 m95 -122.14 143.53 49.49 Favored 'General case' 0 CA--C 1.572 1.808 0 C-N-CA 123.964 0.905 . . . . 0.0 110.102 -169.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -111.67 140.39 46.34 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.035 -1.041 . . . . 0.0 112.306 173.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 50.0 ttm -72.08 125.11 26.45 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.099 -1.001 . . . . 0.0 112.93 176.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 86.4 mt -82.62 -47.87 11.59 Favored 'General case' 0 CA--C 1.567 1.609 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 166.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 80.0 p -148.74 147.96 29.44 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 123.496 0.718 . . . . 0.0 112.242 177.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -120.57 105.8 11.16 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 123.133 0.573 . . . . 0.0 109.535 164.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -101.44 125.48 48.08 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.418 -0.801 . . . . 0.0 109.911 -177.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.273 19.5 t30 64.89 18.91 11.69 Favored 'General case' 0 CA--C 1.583 2.213 0 N-CA-C 117.515 2.413 . . . . 0.0 117.515 -177.588 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -65.28 -47.85 75.22 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 115.516 1.673 . . . . 0.0 115.516 176.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -56.72 -35.32 68.42 Favored 'General case' 0 CA--C 1.576 1.97 0 N-CA-C 117.211 2.3 . . . . 0.0 117.211 172.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -68.4 -46.92 68.67 Favored 'General case' 0 CA--C 1.573 1.834 0 N-CA-C 114.79 1.404 . . . . 0.0 114.79 166.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -52.25 -46.98 66.0 Favored 'General case' 0 N--CA 1.501 2.088 0 N-CA-C 115.369 1.618 . . . . 0.0 115.369 167.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 93.1 mt -61.9 -39.86 93.43 Favored 'General case' 0 CA--C 1.573 1.864 0 N-CA-C 115.061 1.504 . . . . 0.0 115.061 170.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 67.4 ttp85 -56.87 -48.48 78.02 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 115.241 1.571 . . . . 0.0 115.241 164.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.2 -19.15 12.5 Favored 'General case' 0 CA--C 1.569 1.706 0 N-CA-C 118.21 2.671 . . . . 0.0 118.21 167.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 84.5 mt -95.22 3.71 54.31 Favored 'General case' 0 CA--C 1.569 1.694 0 N-CA-C 116.078 1.881 . . . . 0.0 116.078 167.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.566 ' HD2' ' NZ ' ' A' ' 101' ' ' LYS . 31.7 m-20 58.49 46.17 15.39 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 115.452 1.649 . . . . 0.0 115.452 -169.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 70.0 t -90.3 143.07 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.322 -0.861 . . . . 0.0 109.259 178.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -60.3 145.57 47.12 Favored 'General case' 0 CA--C 1.569 1.681 0 N-CA-C 115.556 1.687 . . . . 0.0 115.556 -176.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . 0.272 91.9 t -60.27 -36.01 65.84 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.168 0 N-CA-C 115.137 1.532 . . . . 0.0 115.137 -176.691 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.27 -55.03 38.33 Favored 'General case' 0 CA--C 1.566 1.584 0 N-CA-C 115.889 1.811 . . . . 0.0 115.889 167.256 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 5.5 tt -65.27 -39.6 92.82 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 115.565 1.691 . . . . 0.0 115.565 171.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 37.7 mtp-105 -46.84 -41.6 15.9 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 117.208 2.299 . . . . 0.0 117.208 165.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -74.67 -54.84 6.65 Favored 'General case' 0 CA--C 1.567 1.608 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 164.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 4.8 mt -80.89 60.78 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.585 2.296 0 CA-C-N 120.395 1.452 . . . . 0.0 111.61 -176.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -176.03 -51.71 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 126.392 1.877 . . . . 0.0 110.157 -176.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -63.23 -41.25 99.07 Favored 'General case' 0 CA--C 1.568 1.651 0 N-CA-C 115.76 1.763 . . . . 0.0 115.76 161.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 84.0 mt -75.03 -28.93 60.65 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 115.792 1.775 . . . . 0.0 115.792 178.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . 0.259 3.1 pp -91.0 152.12 20.8 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 119.462 1.028 . . . . 0.0 112.24 170.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 29.6 mmtp -108.23 91.71 8.52 Favored Pre-proline 0 CA--C 1.572 1.821 0 CA-C-O 118.064 -0.969 . . . . 0.0 109.341 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -77.22 175.73 10.98 Favored 'Trans proline' 0 CA--C 1.563 1.931 0 C-N-CA 122.384 2.056 . . . . 0.0 116.317 -172.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -107.92 155.87 19.83 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 114.985 -1.007 . . . . 0.0 112.392 178.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 40.9 mttp -121.02 119.64 33.09 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.663 -0.648 . . . . 0.0 109.382 169.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -96.73 111.01 23.35 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.463 -0.939 . . . . 0.0 108.463 162.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 74.3 mt -106.81 122.38 60.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 92.9 t -103.92 104.48 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 167.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -112.52 97.57 6.68 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 123.562 0.745 . . . . 0.0 111.159 -176.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -96.58 69.32 2.54 Favored 'General case' 0 CA--C 1.567 1.634 0 O-C-N 120.88 -1.138 . . . . 0.0 110.766 172.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 64.45 -89.7 0.09 OUTLIER Glycine 0 N--CA 1.491 2.328 0 N-CA-C 116.169 1.227 . . . . 0.0 116.169 -178.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.541 ' HD2' ' N ' ' A' ' 48' ' ' HIS . 5.8 p30 -81.84 -39.77 23.46 Favored 'General case' 0 CA--C 1.566 1.573 0 N-CA-C 115.91 1.819 . . . . 0.0 115.91 166.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.541 ' N ' ' HD2' ' A' ' 47' ' ' ASP . 11.7 t-160 -80.3 121.74 26.04 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 121.055 1.752 . . . . 0.0 111.893 -178.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 42.2 ttm -130.29 128.48 41.64 Favored 'General case' 0 CA--C 1.556 1.198 0 CA-C-O 121.597 0.713 . . . . 0.0 111.362 -177.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 46.7 mt -113.56 103.37 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 170.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 64.7 mt -92.88 98.8 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 174.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -86.46 98.89 11.28 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.333 -0.854 . . . . 0.0 109.967 174.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 31.9 m -83.57 109.91 17.8 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 172.075 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 53.5 mt -114.79 118.96 35.04 Favored 'General case' 0 CA--C 1.559 1.302 0 C-N-CA 124.005 0.922 . . . . 0.0 109.725 -164.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 9.7 p -133.62 155.42 49.71 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.256 0.55 . . . . 0.0 111.923 177.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 26.1 m -80.86 59.29 3.67 Favored 'General case' 0 N--CA 1.505 2.3 0 O-C-N 120.726 -1.234 . . . . 0.0 112.197 169.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -172.42 -64.53 0.02 OUTLIER 'General case' 0 CA--C 1.568 1.654 0 C-N-CA 125.509 1.524 . . . . 0.0 109.25 -179.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 65.5 ttt180 -138.93 140.3 38.26 Favored 'General case' 0 CA--C 1.568 1.639 0 CA-C-N 118.965 0.802 . . . . 0.0 110.81 175.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -110.28 137.7 47.65 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 123.338 0.655 . . . . 0.0 110.487 174.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -91.41 -74.92 0.49 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.657 -0.652 . . . . 0.0 111.375 178.545 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.363 54.3 mt 75.87 93.45 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 C-N-CA 124.368 1.067 . . . . 0.0 110.664 -177.207 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 81.1 mtp -100.29 99.56 10.24 Favored 'General case' 0 CA--C 1.561 1.37 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 174.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -101.32 113.35 26.34 Favored 'General case' 0 CA--C 1.565 1.52 0 C-N-CA 124.123 0.969 . . . . 0.0 111.614 178.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -157.77 158.32 35.04 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.154 -0.966 . . . . 0.0 113.224 -166.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 30.5 tt0 -95.38 130.6 42.11 Favored 'General case' 0 CA--C 1.564 1.485 0 O-C-N 121.123 -0.986 . . . . 0.0 110.822 160.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.3 t -65.25 117.31 5.64 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.813 0 C-N-CA 124.12 0.968 . . . . 0.0 109.535 170.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 115.25 -46.6 1.14 Allowed Glycine 0 CA--C 1.551 2.313 0 N-CA-C 115.667 1.027 . . . . 0.0 115.667 -159.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -82.77 154.49 24.73 Favored 'General case' 0 CA--C 1.567 1.633 0 CA-C-N 118.662 1.231 . . . . 0.0 113.729 -179.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -99.3 130.86 45.62 Favored 'General case' 0 CA--C 1.57 1.736 0 CA-C-O 121.928 0.871 . . . . 0.0 112.268 175.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -68.8 157.49 36.34 Favored 'General case' 0 CA--C 1.57 1.716 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 168.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -105.64 108.99 20.8 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.258 -0.901 . . . . 0.0 108.578 132.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -79.93 86.76 5.41 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.832 -1.167 . . . . 0.0 110.325 172.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -66.77 -63.69 1.01 Allowed 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 -171.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 95.4 mt -139.83 153.08 46.98 Favored 'General case' 0 CA--C 1.568 1.657 0 CA-C-N 118.894 0.77 . . . . 0.0 111.02 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . 0.298 22.5 m 84.85 118.59 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.116 0 C-N-CA 124.614 1.165 . . . . 0.0 113.39 166.323 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 151.8 -97.72 0.18 Allowed Glycine 0 N--CA 1.486 2.005 0 O-C-N 121.77 -0.581 . . . . 0.0 112.301 169.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 17.0 mm -129.05 -67.39 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 163.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . 0.264 33.8 p30 -51.36 -63.54 1.1 Allowed 'General case' 0 CA--C 1.564 1.503 0 N-CA-C 118.593 2.812 . . . . 0.0 118.593 -175.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.3 t70 70.17 153.93 0.12 Allowed 'General case' 0 CA--C 1.577 1.995 0 N-CA-C 114.853 1.427 . . . . 0.0 114.853 173.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . 0.304 0.9 OUTLIER 73.17 64.86 0.1 Allowed 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 174.183 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 47.9 mtmt 54.2 61.29 3.11 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 116.506 2.039 . . . . 0.0 116.506 169.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 44.9 m -80.84 125.7 30.42 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.141 -0.975 . . . . 0.0 111.175 174.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 4.9 mmt -75.32 74.51 2.42 Favored 'General case' 0 CA--C 1.567 1.62 0 CA-C-O 122.345 1.069 . . . . 0.0 111.241 169.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 100.0 m -93.0 130.21 38.65 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.03 -1.044 . . . . 0.0 109.824 -167.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 91.1 m -123.09 134.14 54.26 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 -178.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 16.1 t -120.64 138.23 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 178.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 59.2 m -147.57 150.8 35.16 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.215 -1.553 . . . . 0.0 113.056 -177.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 75.3 m95 -81.85 126.53 31.99 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.04 -1.037 . . . . 0.0 111.808 176.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -106.5 -21.67 13.0 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 118.145 2.646 . . . . 0.0 118.145 -167.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 159.8 -70.77 0.24 Allowed Glycine 0 N--CA 1.493 2.46 0 CA-C-N 121.296 1.862 . . . . 0.0 112.982 -172.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 34.4 m-20 -126.28 32.04 5.29 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 148.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -141.44 146.94 37.13 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.453 -1.404 . . . . 0.0 110.525 -165.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 35.8 tp -100.08 108.02 20.07 Favored 'General case' 0 CA--C 1.561 1.402 0 O-C-N 121.256 -0.903 . . . . 0.0 109.258 172.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 43.5 mm-40 -93.42 131.25 38.78 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 123.205 0.602 . . . . 0.0 111.535 -179.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 39.5 t -123.12 133.1 54.3 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.663 0.785 . . . . 0.0 111.063 173.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.2 p -115.4 127.41 72.98 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.683 0 C-N-CA 123.33 0.652 . . . . 0.0 109.343 169.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -105.6 91.32 3.71 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 124.096 0.958 . . . . 0.0 109.482 -176.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -90.35 126.51 35.89 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.753 -1.217 . . . . 0.0 112.035 -168.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 165.65 -95.16 0.12 Allowed Glycine 0 N--CA 1.489 2.167 0 O-C-N 121.017 -1.052 . . . . 0.0 114.122 172.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -75.05 -48.32 24.57 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 115.7 1.741 . . . . 0.0 115.7 -173.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.566 ' NZ ' ' HD2' ' A' ' 24' ' ' ASP . 43.6 mttp -115.88 151.47 35.25 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 122.488 1.137 . . . . 0.0 113.908 -168.645 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -75.68 153.52 37.09 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 54.44 36.32 57.89 Favored Glycine 0 N--CA 1.5 2.954 0 N-CA-C 119.949 2.74 . . . . 0.0 119.949 -178.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 32.3 ttt180 -100.53 116.06 31.59 Favored 'General case' 0 CA--C 1.563 1.45 0 C-N-CA 123.861 0.864 . . . . 0.0 111.177 -164.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 178.25 -170.64 42.84 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 115.336 0.894 . . . . 0.0 115.336 -178.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 37.3 p-90 -154.02 151.93 29.93 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 174.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 91.1 m -121.07 121.06 37.1 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.364 -0.835 . . . . 0.0 109.299 173.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -120.8 129.42 53.57 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 123.205 0.602 . . . . 0.0 112.087 -177.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 19.7 p90 -142.96 172.68 12.37 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.995 -1.066 . . . . 0.0 112.836 178.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 72.0 mt -119.86 132.04 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 O-C-N 121.07 -1.019 . . . . 0.0 109.989 175.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -110.19 89.74 3.11 Favored 'General case' 0 CA--C 1.567 1.611 0 C-N-CA 123.847 0.859 . . . . 0.0 108.77 165.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 68.6 -106.99 1.91 Allowed Glycine 0 N--CA 1.492 2.431 0 N-CA-C 115.75 1.06 . . . . 0.0 115.75 179.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 23.4 p-10 -87.79 0.31 55.94 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 117.248 2.314 . . . . 0.0 117.248 167.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -113.13 132.55 55.41 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-N 120.148 1.34 . . . . 0.0 112.116 -173.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 12.3 tp -93.98 124.71 38.17 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 123.726 0.811 . . . . 0.0 109.667 171.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 41.4 m80 -114.52 120.96 42.0 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 123.618 0.767 . . . . 0.0 109.078 -176.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 38.9 tp -122.99 121.67 36.65 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 123.742 0.817 . . . . 0.0 110.166 -175.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -106.35 113.65 27.3 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.601 -0.687 . . . . 0.0 109.957 169.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 66.9 mtm -105.94 127.99 53.51 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 123.164 0.586 . . . . 0.0 111.151 -178.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 73.4 mtm180 -119.14 134.11 55.39 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 124.064 0.945 . . . . 0.0 110.442 -169.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -156.78 129.42 7.64 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.27 -0.894 . . . . 0.0 111.697 170.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . 0.283 11.4 mt-10 52.55 44.77 29.67 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 115.843 1.794 . . . . 0.0 115.843 -177.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 68.41 12.53 63.81 Favored Glycine 0 CA--C 1.553 2.411 0 N-CA-C 120.713 3.045 . . . . 0.0 120.713 -167.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 92.6 t -113.88 124.96 71.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 CA-C-N 120.017 1.909 . . . . 0.0 108.516 -177.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 80.8 m -105.0 119.2 38.44 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 123.266 0.626 . . . . 0.0 110.389 179.079 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 12.6 t -88.71 138.13 31.69 Favored 'General case' 0 CA--C 1.56 1.363 0 C-N-CA 123.644 0.778 . . . . 0.0 111.735 161.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 48.1 mtpt -115.17 111.21 20.65 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.66 -0.65 . . . . 0.0 109.483 177.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -108.08 131.63 54.4 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 123.546 0.738 . . . . 0.0 111.169 176.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 51.6 t -116.58 131.52 68.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 176.15 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -123.08 153.69 39.58 Favored 'General case' 0 CA--C 1.565 1.522 0 C-N-CA 124.724 1.209 . . . . 0.0 110.628 178.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 26.6 ttmt -122.34 145.9 47.82 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.952 -1.092 . . . . 0.0 111.999 170.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 64.9 tttt -76.07 126.33 30.79 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -176.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 34.1 m -104.71 -43.42 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 174.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 68.5 t60 . . . . . 0 N--CA 1.486 1.34 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 168.46 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 74.2 mtp . . . . . 0 CA--C 1.573 1.827 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.505 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -62.89 -85.39 0.01 OUTLIER 'Trans proline' 0 CA--C 1.568 2.211 0 N-CA-C 118.475 2.452 . . . . 0.0 118.475 -174.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.4 p -178.3 130.34 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 C-N-CA 124.714 1.206 . . . . 0.0 108.92 -174.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -83.68 107.16 15.94 Favored 'General case' 0 CA--C 1.565 1.531 0 O-C-N 121.049 -1.032 . . . . 0.0 112.128 170.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -80.73 1.46 30.17 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 117.578 2.436 . . . . 0.0 117.578 175.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -55.06 113.42 1.35 Allowed 'General case' 0 CA--C 1.567 1.627 0 N-CA-C 115.756 1.761 . . . . 0.0 115.756 -174.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 162.51 177.26 35.38 Favored Glycine 0 N--CA 1.486 2.025 0 N-CA-C 116.184 1.234 . . . . 0.0 116.184 178.191 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -106.16 131.98 52.77 Favored 'General case' 0 CA--C 1.566 1.589 0 CA-C-N 114.388 -0.906 . . . . 0.0 109.312 168.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 78.4 m95 -128.06 129.15 46.18 Favored 'General case' 0 CA--C 1.563 1.479 0 C-N-CA 123.945 0.898 . . . . 0.0 109.542 -167.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.96 143.72 26.54 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.027 -1.046 . . . . 0.0 112.204 169.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 52.1 ttm -75.59 124.64 27.56 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.874 -1.142 . . . . 0.0 112.302 173.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 95.1 mt -82.52 -51.78 7.47 Favored 'General case' 0 CA--C 1.567 1.628 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.473 166.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 91.3 p -139.61 144.63 37.81 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-N 118.955 0.798 . . . . 0.0 112.134 177.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -118.18 89.56 3.15 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 121.763 0.792 . . . . 0.0 109.145 163.366 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -96.27 121.04 37.63 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.857 0.863 . . . . 0.0 110.081 -167.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.269 27.7 t30 66.59 24.73 10.12 Favored 'General case' 0 N--CA 1.503 2.184 0 N-CA-C 116.651 2.093 . . . . 0.0 116.651 -171.368 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -68.34 -44.54 75.09 Favored 'General case' 0 CA--C 1.569 1.676 0 N-CA-C 115.579 1.696 . . . . 0.0 115.579 178.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -53.73 -44.35 69.83 Favored 'General case' 0 N--CA 1.503 2.176 0 N-CA-C 116.632 2.086 . . . . 0.0 116.632 168.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -63.25 -44.74 94.3 Favored 'General case' 0 CA--C 1.573 1.858 0 N-CA-C 114.765 1.395 . . . . 0.0 114.765 174.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 44.4 t80 -54.48 -50.56 67.48 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 115.0 1.482 . . . . 0.0 115.0 166.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 94.2 mt -63.61 -41.38 98.31 Favored 'General case' 0 CA--C 1.571 1.762 0 N-CA-C 115.142 1.534 . . . . 0.0 115.142 174.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 71.5 ttp85 -53.4 -50.63 64.74 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 115.173 1.545 . . . . 0.0 115.173 163.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.08 -16.11 17.44 Favored 'General case' 0 CA--C 1.568 1.665 0 N-CA-C 118.591 2.812 . . . . 0.0 118.591 168.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 35.4 mt -91.92 -0.66 57.5 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 115.919 1.822 . . . . 0.0 115.919 166.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 62.43 61.64 1.23 Allowed 'General case' 0 N--CA 1.494 1.77 0 CA-C-N 119.98 1.264 . . . . 0.0 113.392 -165.026 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 96.1 t -111.48 136.97 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 N-CA-C 107.767 -1.198 . . . . 0.0 107.767 170.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 14.3 p30 -64.02 157.47 25.09 Favored 'General case' 0 CA--C 1.57 1.749 0 N-CA-C 116.094 1.887 . . . . 0.0 116.094 -177.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 43.2 t -56.9 -43.87 81.18 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.301 0 N-CA-C 114.753 1.39 . . . . 0.0 114.753 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.63 -50.52 72.86 Favored 'General case' 0 CA--C 1.564 1.518 0 N-CA-C 115.741 1.756 . . . . 0.0 115.741 172.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.2 tt -69.9 -37.78 76.11 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 115.092 1.515 . . . . 0.0 115.092 172.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 69.9 mtp180 -46.78 -52.87 13.13 Favored 'General case' 0 N--CA 1.502 2.166 0 CA-C-N 121.21 1.823 . . . . 0.0 115.695 161.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -65.91 -50.07 65.77 Favored 'General case' 0 CA--C 1.565 1.532 0 N-CA-C 114.004 1.113 . . . . 0.0 114.004 170.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 9.8 mt -78.99 58.68 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.586 2.346 0 CA-C-N 120.952 1.705 . . . . 0.0 110.831 175.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -174.98 -47.21 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 126.425 1.89 . . . . 0.0 111.131 -178.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -76.2 -30.61 58.08 Favored 'General case' 0 CA--C 1.569 1.682 0 N-CA-C 115.794 1.776 . . . . 0.0 115.794 164.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 96.0 mt -76.56 -36.27 57.73 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 114.925 1.454 . . . . 0.0 114.925 177.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -100.2 148.21 24.88 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 118.759 0.709 . . . . 0.0 111.015 170.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 44.5 mmtm -103.09 95.86 7.25 Favored Pre-proline 0 CA--C 1.573 1.854 0 CA-C-O 117.707 -1.14 . . . . 0.0 110.105 -171.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -73.52 158.49 47.66 Favored 'Trans proline' 0 CA--C 1.564 1.998 0 CA-C-N 123.158 2.164 . . . . 0.0 115.898 -176.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -90.78 160.55 15.72 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-N 115.714 -0.675 . . . . 0.0 112.21 178.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 30.4 mttp -120.96 121.28 37.68 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.018 -1.052 . . . . 0.0 110.016 170.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -103.37 105.66 15.99 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 164.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 76.0 mt -97.85 116.83 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 87.0 t -102.12 93.79 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 173.017 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -93.12 94.13 8.67 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 123.163 0.585 . . . . 0.0 109.712 175.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -101.81 73.93 1.45 Allowed 'General case' 0 CA--C 1.566 1.594 0 O-C-N 121.632 -0.668 . . . . 0.0 110.877 -178.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 57.4 71.49 0.74 Allowed Glycine 0 N--CA 1.494 2.506 0 N-CA-C 116.909 1.524 . . . . 0.0 116.909 179.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.471 0.4 OUTLIER 70.2 -30.37 0.2 Allowed 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 118.257 2.688 . . . . 0.0 118.257 -166.499 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 21.9 t-160 -76.42 99.42 4.87 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-N 120.937 1.699 . . . . 0.0 110.543 170.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 3.8 ttp -116.7 119.06 34.28 Favored 'General case' 0 CA--C 1.552 1.054 0 CA-C-O 121.917 0.865 . . . . 0.0 110.08 -169.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 5.2 mp -107.02 106.91 21.52 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.422 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 -178.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 24.1 mm -88.97 99.58 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 177.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 65.4 mtt-85 -95.07 95.67 8.73 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.498 -0.751 . . . . 0.0 109.591 -179.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 16.3 m -82.6 115.87 21.75 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 169.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 45.9 mt -119.65 114.1 21.68 Favored 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 123.665 0.786 . . . . 0.0 109.04 -164.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.6 t -102.12 -67.13 0.88 Allowed 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -178.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . 0.317 8.8 t 160.47 -61.89 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.165 0 C-N-CA 126.884 2.074 . . . . 0.0 106.821 -171.627 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -77.25 -48.57 17.16 Favored 'General case' 0 CA--C 1.579 2.062 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 161.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 3.6 tpm_? -95.02 135.97 35.9 Favored 'General case' 0 CA--C 1.564 1.501 0 CA-C-O 122.434 1.111 . . . . 0.0 113.157 -170.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 47.1 m-80 -121.89 135.51 54.89 Favored 'General case' 0 CA--C 1.568 1.64 0 CA-C-N 114.625 -1.171 . . . . 0.0 108.574 164.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 20.6 m-30 -94.25 -61.0 1.6 Allowed 'General case' 0 N--CA 1.504 2.231 0 O-C-N 120.898 -1.126 . . . . 0.0 113.179 171.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.282 4.3 mm 64.0 57.21 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.429 0 CA-C-N 119.694 1.133 . . . . 0.0 113.606 175.559 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 66.7 mtp -79.61 104.7 10.39 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.007 -1.683 . . . . 0.0 109.69 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -116.56 108.65 16.24 Favored 'General case' 0 CA--C 1.56 1.354 0 C-N-CA 123.739 0.816 . . . . 0.0 110.807 -162.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 20.5 p90 -152.22 145.81 24.95 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -163.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 18.7 mp0 -82.46 124.85 30.44 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.333 -0.854 . . . . 0.0 110.332 159.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 26.0 t -65.88 121.4 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.57 -0.706 . . . . 0.0 110.581 178.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 116.24 -38.85 2.9 Favored Glycine 0 CA--C 1.55 2.26 0 N-CA-C 116.328 1.291 . . . . 0.0 116.328 -160.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -80.89 141.64 34.38 Favored 'General case' 0 CA--C 1.567 1.616 0 CA-C-N 119.397 1.599 . . . . 0.0 114.021 -172.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -96.11 102.35 14.14 Favored 'General case' 0 CA--C 1.568 1.641 0 C-N-CA 123.694 0.798 . . . . 0.0 109.896 171.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -115.41 146.64 41.42 Favored 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 123.883 0.873 . . . . 0.0 113.153 -169.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -70.1 120.77 16.3 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 119.955 -1.716 . . . . 0.0 113.263 171.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -78.1 81.0 4.51 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.087 -1.008 . . . . 0.0 110.332 173.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -104.48 57.19 0.71 Allowed 'General case' 0 CA--C 1.575 1.923 0 CA-C-O 122.083 0.944 . . . . 0.0 111.59 173.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 6.5 tt -133.97 124.03 25.62 Favored 'General case' 0 CA--C 1.567 1.606 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 175.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 11.3 t -90.88 145.18 24.96 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 121.994 0.902 . . . . 0.0 113.383 -178.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 156.31 -61.41 0.35 Allowed Glycine 0 N--CA 1.49 2.295 0 O-C-N 121.637 -0.665 . . . . 0.0 111.629 -170.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 48.2 mm -69.06 158.2 6.11 Favored 'Isoleucine or valine' 0 CA--C 1.587 2.379 0 O-C-N 122.557 -0.378 . . . . 0.0 110.117 140.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -36.96 -52.06 0.94 Allowed 'General case' 0 N--CA 1.504 2.243 0 N-CA-C 118.335 2.717 . . . . 0.0 118.335 178.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.1 t0 74.25 116.43 0.06 Allowed 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 124.571 1.148 . . . . 0.0 113.618 177.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 -132.38 54.62 1.93 Allowed 'General case' 0 CA--C 1.571 1.769 0 O-C-N 121.59 -0.694 . . . . 0.0 111.618 158.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . 0.258 9.7 mtpm? 43.25 57.47 3.78 Favored 'General case' 0 N--CA 1.503 2.181 0 N-CA-C 116.922 2.193 . . . . 0.0 116.922 -178.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 81.2 m -86.3 127.71 34.82 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.43 -0.794 . . . . 0.0 113.036 -164.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 4.6 tpt -78.45 104.18 8.88 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-O 122.153 0.978 . . . . 0.0 110.16 -172.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 85.7 m -110.43 121.97 46.6 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.926 -155.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 91.7 m -113.44 119.68 38.42 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 -179.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.46 HG23 ' SG ' ' A' ' 95' ' ' CYS . 22.0 t -112.19 119.11 59.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 177.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 65.3 m -140.54 156.86 46.18 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 122.049 0.928 . . . . 0.0 112.513 -173.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 34.5 m95 -84.52 118.76 24.52 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.043 -1.035 . . . . 0.0 112.908 -178.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -99.23 75.25 1.99 Allowed 'General case' 0 CA--C 1.567 1.597 0 C-N-CA 123.494 0.718 . . . . 0.0 109.894 167.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 73.19 -104.97 1.66 Allowed Glycine 0 N--CA 1.487 2.092 0 O-C-N 121.544 -0.723 . . . . 0.0 112.7 -174.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -92.48 -18.19 23.52 Favored 'General case' 0 CA--C 1.573 1.832 0 N-CA-C 115.469 1.655 . . . . 0.0 115.469 167.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 78.7 mttt -91.46 137.59 32.24 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 121.111 1.778 . . . . 0.0 112.07 -174.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 22.8 tp -92.25 109.96 21.34 Favored 'General case' 0 CA--C 1.563 1.457 0 O-C-N 121.324 -0.86 . . . . 0.0 110.017 177.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -99.3 125.72 45.0 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.392 0.677 . . . . 0.0 111.411 -175.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . 0.46 ' SG ' HG23 ' A' ' 86' ' ' VAL . 46.1 t -116.89 131.86 56.85 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.725 0.81 . . . . 0.0 110.803 176.461 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 11.0 p -123.66 123.68 67.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 C-N-CA 122.791 0.437 . . . . 0.0 110.281 169.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 69.3 mt-30 -102.57 108.36 19.62 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 124.25 1.02 . . . . 0.0 110.71 -177.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -96.65 127.01 42.22 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 -169.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 167.62 -110.42 0.39 Allowed Glycine 0 N--CA 1.488 2.146 0 O-C-N 121.419 -0.801 . . . . 0.0 114.189 167.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -75.41 -43.16 51.42 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 115.614 1.709 . . . . 0.0 115.614 -176.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 37.4 mmtm -83.9 138.56 33.11 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-O 121.935 0.874 . . . . 0.0 112.713 179.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -78.77 148.09 33.09 Favored 'General case' 0 CA--C 1.566 1.585 0 CA-C-N 115.663 -0.699 . . . . 0.0 112.096 168.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 61.0 23.65 61.87 Favored Glycine 0 N--CA 1.498 2.774 0 N-CA-C 120.85 3.1 . . . . 0.0 120.85 178.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 46.5 ttt180 -87.5 118.25 26.84 Favored 'General case' 0 CA--C 1.564 1.498 0 CA-C-N 118.78 1.29 . . . . 0.0 111.792 -175.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -178.3 -172.18 42.43 Favored Glycine 0 N--CA 1.486 2.029 0 O-C-N 121.449 -0.782 . . . . 0.0 114.925 -175.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 41.8 p-90 -157.42 151.1 24.12 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 172.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 29.3 m -120.47 120.04 34.74 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 123.604 0.761 . . . . 0.0 109.192 173.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 22.6 tt0 -119.61 135.08 54.95 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 123.316 0.646 . . . . 0.0 112.489 -176.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 20.8 p90 -152.41 168.98 23.7 Favored 'General case' 0 N--CA 1.497 1.899 0 C-N-CA 123.792 0.837 . . . . 0.0 112.535 177.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 63.2 mt -113.65 133.42 59.66 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.168 0 O-C-N 120.557 -1.339 . . . . 0.0 110.119 172.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -107.66 90.36 3.28 Favored 'General case' 0 CA--C 1.566 1.596 0 C-N-CA 123.789 0.836 . . . . 0.0 109.313 164.102 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 70.29 -103.98 1.27 Allowed Glycine 0 N--CA 1.491 2.358 0 N-CA-C 115.388 0.915 . . . . 0.0 115.388 179.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 54.1 p30 -95.51 5.17 52.24 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 117.121 2.267 . . . . 0.0 117.121 167.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 77.6 mt-10 -115.33 133.96 55.55 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 120.321 1.419 . . . . 0.0 112.295 -176.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 11.1 tp -91.73 121.63 33.55 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 123.951 0.9 . . . . 0.0 109.357 173.145 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 39.2 m80 -111.72 119.39 38.47 Favored 'General case' 0 CA--C 1.559 1.3 0 C-N-CA 123.655 0.782 . . . . 0.0 108.939 -176.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 37.8 tp -124.8 121.62 35.1 Favored 'General case' 0 CA--C 1.562 1.437 0 C-N-CA 123.885 0.874 . . . . 0.0 109.618 -174.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -108.53 104.2 13.48 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 172.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 64.5 mtm -98.82 125.2 44.13 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.784 -0.572 . . . . 0.0 111.158 -177.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -107.74 142.36 37.86 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 123.443 0.697 . . . . 0.0 112.277 -175.132 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -152.98 124.73 7.81 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-O 121.635 0.731 . . . . 0.0 110.867 164.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . 0.311 13.8 mt-10 60.58 31.61 20.26 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 116.654 2.094 . . . . 0.0 116.654 -178.103 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 83.07 -15.21 34.23 Favored Glycine 0 CA--C 1.553 2.451 0 N-CA-C 119.167 2.427 . . . . 0.0 119.167 -162.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 86.2 t -86.93 122.97 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 CA-C-N 120.04 1.92 . . . . 0.0 109.516 -176.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 42.8 m -100.56 124.68 46.45 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 121.092 0.472 . . . . 0.0 111.198 176.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 16.1 t -89.72 127.48 35.95 Favored 'General case' 0 CA--C 1.559 1.312 0 C-N-CA 123.239 0.616 . . . . 0.0 111.241 160.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp -100.48 107.74 19.53 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 175.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 66.3 mt-30 -103.49 124.38 48.65 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.105 0.562 . . . . 0.0 110.361 175.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 58.1 t -112.08 130.99 64.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 175.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -124.65 155.45 39.15 Favored 'General case' 0 CA--C 1.566 1.575 0 C-N-CA 124.685 1.194 . . . . 0.0 110.763 -179.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -125.89 141.27 52.06 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.811 -1.18 . . . . 0.0 112.492 174.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 43.0 tttm -74.49 125.07 27.78 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 -174.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 35.8 m -108.55 -41.76 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 176.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 47.2 t-80 . . . . . 0 C--O 1.254 1.331 0 CA-C-N 119.932 1.242 . . . . 0.0 108.966 172.651 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 79.3 mtp . . . . . 0 CA--C 1.573 1.84 0 CA-C-O 118.544 -0.741 . . . . 0.0 112.182 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -74.15 168.45 24.78 Favored 'Trans proline' 0 CA--C 1.564 2.006 0 C-N-CA 122.333 2.022 . . . . 0.0 116.711 176.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 32.8 m -76.83 146.26 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 CA-C-N 115.266 -0.879 . . . . 0.0 112.712 177.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -80.94 103.48 10.79 Favored 'General case' 0 CA--C 1.565 1.536 0 O-C-N 120.606 -1.308 . . . . 0.0 111.381 176.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 13.6 m-30 -70.43 -3.43 17.63 Favored 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 117.66 2.466 . . . . 0.0 117.66 172.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -46.5 114.28 0.79 Allowed 'General case' 0 CA--C 1.567 1.62 0 N-CA-C 116.575 2.065 . . . . 0.0 116.575 178.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 157.18 176.01 28.76 Favored Glycine 0 N--CA 1.487 2.08 0 N-CA-C 116.084 1.193 . . . . 0.0 116.084 -179.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -104.6 125.05 50.36 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 121.345 0.593 . . . . 0.0 109.514 172.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 68.5 m95 -123.33 124.66 43.45 Favored 'General case' 0 CA--C 1.568 1.659 0 C-N-CA 123.832 0.853 . . . . 0.0 109.11 -171.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 20.7 pttp -102.96 143.09 33.0 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 120.91 -1.119 . . . . 0.0 112.678 179.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.414 ' SD ' ' HD2' ' A' ' 38' ' ' PRO . 34.0 ttm -66.77 127.23 31.68 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.791 -1.193 . . . . 0.0 113.959 -179.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 93.7 mt -86.46 -55.41 3.9 Favored 'General case' 0 CA--C 1.566 1.595 0 C-N-CA 123.41 0.684 . . . . 0.0 112.467 163.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 88.1 p -139.53 149.5 43.98 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 119.023 0.828 . . . . 0.0 112.759 -177.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -124.49 110.88 15.04 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.07 0.548 . . . . 0.0 109.936 164.063 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -109.77 128.16 55.11 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.861 0.864 . . . . 0.0 109.362 -175.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.268 22.6 t30 64.57 23.02 12.79 Favored 'General case' 0 N--CA 1.504 2.229 0 N-CA-C 116.877 2.177 . . . . 0.0 116.877 -176.218 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -66.59 -45.65 78.54 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 115.471 1.656 . . . . 0.0 115.471 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -55.12 -41.42 71.68 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 116.298 1.962 . . . . 0.0 116.298 169.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -67.31 -41.24 85.66 Favored 'General case' 0 CA--C 1.573 1.835 0 N-CA-C 115.528 1.677 . . . . 0.0 115.528 174.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -53.98 -51.23 64.57 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 163.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.5 mt -63.41 -42.64 98.77 Favored 'General case' 0 CA--C 1.572 1.811 0 N-CA-C 114.641 1.348 . . . . 0.0 114.641 175.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 29.7 ttp85 -49.88 -49.65 48.7 Favored 'General case' 0 CA--C 1.575 1.938 0 N-CA-C 115.525 1.676 . . . . 0.0 115.525 161.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.04 -24.31 57.84 Favored 'General case' 0 CA--C 1.569 1.678 0 N-CA-C 117.709 2.485 . . . . 0.0 117.709 167.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 88.6 mt -83.52 1.61 41.04 Favored 'General case' 0 CA--C 1.572 1.823 0 N-CA-C 116.172 1.916 . . . . 0.0 116.172 166.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.268 20.8 m-20 64.1 48.36 3.02 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 114.834 1.42 . . . . 0.0 114.834 -168.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 92.6 t -96.58 142.42 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 CA-C-O 122.218 1.009 . . . . 0.0 109.429 175.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 7.5 p-10 -69.7 154.65 41.68 Favored 'General case' 0 CA--C 1.57 1.717 0 N-CA-C 115.305 1.594 . . . . 0.0 115.305 176.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 57.7 t -55.55 -41.24 62.96 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.303 0 N-CA-C 115.399 1.629 . . . . 0.0 115.399 -176.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.87 -49.42 76.32 Favored 'General case' 0 CA--C 1.567 1.598 0 N-CA-C 116.09 1.885 . . . . 0.0 116.09 173.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -62.02 -43.46 98.79 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 170.014 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 60.4 mtp180 -46.12 -53.59 10.09 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 116.201 1.926 . . . . 0.0 116.201 162.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 14.2 tptt -65.37 -47.99 74.49 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 115.603 1.705 . . . . 0.0 115.603 173.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 60.9 mt -55.26 -49.7 70.37 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.188 0 CA-C-N 119.806 1.185 . . . . 0.0 113.499 173.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.54 -42.05 92.36 Favored 'General case' 0 CA--C 1.565 1.529 0 N-CA-C 117.339 2.348 . . . . 0.0 117.339 173.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -59.65 -39.87 85.83 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 116.487 2.032 . . . . 0.0 116.487 168.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 89.9 mt -83.06 -16.21 47.88 Favored 'General case' 0 CA--C 1.569 1.681 0 N-CA-C 116.302 1.964 . . . . 0.0 116.302 179.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 69.4 mt -85.43 147.94 26.24 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 120.093 1.315 . . . . 0.0 112.342 171.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -105.21 87.42 1.99 Allowed Pre-proline 0 CA--C 1.574 1.873 0 CA-C-O 118.154 -0.926 . . . . 0.0 109.489 172.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.417 ' C ' ' HD2' ' A' ' 39' ' ' ASP . 60.5 Cg_endo -69.92 174.78 9.14 Favored 'Trans proline' 0 CA--C 1.564 1.992 0 C-N-CA 122.538 2.159 . . . . 0.0 115.423 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.417 ' HD2' ' C ' ' A' ' 38' ' ' PRO . 66.9 m-20 -130.36 136.27 48.91 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.545 -1.347 . . . . 0.0 110.806 -176.524 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 50.2 mttp -103.48 111.65 24.2 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.582 -0.699 . . . . 0.0 109.696 174.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -96.84 101.29 12.85 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 166.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 65.3 mt -93.93 119.15 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -173.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 75.8 t -109.83 95.32 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 177.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -99.31 118.46 36.03 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 123.751 0.82 . . . . 0.0 110.329 178.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -133.58 66.38 1.55 Allowed 'General case' 0 CA--C 1.569 1.696 0 O-C-N 121.51 -0.744 . . . . 0.0 111.867 -178.212 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 72.15 81.39 0.34 Allowed Glycine 0 N--CA 1.493 2.448 0 N-CA-C 115.274 0.87 . . . . 0.0 115.274 174.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.458 0.2 OUTLIER 65.66 -41.59 0.34 Allowed 'General case' 0 N--CA 1.502 2.141 0 N-CA-C 117.861 2.541 . . . . 0.0 117.861 -167.903 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 14.3 t-80 -70.55 120.47 16.23 Favored 'General case' 0 CA--C 1.562 1.416 0 O-C-N 120.984 -1.073 . . . . 0.0 111.595 168.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 17.5 ttp -136.87 125.35 23.52 Favored 'General case' 0 CA--C 1.555 1.163 0 CA-C-O 121.841 0.829 . . . . 0.0 110.522 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 23.0 mt -104.43 107.62 22.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 174.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 83.0 mt -86.67 99.71 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 168.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -85.05 93.07 8.52 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.51 -0.744 . . . . 0.0 109.863 -178.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 80.7 m -87.84 102.29 14.55 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 -177.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 17.6 mt -105.84 121.22 43.61 Favored 'General case' 0 CA--C 1.557 1.241 0 CA-C-N 114.514 -1.221 . . . . 0.0 109.365 -164.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 27.1 t -132.57 143.96 50.07 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.38 0.672 . . . . 0.0 110.528 -178.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 21.6 m -56.05 -34.77 66.21 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 116.123 1.898 . . . . 0.0 116.123 175.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -79.93 -58.64 3.07 Favored 'General case' 0 CA--C 1.569 1.693 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 175.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.456 ' NH2' ' HG1' ' A' ' 75' ' ' THR . 11.9 tpt180 -151.7 127.18 10.04 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-N 119.824 1.193 . . . . 0.0 110.887 177.291 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -76.86 145.14 38.53 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 177.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -95.92 -67.96 0.82 Allowed 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 118.714 -0.66 . . . . 0.0 112.186 178.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.273 11.4 mm 72.52 96.76 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 C-N-CA 124.128 0.971 . . . . 0.0 111.716 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 82.2 mtp -96.25 98.71 10.51 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.02 -1.05 . . . . 0.0 109.568 173.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -100.66 110.57 22.7 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 123.659 0.784 . . . . 0.0 110.183 -179.118 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -150.52 157.45 43.02 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 114.527 1.306 . . . . 0.0 114.527 -167.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -101.08 138.03 38.65 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.586 -0.696 . . . . 0.0 110.312 160.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 92.5 t -67.77 128.18 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.289 -0.882 . . . . 0.0 110.995 -177.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 91.25 -45.7 2.82 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 116.518 1.367 . . . . 0.0 116.518 -165.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 16.7 tttp -67.29 122.49 17.99 Favored 'General case' 0 CA--C 1.571 1.78 0 C-N-CA 125.37 1.468 . . . . 0.0 113.051 178.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -84.43 114.93 22.26 Favored 'General case' 0 CA--C 1.567 1.6 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.888 -176.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -113.17 139.83 48.43 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -169.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -76.97 112.67 13.85 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.154 -0.966 . . . . 0.0 112.496 177.12 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -90.88 111.22 22.54 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.232 0.613 . . . . 0.0 110.334 175.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.67 ' HD2' ' NZ ' ' A' ' 81' ' ' LYS . 1.0 OUTLIER -85.12 178.99 7.34 Favored 'General case' 0 CA--C 1.574 1.896 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -178.57 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 5.4 tt -64.49 -26.26 68.35 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 118.653 2.834 . . . . 0.0 118.653 -160.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.456 ' HG1' ' NH2' ' A' ' 58' ' ' ARG . 53.9 m -71.14 90.44 0.88 Allowed 'General case' 0 N--CA 1.499 1.988 0 CA-C-N 120.529 1.513 . . . . 0.0 110.82 170.132 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 160.58 68.06 0.02 OUTLIER Glycine 0 N--CA 1.483 1.779 0 CA-C-N 115.6 -0.727 . . . . 0.0 113.483 -175.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . 0.364 4.0 mp 68.36 -86.11 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 C-N-CA 124.087 0.955 . . . . 0.0 110.099 -174.35 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 48.5 p-10 -157.76 58.02 0.48 Allowed 'General case' 0 CA--C 1.57 1.74 0 C-N-CA 124.39 1.076 . . . . 0.0 111.081 170.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.457 ' N ' ' HD2' ' A' ' 79' ' ' ASP . 7.9 m-20 -85.1 91.96 8.24 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.48 -1.387 . . . . 0.0 110.408 178.491 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 35.7 ttm105 -81.58 67.95 7.74 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.813 -1.18 . . . . 0.0 113.237 -173.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.67 ' NZ ' ' HD2' ' A' ' 73' ' ' ASP 0.262 61.5 mttm 56.31 60.28 3.24 Favored 'General case' 0 N--CA 1.501 2.099 0 N-CA-C 114.265 1.209 . . . . 0.0 114.265 -170.208 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 73.7 m -92.9 125.85 37.7 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.608 -0.683 . . . . 0.0 111.802 -173.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 15.5 mtp -80.46 98.11 7.4 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-O 121.655 0.74 . . . . 0.0 110.919 177.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 91.2 m -101.46 125.35 48.09 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.658 -0.651 . . . . 0.0 110.7 -167.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 85.3 m -106.3 122.94 47.24 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 176.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 20.6 t -116.19 121.61 67.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 179.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 58.4 m -128.64 139.19 52.38 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 123.829 0.852 . . . . 0.0 111.221 -173.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 2.9 m95 -81.49 122.34 27.41 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.845 -1.16 . . . . 0.0 113.69 179.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -112.32 67.93 0.66 Allowed 'General case' 0 CA--C 1.577 1.996 0 C-N-CA 123.382 0.673 . . . . 0.0 110.632 164.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 69.96 -102.82 1.04 Allowed Glycine 0 N--CA 1.495 2.584 0 N-CA-C 115.968 1.147 . . . . 0.0 115.968 177.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -75.47 -28.93 59.44 Favored 'General case' 0 CA--C 1.574 1.878 0 N-CA-C 115.206 1.558 . . . . 0.0 115.206 162.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 29.8 mtpt -98.87 107.42 19.85 Favored 'General case' 0 N--CA 1.484 1.263 0 CA-C-N 119.469 1.031 . . . . 0.0 110.56 -167.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 30.4 tp -80.75 111.06 16.84 Favored 'General case' 0 CA--C 1.563 1.473 0 O-C-N 120.729 -1.232 . . . . 0.0 109.844 173.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 -97.55 126.94 43.13 Favored 'General case' 0 CA--C 1.558 1.272 0 C-N-CA 124.011 0.925 . . . . 0.0 110.961 -174.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 41.9 t -127.48 133.88 49.86 Favored 'General case' 0 N--CA 1.481 1.108 0 O-C-N 121.674 -0.641 . . . . 0.0 111.831 -178.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 12.2 p -118.78 128.92 75.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 C-N-CA 123.068 0.547 . . . . 0.0 109.78 168.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -99.96 104.28 15.89 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 123.47 0.708 . . . . 0.0 109.753 178.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -91.25 119.79 31.61 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.059 -1.026 . . . . 0.0 110.676 -173.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -174.41 -70.33 0.05 OUTLIER Glycine 0 N--CA 1.489 2.172 0 N-CA-C 116.022 1.169 . . . . 0.0 116.022 -175.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -138.27 -60.45 0.62 Allowed 'General case' 0 N--CA 1.498 1.963 0 CA-C-N 117.755 0.777 . . . . 0.0 111.952 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -72.74 133.04 44.38 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-O 122.231 1.015 . . . . 0.0 111.704 -173.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -68.73 -56.83 6.84 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 115.392 1.627 . . . . 0.0 115.392 -160.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -83.68 44.11 3.26 Favored Glycine 0 CA--C 1.55 2.226 0 N-CA-C 117.728 1.851 . . . . 0.0 117.728 166.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 25.1 ttt180 -85.95 119.04 25.83 Favored 'General case' 0 CA--C 1.566 1.587 0 CA-C-N 119.674 1.737 . . . . 0.0 113.366 -176.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 175.0 -165.84 37.18 Favored Glycine 0 N--CA 1.485 1.906 0 CA-C-O 122.01 0.783 . . . . 0.0 114.73 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 45.3 p-90 -155.66 152.94 29.26 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 172.065 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 81.8 m -119.73 121.38 39.06 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 169.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -121.0 128.52 52.78 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.604 -0.685 . . . . 0.0 111.578 -177.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 16.4 p90 -148.04 155.32 41.36 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.797 -1.19 . . . . 0.0 113.587 -176.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 94.8 mt -94.35 134.46 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.033 -1.042 . . . . 0.0 110.382 174.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -118.4 94.9 4.65 Favored 'General case' 0 CA--C 1.566 1.574 0 CA-C-N 114.897 -1.047 . . . . 0.0 108.441 159.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 69.11 -108.03 2.32 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 115.619 1.008 . . . . 0.0 115.619 -179.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 55.5 p30 -90.18 2.42 55.38 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 117.407 2.373 . . . . 0.0 117.407 168.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -121.24 130.15 53.53 Favored 'General case' 0 N--CA 1.486 1.329 0 CA-C-N 119.827 1.194 . . . . 0.0 111.663 -168.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 18.4 tp -91.64 113.63 25.95 Favored 'General case' 0 CA--C 1.562 1.409 0 C-N-CA 124.424 1.089 . . . . 0.0 109.451 172.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 41.6 m80 -101.16 124.79 47.41 Favored 'General case' 0 CA--C 1.561 1.399 0 C-N-CA 124.33 1.052 . . . . 0.0 108.842 -177.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 43.6 tp -124.99 120.27 31.09 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.824 0.85 . . . . 0.0 110.332 -171.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -105.06 107.02 17.78 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.711 -0.618 . . . . 0.0 109.686 170.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 72.1 mtm -97.72 124.58 42.12 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-N 118.58 0.627 . . . . 0.0 111.131 179.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 84.7 mtm180 -111.55 139.45 46.98 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 123.866 0.866 . . . . 0.0 110.926 -171.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -147.28 132.46 18.36 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.095 -1.003 . . . . 0.0 112.968 167.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . 0.344 24.7 mt-10 65.61 -73.36 0.07 Allowed 'General case' 0 N--CA 1.502 2.126 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 -173.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -160.2 50.3 0.37 Allowed Glycine 0 CA--C 1.552 2.386 0 C-N-CA 123.862 0.744 . . . . 0.0 112.259 157.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 69.0 t -139.96 122.92 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 -163.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 31.3 m -105.47 123.06 47.26 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 122.996 0.518 . . . . 0.0 111.588 -173.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 44.6 t -88.61 128.98 35.59 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.561 -0.712 . . . . 0.0 111.261 159.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -105.39 110.75 23.22 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -179.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 16.4 mt-30 -118.07 139.08 51.74 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 123.559 0.744 . . . . 0.0 111.491 -176.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 33.9 t -122.93 131.79 72.61 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 O-C-N 121.478 -0.764 . . . . 0.0 109.042 -178.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -126.48 138.72 53.54 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 124.146 0.978 . . . . 0.0 110.521 -179.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 76.8 tttt -106.89 140.45 39.69 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.643 -1.286 . . . . 0.0 112.654 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 61.8 tttt -73.63 120.74 19.65 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -179.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 35.9 m -104.92 -41.27 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 175.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 52.8 t-80 . . . . . 0 N--CA 1.486 1.354 0 CA-C-N 119.715 1.143 . . . . 0.0 108.143 168.361 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 68.1 mtt . . . . . 0 CA--C 1.571 1.776 0 CA-C-O 118.385 -0.817 . . . . 0.0 111.755 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.34 161.11 40.99 Favored 'Trans proline' 0 CA--C 1.561 1.846 0 C-N-CA 122.239 1.959 . . . . 0.0 116.367 178.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 29.1 m -78.78 160.88 4.39 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.929 0 CA-C-O 122.399 1.095 . . . . 0.0 113.405 -177.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -90.99 107.1 18.98 Favored 'General case' 0 CA--C 1.565 1.547 0 O-C-N 121.015 -1.053 . . . . 0.0 112.373 -175.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 6.5 m-30 -83.64 -2.2 55.61 Favored 'General case' 0 CA--C 1.577 1.981 0 N-CA-C 116.152 1.908 . . . . 0.0 116.152 171.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 51.1 m-80 -58.52 114.05 2.28 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-N 121.612 2.006 . . . . 0.0 114.22 -178.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 160.05 -178.03 36.28 Favored Glycine 0 N--CA 1.483 1.833 0 CA-C-O 122.623 1.124 . . . . 0.0 115.896 -177.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 12.7 t80 -113.36 119.43 37.61 Favored 'General case' 0 CA--C 1.565 1.533 0 CA-C-N 114.222 -0.989 . . . . 0.0 108.875 178.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 77.2 m95 -123.01 124.37 42.99 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 123.541 0.737 . . . . 0.0 110.182 -165.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 64.1 pttt -98.68 136.81 38.21 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 120.501 -1.374 . . . . 0.0 113.4 -179.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 11.0 ttp -72.09 125.34 27.02 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-N 119.395 0.998 . . . . 0.0 112.901 177.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 78.6 mt -94.69 -56.29 2.83 Favored 'General case' 0 CA--C 1.564 1.503 0 CA-C-N 115.068 -0.969 . . . . 0.0 112.927 178.119 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 92.4 p -141.54 124.12 15.9 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.724 0.81 . . . . 0.0 110.227 -170.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -113.77 119.12 36.28 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 121.343 0.592 . . . . 0.0 111.327 175.107 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -114.37 126.84 55.45 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.81 0.844 . . . . 0.0 109.148 -176.054 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.265 19.0 t30 66.76 22.17 10.37 Favored 'General case' 0 CA--C 1.582 2.185 0 N-CA-C 116.911 2.189 . . . . 0.0 116.911 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -68.39 -43.39 77.39 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 115.382 1.623 . . . . 0.0 115.382 178.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -53.54 -44.86 69.55 Favored 'General case' 0 N--CA 1.501 2.108 0 N-CA-C 116.348 1.981 . . . . 0.0 116.348 167.006 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -65.64 -43.93 87.96 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 115.103 1.519 . . . . 0.0 115.103 175.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -53.44 -49.04 68.2 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 164.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 77.7 mt -63.47 -42.72 98.6 Favored 'General case' 0 CA--C 1.571 1.759 0 N-CA-C 114.539 1.311 . . . . 0.0 114.539 172.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 69.5 ttp85 -54.34 -46.19 72.88 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 115.696 1.739 . . . . 0.0 115.696 166.297 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.98 -31.83 65.45 Favored 'General case' 0 CA--C 1.567 1.63 0 N-CA-C 116.632 2.086 . . . . 0.0 116.632 164.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 82.2 mt -85.88 30.43 0.66 Allowed 'General case' 0 CA--C 1.572 1.818 0 N-CA-C 114.506 1.298 . . . . 0.0 114.506 167.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 64.54 17.98 11.14 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 117.023 2.231 . . . . 0.0 117.023 175.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 94.8 t -88.17 142.41 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 120.504 -1.373 . . . . 0.0 110.932 -168.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 7.8 p-10 -71.9 156.96 38.69 Favored 'General case' 0 CA--C 1.569 1.677 0 N-CA-C 115.363 1.616 . . . . 0.0 115.363 177.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 49.0 t -53.97 -42.71 55.35 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.407 0 N-CA-C 115.203 1.557 . . . . 0.0 115.203 -176.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.03 -52.4 65.53 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 115.871 1.804 . . . . 0.0 115.871 173.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -59.47 -42.27 91.64 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 115.934 1.827 . . . . 0.0 115.934 169.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 54.0 mtp180 -51.68 -57.53 8.95 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 164.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -59.63 -47.34 85.98 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 115.054 1.502 . . . . 0.0 115.054 175.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 64.7 mt -56.05 -57.06 9.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 CA-C-N 119.622 1.101 . . . . 0.0 112.675 172.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.0 -44.1 91.6 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 117.704 2.483 . . . . 0.0 117.704 176.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -67.61 -27.64 67.07 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 116.375 1.991 . . . . 0.0 116.375 172.289 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 88.5 mt -79.81 -31.45 40.66 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 115.686 1.735 . . . . 0.0 115.686 171.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . 0.272 4.1 pp -80.72 145.79 31.37 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-N 120.148 1.34 . . . . 0.0 114.486 -178.344 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -114.29 93.37 31.02 Favored Pre-proline 0 CA--C 1.573 1.843 0 CA-C-O 118.368 -0.825 . . . . 0.0 108.841 -177.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -81.19 166.93 18.15 Favored 'Trans proline' 0 CA--C 1.56 1.817 0 C-N-CA 122.969 2.446 . . . . 0.0 115.083 -174.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -106.0 118.65 37.17 Favored 'General case' 0 N--CA 1.487 1.379 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.303 173.128 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.451 ' NZ ' ' HG1' ' A' ' 53' ' ' THR . 35.4 mttp -83.33 107.08 15.61 Favored 'General case' 0 N--CA 1.485 1.284 0 O-C-N 121.302 -0.874 . . . . 0.0 110.331 169.508 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -91.33 113.18 25.37 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 164.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 82.7 mt -108.9 122.94 64.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 -177.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 91.3 t -108.3 102.47 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 169.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 42.7 tt0 -98.69 100.55 11.78 Favored 'General case' 0 CA--C 1.565 1.54 0 C-N-CA 123.825 0.85 . . . . 0.0 110.031 175.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -93.91 74.01 4.17 Favored 'General case' 0 CA--C 1.57 1.737 0 O-C-N 121.438 -0.789 . . . . 0.0 110.228 168.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 65.03 -99.0 0.32 Allowed Glycine 0 N--CA 1.492 2.374 0 N-CA-C 115.053 0.781 . . . . 0.0 115.053 -174.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -83.26 -31.36 26.99 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 116.406 2.002 . . . . 0.0 116.406 165.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 22.6 t-160 -80.19 108.72 14.02 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 121.228 1.831 . . . . 0.0 110.915 -177.2 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 45.2 ttm -118.75 123.6 45.23 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 123.511 0.724 . . . . 0.0 110.046 -172.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 35.9 mt -107.36 106.14 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 175.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 33.9 mm -90.7 108.67 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 174.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 67.2 mtt85 -105.66 100.09 9.67 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.654 -0.654 . . . . 0.0 109.464 173.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.451 ' HG1' ' NZ ' ' A' ' 40' ' ' LYS . 59.1 m -89.9 102.74 15.44 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 176.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 15.2 mt -101.08 125.05 47.67 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.367 0.667 . . . . 0.0 111.132 -160.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.4 t -147.88 156.61 42.88 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 122.009 0.909 . . . . 0.0 111.126 179.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 25.2 m -59.57 -38.7 81.83 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 115.3 1.593 . . . . 0.0 115.3 171.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 35.5 t80 -74.54 -53.24 9.83 Favored 'General case' 0 CA--C 1.572 1.82 0 N-CA-C 114.733 1.382 . . . . 0.0 114.733 174.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 71.2 ttt180 -142.85 130.15 21.01 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 119.526 1.057 . . . . 0.0 110.274 174.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 71.5 m-80 -93.5 117.29 29.9 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 166.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 75.6 t80 -105.01 105.43 15.47 Favored 'General case' 0 CA--C 1.566 1.59 0 C-N-CA 123.28 0.632 . . . . 0.0 111.087 -172.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.9 mp -99.19 121.53 49.9 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.833 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -178.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 95.9 mtp -115.39 103.37 10.72 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.568 -0.707 . . . . 0.0 109.369 167.259 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -101.22 112.92 25.54 Favored 'General case' 0 CA--C 1.566 1.577 0 C-N-CA 124.163 0.985 . . . . 0.0 111.806 177.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -153.74 154.28 33.76 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 115.047 1.499 . . . . 0.0 115.047 -166.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 28.0 mp0 -89.24 121.62 31.71 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.445 -0.784 . . . . 0.0 110.671 167.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 37.3 t -66.85 116.11 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 C-N-CA 123.785 0.834 . . . . 0.0 109.512 172.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 121.55 -46.31 1.13 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 115.589 0.996 . . . . 0.0 115.589 -158.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -84.34 145.75 28.08 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 118.726 1.263 . . . . 0.0 113.297 -174.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -91.9 100.34 13.03 Favored 'General case' 0 CA--C 1.568 1.638 0 O-C-N 121.788 -0.57 . . . . 0.0 110.895 173.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -107.63 145.7 32.96 Favored 'General case' 0 N--CA 1.495 1.813 0 C-N-CA 124.073 0.949 . . . . 0.0 113.429 -169.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -68.57 118.79 12.05 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.234 -1.541 . . . . 0.0 114.133 176.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -75.71 85.13 2.72 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 122.448 1.118 . . . . 0.0 109.672 163.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -134.07 126.28 29.79 Favored 'General case' 0 CA--C 1.558 1.276 0 CA-C-N 114.421 -1.263 . . . . 0.0 107.765 -173.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . 0.322 2.6 mm? 71.63 -61.87 0.48 Allowed 'General case' 0 N--CA 1.502 2.131 0 C-N-CA 123.59 0.756 . . . . 0.0 112.347 -166.673 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 7.2 t -77.52 58.1 1.68 Allowed 'General case' 0 CA--C 1.578 2.023 0 N-CA-C 114.455 1.28 . . . . 0.0 114.455 166.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -132.81 176.07 19.68 Favored Glycine 0 N--CA 1.488 2.134 0 O-C-N 120.512 -1.368 . . . . 0.0 113.937 172.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 46.2 mm -101.19 -67.81 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 122.302 -0.528 . . . . 0.0 110.77 -177.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 51.2 t0 -96.82 160.75 14.19 Favored 'General case' 0 CA--C 1.569 1.691 0 CA-C-O 122.317 1.056 . . . . 0.0 112.328 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -63.98 152.1 40.99 Favored 'General case' 0 CA--C 1.57 1.731 0 N-CA-C 114.347 1.24 . . . . 0.0 114.347 178.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . 0.323 0.0 OUTLIER 82.44 121.02 0.05 OUTLIER 'General case' 0 N--CA 1.498 1.931 0 C-N-CA 124.863 1.265 . . . . 0.0 111.656 -169.38 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? -79.01 128.34 33.13 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.506 0.723 . . . . 0.0 112.717 -169.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 99.4 m -101.27 117.18 34.45 Favored 'General case' 0 N--CA 1.487 1.394 0 CA-C-O 121.77 0.795 . . . . 0.0 112.151 -177.222 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 3.9 tpt -78.78 107.28 11.37 Favored 'General case' 0 CA--C 1.563 1.472 0 CA-C-O 122.211 1.005 . . . . 0.0 109.822 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 90.4 m -111.8 115.91 29.83 Favored 'General case' 0 N--CA 1.484 1.227 0 O-C-N 121.545 -0.722 . . . . 0.0 110.737 -152.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 50.3 m -89.96 123.53 33.96 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 168.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 59.7 t -108.87 131.8 58.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 166.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 58.7 m -143.36 150.94 39.84 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.771 -1.205 . . . . 0.0 112.676 -175.205 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 20.5 m95 -86.24 120.25 27.39 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 -178.001 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -105.23 62.76 0.69 Allowed 'General case' 0 CA--C 1.58 2.099 0 C-N-CA 123.871 0.868 . . . . 0.0 110.405 158.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 64.5 -98.99 0.3 Allowed Glycine 0 N--CA 1.496 2.634 0 N-CA-C 116.978 1.551 . . . . 0.0 116.978 178.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -68.96 -35.99 77.39 Favored 'General case' 0 CA--C 1.574 1.886 0 N-CA-C 115.121 1.526 . . . . 0.0 115.121 165.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -92.4 124.34 36.38 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.906 0.883 . . . . 0.0 112.073 -176.199 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 22.0 tp -89.99 108.69 19.87 Favored 'General case' 0 CA--C 1.564 1.491 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 166.087 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 30.3 mm-40 -97.95 130.82 44.79 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.709 0.804 . . . . 0.0 110.991 -172.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 42.4 t -127.67 127.92 44.57 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.015 0.526 . . . . 0.0 111.711 -175.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.6 p -115.07 115.21 48.75 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.625 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 169.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -93.59 94.95 8.91 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 123.628 0.771 . . . . 0.0 109.124 179.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 64.8 mttm -88.43 109.39 19.98 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.123 -0.986 . . . . 0.0 112.075 -169.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -179.83 85.37 0.07 OUTLIER Glycine 0 N--CA 1.484 1.871 0 CA-C-N 116.1 -0.5 . . . . 0.0 113.174 177.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . 0.271 29.1 tt0 70.35 -55.25 0.62 Allowed 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 116.697 2.11 . . . . 0.0 116.697 178.692 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.0 mmmp? -72.94 141.5 47.82 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 114.798 1.407 . . . . 0.0 114.798 -166.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -80.69 94.68 6.41 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.98 0.895 . . . . 0.0 112.526 -164.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 77.37 46.0 10.58 Favored Glycine 0 N--CA 1.486 1.988 0 N-CA-C 117.208 1.643 . . . . 0.0 117.208 -173.317 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 14.8 ttm180 -77.56 121.51 24.0 Favored 'General case' 0 CA--C 1.568 1.654 0 CA-C-N 118.546 1.173 . . . . 0.0 110.725 167.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 177.37 -171.74 44.51 Favored Glycine 0 N--CA 1.486 2.012 0 O-C-N 121.502 -0.749 . . . . 0.0 114.874 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 51.7 p-90 -157.96 154.04 27.13 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 114.125 1.157 . . . . 0.0 114.125 178.095 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 74.1 m -121.95 116.95 25.27 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 171.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 19.2 tt0 -115.7 126.73 54.48 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 123.398 0.679 . . . . 0.0 110.682 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 14.1 p90 -147.18 157.32 43.56 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.685 -1.259 . . . . 0.0 114.089 -175.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 95.8 mt -100.82 128.8 52.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.434 -0.791 . . . . 0.0 110.038 175.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -112.33 100.03 8.48 Favored 'General case' 0 CA--C 1.567 1.611 0 CA-C-N 114.697 -1.138 . . . . 0.0 108.543 160.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 70.53 -106.58 1.89 Allowed Glycine 0 N--CA 1.494 2.5 0 N-CA-C 115.442 0.937 . . . . 0.0 115.442 -179.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -112.43 33.7 4.76 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 114.767 1.395 . . . . 0.0 114.767 162.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -125.7 127.52 46.37 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 124.058 0.943 . . . . 0.0 109.707 177.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 17.0 tp -93.09 115.55 28.19 Favored 'General case' 0 CA--C 1.563 1.461 0 CA-C-O 122.097 0.951 . . . . 0.0 109.412 173.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 48.1 m80 -102.6 123.81 47.0 Favored 'General case' 0 CA--C 1.558 1.253 0 C-N-CA 124.17 0.988 . . . . 0.0 108.878 -176.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 43.3 tp -124.56 118.52 26.76 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.508 0.723 . . . . 0.0 109.654 -172.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 82.1 mt-10 -114.05 110.65 20.37 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.75 -0.594 . . . . 0.0 109.764 173.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 68.0 mtm -105.77 125.25 50.77 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 123.591 0.756 . . . . 0.0 110.755 -174.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 54.6 mtp180 -111.22 142.97 42.73 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.584 -0.697 . . . . 0.0 112.338 -177.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -156.52 133.05 10.09 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 123.08 0.552 . . . . 0.0 110.898 161.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 60.7 34.93 19.85 Favored 'General case' 0 N--CA 1.509 2.478 0 N-CA-C 115.339 1.607 . . . . 0.0 115.339 -168.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 67.35 -0.81 7.86 Favored Glycine 0 CA--C 1.561 2.913 0 N-CA-C 119.984 2.753 . . . . 0.0 119.984 -159.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 75.2 t -95.51 114.14 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 CA-C-N 120.81 2.305 . . . . 0.0 109.446 -167.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 25.0 m -94.63 118.63 32.0 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 123.094 0.557 . . . . 0.0 111.295 -173.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 13.9 t -91.6 124.65 35.91 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.306 0.642 . . . . 0.0 111.238 162.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -108.55 115.5 30.21 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.192 0.597 . . . . 0.0 109.659 -175.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -124.22 135.43 53.43 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.636 -0.665 . . . . 0.0 111.854 -174.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 61.7 t -112.97 131.62 64.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -125.34 145.13 50.17 Favored 'General case' 0 CA--C 1.563 1.463 0 C-N-CA 124.844 1.258 . . . . 0.0 109.778 179.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 30.3 ttmt -120.25 140.61 50.94 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.651 -1.281 . . . . 0.0 112.804 179.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 54.5 tttt -74.97 115.81 15.0 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -177.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 35.0 m -97.21 -40.73 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 174.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 79.5 t60 . . . . . 0 N--CA 1.486 1.343 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 164.628 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 65.6 mtt . . . . . 0 CA--C 1.569 1.674 0 CA-C-O 118.499 -0.762 . . . . 0.0 109.759 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_exo -64.45 117.51 4.55 Favored 'Trans proline' 0 CA--C 1.561 1.871 0 C-N-CA 122.725 2.283 . . . . 0.0 116.563 -178.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 22.0 m -107.01 176.43 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 CA-C-O 122.248 1.023 . . . . 0.0 112.067 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -79.19 82.21 5.37 Favored 'General case' 0 CA--C 1.569 1.676 0 O-C-N 120.158 -1.589 . . . . 0.0 113.862 -171.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -73.41 -11.71 60.56 Favored 'General case' 0 CA--C 1.576 1.97 0 N-CA-C 115.614 1.709 . . . . 0.0 115.614 167.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -45.78 121.96 3.45 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 115.793 1.775 . . . . 0.0 115.793 168.007 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 154.84 174.39 24.74 Favored Glycine 0 N--CA 1.484 1.876 0 N-CA-C 115.976 1.15 . . . . 0.0 115.976 175.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 17.3 t80 -103.28 121.2 42.22 Favored 'General case' 0 CA--C 1.563 1.449 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 167.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 70.4 m95 -120.39 121.5 38.69 Favored 'General case' 0 CA--C 1.562 1.434 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 -170.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 63.7 pttt -89.47 137.74 32.07 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.249 -0.907 . . . . 0.0 112.169 177.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 51.3 ttm -73.38 121.84 21.11 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 122.092 0.949 . . . . 0.0 112.423 176.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 89.6 mt -81.79 -48.13 12.0 Favored 'General case' 0 CA--C 1.568 1.66 0 CA-C-N 115.242 -0.89 . . . . 0.0 113.157 167.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 88.6 p -136.55 146.29 45.99 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 119.225 0.92 . . . . 0.0 112.873 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 20.9 p30 -124.45 81.72 1.97 Allowed 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 121.694 0.759 . . . . 0.0 110.709 167.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -94.72 125.56 39.45 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.138 -0.976 . . . . 0.0 111.56 -167.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.257 51.2 t30 59.15 25.16 13.63 Favored 'General case' 0 N--CA 1.503 2.183 0 N-CA-C 116.968 2.21 . . . . 0.0 116.968 -170.453 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -66.97 -40.47 87.47 Favored 'General case' 0 CA--C 1.568 1.643 0 N-CA-C 114.969 1.47 . . . . 0.0 114.969 172.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -52.93 -53.42 49.79 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 115.484 1.661 . . . . 0.0 115.484 172.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.516 ' HE2' ' NH2' ' A' ' 21' ' ' ARG . 11.9 tp10 -72.08 -37.01 69.69 Favored 'General case' 0 CA--C 1.566 1.565 0 N-CA-C 115.796 1.776 . . . . 0.0 115.796 176.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 61.3 t80 -50.2 -49.96 51.0 Favored 'General case' 0 N--CA 1.499 2.02 0 CA-C-N 120.526 1.512 . . . . 0.0 114.859 161.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 93.9 mt -62.57 -41.47 98.94 Favored 'General case' 0 CA--C 1.57 1.734 0 N-CA-C 115.51 1.67 . . . . 0.0 115.51 171.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.516 ' NH2' ' HE2' ' A' ' 18' ' ' GLU . 35.2 ttp180 -62.07 -44.85 95.78 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 115.091 1.515 . . . . 0.0 115.091 169.563 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -49.82 -28.96 7.09 Favored 'General case' 0 CA--C 1.571 1.781 0 N-CA-C 118.234 2.679 . . . . 0.0 118.234 162.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 91.0 mt -86.97 0.68 54.72 Favored 'General case' 0 CA--C 1.569 1.7 0 N-CA-C 116.45 2.019 . . . . 0.0 116.45 168.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 62.32 39.07 12.68 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 115.458 1.651 . . . . 0.0 115.458 -169.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 86.1 t -92.88 140.25 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 CA-C-O 122.195 0.997 . . . . 0.0 109.02 178.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.8 p-10 -67.0 146.05 54.77 Favored 'General case' 0 CA--C 1.567 1.613 0 N-CA-C 116.287 1.958 . . . . 0.0 116.287 -170.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 58.5 t -59.57 -38.75 77.02 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.162 0 N-CA-C 115.622 1.712 . . . . 0.0 115.622 -173.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.12 -38.95 84.58 Favored 'General case' 0 CA--C 1.569 1.711 0 N-CA-C 116.412 2.005 . . . . 0.0 116.412 169.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 6.1 tt -65.49 -50.67 64.45 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-N 119.318 0.963 . . . . 0.0 113.553 165.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 35.2 mtp-105 -47.62 -50.35 24.63 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 116.263 1.949 . . . . 0.0 116.263 172.203 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -70.91 -36.29 72.62 Favored 'General case' 0 CA--C 1.564 1.493 0 N-CA-C 115.239 1.57 . . . . 0.0 115.239 174.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 41.0 mt -71.99 -55.78 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.22 0 CA-C-N 122.334 2.334 . . . . 0.0 110.559 174.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -61.14 -23.3 65.43 Favored 'General case' 0 CA--C 1.565 1.54 0 N-CA-C 119.255 3.057 . . . . 0.0 119.255 176.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -75.28 -47.59 27.21 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 115.454 1.65 . . . . 0.0 115.454 160.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 97.4 mt -75.25 -25.56 58.14 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 116.29 1.959 . . . . 0.0 116.29 -175.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . 0.25 1.4 pp -96.34 149.89 21.19 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 119.444 1.02 . . . . 0.0 110.397 158.327 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -107.06 92.32 7.6 Favored Pre-proline 0 CA--C 1.574 1.873 0 CA-C-O 117.78 -1.105 . . . . 0.0 109.222 -176.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -72.04 155.85 56.67 Favored 'Trans proline' 0 CA--C 1.562 1.901 0 C-N-CA 122.535 2.157 . . . . 0.0 116.739 -170.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -101.14 136.22 41.34 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.926 -170.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 60.8 mttm -96.02 112.1 23.93 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.123 -0.986 . . . . 0.0 110.19 174.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -94.5 108.13 20.08 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 163.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 78.0 mt -103.07 117.14 48.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 -175.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 91.1 t -100.18 93.75 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 173.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -95.31 97.17 9.65 Favored 'General case' 0 CA--C 1.566 1.568 0 CA-C-O 121.395 0.617 . . . . 0.0 110.831 176.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -89.97 79.23 6.61 Favored 'General case' 0 CA--C 1.568 1.666 0 O-C-N 121.275 -0.89 . . . . 0.0 109.815 167.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 65.94 -102.66 0.73 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 114.897 0.719 . . . . 0.0 114.897 -174.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -86.07 -23.29 26.77 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 116.531 2.048 . . . . 0.0 116.531 165.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 18.5 t-160 -78.9 108.89 12.69 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 121.602 2.001 . . . . 0.0 111.148 178.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 47.1 ttm -117.64 121.08 39.94 Favored 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 123.676 0.79 . . . . 0.0 109.932 -174.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 29.6 mt -107.41 101.94 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 173.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 78.8 mt -88.89 100.63 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 177.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 62.6 mtt180 -94.5 98.48 10.88 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.774 -0.579 . . . . 0.0 110.251 -179.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 11.4 m -87.6 107.92 18.83 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 177.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 13.5 mt -108.96 120.35 42.26 Favored 'General case' 0 CA--C 1.558 1.273 0 C-N-CA 123.478 0.711 . . . . 0.0 110.486 -160.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 38.7 t -116.45 -93.41 0.5 Allowed 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.147 0.579 . . . . 0.0 110.624 177.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 52.8 m 176.83 -62.18 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.033 0 C-N-CA 126.618 1.967 . . . . 0.0 106.015 -170.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -72.89 -48.63 35.61 Favored 'General case' 0 CA--C 1.573 1.838 0 N-CA-C 115.935 1.828 . . . . 0.0 115.935 176.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 42.7 tpt85 -139.08 124.64 19.44 Favored 'General case' 0 CA--C 1.564 1.492 0 CA-C-N 118.995 0.816 . . . . 0.0 109.755 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -83.46 173.72 11.25 Favored 'General case' 0 CA--C 1.569 1.69 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 169.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -112.9 -76.24 0.59 Allowed 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.337 -0.852 . . . . 0.0 110.196 170.012 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.374 58.5 mt 70.5 85.51 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.127 0 C-N-CA 124.5 1.12 . . . . 0.0 111.678 173.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 94.4 mtp -102.05 102.64 13.16 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.5 p30 -99.96 110.44 22.77 Favored 'General case' 0 CA--C 1.562 1.434 0 C-N-CA 123.899 0.88 . . . . 0.0 112.554 -178.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -155.04 148.78 25.48 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 -168.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 23.1 mp0 -82.65 125.76 31.57 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.219 -0.926 . . . . 0.0 110.667 160.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 13.1 t -66.17 123.34 18.94 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.91 0 O-C-N 121.31 -0.869 . . . . 0.0 110.142 176.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 115.81 -44.26 1.51 Allowed Glycine 0 CA--C 1.55 2.253 0 N-CA-C 115.597 0.999 . . . . 0.0 115.597 -157.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 83.8 mttt -83.6 146.62 28.19 Favored 'General case' 0 CA--C 1.566 1.593 0 CA-C-N 118.822 1.311 . . . . 0.0 114.18 -172.237 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -91.05 103.71 16.38 Favored 'General case' 0 CA--C 1.564 1.51 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.995 167.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 11.1 p90 -102.72 145.49 29.63 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -171.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -78.81 124.67 28.45 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 177.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -117.1 100.96 8.08 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 169.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -125.06 109.91 13.51 Favored 'General case' 0 CA--C 1.563 1.462 0 C-N-CA 123.35 0.66 . . . . 0.0 109.645 173.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 19.2 tp -150.26 -114.63 0.05 Allowed 'General case' 0 CA--C 1.57 1.74 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 172.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 85.5 m -162.63 113.35 1.5 Allowed 'General case' 0 N--CA 1.498 1.935 0 O-C-N 119.934 -1.729 . . . . 0.0 107.153 172.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 165.78 -83.06 0.1 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 115.555 0.982 . . . . 0.0 115.555 178.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.414 HG23 ' H ' ' A' ' 78' ' ' ASP 0.294 18.8 tt -130.16 -96.04 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 -170.254 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.414 ' H ' HG23 ' A' ' 77' ' ' ILE . 36.0 t0 -80.17 71.52 6.93 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.998 0.904 . . . . 0.0 110.92 168.661 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 46.9 m-20 -150.53 -1.67 0.38 Allowed 'General case' 0 CA--C 1.573 1.841 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 -164.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 72.0 ttt-85 -95.8 73.06 3.08 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-N 121.004 1.729 . . . . 0.0 110.475 177.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 10.2 mtmp? 43.44 65.38 1.0 Allowed 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 116.278 1.955 . . . . 0.0 116.278 -170.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 73.3 m -100.79 126.09 47.34 Favored 'General case' 0 CA--C 1.557 1.213 0 CA-C-O 121.713 0.768 . . . . 0.0 111.835 -174.321 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 12.4 mmt -88.82 90.13 8.28 Favored 'General case' 0 CA--C 1.56 1.33 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 173.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 86.0 m -92.78 122.41 35.14 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.166 -0.958 . . . . 0.0 110.265 -174.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 58.5 m -110.04 122.73 48.26 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.477 HG21 ' SG ' ' A' ' 95' ' ' CYS . 17.8 t -118.0 128.09 75.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 92.0 p -130.6 166.58 20.33 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 122.506 1.146 . . . . 0.0 113.256 -176.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 68.5 m95 -97.19 129.67 44.52 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.615 -0.678 . . . . 0.0 111.932 175.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -126.49 81.84 2.03 Favored 'General case' 0 CA--C 1.567 1.597 0 C-N-CA 123.668 0.787 . . . . 0.0 109.647 177.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 63.21 17.44 59.24 Favored Glycine 0 N--CA 1.496 2.69 0 N-CA-C 121.74 3.456 . . . . 0.0 121.74 172.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . 0.269 0.8 OUTLIER 126.33 -45.41 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.472 0 C-N-CA 127.374 2.269 . . . . 0.0 111.087 -159.543 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 64.3 mttm -77.7 142.21 38.91 Favored 'General case' 0 CA--C 1.562 1.408 0 C-N-CA 123.68 0.792 . . . . 0.0 111.937 -176.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 25.7 tp -97.62 104.1 16.09 Favored 'General case' 0 CA--C 1.564 1.514 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 172.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 32.9 mm-40 -92.57 142.69 27.12 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 123.332 0.653 . . . . 0.0 111.831 -177.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . 0.477 ' SG ' HG21 ' A' ' 86' ' ' VAL . 49.3 t -139.64 136.88 34.78 Favored 'General case' 0 N--CA 1.484 1.238 0 O-C-N 121.441 -0.787 . . . . 0.0 112.127 -178.67 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.7 p -114.78 129.25 71.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 C-N-CA 123.203 0.601 . . . . 0.0 109.506 162.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -105.95 75.55 1.12 Allowed 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 123.593 0.757 . . . . 0.0 109.687 179.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -86.92 141.07 29.01 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.487 -1.383 . . . . 0.0 113.388 -173.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 135.69 -66.93 0.55 Allowed Glycine 0 N--CA 1.491 2.312 0 O-C-N 121.73 -0.606 . . . . 0.0 113.957 -171.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -79.54 -53.54 6.77 Favored 'General case' 0 CA--C 1.57 1.739 0 N-CA-C 115.335 1.606 . . . . 0.0 115.335 -175.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 45.1 mmtm -133.12 160.61 36.72 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-N 119.903 1.228 . . . . 0.0 114.313 -166.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -77.04 137.9 39.25 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.43 175.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 61.6 35.8 91.68 Favored Glycine 0 N--CA 1.496 2.652 0 N-CA-C 118.785 2.274 . . . . 0.0 118.785 -176.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 46.1 ttt180 -96.93 123.95 40.77 Favored 'General case' 0 CA--C 1.561 1.395 0 CA-C-N 118.16 0.98 . . . . 0.0 112.59 -170.095 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 179.92 -169.13 39.81 Favored Glycine 0 N--CA 1.483 1.776 0 CA-C-O 122.129 0.849 . . . . 0.0 114.847 176.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 43.4 p-90 -155.1 156.27 35.51 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 175.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 49.2 m -125.29 118.71 26.56 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 173.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 -118.52 129.81 55.57 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 123.345 0.658 . . . . 0.0 111.07 -178.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 15.3 p90 -150.34 156.72 42.05 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.761 -1.212 . . . . 0.0 113.396 -175.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 73.8 mt -101.44 141.76 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.186 0 CA-C-O 122.697 1.237 . . . . 0.0 111.346 -176.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -139.7 88.25 2.23 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 123.997 0.919 . . . . 0.0 109.12 -177.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 72.29 -112.61 4.1 Favored Glycine 0 N--CA 1.49 2.257 0 CA-C-N 115.87 -0.605 . . . . 0.0 113.755 -173.021 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 54.8 p30 -92.28 7.35 43.11 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 116.78 2.141 . . . . 0.0 116.78 164.034 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -107.87 146.76 31.87 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-N 120.519 1.509 . . . . 0.0 112.526 -174.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 13.8 tp -108.01 118.98 38.17 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 169.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 34.1 m80 -106.51 124.24 49.3 Favored 'General case' 0 CA--C 1.559 1.326 0 C-N-CA 123.713 0.805 . . . . 0.0 109.202 -175.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 20.1 tp -120.49 130.29 54.22 Favored 'General case' 0 CA--C 1.561 1.374 0 C-N-CA 123.8 0.84 . . . . 0.0 109.736 -176.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -117.76 114.51 23.42 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.567 -0.708 . . . . 0.0 109.532 166.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 68.2 mtm -106.81 125.0 50.44 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 123.368 0.667 . . . . 0.0 110.923 -178.224 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 72.7 mtp85 -111.6 140.93 45.81 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 123.381 0.673 . . . . 0.0 112.299 -176.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -159.22 135.18 8.81 Favored 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 123.301 0.64 . . . . 0.0 111.876 167.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 60.5 21.7 11.41 Favored 'General case' 0 N--CA 1.506 2.351 0 N-CA-C 115.963 1.838 . . . . 0.0 115.963 -170.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 82.88 -12.47 48.64 Favored Glycine 0 CA--C 1.56 2.858 0 N-CA-C 119.29 2.476 . . . . 0.0 119.29 -158.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 92.3 t -89.11 123.6 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 CA-C-N 120.015 1.908 . . . . 0.0 109.825 -171.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 24.1 m -101.16 120.81 40.78 Favored 'General case' 0 N--CA 1.494 1.773 0 C-N-CA 122.922 0.489 . . . . 0.0 112.092 -178.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 13.3 t -90.64 125.86 35.78 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.576 0.75 . . . . 0.0 111.655 162.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -107.86 113.57 26.89 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -177.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 14.4 mt-30 -121.51 126.97 50.5 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.431 -0.793 . . . . 0.0 110.882 -174.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 58.1 t -110.83 132.87 58.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -179.083 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -124.84 152.7 43.61 Favored 'General case' 0 CA--C 1.563 1.468 0 C-N-CA 124.307 1.043 . . . . 0.0 110.866 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -120.3 139.24 53.02 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.263 -0.898 . . . . 0.0 111.899 174.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 73.3 tttt -73.14 120.32 18.61 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.452 -0.78 . . . . 0.0 112.795 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . 0.253 34.7 m -105.81 -40.18 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 173.743 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 44.6 t60 . . . . . 0 N--CA 1.486 1.365 0 CA-C-N 119.988 1.267 . . . . 0.0 108.192 165.686 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 17.9 ptp . . . . . 0 CA--C 1.575 1.904 0 CA-C-O 119.063 -0.494 . . . . 0.0 112.255 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -88.89 166.29 5.88 Favored 'Trans proline' 0 CA--C 1.564 2.008 0 C-N-CA 122.574 2.183 . . . . 0.0 115.813 -176.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 19.0 m -76.52 152.63 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 CA-C-O 122.302 1.049 . . . . 0.0 112.307 165.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -76.74 118.08 19.0 Favored 'General case' 0 CA--C 1.565 1.545 0 O-C-N 121.242 -0.911 . . . . 0.0 113.383 178.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 6.2 m-30 -84.77 8.47 17.07 Favored 'General case' 0 CA--C 1.579 2.065 0 N-CA-C 115.57 1.693 . . . . 0.0 115.57 169.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -57.59 111.99 1.29 Allowed 'General case' 0 CA--C 1.564 1.499 0 N-CA-C 114.916 1.45 . . . . 0.0 114.916 -179.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 164.24 173.29 32.74 Favored Glycine 0 N--CA 1.484 1.862 0 N-CA-C 115.944 1.138 . . . . 0.0 115.944 -178.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -102.69 120.58 40.82 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-N 114.648 -0.776 . . . . 0.0 108.974 172.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 75.6 m95 -119.14 118.64 31.91 Favored 'General case' 0 CA--C 1.566 1.58 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -170.048 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 59.9 pttt -102.72 141.49 35.45 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.144 -0.972 . . . . 0.0 112.76 -176.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 45.6 ttm -66.05 124.78 23.49 Favored 'General case' 0 CA--C 1.569 1.689 0 N-CA-C 115.188 1.551 . . . . 0.0 115.188 -175.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 94.9 mt -88.32 -49.93 6.65 Favored 'General case' 0 CA--C 1.569 1.675 0 CA-C-N 115.128 -0.942 . . . . 0.0 112.986 164.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 87.0 p -136.6 149.56 48.09 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-N 119.143 0.883 . . . . 0.0 112.848 -178.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -135.7 87.24 2.3 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 123.671 0.789 . . . . 0.0 110.175 172.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -98.27 132.7 43.54 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.543 0.737 . . . . 0.0 110.872 -175.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.271 41.5 t30 62.75 17.08 9.53 Favored 'General case' 0 N--CA 1.503 2.203 0 N-CA-C 117.588 2.44 . . . . 0.0 117.588 179.757 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -62.4 -46.39 88.83 Favored 'General case' 0 CA--C 1.565 1.551 0 N-CA-C 115.764 1.764 . . . . 0.0 115.764 177.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -61.47 -38.93 89.04 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 116.764 2.135 . . . . 0.0 116.764 173.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -65.5 -41.43 93.21 Favored 'General case' 0 CA--C 1.572 1.825 0 CA-C-N 120.684 1.583 . . . . 0.0 114.924 168.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 39.4 t80 -55.0 -50.32 69.3 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 114.754 1.39 . . . . 0.0 114.754 166.048 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 91.9 mt -61.87 -43.4 98.91 Favored 'General case' 0 CA--C 1.571 1.775 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 171.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 20.4 ttm180 -53.12 -47.55 68.58 Favored 'General case' 0 CA--C 1.578 2.037 0 CA-C-N 120.746 1.612 . . . . 0.0 114.896 164.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.46 -19.11 45.19 Favored 'General case' 0 CA--C 1.568 1.647 0 N-CA-C 118.317 2.71 . . . . 0.0 118.317 166.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 95.4 mt -92.73 12.55 23.03 Favored 'General case' 0 CA--C 1.572 1.815 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 164.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 61.25 45.6 8.68 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 115.21 1.559 . . . . 0.0 115.21 -174.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 57.4 t -96.85 143.37 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 CA-C-O 122.388 1.09 . . . . 0.0 110.123 -176.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 -71.46 152.74 42.8 Favored 'General case' 0 CA--C 1.569 1.676 0 N-CA-C 115.022 1.49 . . . . 0.0 115.022 177.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 57.8 t -57.37 -41.1 77.8 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.166 0 N-CA-C 115.14 1.533 . . . . 0.0 115.14 -176.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.09 -49.32 78.31 Favored 'General case' 0 CA--C 1.567 1.624 0 N-CA-C 116.296 1.961 . . . . 0.0 116.296 174.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -59.55 -48.19 82.61 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 114.136 1.162 . . . . 0.0 114.136 168.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 53.2 mtp180 -50.82 -45.42 59.47 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 117.444 2.387 . . . . 0.0 117.444 168.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -72.5 -51.7 18.91 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-N 119.978 1.263 . . . . 0.0 113.807 172.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 45.2 mt -58.72 -51.5 71.24 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.23 0 CA-C-N 120.498 1.499 . . . . 0.0 113.293 178.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.83 -35.77 82.19 Favored 'General case' 0 CA--C 1.563 1.477 0 N-CA-C 117.76 2.504 . . . . 0.0 117.76 175.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -74.33 -30.82 62.19 Favored 'General case' 0 CA--C 1.571 1.777 0 N-CA-C 116.357 1.984 . . . . 0.0 116.357 169.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 79.4 mt -73.02 -34.38 66.31 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 115.209 1.559 . . . . 0.0 115.209 169.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 81.9 mt -72.5 152.81 41.69 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 119.318 0.963 . . . . 0.0 112.574 169.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -102.65 89.52 1.83 Allowed Pre-proline 0 CA--C 1.57 1.72 0 CA-C-O 118.234 -0.889 . . . . 0.0 109.339 167.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -70.16 168.67 21.42 Favored 'Trans proline' 0 CA--C 1.563 1.964 0 C-N-CA 122.47 2.114 . . . . 0.0 115.399 -179.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -131.95 128.6 38.81 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.905 -169.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -99.79 109.11 21.55 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.161 -0.962 . . . . 0.0 109.822 177.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -93.76 102.74 14.89 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 169.15 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 92.2 mt -94.91 121.38 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -172.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 96.0 t -112.1 93.2 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 107.067 -1.456 . . . . 0.0 107.067 176.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -89.69 115.97 27.45 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 123.72 0.808 . . . . 0.0 110.556 176.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -135.62 70.51 1.43 Allowed 'General case' 0 CA--C 1.569 1.682 0 C-N-CA 123.212 0.605 . . . . 0.0 110.811 -173.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 61.98 81.62 0.09 OUTLIER Glycine 0 N--CA 1.495 2.627 0 N-CA-C 116.488 1.355 . . . . 0.0 116.488 173.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.452 1.1 p30 63.85 -39.02 0.2 Allowed 'General case' 0 N--CA 1.504 2.225 0 N-CA-C 118.332 2.716 . . . . 0.0 118.332 -165.181 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 12.4 t-80 -79.15 121.64 25.26 Favored 'General case' 0 CA--C 1.56 1.346 0 CA-C-N 120.157 1.344 . . . . 0.0 111.406 173.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 11.3 ttp -134.6 129.51 35.07 Favored 'General case' 0 CA--C 1.556 1.204 0 CA-C-O 122.08 0.943 . . . . 0.0 110.979 -179.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 4.4 mp -105.06 113.57 42.45 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.377 0 N-CA-C 107.081 -1.452 . . . . 0.0 107.081 174.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 24.5 mm -89.04 93.57 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 167.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -80.18 96.68 6.63 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.146 -0.971 . . . . 0.0 109.733 -179.036 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 26.3 m -90.24 100.85 13.6 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 -175.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 23.6 mt -105.86 135.13 47.85 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 124.214 1.006 . . . . 0.0 110.491 -164.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 12.5 p -144.26 156.36 44.24 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.136 -0.978 . . . . 0.0 112.597 177.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.6 m -77.75 61.08 2.35 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 120.742 -1.223 . . . . 0.0 112.316 172.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -177.14 -67.55 0.01 OUTLIER 'General case' 0 CA--C 1.568 1.657 0 C-N-CA 126.013 1.725 . . . . 0.0 107.946 -174.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 56.7 ttt85 -144.76 140.94 28.84 Favored 'General case' 0 CA--C 1.565 1.528 0 CA-C-O 121.784 0.802 . . . . 0.0 110.217 177.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -105.18 119.43 39.03 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 175.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 19.3 t80 -81.75 -57.73 3.31 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 114.074 1.139 . . . . 0.0 114.074 -172.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.272 10.4 mm 76.2 95.97 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 C-N-CA 124.071 0.949 . . . . 0.0 111.798 172.395 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 91.1 mtp -97.52 94.2 6.88 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.994 -1.066 . . . . 0.0 109.628 173.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.9 p30 -96.19 111.29 23.39 Favored 'General case' 0 CA--C 1.561 1.38 0 C-N-CA 124.069 0.948 . . . . 0.0 112.136 179.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 20.4 p90 -150.38 158.57 44.31 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 -168.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -95.22 134.19 38.25 Favored 'General case' 0 CA--C 1.563 1.47 0 O-C-N 121.464 -0.773 . . . . 0.0 110.938 164.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 36.4 t -72.53 122.92 26.09 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.807 0 C-N-CA 123.845 0.858 . . . . 0.0 109.431 178.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 104.74 -48.55 0.98 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 115.56 0.984 . . . . 0.0 115.56 -163.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 26.2 tptp -65.14 133.48 51.66 Favored 'General case' 0 CA--C 1.567 1.618 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 176.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -92.48 110.19 21.6 Favored 'General case' 0 CA--C 1.569 1.709 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.139 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -118.99 134.44 55.19 Favored 'General case' 0 N--CA 1.498 1.947 0 C-N-CA 124.092 0.957 . . . . 0.0 112.664 -169.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -73.41 131.78 42.23 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.248 -1.532 . . . . 0.0 114.245 178.704 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -77.09 61.65 2.07 Favored 'General case' 0 N--CA 1.5 2.068 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 176.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -87.49 62.54 7.18 Favored 'General case' 0 CA--C 1.57 1.748 0 O-C-N 120.029 -1.67 . . . . 0.0 112.628 -177.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 48.3 tp -148.17 118.35 7.28 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.209 -0.932 . . . . 0.0 110.746 -159.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 94.7 m -74.33 135.07 42.52 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -173.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 150.91 -63.17 0.4 Allowed Glycine 0 N--CA 1.488 2.143 0 CA-C-O 119.51 -0.606 . . . . 0.0 114.575 179.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 65.4 mt -80.91 -78.99 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 178.122 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -132.68 141.44 48.6 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-N 119.522 1.055 . . . . 0.0 110.192 167.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.504 ' N ' ' HD2' ' A' ' 79' ' ' ASP . 0.9 OUTLIER -91.25 67.79 5.85 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.041 -1.037 . . . . 0.0 112.803 178.505 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.3 ttp180 -150.5 115.09 5.21 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 168.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.13 149.08 43.32 Favored 'General case' 0 CA--C 1.565 1.528 0 N-CA-C 116.355 1.983 . . . . 0.0 116.355 -168.702 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 97.8 m -139.3 127.92 23.15 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.626 179.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 33.7 mtp -71.2 105.37 3.4 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-O 122.305 1.05 . . . . 0.0 111.799 -179.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 53.8 m -106.13 119.2 38.61 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.638 -161.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 87.6 m -94.79 124.68 38.98 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 166.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 57.8 t -105.45 135.95 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 167.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 52.4 m -147.5 146.88 29.66 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.286 -1.509 . . . . 0.0 112.528 -177.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 47.1 m95 -83.94 119.03 24.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.177 -0.952 . . . . 0.0 112.782 178.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -96.13 71.55 2.86 Favored 'General case' 0 CA--C 1.573 1.849 0 C-N-CA 123.061 0.544 . . . . 0.0 109.569 157.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 62.65 -102.83 0.54 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 115.653 1.021 . . . . 0.0 115.653 -175.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -80.77 -22.29 40.26 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 116.312 1.967 . . . . 0.0 116.312 169.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 61.2 mtpt -92.92 121.83 34.67 Favored 'General case' 0 CA--C 1.56 1.349 0 CA-C-N 119.547 1.067 . . . . 0.0 110.499 -177.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 33.0 tp -89.17 106.98 18.79 Favored 'General case' 0 CA--C 1.564 1.492 0 O-C-N 121.407 -0.808 . . . . 0.0 109.345 174.099 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 -96.59 137.21 36.01 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.724 0.81 . . . . 0.0 111.349 -175.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 40.7 t -134.17 128.35 33.86 Favored 'General case' 0 N--CA 1.483 1.189 0 O-C-N 121.732 -0.605 . . . . 0.0 111.742 -177.056 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 11.1 p -122.47 124.1 70.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 C-N-CA 123.284 0.634 . . . . 0.0 109.84 176.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -102.66 106.85 17.57 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 123.855 0.862 . . . . 0.0 110.385 -176.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -101.85 124.12 46.94 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.289 -0.882 . . . . 0.0 111.666 -169.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 177.49 -62.17 0.09 OUTLIER Glycine 0 N--CA 1.494 2.541 0 N-CA-C 117.388 1.715 . . . . 0.0 117.388 178.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -134.12 -58.41 0.85 Allowed 'General case' 0 N--CA 1.496 1.836 0 CA-C-N 117.529 0.664 . . . . 0.0 112.151 178.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 53.8 mttm -79.37 139.78 37.65 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 114.374 1.25 . . . . 0.0 114.374 -176.042 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -80.33 146.98 31.3 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-N 114.638 -1.165 . . . . 0.0 112.705 175.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 65.04 20.3 66.76 Favored Glycine 0 N--CA 1.495 2.59 0 N-CA-C 119.802 2.681 . . . . 0.0 119.802 -173.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 26.6 ttt180 -84.36 118.17 24.06 Favored 'General case' 0 CA--C 1.566 1.577 0 CA-C-N 118.91 1.355 . . . . 0.0 111.654 -177.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 179.29 -171.77 43.7 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 115.298 0.879 . . . . 0.0 115.298 -174.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . 0.259 39.9 p-90 -156.49 155.0 31.24 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 170.647 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 84.7 m -128.06 116.55 20.18 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 177.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -120.26 126.98 51.93 Favored 'General case' 0 N--CA 1.495 1.821 0 C-N-CA 123.545 0.738 . . . . 0.0 111.537 -174.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 16.3 p90 -148.61 155.38 41.0 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 120.893 -1.13 . . . . 0.0 113.364 -178.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 90.7 mt -98.1 132.96 41.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.02 -1.05 . . . . 0.0 110.291 177.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -118.79 94.04 4.31 Favored 'General case' 0 CA--C 1.566 1.594 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 162.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 69.07 -112.38 4.52 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 115.396 0.919 . . . . 0.0 115.396 -178.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 16.0 p30 -85.96 -2.42 58.27 Favored 'General case' 0 CA--C 1.572 1.827 0 N-CA-C 117.139 2.274 . . . . 0.0 117.139 166.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 88.2 mt-10 -109.93 128.95 55.69 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-N 120.646 1.566 . . . . 0.0 111.712 -174.142 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 12.2 tp -90.59 116.03 28.17 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.962 0.905 . . . . 0.0 109.421 167.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 57.7 m80 -99.9 122.45 42.84 Favored 'General case' 0 CA--C 1.559 1.295 0 C-N-CA 123.936 0.895 . . . . 0.0 109.422 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 47.6 tp -123.96 119.65 30.21 Favored 'General case' 0 CA--C 1.561 1.368 0 C-N-CA 123.974 0.909 . . . . 0.0 109.878 -174.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -108.74 106.62 16.73 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 171.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 62.0 mtm -99.72 125.83 45.67 Favored 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 123.043 0.537 . . . . 0.0 111.05 -178.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 71.5 mtm180 -114.56 139.41 49.61 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 123.629 0.772 . . . . 0.0 111.551 -168.114 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -155.64 124.6 6.11 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.583 -0.698 . . . . 0.0 110.798 168.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 60.55 36.21 19.95 Favored 'General case' 0 N--CA 1.505 2.32 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 -178.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 78.64 -22.39 3.36 Favored Glycine 0 CA--C 1.554 2.524 0 N-CA-C 119.3 2.48 . . . . 0.0 119.3 -162.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 85.7 t -80.15 120.83 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 CA-C-N 119.886 1.843 . . . . 0.0 110.091 -171.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 57.0 m -103.74 118.22 36.2 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 122.923 0.489 . . . . 0.0 111.015 -179.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 37.7 t -84.74 127.79 34.28 Favored 'General case' 0 CA--C 1.559 1.291 0 C-N-CA 123.115 0.566 . . . . 0.0 111.953 162.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 38.2 mtmm -106.21 109.39 21.31 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -179.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -114.69 133.19 56.07 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 123.674 0.79 . . . . 0.0 111.14 179.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 44.7 t -118.06 131.3 71.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 177.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -125.96 138.26 53.75 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 123.328 0.651 . . . . 0.0 111.656 -179.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 29.0 tptp -96.39 137.25 35.74 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.156 -0.965 . . . . 0.0 112.623 178.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 73.1 tttt -70.73 123.6 22.31 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 174.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 24.4 m -107.0 -42.67 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.13 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 173.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 32.8 m80 . . . . . 0 C--O 1.254 1.293 0 CA-C-N 119.601 1.091 . . . . 0.0 108.683 179.256 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 60.4 mtt . . . . . 0 CA--C 1.571 1.785 0 CA-C-O 118.59 -0.719 . . . . 0.0 112.156 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -75.97 139.45 21.87 Favored 'Trans proline' 0 CA--C 1.561 1.849 0 C-N-CA 122.428 2.085 . . . . 0.0 115.728 179.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 33.0 m -75.37 152.91 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 CA-C-O 122.305 1.05 . . . . 0.0 113.121 177.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -71.93 113.53 9.06 Favored 'General case' 0 CA--C 1.56 1.365 0 O-C-N 121.328 -0.857 . . . . 0.0 112.212 172.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 6.0 m-30 -77.02 6.38 6.44 Favored 'General case' 0 CA--C 1.582 2.173 0 N-CA-C 116.188 1.922 . . . . 0.0 116.188 173.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -53.51 111.42 0.71 Allowed 'General case' 0 CA--C 1.565 1.532 0 C-N-CA 126.376 1.87 . . . . 0.0 115.597 -178.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 163.1 178.18 36.68 Favored Glycine 0 N--CA 1.482 1.759 0 CA-C-O 123.01 1.339 . . . . 0.0 116.104 177.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -107.76 124.6 50.27 Favored 'General case' 0 CA--C 1.563 1.46 0 CA-C-N 113.869 -1.165 . . . . 0.0 109.088 175.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -118.92 140.92 49.18 Favored 'General case' 0 CA--C 1.569 1.674 0 C-N-CA 123.9 0.88 . . . . 0.0 110.357 -168.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -115.6 133.04 56.42 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.165 -0.959 . . . . 0.0 111.841 176.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 53.9 ttm -71.61 123.83 23.37 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.096 -1.002 . . . . 0.0 113.562 -177.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 94.9 mt -81.19 -53.18 6.6 Favored 'General case' 0 CA--C 1.567 1.626 0 CA-C-N 115.307 -0.861 . . . . 0.0 112.466 169.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 92.4 p -145.65 124.8 12.89 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.662 0.785 . . . . 0.0 111.106 -175.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -103.19 96.21 6.63 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.92 0.867 . . . . 0.0 110.527 166.047 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.578 ' HE2' ' NZ ' ' A' ' 127' ' ' LYS . 24.4 tt0 -99.24 127.05 45.18 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 124.007 0.923 . . . . 0.0 109.592 -171.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 5.9 t30 66.32 23.16 10.76 Favored 'General case' 0 N--CA 1.508 2.443 0 N-CA-C 116.794 2.146 . . . . 0.0 116.794 -174.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -69.08 -46.96 66.47 Favored 'General case' 0 CA--C 1.568 1.656 0 N-CA-C 115.034 1.494 . . . . 0.0 115.034 178.135 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -42.09 -54.42 3.59 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 118.091 2.626 . . . . 0.0 118.091 167.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.28 8.5 pt-20 -75.67 -31.3 59.69 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 116.612 2.079 . . . . 0.0 116.612 176.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 79.5 t80 -55.4 -48.4 74.41 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-N 120.36 1.437 . . . . 0.0 114.569 160.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 69.3 mt -60.82 -40.97 94.75 Favored 'General case' 0 CA--C 1.574 1.898 0 N-CA-C 114.887 1.439 . . . . 0.0 114.887 170.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 37.6 ttm-85 -51.73 -50.84 59.77 Favored 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 115.262 1.578 . . . . 0.0 115.262 163.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.32 -25.37 59.24 Favored 'General case' 0 CA--C 1.566 1.574 0 N-CA-C 117.87 2.544 . . . . 0.0 117.87 168.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 97.0 mt -87.58 9.81 19.96 Favored 'General case' 0 CA--C 1.573 1.864 0 N-CA-C 115.656 1.724 . . . . 0.0 115.656 168.243 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 60.54 43.91 12.36 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 115.606 1.706 . . . . 0.0 115.606 -172.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 95.4 t -93.9 138.7 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.193 -0.942 . . . . 0.0 109.231 177.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 13.1 p30 -63.79 150.38 44.78 Favored 'General case' 0 CA--C 1.57 1.731 0 N-CA-C 115.251 1.575 . . . . 0.0 115.251 178.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 88.8 t -56.41 -40.24 66.01 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.22 0 N-CA-C 115.522 1.675 . . . . 0.0 115.522 -177.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.5 -53.69 55.35 Favored 'General case' 0 CA--C 1.568 1.672 0 N-CA-C 115.739 1.755 . . . . 0.0 115.739 169.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 28.9 tp -63.39 -38.28 90.52 Favored 'General case' 0 CA--C 1.571 1.781 0 N-CA-C 116.175 1.917 . . . . 0.0 116.175 171.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 34.6 mtp-105 -49.76 -52.05 34.58 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 115.801 1.778 . . . . 0.0 115.801 163.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -64.15 -49.09 73.49 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 114.547 1.314 . . . . 0.0 114.547 172.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 64.6 mt -58.49 -51.98 65.02 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 CA-C-N 119.996 1.271 . . . . 0.0 113.152 176.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.01 -35.82 81.97 Favored 'General case' 0 CA--C 1.563 1.47 0 N-CA-C 117.682 2.475 . . . . 0.0 117.682 175.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -72.23 -31.02 65.45 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 116.049 1.87 . . . . 0.0 116.049 168.115 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 78.3 mt -73.46 -35.15 65.67 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 115.317 1.599 . . . . 0.0 115.317 171.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 86.6 mt -83.22 143.68 30.29 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 119.069 0.85 . . . . 0.0 111.858 175.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 29.9 mmtp -106.05 88.36 3.01 Favored Pre-proline 0 CA--C 1.574 1.903 0 CA-C-O 117.982 -1.009 . . . . 0.0 109.641 176.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -73.18 166.41 30.04 Favored 'Trans proline' 0 CA--C 1.564 1.981 0 C-N-CA 122.45 2.1 . . . . 0.0 116.089 -175.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -98.74 155.7 17.21 Favored 'General case' 0 N--CA 1.488 1.425 0 CA-C-O 121.824 0.821 . . . . 0.0 112.373 177.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 65.2 mttt -117.4 121.14 40.27 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.508 -0.745 . . . . 0.0 109.357 164.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -94.61 109.77 21.66 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.104 -0.997 . . . . 0.0 108.594 161.17 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 68.3 mt -102.32 118.76 49.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 N-CA-C 107.424 -1.325 . . . . 0.0 107.424 179.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 57.3 t -111.35 95.43 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 172.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -88.32 97.87 11.28 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 123.519 0.728 . . . . 0.0 110.298 173.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -114.94 88.92 2.97 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 123.452 0.701 . . . . 0.0 109.973 -176.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 57.98 67.68 2.08 Favored Glycine 0 N--CA 1.495 2.607 0 N-CA-C 116.631 1.412 . . . . 0.0 116.631 178.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.477 0.6 OUTLIER 64.26 -25.46 0.08 Allowed 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 119.183 3.031 . . . . 0.0 119.183 -165.08 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 15.7 t-160 -78.09 109.48 12.21 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 121.284 1.856 . . . . 0.0 111.156 174.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 46.3 ttm -110.19 114.06 27.24 Favored 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 123.729 0.812 . . . . 0.0 109.496 -175.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 49.7 mt -100.15 102.59 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 175.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 59.1 mt -95.92 104.73 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 175.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 89.3 mtt180 -90.65 103.52 16.21 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.648 -0.658 . . . . 0.0 109.276 175.036 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 22.1 m -87.36 101.42 13.54 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 5.9 mt -111.96 118.48 35.59 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 124.009 0.924 . . . . 0.0 110.093 -163.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.1 t -99.08 -78.43 0.5 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.45 -0.781 . . . . 0.0 112.614 178.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.7 t 178.58 -61.58 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 125.699 1.6 . . . . 0.0 107.444 -170.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 7.9 p90 -83.89 -41.37 17.5 Favored 'General case' 0 CA--C 1.573 1.865 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 163.082 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 42.1 ttt85 -109.43 143.16 39.4 Favored 'General case' 0 CA--C 1.565 1.537 0 C-N-CA 124.124 0.97 . . . . 0.0 112.083 -168.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 46.1 t-20 -135.4 131.73 36.65 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 123.383 0.673 . . . . 0.0 110.096 175.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 9.2 t80 -124.78 110.24 14.07 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 172.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 87.1 mt -102.29 112.42 35.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -176.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 27.0 mmm -95.83 94.81 7.87 Favored 'General case' 0 CA--C 1.56 1.359 0 C-N-CA 123.628 0.771 . . . . 0.0 109.238 174.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.1 p30 -101.29 100.38 10.89 Favored 'General case' 0 CA--C 1.561 1.377 0 C-N-CA 123.725 0.81 . . . . 0.0 111.616 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -143.96 150.83 38.92 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -166.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -90.44 125.19 35.48 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.977 -1.077 . . . . 0.0 111.81 169.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 17.2 t -68.84 119.03 14.0 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.735 0 C-N-CA 123.858 0.863 . . . . 0.0 110.043 179.208 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 111.7 -43.49 1.71 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 115.778 1.071 . . . . 0.0 115.778 -160.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 51.2 mttm -83.71 143.87 29.74 Favored 'General case' 0 CA--C 1.567 1.608 0 CA-C-N 118.884 1.342 . . . . 0.0 113.41 -175.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.617 ' HE2' ' NZ ' ' A' ' 98' ' ' LYS . 19.1 tt0 -92.04 121.07 33.26 Favored 'General case' 0 CA--C 1.567 1.615 0 O-C-N 121.882 -0.511 . . . . 0.0 111.277 172.727 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 22.5 p90 -120.63 152.25 38.41 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 123.777 0.831 . . . . 0.0 112.668 -176.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -74.2 120.37 19.67 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.183 -1.573 . . . . 0.0 112.181 167.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -71.93 86.93 1.01 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.326 -0.859 . . . . 0.0 111.077 169.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 52.5 p-10 -90.46 -62.38 1.47 Allowed 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 114.346 1.239 . . . . 0.0 114.346 -173.165 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -85.63 74.51 10.26 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-N 119.297 0.953 . . . . 0.0 110.75 178.002 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 40.9 p -88.16 91.08 8.64 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.371 -0.831 . . . . 0.0 110.917 -175.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -73.62 34.61 0.84 Allowed Glycine 0 N--CA 1.498 2.794 0 N-CA-C 118.78 2.272 . . . . 0.0 118.78 173.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 38.8 mm -145.82 -69.52 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.575 1.906 0 N-CA-C 105.88 -1.896 . . . . 0.0 105.88 173.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -88.4 146.05 25.46 Favored 'General case' 0 CA--C 1.569 1.673 0 C-N-CA 124.198 0.999 . . . . 0.0 113.209 -176.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -86.99 145.3 26.55 Favored 'General case' 0 CA--C 1.572 1.818 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.353 161.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . 0.281 10.0 tpt180 94.44 126.21 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.182 0 C-N-CA 125.586 1.554 . . . . 0.0 111.74 -175.423 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 7.9 mptt -75.97 144.24 41.08 Favored 'General case' 0 CA--C 1.566 1.583 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 176.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 85.6 m -132.67 129.74 39.21 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-O 121.723 0.773 . . . . 0.0 111.741 -177.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 8.9 tpt -79.01 108.67 12.67 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.879 -1.138 . . . . 0.0 110.743 -178.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 97.4 m -119.71 114.57 22.38 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.146 -0.971 . . . . 0.0 111.069 -151.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 52.7 m -92.07 129.95 37.91 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 165.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.6 t -113.43 129.08 69.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 163.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 52.2 m -149.04 156.8 42.77 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.587 -1.32 . . . . 0.0 112.843 -175.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 72.8 m95 -82.23 115.39 21.29 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.89 -1.131 . . . . 0.0 112.308 179.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -84.83 72.99 10.7 Favored 'General case' 0 CA--C 1.569 1.709 0 O-C-N 121.382 -0.824 . . . . 0.0 109.869 163.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 69.42 -98.51 0.59 Allowed Glycine 0 N--CA 1.488 2.125 0 O-C-N 122.188 -0.32 . . . . 0.0 113.646 -167.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -99.95 -14.63 18.62 Favored 'General case' 0 CA--C 1.575 1.916 0 N-CA-C 116.393 1.997 . . . . 0.0 116.393 169.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 48.7 mtpt -92.82 127.33 38.29 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-N 120.407 1.458 . . . . 0.0 110.236 -176.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 26.0 tp -85.03 105.86 16.1 Favored 'General case' 0 CA--C 1.563 1.462 0 O-C-N 120.739 -1.226 . . . . 0.0 110.562 -177.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 29.5 mm-40 -95.16 129.34 42.3 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 123.369 0.668 . . . . 0.0 111.478 -177.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 41.4 t -116.35 128.34 55.45 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.666 0.786 . . . . 0.0 110.896 173.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.6 p -118.76 116.72 52.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 173.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 68.7 mt-30 -104.18 98.01 7.88 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 123.84 0.856 . . . . 0.0 109.079 -173.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.617 ' NZ ' ' HE2' ' A' ' 69' ' ' GLU . 92.7 mttt -91.49 134.89 34.26 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.424 -0.797 . . . . 0.0 113.074 -164.275 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 160.43 -109.89 0.42 Allowed Glycine 0 N--CA 1.486 2.009 0 O-C-N 121.504 -0.748 . . . . 0.0 113.526 165.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -84.63 -39.08 19.08 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 115.906 1.817 . . . . 0.0 115.906 -175.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 17.8 ttmm -88.6 129.07 35.57 Favored 'General case' 0 CA--C 1.564 1.504 0 CA-C-N 119.5 1.046 . . . . 0.0 112.315 -175.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -76.16 134.13 40.02 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -172.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 61.93 32.97 83.94 Favored Glycine 0 N--CA 1.496 2.637 0 N-CA-C 119.622 2.609 . . . . 0.0 119.622 -177.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 3.9 ttt85 -86.97 119.77 27.53 Favored 'General case' 0 CA--C 1.564 1.515 0 CA-C-N 118.863 1.331 . . . . 0.0 111.264 -179.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -178.62 -171.83 42.32 Favored Glycine 0 N--CA 1.483 1.804 0 CA-C-O 122.102 0.834 . . . . 0.0 114.366 179.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 47.7 p-90 -156.08 156.24 33.98 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 175.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 29.4 m -127.96 119.65 25.95 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 177.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -122.72 131.49 53.81 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 -176.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 23.9 p90 -148.87 160.66 43.04 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.202 -0.937 . . . . 0.0 112.184 -179.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 96.1 mt -109.09 135.04 49.2 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.182 0 O-C-N 120.722 -1.236 . . . . 0.0 110.637 178.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -122.51 94.52 4.31 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 124.417 1.087 . . . . 0.0 108.156 176.293 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 73.11 -109.56 2.85 Favored Glycine 0 N--CA 1.491 2.34 0 O-C-N 121.494 -0.754 . . . . 0.0 114.024 -174.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -111.55 37.3 2.94 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 114.514 1.301 . . . . 0.0 114.514 164.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 81.3 mt-10 -130.72 130.66 44.09 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.709 0.804 . . . . 0.0 110.642 178.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 15.5 tp -90.85 118.09 29.98 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 123.892 0.877 . . . . 0.0 109.526 173.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 43.1 m80 -106.39 118.76 37.48 Favored 'General case' 0 CA--C 1.559 1.294 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -178.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 46.8 tp -122.24 124.53 44.02 Favored 'General case' 0 CA--C 1.559 1.301 0 C-N-CA 124.078 0.951 . . . . 0.0 109.572 -173.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 77.5 mt-10 -114.03 109.89 19.18 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.547 -0.72 . . . . 0.0 109.661 170.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 68.7 mtm -101.64 127.2 48.49 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 123.336 0.654 . . . . 0.0 110.858 -177.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 54.2 mtp85 -116.83 137.62 52.08 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 123.416 0.687 . . . . 0.0 110.932 -171.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -157.18 129.38 7.29 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.562 -0.711 . . . . 0.0 111.278 170.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . 0.276 22.6 mt-10 57.57 38.37 27.87 Favored 'General case' 0 N--CA 1.502 2.15 0 N-CA-C 115.77 1.767 . . . . 0.0 115.77 -176.256 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 69.14 9.26 60.05 Favored Glycine 0 CA--C 1.555 2.586 0 N-CA-C 120.365 2.906 . . . . 0.0 120.365 -164.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 95.0 t -111.59 125.54 68.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 CA-C-N 119.989 1.894 . . . . 0.0 108.972 -174.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 41.7 m -106.73 123.24 47.85 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 123.137 0.575 . . . . 0.0 111.168 -176.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 22.1 t -94.27 124.2 38.14 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.541 0.736 . . . . 0.0 111.513 164.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.578 ' NZ ' ' HE2' ' A' ' 14' ' ' GLU . 48.5 mtpt -99.02 114.74 27.56 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 123.38 0.672 . . . . 0.0 109.65 177.773 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 20.2 mt-30 -119.78 123.59 44.09 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 123.35 0.66 . . . . 0.0 110.729 -178.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 43.8 t -112.91 130.49 66.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -123.97 147.45 47.74 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 123.595 0.758 . . . . 0.0 110.909 177.327 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -107.02 143.5 35.03 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.222 -0.924 . . . . 0.0 112.24 174.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 64.9 tttt -77.08 124.65 28.1 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 -177.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 27.7 m -110.86 -40.22 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 178.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 47.6 t-80 . . . . . 0 N--CA 1.486 1.373 0 CA-C-N 120.474 1.488 . . . . 0.0 108.488 174.824 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 0' ' ' MET . . . . . . . . . . . . 0.291 68.5 mtt . . . . . 0 CA--C 1.573 1.839 0 CA-C-O 116.764 -1.588 . . . . 0.0 114.339 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -65.19 -105.41 0.0 OUTLIER 'Trans proline' 0 CA--C 1.574 2.496 0 C-N-CA 123.734 2.956 . . . . 0.0 115.867 173.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 16.9 t -151.0 132.06 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 -172.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -75.78 90.09 2.88 Favored 'General case' 0 CA--C 1.569 1.698 0 O-C-N 121.193 -0.942 . . . . 0.0 111.76 172.065 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 10.6 m-30 -70.36 -1.38 10.4 Favored 'General case' 0 CA--C 1.58 2.119 0 N-CA-C 117.834 2.531 . . . . 0.0 117.834 176.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -51.96 123.61 10.8 Favored 'General case' 0 CA--C 1.566 1.594 0 N-CA-C 115.668 1.729 . . . . 0.0 115.668 177.382 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 163.21 176.93 35.73 Favored Glycine 0 N--CA 1.486 1.995 0 N-CA-C 116.153 1.221 . . . . 0.0 116.153 178.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -111.58 121.0 43.97 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 171.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 78.9 m95 -124.71 126.11 45.17 Favored 'General case' 0 CA--C 1.566 1.594 0 C-N-CA 123.297 0.639 . . . . 0.0 110.591 -165.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -96.62 138.97 33.39 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 120.673 -1.267 . . . . 0.0 113.215 177.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 6.5 ttp -74.68 128.41 35.49 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.683 -1.261 . . . . 0.0 114.207 -178.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 91.0 mt -90.39 -50.05 6.18 Favored 'General case' 0 CA--C 1.567 1.617 0 N-CA-C 113.874 1.065 . . . . 0.0 113.874 172.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 91.3 p -139.98 154.81 47.27 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -175.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 24.7 p30 -135.77 81.36 1.88 Allowed 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 124.133 0.973 . . . . 0.0 111.092 173.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -88.67 119.58 29.27 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.102 -0.999 . . . . 0.0 110.144 -174.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.273 41.9 t30 67.95 21.68 8.84 Favored 'General case' 0 N--CA 1.504 2.251 0 N-CA-C 116.821 2.156 . . . . 0.0 116.821 -175.533 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -69.29 -47.14 65.41 Favored 'General case' 0 CA--C 1.568 1.666 0 N-CA-C 115.795 1.776 . . . . 0.0 115.795 178.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -46.48 -44.41 17.55 Favored 'General case' 0 N--CA 1.502 2.173 0 N-CA-C 117.534 2.42 . . . . 0.0 117.534 165.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -69.44 -44.79 70.57 Favored 'General case' 0 CA--C 1.57 1.731 0 N-CA-C 114.992 1.479 . . . . 0.0 114.992 172.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -52.94 -47.35 68.14 Favored 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 115.123 1.527 . . . . 0.0 115.123 166.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.7 mt -61.14 -41.63 97.08 Favored 'General case' 0 CA--C 1.571 1.782 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 169.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 44.2 ttp85 -56.62 -45.52 81.47 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 115.36 1.615 . . . . 0.0 115.36 166.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.12 -25.1 60.98 Favored 'General case' 0 CA--C 1.567 1.606 0 N-CA-C 117.827 2.528 . . . . 0.0 117.827 165.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 98.1 mt -89.39 21.79 3.19 Favored 'General case' 0 CA--C 1.573 1.836 0 N-CA-C 115.23 1.567 . . . . 0.0 115.23 164.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.486 ' HD2' ' NZ ' ' A' ' 101' ' ' LYS . 11.7 m-20 66.9 16.39 10.36 Favored 'General case' 0 N--CA 1.504 2.236 0 N-CA-C 116.682 2.104 . . . . 0.0 116.682 179.551 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 91.4 t -82.03 136.35 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 120.223 -1.548 . . . . 0.0 110.215 -167.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 13.7 p30 -62.06 152.86 31.45 Favored 'General case' 0 CA--C 1.57 1.727 0 N-CA-C 115.208 1.559 . . . . 0.0 115.208 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 91.5 t -58.7 -38.4 71.53 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.153 0 N-CA-C 115.219 1.563 . . . . 0.0 115.219 -176.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.12 -55.98 27.64 Favored 'General case' 0 CA--C 1.569 1.687 0 N-CA-C 115.448 1.647 . . . . 0.0 115.448 167.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -56.52 -43.29 79.65 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 116.275 1.954 . . . . 0.0 116.275 169.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 37.3 mtp-105 -52.07 -53.06 46.85 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 116.017 1.858 . . . . 0.0 116.017 168.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -66.75 -47.75 71.27 Favored 'General case' 0 CA--C 1.567 1.629 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 174.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 66.1 mt -55.34 -54.87 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 CA-C-N 120.047 1.294 . . . . 0.0 113.266 174.042 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.84 -38.02 89.13 Favored 'General case' 0 CA--C 1.564 1.514 0 N-CA-C 117.635 2.457 . . . . 0.0 117.635 176.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -74.16 -24.11 59.35 Favored 'General case' 0 CA--C 1.571 1.759 0 N-CA-C 116.138 1.903 . . . . 0.0 116.138 171.265 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 73.6 mt -73.2 -37.79 66.34 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 115.405 1.631 . . . . 0.0 115.405 168.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.5 pp -84.28 143.92 29.23 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 119.597 1.089 . . . . 0.0 113.923 -178.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm -104.53 101.88 30.58 Favored Pre-proline 0 CA--C 1.572 1.818 0 CA-C-O 117.954 -1.022 . . . . 0.0 109.348 174.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -82.26 172.12 11.96 Favored 'Trans proline' 0 CA--C 1.564 2.014 0 C-N-CA 122.805 2.337 . . . . 0.0 114.778 -176.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -109.2 118.97 38.11 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.278 176.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 52.6 mttm -85.38 108.3 17.78 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.073 -1.017 . . . . 0.0 109.895 172.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -91.89 108.06 19.65 Favored 'General case' 0 CA--C 1.559 1.302 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 164.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 84.9 mt -97.6 114.15 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 -179.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 98.0 t -101.06 97.72 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 168.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -95.66 99.63 11.46 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 123.673 0.789 . . . . 0.0 109.727 175.328 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -106.64 75.25 1.05 Allowed 'General case' 0 CA--C 1.567 1.612 0 C-N-CA 123.557 0.743 . . . . 0.0 110.563 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 57.61 68.24 1.8 Allowed Glycine 0 N--CA 1.494 2.552 0 N-CA-C 117.628 1.811 . . . . 0.0 117.628 177.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.494 0.0 OUTLIER 81.99 -39.24 0.12 Allowed 'General case' 0 N--CA 1.501 2.108 0 N-CA-C 115.837 1.792 . . . . 0.0 115.837 -165.358 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 21.8 t-160 -74.32 100.49 3.77 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 120.677 1.58 . . . . 0.0 111.183 177.327 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 42.5 ttm -113.14 111.26 21.8 Favored 'General case' 0 CA--C 1.552 1.031 0 CA-C-O 121.665 0.745 . . . . 0.0 109.137 -170.191 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 51.8 mt -102.79 103.12 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 -175.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 26.0 mm -89.22 93.72 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 -178.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 61.1 mtt85 -90.45 97.38 11.15 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.232 -0.918 . . . . 0.0 110.099 178.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 14.3 m -89.41 99.19 12.24 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 15.1 mt -93.77 117.36 29.99 Favored 'General case' 0 N--CA 1.484 1.266 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.594 -162.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 42.2 t -133.11 141.27 48.09 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.849 0.859 . . . . 0.0 110.752 -159.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 13.1 t -74.09 39.35 0.11 Allowed 'General case' 0 CA--C 1.581 2.144 0 N-CA-C 116.701 2.112 . . . . 0.0 116.701 172.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -159.52 -65.29 0.08 Allowed 'General case' 0 CA--C 1.567 1.621 0 C-N-CA 124.676 1.19 . . . . 0.0 109.92 178.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 53.4 ttm-85 -140.09 117.52 11.42 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 123.625 0.77 . . . . 0.0 108.942 174.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 72.0 m-80 -76.77 126.99 31.92 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.785 -0.572 . . . . 0.0 111.993 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 40.9 t80 -106.47 100.28 9.82 Favored 'General case' 0 CA--C 1.567 1.606 0 O-C-N 121.645 -0.66 . . . . 0.0 110.724 -172.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 4.1 mp -95.36 111.22 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 C-N-CA 123.73 0.812 . . . . 0.0 109.051 178.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -103.55 94.83 5.67 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 123.413 0.685 . . . . 0.0 109.621 176.672 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -100.38 118.07 35.87 Favored 'General case' 0 CA--C 1.564 1.486 0 C-N-CA 123.913 0.885 . . . . 0.0 112.805 -174.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -155.15 143.2 20.11 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 -170.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 17.9 mp0 -85.18 116.17 23.39 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.441 -0.787 . . . . 0.0 110.376 166.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 41.2 t -65.08 117.54 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 C-N-CA 123.769 0.828 . . . . 0.0 110.047 177.242 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 118.61 -54.68 0.61 Allowed Glycine 0 N--CA 1.488 2.139 0 N-CA-C 114.675 0.63 . . . . 0.0 114.675 -159.049 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 5.9 mtmp? -80.79 148.02 30.21 Favored 'General case' 0 CA--C 1.566 1.586 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 -173.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -98.78 124.13 43.45 Favored 'General case' 0 CA--C 1.568 1.665 0 C-N-CA 123.183 0.593 . . . . 0.0 111.78 178.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 9.0 p90 -135.76 145.63 46.79 Favored 'General case' 0 N--CA 1.498 1.967 0 C-N-CA 123.837 0.855 . . . . 0.0 112.024 -171.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -79.15 128.29 33.1 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 119.54 -1.975 . . . . 0.0 113.64 177.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -73.95 85.53 1.76 Allowed 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 122.238 1.018 . . . . 0.0 112.079 173.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -126.46 -55.48 1.43 Allowed 'General case' 0 CA--C 1.567 1.629 0 C-N-CA 124.087 0.955 . . . . 0.0 111.855 176.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.1 tt -70.01 137.05 51.05 Favored 'General case' 0 CA--C 1.568 1.658 0 C-N-CA 123.631 0.772 . . . . 0.0 111.855 173.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . 0.332 29.1 m 87.69 136.62 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.168 0 C-N-CA 124.897 1.279 . . . . 0.0 110.51 -166.304 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -71.67 81.42 0.52 Allowed Glycine 0 N--CA 1.492 2.417 0 N-CA-C 117.796 1.878 . . . . 0.0 117.796 -172.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.43 HG13 ' H ' ' A' ' 78' ' ' ASP 0.253 5.4 tp -108.27 -162.46 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.58 2.103 0 C-N-CA 124.788 1.235 . . . . 0.0 110.881 175.537 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.43 ' H ' HG13 ' A' ' 77' ' ' ILE . 34.7 t70 -64.82 129.79 41.09 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 119.744 -1.847 . . . . 0.0 111.952 164.327 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -75.6 65.29 1.78 Allowed 'General case' 0 CA--C 1.575 1.917 0 N-CA-C 114.615 1.339 . . . . 0.0 114.615 -176.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 7.4 mpt_? -136.16 135.75 39.45 Favored 'General case' 0 CA--C 1.561 1.378 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 160.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 10.3 mtmt -79.55 72.43 6.21 Favored 'General case' 0 CA--C 1.571 1.782 0 O-C-N 121.225 -0.922 . . . . 0.0 113.156 -170.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 73.0 m -80.73 121.1 25.48 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 121.922 0.868 . . . . 0.0 113.038 -164.131 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 7.2 tpt -75.88 111.13 10.92 Favored 'General case' 0 CA--C 1.56 1.331 0 CA-C-O 122.175 0.988 . . . . 0.0 110.522 -170.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 93.8 m -120.61 120.61 36.27 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 115.377 -0.828 . . . . 0.0 110.399 -153.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 50.9 m -105.79 125.29 50.82 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 171.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.454 HG21 ' SG ' ' A' ' 95' ' ' CYS . 20.4 t -104.61 130.8 54.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 165.794 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 58.7 m -149.94 152.35 34.85 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.455 -1.403 . . . . 0.0 112.871 -178.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 52.3 m95 -83.78 118.96 24.26 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.939 -1.1 . . . . 0.0 113.544 -176.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -94.13 67.38 3.61 Favored 'General case' 0 CA--C 1.572 1.819 0 O-C-N 121.594 -0.691 . . . . 0.0 110.101 159.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 67.09 -102.63 0.81 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 114.798 0.679 . . . . 0.0 114.798 -176.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -80.81 -23.22 39.38 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 116.523 2.045 . . . . 0.0 116.523 169.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 60.1 mtpt -98.77 116.15 30.36 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 119.317 0.962 . . . . 0.0 110.182 -174.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 29.2 tp -82.83 109.47 16.99 Favored 'General case' 0 CA--C 1.564 1.485 0 O-C-N 121.277 -0.89 . . . . 0.0 110.057 175.438 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 -97.78 131.93 43.85 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.644 0.778 . . . . 0.0 111.538 -174.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . 0.454 ' SG ' HG21 ' A' ' 86' ' ' VAL . 44.9 t -122.26 128.92 51.71 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.341 0.657 . . . . 0.0 110.744 175.208 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.1 p -110.69 127.6 67.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 166.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -109.05 88.62 2.77 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 123.453 0.701 . . . . 0.0 109.665 175.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 12.0 ptmm? -97.22 145.19 26.3 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 114.309 1.225 . . . . 0.0 114.309 -172.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 159.75 -97.52 0.16 Allowed Glycine 0 N--CA 1.488 2.133 0 O-C-N 121.282 -0.886 . . . . 0.0 112.626 173.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -75.2 -47.16 29.63 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 115.125 1.528 . . . . 0.0 115.125 173.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.486 ' NZ ' ' HD2' ' A' ' 24' ' ' ASP . 1.6 ttmp? -103.51 131.79 50.33 Favored 'General case' 0 CA--C 1.561 1.38 0 C-N-CA 123.636 0.774 . . . . 0.0 111.77 -161.796 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -77.87 160.38 28.32 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -179.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 56.57 21.43 35.08 Favored Glycine 0 N--CA 1.498 2.774 0 N-CA-C 120.722 3.049 . . . . 0.0 120.722 -179.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 45.1 ttt180 -96.02 123.21 39.53 Favored 'General case' 0 CA--C 1.563 1.459 0 CA-C-N 118.481 1.14 . . . . 0.0 112.42 -168.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 173.39 -169.78 42.9 Favored Glycine 0 N--CA 1.484 1.887 0 CA-C-O 121.949 0.75 . . . . 0.0 114.558 -176.327 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . 0.253 41.5 p-90 -156.82 157.17 34.47 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 113.804 1.038 . . . . 0.0 113.804 173.536 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 34.5 m -129.63 118.57 22.17 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 123.782 0.833 . . . . 0.0 108.765 176.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 -121.42 130.15 53.42 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.743 -0.598 . . . . 0.0 112.434 -175.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 25.4 p90 -144.66 164.86 29.7 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.251 -0.906 . . . . 0.0 112.059 176.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 96.3 mt -109.79 127.82 66.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 120.915 -1.116 . . . . 0.0 109.789 175.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -102.02 84.54 2.53 Favored 'General case' 0 CA--C 1.567 1.616 0 C-N-CA 123.997 0.919 . . . . 0.0 109.185 163.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 64.84 -98.06 0.28 Allowed Glycine 0 N--CA 1.493 2.442 0 N-CA-C 116.452 1.341 . . . . 0.0 116.452 -179.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 41.1 p30 -88.94 -5.46 57.96 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 117.36 2.356 . . . . 0.0 117.36 167.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -114.63 125.53 53.87 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-N 120.874 1.67 . . . . 0.0 111.529 -172.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 14.2 tp -86.26 115.13 23.61 Favored 'General case' 0 CA--C 1.563 1.474 0 C-N-CA 123.869 0.867 . . . . 0.0 109.472 169.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 51.8 m80 -102.42 121.09 41.65 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.651 0.78 . . . . 0.0 109.029 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 53.6 tp -121.16 119.41 32.28 Favored 'General case' 0 CA--C 1.562 1.433 0 C-N-CA 123.714 0.806 . . . . 0.0 110.005 -176.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -100.19 116.55 32.45 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 168.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 71.9 mtm -109.76 124.97 52.19 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 118.974 0.806 . . . . 0.0 110.977 -178.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 87.4 mtm180 -112.3 137.13 50.86 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 123.963 0.905 . . . . 0.0 110.809 -171.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -154.03 129.97 10.21 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.372 -0.83 . . . . 0.0 111.344 168.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . 0.273 7.9 mm-40 64.05 9.19 4.47 Favored 'General case' 0 N--CA 1.502 2.125 0 N-CA-C 117.59 2.441 . . . . 0.0 117.59 -175.303 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 99.88 -19.08 54.74 Favored Glycine 0 CA--C 1.556 2.615 0 N-CA-C 117.792 1.877 . . . . 0.0 117.792 -157.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 96.8 t -83.86 124.27 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 CA-C-N 119.7 1.75 . . . . 0.0 109.77 -177.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 47.9 m -103.74 119.73 39.51 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 121.108 0.48 . . . . 0.0 111.205 176.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 8.8 t -88.94 136.45 33.0 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.656 0.783 . . . . 0.0 112.075 162.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -111.23 114.93 28.5 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.718 -0.614 . . . . 0.0 109.832 176.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -113.81 140.38 48.36 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.857 0.863 . . . . 0.0 111.545 176.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 34.5 t -123.06 134.84 65.0 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 177.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -130.24 132.56 46.01 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 123.878 0.871 . . . . 0.0 111.215 -177.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 20.2 tptm -98.06 136.11 38.78 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.997 -1.065 . . . . 0.0 112.161 -178.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 67.7 tttt -74.5 118.33 17.33 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.522 -0.737 . . . . 0.0 112.777 179.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . 0.254 35.0 m -102.85 -40.79 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 175.067 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 67.0 t60 . . . . . 0 N--CA 1.486 1.351 0 CA-C-N 119.838 1.199 . . . . 0.0 107.95 164.212 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo . . . . . 0 CA--C 1.563 1.967 0 N-CA-C 114.658 0.984 . . . . 0.0 114.658 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 33.0 m -78.73 125.84 38.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -166.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -75.67 97.49 3.82 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.026 -1.046 . . . . 0.0 112.532 -176.091 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -72.76 1.22 8.9 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 117.981 2.586 . . . . 0.0 117.981 -178.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -51.84 109.51 0.37 Allowed 'General case' 0 CA--C 1.566 1.594 0 N-CA-C 115.716 1.747 . . . . 0.0 115.716 -176.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 161.24 179.05 35.72 Favored Glycine 0 N--CA 1.484 1.894 0 CA-C-O 122.666 1.148 . . . . 0.0 115.94 -178.19 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -110.92 126.09 54.36 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 114.052 -1.074 . . . . 0.0 108.541 172.591 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 49.7 m95 -128.94 125.09 36.75 Favored 'General case' 0 CA--C 1.566 1.578 0 C-N-CA 123.358 0.663 . . . . 0.0 109.46 -167.02 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 16.7 ptpt -89.78 143.95 26.37 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.857 -1.152 . . . . 0.0 112.933 174.842 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.41 ' SD ' ' OD1' ' A' ' 13' ' ' ASN . 49.1 ttm -75.99 127.87 33.87 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.845 -1.16 . . . . 0.0 112.585 174.25 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 88.7 mt -87.06 -49.91 7.0 Favored 'General case' 0 CA--C 1.568 1.639 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 171.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 91.9 p -143.46 142.04 31.03 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 119.428 1.013 . . . . 0.0 113.368 -170.339 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.41 ' OD1' ' SD ' ' A' ' 10' ' ' MET . 2.3 m120 -117.99 93.42 4.13 Favored 'General case' 0 CA--C 1.565 1.527 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 -177.671 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -77.18 -70.23 0.48 Allowed 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 115.585 1.698 . . . . 0.0 115.585 -165.248 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -119.08 44.56 2.3 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.907 0.861 . . . . 0.0 111.237 175.155 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -72.38 -37.53 68.72 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 114.894 1.442 . . . . 0.0 114.894 175.553 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -50.02 -54.08 22.51 Favored 'General case' 0 CA--C 1.574 1.889 0 N-CA-C 115.288 1.588 . . . . 0.0 115.288 166.827 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -71.62 -36.94 70.93 Favored 'General case' 0 CA--C 1.574 1.881 0 N-CA-C 115.978 1.844 . . . . 0.0 115.978 175.154 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -55.09 -49.54 71.44 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 114.84 1.422 . . . . 0.0 114.84 165.749 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 78.7 mt -60.96 -39.91 91.33 Favored 'General case' 0 CA--C 1.574 1.889 0 N-CA-C 114.819 1.414 . . . . 0.0 114.819 169.337 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 26.9 ttm180 -51.52 -51.73 52.8 Favored 'General case' 0 N--CA 1.502 2.173 0 N-CA-C 115.467 1.654 . . . . 0.0 115.467 163.763 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.51 -27.7 62.78 Favored 'General case' 0 CA--C 1.567 1.635 0 N-CA-C 117.908 2.559 . . . . 0.0 117.908 167.365 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 95.8 mt -81.52 10.92 5.1 Favored 'General case' 0 CA--C 1.573 1.837 0 N-CA-C 115.614 1.709 . . . . 0.0 115.614 167.559 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.252 0.9 OUTLIER 64.03 40.0 7.47 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 115.434 1.642 . . . . 0.0 115.434 -175.429 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 89.0 t -100.15 151.0 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 CA-C-O 122.379 1.085 . . . . 0.0 110.645 -178.383 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 9.7 p-10 -74.12 154.39 39.16 Favored 'General case' 0 CA--C 1.568 1.656 0 N-CA-C 115.59 1.7 . . . . 0.0 115.59 -179.449 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 45.9 t -54.58 -45.72 71.72 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.345 0 N-CA-C 115.059 1.503 . . . . 0.0 115.059 -176.139 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.33 -47.98 83.41 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 115.922 1.823 . . . . 0.0 115.922 176.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.77 -49.89 75.96 Favored 'General case' 0 CA--C 1.571 1.75 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 168.02 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 56.3 mtp180 -48.55 -55.47 11.0 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 116.302 1.964 . . . . 0.0 116.302 167.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 35.8 tptt -59.32 -50.78 72.67 Favored 'General case' 0 CA--C 1.564 1.504 0 N-CA-C 115.471 1.656 . . . . 0.0 115.471 176.005 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 22.2 mt -67.86 -45.69 83.64 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.806 0 CA-C-O 118.03 -0.986 . . . . 0.0 112.286 177.318 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -57.9 -39.89 79.0 Favored 'General case' 0 CA--C 1.565 1.548 0 N-CA-C 117.229 2.307 . . . . 0.0 117.229 170.726 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -65.94 -28.67 69.09 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 116.411 2.004 . . . . 0.0 116.411 166.305 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 80.4 mt -72.99 -37.17 67.1 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 115.727 1.751 . . . . 0.0 115.727 165.236 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 44.2 mt -68.74 141.48 55.23 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 119.45 1.023 . . . . 0.0 113.711 -175.806 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 39.2 mmtm -112.54 78.99 2.89 Favored Pre-proline 0 CA--C 1.575 1.91 0 CA-C-O 118.411 -0.804 . . . . 0.0 109.934 177.733 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.409 ' HD2' ' SD ' ' A' ' 10' ' ' MET . 74.1 Cg_endo -75.34 168.4 24.68 Favored 'Trans proline' 0 CA--C 1.562 1.895 0 C-N-CA 122.528 2.152 . . . . 0.0 115.708 -176.645 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -108.58 127.36 53.88 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.664 -174.592 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 38.7 mttp -97.6 113.95 25.77 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.563 -0.71 . . . . 0.0 109.651 172.179 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -98.69 108.26 20.9 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 165.071 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.3 mp -96.97 120.05 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 177.335 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 75.4 t -99.67 101.85 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 166.776 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -104.59 114.02 27.97 Favored 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 123.469 0.708 . . . . 0.0 110.927 -178.628 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -123.7 74.48 1.27 Allowed 'General case' 0 CA--C 1.569 1.685 0 C-N-CA 123.843 0.857 . . . . 0.0 110.493 177.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.76 -100.37 1.45 Allowed Glycine 0 N--CA 1.489 2.229 0 O-C-N 121.48 -0.762 . . . . 0.0 114.063 177.198 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -85.22 -33.84 22.14 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 115.218 1.562 . . . . 0.0 115.218 162.043 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -78.16 114.15 16.78 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-N 120.682 1.583 . . . . 0.0 112.11 -174.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 48.2 ttm -128.29 118.63 23.6 Favored 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 123.43 0.692 . . . . 0.0 109.644 -175.28 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 52.4 mt -107.02 103.33 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 176.188 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 73.2 mt -90.39 99.53 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 175.512 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 70.5 mtt85 -89.42 95.96 10.5 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.467 -0.771 . . . . 0.0 110.673 178.527 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 49.5 m -88.29 105.08 17.32 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 177.816 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 12.2 mt -106.01 113.9 27.72 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 123.684 0.793 . . . . 0.0 109.213 -163.302 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 9.1 t -139.68 155.91 47.11 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.856 0.836 . . . . 0.0 112.434 -166.65 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 26.9 m -61.57 -40.74 95.83 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 115.745 1.757 . . . . 0.0 115.745 178.436 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -69.04 -58.13 4.51 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 114.699 1.37 . . . . 0.0 114.699 171.16 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 26.4 tpt180 -152.15 135.67 16.09 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-N 118.516 0.598 . . . . 0.0 109.863 175.578 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -73.98 112.42 10.09 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.776 -0.577 . . . . 0.0 109.706 163.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 52.8 t80 -79.29 -61.68 1.93 Allowed 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -167.659 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.334 49.7 mt 74.5 97.64 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 C-N-CA 123.932 0.893 . . . . 0.0 111.91 167.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 89.0 mtp -100.18 99.42 10.11 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.486 -0.759 . . . . 0.0 109.352 172.451 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -98.71 114.45 26.97 Favored 'General case' 0 CA--C 1.563 1.479 0 C-N-CA 124.013 0.925 . . . . 0.0 111.663 177.009 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -156.55 157.17 34.89 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 -168.184 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 66.1 mt-30 -100.28 127.16 46.63 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.581 -0.7 . . . . 0.0 110.481 165.078 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 37.3 t -63.53 123.5 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 C-N-CA 124.103 0.961 . . . . 0.0 110.503 178.681 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 107.67 -43.28 1.73 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 116.199 1.24 . . . . 0.0 116.199 -158.158 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 76.1 mttt -86.72 152.57 22.42 Favored 'General case' 0 CA--C 1.568 1.642 0 CA-C-N 118.612 1.206 . . . . 0.0 113.489 -172.322 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -107.92 117.92 35.39 Favored 'General case' 0 CA--C 1.569 1.674 0 C-N-CA 123.469 0.707 . . . . 0.0 111.469 -173.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 8.8 p90 -127.28 151.57 48.57 Favored 'General case' 0 N--CA 1.501 2.108 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 -171.047 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -80.43 123.89 28.43 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.015 -1.678 . . . . 0.0 114.81 -176.73 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 . . . . . 0 N--CA 1.502 2.136 0 N-CA-C 115.696 1.739 . . . . 0.0 115.696 177.501 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 99.2 m . . . . . 0 CA--C 1.56 1.328 0 CA-C-O 121.227 0.536 . . . . 0.0 111.033 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -79.51 94.83 5.68 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 122.999 1.38 . . . . 0.0 110.255 -170.04 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 99.5 m -100.0 118.02 35.5 Favored 'General case' 0 N--CA 1.48 1.036 0 O-C-N 121.292 -0.88 . . . . 0.0 110.372 -153.538 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 25.0 m -112.74 122.53 47.95 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-N 115.102 -0.954 . . . . 0.0 108.504 -174.428 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 20.7 t -113.26 127.77 70.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 -177.304 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 60.9 p -131.36 159.21 38.63 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 122.223 1.011 . . . . 0.0 112.609 -175.702 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 55.5 m95 -92.13 113.76 26.12 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.782 -0.574 . . . . 0.0 110.605 171.247 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -92.71 73.22 4.99 Favored 'General case' 0 CA--C 1.566 1.58 0 C-N-CA 123.253 0.621 . . . . 0.0 110.291 171.426 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.05 -94.56 0.18 Allowed Glycine 0 N--CA 1.489 2.187 0 N-CA-C 114.637 0.615 . . . . 0.0 114.637 -171.011 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -85.39 -38.37 18.79 Favored 'General case' 0 CA--C 1.569 1.676 0 N-CA-C 115.405 1.631 . . . . 0.0 115.405 171.076 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -93.31 154.65 17.87 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 119.163 0.892 . . . . 0.0 112.733 -167.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 18.5 tp -99.16 109.68 22.34 Favored 'General case' 0 CA--C 1.564 1.504 0 O-C-N 121.04 -1.037 . . . . 0.0 110.273 178.498 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 31.7 mm-40 -97.48 122.61 40.74 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 123.862 0.865 . . . . 0.0 111.3 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 41.7 t -114.6 131.39 56.71 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.38 0.672 . . . . 0.0 111.609 175.183 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 15.0 p -117.03 123.59 72.02 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.699 0 C-N-CA 123.174 0.59 . . . . 0.0 109.579 170.472 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -98.73 97.05 8.34 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 124.033 0.933 . . . . 0.0 109.277 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 30.4 mmtp -81.31 119.72 24.02 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 -168.281 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -174.3 -121.38 0.62 Allowed Glycine 0 N--CA 1.484 1.861 0 O-C-N 121.994 -0.441 . . . . 0.0 112.425 171.366 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -87.05 -32.51 19.94 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 116.619 2.081 . . . . 0.0 116.619 -178.497 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 50.7 mttp -89.57 135.73 33.43 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 120.711 1.596 . . . . 0.0 112.756 -165.481 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -81.09 102.83 10.5 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.742 0.782 . . . . 0.0 112.989 -164.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 82.35 41.75 9.02 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 117.308 1.683 . . . . 0.0 117.308 -168.474 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 46.9 ttt180 -84.8 118.46 24.48 Favored 'General case' 0 CA--C 1.564 1.503 0 CA-C-N 118.857 1.329 . . . . 0.0 111.121 175.127 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 170.84 -165.55 38.75 Favored Glycine 0 N--CA 1.484 1.861 0 N-CA-C 114.827 0.691 . . . . 0.0 114.827 -178.012 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 28.9 p-90 -157.43 157.13 33.4 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 114.6 1.333 . . . . 0.0 114.6 176.761 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 25.5 m -120.25 122.37 40.74 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 171.487 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -119.72 133.89 55.44 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 123.187 0.595 . . . . 0.0 111.834 -178.07 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 19.0 p90 -149.1 174.45 12.32 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 178.171 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 55.5 mt -116.46 133.13 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.212 -0.93 . . . . 0.0 108.988 176.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -112.13 90.19 3.27 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 123.773 0.829 . . . . 0.0 109.092 163.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 64.49 -104.66 0.95 Allowed Glycine 0 N--CA 1.492 2.4 0 N-CA-C 115.754 1.062 . . . . 0.0 115.754 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 57.3 p30 -84.13 -2.02 56.04 Favored 'General case' 0 CA--C 1.571 1.775 0 N-CA-C 117.86 2.541 . . . . 0.0 117.86 166.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -118.47 135.9 54.11 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-N 120.657 1.572 . . . . 0.0 112.424 -168.156 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 12.4 tp -94.38 120.91 35.33 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 123.73 0.812 . . . . 0.0 108.969 174.319 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 37.3 m80 -109.99 120.1 41.4 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -176.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 42.3 tp -121.51 121.53 37.69 Favored 'General case' 0 CA--C 1.56 1.35 0 C-N-CA 123.576 0.75 . . . . 0.0 109.543 -176.726 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -107.97 117.89 35.32 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.878 -0.513 . . . . 0.0 109.679 168.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 66.9 mtm -110.46 127.41 55.12 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-N 118.61 0.641 . . . . 0.0 111.1 -178.195 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 69.1 mtp180 -110.88 144.66 39.56 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -179.172 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -159.36 131.18 6.36 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.187 0.595 . . . . 0.0 111.153 166.031 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 59.0 38.07 24.32 Favored 'General case' 0 N--CA 1.507 2.402 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 -173.71 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 75.75 -26.21 1.4 Allowed Glycine 0 CA--C 1.559 2.827 0 N-CA-C 119.597 2.599 . . . . 0.0 119.597 -160.265 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 86.8 t -81.02 122.79 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 CA-C-N 119.392 1.596 . . . . 0.0 110.571 -163.505 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 24.1 m -100.9 120.95 40.9 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 122.909 0.484 . . . . 0.0 111.489 -176.254 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 44.1 t -88.34 139.45 30.48 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.306 0.643 . . . . 0.0 112.242 160.487 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 44.8 mtpt -109.51 126.2 53.28 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 168.003 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -123.03 126.14 46.55 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 123.742 0.817 . . . . 0.0 109.543 174.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 72.8 t -109.1 132.57 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 179.283 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -122.18 153.07 39.27 Favored 'General case' 0 CA--C 1.565 1.558 0 C-N-CA 124.541 1.136 . . . . 0.0 111.442 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 8.9 tmtt? -120.87 136.88 54.82 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.199 -0.938 . . . . 0.0 111.607 175.651 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -72.5 120.49 18.19 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 33.4 m -101.49 -43.75 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 N-CA-C 113.194 0.812 . . . . 0.0 113.194 174.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 53.7 t-80 . . . . . 0 N--CA 1.485 1.317 0 CA-C-N 119.75 1.159 . . . . 0.0 108.124 168.472 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo . . . . . 0 CA--C 1.566 2.114 0 N-CA-C 115.356 1.252 . . . . 0.0 115.356 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 25.9 m -81.2 140.04 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.468 -0.77 . . . . 0.0 112.56 177.697 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.5 100.51 10.13 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.514 -1.366 . . . . 0.0 111.459 175.355 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -72.72 -2.24 19.5 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 118.307 2.706 . . . . 0.0 118.307 177.475 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -56.29 112.27 1.19 Allowed 'General case' 0 CA--C 1.567 1.601 0 N-CA-C 115.945 1.831 . . . . 0.0 115.945 -172.393 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 155.46 -161.89 30.78 Favored Glycine 0 N--CA 1.486 1.996 0 N-CA-C 115.7 1.04 . . . . 0.0 115.7 178.466 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -124.13 127.83 48.37 Favored 'General case' 0 CA--C 1.564 1.498 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 -179.444 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 61.4 m95 -129.0 125.26 37.0 Favored 'General case' 0 CA--C 1.566 1.567 0 C-N-CA 123.273 0.629 . . . . 0.0 109.489 -166.656 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 24.8 pttm -96.17 141.19 29.83 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.089 -1.007 . . . . 0.0 112.903 177.484 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.434 ' SD ' ' HD2' ' A' ' 38' ' ' PRO . 32.8 ttm -68.89 125.89 28.04 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-N 120.044 1.293 . . . . 0.0 113.264 176.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 91.9 mt -85.87 -53.97 4.79 Favored 'General case' 0 CA--C 1.565 1.552 0 C-N-CA 123.387 0.675 . . . . 0.0 112.798 166.371 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 92.7 p -142.88 150.53 39.96 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 119.243 0.929 . . . . 0.0 112.838 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 24.1 p30 -125.92 84.65 2.3 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-O 122.235 1.017 . . . . 0.0 110.665 178.098 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -93.8 119.07 32.27 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.825 -1.172 . . . . 0.0 110.656 -163.613 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.281 32.1 t30 62.96 24.45 14.56 Favored 'General case' 0 N--CA 1.503 2.186 0 N-CA-C 116.617 2.08 . . . . 0.0 116.617 -169.704 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -69.27 -44.68 71.39 Favored 'General case' 0 CA--C 1.567 1.619 0 N-CA-C 115.223 1.564 . . . . 0.0 115.223 178.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -55.99 -39.91 72.53 Favored 'General case' 0 N--CA 1.504 2.257 0 N-CA-C 117.412 2.375 . . . . 0.0 117.412 169.005 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -65.38 -43.05 91.93 Favored 'General case' 0 CA--C 1.573 1.854 0 CA-C-N 120.252 1.387 . . . . 0.0 114.639 169.423 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -57.35 -47.83 80.59 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 115.31 1.596 . . . . 0.0 115.31 166.293 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 90.0 mt -58.25 -43.55 87.92 Favored 'General case' 0 CA--C 1.57 1.744 0 N-CA-C 114.633 1.346 . . . . 0.0 114.633 169.555 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.25 -49.2 72.63 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 115.639 1.718 . . . . 0.0 115.639 166.475 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.49 -21.25 9.51 Favored 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 118.507 2.78 . . . . 0.0 118.507 163.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 95.9 mt -91.9 15.87 12.19 Favored 'General case' 0 CA--C 1.576 1.959 0 N-CA-C 114.867 1.432 . . . . 0.0 114.867 166.559 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 60.41 42.72 14.22 Favored 'General case' 0 N--CA 1.502 2.138 0 N-CA-C 116.149 1.907 . . . . 0.0 116.149 -175.749 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 91.3 t -93.62 140.05 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.091 -1.006 . . . . 0.0 110.179 -179.045 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 15.1 p30 -65.37 155.59 34.87 Favored 'General case' 0 CA--C 1.572 1.803 0 N-CA-C 115.188 1.551 . . . . 0.0 115.188 171.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 61.6 t -57.78 -41.32 79.38 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.251 0 N-CA-C 114.668 1.358 . . . . 0.0 114.668 179.26 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.72 -50.73 72.24 Favored 'General case' 0 CA--C 1.565 1.534 0 N-CA-C 116.163 1.912 . . . . 0.0 116.163 172.43 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 6.1 tt -67.2 -39.08 86.28 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-N 120.637 1.562 . . . . 0.0 115.13 170.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 53.3 mtp180 -49.17 -42.42 39.74 Favored 'General case' 0 N--CA 1.502 2.128 0 N-CA-C 116.551 2.056 . . . . 0.0 116.551 163.421 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -72.77 -52.15 16.2 Favored 'General case' 0 CA--C 1.567 1.623 0 CA-C-O 118.284 -0.865 . . . . 0.0 113.324 167.034 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 5.6 mt -80.74 58.16 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.587 2.397 0 CA-C-N 121.107 1.776 . . . . 0.0 111.761 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -172.79 -51.95 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 126.187 1.795 . . . . 0.0 110.415 -178.466 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -66.53 -36.52 82.88 Favored 'General case' 0 CA--C 1.568 1.655 0 N-CA-C 116.0 1.852 . . . . 0.0 116.0 164.411 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 91.9 mt -74.53 -30.49 61.79 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 176.704 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.6 pp -84.27 149.63 25.96 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 119.408 1.004 . . . . 0.0 111.971 167.007 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp -104.67 94.74 7.68 Favored Pre-proline 0 CA--C 1.57 1.749 0 CA-C-O 118.091 -0.957 . . . . 0.0 108.492 174.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.434 ' HD2' ' SD ' ' A' ' 10' ' ' MET . 88.9 Cg_endo -75.27 172.71 15.82 Favored 'Trans proline' 0 CA--C 1.562 1.911 0 C-N-CA 122.642 2.228 . . . . 0.0 114.694 -175.263 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -123.95 130.56 52.79 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.663 -171.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 57.2 mttm -98.46 112.67 24.61 Favored 'General case' 0 N--CA 1.485 1.315 0 O-C-N 121.441 -0.787 . . . . 0.0 109.808 177.31 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -97.09 110.06 22.68 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 166.383 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 64.8 mt -105.7 116.66 49.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -174.033 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 63.2 t -99.25 98.75 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 169.24 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -100.63 115.71 30.84 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 123.725 0.81 . . . . 0.0 110.848 -178.291 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -125.6 72.95 1.29 Allowed 'General case' 0 CA--C 1.568 1.659 0 O-C-N 121.647 -0.658 . . . . 0.0 111.186 176.088 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 70.92 -93.52 0.49 Allowed Glycine 0 N--CA 1.49 2.24 0 O-C-N 121.468 -0.77 . . . . 0.0 114.879 178.442 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -88.2 -38.57 15.18 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 115.307 1.595 . . . . 0.0 115.307 164.109 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 20.8 t-160 -80.62 110.27 15.95 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 121.218 1.826 . . . . 0.0 111.717 -176.129 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 45.6 ttm -126.29 121.82 33.73 Favored 'General case' 0 CA--C 1.556 1.2 0 C-N-CA 123.448 0.699 . . . . 0.0 109.733 -172.074 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 4.6 mp -112.04 97.06 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 -179.146 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 73.3 mt -89.77 101.59 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 176.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -91.58 98.03 11.41 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.597 -0.689 . . . . 0.0 109.78 -179.267 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 18.9 m -87.38 104.76 16.74 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 178.217 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 18.0 mt -103.22 116.66 32.88 Favored 'General case' 0 CA--C 1.557 1.241 0 CA-C-N 115.417 -0.811 . . . . 0.0 109.991 -162.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 31.3 t -128.91 143.64 50.95 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 123.929 0.892 . . . . 0.0 110.535 -177.159 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.4 m -77.64 49.22 0.73 Allowed 'General case' 0 CA--C 1.586 2.353 0 O-C-N 121.256 -0.902 . . . . 0.0 113.159 171.357 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -172.53 -66.43 0.02 OUTLIER 'General case' 0 CA--C 1.566 1.587 0 C-N-CA 125.762 1.625 . . . . 0.0 109.082 -179.223 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -134.34 101.64 5.07 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-N 119.306 0.957 . . . . 0.0 110.299 -174.04 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 -83.15 139.72 33.01 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.515 -0.74 . . . . 0.0 112.6 -178.205 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -128.56 100.69 5.85 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.41 0.624 . . . . 0.0 109.726 -178.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.6 mt -100.23 112.8 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 -179.243 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 24.6 mmm -96.05 91.56 6.02 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 175.667 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -96.55 101.97 13.67 Favored 'General case' 0 CA--C 1.561 1.389 0 C-N-CA 123.977 0.911 . . . . 0.0 111.793 178.558 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -145.73 151.98 38.86 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 -166.635 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 23.6 mp0 -93.31 122.44 35.72 Favored 'General case' 0 CA--C 1.566 1.585 0 O-C-N 121.672 -0.643 . . . . 0.0 110.043 166.23 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 49.0 t -63.57 126.77 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 C-N-CA 123.912 0.885 . . . . 0.0 110.834 177.425 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 102.28 -38.2 3.31 Favored Glycine 0 CA--C 1.552 2.344 0 N-CA-C 116.752 1.461 . . . . 0.0 116.752 -162.349 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 11.2 mmpt? -88.34 134.34 33.84 Favored 'General case' 0 CA--C 1.564 1.503 0 CA-C-N 118.981 1.39 . . . . 0.0 112.254 -175.311 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -88.47 119.87 29.32 Favored 'General case' 0 CA--C 1.566 1.577 0 O-C-N 121.706 -0.622 . . . . 0.0 112.391 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 33.0 p90 -120.07 157.74 28.31 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 113.753 1.019 . . . . 0.0 113.753 -172.303 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.39 132.17 36.32 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.726 -1.234 . . . . 0.0 113.786 177.448 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 . . . . . 0 N--CA 1.496 1.849 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 168.145 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 95.8 m . . . . . 0 CA--C 1.563 1.461 0 CA-C-O 122.14 0.972 . . . . 0.0 112.238 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -88.09 101.99 14.34 Favored 'General case' 0 CA--C 1.56 1.332 0 C-N-CA 124.486 1.115 . . . . 0.0 110.046 -178.427 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 87.8 m -97.07 108.78 21.58 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.549 -0.719 . . . . 0.0 111.516 -170.609 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 53.8 m -91.82 131.62 37.03 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 164.677 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.4 t -116.76 136.33 54.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 171.213 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 68.2 m -150.17 148.57 29.1 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.141 -1.599 . . . . 0.0 113.029 -175.776 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 75.3 m95 -81.23 130.95 35.25 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.906 -1.121 . . . . 0.0 112.99 178.13 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -137.47 79.38 1.74 Allowed 'General case' 0 CA--C 1.569 1.688 0 C-N-CA 123.425 0.69 . . . . 0.0 110.344 178.327 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 64.23 76.97 0.25 Allowed Glycine 0 N--CA 1.497 2.71 0 N-CA-C 117.317 1.687 . . . . 0.0 117.317 170.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . 0.265 6.9 m-20 63.57 2.14 1.18 Allowed 'General case' 0 N--CA 1.505 2.286 0 N-CA-C 117.855 2.539 . . . . 0.0 117.855 -167.852 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 72.5 mttt -134.2 135.63 43.15 Favored 'General case' 0 N--CA 1.485 1.278 0 O-C-N 121.113 -0.992 . . . . 0.0 109.807 -168.444 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 22.0 tp -95.37 108.78 20.99 Favored 'General case' 0 CA--C 1.56 1.357 0 O-C-N 121.428 -0.795 . . . . 0.0 109.958 178.029 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 21.0 mm100 -86.46 141.05 29.39 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.371 0.669 . . . . 0.0 111.639 176.637 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 41.0 t -133.71 135.76 44.23 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.381 0.672 . . . . 0.0 111.329 175.038 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.7 p -127.99 116.92 44.47 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.647 0 C-N-CA 123.145 0.578 . . . . 0.0 109.576 174.218 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -93.36 100.46 12.78 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 124.118 0.967 . . . . 0.0 109.93 176.114 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -91.92 121.11 33.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.437 -0.789 . . . . 0.0 111.72 -169.152 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 167.81 -105.44 0.23 Allowed Glycine 0 N--CA 1.486 1.979 0 O-C-N 121.319 -0.863 . . . . 0.0 113.995 172.637 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -85.79 -46.98 10.16 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 115.091 1.515 . . . . 0.0 115.091 -172.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 48.9 mmtm -78.62 134.04 37.22 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 119.688 1.131 . . . . 0.0 112.433 179.315 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -88.5 109.33 19.96 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.017 -168.051 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 76.95 41.12 23.66 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 117.47 1.748 . . . . 0.0 117.47 -167.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 53.8 ttt180 -86.2 117.25 24.9 Favored 'General case' 0 CA--C 1.563 1.47 0 CA-C-N 118.316 1.058 . . . . 0.0 110.704 177.702 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -172.5 -178.45 42.64 Favored Glycine 0 N--CA 1.484 1.872 0 CA-C-O 122.071 0.817 . . . . 0.0 115.093 -176.136 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 28.3 p-90 -154.94 158.55 39.43 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 172.127 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 55.6 m -123.75 120.36 32.46 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 170.022 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -114.13 132.44 56.07 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 123.196 0.598 . . . . 0.0 111.922 179.257 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 16.4 p90 -148.4 173.07 13.46 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.215 -0.928 . . . . 0.0 113.088 177.602 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 73.9 mt -114.24 133.66 59.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.226 -0.921 . . . . 0.0 110.052 174.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -111.65 88.98 2.93 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 123.729 0.812 . . . . 0.0 108.895 162.473 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 65.35 -104.99 1.08 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 115.832 1.093 . . . . 0.0 115.832 -178.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -85.88 -8.34 58.11 Favored 'General case' 0 CA--C 1.571 1.788 0 N-CA-C 117.591 2.441 . . . . 0.0 117.591 168.083 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 86.9 mt-10 -105.08 135.46 46.39 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 120.316 1.416 . . . . 0.0 112.316 -175.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 15.5 tp -91.79 121.94 33.88 Favored 'General case' 0 CA--C 1.563 1.45 0 C-N-CA 123.861 0.864 . . . . 0.0 109.38 167.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 47.4 m80 -109.52 120.89 43.89 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -179.353 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 48.3 tp -120.5 116.57 25.67 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.444 0.698 . . . . 0.0 109.677 179.179 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -98.19 127.9 44.38 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.764 -0.585 . . . . 0.0 109.898 167.645 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 69.1 mtm -122.85 129.82 52.12 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-N 118.355 0.525 . . . . 0.0 111.241 -175.218 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 71.9 mtm-85 -117.9 139.32 51.3 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 123.588 0.755 . . . . 0.0 111.233 -174.119 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -161.75 131.65 4.77 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.68 -0.637 . . . . 0.0 111.279 170.174 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 55.7 39.09 30.83 Favored 'General case' 0 N--CA 1.507 2.397 0 N-CA-C 115.444 1.646 . . . . 0.0 115.444 -175.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 72.84 -11.76 4.29 Favored Glycine 0 CA--C 1.557 2.682 0 N-CA-C 120.302 2.881 . . . . 0.0 120.302 -163.448 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 88.1 t -89.28 123.54 41.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 CA-C-N 120.291 2.045 . . . . 0.0 109.608 -171.777 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 34.7 m -102.77 123.99 47.47 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.302 0.572 . . . . 0.0 111.169 177.436 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 21.1 t -100.92 146.64 27.11 Favored 'General case' 0 CA--C 1.563 1.462 0 C-N-CA 123.921 0.888 . . . . 0.0 112.079 165.453 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 7.6 mtpm? -118.49 110.66 17.67 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.669 -0.644 . . . . 0.0 109.541 174.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -103.48 130.09 50.77 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.502 -0.749 . . . . 0.0 110.817 174.536 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 44.2 t -113.86 129.91 68.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 176.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -123.67 150.86 43.73 Favored 'General case' 0 CA--C 1.567 1.62 0 C-N-CA 124.729 1.211 . . . . 0.0 110.071 179.062 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.7 tmtt? -122.47 140.95 52.15 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.556 -1.34 . . . . 0.0 111.484 177.712 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 66.0 tttt -71.08 117.75 12.99 Favored 'General case' 0 CA--C 1.565 1.556 0 N-CA-C 113.523 0.934 . . . . 0.0 113.523 -177.398 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 5.5 m -82.59 -34.57 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.273 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 168.069 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 44.6 t-80 . . . . . 0 N--CA 1.484 1.255 0 C-N-CA 125.04 1.336 . . . . 0.0 113.305 175.505 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo . . . . . 0 CA--C 1.56 1.82 0 N-CA-C 114.98 1.108 . . . . 0.0 114.98 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 1.8 t -79.05 146.04 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 CA-C-O 121.701 0.763 . . . . 0.0 110.906 -174.024 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -72.04 97.03 1.82 Allowed 'General case' 0 CA--C 1.568 1.651 0 O-C-N 120.79 -1.194 . . . . 0.0 111.618 173.499 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 4.5 m-30 -77.92 3.74 13.8 Favored 'General case' 0 CA--C 1.581 2.151 0 N-CA-C 116.471 2.026 . . . . 0.0 116.471 179.138 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -60.4 111.02 1.41 Allowed 'General case' 0 CA--C 1.564 1.488 0 C-N-CA 125.339 1.456 . . . . 0.0 114.688 -178.753 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 165.2 177.21 37.48 Favored Glycine 0 N--CA 1.484 1.887 0 N-CA-C 116.319 1.287 . . . . 0.0 116.319 -179.249 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -108.11 122.35 46.71 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 114.35 -0.925 . . . . 0.0 108.781 173.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 83.7 m95 -120.77 120.18 34.89 Favored 'General case' 0 CA--C 1.562 1.412 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -167.046 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 62.1 pttt -88.92 136.5 32.98 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.348 -0.845 . . . . 0.0 112.588 176.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.406 ' SD ' ' ND2' ' A' ' 13' ' ' ASN . 56.3 ttm -77.19 123.47 26.47 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 121.914 0.864 . . . . 0.0 112.139 179.255 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 84.0 mt -90.97 -60.16 1.98 Allowed 'General case' 0 CA--C 1.565 1.527 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.757 175.068 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 67.4 p -130.0 119.29 22.93 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.721 -0.612 . . . . 0.0 110.746 176.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.406 ' ND2' ' SD ' ' A' ' 10' ' ' MET . 18.5 p30 -98.01 93.39 6.28 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 123.252 0.621 . . . . 0.0 109.794 165.227 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -97.12 125.26 41.49 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.66 0.784 . . . . 0.0 110.462 -169.027 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.269 49.2 t30 64.97 15.59 10.06 Favored 'General case' 0 N--CA 1.504 2.272 0 N-CA-C 117.061 2.245 . . . . 0.0 117.061 -172.142 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -61.01 -41.21 96.11 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 116.234 1.939 . . . . 0.0 116.234 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -51.52 -44.78 62.7 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 115.602 1.704 . . . . 0.0 115.602 166.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -68.81 -41.35 78.77 Favored 'General case' 0 CA--C 1.573 1.836 0 N-CA-C 115.228 1.566 . . . . 0.0 115.228 174.47 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 48.7 t80 -55.27 -49.26 72.52 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 114.47 1.285 . . . . 0.0 114.47 165.268 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 97.5 mt -61.0 -40.64 94.31 Favored 'General case' 0 CA--C 1.575 1.922 0 N-CA-C 115.001 1.482 . . . . 0.0 115.001 170.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 49.5 ttp180 -53.86 -49.94 67.37 Favored 'General case' 0 N--CA 1.501 2.11 0 N-CA-C 115.647 1.721 . . . . 0.0 115.647 165.047 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.67 -15.97 9.32 Favored 'General case' 0 CA--C 1.57 1.742 0 N-CA-C 118.409 2.744 . . . . 0.0 118.409 165.405 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 99.3 mt -98.56 23.48 8.55 Favored 'General case' 0 CA--C 1.575 1.926 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 163.734 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 69.39 15.16 8.44 Favored 'General case' 0 N--CA 1.507 2.382 0 N-CA-C 117.482 2.401 . . . . 0.0 117.482 -179.663 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 67.5 t -87.81 141.88 13.71 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.863 0 O-C-N 120.061 -1.65 . . . . 0.0 110.414 -170.354 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -73.46 155.02 39.69 Favored 'General case' 0 CA--C 1.569 1.687 0 N-CA-C 115.714 1.746 . . . . 0.0 115.714 -177.134 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 74.6 t -50.88 -45.83 28.79 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.502 0 N-CA-C 115.715 1.746 . . . . 0.0 115.715 -178.065 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.03 -49.41 77.75 Favored 'General case' 0 CA--C 1.564 1.5 0 N-CA-C 115.434 1.642 . . . . 0.0 115.434 173.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.8 tt -64.49 -44.58 90.5 Favored 'General case' 0 CA--C 1.572 1.794 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 171.491 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 74.9 mtp180 -45.15 -54.45 6.83 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 115.911 1.819 . . . . 0.0 115.911 164.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -71.84 -37.96 70.21 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 115.461 1.652 . . . . 0.0 115.461 174.584 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . 0.25 69.2 mt -62.51 -50.2 80.77 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 CA-C-N 121.116 1.78 . . . . 0.0 112.171 173.19 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -56.93 -42.24 79.65 Favored 'General case' 0 CA--C 1.568 1.67 0 N-CA-C 117.772 2.508 . . . . 0.0 117.772 170.415 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -53.85 -46.09 71.14 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 117.01 2.226 . . . . 0.0 117.01 163.358 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 92.6 mt -80.56 -18.29 48.81 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 116.025 1.861 . . . . 0.0 116.025 179.278 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 18.5 mt -73.46 -37.44 65.8 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 115.789 1.774 . . . . 0.0 115.789 173.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 65.5 mmtt 64.76 65.54 1.01 Allowed Pre-proline 0 CA--C 1.577 1.99 0 C-N-CA 124.546 1.139 . . . . 0.0 112.122 -178.58 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -71.45 135.0 25.59 Favored 'Trans proline' 0 CA--C 1.562 1.913 0 CA-C-N 122.486 1.924 . . . . 0.0 114.765 -165.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -86.67 130.53 34.45 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.832 -0.543 . . . . 0.0 111.897 -175.364 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 47.9 mttp -93.26 112.72 24.73 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.191 -0.943 . . . . 0.0 110.181 -179.479 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -94.59 109.44 21.36 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.388 -0.82 . . . . 0.0 109.034 164.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 97.6 mt -102.49 116.35 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 -175.246 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 54.0 t -98.16 95.95 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 168.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -93.86 108.5 20.28 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 123.876 0.87 . . . . 0.0 110.558 -179.601 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -113.94 69.31 0.7 Allowed 'General case' 0 CA--C 1.569 1.689 0 O-C-N 121.637 -0.664 . . . . 0.0 111.061 175.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 70.09 -85.39 0.31 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 115.798 1.079 . . . . 0.0 115.798 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -94.65 -40.04 10.02 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 114.903 1.446 . . . . 0.0 114.903 163.545 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 20.7 t-160 -79.08 107.19 11.66 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 121.216 1.825 . . . . 0.0 111.243 -175.121 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 41.1 ttm -118.24 120.5 37.85 Favored 'General case' 0 CA--C 1.553 1.064 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -173.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 5.0 mp -106.13 100.49 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 16.4 mm -87.07 101.3 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 176.553 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -94.71 97.93 10.42 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 18.3 m -91.94 100.39 13.06 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 -176.71 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 19.9 mt -99.8 132.85 44.89 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-O 121.812 0.815 . . . . 0.0 112.189 -156.672 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 28.3 t -151.6 145.72 25.31 Favored 'General case' 0 CA--C 1.562 1.425 0 C-N-CA 123.452 0.701 . . . . 0.0 110.97 -176.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.6 t -77.48 54.12 1.13 Allowed 'General case' 0 N--CA 1.505 2.291 0 O-C-N 120.639 -1.288 . . . . 0.0 114.077 165.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -173.2 -67.04 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 124.983 1.313 . . . . 0.0 109.169 -168.713 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.06 103.83 4.37 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.379 -0.826 . . . . 0.0 110.014 -179.454 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -88.48 119.54 29.02 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.738 -0.601 . . . . 0.0 110.357 178.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 51.8 m-85 -107.59 110.11 21.91 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 121.336 0.589 . . . . 0.0 110.573 -175.297 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 25.0 mm -105.95 104.48 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 N-CA-C 108.11 -1.071 . . . . 0.0 108.11 -174.09 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 11.4 mmm -99.11 90.71 4.69 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.523 -0.735 . . . . 0.0 109.27 175.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -93.35 111.55 23.24 Favored 'General case' 0 CA--C 1.561 1.386 0 C-N-CA 123.429 0.692 . . . . 0.0 111.385 175.129 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 11.9 p90 -147.13 148.31 31.45 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.831 0.824 . . . . 0.0 112.849 -170.161 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 23.8 mp0 -87.6 117.15 26.21 Favored 'General case' 0 CA--C 1.561 1.368 0 O-C-N 121.621 -0.674 . . . . 0.0 109.999 168.769 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 44.0 t -66.99 113.04 2.7 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.794 0 C-N-CA 124.159 0.984 . . . . 0.0 109.609 175.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 123.22 -48.68 0.94 Allowed Glycine 0 CA--C 1.549 2.213 0 N-CA-C 115.14 0.816 . . . . 0.0 115.14 -156.237 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 58.4 mttm -86.59 151.77 23.17 Favored 'General case' 0 CA--C 1.568 1.66 0 CA-C-N 118.493 1.146 . . . . 0.0 113.476 -175.497 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -96.8 107.22 19.66 Favored 'General case' 0 CA--C 1.568 1.643 0 C-N-CA 123.275 0.63 . . . . 0.0 110.425 173.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 15.6 p90 -106.92 142.32 36.73 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 113.639 0.978 . . . . 0.0 113.639 -171.293 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -76.9 110.55 11.61 Favored 'General case' 0 CA--C 1.568 1.669 0 N-CA-C 114.411 1.263 . . . . 0.0 114.411 179.122 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 . . . . . 0 N--CA 1.497 1.888 0 O-C-N 120.96 -1.087 . . . . 0.0 113.262 173.365 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 72.6 m . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 121.055 0.455 . . . . 0.0 110.05 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 82.5 mmm -79.48 95.75 5.89 Favored 'General case' 0 CA--C 1.563 1.454 0 CA-C-O 121.98 0.895 . . . . 0.0 109.338 170.558 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 37.8 m -102.65 117.11 33.95 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.114 0.566 . . . . 0.0 110.698 -160.241 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 92.3 m -95.16 122.43 37.83 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 173.628 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 22.1 t -109.97 135.79 47.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 170.114 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 58.0 m -148.55 147.27 28.85 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.265 -1.522 . . . . 0.0 112.481 -176.621 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 59.9 m95 -79.41 109.06 13.41 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.255 -0.903 . . . . 0.0 111.095 174.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -86.73 76.21 9.53 Favored 'General case' 0 CA--C 1.566 1.572 0 C-N-CA 123.813 0.845 . . . . 0.0 110.429 172.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 64.72 -99.53 0.36 Allowed Glycine 0 N--CA 1.489 2.199 0 N-CA-C 114.433 0.533 . . . . 0.0 114.433 -169.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -84.4 -32.85 23.92 Favored 'General case' 0 CA--C 1.574 1.88 0 N-CA-C 115.705 1.743 . . . . 0.0 115.705 170.312 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 48.9 mtpt -94.1 150.14 20.6 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 124.125 0.97 . . . . 0.0 112.011 -168.182 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 24.0 tp -98.46 109.7 22.41 Favored 'General case' 0 CA--C 1.563 1.464 0 O-C-N 120.329 -1.482 . . . . 0.0 110.345 177.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 31.8 mm-40 -96.65 146.4 24.89 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 123.383 0.673 . . . . 0.0 111.909 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 42.6 t -138.74 131.27 28.87 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.316 0.646 . . . . 0.0 111.527 176.679 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.9 p -113.81 122.01 67.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 166.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -101.95 75.02 1.5 Allowed 'General case' 0 CA--C 1.567 1.609 0 C-N-CA 123.461 0.704 . . . . 0.0 110.299 -178.503 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -91.17 129.68 37.14 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.011 -1.056 . . . . 0.0 113.427 -170.164 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 164.81 -94.1 0.11 Allowed Glycine 0 N--CA 1.487 2.084 0 O-C-N 121.335 -0.853 . . . . 0.0 112.477 177.162 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -72.2 -46.67 55.28 Favored 'General case' 0 CA--C 1.572 1.815 0 N-CA-C 115.614 1.709 . . . . 0.0 115.614 178.004 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -101.26 143.31 31.49 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 119.362 0.983 . . . . 0.0 112.945 -175.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -76.5 155.9 33.41 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.774 -0.579 . . . . 0.0 112.241 165.271 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 61.95 12.6 36.83 Favored Glycine 0 N--CA 1.497 2.757 0 N-CA-C 120.488 2.955 . . . . 0.0 120.488 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 36.8 ttt180 -88.16 129.11 35.42 Favored 'General case' 0 CA--C 1.564 1.511 0 CA-C-N 119.082 1.441 . . . . 0.0 112.591 -172.295 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 178.32 -173.27 45.73 Favored Glycine 0 N--CA 1.486 1.972 0 CA-C-O 121.707 0.615 . . . . 0.0 114.052 -175.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . 0.277 44.2 p-90 -159.43 156.8 29.0 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 171.469 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 58.9 m -129.56 119.13 23.15 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 176.207 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 16.2 tt0 -122.98 131.58 53.78 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 123.277 0.631 . . . . 0.0 112.202 -174.714 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 21.8 p90 -148.71 169.12 21.12 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.379 -0.826 . . . . 0.0 112.302 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 96.4 mt -115.53 145.26 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.22 0 CA-C-O 122.998 1.38 . . . . 0.0 111.062 177.421 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -136.65 90.58 2.56 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 71.42 -111.8 3.84 Favored Glycine 0 N--CA 1.49 2.269 0 O-C-N 121.983 -0.448 . . . . 0.0 114.158 -174.03 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 16.5 p-10 -94.66 15.36 18.38 Favored 'General case' 0 CA--C 1.576 1.975 0 N-CA-C 116.585 2.069 . . . . 0.0 116.585 167.417 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -120.65 136.54 54.81 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-N 120.177 1.353 . . . . 0.0 111.946 -171.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 8.6 tp -97.34 123.09 41.04 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 171.351 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 36.4 m80 -111.65 121.58 45.49 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 -176.704 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 50.7 tp -128.48 120.78 27.48 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.618 0.767 . . . . 0.0 109.963 -172.573 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -105.55 113.83 27.64 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.511 -0.743 . . . . 0.0 109.038 170.604 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' MET . . . . . 0.423 ' HB2' ' SG ' ' A' ' 126' ' ' CYS . 63.1 mtm -106.85 131.9 53.42 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-N 118.891 0.769 . . . . 0.0 111.438 -178.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? -114.76 140.88 48.54 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.784 0.834 . . . . 0.0 111.445 -171.769 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -156.07 129.37 8.18 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 123.207 0.603 . . . . 0.0 111.111 170.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . 0.265 8.7 mm-40 64.8 -0.32 1.02 Allowed 'General case' 0 N--CA 1.504 2.254 0 N-CA-C 118.135 2.643 . . . . 0.0 118.135 -176.252 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 109.69 -24.4 19.74 Favored Glycine 0 CA--C 1.554 2.531 0 N-CA-C 117.096 1.598 . . . . 0.0 117.096 -156.374 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 93.6 t -78.1 127.71 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 CA-C-N 119.857 1.829 . . . . 0.0 110.115 177.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 45.6 m -106.86 124.67 49.96 Favored 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 123.032 0.533 . . . . 0.0 110.118 173.102 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' CYS . . . . . 0.423 ' SG ' ' HB2' ' A' ' 119' ' ' MET . 19.3 p -107.14 142.08 37.38 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-O 121.701 0.762 . . . . 0.0 112.424 168.047 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 60.1 mttp -114.76 111.14 20.8 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.666 -0.646 . . . . 0.0 109.36 -168.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 82.9 mt-30 -105.35 123.84 48.54 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 123.403 0.681 . . . . 0.0 111.178 178.234 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 79.1 t -111.27 131.47 62.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 176.746 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -121.67 164.04 18.0 Favored 'General case' 0 CA--C 1.567 1.608 0 CA-C-N 115.113 -0.949 . . . . 0.0 111.474 -178.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 29.3 ttmt -130.57 142.82 50.46 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.065 -1.022 . . . . 0.0 111.984 165.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 59.8 tttt -76.31 120.15 21.17 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.49 -0.756 . . . . 0.0 112.882 -176.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 32.8 m -97.21 -43.41 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.112 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 174.168 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 72.0 t60 . . . . . 0 N--CA 1.485 1.302 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 169.235 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo . . . . . 0 CA--C 1.561 1.868 0 N-CA-C 115.375 1.26 . . . . 0.0 115.375 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 31.6 m -80.08 156.48 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 CA-C-O 121.934 0.873 . . . . 0.0 112.761 176.797 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -77.74 113.17 15.33 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.124 -0.985 . . . . 0.0 112.759 176.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -90.28 7.95 35.73 Favored 'General case' 0 CA--C 1.576 1.966 0 N-CA-C 115.389 1.626 . . . . 0.0 115.389 173.124 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 62.6 m-80 -67.02 110.19 3.28 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 120.262 1.392 . . . . 0.0 113.077 -176.77 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 169.63 173.81 37.45 Favored Glycine 0 N--CA 1.478 1.441 0 N-CA-C 116.638 1.415 . . . . 0.0 116.638 -177.081 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 19.5 t80 -104.19 124.53 49.29 Favored 'General case' 0 CA--C 1.563 1.48 0 CA-C-N 113.675 -1.262 . . . . 0.0 108.516 168.747 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 82.4 m95 -120.82 122.71 40.89 Favored 'General case' 0 CA--C 1.561 1.394 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -169.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -96.08 135.51 37.76 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.579 -0.701 . . . . 0.0 111.449 178.212 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 53.6 ttm -71.93 124.34 24.67 Favored 'General case' 0 CA--C 1.565 1.524 0 CA-C-O 122.079 0.942 . . . . 0.0 113.058 -178.232 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 97.5 mt -81.99 -50.14 9.47 Favored 'General case' 0 CA--C 1.567 1.615 0 CA-C-N 115.191 -0.913 . . . . 0.0 112.292 168.029 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 89.7 p -149.92 126.79 11.1 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 118.727 0.694 . . . . 0.0 111.751 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -99.69 108.77 21.2 Favored 'General case' 0 N--CA 1.494 1.767 0 C-N-CA 122.944 0.497 . . . . 0.0 110.889 162.597 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -112.26 125.57 54.31 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.503 -0.748 . . . . 0.0 109.803 -172.507 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.258 5.3 t30 63.53 27.84 15.13 Favored 'General case' 0 N--CA 1.507 2.414 0 N-CA-C 116.325 1.972 . . . . 0.0 116.325 -174.146 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -70.39 -44.97 66.92 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 114.436 1.273 . . . . 0.0 114.436 174.718 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -53.43 -51.96 60.96 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 116.813 2.153 . . . . 0.0 116.813 174.269 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.266 1.5 pm0 -76.89 -25.89 53.56 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 116.394 1.998 . . . . 0.0 116.394 178.328 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 38.6 t80 -54.84 -49.56 70.79 Favored 'General case' 0 N--CA 1.498 1.967 0 CA-C-N 120.797 1.635 . . . . 0.0 114.481 154.274 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 68.8 mt -61.98 -35.35 78.24 Favored 'General case' 0 CA--C 1.576 1.965 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 170.154 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 8.7 ttm180 -56.99 -48.1 79.26 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-N 120.415 1.462 . . . . 0.0 114.645 162.779 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.74 -13.53 24.14 Favored 'General case' 0 CA--C 1.569 1.703 0 N-CA-C 118.414 2.746 . . . . 0.0 118.414 168.281 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 48.0 mt -90.15 -1.38 57.94 Favored 'General case' 0 CA--C 1.573 1.845 0 N-CA-C 116.071 1.878 . . . . 0.0 116.071 162.414 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.277 51.6 m-20 63.02 46.54 4.69 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 115.411 1.634 . . . . 0.0 115.411 -166.48 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 98.7 t -95.26 135.23 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 174.372 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 5.5 p-10 -64.3 152.08 42.05 Favored 'General case' 0 CA--C 1.566 1.592 0 N-CA-C 115.192 1.552 . . . . 0.0 115.192 178.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.494 HG22 HH11 ' A' ' 30' ' ' ARG 0.262 38.5 t -58.84 -35.47 56.27 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.224 0 N-CA-C 115.719 1.748 . . . . 0.0 115.719 -172.257 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.8 -50.93 69.16 Favored 'General case' 0 CA--C 1.567 1.62 0 N-CA-C 115.969 1.841 . . . . 0.0 115.969 166.775 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -71.45 -28.41 63.95 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 116.697 2.11 . . . . 0.0 116.697 171.025 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.494 HH11 HG22 ' A' ' 27' ' ' VAL . 54.2 mtp180 -55.83 -53.53 55.62 Favored 'General case' 0 N--CA 1.498 1.959 0 CA-C-N 120.824 1.647 . . . . 0.0 114.135 162.229 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 48.1 mmtm -64.39 -49.99 69.43 Favored 'General case' 0 CA--C 1.566 1.596 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 170.649 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 11.9 mt -77.38 62.12 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.323 0 CA-C-O 123.493 1.615 . . . . 0.0 110.974 175.1 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -176.03 -53.59 0.01 OUTLIER 'General case' 0 CA--C 1.558 1.28 0 C-N-CA 126.752 2.021 . . . . 0.0 110.044 -177.637 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -71.52 -35.51 70.73 Favored 'General case' 0 CA--C 1.567 1.619 0 N-CA-C 116.04 1.867 . . . . 0.0 116.04 167.057 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 92.9 mt -71.85 -35.3 69.81 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 115.153 1.538 . . . . 0.0 115.153 177.003 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.9 pp -88.71 148.94 23.73 Favored 'General case' 0 CA--C 1.566 1.57 0 CA-C-N 118.671 0.669 . . . . 0.0 111.084 169.179 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 29.0 mmtp -103.94 93.98 5.96 Favored Pre-proline 0 CA--C 1.573 1.827 0 CA-C-O 117.813 -1.089 . . . . 0.0 109.764 178.402 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -73.82 160.39 43.59 Favored 'Trans proline' 0 CA--C 1.566 2.09 0 C-N-CA 122.49 2.126 . . . . 0.0 115.489 -175.665 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -104.2 141.96 35.34 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.508 -0.745 . . . . 0.0 110.795 -179.382 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 41.8 mttp -102.9 115.38 30.48 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.857 -1.152 . . . . 0.0 109.742 171.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -95.36 110.37 22.4 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 163.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 78.7 mt -106.8 128.33 61.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -177.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 93.1 t -106.27 118.41 53.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 106.026 -1.842 . . . . 0.0 106.026 163.392 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -111.95 113.51 25.86 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 124.147 0.979 . . . . 0.0 109.197 175.431 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -120.19 68.83 0.85 Allowed 'General case' 0 CA--C 1.567 1.613 0 O-C-N 121.339 -0.85 . . . . 0.0 110.334 174.354 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.65 -97.39 0.7 Allowed Glycine 0 N--CA 1.488 2.164 0 N-CA-C 114.672 0.629 . . . . 0.0 114.672 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -85.07 -40.45 16.8 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 115.314 1.598 . . . . 0.0 115.314 165.561 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 18.7 t-160 -77.41 119.97 21.76 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 120.899 1.681 . . . . 0.0 111.781 -178.337 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.43 ' SD ' HD21 ' A' ' 93' ' ' LEU . 46.5 ttm -133.9 133.98 42.11 Favored 'General case' 0 CA--C 1.557 1.231 0 CA-C-O 121.488 0.661 . . . . 0.0 110.674 -173.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 33.6 mt -118.56 107.76 22.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 24.8 mm -94.24 100.23 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 176.447 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 68.4 mtt85 -93.85 100.57 12.73 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.135 -0.978 . . . . 0.0 109.201 178.156 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 16.6 m -88.46 102.12 14.59 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 178.166 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 48.0 mt -97.78 112.23 24.21 Favored 'General case' 0 CA--C 1.556 1.209 0 C-N-CA 123.841 0.856 . . . . 0.0 109.286 -165.259 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 46.0 t -130.18 143.48 50.81 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.972 -171.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.1 m -78.96 56.42 1.95 Allowed 'General case' 0 CA--C 1.579 2.089 0 CA-C-O 122.036 0.922 . . . . 0.0 112.715 175.578 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -168.99 -67.93 0.02 OUTLIER 'General case' 0 CA--C 1.567 1.598 0 C-N-CA 124.999 1.32 . . . . 0.0 109.267 -179.399 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 32.3 tpt180 -135.78 115.72 13.17 Favored 'General case' 0 CA--C 1.565 1.55 0 C-N-CA 123.777 0.831 . . . . 0.0 109.193 173.408 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 71.9 m-80 -83.63 125.05 31.43 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.685 -0.634 . . . . 0.0 111.501 178.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 86.2 t80 -110.87 105.99 14.99 Favored 'General case' 0 CA--C 1.567 1.602 0 C-N-CA 123.24 0.616 . . . . 0.0 110.744 -169.135 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.8 mp -93.38 115.35 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 178.371 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -107.31 90.98 3.47 Favored 'General case' 0 CA--C 1.568 1.64 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 175.619 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -102.4 119.6 39.08 Favored 'General case' 0 CA--C 1.565 1.551 0 C-N-CA 124.159 0.984 . . . . 0.0 112.633 -175.837 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -157.72 154.79 28.81 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 114.784 1.401 . . . . 0.0 114.784 -166.787 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 25.2 mp0 -92.82 121.7 34.46 Favored 'General case' 0 CA--C 1.564 1.486 0 O-C-N 121.577 -0.702 . . . . 0.0 110.553 166.064 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 40.0 t -66.25 121.7 15.83 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.808 0 C-N-CA 124.218 1.007 . . . . 0.0 109.915 174.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 117.2 -42.45 1.85 Allowed Glycine 0 CA--C 1.55 2.236 0 N-CA-C 115.729 1.052 . . . . 0.0 115.729 -160.293 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 55.9 mttm -82.64 144.78 30.05 Favored 'General case' 0 CA--C 1.566 1.564 0 CA-C-N 118.916 1.358 . . . . 0.0 113.557 -174.663 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -90.95 97.8 11.4 Favored 'General case' 0 CA--C 1.566 1.588 0 CA-C-O 121.349 0.595 . . . . 0.0 110.014 167.439 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -107.54 151.7 25.23 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 123.999 0.92 . . . . 0.0 113.083 -169.379 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -77.1 135.36 38.58 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.693 -1.254 . . . . 0.0 112.918 169.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 . . . . . 0 N--CA 1.497 1.919 0 O-C-N 121.428 -0.795 . . . . 0.0 112.886 175.278 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 72.8 m . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.835 0.35 . . . . 0.0 111.856 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 23.5 mmt -68.63 96.16 0.7 Allowed 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 124.576 1.15 . . . . 0.0 111.579 -177.153 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 89.6 m -111.59 118.09 34.73 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 -162.629 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 93.8 m -101.85 118.94 37.95 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 176.746 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.479 HG22 ' SG ' ' A' ' 95' ' ' CYS . 57.1 t -108.73 124.93 65.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 171.853 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 57.9 m -130.57 151.54 50.93 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 121.935 0.874 . . . . 0.0 111.529 -177.434 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 28.1 m95 -83.66 116.66 22.74 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.992 -1.067 . . . . 0.0 112.726 176.651 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -103.77 65.79 0.83 Allowed 'General case' 0 CA--C 1.572 1.805 0 C-N-CA 123.428 0.691 . . . . 0.0 109.909 162.163 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 58.28 -114.59 5.99 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 115.538 0.975 . . . . 0.0 115.538 -172.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -61.42 -28.22 69.11 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 116.934 2.198 . . . . 0.0 116.934 168.55 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 63.5 mttm -93.69 120.96 34.61 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-O 122.097 0.951 . . . . 0.0 110.583 -178.606 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.43 HD21 ' SD ' ' A' ' 49' ' ' MET . 34.7 tp -86.79 107.11 18.14 Favored 'General case' 0 CA--C 1.564 1.515 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 168.778 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -98.59 132.64 43.84 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 123.27 0.628 . . . . 0.0 111.544 -172.452 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' CYS . . . . . 0.479 ' SG ' HG22 ' A' ' 86' ' ' VAL . 35.4 t -128.33 134.97 48.99 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.158 0.583 . . . . 0.0 111.728 -179.243 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.9 p -115.82 128.91 72.93 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.792 0 C-N-CA 123.151 0.581 . . . . 0.0 109.758 164.504 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -106.15 108.2 19.59 Favored 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 123.548 0.739 . . . . 0.0 110.4 -178.079 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 62.1 mttm -101.08 118.45 37.03 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.042 -1.036 . . . . 0.0 110.814 -174.593 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -178.91 -60.78 0.07 OUTLIER Glycine 0 N--CA 1.491 2.348 0 N-CA-C 116.546 1.379 . . . . 0.0 116.546 -177.343 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -125.18 -58.76 1.44 Allowed 'General case' 0 N--CA 1.497 1.893 0 CA-C-N 117.872 0.836 . . . . 0.0 111.938 173.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 41.9 mmtm -87.72 151.51 22.86 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-O 122.189 0.995 . . . . 0.0 113.509 -161.052 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -73.48 -68.92 0.46 Allowed 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 -169.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -78.35 51.46 3.63 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 116.804 1.482 . . . . 0.0 116.804 171.6 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 21.2 ttt180 -98.35 118.59 35.36 Favored 'General case' 0 CA--C 1.563 1.461 0 CA-C-N 118.659 1.23 . . . . 0.0 114.041 -169.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 177.46 -165.05 34.6 Favored Glycine 0 N--CA 1.482 1.756 0 CA-C-O 121.844 0.691 . . . . 0.0 114.554 178.029 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 53.2 p-90 -157.81 152.9 25.61 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 173.197 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 56.6 m -125.59 118.07 24.92 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 174.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -118.6 125.51 49.93 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 123.021 0.528 . . . . 0.0 111.77 -178.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 17.0 p90 -140.62 170.63 15.42 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.491 -0.755 . . . . 0.0 112.631 178.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 77.4 mt -117.57 135.85 56.63 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.031 -1.043 . . . . 0.0 110.006 176.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -121.52 95.81 4.83 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 173.23 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 71.93 -109.77 2.95 Favored Glycine 0 N--CA 1.491 2.312 0 O-C-N 121.619 -0.675 . . . . 0.0 114.11 -176.041 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -110.17 38.42 2.43 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 114.338 1.236 . . . . 0.0 114.338 165.665 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 82.8 mt-10 -132.62 136.17 46.35 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-N 118.891 0.768 . . . . 0.0 111.199 178.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 20.8 tp -90.75 124.71 35.33 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 123.354 0.662 . . . . 0.0 109.785 173.48 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 51.5 m80 -113.68 117.52 31.79 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 179.27 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 51.4 tp -126.53 120.02 28.6 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.884 0.873 . . . . 0.0 109.445 -171.446 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -111.54 110.03 20.26 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 109.389 -0.596 . . . . 0.0 109.389 173.324 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 71.9 mtm -104.41 127.13 52.03 Favored 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 123.492 0.717 . . . . 0.0 111.028 -179.185 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 36.9 mtp-105 -114.04 145.58 41.39 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.377 -0.827 . . . . 0.0 112.659 -175.339 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -149.88 138.91 21.11 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.705 -0.622 . . . . 0.0 112.002 163.675 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . 0.287 6.0 mm-40 69.58 -76.19 0.06 Allowed 'General case' 0 N--CA 1.503 2.215 0 C-N-CA 124.326 1.05 . . . . 0.0 112.884 -177.436 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -159.78 46.42 0.42 Allowed Glycine 0 CA--C 1.553 2.408 0 CA-C-N 116.042 -0.526 . . . . 0.0 113.202 153.087 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 72.1 t -133.93 121.8 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 -163.186 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 16.2 m -101.97 120.91 41.17 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -173.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 26.7 t -84.73 125.5 32.59 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.657 -0.652 . . . . 0.0 111.821 160.343 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 28.5 mtmm -111.7 109.05 18.72 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 -173.538 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -117.95 130.6 56.31 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.613 -0.679 . . . . 0.0 111.565 -172.005 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 39.7 t -116.97 129.25 73.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 N-CA-C 107.969 -1.122 . . . . 0.0 107.969 179.101 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -122.0 157.55 31.09 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 123.479 0.712 . . . . 0.0 110.71 173.309 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 75.4 tttt -114.56 141.29 47.93 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.332 -0.855 . . . . 0.0 112.06 172.14 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 33.9 tttm -76.41 118.04 18.69 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.605 -0.684 . . . . 0.0 112.758 -178.279 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 33.6 m -103.38 -35.36 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.2 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 175.094 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 81.7 t60 . . . . . 0 N--CA 1.484 1.239 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 169.063 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo . . . . . 0 CA--C 1.564 1.975 0 N-CA-C 116.175 1.567 . . . . 0.0 116.175 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 34.3 m -69.88 156.65 7.04 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.854 0 CA-C-O 122.216 1.008 . . . . 0.0 113.399 172.67 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -87.43 116.5 25.58 Favored 'General case' 0 CA--C 1.56 1.334 0 O-C-N 121.129 -0.982 . . . . 0.0 111.249 169.696 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 11.1 m-30 -80.07 0.95 29.74 Favored 'General case' 0 CA--C 1.578 2.052 0 N-CA-C 115.504 1.668 . . . . 0.0 115.504 163.302 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 43.7 m-20 -53.01 113.16 1.01 Allowed 'General case' 0 N--CA 1.493 1.689 0 CA-C-N 120.665 1.575 . . . . 0.0 115.044 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 159.92 173.31 28.27 Favored Glycine 0 N--CA 1.481 1.7 0 CA-C-O 122.378 0.988 . . . . 0.0 115.272 -175.587 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -104.87 126.5 52.01 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 170.718 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 65.5 m95 -124.37 122.77 38.62 Favored 'General case' 0 CA--C 1.565 1.522 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 -169.836 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 21.7 pttp -96.35 138.35 34.08 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.555 -0.716 . . . . 0.0 112.054 -178.649 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 54.9 ttm -69.71 127.82 34.29 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 119.594 1.088 . . . . 0.0 113.91 -178.014 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 98.2 mt -87.52 -50.69 6.36 Favored 'General case' 0 CA--C 1.567 1.621 0 CA-C-N 115.291 -0.868 . . . . 0.0 112.757 167.382 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 80.7 p -144.86 144.6 31.2 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 118.984 0.811 . . . . 0.0 112.188 176.25 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -114.72 101.75 9.37 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.519 0.676 . . . . 0.0 109.745 164.261 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -101.84 121.67 42.54 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 123.858 0.863 . . . . 0.0 109.691 -171.236 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.264 27.9 t30 66.51 22.34 10.64 Favored 'General case' 0 N--CA 1.504 2.264 0 N-CA-C 116.971 2.212 . . . . 0.0 116.971 -174.701 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -66.28 -40.44 90.08 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 116.055 1.872 . . . . 0.0 116.055 177.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -58.45 -41.09 84.36 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 116.074 1.879 . . . . 0.0 116.074 170.748 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -65.85 -43.0 89.78 Favored 'General case' 0 CA--C 1.571 1.774 0 N-CA-C 114.724 1.379 . . . . 0.0 114.724 170.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -56.87 -47.2 80.98 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 115.137 1.532 . . . . 0.0 115.137 167.104 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 84.2 mt -61.1 -42.69 98.98 Favored 'General case' 0 CA--C 1.574 1.893 0 N-CA-C 114.618 1.34 . . . . 0.0 114.618 169.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 48.1 ttp180 -53.11 -47.55 68.53 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 115.395 1.628 . . . . 0.0 115.395 164.011 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.12 -22.71 61.29 Favored 'General case' 0 CA--C 1.568 1.641 0 N-CA-C 118.239 2.681 . . . . 0.0 118.239 166.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 98.5 mt -88.39 11.56 16.53 Favored 'General case' 0 CA--C 1.573 1.849 0 N-CA-C 115.46 1.652 . . . . 0.0 115.46 164.23 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.25 10.7 m-20 61.34 40.7 13.92 Favored 'General case' 0 CA--C 1.576 1.964 0 N-CA-C 115.493 1.664 . . . . 0.0 115.493 -175.443 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 91.2 t -94.88 141.89 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.191 -0.943 . . . . 0.0 109.931 -176.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 14.0 p30 -64.48 154.44 35.86 Favored 'General case' 0 CA--C 1.572 1.812 0 N-CA-C 115.82 1.785 . . . . 0.0 115.82 178.295 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 96.8 t -58.63 -40.84 80.45 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.276 0 N-CA-C 115.127 1.528 . . . . 0.0 115.127 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.58 -50.3 72.34 Favored 'General case' 0 CA--C 1.567 1.631 0 N-CA-C 116.029 1.863 . . . . 0.0 116.029 171.335 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -71.65 -34.65 69.93 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 115.322 1.601 . . . . 0.0 115.322 172.049 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 74.3 mtp180 -50.68 -41.71 55.99 Favored 'General case' 0 N--CA 1.503 2.197 0 N-CA-C 116.131 1.9 . . . . 0.0 116.131 160.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp -71.48 -54.05 11.89 Favored 'General case' 0 CA--C 1.567 1.621 0 O-C-N 120.96 -1.088 . . . . 0.0 113.574 166.257 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 12.0 mt -77.98 60.44 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.509 2.484 0 CA-C-N 120.923 1.692 . . . . 0.0 111.708 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -179.45 -47.29 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 126.701 2.0 . . . . 0.0 110.969 -174.358 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -64.49 -45.45 87.26 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 115.99 1.848 . . . . 0.0 115.99 158.008 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 65.2 mt -78.02 -24.94 47.69 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 115.645 1.72 . . . . 0.0 115.645 -175.206 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.9 pp -96.0 134.61 38.82 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 162.147 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 62.4 pttt -98.91 102.06 14.09 Favored Pre-proline 0 CA--C 1.574 1.896 0 CA-C-O 117.906 -1.045 . . . . 0.0 110.644 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -73.61 166.03 30.83 Favored 'Trans proline' 0 CA--C 1.565 2.041 0 CA-C-N 123.101 2.143 . . . . 0.0 115.77 -173.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -110.69 136.27 50.02 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.621 -0.674 . . . . 0.0 110.345 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 43.0 mttp -100.51 116.58 32.79 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 120.918 -1.114 . . . . 0.0 109.851 176.057 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -101.46 109.29 21.08 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 167.563 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.1 mp -96.06 127.12 48.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 178.688 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 74.7 t -110.21 106.55 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 164.663 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -103.69 105.69 15.99 Favored 'General case' 0 CA--C 1.565 1.535 0 C-N-CA 124.361 1.064 . . . . 0.0 109.222 177.049 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -125.97 87.42 2.68 Favored 'General case' 0 CA--C 1.565 1.532 0 C-N-CA 123.509 0.724 . . . . 0.0 110.061 -176.179 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 57.36 72.03 0.65 Allowed Glycine 0 N--CA 1.496 2.662 0 N-CA-C 117.106 1.602 . . . . 0.0 117.106 175.457 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.471 0.6 OUTLIER 65.26 -33.8 0.17 Allowed 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 118.476 2.769 . . . . 0.0 118.476 -166.473 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 15.6 t-160 -73.69 114.78 12.35 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-N 120.62 1.555 . . . . 0.0 111.471 172.295 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 44.7 ttm -123.35 124.18 42.37 Favored 'General case' 0 CA--C 1.557 1.227 0 C-N-CA 123.707 0.803 . . . . 0.0 109.646 -175.241 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 43.2 mt -108.46 104.4 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 178.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 17.0 mm -90.39 98.29 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 176.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -90.39 100.82 13.58 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.225 -0.922 . . . . 0.0 109.2 -176.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 28.6 m -88.55 104.49 16.87 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.169 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 43.7 mt -103.2 117.38 34.4 Favored 'General case' 0 CA--C 1.557 1.225 0 C-N-CA 123.852 0.861 . . . . 0.0 109.499 -163.506 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 43.7 t -128.58 143.03 50.88 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.063 0.945 . . . . 0.0 110.453 -165.676 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . 0.253 12.7 t -77.34 50.83 0.81 Allowed 'General case' 0 N--CA 1.503 2.191 0 N-CA-C 114.55 1.315 . . . . 0.0 114.55 168.776 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -167.26 -68.64 0.03 OUTLIER 'General case' 0 CA--C 1.568 1.639 0 C-N-CA 125.537 1.535 . . . . 0.0 108.057 -178.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 33.5 ttm105 -151.19 123.14 8.14 Favored 'General case' 0 CA--C 1.565 1.551 0 CA-C-N 118.959 0.8 . . . . 0.0 110.322 -179.273 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -80.16 139.44 36.79 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 -178.368 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -114.0 107.36 15.57 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.745 -0.597 . . . . 0.0 109.465 177.214 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 43.9 mm -100.51 106.5 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -171.722 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 1.2 mmm -96.24 87.32 4.47 Favored 'General case' 0 CA--C 1.564 1.493 0 CA-C-O 121.638 0.732 . . . . 0.0 110.207 -176.752 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -100.01 116.99 33.35 Favored 'General case' 0 CA--C 1.562 1.41 0 C-N-CA 123.928 0.891 . . . . 0.0 112.282 -175.357 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -155.59 153.54 30.28 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 -168.376 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -95.09 122.95 38.29 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.507 -0.746 . . . . 0.0 111.425 166.526 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 31.7 t -65.46 121.85 15.29 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.831 0 C-N-CA 124.169 0.987 . . . . 0.0 110.538 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 105.54 -34.57 5.67 Favored Glycine 0 CA--C 1.552 2.389 0 N-CA-C 116.955 1.542 . . . . 0.0 116.955 -162.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 52.4 mttp -95.55 122.96 38.84 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 119.265 1.532 . . . . 0.0 111.454 -171.496 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -78.9 116.52 19.28 Favored 'General case' 0 CA--C 1.569 1.697 0 O-C-N 121.491 -0.756 . . . . 0.0 112.587 -178.836 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -124.71 147.83 48.38 Favored 'General case' 0 N--CA 1.496 1.828 0 C-N-CA 123.787 0.835 . . . . 0.0 112.346 -170.256 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -68.29 127.18 32.01 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 119.91 -1.744 . . . . 0.0 113.92 172.014 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 . . . . . 0 N--CA 1.5 2.056 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 176.956 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 84.5 m . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 121.235 0.54 . . . . 0.0 111.211 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 79.1 mmm -72.21 103.4 3.33 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 121.979 0.895 . . . . 0.0 110.398 -174.141 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 85.8 m -107.76 113.6 26.97 Favored 'General case' 0 N--CA 1.48 1.038 0 O-C-N 121.162 -0.961 . . . . 0.0 110.07 -159.579 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 40.5 m -98.57 121.37 40.42 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 170.423 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.524 HG22 ' SG ' ' A' ' 95' ' ' CYS . 20.2 t -109.21 126.36 66.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 170.304 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 58.3 m -133.22 144.41 49.78 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 123.627 0.771 . . . . 0.0 111.323 -176.103 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 8.2 m95 -83.88 122.55 28.87 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.821 -1.174 . . . . 0.0 113.656 179.244 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -108.58 65.7 0.63 Allowed 'General case' 0 CA--C 1.576 1.964 0 C-N-CA 123.485 0.714 . . . . 0.0 110.424 163.287 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 67.65 -94.61 0.29 Allowed Glycine 0 N--CA 1.493 2.477 0 N-CA-C 116.322 1.289 . . . . 0.0 116.322 178.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -82.47 -30.52 29.92 Favored 'General case' 0 CA--C 1.573 1.857 0 N-CA-C 115.34 1.607 . . . . 0.0 115.34 165.034 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 33.8 mtpt -96.24 116.38 28.92 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-N 119.853 1.206 . . . . 0.0 110.434 -171.731 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 33.6 tp -86.96 110.8 20.27 Favored 'General case' 0 CA--C 1.564 1.509 0 O-C-N 120.992 -1.068 . . . . 0.0 109.711 174.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 18.2 mm100 -103.05 126.01 50.04 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.863 0.865 . . . . 0.0 110.226 -167.755 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' CYS . . . . . 0.524 ' SG ' HG22 ' A' ' 86' ' ' VAL . 41.0 t -127.6 129.11 46.7 Favored 'General case' 0 N--CA 1.481 1.083 0 O-C-N 121.822 -0.549 . . . . 0.0 111.417 -175.028 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 12.0 p -109.5 127.59 66.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 162.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -103.93 75.98 1.33 Allowed 'General case' 0 CA--C 1.57 1.712 0 C-N-CA 123.805 0.842 . . . . 0.0 109.263 175.163 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 15.7 ptpt -84.44 143.91 29.1 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 114.586 1.328 . . . . 0.0 114.586 -166.704 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 161.66 -114.15 0.59 Allowed Glycine 0 N--CA 1.484 1.884 0 O-C-N 121.663 -0.648 . . . . 0.0 111.949 172.438 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -80.33 -36.08 34.71 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 115.655 1.724 . . . . 0.0 115.655 175.684 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 9.4 tppt? -77.02 114.68 16.09 Favored 'General case' 0 CA--C 1.567 1.605 0 CA-C-N 119.559 1.072 . . . . 0.0 111.58 -177.582 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -74.17 119.46 18.41 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.418 -0.801 . . . . 0.0 112.854 -169.603 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 68.48 40.83 86.34 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 118.594 2.197 . . . . 0.0 118.594 -172.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 45.7 ttt180 -92.0 130.22 37.79 Favored 'General case' 0 CA--C 1.566 1.572 0 CA-C-N 118.514 1.157 . . . . 0.0 111.854 179.034 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 179.73 -168.52 38.98 Favored Glycine 0 N--CA 1.484 1.859 0 CA-C-O 122.368 0.982 . . . . 0.0 114.021 175.489 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 58.2 p-90 -156.62 153.3 28.37 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 122.214 1.007 . . . . 0.0 112.989 174.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 39.8 m -129.71 117.72 20.75 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 176.4 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -121.29 129.2 53.01 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 123.247 0.619 . . . . 0.0 111.621 -174.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 17.8 p90 -146.78 163.63 35.37 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.025 -1.047 . . . . 0.0 113.339 -174.421 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 76.0 mt -106.52 143.39 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.298 0 CA-C-O 123.224 1.488 . . . . 0.0 111.654 178.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -137.06 84.97 2.1 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 178.13 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 72.39 -110.04 3.04 Favored Glycine 0 N--CA 1.489 2.208 0 CA-C-N 116.025 -0.534 . . . . 0.0 114.415 -174.037 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 55.6 p30 -88.9 7.22 35.5 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 117.473 2.397 . . . . 0.0 117.473 169.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -124.07 137.93 54.51 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-N 120.085 1.311 . . . . 0.0 112.754 -166.695 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 26.4 tp -97.01 118.65 33.88 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 123.947 0.899 . . . . 0.0 108.984 172.551 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 34.1 m80 -107.83 123.29 48.35 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.926 0.89 . . . . 0.0 108.977 -176.717 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 45.4 tp -123.17 121.14 35.21 Favored 'General case' 0 CA--C 1.559 1.323 0 C-N-CA 123.82 0.848 . . . . 0.0 110.004 -172.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -102.13 114.66 28.98 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.594 -0.691 . . . . 0.0 109.296 166.034 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 73.5 mtm -103.89 126.85 51.31 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-N 118.557 0.617 . . . . 0.0 110.582 175.305 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 87.0 mtm180 -120.0 134.43 55.25 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 123.837 0.855 . . . . 0.0 110.471 -167.467 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -162.53 137.22 6.71 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.372 -0.83 . . . . 0.0 112.236 173.592 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . 0.328 12.1 mt-10 48.68 43.83 20.94 Favored 'General case' 0 N--CA 1.504 2.265 0 N-CA-C 116.156 1.91 . . . . 0.0 116.156 -178.197 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 65.71 26.24 71.99 Favored Glycine 0 CA--C 1.552 2.363 0 N-CA-C 120.609 3.004 . . . . 0.0 120.609 -167.715 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 87.6 t -130.83 128.36 62.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 CA-C-N 119.605 1.703 . . . . 0.0 109.202 -175.635 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 52.4 m -106.07 126.11 51.81 Favored 'General case' 0 N--CA 1.496 1.834 0 C-N-CA 123.284 0.634 . . . . 0.0 111.267 176.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 9.2 t -96.67 128.65 43.81 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.698 0.799 . . . . 0.0 111.542 162.541 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 47.0 mttp -102.02 111.1 23.25 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 121.427 0.632 . . . . 0.0 110.536 176.102 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 64.2 mt-30 -108.98 126.74 53.42 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.693 0.797 . . . . 0.0 110.767 176.705 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 47.7 t -114.27 132.0 64.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.075 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -126.87 149.6 49.67 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 123.742 0.817 . . . . 0.0 111.329 178.654 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 75.4 tttt -111.33 140.18 46.11 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.374 -0.829 . . . . 0.0 112.164 175.49 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 73.0 tttt -74.19 122.93 23.55 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.448 -0.782 . . . . 0.0 113.07 -178.505 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 31.7 m -109.32 -42.31 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 175.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 50.2 t-80 . . . . . 0 N--CA 1.485 1.309 0 CA-C-N 119.712 1.142 . . . . 0.0 108.268 167.782 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo . . . . . 0 CA--C 1.565 2.028 0 N-CA-C 117.35 2.019 . . . . 0.0 117.35 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 27.6 m -108.98 175.42 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 CA-C-O 122.666 1.222 . . . . 0.0 112.719 174.297 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -78.14 96.74 5.24 Favored 'General case' 0 CA--C 1.568 1.643 0 O-C-N 120.874 -1.141 . . . . 0.0 113.287 -172.656 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -78.14 -0.22 27.4 Favored 'General case' 0 N--CA 1.501 2.116 0 N-CA-C 116.334 1.976 . . . . 0.0 116.334 169.151 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -60.24 116.07 3.97 Favored 'General case' 0 CA--C 1.563 1.47 0 C-N-CA 125.826 1.65 . . . . 0.0 114.343 179.234 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 163.44 177.99 36.77 Favored Glycine 0 N--CA 1.484 1.879 0 N-CA-C 116.743 1.457 . . . . 0.0 116.743 177.788 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -106.57 120.07 40.96 Favored 'General case' 0 CA--C 1.563 1.459 0 CA-C-N 113.961 -1.12 . . . . 0.0 108.536 170.05 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 64.5 m95 -120.03 124.98 47.22 Favored 'General case' 0 CA--C 1.565 1.547 0 C-N-CA 123.882 0.873 . . . . 0.0 108.766 -169.556 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -95.24 137.06 34.81 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.67 -1.269 . . . . 0.0 112.619 179.539 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 4.3 ttp -74.86 121.64 22.15 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 122.133 0.968 . . . . 0.0 112.773 179.565 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 93.4 mt -79.47 -54.65 5.71 Favored 'General case' 0 CA--C 1.566 1.592 0 CA-C-N 115.029 -0.987 . . . . 0.0 112.609 171.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 89.6 p -144.33 151.77 39.82 Favored 'General case' 0 CA--C 1.563 1.45 0 C-N-CA 123.717 0.807 . . . . 0.0 112.624 -173.29 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -122.64 133.49 54.52 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.43 0.634 . . . . 0.0 110.901 160.715 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -125.58 117.78 24.3 Favored 'General case' 0 CA--C 1.561 1.367 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 -179.542 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.292 31.3 t30 68.88 31.65 4.23 Favored 'General case' 0 CA--C 1.579 2.089 0 N-CA-C 117.082 2.253 . . . . 0.0 117.082 -175.806 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -71.8 -42.97 66.42 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 115.215 1.561 . . . . 0.0 115.215 175.012 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -47.3 -47.33 25.37 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 116.442 2.015 . . . . 0.0 116.442 166.387 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -70.26 -38.62 75.15 Favored 'General case' 0 CA--C 1.57 1.736 0 N-CA-C 115.686 1.736 . . . . 0.0 115.686 176.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 81.5 t80 -55.41 -49.4 72.45 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-N 120.519 1.508 . . . . 0.0 114.201 165.236 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 79.8 mt -59.37 -43.01 92.91 Favored 'General case' 0 CA--C 1.574 1.895 0 N-CA-C 115.493 1.664 . . . . 0.0 115.493 169.29 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 36.4 ttp180 -51.2 -51.16 56.44 Favored 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 115.325 1.602 . . . . 0.0 115.325 165.13 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.87 -24.53 52.39 Favored 'General case' 0 CA--C 1.565 1.538 0 N-CA-C 118.364 2.728 . . . . 0.0 118.364 165.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 93.3 mt -87.18 8.91 21.87 Favored 'General case' 0 CA--C 1.575 1.912 0 N-CA-C 115.735 1.754 . . . . 0.0 115.735 167.522 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.256 25.8 m-20 67.24 41.46 2.52 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 -175.241 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 90.3 t -100.37 141.66 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 121.031 -1.043 . . . . 0.0 110.014 -178.514 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 12.1 p30 -68.68 159.89 31.28 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 115.887 1.81 . . . . 0.0 115.887 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 65.0 t -58.52 -46.2 89.9 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.256 0 N-CA-C 114.895 1.443 . . . . 0.0 114.895 -179.533 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.55 -47.4 84.36 Favored 'General case' 0 CA--C 1.57 1.717 0 N-CA-C 116.052 1.871 . . . . 0.0 116.052 173.493 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.49 -43.83 97.85 Favored 'General case' 0 CA--C 1.574 1.9 0 N-CA-C 114.873 1.434 . . . . 0.0 114.873 169.259 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 77.1 mtp180 -49.92 -50.92 44.55 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 115.569 1.692 . . . . 0.0 115.569 164.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -54.95 -54.15 46.51 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 115.258 1.577 . . . . 0.0 115.258 168.183 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 34.9 mt -59.73 -53.2 51.71 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 CA-C-N 119.808 1.185 . . . . 0.0 113.162 178.245 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -61.94 -40.41 95.45 Favored 'General case' 0 CA--C 1.566 1.569 0 N-CA-C 117.529 2.418 . . . . 0.0 117.529 175.658 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -65.64 -32.08 73.45 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 116.003 1.853 . . . . 0.0 116.003 169.242 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 81.5 mt -72.79 -30.45 64.1 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 116.139 1.903 . . . . 0.0 116.139 170.601 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 38.6 mt -73.95 139.8 45.12 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 119.539 1.063 . . . . 0.0 113.547 -179.642 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -110.96 86.01 5.61 Favored Pre-proline 0 CA--C 1.572 1.826 0 CA-C-O 118.299 -0.858 . . . . 0.0 109.723 172.24 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -76.87 174.02 13.53 Favored 'Trans proline' 0 CA--C 1.563 1.926 0 C-N-CA 122.558 2.172 . . . . 0.0 115.67 -176.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -111.88 130.27 55.89 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.699 -0.625 . . . . 0.0 111.315 178.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 47.6 mttm -90.12 109.93 20.97 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.275 -0.891 . . . . 0.0 110.137 171.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -92.55 110.94 22.37 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 163.147 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 74.3 mt -109.03 118.35 56.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 107.475 -1.305 . . . . 0.0 107.475 -178.536 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 72.1 t -100.87 98.48 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 106.676 -1.602 . . . . 0.0 106.676 166.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -90.44 93.0 9.12 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.537 0.684 . . . . 0.0 109.731 174.781 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -100.33 70.58 1.52 Allowed 'General case' 0 CA--C 1.567 1.624 0 O-C-N 121.478 -0.764 . . . . 0.0 111.403 -177.35 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 53.56 67.46 2.13 Favored Glycine 0 N--CA 1.496 2.695 0 N-CA-C 117.64 1.816 . . . . 0.0 117.64 176.56 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.438 0.5 OUTLIER 61.0 8.22 1.82 Allowed 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 119.617 3.192 . . . . 0.0 119.617 -163.579 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 17.5 t-160 -107.48 106.56 17.01 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 121.276 1.853 . . . . 0.0 107.643 161.204 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 6.6 tpp -109.45 132.19 54.36 Favored 'General case' 0 CA--C 1.556 1.186 0 O-C-N 121.458 -0.776 . . . . 0.0 110.969 -172.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 47.1 mt -116.47 101.87 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 173.26 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 72.9 mt -99.13 116.31 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 178.744 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -115.86 103.39 10.59 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.427 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 70.4 m -88.42 112.62 23.12 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 172.274 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 24.0 mt -110.96 119.01 37.64 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.303 -158.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 36.1 t -130.76 153.53 48.93 Favored 'General case' 0 CA--C 1.56 1.346 0 C-N-CA 123.668 0.787 . . . . 0.0 110.529 173.611 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 70.2 p -80.98 62.32 4.92 Favored 'General case' 0 N--CA 1.504 2.247 0 O-C-N 120.636 -1.29 . . . . 0.0 111.633 163.49 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -174.06 -68.61 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 125.097 1.359 . . . . 0.0 108.985 -174.515 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 14.8 ttm180 -146.61 118.08 7.96 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 123.634 0.773 . . . . 0.0 109.103 -173.145 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -106.11 130.55 53.98 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 123.229 0.612 . . . . 0.0 110.588 -170.314 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 10.3 t80 -101.45 109.55 21.4 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.544 -0.722 . . . . 0.0 109.871 178.045 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 41.6 mm -116.67 117.47 55.58 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -169.068 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 25.4 mmm -126.6 97.54 5.06 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 123.226 0.61 . . . . 0.0 109.77 -175.132 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -104.84 103.7 13.34 Favored 'General case' 0 CA--C 1.563 1.463 0 C-N-CA 124.06 0.944 . . . . 0.0 111.875 177.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -151.49 154.24 36.17 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 -163.101 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 17.8 mp0 -84.57 126.53 33.4 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.11 -0.994 . . . . 0.0 111.08 164.622 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 15.1 t -69.06 114.15 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 174.387 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 124.88 -46.72 1.07 Allowed Glycine 0 N--CA 1.488 2.146 0 N-CA-C 115.807 1.083 . . . . 0.0 115.807 -160.255 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 34.9 mtmt -83.74 142.83 30.42 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 118.872 1.336 . . . . 0.0 113.861 -173.268 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -93.25 95.54 9.43 Favored 'General case' 0 CA--C 1.566 1.58 0 CA-C-O 121.321 0.582 . . . . 0.0 111.252 176.589 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -104.56 142.14 35.16 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 124.032 0.933 . . . . 0.0 113.058 -170.333 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -71.58 115.7 11.07 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.164 -1.585 . . . . 0.0 113.46 176.401 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 . . . . . 0 CA--C 1.564 1.508 0 O-C-N 121.397 -0.814 . . . . 0.0 109.423 165.501 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 72.5 m . . . . . 0 CA--C 1.559 1.31 0 CA-C-O 121.466 0.651 . . . . 0.0 110.866 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 2.4 tpt -75.58 98.66 4.06 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 122.195 0.998 . . . . 0.0 109.638 -176.442 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 65.3 m -104.72 110.26 22.51 Favored 'General case' 0 N--CA 1.48 1.059 0 O-C-N 121.695 -0.628 . . . . 0.0 110.065 -154.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 54.6 m -88.79 121.82 31.56 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 167.343 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 22.9 t -110.35 121.51 63.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 165.546 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 31.8 m -128.08 154.11 46.07 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 122.125 0.964 . . . . 0.0 111.545 -175.069 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 29.0 m95 -84.69 114.98 22.42 Favored 'General case' 0 CA--C 1.562 1.422 0 O-C-N 121.223 -0.923 . . . . 0.0 111.939 174.663 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -93.5 70.92 4.3 Favored 'General case' 0 CA--C 1.571 1.783 0 CA-C-O 121.539 0.685 . . . . 0.0 109.57 159.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 61.14 -114.72 6.96 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 114.901 0.72 . . . . 0.0 114.901 -168.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -64.87 -30.56 71.57 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 116.461 2.023 . . . . 0.0 116.461 166.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -86.87 127.81 35.04 Favored 'General case' 0 CA--C 1.561 1.384 0 CA-C-N 119.443 1.019 . . . . 0.0 111.256 -173.065 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 25.8 tp -92.28 106.56 18.54 Favored 'General case' 0 CA--C 1.566 1.562 0 O-C-N 121.378 -0.826 . . . . 0.0 109.097 176.346 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 -100.46 128.83 46.41 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 123.658 0.783 . . . . 0.0 111.132 -173.302 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 40.9 t -124.19 131.64 53.55 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.436 0.694 . . . . 0.0 111.975 -177.459 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.5 p -120.15 125.65 74.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 C-N-CA 122.979 0.511 . . . . 0.0 109.628 168.133 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -100.87 90.26 4.14 Favored 'General case' 0 CA--C 1.568 1.657 0 C-N-CA 124.092 0.957 . . . . 0.0 109.58 -176.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -84.88 122.47 29.21 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.66 -1.275 . . . . 0.0 113.525 -166.646 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -169.76 -130.64 1.23 Allowed Glycine 0 N--CA 1.485 1.947 0 O-C-N 121.593 -0.692 . . . . 0.0 112.157 171.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.68 -16.44 58.49 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 117.157 2.281 . . . . 0.0 117.157 176.165 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 16.7 ttmt -98.82 129.64 45.22 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 119.97 1.259 . . . . 0.0 111.561 -170.354 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -79.01 128.55 33.4 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.472 -0.767 . . . . 0.0 112.816 -172.192 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 66.61 34.1 86.53 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 118.975 2.35 . . . . 0.0 118.975 -176.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 36.7 ttt180 -85.92 124.36 32.3 Favored 'General case' 0 CA--C 1.565 1.527 0 CA-C-N 118.734 1.267 . . . . 0.0 111.577 -177.636 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -179.18 -168.96 39.03 Favored Glycine 0 N--CA 1.486 1.989 0 N-CA-C 115.687 1.035 . . . . 0.0 115.687 -177.193 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 41.8 p-90 -157.43 155.47 30.53 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.958 0.885 . . . . 0.0 112.898 170.482 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 97.5 m -126.16 120.47 30.2 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.344 -0.848 . . . . 0.0 108.712 176.31 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 16.8 tt0 -124.42 124.72 42.95 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.846 -0.534 . . . . 0.0 111.992 -175.522 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 14.0 p90 -143.17 163.02 34.04 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.079 -1.013 . . . . 0.0 113.227 -177.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 86.1 mt -107.92 133.94 51.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 CA-C-O 122.266 1.031 . . . . 0.0 110.652 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -120.71 85.34 2.38 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 124.525 1.13 . . . . 0.0 108.451 173.434 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 69.68 -108.06 2.34 Favored Glycine 0 N--CA 1.491 2.315 0 O-C-N 121.584 -0.697 . . . . 0.0 114.752 -175.426 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 31.6 p-10 -87.96 -5.16 58.68 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 117.427 2.38 . . . . 0.0 117.427 166.718 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -103.41 139.59 38.59 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-N 120.408 1.458 . . . . 0.0 112.368 -175.025 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 10.7 tp -101.46 122.08 43.12 Favored 'General case' 0 CA--C 1.562 1.417 0 C-N-CA 123.873 0.869 . . . . 0.0 108.957 169.348 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 36.9 m80 -109.27 119.87 40.81 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.533 0.733 . . . . 0.0 109.208 -175.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 20.0 tp -114.38 129.86 56.67 Favored 'General case' 0 CA--C 1.56 1.327 0 C-N-CA 123.737 0.815 . . . . 0.0 110.183 -178.049 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -119.16 108.7 14.99 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.936 -0.478 . . . . 0.0 110.003 169.09 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 76.8 mtm -97.82 127.49 43.8 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 123.62 0.768 . . . . 0.0 111.515 -176.719 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 78.7 mtm180 -118.14 135.2 54.37 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 123.329 0.651 . . . . 0.0 111.693 -167.732 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -160.23 132.89 6.46 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.26 -0.9 . . . . 0.0 111.515 170.04 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 33.8 mm-40 58.13 36.88 26.24 Favored 'General case' 0 N--CA 1.505 2.3 0 N-CA-C 115.361 1.615 . . . . 0.0 115.361 -177.348 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 72.9 -8.62 7.56 Favored Glycine 0 CA--C 1.556 2.603 0 N-CA-C 120.399 2.92 . . . . 0.0 120.399 -162.46 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 97.1 t -92.88 128.23 44.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 CA-C-N 120.137 1.969 . . . . 0.0 109.76 -171.116 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 37.8 m -105.9 124.25 49.28 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 122.73 0.412 . . . . 0.0 111.5 177.3 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 11.2 t -95.14 126.21 40.31 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.426 0.69 . . . . 0.0 111.234 162.271 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -103.4 121.1 42.09 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 123.381 0.672 . . . . 0.0 109.569 -179.004 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 20.0 mt-30 -126.64 134.24 50.8 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.588 -0.695 . . . . 0.0 111.227 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 57.1 t -115.24 131.07 68.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 -177.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -123.5 149.83 44.69 Favored 'General case' 0 CA--C 1.563 1.478 0 C-N-CA 124.72 1.208 . . . . 0.0 110.232 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 29.6 ttmt -123.61 141.08 52.36 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.789 -1.194 . . . . 0.0 112.153 175.413 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 70.8 tttt -73.84 123.4 24.13 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 -175.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . 0.255 34.5 m -107.86 -43.07 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 175.248 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 . . . . . 0 N--CA 1.487 1.414 0 CA-C-N 120.206 1.366 . . . . 0.0 108.312 167.011 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo . . . . . 0 CA--C 1.561 1.859 0 N-CA-C 115.405 1.271 . . . . 0.0 115.405 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 15.6 m -72.58 141.26 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 CA-C-O 121.936 0.874 . . . . 0.0 113.079 178.503 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -76.25 121.48 23.0 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 -176.024 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 8.6 m-30 -85.05 8.4 18.04 Favored 'General case' 0 CA--C 1.572 1.807 0 N-CA-C 115.647 1.721 . . . . 0.0 115.647 177.498 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 71.4 m-80 -51.43 121.82 6.93 Favored 'General case' 0 N--CA 1.499 2.004 0 CA-C-N 121.496 1.953 . . . . 0.0 115.082 172.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 160.45 177.88 33.95 Favored Glycine 0 N--CA 1.481 1.685 0 CA-C-O 123.002 1.334 . . . . 0.0 116.031 174.009 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 14.8 t80 -110.74 128.84 55.89 Favored 'General case' 0 CA--C 1.564 1.491 0 CA-C-N 113.578 -1.311 . . . . 0.0 108.364 165.382 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 55.3 m95 -126.81 138.51 53.36 Favored 'General case' 0 CA--C 1.573 1.832 0 C-N-CA 123.733 0.813 . . . . 0.0 110.144 -167.477 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -112.11 137.05 50.71 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 120.678 -1.264 . . . . 0.0 112.633 178.73 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.45 ' SD ' ' HD2' ' A' ' 38' ' ' PRO . 1.9 ttt -75.0 123.45 25.18 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.454 -1.404 . . . . 0.0 114.281 -175.122 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 97.5 mt -85.92 -52.67 5.58 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 113.688 0.996 . . . . 0.0 113.688 176.689 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 83.3 p -142.36 148.25 37.61 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 123.671 0.788 . . . . 0.0 112.112 -176.197 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -126.75 116.73 21.38 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 123.107 0.563 . . . . 0.0 110.078 170.484 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -112.15 116.05 29.85 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 178.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.293 18.7 t30 69.71 25.47 5.14 Favored 'General case' 0 CA--C 1.579 2.096 0 N-CA-C 117.964 2.579 . . . . 0.0 117.964 177.78 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 15.7 t80 -63.41 -45.14 92.39 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 115.459 1.651 . . . . 0.0 115.459 170.597 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -54.68 -40.78 69.47 Favored 'General case' 0 CA--C 1.573 1.836 0 N-CA-C 117.868 2.544 . . . . 0.0 117.868 172.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -74.22 -40.72 62.26 Favored 'General case' 0 CA--C 1.571 1.775 0 N-CA-C 115.264 1.579 . . . . 0.0 115.264 171.114 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -49.06 -48.92 43.67 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 115.19 1.552 . . . . 0.0 115.19 162.501 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 88.5 mt -62.06 -40.19 94.94 Favored 'General case' 0 CA--C 1.573 1.835 0 N-CA-C 115.339 1.607 . . . . 0.0 115.339 169.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 46.9 ttp180 -54.0 -50.47 66.52 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 165.181 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.58 -21.52 53.34 Favored 'General case' 0 CA--C 1.567 1.622 0 N-CA-C 118.223 2.675 . . . . 0.0 118.223 167.203 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 37.7 mt -90.83 8.53 34.36 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 115.988 1.847 . . . . 0.0 115.988 168.716 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 69.84 32.94 3.01 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 115.141 1.534 . . . . 0.0 115.141 -177.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 70.3 t -95.36 144.08 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 120.666 -1.271 . . . . 0.0 110.623 -172.056 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -64.74 152.64 42.04 Favored 'General case' 0 CA--C 1.573 1.835 0 N-CA-C 116.213 1.931 . . . . 0.0 116.213 -176.49 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . 0.251 56.1 t -58.45 -42.47 84.37 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.156 0 N-CA-C 115.682 1.734 . . . . 0.0 115.682 -179.251 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.05 -51.3 70.65 Favored 'General case' 0 CA--C 1.57 1.72 0 N-CA-C 115.878 1.807 . . . . 0.0 115.878 173.224 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -54.28 -53.49 53.05 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 114.314 1.227 . . . . 0.0 114.314 166.048 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 56.3 mtp180 -47.52 -41.57 21.33 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 118.378 2.732 . . . . 0.0 118.378 171.269 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -75.73 -52.88 9.48 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 174.167 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 19.9 mt -63.33 -49.75 81.64 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 CA-C-N 119.251 0.932 . . . . 0.0 112.961 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.93 -33.07 74.88 Favored 'General case' 0 CA--C 1.568 1.664 0 N-CA-C 117.821 2.526 . . . . 0.0 117.821 175.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -69.14 -31.27 69.82 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 116.11 1.893 . . . . 0.0 116.11 165.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 79.9 mt -72.25 -36.49 69.08 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 116.075 1.88 . . . . 0.0 116.075 171.186 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . 0.293 2.5 pp -80.82 152.69 28.1 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-N 120.196 1.362 . . . . 0.0 114.545 -178.716 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 30.8 mmtp -111.07 99.29 42.54 Favored Pre-proline 0 CA--C 1.572 1.808 0 CA-C-O 118.348 -0.834 . . . . 0.0 108.818 176.475 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.45 ' HD2' ' SD ' ' A' ' 10' ' ' MET . 91.0 Cg_endo -77.92 176.92 9.42 Favored 'Trans proline' 0 CA--C 1.565 2.032 0 C-N-CA 122.948 2.432 . . . . 0.0 116.025 -175.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -109.98 163.45 13.55 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.969 0.89 . . . . 0.0 112.213 173.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 43.2 mttm -135.46 120.53 18.78 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.099 -1.001 . . . . 0.0 110.123 176.196 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -100.57 118.57 37.0 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.422 -0.798 . . . . 0.0 109.656 163.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 78.6 mt -113.75 121.42 65.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 177.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 52.9 t -107.09 97.35 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 107.788 -1.189 . . . . 0.0 107.788 167.688 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -88.48 117.04 27.14 Favored 'General case' 0 CA--C 1.567 1.604 0 C-N-CA 123.454 0.701 . . . . 0.0 110.019 165.459 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -142.9 102.04 3.95 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.241 -0.912 . . . . 0.0 109.762 -179.136 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 56.8 62.36 6.45 Favored Glycine 0 N--CA 1.497 2.706 0 N-CA-C 117.409 1.724 . . . . 0.0 117.409 178.013 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.416 0.6 OUTLIER 59.97 -10.79 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 119.914 3.302 . . . . 0.0 119.914 -165.291 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 12.4 t-80 -88.4 121.93 31.33 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-N 121.192 1.814 . . . . 0.0 110.127 174.46 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 40.4 ttm -123.58 116.99 24.04 Favored 'General case' 0 CA--C 1.556 1.208 0 CA-C-O 121.553 0.692 . . . . 0.0 110.161 -174.523 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 27.6 mt -104.13 98.91 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 177.453 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 72.0 mt -94.23 111.76 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 178.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 41.9 mtt85 -110.27 101.79 10.5 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 178.703 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.2 m -80.0 120.7 24.54 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 167.247 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 74.9 mt -124.39 118.21 26.19 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-O 121.649 0.738 . . . . 0.0 109.638 -164.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.47 -3.13 0.2 Allowed 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 117.018 2.229 . . . . 0.0 117.018 -178.191 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . 0.344 30.3 m 75.4 -62.97 0.43 Allowed 'General case' 0 N--CA 1.505 2.293 0 CA-C-N 121.556 1.98 . . . . 0.0 112.893 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -63.15 -44.44 95.51 Favored 'General case' 0 CA--C 1.571 1.778 0 N-CA-C 115.174 1.546 . . . . 0.0 115.174 165.524 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 31.4 ttt85 -128.16 130.77 48.59 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 120.081 1.309 . . . . 0.0 110.397 172.747 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -133.82 135.21 43.65 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.764 -0.585 . . . . 0.0 110.507 176.036 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -120.0 119.99 35.01 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 170.282 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 33.9 mm -112.4 104.88 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 174.324 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 94.4 mtp -110.74 98.71 7.8 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 -179.469 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -102.01 98.35 8.56 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 123.523 0.729 . . . . 0.0 110.136 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -142.78 156.78 45.03 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -168.38 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -94.7 131.26 40.7 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.105 -0.997 . . . . 0.0 110.824 166.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 22.0 t -66.85 113.3 2.84 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.776 0 C-N-CA 123.501 0.721 . . . . 0.0 109.978 -179.128 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 127.4 -55.45 0.75 Allowed Glycine 0 CA--C 1.548 2.109 0 CA-C-O 119.059 -0.856 . . . . 0.0 114.923 -158.609 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 13.9 pttt -75.76 145.58 40.69 Favored 'General case' 0 CA--C 1.567 1.627 0 N-CA-C 116.286 1.958 . . . . 0.0 116.286 -170.151 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -95.01 108.85 20.93 Favored 'General case' 0 CA--C 1.567 1.627 0 C-N-CA 123.172 0.589 . . . . 0.0 110.835 174.307 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -116.02 143.12 45.89 Favored 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 123.666 0.786 . . . . 0.0 112.819 -173.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -70.66 116.24 10.75 Favored 'General case' 0 CA--C 1.569 1.709 0 O-C-N 120.042 -1.661 . . . . 0.0 113.975 175.539 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.777 0 O-C-N 121.166 -0.959 . . . . 0.0 108.763 167.316 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 22.1 m . . . . . 0 CA--C 1.562 1.423 0 CA-C-O 122.208 1.004 . . . . 0.0 111.435 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 72.1 mmm -74.05 110.46 8.36 Favored 'General case' 0 CA--C 1.562 1.439 0 C-N-CA 123.744 0.818 . . . . 0.0 109.757 172.028 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 76.6 m -108.81 116.16 31.46 Favored 'General case' 0 N--CA 1.484 1.256 0 O-C-N 121.668 -0.645 . . . . 0.0 110.714 -161.31 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 89.8 m -104.68 125.81 51.15 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 176.642 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.409 HG22 ' SG ' ' A' ' 95' ' ' CYS . 15.4 t -117.85 119.24 60.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 177.814 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 56.8 m -140.56 150.18 43.35 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 123.341 0.656 . . . . 0.0 112.161 -174.115 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 90.7 m95 -79.27 119.74 22.76 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.462 -1.399 . . . . 0.0 112.847 177.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -93.55 78.52 4.34 Favored 'General case' 0 CA--C 1.567 1.616 0 O-C-N 121.631 -0.668 . . . . 0.0 109.295 163.276 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 67.65 -99.27 0.52 Allowed Glycine 0 N--CA 1.49 2.264 0 O-C-N 121.818 -0.551 . . . . 0.0 114.451 -171.147 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -102.95 -6.05 22.82 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 116.454 2.02 . . . . 0.0 116.454 170.448 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 35.8 mtmm -97.39 127.59 43.48 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-N 120.539 1.518 . . . . 0.0 110.026 176.536 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 22.3 tp -84.73 110.15 18.56 Favored 'General case' 0 CA--C 1.564 1.489 0 O-C-N 121.034 -1.041 . . . . 0.0 110.071 174.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -97.39 125.53 42.07 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.693 0.797 . . . . 0.0 110.841 -175.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' CYS . . . . . 0.409 ' SG ' HG22 ' A' ' 86' ' ' VAL . 39.4 t -114.03 124.33 51.87 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 123.284 0.633 . . . . 0.0 110.154 175.075 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.6 p -107.3 118.47 55.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 166.046 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -97.97 88.14 4.17 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 174.145 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -99.07 126.74 44.87 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.092 -1.005 . . . . 0.0 112.462 -174.398 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 166.39 -107.25 0.28 Allowed Glycine 0 N--CA 1.487 2.072 0 O-C-N 121.28 -0.887 . . . . 0.0 112.915 176.028 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -76.87 -10.22 59.22 Favored 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 117.764 2.505 . . . . 0.0 117.764 -177.802 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -122.94 142.84 50.37 Favored 'General case' 0 CA--C 1.566 1.563 0 CA-C-N 120.086 1.312 . . . . 0.0 111.294 177.182 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -81.79 144.32 31.16 Favored 'General case' 0 CA--C 1.563 1.467 0 O-C-N 121.491 -0.756 . . . . 0.0 111.565 173.682 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 57.63 23.96 51.4 Favored Glycine 0 N--CA 1.498 2.81 0 N-CA-C 120.854 3.102 . . . . 0.0 120.854 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 57.8 ttt180 -85.95 124.8 32.82 Favored 'General case' 0 CA--C 1.565 1.544 0 CA-C-N 118.501 1.151 . . . . 0.0 111.28 -178.174 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 178.25 -173.67 46.09 Favored Glycine 0 N--CA 1.488 2.119 0 O-C-N 121.341 -0.849 . . . . 0.0 114.852 -178.75 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . 0.25 16.8 p-90 -155.12 157.77 37.99 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 114.66 1.356 . . . . 0.0 114.66 171.735 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 31.8 m -123.77 123.7 41.06 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 123.831 0.852 . . . . 0.0 108.842 170.557 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -123.44 131.99 53.81 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 123.287 0.635 . . . . 0.0 111.882 -176.117 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 23.4 p90 -150.54 167.08 28.27 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.045 -1.034 . . . . 0.0 113.014 -179.153 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 89.3 mt -107.94 136.83 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.193 0 O-C-N 120.776 -1.202 . . . . 0.0 110.447 175.203 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -123.3 97.09 5.25 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 123.578 0.751 . . . . 0.0 109.701 164.463 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 76.97 -111.3 3.23 Favored Glycine 0 N--CA 1.491 2.316 0 O-C-N 121.275 -0.89 . . . . 0.0 113.9 -176.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -107.37 37.87 2.28 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 164.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -131.65 117.01 18.1 Favored 'General case' 0 CA--C 1.559 1.326 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 -168.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 17.2 tp -87.42 114.4 24.0 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-O 121.755 0.788 . . . . 0.0 109.914 172.309 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 48.9 m80 -102.66 120.09 39.96 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.972 0.909 . . . . 0.0 109.076 -177.661 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 49.5 tp -120.31 120.08 35.01 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 123.784 0.834 . . . . 0.0 109.833 -177.587 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -105.43 116.3 31.71 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.577 -0.702 . . . . 0.0 109.454 168.331 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 69.3 mtm -108.5 131.13 55.13 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 123.372 0.669 . . . . 0.0 111.023 -178.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 77.6 mtm-85 -115.16 143.87 44.56 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.534 -0.729 . . . . 0.0 111.411 -175.714 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -149.17 124.07 9.96 Favored 'General case' 0 N--CA 1.484 1.259 0 CA-C-O 121.456 0.646 . . . . 0.0 110.707 166.504 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 62.0 24.71 14.75 Favored 'General case' 0 CA--C 1.581 2.17 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 -172.678 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 88.33 -28.96 5.89 Favored Glycine 0 CA--C 1.557 2.694 0 N-CA-C 118.256 2.062 . . . . 0.0 118.256 -158.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 87.4 t -72.19 120.58 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 CA-C-N 119.644 1.722 . . . . 0.0 110.588 -173.425 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 29.4 m -102.12 123.74 46.5 Favored 'General case' 0 CA--C 1.566 1.573 0 CA-C-O 121.585 0.707 . . . . 0.0 111.484 -173.153 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 10.7 t -96.0 138.18 34.0 Favored 'General case' 0 CA--C 1.559 1.316 0 C-N-CA 124.3 1.04 . . . . 0.0 111.475 162.197 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 6.0 mtmt -118.07 124.14 47.36 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.333 -0.854 . . . . 0.0 110.051 179.058 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -127.24 134.45 50.08 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 123.593 0.757 . . . . 0.0 111.353 -177.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 38.0 t -116.68 132.39 66.52 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.721 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.439 ' CZ ' ' SD ' ' A' ' 10' ' ' MET . 38.3 m-85 -126.89 134.84 50.39 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.999 0.92 . . . . 0.0 111.062 -178.402 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 74.9 tttt -99.89 137.24 38.62 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.636 -1.29 . . . . 0.0 112.446 -179.062 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -71.56 118.82 14.86 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 179.276 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 26.8 m -104.04 -40.72 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 174.8 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 76.9 t60 . . . . . 0 C--O 1.253 1.273 0 CA-C-N 119.629 1.104 . . . . 0.0 108.416 166.275 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo . . . . . 0 CA--C 1.565 2.053 0 N-CA-C 117.061 1.908 . . . . 0.0 117.061 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.1 t -81.9 139.85 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.53 -0.731 . . . . 0.0 110.76 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -67.92 99.41 0.84 Allowed 'General case' 0 CA--C 1.569 1.674 0 O-C-N 121.109 -0.994 . . . . 0.0 113.35 167.449 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 10.6 m-30 -79.26 5.46 12.28 Favored 'General case' 0 CA--C 1.579 2.086 0 N-CA-C 116.364 1.987 . . . . 0.0 116.364 175.406 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -60.43 116.09 4.05 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 125.711 1.604 . . . . 0.0 114.616 -176.239 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 162.89 -177.9 38.8 Favored Glycine 0 N--CA 1.482 1.767 0 N-CA-C 116.646 1.419 . . . . 0.0 116.646 179.467 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 24.2 t80 -111.25 122.78 48.75 Favored 'General case' 0 CA--C 1.564 1.484 0 CA-C-N 113.514 -1.343 . . . . 0.0 108.138 170.302 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 83.1 m95 -122.43 125.82 46.64 Favored 'General case' 0 CA--C 1.564 1.497 0 C-N-CA 123.47 0.708 . . . . 0.0 109.93 -167.058 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -101.21 139.19 37.22 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.111 -0.993 . . . . 0.0 112.816 -179.192 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.464 ' SD ' ' HD2' ' A' ' 38' ' ' PRO . 42.0 ttm -67.1 126.12 28.19 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-N 120.241 1.382 . . . . 0.0 113.912 -179.66 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 91.3 mt -85.07 -55.54 4.0 Favored 'General case' 0 CA--C 1.567 1.611 0 CA-C-N 115.723 -0.672 . . . . 0.0 112.55 163.798 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 99.7 p -138.65 150.25 46.05 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 123.526 0.73 . . . . 0.0 112.773 -177.146 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -132.76 104.74 6.77 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.683 0.754 . . . . 0.0 109.453 165.605 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -108.0 124.77 50.66 Favored 'General case' 0 CA--C 1.56 1.357 0 C-N-CA 124.155 0.982 . . . . 0.0 109.487 -170.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.286 33.4 t30 64.87 24.3 12.74 Favored 'General case' 0 N--CA 1.502 2.165 0 N-CA-C 117.105 2.261 . . . . 0.0 117.105 -173.673 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -68.21 -45.02 74.45 Favored 'General case' 0 CA--C 1.569 1.68 0 N-CA-C 115.271 1.582 . . . . 0.0 115.271 176.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -43.36 -50.5 6.75 Favored 'General case' 0 N--CA 1.501 2.124 0 N-CA-C 117.319 2.341 . . . . 0.0 117.319 164.541 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -71.68 -38.45 70.61 Favored 'General case' 0 CA--C 1.571 1.752 0 N-CA-C 115.563 1.69 . . . . 0.0 115.563 177.436 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 73.0 t80 -53.98 -47.52 71.32 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 114.907 1.447 . . . . 0.0 114.907 162.604 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 72.6 mt -62.17 -42.0 98.85 Favored 'General case' 0 CA--C 1.574 1.871 0 N-CA-C 114.681 1.363 . . . . 0.0 114.681 171.278 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 26.1 ttt-85 -50.41 -50.74 51.01 Favored 'General case' 0 N--CA 1.501 2.118 0 N-CA-C 115.586 1.699 . . . . 0.0 115.586 163.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.25 -23.2 55.23 Favored 'General case' 0 CA--C 1.566 1.576 0 N-CA-C 118.181 2.66 . . . . 0.0 118.181 167.804 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 96.1 mt -88.95 13.83 11.9 Favored 'General case' 0 CA--C 1.574 1.901 0 N-CA-C 115.484 1.661 . . . . 0.0 115.484 165.757 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 60.29 40.59 17.57 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 115.984 1.846 . . . . 0.0 115.984 -174.037 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 88.9 t -93.65 137.83 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 120.99 -1.069 . . . . 0.0 109.185 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.5 p-10 -66.83 150.24 49.44 Favored 'General case' 0 CA--C 1.567 1.628 0 N-CA-C 115.19 1.552 . . . . 0.0 115.19 178.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 77.5 t -53.31 -41.23 43.01 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.291 0 N-CA-C 116.057 1.873 . . . . 0.0 116.057 -175.604 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.54 -49.19 78.75 Favored 'General case' 0 CA--C 1.568 1.635 0 N-CA-C 115.726 1.75 . . . . 0.0 115.726 170.695 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.6 tt -65.53 -41.86 92.62 Favored 'General case' 0 CA--C 1.574 1.887 0 N-CA-C 114.66 1.355 . . . . 0.0 114.66 171.653 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 74.8 mtp180 -46.85 -52.14 15.0 Favored 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 115.773 1.768 . . . . 0.0 115.773 164.03 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -65.71 -47.29 75.88 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 114.88 1.437 . . . . 0.0 114.88 171.786 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 61.4 mt -55.73 -57.98 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 CA-C-N 120.289 1.404 . . . . 0.0 112.766 175.448 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.27 -36.56 73.46 Favored 'General case' 0 CA--C 1.564 1.49 0 N-CA-C 118.409 2.744 . . . . 0.0 118.409 176.569 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -73.59 -30.71 63.17 Favored 'General case' 0 CA--C 1.57 1.724 0 N-CA-C 116.017 1.858 . . . . 0.0 116.017 171.051 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 73.8 mt -72.0 -33.54 68.18 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 116.001 1.852 . . . . 0.0 116.001 173.663 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.9 pp -78.94 150.64 32.02 Favored 'General case' 0 CA--C 1.566 1.588 0 N-CA-C 114.678 1.362 . . . . 0.0 114.678 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -109.52 94.06 15.4 Favored Pre-proline 0 CA--C 1.571 1.784 0 CA-C-O 118.286 -0.864 . . . . 0.0 108.797 176.058 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.464 ' HD2' ' SD ' ' A' ' 10' ' ' MET . 83.3 Cg_endo -78.44 171.07 17.45 Favored 'Trans proline' 0 CA--C 1.563 1.966 0 C-N-CA 122.806 2.337 . . . . 0.0 114.504 -178.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -116.61 127.7 54.71 Favored 'General case' 0 CA--C 1.56 1.359 0 CA-C-N 114.992 -1.003 . . . . 0.0 110.405 177.356 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 58.1 mttm -91.15 113.11 25.29 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.088 -1.007 . . . . 0.0 109.739 170.715 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -94.48 112.41 24.18 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 165.044 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 63.6 mt -110.86 119.35 59.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 -174.169 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 95.4 t -101.9 98.98 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 166.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -95.87 113.45 25.08 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 123.316 0.647 . . . . 0.0 110.028 175.489 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -116.2 64.59 0.7 Allowed 'General case' 0 CA--C 1.569 1.692 0 O-C-N 121.477 -0.765 . . . . 0.0 110.36 171.099 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 66.3 -97.95 0.35 Allowed Glycine 0 N--CA 1.487 2.07 0 N-CA-C 115.743 1.057 . . . . 0.0 115.743 -179.145 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -76.86 -41.84 42.43 Favored 'General case' 0 CA--C 1.565 1.541 0 N-CA-C 115.832 1.79 . . . . 0.0 115.832 169.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 13.1 t-160 -84.12 122.85 29.38 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 120.699 1.591 . . . . 0.0 111.429 175.158 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 8.6 ttp -137.93 131.34 30.75 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-O 122.116 0.96 . . . . 0.0 111.857 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 48.3 mt -115.24 107.84 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 73.1 mt -98.36 106.15 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 173.62 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 69.8 mtt180 -95.97 103.52 15.41 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.24 -0.912 . . . . 0.0 110.307 174.029 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 23.7 m -85.49 103.05 14.01 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 175.432 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.4 mt -104.5 118.32 36.32 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 124.104 0.962 . . . . 0.0 109.189 -166.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 47.1 t -118.84 161.67 19.77 Favored 'General case' 0 CA--C 1.556 1.183 0 CA-C-O 122.27 1.034 . . . . 0.0 111.181 -170.262 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 70.6 p -65.99 -19.76 65.97 Favored 'General case' 0 N--CA 1.5 2.025 0 N-CA-C 116.191 1.922 . . . . 0.0 116.191 161.181 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -78.08 -67.9 0.69 Allowed 'General case' 0 CA--C 1.569 1.679 0 CA-C-N 119.477 1.035 . . . . 0.0 112.185 169.307 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . 0.263 64.9 ttt180 -151.08 -117.15 0.04 OUTLIER 'General case' 0 CA--C 1.577 1.981 0 CA-C-N 120.516 1.507 . . . . 0.0 111.074 163.756 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 49.6 t-20 -164.48 138.44 5.27 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.178 -1.576 . . . . 0.0 109.237 -168.127 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 25.7 t80 -98.07 -55.4 2.79 Favored 'General case' 0 N--CA 1.5 2.054 0 N-CA-C 115.455 1.65 . . . . 0.0 115.455 -173.071 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.332 3.7 mp 62.02 92.7 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 -176.025 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 45.9 mmm -91.54 94.28 9.36 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.007 -1.058 . . . . 0.0 108.718 160.368 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.8 p30 -100.13 108.76 20.97 Favored 'General case' 0 CA--C 1.559 1.308 0 C-N-CA 123.954 0.902 . . . . 0.0 110.918 176.559 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 40.6 p90 -147.67 149.3 32.22 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-O 122.546 1.165 . . . . 0.0 114.029 -165.269 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -91.75 123.27 35.01 Favored 'General case' 0 CA--C 1.559 1.326 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.739 160.733 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 66.3 t -62.45 125.18 18.37 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.787 0 C-N-CA 124.109 0.964 . . . . 0.0 110.539 176.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 100.92 -36.66 4.03 Favored Glycine 0 CA--C 1.55 2.278 0 N-CA-C 117.075 1.59 . . . . 0.0 117.075 -167.075 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 84.5 mttt -81.21 129.88 34.78 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-N 119.775 1.788 . . . . 0.0 112.207 -176.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -88.93 103.69 16.26 Favored 'General case' 0 CA--C 1.566 1.578 0 O-C-N 121.789 -0.569 . . . . 0.0 111.668 -179.118 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -106.11 147.73 28.63 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -173.813 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.46 125.34 28.81 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.7 -1.25 . . . . 0.0 112.759 170.145 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 . . . . . 0 N--CA 1.5 2.045 0 CA-C-O 122.66 1.219 . . . . 0.0 113.487 174.85 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 89.2 m . . . . . 0 N--CA 1.489 1.502 0 N-CA-C 111.378 0.14 . . . . 0.0 111.378 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 2.7 mmt -70.83 99.19 1.69 Allowed 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 121.816 0.817 . . . . 0.0 111.123 176.222 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 64.7 m -114.47 111.37 21.3 Favored 'General case' 0 N--CA 1.483 1.186 0 O-C-N 121.648 -0.657 . . . . 0.0 110.541 -156.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 36.9 m -95.37 129.64 42.44 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 169.506 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.1 t -108.58 129.2 63.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 163.32 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 49.4 m -133.89 141.25 47.29 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.291 -0.88 . . . . 0.0 111.109 -175.199 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 42.6 m95 -78.29 107.74 11.12 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.66 -1.275 . . . . 0.0 110.859 169.366 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -85.61 74.92 10.2 Favored 'General case' 0 CA--C 1.568 1.645 0 O-C-N 121.362 -0.836 . . . . 0.0 109.822 168.032 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.95 -98.46 0.36 Allowed Glycine 0 N--CA 1.487 2.086 0 CA-C-N 116.18 -0.464 . . . . 0.0 114.133 -167.177 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -105.86 -4.05 21.18 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 116.378 1.992 . . . . 0.0 116.378 173.605 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 41.7 mtpt -103.36 124.98 49.71 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-N 120.327 1.421 . . . . 0.0 109.247 177.405 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 24.7 tp -84.79 107.48 16.99 Favored 'General case' 0 CA--C 1.563 1.458 0 O-C-N 120.858 -1.151 . . . . 0.0 110.493 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -96.54 131.25 43.35 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.704 0.802 . . . . 0.0 111.065 -175.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 53.8 t -122.67 136.87 55.0 Favored 'General case' 0 N--CA 1.484 1.269 0 O-C-N 121.645 -0.66 . . . . 0.0 111.693 175.447 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.7 p -127.08 119.46 52.94 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.637 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 171.006 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 19.2 mp0 -91.93 104.83 17.2 Favored 'General case' 0 CA--C 1.565 1.541 0 C-N-CA 124.001 0.921 . . . . 0.0 109.976 173.056 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -91.26 131.44 36.77 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.161 -0.962 . . . . 0.0 112.442 -174.706 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 161.79 -98.37 0.16 Allowed Glycine 0 N--CA 1.485 1.92 0 O-C-N 121.949 -0.469 . . . . 0.0 112.854 168.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -77.41 -51.83 10.14 Favored 'General case' 0 CA--C 1.568 1.652 0 N-CA-C 115.649 1.722 . . . . 0.0 115.649 -177.326 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 58.3 mttm -99.31 143.03 30.04 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 122.613 1.197 . . . . 0.0 114.058 -160.206 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -83.95 97.33 9.19 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 122.144 0.973 . . . . 0.0 112.505 -166.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 82.31 41.48 9.23 Favored Glycine 0 N--CA 1.485 1.924 0 N-CA-C 117.443 1.737 . . . . 0.0 117.443 -168.421 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 64.0 ttt180 -77.25 113.01 14.56 Favored 'General case' 0 CA--C 1.566 1.594 0 CA-C-N 119.561 1.68 . . . . 0.0 110.41 164.183 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -169.3 177.79 42.77 Favored Glycine 0 N--CA 1.482 1.724 0 CA-C-O 122.184 0.88 . . . . 0.0 113.978 -177.498 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . 0.257 28.1 p-90 -152.13 158.47 42.99 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 171.789 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 33.5 m -129.14 118.64 22.77 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 176.09 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 -120.29 128.85 53.68 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 123.284 0.634 . . . . 0.0 111.79 -176.66 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 19.6 p90 -148.81 166.91 27.07 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.997 -1.064 . . . . 0.0 112.21 -179.34 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 96.2 mt -108.16 132.69 55.26 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.121 0 O-C-N 120.677 -1.264 . . . . 0.0 110.369 176.108 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -112.42 100.91 9.14 Favored 'General case' 0 CA--C 1.566 1.563 0 C-N-CA 123.796 0.838 . . . . 0.0 108.96 162.423 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 72.04 -109.51 2.85 Favored Glycine 0 N--CA 1.493 2.463 0 O-C-N 121.366 -0.833 . . . . 0.0 114.792 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -109.14 35.4 3.28 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 163.636 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -131.91 126.26 33.7 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.799 0.84 . . . . 0.0 109.53 -178.64 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 23.6 tp -88.6 118.45 28.26 Favored 'General case' 0 CA--C 1.56 1.363 0 C-N-CA 124.008 0.923 . . . . 0.0 109.954 173.522 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 44.8 m80 -105.47 120.83 42.6 Favored 'General case' 0 CA--C 1.56 1.328 0 C-N-CA 123.949 0.9 . . . . 0.0 108.972 -177.489 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 28.2 tp -119.38 123.81 45.04 Favored 'General case' 0 CA--C 1.561 1.397 0 C-N-CA 124.056 0.942 . . . . 0.0 109.798 -177.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -105.0 123.42 47.77 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.614 -0.679 . . . . 0.0 109.266 165.115 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 70.0 mtm -115.3 125.21 53.0 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-N 118.896 0.771 . . . . 0.0 110.659 178.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 69.3 mtp180 -112.89 144.64 42.1 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 123.169 0.588 . . . . 0.0 111.881 -178.702 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -156.89 129.76 7.73 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 123.079 0.551 . . . . 0.0 111.183 166.666 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 56.32 40.21 29.91 Favored 'General case' 0 N--CA 1.506 2.355 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 -172.642 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 77.47 -31.12 1.65 Allowed Glycine 0 CA--C 1.558 2.744 0 N-CA-C 119.536 2.575 . . . . 0.0 119.536 -160.838 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 90.0 t -77.87 123.39 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 CA-C-N 119.15 1.475 . . . . 0.0 111.114 -162.26 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 34.2 m -104.99 118.11 35.69 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 123.064 0.546 . . . . 0.0 111.629 -171.134 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 18.1 t -92.22 141.86 28.11 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.495 0.718 . . . . 0.0 112.006 163.129 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -117.75 118.16 31.3 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 123.348 0.659 . . . . 0.0 110.006 178.505 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 71.1 mt-30 -119.09 140.98 49.19 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 123.804 0.841 . . . . 0.0 111.695 179.227 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 25.0 t -128.46 132.56 67.91 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 177.27 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -126.64 139.86 52.85 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 123.584 0.754 . . . . 0.0 111.425 179.039 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 22.3 ttmt -99.49 139.73 34.71 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.881 -1.137 . . . . 0.0 112.67 178.241 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 73.7 tttt -73.66 118.83 17.08 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 178.424 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 34.2 m -103.03 -43.08 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 173.458 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 55.5 t-80 . . . . . 0 N--CA 1.484 1.266 0 CA-C-N 119.491 1.041 . . . . 0.0 108.259 168.079 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo . . . . . 0 CA--C 1.575 2.571 0 N-CA-C 114.039 0.746 . . . . 0.0 114.039 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 22.9 t -131.27 139.14 51.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 -175.471 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -76.89 107.53 9.29 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.641 -1.287 . . . . 0.0 110.76 163.6 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 15.9 m-30 -80.98 14.79 2.08 Favored 'General case' 0 CA--C 1.582 2.207 0 N-CA-C 115.905 1.817 . . . . 0.0 115.905 173.459 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -62.68 111.99 2.32 Favored 'General case' 0 CA--C 1.563 1.474 0 C-N-CA 125.667 1.587 . . . . 0.0 115.136 -172.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 161.09 -178.17 37.15 Favored Glycine 0 N--CA 1.486 1.984 0 N-CA-C 116.026 1.17 . . . . 0.0 116.026 178.504 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -106.29 123.64 48.37 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-N 114.917 -0.642 . . . . 0.0 109.468 174.795 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 80.6 m95 -121.55 122.08 38.9 Favored 'General case' 0 CA--C 1.561 1.391 0 C-N-CA 123.481 0.712 . . . . 0.0 109.329 -169.325 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -96.47 140.87 30.48 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.313 -0.867 . . . . 0.0 112.711 176.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 41.9 ttm -69.47 124.23 23.35 Favored 'General case' 0 CA--C 1.569 1.705 0 O-C-N 120.94 -1.1 . . . . 0.0 113.129 176.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 91.9 mt -82.68 -50.29 8.88 Favored 'General case' 0 CA--C 1.564 1.486 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 165.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 87.3 p -151.75 154.53 36.46 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 119.285 0.948 . . . . 0.0 113.274 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 13.5 p30 -127.37 105.6 8.63 Favored 'General case' 0 CA--C 1.568 1.673 0 C-N-CA 123.64 0.776 . . . . 0.0 110.632 174.354 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -96.19 129.78 43.41 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 124.608 1.163 . . . . 0.0 109.965 -174.429 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 34.3 t30 62.39 18.31 10.19 Favored 'General case' 0 N--CA 1.506 2.368 0 N-CA-C 117.048 2.24 . . . . 0.0 117.048 -179.132 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -65.59 -42.1 92.08 Favored 'General case' 0 CA--C 1.566 1.583 0 N-CA-C 115.832 1.79 . . . . 0.0 115.832 -178.403 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -58.37 -39.06 78.58 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 116.243 1.942 . . . . 0.0 116.243 168.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -66.19 -45.78 79.62 Favored 'General case' 0 CA--C 1.571 1.78 0 N-CA-C 114.849 1.426 . . . . 0.0 114.849 170.648 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -52.82 -48.82 66.7 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 115.121 1.526 . . . . 0.0 115.121 165.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 64.5 mt -62.46 -40.73 97.6 Favored 'General case' 0 CA--C 1.57 1.745 0 N-CA-C 114.746 1.387 . . . . 0.0 114.746 171.545 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 65.1 ttp85 -55.56 -46.68 77.14 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 115.229 1.566 . . . . 0.0 115.229 164.584 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.1 -18.85 39.09 Favored 'General case' 0 CA--C 1.569 1.681 0 N-CA-C 118.29 2.7 . . . . 0.0 118.29 164.645 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 92.3 mt -91.83 15.31 13.23 Favored 'General case' 0 CA--C 1.574 1.898 0 N-CA-C 115.265 1.58 . . . . 0.0 115.265 163.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.259 49.7 m-20 66.72 39.86 3.43 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 115.887 1.81 . . . . 0.0 115.887 -177.523 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 65.6 t -99.61 140.9 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 120.815 -1.178 . . . . 0.0 110.489 -177.599 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 8.3 p-10 -71.33 156.52 39.41 Favored 'General case' 0 CA--C 1.569 1.679 0 N-CA-C 115.265 1.579 . . . . 0.0 115.265 174.357 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 61.9 t -53.14 -44.95 53.38 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.373 0 N-CA-C 115.27 1.581 . . . . 0.0 115.27 -177.636 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.57 -49.2 78.49 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 116.101 1.889 . . . . 0.0 116.101 174.549 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 31.9 tp -65.8 -36.67 84.16 Favored 'General case' 0 CA--C 1.573 1.842 0 N-CA-C 115.777 1.769 . . . . 0.0 115.777 171.004 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 55.1 mtp180 -51.36 -52.55 44.67 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 115.394 1.627 . . . . 0.0 115.394 160.63 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -63.13 -43.29 98.78 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 115.679 1.733 . . . . 0.0 115.679 172.403 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 59.3 mt -55.76 -55.31 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.192 0 CA-C-N 120.276 1.398 . . . . 0.0 112.72 170.271 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.86 -43.53 94.62 Favored 'General case' 0 CA--C 1.566 1.573 0 N-CA-C 117.294 2.331 . . . . 0.0 117.294 173.555 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -53.91 -39.97 66.27 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 117.471 2.397 . . . . 0.0 117.471 167.25 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 80.7 mt -86.27 -13.21 47.39 Favored 'General case' 0 CA--C 1.572 1.815 0 N-CA-C 116.103 1.89 . . . . 0.0 116.103 175.655 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 37.9 mt -80.07 133.12 36.08 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-N 119.949 1.25 . . . . 0.0 111.314 169.703 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 29.1 mmtp -101.31 93.04 2.94 Favored Pre-proline 0 CA--C 1.571 1.755 0 CA-C-O 118.045 -0.978 . . . . 0.0 109.705 171.367 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -72.41 154.3 55.78 Favored 'Trans proline' 0 CA--C 1.563 1.943 0 CA-C-N 122.852 2.054 . . . . 0.0 114.739 177.181 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -112.3 127.5 56.0 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.685 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 45.8 mttp -95.42 110.06 22.15 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.508 -0.745 . . . . 0.0 109.854 177.751 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -95.48 104.77 16.68 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.379 -0.826 . . . . 0.0 108.825 166.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 76.0 mt -98.55 118.29 44.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 -173.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 83.4 t -109.86 95.86 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 107.289 -1.375 . . . . 0.0 107.289 176.683 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -96.34 114.0 25.64 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 123.567 0.747 . . . . 0.0 111.084 177.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -132.16 93.27 3.24 Favored 'General case' 0 CA--C 1.566 1.577 0 C-N-CA 123.401 0.68 . . . . 0.0 110.004 -178.354 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 53.67 63.68 4.89 Favored Glycine 0 N--CA 1.497 2.756 0 N-CA-C 118.569 2.188 . . . . 0.0 118.569 172.045 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.471 0.0 OUTLIER 76.71 -34.56 0.22 Allowed 'General case' 0 N--CA 1.501 2.077 0 N-CA-C 117.317 2.34 . . . . 0.0 117.317 -164.423 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 9.4 t-160 -82.4 108.97 16.23 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 120.923 1.692 . . . . 0.0 110.898 178.404 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 6.5 ttp -121.25 125.1 46.26 Favored 'General case' 0 CA--C 1.556 1.194 0 CA-C-O 122.147 0.975 . . . . 0.0 110.888 -176.674 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 4.4 mp -110.1 104.43 17.06 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.353 0 N-CA-C 106.53 -1.656 . . . . 0.0 106.53 -178.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 80.0 mt -89.33 96.09 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 174.57 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 93.1 mtt180 -84.9 97.27 9.67 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.656 -0.652 . . . . 0.0 110.038 -178.742 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 51.0 m -89.78 101.39 14.08 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.761 0.791 . . . . 0.0 109.312 -178.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 16.1 mt -102.94 120.93 41.5 Favored 'General case' 0 N--CA 1.485 1.312 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.033 -164.005 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 10.3 t -136.7 146.53 45.98 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.684 -0.635 . . . . 0.0 111.629 -178.631 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . 0.253 13.7 t -77.73 56.19 1.46 Allowed 'General case' 0 N--CA 1.503 2.181 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 172.179 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -168.81 -67.82 0.02 OUTLIER 'General case' 0 CA--C 1.567 1.623 0 C-N-CA 125.274 1.429 . . . . 0.0 108.517 -177.064 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 62.9 ttt-85 -136.67 124.75 22.93 Favored 'General case' 0 CA--C 1.565 1.521 0 CA-C-N 118.754 0.706 . . . . 0.0 109.517 172.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 44.1 t-20 -85.26 130.59 34.57 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.78 -0.575 . . . . 0.0 111.038 170.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -95.96 -75.02 0.54 Allowed 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 118.899 -0.572 . . . . 0.0 112.338 -175.173 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.331 38.5 mt 74.62 108.75 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 C-N-CA 124.261 1.025 . . . . 0.0 111.9 178.28 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 86.9 mtp -104.95 99.22 8.85 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.478 -0.764 . . . . 0.0 109.491 170.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.7 p30 -96.97 108.54 21.28 Favored 'General case' 0 CA--C 1.56 1.365 0 C-N-CA 124.064 0.946 . . . . 0.0 111.935 176.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 35.2 p90 -148.68 151.91 35.75 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-N 119.029 0.831 . . . . 0.0 113.103 -168.227 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 54.6 mt-30 -89.86 135.23 33.76 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.289 -0.882 . . . . 0.0 110.796 161.264 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 41.0 t -69.56 109.54 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.28 -0.888 . . . . 0.0 109.305 179.108 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 128.27 -50.49 0.89 Allowed Glycine 0 CA--C 1.548 2.122 0 CA-C-O 118.542 -1.143 . . . . 0.0 115.904 -162.072 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 15.3 ptpt -70.41 139.22 51.79 Favored 'General case' 0 CA--C 1.566 1.578 0 CA-C-N 119.8 1.8 . . . . 0.0 115.231 -173.607 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -97.71 97.42 9.0 Favored 'General case' 0 CA--C 1.566 1.578 0 C-N-CA 123.116 0.566 . . . . 0.0 110.135 175.115 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -103.92 130.67 51.55 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 -170.618 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -69.21 111.75 5.35 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.671 -1.268 . . . . 0.0 113.524 175.657 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 . . . . . 0 N--CA 1.491 1.577 0 O-C-N 121.22 -0.925 . . . . 0.0 110.683 -177.617 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 95.3 m . . . . . 0 N--CA 1.488 1.454 0 CA-C-O 122.416 1.103 . . . . 0.0 111.383 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 23.6 mtp -76.3 100.06 4.99 Favored 'General case' 0 CA--C 1.557 1.25 0 CA-C-O 122.434 1.111 . . . . 0.0 110.622 -170.186 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 88.5 m -103.23 112.89 25.97 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.329 -158.059 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 87.1 m -99.7 125.71 45.61 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 174.374 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 16.9 t -111.6 123.0 67.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 171.159 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 71.1 m -138.87 148.78 44.1 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.247 -0.908 . . . . 0.0 112.348 -175.842 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 10.9 m95 -82.79 122.76 28.61 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.68 -1.263 . . . . 0.0 113.694 -179.215 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -107.57 71.0 0.8 Allowed 'General case' 0 CA--C 1.572 1.815 0 C-N-CA 123.481 0.712 . . . . 0.0 109.737 160.825 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.24 -103.15 0.75 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 115.669 1.028 . . . . 0.0 115.669 -179.129 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -80.4 -25.17 39.22 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 116.322 1.971 . . . . 0.0 116.322 165.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -90.62 110.31 21.46 Favored 'General case' 0 N--CA 1.484 1.269 0 CA-C-N 119.861 1.21 . . . . 0.0 111.261 -179.09 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 32.7 tp -77.93 111.5 13.85 Favored 'General case' 0 CA--C 1.564 1.516 0 O-C-N 121.354 -0.841 . . . . 0.0 109.671 168.631 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 31.5 mm-40 -100.39 119.44 38.45 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.567 0.747 . . . . 0.0 110.862 -170.149 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 40.8 t -111.97 128.93 56.31 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.283 0.633 . . . . 0.0 111.068 175.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.1 p -126.83 121.04 57.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 CA-C-O 121.331 0.586 . . . . 0.0 109.845 174.289 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -100.79 98.8 9.28 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 124.018 0.927 . . . . 0.0 109.777 -174.729 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 55.4 mttp -90.84 118.06 29.95 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.337 -0.852 . . . . 0.0 112.238 -167.833 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 178.68 -118.95 0.63 Allowed Glycine 0 N--CA 1.486 2.008 0 O-C-N 121.137 -0.977 . . . . 0.0 113.624 172.5 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -75.74 -46.84 28.75 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 115.998 1.851 . . . . 0.0 115.998 -174.264 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 1.7 ttmp? -91.02 130.77 36.9 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 119.173 0.897 . . . . 0.0 112.081 -176.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -74.52 145.08 43.78 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -176.785 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 62.38 23.29 64.38 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 120.154 2.822 . . . . 0.0 120.154 -178.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 10.5 ttt85 -83.25 120.51 25.92 Favored 'General case' 0 CA--C 1.563 1.444 0 CA-C-N 119.165 1.483 . . . . 0.0 111.615 -179.692 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 172.99 -165.1 37.31 Favored Glycine 0 N--CA 1.484 1.865 0 CA-C-O 121.921 0.734 . . . . 0.0 114.605 -179.184 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 49.9 p-90 -157.14 158.09 35.69 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 114.341 1.237 . . . . 0.0 114.341 176.548 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 62.9 m -127.03 119.12 25.86 Favored 'General case' 0 CA--C 1.567 1.616 0 C-N-CA 124.117 0.967 . . . . 0.0 108.465 174.674 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -120.89 127.34 51.78 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.795 -0.566 . . . . 0.0 112.296 -175.389 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 23.6 p90 -142.76 169.75 16.99 Favored 'General case' 0 N--CA 1.499 1.977 0 C-N-CA 123.763 0.825 . . . . 0.0 112.978 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 94.5 mt -113.42 146.11 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.285 0 CA-C-O 123.145 1.45 . . . . 0.0 111.322 176.728 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -137.37 90.05 2.48 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 177.391 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 73.39 -119.35 6.59 Favored Glycine 0 N--CA 1.491 2.305 0 O-C-N 121.867 -0.521 . . . . 0.0 114.258 -172.351 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -91.16 11.44 23.26 Favored 'General case' 0 N--CA 1.5 2.045 0 N-CA-C 116.742 2.127 . . . . 0.0 116.742 165.58 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 75.8 mt-10 -111.29 138.29 47.95 Favored 'General case' 0 CA--C 1.56 1.34 0 CA-C-N 119.78 1.173 . . . . 0.0 111.999 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 10.4 tp -98.03 125.96 43.23 Favored 'General case' 0 CA--C 1.563 1.454 0 C-N-CA 123.902 0.881 . . . . 0.0 109.148 170.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 45.4 m80 -113.22 123.08 49.35 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.713 0.805 . . . . 0.0 109.126 -175.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 32.4 tp -122.59 122.26 38.43 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.596 0.758 . . . . 0.0 110.218 -174.135 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -100.51 117.15 34.06 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.715 -0.615 . . . . 0.0 109.589 164.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 74.3 mtm -105.09 125.93 51.52 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-N 118.782 0.719 . . . . 0.0 110.493 175.005 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 49.0 mtp180 -114.22 140.13 48.82 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.604 -0.685 . . . . 0.0 111.459 -174.099 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -151.51 126.75 9.91 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.787 -0.571 . . . . 0.0 110.616 167.062 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 61.72 28.92 17.87 Favored 'General case' 0 N--CA 1.504 2.232 0 N-CA-C 115.375 1.62 . . . . 0.0 115.375 -172.54 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 82.4 -27.6 3.62 Favored Glycine 0 CA--C 1.558 2.73 0 N-CA-C 118.693 2.237 . . . . 0.0 118.693 -158.839 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 96.4 t -73.8 119.38 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 CA-C-N 119.221 1.511 . . . . 0.0 110.416 -169.245 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 59.4 m -106.35 120.74 42.66 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.182 -169.081 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 6.6 t -97.31 122.8 40.75 Favored 'General case' 0 CA--C 1.558 1.28 0 C-N-CA 124.082 0.953 . . . . 0.0 111.528 170.145 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 85.6 mttt -96.19 119.62 35.02 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.824 -0.548 . . . . 0.0 110.059 176.235 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 18.2 mt-30 -119.68 123.4 43.73 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.706 -0.621 . . . . 0.0 110.686 -179.346 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 47.5 t -105.03 131.78 53.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 -177.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -126.17 149.08 49.24 Favored 'General case' 0 CA--C 1.563 1.455 0 C-N-CA 124.515 1.126 . . . . 0.0 110.511 -178.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 22.2 ttmt -118.62 141.0 49.01 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.94 -1.1 . . . . 0.0 112.002 175.409 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 61.6 tttt -74.87 126.43 30.93 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 179.177 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 33.3 m -107.09 -40.7 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 174.848 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 33.9 m170 . . . . . 0 C--O 1.255 1.354 0 CA-C-N 120.138 1.336 . . . . 0.0 108.784 -177.751 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo . . . . . 0 CA--C 1.575 2.531 0 N-CA-C 114.634 0.974 . . . . 0.0 114.634 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 18.1 m -144.95 153.64 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 120.595 -1.316 . . . . 0.0 110.393 -171.838 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -73.3 98.64 2.72 Favored 'General case' 0 CA--C 1.569 1.679 0 O-C-N 121.1 -1.0 . . . . 0.0 112.362 174.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 7.4 m-30 -78.95 -9.55 59.55 Favored 'General case' 0 CA--C 1.577 2.012 0 N-CA-C 115.471 1.656 . . . . 0.0 115.471 161.315 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -57.9 116.36 3.43 Favored 'General case' 0 CA--C 1.564 1.485 0 CA-C-N 120.837 1.653 . . . . 0.0 114.713 -176.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 152.62 -177.59 30.26 Favored Glycine 0 N--CA 1.486 2.028 0 CA-C-O 122.54 1.078 . . . . 0.0 115.711 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -105.42 123.35 47.72 Favored 'General case' 0 CA--C 1.562 1.434 0 CA-C-N 114.638 -0.781 . . . . 0.0 109.514 178.076 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 72.2 m95 -122.81 126.02 46.59 Favored 'General case' 0 CA--C 1.567 1.605 0 C-N-CA 123.364 0.666 . . . . 0.0 110.004 -170.009 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 62.2 pttt -95.06 140.16 30.4 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.244 -0.91 . . . . 0.0 113.167 177.674 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 50.4 ttm -69.73 129.69 40.29 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.638 -1.289 . . . . 0.0 113.626 174.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 87.4 mt -94.4 -58.27 2.25 Favored 'General case' 0 CA--C 1.567 1.611 0 CA-C-N 115.584 -0.735 . . . . 0.0 112.65 170.053 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 94.2 p -139.48 130.02 25.73 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 119.632 1.106 . . . . 0.0 113.431 -165.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -102.41 81.45 2.06 Favored 'General case' 0 CA--C 1.568 1.671 0 C-N-CA 123.871 0.868 . . . . 0.0 110.277 176.432 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -93.93 114.61 26.86 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.656 -1.278 . . . . 0.0 111.013 -170.51 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.272 22.2 t30 63.15 27.09 15.56 Favored 'General case' 0 N--CA 1.506 2.355 0 N-CA-C 116.801 2.148 . . . . 0.0 116.801 -171.138 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -69.94 -49.18 54.43 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 115.18 1.548 . . . . 0.0 115.18 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 90.0 mt-10 -61.35 -35.52 77.66 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 116.506 2.039 . . . . 0.0 116.506 174.043 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -63.69 -42.99 97.93 Favored 'General case' 0 CA--C 1.576 1.948 0 N-CA-C 115.187 1.551 . . . . 0.0 115.187 167.405 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 28.2 t80 -56.31 -50.68 70.74 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 115.041 1.496 . . . . 0.0 115.041 165.136 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.2 mt -61.3 -40.67 95.02 Favored 'General case' 0 CA--C 1.573 1.834 0 N-CA-C 115.191 1.552 . . . . 0.0 115.191 173.776 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 41.9 ttp85 -51.15 -50.66 58.49 Favored 'General case' 0 CA--C 1.575 1.904 0 N-CA-C 115.086 1.513 . . . . 0.0 115.086 162.552 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.74 -19.3 58.65 Favored 'General case' 0 CA--C 1.573 1.83 0 N-CA-C 118.462 2.764 . . . . 0.0 118.462 168.486 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 43.7 mt -86.51 2.08 49.24 Favored 'General case' 0 CA--C 1.572 1.79 0 N-CA-C 116.12 1.896 . . . . 0.0 116.12 165.401 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 61.04 46.66 8.05 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 115.126 1.528 . . . . 0.0 115.126 -169.307 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 99.0 t -93.95 135.04 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.403 -0.81 . . . . 0.0 108.838 176.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.0 p-10 -67.91 147.55 52.33 Favored 'General case' 0 CA--C 1.566 1.584 0 N-CA-C 115.504 1.668 . . . . 0.0 115.504 179.009 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 25.3 t -49.32 -44.98 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.327 0 N-CA-C 115.796 1.776 . . . . 0.0 115.796 -174.376 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.99 -46.19 88.75 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 116.3 1.963 . . . . 0.0 116.3 173.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.62 -43.69 96.12 Favored 'General case' 0 CA--C 1.572 1.794 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 168.579 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 27.5 mtm-85 -53.37 -41.1 65.53 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 116.516 2.043 . . . . 0.0 116.516 167.293 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -68.6 -54.9 13.63 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 168.415 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 63.1 mt -54.47 -51.62 47.88 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.303 0 CA-C-N 120.435 1.47 . . . . 0.0 113.841 178.22 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.78 -38.66 91.95 Favored 'General case' 0 CA--C 1.562 1.435 0 N-CA-C 117.642 2.46 . . . . 0.0 117.642 175.105 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 16.4 t30 -72.44 -30.33 64.49 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 116.395 1.998 . . . . 0.0 116.395 170.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 83.4 mt -75.05 -32.85 61.64 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 115.331 1.604 . . . . 0.0 115.331 172.008 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 93.6 mt -81.35 142.2 33.27 Favored 'General case' 0 CA--C 1.564 1.505 0 CA-C-N 119.384 0.993 . . . . 0.0 112.139 174.745 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -106.94 84.89 1.7 Allowed Pre-proline 0 CA--C 1.575 1.917 0 CA-C-O 118.248 -0.882 . . . . 0.0 109.947 175.359 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -72.94 166.27 30.5 Favored 'Trans proline' 0 CA--C 1.563 1.965 0 C-N-CA 122.537 2.158 . . . . 0.0 116.028 -178.295 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -111.25 138.83 47.21 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.214 -177.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 58.6 mttm -104.88 111.65 24.48 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.399 -0.813 . . . . 0.0 109.376 173.707 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 54.9 tt0 -98.74 102.87 14.74 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 171.013 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 61.3 mt -97.67 123.68 50.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.513 -0.742 . . . . 0.0 109.202 -169.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 88.4 t -102.48 101.93 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 166.49 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -104.2 108.19 19.45 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 123.706 0.803 . . . . 0.0 110.358 -179.666 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -112.56 72.32 0.77 Allowed 'General case' 0 CA--C 1.567 1.634 0 O-C-N 121.683 -0.636 . . . . 0.0 110.634 175.062 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 68.48 -95.65 0.39 Allowed Glycine 0 N--CA 1.489 2.21 0 N-CA-C 115.014 0.766 . . . . 0.0 115.014 -179.015 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -86.67 -37.09 18.34 Favored 'General case' 0 CA--C 1.566 1.574 0 N-CA-C 115.743 1.757 . . . . 0.0 115.743 166.077 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 20.8 t-160 -80.66 113.66 19.01 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 121.099 1.772 . . . . 0.0 111.463 -178.32 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 46.6 ttm -130.5 123.19 29.12 Favored 'General case' 0 CA--C 1.555 1.165 0 CA-C-O 121.386 0.612 . . . . 0.0 110.074 -169.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 54.5 mt -115.86 101.22 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 87.9 mt -89.79 90.67 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -77.59 99.01 5.59 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.303 -0.873 . . . . 0.0 110.715 -173.609 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 29.4 m -97.13 105.64 17.83 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-O 121.803 0.811 . . . . 0.0 109.016 -169.805 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 22.2 mt -109.49 117.17 33.3 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.991 0.917 . . . . 0.0 110.072 -159.138 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 19.2 t -133.87 146.55 50.69 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 123.154 0.582 . . . . 0.0 111.976 -174.212 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 43.5 p -79.92 61.66 3.89 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.122 -0.986 . . . . 0.0 112.631 172.578 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -169.95 -70.79 0.02 OUTLIER 'General case' 0 CA--C 1.569 1.693 0 C-N-CA 125.648 1.579 . . . . 0.0 107.513 178.572 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 32.1 mtt180 -139.8 131.5 27.35 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 123.803 0.841 . . . . 0.0 109.648 171.249 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -85.4 129.14 34.88 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.039 0.447 . . . . 0.0 111.027 176.392 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -91.35 -77.4 0.42 Allowed 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 123.146 0.579 . . . . 0.0 111.972 -172.066 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.36 14.9 mt 79.46 108.35 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 C-N-CA 124.216 1.006 . . . . 0.0 110.986 -179.675 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.76 95.74 6.85 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 123.513 0.725 . . . . 0.0 109.729 177.064 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -101.53 116.34 32.55 Favored 'General case' 0 CA--C 1.564 1.515 0 C-N-CA 124.228 1.011 . . . . 0.0 112.321 -175.722 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -157.91 156.44 31.33 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 115.07 1.507 . . . . 0.0 115.07 -171.186 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -104.23 119.24 38.52 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 123.474 0.709 . . . . 0.0 109.857 167.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 54.0 t -61.98 128.9 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 C-N-CA 123.936 0.894 . . . . 0.0 111.674 -178.335 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 99.74 -37.13 3.67 Favored Glycine 0 CA--C 1.55 2.279 0 N-CA-C 116.704 1.442 . . . . 0.0 116.704 -163.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 77.7 mttt -89.43 129.83 35.88 Favored 'General case' 0 CA--C 1.565 1.539 0 CA-C-N 118.88 1.34 . . . . 0.0 111.746 -172.203 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -81.84 106.61 13.9 Favored 'General case' 0 CA--C 1.567 1.615 0 O-C-N 121.321 -0.862 . . . . 0.0 111.771 178.119 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -109.88 148.89 30.72 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 123.856 0.862 . . . . 0.0 112.006 -175.058 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.62 124.09 23.04 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.2 -1.562 . . . . 0.0 111.73 168.15 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.496 1.84 0 CA-C-N 119.137 0.88 . . . . 0.0 111.612 -174.488 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 74.1 m . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 1.1 mmt -70.55 98.18 1.43 Allowed 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 122.216 1.008 . . . . 0.0 111.697 -176.124 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 95.5 m -112.36 114.53 27.31 Favored 'General case' 0 N--CA 1.481 1.115 0 O-C-N 121.51 -0.744 . . . . 0.0 110.452 -157.641 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 63.0 m -92.79 124.47 36.81 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 168.321 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.7 t -112.3 130.33 66.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 169.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 74.9 m -134.79 140.34 45.81 Favored 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 123.791 0.836 . . . . 0.0 111.989 -173.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 8.4 m95 -80.98 116.35 20.9 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.457 -1.402 . . . . 0.0 112.874 177.029 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 38.8 t0 -103.66 67.18 0.89 Allowed 'General case' 0 CA--C 1.576 1.95 0 C-N-CA 124.063 0.945 . . . . 0.0 110.189 164.273 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 68.08 -105.82 1.53 Allowed Glycine 0 N--CA 1.492 2.418 0 N-CA-C 115.641 1.016 . . . . 0.0 115.641 -179.083 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -72.87 -30.25 63.83 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 115.123 1.527 . . . . 0.0 115.123 163.374 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 24.0 mttt -92.78 110.59 22.03 Favored 'General case' 0 CA--C 1.557 1.221 0 CA-C-N 119.443 1.019 . . . . 0.0 111.62 -171.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 29.0 tp -82.07 105.57 13.28 Favored 'General case' 0 CA--C 1.563 1.479 0 O-C-N 120.47 -1.394 . . . . 0.0 110.164 171.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 11.2 mm100 -87.42 145.89 26.1 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 124.51 1.124 . . . . 0.0 110.721 -174.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 42.9 t -143.63 133.47 23.93 Favored 'General case' 0 N--CA 1.484 1.25 0 O-C-N 121.541 -0.724 . . . . 0.0 112.421 178.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.2 p -118.33 123.8 72.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 165.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -104.46 97.09 7.06 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 123.626 0.77 . . . . 0.0 109.427 -178.323 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -83.42 111.43 19.03 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.761 -1.212 . . . . 0.0 111.425 -170.578 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 162.56 103.98 0.18 Allowed Glycine 0 N--CA 1.483 1.798 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.898 -172.394 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . 0.282 42.3 mt-10 69.61 -68.47 0.19 Allowed 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 116.142 1.904 . . . . 0.0 116.142 174.027 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -82.08 129.89 34.93 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 122.153 0.978 . . . . 0.0 111.242 -170.666 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -67.78 -45.97 73.3 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 116.096 1.887 . . . . 0.0 116.096 -162.387 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -101.68 54.52 0.78 Allowed Glycine 0 N--CA 1.49 2.286 0 CA-C-O 118.63 -1.095 . . . . 0.0 115.727 164.619 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.9 ttt-85 -85.25 116.88 23.85 Favored 'General case' 0 CA--C 1.565 1.543 0 CA-C-N 118.844 1.322 . . . . 0.0 112.062 -179.251 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 178.7 -173.24 45.58 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 115.139 0.816 . . . . 0.0 115.139 -174.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . 0.279 49.6 p-90 -155.48 167.89 28.92 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 123.338 1.542 . . . . 0.0 113.918 174.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 96.0 m -144.93 114.14 7.01 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.147 -1.596 . . . . 0.0 107.81 174.234 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 45.6 tt0 -114.67 127.56 55.83 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 123.566 0.746 . . . . 0.0 111.444 -173.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 9.6 p90 -148.34 154.85 40.54 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.706 -1.246 . . . . 0.0 113.679 -174.25 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 94.8 mt -98.84 133.98 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 O-C-N 120.793 -1.192 . . . . 0.0 110.823 176.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -120.09 91.79 3.62 Favored 'General case' 0 CA--C 1.567 1.618 0 C-N-CA 124.291 1.036 . . . . 0.0 108.387 162.136 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 69.36 -113.17 4.96 Favored Glycine 0 N--CA 1.492 2.402 0 O-C-N 121.238 -0.914 . . . . 0.0 114.927 -177.81 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -84.54 -8.75 58.81 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 117.423 2.379 . . . . 0.0 117.423 167.396 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 62.1 mt-10 -99.95 126.56 46.13 Favored 'General case' 0 CA--C 1.56 1.363 0 CA-C-N 120.549 1.522 . . . . 0.0 111.292 -176.627 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 21.2 tp -89.22 115.5 26.77 Favored 'General case' 0 CA--C 1.563 1.448 0 C-N-CA 124.224 1.01 . . . . 0.0 109.122 164.136 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 48.7 m80 -101.83 119.09 38.23 Favored 'General case' 0 CA--C 1.556 1.207 0 C-N-CA 123.979 0.911 . . . . 0.0 108.857 -178.674 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 42.7 tp -113.31 114.76 27.12 Favored 'General case' 0 CA--C 1.557 1.228 0 C-N-CA 123.677 0.791 . . . . 0.0 109.642 179.363 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -90.04 126.88 35.92 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.906 -0.496 . . . . 0.0 109.74 163.59 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 75.5 mtm -119.99 127.79 52.94 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-N 118.658 0.663 . . . . 0.0 110.297 176.615 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 88.0 mtm-85 -114.82 141.26 48.13 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 123.429 0.692 . . . . 0.0 111.326 -174.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -150.29 131.05 14.09 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.676 -0.64 . . . . 0.0 110.931 163.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 54.79 34.4 21.79 Favored 'General case' 0 N--CA 1.507 2.415 0 N-CA-C 116.169 1.914 . . . . 0.0 116.169 -172.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 76.43 -1.29 61.56 Favored Glycine 0 CA--C 1.557 2.709 0 N-CA-C 120.173 2.829 . . . . 0.0 120.173 -165.128 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 89.6 t -98.7 120.09 47.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 CA-C-N 120.453 2.126 . . . . 0.0 109.49 -173.481 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 30.7 m -102.88 120.9 41.44 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 123.243 0.617 . . . . 0.0 111.357 -172.414 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 33.5 t -92.32 140.34 29.7 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 123.384 0.674 . . . . 0.0 112.041 161.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 33.9 mtpt -104.24 114.94 29.53 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.6 -0.688 . . . . 0.0 110.564 164.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -104.48 124.27 48.97 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.334 0.654 . . . . 0.0 110.291 168.017 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 62.7 t -109.93 132.79 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -127.23 134.96 50.03 Favored 'General case' 0 CA--C 1.561 1.398 0 C-N-CA 124.104 0.962 . . . . 0.0 110.823 -177.296 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -103.57 137.38 41.72 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.837 -1.165 . . . . 0.0 112.493 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 71.4 tttt -71.35 125.79 27.93 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 177.677 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 27.7 m -116.24 -40.17 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.128 0 N-CA-C 114.058 1.133 . . . . 0.0 114.058 177.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 50.5 t60 . . . . . 0 N--CA 1.487 1.395 0 CA-C-N 120.47 1.487 . . . . 0.0 108.53 175.229 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo . . . . . 0 CA--C 1.557 1.658 0 CA-C-O 122.604 1.002 . . . . 0.0 113.919 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 27.6 m -78.38 155.16 5.06 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.687 0 CA-C-N 114.71 -1.132 . . . . 0.0 113.262 -174.359 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -68.93 100.93 1.27 Allowed 'General case' 0 CA--C 1.563 1.453 0 O-C-N 120.93 -1.106 . . . . 0.0 113.93 176.781 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 4.5 m-30 -70.61 -1.5 11.36 Favored 'General case' 0 CA--C 1.581 2.161 0 N-CA-C 116.871 2.175 . . . . 0.0 116.871 177.377 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -45.05 111.03 0.28 Allowed 'General case' 0 CA--C 1.566 1.569 0 N-CA-C 116.122 1.897 . . . . 0.0 116.122 173.375 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 165.96 175.85 36.76 Favored Glycine 0 N--CA 1.484 1.848 0 N-CA-C 116.313 1.285 . . . . 0.0 116.313 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 12.7 t80 -110.19 125.65 53.28 Favored 'General case' 0 CA--C 1.562 1.409 0 CA-C-N 113.952 -1.124 . . . . 0.0 108.657 173.214 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 82.3 m95 -124.67 127.4 47.24 Favored 'General case' 0 CA--C 1.565 1.539 0 C-N-CA 123.49 0.716 . . . . 0.0 109.982 -167.047 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -97.1 140.37 31.71 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.188 -0.945 . . . . 0.0 112.853 175.368 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 37.4 ttm -70.79 125.08 25.86 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.819 -1.176 . . . . 0.0 113.024 177.624 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 90.2 mt -84.62 -51.56 6.76 Favored 'General case' 0 CA--C 1.566 1.595 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 167.171 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 92.3 p -144.52 150.75 38.08 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 118.806 0.73 . . . . 0.0 112.2 177.733 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -125.84 114.11 18.13 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 123.13 0.572 . . . . 0.0 109.734 165.457 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -115.25 124.1 50.5 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 123.387 0.675 . . . . 0.0 109.651 -168.298 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.264 23.4 t30 62.16 25.26 15.11 Favored 'General case' 0 N--CA 1.504 2.251 0 N-CA-C 116.699 2.111 . . . . 0.0 116.699 -172.224 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -67.8 -43.5 79.51 Favored 'General case' 0 CA--C 1.567 1.633 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 175.615 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -45.96 -50.0 15.22 Favored 'General case' 0 N--CA 1.505 2.324 0 N-CA-C 116.433 2.012 . . . . 0.0 116.433 167.193 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -70.86 -41.01 71.95 Favored 'General case' 0 CA--C 1.57 1.747 0 N-CA-C 115.463 1.653 . . . . 0.0 115.463 178.379 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -50.84 -49.38 59.03 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 114.9 1.445 . . . . 0.0 114.9 160.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 81.2 mt -62.96 -39.5 94.84 Favored 'General case' 0 CA--C 1.574 1.877 0 N-CA-C 114.866 1.432 . . . . 0.0 114.866 173.115 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 69.0 ttp85 -52.45 -50.97 61.55 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 115.087 1.514 . . . . 0.0 115.087 164.176 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.54 -14.88 22.49 Favored 'General case' 0 CA--C 1.572 1.79 0 N-CA-C 118.545 2.794 . . . . 0.0 118.545 167.729 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 94.8 mt -97.36 16.48 19.95 Favored 'General case' 0 CA--C 1.57 1.742 0 N-CA-C 115.159 1.54 . . . . 0.0 115.159 164.463 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 60.74 45.37 10.14 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 115.547 1.684 . . . . 0.0 115.547 -177.41 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 98.0 t -99.83 138.24 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.22 -0.925 . . . . 0.0 109.794 -178.025 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 12.6 p30 -63.68 152.28 39.51 Favored 'General case' 0 CA--C 1.57 1.746 0 N-CA-C 115.112 1.523 . . . . 0.0 115.112 176.124 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . 0.251 78.8 t -58.62 -40.8 80.3 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.303 0 N-CA-C 115.307 1.595 . . . . 0.0 115.307 -177.828 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.26 -50.18 72.08 Favored 'General case' 0 CA--C 1.567 1.607 0 N-CA-C 115.953 1.834 . . . . 0.0 115.953 168.861 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 25.4 tp -66.9 -38.82 86.97 Favored 'General case' 0 CA--C 1.573 1.829 0 N-CA-C 116.052 1.871 . . . . 0.0 116.052 171.068 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 69.6 mtp180 -50.85 -47.87 60.19 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 115.303 1.594 . . . . 0.0 115.303 162.746 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -65.05 -54.42 30.49 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 170.402 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 61.6 mt -51.77 -55.66 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.246 0 CA-C-N 120.41 1.459 . . . . 0.0 113.172 175.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.23 -35.89 80.28 Favored 'General case' 0 CA--C 1.563 1.453 0 N-CA-C 118.352 2.723 . . . . 0.0 118.352 176.491 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -76.16 -33.43 59.37 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 116.018 1.859 . . . . 0.0 116.018 171.117 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 77.2 mt -72.85 -36.54 67.45 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 115.387 1.625 . . . . 0.0 115.387 178.633 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . 0.262 3.7 pp -93.92 151.94 19.21 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 119.327 0.967 . . . . 0.0 113.208 179.457 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 28.0 mmtp -108.42 93.37 11.48 Favored Pre-proline 0 CA--C 1.574 1.871 0 CA-C-O 118.078 -0.963 . . . . 0.0 110.03 -173.847 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -75.6 169.37 22.47 Favored 'Trans proline' 0 CA--C 1.565 2.043 0 C-N-CA 122.664 2.243 . . . . 0.0 115.605 -178.001 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -112.67 134.05 54.39 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-N 116.03 -0.532 . . . . 0.0 112.106 -177.434 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 23.5 mtpp -102.51 113.88 27.6 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.037 -1.04 . . . . 0.0 110.578 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -97.99 109.68 22.39 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.694 -0.629 . . . . 0.0 109.319 167.868 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 76.2 mt -102.42 120.56 52.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 -179.421 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 88.9 t -109.85 95.05 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 174.402 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -86.87 97.13 10.49 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 123.324 0.65 . . . . 0.0 110.362 173.77 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -102.27 70.46 1.18 Allowed 'General case' 0 CA--C 1.567 1.633 0 C-N-CA 123.556 0.742 . . . . 0.0 111.332 -178.307 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 57.94 65.8 3.27 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 117.368 1.707 . . . . 0.0 117.368 177.353 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.478 0.0 OUTLIER 82.07 -36.99 0.1 Allowed 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 116.473 2.027 . . . . 0.0 116.473 -165.235 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 12.3 t-160 -79.81 95.29 5.98 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-N 120.834 1.652 . . . . 0.0 110.513 175.217 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 4.1 ttp -104.6 119.52 39.19 Favored 'General case' 0 CA--C 1.552 1.052 0 CA-C-O 121.982 0.896 . . . . 0.0 110.094 -175.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 37.4 mt -106.32 101.16 12.05 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.479 0 N-CA-C 106.587 -1.634 . . . . 0.0 106.587 -178.262 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 88.1 mt -89.3 111.91 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 177.072 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 90.3 mtt180 -109.6 100.27 9.34 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -174.674 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 16.8 m -92.99 109.62 21.07 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.16 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 39.7 mt -102.64 123.62 46.69 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.349 0.66 . . . . 0.0 110.938 -159.779 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 10.2 t -151.01 160.51 43.88 Favored 'General case' 0 CA--C 1.571 1.763 0 CA-C-O 121.31 0.576 . . . . 0.0 112.474 -176.001 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.0 t -63.05 -36.07 82.35 Favored 'General case' 0 N--CA 1.504 2.235 0 N-CA-C 117.738 2.496 . . . . 0.0 117.738 175.386 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -76.48 -52.32 10.04 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 175.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.6 tmm_? -149.05 138.03 21.37 Favored 'General case' 0 CA--C 1.56 1.349 0 C-N-CA 124.212 1.005 . . . . 0.0 108.767 -178.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -102.06 114.93 29.48 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 174.172 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -87.54 121.42 29.96 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 122.862 0.465 . . . . 0.0 110.598 -173.204 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 43.2 mm -114.27 101.98 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 -177.642 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 76.5 mtp -95.28 90.53 5.88 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.126 -0.984 . . . . 0.0 109.132 169.169 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.6 p30 -95.15 108.17 20.27 Favored 'General case' 0 CA--C 1.561 1.376 0 C-N-CA 123.821 0.849 . . . . 0.0 111.82 178.045 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 29.4 p90 -147.77 142.88 27.1 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 113.844 1.054 . . . . 0.0 113.844 -169.107 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 17.1 mp0 -79.96 123.46 27.82 Favored 'General case' 0 CA--C 1.563 1.459 0 O-C-N 121.543 -0.723 . . . . 0.0 110.289 162.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 46.9 t -65.98 117.68 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 C-N-CA 123.315 0.646 . . . . 0.0 110.422 -179.204 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 115.44 -45.18 1.34 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 116.006 1.162 . . . . 0.0 116.006 -160.903 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -82.29 144.15 30.81 Favored 'General case' 0 CA--C 1.567 1.617 0 CA-C-N 118.802 1.301 . . . . 0.0 113.284 -173.673 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -95.14 111.56 23.38 Favored 'General case' 0 CA--C 1.564 1.504 0 O-C-N 121.76 -0.588 . . . . 0.0 111.481 176.528 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 22.8 p90 -106.94 142.74 36.07 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 123.33 0.652 . . . . 0.0 112.748 -177.628 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -71.13 114.2 8.95 Favored 'General case' 0 CA--C 1.567 1.622 0 O-C-N 120.358 -1.464 . . . . 0.0 112.177 170.719 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 . . . . . 0 CA--C 1.568 1.646 0 CA-C-O 122.125 0.965 . . . . 0.0 111.266 -175.904 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 93.5 m . . . . . 0 N--CA 1.488 1.447 0 CA-C-O 121.469 0.652 . . . . 0.0 111.24 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 80.6 mmm -71.61 103.73 3.11 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 121.714 0.768 . . . . 0.0 110.277 177.223 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 92.1 m -109.56 111.53 23.09 Favored 'General case' 0 N--CA 1.483 1.178 0 O-C-N 121.671 -0.643 . . . . 0.0 110.866 -159.031 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 95.1 m -94.71 128.24 41.25 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 170.698 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.9 t -116.41 129.66 72.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 172.903 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 58.2 m -149.09 157.12 43.14 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.423 -1.423 . . . . 0.0 113.316 -177.31 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 45.7 m95 -86.84 123.61 32.16 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.751 -1.218 . . . . 0.0 113.775 -174.343 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -109.35 73.3 0.84 Allowed 'General case' 0 CA--C 1.57 1.712 0 C-N-CA 124.064 0.946 . . . . 0.0 109.356 164.299 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.0 -125.14 29.68 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 114.637 0.615 . . . . 0.0 114.637 -172.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -61.12 -19.81 61.93 Favored 'General case' 0 N--CA 1.501 2.09 0 N-CA-C 116.526 2.047 . . . . 0.0 116.526 166.445 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 43.7 mttt -97.15 121.11 38.67 Favored 'General case' 0 CA--C 1.556 1.206 0 CA-C-N 119.554 1.07 . . . . 0.0 111.554 -174.791 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 24.3 tp -84.68 108.05 17.2 Favored 'General case' 0 CA--C 1.565 1.544 0 O-C-N 121.326 -0.859 . . . . 0.0 109.086 170.236 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -93.81 132.02 38.62 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.703 0.801 . . . . 0.0 111.036 -176.675 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 42.1 t -126.96 128.28 46.16 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.213 0.605 . . . . 0.0 111.315 178.626 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 12.7 p -109.8 118.12 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 168.009 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 55.7 mt-30 -99.42 73.69 1.87 Allowed 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 123.577 0.751 . . . . 0.0 109.813 178.438 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -83.96 134.13 34.67 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.577 -1.327 . . . . 0.0 113.781 -169.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 178.46 -85.03 0.07 OUTLIER Glycine 0 N--CA 1.485 1.932 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.955 -177.516 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -104.16 -58.25 1.91 Allowed 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 177.752 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -76.88 133.26 39.34 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 119.985 1.266 . . . . 0.0 112.07 -173.856 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -61.52 -54.73 39.34 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 116.171 1.915 . . . . 0.0 116.171 -167.107 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -98.67 53.42 1.11 Allowed Glycine 0 N--CA 1.489 2.177 0 N-CA-C 115.97 1.148 . . . . 0.0 115.97 169.223 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 25.7 ttt-85 -87.57 118.62 27.17 Favored 'General case' 0 CA--C 1.563 1.479 0 CA-C-N 118.685 1.243 . . . . 0.0 111.713 179.393 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 171.18 -168.9 42.02 Favored Glycine 0 N--CA 1.485 1.918 0 CA-C-O 121.892 0.718 . . . . 0.0 114.226 -179.461 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 38.5 p-90 -155.99 157.07 35.57 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 176.508 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 83.1 m -125.89 114.21 18.24 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 175.608 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 41.1 tt0 -117.57 123.01 45.19 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 123.413 0.685 . . . . 0.0 111.142 -175.217 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 12.5 p90 -144.36 148.58 34.9 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.966 -1.084 . . . . 0.0 113.229 -176.798 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 94.3 mt -97.3 135.87 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 CA-C-O 122.374 1.083 . . . . 0.0 110.374 177.6 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -122.9 87.21 2.71 Favored 'General case' 0 CA--C 1.563 1.445 0 CA-C-N 114.214 -1.357 . . . . 0.0 107.781 174.219 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 70.97 -105.25 1.58 Allowed Glycine 0 N--CA 1.491 2.323 0 O-C-N 121.488 -0.758 . . . . 0.0 114.714 -175.003 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 54.8 p30 -99.95 7.23 44.97 Favored 'General case' 0 CA--C 1.574 1.898 0 N-CA-C 116.868 2.173 . . . . 0.0 116.868 169.118 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -115.33 130.11 56.8 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-N 120.43 1.468 . . . . 0.0 111.694 -178.008 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 13.3 tp -90.94 115.56 28.06 Favored 'General case' 0 CA--C 1.561 1.384 0 C-N-CA 124.224 1.01 . . . . 0.0 109.356 170.551 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 43.4 m80 -102.31 122.45 44.27 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.873 0.869 . . . . 0.0 109.04 -178.84 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 49.3 tp -122.96 117.63 25.96 Favored 'General case' 0 CA--C 1.56 1.34 0 C-N-CA 123.701 0.801 . . . . 0.0 109.924 -174.433 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -104.77 107.87 19.05 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 169.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 68.5 mtm -100.18 128.5 46.24 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.881 -0.512 . . . . 0.0 110.682 178.513 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 68.5 mtp180 -115.03 143.45 45.17 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.656 -0.653 . . . . 0.0 111.868 -178.57 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -148.34 130.07 15.09 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.601 -0.687 . . . . 0.0 111.567 164.606 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 58.27 25.6 12.88 Favored 'General case' 0 N--CA 1.506 2.361 0 N-CA-C 115.716 1.746 . . . . 0.0 115.716 -167.505 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 90.37 -34.04 4.31 Favored Glycine 0 CA--C 1.557 2.685 0 N-CA-C 118.095 1.998 . . . . 0.0 118.095 -159.618 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 76.5 t -70.49 119.41 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 CA-C-N 119.276 1.538 . . . . 0.0 111.614 -165.628 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 21.0 m -95.13 123.36 38.58 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.166 0.507 . . . . 0.0 112.091 -173.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 10.4 t -94.03 130.87 40.0 Favored 'General case' 0 CA--C 1.561 1.383 0 C-N-CA 123.518 0.727 . . . . 0.0 110.99 159.489 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -108.36 111.63 23.65 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.558 -0.713 . . . . 0.0 109.45 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -111.46 132.07 54.75 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 123.612 0.765 . . . . 0.0 111.384 178.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 43.9 t -115.35 130.42 69.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 176.717 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -126.59 141.63 51.8 Favored 'General case' 0 CA--C 1.563 1.448 0 C-N-CA 124.232 1.013 . . . . 0.0 110.78 -178.069 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 10.3 tmtt? -110.46 139.7 45.42 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.966 -1.084 . . . . 0.0 112.288 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 37.0 tttp -73.68 117.23 15.21 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 113.464 0.913 . . . . 0.0 113.464 -177.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . 0.263 34.8 m -103.25 -39.28 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.152 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 174.71 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 38.2 t60 . . . . . 0 N--CA 1.486 1.344 0 CA-C-N 119.863 1.21 . . . . 0.0 107.956 163.654 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo . . . . . 0 CA--C 1.575 2.555 0 N-CA-C 114.877 1.068 . . . . 0.0 114.877 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -152.77 164.56 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 -178.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -87.85 104.67 16.81 Favored 'General case' 0 CA--C 1.567 1.612 0 O-C-N 119.89 -1.756 . . . . 0.0 111.308 167.225 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -88.73 3.52 50.59 Favored 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 115.808 1.781 . . . . 0.0 115.808 171.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 62.8 m-80 -65.22 114.63 4.83 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 120.93 1.695 . . . . 0.0 113.426 -178.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 168.33 169.04 31.28 Favored Glycine 0 N--CA 1.483 1.767 0 N-CA-C 116.113 1.205 . . . . 0.0 116.113 -176.391 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -103.19 128.07 50.29 Favored 'General case' 0 CA--C 1.565 1.52 0 CA-C-N 114.125 -1.037 . . . . 0.0 109.251 169.762 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 63.1 m95 -125.31 128.54 48.38 Favored 'General case' 0 CA--C 1.568 1.65 0 C-N-CA 123.663 0.785 . . . . 0.0 109.361 -170.554 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -92.73 147.5 22.81 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.753 -1.217 . . . . 0.0 112.831 171.297 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.412 ' SD ' ' HD2' ' A' ' 38' ' ' PRO . 42.7 ttm -72.64 130.52 40.76 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.723 -1.235 . . . . 0.0 112.528 171.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 83.3 mt -89.08 -53.24 4.67 Favored 'General case' 0 CA--C 1.568 1.636 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.622 163.372 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 87.3 p -140.4 151.67 45.12 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-N 119.175 0.898 . . . . 0.0 112.784 -176.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -128.75 112.71 14.48 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.744 -0.597 . . . . 0.0 110.21 166.002 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -110.91 122.93 49.11 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.911 0.885 . . . . 0.0 109.252 -172.843 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.263 27.1 t30 65.36 25.33 12.07 Favored 'General case' 0 N--CA 1.503 2.222 0 N-CA-C 116.901 2.186 . . . . 0.0 116.901 -175.358 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -68.09 -41.43 81.85 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 115.925 1.824 . . . . 0.0 115.925 178.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -58.52 -40.54 83.21 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 116.213 1.931 . . . . 0.0 116.213 170.303 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -69.63 -40.8 76.32 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 115.031 1.493 . . . . 0.0 115.031 174.739 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -51.39 -52.18 48.1 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 114.79 1.404 . . . . 0.0 114.79 161.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 75.0 mt -61.25 -40.46 94.15 Favored 'General case' 0 CA--C 1.573 1.851 0 N-CA-C 115.045 1.498 . . . . 0.0 115.045 172.781 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 45.7 ttp180 -53.95 -50.17 67.07 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 115.366 1.617 . . . . 0.0 115.366 164.34 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.63 -22.92 48.37 Favored 'General case' 0 CA--C 1.568 1.639 0 N-CA-C 118.172 2.656 . . . . 0.0 118.172 166.733 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 93.5 mt -85.83 11.84 10.37 Favored 'General case' 0 CA--C 1.574 1.88 0 N-CA-C 115.88 1.807 . . . . 0.0 115.88 165.02 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 60.69 35.82 19.67 Favored 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 115.951 1.834 . . . . 0.0 115.951 -172.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 97.5 t -96.44 138.62 21.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 120.797 -1.189 . . . . 0.0 109.119 -177.184 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 7.8 p-10 -67.01 154.35 41.41 Favored 'General case' 0 CA--C 1.567 1.615 0 N-CA-C 115.752 1.76 . . . . 0.0 115.752 -178.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 87.8 t -53.34 -43.65 51.93 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.349 0 N-CA-C 115.502 1.667 . . . . 0.0 115.502 -177.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.95 -47.36 83.14 Favored 'General case' 0 CA--C 1.567 1.608 0 N-CA-C 116.264 1.95 . . . . 0.0 116.264 172.109 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 31.2 tp -75.77 -26.32 57.26 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 116.477 2.028 . . . . 0.0 116.477 171.493 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 77.4 mtp180 -54.05 -52.65 60.2 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-N 120.695 1.589 . . . . 0.0 114.092 158.09 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 30.9 mmtp -63.38 -51.17 66.99 Favored 'General case' 0 CA--C 1.568 1.637 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 170.145 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 15.3 mt -78.42 60.98 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.408 0 CA-C-O 123.63 1.681 . . . . 0.0 111.166 178.012 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -177.07 -56.98 0.01 OUTLIER 'General case' 0 CA--C 1.562 1.429 0 C-N-CA 126.735 2.014 . . . . 0.0 109.139 -174.461 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -57.74 -42.69 84.46 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 116.504 2.038 . . . . 0.0 116.504 161.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 74.1 mt -79.31 -19.74 49.64 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 116.067 1.877 . . . . 0.0 116.067 -177.719 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.0 pp -101.91 141.91 34.03 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 118.988 0.813 . . . . 0.0 111.522 171.523 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 7.0 mtmp? -102.38 100.65 16.29 Favored Pre-proline 0 CA--C 1.572 1.811 0 CA-C-O 117.878 -1.058 . . . . 0.0 110.37 -177.144 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.412 ' HD2' ' SD ' ' A' ' 10' ' ' MET . 73.6 Cg_endo -75.76 170.18 20.72 Favored 'Trans proline' 0 CA--C 1.566 2.11 0 CA-C-N 122.85 2.054 . . . . 0.0 116.857 -175.09 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -102.52 154.45 19.09 Favored 'General case' 0 CA--C 1.566 1.558 0 CA-C-N 113.983 -1.462 . . . . 0.0 109.988 176.353 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 21.8 mtpp -128.46 114.06 16.31 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.807 -1.183 . . . . 0.0 109.227 171.502 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -102.1 103.56 14.14 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 169.683 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 73.1 mt -98.24 124.72 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 -177.126 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.466 HG23 HH12 ' A' ' 52' ' ' ARG . 36.6 t -108.57 111.95 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 164.31 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -99.5 101.55 12.82 Favored 'General case' 0 CA--C 1.566 1.561 0 C-N-CA 123.943 0.897 . . . . 0.0 109.117 172.406 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -121.36 76.39 1.24 Allowed 'General case' 0 CA--C 1.567 1.627 0 C-N-CA 123.219 0.608 . . . . 0.0 111.409 -174.129 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 57.1 67.23 2.33 Favored Glycine 0 N--CA 1.497 2.723 0 N-CA-C 117.672 1.829 . . . . 0.0 117.672 171.477 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.488 0.0 OUTLIER 77.81 -43.53 0.4 Allowed 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 116.209 1.929 . . . . 0.0 116.209 -163.204 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 21.1 t-160 -73.56 109.26 6.93 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-N 120.797 1.635 . . . . 0.0 111.168 176.32 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 2.9 tpp -114.64 124.99 53.24 Favored 'General case' 0 CA--C 1.555 1.171 0 CA-C-O 122.045 0.926 . . . . 0.0 110.111 178.43 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 19.3 mt -108.63 103.86 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 N-CA-C 105.407 -2.072 . . . . 0.0 105.407 174.734 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 90.0 mt -93.41 95.16 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 172.693 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.466 HH12 HG23 ' A' ' 43' ' ' VAL . 63.1 mtt85 -82.68 94.66 7.62 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.345 -0.847 . . . . 0.0 110.003 177.02 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 34.1 m -84.8 109.29 17.97 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.137 -1.061 . . . . 0.0 108.137 172.852 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 15.3 mt -116.66 107.66 14.97 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 -164.723 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 36.7 p -116.45 155.5 28.47 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.349 0.66 . . . . 0.0 111.314 -173.306 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.3 t -68.35 4.16 1.43 Allowed 'General case' 0 CA--C 1.581 2.149 0 N-CA-C 117.992 2.59 . . . . 0.0 117.992 167.045 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -104.13 -58.86 1.82 Allowed 'General case' 0 CA--C 1.568 1.671 0 CA-C-N 119.619 1.099 . . . . 0.0 111.836 163.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 11.8 ptm180 -140.02 160.62 39.52 Favored 'General case' 0 CA--C 1.568 1.665 0 CA-C-O 122.56 1.172 . . . . 0.0 114.026 175.43 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -82.49 128.55 34.38 Favored 'General case' 0 CA--C 1.568 1.652 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.333 160.826 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -95.97 -66.91 0.88 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.592 -0.692 . . . . 0.0 110.92 178.855 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.359 58.6 mt 69.76 91.35 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 C-N-CA 124.563 1.145 . . . . 0.0 112.893 170.215 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 75.9 mtp -91.57 96.57 10.55 Favored 'General case' 0 CA--C 1.565 1.55 0 O-C-N 121.544 -0.723 . . . . 0.0 109.276 173.058 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -96.89 113.38 24.92 Favored 'General case' 0 CA--C 1.564 1.517 0 C-N-CA 123.893 0.877 . . . . 0.0 110.108 178.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -153.98 156.15 36.9 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -171.17 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 11.5 mp0 -91.62 126.27 36.65 Favored 'General case' 0 CA--C 1.564 1.505 0 O-C-N 121.403 -0.811 . . . . 0.0 110.286 163.401 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 41.5 t -67.41 114.69 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 C-N-CA 124.194 0.998 . . . . 0.0 109.381 174.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 119.88 -47.69 1.01 Allowed Glycine 0 N--CA 1.489 2.172 0 N-CA-C 115.58 0.992 . . . . 0.0 115.58 -160.183 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 85.1 mttt -79.75 141.01 36.72 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-N 118.743 1.272 . . . . 0.0 113.53 -173.615 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 55.4 tt0 -100.83 100.79 11.49 Favored 'General case' 0 CA--C 1.565 1.532 0 C-N-CA 123.275 0.63 . . . . 0.0 111.164 -178.7 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -105.96 144.53 32.55 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 -168.863 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -73.43 103.69 4.17 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.691 -1.255 . . . . 0.0 111.735 173.51 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.571 1.767 0 N-CA-C 114.534 1.309 . . . . 0.0 114.534 -170.747 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 88.2 m . . . . . 0 CA--C 1.556 1.187 0 CA-C-O 121.533 0.682 . . . . 0.0 111.134 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 87.7 mmm -73.08 101.55 3.3 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-O 121.878 0.847 . . . . 0.0 110.751 -172.179 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 92.2 m -109.16 107.1 17.26 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.535 -158.68 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 64.6 m -92.8 128.68 38.75 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 172.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 18.2 t -112.55 130.67 65.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 167.629 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 39.5 m -150.74 155.89 40.19 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.589 -1.319 . . . . 0.0 112.853 -175.86 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 55.8 m95 -86.24 122.47 30.27 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.836 -1.165 . . . . 0.0 113.601 -175.046 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -102.54 67.03 0.99 Allowed 'General case' 0 CA--C 1.574 1.897 0 C-N-CA 123.286 0.634 . . . . 0.0 109.646 157.106 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 60.87 -104.17 0.62 Allowed Glycine 0 N--CA 1.492 2.387 0 N-CA-C 115.825 1.09 . . . . 0.0 115.825 -175.759 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -72.46 -27.78 62.52 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 116.357 1.984 . . . . 0.0 116.357 168.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -91.08 115.23 27.85 Favored 'General case' 0 N--CA 1.485 1.294 0 CA-C-N 119.505 1.048 . . . . 0.0 111.301 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 31.4 tp -80.22 110.38 15.59 Favored 'General case' 0 CA--C 1.565 1.555 0 O-C-N 121.401 -0.812 . . . . 0.0 109.207 167.022 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 30.4 mm-40 -101.07 126.05 47.73 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.713 0.805 . . . . 0.0 110.884 -170.74 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 40.4 t -118.05 128.9 55.21 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.592 0.757 . . . . 0.0 111.058 176.758 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.6 p -120.67 118.45 56.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 172.53 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 63.4 mt-30 -103.21 95.47 6.13 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 123.919 0.887 . . . . 0.0 109.339 -175.475 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 81.4 mttt -85.23 119.98 26.21 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.749 -1.22 . . . . 0.0 112.373 -168.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 176.51 -101.55 0.16 Allowed Glycine 0 N--CA 1.486 2.004 0 O-C-N 121.458 -0.776 . . . . 0.0 114.0 170.629 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -86.99 -59.35 2.28 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 -173.814 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 12.3 mptt -75.26 129.81 38.06 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 122.551 1.167 . . . . 0.0 110.945 -179.068 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 -76.47 -38.16 55.79 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 116.659 2.096 . . . . 0.0 116.659 -157.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -106.18 56.25 0.51 Allowed Glycine 0 N--CA 1.49 2.249 0 CA-C-N 119.258 0.936 . . . . 0.0 114.81 162.205 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 35.9 ttt180 -87.44 122.06 30.68 Favored 'General case' 0 CA--C 1.567 1.597 0 CA-C-N 118.364 1.082 . . . . 0.0 112.573 -177.185 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 172.9 -167.1 39.87 Favored Glycine 0 CA--C 1.546 2.019 0 N-CA-C 114.991 0.757 . . . . 0.0 114.991 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . 0.254 34.7 p-90 -155.26 156.03 34.86 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 113.888 1.069 . . . . 0.0 113.888 170.854 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 91.1 m -127.74 118.43 23.77 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 176.03 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -122.66 121.23 35.9 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.743 -0.598 . . . . 0.0 111.728 -174.867 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 21.9 p90 -134.45 165.74 24.47 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.347 -0.846 . . . . 0.0 113.138 178.825 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 95.4 mt -110.12 132.55 58.12 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.135 -0.978 . . . . 0.0 109.819 175.44 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -114.47 91.98 3.81 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 123.979 0.912 . . . . 0.0 108.878 168.248 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 71.67 -106.49 1.92 Allowed Glycine 0 N--CA 1.491 2.328 0 O-C-N 121.463 -0.773 . . . . 0.0 114.732 -177.518 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -108.06 32.76 4.53 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 115.111 1.523 . . . . 0.0 115.111 165.106 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -129.33 131.46 46.9 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-N 119.073 0.851 . . . . 0.0 110.345 178.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 12.9 tp -95.83 122.08 38.23 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 121.675 0.75 . . . . 0.0 109.531 175.645 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 41.0 m80 -111.28 117.31 32.8 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -174.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 42.4 tp -119.81 118.71 31.54 Favored 'General case' 0 CA--C 1.561 1.399 0 C-N-CA 123.764 0.826 . . . . 0.0 110.051 -172.263 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -106.57 107.72 18.86 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.68 -0.638 . . . . 0.0 109.603 171.364 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 72.9 mtm -99.58 129.92 45.78 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 123.035 0.534 . . . . 0.0 111.072 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 73.4 mtp85 -117.68 141.85 47.91 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.548 -0.72 . . . . 0.0 112.515 -172.205 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -151.23 133.47 15.31 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 123.187 0.595 . . . . 0.0 111.274 165.122 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 59.3 20.82 9.01 Favored 'General case' 0 N--CA 1.509 2.484 0 N-CA-C 116.373 1.99 . . . . 0.0 116.373 -173.782 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 86.91 -18.61 34.42 Favored Glycine 0 CA--C 1.557 2.715 0 N-CA-C 119.018 2.367 . . . . 0.0 119.018 -159.78 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 87.4 t -81.31 121.27 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 CA-C-N 119.498 1.649 . . . . 0.0 109.869 -174.378 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 25.0 m -101.75 126.03 48.53 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.217 0.532 . . . . 0.0 111.812 -177.057 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 7.7 t -95.59 125.64 40.32 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.885 0.874 . . . . 0.0 110.919 162.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 51.7 mtpt -105.5 113.25 26.72 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 123.123 0.569 . . . . 0.0 109.815 -177.399 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 -114.28 136.56 52.83 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.516 -0.74 . . . . 0.0 111.652 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 62.6 t -116.98 130.31 72.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 178.101 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -124.78 149.87 46.91 Favored 'General case' 0 CA--C 1.565 1.536 0 C-N-CA 124.536 1.134 . . . . 0.0 110.696 -179.154 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 25.8 ttmt -119.7 141.95 48.93 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.028 -1.045 . . . . 0.0 112.293 175.214 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 36.5 tttm -74.68 128.56 35.84 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -177.686 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 29.2 m -111.73 -33.74 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 178.177 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 49.1 t-80 . . . . . 0 N--CA 1.485 1.292 0 CA-C-N 120.569 1.531 . . . . 0.0 109.112 174.215 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_endo . . . . . 0 CA--C 1.56 1.796 0 N-CA-C 115.017 1.122 . . . . 0.0 115.017 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 27.5 t -97.56 -98.31 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.57 1.712 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 -171.429 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -152.1 79.15 1.25 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.809 -1.182 . . . . 0.0 108.052 160.014 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -74.46 -11.34 60.21 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 116.514 2.042 . . . . 0.0 116.514 179.37 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -61.83 108.56 1.04 Allowed 'General case' 0 CA--C 1.563 1.473 0 C-N-CA 125.813 1.645 . . . . 0.0 114.02 -178.842 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 163.2 -179.27 38.48 Favored Glycine 0 N--CA 1.483 1.802 0 N-CA-C 116.453 1.341 . . . . 0.0 116.453 -179.059 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -106.92 128.3 54.19 Favored 'General case' 0 CA--C 1.564 1.505 0 CA-C-N 114.035 -1.082 . . . . 0.0 109.234 171.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 73.4 m95 -122.14 143.53 49.49 Favored 'General case' 0 CA--C 1.572 1.808 0 C-N-CA 123.964 0.905 . . . . 0.0 110.102 -169.27 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -111.67 140.39 46.34 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.035 -1.041 . . . . 0.0 112.306 173.691 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 50.0 ttm -72.08 125.11 26.45 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.099 -1.001 . . . . 0.0 112.93 176.555 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 86.4 mt -82.62 -47.87 11.59 Favored 'General case' 0 CA--C 1.567 1.609 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 166.513 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 80.0 p -148.74 147.96 29.44 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 123.496 0.718 . . . . 0.0 112.242 177.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -120.57 105.8 11.16 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 123.133 0.573 . . . . 0.0 109.535 164.299 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -101.44 125.48 48.08 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.418 -0.801 . . . . 0.0 109.911 -177.283 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.273 19.5 t30 64.89 18.91 11.69 Favored 'General case' 0 CA--C 1.583 2.213 0 N-CA-C 117.515 2.413 . . . . 0.0 117.515 -177.588 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -65.28 -47.85 75.22 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 115.516 1.673 . . . . 0.0 115.516 176.82 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -56.72 -35.32 68.42 Favored 'General case' 0 CA--C 1.576 1.97 0 N-CA-C 117.211 2.3 . . . . 0.0 117.211 172.22 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -68.4 -46.92 68.67 Favored 'General case' 0 CA--C 1.573 1.834 0 N-CA-C 114.79 1.404 . . . . 0.0 114.79 166.363 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -52.25 -46.98 66.0 Favored 'General case' 0 N--CA 1.501 2.088 0 N-CA-C 115.369 1.618 . . . . 0.0 115.369 167.579 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 93.1 mt -61.9 -39.86 93.43 Favored 'General case' 0 CA--C 1.573 1.864 0 N-CA-C 115.061 1.504 . . . . 0.0 115.061 170.714 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 67.4 ttp85 -56.87 -48.48 78.02 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 115.241 1.571 . . . . 0.0 115.241 164.312 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.2 -19.15 12.5 Favored 'General case' 0 CA--C 1.569 1.706 0 N-CA-C 118.21 2.671 . . . . 0.0 118.21 167.391 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 84.5 mt -95.22 3.71 54.31 Favored 'General case' 0 CA--C 1.569 1.694 0 N-CA-C 116.078 1.881 . . . . 0.0 116.078 167.262 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 58.49 46.17 15.39 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 115.452 1.649 . . . . 0.0 115.452 -169.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 70.0 t -90.3 143.07 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.322 -0.861 . . . . 0.0 109.259 178.372 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -60.3 145.57 47.12 Favored 'General case' 0 CA--C 1.569 1.681 0 N-CA-C 115.556 1.687 . . . . 0.0 115.556 -176.133 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . 0.272 91.9 t -60.27 -36.01 65.84 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.168 0 N-CA-C 115.137 1.532 . . . . 0.0 115.137 -176.691 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.27 -55.03 38.33 Favored 'General case' 0 CA--C 1.566 1.584 0 N-CA-C 115.889 1.811 . . . . 0.0 115.889 167.256 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 5.5 tt -65.27 -39.6 92.82 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 115.565 1.691 . . . . 0.0 115.565 171.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 37.7 mtp-105 -46.84 -41.6 15.9 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 117.208 2.299 . . . . 0.0 117.208 165.239 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -74.67 -54.84 6.65 Favored 'General case' 0 CA--C 1.567 1.608 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 164.648 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 4.8 mt -80.89 60.78 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.585 2.296 0 CA-C-N 120.395 1.452 . . . . 0.0 111.61 -176.683 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -176.03 -51.71 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 126.392 1.877 . . . . 0.0 110.157 -176.474 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -63.23 -41.25 99.07 Favored 'General case' 0 CA--C 1.568 1.651 0 N-CA-C 115.76 1.763 . . . . 0.0 115.76 161.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 84.0 mt -75.03 -28.93 60.65 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 115.792 1.775 . . . . 0.0 115.792 178.684 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . 0.259 3.1 pp -91.0 152.12 20.8 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 119.462 1.028 . . . . 0.0 112.24 170.941 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 29.6 mmtp -108.23 91.71 8.52 Favored Pre-proline 0 CA--C 1.572 1.821 0 CA-C-O 118.064 -0.969 . . . . 0.0 109.341 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -77.22 175.73 10.98 Favored 'Trans proline' 0 CA--C 1.563 1.931 0 C-N-CA 122.384 2.056 . . . . 0.0 116.317 -172.772 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -107.92 155.87 19.83 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 114.985 -1.007 . . . . 0.0 112.392 178.742 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 40.9 mttp -121.02 119.64 33.09 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.663 -0.648 . . . . 0.0 109.382 169.352 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -96.73 111.01 23.35 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.463 -0.939 . . . . 0.0 108.463 162.729 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 74.3 mt -106.81 122.38 60.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 92.9 t -103.92 104.48 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 167.706 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -112.52 97.57 6.68 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 123.562 0.745 . . . . 0.0 111.159 -176.491 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -96.58 69.32 2.54 Favored 'General case' 0 CA--C 1.567 1.634 0 O-C-N 120.88 -1.138 . . . . 0.0 110.766 172.651 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 64.45 -89.7 0.09 OUTLIER Glycine 0 N--CA 1.491 2.328 0 N-CA-C 116.169 1.227 . . . . 0.0 116.169 -178.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.8 p30 -81.84 -39.77 23.46 Favored 'General case' 0 CA--C 1.566 1.573 0 N-CA-C 115.91 1.819 . . . . 0.0 115.91 166.764 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -80.3 121.74 26.04 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 121.055 1.752 . . . . 0.0 111.893 -178.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 42.2 ttm -130.29 128.48 41.64 Favored 'General case' 0 CA--C 1.556 1.198 0 CA-C-O 121.597 0.713 . . . . 0.0 111.362 -177.379 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 46.7 mt -113.56 103.37 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 170.707 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 64.7 mt -92.88 98.8 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 174.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -86.46 98.89 11.28 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.333 -0.854 . . . . 0.0 109.967 174.399 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 31.9 m -83.57 109.91 17.8 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 172.075 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 53.5 mt -114.79 118.96 35.04 Favored 'General case' 0 CA--C 1.559 1.302 0 C-N-CA 124.005 0.922 . . . . 0.0 109.725 -164.477 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 9.7 p -133.62 155.42 49.71 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.256 0.55 . . . . 0.0 111.923 177.404 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 26.1 m -80.86 59.29 3.67 Favored 'General case' 0 N--CA 1.505 2.3 0 O-C-N 120.726 -1.234 . . . . 0.0 112.197 169.76 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -172.42 -64.53 0.02 OUTLIER 'General case' 0 CA--C 1.568 1.654 0 C-N-CA 125.509 1.524 . . . . 0.0 109.25 -179.64 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 65.5 ttt180 -138.93 140.3 38.26 Favored 'General case' 0 CA--C 1.568 1.639 0 CA-C-N 118.965 0.802 . . . . 0.0 110.81 175.43 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -110.28 137.7 47.65 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 123.338 0.655 . . . . 0.0 110.487 174.31 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -91.41 -74.92 0.49 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.657 -0.652 . . . . 0.0 111.375 178.545 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.363 54.3 mt 75.87 93.45 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 C-N-CA 124.368 1.067 . . . . 0.0 110.664 -177.207 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 81.1 mtp -100.29 99.56 10.24 Favored 'General case' 0 CA--C 1.561 1.37 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 174.222 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -101.32 113.35 26.34 Favored 'General case' 0 CA--C 1.565 1.52 0 C-N-CA 124.123 0.969 . . . . 0.0 111.614 178.112 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -157.77 158.32 35.04 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.154 -0.966 . . . . 0.0 113.224 -166.346 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 30.5 tt0 -95.38 130.6 42.11 Favored 'General case' 0 CA--C 1.564 1.485 0 O-C-N 121.123 -0.986 . . . . 0.0 110.822 160.58 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.3 t -65.25 117.31 5.64 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.813 0 C-N-CA 124.12 0.968 . . . . 0.0 109.535 170.684 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 115.25 -46.6 1.14 Allowed Glycine 0 CA--C 1.551 2.313 0 N-CA-C 115.667 1.027 . . . . 0.0 115.667 -159.433 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -82.77 154.49 24.73 Favored 'General case' 0 CA--C 1.567 1.633 0 CA-C-N 118.662 1.231 . . . . 0.0 113.729 -179.621 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -99.3 130.86 45.62 Favored 'General case' 0 CA--C 1.57 1.736 0 CA-C-O 121.928 0.871 . . . . 0.0 112.268 175.094 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -68.8 157.49 36.34 Favored 'General case' 0 CA--C 1.57 1.716 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 168.65 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -105.64 108.99 20.8 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.258 -0.901 . . . . 0.0 108.578 132.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 . . . . . 0 N--CA 1.496 1.861 0 O-C-N 120.832 -1.167 . . . . 0.0 110.325 172.447 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 44.9 m . . . . . 0 N--CA 1.487 1.412 0 CA-C-O 120.987 0.422 . . . . 0.0 111.175 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 4.9 mmt -75.32 74.51 2.42 Favored 'General case' 0 CA--C 1.567 1.62 0 CA-C-O 122.345 1.069 . . . . 0.0 111.241 169.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 100.0 m -93.0 130.21 38.65 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.03 -1.044 . . . . 0.0 109.824 -167.874 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 91.1 m -123.09 134.14 54.26 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 -178.742 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 16.1 t -120.64 138.23 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 178.446 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 59.2 m -147.57 150.8 35.16 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.215 -1.553 . . . . 0.0 113.056 -177.038 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 75.3 m95 -81.85 126.53 31.99 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.04 -1.037 . . . . 0.0 111.808 176.871 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -106.5 -21.67 13.0 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 118.145 2.646 . . . . 0.0 118.145 -167.429 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 159.8 -70.77 0.24 Allowed Glycine 0 N--CA 1.493 2.46 0 CA-C-N 121.296 1.862 . . . . 0.0 112.982 -172.64 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 34.4 m-20 -126.28 32.04 5.29 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 148.321 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -141.44 146.94 37.13 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.453 -1.404 . . . . 0.0 110.525 -165.406 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 35.8 tp -100.08 108.02 20.07 Favored 'General case' 0 CA--C 1.561 1.402 0 O-C-N 121.256 -0.903 . . . . 0.0 109.258 172.203 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 43.5 mm-40 -93.42 131.25 38.78 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 123.205 0.602 . . . . 0.0 111.535 -179.502 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 39.5 t -123.12 133.1 54.3 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.663 0.785 . . . . 0.0 111.063 173.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.2 p -115.4 127.41 72.98 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.683 0 C-N-CA 123.33 0.652 . . . . 0.0 109.343 169.156 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -105.6 91.32 3.71 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 124.096 0.958 . . . . 0.0 109.482 -176.357 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -90.35 126.51 35.89 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.753 -1.217 . . . . 0.0 112.035 -168.531 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 165.65 -95.16 0.12 Allowed Glycine 0 N--CA 1.489 2.167 0 O-C-N 121.017 -1.052 . . . . 0.0 114.122 172.108 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -75.05 -48.32 24.57 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 115.7 1.741 . . . . 0.0 115.7 -173.47 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 43.6 mttp -115.88 151.47 35.25 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 122.488 1.137 . . . . 0.0 113.908 -168.645 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -75.68 153.52 37.09 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 54.44 36.32 57.89 Favored Glycine 0 N--CA 1.5 2.954 0 N-CA-C 119.949 2.74 . . . . 0.0 119.949 -178.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 32.3 ttt180 -100.53 116.06 31.59 Favored 'General case' 0 CA--C 1.563 1.45 0 C-N-CA 123.861 0.864 . . . . 0.0 111.177 -164.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 178.25 -170.64 42.84 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 115.336 0.894 . . . . 0.0 115.336 -178.493 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 37.3 p-90 -154.02 151.93 29.93 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 174.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 91.1 m -121.07 121.06 37.1 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.364 -0.835 . . . . 0.0 109.299 173.435 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -120.8 129.42 53.57 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 123.205 0.602 . . . . 0.0 112.087 -177.319 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 19.7 p90 -142.96 172.68 12.37 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.995 -1.066 . . . . 0.0 112.836 178.345 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 72.0 mt -119.86 132.04 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 O-C-N 121.07 -1.019 . . . . 0.0 109.989 175.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -110.19 89.74 3.11 Favored 'General case' 0 CA--C 1.567 1.611 0 C-N-CA 123.847 0.859 . . . . 0.0 108.77 165.387 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 68.6 -106.99 1.91 Allowed Glycine 0 N--CA 1.492 2.431 0 N-CA-C 115.75 1.06 . . . . 0.0 115.75 179.446 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 23.4 p-10 -87.79 0.31 55.94 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 117.248 2.314 . . . . 0.0 117.248 167.685 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -113.13 132.55 55.41 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-N 120.148 1.34 . . . . 0.0 112.116 -173.565 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 12.3 tp -93.98 124.71 38.17 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 123.726 0.811 . . . . 0.0 109.667 171.046 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 41.4 m80 -114.52 120.96 42.0 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 123.618 0.767 . . . . 0.0 109.078 -176.153 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 38.9 tp -122.99 121.67 36.65 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 123.742 0.817 . . . . 0.0 110.166 -175.765 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -106.35 113.65 27.3 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.601 -0.687 . . . . 0.0 109.957 169.252 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 66.9 mtm -105.94 127.99 53.51 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 123.164 0.586 . . . . 0.0 111.151 -178.703 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 73.4 mtm180 -119.14 134.11 55.39 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 124.064 0.945 . . . . 0.0 110.442 -169.061 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -156.78 129.42 7.64 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.27 -0.894 . . . . 0.0 111.697 170.302 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . 0.283 11.4 mt-10 52.55 44.77 29.67 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 115.843 1.794 . . . . 0.0 115.843 -177.779 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 68.41 12.53 63.81 Favored Glycine 0 CA--C 1.553 2.411 0 N-CA-C 120.713 3.045 . . . . 0.0 120.713 -167.464 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 92.6 t -113.88 124.96 71.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 CA-C-N 120.017 1.909 . . . . 0.0 108.516 -177.733 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 80.8 m -105.0 119.2 38.44 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 123.266 0.626 . . . . 0.0 110.389 179.079 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 12.6 t -88.71 138.13 31.69 Favored 'General case' 0 CA--C 1.56 1.363 0 C-N-CA 123.644 0.778 . . . . 0.0 111.735 161.293 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 48.1 mtpt -115.17 111.21 20.65 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.66 -0.65 . . . . 0.0 109.483 177.135 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -108.08 131.63 54.4 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 123.546 0.738 . . . . 0.0 111.169 176.867 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 51.6 t -116.58 131.52 68.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 176.15 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -123.08 153.69 39.58 Favored 'General case' 0 CA--C 1.565 1.522 0 C-N-CA 124.724 1.209 . . . . 0.0 110.628 178.784 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 26.6 ttmt -122.34 145.9 47.82 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.952 -1.092 . . . . 0.0 111.999 170.098 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 64.9 tttt -76.07 126.33 30.79 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -176.749 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 34.1 m -104.71 -43.42 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 174.743 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 68.5 t60 . . . . . 0 N--CA 1.486 1.34 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 168.46 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo . . . . . 0 CA--C 1.568 2.211 0 N-CA-C 118.475 2.452 . . . . 0.0 118.475 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.4 p -178.3 130.34 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 C-N-CA 124.714 1.206 . . . . 0.0 108.92 -174.704 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -83.68 107.16 15.94 Favored 'General case' 0 CA--C 1.565 1.531 0 O-C-N 121.049 -1.032 . . . . 0.0 112.128 170.0 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -80.73 1.46 30.17 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 117.578 2.436 . . . . 0.0 117.578 175.08 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -55.06 113.42 1.35 Allowed 'General case' 0 CA--C 1.567 1.627 0 N-CA-C 115.756 1.761 . . . . 0.0 115.756 -174.714 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 162.51 177.26 35.38 Favored Glycine 0 N--CA 1.486 2.025 0 N-CA-C 116.184 1.234 . . . . 0.0 116.184 178.191 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -106.16 131.98 52.77 Favored 'General case' 0 CA--C 1.566 1.589 0 CA-C-N 114.388 -0.906 . . . . 0.0 109.312 168.515 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 78.4 m95 -128.06 129.15 46.18 Favored 'General case' 0 CA--C 1.563 1.479 0 C-N-CA 123.945 0.898 . . . . 0.0 109.542 -167.406 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.96 143.72 26.54 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.027 -1.046 . . . . 0.0 112.204 169.915 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 52.1 ttm -75.59 124.64 27.56 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.874 -1.142 . . . . 0.0 112.302 173.441 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 95.1 mt -82.52 -51.78 7.47 Favored 'General case' 0 CA--C 1.567 1.628 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.473 166.352 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 91.3 p -139.61 144.63 37.81 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-N 118.955 0.798 . . . . 0.0 112.134 177.546 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -118.18 89.56 3.15 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 121.763 0.792 . . . . 0.0 109.145 163.366 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -96.27 121.04 37.63 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.857 0.863 . . . . 0.0 110.081 -167.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.269 27.7 t30 66.59 24.73 10.12 Favored 'General case' 0 N--CA 1.503 2.184 0 N-CA-C 116.651 2.093 . . . . 0.0 116.651 -171.368 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -68.34 -44.54 75.09 Favored 'General case' 0 CA--C 1.569 1.676 0 N-CA-C 115.579 1.696 . . . . 0.0 115.579 178.759 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -53.73 -44.35 69.83 Favored 'General case' 0 N--CA 1.503 2.176 0 N-CA-C 116.632 2.086 . . . . 0.0 116.632 168.011 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -63.25 -44.74 94.3 Favored 'General case' 0 CA--C 1.573 1.858 0 N-CA-C 114.765 1.395 . . . . 0.0 114.765 174.492 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 44.4 t80 -54.48 -50.56 67.48 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 115.0 1.482 . . . . 0.0 115.0 166.029 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 94.2 mt -63.61 -41.38 98.31 Favored 'General case' 0 CA--C 1.571 1.762 0 N-CA-C 115.142 1.534 . . . . 0.0 115.142 174.643 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 71.5 ttp85 -53.4 -50.63 64.74 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 115.173 1.545 . . . . 0.0 115.173 163.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.08 -16.11 17.44 Favored 'General case' 0 CA--C 1.568 1.665 0 N-CA-C 118.591 2.812 . . . . 0.0 118.591 168.252 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 35.4 mt -91.92 -0.66 57.5 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 115.919 1.822 . . . . 0.0 115.919 166.804 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 62.43 61.64 1.23 Allowed 'General case' 0 N--CA 1.494 1.77 0 CA-C-N 119.98 1.264 . . . . 0.0 113.392 -165.026 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 96.1 t -111.48 136.97 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 N-CA-C 107.767 -1.198 . . . . 0.0 107.767 170.715 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 14.3 p30 -64.02 157.47 25.09 Favored 'General case' 0 CA--C 1.57 1.749 0 N-CA-C 116.094 1.887 . . . . 0.0 116.094 -177.618 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 43.2 t -56.9 -43.87 81.18 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.301 0 N-CA-C 114.753 1.39 . . . . 0.0 114.753 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.63 -50.52 72.86 Favored 'General case' 0 CA--C 1.564 1.518 0 N-CA-C 115.741 1.756 . . . . 0.0 115.741 172.615 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.2 tt -69.9 -37.78 76.11 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 115.092 1.515 . . . . 0.0 115.092 172.813 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 69.9 mtp180 -46.78 -52.87 13.13 Favored 'General case' 0 N--CA 1.502 2.166 0 CA-C-N 121.21 1.823 . . . . 0.0 115.695 161.715 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -65.91 -50.07 65.77 Favored 'General case' 0 CA--C 1.565 1.532 0 N-CA-C 114.004 1.113 . . . . 0.0 114.004 170.466 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 9.8 mt -78.99 58.68 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.586 2.346 0 CA-C-N 120.952 1.705 . . . . 0.0 110.831 175.647 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -174.98 -47.21 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 126.425 1.89 . . . . 0.0 111.131 -178.353 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -76.2 -30.61 58.08 Favored 'General case' 0 CA--C 1.569 1.682 0 N-CA-C 115.794 1.776 . . . . 0.0 115.794 164.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 96.0 mt -76.56 -36.27 57.73 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 114.925 1.454 . . . . 0.0 114.925 177.836 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -100.2 148.21 24.88 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 118.759 0.709 . . . . 0.0 111.015 170.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 44.5 mmtm -103.09 95.86 7.25 Favored Pre-proline 0 CA--C 1.573 1.854 0 CA-C-O 117.707 -1.14 . . . . 0.0 110.105 -171.845 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -73.52 158.49 47.66 Favored 'Trans proline' 0 CA--C 1.564 1.998 0 CA-C-N 123.158 2.164 . . . . 0.0 115.898 -176.062 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -90.78 160.55 15.72 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-N 115.714 -0.675 . . . . 0.0 112.21 178.755 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 30.4 mttp -120.96 121.28 37.68 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.018 -1.052 . . . . 0.0 110.016 170.645 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -103.37 105.66 15.99 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 164.696 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 76.0 mt -97.85 116.83 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 87.0 t -102.12 93.79 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 173.017 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -93.12 94.13 8.67 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 123.163 0.585 . . . . 0.0 109.712 175.482 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -101.81 73.93 1.45 Allowed 'General case' 0 CA--C 1.566 1.594 0 O-C-N 121.632 -0.668 . . . . 0.0 110.877 -178.245 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 57.4 71.49 0.74 Allowed Glycine 0 N--CA 1.494 2.506 0 N-CA-C 116.909 1.524 . . . . 0.0 116.909 179.32 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.471 0.4 OUTLIER 70.2 -30.37 0.2 Allowed 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 118.257 2.688 . . . . 0.0 118.257 -166.499 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 21.9 t-160 -76.42 99.42 4.87 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-N 120.937 1.699 . . . . 0.0 110.543 170.089 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 3.8 ttp -116.7 119.06 34.28 Favored 'General case' 0 CA--C 1.552 1.054 0 CA-C-O 121.917 0.865 . . . . 0.0 110.08 -169.749 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 5.2 mp -107.02 106.91 21.52 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.422 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 -178.366 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 24.1 mm -88.97 99.58 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 177.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 65.4 mtt-85 -95.07 95.67 8.73 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.498 -0.751 . . . . 0.0 109.591 -179.515 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 16.3 m -82.6 115.87 21.75 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 169.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 45.9 mt -119.65 114.1 21.68 Favored 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 123.665 0.786 . . . . 0.0 109.04 -164.774 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.6 t -102.12 -67.13 0.88 Allowed 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -178.65 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . 0.317 8.8 t 160.47 -61.89 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.165 0 C-N-CA 126.884 2.074 . . . . 0.0 106.821 -171.627 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -77.25 -48.57 17.16 Favored 'General case' 0 CA--C 1.579 2.062 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 161.195 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 3.6 tpm_? -95.02 135.97 35.9 Favored 'General case' 0 CA--C 1.564 1.501 0 CA-C-O 122.434 1.111 . . . . 0.0 113.157 -170.847 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 47.1 m-80 -121.89 135.51 54.89 Favored 'General case' 0 CA--C 1.568 1.64 0 CA-C-N 114.625 -1.171 . . . . 0.0 108.574 164.317 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 20.6 m-30 -94.25 -61.0 1.6 Allowed 'General case' 0 N--CA 1.504 2.231 0 O-C-N 120.898 -1.126 . . . . 0.0 113.179 171.626 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.282 4.3 mm 64.0 57.21 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.429 0 CA-C-N 119.694 1.133 . . . . 0.0 113.606 175.559 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 66.7 mtp -79.61 104.7 10.39 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.007 -1.683 . . . . 0.0 109.69 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -116.56 108.65 16.24 Favored 'General case' 0 CA--C 1.56 1.354 0 C-N-CA 123.739 0.816 . . . . 0.0 110.807 -162.122 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 20.5 p90 -152.22 145.81 24.95 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -163.381 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 18.7 mp0 -82.46 124.85 30.44 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.333 -0.854 . . . . 0.0 110.332 159.791 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 26.0 t -65.88 121.4 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.57 -0.706 . . . . 0.0 110.581 178.562 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 116.24 -38.85 2.9 Favored Glycine 0 CA--C 1.55 2.26 0 N-CA-C 116.328 1.291 . . . . 0.0 116.328 -160.316 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -80.89 141.64 34.38 Favored 'General case' 0 CA--C 1.567 1.616 0 CA-C-N 119.397 1.599 . . . . 0.0 114.021 -172.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -96.11 102.35 14.14 Favored 'General case' 0 CA--C 1.568 1.641 0 C-N-CA 123.694 0.798 . . . . 0.0 109.896 171.38 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -115.41 146.64 41.42 Favored 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 123.883 0.873 . . . . 0.0 113.153 -169.337 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -70.1 120.77 16.3 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 119.955 -1.716 . . . . 0.0 113.263 171.714 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 . . . . . 0 N--CA 1.493 1.693 0 O-C-N 121.087 -1.008 . . . . 0.0 110.332 173.334 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 81.2 m . . . . . 0 N--CA 1.486 1.368 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 4.6 tpt -78.45 104.18 8.88 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-O 122.153 0.978 . . . . 0.0 110.16 -172.206 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 85.7 m -110.43 121.97 46.6 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.926 -155.837 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 91.7 m -113.44 119.68 38.42 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 -179.22 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.448 HG22 ' SG ' ' A' ' 95' ' ' CYS . 22.0 t -112.19 119.11 59.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 177.772 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 65.3 m -140.54 156.86 46.18 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 122.049 0.928 . . . . 0.0 112.513 -173.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 34.5 m95 -84.52 118.76 24.52 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.043 -1.035 . . . . 0.0 112.908 -178.342 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -99.23 75.25 1.99 Allowed 'General case' 0 CA--C 1.567 1.597 0 C-N-CA 123.494 0.718 . . . . 0.0 109.894 167.647 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 73.19 -104.97 1.66 Allowed Glycine 0 N--CA 1.487 2.092 0 O-C-N 121.544 -0.723 . . . . 0.0 112.7 -174.18 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -92.48 -18.19 23.52 Favored 'General case' 0 CA--C 1.573 1.832 0 N-CA-C 115.469 1.655 . . . . 0.0 115.469 167.271 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 78.7 mttt -91.46 137.59 32.24 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 121.111 1.778 . . . . 0.0 112.07 -174.684 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 22.8 tp -92.25 109.96 21.34 Favored 'General case' 0 CA--C 1.563 1.457 0 O-C-N 121.324 -0.86 . . . . 0.0 110.017 177.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -99.3 125.72 45.0 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.392 0.677 . . . . 0.0 111.411 -175.562 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' CYS . . . . . 0.448 ' SG ' HG22 ' A' ' 86' ' ' VAL . 46.1 t -116.89 131.86 56.85 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.725 0.81 . . . . 0.0 110.803 176.461 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 11.0 p -123.66 123.68 67.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 C-N-CA 122.791 0.437 . . . . 0.0 110.281 169.494 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 69.3 mt-30 -102.57 108.36 19.62 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 124.25 1.02 . . . . 0.0 110.71 -177.66 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -96.65 127.01 42.22 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 -169.45 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 167.62 -110.42 0.39 Allowed Glycine 0 N--CA 1.488 2.146 0 O-C-N 121.419 -0.801 . . . . 0.0 114.189 167.152 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -75.41 -43.16 51.42 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 115.614 1.709 . . . . 0.0 115.614 -176.477 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 37.4 mmtm -83.9 138.56 33.11 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-O 121.935 0.874 . . . . 0.0 112.713 179.062 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -78.77 148.09 33.09 Favored 'General case' 0 CA--C 1.566 1.585 0 CA-C-N 115.663 -0.699 . . . . 0.0 112.096 168.475 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 61.0 23.65 61.87 Favored Glycine 0 N--CA 1.498 2.774 0 N-CA-C 120.85 3.1 . . . . 0.0 120.85 178.439 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 46.5 ttt180 -87.5 118.25 26.84 Favored 'General case' 0 CA--C 1.564 1.498 0 CA-C-N 118.78 1.29 . . . . 0.0 111.792 -175.583 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -178.3 -172.18 42.43 Favored Glycine 0 N--CA 1.486 2.029 0 O-C-N 121.449 -0.782 . . . . 0.0 114.925 -175.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 41.8 p-90 -157.42 151.1 24.12 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 172.437 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 29.3 m -120.47 120.04 34.74 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 123.604 0.761 . . . . 0.0 109.192 173.394 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 22.6 tt0 -119.61 135.08 54.95 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 123.316 0.646 . . . . 0.0 112.489 -176.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 20.8 p90 -152.41 168.98 23.7 Favored 'General case' 0 N--CA 1.497 1.899 0 C-N-CA 123.792 0.837 . . . . 0.0 112.535 177.735 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 63.2 mt -113.65 133.42 59.66 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.168 0 O-C-N 120.557 -1.339 . . . . 0.0 110.119 172.68 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -107.66 90.36 3.28 Favored 'General case' 0 CA--C 1.566 1.596 0 C-N-CA 123.789 0.836 . . . . 0.0 109.313 164.102 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 70.29 -103.98 1.27 Allowed Glycine 0 N--CA 1.491 2.358 0 N-CA-C 115.388 0.915 . . . . 0.0 115.388 179.288 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 54.1 p30 -95.51 5.17 52.24 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 117.121 2.267 . . . . 0.0 117.121 167.359 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 77.6 mt-10 -115.33 133.96 55.55 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 120.321 1.419 . . . . 0.0 112.295 -176.285 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 11.1 tp -91.73 121.63 33.55 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 123.951 0.9 . . . . 0.0 109.357 173.145 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 39.2 m80 -111.72 119.39 38.47 Favored 'General case' 0 CA--C 1.559 1.3 0 C-N-CA 123.655 0.782 . . . . 0.0 108.939 -176.745 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 37.8 tp -124.8 121.62 35.1 Favored 'General case' 0 CA--C 1.562 1.437 0 C-N-CA 123.885 0.874 . . . . 0.0 109.618 -174.613 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -108.53 104.2 13.48 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 172.446 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 64.5 mtm -98.82 125.2 44.13 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.784 -0.572 . . . . 0.0 111.158 -177.716 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -107.74 142.36 37.86 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 123.443 0.697 . . . . 0.0 112.277 -175.132 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -152.98 124.73 7.81 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-O 121.635 0.731 . . . . 0.0 110.867 164.367 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . 0.311 13.8 mt-10 60.58 31.61 20.26 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 116.654 2.094 . . . . 0.0 116.654 -178.103 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 83.07 -15.21 34.23 Favored Glycine 0 CA--C 1.553 2.451 0 N-CA-C 119.167 2.427 . . . . 0.0 119.167 -162.859 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 86.2 t -86.93 122.97 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 CA-C-N 120.04 1.92 . . . . 0.0 109.516 -176.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 42.8 m -100.56 124.68 46.45 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 121.092 0.472 . . . . 0.0 111.198 176.423 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 16.1 t -89.72 127.48 35.95 Favored 'General case' 0 CA--C 1.559 1.312 0 C-N-CA 123.239 0.616 . . . . 0.0 111.241 160.07 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp -100.48 107.74 19.53 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 175.474 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 66.3 mt-30 -103.49 124.38 48.65 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.105 0.562 . . . . 0.0 110.361 175.516 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 58.1 t -112.08 130.99 64.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 175.683 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -124.65 155.45 39.15 Favored 'General case' 0 CA--C 1.566 1.575 0 C-N-CA 124.685 1.194 . . . . 0.0 110.763 -179.748 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -125.89 141.27 52.06 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.811 -1.18 . . . . 0.0 112.492 174.309 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 43.0 tttm -74.49 125.07 27.78 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 -174.405 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 35.8 m -108.55 -41.76 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 176.52 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 47.2 t-80 . . . . . 0 C--O 1.254 1.331 0 CA-C-N 119.932 1.242 . . . . 0.0 108.966 172.651 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo . . . . . 0 CA--C 1.564 2.006 0 N-CA-C 116.711 1.773 . . . . 0.0 116.711 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 32.8 m -76.83 146.26 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 CA-C-N 115.266 -0.879 . . . . 0.0 112.712 177.262 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -80.94 103.48 10.79 Favored 'General case' 0 CA--C 1.565 1.536 0 O-C-N 120.606 -1.308 . . . . 0.0 111.381 176.864 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 13.6 m-30 -70.43 -3.43 17.63 Favored 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 117.66 2.466 . . . . 0.0 117.66 172.524 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -46.5 114.28 0.79 Allowed 'General case' 0 CA--C 1.567 1.62 0 N-CA-C 116.575 2.065 . . . . 0.0 116.575 178.117 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 157.18 176.01 28.76 Favored Glycine 0 N--CA 1.487 2.08 0 N-CA-C 116.084 1.193 . . . . 0.0 116.084 -179.213 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -104.6 125.05 50.36 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 121.345 0.593 . . . . 0.0 109.514 172.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 68.5 m95 -123.33 124.66 43.45 Favored 'General case' 0 CA--C 1.568 1.659 0 C-N-CA 123.832 0.853 . . . . 0.0 109.11 -171.126 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 20.7 pttp -102.96 143.09 33.0 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 120.91 -1.119 . . . . 0.0 112.678 179.135 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.409 ' SD ' ' HD2' ' A' ' 38' ' ' PRO . 34.0 ttm -66.77 127.23 31.68 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.791 -1.193 . . . . 0.0 113.959 -179.81 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 93.7 mt -86.46 -55.41 3.9 Favored 'General case' 0 CA--C 1.566 1.595 0 C-N-CA 123.41 0.684 . . . . 0.0 112.467 163.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 88.1 p -139.53 149.5 43.98 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 119.023 0.828 . . . . 0.0 112.759 -177.225 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -124.49 110.88 15.04 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.07 0.548 . . . . 0.0 109.936 164.063 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -109.77 128.16 55.11 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.861 0.864 . . . . 0.0 109.362 -175.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.268 22.6 t30 64.57 23.02 12.79 Favored 'General case' 0 N--CA 1.504 2.229 0 N-CA-C 116.877 2.177 . . . . 0.0 116.877 -176.218 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -66.59 -45.65 78.54 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 115.471 1.656 . . . . 0.0 115.471 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -55.12 -41.42 71.68 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 116.298 1.962 . . . . 0.0 116.298 169.826 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -67.31 -41.24 85.66 Favored 'General case' 0 CA--C 1.573 1.835 0 N-CA-C 115.528 1.677 . . . . 0.0 115.528 174.011 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -53.98 -51.23 64.57 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 163.359 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.5 mt -63.41 -42.64 98.77 Favored 'General case' 0 CA--C 1.572 1.811 0 N-CA-C 114.641 1.348 . . . . 0.0 114.641 175.049 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 29.7 ttp85 -49.88 -49.65 48.7 Favored 'General case' 0 CA--C 1.575 1.938 0 N-CA-C 115.525 1.676 . . . . 0.0 115.525 161.621 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.04 -24.31 57.84 Favored 'General case' 0 CA--C 1.569 1.678 0 N-CA-C 117.709 2.485 . . . . 0.0 117.709 167.847 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 88.6 mt -83.52 1.61 41.04 Favored 'General case' 0 CA--C 1.572 1.823 0 N-CA-C 116.172 1.916 . . . . 0.0 116.172 166.25 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.268 20.8 m-20 64.1 48.36 3.02 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 114.834 1.42 . . . . 0.0 114.834 -168.866 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 92.6 t -96.58 142.42 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 CA-C-O 122.218 1.009 . . . . 0.0 109.429 175.292 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 7.5 p-10 -69.7 154.65 41.68 Favored 'General case' 0 CA--C 1.57 1.717 0 N-CA-C 115.305 1.594 . . . . 0.0 115.305 176.169 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 57.7 t -55.55 -41.24 62.96 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.303 0 N-CA-C 115.399 1.629 . . . . 0.0 115.399 -176.424 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.87 -49.42 76.32 Favored 'General case' 0 CA--C 1.567 1.598 0 N-CA-C 116.09 1.885 . . . . 0.0 116.09 173.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -62.02 -43.46 98.79 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 170.014 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 60.4 mtp180 -46.12 -53.59 10.09 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 116.201 1.926 . . . . 0.0 116.201 162.473 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 14.2 tptt -65.37 -47.99 74.49 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 115.603 1.705 . . . . 0.0 115.603 173.652 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 60.9 mt -55.26 -49.7 70.37 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.188 0 CA-C-N 119.806 1.185 . . . . 0.0 113.499 173.535 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.54 -42.05 92.36 Favored 'General case' 0 CA--C 1.565 1.529 0 N-CA-C 117.339 2.348 . . . . 0.0 117.339 173.426 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -59.65 -39.87 85.83 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 116.487 2.032 . . . . 0.0 116.487 168.236 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 89.9 mt -83.06 -16.21 47.88 Favored 'General case' 0 CA--C 1.569 1.681 0 N-CA-C 116.302 1.964 . . . . 0.0 116.302 179.203 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 69.4 mt -85.43 147.94 26.24 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 120.093 1.315 . . . . 0.0 112.342 171.833 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -105.21 87.42 1.99 Allowed Pre-proline 0 CA--C 1.574 1.873 0 CA-C-O 118.154 -0.926 . . . . 0.0 109.489 172.646 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.409 ' HD2' ' SD ' ' A' ' 10' ' ' MET . 60.5 Cg_endo -69.92 174.78 9.14 Favored 'Trans proline' 0 CA--C 1.564 1.992 0 C-N-CA 122.538 2.159 . . . . 0.0 115.423 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -130.36 136.27 48.91 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.545 -1.347 . . . . 0.0 110.806 -176.524 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 50.2 mttp -103.48 111.65 24.2 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.582 -0.699 . . . . 0.0 109.696 174.863 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -96.84 101.29 12.85 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 166.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 65.3 mt -93.93 119.15 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -173.718 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 75.8 t -109.83 95.32 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 177.37 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -99.31 118.46 36.03 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 123.751 0.82 . . . . 0.0 110.329 178.702 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -133.58 66.38 1.55 Allowed 'General case' 0 CA--C 1.569 1.696 0 O-C-N 121.51 -0.744 . . . . 0.0 111.867 -178.212 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 72.15 81.39 0.34 Allowed Glycine 0 N--CA 1.493 2.448 0 N-CA-C 115.274 0.87 . . . . 0.0 115.274 174.623 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.458 0.2 OUTLIER 65.66 -41.59 0.34 Allowed 'General case' 0 N--CA 1.502 2.141 0 N-CA-C 117.861 2.541 . . . . 0.0 117.861 -167.903 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 14.3 t-80 -70.55 120.47 16.23 Favored 'General case' 0 CA--C 1.562 1.416 0 O-C-N 120.984 -1.073 . . . . 0.0 111.595 168.482 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 17.5 ttp -136.87 125.35 23.52 Favored 'General case' 0 CA--C 1.555 1.163 0 CA-C-O 121.841 0.829 . . . . 0.0 110.522 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 23.0 mt -104.43 107.62 22.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 174.828 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 83.0 mt -86.67 99.71 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 168.307 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -85.05 93.07 8.52 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.51 -0.744 . . . . 0.0 109.863 -178.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 80.7 m -87.84 102.29 14.55 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 -177.687 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 17.6 mt -105.84 121.22 43.61 Favored 'General case' 0 CA--C 1.557 1.241 0 CA-C-N 114.514 -1.221 . . . . 0.0 109.365 -164.127 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 27.1 t -132.57 143.96 50.07 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.38 0.672 . . . . 0.0 110.528 -178.309 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 21.6 m -56.05 -34.77 66.21 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 116.123 1.898 . . . . 0.0 116.123 175.334 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -79.93 -58.64 3.07 Favored 'General case' 0 CA--C 1.569 1.693 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 175.443 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 11.9 tpt180 -151.7 127.18 10.04 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-N 119.824 1.193 . . . . 0.0 110.887 177.291 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -76.86 145.14 38.53 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 177.302 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -95.92 -67.96 0.82 Allowed 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 118.714 -0.66 . . . . 0.0 112.186 178.567 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.273 11.4 mm 72.52 96.76 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 C-N-CA 124.128 0.971 . . . . 0.0 111.716 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 82.2 mtp -96.25 98.71 10.51 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.02 -1.05 . . . . 0.0 109.568 173.399 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -100.66 110.57 22.7 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 123.659 0.784 . . . . 0.0 110.183 -179.118 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -150.52 157.45 43.02 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 114.527 1.306 . . . . 0.0 114.527 -167.566 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -101.08 138.03 38.65 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.586 -0.696 . . . . 0.0 110.312 160.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 92.5 t -67.77 128.18 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.289 -0.882 . . . . 0.0 110.995 -177.72 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 91.25 -45.7 2.82 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 116.518 1.367 . . . . 0.0 116.518 -165.726 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 16.7 tttp -67.29 122.49 17.99 Favored 'General case' 0 CA--C 1.571 1.78 0 C-N-CA 125.37 1.468 . . . . 0.0 113.051 178.15 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -84.43 114.93 22.26 Favored 'General case' 0 CA--C 1.567 1.6 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.888 -176.206 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -113.17 139.83 48.43 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -169.693 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -76.97 112.67 13.85 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.154 -0.966 . . . . 0.0 112.496 177.12 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 . . . . . 0 N--CA 1.487 1.392 0 C-N-CA 123.232 0.613 . . . . 0.0 110.334 175.541 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 73.7 m . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 120.931 0.395 . . . . 0.0 111.802 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 15.5 mtp -80.46 98.11 7.4 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-O 121.655 0.74 . . . . 0.0 110.919 177.673 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 91.2 m -101.46 125.35 48.09 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.658 -0.651 . . . . 0.0 110.7 -167.314 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 85.3 m -106.3 122.94 47.24 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 176.675 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 20.6 t -116.19 121.61 67.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 179.684 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 58.4 m -128.64 139.19 52.38 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 123.829 0.852 . . . . 0.0 111.221 -173.569 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 2.9 m95 -81.49 122.34 27.41 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.845 -1.16 . . . . 0.0 113.69 179.056 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -112.32 67.93 0.66 Allowed 'General case' 0 CA--C 1.577 1.996 0 C-N-CA 123.382 0.673 . . . . 0.0 110.632 164.783 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 69.96 -102.82 1.04 Allowed Glycine 0 N--CA 1.495 2.584 0 N-CA-C 115.968 1.147 . . . . 0.0 115.968 177.456 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -75.47 -28.93 59.44 Favored 'General case' 0 CA--C 1.574 1.878 0 N-CA-C 115.206 1.558 . . . . 0.0 115.206 162.216 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 29.8 mtpt -98.87 107.42 19.85 Favored 'General case' 0 N--CA 1.484 1.263 0 CA-C-N 119.469 1.031 . . . . 0.0 110.56 -167.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 30.4 tp -80.75 111.06 16.84 Favored 'General case' 0 CA--C 1.563 1.473 0 O-C-N 120.729 -1.232 . . . . 0.0 109.844 173.191 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 -97.55 126.94 43.13 Favored 'General case' 0 CA--C 1.558 1.272 0 C-N-CA 124.011 0.925 . . . . 0.0 110.961 -174.353 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 41.9 t -127.48 133.88 49.86 Favored 'General case' 0 N--CA 1.481 1.108 0 O-C-N 121.674 -0.641 . . . . 0.0 111.831 -178.735 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 12.2 p -118.78 128.92 75.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 C-N-CA 123.068 0.547 . . . . 0.0 109.78 168.604 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -99.96 104.28 15.89 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 123.47 0.708 . . . . 0.0 109.753 178.306 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -91.25 119.79 31.61 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.059 -1.026 . . . . 0.0 110.676 -173.67 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -174.41 -70.33 0.05 OUTLIER Glycine 0 N--CA 1.489 2.172 0 N-CA-C 116.022 1.169 . . . . 0.0 116.022 -175.099 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -138.27 -60.45 0.62 Allowed 'General case' 0 N--CA 1.498 1.963 0 CA-C-N 117.755 0.777 . . . . 0.0 111.952 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -72.74 133.04 44.38 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-O 122.231 1.015 . . . . 0.0 111.704 -173.187 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -68.73 -56.83 6.84 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 115.392 1.627 . . . . 0.0 115.392 -160.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -83.68 44.11 3.26 Favored Glycine 0 CA--C 1.55 2.226 0 N-CA-C 117.728 1.851 . . . . 0.0 117.728 166.271 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 25.1 ttt180 -85.95 119.04 25.83 Favored 'General case' 0 CA--C 1.566 1.587 0 CA-C-N 119.674 1.737 . . . . 0.0 113.366 -176.579 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 175.0 -165.84 37.18 Favored Glycine 0 N--CA 1.485 1.906 0 CA-C-O 122.01 0.783 . . . . 0.0 114.73 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 45.3 p-90 -155.66 152.94 29.26 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 172.065 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 81.8 m -119.73 121.38 39.06 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 169.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -121.0 128.52 52.78 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.604 -0.685 . . . . 0.0 111.578 -177.447 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 16.4 p90 -148.04 155.32 41.36 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.797 -1.19 . . . . 0.0 113.587 -176.232 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 94.8 mt -94.35 134.46 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.033 -1.042 . . . . 0.0 110.382 174.902 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -118.4 94.9 4.65 Favored 'General case' 0 CA--C 1.566 1.574 0 CA-C-N 114.897 -1.047 . . . . 0.0 108.441 159.666 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 69.11 -108.03 2.32 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 115.619 1.008 . . . . 0.0 115.619 -179.336 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 55.5 p30 -90.18 2.42 55.38 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 117.407 2.373 . . . . 0.0 117.407 168.761 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -121.24 130.15 53.53 Favored 'General case' 0 N--CA 1.486 1.329 0 CA-C-N 119.827 1.194 . . . . 0.0 111.663 -168.14 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 18.4 tp -91.64 113.63 25.95 Favored 'General case' 0 CA--C 1.562 1.409 0 C-N-CA 124.424 1.089 . . . . 0.0 109.451 172.855 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 41.6 m80 -101.16 124.79 47.41 Favored 'General case' 0 CA--C 1.561 1.399 0 C-N-CA 124.33 1.052 . . . . 0.0 108.842 -177.407 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 43.6 tp -124.99 120.27 31.09 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.824 0.85 . . . . 0.0 110.332 -171.39 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -105.06 107.02 17.78 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.711 -0.618 . . . . 0.0 109.686 170.645 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 72.1 mtm -97.72 124.58 42.12 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-N 118.58 0.627 . . . . 0.0 111.131 179.186 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 84.7 mtm180 -111.55 139.45 46.98 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 123.866 0.866 . . . . 0.0 110.926 -171.128 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -147.28 132.46 18.36 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.095 -1.003 . . . . 0.0 112.968 167.432 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . 0.344 24.7 mt-10 65.61 -73.36 0.07 Allowed 'General case' 0 N--CA 1.502 2.126 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 -173.728 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -160.2 50.3 0.37 Allowed Glycine 0 CA--C 1.552 2.386 0 C-N-CA 123.862 0.744 . . . . 0.0 112.259 157.388 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 69.0 t -139.96 122.92 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 -163.852 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 31.3 m -105.47 123.06 47.26 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 122.996 0.518 . . . . 0.0 111.588 -173.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 44.6 t -88.61 128.98 35.59 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.561 -0.712 . . . . 0.0 111.261 159.527 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -105.39 110.75 23.22 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -179.409 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 16.4 mt-30 -118.07 139.08 51.74 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 123.559 0.744 . . . . 0.0 111.491 -176.093 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 33.9 t -122.93 131.79 72.61 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 O-C-N 121.478 -0.764 . . . . 0.0 109.042 -178.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -126.48 138.72 53.54 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 124.146 0.978 . . . . 0.0 110.521 -179.524 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 76.8 tttt -106.89 140.45 39.69 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.643 -1.286 . . . . 0.0 112.654 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 61.8 tttt -73.63 120.74 19.65 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -179.356 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 35.9 m -104.92 -41.27 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 175.476 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 52.8 t-80 . . . . . 0 N--CA 1.486 1.354 0 CA-C-N 119.715 1.143 . . . . 0.0 108.143 168.361 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo . . . . . 0 CA--C 1.561 1.846 0 N-CA-C 116.367 1.641 . . . . 0.0 116.367 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 29.1 m -78.78 160.88 4.39 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.929 0 CA-C-O 122.399 1.095 . . . . 0.0 113.405 -177.659 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -90.99 107.1 18.98 Favored 'General case' 0 CA--C 1.565 1.547 0 O-C-N 121.015 -1.053 . . . . 0.0 112.373 -175.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 6.5 m-30 -83.64 -2.2 55.61 Favored 'General case' 0 CA--C 1.577 1.981 0 N-CA-C 116.152 1.908 . . . . 0.0 116.152 171.621 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 51.1 m-80 -58.52 114.05 2.28 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-N 121.612 2.006 . . . . 0.0 114.22 -178.652 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 160.05 -178.03 36.28 Favored Glycine 0 N--CA 1.483 1.833 0 CA-C-O 122.623 1.124 . . . . 0.0 115.896 -177.384 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 12.7 t80 -113.36 119.43 37.61 Favored 'General case' 0 CA--C 1.565 1.533 0 CA-C-N 114.222 -0.989 . . . . 0.0 108.875 178.773 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 77.2 m95 -123.01 124.37 42.99 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 123.541 0.737 . . . . 0.0 110.182 -165.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 64.1 pttt -98.68 136.81 38.21 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 120.501 -1.374 . . . . 0.0 113.4 -179.399 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 11.0 ttp -72.09 125.34 27.02 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-N 119.395 0.998 . . . . 0.0 112.901 177.907 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 78.6 mt -94.69 -56.29 2.83 Favored 'General case' 0 CA--C 1.564 1.503 0 CA-C-N 115.068 -0.969 . . . . 0.0 112.927 178.119 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 92.4 p -141.54 124.12 15.9 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.724 0.81 . . . . 0.0 110.227 -170.623 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -113.77 119.12 36.28 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 121.343 0.592 . . . . 0.0 111.327 175.107 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -114.37 126.84 55.45 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.81 0.844 . . . . 0.0 109.148 -176.054 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.265 19.0 t30 66.76 22.17 10.37 Favored 'General case' 0 CA--C 1.582 2.185 0 N-CA-C 116.911 2.189 . . . . 0.0 116.911 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -68.39 -43.39 77.39 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 115.382 1.623 . . . . 0.0 115.382 178.828 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -53.54 -44.86 69.55 Favored 'General case' 0 N--CA 1.501 2.108 0 N-CA-C 116.348 1.981 . . . . 0.0 116.348 167.006 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -65.64 -43.93 87.96 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 115.103 1.519 . . . . 0.0 115.103 175.779 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -53.44 -49.04 68.2 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 164.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 77.7 mt -63.47 -42.72 98.6 Favored 'General case' 0 CA--C 1.571 1.759 0 N-CA-C 114.539 1.311 . . . . 0.0 114.539 172.302 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 69.5 ttp85 -54.34 -46.19 72.88 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 115.696 1.739 . . . . 0.0 115.696 166.297 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.98 -31.83 65.45 Favored 'General case' 0 CA--C 1.567 1.63 0 N-CA-C 116.632 2.086 . . . . 0.0 116.632 164.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 82.2 mt -85.88 30.43 0.66 Allowed 'General case' 0 CA--C 1.572 1.818 0 N-CA-C 114.506 1.298 . . . . 0.0 114.506 167.255 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 64.54 17.98 11.14 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 117.023 2.231 . . . . 0.0 117.023 175.428 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 94.8 t -88.17 142.41 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 120.504 -1.373 . . . . 0.0 110.932 -168.204 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 7.8 p-10 -71.9 156.96 38.69 Favored 'General case' 0 CA--C 1.569 1.677 0 N-CA-C 115.363 1.616 . . . . 0.0 115.363 177.801 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 49.0 t -53.97 -42.71 55.35 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.407 0 N-CA-C 115.203 1.557 . . . . 0.0 115.203 -176.715 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.03 -52.4 65.53 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 115.871 1.804 . . . . 0.0 115.871 173.782 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -59.47 -42.27 91.64 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 115.934 1.827 . . . . 0.0 115.934 169.779 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 54.0 mtp180 -51.68 -57.53 8.95 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 164.527 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -59.63 -47.34 85.98 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 115.054 1.502 . . . . 0.0 115.054 175.019 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 64.7 mt -56.05 -57.06 9.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 CA-C-N 119.622 1.101 . . . . 0.0 112.675 172.338 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.0 -44.1 91.6 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 117.704 2.483 . . . . 0.0 117.704 176.889 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -67.61 -27.64 67.07 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 116.375 1.991 . . . . 0.0 116.375 172.289 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 88.5 mt -79.81 -31.45 40.66 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 115.686 1.735 . . . . 0.0 115.686 171.535 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . 0.272 4.1 pp -80.72 145.79 31.37 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-N 120.148 1.34 . . . . 0.0 114.486 -178.344 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -114.29 93.37 31.02 Favored Pre-proline 0 CA--C 1.573 1.843 0 CA-C-O 118.368 -0.825 . . . . 0.0 108.841 -177.456 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -81.19 166.93 18.15 Favored 'Trans proline' 0 CA--C 1.56 1.817 0 C-N-CA 122.969 2.446 . . . . 0.0 115.083 -174.671 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -106.0 118.65 37.17 Favored 'General case' 0 N--CA 1.487 1.379 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.303 173.128 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 35.4 mttp -83.33 107.08 15.61 Favored 'General case' 0 N--CA 1.485 1.284 0 O-C-N 121.302 -0.874 . . . . 0.0 110.331 169.508 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -91.33 113.18 25.37 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 164.327 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 82.7 mt -108.9 122.94 64.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 -177.529 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 91.3 t -108.3 102.47 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 169.791 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 42.7 tt0 -98.69 100.55 11.78 Favored 'General case' 0 CA--C 1.565 1.54 0 C-N-CA 123.825 0.85 . . . . 0.0 110.031 175.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -93.91 74.01 4.17 Favored 'General case' 0 CA--C 1.57 1.737 0 O-C-N 121.438 -0.789 . . . . 0.0 110.228 168.558 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 65.03 -99.0 0.32 Allowed Glycine 0 N--CA 1.492 2.374 0 N-CA-C 115.053 0.781 . . . . 0.0 115.053 -174.486 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -83.26 -31.36 26.99 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 116.406 2.002 . . . . 0.0 116.406 165.177 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 22.6 t-160 -80.19 108.72 14.02 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 121.228 1.831 . . . . 0.0 110.915 -177.2 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 45.2 ttm -118.75 123.6 45.23 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 123.511 0.724 . . . . 0.0 110.046 -172.543 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 35.9 mt -107.36 106.14 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 175.283 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 33.9 mm -90.7 108.67 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 174.266 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 67.2 mtt85 -105.66 100.09 9.67 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.654 -0.654 . . . . 0.0 109.464 173.551 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 59.1 m -89.9 102.74 15.44 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 176.805 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 15.2 mt -101.08 125.05 47.67 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.367 0.667 . . . . 0.0 111.132 -160.068 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.4 t -147.88 156.61 42.88 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 122.009 0.909 . . . . 0.0 111.126 179.404 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 25.2 m -59.57 -38.7 81.83 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 115.3 1.593 . . . . 0.0 115.3 171.392 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 35.5 t80 -74.54 -53.24 9.83 Favored 'General case' 0 CA--C 1.572 1.82 0 N-CA-C 114.733 1.382 . . . . 0.0 114.733 174.75 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 71.2 ttt180 -142.85 130.15 21.01 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 119.526 1.057 . . . . 0.0 110.274 174.279 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 71.5 m-80 -93.5 117.29 29.9 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 166.872 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 75.6 t80 -105.01 105.43 15.47 Favored 'General case' 0 CA--C 1.566 1.59 0 C-N-CA 123.28 0.632 . . . . 0.0 111.087 -172.427 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.9 mp -99.19 121.53 49.9 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.833 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -178.652 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 95.9 mtp -115.39 103.37 10.72 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.568 -0.707 . . . . 0.0 109.369 167.259 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -101.22 112.92 25.54 Favored 'General case' 0 CA--C 1.566 1.577 0 C-N-CA 124.163 0.985 . . . . 0.0 111.806 177.851 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -153.74 154.28 33.76 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 115.047 1.499 . . . . 0.0 115.047 -166.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 28.0 mp0 -89.24 121.62 31.71 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.445 -0.784 . . . . 0.0 110.671 167.65 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 37.3 t -66.85 116.11 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 C-N-CA 123.785 0.834 . . . . 0.0 109.512 172.178 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 121.55 -46.31 1.13 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 115.589 0.996 . . . . 0.0 115.589 -158.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -84.34 145.75 28.08 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 118.726 1.263 . . . . 0.0 113.297 -174.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -91.9 100.34 13.03 Favored 'General case' 0 CA--C 1.568 1.638 0 O-C-N 121.788 -0.57 . . . . 0.0 110.895 173.324 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -107.63 145.7 32.96 Favored 'General case' 0 N--CA 1.495 1.813 0 C-N-CA 124.073 0.949 . . . . 0.0 113.429 -169.352 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -68.57 118.79 12.05 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.234 -1.541 . . . . 0.0 114.133 176.622 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 . . . . . 0 N--CA 1.493 1.697 0 CA-C-O 122.448 1.118 . . . . 0.0 109.672 163.012 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 99.4 m . . . . . 0 N--CA 1.487 1.394 0 CA-C-O 121.77 0.795 . . . . 0.0 112.151 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 3.9 tpt -78.78 107.28 11.37 Favored 'General case' 0 CA--C 1.563 1.472 0 CA-C-O 122.211 1.005 . . . . 0.0 109.822 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 90.4 m -111.8 115.91 29.83 Favored 'General case' 0 N--CA 1.484 1.227 0 O-C-N 121.545 -0.722 . . . . 0.0 110.737 -152.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 50.3 m -89.96 123.53 33.96 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 168.414 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 59.7 t -108.87 131.8 58.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 166.708 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 58.7 m -143.36 150.94 39.84 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.771 -1.205 . . . . 0.0 112.676 -175.205 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 20.5 m95 -86.24 120.25 27.39 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 -178.001 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -105.23 62.76 0.69 Allowed 'General case' 0 CA--C 1.58 2.099 0 C-N-CA 123.871 0.868 . . . . 0.0 110.405 158.345 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 64.5 -98.99 0.3 Allowed Glycine 0 N--CA 1.496 2.634 0 N-CA-C 116.978 1.551 . . . . 0.0 116.978 178.566 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -68.96 -35.99 77.39 Favored 'General case' 0 CA--C 1.574 1.886 0 N-CA-C 115.121 1.526 . . . . 0.0 115.121 165.531 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -92.4 124.34 36.38 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.906 0.883 . . . . 0.0 112.073 -176.199 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 22.0 tp -89.99 108.69 19.87 Favored 'General case' 0 CA--C 1.564 1.491 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 166.087 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 30.3 mm-40 -97.95 130.82 44.79 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.709 0.804 . . . . 0.0 110.991 -172.287 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 42.4 t -127.67 127.92 44.57 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.015 0.526 . . . . 0.0 111.711 -175.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.6 p -115.07 115.21 48.75 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.625 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 169.539 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -93.59 94.95 8.91 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 123.628 0.771 . . . . 0.0 109.124 179.72 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 64.8 mttm -88.43 109.39 19.98 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.123 -0.986 . . . . 0.0 112.075 -169.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -179.83 85.37 0.07 OUTLIER Glycine 0 N--CA 1.484 1.871 0 CA-C-N 116.1 -0.5 . . . . 0.0 113.174 177.096 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . 0.271 29.1 tt0 70.35 -55.25 0.62 Allowed 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 116.697 2.11 . . . . 0.0 116.697 178.692 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.0 mmmp? -72.94 141.5 47.82 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 114.798 1.407 . . . . 0.0 114.798 -166.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -80.69 94.68 6.41 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.98 0.895 . . . . 0.0 112.526 -164.877 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 77.37 46.0 10.58 Favored Glycine 0 N--CA 1.486 1.988 0 N-CA-C 117.208 1.643 . . . . 0.0 117.208 -173.317 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 14.8 ttm180 -77.56 121.51 24.0 Favored 'General case' 0 CA--C 1.568 1.654 0 CA-C-N 118.546 1.173 . . . . 0.0 110.725 167.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 177.37 -171.74 44.51 Favored Glycine 0 N--CA 1.486 2.012 0 O-C-N 121.502 -0.749 . . . . 0.0 114.874 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 51.7 p-90 -157.96 154.04 27.13 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 114.125 1.157 . . . . 0.0 114.125 178.095 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 74.1 m -121.95 116.95 25.27 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 171.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 19.2 tt0 -115.7 126.73 54.48 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 123.398 0.679 . . . . 0.0 110.682 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 14.1 p90 -147.18 157.32 43.56 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.685 -1.259 . . . . 0.0 114.089 -175.345 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 95.8 mt -100.82 128.8 52.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.434 -0.791 . . . . 0.0 110.038 175.594 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -112.33 100.03 8.48 Favored 'General case' 0 CA--C 1.567 1.611 0 CA-C-N 114.697 -1.138 . . . . 0.0 108.543 160.672 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 70.53 -106.58 1.89 Allowed Glycine 0 N--CA 1.494 2.5 0 N-CA-C 115.442 0.937 . . . . 0.0 115.442 -179.762 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -112.43 33.7 4.76 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 114.767 1.395 . . . . 0.0 114.767 162.936 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -125.7 127.52 46.37 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 124.058 0.943 . . . . 0.0 109.707 177.686 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 17.0 tp -93.09 115.55 28.19 Favored 'General case' 0 CA--C 1.563 1.461 0 CA-C-O 122.097 0.951 . . . . 0.0 109.412 173.275 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 48.1 m80 -102.6 123.81 47.0 Favored 'General case' 0 CA--C 1.558 1.253 0 C-N-CA 124.17 0.988 . . . . 0.0 108.878 -176.549 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 43.3 tp -124.56 118.52 26.76 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.508 0.723 . . . . 0.0 109.654 -172.801 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 82.1 mt-10 -114.05 110.65 20.37 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.75 -0.594 . . . . 0.0 109.764 173.874 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 68.0 mtm -105.77 125.25 50.77 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 123.591 0.756 . . . . 0.0 110.755 -174.815 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 54.6 mtp180 -111.22 142.97 42.73 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.584 -0.697 . . . . 0.0 112.338 -177.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -156.52 133.05 10.09 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 123.08 0.552 . . . . 0.0 110.898 161.701 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 60.7 34.93 19.85 Favored 'General case' 0 N--CA 1.509 2.478 0 N-CA-C 115.339 1.607 . . . . 0.0 115.339 -168.041 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 67.35 -0.81 7.86 Favored Glycine 0 CA--C 1.561 2.913 0 N-CA-C 119.984 2.753 . . . . 0.0 119.984 -159.905 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 75.2 t -95.51 114.14 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 CA-C-N 120.81 2.305 . . . . 0.0 109.446 -167.165 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 25.0 m -94.63 118.63 32.0 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 123.094 0.557 . . . . 0.0 111.295 -173.249 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 13.9 t -91.6 124.65 35.91 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.306 0.642 . . . . 0.0 111.238 162.354 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -108.55 115.5 30.21 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.192 0.597 . . . . 0.0 109.659 -175.752 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -124.22 135.43 53.43 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.636 -0.665 . . . . 0.0 111.854 -174.159 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 61.7 t -112.97 131.62 64.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.312 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -125.34 145.13 50.17 Favored 'General case' 0 CA--C 1.563 1.463 0 C-N-CA 124.844 1.258 . . . . 0.0 109.778 179.151 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 30.3 ttmt -120.25 140.61 50.94 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.651 -1.281 . . . . 0.0 112.804 179.173 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 54.5 tttt -74.97 115.81 15.0 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -177.106 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 35.0 m -97.21 -40.73 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 174.569 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 79.5 t60 . . . . . 0 N--CA 1.486 1.343 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 164.628 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_exo . . . . . 0 CA--C 1.561 1.871 0 N-CA-C 116.563 1.717 . . . . 0.0 116.563 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 22.0 m -107.01 176.43 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 CA-C-O 122.248 1.023 . . . . 0.0 112.067 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -79.19 82.21 5.37 Favored 'General case' 0 CA--C 1.569 1.676 0 O-C-N 120.158 -1.589 . . . . 0.0 113.862 -171.267 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -73.41 -11.71 60.56 Favored 'General case' 0 CA--C 1.576 1.97 0 N-CA-C 115.614 1.709 . . . . 0.0 115.614 167.622 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -45.78 121.96 3.45 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 115.793 1.775 . . . . 0.0 115.793 168.007 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 154.84 174.39 24.74 Favored Glycine 0 N--CA 1.484 1.876 0 N-CA-C 115.976 1.15 . . . . 0.0 115.976 175.43 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 17.3 t80 -103.28 121.2 42.22 Favored 'General case' 0 CA--C 1.563 1.449 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 167.032 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 70.4 m95 -120.39 121.5 38.69 Favored 'General case' 0 CA--C 1.562 1.434 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 -170.146 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 63.7 pttt -89.47 137.74 32.07 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.249 -0.907 . . . . 0.0 112.169 177.539 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 51.3 ttm -73.38 121.84 21.11 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 122.092 0.949 . . . . 0.0 112.423 176.685 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 89.6 mt -81.79 -48.13 12.0 Favored 'General case' 0 CA--C 1.568 1.66 0 CA-C-N 115.242 -0.89 . . . . 0.0 113.157 167.252 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 88.6 p -136.55 146.29 45.99 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 119.225 0.92 . . . . 0.0 112.873 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 20.9 p30 -124.45 81.72 1.97 Allowed 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 121.694 0.759 . . . . 0.0 110.709 167.914 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -94.72 125.56 39.45 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.138 -0.976 . . . . 0.0 111.56 -167.752 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.257 51.2 t30 59.15 25.16 13.63 Favored 'General case' 0 N--CA 1.503 2.183 0 N-CA-C 116.968 2.21 . . . . 0.0 116.968 -170.453 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -66.97 -40.47 87.47 Favored 'General case' 0 CA--C 1.568 1.643 0 N-CA-C 114.969 1.47 . . . . 0.0 114.969 172.59 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -52.93 -53.42 49.79 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 115.484 1.661 . . . . 0.0 115.484 172.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -72.08 -37.01 69.69 Favored 'General case' 0 CA--C 1.566 1.565 0 N-CA-C 115.796 1.776 . . . . 0.0 115.796 176.909 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 61.3 t80 -50.2 -49.96 51.0 Favored 'General case' 0 N--CA 1.499 2.02 0 CA-C-N 120.526 1.512 . . . . 0.0 114.859 161.871 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 93.9 mt -62.57 -41.47 98.94 Favored 'General case' 0 CA--C 1.57 1.734 0 N-CA-C 115.51 1.67 . . . . 0.0 115.51 171.219 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 35.2 ttp180 -62.07 -44.85 95.78 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 115.091 1.515 . . . . 0.0 115.091 169.563 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -49.82 -28.96 7.09 Favored 'General case' 0 CA--C 1.571 1.781 0 N-CA-C 118.234 2.679 . . . . 0.0 118.234 162.305 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 91.0 mt -86.97 0.68 54.72 Favored 'General case' 0 CA--C 1.569 1.7 0 N-CA-C 116.45 2.019 . . . . 0.0 116.45 168.349 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 62.32 39.07 12.68 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 115.458 1.651 . . . . 0.0 115.458 -169.283 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 86.1 t -92.88 140.25 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 CA-C-O 122.195 0.997 . . . . 0.0 109.02 178.754 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.8 p-10 -67.0 146.05 54.77 Favored 'General case' 0 CA--C 1.567 1.613 0 N-CA-C 116.287 1.958 . . . . 0.0 116.287 -170.818 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 58.5 t -59.57 -38.75 77.02 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.162 0 N-CA-C 115.622 1.712 . . . . 0.0 115.622 -173.183 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.12 -38.95 84.58 Favored 'General case' 0 CA--C 1.569 1.711 0 N-CA-C 116.412 2.005 . . . . 0.0 116.412 169.431 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 6.1 tt -65.49 -50.67 64.45 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-N 119.318 0.963 . . . . 0.0 113.553 165.301 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 35.2 mtp-105 -47.62 -50.35 24.63 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 116.263 1.949 . . . . 0.0 116.263 172.203 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -70.91 -36.29 72.62 Favored 'General case' 0 CA--C 1.564 1.493 0 N-CA-C 115.239 1.57 . . . . 0.0 115.239 174.219 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 41.0 mt -71.99 -55.78 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.22 0 CA-C-N 122.334 2.334 . . . . 0.0 110.559 174.67 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -61.14 -23.3 65.43 Favored 'General case' 0 CA--C 1.565 1.54 0 N-CA-C 119.255 3.057 . . . . 0.0 119.255 176.362 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -75.28 -47.59 27.21 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 115.454 1.65 . . . . 0.0 115.454 160.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 97.4 mt -75.25 -25.56 58.14 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 116.29 1.959 . . . . 0.0 116.29 -175.201 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . 0.25 1.4 pp -96.34 149.89 21.19 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 119.444 1.02 . . . . 0.0 110.397 158.327 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -107.06 92.32 7.6 Favored Pre-proline 0 CA--C 1.574 1.873 0 CA-C-O 117.78 -1.105 . . . . 0.0 109.222 -176.565 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -72.04 155.85 56.67 Favored 'Trans proline' 0 CA--C 1.562 1.901 0 C-N-CA 122.535 2.157 . . . . 0.0 116.739 -170.767 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -101.14 136.22 41.34 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.926 -170.722 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 60.8 mttm -96.02 112.1 23.93 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.123 -0.986 . . . . 0.0 110.19 174.409 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -94.5 108.13 20.08 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 163.329 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 78.0 mt -103.07 117.14 48.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 -175.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 91.1 t -100.18 93.75 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 173.683 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -95.31 97.17 9.65 Favored 'General case' 0 CA--C 1.566 1.568 0 CA-C-O 121.395 0.617 . . . . 0.0 110.831 176.524 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -89.97 79.23 6.61 Favored 'General case' 0 CA--C 1.568 1.666 0 O-C-N 121.275 -0.89 . . . . 0.0 109.815 167.855 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 65.94 -102.66 0.73 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 114.897 0.719 . . . . 0.0 114.897 -174.176 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -86.07 -23.29 26.77 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 116.531 2.048 . . . . 0.0 116.531 165.56 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 18.5 t-160 -78.9 108.89 12.69 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 121.602 2.001 . . . . 0.0 111.148 178.283 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 47.1 ttm -117.64 121.08 39.94 Favored 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 123.676 0.79 . . . . 0.0 109.932 -174.789 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 29.6 mt -107.41 101.94 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 173.388 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 78.8 mt -88.89 100.63 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 177.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 62.6 mtt180 -94.5 98.48 10.88 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.774 -0.579 . . . . 0.0 110.251 -179.572 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 11.4 m -87.6 107.92 18.83 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 177.306 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 13.5 mt -108.96 120.35 42.26 Favored 'General case' 0 CA--C 1.558 1.273 0 C-N-CA 123.478 0.711 . . . . 0.0 110.486 -160.526 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 38.7 t -116.45 -93.41 0.5 Allowed 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.147 0.579 . . . . 0.0 110.624 177.452 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 52.8 m 176.83 -62.18 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.033 0 C-N-CA 126.618 1.967 . . . . 0.0 106.015 -170.597 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -72.89 -48.63 35.61 Favored 'General case' 0 CA--C 1.573 1.838 0 N-CA-C 115.935 1.828 . . . . 0.0 115.935 176.54 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 42.7 tpt85 -139.08 124.64 19.44 Favored 'General case' 0 CA--C 1.564 1.492 0 CA-C-N 118.995 0.816 . . . . 0.0 109.755 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -83.46 173.72 11.25 Favored 'General case' 0 CA--C 1.569 1.69 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 169.859 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -112.9 -76.24 0.59 Allowed 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.337 -0.852 . . . . 0.0 110.196 170.012 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.374 58.5 mt 70.5 85.51 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.127 0 C-N-CA 124.5 1.12 . . . . 0.0 111.678 173.94 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 94.4 mtp -102.05 102.64 13.16 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.062 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.5 p30 -99.96 110.44 22.77 Favored 'General case' 0 CA--C 1.562 1.434 0 C-N-CA 123.899 0.88 . . . . 0.0 112.554 -178.325 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -155.04 148.78 25.48 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 -168.786 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 23.1 mp0 -82.65 125.76 31.57 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.219 -0.926 . . . . 0.0 110.667 160.243 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 13.1 t -66.17 123.34 18.94 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.91 0 O-C-N 121.31 -0.869 . . . . 0.0 110.142 176.486 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 115.81 -44.26 1.51 Allowed Glycine 0 CA--C 1.55 2.253 0 N-CA-C 115.597 0.999 . . . . 0.0 115.597 -157.555 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 83.8 mttt -83.6 146.62 28.19 Favored 'General case' 0 CA--C 1.566 1.593 0 CA-C-N 118.822 1.311 . . . . 0.0 114.18 -172.237 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -91.05 103.71 16.38 Favored 'General case' 0 CA--C 1.564 1.51 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.995 167.065 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 11.1 p90 -102.72 145.49 29.63 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -171.869 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -78.81 124.67 28.45 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 177.01 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 . . . . . 0 N--CA 1.487 1.385 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 169.655 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 73.3 m . . . . . 0 CA--C 1.557 1.213 0 CA-C-O 121.713 0.768 . . . . 0.0 111.835 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 12.4 mmt -88.82 90.13 8.28 Favored 'General case' 0 CA--C 1.56 1.33 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 173.771 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 86.0 m -92.78 122.41 35.14 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.166 -0.958 . . . . 0.0 110.265 -174.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 58.5 m -110.04 122.73 48.26 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.827 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.457 HG22 ' SG ' ' A' ' 95' ' ' CYS . 17.8 t -118.0 128.09 75.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 92.0 p -130.6 166.58 20.33 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 122.506 1.146 . . . . 0.0 113.256 -176.908 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 68.5 m95 -97.19 129.67 44.52 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.615 -0.678 . . . . 0.0 111.932 175.396 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -126.49 81.84 2.03 Favored 'General case' 0 CA--C 1.567 1.597 0 C-N-CA 123.668 0.787 . . . . 0.0 109.647 177.153 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 63.21 17.44 59.24 Favored Glycine 0 N--CA 1.496 2.69 0 N-CA-C 121.74 3.456 . . . . 0.0 121.74 172.752 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . 0.269 0.8 OUTLIER 126.33 -45.41 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.472 0 C-N-CA 127.374 2.269 . . . . 0.0 111.087 -159.543 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 64.3 mttm -77.7 142.21 38.91 Favored 'General case' 0 CA--C 1.562 1.408 0 C-N-CA 123.68 0.792 . . . . 0.0 111.937 -176.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 25.7 tp -97.62 104.1 16.09 Favored 'General case' 0 CA--C 1.564 1.514 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 172.088 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 32.9 mm-40 -92.57 142.69 27.12 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 123.332 0.653 . . . . 0.0 111.831 -177.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' CYS . . . . . 0.457 ' SG ' HG22 ' A' ' 86' ' ' VAL . 49.3 t -139.64 136.88 34.78 Favored 'General case' 0 N--CA 1.484 1.238 0 O-C-N 121.441 -0.787 . . . . 0.0 112.127 -178.67 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.7 p -114.78 129.25 71.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 C-N-CA 123.203 0.601 . . . . 0.0 109.506 162.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -105.95 75.55 1.12 Allowed 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 123.593 0.757 . . . . 0.0 109.687 179.575 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -86.92 141.07 29.01 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.487 -1.383 . . . . 0.0 113.388 -173.21 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 135.69 -66.93 0.55 Allowed Glycine 0 N--CA 1.491 2.312 0 O-C-N 121.73 -0.606 . . . . 0.0 113.957 -171.199 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -79.54 -53.54 6.77 Favored 'General case' 0 CA--C 1.57 1.739 0 N-CA-C 115.335 1.606 . . . . 0.0 115.335 -175.719 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 45.1 mmtm -133.12 160.61 36.72 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-N 119.903 1.228 . . . . 0.0 114.313 -166.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -77.04 137.9 39.25 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.43 175.785 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 61.6 35.8 91.68 Favored Glycine 0 N--CA 1.496 2.652 0 N-CA-C 118.785 2.274 . . . . 0.0 118.785 -176.421 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 46.1 ttt180 -96.93 123.95 40.77 Favored 'General case' 0 CA--C 1.561 1.395 0 CA-C-N 118.16 0.98 . . . . 0.0 112.59 -170.095 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 179.92 -169.13 39.81 Favored Glycine 0 N--CA 1.483 1.776 0 CA-C-O 122.129 0.849 . . . . 0.0 114.847 176.647 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 43.4 p-90 -155.1 156.27 35.51 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 175.169 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 49.2 m -125.29 118.71 26.56 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 173.481 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 -118.52 129.81 55.57 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 123.345 0.658 . . . . 0.0 111.07 -178.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 15.3 p90 -150.34 156.72 42.05 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.761 -1.212 . . . . 0.0 113.396 -175.038 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 73.8 mt -101.44 141.76 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.186 0 CA-C-O 122.697 1.237 . . . . 0.0 111.346 -176.872 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -139.7 88.25 2.23 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 123.997 0.919 . . . . 0.0 109.12 -177.594 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 72.29 -112.61 4.1 Favored Glycine 0 N--CA 1.49 2.257 0 CA-C-N 115.87 -0.605 . . . . 0.0 113.755 -173.021 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 54.8 p30 -92.28 7.35 43.11 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 116.78 2.141 . . . . 0.0 116.78 164.034 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -107.87 146.76 31.87 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-N 120.519 1.509 . . . . 0.0 112.526 -174.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 13.8 tp -108.01 118.98 38.17 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 169.056 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 34.1 m80 -106.51 124.24 49.3 Favored 'General case' 0 CA--C 1.559 1.326 0 C-N-CA 123.713 0.805 . . . . 0.0 109.202 -175.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 20.1 tp -120.49 130.29 54.22 Favored 'General case' 0 CA--C 1.561 1.374 0 C-N-CA 123.8 0.84 . . . . 0.0 109.736 -176.876 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -117.76 114.51 23.42 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.567 -0.708 . . . . 0.0 109.532 166.77 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 68.2 mtm -106.81 125.0 50.44 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 123.368 0.667 . . . . 0.0 110.923 -178.224 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 72.7 mtp85 -111.6 140.93 45.81 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 123.381 0.673 . . . . 0.0 112.299 -176.251 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -159.22 135.18 8.81 Favored 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 123.301 0.64 . . . . 0.0 111.876 167.493 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 60.5 21.7 11.41 Favored 'General case' 0 N--CA 1.506 2.351 0 N-CA-C 115.963 1.838 . . . . 0.0 115.963 -170.434 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 82.88 -12.47 48.64 Favored Glycine 0 CA--C 1.56 2.858 0 N-CA-C 119.29 2.476 . . . . 0.0 119.29 -158.812 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 92.3 t -89.11 123.6 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 CA-C-N 120.015 1.908 . . . . 0.0 109.825 -171.723 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 24.1 m -101.16 120.81 40.78 Favored 'General case' 0 N--CA 1.494 1.773 0 C-N-CA 122.922 0.489 . . . . 0.0 112.092 -178.212 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 13.3 t -90.64 125.86 35.78 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.576 0.75 . . . . 0.0 111.655 162.892 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -107.86 113.57 26.89 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -177.153 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 14.4 mt-30 -121.51 126.97 50.5 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.431 -0.793 . . . . 0.0 110.882 -174.7 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 58.1 t -110.83 132.87 58.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -179.083 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -124.84 152.7 43.61 Favored 'General case' 0 CA--C 1.563 1.468 0 C-N-CA 124.307 1.043 . . . . 0.0 110.866 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -120.3 139.24 53.02 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.263 -0.898 . . . . 0.0 111.899 174.198 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 73.3 tttt -73.14 120.32 18.61 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.452 -0.78 . . . . 0.0 112.795 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . 0.253 34.7 m -105.81 -40.18 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 173.743 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 44.6 t60 . . . . . 0 N--CA 1.486 1.365 0 CA-C-N 119.988 1.267 . . . . 0.0 108.192 165.686 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo . . . . . 0 CA--C 1.564 2.008 0 N-CA-C 115.813 1.428 . . . . 0.0 115.813 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 19.0 m -76.52 152.63 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 CA-C-O 122.302 1.049 . . . . 0.0 112.307 165.586 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -76.74 118.08 19.0 Favored 'General case' 0 CA--C 1.565 1.545 0 O-C-N 121.242 -0.911 . . . . 0.0 113.383 178.835 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 6.2 m-30 -84.77 8.47 17.07 Favored 'General case' 0 CA--C 1.579 2.065 0 N-CA-C 115.57 1.693 . . . . 0.0 115.57 169.59 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -57.59 111.99 1.29 Allowed 'General case' 0 CA--C 1.564 1.499 0 N-CA-C 114.916 1.45 . . . . 0.0 114.916 -179.272 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 164.24 173.29 32.74 Favored Glycine 0 N--CA 1.484 1.862 0 N-CA-C 115.944 1.138 . . . . 0.0 115.944 -178.644 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -102.69 120.58 40.82 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-N 114.648 -0.776 . . . . 0.0 108.974 172.854 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 75.6 m95 -119.14 118.64 31.91 Favored 'General case' 0 CA--C 1.566 1.58 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -170.048 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 59.9 pttt -102.72 141.49 35.45 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.144 -0.972 . . . . 0.0 112.76 -176.604 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 45.6 ttm -66.05 124.78 23.49 Favored 'General case' 0 CA--C 1.569 1.689 0 N-CA-C 115.188 1.551 . . . . 0.0 115.188 -175.373 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 94.9 mt -88.32 -49.93 6.65 Favored 'General case' 0 CA--C 1.569 1.675 0 CA-C-N 115.128 -0.942 . . . . 0.0 112.986 164.0 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 87.0 p -136.6 149.56 48.09 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-N 119.143 0.883 . . . . 0.0 112.848 -178.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -135.7 87.24 2.3 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 123.671 0.789 . . . . 0.0 110.175 172.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -98.27 132.7 43.54 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.543 0.737 . . . . 0.0 110.872 -175.406 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.271 41.5 t30 62.75 17.08 9.53 Favored 'General case' 0 N--CA 1.503 2.203 0 N-CA-C 117.588 2.44 . . . . 0.0 117.588 179.757 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -62.4 -46.39 88.83 Favored 'General case' 0 CA--C 1.565 1.551 0 N-CA-C 115.764 1.764 . . . . 0.0 115.764 177.236 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -61.47 -38.93 89.04 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 116.764 2.135 . . . . 0.0 116.764 173.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -65.5 -41.43 93.21 Favored 'General case' 0 CA--C 1.572 1.825 0 CA-C-N 120.684 1.583 . . . . 0.0 114.924 168.768 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 39.4 t80 -55.0 -50.32 69.3 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 114.754 1.39 . . . . 0.0 114.754 166.048 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 91.9 mt -61.87 -43.4 98.91 Favored 'General case' 0 CA--C 1.571 1.775 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 171.799 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 20.4 ttm180 -53.12 -47.55 68.58 Favored 'General case' 0 CA--C 1.578 2.037 0 CA-C-N 120.746 1.612 . . . . 0.0 114.896 164.644 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.46 -19.11 45.19 Favored 'General case' 0 CA--C 1.568 1.647 0 N-CA-C 118.317 2.71 . . . . 0.0 118.317 166.666 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 95.4 mt -92.73 12.55 23.03 Favored 'General case' 0 CA--C 1.572 1.815 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 164.824 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 61.25 45.6 8.68 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 115.21 1.559 . . . . 0.0 115.21 -174.511 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 57.4 t -96.85 143.37 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 CA-C-O 122.388 1.09 . . . . 0.0 110.123 -176.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 -71.46 152.74 42.8 Favored 'General case' 0 CA--C 1.569 1.676 0 N-CA-C 115.022 1.49 . . . . 0.0 115.022 177.234 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 57.8 t -57.37 -41.1 77.8 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.166 0 N-CA-C 115.14 1.533 . . . . 0.0 115.14 -176.159 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.09 -49.32 78.31 Favored 'General case' 0 CA--C 1.567 1.624 0 N-CA-C 116.296 1.961 . . . . 0.0 116.296 174.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -59.55 -48.19 82.61 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 114.136 1.162 . . . . 0.0 114.136 168.406 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 53.2 mtp180 -50.82 -45.42 59.47 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 117.444 2.387 . . . . 0.0 117.444 168.132 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -72.5 -51.7 18.91 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-N 119.978 1.263 . . . . 0.0 113.807 172.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 45.2 mt -58.72 -51.5 71.24 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.23 0 CA-C-N 120.498 1.499 . . . . 0.0 113.293 178.747 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.83 -35.77 82.19 Favored 'General case' 0 CA--C 1.563 1.477 0 N-CA-C 117.76 2.504 . . . . 0.0 117.76 175.696 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -74.33 -30.82 62.19 Favored 'General case' 0 CA--C 1.571 1.777 0 N-CA-C 116.357 1.984 . . . . 0.0 116.357 169.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 79.4 mt -73.02 -34.38 66.31 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 115.209 1.559 . . . . 0.0 115.209 169.752 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 81.9 mt -72.5 152.81 41.69 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 119.318 0.963 . . . . 0.0 112.574 169.911 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -102.65 89.52 1.83 Allowed Pre-proline 0 CA--C 1.57 1.72 0 CA-C-O 118.234 -0.889 . . . . 0.0 109.339 167.701 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -70.16 168.67 21.42 Favored 'Trans proline' 0 CA--C 1.563 1.964 0 C-N-CA 122.47 2.114 . . . . 0.0 115.399 -179.452 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -131.95 128.6 38.81 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.905 -169.113 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -99.79 109.11 21.55 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.161 -0.962 . . . . 0.0 109.822 177.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -93.76 102.74 14.89 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 169.15 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 92.2 mt -94.91 121.38 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -172.784 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 96.0 t -112.1 93.2 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 107.067 -1.456 . . . . 0.0 107.067 176.853 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -89.69 115.97 27.45 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 123.72 0.808 . . . . 0.0 110.556 176.125 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -135.62 70.51 1.43 Allowed 'General case' 0 CA--C 1.569 1.682 0 C-N-CA 123.212 0.605 . . . . 0.0 110.811 -173.663 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 61.98 81.62 0.09 OUTLIER Glycine 0 N--CA 1.495 2.627 0 N-CA-C 116.488 1.355 . . . . 0.0 116.488 173.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.452 1.1 p30 63.85 -39.02 0.2 Allowed 'General case' 0 N--CA 1.504 2.225 0 N-CA-C 118.332 2.716 . . . . 0.0 118.332 -165.181 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 12.4 t-80 -79.15 121.64 25.26 Favored 'General case' 0 CA--C 1.56 1.346 0 CA-C-N 120.157 1.344 . . . . 0.0 111.406 173.333 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 11.3 ttp -134.6 129.51 35.07 Favored 'General case' 0 CA--C 1.556 1.204 0 CA-C-O 122.08 0.943 . . . . 0.0 110.979 -179.639 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 4.4 mp -105.06 113.57 42.45 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.377 0 N-CA-C 107.081 -1.452 . . . . 0.0 107.081 174.696 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 24.5 mm -89.04 93.57 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 167.804 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -80.18 96.68 6.63 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.146 -0.971 . . . . 0.0 109.733 -179.036 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 26.3 m -90.24 100.85 13.6 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 -175.61 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 23.6 mt -105.86 135.13 47.85 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 124.214 1.006 . . . . 0.0 110.491 -164.05 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 12.5 p -144.26 156.36 44.24 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.136 -0.978 . . . . 0.0 112.597 177.692 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.6 m -77.75 61.08 2.35 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 120.742 -1.223 . . . . 0.0 112.316 172.24 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -177.14 -67.55 0.01 OUTLIER 'General case' 0 CA--C 1.568 1.657 0 C-N-CA 126.013 1.725 . . . . 0.0 107.946 -174.289 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 56.7 ttt85 -144.76 140.94 28.84 Favored 'General case' 0 CA--C 1.565 1.528 0 CA-C-O 121.784 0.802 . . . . 0.0 110.217 177.382 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -105.18 119.43 39.03 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 175.003 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 19.3 t80 -81.75 -57.73 3.31 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 114.074 1.139 . . . . 0.0 114.074 -172.551 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.272 10.4 mm 76.2 95.97 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 C-N-CA 124.071 0.949 . . . . 0.0 111.798 172.395 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 91.1 mtp -97.52 94.2 6.88 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.994 -1.066 . . . . 0.0 109.628 173.71 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.9 p30 -96.19 111.29 23.39 Favored 'General case' 0 CA--C 1.561 1.38 0 C-N-CA 124.069 0.948 . . . . 0.0 112.136 179.163 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 20.4 p90 -150.38 158.57 44.31 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 -168.882 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -95.22 134.19 38.25 Favored 'General case' 0 CA--C 1.563 1.47 0 O-C-N 121.464 -0.773 . . . . 0.0 110.938 164.491 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 36.4 t -72.53 122.92 26.09 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.807 0 C-N-CA 123.845 0.858 . . . . 0.0 109.431 178.661 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 104.74 -48.55 0.98 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 115.56 0.984 . . . . 0.0 115.56 -163.636 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 26.2 tptp -65.14 133.48 51.66 Favored 'General case' 0 CA--C 1.567 1.618 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 176.225 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -92.48 110.19 21.6 Favored 'General case' 0 CA--C 1.569 1.709 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.139 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -118.99 134.44 55.19 Favored 'General case' 0 N--CA 1.498 1.947 0 C-N-CA 124.092 0.957 . . . . 0.0 112.664 -169.385 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -73.41 131.78 42.23 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.248 -1.532 . . . . 0.0 114.245 178.704 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 . . . . . 0 N--CA 1.5 2.068 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 176.819 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 97.8 m . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 121.384 0.611 . . . . 0.0 110.626 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 33.7 mtp -71.2 105.37 3.4 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-O 122.305 1.05 . . . . 0.0 111.799 -179.64 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 53.8 m -106.13 119.2 38.61 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.638 -161.406 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 87.6 m -94.79 124.68 38.98 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 166.727 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 57.8 t -105.45 135.95 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 167.141 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 52.4 m -147.5 146.88 29.66 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.286 -1.509 . . . . 0.0 112.528 -177.47 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 47.1 m95 -83.94 119.03 24.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.177 -0.952 . . . . 0.0 112.782 178.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -96.13 71.55 2.86 Favored 'General case' 0 CA--C 1.573 1.849 0 C-N-CA 123.061 0.544 . . . . 0.0 109.569 157.755 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 62.65 -102.83 0.54 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 115.653 1.021 . . . . 0.0 115.653 -175.21 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -80.77 -22.29 40.26 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 116.312 1.967 . . . . 0.0 116.312 169.124 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 61.2 mtpt -92.92 121.83 34.67 Favored 'General case' 0 CA--C 1.56 1.349 0 CA-C-N 119.547 1.067 . . . . 0.0 110.499 -177.889 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 33.0 tp -89.17 106.98 18.79 Favored 'General case' 0 CA--C 1.564 1.492 0 O-C-N 121.407 -0.808 . . . . 0.0 109.345 174.099 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 -96.59 137.21 36.01 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.724 0.81 . . . . 0.0 111.349 -175.545 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 40.7 t -134.17 128.35 33.86 Favored 'General case' 0 N--CA 1.483 1.189 0 O-C-N 121.732 -0.605 . . . . 0.0 111.742 -177.056 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 11.1 p -122.47 124.1 70.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 C-N-CA 123.284 0.634 . . . . 0.0 109.84 176.133 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -102.66 106.85 17.57 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 123.855 0.862 . . . . 0.0 110.385 -176.272 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -101.85 124.12 46.94 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.289 -0.882 . . . . 0.0 111.666 -169.716 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 177.49 -62.17 0.09 OUTLIER Glycine 0 N--CA 1.494 2.541 0 N-CA-C 117.388 1.715 . . . . 0.0 117.388 178.337 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -134.12 -58.41 0.85 Allowed 'General case' 0 N--CA 1.496 1.836 0 CA-C-N 117.529 0.664 . . . . 0.0 112.151 178.489 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 53.8 mttm -79.37 139.78 37.65 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 114.374 1.25 . . . . 0.0 114.374 -176.042 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -80.33 146.98 31.3 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-N 114.638 -1.165 . . . . 0.0 112.705 175.337 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 65.04 20.3 66.76 Favored Glycine 0 N--CA 1.495 2.59 0 N-CA-C 119.802 2.681 . . . . 0.0 119.802 -173.629 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 26.6 ttt180 -84.36 118.17 24.06 Favored 'General case' 0 CA--C 1.566 1.577 0 CA-C-N 118.91 1.355 . . . . 0.0 111.654 -177.883 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 179.29 -171.77 43.7 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 115.298 0.879 . . . . 0.0 115.298 -174.93 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . 0.259 39.9 p-90 -156.49 155.0 31.24 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 170.647 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 84.7 m -128.06 116.55 20.18 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 177.192 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -120.26 126.98 51.93 Favored 'General case' 0 N--CA 1.495 1.821 0 C-N-CA 123.545 0.738 . . . . 0.0 111.537 -174.302 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 16.3 p90 -148.61 155.38 41.0 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 120.893 -1.13 . . . . 0.0 113.364 -178.052 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 90.7 mt -98.1 132.96 41.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.02 -1.05 . . . . 0.0 110.291 177.298 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -118.79 94.04 4.31 Favored 'General case' 0 CA--C 1.566 1.594 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 162.239 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 69.07 -112.38 4.52 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 115.396 0.919 . . . . 0.0 115.396 -178.786 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 16.0 p30 -85.96 -2.42 58.27 Favored 'General case' 0 CA--C 1.572 1.827 0 N-CA-C 117.139 2.274 . . . . 0.0 117.139 166.32 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 88.2 mt-10 -109.93 128.95 55.69 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-N 120.646 1.566 . . . . 0.0 111.712 -174.142 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 12.2 tp -90.59 116.03 28.17 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.962 0.905 . . . . 0.0 109.421 167.93 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 57.7 m80 -99.9 122.45 42.84 Favored 'General case' 0 CA--C 1.559 1.295 0 C-N-CA 123.936 0.895 . . . . 0.0 109.422 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 47.6 tp -123.96 119.65 30.21 Favored 'General case' 0 CA--C 1.561 1.368 0 C-N-CA 123.974 0.909 . . . . 0.0 109.878 -174.719 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -108.74 106.62 16.73 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 171.402 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 62.0 mtm -99.72 125.83 45.67 Favored 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 123.043 0.537 . . . . 0.0 111.05 -178.589 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 71.5 mtm180 -114.56 139.41 49.61 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 123.629 0.772 . . . . 0.0 111.551 -168.114 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -155.64 124.6 6.11 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.583 -0.698 . . . . 0.0 110.798 168.309 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 60.55 36.21 19.95 Favored 'General case' 0 N--CA 1.505 2.32 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 -178.176 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 78.64 -22.39 3.36 Favored Glycine 0 CA--C 1.554 2.524 0 N-CA-C 119.3 2.48 . . . . 0.0 119.3 -162.006 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 85.7 t -80.15 120.83 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 CA-C-N 119.886 1.843 . . . . 0.0 110.091 -171.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 57.0 m -103.74 118.22 36.2 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 122.923 0.489 . . . . 0.0 111.015 -179.399 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 37.7 t -84.74 127.79 34.28 Favored 'General case' 0 CA--C 1.559 1.291 0 C-N-CA 123.115 0.566 . . . . 0.0 111.953 162.557 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 38.2 mtmm -106.21 109.39 21.31 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -179.36 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -114.69 133.19 56.07 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 123.674 0.79 . . . . 0.0 111.14 179.115 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 44.7 t -118.06 131.3 71.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 177.405 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -125.96 138.26 53.75 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 123.328 0.651 . . . . 0.0 111.656 -179.422 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 29.0 tptp -96.39 137.25 35.74 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.156 -0.965 . . . . 0.0 112.623 178.691 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 73.1 tttt -70.73 123.6 22.31 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 174.462 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 24.4 m -107.0 -42.67 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.13 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 173.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 32.8 m80 . . . . . 0 C--O 1.254 1.293 0 CA-C-N 119.601 1.091 . . . . 0.0 108.683 179.256 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo . . . . . 0 CA--C 1.561 1.849 0 N-CA-C 115.728 1.395 . . . . 0.0 115.728 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 33.0 m -75.37 152.91 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 CA-C-O 122.305 1.05 . . . . 0.0 113.121 177.226 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -71.93 113.53 9.06 Favored 'General case' 0 CA--C 1.56 1.365 0 O-C-N 121.328 -0.857 . . . . 0.0 112.212 172.341 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 6.0 m-30 -77.02 6.38 6.44 Favored 'General case' 0 CA--C 1.582 2.173 0 N-CA-C 116.188 1.922 . . . . 0.0 116.188 173.339 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -53.51 111.42 0.71 Allowed 'General case' 0 CA--C 1.565 1.532 0 C-N-CA 126.376 1.87 . . . . 0.0 115.597 -178.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 163.1 178.18 36.68 Favored Glycine 0 N--CA 1.482 1.759 0 CA-C-O 123.01 1.339 . . . . 0.0 116.104 177.868 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -107.76 124.6 50.27 Favored 'General case' 0 CA--C 1.563 1.46 0 CA-C-N 113.869 -1.165 . . . . 0.0 109.088 175.61 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -118.92 140.92 49.18 Favored 'General case' 0 CA--C 1.569 1.674 0 C-N-CA 123.9 0.88 . . . . 0.0 110.357 -168.242 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -115.6 133.04 56.42 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.165 -0.959 . . . . 0.0 111.841 176.751 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 53.9 ttm -71.61 123.83 23.37 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.096 -1.002 . . . . 0.0 113.562 -177.295 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 94.9 mt -81.19 -53.18 6.6 Favored 'General case' 0 CA--C 1.567 1.626 0 CA-C-N 115.307 -0.861 . . . . 0.0 112.466 169.35 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 92.4 p -145.65 124.8 12.89 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.662 0.785 . . . . 0.0 111.106 -175.475 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -103.19 96.21 6.63 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.92 0.867 . . . . 0.0 110.527 166.047 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -99.24 127.05 45.18 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 124.007 0.923 . . . . 0.0 109.592 -171.902 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 5.9 t30 66.32 23.16 10.76 Favored 'General case' 0 N--CA 1.508 2.443 0 N-CA-C 116.794 2.146 . . . . 0.0 116.794 -174.568 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -69.08 -46.96 66.47 Favored 'General case' 0 CA--C 1.568 1.656 0 N-CA-C 115.034 1.494 . . . . 0.0 115.034 178.135 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -42.09 -54.42 3.59 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 118.091 2.626 . . . . 0.0 118.091 167.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.28 8.5 pt-20 -75.67 -31.3 59.69 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 116.612 2.079 . . . . 0.0 116.612 176.908 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 79.5 t80 -55.4 -48.4 74.41 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-N 120.36 1.437 . . . . 0.0 114.569 160.119 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 69.3 mt -60.82 -40.97 94.75 Favored 'General case' 0 CA--C 1.574 1.898 0 N-CA-C 114.887 1.439 . . . . 0.0 114.887 170.753 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 37.6 ttm-85 -51.73 -50.84 59.77 Favored 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 115.262 1.578 . . . . 0.0 115.262 163.25 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.32 -25.37 59.24 Favored 'General case' 0 CA--C 1.566 1.574 0 N-CA-C 117.87 2.544 . . . . 0.0 117.87 168.681 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 97.0 mt -87.58 9.81 19.96 Favored 'General case' 0 CA--C 1.573 1.864 0 N-CA-C 115.656 1.724 . . . . 0.0 115.656 168.243 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 60.54 43.91 12.36 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 115.606 1.706 . . . . 0.0 115.606 -172.273 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 95.4 t -93.9 138.7 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.193 -0.942 . . . . 0.0 109.231 177.818 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 13.1 p30 -63.79 150.38 44.78 Favored 'General case' 0 CA--C 1.57 1.731 0 N-CA-C 115.251 1.575 . . . . 0.0 115.251 178.627 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 88.8 t -56.41 -40.24 66.01 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.22 0 N-CA-C 115.522 1.675 . . . . 0.0 115.522 -177.76 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.5 -53.69 55.35 Favored 'General case' 0 CA--C 1.568 1.672 0 N-CA-C 115.739 1.755 . . . . 0.0 115.739 169.215 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 28.9 tp -63.39 -38.28 90.52 Favored 'General case' 0 CA--C 1.571 1.781 0 N-CA-C 116.175 1.917 . . . . 0.0 116.175 171.22 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 34.6 mtp-105 -49.76 -52.05 34.58 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 115.801 1.778 . . . . 0.0 115.801 163.533 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -64.15 -49.09 73.49 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 114.547 1.314 . . . . 0.0 114.547 172.394 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 64.6 mt -58.49 -51.98 65.02 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 CA-C-N 119.996 1.271 . . . . 0.0 113.152 176.358 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.01 -35.82 81.97 Favored 'General case' 0 CA--C 1.563 1.47 0 N-CA-C 117.682 2.475 . . . . 0.0 117.682 175.497 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -72.23 -31.02 65.45 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 116.049 1.87 . . . . 0.0 116.049 168.115 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 78.3 mt -73.46 -35.15 65.67 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 115.317 1.599 . . . . 0.0 115.317 171.176 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 86.6 mt -83.22 143.68 30.29 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 119.069 0.85 . . . . 0.0 111.858 175.513 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 29.9 mmtp -106.05 88.36 3.01 Favored Pre-proline 0 CA--C 1.574 1.903 0 CA-C-O 117.982 -1.009 . . . . 0.0 109.641 176.078 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -73.18 166.41 30.04 Favored 'Trans proline' 0 CA--C 1.564 1.981 0 C-N-CA 122.45 2.1 . . . . 0.0 116.089 -175.401 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -98.74 155.7 17.21 Favored 'General case' 0 N--CA 1.488 1.425 0 CA-C-O 121.824 0.821 . . . . 0.0 112.373 177.192 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 65.2 mttt -117.4 121.14 40.27 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.508 -0.745 . . . . 0.0 109.357 164.382 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -94.61 109.77 21.66 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.104 -0.997 . . . . 0.0 108.594 161.17 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 68.3 mt -102.32 118.76 49.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 N-CA-C 107.424 -1.325 . . . . 0.0 107.424 179.187 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 57.3 t -111.35 95.43 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 172.099 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -88.32 97.87 11.28 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 123.519 0.728 . . . . 0.0 110.298 173.377 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -114.94 88.92 2.97 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 123.452 0.701 . . . . 0.0 109.973 -176.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 57.98 67.68 2.08 Favored Glycine 0 N--CA 1.495 2.607 0 N-CA-C 116.631 1.412 . . . . 0.0 116.631 178.833 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.477 0.6 OUTLIER 64.26 -25.46 0.08 Allowed 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 119.183 3.031 . . . . 0.0 119.183 -165.08 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 15.7 t-160 -78.09 109.48 12.21 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 121.284 1.856 . . . . 0.0 111.156 174.504 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 46.3 ttm -110.19 114.06 27.24 Favored 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 123.729 0.812 . . . . 0.0 109.496 -175.86 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 49.7 mt -100.15 102.59 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 175.919 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 59.1 mt -95.92 104.73 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 175.311 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 89.3 mtt180 -90.65 103.52 16.21 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.648 -0.658 . . . . 0.0 109.276 175.036 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 22.1 m -87.36 101.42 13.54 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.052 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 5.9 mt -111.96 118.48 35.59 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 124.009 0.924 . . . . 0.0 110.093 -163.707 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.1 t -99.08 -78.43 0.5 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.45 -0.781 . . . . 0.0 112.614 178.358 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.7 t 178.58 -61.58 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 125.699 1.6 . . . . 0.0 107.444 -170.176 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 7.9 p90 -83.89 -41.37 17.5 Favored 'General case' 0 CA--C 1.573 1.865 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 163.082 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 42.1 ttt85 -109.43 143.16 39.4 Favored 'General case' 0 CA--C 1.565 1.537 0 C-N-CA 124.124 0.97 . . . . 0.0 112.083 -168.147 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 46.1 t-20 -135.4 131.73 36.65 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 123.383 0.673 . . . . 0.0 110.096 175.486 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 9.2 t80 -124.78 110.24 14.07 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 172.813 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 87.1 mt -102.29 112.42 35.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -176.422 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 27.0 mmm -95.83 94.81 7.87 Favored 'General case' 0 CA--C 1.56 1.359 0 C-N-CA 123.628 0.771 . . . . 0.0 109.238 174.419 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.1 p30 -101.29 100.38 10.89 Favored 'General case' 0 CA--C 1.561 1.377 0 C-N-CA 123.725 0.81 . . . . 0.0 111.616 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -143.96 150.83 38.92 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -166.646 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 -90.44 125.19 35.48 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.977 -1.077 . . . . 0.0 111.81 169.389 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 17.2 t -68.84 119.03 14.0 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.735 0 C-N-CA 123.858 0.863 . . . . 0.0 110.043 179.208 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 111.7 -43.49 1.71 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 115.778 1.071 . . . . 0.0 115.778 -160.08 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 51.2 mttm -83.71 143.87 29.74 Favored 'General case' 0 CA--C 1.567 1.608 0 CA-C-N 118.884 1.342 . . . . 0.0 113.41 -175.898 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -92.04 121.07 33.26 Favored 'General case' 0 CA--C 1.567 1.615 0 O-C-N 121.882 -0.511 . . . . 0.0 111.277 172.727 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 22.5 p90 -120.63 152.25 38.41 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 123.777 0.831 . . . . 0.0 112.668 -176.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -74.2 120.37 19.67 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.183 -1.573 . . . . 0.0 112.181 167.912 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 . . . . . 0 N--CA 1.492 1.67 0 O-C-N 121.326 -0.859 . . . . 0.0 111.077 169.868 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 85.6 m . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 121.723 0.773 . . . . 0.0 111.741 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 8.9 tpt -79.01 108.67 12.67 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.879 -1.138 . . . . 0.0 110.743 -178.839 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 97.4 m -119.71 114.57 22.38 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.146 -0.971 . . . . 0.0 111.069 -151.211 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 52.7 m -92.07 129.95 37.91 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 165.542 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.6 t -113.43 129.08 69.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 163.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 52.2 m -149.04 156.8 42.77 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.587 -1.32 . . . . 0.0 112.843 -175.859 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 72.8 m95 -82.23 115.39 21.29 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.89 -1.131 . . . . 0.0 112.308 179.305 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -84.83 72.99 10.7 Favored 'General case' 0 CA--C 1.569 1.709 0 O-C-N 121.382 -0.824 . . . . 0.0 109.869 163.864 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 69.42 -98.51 0.59 Allowed Glycine 0 N--CA 1.488 2.125 0 O-C-N 122.188 -0.32 . . . . 0.0 113.646 -167.147 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -99.95 -14.63 18.62 Favored 'General case' 0 CA--C 1.575 1.916 0 N-CA-C 116.393 1.997 . . . . 0.0 116.393 169.5 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 48.7 mtpt -92.82 127.33 38.29 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-N 120.407 1.458 . . . . 0.0 110.236 -176.08 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 26.0 tp -85.03 105.86 16.1 Favored 'General case' 0 CA--C 1.563 1.462 0 O-C-N 120.739 -1.226 . . . . 0.0 110.562 -177.375 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 29.5 mm-40 -95.16 129.34 42.3 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 123.369 0.668 . . . . 0.0 111.478 -177.704 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 41.4 t -116.35 128.34 55.45 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.666 0.786 . . . . 0.0 110.896 173.719 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.6 p -118.76 116.72 52.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 173.454 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 68.7 mt-30 -104.18 98.01 7.88 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 123.84 0.856 . . . . 0.0 109.079 -173.549 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -91.49 134.89 34.26 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.424 -0.797 . . . . 0.0 113.074 -164.275 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 160.43 -109.89 0.42 Allowed Glycine 0 N--CA 1.486 2.009 0 O-C-N 121.504 -0.748 . . . . 0.0 113.526 165.716 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -84.63 -39.08 19.08 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 115.906 1.817 . . . . 0.0 115.906 -175.64 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 17.8 ttmm -88.6 129.07 35.57 Favored 'General case' 0 CA--C 1.564 1.504 0 CA-C-N 119.5 1.046 . . . . 0.0 112.315 -175.397 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -76.16 134.13 40.02 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -172.911 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 61.93 32.97 83.94 Favored Glycine 0 N--CA 1.496 2.637 0 N-CA-C 119.622 2.609 . . . . 0.0 119.622 -177.444 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 3.9 ttt85 -86.97 119.77 27.53 Favored 'General case' 0 CA--C 1.564 1.515 0 CA-C-N 118.863 1.331 . . . . 0.0 111.264 -179.032 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -178.62 -171.83 42.32 Favored Glycine 0 N--CA 1.483 1.804 0 CA-C-O 122.102 0.834 . . . . 0.0 114.366 179.48 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 47.7 p-90 -156.08 156.24 33.98 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 175.382 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 29.4 m -127.96 119.65 25.95 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 177.004 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -122.72 131.49 53.81 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 -176.44 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 23.9 p90 -148.87 160.66 43.04 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.202 -0.937 . . . . 0.0 112.184 -179.314 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 96.1 mt -109.09 135.04 49.2 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.182 0 O-C-N 120.722 -1.236 . . . . 0.0 110.637 178.498 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -122.51 94.52 4.31 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 124.417 1.087 . . . . 0.0 108.156 176.293 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 73.11 -109.56 2.85 Favored Glycine 0 N--CA 1.491 2.34 0 O-C-N 121.494 -0.754 . . . . 0.0 114.024 -174.231 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -111.55 37.3 2.94 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 114.514 1.301 . . . . 0.0 114.514 164.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 81.3 mt-10 -130.72 130.66 44.09 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.709 0.804 . . . . 0.0 110.642 178.72 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 15.5 tp -90.85 118.09 29.98 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 123.892 0.877 . . . . 0.0 109.526 173.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 43.1 m80 -106.39 118.76 37.48 Favored 'General case' 0 CA--C 1.559 1.294 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -178.532 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 46.8 tp -122.24 124.53 44.02 Favored 'General case' 0 CA--C 1.559 1.301 0 C-N-CA 124.078 0.951 . . . . 0.0 109.572 -173.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 77.5 mt-10 -114.03 109.89 19.18 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.547 -0.72 . . . . 0.0 109.661 170.604 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 68.7 mtm -101.64 127.2 48.49 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 123.336 0.654 . . . . 0.0 110.858 -177.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 54.2 mtp85 -116.83 137.62 52.08 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 123.416 0.687 . . . . 0.0 110.932 -171.44 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -157.18 129.38 7.29 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.562 -0.711 . . . . 0.0 111.278 170.787 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . 0.276 22.6 mt-10 57.57 38.37 27.87 Favored 'General case' 0 N--CA 1.502 2.15 0 N-CA-C 115.77 1.767 . . . . 0.0 115.77 -176.256 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 69.14 9.26 60.05 Favored Glycine 0 CA--C 1.555 2.586 0 N-CA-C 120.365 2.906 . . . . 0.0 120.365 -164.344 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 95.0 t -111.59 125.54 68.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 CA-C-N 119.989 1.894 . . . . 0.0 108.972 -174.641 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 41.7 m -106.73 123.24 47.85 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 123.137 0.575 . . . . 0.0 111.168 -176.193 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 22.1 t -94.27 124.2 38.14 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.541 0.736 . . . . 0.0 111.513 164.378 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 48.5 mtpt -99.02 114.74 27.56 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 123.38 0.672 . . . . 0.0 109.65 177.773 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 20.2 mt-30 -119.78 123.59 44.09 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 123.35 0.66 . . . . 0.0 110.729 -178.606 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 43.8 t -112.91 130.49 66.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.411 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -123.97 147.45 47.74 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 123.595 0.758 . . . . 0.0 110.909 177.327 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -107.02 143.5 35.03 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.222 -0.924 . . . . 0.0 112.24 174.86 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 64.9 tttt -77.08 124.65 28.1 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 -177.186 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 27.7 m -110.86 -40.22 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 178.384 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 47.6 t-80 . . . . . 0 N--CA 1.486 1.373 0 CA-C-N 120.474 1.488 . . . . 0.0 108.488 174.824 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo . . . . . 0 CA--C 1.574 2.496 0 N-CA-C 115.867 1.449 . . . . 0.0 115.867 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 16.9 t -151.0 132.06 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 -172.227 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -75.78 90.09 2.88 Favored 'General case' 0 CA--C 1.569 1.698 0 O-C-N 121.193 -0.942 . . . . 0.0 111.76 172.065 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 10.6 m-30 -70.36 -1.38 10.4 Favored 'General case' 0 CA--C 1.58 2.119 0 N-CA-C 117.834 2.531 . . . . 0.0 117.834 176.904 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -51.96 123.61 10.8 Favored 'General case' 0 CA--C 1.566 1.594 0 N-CA-C 115.668 1.729 . . . . 0.0 115.668 177.382 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 163.21 176.93 35.73 Favored Glycine 0 N--CA 1.486 1.995 0 N-CA-C 116.153 1.221 . . . . 0.0 116.153 178.783 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -111.58 121.0 43.97 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 171.335 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 78.9 m95 -124.71 126.11 45.17 Favored 'General case' 0 CA--C 1.566 1.594 0 C-N-CA 123.297 0.639 . . . . 0.0 110.591 -165.498 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -96.62 138.97 33.39 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 120.673 -1.267 . . . . 0.0 113.215 177.446 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 6.5 ttp -74.68 128.41 35.49 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.683 -1.261 . . . . 0.0 114.207 -178.177 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 91.0 mt -90.39 -50.05 6.18 Favored 'General case' 0 CA--C 1.567 1.617 0 N-CA-C 113.874 1.065 . . . . 0.0 113.874 172.878 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 91.3 p -139.98 154.81 47.27 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -175.43 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 24.7 p30 -135.77 81.36 1.88 Allowed 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 124.133 0.973 . . . . 0.0 111.092 173.52 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -88.67 119.58 29.27 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.102 -0.999 . . . . 0.0 110.144 -174.547 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.273 41.9 t30 67.95 21.68 8.84 Favored 'General case' 0 N--CA 1.504 2.251 0 N-CA-C 116.821 2.156 . . . . 0.0 116.821 -175.533 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -69.29 -47.14 65.41 Favored 'General case' 0 CA--C 1.568 1.666 0 N-CA-C 115.795 1.776 . . . . 0.0 115.795 178.051 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -46.48 -44.41 17.55 Favored 'General case' 0 N--CA 1.502 2.173 0 N-CA-C 117.534 2.42 . . . . 0.0 117.534 165.89 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -69.44 -44.79 70.57 Favored 'General case' 0 CA--C 1.57 1.731 0 N-CA-C 114.992 1.479 . . . . 0.0 114.992 172.658 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -52.94 -47.35 68.14 Favored 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 115.123 1.527 . . . . 0.0 115.123 166.532 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.7 mt -61.14 -41.63 97.08 Favored 'General case' 0 CA--C 1.571 1.782 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 169.805 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 44.2 ttp85 -56.62 -45.52 81.47 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 115.36 1.615 . . . . 0.0 115.36 166.627 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.12 -25.1 60.98 Favored 'General case' 0 CA--C 1.567 1.606 0 N-CA-C 117.827 2.528 . . . . 0.0 117.827 165.587 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 98.1 mt -89.39 21.79 3.19 Favored 'General case' 0 CA--C 1.573 1.836 0 N-CA-C 115.23 1.567 . . . . 0.0 115.23 164.888 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 66.9 16.39 10.36 Favored 'General case' 0 N--CA 1.504 2.236 0 N-CA-C 116.682 2.104 . . . . 0.0 116.682 179.551 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 91.4 t -82.03 136.35 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 120.223 -1.548 . . . . 0.0 110.215 -167.463 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 13.7 p30 -62.06 152.86 31.45 Favored 'General case' 0 CA--C 1.57 1.727 0 N-CA-C 115.208 1.559 . . . . 0.0 115.208 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 91.5 t -58.7 -38.4 71.53 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.153 0 N-CA-C 115.219 1.563 . . . . 0.0 115.219 -176.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.12 -55.98 27.64 Favored 'General case' 0 CA--C 1.569 1.687 0 N-CA-C 115.448 1.647 . . . . 0.0 115.448 167.784 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -56.52 -43.29 79.65 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 116.275 1.954 . . . . 0.0 116.275 169.744 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 37.3 mtp-105 -52.07 -53.06 46.85 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 116.017 1.858 . . . . 0.0 116.017 168.343 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -66.75 -47.75 71.27 Favored 'General case' 0 CA--C 1.567 1.629 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 174.052 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 66.1 mt -55.34 -54.87 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 CA-C-N 120.047 1.294 . . . . 0.0 113.266 174.042 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.84 -38.02 89.13 Favored 'General case' 0 CA--C 1.564 1.514 0 N-CA-C 117.635 2.457 . . . . 0.0 117.635 176.257 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -74.16 -24.11 59.35 Favored 'General case' 0 CA--C 1.571 1.759 0 N-CA-C 116.138 1.903 . . . . 0.0 116.138 171.265 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 73.6 mt -73.2 -37.79 66.34 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 115.405 1.631 . . . . 0.0 115.405 168.255 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.5 pp -84.28 143.92 29.23 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 119.597 1.089 . . . . 0.0 113.923 -178.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm -104.53 101.88 30.58 Favored Pre-proline 0 CA--C 1.572 1.818 0 CA-C-O 117.954 -1.022 . . . . 0.0 109.348 174.111 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -82.26 172.12 11.96 Favored 'Trans proline' 0 CA--C 1.564 2.014 0 C-N-CA 122.805 2.337 . . . . 0.0 114.778 -176.925 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -109.2 118.97 38.11 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.278 176.782 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 52.6 mttm -85.38 108.3 17.78 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.073 -1.017 . . . . 0.0 109.895 172.417 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -91.89 108.06 19.65 Favored 'General case' 0 CA--C 1.559 1.302 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 164.676 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 84.9 mt -97.6 114.15 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 -179.651 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 98.0 t -101.06 97.72 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 168.49 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -95.66 99.63 11.46 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 123.673 0.789 . . . . 0.0 109.727 175.328 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -106.64 75.25 1.05 Allowed 'General case' 0 CA--C 1.567 1.612 0 C-N-CA 123.557 0.743 . . . . 0.0 110.563 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 57.61 68.24 1.8 Allowed Glycine 0 N--CA 1.494 2.552 0 N-CA-C 117.628 1.811 . . . . 0.0 117.628 177.789 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.494 0.0 OUTLIER 81.99 -39.24 0.12 Allowed 'General case' 0 N--CA 1.501 2.108 0 N-CA-C 115.837 1.792 . . . . 0.0 115.837 -165.358 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 21.8 t-160 -74.32 100.49 3.77 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 120.677 1.58 . . . . 0.0 111.183 177.327 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 42.5 ttm -113.14 111.26 21.8 Favored 'General case' 0 CA--C 1.552 1.031 0 CA-C-O 121.665 0.745 . . . . 0.0 109.137 -170.191 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 51.8 mt -102.79 103.12 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 -175.866 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 26.0 mm -89.22 93.72 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 -178.925 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 61.1 mtt85 -90.45 97.38 11.15 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.232 -0.918 . . . . 0.0 110.099 178.565 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 14.3 m -89.41 99.19 12.24 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.69 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 15.1 mt -93.77 117.36 29.99 Favored 'General case' 0 N--CA 1.484 1.266 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.594 -162.308 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 42.2 t -133.11 141.27 48.09 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.849 0.859 . . . . 0.0 110.752 -159.462 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 13.1 t -74.09 39.35 0.11 Allowed 'General case' 0 CA--C 1.581 2.144 0 N-CA-C 116.701 2.112 . . . . 0.0 116.701 172.834 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -159.52 -65.29 0.08 Allowed 'General case' 0 CA--C 1.567 1.621 0 C-N-CA 124.676 1.19 . . . . 0.0 109.92 178.846 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 53.4 ttm-85 -140.09 117.52 11.42 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 123.625 0.77 . . . . 0.0 108.942 174.819 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 72.0 m-80 -76.77 126.99 31.92 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.785 -0.572 . . . . 0.0 111.993 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 40.9 t80 -106.47 100.28 9.82 Favored 'General case' 0 CA--C 1.567 1.606 0 O-C-N 121.645 -0.66 . . . . 0.0 110.724 -172.317 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 4.1 mp -95.36 111.22 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 C-N-CA 123.73 0.812 . . . . 0.0 109.051 178.392 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -103.55 94.83 5.67 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 123.413 0.685 . . . . 0.0 109.621 176.672 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -100.38 118.07 35.87 Favored 'General case' 0 CA--C 1.564 1.486 0 C-N-CA 123.913 0.885 . . . . 0.0 112.805 -174.489 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -155.15 143.2 20.11 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 -170.147 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 17.9 mp0 -85.18 116.17 23.39 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.441 -0.787 . . . . 0.0 110.376 166.405 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 41.2 t -65.08 117.54 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 C-N-CA 123.769 0.828 . . . . 0.0 110.047 177.242 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 118.61 -54.68 0.61 Allowed Glycine 0 N--CA 1.488 2.139 0 N-CA-C 114.675 0.63 . . . . 0.0 114.675 -159.049 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 5.9 mtmp? -80.79 148.02 30.21 Favored 'General case' 0 CA--C 1.566 1.586 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 -173.519 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -98.78 124.13 43.45 Favored 'General case' 0 CA--C 1.568 1.665 0 C-N-CA 123.183 0.593 . . . . 0.0 111.78 178.497 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 9.0 p90 -135.76 145.63 46.79 Favored 'General case' 0 N--CA 1.498 1.967 0 C-N-CA 123.837 0.855 . . . . 0.0 112.024 -171.605 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -79.15 128.29 33.1 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 119.54 -1.975 . . . . 0.0 113.64 177.675 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 . . . . . 0 N--CA 1.493 1.677 0 CA-C-O 122.238 1.018 . . . . 0.0 112.079 173.267 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 73.0 m . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 121.922 0.868 . . . . 0.0 113.038 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 7.2 tpt -75.88 111.13 10.92 Favored 'General case' 0 CA--C 1.56 1.331 0 CA-C-O 122.175 0.988 . . . . 0.0 110.522 -170.318 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 93.8 m -120.61 120.61 36.27 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 115.377 -0.828 . . . . 0.0 110.399 -153.501 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 50.9 m -105.79 125.29 50.82 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 171.902 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.435 HG22 ' SG ' ' A' ' 95' ' ' CYS . 20.4 t -104.61 130.8 54.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 165.794 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 58.7 m -149.94 152.35 34.85 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.455 -1.403 . . . . 0.0 112.871 -178.418 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 52.3 m95 -83.78 118.96 24.26 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.939 -1.1 . . . . 0.0 113.544 -176.907 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -94.13 67.38 3.61 Favored 'General case' 0 CA--C 1.572 1.819 0 O-C-N 121.594 -0.691 . . . . 0.0 110.101 159.126 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 67.09 -102.63 0.81 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 114.798 0.679 . . . . 0.0 114.798 -176.371 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -80.81 -23.22 39.38 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 116.523 2.045 . . . . 0.0 116.523 169.284 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 60.1 mtpt -98.77 116.15 30.36 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 119.317 0.962 . . . . 0.0 110.182 -174.659 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 29.2 tp -82.83 109.47 16.99 Favored 'General case' 0 CA--C 1.564 1.485 0 O-C-N 121.277 -0.89 . . . . 0.0 110.057 175.438 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 -97.78 131.93 43.85 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.644 0.778 . . . . 0.0 111.538 -174.194 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' CYS . . . . . 0.435 ' SG ' HG22 ' A' ' 86' ' ' VAL . 44.9 t -122.26 128.92 51.71 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.341 0.657 . . . . 0.0 110.744 175.208 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.1 p -110.69 127.6 67.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 166.221 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -109.05 88.62 2.77 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 123.453 0.701 . . . . 0.0 109.665 175.821 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 12.0 ptmm? -97.22 145.19 26.3 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 114.309 1.225 . . . . 0.0 114.309 -172.23 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 159.75 -97.52 0.16 Allowed Glycine 0 N--CA 1.488 2.133 0 O-C-N 121.282 -0.886 . . . . 0.0 112.626 173.092 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -75.2 -47.16 29.63 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 115.125 1.528 . . . . 0.0 115.125 173.788 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 1.6 ttmp? -103.51 131.79 50.33 Favored 'General case' 0 CA--C 1.561 1.38 0 C-N-CA 123.636 0.774 . . . . 0.0 111.77 -161.796 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -77.87 160.38 28.32 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -179.41 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 56.57 21.43 35.08 Favored Glycine 0 N--CA 1.498 2.774 0 N-CA-C 120.722 3.049 . . . . 0.0 120.722 -179.59 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 45.1 ttt180 -96.02 123.21 39.53 Favored 'General case' 0 CA--C 1.563 1.459 0 CA-C-N 118.481 1.14 . . . . 0.0 112.42 -168.923 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 173.39 -169.78 42.9 Favored Glycine 0 N--CA 1.484 1.887 0 CA-C-O 121.949 0.75 . . . . 0.0 114.558 -176.327 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . 0.253 41.5 p-90 -156.82 157.17 34.47 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 113.804 1.038 . . . . 0.0 113.804 173.536 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 34.5 m -129.63 118.57 22.17 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 123.782 0.833 . . . . 0.0 108.765 176.89 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 -121.42 130.15 53.42 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.743 -0.598 . . . . 0.0 112.434 -175.823 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 25.4 p90 -144.66 164.86 29.7 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.251 -0.906 . . . . 0.0 112.059 176.477 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 96.3 mt -109.79 127.82 66.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 120.915 -1.116 . . . . 0.0 109.789 175.734 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -102.02 84.54 2.53 Favored 'General case' 0 CA--C 1.567 1.616 0 C-N-CA 123.997 0.919 . . . . 0.0 109.185 163.9 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 64.84 -98.06 0.28 Allowed Glycine 0 N--CA 1.493 2.442 0 N-CA-C 116.452 1.341 . . . . 0.0 116.452 -179.012 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 41.1 p30 -88.94 -5.46 57.96 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 117.36 2.356 . . . . 0.0 117.36 167.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -114.63 125.53 53.87 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-N 120.874 1.67 . . . . 0.0 111.529 -172.575 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 14.2 tp -86.26 115.13 23.61 Favored 'General case' 0 CA--C 1.563 1.474 0 C-N-CA 123.869 0.867 . . . . 0.0 109.472 169.605 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 51.8 m80 -102.42 121.09 41.65 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.651 0.78 . . . . 0.0 109.029 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 53.6 tp -121.16 119.41 32.28 Favored 'General case' 0 CA--C 1.562 1.433 0 C-N-CA 123.714 0.806 . . . . 0.0 110.005 -176.637 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -100.19 116.55 32.45 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 168.605 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 71.9 mtm -109.76 124.97 52.19 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 118.974 0.806 . . . . 0.0 110.977 -178.723 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 87.4 mtm180 -112.3 137.13 50.86 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 123.963 0.905 . . . . 0.0 110.809 -171.061 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -154.03 129.97 10.21 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.372 -0.83 . . . . 0.0 111.344 168.481 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . 0.273 7.9 mm-40 64.05 9.19 4.47 Favored 'General case' 0 N--CA 1.502 2.125 0 N-CA-C 117.59 2.441 . . . . 0.0 117.59 -175.303 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 99.88 -19.08 54.74 Favored Glycine 0 CA--C 1.556 2.615 0 N-CA-C 117.792 1.877 . . . . 0.0 117.792 -157.914 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 96.8 t -83.86 124.27 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 CA-C-N 119.7 1.75 . . . . 0.0 109.77 -177.658 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 47.9 m -103.74 119.73 39.51 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 121.108 0.48 . . . . 0.0 111.205 176.779 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 8.8 t -88.94 136.45 33.0 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.656 0.783 . . . . 0.0 112.075 162.476 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -111.23 114.93 28.5 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.718 -0.614 . . . . 0.0 109.832 176.499 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -113.81 140.38 48.36 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.857 0.863 . . . . 0.0 111.545 176.266 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 34.5 t -123.06 134.84 65.0 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 177.566 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -130.24 132.56 46.01 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 123.878 0.871 . . . . 0.0 111.215 -177.273 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 20.2 tptm -98.06 136.11 38.78 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.997 -1.065 . . . . 0.0 112.161 -178.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 67.7 tttt -74.5 118.33 17.33 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.522 -0.737 . . . . 0.0 112.777 179.531 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . 0.254 35.0 m -102.85 -40.79 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 175.067 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 67.0 t60 . . . . . 0 N--CA 1.486 1.351 0 CA-C-N 119.838 1.199 . . . . 0.0 107.95 164.212 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 67.5 mtt . . . . . 0 CA--C 1.572 1.793 0 CA-C-O 117.852 -1.071 . . . . 0.0 109.792 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.64 130.0 16.44 Favored 'Trans proline' 0 CA--C 1.563 1.967 0 C-N-CA 122.881 2.387 . . . . 0.0 114.658 -175.349 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 33.0 m -78.73 125.84 38.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -166.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -75.67 97.49 3.82 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.026 -1.046 . . . . 0.0 112.532 -176.091 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -72.76 1.22 8.9 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 117.981 2.586 . . . . 0.0 117.981 -178.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -51.84 109.51 0.37 Allowed 'General case' 0 CA--C 1.566 1.594 0 N-CA-C 115.716 1.747 . . . . 0.0 115.716 -176.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 161.24 179.05 35.72 Favored Glycine 0 N--CA 1.484 1.894 0 CA-C-O 122.666 1.148 . . . . 0.0 115.94 -178.19 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -110.92 126.09 54.36 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 114.052 -1.074 . . . . 0.0 108.541 172.591 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 49.7 m95 -128.94 125.09 36.75 Favored 'General case' 0 CA--C 1.566 1.578 0 C-N-CA 123.358 0.663 . . . . 0.0 109.46 -167.02 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 16.7 ptpt -89.78 143.95 26.37 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.857 -1.152 . . . . 0.0 112.933 174.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.41 ' SD ' ' OD1' ' A' ' 13' ' ' ASN . 49.1 ttm -75.99 127.87 33.87 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.845 -1.16 . . . . 0.0 112.585 174.25 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 88.7 mt -87.06 -49.91 7.0 Favored 'General case' 0 CA--C 1.568 1.639 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 171.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 91.9 p -143.46 142.04 31.03 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 119.428 1.013 . . . . 0.0 113.368 -170.339 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.41 ' OD1' ' SD ' ' A' ' 10' ' ' MET . 2.3 m120 -117.99 93.42 4.13 Favored 'General case' 0 CA--C 1.565 1.527 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 -177.671 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -77.18 -70.23 0.48 Allowed 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 115.585 1.698 . . . . 0.0 115.585 -165.248 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -119.08 44.56 2.3 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.907 0.861 . . . . 0.0 111.237 175.155 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -72.38 -37.53 68.72 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 114.894 1.442 . . . . 0.0 114.894 175.553 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -50.02 -54.08 22.51 Favored 'General case' 0 CA--C 1.574 1.889 0 N-CA-C 115.288 1.588 . . . . 0.0 115.288 166.827 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -71.62 -36.94 70.93 Favored 'General case' 0 CA--C 1.574 1.881 0 N-CA-C 115.978 1.844 . . . . 0.0 115.978 175.154 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -55.09 -49.54 71.44 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 114.84 1.422 . . . . 0.0 114.84 165.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 78.7 mt -60.96 -39.91 91.33 Favored 'General case' 0 CA--C 1.574 1.889 0 N-CA-C 114.819 1.414 . . . . 0.0 114.819 169.337 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 26.9 ttm180 -51.52 -51.73 52.8 Favored 'General case' 0 N--CA 1.502 2.173 0 N-CA-C 115.467 1.654 . . . . 0.0 115.467 163.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.51 -27.7 62.78 Favored 'General case' 0 CA--C 1.567 1.635 0 N-CA-C 117.908 2.559 . . . . 0.0 117.908 167.365 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 95.8 mt -81.52 10.92 5.1 Favored 'General case' 0 CA--C 1.573 1.837 0 N-CA-C 115.614 1.709 . . . . 0.0 115.614 167.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.252 0.9 OUTLIER 64.03 40.0 7.47 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 115.434 1.642 . . . . 0.0 115.434 -175.429 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 89.0 t -100.15 151.0 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 CA-C-O 122.379 1.085 . . . . 0.0 110.645 -178.383 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 9.7 p-10 -74.12 154.39 39.16 Favored 'General case' 0 CA--C 1.568 1.656 0 N-CA-C 115.59 1.7 . . . . 0.0 115.59 -179.449 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 45.9 t -54.58 -45.72 71.72 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.345 0 N-CA-C 115.059 1.503 . . . . 0.0 115.059 -176.139 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.33 -47.98 83.41 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 115.922 1.823 . . . . 0.0 115.922 176.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.77 -49.89 75.96 Favored 'General case' 0 CA--C 1.571 1.75 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 168.02 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 56.3 mtp180 -48.55 -55.47 11.0 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 116.302 1.964 . . . . 0.0 116.302 167.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 35.8 tptt -59.32 -50.78 72.67 Favored 'General case' 0 CA--C 1.564 1.504 0 N-CA-C 115.471 1.656 . . . . 0.0 115.471 176.005 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 22.2 mt -67.86 -45.69 83.64 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.806 0 CA-C-O 118.03 -0.986 . . . . 0.0 112.286 177.318 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -57.9 -39.89 79.0 Favored 'General case' 0 CA--C 1.565 1.548 0 N-CA-C 117.229 2.307 . . . . 0.0 117.229 170.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -65.94 -28.67 69.09 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 116.411 2.004 . . . . 0.0 116.411 166.305 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 80.4 mt -72.99 -37.17 67.1 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 115.727 1.751 . . . . 0.0 115.727 165.236 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 44.2 mt -68.74 141.48 55.23 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 119.45 1.023 . . . . 0.0 113.711 -175.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 39.2 mmtm -112.54 78.99 2.89 Favored Pre-proline 0 CA--C 1.575 1.91 0 CA-C-O 118.411 -0.804 . . . . 0.0 109.934 177.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.409 ' HD2' ' SD ' ' A' ' 10' ' ' MET . 74.1 Cg_endo -75.34 168.4 24.68 Favored 'Trans proline' 0 CA--C 1.562 1.895 0 C-N-CA 122.528 2.152 . . . . 0.0 115.708 -176.645 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -108.58 127.36 53.88 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.664 -174.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 38.7 mttp -97.6 113.95 25.77 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.563 -0.71 . . . . 0.0 109.651 172.179 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -98.69 108.26 20.9 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 165.071 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.3 mp -96.97 120.05 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 177.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 75.4 t -99.67 101.85 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 166.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -104.59 114.02 27.97 Favored 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 123.469 0.708 . . . . 0.0 110.927 -178.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -123.7 74.48 1.27 Allowed 'General case' 0 CA--C 1.569 1.685 0 C-N-CA 123.843 0.857 . . . . 0.0 110.493 177.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.76 -100.37 1.45 Allowed Glycine 0 N--CA 1.489 2.229 0 O-C-N 121.48 -0.762 . . . . 0.0 114.063 177.198 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -85.22 -33.84 22.14 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 115.218 1.562 . . . . 0.0 115.218 162.043 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -78.16 114.15 16.78 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-N 120.682 1.583 . . . . 0.0 112.11 -174.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 48.2 ttm -128.29 118.63 23.6 Favored 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 123.43 0.692 . . . . 0.0 109.644 -175.28 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 52.4 mt -107.02 103.33 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 176.188 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 73.2 mt -90.39 99.53 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 175.512 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 70.5 mtt85 -89.42 95.96 10.5 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.467 -0.771 . . . . 0.0 110.673 178.527 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 49.5 m -88.29 105.08 17.32 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 177.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 12.2 mt -106.01 113.9 27.72 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 123.684 0.793 . . . . 0.0 109.213 -163.302 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 9.1 t -139.68 155.91 47.11 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.856 0.836 . . . . 0.0 112.434 -166.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 26.9 m -61.57 -40.74 95.83 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 115.745 1.757 . . . . 0.0 115.745 178.436 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -69.04 -58.13 4.51 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 114.699 1.37 . . . . 0.0 114.699 171.16 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 26.4 tpt180 -152.15 135.67 16.09 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-N 118.516 0.598 . . . . 0.0 109.863 175.578 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -73.98 112.42 10.09 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.776 -0.577 . . . . 0.0 109.706 163.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 52.8 t80 -79.29 -61.68 1.93 Allowed 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -167.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.334 49.7 mt 74.5 97.64 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 C-N-CA 123.932 0.893 . . . . 0.0 111.91 167.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 89.0 mtp -100.18 99.42 10.11 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.486 -0.759 . . . . 0.0 109.352 172.451 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -98.71 114.45 26.97 Favored 'General case' 0 CA--C 1.563 1.479 0 C-N-CA 124.013 0.925 . . . . 0.0 111.663 177.009 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -156.55 157.17 34.89 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 -168.184 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 66.1 mt-30 -100.28 127.16 46.63 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.581 -0.7 . . . . 0.0 110.481 165.078 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 37.3 t -63.53 123.5 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 C-N-CA 124.103 0.961 . . . . 0.0 110.503 178.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 107.67 -43.28 1.73 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 116.199 1.24 . . . . 0.0 116.199 -158.158 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 76.1 mttt -86.72 152.57 22.42 Favored 'General case' 0 CA--C 1.568 1.642 0 CA-C-N 118.612 1.206 . . . . 0.0 113.489 -172.322 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -107.92 117.92 35.39 Favored 'General case' 0 CA--C 1.569 1.674 0 C-N-CA 123.469 0.707 . . . . 0.0 111.469 -173.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 8.8 p90 -127.28 151.57 48.57 Favored 'General case' 0 N--CA 1.501 2.108 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 -171.047 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -80.43 123.89 28.43 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.015 -1.678 . . . . 0.0 114.81 -176.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -85.65 53.1 2.65 Favored 'General case' 0 N--CA 1.502 2.136 0 N-CA-C 115.696 1.739 . . . . 0.0 115.696 177.501 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 19.2 p30 -83.68 75.19 10.08 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.134 -1.604 . . . . 0.0 112.378 167.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 95.1 mt -127.64 129.96 48.13 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.633 0.73 . . . . 0.0 109.933 -175.117 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 67.4 p -83.5 59.84 5.32 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 115.472 1.656 . . . . 0.0 115.472 -163.317 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -153.38 -70.56 0.01 OUTLIER Glycine 0 N--CA 1.491 2.339 0 O-C-N 120.697 -1.252 . . . . 0.0 115.325 -177.005 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 50.5 mm -77.19 -60.12 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 C-N-CA 123.291 0.636 . . . . 0.0 111.939 -176.363 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 41.6 t0 -152.94 107.03 3.1 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-N 119.544 1.066 . . . . 0.0 108.219 167.479 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -81.33 87.45 6.14 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.383 -0.823 . . . . 0.0 112.971 -172.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 7.4 ptm180 -165.27 141.23 5.41 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 123.509 0.724 . . . . 0.0 110.044 -177.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 57.5 mtmt -73.3 80.88 1.35 Allowed 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 114.807 1.41 . . . . 0.0 114.807 -167.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 99.2 m -89.48 126.61 35.65 Favored 'General case' 0 CA--C 1.56 1.328 0 O-C-N 121.814 -0.554 . . . . 0.0 111.033 173.33 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -79.51 94.83 5.68 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 122.999 1.38 . . . . 0.0 110.255 -170.04 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 99.5 m -100.0 118.02 35.5 Favored 'General case' 0 N--CA 1.48 1.036 0 O-C-N 121.292 -0.88 . . . . 0.0 110.372 -153.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 25.0 m -112.74 122.53 47.95 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-N 115.102 -0.954 . . . . 0.0 108.504 -174.428 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 20.7 t -113.26 127.77 70.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 -177.304 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 60.9 p -131.36 159.21 38.63 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 122.223 1.011 . . . . 0.0 112.609 -175.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 55.5 m95 -92.13 113.76 26.12 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.782 -0.574 . . . . 0.0 110.605 171.247 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -92.71 73.22 4.99 Favored 'General case' 0 CA--C 1.566 1.58 0 C-N-CA 123.253 0.621 . . . . 0.0 110.291 171.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.05 -94.56 0.18 Allowed Glycine 0 N--CA 1.489 2.187 0 N-CA-C 114.637 0.615 . . . . 0.0 114.637 -171.011 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -85.39 -38.37 18.79 Favored 'General case' 0 CA--C 1.569 1.676 0 N-CA-C 115.405 1.631 . . . . 0.0 115.405 171.076 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -93.31 154.65 17.87 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 119.163 0.892 . . . . 0.0 112.733 -167.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 18.5 tp -99.16 109.68 22.34 Favored 'General case' 0 CA--C 1.564 1.504 0 O-C-N 121.04 -1.037 . . . . 0.0 110.273 178.498 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 31.7 mm-40 -97.48 122.61 40.74 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 123.862 0.865 . . . . 0.0 111.3 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 41.7 t -114.6 131.39 56.71 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.38 0.672 . . . . 0.0 111.609 175.183 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 15.0 p -117.03 123.59 72.02 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.699 0 C-N-CA 123.174 0.59 . . . . 0.0 109.579 170.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -98.73 97.05 8.34 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 124.033 0.933 . . . . 0.0 109.277 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 30.4 mmtp -81.31 119.72 24.02 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 -168.281 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -174.3 -121.38 0.62 Allowed Glycine 0 N--CA 1.484 1.861 0 O-C-N 121.994 -0.441 . . . . 0.0 112.425 171.366 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -87.05 -32.51 19.94 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 116.619 2.081 . . . . 0.0 116.619 -178.497 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 50.7 mttp -89.57 135.73 33.43 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 120.711 1.596 . . . . 0.0 112.756 -165.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -81.09 102.83 10.5 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.742 0.782 . . . . 0.0 112.989 -164.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 82.35 41.75 9.02 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 117.308 1.683 . . . . 0.0 117.308 -168.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 46.9 ttt180 -84.8 118.46 24.48 Favored 'General case' 0 CA--C 1.564 1.503 0 CA-C-N 118.857 1.329 . . . . 0.0 111.121 175.127 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 170.84 -165.55 38.75 Favored Glycine 0 N--CA 1.484 1.861 0 N-CA-C 114.827 0.691 . . . . 0.0 114.827 -178.012 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 28.9 p-90 -157.43 157.13 33.4 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 114.6 1.333 . . . . 0.0 114.6 176.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 25.5 m -120.25 122.37 40.74 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 171.487 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -119.72 133.89 55.44 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 123.187 0.595 . . . . 0.0 111.834 -178.07 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 19.0 p90 -149.1 174.45 12.32 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 178.171 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 55.5 mt -116.46 133.13 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.212 -0.93 . . . . 0.0 108.988 176.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -112.13 90.19 3.27 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 123.773 0.829 . . . . 0.0 109.092 163.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 64.49 -104.66 0.95 Allowed Glycine 0 N--CA 1.492 2.4 0 N-CA-C 115.754 1.062 . . . . 0.0 115.754 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 57.3 p30 -84.13 -2.02 56.04 Favored 'General case' 0 CA--C 1.571 1.775 0 N-CA-C 117.86 2.541 . . . . 0.0 117.86 166.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -118.47 135.9 54.11 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-N 120.657 1.572 . . . . 0.0 112.424 -168.156 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 12.4 tp -94.38 120.91 35.33 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 123.73 0.812 . . . . 0.0 108.969 174.319 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 37.3 m80 -109.99 120.1 41.4 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -176.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 42.3 tp -121.51 121.53 37.69 Favored 'General case' 0 CA--C 1.56 1.35 0 C-N-CA 123.576 0.75 . . . . 0.0 109.543 -176.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -107.97 117.89 35.32 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.878 -0.513 . . . . 0.0 109.679 168.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 66.9 mtm -110.46 127.41 55.12 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-N 118.61 0.641 . . . . 0.0 111.1 -178.195 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 69.1 mtp180 -110.88 144.66 39.56 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -179.172 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -159.36 131.18 6.36 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.187 0.595 . . . . 0.0 111.153 166.031 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 59.0 38.07 24.32 Favored 'General case' 0 N--CA 1.507 2.402 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 -173.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 75.75 -26.21 1.4 Allowed Glycine 0 CA--C 1.559 2.827 0 N-CA-C 119.597 2.599 . . . . 0.0 119.597 -160.265 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 86.8 t -81.02 122.79 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 CA-C-N 119.392 1.596 . . . . 0.0 110.571 -163.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 24.1 m -100.9 120.95 40.9 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 122.909 0.484 . . . . 0.0 111.489 -176.254 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 44.1 t -88.34 139.45 30.48 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.306 0.643 . . . . 0.0 112.242 160.487 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 44.8 mtpt -109.51 126.2 53.28 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 168.003 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -123.03 126.14 46.55 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 123.742 0.817 . . . . 0.0 109.543 174.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 72.8 t -109.1 132.57 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 179.283 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -122.18 153.07 39.27 Favored 'General case' 0 CA--C 1.565 1.558 0 C-N-CA 124.541 1.136 . . . . 0.0 111.442 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 8.9 tmtt? -120.87 136.88 54.82 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.199 -0.938 . . . . 0.0 111.607 175.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -72.5 120.49 18.19 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 33.4 m -101.49 -43.75 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 N-CA-C 113.194 0.812 . . . . 0.0 113.194 174.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 53.7 t-80 . . . . . 0 N--CA 1.485 1.317 0 CA-C-N 119.75 1.159 . . . . 0.0 108.124 168.472 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 1.8 mpt? . . . . . 0 CA--C 1.569 1.696 0 CA-C-O 117.92 -1.038 . . . . 0.0 109.601 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -84.66 147.53 10.93 Favored 'Trans proline' 0 CA--C 1.566 2.114 0 C-N-CA 122.472 2.114 . . . . 0.0 115.356 -177.365 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 25.9 m -81.2 140.04 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.468 -0.77 . . . . 0.0 112.56 177.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.5 100.51 10.13 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.514 -1.366 . . . . 0.0 111.459 175.355 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -72.72 -2.24 19.5 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 118.307 2.706 . . . . 0.0 118.307 177.475 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -56.29 112.27 1.19 Allowed 'General case' 0 CA--C 1.567 1.601 0 N-CA-C 115.945 1.831 . . . . 0.0 115.945 -172.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 155.46 -161.89 30.78 Favored Glycine 0 N--CA 1.486 1.996 0 N-CA-C 115.7 1.04 . . . . 0.0 115.7 178.466 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -124.13 127.83 48.37 Favored 'General case' 0 CA--C 1.564 1.498 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 -179.444 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 61.4 m95 -129.0 125.26 37.0 Favored 'General case' 0 CA--C 1.566 1.567 0 C-N-CA 123.273 0.629 . . . . 0.0 109.489 -166.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 24.8 pttm -96.17 141.19 29.83 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.089 -1.007 . . . . 0.0 112.903 177.484 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.434 ' SD ' ' HD2' ' A' ' 38' ' ' PRO . 32.8 ttm -68.89 125.89 28.04 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-N 120.044 1.293 . . . . 0.0 113.264 176.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 91.9 mt -85.87 -53.97 4.79 Favored 'General case' 0 CA--C 1.565 1.552 0 C-N-CA 123.387 0.675 . . . . 0.0 112.798 166.371 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 92.7 p -142.88 150.53 39.96 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 119.243 0.929 . . . . 0.0 112.838 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 24.1 p30 -125.92 84.65 2.3 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-O 122.235 1.017 . . . . 0.0 110.665 178.098 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -93.8 119.07 32.27 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.825 -1.172 . . . . 0.0 110.656 -163.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.281 32.1 t30 62.96 24.45 14.56 Favored 'General case' 0 N--CA 1.503 2.186 0 N-CA-C 116.617 2.08 . . . . 0.0 116.617 -169.704 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -69.27 -44.68 71.39 Favored 'General case' 0 CA--C 1.567 1.619 0 N-CA-C 115.223 1.564 . . . . 0.0 115.223 178.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -55.99 -39.91 72.53 Favored 'General case' 0 N--CA 1.504 2.257 0 N-CA-C 117.412 2.375 . . . . 0.0 117.412 169.005 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -65.38 -43.05 91.93 Favored 'General case' 0 CA--C 1.573 1.854 0 CA-C-N 120.252 1.387 . . . . 0.0 114.639 169.423 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -57.35 -47.83 80.59 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 115.31 1.596 . . . . 0.0 115.31 166.293 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 90.0 mt -58.25 -43.55 87.92 Favored 'General case' 0 CA--C 1.57 1.744 0 N-CA-C 114.633 1.346 . . . . 0.0 114.633 169.555 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.25 -49.2 72.63 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 115.639 1.718 . . . . 0.0 115.639 166.475 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.49 -21.25 9.51 Favored 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 118.507 2.78 . . . . 0.0 118.507 163.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 95.9 mt -91.9 15.87 12.19 Favored 'General case' 0 CA--C 1.576 1.959 0 N-CA-C 114.867 1.432 . . . . 0.0 114.867 166.559 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 60.41 42.72 14.22 Favored 'General case' 0 N--CA 1.502 2.138 0 N-CA-C 116.149 1.907 . . . . 0.0 116.149 -175.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 91.3 t -93.62 140.05 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.091 -1.006 . . . . 0.0 110.179 -179.045 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 15.1 p30 -65.37 155.59 34.87 Favored 'General case' 0 CA--C 1.572 1.803 0 N-CA-C 115.188 1.551 . . . . 0.0 115.188 171.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 61.6 t -57.78 -41.32 79.38 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.251 0 N-CA-C 114.668 1.358 . . . . 0.0 114.668 179.26 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.72 -50.73 72.24 Favored 'General case' 0 CA--C 1.565 1.534 0 N-CA-C 116.163 1.912 . . . . 0.0 116.163 172.43 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 6.1 tt -67.2 -39.08 86.28 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-N 120.637 1.562 . . . . 0.0 115.13 170.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 53.3 mtp180 -49.17 -42.42 39.74 Favored 'General case' 0 N--CA 1.502 2.128 0 N-CA-C 116.551 2.056 . . . . 0.0 116.551 163.421 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -72.77 -52.15 16.2 Favored 'General case' 0 CA--C 1.567 1.623 0 CA-C-O 118.284 -0.865 . . . . 0.0 113.324 167.034 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 5.6 mt -80.74 58.16 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.587 2.397 0 CA-C-N 121.107 1.776 . . . . 0.0 111.761 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -172.79 -51.95 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 126.187 1.795 . . . . 0.0 110.415 -178.466 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -66.53 -36.52 82.88 Favored 'General case' 0 CA--C 1.568 1.655 0 N-CA-C 116.0 1.852 . . . . 0.0 116.0 164.411 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 91.9 mt -74.53 -30.49 61.79 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 176.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.6 pp -84.27 149.63 25.96 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 119.408 1.004 . . . . 0.0 111.971 167.007 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp -104.67 94.74 7.68 Favored Pre-proline 0 CA--C 1.57 1.749 0 CA-C-O 118.091 -0.957 . . . . 0.0 108.492 174.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.434 ' HD2' ' SD ' ' A' ' 10' ' ' MET . 88.9 Cg_endo -75.27 172.71 15.82 Favored 'Trans proline' 0 CA--C 1.562 1.911 0 C-N-CA 122.642 2.228 . . . . 0.0 114.694 -175.263 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -123.95 130.56 52.79 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.663 -171.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 57.2 mttm -98.46 112.67 24.61 Favored 'General case' 0 N--CA 1.485 1.315 0 O-C-N 121.441 -0.787 . . . . 0.0 109.808 177.31 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -97.09 110.06 22.68 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 166.383 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 64.8 mt -105.7 116.66 49.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -174.033 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 63.2 t -99.25 98.75 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 169.24 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -100.63 115.71 30.84 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 123.725 0.81 . . . . 0.0 110.848 -178.291 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -125.6 72.95 1.29 Allowed 'General case' 0 CA--C 1.568 1.659 0 O-C-N 121.647 -0.658 . . . . 0.0 111.186 176.088 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 70.92 -93.52 0.49 Allowed Glycine 0 N--CA 1.49 2.24 0 O-C-N 121.468 -0.77 . . . . 0.0 114.879 178.442 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -88.2 -38.57 15.18 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 115.307 1.595 . . . . 0.0 115.307 164.109 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 20.8 t-160 -80.62 110.27 15.95 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 121.218 1.826 . . . . 0.0 111.717 -176.129 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 45.6 ttm -126.29 121.82 33.73 Favored 'General case' 0 CA--C 1.556 1.2 0 C-N-CA 123.448 0.699 . . . . 0.0 109.733 -172.074 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 4.6 mp -112.04 97.06 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 -179.146 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 73.3 mt -89.77 101.59 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 176.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -91.58 98.03 11.41 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.597 -0.689 . . . . 0.0 109.78 -179.267 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 18.9 m -87.38 104.76 16.74 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 178.217 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 18.0 mt -103.22 116.66 32.88 Favored 'General case' 0 CA--C 1.557 1.241 0 CA-C-N 115.417 -0.811 . . . . 0.0 109.991 -162.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 31.3 t -128.91 143.64 50.95 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 123.929 0.892 . . . . 0.0 110.535 -177.159 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.4 m -77.64 49.22 0.73 Allowed 'General case' 0 CA--C 1.586 2.353 0 O-C-N 121.256 -0.902 . . . . 0.0 113.159 171.357 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -172.53 -66.43 0.02 OUTLIER 'General case' 0 CA--C 1.566 1.587 0 C-N-CA 125.762 1.625 . . . . 0.0 109.082 -179.223 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -134.34 101.64 5.07 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-N 119.306 0.957 . . . . 0.0 110.299 -174.04 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 -83.15 139.72 33.01 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.515 -0.74 . . . . 0.0 112.6 -178.205 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -128.56 100.69 5.85 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.41 0.624 . . . . 0.0 109.726 -178.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.6 mt -100.23 112.8 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 -179.243 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 24.6 mmm -96.05 91.56 6.02 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 175.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -96.55 101.97 13.67 Favored 'General case' 0 CA--C 1.561 1.389 0 C-N-CA 123.977 0.911 . . . . 0.0 111.793 178.558 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -145.73 151.98 38.86 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 -166.635 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 23.6 mp0 -93.31 122.44 35.72 Favored 'General case' 0 CA--C 1.566 1.585 0 O-C-N 121.672 -0.643 . . . . 0.0 110.043 166.23 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 49.0 t -63.57 126.77 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 C-N-CA 123.912 0.885 . . . . 0.0 110.834 177.425 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 102.28 -38.2 3.31 Favored Glycine 0 CA--C 1.552 2.344 0 N-CA-C 116.752 1.461 . . . . 0.0 116.752 -162.349 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 11.2 mmpt? -88.34 134.34 33.84 Favored 'General case' 0 CA--C 1.564 1.503 0 CA-C-N 118.981 1.39 . . . . 0.0 112.254 -175.311 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -88.47 119.87 29.32 Favored 'General case' 0 CA--C 1.566 1.577 0 O-C-N 121.706 -0.622 . . . . 0.0 112.391 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 33.0 p90 -120.07 157.74 28.31 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 113.753 1.019 . . . . 0.0 113.753 -172.303 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.39 132.17 36.32 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.726 -1.234 . . . . 0.0 113.786 177.448 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -71.63 -66.05 0.68 Allowed 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 168.145 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . 0.373 35.6 t0 69.49 -123.6 0.12 Allowed 'General case' 0 CA--C 1.571 1.765 0 C-N-CA 124.588 1.155 . . . . 0.0 113.143 175.487 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 5.9 tt -85.38 88.14 7.47 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-N 120.101 1.318 . . . . 0.0 109.759 -177.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 74.8 p -87.32 -13.48 43.49 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 117.146 2.276 . . . . 0.0 117.146 -174.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 82.79 -44.0 3.18 Favored Glycine 0 N--CA 1.495 2.607 0 CA-C-N 120.834 1.652 . . . . 0.0 116.56 -166.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 3.6 mp -83.55 -75.0 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.576 1.947 0 C-N-CA 124.493 1.117 . . . . 0.0 109.454 177.49 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -89.4 -43.56 10.8 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 115.279 1.585 . . . . 0.0 115.279 -174.033 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.0 t70 64.58 73.09 0.43 Allowed 'General case' 0 CA--C 1.572 1.804 0 C-N-CA 124.444 1.098 . . . . 0.0 113.899 -171.098 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -155.9 141.94 18.21 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.562 -0.711 . . . . 0.0 112.157 177.241 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -77.99 73.59 4.55 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.147 -0.97 . . . . 0.0 113.132 177.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 95.8 m -92.48 142.47 27.38 Favored 'General case' 0 CA--C 1.563 1.461 0 CA-C-O 122.14 0.972 . . . . 0.0 112.238 176.433 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -88.09 101.99 14.34 Favored 'General case' 0 CA--C 1.56 1.332 0 C-N-CA 124.486 1.115 . . . . 0.0 110.046 -178.427 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 87.8 m -97.07 108.78 21.58 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.549 -0.719 . . . . 0.0 111.516 -170.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 53.8 m -91.82 131.62 37.03 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 164.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.4 t -116.76 136.33 54.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 171.213 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 68.2 m -150.17 148.57 29.1 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.141 -1.599 . . . . 0.0 113.029 -175.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 75.3 m95 -81.23 130.95 35.25 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.906 -1.121 . . . . 0.0 112.99 178.13 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -137.47 79.38 1.74 Allowed 'General case' 0 CA--C 1.569 1.688 0 C-N-CA 123.425 0.69 . . . . 0.0 110.344 178.327 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 64.23 76.97 0.25 Allowed Glycine 0 N--CA 1.497 2.71 0 N-CA-C 117.317 1.687 . . . . 0.0 117.317 170.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . 0.265 6.9 m-20 63.57 2.14 1.18 Allowed 'General case' 0 N--CA 1.505 2.286 0 N-CA-C 117.855 2.539 . . . . 0.0 117.855 -167.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 72.5 mttt -134.2 135.63 43.15 Favored 'General case' 0 N--CA 1.485 1.278 0 O-C-N 121.113 -0.992 . . . . 0.0 109.807 -168.444 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 22.0 tp -95.37 108.78 20.99 Favored 'General case' 0 CA--C 1.56 1.357 0 O-C-N 121.428 -0.795 . . . . 0.0 109.958 178.029 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 21.0 mm100 -86.46 141.05 29.39 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.371 0.669 . . . . 0.0 111.639 176.637 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 41.0 t -133.71 135.76 44.23 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.381 0.672 . . . . 0.0 111.329 175.038 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.7 p -127.99 116.92 44.47 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.647 0 C-N-CA 123.145 0.578 . . . . 0.0 109.576 174.218 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -93.36 100.46 12.78 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 124.118 0.967 . . . . 0.0 109.93 176.114 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -91.92 121.11 33.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.437 -0.789 . . . . 0.0 111.72 -169.152 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 167.81 -105.44 0.23 Allowed Glycine 0 N--CA 1.486 1.979 0 O-C-N 121.319 -0.863 . . . . 0.0 113.995 172.637 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -85.79 -46.98 10.16 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 115.091 1.515 . . . . 0.0 115.091 -172.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 48.9 mmtm -78.62 134.04 37.22 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 119.688 1.131 . . . . 0.0 112.433 179.315 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -88.5 109.33 19.96 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.017 -168.051 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 76.95 41.12 23.66 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 117.47 1.748 . . . . 0.0 117.47 -167.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 53.8 ttt180 -86.2 117.25 24.9 Favored 'General case' 0 CA--C 1.563 1.47 0 CA-C-N 118.316 1.058 . . . . 0.0 110.704 177.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -172.5 -178.45 42.64 Favored Glycine 0 N--CA 1.484 1.872 0 CA-C-O 122.071 0.817 . . . . 0.0 115.093 -176.136 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 28.3 p-90 -154.94 158.55 39.43 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 172.127 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 55.6 m -123.75 120.36 32.46 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 170.022 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -114.13 132.44 56.07 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 123.196 0.598 . . . . 0.0 111.922 179.257 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 16.4 p90 -148.4 173.07 13.46 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.215 -0.928 . . . . 0.0 113.088 177.602 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 73.9 mt -114.24 133.66 59.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.226 -0.921 . . . . 0.0 110.052 174.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -111.65 88.98 2.93 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 123.729 0.812 . . . . 0.0 108.895 162.473 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 65.35 -104.99 1.08 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 115.832 1.093 . . . . 0.0 115.832 -178.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -85.88 -8.34 58.11 Favored 'General case' 0 CA--C 1.571 1.788 0 N-CA-C 117.591 2.441 . . . . 0.0 117.591 168.083 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 86.9 mt-10 -105.08 135.46 46.39 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 120.316 1.416 . . . . 0.0 112.316 -175.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 15.5 tp -91.79 121.94 33.88 Favored 'General case' 0 CA--C 1.563 1.45 0 C-N-CA 123.861 0.864 . . . . 0.0 109.38 167.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 47.4 m80 -109.52 120.89 43.89 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -179.353 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 48.3 tp -120.5 116.57 25.67 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.444 0.698 . . . . 0.0 109.677 179.179 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -98.19 127.9 44.38 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.764 -0.585 . . . . 0.0 109.898 167.645 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 69.1 mtm -122.85 129.82 52.12 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-N 118.355 0.525 . . . . 0.0 111.241 -175.218 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 71.9 mtm-85 -117.9 139.32 51.3 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 123.588 0.755 . . . . 0.0 111.233 -174.119 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -161.75 131.65 4.77 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.68 -0.637 . . . . 0.0 111.279 170.174 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 55.7 39.09 30.83 Favored 'General case' 0 N--CA 1.507 2.397 0 N-CA-C 115.444 1.646 . . . . 0.0 115.444 -175.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 72.84 -11.76 4.29 Favored Glycine 0 CA--C 1.557 2.682 0 N-CA-C 120.302 2.881 . . . . 0.0 120.302 -163.448 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 88.1 t -89.28 123.54 41.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 CA-C-N 120.291 2.045 . . . . 0.0 109.608 -171.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 34.7 m -102.77 123.99 47.47 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.302 0.572 . . . . 0.0 111.169 177.436 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 21.1 t -100.92 146.64 27.11 Favored 'General case' 0 CA--C 1.563 1.462 0 C-N-CA 123.921 0.888 . . . . 0.0 112.079 165.453 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 7.6 mtpm? -118.49 110.66 17.67 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.669 -0.644 . . . . 0.0 109.541 174.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -103.48 130.09 50.77 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.502 -0.749 . . . . 0.0 110.817 174.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 44.2 t -113.86 129.91 68.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 176.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -123.67 150.86 43.73 Favored 'General case' 0 CA--C 1.567 1.62 0 C-N-CA 124.729 1.211 . . . . 0.0 110.071 179.062 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.7 tmtt? -122.47 140.95 52.15 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.556 -1.34 . . . . 0.0 111.484 177.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 66.0 tttt -71.08 117.75 12.99 Favored 'General case' 0 CA--C 1.565 1.556 0 N-CA-C 113.523 0.934 . . . . 0.0 113.523 -177.398 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 5.5 m -82.59 -34.57 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.273 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 168.069 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 44.6 t-80 . . . . . 0 N--CA 1.484 1.255 0 C-N-CA 125.04 1.336 . . . . 0.0 113.305 175.505 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 66.1 mtt . . . . . 0 CA--C 1.57 1.718 0 CA-C-O 118.123 -0.942 . . . . 0.0 109.532 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -73.58 139.21 27.98 Favored 'Trans proline' 0 CA--C 1.56 1.82 0 C-N-CA 122.54 2.16 . . . . 0.0 114.98 -174.296 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 1.8 t -79.05 146.04 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 CA-C-O 121.701 0.763 . . . . 0.0 110.906 -174.024 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -72.04 97.03 1.82 Allowed 'General case' 0 CA--C 1.568 1.651 0 O-C-N 120.79 -1.194 . . . . 0.0 111.618 173.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 4.5 m-30 -77.92 3.74 13.8 Favored 'General case' 0 CA--C 1.581 2.151 0 N-CA-C 116.471 2.026 . . . . 0.0 116.471 179.138 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -60.4 111.02 1.41 Allowed 'General case' 0 CA--C 1.564 1.488 0 C-N-CA 125.339 1.456 . . . . 0.0 114.688 -178.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 165.2 177.21 37.48 Favored Glycine 0 N--CA 1.484 1.887 0 N-CA-C 116.319 1.287 . . . . 0.0 116.319 -179.249 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -108.11 122.35 46.71 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 114.35 -0.925 . . . . 0.0 108.781 173.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 83.7 m95 -120.77 120.18 34.89 Favored 'General case' 0 CA--C 1.562 1.412 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -167.046 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 62.1 pttt -88.92 136.5 32.98 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.348 -0.845 . . . . 0.0 112.588 176.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.406 ' SD ' ' ND2' ' A' ' 13' ' ' ASN . 56.3 ttm -77.19 123.47 26.47 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 121.914 0.864 . . . . 0.0 112.139 179.255 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 84.0 mt -90.97 -60.16 1.98 Allowed 'General case' 0 CA--C 1.565 1.527 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.757 175.068 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 67.4 p -130.0 119.29 22.93 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.721 -0.612 . . . . 0.0 110.746 176.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.406 ' ND2' ' SD ' ' A' ' 10' ' ' MET . 18.5 p30 -98.01 93.39 6.28 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 123.252 0.621 . . . . 0.0 109.794 165.227 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -97.12 125.26 41.49 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.66 0.784 . . . . 0.0 110.462 -169.027 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.269 49.2 t30 64.97 15.59 10.06 Favored 'General case' 0 N--CA 1.504 2.272 0 N-CA-C 117.061 2.245 . . . . 0.0 117.061 -172.142 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -61.01 -41.21 96.11 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 116.234 1.939 . . . . 0.0 116.234 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -51.52 -44.78 62.7 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 115.602 1.704 . . . . 0.0 115.602 166.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -68.81 -41.35 78.77 Favored 'General case' 0 CA--C 1.573 1.836 0 N-CA-C 115.228 1.566 . . . . 0.0 115.228 174.47 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 48.7 t80 -55.27 -49.26 72.52 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 114.47 1.285 . . . . 0.0 114.47 165.268 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 97.5 mt -61.0 -40.64 94.31 Favored 'General case' 0 CA--C 1.575 1.922 0 N-CA-C 115.001 1.482 . . . . 0.0 115.001 170.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 49.5 ttp180 -53.86 -49.94 67.37 Favored 'General case' 0 N--CA 1.501 2.11 0 N-CA-C 115.647 1.721 . . . . 0.0 115.647 165.047 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.67 -15.97 9.32 Favored 'General case' 0 CA--C 1.57 1.742 0 N-CA-C 118.409 2.744 . . . . 0.0 118.409 165.405 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 99.3 mt -98.56 23.48 8.55 Favored 'General case' 0 CA--C 1.575 1.926 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 163.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 69.39 15.16 8.44 Favored 'General case' 0 N--CA 1.507 2.382 0 N-CA-C 117.482 2.401 . . . . 0.0 117.482 -179.663 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 67.5 t -87.81 141.88 13.71 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.863 0 O-C-N 120.061 -1.65 . . . . 0.0 110.414 -170.354 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -73.46 155.02 39.69 Favored 'General case' 0 CA--C 1.569 1.687 0 N-CA-C 115.714 1.746 . . . . 0.0 115.714 -177.134 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 74.6 t -50.88 -45.83 28.79 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.502 0 N-CA-C 115.715 1.746 . . . . 0.0 115.715 -178.065 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.03 -49.41 77.75 Favored 'General case' 0 CA--C 1.564 1.5 0 N-CA-C 115.434 1.642 . . . . 0.0 115.434 173.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.8 tt -64.49 -44.58 90.5 Favored 'General case' 0 CA--C 1.572 1.794 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 171.491 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 74.9 mtp180 -45.15 -54.45 6.83 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 115.911 1.819 . . . . 0.0 115.911 164.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -71.84 -37.96 70.21 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 115.461 1.652 . . . . 0.0 115.461 174.584 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . 0.25 69.2 mt -62.51 -50.2 80.77 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 CA-C-N 121.116 1.78 . . . . 0.0 112.171 173.19 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -56.93 -42.24 79.65 Favored 'General case' 0 CA--C 1.568 1.67 0 N-CA-C 117.772 2.508 . . . . 0.0 117.772 170.415 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -53.85 -46.09 71.14 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 117.01 2.226 . . . . 0.0 117.01 163.358 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 92.6 mt -80.56 -18.29 48.81 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 116.025 1.861 . . . . 0.0 116.025 179.278 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 18.5 mt -73.46 -37.44 65.8 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 115.789 1.774 . . . . 0.0 115.789 173.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 65.5 mmtt 64.76 65.54 1.01 Allowed Pre-proline 0 CA--C 1.577 1.99 0 C-N-CA 124.546 1.139 . . . . 0.0 112.122 -178.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -71.45 135.0 25.59 Favored 'Trans proline' 0 CA--C 1.562 1.913 0 CA-C-N 122.486 1.924 . . . . 0.0 114.765 -165.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -86.67 130.53 34.45 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.832 -0.543 . . . . 0.0 111.897 -175.364 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 47.9 mttp -93.26 112.72 24.73 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.191 -0.943 . . . . 0.0 110.181 -179.479 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -94.59 109.44 21.36 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.388 -0.82 . . . . 0.0 109.034 164.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 97.6 mt -102.49 116.35 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 -175.246 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 54.0 t -98.16 95.95 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 168.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -93.86 108.5 20.28 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 123.876 0.87 . . . . 0.0 110.558 -179.601 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -113.94 69.31 0.7 Allowed 'General case' 0 CA--C 1.569 1.689 0 O-C-N 121.637 -0.664 . . . . 0.0 111.061 175.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 70.09 -85.39 0.31 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 115.798 1.079 . . . . 0.0 115.798 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -94.65 -40.04 10.02 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 114.903 1.446 . . . . 0.0 114.903 163.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 20.7 t-160 -79.08 107.19 11.66 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 121.216 1.825 . . . . 0.0 111.243 -175.121 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 41.1 ttm -118.24 120.5 37.85 Favored 'General case' 0 CA--C 1.553 1.064 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -173.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 5.0 mp -106.13 100.49 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 16.4 mm -87.07 101.3 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 176.553 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -94.71 97.93 10.42 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 18.3 m -91.94 100.39 13.06 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 -176.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 19.9 mt -99.8 132.85 44.89 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-O 121.812 0.815 . . . . 0.0 112.189 -156.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 28.3 t -151.6 145.72 25.31 Favored 'General case' 0 CA--C 1.562 1.425 0 C-N-CA 123.452 0.701 . . . . 0.0 110.97 -176.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.6 t -77.48 54.12 1.13 Allowed 'General case' 0 N--CA 1.505 2.291 0 O-C-N 120.639 -1.288 . . . . 0.0 114.077 165.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -173.2 -67.04 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 124.983 1.313 . . . . 0.0 109.169 -168.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.06 103.83 4.37 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.379 -0.826 . . . . 0.0 110.014 -179.454 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -88.48 119.54 29.02 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.738 -0.601 . . . . 0.0 110.357 178.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 51.8 m-85 -107.59 110.11 21.91 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 121.336 0.589 . . . . 0.0 110.573 -175.297 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 25.0 mm -105.95 104.48 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 N-CA-C 108.11 -1.071 . . . . 0.0 108.11 -174.09 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 11.4 mmm -99.11 90.71 4.69 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.523 -0.735 . . . . 0.0 109.27 175.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -93.35 111.55 23.24 Favored 'General case' 0 CA--C 1.561 1.386 0 C-N-CA 123.429 0.692 . . . . 0.0 111.385 175.129 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 11.9 p90 -147.13 148.31 31.45 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.831 0.824 . . . . 0.0 112.849 -170.161 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 23.8 mp0 -87.6 117.15 26.21 Favored 'General case' 0 CA--C 1.561 1.368 0 O-C-N 121.621 -0.674 . . . . 0.0 109.999 168.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 44.0 t -66.99 113.04 2.7 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.794 0 C-N-CA 124.159 0.984 . . . . 0.0 109.609 175.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 123.22 -48.68 0.94 Allowed Glycine 0 CA--C 1.549 2.213 0 N-CA-C 115.14 0.816 . . . . 0.0 115.14 -156.237 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 58.4 mttm -86.59 151.77 23.17 Favored 'General case' 0 CA--C 1.568 1.66 0 CA-C-N 118.493 1.146 . . . . 0.0 113.476 -175.497 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -96.8 107.22 19.66 Favored 'General case' 0 CA--C 1.568 1.643 0 C-N-CA 123.275 0.63 . . . . 0.0 110.425 173.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 15.6 p90 -106.92 142.32 36.73 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 113.639 0.978 . . . . 0.0 113.639 -171.293 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -76.9 110.55 11.61 Favored 'General case' 0 CA--C 1.568 1.669 0 N-CA-C 114.411 1.263 . . . . 0.0 114.411 179.122 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -81.08 62.0 4.87 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.96 -1.087 . . . . 0.0 113.262 173.365 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -84.2 -44.21 14.16 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.877 -1.139 . . . . 0.0 113.86 164.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -103.99 -54.87 2.47 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-N 119.113 0.87 . . . . 0.0 112.058 169.3 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 48.3 p -79.75 84.99 5.48 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-N 119.682 1.128 . . . . 0.0 113.239 -172.386 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -177.09 161.97 29.89 Favored Glycine 0 N--CA 1.488 2.119 0 O-C-N 121.349 -0.845 . . . . 0.0 114.935 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 2.6 mp -66.64 -61.48 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.292 0 C-N-CA 123.555 0.742 . . . . 0.0 111.842 -175.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -104.17 93.21 4.71 Favored 'General case' 0 CA--C 1.561 1.392 0 O-C-N 120.895 -1.128 . . . . 0.0 108.065 155.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -75.45 63.65 1.49 Allowed 'General case' 0 CA--C 1.573 1.851 0 N-CA-C 115.929 1.826 . . . . 0.0 115.929 -173.317 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 76.3 mtt180 -108.11 52.01 0.73 Allowed 'General case' 0 CA--C 1.575 1.935 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -177.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . 0.254 62.1 mttp 61.88 81.6 0.19 Allowed 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 115.453 1.649 . . . . 0.0 115.453 175.723 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 72.6 m -121.6 127.89 51.37 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.363 0.665 . . . . 0.0 110.05 166.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 82.5 mmm -79.48 95.75 5.89 Favored 'General case' 0 CA--C 1.563 1.454 0 CA-C-O 121.98 0.895 . . . . 0.0 109.338 170.558 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 37.8 m -102.65 117.11 33.95 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.114 0.566 . . . . 0.0 110.698 -160.241 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 92.3 m -95.16 122.43 37.83 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 173.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 22.1 t -109.97 135.79 47.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 170.114 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 58.0 m -148.55 147.27 28.85 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.265 -1.522 . . . . 0.0 112.481 -176.621 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 59.9 m95 -79.41 109.06 13.41 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.255 -0.903 . . . . 0.0 111.095 174.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -86.73 76.21 9.53 Favored 'General case' 0 CA--C 1.566 1.572 0 C-N-CA 123.813 0.845 . . . . 0.0 110.429 172.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 64.72 -99.53 0.36 Allowed Glycine 0 N--CA 1.489 2.199 0 N-CA-C 114.433 0.533 . . . . 0.0 114.433 -169.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -84.4 -32.85 23.92 Favored 'General case' 0 CA--C 1.574 1.88 0 N-CA-C 115.705 1.743 . . . . 0.0 115.705 170.312 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 48.9 mtpt -94.1 150.14 20.6 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 124.125 0.97 . . . . 0.0 112.011 -168.182 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 24.0 tp -98.46 109.7 22.41 Favored 'General case' 0 CA--C 1.563 1.464 0 O-C-N 120.329 -1.482 . . . . 0.0 110.345 177.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 31.8 mm-40 -96.65 146.4 24.89 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 123.383 0.673 . . . . 0.0 111.909 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 42.6 t -138.74 131.27 28.87 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.316 0.646 . . . . 0.0 111.527 176.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.9 p -113.81 122.01 67.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 166.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -101.95 75.02 1.5 Allowed 'General case' 0 CA--C 1.567 1.609 0 C-N-CA 123.461 0.704 . . . . 0.0 110.299 -178.503 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -91.17 129.68 37.14 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.011 -1.056 . . . . 0.0 113.427 -170.164 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 164.81 -94.1 0.11 Allowed Glycine 0 N--CA 1.487 2.084 0 O-C-N 121.335 -0.853 . . . . 0.0 112.477 177.162 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -72.2 -46.67 55.28 Favored 'General case' 0 CA--C 1.572 1.815 0 N-CA-C 115.614 1.709 . . . . 0.0 115.614 178.004 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -101.26 143.31 31.49 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 119.362 0.983 . . . . 0.0 112.945 -175.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -76.5 155.9 33.41 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.774 -0.579 . . . . 0.0 112.241 165.271 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 61.95 12.6 36.83 Favored Glycine 0 N--CA 1.497 2.757 0 N-CA-C 120.488 2.955 . . . . 0.0 120.488 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 36.8 ttt180 -88.16 129.11 35.42 Favored 'General case' 0 CA--C 1.564 1.511 0 CA-C-N 119.082 1.441 . . . . 0.0 112.591 -172.295 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 178.32 -173.27 45.73 Favored Glycine 0 N--CA 1.486 1.972 0 CA-C-O 121.707 0.615 . . . . 0.0 114.052 -175.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . 0.277 44.2 p-90 -159.43 156.8 29.0 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 171.469 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 58.9 m -129.56 119.13 23.15 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 176.207 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 16.2 tt0 -122.98 131.58 53.78 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 123.277 0.631 . . . . 0.0 112.202 -174.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 21.8 p90 -148.71 169.12 21.12 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.379 -0.826 . . . . 0.0 112.302 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 96.4 mt -115.53 145.26 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.22 0 CA-C-O 122.998 1.38 . . . . 0.0 111.062 177.421 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -136.65 90.58 2.56 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 71.42 -111.8 3.84 Favored Glycine 0 N--CA 1.49 2.269 0 O-C-N 121.983 -0.448 . . . . 0.0 114.158 -174.03 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 16.5 p-10 -94.66 15.36 18.38 Favored 'General case' 0 CA--C 1.576 1.975 0 N-CA-C 116.585 2.069 . . . . 0.0 116.585 167.417 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -120.65 136.54 54.81 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-N 120.177 1.353 . . . . 0.0 111.946 -171.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 8.6 tp -97.34 123.09 41.04 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 171.351 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 36.4 m80 -111.65 121.58 45.49 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 -176.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 50.7 tp -128.48 120.78 27.48 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.618 0.767 . . . . 0.0 109.963 -172.573 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -105.55 113.83 27.64 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.511 -0.743 . . . . 0.0 109.038 170.604 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' MET . . . . . 0.423 ' HB2' ' SG ' ' A' ' 126' ' ' CYS . 63.1 mtm -106.85 131.9 53.42 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-N 118.891 0.769 . . . . 0.0 111.438 -178.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? -114.76 140.88 48.54 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.784 0.834 . . . . 0.0 111.445 -171.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -156.07 129.37 8.18 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 123.207 0.603 . . . . 0.0 111.111 170.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . 0.265 8.7 mm-40 64.8 -0.32 1.02 Allowed 'General case' 0 N--CA 1.504 2.254 0 N-CA-C 118.135 2.643 . . . . 0.0 118.135 -176.252 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 109.69 -24.4 19.74 Favored Glycine 0 CA--C 1.554 2.531 0 N-CA-C 117.096 1.598 . . . . 0.0 117.096 -156.374 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 93.6 t -78.1 127.71 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 CA-C-N 119.857 1.829 . . . . 0.0 110.115 177.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 45.6 m -106.86 124.67 49.96 Favored 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 123.032 0.533 . . . . 0.0 110.118 173.102 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' CYS . . . . . 0.423 ' SG ' ' HB2' ' A' ' 119' ' ' MET . 19.3 p -107.14 142.08 37.38 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-O 121.701 0.762 . . . . 0.0 112.424 168.047 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 60.1 mttp -114.76 111.14 20.8 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.666 -0.646 . . . . 0.0 109.36 -168.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 82.9 mt-30 -105.35 123.84 48.54 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 123.403 0.681 . . . . 0.0 111.178 178.234 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 79.1 t -111.27 131.47 62.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 176.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -121.67 164.04 18.0 Favored 'General case' 0 CA--C 1.567 1.608 0 CA-C-N 115.113 -0.949 . . . . 0.0 111.474 -178.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 29.3 ttmt -130.57 142.82 50.46 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.065 -1.022 . . . . 0.0 111.984 165.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 59.8 tttt -76.31 120.15 21.17 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.49 -0.756 . . . . 0.0 112.882 -176.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 32.8 m -97.21 -43.41 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.112 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 174.168 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 72.0 t60 . . . . . 0 N--CA 1.485 1.302 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 169.235 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 81.6 mtp . . . . . 0 CA--C 1.57 1.75 0 CA-C-O 118.33 -0.843 . . . . 0.0 110.238 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -84.17 136.91 7.0 Favored 'Trans proline' 0 CA--C 1.561 1.868 0 C-N-CA 122.301 2.0 . . . . 0.0 115.375 -176.447 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 31.6 m -80.08 156.48 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 CA-C-O 121.934 0.873 . . . . 0.0 112.761 176.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -77.74 113.17 15.33 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.124 -0.985 . . . . 0.0 112.759 176.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -90.28 7.95 35.73 Favored 'General case' 0 CA--C 1.576 1.966 0 N-CA-C 115.389 1.626 . . . . 0.0 115.389 173.124 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 62.6 m-80 -67.02 110.19 3.28 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 120.262 1.392 . . . . 0.0 113.077 -176.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 169.63 173.81 37.45 Favored Glycine 0 N--CA 1.478 1.441 0 N-CA-C 116.638 1.415 . . . . 0.0 116.638 -177.081 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 19.5 t80 -104.19 124.53 49.29 Favored 'General case' 0 CA--C 1.563 1.48 0 CA-C-N 113.675 -1.262 . . . . 0.0 108.516 168.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 82.4 m95 -120.82 122.71 40.89 Favored 'General case' 0 CA--C 1.561 1.394 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -169.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -96.08 135.51 37.76 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.579 -0.701 . . . . 0.0 111.449 178.212 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 53.6 ttm -71.93 124.34 24.67 Favored 'General case' 0 CA--C 1.565 1.524 0 CA-C-O 122.079 0.942 . . . . 0.0 113.058 -178.232 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 97.5 mt -81.99 -50.14 9.47 Favored 'General case' 0 CA--C 1.567 1.615 0 CA-C-N 115.191 -0.913 . . . . 0.0 112.292 168.029 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 89.7 p -149.92 126.79 11.1 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 118.727 0.694 . . . . 0.0 111.751 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -99.69 108.77 21.2 Favored 'General case' 0 N--CA 1.494 1.767 0 C-N-CA 122.944 0.497 . . . . 0.0 110.889 162.597 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -112.26 125.57 54.31 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.503 -0.748 . . . . 0.0 109.803 -172.507 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.258 5.3 t30 63.53 27.84 15.13 Favored 'General case' 0 N--CA 1.507 2.414 0 N-CA-C 116.325 1.972 . . . . 0.0 116.325 -174.146 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -70.39 -44.97 66.92 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 114.436 1.273 . . . . 0.0 114.436 174.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -53.43 -51.96 60.96 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 116.813 2.153 . . . . 0.0 116.813 174.269 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.266 1.5 pm0 -76.89 -25.89 53.56 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 116.394 1.998 . . . . 0.0 116.394 178.328 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 38.6 t80 -54.84 -49.56 70.79 Favored 'General case' 0 N--CA 1.498 1.967 0 CA-C-N 120.797 1.635 . . . . 0.0 114.481 154.274 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 68.8 mt -61.98 -35.35 78.24 Favored 'General case' 0 CA--C 1.576 1.965 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 170.154 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 8.7 ttm180 -56.99 -48.1 79.26 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-N 120.415 1.462 . . . . 0.0 114.645 162.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.74 -13.53 24.14 Favored 'General case' 0 CA--C 1.569 1.703 0 N-CA-C 118.414 2.746 . . . . 0.0 118.414 168.281 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 48.0 mt -90.15 -1.38 57.94 Favored 'General case' 0 CA--C 1.573 1.845 0 N-CA-C 116.071 1.878 . . . . 0.0 116.071 162.414 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.277 51.6 m-20 63.02 46.54 4.69 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 115.411 1.634 . . . . 0.0 115.411 -166.48 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 98.7 t -95.26 135.23 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 174.372 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 5.5 p-10 -64.3 152.08 42.05 Favored 'General case' 0 CA--C 1.566 1.592 0 N-CA-C 115.192 1.552 . . . . 0.0 115.192 178.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.494 HG22 HH11 ' A' ' 30' ' ' ARG 0.262 38.5 t -58.84 -35.47 56.27 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.224 0 N-CA-C 115.719 1.748 . . . . 0.0 115.719 -172.257 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.8 -50.93 69.16 Favored 'General case' 0 CA--C 1.567 1.62 0 N-CA-C 115.969 1.841 . . . . 0.0 115.969 166.775 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -71.45 -28.41 63.95 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 116.697 2.11 . . . . 0.0 116.697 171.025 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.494 HH11 HG22 ' A' ' 27' ' ' VAL . 54.2 mtp180 -55.83 -53.53 55.62 Favored 'General case' 0 N--CA 1.498 1.959 0 CA-C-N 120.824 1.647 . . . . 0.0 114.135 162.229 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 48.1 mmtm -64.39 -49.99 69.43 Favored 'General case' 0 CA--C 1.566 1.596 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 170.649 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 11.9 mt -77.38 62.12 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.323 0 CA-C-O 123.493 1.615 . . . . 0.0 110.974 175.1 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -176.03 -53.59 0.01 OUTLIER 'General case' 0 CA--C 1.558 1.28 0 C-N-CA 126.752 2.021 . . . . 0.0 110.044 -177.637 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -71.52 -35.51 70.73 Favored 'General case' 0 CA--C 1.567 1.619 0 N-CA-C 116.04 1.867 . . . . 0.0 116.04 167.057 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 92.9 mt -71.85 -35.3 69.81 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 115.153 1.538 . . . . 0.0 115.153 177.003 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.9 pp -88.71 148.94 23.73 Favored 'General case' 0 CA--C 1.566 1.57 0 CA-C-N 118.671 0.669 . . . . 0.0 111.084 169.179 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 29.0 mmtp -103.94 93.98 5.96 Favored Pre-proline 0 CA--C 1.573 1.827 0 CA-C-O 117.813 -1.089 . . . . 0.0 109.764 178.402 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -73.82 160.39 43.59 Favored 'Trans proline' 0 CA--C 1.566 2.09 0 C-N-CA 122.49 2.126 . . . . 0.0 115.489 -175.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -104.2 141.96 35.34 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.508 -0.745 . . . . 0.0 110.795 -179.382 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 41.8 mttp -102.9 115.38 30.48 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.857 -1.152 . . . . 0.0 109.742 171.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -95.36 110.37 22.4 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 163.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 78.7 mt -106.8 128.33 61.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -177.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 93.1 t -106.27 118.41 53.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 106.026 -1.842 . . . . 0.0 106.026 163.392 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -111.95 113.51 25.86 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 124.147 0.979 . . . . 0.0 109.197 175.431 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -120.19 68.83 0.85 Allowed 'General case' 0 CA--C 1.567 1.613 0 O-C-N 121.339 -0.85 . . . . 0.0 110.334 174.354 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.65 -97.39 0.7 Allowed Glycine 0 N--CA 1.488 2.164 0 N-CA-C 114.672 0.629 . . . . 0.0 114.672 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -85.07 -40.45 16.8 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 115.314 1.598 . . . . 0.0 115.314 165.561 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 18.7 t-160 -77.41 119.97 21.76 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 120.899 1.681 . . . . 0.0 111.781 -178.337 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.43 ' SD ' HD21 ' A' ' 93' ' ' LEU . 46.5 ttm -133.9 133.98 42.11 Favored 'General case' 0 CA--C 1.557 1.231 0 CA-C-O 121.488 0.661 . . . . 0.0 110.674 -173.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 33.6 mt -118.56 107.76 22.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 24.8 mm -94.24 100.23 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 176.447 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 68.4 mtt85 -93.85 100.57 12.73 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.135 -0.978 . . . . 0.0 109.201 178.156 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 16.6 m -88.46 102.12 14.59 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 178.166 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 48.0 mt -97.78 112.23 24.21 Favored 'General case' 0 CA--C 1.556 1.209 0 C-N-CA 123.841 0.856 . . . . 0.0 109.286 -165.259 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 46.0 t -130.18 143.48 50.81 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.972 -171.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.1 m -78.96 56.42 1.95 Allowed 'General case' 0 CA--C 1.579 2.089 0 CA-C-O 122.036 0.922 . . . . 0.0 112.715 175.578 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -168.99 -67.93 0.02 OUTLIER 'General case' 0 CA--C 1.567 1.598 0 C-N-CA 124.999 1.32 . . . . 0.0 109.267 -179.399 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 32.3 tpt180 -135.78 115.72 13.17 Favored 'General case' 0 CA--C 1.565 1.55 0 C-N-CA 123.777 0.831 . . . . 0.0 109.193 173.408 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 71.9 m-80 -83.63 125.05 31.43 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.685 -0.634 . . . . 0.0 111.501 178.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 86.2 t80 -110.87 105.99 14.99 Favored 'General case' 0 CA--C 1.567 1.602 0 C-N-CA 123.24 0.616 . . . . 0.0 110.744 -169.135 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.8 mp -93.38 115.35 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 178.371 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -107.31 90.98 3.47 Favored 'General case' 0 CA--C 1.568 1.64 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 175.619 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -102.4 119.6 39.08 Favored 'General case' 0 CA--C 1.565 1.551 0 C-N-CA 124.159 0.984 . . . . 0.0 112.633 -175.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -157.72 154.79 28.81 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 114.784 1.401 . . . . 0.0 114.784 -166.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 25.2 mp0 -92.82 121.7 34.46 Favored 'General case' 0 CA--C 1.564 1.486 0 O-C-N 121.577 -0.702 . . . . 0.0 110.553 166.064 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 40.0 t -66.25 121.7 15.83 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.808 0 C-N-CA 124.218 1.007 . . . . 0.0 109.915 174.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 117.2 -42.45 1.85 Allowed Glycine 0 CA--C 1.55 2.236 0 N-CA-C 115.729 1.052 . . . . 0.0 115.729 -160.293 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 55.9 mttm -82.64 144.78 30.05 Favored 'General case' 0 CA--C 1.566 1.564 0 CA-C-N 118.916 1.358 . . . . 0.0 113.557 -174.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -90.95 97.8 11.4 Favored 'General case' 0 CA--C 1.566 1.588 0 CA-C-O 121.349 0.595 . . . . 0.0 110.014 167.439 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -107.54 151.7 25.23 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 123.999 0.92 . . . . 0.0 113.083 -169.379 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -77.1 135.36 38.58 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.693 -1.254 . . . . 0.0 112.918 169.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -70.98 -69.23 0.38 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.428 -0.795 . . . . 0.0 112.886 175.278 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 19.0 t70 59.93 55.2 3.92 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 116.854 2.168 . . . . 0.0 116.854 168.539 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -156.01 158.14 37.34 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.271 -0.893 . . . . 0.0 111.322 177.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 41.0 m -75.63 99.05 4.2 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.759 -1.213 . . . . 0.0 110.735 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 151.87 142.92 3.59 Favored Glycine 0 CA--C 1.547 2.077 0 C-N-CA 123.304 0.478 . . . . 0.0 112.3 -175.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . 0.492 1.3 tp 70.04 -71.57 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.318 0 C-N-CA 124.25 1.02 . . . . 0.0 113.548 -173.185 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -156.96 120.39 4.16 Favored 'General case' 0 CA--C 1.567 1.597 0 N-CA-C 105.343 -2.095 . . . . 0.0 105.343 168.402 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -74.76 80.5 2.07 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 113.904 1.075 . . . . 0.0 113.904 -176.201 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 27.1 tpt180 -154.37 151.95 29.64 Favored 'General case' 0 CA--C 1.563 1.481 0 CA-C-O 122.276 1.036 . . . . 0.0 110.722 -170.088 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 58.1 mtmt -72.48 71.22 0.93 Allowed 'General case' 0 CA--C 1.577 1.985 0 O-C-N 121.153 -0.967 . . . . 0.0 112.8 166.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 72.8 m -87.61 118.63 27.23 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.139 -0.976 . . . . 0.0 111.856 -174.159 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 23.5 mmt -68.63 96.16 0.7 Allowed 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 124.576 1.15 . . . . 0.0 111.579 -177.153 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 89.6 m -111.59 118.09 34.73 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 -162.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 93.8 m -101.85 118.94 37.95 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 176.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.479 HG22 ' SG ' ' A' ' 95' ' ' CYS . 57.1 t -108.73 124.93 65.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 171.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 57.9 m -130.57 151.54 50.93 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 121.935 0.874 . . . . 0.0 111.529 -177.434 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 28.1 m95 -83.66 116.66 22.74 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.992 -1.067 . . . . 0.0 112.726 176.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -103.77 65.79 0.83 Allowed 'General case' 0 CA--C 1.572 1.805 0 C-N-CA 123.428 0.691 . . . . 0.0 109.909 162.163 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 58.28 -114.59 5.99 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 115.538 0.975 . . . . 0.0 115.538 -172.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -61.42 -28.22 69.11 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 116.934 2.198 . . . . 0.0 116.934 168.55 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 63.5 mttm -93.69 120.96 34.61 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-O 122.097 0.951 . . . . 0.0 110.583 -178.606 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.43 HD21 ' SD ' ' A' ' 49' ' ' MET . 34.7 tp -86.79 107.11 18.14 Favored 'General case' 0 CA--C 1.564 1.515 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 168.778 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -98.59 132.64 43.84 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 123.27 0.628 . . . . 0.0 111.544 -172.452 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' CYS . . . . . 0.479 ' SG ' HG22 ' A' ' 86' ' ' VAL . 35.4 t -128.33 134.97 48.99 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.158 0.583 . . . . 0.0 111.728 -179.243 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.9 p -115.82 128.91 72.93 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.792 0 C-N-CA 123.151 0.581 . . . . 0.0 109.758 164.504 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -106.15 108.2 19.59 Favored 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 123.548 0.739 . . . . 0.0 110.4 -178.079 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 62.1 mttm -101.08 118.45 37.03 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.042 -1.036 . . . . 0.0 110.814 -174.593 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -178.91 -60.78 0.07 OUTLIER Glycine 0 N--CA 1.491 2.348 0 N-CA-C 116.546 1.379 . . . . 0.0 116.546 -177.343 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -125.18 -58.76 1.44 Allowed 'General case' 0 N--CA 1.497 1.893 0 CA-C-N 117.872 0.836 . . . . 0.0 111.938 173.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 41.9 mmtm -87.72 151.51 22.86 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-O 122.189 0.995 . . . . 0.0 113.509 -161.052 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -73.48 -68.92 0.46 Allowed 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 -169.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -78.35 51.46 3.63 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 116.804 1.482 . . . . 0.0 116.804 171.6 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 21.2 ttt180 -98.35 118.59 35.36 Favored 'General case' 0 CA--C 1.563 1.461 0 CA-C-N 118.659 1.23 . . . . 0.0 114.041 -169.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 177.46 -165.05 34.6 Favored Glycine 0 N--CA 1.482 1.756 0 CA-C-O 121.844 0.691 . . . . 0.0 114.554 178.029 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 53.2 p-90 -157.81 152.9 25.61 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 173.197 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 56.6 m -125.59 118.07 24.92 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 174.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -118.6 125.51 49.93 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 123.021 0.528 . . . . 0.0 111.77 -178.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 17.0 p90 -140.62 170.63 15.42 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.491 -0.755 . . . . 0.0 112.631 178.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 77.4 mt -117.57 135.85 56.63 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.031 -1.043 . . . . 0.0 110.006 176.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -121.52 95.81 4.83 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 173.23 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 71.93 -109.77 2.95 Favored Glycine 0 N--CA 1.491 2.312 0 O-C-N 121.619 -0.675 . . . . 0.0 114.11 -176.041 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -110.17 38.42 2.43 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 114.338 1.236 . . . . 0.0 114.338 165.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 82.8 mt-10 -132.62 136.17 46.35 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-N 118.891 0.768 . . . . 0.0 111.199 178.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 20.8 tp -90.75 124.71 35.33 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 123.354 0.662 . . . . 0.0 109.785 173.48 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 51.5 m80 -113.68 117.52 31.79 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 179.27 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 51.4 tp -126.53 120.02 28.6 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.884 0.873 . . . . 0.0 109.445 -171.446 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -111.54 110.03 20.26 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 109.389 -0.596 . . . . 0.0 109.389 173.324 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 71.9 mtm -104.41 127.13 52.03 Favored 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 123.492 0.717 . . . . 0.0 111.028 -179.185 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 36.9 mtp-105 -114.04 145.58 41.39 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.377 -0.827 . . . . 0.0 112.659 -175.339 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -149.88 138.91 21.11 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.705 -0.622 . . . . 0.0 112.002 163.675 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . 0.287 6.0 mm-40 69.58 -76.19 0.06 Allowed 'General case' 0 N--CA 1.503 2.215 0 C-N-CA 124.326 1.05 . . . . 0.0 112.884 -177.436 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -159.78 46.42 0.42 Allowed Glycine 0 CA--C 1.553 2.408 0 CA-C-N 116.042 -0.526 . . . . 0.0 113.202 153.087 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 72.1 t -133.93 121.8 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 -163.186 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 16.2 m -101.97 120.91 41.17 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -173.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 26.7 t -84.73 125.5 32.59 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.657 -0.652 . . . . 0.0 111.821 160.343 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 28.5 mtmm -111.7 109.05 18.72 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 -173.538 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -117.95 130.6 56.31 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.613 -0.679 . . . . 0.0 111.565 -172.005 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 39.7 t -116.97 129.25 73.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 N-CA-C 107.969 -1.122 . . . . 0.0 107.969 179.101 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -122.0 157.55 31.09 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 123.479 0.712 . . . . 0.0 110.71 173.309 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 75.4 tttt -114.56 141.29 47.93 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.332 -0.855 . . . . 0.0 112.06 172.14 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 33.9 tttm -76.41 118.04 18.69 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.605 -0.684 . . . . 0.0 112.758 -178.279 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 33.6 m -103.38 -35.36 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.2 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 175.094 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 81.7 t60 . . . . . 0 N--CA 1.484 1.239 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 169.063 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 62.8 mtt . . . . . 0 CA--C 1.572 1.806 0 CA-C-O 118.583 -0.722 . . . . 0.0 112.074 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -73.98 168.76 24.01 Favored 'Trans proline' 0 CA--C 1.564 1.975 0 C-N-CA 122.445 2.097 . . . . 0.0 116.175 176.049 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 34.3 m -69.88 156.65 7.04 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.854 0 CA-C-O 122.216 1.008 . . . . 0.0 113.399 172.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -87.43 116.5 25.58 Favored 'General case' 0 CA--C 1.56 1.334 0 O-C-N 121.129 -0.982 . . . . 0.0 111.249 169.696 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 11.1 m-30 -80.07 0.95 29.74 Favored 'General case' 0 CA--C 1.578 2.052 0 N-CA-C 115.504 1.668 . . . . 0.0 115.504 163.302 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 43.7 m-20 -53.01 113.16 1.01 Allowed 'General case' 0 N--CA 1.493 1.689 0 CA-C-N 120.665 1.575 . . . . 0.0 115.044 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 159.92 173.31 28.27 Favored Glycine 0 N--CA 1.481 1.7 0 CA-C-O 122.378 0.988 . . . . 0.0 115.272 -175.587 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -104.87 126.5 52.01 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 170.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 65.5 m95 -124.37 122.77 38.62 Favored 'General case' 0 CA--C 1.565 1.522 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 -169.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 21.7 pttp -96.35 138.35 34.08 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.555 -0.716 . . . . 0.0 112.054 -178.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 54.9 ttm -69.71 127.82 34.29 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 119.594 1.088 . . . . 0.0 113.91 -178.014 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 98.2 mt -87.52 -50.69 6.36 Favored 'General case' 0 CA--C 1.567 1.621 0 CA-C-N 115.291 -0.868 . . . . 0.0 112.757 167.382 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 80.7 p -144.86 144.6 31.2 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 118.984 0.811 . . . . 0.0 112.188 176.25 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -114.72 101.75 9.37 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.519 0.676 . . . . 0.0 109.745 164.261 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -101.84 121.67 42.54 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 123.858 0.863 . . . . 0.0 109.691 -171.236 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.264 27.9 t30 66.51 22.34 10.64 Favored 'General case' 0 N--CA 1.504 2.264 0 N-CA-C 116.971 2.212 . . . . 0.0 116.971 -174.701 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -66.28 -40.44 90.08 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 116.055 1.872 . . . . 0.0 116.055 177.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -58.45 -41.09 84.36 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 116.074 1.879 . . . . 0.0 116.074 170.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -65.85 -43.0 89.78 Favored 'General case' 0 CA--C 1.571 1.774 0 N-CA-C 114.724 1.379 . . . . 0.0 114.724 170.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -56.87 -47.2 80.98 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 115.137 1.532 . . . . 0.0 115.137 167.104 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 84.2 mt -61.1 -42.69 98.98 Favored 'General case' 0 CA--C 1.574 1.893 0 N-CA-C 114.618 1.34 . . . . 0.0 114.618 169.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 48.1 ttp180 -53.11 -47.55 68.53 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 115.395 1.628 . . . . 0.0 115.395 164.011 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.12 -22.71 61.29 Favored 'General case' 0 CA--C 1.568 1.641 0 N-CA-C 118.239 2.681 . . . . 0.0 118.239 166.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 98.5 mt -88.39 11.56 16.53 Favored 'General case' 0 CA--C 1.573 1.849 0 N-CA-C 115.46 1.652 . . . . 0.0 115.46 164.23 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.25 10.7 m-20 61.34 40.7 13.92 Favored 'General case' 0 CA--C 1.576 1.964 0 N-CA-C 115.493 1.664 . . . . 0.0 115.493 -175.443 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 91.2 t -94.88 141.89 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.191 -0.943 . . . . 0.0 109.931 -176.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 14.0 p30 -64.48 154.44 35.86 Favored 'General case' 0 CA--C 1.572 1.812 0 N-CA-C 115.82 1.785 . . . . 0.0 115.82 178.295 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 96.8 t -58.63 -40.84 80.45 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.276 0 N-CA-C 115.127 1.528 . . . . 0.0 115.127 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.58 -50.3 72.34 Favored 'General case' 0 CA--C 1.567 1.631 0 N-CA-C 116.029 1.863 . . . . 0.0 116.029 171.335 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -71.65 -34.65 69.93 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 115.322 1.601 . . . . 0.0 115.322 172.049 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 74.3 mtp180 -50.68 -41.71 55.99 Favored 'General case' 0 N--CA 1.503 2.197 0 N-CA-C 116.131 1.9 . . . . 0.0 116.131 160.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp -71.48 -54.05 11.89 Favored 'General case' 0 CA--C 1.567 1.621 0 O-C-N 120.96 -1.088 . . . . 0.0 113.574 166.257 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 12.0 mt -77.98 60.44 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.509 2.484 0 CA-C-N 120.923 1.692 . . . . 0.0 111.708 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -179.45 -47.29 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 126.701 2.0 . . . . 0.0 110.969 -174.358 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -64.49 -45.45 87.26 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 115.99 1.848 . . . . 0.0 115.99 158.008 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 65.2 mt -78.02 -24.94 47.69 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 115.645 1.72 . . . . 0.0 115.645 -175.206 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.9 pp -96.0 134.61 38.82 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 162.147 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 62.4 pttt -98.91 102.06 14.09 Favored Pre-proline 0 CA--C 1.574 1.896 0 CA-C-O 117.906 -1.045 . . . . 0.0 110.644 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -73.61 166.03 30.83 Favored 'Trans proline' 0 CA--C 1.565 2.041 0 CA-C-N 123.101 2.143 . . . . 0.0 115.77 -173.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -110.69 136.27 50.02 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.621 -0.674 . . . . 0.0 110.345 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 43.0 mttp -100.51 116.58 32.79 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 120.918 -1.114 . . . . 0.0 109.851 176.057 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -101.46 109.29 21.08 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 167.563 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.1 mp -96.06 127.12 48.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 178.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 74.7 t -110.21 106.55 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 164.663 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -103.69 105.69 15.99 Favored 'General case' 0 CA--C 1.565 1.535 0 C-N-CA 124.361 1.064 . . . . 0.0 109.222 177.049 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -125.97 87.42 2.68 Favored 'General case' 0 CA--C 1.565 1.532 0 C-N-CA 123.509 0.724 . . . . 0.0 110.061 -176.179 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 57.36 72.03 0.65 Allowed Glycine 0 N--CA 1.496 2.662 0 N-CA-C 117.106 1.602 . . . . 0.0 117.106 175.457 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.471 0.6 OUTLIER 65.26 -33.8 0.17 Allowed 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 118.476 2.769 . . . . 0.0 118.476 -166.473 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 15.6 t-160 -73.69 114.78 12.35 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-N 120.62 1.555 . . . . 0.0 111.471 172.295 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 44.7 ttm -123.35 124.18 42.37 Favored 'General case' 0 CA--C 1.557 1.227 0 C-N-CA 123.707 0.803 . . . . 0.0 109.646 -175.241 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 43.2 mt -108.46 104.4 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 178.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 17.0 mm -90.39 98.29 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 176.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -90.39 100.82 13.58 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.225 -0.922 . . . . 0.0 109.2 -176.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 28.6 m -88.55 104.49 16.87 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.169 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 43.7 mt -103.2 117.38 34.4 Favored 'General case' 0 CA--C 1.557 1.225 0 C-N-CA 123.852 0.861 . . . . 0.0 109.499 -163.506 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 43.7 t -128.58 143.03 50.88 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.063 0.945 . . . . 0.0 110.453 -165.676 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . 0.253 12.7 t -77.34 50.83 0.81 Allowed 'General case' 0 N--CA 1.503 2.191 0 N-CA-C 114.55 1.315 . . . . 0.0 114.55 168.776 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -167.26 -68.64 0.03 OUTLIER 'General case' 0 CA--C 1.568 1.639 0 C-N-CA 125.537 1.535 . . . . 0.0 108.057 -178.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 33.5 ttm105 -151.19 123.14 8.14 Favored 'General case' 0 CA--C 1.565 1.551 0 CA-C-N 118.959 0.8 . . . . 0.0 110.322 -179.273 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -80.16 139.44 36.79 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 -178.368 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -114.0 107.36 15.57 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.745 -0.597 . . . . 0.0 109.465 177.214 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 43.9 mm -100.51 106.5 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -171.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 1.2 mmm -96.24 87.32 4.47 Favored 'General case' 0 CA--C 1.564 1.493 0 CA-C-O 121.638 0.732 . . . . 0.0 110.207 -176.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -100.01 116.99 33.35 Favored 'General case' 0 CA--C 1.562 1.41 0 C-N-CA 123.928 0.891 . . . . 0.0 112.282 -175.357 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -155.59 153.54 30.28 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 -168.376 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -95.09 122.95 38.29 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.507 -0.746 . . . . 0.0 111.425 166.526 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 31.7 t -65.46 121.85 15.29 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.831 0 C-N-CA 124.169 0.987 . . . . 0.0 110.538 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 105.54 -34.57 5.67 Favored Glycine 0 CA--C 1.552 2.389 0 N-CA-C 116.955 1.542 . . . . 0.0 116.955 -162.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 52.4 mttp -95.55 122.96 38.84 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 119.265 1.532 . . . . 0.0 111.454 -171.496 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -78.9 116.52 19.28 Favored 'General case' 0 CA--C 1.569 1.697 0 O-C-N 121.491 -0.756 . . . . 0.0 112.587 -178.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -124.71 147.83 48.38 Favored 'General case' 0 N--CA 1.496 1.828 0 C-N-CA 123.787 0.835 . . . . 0.0 112.346 -170.256 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -68.29 127.18 32.01 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 119.91 -1.744 . . . . 0.0 113.92 172.014 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -77.03 61.15 1.94 Allowed 'General case' 0 N--CA 1.5 2.056 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 176.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -90.59 74.41 6.75 Favored 'General case' 0 CA--C 1.568 1.667 0 O-C-N 120.481 -1.387 . . . . 0.0 111.69 -174.068 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 92.3 mt -125.29 140.06 53.16 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 121.573 0.702 . . . . 0.0 110.897 -174.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 34.4 p -92.64 98.34 11.37 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.899 -1.126 . . . . 0.0 111.284 -175.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 173.21 -76.54 0.09 OUTLIER Glycine 0 N--CA 1.486 1.976 0 N-CA-C 115.663 1.025 . . . . 0.0 115.663 173.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 49.6 mm -74.33 -65.98 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 CA-C-N 117.413 0.606 . . . . 0.0 112.144 -173.288 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -108.74 -52.2 2.79 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-N 119.276 0.944 . . . . 0.0 113.354 174.318 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.271 13.9 t70 63.34 66.11 0.73 Allowed 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 114.452 1.278 . . . . 0.0 114.452 -171.329 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 19.6 ttp85 -147.2 141.03 25.77 Favored 'General case' 0 CA--C 1.562 1.426 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 173.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? -75.16 71.84 2.21 Favored 'General case' 0 CA--C 1.572 1.805 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 -172.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 84.5 m -87.13 122.74 31.35 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.585 -0.697 . . . . 0.0 111.211 -178.076 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 79.1 mmm -72.21 103.4 3.33 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 121.979 0.895 . . . . 0.0 110.398 -174.141 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 85.8 m -107.76 113.6 26.97 Favored 'General case' 0 N--CA 1.48 1.038 0 O-C-N 121.162 -0.961 . . . . 0.0 110.07 -159.579 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 40.5 m -98.57 121.37 40.42 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 170.423 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.524 HG22 ' SG ' ' A' ' 95' ' ' CYS . 20.2 t -109.21 126.36 66.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 170.304 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 58.3 m -133.22 144.41 49.78 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 123.627 0.771 . . . . 0.0 111.323 -176.103 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 8.2 m95 -83.88 122.55 28.87 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.821 -1.174 . . . . 0.0 113.656 179.244 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -108.58 65.7 0.63 Allowed 'General case' 0 CA--C 1.576 1.964 0 C-N-CA 123.485 0.714 . . . . 0.0 110.424 163.287 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 67.65 -94.61 0.29 Allowed Glycine 0 N--CA 1.493 2.477 0 N-CA-C 116.322 1.289 . . . . 0.0 116.322 178.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -82.47 -30.52 29.92 Favored 'General case' 0 CA--C 1.573 1.857 0 N-CA-C 115.34 1.607 . . . . 0.0 115.34 165.034 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 33.8 mtpt -96.24 116.38 28.92 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-N 119.853 1.206 . . . . 0.0 110.434 -171.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 33.6 tp -86.96 110.8 20.27 Favored 'General case' 0 CA--C 1.564 1.509 0 O-C-N 120.992 -1.068 . . . . 0.0 109.711 174.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 18.2 mm100 -103.05 126.01 50.04 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.863 0.865 . . . . 0.0 110.226 -167.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' CYS . . . . . 0.524 ' SG ' HG22 ' A' ' 86' ' ' VAL . 41.0 t -127.6 129.11 46.7 Favored 'General case' 0 N--CA 1.481 1.083 0 O-C-N 121.822 -0.549 . . . . 0.0 111.417 -175.028 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 12.0 p -109.5 127.59 66.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 162.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -103.93 75.98 1.33 Allowed 'General case' 0 CA--C 1.57 1.712 0 C-N-CA 123.805 0.842 . . . . 0.0 109.263 175.163 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 15.7 ptpt -84.44 143.91 29.1 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 114.586 1.328 . . . . 0.0 114.586 -166.704 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 161.66 -114.15 0.59 Allowed Glycine 0 N--CA 1.484 1.884 0 O-C-N 121.663 -0.648 . . . . 0.0 111.949 172.438 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -80.33 -36.08 34.71 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 115.655 1.724 . . . . 0.0 115.655 175.684 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 9.4 tppt? -77.02 114.68 16.09 Favored 'General case' 0 CA--C 1.567 1.605 0 CA-C-N 119.559 1.072 . . . . 0.0 111.58 -177.582 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -74.17 119.46 18.41 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.418 -0.801 . . . . 0.0 112.854 -169.603 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 68.48 40.83 86.34 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 118.594 2.197 . . . . 0.0 118.594 -172.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 45.7 ttt180 -92.0 130.22 37.79 Favored 'General case' 0 CA--C 1.566 1.572 0 CA-C-N 118.514 1.157 . . . . 0.0 111.854 179.034 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 179.73 -168.52 38.98 Favored Glycine 0 N--CA 1.484 1.859 0 CA-C-O 122.368 0.982 . . . . 0.0 114.021 175.489 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 58.2 p-90 -156.62 153.3 28.37 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 122.214 1.007 . . . . 0.0 112.989 174.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 39.8 m -129.71 117.72 20.75 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 176.4 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -121.29 129.2 53.01 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 123.247 0.619 . . . . 0.0 111.621 -174.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 17.8 p90 -146.78 163.63 35.37 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.025 -1.047 . . . . 0.0 113.339 -174.421 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 76.0 mt -106.52 143.39 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.298 0 CA-C-O 123.224 1.488 . . . . 0.0 111.654 178.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -137.06 84.97 2.1 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 178.13 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 72.39 -110.04 3.04 Favored Glycine 0 N--CA 1.489 2.208 0 CA-C-N 116.025 -0.534 . . . . 0.0 114.415 -174.037 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 55.6 p30 -88.9 7.22 35.5 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 117.473 2.397 . . . . 0.0 117.473 169.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -124.07 137.93 54.51 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-N 120.085 1.311 . . . . 0.0 112.754 -166.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 26.4 tp -97.01 118.65 33.88 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 123.947 0.899 . . . . 0.0 108.984 172.551 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 34.1 m80 -107.83 123.29 48.35 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.926 0.89 . . . . 0.0 108.977 -176.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 45.4 tp -123.17 121.14 35.21 Favored 'General case' 0 CA--C 1.559 1.323 0 C-N-CA 123.82 0.848 . . . . 0.0 110.004 -172.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -102.13 114.66 28.98 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.594 -0.691 . . . . 0.0 109.296 166.034 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 73.5 mtm -103.89 126.85 51.31 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-N 118.557 0.617 . . . . 0.0 110.582 175.305 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 87.0 mtm180 -120.0 134.43 55.25 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 123.837 0.855 . . . . 0.0 110.471 -167.467 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -162.53 137.22 6.71 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.372 -0.83 . . . . 0.0 112.236 173.592 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . 0.328 12.1 mt-10 48.68 43.83 20.94 Favored 'General case' 0 N--CA 1.504 2.265 0 N-CA-C 116.156 1.91 . . . . 0.0 116.156 -178.197 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 65.71 26.24 71.99 Favored Glycine 0 CA--C 1.552 2.363 0 N-CA-C 120.609 3.004 . . . . 0.0 120.609 -167.715 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 87.6 t -130.83 128.36 62.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 CA-C-N 119.605 1.703 . . . . 0.0 109.202 -175.635 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 52.4 m -106.07 126.11 51.81 Favored 'General case' 0 N--CA 1.496 1.834 0 C-N-CA 123.284 0.634 . . . . 0.0 111.267 176.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 9.2 t -96.67 128.65 43.81 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.698 0.799 . . . . 0.0 111.542 162.541 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 47.0 mttp -102.02 111.1 23.25 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 121.427 0.632 . . . . 0.0 110.536 176.102 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 64.2 mt-30 -108.98 126.74 53.42 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.693 0.797 . . . . 0.0 110.767 176.705 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 47.7 t -114.27 132.0 64.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.075 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -126.87 149.6 49.67 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 123.742 0.817 . . . . 0.0 111.329 178.654 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 75.4 tttt -111.33 140.18 46.11 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.374 -0.829 . . . . 0.0 112.164 175.49 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 73.0 tttt -74.19 122.93 23.55 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.448 -0.782 . . . . 0.0 113.07 -178.505 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 31.7 m -109.32 -42.31 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 175.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 50.2 t-80 . . . . . 0 N--CA 1.485 1.309 0 CA-C-N 119.712 1.142 . . . . 0.0 108.268 167.782 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 72.3 mtm . . . . . 0 CA--C 1.575 1.928 0 CA-C-O 118.525 -0.75 . . . . 0.0 110.924 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -89.98 163.17 4.92 Favored 'Trans proline' 0 CA--C 1.565 2.028 0 N-CA-C 117.35 2.019 . . . . 0.0 117.35 -173.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 27.6 m -108.98 175.42 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 CA-C-O 122.666 1.222 . . . . 0.0 112.719 174.297 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -78.14 96.74 5.24 Favored 'General case' 0 CA--C 1.568 1.643 0 O-C-N 120.874 -1.141 . . . . 0.0 113.287 -172.656 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -78.14 -0.22 27.4 Favored 'General case' 0 N--CA 1.501 2.116 0 N-CA-C 116.334 1.976 . . . . 0.0 116.334 169.151 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -60.24 116.07 3.97 Favored 'General case' 0 CA--C 1.563 1.47 0 C-N-CA 125.826 1.65 . . . . 0.0 114.343 179.234 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 163.44 177.99 36.77 Favored Glycine 0 N--CA 1.484 1.879 0 N-CA-C 116.743 1.457 . . . . 0.0 116.743 177.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -106.57 120.07 40.96 Favored 'General case' 0 CA--C 1.563 1.459 0 CA-C-N 113.961 -1.12 . . . . 0.0 108.536 170.05 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 64.5 m95 -120.03 124.98 47.22 Favored 'General case' 0 CA--C 1.565 1.547 0 C-N-CA 123.882 0.873 . . . . 0.0 108.766 -169.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -95.24 137.06 34.81 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.67 -1.269 . . . . 0.0 112.619 179.539 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 4.3 ttp -74.86 121.64 22.15 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 122.133 0.968 . . . . 0.0 112.773 179.565 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 93.4 mt -79.47 -54.65 5.71 Favored 'General case' 0 CA--C 1.566 1.592 0 CA-C-N 115.029 -0.987 . . . . 0.0 112.609 171.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 89.6 p -144.33 151.77 39.82 Favored 'General case' 0 CA--C 1.563 1.45 0 C-N-CA 123.717 0.807 . . . . 0.0 112.624 -173.29 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -122.64 133.49 54.52 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.43 0.634 . . . . 0.0 110.901 160.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -125.58 117.78 24.3 Favored 'General case' 0 CA--C 1.561 1.367 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 -179.542 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.292 31.3 t30 68.88 31.65 4.23 Favored 'General case' 0 CA--C 1.579 2.089 0 N-CA-C 117.082 2.253 . . . . 0.0 117.082 -175.806 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -71.8 -42.97 66.42 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 115.215 1.561 . . . . 0.0 115.215 175.012 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -47.3 -47.33 25.37 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 116.442 2.015 . . . . 0.0 116.442 166.387 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -70.26 -38.62 75.15 Favored 'General case' 0 CA--C 1.57 1.736 0 N-CA-C 115.686 1.736 . . . . 0.0 115.686 176.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 81.5 t80 -55.41 -49.4 72.45 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-N 120.519 1.508 . . . . 0.0 114.201 165.236 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 79.8 mt -59.37 -43.01 92.91 Favored 'General case' 0 CA--C 1.574 1.895 0 N-CA-C 115.493 1.664 . . . . 0.0 115.493 169.29 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 36.4 ttp180 -51.2 -51.16 56.44 Favored 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 115.325 1.602 . . . . 0.0 115.325 165.13 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.87 -24.53 52.39 Favored 'General case' 0 CA--C 1.565 1.538 0 N-CA-C 118.364 2.728 . . . . 0.0 118.364 165.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 93.3 mt -87.18 8.91 21.87 Favored 'General case' 0 CA--C 1.575 1.912 0 N-CA-C 115.735 1.754 . . . . 0.0 115.735 167.522 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.256 25.8 m-20 67.24 41.46 2.52 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 -175.241 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 90.3 t -100.37 141.66 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 121.031 -1.043 . . . . 0.0 110.014 -178.514 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 12.1 p30 -68.68 159.89 31.28 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 115.887 1.81 . . . . 0.0 115.887 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 65.0 t -58.52 -46.2 89.9 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.256 0 N-CA-C 114.895 1.443 . . . . 0.0 114.895 -179.533 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.55 -47.4 84.36 Favored 'General case' 0 CA--C 1.57 1.717 0 N-CA-C 116.052 1.871 . . . . 0.0 116.052 173.493 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.49 -43.83 97.85 Favored 'General case' 0 CA--C 1.574 1.9 0 N-CA-C 114.873 1.434 . . . . 0.0 114.873 169.259 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 77.1 mtp180 -49.92 -50.92 44.55 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 115.569 1.692 . . . . 0.0 115.569 164.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -54.95 -54.15 46.51 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 115.258 1.577 . . . . 0.0 115.258 168.183 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 34.9 mt -59.73 -53.2 51.71 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 CA-C-N 119.808 1.185 . . . . 0.0 113.162 178.245 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -61.94 -40.41 95.45 Favored 'General case' 0 CA--C 1.566 1.569 0 N-CA-C 117.529 2.418 . . . . 0.0 117.529 175.658 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -65.64 -32.08 73.45 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 116.003 1.853 . . . . 0.0 116.003 169.242 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 81.5 mt -72.79 -30.45 64.1 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 116.139 1.903 . . . . 0.0 116.139 170.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 38.6 mt -73.95 139.8 45.12 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 119.539 1.063 . . . . 0.0 113.547 -179.642 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -110.96 86.01 5.61 Favored Pre-proline 0 CA--C 1.572 1.826 0 CA-C-O 118.299 -0.858 . . . . 0.0 109.723 172.24 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -76.87 174.02 13.53 Favored 'Trans proline' 0 CA--C 1.563 1.926 0 C-N-CA 122.558 2.172 . . . . 0.0 115.67 -176.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -111.88 130.27 55.89 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.699 -0.625 . . . . 0.0 111.315 178.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 47.6 mttm -90.12 109.93 20.97 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.275 -0.891 . . . . 0.0 110.137 171.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -92.55 110.94 22.37 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 163.147 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 74.3 mt -109.03 118.35 56.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 107.475 -1.305 . . . . 0.0 107.475 -178.536 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 72.1 t -100.87 98.48 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 106.676 -1.602 . . . . 0.0 106.676 166.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -90.44 93.0 9.12 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.537 0.684 . . . . 0.0 109.731 174.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -100.33 70.58 1.52 Allowed 'General case' 0 CA--C 1.567 1.624 0 O-C-N 121.478 -0.764 . . . . 0.0 111.403 -177.35 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 53.56 67.46 2.13 Favored Glycine 0 N--CA 1.496 2.695 0 N-CA-C 117.64 1.816 . . . . 0.0 117.64 176.56 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.438 0.5 OUTLIER 61.0 8.22 1.82 Allowed 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 119.617 3.192 . . . . 0.0 119.617 -163.579 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 17.5 t-160 -107.48 106.56 17.01 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 121.276 1.853 . . . . 0.0 107.643 161.204 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 6.6 tpp -109.45 132.19 54.36 Favored 'General case' 0 CA--C 1.556 1.186 0 O-C-N 121.458 -0.776 . . . . 0.0 110.969 -172.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 47.1 mt -116.47 101.87 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 173.26 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 72.9 mt -99.13 116.31 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 178.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -115.86 103.39 10.59 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.427 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 70.4 m -88.42 112.62 23.12 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 172.274 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 24.0 mt -110.96 119.01 37.64 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.303 -158.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 36.1 t -130.76 153.53 48.93 Favored 'General case' 0 CA--C 1.56 1.346 0 C-N-CA 123.668 0.787 . . . . 0.0 110.529 173.611 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 70.2 p -80.98 62.32 4.92 Favored 'General case' 0 N--CA 1.504 2.247 0 O-C-N 120.636 -1.29 . . . . 0.0 111.633 163.49 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -174.06 -68.61 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 125.097 1.359 . . . . 0.0 108.985 -174.515 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 14.8 ttm180 -146.61 118.08 7.96 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 123.634 0.773 . . . . 0.0 109.103 -173.145 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -106.11 130.55 53.98 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 123.229 0.612 . . . . 0.0 110.588 -170.314 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 10.3 t80 -101.45 109.55 21.4 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.544 -0.722 . . . . 0.0 109.871 178.045 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 41.6 mm -116.67 117.47 55.58 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -169.068 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 25.4 mmm -126.6 97.54 5.06 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 123.226 0.61 . . . . 0.0 109.77 -175.132 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -104.84 103.7 13.34 Favored 'General case' 0 CA--C 1.563 1.463 0 C-N-CA 124.06 0.944 . . . . 0.0 111.875 177.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -151.49 154.24 36.17 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 -163.101 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 17.8 mp0 -84.57 126.53 33.4 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.11 -0.994 . . . . 0.0 111.08 164.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 15.1 t -69.06 114.15 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 174.387 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 124.88 -46.72 1.07 Allowed Glycine 0 N--CA 1.488 2.146 0 N-CA-C 115.807 1.083 . . . . 0.0 115.807 -160.255 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 34.9 mtmt -83.74 142.83 30.42 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 118.872 1.336 . . . . 0.0 113.861 -173.268 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -93.25 95.54 9.43 Favored 'General case' 0 CA--C 1.566 1.58 0 CA-C-O 121.321 0.582 . . . . 0.0 111.252 176.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -104.56 142.14 35.16 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 124.032 0.933 . . . . 0.0 113.058 -170.333 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -71.58 115.7 11.07 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.164 -1.585 . . . . 0.0 113.46 176.401 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -81.97 100.34 9.63 Favored 'General case' 0 CA--C 1.564 1.508 0 O-C-N 121.397 -0.814 . . . . 0.0 109.423 165.501 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -109.2 92.23 3.97 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 123.736 0.815 . . . . 0.0 110.601 179.162 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . 0.278 2.2 tt 57.16 74.98 0.39 Allowed 'General case' 0 N--CA 1.498 1.968 0 C-N-CA 124.783 1.233 . . . . 0.0 113.906 -170.618 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 28.5 m -90.06 3.62 52.72 Favored 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 116.095 1.887 . . . . 0.0 116.095 -173.433 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 138.84 -73.55 0.41 Allowed Glycine 0 N--CA 1.487 2.037 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 -164.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 47.3 mm -86.28 173.55 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.587 2.396 0 CA-C-O 122.3 1.048 . . . . 0.0 109.801 164.14 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 -67.04 68.74 0.07 Allowed 'General case' 0 CA--C 1.576 1.965 0 N-CA-C 117.404 2.372 . . . . 0.0 117.404 -177.233 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -83.95 98.85 10.03 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.048 -1.033 . . . . 0.0 110.486 171.156 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 -89.57 78.03 7.12 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.065 -1.022 . . . . 0.0 111.648 -178.483 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . 0.254 52.2 mtmt 54.81 57.25 5.83 Favored 'General case' 0 N--CA 1.5 2.072 0 N-CA-C 115.711 1.745 . . . . 0.0 115.711 -173.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 72.5 m -86.07 113.9 22.51 Favored 'General case' 0 CA--C 1.559 1.31 0 O-C-N 121.082 -1.011 . . . . 0.0 110.866 178.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 2.4 tpt -75.58 98.66 4.06 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 122.195 0.998 . . . . 0.0 109.638 -176.442 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 65.3 m -104.72 110.26 22.51 Favored 'General case' 0 N--CA 1.48 1.059 0 O-C-N 121.695 -0.628 . . . . 0.0 110.065 -154.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 54.6 m -88.79 121.82 31.56 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 167.343 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 22.9 t -110.35 121.51 63.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 165.546 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 31.8 m -128.08 154.11 46.07 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 122.125 0.964 . . . . 0.0 111.545 -175.069 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 29.0 m95 -84.69 114.98 22.42 Favored 'General case' 0 CA--C 1.562 1.422 0 O-C-N 121.223 -0.923 . . . . 0.0 111.939 174.663 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -93.5 70.92 4.3 Favored 'General case' 0 CA--C 1.571 1.783 0 CA-C-O 121.539 0.685 . . . . 0.0 109.57 159.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 61.14 -114.72 6.96 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 114.901 0.72 . . . . 0.0 114.901 -168.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -64.87 -30.56 71.57 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 116.461 2.023 . . . . 0.0 116.461 166.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -86.87 127.81 35.04 Favored 'General case' 0 CA--C 1.561 1.384 0 CA-C-N 119.443 1.019 . . . . 0.0 111.256 -173.065 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 25.8 tp -92.28 106.56 18.54 Favored 'General case' 0 CA--C 1.566 1.562 0 O-C-N 121.378 -0.826 . . . . 0.0 109.097 176.346 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 -100.46 128.83 46.41 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 123.658 0.783 . . . . 0.0 111.132 -173.302 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 40.9 t -124.19 131.64 53.55 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.436 0.694 . . . . 0.0 111.975 -177.459 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.5 p -120.15 125.65 74.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 C-N-CA 122.979 0.511 . . . . 0.0 109.628 168.133 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -100.87 90.26 4.14 Favored 'General case' 0 CA--C 1.568 1.657 0 C-N-CA 124.092 0.957 . . . . 0.0 109.58 -176.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -84.88 122.47 29.21 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.66 -1.275 . . . . 0.0 113.525 -166.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -169.76 -130.64 1.23 Allowed Glycine 0 N--CA 1.485 1.947 0 O-C-N 121.593 -0.692 . . . . 0.0 112.157 171.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.68 -16.44 58.49 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 117.157 2.281 . . . . 0.0 117.157 176.165 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 16.7 ttmt -98.82 129.64 45.22 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 119.97 1.259 . . . . 0.0 111.561 -170.354 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -79.01 128.55 33.4 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.472 -0.767 . . . . 0.0 112.816 -172.192 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 66.61 34.1 86.53 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 118.975 2.35 . . . . 0.0 118.975 -176.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 36.7 ttt180 -85.92 124.36 32.3 Favored 'General case' 0 CA--C 1.565 1.527 0 CA-C-N 118.734 1.267 . . . . 0.0 111.577 -177.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -179.18 -168.96 39.03 Favored Glycine 0 N--CA 1.486 1.989 0 N-CA-C 115.687 1.035 . . . . 0.0 115.687 -177.193 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 41.8 p-90 -157.43 155.47 30.53 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.958 0.885 . . . . 0.0 112.898 170.482 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 97.5 m -126.16 120.47 30.2 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.344 -0.848 . . . . 0.0 108.712 176.31 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 16.8 tt0 -124.42 124.72 42.95 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.846 -0.534 . . . . 0.0 111.992 -175.522 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 14.0 p90 -143.17 163.02 34.04 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.079 -1.013 . . . . 0.0 113.227 -177.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 86.1 mt -107.92 133.94 51.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 CA-C-O 122.266 1.031 . . . . 0.0 110.652 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -120.71 85.34 2.38 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 124.525 1.13 . . . . 0.0 108.451 173.434 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 69.68 -108.06 2.34 Favored Glycine 0 N--CA 1.491 2.315 0 O-C-N 121.584 -0.697 . . . . 0.0 114.752 -175.426 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 31.6 p-10 -87.96 -5.16 58.68 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 117.427 2.38 . . . . 0.0 117.427 166.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -103.41 139.59 38.59 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-N 120.408 1.458 . . . . 0.0 112.368 -175.025 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 10.7 tp -101.46 122.08 43.12 Favored 'General case' 0 CA--C 1.562 1.417 0 C-N-CA 123.873 0.869 . . . . 0.0 108.957 169.348 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 36.9 m80 -109.27 119.87 40.81 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.533 0.733 . . . . 0.0 109.208 -175.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 20.0 tp -114.38 129.86 56.67 Favored 'General case' 0 CA--C 1.56 1.327 0 C-N-CA 123.737 0.815 . . . . 0.0 110.183 -178.049 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -119.16 108.7 14.99 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.936 -0.478 . . . . 0.0 110.003 169.09 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 76.8 mtm -97.82 127.49 43.8 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 123.62 0.768 . . . . 0.0 111.515 -176.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 78.7 mtm180 -118.14 135.2 54.37 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 123.329 0.651 . . . . 0.0 111.693 -167.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -160.23 132.89 6.46 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.26 -0.9 . . . . 0.0 111.515 170.04 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 33.8 mm-40 58.13 36.88 26.24 Favored 'General case' 0 N--CA 1.505 2.3 0 N-CA-C 115.361 1.615 . . . . 0.0 115.361 -177.348 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 72.9 -8.62 7.56 Favored Glycine 0 CA--C 1.556 2.603 0 N-CA-C 120.399 2.92 . . . . 0.0 120.399 -162.46 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 97.1 t -92.88 128.23 44.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 CA-C-N 120.137 1.969 . . . . 0.0 109.76 -171.116 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 37.8 m -105.9 124.25 49.28 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 122.73 0.412 . . . . 0.0 111.5 177.3 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 11.2 t -95.14 126.21 40.31 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.426 0.69 . . . . 0.0 111.234 162.271 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -103.4 121.1 42.09 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 123.381 0.672 . . . . 0.0 109.569 -179.004 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 20.0 mt-30 -126.64 134.24 50.8 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.588 -0.695 . . . . 0.0 111.227 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 57.1 t -115.24 131.07 68.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 -177.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -123.5 149.83 44.69 Favored 'General case' 0 CA--C 1.563 1.478 0 C-N-CA 124.72 1.208 . . . . 0.0 110.232 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 29.6 ttmt -123.61 141.08 52.36 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.789 -1.194 . . . . 0.0 112.153 175.413 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 70.8 tttt -73.84 123.4 24.13 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 -175.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . 0.255 34.5 m -107.86 -43.07 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 175.248 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 . . . . . 0 N--CA 1.487 1.414 0 CA-C-N 120.206 1.366 . . . . 0.0 108.312 167.011 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 26.6 ttt . . . . . 0 CA--C 1.571 1.78 0 CA-C-O 118.269 -0.872 . . . . 0.0 109.871 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -75.71 134.51 16.75 Favored 'Trans proline' 0 CA--C 1.561 1.859 0 C-N-CA 122.507 2.138 . . . . 0.0 115.405 -173.524 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 15.6 m -72.58 141.26 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 CA-C-O 121.936 0.874 . . . . 0.0 113.079 178.503 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -76.25 121.48 23.0 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 -176.024 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 8.6 m-30 -85.05 8.4 18.04 Favored 'General case' 0 CA--C 1.572 1.807 0 N-CA-C 115.647 1.721 . . . . 0.0 115.647 177.498 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 71.4 m-80 -51.43 121.82 6.93 Favored 'General case' 0 N--CA 1.499 2.004 0 CA-C-N 121.496 1.953 . . . . 0.0 115.082 172.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 160.45 177.88 33.95 Favored Glycine 0 N--CA 1.481 1.685 0 CA-C-O 123.002 1.334 . . . . 0.0 116.031 174.009 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 14.8 t80 -110.74 128.84 55.89 Favored 'General case' 0 CA--C 1.564 1.491 0 CA-C-N 113.578 -1.311 . . . . 0.0 108.364 165.382 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 55.3 m95 -126.81 138.51 53.36 Favored 'General case' 0 CA--C 1.573 1.832 0 C-N-CA 123.733 0.813 . . . . 0.0 110.144 -167.477 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -112.11 137.05 50.71 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 120.678 -1.264 . . . . 0.0 112.633 178.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.45 ' SD ' ' HD2' ' A' ' 38' ' ' PRO . 1.9 ttt -75.0 123.45 25.18 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.454 -1.404 . . . . 0.0 114.281 -175.122 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 97.5 mt -85.92 -52.67 5.58 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 113.688 0.996 . . . . 0.0 113.688 176.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 83.3 p -142.36 148.25 37.61 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 123.671 0.788 . . . . 0.0 112.112 -176.197 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -126.75 116.73 21.38 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 123.107 0.563 . . . . 0.0 110.078 170.484 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -112.15 116.05 29.85 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 178.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.293 18.7 t30 69.71 25.47 5.14 Favored 'General case' 0 CA--C 1.579 2.096 0 N-CA-C 117.964 2.579 . . . . 0.0 117.964 177.78 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 15.7 t80 -63.41 -45.14 92.39 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 115.459 1.651 . . . . 0.0 115.459 170.597 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -54.68 -40.78 69.47 Favored 'General case' 0 CA--C 1.573 1.836 0 N-CA-C 117.868 2.544 . . . . 0.0 117.868 172.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -74.22 -40.72 62.26 Favored 'General case' 0 CA--C 1.571 1.775 0 N-CA-C 115.264 1.579 . . . . 0.0 115.264 171.114 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -49.06 -48.92 43.67 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 115.19 1.552 . . . . 0.0 115.19 162.501 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 88.5 mt -62.06 -40.19 94.94 Favored 'General case' 0 CA--C 1.573 1.835 0 N-CA-C 115.339 1.607 . . . . 0.0 115.339 169.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 46.9 ttp180 -54.0 -50.47 66.52 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 165.181 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.58 -21.52 53.34 Favored 'General case' 0 CA--C 1.567 1.622 0 N-CA-C 118.223 2.675 . . . . 0.0 118.223 167.203 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 37.7 mt -90.83 8.53 34.36 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 115.988 1.847 . . . . 0.0 115.988 168.716 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 69.84 32.94 3.01 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 115.141 1.534 . . . . 0.0 115.141 -177.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 70.3 t -95.36 144.08 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 120.666 -1.271 . . . . 0.0 110.623 -172.056 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -64.74 152.64 42.04 Favored 'General case' 0 CA--C 1.573 1.835 0 N-CA-C 116.213 1.931 . . . . 0.0 116.213 -176.49 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . 0.251 56.1 t -58.45 -42.47 84.37 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.156 0 N-CA-C 115.682 1.734 . . . . 0.0 115.682 -179.251 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.05 -51.3 70.65 Favored 'General case' 0 CA--C 1.57 1.72 0 N-CA-C 115.878 1.807 . . . . 0.0 115.878 173.224 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -54.28 -53.49 53.05 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 114.314 1.227 . . . . 0.0 114.314 166.048 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 56.3 mtp180 -47.52 -41.57 21.33 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 118.378 2.732 . . . . 0.0 118.378 171.269 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -75.73 -52.88 9.48 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 174.167 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 19.9 mt -63.33 -49.75 81.64 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 CA-C-N 119.251 0.932 . . . . 0.0 112.961 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.93 -33.07 74.88 Favored 'General case' 0 CA--C 1.568 1.664 0 N-CA-C 117.821 2.526 . . . . 0.0 117.821 175.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -69.14 -31.27 69.82 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 116.11 1.893 . . . . 0.0 116.11 165.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 79.9 mt -72.25 -36.49 69.08 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 116.075 1.88 . . . . 0.0 116.075 171.186 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . 0.293 2.5 pp -80.82 152.69 28.1 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-N 120.196 1.362 . . . . 0.0 114.545 -178.716 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 30.8 mmtp -111.07 99.29 42.54 Favored Pre-proline 0 CA--C 1.572 1.808 0 CA-C-O 118.348 -0.834 . . . . 0.0 108.818 176.475 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.45 ' HD2' ' SD ' ' A' ' 10' ' ' MET . 91.0 Cg_endo -77.92 176.92 9.42 Favored 'Trans proline' 0 CA--C 1.565 2.032 0 C-N-CA 122.948 2.432 . . . . 0.0 116.025 -175.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -109.98 163.45 13.55 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.969 0.89 . . . . 0.0 112.213 173.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 43.2 mttm -135.46 120.53 18.78 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.099 -1.001 . . . . 0.0 110.123 176.196 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -100.57 118.57 37.0 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.422 -0.798 . . . . 0.0 109.656 163.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 78.6 mt -113.75 121.42 65.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 177.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 52.9 t -107.09 97.35 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 107.788 -1.189 . . . . 0.0 107.788 167.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -88.48 117.04 27.14 Favored 'General case' 0 CA--C 1.567 1.604 0 C-N-CA 123.454 0.701 . . . . 0.0 110.019 165.459 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -142.9 102.04 3.95 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.241 -0.912 . . . . 0.0 109.762 -179.136 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 56.8 62.36 6.45 Favored Glycine 0 N--CA 1.497 2.706 0 N-CA-C 117.409 1.724 . . . . 0.0 117.409 178.013 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.416 0.6 OUTLIER 59.97 -10.79 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 119.914 3.302 . . . . 0.0 119.914 -165.291 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 12.4 t-80 -88.4 121.93 31.33 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-N 121.192 1.814 . . . . 0.0 110.127 174.46 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 40.4 ttm -123.58 116.99 24.04 Favored 'General case' 0 CA--C 1.556 1.208 0 CA-C-O 121.553 0.692 . . . . 0.0 110.161 -174.523 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 27.6 mt -104.13 98.91 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 177.453 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 72.0 mt -94.23 111.76 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 178.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 41.9 mtt85 -110.27 101.79 10.5 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 178.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.2 m -80.0 120.7 24.54 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 167.247 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 74.9 mt -124.39 118.21 26.19 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-O 121.649 0.738 . . . . 0.0 109.638 -164.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.47 -3.13 0.2 Allowed 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 117.018 2.229 . . . . 0.0 117.018 -178.191 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . 0.344 30.3 m 75.4 -62.97 0.43 Allowed 'General case' 0 N--CA 1.505 2.293 0 CA-C-N 121.556 1.98 . . . . 0.0 112.893 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -63.15 -44.44 95.51 Favored 'General case' 0 CA--C 1.571 1.778 0 N-CA-C 115.174 1.546 . . . . 0.0 115.174 165.524 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 31.4 ttt85 -128.16 130.77 48.59 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 120.081 1.309 . . . . 0.0 110.397 172.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -133.82 135.21 43.65 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.764 -0.585 . . . . 0.0 110.507 176.036 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -120.0 119.99 35.01 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 170.282 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 33.9 mm -112.4 104.88 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 174.324 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 94.4 mtp -110.74 98.71 7.8 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 -179.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -102.01 98.35 8.56 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 123.523 0.729 . . . . 0.0 110.136 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -142.78 156.78 45.03 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -168.38 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -94.7 131.26 40.7 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.105 -0.997 . . . . 0.0 110.824 166.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 22.0 t -66.85 113.3 2.84 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.776 0 C-N-CA 123.501 0.721 . . . . 0.0 109.978 -179.128 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 127.4 -55.45 0.75 Allowed Glycine 0 CA--C 1.548 2.109 0 CA-C-O 119.059 -0.856 . . . . 0.0 114.923 -158.609 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 13.9 pttt -75.76 145.58 40.69 Favored 'General case' 0 CA--C 1.567 1.627 0 N-CA-C 116.286 1.958 . . . . 0.0 116.286 -170.151 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -95.01 108.85 20.93 Favored 'General case' 0 CA--C 1.567 1.627 0 C-N-CA 123.172 0.589 . . . . 0.0 110.835 174.307 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -116.02 143.12 45.89 Favored 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 123.666 0.786 . . . . 0.0 112.819 -173.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -70.66 116.24 10.75 Favored 'General case' 0 CA--C 1.569 1.709 0 O-C-N 120.042 -1.661 . . . . 0.0 113.975 175.539 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -71.62 99.85 2.17 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.166 -0.959 . . . . 0.0 108.763 167.316 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . 0.28 3.4 p30 -119.27 -159.75 0.78 Allowed 'General case' 0 CA--C 1.568 1.647 0 N-CA-C 113.369 0.878 . . . . 0.0 113.369 -156.132 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 72.5 mt 55.33 60.0 3.63 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 -171.383 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . 0.438 4.1 t 55.58 -1.7 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.222 0 N-CA-C 120.696 3.591 . . . . 0.0 120.696 -165.621 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 88.91 146.26 12.75 Favored Glycine 0 N--CA 1.487 2.079 0 CA-C-N 120.774 1.624 . . . . 0.0 115.453 -174.144 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 31.7 mt -90.05 -56.48 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.175 0 O-C-N 122.104 -0.645 . . . . 0.0 111.06 178.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -87.94 -66.99 0.86 Allowed 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 119.962 1.255 . . . . 0.0 113.173 171.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -99.07 -101.88 0.22 Allowed 'General case' 0 CA--C 1.566 1.587 0 CA-C-N 119.445 1.02 . . . . 0.0 110.401 175.619 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . 0.282 39.6 ttt85 -140.83 -124.43 0.1 Allowed 'General case' 0 CA--C 1.567 1.633 0 CA-C-N 119.935 1.243 . . . . 0.0 110.081 -176.126 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -106.33 121.68 44.72 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 120.644 1.565 . . . . 0.0 111.974 -168.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 22.1 m -134.96 132.03 37.91 Favored 'General case' 0 CA--C 1.562 1.423 0 CA-C-O 122.208 1.004 . . . . 0.0 111.435 177.332 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 72.1 mmm -74.05 110.46 8.36 Favored 'General case' 0 CA--C 1.562 1.439 0 C-N-CA 123.744 0.818 . . . . 0.0 109.757 172.028 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 76.6 m -108.81 116.16 31.46 Favored 'General case' 0 N--CA 1.484 1.256 0 O-C-N 121.668 -0.645 . . . . 0.0 110.714 -161.31 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 89.8 m -104.68 125.81 51.15 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 176.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.409 HG22 ' SG ' ' A' ' 95' ' ' CYS . 15.4 t -117.85 119.24 60.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 177.814 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 56.8 m -140.56 150.18 43.35 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 123.341 0.656 . . . . 0.0 112.161 -174.115 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 90.7 m95 -79.27 119.74 22.76 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.462 -1.399 . . . . 0.0 112.847 177.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -93.55 78.52 4.34 Favored 'General case' 0 CA--C 1.567 1.616 0 O-C-N 121.631 -0.668 . . . . 0.0 109.295 163.276 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 67.65 -99.27 0.52 Allowed Glycine 0 N--CA 1.49 2.264 0 O-C-N 121.818 -0.551 . . . . 0.0 114.451 -171.147 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -102.95 -6.05 22.82 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 116.454 2.02 . . . . 0.0 116.454 170.448 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 35.8 mtmm -97.39 127.59 43.48 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-N 120.539 1.518 . . . . 0.0 110.026 176.536 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 22.3 tp -84.73 110.15 18.56 Favored 'General case' 0 CA--C 1.564 1.489 0 O-C-N 121.034 -1.041 . . . . 0.0 110.071 174.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -97.39 125.53 42.07 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.693 0.797 . . . . 0.0 110.841 -175.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' CYS . . . . . 0.409 ' SG ' HG22 ' A' ' 86' ' ' VAL . 39.4 t -114.03 124.33 51.87 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 123.284 0.633 . . . . 0.0 110.154 175.075 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.6 p -107.3 118.47 55.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 166.046 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -97.97 88.14 4.17 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 174.145 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -99.07 126.74 44.87 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.092 -1.005 . . . . 0.0 112.462 -174.398 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 166.39 -107.25 0.28 Allowed Glycine 0 N--CA 1.487 2.072 0 O-C-N 121.28 -0.887 . . . . 0.0 112.915 176.028 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -76.87 -10.22 59.22 Favored 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 117.764 2.505 . . . . 0.0 117.764 -177.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -122.94 142.84 50.37 Favored 'General case' 0 CA--C 1.566 1.563 0 CA-C-N 120.086 1.312 . . . . 0.0 111.294 177.182 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -81.79 144.32 31.16 Favored 'General case' 0 CA--C 1.563 1.467 0 O-C-N 121.491 -0.756 . . . . 0.0 111.565 173.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 57.63 23.96 51.4 Favored Glycine 0 N--CA 1.498 2.81 0 N-CA-C 120.854 3.102 . . . . 0.0 120.854 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 57.8 ttt180 -85.95 124.8 32.82 Favored 'General case' 0 CA--C 1.565 1.544 0 CA-C-N 118.501 1.151 . . . . 0.0 111.28 -178.174 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 178.25 -173.67 46.09 Favored Glycine 0 N--CA 1.488 2.119 0 O-C-N 121.341 -0.849 . . . . 0.0 114.852 -178.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . 0.25 16.8 p-90 -155.12 157.77 37.99 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 114.66 1.356 . . . . 0.0 114.66 171.735 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 31.8 m -123.77 123.7 41.06 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 123.831 0.852 . . . . 0.0 108.842 170.557 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -123.44 131.99 53.81 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 123.287 0.635 . . . . 0.0 111.882 -176.117 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 23.4 p90 -150.54 167.08 28.27 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.045 -1.034 . . . . 0.0 113.014 -179.153 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 89.3 mt -107.94 136.83 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.193 0 O-C-N 120.776 -1.202 . . . . 0.0 110.447 175.203 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -123.3 97.09 5.25 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 123.578 0.751 . . . . 0.0 109.701 164.463 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 76.97 -111.3 3.23 Favored Glycine 0 N--CA 1.491 2.316 0 O-C-N 121.275 -0.89 . . . . 0.0 113.9 -176.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -107.37 37.87 2.28 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 164.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -131.65 117.01 18.1 Favored 'General case' 0 CA--C 1.559 1.326 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 -168.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 17.2 tp -87.42 114.4 24.0 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-O 121.755 0.788 . . . . 0.0 109.914 172.309 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 48.9 m80 -102.66 120.09 39.96 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.972 0.909 . . . . 0.0 109.076 -177.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 49.5 tp -120.31 120.08 35.01 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 123.784 0.834 . . . . 0.0 109.833 -177.587 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -105.43 116.3 31.71 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.577 -0.702 . . . . 0.0 109.454 168.331 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 69.3 mtm -108.5 131.13 55.13 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 123.372 0.669 . . . . 0.0 111.023 -178.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 77.6 mtm-85 -115.16 143.87 44.56 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.534 -0.729 . . . . 0.0 111.411 -175.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -149.17 124.07 9.96 Favored 'General case' 0 N--CA 1.484 1.259 0 CA-C-O 121.456 0.646 . . . . 0.0 110.707 166.504 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 62.0 24.71 14.75 Favored 'General case' 0 CA--C 1.581 2.17 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 -172.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 88.33 -28.96 5.89 Favored Glycine 0 CA--C 1.557 2.694 0 N-CA-C 118.256 2.062 . . . . 0.0 118.256 -158.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 87.4 t -72.19 120.58 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 CA-C-N 119.644 1.722 . . . . 0.0 110.588 -173.425 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 29.4 m -102.12 123.74 46.5 Favored 'General case' 0 CA--C 1.566 1.573 0 CA-C-O 121.585 0.707 . . . . 0.0 111.484 -173.153 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 10.7 t -96.0 138.18 34.0 Favored 'General case' 0 CA--C 1.559 1.316 0 C-N-CA 124.3 1.04 . . . . 0.0 111.475 162.197 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 6.0 mtmt -118.07 124.14 47.36 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.333 -0.854 . . . . 0.0 110.051 179.058 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -127.24 134.45 50.08 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 123.593 0.757 . . . . 0.0 111.353 -177.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 38.0 t -116.68 132.39 66.52 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.721 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.439 ' CZ ' ' SD ' ' A' ' 10' ' ' MET . 38.3 m-85 -126.89 134.84 50.39 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.999 0.92 . . . . 0.0 111.062 -178.402 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 74.9 tttt -99.89 137.24 38.62 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.636 -1.29 . . . . 0.0 112.446 -179.062 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -71.56 118.82 14.86 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 179.276 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 26.8 m -104.04 -40.72 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 174.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 76.9 t60 . . . . . 0 C--O 1.253 1.273 0 CA-C-N 119.629 1.104 . . . . 0.0 108.416 166.275 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.57 1.747 0 CA-C-O 117.636 -1.174 . . . . 0.0 109.382 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -78.78 168.12 21.41 Favored 'Trans proline' 0 CA--C 1.565 2.053 0 C-N-CA 122.555 2.17 . . . . 0.0 117.061 -172.701 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.1 t -81.9 139.85 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.53 -0.731 . . . . 0.0 110.76 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -67.92 99.41 0.84 Allowed 'General case' 0 CA--C 1.569 1.674 0 O-C-N 121.109 -0.994 . . . . 0.0 113.35 167.449 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 10.6 m-30 -79.26 5.46 12.28 Favored 'General case' 0 CA--C 1.579 2.086 0 N-CA-C 116.364 1.987 . . . . 0.0 116.364 175.406 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -60.43 116.09 4.05 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 125.711 1.604 . . . . 0.0 114.616 -176.239 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 162.89 -177.9 38.8 Favored Glycine 0 N--CA 1.482 1.767 0 N-CA-C 116.646 1.419 . . . . 0.0 116.646 179.467 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 24.2 t80 -111.25 122.78 48.75 Favored 'General case' 0 CA--C 1.564 1.484 0 CA-C-N 113.514 -1.343 . . . . 0.0 108.138 170.302 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 83.1 m95 -122.43 125.82 46.64 Favored 'General case' 0 CA--C 1.564 1.497 0 C-N-CA 123.47 0.708 . . . . 0.0 109.93 -167.058 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -101.21 139.19 37.22 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.111 -0.993 . . . . 0.0 112.816 -179.192 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.464 ' SD ' ' HD2' ' A' ' 38' ' ' PRO . 42.0 ttm -67.1 126.12 28.19 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-N 120.241 1.382 . . . . 0.0 113.912 -179.66 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 91.3 mt -85.07 -55.54 4.0 Favored 'General case' 0 CA--C 1.567 1.611 0 CA-C-N 115.723 -0.672 . . . . 0.0 112.55 163.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 99.7 p -138.65 150.25 46.05 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 123.526 0.73 . . . . 0.0 112.773 -177.146 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -132.76 104.74 6.77 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.683 0.754 . . . . 0.0 109.453 165.605 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -108.0 124.77 50.66 Favored 'General case' 0 CA--C 1.56 1.357 0 C-N-CA 124.155 0.982 . . . . 0.0 109.487 -170.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.286 33.4 t30 64.87 24.3 12.74 Favored 'General case' 0 N--CA 1.502 2.165 0 N-CA-C 117.105 2.261 . . . . 0.0 117.105 -173.673 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -68.21 -45.02 74.45 Favored 'General case' 0 CA--C 1.569 1.68 0 N-CA-C 115.271 1.582 . . . . 0.0 115.271 176.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -43.36 -50.5 6.75 Favored 'General case' 0 N--CA 1.501 2.124 0 N-CA-C 117.319 2.341 . . . . 0.0 117.319 164.541 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -71.68 -38.45 70.61 Favored 'General case' 0 CA--C 1.571 1.752 0 N-CA-C 115.563 1.69 . . . . 0.0 115.563 177.436 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 73.0 t80 -53.98 -47.52 71.32 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 114.907 1.447 . . . . 0.0 114.907 162.604 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 72.6 mt -62.17 -42.0 98.85 Favored 'General case' 0 CA--C 1.574 1.871 0 N-CA-C 114.681 1.363 . . . . 0.0 114.681 171.278 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 26.1 ttt-85 -50.41 -50.74 51.01 Favored 'General case' 0 N--CA 1.501 2.118 0 N-CA-C 115.586 1.699 . . . . 0.0 115.586 163.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.25 -23.2 55.23 Favored 'General case' 0 CA--C 1.566 1.576 0 N-CA-C 118.181 2.66 . . . . 0.0 118.181 167.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 96.1 mt -88.95 13.83 11.9 Favored 'General case' 0 CA--C 1.574 1.901 0 N-CA-C 115.484 1.661 . . . . 0.0 115.484 165.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 60.29 40.59 17.57 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 115.984 1.846 . . . . 0.0 115.984 -174.037 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 88.9 t -93.65 137.83 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 120.99 -1.069 . . . . 0.0 109.185 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.5 p-10 -66.83 150.24 49.44 Favored 'General case' 0 CA--C 1.567 1.628 0 N-CA-C 115.19 1.552 . . . . 0.0 115.19 178.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 77.5 t -53.31 -41.23 43.01 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.291 0 N-CA-C 116.057 1.873 . . . . 0.0 116.057 -175.604 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.54 -49.19 78.75 Favored 'General case' 0 CA--C 1.568 1.635 0 N-CA-C 115.726 1.75 . . . . 0.0 115.726 170.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.6 tt -65.53 -41.86 92.62 Favored 'General case' 0 CA--C 1.574 1.887 0 N-CA-C 114.66 1.355 . . . . 0.0 114.66 171.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 74.8 mtp180 -46.85 -52.14 15.0 Favored 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 115.773 1.768 . . . . 0.0 115.773 164.03 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -65.71 -47.29 75.88 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 114.88 1.437 . . . . 0.0 114.88 171.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 61.4 mt -55.73 -57.98 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 CA-C-N 120.289 1.404 . . . . 0.0 112.766 175.448 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.27 -36.56 73.46 Favored 'General case' 0 CA--C 1.564 1.49 0 N-CA-C 118.409 2.744 . . . . 0.0 118.409 176.569 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -73.59 -30.71 63.17 Favored 'General case' 0 CA--C 1.57 1.724 0 N-CA-C 116.017 1.858 . . . . 0.0 116.017 171.051 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 73.8 mt -72.0 -33.54 68.18 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 116.001 1.852 . . . . 0.0 116.001 173.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.9 pp -78.94 150.64 32.02 Favored 'General case' 0 CA--C 1.566 1.588 0 N-CA-C 114.678 1.362 . . . . 0.0 114.678 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -109.52 94.06 15.4 Favored Pre-proline 0 CA--C 1.571 1.784 0 CA-C-O 118.286 -0.864 . . . . 0.0 108.797 176.058 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.464 ' HD2' ' SD ' ' A' ' 10' ' ' MET . 83.3 Cg_endo -78.44 171.07 17.45 Favored 'Trans proline' 0 CA--C 1.563 1.966 0 C-N-CA 122.806 2.337 . . . . 0.0 114.504 -178.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -116.61 127.7 54.71 Favored 'General case' 0 CA--C 1.56 1.359 0 CA-C-N 114.992 -1.003 . . . . 0.0 110.405 177.356 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 58.1 mttm -91.15 113.11 25.29 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.088 -1.007 . . . . 0.0 109.739 170.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -94.48 112.41 24.18 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 165.044 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 63.6 mt -110.86 119.35 59.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 -174.169 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 95.4 t -101.9 98.98 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 166.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -95.87 113.45 25.08 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 123.316 0.647 . . . . 0.0 110.028 175.489 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -116.2 64.59 0.7 Allowed 'General case' 0 CA--C 1.569 1.692 0 O-C-N 121.477 -0.765 . . . . 0.0 110.36 171.099 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 66.3 -97.95 0.35 Allowed Glycine 0 N--CA 1.487 2.07 0 N-CA-C 115.743 1.057 . . . . 0.0 115.743 -179.145 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -76.86 -41.84 42.43 Favored 'General case' 0 CA--C 1.565 1.541 0 N-CA-C 115.832 1.79 . . . . 0.0 115.832 169.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 13.1 t-160 -84.12 122.85 29.38 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 120.699 1.591 . . . . 0.0 111.429 175.158 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 8.6 ttp -137.93 131.34 30.75 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-O 122.116 0.96 . . . . 0.0 111.857 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 48.3 mt -115.24 107.84 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 73.1 mt -98.36 106.15 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 173.62 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 69.8 mtt180 -95.97 103.52 15.41 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.24 -0.912 . . . . 0.0 110.307 174.029 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 23.7 m -85.49 103.05 14.01 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 175.432 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.4 mt -104.5 118.32 36.32 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 124.104 0.962 . . . . 0.0 109.189 -166.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 47.1 t -118.84 161.67 19.77 Favored 'General case' 0 CA--C 1.556 1.183 0 CA-C-O 122.27 1.034 . . . . 0.0 111.181 -170.262 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 70.6 p -65.99 -19.76 65.97 Favored 'General case' 0 N--CA 1.5 2.025 0 N-CA-C 116.191 1.922 . . . . 0.0 116.191 161.181 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -78.08 -67.9 0.69 Allowed 'General case' 0 CA--C 1.569 1.679 0 CA-C-N 119.477 1.035 . . . . 0.0 112.185 169.307 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . 0.263 64.9 ttt180 -151.08 -117.15 0.04 OUTLIER 'General case' 0 CA--C 1.577 1.981 0 CA-C-N 120.516 1.507 . . . . 0.0 111.074 163.756 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 49.6 t-20 -164.48 138.44 5.27 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.178 -1.576 . . . . 0.0 109.237 -168.127 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 25.7 t80 -98.07 -55.4 2.79 Favored 'General case' 0 N--CA 1.5 2.054 0 N-CA-C 115.455 1.65 . . . . 0.0 115.455 -173.071 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.332 3.7 mp 62.02 92.7 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 -176.025 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 45.9 mmm -91.54 94.28 9.36 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.007 -1.058 . . . . 0.0 108.718 160.368 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.8 p30 -100.13 108.76 20.97 Favored 'General case' 0 CA--C 1.559 1.308 0 C-N-CA 123.954 0.902 . . . . 0.0 110.918 176.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 40.6 p90 -147.67 149.3 32.22 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-O 122.546 1.165 . . . . 0.0 114.029 -165.269 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -91.75 123.27 35.01 Favored 'General case' 0 CA--C 1.559 1.326 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.739 160.733 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 66.3 t -62.45 125.18 18.37 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.787 0 C-N-CA 124.109 0.964 . . . . 0.0 110.539 176.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 100.92 -36.66 4.03 Favored Glycine 0 CA--C 1.55 2.278 0 N-CA-C 117.075 1.59 . . . . 0.0 117.075 -167.075 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 84.5 mttt -81.21 129.88 34.78 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-N 119.775 1.788 . . . . 0.0 112.207 -176.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -88.93 103.69 16.26 Favored 'General case' 0 CA--C 1.566 1.578 0 O-C-N 121.789 -0.569 . . . . 0.0 111.668 -179.118 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -106.11 147.73 28.63 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -173.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.46 125.34 28.81 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.7 -1.25 . . . . 0.0 112.759 170.145 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -76.41 68.34 2.74 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 122.66 1.219 . . . . 0.0 113.487 174.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -81.85 104.53 12.29 Favored 'General case' 0 CA--C 1.564 1.505 0 O-C-N 120.644 -1.285 . . . . 0.0 112.258 -169.17 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.7 tp 69.57 49.25 0.57 Allowed 'General case' 0 N--CA 1.503 2.202 0 N-CA-C 114.586 1.328 . . . . 0.0 114.586 178.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 12.4 t -93.95 -8.13 40.96 Favored 'General case' 0 N--CA 1.5 2.073 0 N-CA-C 118.716 2.858 . . . . 0.0 118.716 -171.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 90.24 165.04 40.28 Favored Glycine 0 CA--C 1.552 2.384 0 CA-C-N 121.122 1.783 . . . . 0.0 115.811 -169.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . 0.43 1.7 mp 68.79 -87.58 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.351 0 C-N-CA 124.387 1.075 . . . . 0.0 111.294 176.4 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -78.64 -40.87 32.97 Favored 'General case' 0 CA--C 1.57 1.723 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 163.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.6 t70 58.12 58.18 3.66 Favored 'General case' 0 CA--C 1.572 1.825 0 N-CA-C 115.289 1.589 . . . . 0.0 115.289 176.103 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.1 ttp85 -148.26 144.35 27.59 Favored 'General case' 0 CA--C 1.565 1.545 0 C-N-CA 123.212 0.605 . . . . 0.0 110.059 -169.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 61.3 mtpt -71.28 82.14 0.75 Allowed 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -177.569 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 89.2 m -93.27 127.11 38.73 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 123.128 0.571 . . . . 0.0 111.378 178.59 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 2.7 mmt -70.83 99.19 1.69 Allowed 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 121.816 0.817 . . . . 0.0 111.123 176.222 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 64.7 m -114.47 111.37 21.3 Favored 'General case' 0 N--CA 1.483 1.186 0 O-C-N 121.648 -0.657 . . . . 0.0 110.541 -156.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 36.9 m -95.37 129.64 42.44 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 169.506 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.1 t -108.58 129.2 63.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 163.32 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 49.4 m -133.89 141.25 47.29 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.291 -0.88 . . . . 0.0 111.109 -175.199 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 42.6 m95 -78.29 107.74 11.12 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.66 -1.275 . . . . 0.0 110.859 169.366 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -85.61 74.92 10.2 Favored 'General case' 0 CA--C 1.568 1.645 0 O-C-N 121.362 -0.836 . . . . 0.0 109.822 168.032 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.95 -98.46 0.36 Allowed Glycine 0 N--CA 1.487 2.086 0 CA-C-N 116.18 -0.464 . . . . 0.0 114.133 -167.177 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -105.86 -4.05 21.18 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 116.378 1.992 . . . . 0.0 116.378 173.605 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 41.7 mtpt -103.36 124.98 49.71 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-N 120.327 1.421 . . . . 0.0 109.247 177.405 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 24.7 tp -84.79 107.48 16.99 Favored 'General case' 0 CA--C 1.563 1.458 0 O-C-N 120.858 -1.151 . . . . 0.0 110.493 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -96.54 131.25 43.35 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.704 0.802 . . . . 0.0 111.065 -175.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 53.8 t -122.67 136.87 55.0 Favored 'General case' 0 N--CA 1.484 1.269 0 O-C-N 121.645 -0.66 . . . . 0.0 111.693 175.447 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.7 p -127.08 119.46 52.94 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.637 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 171.006 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 19.2 mp0 -91.93 104.83 17.2 Favored 'General case' 0 CA--C 1.565 1.541 0 C-N-CA 124.001 0.921 . . . . 0.0 109.976 173.056 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -91.26 131.44 36.77 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.161 -0.962 . . . . 0.0 112.442 -174.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 161.79 -98.37 0.16 Allowed Glycine 0 N--CA 1.485 1.92 0 O-C-N 121.949 -0.469 . . . . 0.0 112.854 168.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -77.41 -51.83 10.14 Favored 'General case' 0 CA--C 1.568 1.652 0 N-CA-C 115.649 1.722 . . . . 0.0 115.649 -177.326 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 58.3 mttm -99.31 143.03 30.04 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 122.613 1.197 . . . . 0.0 114.058 -160.206 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -83.95 97.33 9.19 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 122.144 0.973 . . . . 0.0 112.505 -166.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 82.31 41.48 9.23 Favored Glycine 0 N--CA 1.485 1.924 0 N-CA-C 117.443 1.737 . . . . 0.0 117.443 -168.421 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 64.0 ttt180 -77.25 113.01 14.56 Favored 'General case' 0 CA--C 1.566 1.594 0 CA-C-N 119.561 1.68 . . . . 0.0 110.41 164.183 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -169.3 177.79 42.77 Favored Glycine 0 N--CA 1.482 1.724 0 CA-C-O 122.184 0.88 . . . . 0.0 113.978 -177.498 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . 0.257 28.1 p-90 -152.13 158.47 42.99 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 171.789 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 33.5 m -129.14 118.64 22.77 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 176.09 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 -120.29 128.85 53.68 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 123.284 0.634 . . . . 0.0 111.79 -176.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 19.6 p90 -148.81 166.91 27.07 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.997 -1.064 . . . . 0.0 112.21 -179.34 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 96.2 mt -108.16 132.69 55.26 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.121 0 O-C-N 120.677 -1.264 . . . . 0.0 110.369 176.108 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -112.42 100.91 9.14 Favored 'General case' 0 CA--C 1.566 1.563 0 C-N-CA 123.796 0.838 . . . . 0.0 108.96 162.423 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 72.04 -109.51 2.85 Favored Glycine 0 N--CA 1.493 2.463 0 O-C-N 121.366 -0.833 . . . . 0.0 114.792 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -109.14 35.4 3.28 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 163.636 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -131.91 126.26 33.7 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.799 0.84 . . . . 0.0 109.53 -178.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 23.6 tp -88.6 118.45 28.26 Favored 'General case' 0 CA--C 1.56 1.363 0 C-N-CA 124.008 0.923 . . . . 0.0 109.954 173.522 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 44.8 m80 -105.47 120.83 42.6 Favored 'General case' 0 CA--C 1.56 1.328 0 C-N-CA 123.949 0.9 . . . . 0.0 108.972 -177.489 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 28.2 tp -119.38 123.81 45.04 Favored 'General case' 0 CA--C 1.561 1.397 0 C-N-CA 124.056 0.942 . . . . 0.0 109.798 -177.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -105.0 123.42 47.77 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.614 -0.679 . . . . 0.0 109.266 165.115 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 70.0 mtm -115.3 125.21 53.0 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-N 118.896 0.771 . . . . 0.0 110.659 178.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 69.3 mtp180 -112.89 144.64 42.1 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 123.169 0.588 . . . . 0.0 111.881 -178.702 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -156.89 129.76 7.73 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 123.079 0.551 . . . . 0.0 111.183 166.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 56.32 40.21 29.91 Favored 'General case' 0 N--CA 1.506 2.355 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 -172.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 77.47 -31.12 1.65 Allowed Glycine 0 CA--C 1.558 2.744 0 N-CA-C 119.536 2.575 . . . . 0.0 119.536 -160.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 90.0 t -77.87 123.39 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 CA-C-N 119.15 1.475 . . . . 0.0 111.114 -162.26 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 34.2 m -104.99 118.11 35.69 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 123.064 0.546 . . . . 0.0 111.629 -171.134 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 18.1 t -92.22 141.86 28.11 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.495 0.718 . . . . 0.0 112.006 163.129 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -117.75 118.16 31.3 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 123.348 0.659 . . . . 0.0 110.006 178.505 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 71.1 mt-30 -119.09 140.98 49.19 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 123.804 0.841 . . . . 0.0 111.695 179.227 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 25.0 t -128.46 132.56 67.91 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 177.27 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -126.64 139.86 52.85 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 123.584 0.754 . . . . 0.0 111.425 179.039 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 22.3 ttmt -99.49 139.73 34.71 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.881 -1.137 . . . . 0.0 112.67 178.241 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 73.7 tttt -73.66 118.83 17.08 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 178.424 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 34.2 m -103.03 -43.08 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 173.458 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 55.5 t-80 . . . . . 0 N--CA 1.484 1.266 0 CA-C-N 119.491 1.041 . . . . 0.0 108.259 168.079 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 26.7 ptt? . . . . . 0 CA--C 1.575 1.936 0 N-CA-C 113.7 1.0 . . . . 0.0 113.7 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -80.72 -137.97 0.02 OUTLIER 'Trans proline' 0 CA--C 1.575 2.571 0 C-N-CA 122.355 2.037 . . . . 0.0 114.039 173.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 22.9 t -131.27 139.14 51.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 -175.471 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -76.89 107.53 9.29 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.641 -1.287 . . . . 0.0 110.76 163.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 15.9 m-30 -80.98 14.79 2.08 Favored 'General case' 0 CA--C 1.582 2.207 0 N-CA-C 115.905 1.817 . . . . 0.0 115.905 173.459 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -62.68 111.99 2.32 Favored 'General case' 0 CA--C 1.563 1.474 0 C-N-CA 125.667 1.587 . . . . 0.0 115.136 -172.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 161.09 -178.17 37.15 Favored Glycine 0 N--CA 1.486 1.984 0 N-CA-C 116.026 1.17 . . . . 0.0 116.026 178.504 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -106.29 123.64 48.37 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-N 114.917 -0.642 . . . . 0.0 109.468 174.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 80.6 m95 -121.55 122.08 38.9 Favored 'General case' 0 CA--C 1.561 1.391 0 C-N-CA 123.481 0.712 . . . . 0.0 109.329 -169.325 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -96.47 140.87 30.48 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.313 -0.867 . . . . 0.0 112.711 176.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 41.9 ttm -69.47 124.23 23.35 Favored 'General case' 0 CA--C 1.569 1.705 0 O-C-N 120.94 -1.1 . . . . 0.0 113.129 176.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 91.9 mt -82.68 -50.29 8.88 Favored 'General case' 0 CA--C 1.564 1.486 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 165.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 87.3 p -151.75 154.53 36.46 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 119.285 0.948 . . . . 0.0 113.274 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 13.5 p30 -127.37 105.6 8.63 Favored 'General case' 0 CA--C 1.568 1.673 0 C-N-CA 123.64 0.776 . . . . 0.0 110.632 174.354 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -96.19 129.78 43.41 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 124.608 1.163 . . . . 0.0 109.965 -174.429 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 34.3 t30 62.39 18.31 10.19 Favored 'General case' 0 N--CA 1.506 2.368 0 N-CA-C 117.048 2.24 . . . . 0.0 117.048 -179.132 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -65.59 -42.1 92.08 Favored 'General case' 0 CA--C 1.566 1.583 0 N-CA-C 115.832 1.79 . . . . 0.0 115.832 -178.403 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -58.37 -39.06 78.58 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 116.243 1.942 . . . . 0.0 116.243 168.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -66.19 -45.78 79.62 Favored 'General case' 0 CA--C 1.571 1.78 0 N-CA-C 114.849 1.426 . . . . 0.0 114.849 170.648 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -52.82 -48.82 66.7 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 115.121 1.526 . . . . 0.0 115.121 165.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 64.5 mt -62.46 -40.73 97.6 Favored 'General case' 0 CA--C 1.57 1.745 0 N-CA-C 114.746 1.387 . . . . 0.0 114.746 171.545 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 65.1 ttp85 -55.56 -46.68 77.14 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 115.229 1.566 . . . . 0.0 115.229 164.584 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.1 -18.85 39.09 Favored 'General case' 0 CA--C 1.569 1.681 0 N-CA-C 118.29 2.7 . . . . 0.0 118.29 164.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 92.3 mt -91.83 15.31 13.23 Favored 'General case' 0 CA--C 1.574 1.898 0 N-CA-C 115.265 1.58 . . . . 0.0 115.265 163.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.259 49.7 m-20 66.72 39.86 3.43 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 115.887 1.81 . . . . 0.0 115.887 -177.523 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 65.6 t -99.61 140.9 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 120.815 -1.178 . . . . 0.0 110.489 -177.599 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 8.3 p-10 -71.33 156.52 39.41 Favored 'General case' 0 CA--C 1.569 1.679 0 N-CA-C 115.265 1.579 . . . . 0.0 115.265 174.357 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 61.9 t -53.14 -44.95 53.38 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.373 0 N-CA-C 115.27 1.581 . . . . 0.0 115.27 -177.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.57 -49.2 78.49 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 116.101 1.889 . . . . 0.0 116.101 174.549 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 31.9 tp -65.8 -36.67 84.16 Favored 'General case' 0 CA--C 1.573 1.842 0 N-CA-C 115.777 1.769 . . . . 0.0 115.777 171.004 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 55.1 mtp180 -51.36 -52.55 44.67 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 115.394 1.627 . . . . 0.0 115.394 160.63 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -63.13 -43.29 98.78 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 115.679 1.733 . . . . 0.0 115.679 172.403 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 59.3 mt -55.76 -55.31 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.192 0 CA-C-N 120.276 1.398 . . . . 0.0 112.72 170.271 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.86 -43.53 94.62 Favored 'General case' 0 CA--C 1.566 1.573 0 N-CA-C 117.294 2.331 . . . . 0.0 117.294 173.555 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -53.91 -39.97 66.27 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 117.471 2.397 . . . . 0.0 117.471 167.25 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 80.7 mt -86.27 -13.21 47.39 Favored 'General case' 0 CA--C 1.572 1.815 0 N-CA-C 116.103 1.89 . . . . 0.0 116.103 175.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 37.9 mt -80.07 133.12 36.08 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-N 119.949 1.25 . . . . 0.0 111.314 169.703 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 29.1 mmtp -101.31 93.04 2.94 Favored Pre-proline 0 CA--C 1.571 1.755 0 CA-C-O 118.045 -0.978 . . . . 0.0 109.705 171.367 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -72.41 154.3 55.78 Favored 'Trans proline' 0 CA--C 1.563 1.943 0 CA-C-N 122.852 2.054 . . . . 0.0 114.739 177.181 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -112.3 127.5 56.0 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.685 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 45.8 mttp -95.42 110.06 22.15 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.508 -0.745 . . . . 0.0 109.854 177.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -95.48 104.77 16.68 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.379 -0.826 . . . . 0.0 108.825 166.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 76.0 mt -98.55 118.29 44.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 -173.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 83.4 t -109.86 95.86 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 107.289 -1.375 . . . . 0.0 107.289 176.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -96.34 114.0 25.64 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 123.567 0.747 . . . . 0.0 111.084 177.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -132.16 93.27 3.24 Favored 'General case' 0 CA--C 1.566 1.577 0 C-N-CA 123.401 0.68 . . . . 0.0 110.004 -178.354 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 53.67 63.68 4.89 Favored Glycine 0 N--CA 1.497 2.756 0 N-CA-C 118.569 2.188 . . . . 0.0 118.569 172.045 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.471 0.0 OUTLIER 76.71 -34.56 0.22 Allowed 'General case' 0 N--CA 1.501 2.077 0 N-CA-C 117.317 2.34 . . . . 0.0 117.317 -164.423 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 9.4 t-160 -82.4 108.97 16.23 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 120.923 1.692 . . . . 0.0 110.898 178.404 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 6.5 ttp -121.25 125.1 46.26 Favored 'General case' 0 CA--C 1.556 1.194 0 CA-C-O 122.147 0.975 . . . . 0.0 110.888 -176.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 4.4 mp -110.1 104.43 17.06 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.353 0 N-CA-C 106.53 -1.656 . . . . 0.0 106.53 -178.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 80.0 mt -89.33 96.09 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 174.57 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 93.1 mtt180 -84.9 97.27 9.67 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.656 -0.652 . . . . 0.0 110.038 -178.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 51.0 m -89.78 101.39 14.08 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.761 0.791 . . . . 0.0 109.312 -178.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 16.1 mt -102.94 120.93 41.5 Favored 'General case' 0 N--CA 1.485 1.312 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.033 -164.005 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 10.3 t -136.7 146.53 45.98 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.684 -0.635 . . . . 0.0 111.629 -178.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . 0.253 13.7 t -77.73 56.19 1.46 Allowed 'General case' 0 N--CA 1.503 2.181 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 172.179 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -168.81 -67.82 0.02 OUTLIER 'General case' 0 CA--C 1.567 1.623 0 C-N-CA 125.274 1.429 . . . . 0.0 108.517 -177.064 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 62.9 ttt-85 -136.67 124.75 22.93 Favored 'General case' 0 CA--C 1.565 1.521 0 CA-C-N 118.754 0.706 . . . . 0.0 109.517 172.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 44.1 t-20 -85.26 130.59 34.57 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.78 -0.575 . . . . 0.0 111.038 170.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -95.96 -75.02 0.54 Allowed 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 118.899 -0.572 . . . . 0.0 112.338 -175.173 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.331 38.5 mt 74.62 108.75 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 C-N-CA 124.261 1.025 . . . . 0.0 111.9 178.28 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 86.9 mtp -104.95 99.22 8.85 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.478 -0.764 . . . . 0.0 109.491 170.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.7 p30 -96.97 108.54 21.28 Favored 'General case' 0 CA--C 1.56 1.365 0 C-N-CA 124.064 0.946 . . . . 0.0 111.935 176.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 35.2 p90 -148.68 151.91 35.75 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-N 119.029 0.831 . . . . 0.0 113.103 -168.227 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 54.6 mt-30 -89.86 135.23 33.76 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.289 -0.882 . . . . 0.0 110.796 161.264 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 41.0 t -69.56 109.54 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.28 -0.888 . . . . 0.0 109.305 179.108 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 128.27 -50.49 0.89 Allowed Glycine 0 CA--C 1.548 2.122 0 CA-C-O 118.542 -1.143 . . . . 0.0 115.904 -162.072 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 15.3 ptpt -70.41 139.22 51.79 Favored 'General case' 0 CA--C 1.566 1.578 0 CA-C-N 119.8 1.8 . . . . 0.0 115.231 -173.607 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -97.71 97.42 9.0 Favored 'General case' 0 CA--C 1.566 1.578 0 C-N-CA 123.116 0.566 . . . . 0.0 110.135 175.115 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -103.92 130.67 51.55 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 -170.618 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -69.21 111.75 5.35 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.671 -1.268 . . . . 0.0 113.524 175.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -81.88 92.83 6.77 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.22 -0.925 . . . . 0.0 110.683 -177.617 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.2 p30 -120.06 114.52 22.11 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 123.632 0.773 . . . . 0.0 111.702 -172.17 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . 0.291 12.0 tp 62.55 51.78 3.12 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 115.098 1.518 . . . . 0.0 115.098 -172.434 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 97.1 m -162.59 100.67 1.04 Allowed 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 106.139 -1.8 . . . . 0.0 106.139 177.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 122.36 -146.71 16.87 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 115.258 0.863 . . . . 0.0 115.258 177.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . 0.251 5.2 mp -108.83 -87.01 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 -175.593 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -85.08 65.63 9.33 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 120.266 1.394 . . . . 0.0 111.147 171.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.265 2.4 p30 -78.45 -70.79 0.47 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.38 -0.825 . . . . 0.0 112.523 -172.075 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . 0.252 6.6 tpm_? 53.27 36.95 24.04 Favored 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 118.635 2.828 . . . . 0.0 118.635 160.264 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . 0.261 99.6 mttt 60.44 40.23 17.49 Favored 'General case' 0 N--CA 1.501 2.099 0 N-CA-C 115.84 1.793 . . . . 0.0 115.84 -171.625 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 95.3 m -78.98 116.21 19.15 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.441 -1.412 . . . . 0.0 111.383 178.523 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 23.6 mtp -76.3 100.06 4.99 Favored 'General case' 0 CA--C 1.557 1.25 0 CA-C-O 122.434 1.111 . . . . 0.0 110.622 -170.186 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 88.5 m -103.23 112.89 25.97 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.329 -158.059 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 87.1 m -99.7 125.71 45.61 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 174.374 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 16.9 t -111.6 123.0 67.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 171.159 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 71.1 m -138.87 148.78 44.1 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.247 -0.908 . . . . 0.0 112.348 -175.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 10.9 m95 -82.79 122.76 28.61 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.68 -1.263 . . . . 0.0 113.694 -179.215 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -107.57 71.0 0.8 Allowed 'General case' 0 CA--C 1.572 1.815 0 C-N-CA 123.481 0.712 . . . . 0.0 109.737 160.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.24 -103.15 0.75 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 115.669 1.028 . . . . 0.0 115.669 -179.129 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -80.4 -25.17 39.22 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 116.322 1.971 . . . . 0.0 116.322 165.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -90.62 110.31 21.46 Favored 'General case' 0 N--CA 1.484 1.269 0 CA-C-N 119.861 1.21 . . . . 0.0 111.261 -179.09 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 32.7 tp -77.93 111.5 13.85 Favored 'General case' 0 CA--C 1.564 1.516 0 O-C-N 121.354 -0.841 . . . . 0.0 109.671 168.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 31.5 mm-40 -100.39 119.44 38.45 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.567 0.747 . . . . 0.0 110.862 -170.149 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 40.8 t -111.97 128.93 56.31 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.283 0.633 . . . . 0.0 111.068 175.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.1 p -126.83 121.04 57.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 CA-C-O 121.331 0.586 . . . . 0.0 109.845 174.289 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -100.79 98.8 9.28 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 124.018 0.927 . . . . 0.0 109.777 -174.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 55.4 mttp -90.84 118.06 29.95 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.337 -0.852 . . . . 0.0 112.238 -167.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 178.68 -118.95 0.63 Allowed Glycine 0 N--CA 1.486 2.008 0 O-C-N 121.137 -0.977 . . . . 0.0 113.624 172.5 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -75.74 -46.84 28.75 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 115.998 1.851 . . . . 0.0 115.998 -174.264 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 1.7 ttmp? -91.02 130.77 36.9 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 119.173 0.897 . . . . 0.0 112.081 -176.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -74.52 145.08 43.78 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -176.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 62.38 23.29 64.38 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 120.154 2.822 . . . . 0.0 120.154 -178.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 10.5 ttt85 -83.25 120.51 25.92 Favored 'General case' 0 CA--C 1.563 1.444 0 CA-C-N 119.165 1.483 . . . . 0.0 111.615 -179.692 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 172.99 -165.1 37.31 Favored Glycine 0 N--CA 1.484 1.865 0 CA-C-O 121.921 0.734 . . . . 0.0 114.605 -179.184 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 49.9 p-90 -157.14 158.09 35.69 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 114.341 1.237 . . . . 0.0 114.341 176.548 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 62.9 m -127.03 119.12 25.86 Favored 'General case' 0 CA--C 1.567 1.616 0 C-N-CA 124.117 0.967 . . . . 0.0 108.465 174.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -120.89 127.34 51.78 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.795 -0.566 . . . . 0.0 112.296 -175.389 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 23.6 p90 -142.76 169.75 16.99 Favored 'General case' 0 N--CA 1.499 1.977 0 C-N-CA 123.763 0.825 . . . . 0.0 112.978 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 94.5 mt -113.42 146.11 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.285 0 CA-C-O 123.145 1.45 . . . . 0.0 111.322 176.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -137.37 90.05 2.48 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 177.391 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 73.39 -119.35 6.59 Favored Glycine 0 N--CA 1.491 2.305 0 O-C-N 121.867 -0.521 . . . . 0.0 114.258 -172.351 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -91.16 11.44 23.26 Favored 'General case' 0 N--CA 1.5 2.045 0 N-CA-C 116.742 2.127 . . . . 0.0 116.742 165.58 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 75.8 mt-10 -111.29 138.29 47.95 Favored 'General case' 0 CA--C 1.56 1.34 0 CA-C-N 119.78 1.173 . . . . 0.0 111.999 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 10.4 tp -98.03 125.96 43.23 Favored 'General case' 0 CA--C 1.563 1.454 0 C-N-CA 123.902 0.881 . . . . 0.0 109.148 170.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 45.4 m80 -113.22 123.08 49.35 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.713 0.805 . . . . 0.0 109.126 -175.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 32.4 tp -122.59 122.26 38.43 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.596 0.758 . . . . 0.0 110.218 -174.135 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -100.51 117.15 34.06 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.715 -0.615 . . . . 0.0 109.589 164.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 74.3 mtm -105.09 125.93 51.52 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-N 118.782 0.719 . . . . 0.0 110.493 175.005 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 49.0 mtp180 -114.22 140.13 48.82 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.604 -0.685 . . . . 0.0 111.459 -174.099 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -151.51 126.75 9.91 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.787 -0.571 . . . . 0.0 110.616 167.062 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 61.72 28.92 17.87 Favored 'General case' 0 N--CA 1.504 2.232 0 N-CA-C 115.375 1.62 . . . . 0.0 115.375 -172.54 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 82.4 -27.6 3.62 Favored Glycine 0 CA--C 1.558 2.73 0 N-CA-C 118.693 2.237 . . . . 0.0 118.693 -158.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 96.4 t -73.8 119.38 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 CA-C-N 119.221 1.511 . . . . 0.0 110.416 -169.245 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 59.4 m -106.35 120.74 42.66 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.182 -169.081 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 6.6 t -97.31 122.8 40.75 Favored 'General case' 0 CA--C 1.558 1.28 0 C-N-CA 124.082 0.953 . . . . 0.0 111.528 170.145 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 85.6 mttt -96.19 119.62 35.02 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.824 -0.548 . . . . 0.0 110.059 176.235 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 18.2 mt-30 -119.68 123.4 43.73 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.706 -0.621 . . . . 0.0 110.686 -179.346 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 47.5 t -105.03 131.78 53.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 -177.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -126.17 149.08 49.24 Favored 'General case' 0 CA--C 1.563 1.455 0 C-N-CA 124.515 1.126 . . . . 0.0 110.511 -178.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 22.2 ttmt -118.62 141.0 49.01 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.94 -1.1 . . . . 0.0 112.002 175.409 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 61.6 tttt -74.87 126.43 30.93 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 179.177 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 33.3 m -107.09 -40.7 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 174.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 33.9 m170 . . . . . 0 C--O 1.255 1.354 0 CA-C-N 120.138 1.336 . . . . 0.0 108.784 -177.751 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.576 1.978 0 N-CA-C 113.834 1.05 . . . . 0.0 113.834 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -78.15 -122.12 0.01 OUTLIER 'Trans proline' 0 CA--C 1.575 2.531 0 C-N-CA 122.612 2.208 . . . . 0.0 114.634 -178.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 18.1 m -144.95 153.64 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 120.595 -1.316 . . . . 0.0 110.393 -171.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -73.3 98.64 2.72 Favored 'General case' 0 CA--C 1.569 1.679 0 O-C-N 121.1 -1.0 . . . . 0.0 112.362 174.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 7.4 m-30 -78.95 -9.55 59.55 Favored 'General case' 0 CA--C 1.577 2.012 0 N-CA-C 115.471 1.656 . . . . 0.0 115.471 161.315 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -57.9 116.36 3.43 Favored 'General case' 0 CA--C 1.564 1.485 0 CA-C-N 120.837 1.653 . . . . 0.0 114.713 -176.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 152.62 -177.59 30.26 Favored Glycine 0 N--CA 1.486 2.028 0 CA-C-O 122.54 1.078 . . . . 0.0 115.711 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -105.42 123.35 47.72 Favored 'General case' 0 CA--C 1.562 1.434 0 CA-C-N 114.638 -0.781 . . . . 0.0 109.514 178.076 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 72.2 m95 -122.81 126.02 46.59 Favored 'General case' 0 CA--C 1.567 1.605 0 C-N-CA 123.364 0.666 . . . . 0.0 110.004 -170.009 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 62.2 pttt -95.06 140.16 30.4 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.244 -0.91 . . . . 0.0 113.167 177.674 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 50.4 ttm -69.73 129.69 40.29 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.638 -1.289 . . . . 0.0 113.626 174.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 87.4 mt -94.4 -58.27 2.25 Favored 'General case' 0 CA--C 1.567 1.611 0 CA-C-N 115.584 -0.735 . . . . 0.0 112.65 170.053 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 94.2 p -139.48 130.02 25.73 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 119.632 1.106 . . . . 0.0 113.431 -165.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -102.41 81.45 2.06 Favored 'General case' 0 CA--C 1.568 1.671 0 C-N-CA 123.871 0.868 . . . . 0.0 110.277 176.432 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -93.93 114.61 26.86 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.656 -1.278 . . . . 0.0 111.013 -170.51 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.272 22.2 t30 63.15 27.09 15.56 Favored 'General case' 0 N--CA 1.506 2.355 0 N-CA-C 116.801 2.148 . . . . 0.0 116.801 -171.138 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -69.94 -49.18 54.43 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 115.18 1.548 . . . . 0.0 115.18 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 90.0 mt-10 -61.35 -35.52 77.66 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 116.506 2.039 . . . . 0.0 116.506 174.043 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -63.69 -42.99 97.93 Favored 'General case' 0 CA--C 1.576 1.948 0 N-CA-C 115.187 1.551 . . . . 0.0 115.187 167.405 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 28.2 t80 -56.31 -50.68 70.74 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 115.041 1.496 . . . . 0.0 115.041 165.136 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.2 mt -61.3 -40.67 95.02 Favored 'General case' 0 CA--C 1.573 1.834 0 N-CA-C 115.191 1.552 . . . . 0.0 115.191 173.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 41.9 ttp85 -51.15 -50.66 58.49 Favored 'General case' 0 CA--C 1.575 1.904 0 N-CA-C 115.086 1.513 . . . . 0.0 115.086 162.552 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.74 -19.3 58.65 Favored 'General case' 0 CA--C 1.573 1.83 0 N-CA-C 118.462 2.764 . . . . 0.0 118.462 168.486 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 43.7 mt -86.51 2.08 49.24 Favored 'General case' 0 CA--C 1.572 1.79 0 N-CA-C 116.12 1.896 . . . . 0.0 116.12 165.401 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 61.04 46.66 8.05 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 115.126 1.528 . . . . 0.0 115.126 -169.307 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 99.0 t -93.95 135.04 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.403 -0.81 . . . . 0.0 108.838 176.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.0 p-10 -67.91 147.55 52.33 Favored 'General case' 0 CA--C 1.566 1.584 0 N-CA-C 115.504 1.668 . . . . 0.0 115.504 179.009 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 25.3 t -49.32 -44.98 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.327 0 N-CA-C 115.796 1.776 . . . . 0.0 115.796 -174.376 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.99 -46.19 88.75 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 116.3 1.963 . . . . 0.0 116.3 173.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.62 -43.69 96.12 Favored 'General case' 0 CA--C 1.572 1.794 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 168.579 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 27.5 mtm-85 -53.37 -41.1 65.53 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 116.516 2.043 . . . . 0.0 116.516 167.293 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -68.6 -54.9 13.63 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 168.415 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 63.1 mt -54.47 -51.62 47.88 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.303 0 CA-C-N 120.435 1.47 . . . . 0.0 113.841 178.22 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.78 -38.66 91.95 Favored 'General case' 0 CA--C 1.562 1.435 0 N-CA-C 117.642 2.46 . . . . 0.0 117.642 175.105 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 16.4 t30 -72.44 -30.33 64.49 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 116.395 1.998 . . . . 0.0 116.395 170.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 83.4 mt -75.05 -32.85 61.64 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 115.331 1.604 . . . . 0.0 115.331 172.008 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 93.6 mt -81.35 142.2 33.27 Favored 'General case' 0 CA--C 1.564 1.505 0 CA-C-N 119.384 0.993 . . . . 0.0 112.139 174.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -106.94 84.89 1.7 Allowed Pre-proline 0 CA--C 1.575 1.917 0 CA-C-O 118.248 -0.882 . . . . 0.0 109.947 175.359 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -72.94 166.27 30.5 Favored 'Trans proline' 0 CA--C 1.563 1.965 0 C-N-CA 122.537 2.158 . . . . 0.0 116.028 -178.295 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -111.25 138.83 47.21 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.214 -177.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 58.6 mttm -104.88 111.65 24.48 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.399 -0.813 . . . . 0.0 109.376 173.707 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 54.9 tt0 -98.74 102.87 14.74 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 171.013 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 61.3 mt -97.67 123.68 50.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.513 -0.742 . . . . 0.0 109.202 -169.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 88.4 t -102.48 101.93 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 166.49 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -104.2 108.19 19.45 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 123.706 0.803 . . . . 0.0 110.358 -179.666 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -112.56 72.32 0.77 Allowed 'General case' 0 CA--C 1.567 1.634 0 O-C-N 121.683 -0.636 . . . . 0.0 110.634 175.062 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 68.48 -95.65 0.39 Allowed Glycine 0 N--CA 1.489 2.21 0 N-CA-C 115.014 0.766 . . . . 0.0 115.014 -179.015 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -86.67 -37.09 18.34 Favored 'General case' 0 CA--C 1.566 1.574 0 N-CA-C 115.743 1.757 . . . . 0.0 115.743 166.077 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 20.8 t-160 -80.66 113.66 19.01 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 121.099 1.772 . . . . 0.0 111.463 -178.32 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 46.6 ttm -130.5 123.19 29.12 Favored 'General case' 0 CA--C 1.555 1.165 0 CA-C-O 121.386 0.612 . . . . 0.0 110.074 -169.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 54.5 mt -115.86 101.22 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 87.9 mt -89.79 90.67 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -77.59 99.01 5.59 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.303 -0.873 . . . . 0.0 110.715 -173.609 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 29.4 m -97.13 105.64 17.83 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-O 121.803 0.811 . . . . 0.0 109.016 -169.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 22.2 mt -109.49 117.17 33.3 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.991 0.917 . . . . 0.0 110.072 -159.138 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 19.2 t -133.87 146.55 50.69 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 123.154 0.582 . . . . 0.0 111.976 -174.212 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 43.5 p -79.92 61.66 3.89 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.122 -0.986 . . . . 0.0 112.631 172.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -169.95 -70.79 0.02 OUTLIER 'General case' 0 CA--C 1.569 1.693 0 C-N-CA 125.648 1.579 . . . . 0.0 107.513 178.572 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 32.1 mtt180 -139.8 131.5 27.35 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 123.803 0.841 . . . . 0.0 109.648 171.249 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -85.4 129.14 34.88 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.039 0.447 . . . . 0.0 111.027 176.392 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -91.35 -77.4 0.42 Allowed 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 123.146 0.579 . . . . 0.0 111.972 -172.066 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.36 14.9 mt 79.46 108.35 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 C-N-CA 124.216 1.006 . . . . 0.0 110.986 -179.675 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.76 95.74 6.85 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 123.513 0.725 . . . . 0.0 109.729 177.064 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -101.53 116.34 32.55 Favored 'General case' 0 CA--C 1.564 1.515 0 C-N-CA 124.228 1.011 . . . . 0.0 112.321 -175.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -157.91 156.44 31.33 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 115.07 1.507 . . . . 0.0 115.07 -171.186 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -104.23 119.24 38.52 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 123.474 0.709 . . . . 0.0 109.857 167.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 54.0 t -61.98 128.9 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 C-N-CA 123.936 0.894 . . . . 0.0 111.674 -178.335 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 99.74 -37.13 3.67 Favored Glycine 0 CA--C 1.55 2.279 0 N-CA-C 116.704 1.442 . . . . 0.0 116.704 -163.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 77.7 mttt -89.43 129.83 35.88 Favored 'General case' 0 CA--C 1.565 1.539 0 CA-C-N 118.88 1.34 . . . . 0.0 111.746 -172.203 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -81.84 106.61 13.9 Favored 'General case' 0 CA--C 1.567 1.615 0 O-C-N 121.321 -0.862 . . . . 0.0 111.771 178.119 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -109.88 148.89 30.72 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 123.856 0.862 . . . . 0.0 112.006 -175.058 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.62 124.09 23.04 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.2 -1.562 . . . . 0.0 111.73 168.15 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -74.13 89.9 2.01 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-N 119.137 0.88 . . . . 0.0 111.612 -174.488 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -86.3 166.37 15.7 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 117.708 2.485 . . . . 0.0 117.708 -139.71 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . 0.338 2.9 tt 74.79 -76.54 0.06 Allowed 'General case' 0 N--CA 1.499 1.994 0 C-N-CA 124.87 1.268 . . . . 0.0 112.135 -176.611 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 39.0 p -128.18 -47.33 1.34 Allowed 'General case' 0 N--CA 1.5 2.036 0 C-N-CA 124.345 1.058 . . . . 0.0 111.565 168.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 101.4 -127.12 9.13 Favored Glycine 0 CA--C 1.54 1.626 0 C-N-CA 123.695 0.664 . . . . 0.0 111.467 -177.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 54.1 mt -84.6 -59.74 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 CA-C-O 119.15 -0.452 . . . . 0.0 110.449 172.598 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . 0.252 26.5 t70 -100.21 -91.9 0.29 Allowed 'General case' 0 CA--C 1.568 1.652 0 CA-C-O 118.052 -0.975 . . . . 0.0 109.453 172.613 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -154.2 71.29 0.84 Allowed 'General case' 0 N--CA 1.498 1.964 0 CA-C-N 121.118 1.781 . . . . 0.0 112.399 178.125 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.14 134.2 3.44 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.226 -0.921 . . . . 0.0 110.46 174.739 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 72.1 mttt -85.66 93.25 8.79 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.38 -0.825 . . . . 0.0 111.155 -176.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 74.1 m -92.47 135.21 34.24 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 -167.196 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 1.1 mmt -70.55 98.18 1.43 Allowed 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 122.216 1.008 . . . . 0.0 111.697 -176.124 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 95.5 m -112.36 114.53 27.31 Favored 'General case' 0 N--CA 1.481 1.115 0 O-C-N 121.51 -0.744 . . . . 0.0 110.452 -157.641 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 63.0 m -92.79 124.47 36.81 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 168.321 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.7 t -112.3 130.33 66.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 169.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 74.9 m -134.79 140.34 45.81 Favored 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 123.791 0.836 . . . . 0.0 111.989 -173.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 8.4 m95 -80.98 116.35 20.9 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.457 -1.402 . . . . 0.0 112.874 177.029 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 38.8 t0 -103.66 67.18 0.89 Allowed 'General case' 0 CA--C 1.576 1.95 0 C-N-CA 124.063 0.945 . . . . 0.0 110.189 164.273 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 68.08 -105.82 1.53 Allowed Glycine 0 N--CA 1.492 2.418 0 N-CA-C 115.641 1.016 . . . . 0.0 115.641 -179.083 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -72.87 -30.25 63.83 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 115.123 1.527 . . . . 0.0 115.123 163.374 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 24.0 mttt -92.78 110.59 22.03 Favored 'General case' 0 CA--C 1.557 1.221 0 CA-C-N 119.443 1.019 . . . . 0.0 111.62 -171.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 29.0 tp -82.07 105.57 13.28 Favored 'General case' 0 CA--C 1.563 1.479 0 O-C-N 120.47 -1.394 . . . . 0.0 110.164 171.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 11.2 mm100 -87.42 145.89 26.1 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 124.51 1.124 . . . . 0.0 110.721 -174.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 42.9 t -143.63 133.47 23.93 Favored 'General case' 0 N--CA 1.484 1.25 0 O-C-N 121.541 -0.724 . . . . 0.0 112.421 178.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.2 p -118.33 123.8 72.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 165.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -104.46 97.09 7.06 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 123.626 0.77 . . . . 0.0 109.427 -178.323 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -83.42 111.43 19.03 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.761 -1.212 . . . . 0.0 111.425 -170.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 162.56 103.98 0.18 Allowed Glycine 0 N--CA 1.483 1.798 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.898 -172.394 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . 0.282 42.3 mt-10 69.61 -68.47 0.19 Allowed 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 116.142 1.904 . . . . 0.0 116.142 174.027 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -82.08 129.89 34.93 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 122.153 0.978 . . . . 0.0 111.242 -170.666 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -67.78 -45.97 73.3 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 116.096 1.887 . . . . 0.0 116.096 -162.387 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -101.68 54.52 0.78 Allowed Glycine 0 N--CA 1.49 2.286 0 CA-C-O 118.63 -1.095 . . . . 0.0 115.727 164.619 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.9 ttt-85 -85.25 116.88 23.85 Favored 'General case' 0 CA--C 1.565 1.543 0 CA-C-N 118.844 1.322 . . . . 0.0 112.062 -179.251 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 178.7 -173.24 45.58 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 115.139 0.816 . . . . 0.0 115.139 -174.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . 0.279 49.6 p-90 -155.48 167.89 28.92 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 123.338 1.542 . . . . 0.0 113.918 174.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 96.0 m -144.93 114.14 7.01 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.147 -1.596 . . . . 0.0 107.81 174.234 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 45.6 tt0 -114.67 127.56 55.83 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 123.566 0.746 . . . . 0.0 111.444 -173.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 9.6 p90 -148.34 154.85 40.54 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.706 -1.246 . . . . 0.0 113.679 -174.25 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 94.8 mt -98.84 133.98 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 O-C-N 120.793 -1.192 . . . . 0.0 110.823 176.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -120.09 91.79 3.62 Favored 'General case' 0 CA--C 1.567 1.618 0 C-N-CA 124.291 1.036 . . . . 0.0 108.387 162.136 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 69.36 -113.17 4.96 Favored Glycine 0 N--CA 1.492 2.402 0 O-C-N 121.238 -0.914 . . . . 0.0 114.927 -177.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -84.54 -8.75 58.81 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 117.423 2.379 . . . . 0.0 117.423 167.396 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 62.1 mt-10 -99.95 126.56 46.13 Favored 'General case' 0 CA--C 1.56 1.363 0 CA-C-N 120.549 1.522 . . . . 0.0 111.292 -176.627 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 21.2 tp -89.22 115.5 26.77 Favored 'General case' 0 CA--C 1.563 1.448 0 C-N-CA 124.224 1.01 . . . . 0.0 109.122 164.136 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 48.7 m80 -101.83 119.09 38.23 Favored 'General case' 0 CA--C 1.556 1.207 0 C-N-CA 123.979 0.911 . . . . 0.0 108.857 -178.674 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 42.7 tp -113.31 114.76 27.12 Favored 'General case' 0 CA--C 1.557 1.228 0 C-N-CA 123.677 0.791 . . . . 0.0 109.642 179.363 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -90.04 126.88 35.92 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.906 -0.496 . . . . 0.0 109.74 163.59 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 75.5 mtm -119.99 127.79 52.94 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-N 118.658 0.663 . . . . 0.0 110.297 176.615 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 88.0 mtm-85 -114.82 141.26 48.13 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 123.429 0.692 . . . . 0.0 111.326 -174.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -150.29 131.05 14.09 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.676 -0.64 . . . . 0.0 110.931 163.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 54.79 34.4 21.79 Favored 'General case' 0 N--CA 1.507 2.415 0 N-CA-C 116.169 1.914 . . . . 0.0 116.169 -172.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 76.43 -1.29 61.56 Favored Glycine 0 CA--C 1.557 2.709 0 N-CA-C 120.173 2.829 . . . . 0.0 120.173 -165.128 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 89.6 t -98.7 120.09 47.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 CA-C-N 120.453 2.126 . . . . 0.0 109.49 -173.481 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 30.7 m -102.88 120.9 41.44 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 123.243 0.617 . . . . 0.0 111.357 -172.414 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 33.5 t -92.32 140.34 29.7 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 123.384 0.674 . . . . 0.0 112.041 161.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 33.9 mtpt -104.24 114.94 29.53 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.6 -0.688 . . . . 0.0 110.564 164.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -104.48 124.27 48.97 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.334 0.654 . . . . 0.0 110.291 168.017 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 62.7 t -109.93 132.79 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -127.23 134.96 50.03 Favored 'General case' 0 CA--C 1.561 1.398 0 C-N-CA 124.104 0.962 . . . . 0.0 110.823 -177.296 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -103.57 137.38 41.72 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.837 -1.165 . . . . 0.0 112.493 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 71.4 tttt -71.35 125.79 27.93 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 177.677 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 27.7 m -116.24 -40.17 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.128 0 N-CA-C 114.058 1.133 . . . . 0.0 114.058 177.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 50.5 t60 . . . . . 0 N--CA 1.487 1.395 0 CA-C-N 120.47 1.487 . . . . 0.0 108.53 175.229 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 CA--C 1.571 1.781 0 CA-C-O 118.201 -0.904 . . . . 0.0 109.671 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -79.93 105.86 1.86 Allowed 'Trans proline' 0 C--N 1.371 1.727 0 C-N-CA 122.395 2.063 . . . . 0.0 113.919 -177.005 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 27.6 m -78.38 155.16 5.06 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.687 0 CA-C-N 114.71 -1.132 . . . . 0.0 113.262 -174.359 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -68.93 100.93 1.27 Allowed 'General case' 0 CA--C 1.563 1.453 0 O-C-N 120.93 -1.106 . . . . 0.0 113.93 176.781 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 4.5 m-30 -70.61 -1.5 11.36 Favored 'General case' 0 CA--C 1.581 2.161 0 N-CA-C 116.871 2.175 . . . . 0.0 116.871 177.377 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -45.05 111.03 0.28 Allowed 'General case' 0 CA--C 1.566 1.569 0 N-CA-C 116.122 1.897 . . . . 0.0 116.122 173.375 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 165.96 175.85 36.76 Favored Glycine 0 N--CA 1.484 1.848 0 N-CA-C 116.313 1.285 . . . . 0.0 116.313 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 12.7 t80 -110.19 125.65 53.28 Favored 'General case' 0 CA--C 1.562 1.409 0 CA-C-N 113.952 -1.124 . . . . 0.0 108.657 173.214 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 82.3 m95 -124.67 127.4 47.24 Favored 'General case' 0 CA--C 1.565 1.539 0 C-N-CA 123.49 0.716 . . . . 0.0 109.982 -167.047 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -97.1 140.37 31.71 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.188 -0.945 . . . . 0.0 112.853 175.368 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 37.4 ttm -70.79 125.08 25.86 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.819 -1.176 . . . . 0.0 113.024 177.624 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 90.2 mt -84.62 -51.56 6.76 Favored 'General case' 0 CA--C 1.566 1.595 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 167.171 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 92.3 p -144.52 150.75 38.08 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 118.806 0.73 . . . . 0.0 112.2 177.733 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -125.84 114.11 18.13 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 123.13 0.572 . . . . 0.0 109.734 165.457 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -115.25 124.1 50.5 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 123.387 0.675 . . . . 0.0 109.651 -168.298 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.264 23.4 t30 62.16 25.26 15.11 Favored 'General case' 0 N--CA 1.504 2.251 0 N-CA-C 116.699 2.111 . . . . 0.0 116.699 -172.224 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -67.8 -43.5 79.51 Favored 'General case' 0 CA--C 1.567 1.633 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 175.615 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -45.96 -50.0 15.22 Favored 'General case' 0 N--CA 1.505 2.324 0 N-CA-C 116.433 2.012 . . . . 0.0 116.433 167.193 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -70.86 -41.01 71.95 Favored 'General case' 0 CA--C 1.57 1.747 0 N-CA-C 115.463 1.653 . . . . 0.0 115.463 178.379 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -50.84 -49.38 59.03 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 114.9 1.445 . . . . 0.0 114.9 160.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 81.2 mt -62.96 -39.5 94.84 Favored 'General case' 0 CA--C 1.574 1.877 0 N-CA-C 114.866 1.432 . . . . 0.0 114.866 173.115 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 69.0 ttp85 -52.45 -50.97 61.55 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 115.087 1.514 . . . . 0.0 115.087 164.176 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.54 -14.88 22.49 Favored 'General case' 0 CA--C 1.572 1.79 0 N-CA-C 118.545 2.794 . . . . 0.0 118.545 167.729 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 94.8 mt -97.36 16.48 19.95 Favored 'General case' 0 CA--C 1.57 1.742 0 N-CA-C 115.159 1.54 . . . . 0.0 115.159 164.463 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 60.74 45.37 10.14 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 115.547 1.684 . . . . 0.0 115.547 -177.41 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 98.0 t -99.83 138.24 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.22 -0.925 . . . . 0.0 109.794 -178.025 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 12.6 p30 -63.68 152.28 39.51 Favored 'General case' 0 CA--C 1.57 1.746 0 N-CA-C 115.112 1.523 . . . . 0.0 115.112 176.124 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . 0.251 78.8 t -58.62 -40.8 80.3 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.303 0 N-CA-C 115.307 1.595 . . . . 0.0 115.307 -177.828 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.26 -50.18 72.08 Favored 'General case' 0 CA--C 1.567 1.607 0 N-CA-C 115.953 1.834 . . . . 0.0 115.953 168.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 25.4 tp -66.9 -38.82 86.97 Favored 'General case' 0 CA--C 1.573 1.829 0 N-CA-C 116.052 1.871 . . . . 0.0 116.052 171.068 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 69.6 mtp180 -50.85 -47.87 60.19 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 115.303 1.594 . . . . 0.0 115.303 162.746 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -65.05 -54.42 30.49 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 170.402 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 61.6 mt -51.77 -55.66 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.246 0 CA-C-N 120.41 1.459 . . . . 0.0 113.172 175.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.23 -35.89 80.28 Favored 'General case' 0 CA--C 1.563 1.453 0 N-CA-C 118.352 2.723 . . . . 0.0 118.352 176.491 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -76.16 -33.43 59.37 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 116.018 1.859 . . . . 0.0 116.018 171.117 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 77.2 mt -72.85 -36.54 67.45 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 115.387 1.625 . . . . 0.0 115.387 178.633 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . 0.262 3.7 pp -93.92 151.94 19.21 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 119.327 0.967 . . . . 0.0 113.208 179.457 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 28.0 mmtp -108.42 93.37 11.48 Favored Pre-proline 0 CA--C 1.574 1.871 0 CA-C-O 118.078 -0.963 . . . . 0.0 110.03 -173.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -75.6 169.37 22.47 Favored 'Trans proline' 0 CA--C 1.565 2.043 0 C-N-CA 122.664 2.243 . . . . 0.0 115.605 -178.001 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -112.67 134.05 54.39 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-N 116.03 -0.532 . . . . 0.0 112.106 -177.434 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 23.5 mtpp -102.51 113.88 27.6 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.037 -1.04 . . . . 0.0 110.578 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -97.99 109.68 22.39 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.694 -0.629 . . . . 0.0 109.319 167.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 76.2 mt -102.42 120.56 52.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 -179.421 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 88.9 t -109.85 95.05 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 174.402 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -86.87 97.13 10.49 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 123.324 0.65 . . . . 0.0 110.362 173.77 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -102.27 70.46 1.18 Allowed 'General case' 0 CA--C 1.567 1.633 0 C-N-CA 123.556 0.742 . . . . 0.0 111.332 -178.307 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 57.94 65.8 3.27 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 117.368 1.707 . . . . 0.0 117.368 177.353 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.478 0.0 OUTLIER 82.07 -36.99 0.1 Allowed 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 116.473 2.027 . . . . 0.0 116.473 -165.235 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 12.3 t-160 -79.81 95.29 5.98 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-N 120.834 1.652 . . . . 0.0 110.513 175.217 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 4.1 ttp -104.6 119.52 39.19 Favored 'General case' 0 CA--C 1.552 1.052 0 CA-C-O 121.982 0.896 . . . . 0.0 110.094 -175.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 37.4 mt -106.32 101.16 12.05 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.479 0 N-CA-C 106.587 -1.634 . . . . 0.0 106.587 -178.262 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 88.1 mt -89.3 111.91 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 177.072 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 90.3 mtt180 -109.6 100.27 9.34 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -174.674 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 16.8 m -92.99 109.62 21.07 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.16 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 39.7 mt -102.64 123.62 46.69 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.349 0.66 . . . . 0.0 110.938 -159.779 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 10.2 t -151.01 160.51 43.88 Favored 'General case' 0 CA--C 1.571 1.763 0 CA-C-O 121.31 0.576 . . . . 0.0 112.474 -176.001 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.0 t -63.05 -36.07 82.35 Favored 'General case' 0 N--CA 1.504 2.235 0 N-CA-C 117.738 2.496 . . . . 0.0 117.738 175.386 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -76.48 -52.32 10.04 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 175.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.6 tmm_? -149.05 138.03 21.37 Favored 'General case' 0 CA--C 1.56 1.349 0 C-N-CA 124.212 1.005 . . . . 0.0 108.767 -178.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -102.06 114.93 29.48 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 174.172 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -87.54 121.42 29.96 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 122.862 0.465 . . . . 0.0 110.598 -173.204 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 43.2 mm -114.27 101.98 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 -177.642 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 76.5 mtp -95.28 90.53 5.88 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.126 -0.984 . . . . 0.0 109.132 169.169 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.6 p30 -95.15 108.17 20.27 Favored 'General case' 0 CA--C 1.561 1.376 0 C-N-CA 123.821 0.849 . . . . 0.0 111.82 178.045 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 29.4 p90 -147.77 142.88 27.1 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 113.844 1.054 . . . . 0.0 113.844 -169.107 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 17.1 mp0 -79.96 123.46 27.82 Favored 'General case' 0 CA--C 1.563 1.459 0 O-C-N 121.543 -0.723 . . . . 0.0 110.289 162.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 46.9 t -65.98 117.68 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 C-N-CA 123.315 0.646 . . . . 0.0 110.422 -179.204 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 115.44 -45.18 1.34 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 116.006 1.162 . . . . 0.0 116.006 -160.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -82.29 144.15 30.81 Favored 'General case' 0 CA--C 1.567 1.617 0 CA-C-N 118.802 1.301 . . . . 0.0 113.284 -173.673 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -95.14 111.56 23.38 Favored 'General case' 0 CA--C 1.564 1.504 0 O-C-N 121.76 -0.588 . . . . 0.0 111.481 176.528 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 22.8 p90 -106.94 142.74 36.07 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 123.33 0.652 . . . . 0.0 112.748 -177.628 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -71.13 114.2 8.95 Favored 'General case' 0 CA--C 1.567 1.622 0 O-C-N 120.358 -1.464 . . . . 0.0 112.177 170.719 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -79.85 80.33 6.26 Favored 'General case' 0 CA--C 1.568 1.646 0 CA-C-O 122.125 0.965 . . . . 0.0 111.266 -175.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -112.18 -38.9 4.6 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 124.033 0.933 . . . . 0.0 113.479 176.639 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.1 pp -69.53 102.33 1.8 Allowed 'General case' 0 CA--C 1.567 1.608 0 CA-C-N 120.308 1.413 . . . . 0.0 111.768 173.364 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . 0.254 30.4 p 74.45 122.0 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.014 0 C-N-CA 124.308 1.043 . . . . 0.0 112.911 -177.871 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -140.41 177.38 20.76 Favored Glycine 0 N--CA 1.49 2.259 0 CA-C-O 122.353 0.974 . . . . 0.0 115.078 -179.426 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 50.2 mm -82.71 -79.69 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 170.405 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 40.6 t0 -87.48 167.03 14.34 Favored 'General case' 0 CA--C 1.575 1.918 0 CA-C-O 121.818 0.818 . . . . 0.0 110.089 152.532 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -75.83 78.57 2.75 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.318 -1.489 . . . . 0.0 112.191 177.738 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 8.0 tpm_? -136.02 114.44 11.71 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.692 0.797 . . . . 0.0 109.357 -170.79 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 55.5 mtmt -74.87 127.92 34.35 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 123.127 0.571 . . . . 0.0 111.981 178.155 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 93.5 m -136.69 124.69 22.82 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 121.469 0.652 . . . . 0.0 111.24 179.359 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 80.6 mmm -71.61 103.73 3.11 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 121.714 0.768 . . . . 0.0 110.277 177.223 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 92.1 m -109.56 111.53 23.09 Favored 'General case' 0 N--CA 1.483 1.178 0 O-C-N 121.671 -0.643 . . . . 0.0 110.866 -159.031 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 95.1 m -94.71 128.24 41.25 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 170.698 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.9 t -116.41 129.66 72.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 172.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 58.2 m -149.09 157.12 43.14 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.423 -1.423 . . . . 0.0 113.316 -177.31 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 45.7 m95 -86.84 123.61 32.16 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.751 -1.218 . . . . 0.0 113.775 -174.343 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -109.35 73.3 0.84 Allowed 'General case' 0 CA--C 1.57 1.712 0 C-N-CA 124.064 0.946 . . . . 0.0 109.356 164.299 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.0 -125.14 29.68 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 114.637 0.615 . . . . 0.0 114.637 -172.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -61.12 -19.81 61.93 Favored 'General case' 0 N--CA 1.501 2.09 0 N-CA-C 116.526 2.047 . . . . 0.0 116.526 166.445 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 43.7 mttt -97.15 121.11 38.67 Favored 'General case' 0 CA--C 1.556 1.206 0 CA-C-N 119.554 1.07 . . . . 0.0 111.554 -174.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 24.3 tp -84.68 108.05 17.2 Favored 'General case' 0 CA--C 1.565 1.544 0 O-C-N 121.326 -0.859 . . . . 0.0 109.086 170.236 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -93.81 132.02 38.62 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.703 0.801 . . . . 0.0 111.036 -176.675 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 42.1 t -126.96 128.28 46.16 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.213 0.605 . . . . 0.0 111.315 178.626 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 12.7 p -109.8 118.12 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 168.009 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 55.7 mt-30 -99.42 73.69 1.87 Allowed 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 123.577 0.751 . . . . 0.0 109.813 178.438 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -83.96 134.13 34.67 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.577 -1.327 . . . . 0.0 113.781 -169.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 178.46 -85.03 0.07 OUTLIER Glycine 0 N--CA 1.485 1.932 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.955 -177.516 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -104.16 -58.25 1.91 Allowed 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 177.752 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -76.88 133.26 39.34 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 119.985 1.266 . . . . 0.0 112.07 -173.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -61.52 -54.73 39.34 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 116.171 1.915 . . . . 0.0 116.171 -167.107 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -98.67 53.42 1.11 Allowed Glycine 0 N--CA 1.489 2.177 0 N-CA-C 115.97 1.148 . . . . 0.0 115.97 169.223 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 25.7 ttt-85 -87.57 118.62 27.17 Favored 'General case' 0 CA--C 1.563 1.479 0 CA-C-N 118.685 1.243 . . . . 0.0 111.713 179.393 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 171.18 -168.9 42.02 Favored Glycine 0 N--CA 1.485 1.918 0 CA-C-O 121.892 0.718 . . . . 0.0 114.226 -179.461 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 38.5 p-90 -155.99 157.07 35.57 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 176.508 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 83.1 m -125.89 114.21 18.24 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 175.608 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 41.1 tt0 -117.57 123.01 45.19 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 123.413 0.685 . . . . 0.0 111.142 -175.217 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 12.5 p90 -144.36 148.58 34.9 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.966 -1.084 . . . . 0.0 113.229 -176.798 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 94.3 mt -97.3 135.87 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 CA-C-O 122.374 1.083 . . . . 0.0 110.374 177.6 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -122.9 87.21 2.71 Favored 'General case' 0 CA--C 1.563 1.445 0 CA-C-N 114.214 -1.357 . . . . 0.0 107.781 174.219 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 70.97 -105.25 1.58 Allowed Glycine 0 N--CA 1.491 2.323 0 O-C-N 121.488 -0.758 . . . . 0.0 114.714 -175.003 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 54.8 p30 -99.95 7.23 44.97 Favored 'General case' 0 CA--C 1.574 1.898 0 N-CA-C 116.868 2.173 . . . . 0.0 116.868 169.118 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -115.33 130.11 56.8 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-N 120.43 1.468 . . . . 0.0 111.694 -178.008 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 13.3 tp -90.94 115.56 28.06 Favored 'General case' 0 CA--C 1.561 1.384 0 C-N-CA 124.224 1.01 . . . . 0.0 109.356 170.551 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 43.4 m80 -102.31 122.45 44.27 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.873 0.869 . . . . 0.0 109.04 -178.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 49.3 tp -122.96 117.63 25.96 Favored 'General case' 0 CA--C 1.56 1.34 0 C-N-CA 123.701 0.801 . . . . 0.0 109.924 -174.433 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -104.77 107.87 19.05 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 169.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 68.5 mtm -100.18 128.5 46.24 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.881 -0.512 . . . . 0.0 110.682 178.513 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 68.5 mtp180 -115.03 143.45 45.17 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.656 -0.653 . . . . 0.0 111.868 -178.57 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -148.34 130.07 15.09 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.601 -0.687 . . . . 0.0 111.567 164.606 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 58.27 25.6 12.88 Favored 'General case' 0 N--CA 1.506 2.361 0 N-CA-C 115.716 1.746 . . . . 0.0 115.716 -167.505 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 90.37 -34.04 4.31 Favored Glycine 0 CA--C 1.557 2.685 0 N-CA-C 118.095 1.998 . . . . 0.0 118.095 -159.618 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 76.5 t -70.49 119.41 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 CA-C-N 119.276 1.538 . . . . 0.0 111.614 -165.628 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 21.0 m -95.13 123.36 38.58 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.166 0.507 . . . . 0.0 112.091 -173.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 10.4 t -94.03 130.87 40.0 Favored 'General case' 0 CA--C 1.561 1.383 0 C-N-CA 123.518 0.727 . . . . 0.0 110.99 159.489 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -108.36 111.63 23.65 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.558 -0.713 . . . . 0.0 109.45 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -111.46 132.07 54.75 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 123.612 0.765 . . . . 0.0 111.384 178.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 43.9 t -115.35 130.42 69.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 176.717 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -126.59 141.63 51.8 Favored 'General case' 0 CA--C 1.563 1.448 0 C-N-CA 124.232 1.013 . . . . 0.0 110.78 -178.069 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 10.3 tmtt? -110.46 139.7 45.42 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.966 -1.084 . . . . 0.0 112.288 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 37.0 tttp -73.68 117.23 15.21 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 113.464 0.913 . . . . 0.0 113.464 -177.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . 0.263 34.8 m -103.25 -39.28 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.152 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 174.71 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 38.2 t60 . . . . . 0 N--CA 1.486 1.344 0 CA-C-N 119.863 1.21 . . . . 0.0 107.956 163.654 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 56.7 mtm . . . . . 0 CA--C 1.575 1.921 0 CA-C-O 118.559 -0.734 . . . . 0.0 112.633 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -72.28 -99.07 0.01 OUTLIER 'Trans proline' 0 CA--C 1.575 2.555 0 C-N-CA 122.906 2.404 . . . . 0.0 114.877 179.114 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -152.77 164.56 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 -178.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -87.85 104.67 16.81 Favored 'General case' 0 CA--C 1.567 1.612 0 O-C-N 119.89 -1.756 . . . . 0.0 111.308 167.225 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -88.73 3.52 50.59 Favored 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 115.808 1.781 . . . . 0.0 115.808 171.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 62.8 m-80 -65.22 114.63 4.83 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 120.93 1.695 . . . . 0.0 113.426 -178.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 168.33 169.04 31.28 Favored Glycine 0 N--CA 1.483 1.767 0 N-CA-C 116.113 1.205 . . . . 0.0 116.113 -176.391 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -103.19 128.07 50.29 Favored 'General case' 0 CA--C 1.565 1.52 0 CA-C-N 114.125 -1.037 . . . . 0.0 109.251 169.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 63.1 m95 -125.31 128.54 48.38 Favored 'General case' 0 CA--C 1.568 1.65 0 C-N-CA 123.663 0.785 . . . . 0.0 109.361 -170.554 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -92.73 147.5 22.81 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.753 -1.217 . . . . 0.0 112.831 171.297 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.412 ' SD ' ' HD2' ' A' ' 38' ' ' PRO . 42.7 ttm -72.64 130.52 40.76 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.723 -1.235 . . . . 0.0 112.528 171.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 83.3 mt -89.08 -53.24 4.67 Favored 'General case' 0 CA--C 1.568 1.636 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.622 163.372 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 87.3 p -140.4 151.67 45.12 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-N 119.175 0.898 . . . . 0.0 112.784 -176.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -128.75 112.71 14.48 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.744 -0.597 . . . . 0.0 110.21 166.002 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -110.91 122.93 49.11 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.911 0.885 . . . . 0.0 109.252 -172.843 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.263 27.1 t30 65.36 25.33 12.07 Favored 'General case' 0 N--CA 1.503 2.222 0 N-CA-C 116.901 2.186 . . . . 0.0 116.901 -175.358 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -68.09 -41.43 81.85 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 115.925 1.824 . . . . 0.0 115.925 178.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -58.52 -40.54 83.21 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 116.213 1.931 . . . . 0.0 116.213 170.303 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -69.63 -40.8 76.32 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 115.031 1.493 . . . . 0.0 115.031 174.739 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -51.39 -52.18 48.1 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 114.79 1.404 . . . . 0.0 114.79 161.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 75.0 mt -61.25 -40.46 94.15 Favored 'General case' 0 CA--C 1.573 1.851 0 N-CA-C 115.045 1.498 . . . . 0.0 115.045 172.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 45.7 ttp180 -53.95 -50.17 67.07 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 115.366 1.617 . . . . 0.0 115.366 164.34 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.63 -22.92 48.37 Favored 'General case' 0 CA--C 1.568 1.639 0 N-CA-C 118.172 2.656 . . . . 0.0 118.172 166.733 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 93.5 mt -85.83 11.84 10.37 Favored 'General case' 0 CA--C 1.574 1.88 0 N-CA-C 115.88 1.807 . . . . 0.0 115.88 165.02 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 60.69 35.82 19.67 Favored 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 115.951 1.834 . . . . 0.0 115.951 -172.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 97.5 t -96.44 138.62 21.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 120.797 -1.189 . . . . 0.0 109.119 -177.184 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 7.8 p-10 -67.01 154.35 41.41 Favored 'General case' 0 CA--C 1.567 1.615 0 N-CA-C 115.752 1.76 . . . . 0.0 115.752 -178.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 87.8 t -53.34 -43.65 51.93 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.349 0 N-CA-C 115.502 1.667 . . . . 0.0 115.502 -177.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.95 -47.36 83.14 Favored 'General case' 0 CA--C 1.567 1.608 0 N-CA-C 116.264 1.95 . . . . 0.0 116.264 172.109 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 31.2 tp -75.77 -26.32 57.26 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 116.477 2.028 . . . . 0.0 116.477 171.493 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 77.4 mtp180 -54.05 -52.65 60.2 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-N 120.695 1.589 . . . . 0.0 114.092 158.09 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 30.9 mmtp -63.38 -51.17 66.99 Favored 'General case' 0 CA--C 1.568 1.637 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 170.145 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 15.3 mt -78.42 60.98 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.408 0 CA-C-O 123.63 1.681 . . . . 0.0 111.166 178.012 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -177.07 -56.98 0.01 OUTLIER 'General case' 0 CA--C 1.562 1.429 0 C-N-CA 126.735 2.014 . . . . 0.0 109.139 -174.461 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -57.74 -42.69 84.46 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 116.504 2.038 . . . . 0.0 116.504 161.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 74.1 mt -79.31 -19.74 49.64 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 116.067 1.877 . . . . 0.0 116.067 -177.719 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.0 pp -101.91 141.91 34.03 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 118.988 0.813 . . . . 0.0 111.522 171.523 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 7.0 mtmp? -102.38 100.65 16.29 Favored Pre-proline 0 CA--C 1.572 1.811 0 CA-C-O 117.878 -1.058 . . . . 0.0 110.37 -177.144 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.412 ' HD2' ' SD ' ' A' ' 10' ' ' MET . 73.6 Cg_endo -75.76 170.18 20.72 Favored 'Trans proline' 0 CA--C 1.566 2.11 0 CA-C-N 122.85 2.054 . . . . 0.0 116.857 -175.09 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -102.52 154.45 19.09 Favored 'General case' 0 CA--C 1.566 1.558 0 CA-C-N 113.983 -1.462 . . . . 0.0 109.988 176.353 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 21.8 mtpp -128.46 114.06 16.31 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.807 -1.183 . . . . 0.0 109.227 171.502 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -102.1 103.56 14.14 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 169.683 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 73.1 mt -98.24 124.72 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 -177.126 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.466 HG23 HH12 ' A' ' 52' ' ' ARG . 36.6 t -108.57 111.95 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 164.31 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -99.5 101.55 12.82 Favored 'General case' 0 CA--C 1.566 1.561 0 C-N-CA 123.943 0.897 . . . . 0.0 109.117 172.406 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -121.36 76.39 1.24 Allowed 'General case' 0 CA--C 1.567 1.627 0 C-N-CA 123.219 0.608 . . . . 0.0 111.409 -174.129 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 57.1 67.23 2.33 Favored Glycine 0 N--CA 1.497 2.723 0 N-CA-C 117.672 1.829 . . . . 0.0 117.672 171.477 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.488 0.0 OUTLIER 77.81 -43.53 0.4 Allowed 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 116.209 1.929 . . . . 0.0 116.209 -163.204 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 21.1 t-160 -73.56 109.26 6.93 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-N 120.797 1.635 . . . . 0.0 111.168 176.32 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 2.9 tpp -114.64 124.99 53.24 Favored 'General case' 0 CA--C 1.555 1.171 0 CA-C-O 122.045 0.926 . . . . 0.0 110.111 178.43 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 19.3 mt -108.63 103.86 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 N-CA-C 105.407 -2.072 . . . . 0.0 105.407 174.734 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 90.0 mt -93.41 95.16 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 172.693 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.466 HH12 HG23 ' A' ' 43' ' ' VAL . 63.1 mtt85 -82.68 94.66 7.62 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.345 -0.847 . . . . 0.0 110.003 177.02 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 34.1 m -84.8 109.29 17.97 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.137 -1.061 . . . . 0.0 108.137 172.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 15.3 mt -116.66 107.66 14.97 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 -164.723 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 36.7 p -116.45 155.5 28.47 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.349 0.66 . . . . 0.0 111.314 -173.306 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.3 t -68.35 4.16 1.43 Allowed 'General case' 0 CA--C 1.581 2.149 0 N-CA-C 117.992 2.59 . . . . 0.0 117.992 167.045 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -104.13 -58.86 1.82 Allowed 'General case' 0 CA--C 1.568 1.671 0 CA-C-N 119.619 1.099 . . . . 0.0 111.836 163.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 11.8 ptm180 -140.02 160.62 39.52 Favored 'General case' 0 CA--C 1.568 1.665 0 CA-C-O 122.56 1.172 . . . . 0.0 114.026 175.43 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -82.49 128.55 34.38 Favored 'General case' 0 CA--C 1.568 1.652 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.333 160.826 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -95.97 -66.91 0.88 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.592 -0.692 . . . . 0.0 110.92 178.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.359 58.6 mt 69.76 91.35 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 C-N-CA 124.563 1.145 . . . . 0.0 112.893 170.215 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 75.9 mtp -91.57 96.57 10.55 Favored 'General case' 0 CA--C 1.565 1.55 0 O-C-N 121.544 -0.723 . . . . 0.0 109.276 173.058 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -96.89 113.38 24.92 Favored 'General case' 0 CA--C 1.564 1.517 0 C-N-CA 123.893 0.877 . . . . 0.0 110.108 178.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -153.98 156.15 36.9 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -171.17 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 11.5 mp0 -91.62 126.27 36.65 Favored 'General case' 0 CA--C 1.564 1.505 0 O-C-N 121.403 -0.811 . . . . 0.0 110.286 163.401 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 41.5 t -67.41 114.69 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 C-N-CA 124.194 0.998 . . . . 0.0 109.381 174.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 119.88 -47.69 1.01 Allowed Glycine 0 N--CA 1.489 2.172 0 N-CA-C 115.58 0.992 . . . . 0.0 115.58 -160.183 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 85.1 mttt -79.75 141.01 36.72 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-N 118.743 1.272 . . . . 0.0 113.53 -173.615 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 55.4 tt0 -100.83 100.79 11.49 Favored 'General case' 0 CA--C 1.565 1.532 0 C-N-CA 123.275 0.63 . . . . 0.0 111.164 -178.7 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -105.96 144.53 32.55 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 -168.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -73.43 103.69 4.17 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.691 -1.255 . . . . 0.0 111.735 173.51 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -85.41 66.1 9.52 Favored 'General case' 0 CA--C 1.571 1.767 0 N-CA-C 114.534 1.309 . . . . 0.0 114.534 -170.747 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -77.37 -52.19 9.57 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 115.176 1.547 . . . . 0.0 115.176 -177.422 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 93.7 mt -81.2 -162.31 0.49 Allowed 'General case' 0 CA--C 1.576 1.953 0 CA-C-N 119.591 1.087 . . . . 0.0 111.907 177.088 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . 0.381 22.6 m 67.91 37.48 3.09 Favored 'General case' 0 N--CA 1.507 2.407 0 N-CA-C 115.489 1.663 . . . . 0.0 115.489 178.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 62.9 -128.25 39.91 Favored Glycine 0 N--CA 1.489 2.224 0 O-C-N 120.204 -1.56 . . . . 0.0 116.25 175.14 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . 0.513 0.0 OUTLIER 58.32 -83.84 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 N-CA-C 115.82 1.785 . . . . 0.0 115.82 171.169 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -158.37 99.21 1.6 Allowed 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 105.041 -2.207 . . . . 0.0 105.041 170.211 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -74.65 83.85 2.08 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 115.021 1.489 . . . . 0.0 115.021 -160.153 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 86.6 mtt-85 -145.34 149.04 34.07 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 124.615 1.166 . . . . 0.0 108.73 -171.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 57.2 mtmt -74.44 73.91 1.9 Allowed 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.362 -1.461 . . . . 0.0 114.362 -177.42 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 88.2 m -94.54 126.59 39.92 Favored 'General case' 0 CA--C 1.556 1.187 0 O-C-N 121.446 -0.784 . . . . 0.0 111.134 -179.6 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 87.7 mmm -73.08 101.55 3.3 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-O 121.878 0.847 . . . . 0.0 110.751 -172.179 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 92.2 m -109.16 107.1 17.26 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.535 -158.68 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 64.6 m -92.8 128.68 38.75 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 172.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 18.2 t -112.55 130.67 65.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 167.629 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 39.5 m -150.74 155.89 40.19 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.589 -1.319 . . . . 0.0 112.853 -175.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 55.8 m95 -86.24 122.47 30.27 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.836 -1.165 . . . . 0.0 113.601 -175.046 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -102.54 67.03 0.99 Allowed 'General case' 0 CA--C 1.574 1.897 0 C-N-CA 123.286 0.634 . . . . 0.0 109.646 157.106 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 60.87 -104.17 0.62 Allowed Glycine 0 N--CA 1.492 2.387 0 N-CA-C 115.825 1.09 . . . . 0.0 115.825 -175.759 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -72.46 -27.78 62.52 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 116.357 1.984 . . . . 0.0 116.357 168.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -91.08 115.23 27.85 Favored 'General case' 0 N--CA 1.485 1.294 0 CA-C-N 119.505 1.048 . . . . 0.0 111.301 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 31.4 tp -80.22 110.38 15.59 Favored 'General case' 0 CA--C 1.565 1.555 0 O-C-N 121.401 -0.812 . . . . 0.0 109.207 167.022 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 30.4 mm-40 -101.07 126.05 47.73 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.713 0.805 . . . . 0.0 110.884 -170.74 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 40.4 t -118.05 128.9 55.21 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.592 0.757 . . . . 0.0 111.058 176.758 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.6 p -120.67 118.45 56.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 172.53 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 63.4 mt-30 -103.21 95.47 6.13 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 123.919 0.887 . . . . 0.0 109.339 -175.475 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 81.4 mttt -85.23 119.98 26.21 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.749 -1.22 . . . . 0.0 112.373 -168.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 176.51 -101.55 0.16 Allowed Glycine 0 N--CA 1.486 2.004 0 O-C-N 121.458 -0.776 . . . . 0.0 114.0 170.629 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -86.99 -59.35 2.28 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 -173.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 12.3 mptt -75.26 129.81 38.06 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 122.551 1.167 . . . . 0.0 110.945 -179.068 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 -76.47 -38.16 55.79 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 116.659 2.096 . . . . 0.0 116.659 -157.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -106.18 56.25 0.51 Allowed Glycine 0 N--CA 1.49 2.249 0 CA-C-N 119.258 0.936 . . . . 0.0 114.81 162.205 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 35.9 ttt180 -87.44 122.06 30.68 Favored 'General case' 0 CA--C 1.567 1.597 0 CA-C-N 118.364 1.082 . . . . 0.0 112.573 -177.185 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 172.9 -167.1 39.87 Favored Glycine 0 CA--C 1.546 2.019 0 N-CA-C 114.991 0.757 . . . . 0.0 114.991 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . 0.254 34.7 p-90 -155.26 156.03 34.86 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 113.888 1.069 . . . . 0.0 113.888 170.854 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 91.1 m -127.74 118.43 23.77 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 176.03 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -122.66 121.23 35.9 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.743 -0.598 . . . . 0.0 111.728 -174.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 21.9 p90 -134.45 165.74 24.47 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.347 -0.846 . . . . 0.0 113.138 178.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 95.4 mt -110.12 132.55 58.12 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.135 -0.978 . . . . 0.0 109.819 175.44 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -114.47 91.98 3.81 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 123.979 0.912 . . . . 0.0 108.878 168.248 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 71.67 -106.49 1.92 Allowed Glycine 0 N--CA 1.491 2.328 0 O-C-N 121.463 -0.773 . . . . 0.0 114.732 -177.518 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -108.06 32.76 4.53 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 115.111 1.523 . . . . 0.0 115.111 165.106 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -129.33 131.46 46.9 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-N 119.073 0.851 . . . . 0.0 110.345 178.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 12.9 tp -95.83 122.08 38.23 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 121.675 0.75 . . . . 0.0 109.531 175.645 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 41.0 m80 -111.28 117.31 32.8 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -174.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 42.4 tp -119.81 118.71 31.54 Favored 'General case' 0 CA--C 1.561 1.399 0 C-N-CA 123.764 0.826 . . . . 0.0 110.051 -172.263 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -106.57 107.72 18.86 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.68 -0.638 . . . . 0.0 109.603 171.364 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 72.9 mtm -99.58 129.92 45.78 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 123.035 0.534 . . . . 0.0 111.072 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 73.4 mtp85 -117.68 141.85 47.91 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.548 -0.72 . . . . 0.0 112.515 -172.205 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -151.23 133.47 15.31 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 123.187 0.595 . . . . 0.0 111.274 165.122 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 59.3 20.82 9.01 Favored 'General case' 0 N--CA 1.509 2.484 0 N-CA-C 116.373 1.99 . . . . 0.0 116.373 -173.782 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 86.91 -18.61 34.42 Favored Glycine 0 CA--C 1.557 2.715 0 N-CA-C 119.018 2.367 . . . . 0.0 119.018 -159.78 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 87.4 t -81.31 121.27 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 CA-C-N 119.498 1.649 . . . . 0.0 109.869 -174.378 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 25.0 m -101.75 126.03 48.53 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.217 0.532 . . . . 0.0 111.812 -177.057 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 7.7 t -95.59 125.64 40.32 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.885 0.874 . . . . 0.0 110.919 162.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 51.7 mtpt -105.5 113.25 26.72 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 123.123 0.569 . . . . 0.0 109.815 -177.399 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 -114.28 136.56 52.83 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.516 -0.74 . . . . 0.0 111.652 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 62.6 t -116.98 130.31 72.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 178.101 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -124.78 149.87 46.91 Favored 'General case' 0 CA--C 1.565 1.536 0 C-N-CA 124.536 1.134 . . . . 0.0 110.696 -179.154 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 25.8 ttmt -119.7 141.95 48.93 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.028 -1.045 . . . . 0.0 112.293 175.214 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 36.5 tttm -74.68 128.56 35.84 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -177.686 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 29.2 m -111.73 -33.74 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 178.177 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 49.1 t-80 . . . . . 0 N--CA 1.485 1.292 0 CA-C-N 120.569 1.531 . . . . 0.0 109.112 174.215 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 59.8 mtt . . . . . 0 CA--C 1.569 1.675 0 CA-C-O 118.508 -0.758 . . . . 0.0 111.936 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_endo -67.72 128.82 18.63 Favored 'Trans proline' 0 CA--C 1.56 1.796 0 C-N-CA 122.467 2.112 . . . . 0.0 115.017 171.357 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 27.5 t -97.56 -98.31 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.57 1.712 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 -171.429 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -152.1 79.15 1.25 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.809 -1.182 . . . . 0.0 108.052 160.014 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -74.46 -11.34 60.21 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 116.514 2.042 . . . . 0.0 116.514 179.37 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -61.83 108.56 1.04 Allowed 'General case' 0 CA--C 1.563 1.473 0 C-N-CA 125.813 1.645 . . . . 0.0 114.02 -178.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 163.2 -179.27 38.48 Favored Glycine 0 N--CA 1.483 1.802 0 N-CA-C 116.453 1.341 . . . . 0.0 116.453 -179.059 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -106.92 128.3 54.19 Favored 'General case' 0 CA--C 1.564 1.505 0 CA-C-N 114.035 -1.082 . . . . 0.0 109.234 171.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 73.4 m95 -122.14 143.53 49.49 Favored 'General case' 0 CA--C 1.572 1.808 0 C-N-CA 123.964 0.905 . . . . 0.0 110.102 -169.27 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -111.67 140.39 46.34 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.035 -1.041 . . . . 0.0 112.306 173.691 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 50.0 ttm -72.08 125.11 26.45 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.099 -1.001 . . . . 0.0 112.93 176.555 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 86.4 mt -82.62 -47.87 11.59 Favored 'General case' 0 CA--C 1.567 1.609 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 166.513 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 80.0 p -148.74 147.96 29.44 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 123.496 0.718 . . . . 0.0 112.242 177.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -120.57 105.8 11.16 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 123.133 0.573 . . . . 0.0 109.535 164.299 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -101.44 125.48 48.08 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.418 -0.801 . . . . 0.0 109.911 -177.283 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.273 19.5 t30 64.89 18.91 11.69 Favored 'General case' 0 CA--C 1.583 2.213 0 N-CA-C 117.515 2.413 . . . . 0.0 117.515 -177.588 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -65.28 -47.85 75.22 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 115.516 1.673 . . . . 0.0 115.516 176.82 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -56.72 -35.32 68.42 Favored 'General case' 0 CA--C 1.576 1.97 0 N-CA-C 117.211 2.3 . . . . 0.0 117.211 172.22 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -68.4 -46.92 68.67 Favored 'General case' 0 CA--C 1.573 1.834 0 N-CA-C 114.79 1.404 . . . . 0.0 114.79 166.363 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -52.25 -46.98 66.0 Favored 'General case' 0 N--CA 1.501 2.088 0 N-CA-C 115.369 1.618 . . . . 0.0 115.369 167.579 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 93.1 mt -61.9 -39.86 93.43 Favored 'General case' 0 CA--C 1.573 1.864 0 N-CA-C 115.061 1.504 . . . . 0.0 115.061 170.714 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 67.4 ttp85 -56.87 -48.48 78.02 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 115.241 1.571 . . . . 0.0 115.241 164.312 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.2 -19.15 12.5 Favored 'General case' 0 CA--C 1.569 1.706 0 N-CA-C 118.21 2.671 . . . . 0.0 118.21 167.391 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 84.5 mt -95.22 3.71 54.31 Favored 'General case' 0 CA--C 1.569 1.694 0 N-CA-C 116.078 1.881 . . . . 0.0 116.078 167.262 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 58.49 46.17 15.39 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 115.452 1.649 . . . . 0.0 115.452 -169.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 70.0 t -90.3 143.07 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.322 -0.861 . . . . 0.0 109.259 178.372 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -60.3 145.57 47.12 Favored 'General case' 0 CA--C 1.569 1.681 0 N-CA-C 115.556 1.687 . . . . 0.0 115.556 -176.133 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . 0.272 91.9 t -60.27 -36.01 65.84 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.168 0 N-CA-C 115.137 1.532 . . . . 0.0 115.137 -176.691 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.27 -55.03 38.33 Favored 'General case' 0 CA--C 1.566 1.584 0 N-CA-C 115.889 1.811 . . . . 0.0 115.889 167.256 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 5.5 tt -65.27 -39.6 92.82 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 115.565 1.691 . . . . 0.0 115.565 171.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 37.7 mtp-105 -46.84 -41.6 15.9 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 117.208 2.299 . . . . 0.0 117.208 165.239 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -74.67 -54.84 6.65 Favored 'General case' 0 CA--C 1.567 1.608 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 164.648 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 4.8 mt -80.89 60.78 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.585 2.296 0 CA-C-N 120.395 1.452 . . . . 0.0 111.61 -176.683 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -176.03 -51.71 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 126.392 1.877 . . . . 0.0 110.157 -176.474 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -63.23 -41.25 99.07 Favored 'General case' 0 CA--C 1.568 1.651 0 N-CA-C 115.76 1.763 . . . . 0.0 115.76 161.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 84.0 mt -75.03 -28.93 60.65 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 115.792 1.775 . . . . 0.0 115.792 178.684 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . 0.259 3.1 pp -91.0 152.12 20.8 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 119.462 1.028 . . . . 0.0 112.24 170.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 29.6 mmtp -108.23 91.71 8.52 Favored Pre-proline 0 CA--C 1.572 1.821 0 CA-C-O 118.064 -0.969 . . . . 0.0 109.341 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -77.22 175.73 10.98 Favored 'Trans proline' 0 CA--C 1.563 1.931 0 C-N-CA 122.384 2.056 . . . . 0.0 116.317 -172.772 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -107.92 155.87 19.83 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 114.985 -1.007 . . . . 0.0 112.392 178.742 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 40.9 mttp -121.02 119.64 33.09 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.663 -0.648 . . . . 0.0 109.382 169.352 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -96.73 111.01 23.35 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.463 -0.939 . . . . 0.0 108.463 162.729 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 74.3 mt -106.81 122.38 60.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 92.9 t -103.92 104.48 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 167.706 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -112.52 97.57 6.68 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 123.562 0.745 . . . . 0.0 111.159 -176.491 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -96.58 69.32 2.54 Favored 'General case' 0 CA--C 1.567 1.634 0 O-C-N 120.88 -1.138 . . . . 0.0 110.766 172.651 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 64.45 -89.7 0.09 OUTLIER Glycine 0 N--CA 1.491 2.328 0 N-CA-C 116.169 1.227 . . . . 0.0 116.169 -178.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.8 p30 -81.84 -39.77 23.46 Favored 'General case' 0 CA--C 1.566 1.573 0 N-CA-C 115.91 1.819 . . . . 0.0 115.91 166.764 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -80.3 121.74 26.04 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 121.055 1.752 . . . . 0.0 111.893 -178.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 42.2 ttm -130.29 128.48 41.64 Favored 'General case' 0 CA--C 1.556 1.198 0 CA-C-O 121.597 0.713 . . . . 0.0 111.362 -177.379 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 46.7 mt -113.56 103.37 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 170.707 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 64.7 mt -92.88 98.8 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 174.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -86.46 98.89 11.28 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.333 -0.854 . . . . 0.0 109.967 174.399 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 31.9 m -83.57 109.91 17.8 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 172.075 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 53.5 mt -114.79 118.96 35.04 Favored 'General case' 0 CA--C 1.559 1.302 0 C-N-CA 124.005 0.922 . . . . 0.0 109.725 -164.477 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 9.7 p -133.62 155.42 49.71 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.256 0.55 . . . . 0.0 111.923 177.404 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 26.1 m -80.86 59.29 3.67 Favored 'General case' 0 N--CA 1.505 2.3 0 O-C-N 120.726 -1.234 . . . . 0.0 112.197 169.76 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -172.42 -64.53 0.02 OUTLIER 'General case' 0 CA--C 1.568 1.654 0 C-N-CA 125.509 1.524 . . . . 0.0 109.25 -179.64 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 65.5 ttt180 -138.93 140.3 38.26 Favored 'General case' 0 CA--C 1.568 1.639 0 CA-C-N 118.965 0.802 . . . . 0.0 110.81 175.43 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -110.28 137.7 47.65 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 123.338 0.655 . . . . 0.0 110.487 174.31 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -91.41 -74.92 0.49 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.657 -0.652 . . . . 0.0 111.375 178.545 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.363 54.3 mt 75.87 93.45 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 C-N-CA 124.368 1.067 . . . . 0.0 110.664 -177.207 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 81.1 mtp -100.29 99.56 10.24 Favored 'General case' 0 CA--C 1.561 1.37 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 174.222 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -101.32 113.35 26.34 Favored 'General case' 0 CA--C 1.565 1.52 0 C-N-CA 124.123 0.969 . . . . 0.0 111.614 178.112 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -157.77 158.32 35.04 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.154 -0.966 . . . . 0.0 113.224 -166.346 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 30.5 tt0 -95.38 130.6 42.11 Favored 'General case' 0 CA--C 1.564 1.485 0 O-C-N 121.123 -0.986 . . . . 0.0 110.822 160.58 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.3 t -65.25 117.31 5.64 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.813 0 C-N-CA 124.12 0.968 . . . . 0.0 109.535 170.684 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 115.25 -46.6 1.14 Allowed Glycine 0 CA--C 1.551 2.313 0 N-CA-C 115.667 1.027 . . . . 0.0 115.667 -159.433 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -82.77 154.49 24.73 Favored 'General case' 0 CA--C 1.567 1.633 0 CA-C-N 118.662 1.231 . . . . 0.0 113.729 -179.621 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -99.3 130.86 45.62 Favored 'General case' 0 CA--C 1.57 1.736 0 CA-C-O 121.928 0.871 . . . . 0.0 112.268 175.094 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -68.8 157.49 36.34 Favored 'General case' 0 CA--C 1.57 1.716 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 168.65 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -105.64 108.99 20.8 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.258 -0.901 . . . . 0.0 108.578 132.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -79.93 86.76 5.41 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.832 -1.167 . . . . 0.0 110.325 172.447 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -66.77 -63.69 1.01 Allowed 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 -171.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 95.4 mt -139.83 153.08 46.98 Favored 'General case' 0 CA--C 1.568 1.657 0 CA-C-N 118.894 0.77 . . . . 0.0 111.02 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . 0.298 22.5 m 84.85 118.59 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.116 0 C-N-CA 124.614 1.165 . . . . 0.0 113.39 166.323 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 151.8 -97.72 0.18 Allowed Glycine 0 N--CA 1.486 2.005 0 O-C-N 121.77 -0.581 . . . . 0.0 112.301 169.297 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 17.0 mm -129.05 -67.39 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 163.814 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . 0.264 33.8 p30 -51.36 -63.54 1.1 Allowed 'General case' 0 CA--C 1.564 1.503 0 N-CA-C 118.593 2.812 . . . . 0.0 118.593 -175.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.3 t70 70.17 153.93 0.12 Allowed 'General case' 0 CA--C 1.577 1.995 0 N-CA-C 114.853 1.427 . . . . 0.0 114.853 173.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . 0.304 0.9 OUTLIER 73.17 64.86 0.1 Allowed 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 174.183 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 47.9 mtmt 54.2 61.29 3.11 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 116.506 2.039 . . . . 0.0 116.506 169.662 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 44.9 m -80.84 125.7 30.42 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.141 -0.975 . . . . 0.0 111.175 174.53 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 4.9 mmt -75.32 74.51 2.42 Favored 'General case' 0 CA--C 1.567 1.62 0 CA-C-O 122.345 1.069 . . . . 0.0 111.241 169.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 100.0 m -93.0 130.21 38.65 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.03 -1.044 . . . . 0.0 109.824 -167.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 91.1 m -123.09 134.14 54.26 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 -178.742 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 16.1 t -120.64 138.23 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 178.446 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 59.2 m -147.57 150.8 35.16 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.215 -1.553 . . . . 0.0 113.056 -177.038 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 75.3 m95 -81.85 126.53 31.99 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.04 -1.037 . . . . 0.0 111.808 176.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -106.5 -21.67 13.0 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 118.145 2.646 . . . . 0.0 118.145 -167.429 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 159.8 -70.77 0.24 Allowed Glycine 0 N--CA 1.493 2.46 0 CA-C-N 121.296 1.862 . . . . 0.0 112.982 -172.64 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 34.4 m-20 -126.28 32.04 5.29 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 148.321 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -141.44 146.94 37.13 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.453 -1.404 . . . . 0.0 110.525 -165.406 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 35.8 tp -100.08 108.02 20.07 Favored 'General case' 0 CA--C 1.561 1.402 0 O-C-N 121.256 -0.903 . . . . 0.0 109.258 172.203 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 43.5 mm-40 -93.42 131.25 38.78 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 123.205 0.602 . . . . 0.0 111.535 -179.502 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 39.5 t -123.12 133.1 54.3 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.663 0.785 . . . . 0.0 111.063 173.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.2 p -115.4 127.41 72.98 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.683 0 C-N-CA 123.33 0.652 . . . . 0.0 109.343 169.156 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -105.6 91.32 3.71 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 124.096 0.958 . . . . 0.0 109.482 -176.357 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -90.35 126.51 35.89 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.753 -1.217 . . . . 0.0 112.035 -168.531 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 165.65 -95.16 0.12 Allowed Glycine 0 N--CA 1.489 2.167 0 O-C-N 121.017 -1.052 . . . . 0.0 114.122 172.108 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -75.05 -48.32 24.57 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 115.7 1.741 . . . . 0.0 115.7 -173.47 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 43.6 mttp -115.88 151.47 35.25 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 122.488 1.137 . . . . 0.0 113.908 -168.645 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -75.68 153.52 37.09 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 54.44 36.32 57.89 Favored Glycine 0 N--CA 1.5 2.954 0 N-CA-C 119.949 2.74 . . . . 0.0 119.949 -178.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 32.3 ttt180 -100.53 116.06 31.59 Favored 'General case' 0 CA--C 1.563 1.45 0 C-N-CA 123.861 0.864 . . . . 0.0 111.177 -164.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 178.25 -170.64 42.84 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 115.336 0.894 . . . . 0.0 115.336 -178.493 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 37.3 p-90 -154.02 151.93 29.93 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 174.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 91.1 m -121.07 121.06 37.1 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.364 -0.835 . . . . 0.0 109.299 173.435 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -120.8 129.42 53.57 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 123.205 0.602 . . . . 0.0 112.087 -177.319 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 19.7 p90 -142.96 172.68 12.37 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.995 -1.066 . . . . 0.0 112.836 178.345 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 72.0 mt -119.86 132.04 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 O-C-N 121.07 -1.019 . . . . 0.0 109.989 175.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -110.19 89.74 3.11 Favored 'General case' 0 CA--C 1.567 1.611 0 C-N-CA 123.847 0.859 . . . . 0.0 108.77 165.387 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 68.6 -106.99 1.91 Allowed Glycine 0 N--CA 1.492 2.431 0 N-CA-C 115.75 1.06 . . . . 0.0 115.75 179.446 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 23.4 p-10 -87.79 0.31 55.94 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 117.248 2.314 . . . . 0.0 117.248 167.685 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -113.13 132.55 55.41 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-N 120.148 1.34 . . . . 0.0 112.116 -173.565 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 12.3 tp -93.98 124.71 38.17 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 123.726 0.811 . . . . 0.0 109.667 171.046 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 41.4 m80 -114.52 120.96 42.0 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 123.618 0.767 . . . . 0.0 109.078 -176.153 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 38.9 tp -122.99 121.67 36.65 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 123.742 0.817 . . . . 0.0 110.166 -175.765 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -106.35 113.65 27.3 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.601 -0.687 . . . . 0.0 109.957 169.252 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 66.9 mtm -105.94 127.99 53.51 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 123.164 0.586 . . . . 0.0 111.151 -178.703 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 73.4 mtm180 -119.14 134.11 55.39 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 124.064 0.945 . . . . 0.0 110.442 -169.061 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -156.78 129.42 7.64 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.27 -0.894 . . . . 0.0 111.697 170.302 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . 0.283 11.4 mt-10 52.55 44.77 29.67 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 115.843 1.794 . . . . 0.0 115.843 -177.779 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 68.41 12.53 63.81 Favored Glycine 0 CA--C 1.553 2.411 0 N-CA-C 120.713 3.045 . . . . 0.0 120.713 -167.464 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 92.6 t -113.88 124.96 71.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 CA-C-N 120.017 1.909 . . . . 0.0 108.516 -177.733 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 80.8 m -105.0 119.2 38.44 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 123.266 0.626 . . . . 0.0 110.389 179.079 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 12.6 t -88.71 138.13 31.69 Favored 'General case' 0 CA--C 1.56 1.363 0 C-N-CA 123.644 0.778 . . . . 0.0 111.735 161.293 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 48.1 mtpt -115.17 111.21 20.65 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.66 -0.65 . . . . 0.0 109.483 177.135 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -108.08 131.63 54.4 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 123.546 0.738 . . . . 0.0 111.169 176.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 51.6 t -116.58 131.52 68.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 176.15 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -123.08 153.69 39.58 Favored 'General case' 0 CA--C 1.565 1.522 0 C-N-CA 124.724 1.209 . . . . 0.0 110.628 178.784 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 26.6 ttmt -122.34 145.9 47.82 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.952 -1.092 . . . . 0.0 111.999 170.098 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 64.9 tttt -76.07 126.33 30.79 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -176.749 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 34.1 m -104.71 -43.42 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 174.743 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 68.5 t60 . . . . . 0 N--CA 1.486 1.34 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 168.46 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 74.2 mtp . . . . . 0 CA--C 1.573 1.827 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.505 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -62.89 -85.39 0.01 OUTLIER 'Trans proline' 0 CA--C 1.568 2.211 0 N-CA-C 118.475 2.452 . . . . 0.0 118.475 -174.476 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.4 p -178.3 130.34 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 C-N-CA 124.714 1.206 . . . . 0.0 108.92 -174.704 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -83.68 107.16 15.94 Favored 'General case' 0 CA--C 1.565 1.531 0 O-C-N 121.049 -1.032 . . . . 0.0 112.128 170.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -80.73 1.46 30.17 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 117.578 2.436 . . . . 0.0 117.578 175.08 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -55.06 113.42 1.35 Allowed 'General case' 0 CA--C 1.567 1.627 0 N-CA-C 115.756 1.761 . . . . 0.0 115.756 -174.714 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 162.51 177.26 35.38 Favored Glycine 0 N--CA 1.486 2.025 0 N-CA-C 116.184 1.234 . . . . 0.0 116.184 178.191 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -106.16 131.98 52.77 Favored 'General case' 0 CA--C 1.566 1.589 0 CA-C-N 114.388 -0.906 . . . . 0.0 109.312 168.515 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 78.4 m95 -128.06 129.15 46.18 Favored 'General case' 0 CA--C 1.563 1.479 0 C-N-CA 123.945 0.898 . . . . 0.0 109.542 -167.406 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.96 143.72 26.54 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.027 -1.046 . . . . 0.0 112.204 169.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 52.1 ttm -75.59 124.64 27.56 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.874 -1.142 . . . . 0.0 112.302 173.441 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 95.1 mt -82.52 -51.78 7.47 Favored 'General case' 0 CA--C 1.567 1.628 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.473 166.352 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 91.3 p -139.61 144.63 37.81 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-N 118.955 0.798 . . . . 0.0 112.134 177.546 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -118.18 89.56 3.15 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 121.763 0.792 . . . . 0.0 109.145 163.366 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -96.27 121.04 37.63 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.857 0.863 . . . . 0.0 110.081 -167.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.269 27.7 t30 66.59 24.73 10.12 Favored 'General case' 0 N--CA 1.503 2.184 0 N-CA-C 116.651 2.093 . . . . 0.0 116.651 -171.368 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -68.34 -44.54 75.09 Favored 'General case' 0 CA--C 1.569 1.676 0 N-CA-C 115.579 1.696 . . . . 0.0 115.579 178.759 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -53.73 -44.35 69.83 Favored 'General case' 0 N--CA 1.503 2.176 0 N-CA-C 116.632 2.086 . . . . 0.0 116.632 168.011 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -63.25 -44.74 94.3 Favored 'General case' 0 CA--C 1.573 1.858 0 N-CA-C 114.765 1.395 . . . . 0.0 114.765 174.492 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 44.4 t80 -54.48 -50.56 67.48 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 115.0 1.482 . . . . 0.0 115.0 166.029 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 94.2 mt -63.61 -41.38 98.31 Favored 'General case' 0 CA--C 1.571 1.762 0 N-CA-C 115.142 1.534 . . . . 0.0 115.142 174.643 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 71.5 ttp85 -53.4 -50.63 64.74 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 115.173 1.545 . . . . 0.0 115.173 163.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.08 -16.11 17.44 Favored 'General case' 0 CA--C 1.568 1.665 0 N-CA-C 118.591 2.812 . . . . 0.0 118.591 168.252 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 35.4 mt -91.92 -0.66 57.5 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 115.919 1.822 . . . . 0.0 115.919 166.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 62.43 61.64 1.23 Allowed 'General case' 0 N--CA 1.494 1.77 0 CA-C-N 119.98 1.264 . . . . 0.0 113.392 -165.026 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 96.1 t -111.48 136.97 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 N-CA-C 107.767 -1.198 . . . . 0.0 107.767 170.715 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 14.3 p30 -64.02 157.47 25.09 Favored 'General case' 0 CA--C 1.57 1.749 0 N-CA-C 116.094 1.887 . . . . 0.0 116.094 -177.618 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 43.2 t -56.9 -43.87 81.18 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.301 0 N-CA-C 114.753 1.39 . . . . 0.0 114.753 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.63 -50.52 72.86 Favored 'General case' 0 CA--C 1.564 1.518 0 N-CA-C 115.741 1.756 . . . . 0.0 115.741 172.615 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.2 tt -69.9 -37.78 76.11 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 115.092 1.515 . . . . 0.0 115.092 172.813 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 69.9 mtp180 -46.78 -52.87 13.13 Favored 'General case' 0 N--CA 1.502 2.166 0 CA-C-N 121.21 1.823 . . . . 0.0 115.695 161.715 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -65.91 -50.07 65.77 Favored 'General case' 0 CA--C 1.565 1.532 0 N-CA-C 114.004 1.113 . . . . 0.0 114.004 170.466 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 9.8 mt -78.99 58.68 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.586 2.346 0 CA-C-N 120.952 1.705 . . . . 0.0 110.831 175.647 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -174.98 -47.21 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 126.425 1.89 . . . . 0.0 111.131 -178.353 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -76.2 -30.61 58.08 Favored 'General case' 0 CA--C 1.569 1.682 0 N-CA-C 115.794 1.776 . . . . 0.0 115.794 164.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 96.0 mt -76.56 -36.27 57.73 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 114.925 1.454 . . . . 0.0 114.925 177.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -100.2 148.21 24.88 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 118.759 0.709 . . . . 0.0 111.015 170.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 44.5 mmtm -103.09 95.86 7.25 Favored Pre-proline 0 CA--C 1.573 1.854 0 CA-C-O 117.707 -1.14 . . . . 0.0 110.105 -171.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -73.52 158.49 47.66 Favored 'Trans proline' 0 CA--C 1.564 1.998 0 CA-C-N 123.158 2.164 . . . . 0.0 115.898 -176.062 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -90.78 160.55 15.72 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-N 115.714 -0.675 . . . . 0.0 112.21 178.755 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 30.4 mttp -120.96 121.28 37.68 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.018 -1.052 . . . . 0.0 110.016 170.645 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -103.37 105.66 15.99 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 164.696 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 76.0 mt -97.85 116.83 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 87.0 t -102.12 93.79 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 173.017 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -93.12 94.13 8.67 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 123.163 0.585 . . . . 0.0 109.712 175.482 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -101.81 73.93 1.45 Allowed 'General case' 0 CA--C 1.566 1.594 0 O-C-N 121.632 -0.668 . . . . 0.0 110.877 -178.245 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 57.4 71.49 0.74 Allowed Glycine 0 N--CA 1.494 2.506 0 N-CA-C 116.909 1.524 . . . . 0.0 116.909 179.32 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.471 0.4 OUTLIER 70.2 -30.37 0.2 Allowed 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 118.257 2.688 . . . . 0.0 118.257 -166.499 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 21.9 t-160 -76.42 99.42 4.87 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-N 120.937 1.699 . . . . 0.0 110.543 170.089 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 3.8 ttp -116.7 119.06 34.28 Favored 'General case' 0 CA--C 1.552 1.054 0 CA-C-O 121.917 0.865 . . . . 0.0 110.08 -169.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 5.2 mp -107.02 106.91 21.52 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.422 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 -178.366 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 24.1 mm -88.97 99.58 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 177.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 65.4 mtt-85 -95.07 95.67 8.73 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.498 -0.751 . . . . 0.0 109.591 -179.515 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 16.3 m -82.6 115.87 21.75 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 169.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 45.9 mt -119.65 114.1 21.68 Favored 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 123.665 0.786 . . . . 0.0 109.04 -164.774 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.6 t -102.12 -67.13 0.88 Allowed 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -178.65 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . 0.317 8.8 t 160.47 -61.89 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.165 0 C-N-CA 126.884 2.074 . . . . 0.0 106.821 -171.627 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -77.25 -48.57 17.16 Favored 'General case' 0 CA--C 1.579 2.062 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 161.195 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 3.6 tpm_? -95.02 135.97 35.9 Favored 'General case' 0 CA--C 1.564 1.501 0 CA-C-O 122.434 1.111 . . . . 0.0 113.157 -170.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 47.1 m-80 -121.89 135.51 54.89 Favored 'General case' 0 CA--C 1.568 1.64 0 CA-C-N 114.625 -1.171 . . . . 0.0 108.574 164.317 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 20.6 m-30 -94.25 -61.0 1.6 Allowed 'General case' 0 N--CA 1.504 2.231 0 O-C-N 120.898 -1.126 . . . . 0.0 113.179 171.626 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.282 4.3 mm 64.0 57.21 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.429 0 CA-C-N 119.694 1.133 . . . . 0.0 113.606 175.559 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 66.7 mtp -79.61 104.7 10.39 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.007 -1.683 . . . . 0.0 109.69 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -116.56 108.65 16.24 Favored 'General case' 0 CA--C 1.56 1.354 0 C-N-CA 123.739 0.816 . . . . 0.0 110.807 -162.122 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 20.5 p90 -152.22 145.81 24.95 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -163.381 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 18.7 mp0 -82.46 124.85 30.44 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.333 -0.854 . . . . 0.0 110.332 159.791 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 26.0 t -65.88 121.4 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.57 -0.706 . . . . 0.0 110.581 178.562 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 116.24 -38.85 2.9 Favored Glycine 0 CA--C 1.55 2.26 0 N-CA-C 116.328 1.291 . . . . 0.0 116.328 -160.316 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -80.89 141.64 34.38 Favored 'General case' 0 CA--C 1.567 1.616 0 CA-C-N 119.397 1.599 . . . . 0.0 114.021 -172.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -96.11 102.35 14.14 Favored 'General case' 0 CA--C 1.568 1.641 0 C-N-CA 123.694 0.798 . . . . 0.0 109.896 171.38 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -115.41 146.64 41.42 Favored 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 123.883 0.873 . . . . 0.0 113.153 -169.337 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -70.1 120.77 16.3 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 119.955 -1.716 . . . . 0.0 113.263 171.714 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -78.1 81.0 4.51 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.087 -1.008 . . . . 0.0 110.332 173.334 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -104.48 57.19 0.71 Allowed 'General case' 0 CA--C 1.575 1.923 0 CA-C-O 122.083 0.944 . . . . 0.0 111.59 173.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 6.5 tt -133.97 124.03 25.62 Favored 'General case' 0 CA--C 1.567 1.606 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 175.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 11.3 t -90.88 145.18 24.96 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 121.994 0.902 . . . . 0.0 113.383 -178.147 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 156.31 -61.41 0.35 Allowed Glycine 0 N--CA 1.49 2.295 0 O-C-N 121.637 -0.665 . . . . 0.0 111.629 -170.399 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 48.2 mm -69.06 158.2 6.11 Favored 'Isoleucine or valine' 0 CA--C 1.587 2.379 0 O-C-N 122.557 -0.378 . . . . 0.0 110.117 140.617 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -36.96 -52.06 0.94 Allowed 'General case' 0 N--CA 1.504 2.243 0 N-CA-C 118.335 2.717 . . . . 0.0 118.335 178.487 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.1 t0 74.25 116.43 0.06 Allowed 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 124.571 1.148 . . . . 0.0 113.618 177.311 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 -132.38 54.62 1.93 Allowed 'General case' 0 CA--C 1.571 1.769 0 O-C-N 121.59 -0.694 . . . . 0.0 111.618 158.085 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . 0.258 9.7 mtpm? 43.25 57.47 3.78 Favored 'General case' 0 N--CA 1.503 2.181 0 N-CA-C 116.922 2.193 . . . . 0.0 116.922 -178.872 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 81.2 m -86.3 127.71 34.82 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.43 -0.794 . . . . 0.0 113.036 -164.388 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 4.6 tpt -78.45 104.18 8.88 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-O 122.153 0.978 . . . . 0.0 110.16 -172.206 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 85.7 m -110.43 121.97 46.6 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.926 -155.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 91.7 m -113.44 119.68 38.42 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 -179.22 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.448 HG22 ' SG ' ' A' ' 95' ' ' CYS . 22.0 t -112.19 119.11 59.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 177.772 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 65.3 m -140.54 156.86 46.18 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 122.049 0.928 . . . . 0.0 112.513 -173.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 34.5 m95 -84.52 118.76 24.52 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.043 -1.035 . . . . 0.0 112.908 -178.342 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -99.23 75.25 1.99 Allowed 'General case' 0 CA--C 1.567 1.597 0 C-N-CA 123.494 0.718 . . . . 0.0 109.894 167.647 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 73.19 -104.97 1.66 Allowed Glycine 0 N--CA 1.487 2.092 0 O-C-N 121.544 -0.723 . . . . 0.0 112.7 -174.18 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -92.48 -18.19 23.52 Favored 'General case' 0 CA--C 1.573 1.832 0 N-CA-C 115.469 1.655 . . . . 0.0 115.469 167.271 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 78.7 mttt -91.46 137.59 32.24 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 121.111 1.778 . . . . 0.0 112.07 -174.684 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 22.8 tp -92.25 109.96 21.34 Favored 'General case' 0 CA--C 1.563 1.457 0 O-C-N 121.324 -0.86 . . . . 0.0 110.017 177.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -99.3 125.72 45.0 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.392 0.677 . . . . 0.0 111.411 -175.562 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' CYS . . . . . 0.448 ' SG ' HG22 ' A' ' 86' ' ' VAL . 46.1 t -116.89 131.86 56.85 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.725 0.81 . . . . 0.0 110.803 176.461 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 11.0 p -123.66 123.68 67.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 C-N-CA 122.791 0.437 . . . . 0.0 110.281 169.494 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 69.3 mt-30 -102.57 108.36 19.62 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 124.25 1.02 . . . . 0.0 110.71 -177.66 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -96.65 127.01 42.22 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 -169.45 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 167.62 -110.42 0.39 Allowed Glycine 0 N--CA 1.488 2.146 0 O-C-N 121.419 -0.801 . . . . 0.0 114.189 167.152 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -75.41 -43.16 51.42 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 115.614 1.709 . . . . 0.0 115.614 -176.477 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 37.4 mmtm -83.9 138.56 33.11 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-O 121.935 0.874 . . . . 0.0 112.713 179.062 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -78.77 148.09 33.09 Favored 'General case' 0 CA--C 1.566 1.585 0 CA-C-N 115.663 -0.699 . . . . 0.0 112.096 168.475 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 61.0 23.65 61.87 Favored Glycine 0 N--CA 1.498 2.774 0 N-CA-C 120.85 3.1 . . . . 0.0 120.85 178.439 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 46.5 ttt180 -87.5 118.25 26.84 Favored 'General case' 0 CA--C 1.564 1.498 0 CA-C-N 118.78 1.29 . . . . 0.0 111.792 -175.583 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -178.3 -172.18 42.43 Favored Glycine 0 N--CA 1.486 2.029 0 O-C-N 121.449 -0.782 . . . . 0.0 114.925 -175.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 41.8 p-90 -157.42 151.1 24.12 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 172.437 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 29.3 m -120.47 120.04 34.74 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 123.604 0.761 . . . . 0.0 109.192 173.394 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 22.6 tt0 -119.61 135.08 54.95 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 123.316 0.646 . . . . 0.0 112.489 -176.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 20.8 p90 -152.41 168.98 23.7 Favored 'General case' 0 N--CA 1.497 1.899 0 C-N-CA 123.792 0.837 . . . . 0.0 112.535 177.735 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 63.2 mt -113.65 133.42 59.66 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.168 0 O-C-N 120.557 -1.339 . . . . 0.0 110.119 172.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -107.66 90.36 3.28 Favored 'General case' 0 CA--C 1.566 1.596 0 C-N-CA 123.789 0.836 . . . . 0.0 109.313 164.102 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 70.29 -103.98 1.27 Allowed Glycine 0 N--CA 1.491 2.358 0 N-CA-C 115.388 0.915 . . . . 0.0 115.388 179.288 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 54.1 p30 -95.51 5.17 52.24 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 117.121 2.267 . . . . 0.0 117.121 167.359 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 77.6 mt-10 -115.33 133.96 55.55 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 120.321 1.419 . . . . 0.0 112.295 -176.285 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 11.1 tp -91.73 121.63 33.55 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 123.951 0.9 . . . . 0.0 109.357 173.145 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 39.2 m80 -111.72 119.39 38.47 Favored 'General case' 0 CA--C 1.559 1.3 0 C-N-CA 123.655 0.782 . . . . 0.0 108.939 -176.745 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 37.8 tp -124.8 121.62 35.1 Favored 'General case' 0 CA--C 1.562 1.437 0 C-N-CA 123.885 0.874 . . . . 0.0 109.618 -174.613 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -108.53 104.2 13.48 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 172.446 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 64.5 mtm -98.82 125.2 44.13 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.784 -0.572 . . . . 0.0 111.158 -177.716 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -107.74 142.36 37.86 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 123.443 0.697 . . . . 0.0 112.277 -175.132 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -152.98 124.73 7.81 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-O 121.635 0.731 . . . . 0.0 110.867 164.367 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . 0.311 13.8 mt-10 60.58 31.61 20.26 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 116.654 2.094 . . . . 0.0 116.654 -178.103 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 83.07 -15.21 34.23 Favored Glycine 0 CA--C 1.553 2.451 0 N-CA-C 119.167 2.427 . . . . 0.0 119.167 -162.859 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 86.2 t -86.93 122.97 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 CA-C-N 120.04 1.92 . . . . 0.0 109.516 -176.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 42.8 m -100.56 124.68 46.45 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 121.092 0.472 . . . . 0.0 111.198 176.423 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 16.1 t -89.72 127.48 35.95 Favored 'General case' 0 CA--C 1.559 1.312 0 C-N-CA 123.239 0.616 . . . . 0.0 111.241 160.07 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp -100.48 107.74 19.53 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 175.474 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 66.3 mt-30 -103.49 124.38 48.65 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.105 0.562 . . . . 0.0 110.361 175.516 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 58.1 t -112.08 130.99 64.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 175.683 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -124.65 155.45 39.15 Favored 'General case' 0 CA--C 1.566 1.575 0 C-N-CA 124.685 1.194 . . . . 0.0 110.763 -179.748 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -125.89 141.27 52.06 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.811 -1.18 . . . . 0.0 112.492 174.309 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 43.0 tttm -74.49 125.07 27.78 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 -174.405 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 35.8 m -108.55 -41.76 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 176.52 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 47.2 t-80 . . . . . 0 C--O 1.254 1.331 0 CA-C-N 119.932 1.242 . . . . 0.0 108.966 172.651 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 79.3 mtp . . . . . 0 CA--C 1.573 1.84 0 CA-C-O 118.544 -0.741 . . . . 0.0 112.182 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -74.15 168.45 24.78 Favored 'Trans proline' 0 CA--C 1.564 2.006 0 C-N-CA 122.333 2.022 . . . . 0.0 116.711 176.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 32.8 m -76.83 146.26 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 CA-C-N 115.266 -0.879 . . . . 0.0 112.712 177.262 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -80.94 103.48 10.79 Favored 'General case' 0 CA--C 1.565 1.536 0 O-C-N 120.606 -1.308 . . . . 0.0 111.381 176.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 13.6 m-30 -70.43 -3.43 17.63 Favored 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 117.66 2.466 . . . . 0.0 117.66 172.524 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -46.5 114.28 0.79 Allowed 'General case' 0 CA--C 1.567 1.62 0 N-CA-C 116.575 2.065 . . . . 0.0 116.575 178.117 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 157.18 176.01 28.76 Favored Glycine 0 N--CA 1.487 2.08 0 N-CA-C 116.084 1.193 . . . . 0.0 116.084 -179.213 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -104.6 125.05 50.36 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 121.345 0.593 . . . . 0.0 109.514 172.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 68.5 m95 -123.33 124.66 43.45 Favored 'General case' 0 CA--C 1.568 1.659 0 C-N-CA 123.832 0.853 . . . . 0.0 109.11 -171.126 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 20.7 pttp -102.96 143.09 33.0 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 120.91 -1.119 . . . . 0.0 112.678 179.135 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.409 ' SD ' ' HD2' ' A' ' 38' ' ' PRO . 34.0 ttm -66.77 127.23 31.68 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.791 -1.193 . . . . 0.0 113.959 -179.81 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 93.7 mt -86.46 -55.41 3.9 Favored 'General case' 0 CA--C 1.566 1.595 0 C-N-CA 123.41 0.684 . . . . 0.0 112.467 163.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 88.1 p -139.53 149.5 43.98 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 119.023 0.828 . . . . 0.0 112.759 -177.225 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -124.49 110.88 15.04 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.07 0.548 . . . . 0.0 109.936 164.063 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -109.77 128.16 55.11 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.861 0.864 . . . . 0.0 109.362 -175.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.268 22.6 t30 64.57 23.02 12.79 Favored 'General case' 0 N--CA 1.504 2.229 0 N-CA-C 116.877 2.177 . . . . 0.0 116.877 -176.218 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -66.59 -45.65 78.54 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 115.471 1.656 . . . . 0.0 115.471 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -55.12 -41.42 71.68 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 116.298 1.962 . . . . 0.0 116.298 169.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -67.31 -41.24 85.66 Favored 'General case' 0 CA--C 1.573 1.835 0 N-CA-C 115.528 1.677 . . . . 0.0 115.528 174.011 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -53.98 -51.23 64.57 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 163.359 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.5 mt -63.41 -42.64 98.77 Favored 'General case' 0 CA--C 1.572 1.811 0 N-CA-C 114.641 1.348 . . . . 0.0 114.641 175.049 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 29.7 ttp85 -49.88 -49.65 48.7 Favored 'General case' 0 CA--C 1.575 1.938 0 N-CA-C 115.525 1.676 . . . . 0.0 115.525 161.621 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.04 -24.31 57.84 Favored 'General case' 0 CA--C 1.569 1.678 0 N-CA-C 117.709 2.485 . . . . 0.0 117.709 167.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 88.6 mt -83.52 1.61 41.04 Favored 'General case' 0 CA--C 1.572 1.823 0 N-CA-C 116.172 1.916 . . . . 0.0 116.172 166.25 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.268 20.8 m-20 64.1 48.36 3.02 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 114.834 1.42 . . . . 0.0 114.834 -168.866 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 92.6 t -96.58 142.42 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 CA-C-O 122.218 1.009 . . . . 0.0 109.429 175.292 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 7.5 p-10 -69.7 154.65 41.68 Favored 'General case' 0 CA--C 1.57 1.717 0 N-CA-C 115.305 1.594 . . . . 0.0 115.305 176.169 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 57.7 t -55.55 -41.24 62.96 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.303 0 N-CA-C 115.399 1.629 . . . . 0.0 115.399 -176.424 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.87 -49.42 76.32 Favored 'General case' 0 CA--C 1.567 1.598 0 N-CA-C 116.09 1.885 . . . . 0.0 116.09 173.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -62.02 -43.46 98.79 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 170.014 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 60.4 mtp180 -46.12 -53.59 10.09 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 116.201 1.926 . . . . 0.0 116.201 162.473 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 14.2 tptt -65.37 -47.99 74.49 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 115.603 1.705 . . . . 0.0 115.603 173.652 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 60.9 mt -55.26 -49.7 70.37 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.188 0 CA-C-N 119.806 1.185 . . . . 0.0 113.499 173.535 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.54 -42.05 92.36 Favored 'General case' 0 CA--C 1.565 1.529 0 N-CA-C 117.339 2.348 . . . . 0.0 117.339 173.426 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -59.65 -39.87 85.83 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 116.487 2.032 . . . . 0.0 116.487 168.236 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 89.9 mt -83.06 -16.21 47.88 Favored 'General case' 0 CA--C 1.569 1.681 0 N-CA-C 116.302 1.964 . . . . 0.0 116.302 179.203 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 69.4 mt -85.43 147.94 26.24 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 120.093 1.315 . . . . 0.0 112.342 171.833 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -105.21 87.42 1.99 Allowed Pre-proline 0 CA--C 1.574 1.873 0 CA-C-O 118.154 -0.926 . . . . 0.0 109.489 172.646 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.409 ' HD2' ' SD ' ' A' ' 10' ' ' MET . 60.5 Cg_endo -69.92 174.78 9.14 Favored 'Trans proline' 0 CA--C 1.564 1.992 0 C-N-CA 122.538 2.159 . . . . 0.0 115.423 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -130.36 136.27 48.91 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.545 -1.347 . . . . 0.0 110.806 -176.524 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 50.2 mttp -103.48 111.65 24.2 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.582 -0.699 . . . . 0.0 109.696 174.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -96.84 101.29 12.85 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 166.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 65.3 mt -93.93 119.15 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -173.718 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 75.8 t -109.83 95.32 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 177.37 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -99.31 118.46 36.03 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 123.751 0.82 . . . . 0.0 110.329 178.702 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -133.58 66.38 1.55 Allowed 'General case' 0 CA--C 1.569 1.696 0 O-C-N 121.51 -0.744 . . . . 0.0 111.867 -178.212 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 72.15 81.39 0.34 Allowed Glycine 0 N--CA 1.493 2.448 0 N-CA-C 115.274 0.87 . . . . 0.0 115.274 174.623 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.458 0.2 OUTLIER 65.66 -41.59 0.34 Allowed 'General case' 0 N--CA 1.502 2.141 0 N-CA-C 117.861 2.541 . . . . 0.0 117.861 -167.903 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 14.3 t-80 -70.55 120.47 16.23 Favored 'General case' 0 CA--C 1.562 1.416 0 O-C-N 120.984 -1.073 . . . . 0.0 111.595 168.482 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 17.5 ttp -136.87 125.35 23.52 Favored 'General case' 0 CA--C 1.555 1.163 0 CA-C-O 121.841 0.829 . . . . 0.0 110.522 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 23.0 mt -104.43 107.62 22.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 174.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 83.0 mt -86.67 99.71 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 168.307 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -85.05 93.07 8.52 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.51 -0.744 . . . . 0.0 109.863 -178.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 80.7 m -87.84 102.29 14.55 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 -177.687 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 17.6 mt -105.84 121.22 43.61 Favored 'General case' 0 CA--C 1.557 1.241 0 CA-C-N 114.514 -1.221 . . . . 0.0 109.365 -164.127 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 27.1 t -132.57 143.96 50.07 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.38 0.672 . . . . 0.0 110.528 -178.309 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 21.6 m -56.05 -34.77 66.21 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 116.123 1.898 . . . . 0.0 116.123 175.334 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -79.93 -58.64 3.07 Favored 'General case' 0 CA--C 1.569 1.693 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 175.443 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 11.9 tpt180 -151.7 127.18 10.04 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-N 119.824 1.193 . . . . 0.0 110.887 177.291 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -76.86 145.14 38.53 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 177.302 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -95.92 -67.96 0.82 Allowed 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 118.714 -0.66 . . . . 0.0 112.186 178.567 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.273 11.4 mm 72.52 96.76 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 C-N-CA 124.128 0.971 . . . . 0.0 111.716 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 82.2 mtp -96.25 98.71 10.51 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.02 -1.05 . . . . 0.0 109.568 173.399 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -100.66 110.57 22.7 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 123.659 0.784 . . . . 0.0 110.183 -179.118 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -150.52 157.45 43.02 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 114.527 1.306 . . . . 0.0 114.527 -167.566 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -101.08 138.03 38.65 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.586 -0.696 . . . . 0.0 110.312 160.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 92.5 t -67.77 128.18 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.289 -0.882 . . . . 0.0 110.995 -177.72 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 91.25 -45.7 2.82 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 116.518 1.367 . . . . 0.0 116.518 -165.726 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 16.7 tttp -67.29 122.49 17.99 Favored 'General case' 0 CA--C 1.571 1.78 0 C-N-CA 125.37 1.468 . . . . 0.0 113.051 178.15 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -84.43 114.93 22.26 Favored 'General case' 0 CA--C 1.567 1.6 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.888 -176.206 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -113.17 139.83 48.43 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -169.693 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -76.97 112.67 13.85 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.154 -0.966 . . . . 0.0 112.496 177.12 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -90.88 111.22 22.54 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.232 0.613 . . . . 0.0 110.334 175.541 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -85.12 178.99 7.34 Favored 'General case' 0 CA--C 1.574 1.896 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -178.57 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 5.4 tt -64.49 -26.26 68.35 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 118.653 2.834 . . . . 0.0 118.653 -160.69 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 53.9 m -71.14 90.44 0.88 Allowed 'General case' 0 N--CA 1.499 1.988 0 CA-C-N 120.529 1.513 . . . . 0.0 110.82 170.132 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 160.58 68.06 0.02 OUTLIER Glycine 0 N--CA 1.483 1.779 0 CA-C-N 115.6 -0.727 . . . . 0.0 113.483 -175.018 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . 0.364 4.0 mp 68.36 -86.11 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 C-N-CA 124.087 0.955 . . . . 0.0 110.099 -174.35 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 48.5 p-10 -157.76 58.02 0.48 Allowed 'General case' 0 CA--C 1.57 1.74 0 C-N-CA 124.39 1.076 . . . . 0.0 111.081 170.197 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -85.1 91.96 8.24 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.48 -1.387 . . . . 0.0 110.408 178.491 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 35.7 ttm105 -81.58 67.95 7.74 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.813 -1.18 . . . . 0.0 113.237 -173.386 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . 0.262 61.5 mttm 56.31 60.28 3.24 Favored 'General case' 0 N--CA 1.501 2.099 0 N-CA-C 114.265 1.209 . . . . 0.0 114.265 -170.208 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 73.7 m -92.9 125.85 37.7 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.608 -0.683 . . . . 0.0 111.802 -173.434 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 15.5 mtp -80.46 98.11 7.4 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-O 121.655 0.74 . . . . 0.0 110.919 177.673 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 91.2 m -101.46 125.35 48.09 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.658 -0.651 . . . . 0.0 110.7 -167.314 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 85.3 m -106.3 122.94 47.24 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 176.675 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 20.6 t -116.19 121.61 67.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 179.684 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 58.4 m -128.64 139.19 52.38 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 123.829 0.852 . . . . 0.0 111.221 -173.569 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 2.9 m95 -81.49 122.34 27.41 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.845 -1.16 . . . . 0.0 113.69 179.056 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -112.32 67.93 0.66 Allowed 'General case' 0 CA--C 1.577 1.996 0 C-N-CA 123.382 0.673 . . . . 0.0 110.632 164.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 69.96 -102.82 1.04 Allowed Glycine 0 N--CA 1.495 2.584 0 N-CA-C 115.968 1.147 . . . . 0.0 115.968 177.456 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -75.47 -28.93 59.44 Favored 'General case' 0 CA--C 1.574 1.878 0 N-CA-C 115.206 1.558 . . . . 0.0 115.206 162.216 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 29.8 mtpt -98.87 107.42 19.85 Favored 'General case' 0 N--CA 1.484 1.263 0 CA-C-N 119.469 1.031 . . . . 0.0 110.56 -167.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 30.4 tp -80.75 111.06 16.84 Favored 'General case' 0 CA--C 1.563 1.473 0 O-C-N 120.729 -1.232 . . . . 0.0 109.844 173.191 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 -97.55 126.94 43.13 Favored 'General case' 0 CA--C 1.558 1.272 0 C-N-CA 124.011 0.925 . . . . 0.0 110.961 -174.353 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 41.9 t -127.48 133.88 49.86 Favored 'General case' 0 N--CA 1.481 1.108 0 O-C-N 121.674 -0.641 . . . . 0.0 111.831 -178.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 12.2 p -118.78 128.92 75.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 C-N-CA 123.068 0.547 . . . . 0.0 109.78 168.604 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -99.96 104.28 15.89 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 123.47 0.708 . . . . 0.0 109.753 178.306 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -91.25 119.79 31.61 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.059 -1.026 . . . . 0.0 110.676 -173.67 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -174.41 -70.33 0.05 OUTLIER Glycine 0 N--CA 1.489 2.172 0 N-CA-C 116.022 1.169 . . . . 0.0 116.022 -175.099 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -138.27 -60.45 0.62 Allowed 'General case' 0 N--CA 1.498 1.963 0 CA-C-N 117.755 0.777 . . . . 0.0 111.952 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -72.74 133.04 44.38 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-O 122.231 1.015 . . . . 0.0 111.704 -173.187 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -68.73 -56.83 6.84 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 115.392 1.627 . . . . 0.0 115.392 -160.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -83.68 44.11 3.26 Favored Glycine 0 CA--C 1.55 2.226 0 N-CA-C 117.728 1.851 . . . . 0.0 117.728 166.271 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 25.1 ttt180 -85.95 119.04 25.83 Favored 'General case' 0 CA--C 1.566 1.587 0 CA-C-N 119.674 1.737 . . . . 0.0 113.366 -176.579 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 175.0 -165.84 37.18 Favored Glycine 0 N--CA 1.485 1.906 0 CA-C-O 122.01 0.783 . . . . 0.0 114.73 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 45.3 p-90 -155.66 152.94 29.26 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 172.065 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 81.8 m -119.73 121.38 39.06 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 169.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -121.0 128.52 52.78 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.604 -0.685 . . . . 0.0 111.578 -177.447 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 16.4 p90 -148.04 155.32 41.36 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.797 -1.19 . . . . 0.0 113.587 -176.232 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 94.8 mt -94.35 134.46 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.033 -1.042 . . . . 0.0 110.382 174.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -118.4 94.9 4.65 Favored 'General case' 0 CA--C 1.566 1.574 0 CA-C-N 114.897 -1.047 . . . . 0.0 108.441 159.666 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 69.11 -108.03 2.32 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 115.619 1.008 . . . . 0.0 115.619 -179.336 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 55.5 p30 -90.18 2.42 55.38 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 117.407 2.373 . . . . 0.0 117.407 168.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -121.24 130.15 53.53 Favored 'General case' 0 N--CA 1.486 1.329 0 CA-C-N 119.827 1.194 . . . . 0.0 111.663 -168.14 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 18.4 tp -91.64 113.63 25.95 Favored 'General case' 0 CA--C 1.562 1.409 0 C-N-CA 124.424 1.089 . . . . 0.0 109.451 172.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 41.6 m80 -101.16 124.79 47.41 Favored 'General case' 0 CA--C 1.561 1.399 0 C-N-CA 124.33 1.052 . . . . 0.0 108.842 -177.407 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 43.6 tp -124.99 120.27 31.09 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.824 0.85 . . . . 0.0 110.332 -171.39 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -105.06 107.02 17.78 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.711 -0.618 . . . . 0.0 109.686 170.645 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 72.1 mtm -97.72 124.58 42.12 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-N 118.58 0.627 . . . . 0.0 111.131 179.186 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 84.7 mtm180 -111.55 139.45 46.98 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 123.866 0.866 . . . . 0.0 110.926 -171.128 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -147.28 132.46 18.36 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.095 -1.003 . . . . 0.0 112.968 167.432 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . 0.344 24.7 mt-10 65.61 -73.36 0.07 Allowed 'General case' 0 N--CA 1.502 2.126 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 -173.728 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -160.2 50.3 0.37 Allowed Glycine 0 CA--C 1.552 2.386 0 C-N-CA 123.862 0.744 . . . . 0.0 112.259 157.388 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 69.0 t -139.96 122.92 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 -163.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 31.3 m -105.47 123.06 47.26 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 122.996 0.518 . . . . 0.0 111.588 -173.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 44.6 t -88.61 128.98 35.59 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.561 -0.712 . . . . 0.0 111.261 159.527 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -105.39 110.75 23.22 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -179.409 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 16.4 mt-30 -118.07 139.08 51.74 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 123.559 0.744 . . . . 0.0 111.491 -176.093 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 33.9 t -122.93 131.79 72.61 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 O-C-N 121.478 -0.764 . . . . 0.0 109.042 -178.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -126.48 138.72 53.54 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 124.146 0.978 . . . . 0.0 110.521 -179.524 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 76.8 tttt -106.89 140.45 39.69 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.643 -1.286 . . . . 0.0 112.654 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 61.8 tttt -73.63 120.74 19.65 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -179.356 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 35.9 m -104.92 -41.27 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 175.476 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 52.8 t-80 . . . . . 0 N--CA 1.486 1.354 0 CA-C-N 119.715 1.143 . . . . 0.0 108.143 168.361 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 68.1 mtt . . . . . 0 CA--C 1.571 1.776 0 CA-C-O 118.385 -0.817 . . . . 0.0 111.755 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.34 161.11 40.99 Favored 'Trans proline' 0 CA--C 1.561 1.846 0 C-N-CA 122.239 1.959 . . . . 0.0 116.367 178.142 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 29.1 m -78.78 160.88 4.39 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.929 0 CA-C-O 122.399 1.095 . . . . 0.0 113.405 -177.659 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -90.99 107.1 18.98 Favored 'General case' 0 CA--C 1.565 1.547 0 O-C-N 121.015 -1.053 . . . . 0.0 112.373 -175.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 6.5 m-30 -83.64 -2.2 55.61 Favored 'General case' 0 CA--C 1.577 1.981 0 N-CA-C 116.152 1.908 . . . . 0.0 116.152 171.621 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 51.1 m-80 -58.52 114.05 2.28 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-N 121.612 2.006 . . . . 0.0 114.22 -178.652 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 160.05 -178.03 36.28 Favored Glycine 0 N--CA 1.483 1.833 0 CA-C-O 122.623 1.124 . . . . 0.0 115.896 -177.384 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 12.7 t80 -113.36 119.43 37.61 Favored 'General case' 0 CA--C 1.565 1.533 0 CA-C-N 114.222 -0.989 . . . . 0.0 108.875 178.773 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 77.2 m95 -123.01 124.37 42.99 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 123.541 0.737 . . . . 0.0 110.182 -165.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 64.1 pttt -98.68 136.81 38.21 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 120.501 -1.374 . . . . 0.0 113.4 -179.399 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 11.0 ttp -72.09 125.34 27.02 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-N 119.395 0.998 . . . . 0.0 112.901 177.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 78.6 mt -94.69 -56.29 2.83 Favored 'General case' 0 CA--C 1.564 1.503 0 CA-C-N 115.068 -0.969 . . . . 0.0 112.927 178.119 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 92.4 p -141.54 124.12 15.9 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.724 0.81 . . . . 0.0 110.227 -170.623 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -113.77 119.12 36.28 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 121.343 0.592 . . . . 0.0 111.327 175.107 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -114.37 126.84 55.45 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.81 0.844 . . . . 0.0 109.148 -176.054 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.265 19.0 t30 66.76 22.17 10.37 Favored 'General case' 0 CA--C 1.582 2.185 0 N-CA-C 116.911 2.189 . . . . 0.0 116.911 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -68.39 -43.39 77.39 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 115.382 1.623 . . . . 0.0 115.382 178.828 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -53.54 -44.86 69.55 Favored 'General case' 0 N--CA 1.501 2.108 0 N-CA-C 116.348 1.981 . . . . 0.0 116.348 167.006 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -65.64 -43.93 87.96 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 115.103 1.519 . . . . 0.0 115.103 175.779 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -53.44 -49.04 68.2 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 164.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 77.7 mt -63.47 -42.72 98.6 Favored 'General case' 0 CA--C 1.571 1.759 0 N-CA-C 114.539 1.311 . . . . 0.0 114.539 172.302 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 69.5 ttp85 -54.34 -46.19 72.88 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 115.696 1.739 . . . . 0.0 115.696 166.297 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.98 -31.83 65.45 Favored 'General case' 0 CA--C 1.567 1.63 0 N-CA-C 116.632 2.086 . . . . 0.0 116.632 164.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 82.2 mt -85.88 30.43 0.66 Allowed 'General case' 0 CA--C 1.572 1.818 0 N-CA-C 114.506 1.298 . . . . 0.0 114.506 167.255 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 64.54 17.98 11.14 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 117.023 2.231 . . . . 0.0 117.023 175.428 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 94.8 t -88.17 142.41 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 120.504 -1.373 . . . . 0.0 110.932 -168.204 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 7.8 p-10 -71.9 156.96 38.69 Favored 'General case' 0 CA--C 1.569 1.677 0 N-CA-C 115.363 1.616 . . . . 0.0 115.363 177.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 49.0 t -53.97 -42.71 55.35 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.407 0 N-CA-C 115.203 1.557 . . . . 0.0 115.203 -176.715 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.03 -52.4 65.53 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 115.871 1.804 . . . . 0.0 115.871 173.782 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -59.47 -42.27 91.64 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 115.934 1.827 . . . . 0.0 115.934 169.779 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 54.0 mtp180 -51.68 -57.53 8.95 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 164.527 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -59.63 -47.34 85.98 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 115.054 1.502 . . . . 0.0 115.054 175.019 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 64.7 mt -56.05 -57.06 9.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 CA-C-N 119.622 1.101 . . . . 0.0 112.675 172.338 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.0 -44.1 91.6 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 117.704 2.483 . . . . 0.0 117.704 176.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -67.61 -27.64 67.07 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 116.375 1.991 . . . . 0.0 116.375 172.289 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 88.5 mt -79.81 -31.45 40.66 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 115.686 1.735 . . . . 0.0 115.686 171.535 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . 0.272 4.1 pp -80.72 145.79 31.37 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-N 120.148 1.34 . . . . 0.0 114.486 -178.344 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -114.29 93.37 31.02 Favored Pre-proline 0 CA--C 1.573 1.843 0 CA-C-O 118.368 -0.825 . . . . 0.0 108.841 -177.456 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -81.19 166.93 18.15 Favored 'Trans proline' 0 CA--C 1.56 1.817 0 C-N-CA 122.969 2.446 . . . . 0.0 115.083 -174.671 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -106.0 118.65 37.17 Favored 'General case' 0 N--CA 1.487 1.379 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.303 173.128 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 35.4 mttp -83.33 107.08 15.61 Favored 'General case' 0 N--CA 1.485 1.284 0 O-C-N 121.302 -0.874 . . . . 0.0 110.331 169.508 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -91.33 113.18 25.37 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 164.327 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 82.7 mt -108.9 122.94 64.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 -177.529 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 91.3 t -108.3 102.47 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 169.791 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 42.7 tt0 -98.69 100.55 11.78 Favored 'General case' 0 CA--C 1.565 1.54 0 C-N-CA 123.825 0.85 . . . . 0.0 110.031 175.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -93.91 74.01 4.17 Favored 'General case' 0 CA--C 1.57 1.737 0 O-C-N 121.438 -0.789 . . . . 0.0 110.228 168.558 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 65.03 -99.0 0.32 Allowed Glycine 0 N--CA 1.492 2.374 0 N-CA-C 115.053 0.781 . . . . 0.0 115.053 -174.486 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -83.26 -31.36 26.99 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 116.406 2.002 . . . . 0.0 116.406 165.177 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 22.6 t-160 -80.19 108.72 14.02 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 121.228 1.831 . . . . 0.0 110.915 -177.2 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 45.2 ttm -118.75 123.6 45.23 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 123.511 0.724 . . . . 0.0 110.046 -172.543 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 35.9 mt -107.36 106.14 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 175.283 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 33.9 mm -90.7 108.67 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 174.266 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 67.2 mtt85 -105.66 100.09 9.67 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.654 -0.654 . . . . 0.0 109.464 173.551 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 59.1 m -89.9 102.74 15.44 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 176.805 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 15.2 mt -101.08 125.05 47.67 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.367 0.667 . . . . 0.0 111.132 -160.068 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.4 t -147.88 156.61 42.88 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 122.009 0.909 . . . . 0.0 111.126 179.404 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 25.2 m -59.57 -38.7 81.83 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 115.3 1.593 . . . . 0.0 115.3 171.392 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 35.5 t80 -74.54 -53.24 9.83 Favored 'General case' 0 CA--C 1.572 1.82 0 N-CA-C 114.733 1.382 . . . . 0.0 114.733 174.75 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 71.2 ttt180 -142.85 130.15 21.01 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 119.526 1.057 . . . . 0.0 110.274 174.279 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 71.5 m-80 -93.5 117.29 29.9 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 166.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 75.6 t80 -105.01 105.43 15.47 Favored 'General case' 0 CA--C 1.566 1.59 0 C-N-CA 123.28 0.632 . . . . 0.0 111.087 -172.427 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.9 mp -99.19 121.53 49.9 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.833 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -178.652 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 95.9 mtp -115.39 103.37 10.72 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.568 -0.707 . . . . 0.0 109.369 167.259 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -101.22 112.92 25.54 Favored 'General case' 0 CA--C 1.566 1.577 0 C-N-CA 124.163 0.985 . . . . 0.0 111.806 177.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -153.74 154.28 33.76 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 115.047 1.499 . . . . 0.0 115.047 -166.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 28.0 mp0 -89.24 121.62 31.71 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.445 -0.784 . . . . 0.0 110.671 167.65 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 37.3 t -66.85 116.11 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 C-N-CA 123.785 0.834 . . . . 0.0 109.512 172.178 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 121.55 -46.31 1.13 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 115.589 0.996 . . . . 0.0 115.589 -158.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -84.34 145.75 28.08 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 118.726 1.263 . . . . 0.0 113.297 -174.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -91.9 100.34 13.03 Favored 'General case' 0 CA--C 1.568 1.638 0 O-C-N 121.788 -0.57 . . . . 0.0 110.895 173.324 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -107.63 145.7 32.96 Favored 'General case' 0 N--CA 1.495 1.813 0 C-N-CA 124.073 0.949 . . . . 0.0 113.429 -169.352 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -68.57 118.79 12.05 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.234 -1.541 . . . . 0.0 114.133 176.622 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -75.71 85.13 2.72 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 122.448 1.118 . . . . 0.0 109.672 163.012 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -134.07 126.28 29.79 Favored 'General case' 0 CA--C 1.558 1.276 0 CA-C-N 114.421 -1.263 . . . . 0.0 107.765 -173.711 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . 0.322 2.6 mm? 71.63 -61.87 0.48 Allowed 'General case' 0 N--CA 1.502 2.131 0 C-N-CA 123.59 0.756 . . . . 0.0 112.347 -166.673 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 7.2 t -77.52 58.1 1.68 Allowed 'General case' 0 CA--C 1.578 2.023 0 N-CA-C 114.455 1.28 . . . . 0.0 114.455 166.458 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -132.81 176.07 19.68 Favored Glycine 0 N--CA 1.488 2.134 0 O-C-N 120.512 -1.368 . . . . 0.0 113.937 172.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 46.2 mm -101.19 -67.81 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 122.302 -0.528 . . . . 0.0 110.77 -177.822 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 51.2 t0 -96.82 160.75 14.19 Favored 'General case' 0 CA--C 1.569 1.691 0 CA-C-O 122.317 1.056 . . . . 0.0 112.328 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -63.98 152.1 40.99 Favored 'General case' 0 CA--C 1.57 1.731 0 N-CA-C 114.347 1.24 . . . . 0.0 114.347 178.412 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . 0.323 0.0 OUTLIER 82.44 121.02 0.05 OUTLIER 'General case' 0 N--CA 1.498 1.931 0 C-N-CA 124.863 1.265 . . . . 0.0 111.656 -169.38 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? -79.01 128.34 33.13 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.506 0.723 . . . . 0.0 112.717 -169.575 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 99.4 m -101.27 117.18 34.45 Favored 'General case' 0 N--CA 1.487 1.394 0 CA-C-O 121.77 0.795 . . . . 0.0 112.151 -177.222 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 3.9 tpt -78.78 107.28 11.37 Favored 'General case' 0 CA--C 1.563 1.472 0 CA-C-O 122.211 1.005 . . . . 0.0 109.822 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 90.4 m -111.8 115.91 29.83 Favored 'General case' 0 N--CA 1.484 1.227 0 O-C-N 121.545 -0.722 . . . . 0.0 110.737 -152.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 50.3 m -89.96 123.53 33.96 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 168.414 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 59.7 t -108.87 131.8 58.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 166.708 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 58.7 m -143.36 150.94 39.84 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.771 -1.205 . . . . 0.0 112.676 -175.205 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 20.5 m95 -86.24 120.25 27.39 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 -178.001 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -105.23 62.76 0.69 Allowed 'General case' 0 CA--C 1.58 2.099 0 C-N-CA 123.871 0.868 . . . . 0.0 110.405 158.345 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 64.5 -98.99 0.3 Allowed Glycine 0 N--CA 1.496 2.634 0 N-CA-C 116.978 1.551 . . . . 0.0 116.978 178.566 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -68.96 -35.99 77.39 Favored 'General case' 0 CA--C 1.574 1.886 0 N-CA-C 115.121 1.526 . . . . 0.0 115.121 165.531 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -92.4 124.34 36.38 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.906 0.883 . . . . 0.0 112.073 -176.199 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 22.0 tp -89.99 108.69 19.87 Favored 'General case' 0 CA--C 1.564 1.491 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 166.087 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 30.3 mm-40 -97.95 130.82 44.79 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.709 0.804 . . . . 0.0 110.991 -172.287 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 42.4 t -127.67 127.92 44.57 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.015 0.526 . . . . 0.0 111.711 -175.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.6 p -115.07 115.21 48.75 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.625 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 169.539 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -93.59 94.95 8.91 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 123.628 0.771 . . . . 0.0 109.124 179.72 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 64.8 mttm -88.43 109.39 19.98 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.123 -0.986 . . . . 0.0 112.075 -169.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -179.83 85.37 0.07 OUTLIER Glycine 0 N--CA 1.484 1.871 0 CA-C-N 116.1 -0.5 . . . . 0.0 113.174 177.096 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . 0.271 29.1 tt0 70.35 -55.25 0.62 Allowed 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 116.697 2.11 . . . . 0.0 116.697 178.692 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.0 mmmp? -72.94 141.5 47.82 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 114.798 1.407 . . . . 0.0 114.798 -166.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -80.69 94.68 6.41 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.98 0.895 . . . . 0.0 112.526 -164.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 77.37 46.0 10.58 Favored Glycine 0 N--CA 1.486 1.988 0 N-CA-C 117.208 1.643 . . . . 0.0 117.208 -173.317 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 14.8 ttm180 -77.56 121.51 24.0 Favored 'General case' 0 CA--C 1.568 1.654 0 CA-C-N 118.546 1.173 . . . . 0.0 110.725 167.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 177.37 -171.74 44.51 Favored Glycine 0 N--CA 1.486 2.012 0 O-C-N 121.502 -0.749 . . . . 0.0 114.874 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 51.7 p-90 -157.96 154.04 27.13 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 114.125 1.157 . . . . 0.0 114.125 178.095 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 74.1 m -121.95 116.95 25.27 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 171.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 19.2 tt0 -115.7 126.73 54.48 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 123.398 0.679 . . . . 0.0 110.682 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 14.1 p90 -147.18 157.32 43.56 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.685 -1.259 . . . . 0.0 114.089 -175.345 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 95.8 mt -100.82 128.8 52.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.434 -0.791 . . . . 0.0 110.038 175.594 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -112.33 100.03 8.48 Favored 'General case' 0 CA--C 1.567 1.611 0 CA-C-N 114.697 -1.138 . . . . 0.0 108.543 160.672 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 70.53 -106.58 1.89 Allowed Glycine 0 N--CA 1.494 2.5 0 N-CA-C 115.442 0.937 . . . . 0.0 115.442 -179.762 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -112.43 33.7 4.76 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 114.767 1.395 . . . . 0.0 114.767 162.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -125.7 127.52 46.37 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 124.058 0.943 . . . . 0.0 109.707 177.686 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 17.0 tp -93.09 115.55 28.19 Favored 'General case' 0 CA--C 1.563 1.461 0 CA-C-O 122.097 0.951 . . . . 0.0 109.412 173.275 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 48.1 m80 -102.6 123.81 47.0 Favored 'General case' 0 CA--C 1.558 1.253 0 C-N-CA 124.17 0.988 . . . . 0.0 108.878 -176.549 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 43.3 tp -124.56 118.52 26.76 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.508 0.723 . . . . 0.0 109.654 -172.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 82.1 mt-10 -114.05 110.65 20.37 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.75 -0.594 . . . . 0.0 109.764 173.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 68.0 mtm -105.77 125.25 50.77 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 123.591 0.756 . . . . 0.0 110.755 -174.815 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 54.6 mtp180 -111.22 142.97 42.73 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.584 -0.697 . . . . 0.0 112.338 -177.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -156.52 133.05 10.09 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 123.08 0.552 . . . . 0.0 110.898 161.701 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 60.7 34.93 19.85 Favored 'General case' 0 N--CA 1.509 2.478 0 N-CA-C 115.339 1.607 . . . . 0.0 115.339 -168.041 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 67.35 -0.81 7.86 Favored Glycine 0 CA--C 1.561 2.913 0 N-CA-C 119.984 2.753 . . . . 0.0 119.984 -159.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 75.2 t -95.51 114.14 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 CA-C-N 120.81 2.305 . . . . 0.0 109.446 -167.165 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 25.0 m -94.63 118.63 32.0 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 123.094 0.557 . . . . 0.0 111.295 -173.249 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 13.9 t -91.6 124.65 35.91 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.306 0.642 . . . . 0.0 111.238 162.354 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -108.55 115.5 30.21 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.192 0.597 . . . . 0.0 109.659 -175.752 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -124.22 135.43 53.43 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.636 -0.665 . . . . 0.0 111.854 -174.159 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 61.7 t -112.97 131.62 64.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.312 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -125.34 145.13 50.17 Favored 'General case' 0 CA--C 1.563 1.463 0 C-N-CA 124.844 1.258 . . . . 0.0 109.778 179.151 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 30.3 ttmt -120.25 140.61 50.94 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.651 -1.281 . . . . 0.0 112.804 179.173 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 54.5 tttt -74.97 115.81 15.0 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -177.106 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 35.0 m -97.21 -40.73 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 174.569 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 79.5 t60 . . . . . 0 N--CA 1.486 1.343 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 164.628 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 65.6 mtt . . . . . 0 CA--C 1.569 1.674 0 CA-C-O 118.499 -0.762 . . . . 0.0 109.759 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_exo -64.45 117.51 4.55 Favored 'Trans proline' 0 CA--C 1.561 1.871 0 C-N-CA 122.725 2.283 . . . . 0.0 116.563 -178.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 22.0 m -107.01 176.43 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 CA-C-O 122.248 1.023 . . . . 0.0 112.067 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -79.19 82.21 5.37 Favored 'General case' 0 CA--C 1.569 1.676 0 O-C-N 120.158 -1.589 . . . . 0.0 113.862 -171.267 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -73.41 -11.71 60.56 Favored 'General case' 0 CA--C 1.576 1.97 0 N-CA-C 115.614 1.709 . . . . 0.0 115.614 167.622 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -45.78 121.96 3.45 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 115.793 1.775 . . . . 0.0 115.793 168.007 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 154.84 174.39 24.74 Favored Glycine 0 N--CA 1.484 1.876 0 N-CA-C 115.976 1.15 . . . . 0.0 115.976 175.43 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 17.3 t80 -103.28 121.2 42.22 Favored 'General case' 0 CA--C 1.563 1.449 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 167.032 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 70.4 m95 -120.39 121.5 38.69 Favored 'General case' 0 CA--C 1.562 1.434 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 -170.146 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 63.7 pttt -89.47 137.74 32.07 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.249 -0.907 . . . . 0.0 112.169 177.539 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 51.3 ttm -73.38 121.84 21.11 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 122.092 0.949 . . . . 0.0 112.423 176.685 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 89.6 mt -81.79 -48.13 12.0 Favored 'General case' 0 CA--C 1.568 1.66 0 CA-C-N 115.242 -0.89 . . . . 0.0 113.157 167.252 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 88.6 p -136.55 146.29 45.99 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 119.225 0.92 . . . . 0.0 112.873 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 20.9 p30 -124.45 81.72 1.97 Allowed 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 121.694 0.759 . . . . 0.0 110.709 167.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -94.72 125.56 39.45 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.138 -0.976 . . . . 0.0 111.56 -167.752 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.257 51.2 t30 59.15 25.16 13.63 Favored 'General case' 0 N--CA 1.503 2.183 0 N-CA-C 116.968 2.21 . . . . 0.0 116.968 -170.453 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -66.97 -40.47 87.47 Favored 'General case' 0 CA--C 1.568 1.643 0 N-CA-C 114.969 1.47 . . . . 0.0 114.969 172.59 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -52.93 -53.42 49.79 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 115.484 1.661 . . . . 0.0 115.484 172.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -72.08 -37.01 69.69 Favored 'General case' 0 CA--C 1.566 1.565 0 N-CA-C 115.796 1.776 . . . . 0.0 115.796 176.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 61.3 t80 -50.2 -49.96 51.0 Favored 'General case' 0 N--CA 1.499 2.02 0 CA-C-N 120.526 1.512 . . . . 0.0 114.859 161.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 93.9 mt -62.57 -41.47 98.94 Favored 'General case' 0 CA--C 1.57 1.734 0 N-CA-C 115.51 1.67 . . . . 0.0 115.51 171.219 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 35.2 ttp180 -62.07 -44.85 95.78 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 115.091 1.515 . . . . 0.0 115.091 169.563 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -49.82 -28.96 7.09 Favored 'General case' 0 CA--C 1.571 1.781 0 N-CA-C 118.234 2.679 . . . . 0.0 118.234 162.305 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 91.0 mt -86.97 0.68 54.72 Favored 'General case' 0 CA--C 1.569 1.7 0 N-CA-C 116.45 2.019 . . . . 0.0 116.45 168.349 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 62.32 39.07 12.68 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 115.458 1.651 . . . . 0.0 115.458 -169.283 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 86.1 t -92.88 140.25 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 CA-C-O 122.195 0.997 . . . . 0.0 109.02 178.754 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.8 p-10 -67.0 146.05 54.77 Favored 'General case' 0 CA--C 1.567 1.613 0 N-CA-C 116.287 1.958 . . . . 0.0 116.287 -170.818 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 58.5 t -59.57 -38.75 77.02 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.162 0 N-CA-C 115.622 1.712 . . . . 0.0 115.622 -173.183 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.12 -38.95 84.58 Favored 'General case' 0 CA--C 1.569 1.711 0 N-CA-C 116.412 2.005 . . . . 0.0 116.412 169.431 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 6.1 tt -65.49 -50.67 64.45 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-N 119.318 0.963 . . . . 0.0 113.553 165.301 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 35.2 mtp-105 -47.62 -50.35 24.63 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 116.263 1.949 . . . . 0.0 116.263 172.203 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -70.91 -36.29 72.62 Favored 'General case' 0 CA--C 1.564 1.493 0 N-CA-C 115.239 1.57 . . . . 0.0 115.239 174.219 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 41.0 mt -71.99 -55.78 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.22 0 CA-C-N 122.334 2.334 . . . . 0.0 110.559 174.67 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -61.14 -23.3 65.43 Favored 'General case' 0 CA--C 1.565 1.54 0 N-CA-C 119.255 3.057 . . . . 0.0 119.255 176.362 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -75.28 -47.59 27.21 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 115.454 1.65 . . . . 0.0 115.454 160.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 97.4 mt -75.25 -25.56 58.14 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 116.29 1.959 . . . . 0.0 116.29 -175.201 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . 0.25 1.4 pp -96.34 149.89 21.19 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 119.444 1.02 . . . . 0.0 110.397 158.327 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -107.06 92.32 7.6 Favored Pre-proline 0 CA--C 1.574 1.873 0 CA-C-O 117.78 -1.105 . . . . 0.0 109.222 -176.565 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -72.04 155.85 56.67 Favored 'Trans proline' 0 CA--C 1.562 1.901 0 C-N-CA 122.535 2.157 . . . . 0.0 116.739 -170.767 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -101.14 136.22 41.34 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.926 -170.722 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 60.8 mttm -96.02 112.1 23.93 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.123 -0.986 . . . . 0.0 110.19 174.409 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -94.5 108.13 20.08 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 163.329 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 78.0 mt -103.07 117.14 48.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 -175.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 91.1 t -100.18 93.75 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 173.683 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -95.31 97.17 9.65 Favored 'General case' 0 CA--C 1.566 1.568 0 CA-C-O 121.395 0.617 . . . . 0.0 110.831 176.524 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -89.97 79.23 6.61 Favored 'General case' 0 CA--C 1.568 1.666 0 O-C-N 121.275 -0.89 . . . . 0.0 109.815 167.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 65.94 -102.66 0.73 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 114.897 0.719 . . . . 0.0 114.897 -174.176 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -86.07 -23.29 26.77 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 116.531 2.048 . . . . 0.0 116.531 165.56 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 18.5 t-160 -78.9 108.89 12.69 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 121.602 2.001 . . . . 0.0 111.148 178.283 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 47.1 ttm -117.64 121.08 39.94 Favored 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 123.676 0.79 . . . . 0.0 109.932 -174.789 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 29.6 mt -107.41 101.94 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 173.388 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 78.8 mt -88.89 100.63 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 177.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 62.6 mtt180 -94.5 98.48 10.88 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.774 -0.579 . . . . 0.0 110.251 -179.572 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 11.4 m -87.6 107.92 18.83 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 177.306 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 13.5 mt -108.96 120.35 42.26 Favored 'General case' 0 CA--C 1.558 1.273 0 C-N-CA 123.478 0.711 . . . . 0.0 110.486 -160.526 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 38.7 t -116.45 -93.41 0.5 Allowed 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.147 0.579 . . . . 0.0 110.624 177.452 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 52.8 m 176.83 -62.18 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.033 0 C-N-CA 126.618 1.967 . . . . 0.0 106.015 -170.597 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -72.89 -48.63 35.61 Favored 'General case' 0 CA--C 1.573 1.838 0 N-CA-C 115.935 1.828 . . . . 0.0 115.935 176.54 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 42.7 tpt85 -139.08 124.64 19.44 Favored 'General case' 0 CA--C 1.564 1.492 0 CA-C-N 118.995 0.816 . . . . 0.0 109.755 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -83.46 173.72 11.25 Favored 'General case' 0 CA--C 1.569 1.69 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 169.859 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -112.9 -76.24 0.59 Allowed 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.337 -0.852 . . . . 0.0 110.196 170.012 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.374 58.5 mt 70.5 85.51 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.127 0 C-N-CA 124.5 1.12 . . . . 0.0 111.678 173.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 94.4 mtp -102.05 102.64 13.16 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.062 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.5 p30 -99.96 110.44 22.77 Favored 'General case' 0 CA--C 1.562 1.434 0 C-N-CA 123.899 0.88 . . . . 0.0 112.554 -178.325 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -155.04 148.78 25.48 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 -168.786 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 23.1 mp0 -82.65 125.76 31.57 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.219 -0.926 . . . . 0.0 110.667 160.243 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 13.1 t -66.17 123.34 18.94 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.91 0 O-C-N 121.31 -0.869 . . . . 0.0 110.142 176.486 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 115.81 -44.26 1.51 Allowed Glycine 0 CA--C 1.55 2.253 0 N-CA-C 115.597 0.999 . . . . 0.0 115.597 -157.555 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 83.8 mttt -83.6 146.62 28.19 Favored 'General case' 0 CA--C 1.566 1.593 0 CA-C-N 118.822 1.311 . . . . 0.0 114.18 -172.237 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -91.05 103.71 16.38 Favored 'General case' 0 CA--C 1.564 1.51 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.995 167.065 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 11.1 p90 -102.72 145.49 29.63 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -171.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -78.81 124.67 28.45 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 177.01 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -117.1 100.96 8.08 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 169.655 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -125.06 109.91 13.51 Favored 'General case' 0 CA--C 1.563 1.462 0 C-N-CA 123.35 0.66 . . . . 0.0 109.645 173.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 19.2 tp -150.26 -114.63 0.05 Allowed 'General case' 0 CA--C 1.57 1.74 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 172.522 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 85.5 m -162.63 113.35 1.5 Allowed 'General case' 0 N--CA 1.498 1.935 0 O-C-N 119.934 -1.729 . . . . 0.0 107.153 172.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 165.78 -83.06 0.1 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 115.555 0.982 . . . . 0.0 115.555 178.463 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.474 HG23 ' H ' ' A' ' 78' ' ' ASP 0.294 18.8 tt -130.16 -96.04 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 -170.254 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.474 ' H ' HG23 ' A' ' 77' ' ' ILE . 36.0 t0 -80.17 71.52 6.93 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.998 0.904 . . . . 0.0 110.92 168.661 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 46.9 m-20 -150.53 -1.67 0.38 Allowed 'General case' 0 CA--C 1.573 1.841 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 -164.818 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 72.0 ttt-85 -95.8 73.06 3.08 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-N 121.004 1.729 . . . . 0.0 110.475 177.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 10.2 mtmp? 43.44 65.38 1.0 Allowed 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 116.278 1.955 . . . . 0.0 116.278 -170.268 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 73.3 m -100.79 126.09 47.34 Favored 'General case' 0 CA--C 1.557 1.213 0 CA-C-O 121.713 0.768 . . . . 0.0 111.835 -174.321 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 12.4 mmt -88.82 90.13 8.28 Favored 'General case' 0 CA--C 1.56 1.33 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 173.771 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 86.0 m -92.78 122.41 35.14 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.166 -0.958 . . . . 0.0 110.265 -174.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 58.5 m -110.04 122.73 48.26 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.827 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.457 HG22 ' SG ' ' A' ' 95' ' ' CYS . 17.8 t -118.0 128.09 75.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 92.0 p -130.6 166.58 20.33 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 122.506 1.146 . . . . 0.0 113.256 -176.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 68.5 m95 -97.19 129.67 44.52 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.615 -0.678 . . . . 0.0 111.932 175.396 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -126.49 81.84 2.03 Favored 'General case' 0 CA--C 1.567 1.597 0 C-N-CA 123.668 0.787 . . . . 0.0 109.647 177.153 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 63.21 17.44 59.24 Favored Glycine 0 N--CA 1.496 2.69 0 N-CA-C 121.74 3.456 . . . . 0.0 121.74 172.752 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . 0.269 0.8 OUTLIER 126.33 -45.41 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.472 0 C-N-CA 127.374 2.269 . . . . 0.0 111.087 -159.543 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 64.3 mttm -77.7 142.21 38.91 Favored 'General case' 0 CA--C 1.562 1.408 0 C-N-CA 123.68 0.792 . . . . 0.0 111.937 -176.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 25.7 tp -97.62 104.1 16.09 Favored 'General case' 0 CA--C 1.564 1.514 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 172.088 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 32.9 mm-40 -92.57 142.69 27.12 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 123.332 0.653 . . . . 0.0 111.831 -177.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' CYS . . . . . 0.457 ' SG ' HG22 ' A' ' 86' ' ' VAL . 49.3 t -139.64 136.88 34.78 Favored 'General case' 0 N--CA 1.484 1.238 0 O-C-N 121.441 -0.787 . . . . 0.0 112.127 -178.67 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.7 p -114.78 129.25 71.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 C-N-CA 123.203 0.601 . . . . 0.0 109.506 162.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -105.95 75.55 1.12 Allowed 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 123.593 0.757 . . . . 0.0 109.687 179.575 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -86.92 141.07 29.01 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.487 -1.383 . . . . 0.0 113.388 -173.21 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 135.69 -66.93 0.55 Allowed Glycine 0 N--CA 1.491 2.312 0 O-C-N 121.73 -0.606 . . . . 0.0 113.957 -171.199 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -79.54 -53.54 6.77 Favored 'General case' 0 CA--C 1.57 1.739 0 N-CA-C 115.335 1.606 . . . . 0.0 115.335 -175.719 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 45.1 mmtm -133.12 160.61 36.72 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-N 119.903 1.228 . . . . 0.0 114.313 -166.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -77.04 137.9 39.25 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.43 175.785 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 61.6 35.8 91.68 Favored Glycine 0 N--CA 1.496 2.652 0 N-CA-C 118.785 2.274 . . . . 0.0 118.785 -176.421 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 46.1 ttt180 -96.93 123.95 40.77 Favored 'General case' 0 CA--C 1.561 1.395 0 CA-C-N 118.16 0.98 . . . . 0.0 112.59 -170.095 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 179.92 -169.13 39.81 Favored Glycine 0 N--CA 1.483 1.776 0 CA-C-O 122.129 0.849 . . . . 0.0 114.847 176.647 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 43.4 p-90 -155.1 156.27 35.51 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 175.169 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 49.2 m -125.29 118.71 26.56 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 173.481 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 -118.52 129.81 55.57 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 123.345 0.658 . . . . 0.0 111.07 -178.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 15.3 p90 -150.34 156.72 42.05 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.761 -1.212 . . . . 0.0 113.396 -175.038 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 73.8 mt -101.44 141.76 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.186 0 CA-C-O 122.697 1.237 . . . . 0.0 111.346 -176.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -139.7 88.25 2.23 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 123.997 0.919 . . . . 0.0 109.12 -177.594 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 72.29 -112.61 4.1 Favored Glycine 0 N--CA 1.49 2.257 0 CA-C-N 115.87 -0.605 . . . . 0.0 113.755 -173.021 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 54.8 p30 -92.28 7.35 43.11 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 116.78 2.141 . . . . 0.0 116.78 164.034 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -107.87 146.76 31.87 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-N 120.519 1.509 . . . . 0.0 112.526 -174.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 13.8 tp -108.01 118.98 38.17 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 169.056 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 34.1 m80 -106.51 124.24 49.3 Favored 'General case' 0 CA--C 1.559 1.326 0 C-N-CA 123.713 0.805 . . . . 0.0 109.202 -175.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 20.1 tp -120.49 130.29 54.22 Favored 'General case' 0 CA--C 1.561 1.374 0 C-N-CA 123.8 0.84 . . . . 0.0 109.736 -176.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -117.76 114.51 23.42 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.567 -0.708 . . . . 0.0 109.532 166.77 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 68.2 mtm -106.81 125.0 50.44 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 123.368 0.667 . . . . 0.0 110.923 -178.224 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 72.7 mtp85 -111.6 140.93 45.81 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 123.381 0.673 . . . . 0.0 112.299 -176.251 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -159.22 135.18 8.81 Favored 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 123.301 0.64 . . . . 0.0 111.876 167.493 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 60.5 21.7 11.41 Favored 'General case' 0 N--CA 1.506 2.351 0 N-CA-C 115.963 1.838 . . . . 0.0 115.963 -170.434 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 82.88 -12.47 48.64 Favored Glycine 0 CA--C 1.56 2.858 0 N-CA-C 119.29 2.476 . . . . 0.0 119.29 -158.812 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 92.3 t -89.11 123.6 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 CA-C-N 120.015 1.908 . . . . 0.0 109.825 -171.723 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 24.1 m -101.16 120.81 40.78 Favored 'General case' 0 N--CA 1.494 1.773 0 C-N-CA 122.922 0.489 . . . . 0.0 112.092 -178.212 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 13.3 t -90.64 125.86 35.78 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.576 0.75 . . . . 0.0 111.655 162.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -107.86 113.57 26.89 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -177.153 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 14.4 mt-30 -121.51 126.97 50.5 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.431 -0.793 . . . . 0.0 110.882 -174.7 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 58.1 t -110.83 132.87 58.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -179.083 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -124.84 152.7 43.61 Favored 'General case' 0 CA--C 1.563 1.468 0 C-N-CA 124.307 1.043 . . . . 0.0 110.866 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -120.3 139.24 53.02 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.263 -0.898 . . . . 0.0 111.899 174.198 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 73.3 tttt -73.14 120.32 18.61 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.452 -0.78 . . . . 0.0 112.795 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . 0.253 34.7 m -105.81 -40.18 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 173.743 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 44.6 t60 . . . . . 0 N--CA 1.486 1.365 0 CA-C-N 119.988 1.267 . . . . 0.0 108.192 165.686 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 17.9 ptp . . . . . 0 CA--C 1.575 1.904 0 CA-C-O 119.063 -0.494 . . . . 0.0 112.255 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -88.89 166.29 5.88 Favored 'Trans proline' 0 CA--C 1.564 2.008 0 C-N-CA 122.574 2.183 . . . . 0.0 115.813 -176.551 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 19.0 m -76.52 152.63 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 CA-C-O 122.302 1.049 . . . . 0.0 112.307 165.586 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -76.74 118.08 19.0 Favored 'General case' 0 CA--C 1.565 1.545 0 O-C-N 121.242 -0.911 . . . . 0.0 113.383 178.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 6.2 m-30 -84.77 8.47 17.07 Favored 'General case' 0 CA--C 1.579 2.065 0 N-CA-C 115.57 1.693 . . . . 0.0 115.57 169.59 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -57.59 111.99 1.29 Allowed 'General case' 0 CA--C 1.564 1.499 0 N-CA-C 114.916 1.45 . . . . 0.0 114.916 -179.272 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 164.24 173.29 32.74 Favored Glycine 0 N--CA 1.484 1.862 0 N-CA-C 115.944 1.138 . . . . 0.0 115.944 -178.644 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -102.69 120.58 40.82 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-N 114.648 -0.776 . . . . 0.0 108.974 172.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 75.6 m95 -119.14 118.64 31.91 Favored 'General case' 0 CA--C 1.566 1.58 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -170.048 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 59.9 pttt -102.72 141.49 35.45 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.144 -0.972 . . . . 0.0 112.76 -176.604 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 45.6 ttm -66.05 124.78 23.49 Favored 'General case' 0 CA--C 1.569 1.689 0 N-CA-C 115.188 1.551 . . . . 0.0 115.188 -175.373 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 94.9 mt -88.32 -49.93 6.65 Favored 'General case' 0 CA--C 1.569 1.675 0 CA-C-N 115.128 -0.942 . . . . 0.0 112.986 164.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 87.0 p -136.6 149.56 48.09 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-N 119.143 0.883 . . . . 0.0 112.848 -178.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -135.7 87.24 2.3 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 123.671 0.789 . . . . 0.0 110.175 172.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -98.27 132.7 43.54 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.543 0.737 . . . . 0.0 110.872 -175.406 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.271 41.5 t30 62.75 17.08 9.53 Favored 'General case' 0 N--CA 1.503 2.203 0 N-CA-C 117.588 2.44 . . . . 0.0 117.588 179.757 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -62.4 -46.39 88.83 Favored 'General case' 0 CA--C 1.565 1.551 0 N-CA-C 115.764 1.764 . . . . 0.0 115.764 177.236 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -61.47 -38.93 89.04 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 116.764 2.135 . . . . 0.0 116.764 173.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -65.5 -41.43 93.21 Favored 'General case' 0 CA--C 1.572 1.825 0 CA-C-N 120.684 1.583 . . . . 0.0 114.924 168.768 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 39.4 t80 -55.0 -50.32 69.3 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 114.754 1.39 . . . . 0.0 114.754 166.048 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 91.9 mt -61.87 -43.4 98.91 Favored 'General case' 0 CA--C 1.571 1.775 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 171.799 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 20.4 ttm180 -53.12 -47.55 68.58 Favored 'General case' 0 CA--C 1.578 2.037 0 CA-C-N 120.746 1.612 . . . . 0.0 114.896 164.644 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.46 -19.11 45.19 Favored 'General case' 0 CA--C 1.568 1.647 0 N-CA-C 118.317 2.71 . . . . 0.0 118.317 166.666 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 95.4 mt -92.73 12.55 23.03 Favored 'General case' 0 CA--C 1.572 1.815 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 164.824 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 61.25 45.6 8.68 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 115.21 1.559 . . . . 0.0 115.21 -174.511 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 57.4 t -96.85 143.37 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 CA-C-O 122.388 1.09 . . . . 0.0 110.123 -176.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 -71.46 152.74 42.8 Favored 'General case' 0 CA--C 1.569 1.676 0 N-CA-C 115.022 1.49 . . . . 0.0 115.022 177.234 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 57.8 t -57.37 -41.1 77.8 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.166 0 N-CA-C 115.14 1.533 . . . . 0.0 115.14 -176.159 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.09 -49.32 78.31 Favored 'General case' 0 CA--C 1.567 1.624 0 N-CA-C 116.296 1.961 . . . . 0.0 116.296 174.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -59.55 -48.19 82.61 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 114.136 1.162 . . . . 0.0 114.136 168.406 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 53.2 mtp180 -50.82 -45.42 59.47 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 117.444 2.387 . . . . 0.0 117.444 168.132 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -72.5 -51.7 18.91 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-N 119.978 1.263 . . . . 0.0 113.807 172.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 45.2 mt -58.72 -51.5 71.24 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.23 0 CA-C-N 120.498 1.499 . . . . 0.0 113.293 178.747 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.83 -35.77 82.19 Favored 'General case' 0 CA--C 1.563 1.477 0 N-CA-C 117.76 2.504 . . . . 0.0 117.76 175.696 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -74.33 -30.82 62.19 Favored 'General case' 0 CA--C 1.571 1.777 0 N-CA-C 116.357 1.984 . . . . 0.0 116.357 169.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 79.4 mt -73.02 -34.38 66.31 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 115.209 1.559 . . . . 0.0 115.209 169.752 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 81.9 mt -72.5 152.81 41.69 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 119.318 0.963 . . . . 0.0 112.574 169.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -102.65 89.52 1.83 Allowed Pre-proline 0 CA--C 1.57 1.72 0 CA-C-O 118.234 -0.889 . . . . 0.0 109.339 167.701 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -70.16 168.67 21.42 Favored 'Trans proline' 0 CA--C 1.563 1.964 0 C-N-CA 122.47 2.114 . . . . 0.0 115.399 -179.452 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -131.95 128.6 38.81 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.905 -169.113 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -99.79 109.11 21.55 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.161 -0.962 . . . . 0.0 109.822 177.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -93.76 102.74 14.89 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 169.15 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 92.2 mt -94.91 121.38 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -172.784 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 96.0 t -112.1 93.2 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 107.067 -1.456 . . . . 0.0 107.067 176.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -89.69 115.97 27.45 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 123.72 0.808 . . . . 0.0 110.556 176.125 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -135.62 70.51 1.43 Allowed 'General case' 0 CA--C 1.569 1.682 0 C-N-CA 123.212 0.605 . . . . 0.0 110.811 -173.663 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 61.98 81.62 0.09 OUTLIER Glycine 0 N--CA 1.495 2.627 0 N-CA-C 116.488 1.355 . . . . 0.0 116.488 173.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.452 1.1 p30 63.85 -39.02 0.2 Allowed 'General case' 0 N--CA 1.504 2.225 0 N-CA-C 118.332 2.716 . . . . 0.0 118.332 -165.181 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 12.4 t-80 -79.15 121.64 25.26 Favored 'General case' 0 CA--C 1.56 1.346 0 CA-C-N 120.157 1.344 . . . . 0.0 111.406 173.333 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 11.3 ttp -134.6 129.51 35.07 Favored 'General case' 0 CA--C 1.556 1.204 0 CA-C-O 122.08 0.943 . . . . 0.0 110.979 -179.639 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 4.4 mp -105.06 113.57 42.45 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.377 0 N-CA-C 107.081 -1.452 . . . . 0.0 107.081 174.696 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 24.5 mm -89.04 93.57 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 167.804 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -80.18 96.68 6.63 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.146 -0.971 . . . . 0.0 109.733 -179.036 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 26.3 m -90.24 100.85 13.6 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 -175.61 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 23.6 mt -105.86 135.13 47.85 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 124.214 1.006 . . . . 0.0 110.491 -164.05 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 12.5 p -144.26 156.36 44.24 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.136 -0.978 . . . . 0.0 112.597 177.692 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.6 m -77.75 61.08 2.35 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 120.742 -1.223 . . . . 0.0 112.316 172.24 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -177.14 -67.55 0.01 OUTLIER 'General case' 0 CA--C 1.568 1.657 0 C-N-CA 126.013 1.725 . . . . 0.0 107.946 -174.289 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 56.7 ttt85 -144.76 140.94 28.84 Favored 'General case' 0 CA--C 1.565 1.528 0 CA-C-O 121.784 0.802 . . . . 0.0 110.217 177.382 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -105.18 119.43 39.03 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 175.003 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 19.3 t80 -81.75 -57.73 3.31 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 114.074 1.139 . . . . 0.0 114.074 -172.551 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.272 10.4 mm 76.2 95.97 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 C-N-CA 124.071 0.949 . . . . 0.0 111.798 172.395 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 91.1 mtp -97.52 94.2 6.88 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.994 -1.066 . . . . 0.0 109.628 173.71 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.9 p30 -96.19 111.29 23.39 Favored 'General case' 0 CA--C 1.561 1.38 0 C-N-CA 124.069 0.948 . . . . 0.0 112.136 179.163 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 20.4 p90 -150.38 158.57 44.31 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 -168.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -95.22 134.19 38.25 Favored 'General case' 0 CA--C 1.563 1.47 0 O-C-N 121.464 -0.773 . . . . 0.0 110.938 164.491 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 36.4 t -72.53 122.92 26.09 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.807 0 C-N-CA 123.845 0.858 . . . . 0.0 109.431 178.661 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 104.74 -48.55 0.98 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 115.56 0.984 . . . . 0.0 115.56 -163.636 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 26.2 tptp -65.14 133.48 51.66 Favored 'General case' 0 CA--C 1.567 1.618 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 176.225 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -92.48 110.19 21.6 Favored 'General case' 0 CA--C 1.569 1.709 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.139 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -118.99 134.44 55.19 Favored 'General case' 0 N--CA 1.498 1.947 0 C-N-CA 124.092 0.957 . . . . 0.0 112.664 -169.385 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -73.41 131.78 42.23 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.248 -1.532 . . . . 0.0 114.245 178.704 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -77.09 61.65 2.07 Favored 'General case' 0 N--CA 1.5 2.068 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 176.819 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -87.49 62.54 7.18 Favored 'General case' 0 CA--C 1.57 1.748 0 O-C-N 120.029 -1.67 . . . . 0.0 112.628 -177.815 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 48.3 tp -148.17 118.35 7.28 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.209 -0.932 . . . . 0.0 110.746 -159.391 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 94.7 m -74.33 135.07 42.52 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -173.857 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 150.91 -63.17 0.4 Allowed Glycine 0 N--CA 1.488 2.143 0 CA-C-O 119.51 -0.606 . . . . 0.0 114.575 179.363 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 65.4 mt -80.91 -78.99 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 178.122 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -132.68 141.44 48.6 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-N 119.522 1.055 . . . . 0.0 110.192 167.217 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -91.25 67.79 5.85 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.041 -1.037 . . . . 0.0 112.803 178.505 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.3 ttp180 -150.5 115.09 5.21 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 168.246 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.13 149.08 43.32 Favored 'General case' 0 CA--C 1.565 1.528 0 N-CA-C 116.355 1.983 . . . . 0.0 116.355 -168.702 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 97.8 m -139.3 127.92 23.15 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.626 179.711 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 33.7 mtp -71.2 105.37 3.4 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-O 122.305 1.05 . . . . 0.0 111.799 -179.64 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 53.8 m -106.13 119.2 38.61 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.638 -161.406 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 87.6 m -94.79 124.68 38.98 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 166.727 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 57.8 t -105.45 135.95 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 167.141 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 52.4 m -147.5 146.88 29.66 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.286 -1.509 . . . . 0.0 112.528 -177.47 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 47.1 m95 -83.94 119.03 24.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.177 -0.952 . . . . 0.0 112.782 178.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -96.13 71.55 2.86 Favored 'General case' 0 CA--C 1.573 1.849 0 C-N-CA 123.061 0.544 . . . . 0.0 109.569 157.755 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 62.65 -102.83 0.54 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 115.653 1.021 . . . . 0.0 115.653 -175.21 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -80.77 -22.29 40.26 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 116.312 1.967 . . . . 0.0 116.312 169.124 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 61.2 mtpt -92.92 121.83 34.67 Favored 'General case' 0 CA--C 1.56 1.349 0 CA-C-N 119.547 1.067 . . . . 0.0 110.499 -177.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 33.0 tp -89.17 106.98 18.79 Favored 'General case' 0 CA--C 1.564 1.492 0 O-C-N 121.407 -0.808 . . . . 0.0 109.345 174.099 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 -96.59 137.21 36.01 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.724 0.81 . . . . 0.0 111.349 -175.545 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 40.7 t -134.17 128.35 33.86 Favored 'General case' 0 N--CA 1.483 1.189 0 O-C-N 121.732 -0.605 . . . . 0.0 111.742 -177.056 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 11.1 p -122.47 124.1 70.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 C-N-CA 123.284 0.634 . . . . 0.0 109.84 176.133 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -102.66 106.85 17.57 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 123.855 0.862 . . . . 0.0 110.385 -176.272 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -101.85 124.12 46.94 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.289 -0.882 . . . . 0.0 111.666 -169.716 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 177.49 -62.17 0.09 OUTLIER Glycine 0 N--CA 1.494 2.541 0 N-CA-C 117.388 1.715 . . . . 0.0 117.388 178.337 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -134.12 -58.41 0.85 Allowed 'General case' 0 N--CA 1.496 1.836 0 CA-C-N 117.529 0.664 . . . . 0.0 112.151 178.489 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 53.8 mttm -79.37 139.78 37.65 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 114.374 1.25 . . . . 0.0 114.374 -176.042 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -80.33 146.98 31.3 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-N 114.638 -1.165 . . . . 0.0 112.705 175.337 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 65.04 20.3 66.76 Favored Glycine 0 N--CA 1.495 2.59 0 N-CA-C 119.802 2.681 . . . . 0.0 119.802 -173.629 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 26.6 ttt180 -84.36 118.17 24.06 Favored 'General case' 0 CA--C 1.566 1.577 0 CA-C-N 118.91 1.355 . . . . 0.0 111.654 -177.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 179.29 -171.77 43.7 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 115.298 0.879 . . . . 0.0 115.298 -174.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . 0.259 39.9 p-90 -156.49 155.0 31.24 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 170.647 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 84.7 m -128.06 116.55 20.18 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 177.192 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -120.26 126.98 51.93 Favored 'General case' 0 N--CA 1.495 1.821 0 C-N-CA 123.545 0.738 . . . . 0.0 111.537 -174.302 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 16.3 p90 -148.61 155.38 41.0 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 120.893 -1.13 . . . . 0.0 113.364 -178.052 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 90.7 mt -98.1 132.96 41.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.02 -1.05 . . . . 0.0 110.291 177.298 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -118.79 94.04 4.31 Favored 'General case' 0 CA--C 1.566 1.594 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 162.239 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 69.07 -112.38 4.52 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 115.396 0.919 . . . . 0.0 115.396 -178.786 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 16.0 p30 -85.96 -2.42 58.27 Favored 'General case' 0 CA--C 1.572 1.827 0 N-CA-C 117.139 2.274 . . . . 0.0 117.139 166.32 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 88.2 mt-10 -109.93 128.95 55.69 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-N 120.646 1.566 . . . . 0.0 111.712 -174.142 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 12.2 tp -90.59 116.03 28.17 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.962 0.905 . . . . 0.0 109.421 167.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 57.7 m80 -99.9 122.45 42.84 Favored 'General case' 0 CA--C 1.559 1.295 0 C-N-CA 123.936 0.895 . . . . 0.0 109.422 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 47.6 tp -123.96 119.65 30.21 Favored 'General case' 0 CA--C 1.561 1.368 0 C-N-CA 123.974 0.909 . . . . 0.0 109.878 -174.719 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -108.74 106.62 16.73 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 171.402 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 62.0 mtm -99.72 125.83 45.67 Favored 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 123.043 0.537 . . . . 0.0 111.05 -178.589 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 71.5 mtm180 -114.56 139.41 49.61 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 123.629 0.772 . . . . 0.0 111.551 -168.114 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -155.64 124.6 6.11 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.583 -0.698 . . . . 0.0 110.798 168.309 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 60.55 36.21 19.95 Favored 'General case' 0 N--CA 1.505 2.32 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 -178.176 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 78.64 -22.39 3.36 Favored Glycine 0 CA--C 1.554 2.524 0 N-CA-C 119.3 2.48 . . . . 0.0 119.3 -162.006 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 85.7 t -80.15 120.83 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 CA-C-N 119.886 1.843 . . . . 0.0 110.091 -171.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 57.0 m -103.74 118.22 36.2 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 122.923 0.489 . . . . 0.0 111.015 -179.399 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 37.7 t -84.74 127.79 34.28 Favored 'General case' 0 CA--C 1.559 1.291 0 C-N-CA 123.115 0.566 . . . . 0.0 111.953 162.557 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 38.2 mtmm -106.21 109.39 21.31 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -179.36 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -114.69 133.19 56.07 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 123.674 0.79 . . . . 0.0 111.14 179.115 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 44.7 t -118.06 131.3 71.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 177.405 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -125.96 138.26 53.75 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 123.328 0.651 . . . . 0.0 111.656 -179.422 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 29.0 tptp -96.39 137.25 35.74 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.156 -0.965 . . . . 0.0 112.623 178.691 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 73.1 tttt -70.73 123.6 22.31 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 174.462 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 24.4 m -107.0 -42.67 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.13 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 173.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 32.8 m80 . . . . . 0 C--O 1.254 1.293 0 CA-C-N 119.601 1.091 . . . . 0.0 108.683 179.256 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 60.4 mtt . . . . . 0 CA--C 1.571 1.785 0 CA-C-O 118.59 -0.719 . . . . 0.0 112.156 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -75.97 139.45 21.87 Favored 'Trans proline' 0 CA--C 1.561 1.849 0 C-N-CA 122.428 2.085 . . . . 0.0 115.728 179.331 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 33.0 m -75.37 152.91 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 CA-C-O 122.305 1.05 . . . . 0.0 113.121 177.226 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -71.93 113.53 9.06 Favored 'General case' 0 CA--C 1.56 1.365 0 O-C-N 121.328 -0.857 . . . . 0.0 112.212 172.341 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 6.0 m-30 -77.02 6.38 6.44 Favored 'General case' 0 CA--C 1.582 2.173 0 N-CA-C 116.188 1.922 . . . . 0.0 116.188 173.339 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -53.51 111.42 0.71 Allowed 'General case' 0 CA--C 1.565 1.532 0 C-N-CA 126.376 1.87 . . . . 0.0 115.597 -178.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 163.1 178.18 36.68 Favored Glycine 0 N--CA 1.482 1.759 0 CA-C-O 123.01 1.339 . . . . 0.0 116.104 177.868 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -107.76 124.6 50.27 Favored 'General case' 0 CA--C 1.563 1.46 0 CA-C-N 113.869 -1.165 . . . . 0.0 109.088 175.61 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -118.92 140.92 49.18 Favored 'General case' 0 CA--C 1.569 1.674 0 C-N-CA 123.9 0.88 . . . . 0.0 110.357 -168.242 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -115.6 133.04 56.42 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.165 -0.959 . . . . 0.0 111.841 176.751 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 53.9 ttm -71.61 123.83 23.37 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.096 -1.002 . . . . 0.0 113.562 -177.295 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 94.9 mt -81.19 -53.18 6.6 Favored 'General case' 0 CA--C 1.567 1.626 0 CA-C-N 115.307 -0.861 . . . . 0.0 112.466 169.35 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 92.4 p -145.65 124.8 12.89 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.662 0.785 . . . . 0.0 111.106 -175.475 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -103.19 96.21 6.63 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.92 0.867 . . . . 0.0 110.527 166.047 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -99.24 127.05 45.18 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 124.007 0.923 . . . . 0.0 109.592 -171.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 5.9 t30 66.32 23.16 10.76 Favored 'General case' 0 N--CA 1.508 2.443 0 N-CA-C 116.794 2.146 . . . . 0.0 116.794 -174.568 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -69.08 -46.96 66.47 Favored 'General case' 0 CA--C 1.568 1.656 0 N-CA-C 115.034 1.494 . . . . 0.0 115.034 178.135 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -42.09 -54.42 3.59 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 118.091 2.626 . . . . 0.0 118.091 167.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.28 8.5 pt-20 -75.67 -31.3 59.69 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 116.612 2.079 . . . . 0.0 116.612 176.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 79.5 t80 -55.4 -48.4 74.41 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-N 120.36 1.437 . . . . 0.0 114.569 160.119 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 69.3 mt -60.82 -40.97 94.75 Favored 'General case' 0 CA--C 1.574 1.898 0 N-CA-C 114.887 1.439 . . . . 0.0 114.887 170.753 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 37.6 ttm-85 -51.73 -50.84 59.77 Favored 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 115.262 1.578 . . . . 0.0 115.262 163.25 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.32 -25.37 59.24 Favored 'General case' 0 CA--C 1.566 1.574 0 N-CA-C 117.87 2.544 . . . . 0.0 117.87 168.681 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 97.0 mt -87.58 9.81 19.96 Favored 'General case' 0 CA--C 1.573 1.864 0 N-CA-C 115.656 1.724 . . . . 0.0 115.656 168.243 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 60.54 43.91 12.36 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 115.606 1.706 . . . . 0.0 115.606 -172.273 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 95.4 t -93.9 138.7 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.193 -0.942 . . . . 0.0 109.231 177.818 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 13.1 p30 -63.79 150.38 44.78 Favored 'General case' 0 CA--C 1.57 1.731 0 N-CA-C 115.251 1.575 . . . . 0.0 115.251 178.627 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 88.8 t -56.41 -40.24 66.01 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.22 0 N-CA-C 115.522 1.675 . . . . 0.0 115.522 -177.76 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.5 -53.69 55.35 Favored 'General case' 0 CA--C 1.568 1.672 0 N-CA-C 115.739 1.755 . . . . 0.0 115.739 169.215 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 28.9 tp -63.39 -38.28 90.52 Favored 'General case' 0 CA--C 1.571 1.781 0 N-CA-C 116.175 1.917 . . . . 0.0 116.175 171.22 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 34.6 mtp-105 -49.76 -52.05 34.58 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 115.801 1.778 . . . . 0.0 115.801 163.533 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -64.15 -49.09 73.49 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 114.547 1.314 . . . . 0.0 114.547 172.394 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 64.6 mt -58.49 -51.98 65.02 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 CA-C-N 119.996 1.271 . . . . 0.0 113.152 176.358 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.01 -35.82 81.97 Favored 'General case' 0 CA--C 1.563 1.47 0 N-CA-C 117.682 2.475 . . . . 0.0 117.682 175.497 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -72.23 -31.02 65.45 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 116.049 1.87 . . . . 0.0 116.049 168.115 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 78.3 mt -73.46 -35.15 65.67 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 115.317 1.599 . . . . 0.0 115.317 171.176 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 86.6 mt -83.22 143.68 30.29 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 119.069 0.85 . . . . 0.0 111.858 175.513 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 29.9 mmtp -106.05 88.36 3.01 Favored Pre-proline 0 CA--C 1.574 1.903 0 CA-C-O 117.982 -1.009 . . . . 0.0 109.641 176.078 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -73.18 166.41 30.04 Favored 'Trans proline' 0 CA--C 1.564 1.981 0 C-N-CA 122.45 2.1 . . . . 0.0 116.089 -175.401 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -98.74 155.7 17.21 Favored 'General case' 0 N--CA 1.488 1.425 0 CA-C-O 121.824 0.821 . . . . 0.0 112.373 177.192 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 65.2 mttt -117.4 121.14 40.27 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.508 -0.745 . . . . 0.0 109.357 164.382 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -94.61 109.77 21.66 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.104 -0.997 . . . . 0.0 108.594 161.17 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 68.3 mt -102.32 118.76 49.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 N-CA-C 107.424 -1.325 . . . . 0.0 107.424 179.187 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 57.3 t -111.35 95.43 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 172.099 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -88.32 97.87 11.28 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 123.519 0.728 . . . . 0.0 110.298 173.377 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -114.94 88.92 2.97 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 123.452 0.701 . . . . 0.0 109.973 -176.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 57.98 67.68 2.08 Favored Glycine 0 N--CA 1.495 2.607 0 N-CA-C 116.631 1.412 . . . . 0.0 116.631 178.833 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.477 0.6 OUTLIER 64.26 -25.46 0.08 Allowed 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 119.183 3.031 . . . . 0.0 119.183 -165.08 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 15.7 t-160 -78.09 109.48 12.21 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 121.284 1.856 . . . . 0.0 111.156 174.504 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 46.3 ttm -110.19 114.06 27.24 Favored 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 123.729 0.812 . . . . 0.0 109.496 -175.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 49.7 mt -100.15 102.59 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 175.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 59.1 mt -95.92 104.73 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 175.311 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 89.3 mtt180 -90.65 103.52 16.21 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.648 -0.658 . . . . 0.0 109.276 175.036 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 22.1 m -87.36 101.42 13.54 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.052 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 5.9 mt -111.96 118.48 35.59 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 124.009 0.924 . . . . 0.0 110.093 -163.707 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.1 t -99.08 -78.43 0.5 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.45 -0.781 . . . . 0.0 112.614 178.358 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.7 t 178.58 -61.58 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 125.699 1.6 . . . . 0.0 107.444 -170.176 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 7.9 p90 -83.89 -41.37 17.5 Favored 'General case' 0 CA--C 1.573 1.865 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 163.082 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 42.1 ttt85 -109.43 143.16 39.4 Favored 'General case' 0 CA--C 1.565 1.537 0 C-N-CA 124.124 0.97 . . . . 0.0 112.083 -168.147 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 46.1 t-20 -135.4 131.73 36.65 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 123.383 0.673 . . . . 0.0 110.096 175.486 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 9.2 t80 -124.78 110.24 14.07 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 172.813 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 87.1 mt -102.29 112.42 35.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -176.422 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 27.0 mmm -95.83 94.81 7.87 Favored 'General case' 0 CA--C 1.56 1.359 0 C-N-CA 123.628 0.771 . . . . 0.0 109.238 174.419 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.1 p30 -101.29 100.38 10.89 Favored 'General case' 0 CA--C 1.561 1.377 0 C-N-CA 123.725 0.81 . . . . 0.0 111.616 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -143.96 150.83 38.92 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -166.646 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 -90.44 125.19 35.48 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.977 -1.077 . . . . 0.0 111.81 169.389 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 17.2 t -68.84 119.03 14.0 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.735 0 C-N-CA 123.858 0.863 . . . . 0.0 110.043 179.208 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 111.7 -43.49 1.71 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 115.778 1.071 . . . . 0.0 115.778 -160.08 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 51.2 mttm -83.71 143.87 29.74 Favored 'General case' 0 CA--C 1.567 1.608 0 CA-C-N 118.884 1.342 . . . . 0.0 113.41 -175.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -92.04 121.07 33.26 Favored 'General case' 0 CA--C 1.567 1.615 0 O-C-N 121.882 -0.511 . . . . 0.0 111.277 172.727 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 22.5 p90 -120.63 152.25 38.41 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 123.777 0.831 . . . . 0.0 112.668 -176.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -74.2 120.37 19.67 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.183 -1.573 . . . . 0.0 112.181 167.912 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -71.93 86.93 1.01 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.326 -0.859 . . . . 0.0 111.077 169.868 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 52.5 p-10 -90.46 -62.38 1.47 Allowed 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 114.346 1.239 . . . . 0.0 114.346 -173.165 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -85.63 74.51 10.26 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-N 119.297 0.953 . . . . 0.0 110.75 178.002 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 40.9 p -88.16 91.08 8.64 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.371 -0.831 . . . . 0.0 110.917 -175.834 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -73.62 34.61 0.84 Allowed Glycine 0 N--CA 1.498 2.794 0 N-CA-C 118.78 2.272 . . . . 0.0 118.78 173.362 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 38.8 mm -145.82 -69.52 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.575 1.906 0 N-CA-C 105.88 -1.896 . . . . 0.0 105.88 173.302 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -88.4 146.05 25.46 Favored 'General case' 0 CA--C 1.569 1.673 0 C-N-CA 124.198 0.999 . . . . 0.0 113.209 -176.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -86.99 145.3 26.55 Favored 'General case' 0 CA--C 1.572 1.818 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.353 161.122 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . 0.281 10.0 tpt180 94.44 126.21 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.182 0 C-N-CA 125.586 1.554 . . . . 0.0 111.74 -175.423 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 7.9 mptt -75.97 144.24 41.08 Favored 'General case' 0 CA--C 1.566 1.583 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 176.353 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 85.6 m -132.67 129.74 39.21 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-O 121.723 0.773 . . . . 0.0 111.741 -177.151 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 8.9 tpt -79.01 108.67 12.67 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.879 -1.138 . . . . 0.0 110.743 -178.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 97.4 m -119.71 114.57 22.38 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.146 -0.971 . . . . 0.0 111.069 -151.211 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 52.7 m -92.07 129.95 37.91 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 165.542 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.6 t -113.43 129.08 69.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 163.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 52.2 m -149.04 156.8 42.77 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.587 -1.32 . . . . 0.0 112.843 -175.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 72.8 m95 -82.23 115.39 21.29 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.89 -1.131 . . . . 0.0 112.308 179.305 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -84.83 72.99 10.7 Favored 'General case' 0 CA--C 1.569 1.709 0 O-C-N 121.382 -0.824 . . . . 0.0 109.869 163.864 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 69.42 -98.51 0.59 Allowed Glycine 0 N--CA 1.488 2.125 0 O-C-N 122.188 -0.32 . . . . 0.0 113.646 -167.147 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -99.95 -14.63 18.62 Favored 'General case' 0 CA--C 1.575 1.916 0 N-CA-C 116.393 1.997 . . . . 0.0 116.393 169.5 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 48.7 mtpt -92.82 127.33 38.29 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-N 120.407 1.458 . . . . 0.0 110.236 -176.08 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 26.0 tp -85.03 105.86 16.1 Favored 'General case' 0 CA--C 1.563 1.462 0 O-C-N 120.739 -1.226 . . . . 0.0 110.562 -177.375 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 29.5 mm-40 -95.16 129.34 42.3 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 123.369 0.668 . . . . 0.0 111.478 -177.704 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 41.4 t -116.35 128.34 55.45 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.666 0.786 . . . . 0.0 110.896 173.719 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.6 p -118.76 116.72 52.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 173.454 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 68.7 mt-30 -104.18 98.01 7.88 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 123.84 0.856 . . . . 0.0 109.079 -173.549 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -91.49 134.89 34.26 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.424 -0.797 . . . . 0.0 113.074 -164.275 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 160.43 -109.89 0.42 Allowed Glycine 0 N--CA 1.486 2.009 0 O-C-N 121.504 -0.748 . . . . 0.0 113.526 165.716 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -84.63 -39.08 19.08 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 115.906 1.817 . . . . 0.0 115.906 -175.64 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 17.8 ttmm -88.6 129.07 35.57 Favored 'General case' 0 CA--C 1.564 1.504 0 CA-C-N 119.5 1.046 . . . . 0.0 112.315 -175.397 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -76.16 134.13 40.02 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -172.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 61.93 32.97 83.94 Favored Glycine 0 N--CA 1.496 2.637 0 N-CA-C 119.622 2.609 . . . . 0.0 119.622 -177.444 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 3.9 ttt85 -86.97 119.77 27.53 Favored 'General case' 0 CA--C 1.564 1.515 0 CA-C-N 118.863 1.331 . . . . 0.0 111.264 -179.032 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -178.62 -171.83 42.32 Favored Glycine 0 N--CA 1.483 1.804 0 CA-C-O 122.102 0.834 . . . . 0.0 114.366 179.48 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 47.7 p-90 -156.08 156.24 33.98 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 175.382 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 29.4 m -127.96 119.65 25.95 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 177.004 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -122.72 131.49 53.81 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 -176.44 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 23.9 p90 -148.87 160.66 43.04 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.202 -0.937 . . . . 0.0 112.184 -179.314 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 96.1 mt -109.09 135.04 49.2 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.182 0 O-C-N 120.722 -1.236 . . . . 0.0 110.637 178.498 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -122.51 94.52 4.31 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 124.417 1.087 . . . . 0.0 108.156 176.293 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 73.11 -109.56 2.85 Favored Glycine 0 N--CA 1.491 2.34 0 O-C-N 121.494 -0.754 . . . . 0.0 114.024 -174.231 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -111.55 37.3 2.94 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 114.514 1.301 . . . . 0.0 114.514 164.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 81.3 mt-10 -130.72 130.66 44.09 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.709 0.804 . . . . 0.0 110.642 178.72 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 15.5 tp -90.85 118.09 29.98 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 123.892 0.877 . . . . 0.0 109.526 173.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 43.1 m80 -106.39 118.76 37.48 Favored 'General case' 0 CA--C 1.559 1.294 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -178.532 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 46.8 tp -122.24 124.53 44.02 Favored 'General case' 0 CA--C 1.559 1.301 0 C-N-CA 124.078 0.951 . . . . 0.0 109.572 -173.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 77.5 mt-10 -114.03 109.89 19.18 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.547 -0.72 . . . . 0.0 109.661 170.604 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 68.7 mtm -101.64 127.2 48.49 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 123.336 0.654 . . . . 0.0 110.858 -177.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 54.2 mtp85 -116.83 137.62 52.08 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 123.416 0.687 . . . . 0.0 110.932 -171.44 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -157.18 129.38 7.29 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.562 -0.711 . . . . 0.0 111.278 170.787 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . 0.276 22.6 mt-10 57.57 38.37 27.87 Favored 'General case' 0 N--CA 1.502 2.15 0 N-CA-C 115.77 1.767 . . . . 0.0 115.77 -176.256 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 69.14 9.26 60.05 Favored Glycine 0 CA--C 1.555 2.586 0 N-CA-C 120.365 2.906 . . . . 0.0 120.365 -164.344 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 95.0 t -111.59 125.54 68.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 CA-C-N 119.989 1.894 . . . . 0.0 108.972 -174.641 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 41.7 m -106.73 123.24 47.85 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 123.137 0.575 . . . . 0.0 111.168 -176.193 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 22.1 t -94.27 124.2 38.14 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.541 0.736 . . . . 0.0 111.513 164.378 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 48.5 mtpt -99.02 114.74 27.56 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 123.38 0.672 . . . . 0.0 109.65 177.773 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 20.2 mt-30 -119.78 123.59 44.09 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 123.35 0.66 . . . . 0.0 110.729 -178.606 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 43.8 t -112.91 130.49 66.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.411 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -123.97 147.45 47.74 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 123.595 0.758 . . . . 0.0 110.909 177.327 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -107.02 143.5 35.03 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.222 -0.924 . . . . 0.0 112.24 174.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 64.9 tttt -77.08 124.65 28.1 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 -177.186 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 27.7 m -110.86 -40.22 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 178.384 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 47.6 t-80 . . . . . 0 N--CA 1.486 1.373 0 CA-C-N 120.474 1.488 . . . . 0.0 108.488 174.824 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 0' ' ' MET . . . . . . . . . . . . 0.291 68.5 mtt . . . . . 0 CA--C 1.573 1.839 0 CA-C-O 116.764 -1.588 . . . . 0.0 114.339 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -65.19 -105.41 0.0 OUTLIER 'Trans proline' 0 CA--C 1.574 2.496 0 C-N-CA 123.734 2.956 . . . . 0.0 115.867 173.675 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 16.9 t -151.0 132.06 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 -172.227 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -75.78 90.09 2.88 Favored 'General case' 0 CA--C 1.569 1.698 0 O-C-N 121.193 -0.942 . . . . 0.0 111.76 172.065 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 10.6 m-30 -70.36 -1.38 10.4 Favored 'General case' 0 CA--C 1.58 2.119 0 N-CA-C 117.834 2.531 . . . . 0.0 117.834 176.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -51.96 123.61 10.8 Favored 'General case' 0 CA--C 1.566 1.594 0 N-CA-C 115.668 1.729 . . . . 0.0 115.668 177.382 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 163.21 176.93 35.73 Favored Glycine 0 N--CA 1.486 1.995 0 N-CA-C 116.153 1.221 . . . . 0.0 116.153 178.783 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -111.58 121.0 43.97 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 171.335 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 78.9 m95 -124.71 126.11 45.17 Favored 'General case' 0 CA--C 1.566 1.594 0 C-N-CA 123.297 0.639 . . . . 0.0 110.591 -165.498 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -96.62 138.97 33.39 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 120.673 -1.267 . . . . 0.0 113.215 177.446 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 6.5 ttp -74.68 128.41 35.49 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.683 -1.261 . . . . 0.0 114.207 -178.177 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 91.0 mt -90.39 -50.05 6.18 Favored 'General case' 0 CA--C 1.567 1.617 0 N-CA-C 113.874 1.065 . . . . 0.0 113.874 172.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 91.3 p -139.98 154.81 47.27 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -175.43 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 24.7 p30 -135.77 81.36 1.88 Allowed 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 124.133 0.973 . . . . 0.0 111.092 173.52 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -88.67 119.58 29.27 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.102 -0.999 . . . . 0.0 110.144 -174.547 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.273 41.9 t30 67.95 21.68 8.84 Favored 'General case' 0 N--CA 1.504 2.251 0 N-CA-C 116.821 2.156 . . . . 0.0 116.821 -175.533 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -69.29 -47.14 65.41 Favored 'General case' 0 CA--C 1.568 1.666 0 N-CA-C 115.795 1.776 . . . . 0.0 115.795 178.051 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -46.48 -44.41 17.55 Favored 'General case' 0 N--CA 1.502 2.173 0 N-CA-C 117.534 2.42 . . . . 0.0 117.534 165.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -69.44 -44.79 70.57 Favored 'General case' 0 CA--C 1.57 1.731 0 N-CA-C 114.992 1.479 . . . . 0.0 114.992 172.658 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -52.94 -47.35 68.14 Favored 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 115.123 1.527 . . . . 0.0 115.123 166.532 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.7 mt -61.14 -41.63 97.08 Favored 'General case' 0 CA--C 1.571 1.782 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 169.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 44.2 ttp85 -56.62 -45.52 81.47 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 115.36 1.615 . . . . 0.0 115.36 166.627 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.12 -25.1 60.98 Favored 'General case' 0 CA--C 1.567 1.606 0 N-CA-C 117.827 2.528 . . . . 0.0 117.827 165.587 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 98.1 mt -89.39 21.79 3.19 Favored 'General case' 0 CA--C 1.573 1.836 0 N-CA-C 115.23 1.567 . . . . 0.0 115.23 164.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 66.9 16.39 10.36 Favored 'General case' 0 N--CA 1.504 2.236 0 N-CA-C 116.682 2.104 . . . . 0.0 116.682 179.551 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 91.4 t -82.03 136.35 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 120.223 -1.548 . . . . 0.0 110.215 -167.463 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 13.7 p30 -62.06 152.86 31.45 Favored 'General case' 0 CA--C 1.57 1.727 0 N-CA-C 115.208 1.559 . . . . 0.0 115.208 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 91.5 t -58.7 -38.4 71.53 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.153 0 N-CA-C 115.219 1.563 . . . . 0.0 115.219 -176.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.12 -55.98 27.64 Favored 'General case' 0 CA--C 1.569 1.687 0 N-CA-C 115.448 1.647 . . . . 0.0 115.448 167.784 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -56.52 -43.29 79.65 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 116.275 1.954 . . . . 0.0 116.275 169.744 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 37.3 mtp-105 -52.07 -53.06 46.85 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 116.017 1.858 . . . . 0.0 116.017 168.343 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -66.75 -47.75 71.27 Favored 'General case' 0 CA--C 1.567 1.629 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 174.052 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 66.1 mt -55.34 -54.87 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 CA-C-N 120.047 1.294 . . . . 0.0 113.266 174.042 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.84 -38.02 89.13 Favored 'General case' 0 CA--C 1.564 1.514 0 N-CA-C 117.635 2.457 . . . . 0.0 117.635 176.257 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -74.16 -24.11 59.35 Favored 'General case' 0 CA--C 1.571 1.759 0 N-CA-C 116.138 1.903 . . . . 0.0 116.138 171.265 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 73.6 mt -73.2 -37.79 66.34 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 115.405 1.631 . . . . 0.0 115.405 168.255 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.5 pp -84.28 143.92 29.23 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 119.597 1.089 . . . . 0.0 113.923 -178.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm -104.53 101.88 30.58 Favored Pre-proline 0 CA--C 1.572 1.818 0 CA-C-O 117.954 -1.022 . . . . 0.0 109.348 174.111 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -82.26 172.12 11.96 Favored 'Trans proline' 0 CA--C 1.564 2.014 0 C-N-CA 122.805 2.337 . . . . 0.0 114.778 -176.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -109.2 118.97 38.11 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.278 176.782 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 52.6 mttm -85.38 108.3 17.78 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.073 -1.017 . . . . 0.0 109.895 172.417 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -91.89 108.06 19.65 Favored 'General case' 0 CA--C 1.559 1.302 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 164.676 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 84.9 mt -97.6 114.15 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 -179.651 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 98.0 t -101.06 97.72 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 168.49 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -95.66 99.63 11.46 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 123.673 0.789 . . . . 0.0 109.727 175.328 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -106.64 75.25 1.05 Allowed 'General case' 0 CA--C 1.567 1.612 0 C-N-CA 123.557 0.743 . . . . 0.0 110.563 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 57.61 68.24 1.8 Allowed Glycine 0 N--CA 1.494 2.552 0 N-CA-C 117.628 1.811 . . . . 0.0 117.628 177.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.494 0.0 OUTLIER 81.99 -39.24 0.12 Allowed 'General case' 0 N--CA 1.501 2.108 0 N-CA-C 115.837 1.792 . . . . 0.0 115.837 -165.358 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 21.8 t-160 -74.32 100.49 3.77 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 120.677 1.58 . . . . 0.0 111.183 177.327 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 42.5 ttm -113.14 111.26 21.8 Favored 'General case' 0 CA--C 1.552 1.031 0 CA-C-O 121.665 0.745 . . . . 0.0 109.137 -170.191 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 51.8 mt -102.79 103.12 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 -175.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 26.0 mm -89.22 93.72 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 -178.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 61.1 mtt85 -90.45 97.38 11.15 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.232 -0.918 . . . . 0.0 110.099 178.565 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 14.3 m -89.41 99.19 12.24 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.69 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 15.1 mt -93.77 117.36 29.99 Favored 'General case' 0 N--CA 1.484 1.266 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.594 -162.308 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 42.2 t -133.11 141.27 48.09 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.849 0.859 . . . . 0.0 110.752 -159.462 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 13.1 t -74.09 39.35 0.11 Allowed 'General case' 0 CA--C 1.581 2.144 0 N-CA-C 116.701 2.112 . . . . 0.0 116.701 172.834 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -159.52 -65.29 0.08 Allowed 'General case' 0 CA--C 1.567 1.621 0 C-N-CA 124.676 1.19 . . . . 0.0 109.92 178.846 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 53.4 ttm-85 -140.09 117.52 11.42 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 123.625 0.77 . . . . 0.0 108.942 174.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 72.0 m-80 -76.77 126.99 31.92 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.785 -0.572 . . . . 0.0 111.993 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 40.9 t80 -106.47 100.28 9.82 Favored 'General case' 0 CA--C 1.567 1.606 0 O-C-N 121.645 -0.66 . . . . 0.0 110.724 -172.317 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 4.1 mp -95.36 111.22 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 C-N-CA 123.73 0.812 . . . . 0.0 109.051 178.392 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -103.55 94.83 5.67 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 123.413 0.685 . . . . 0.0 109.621 176.672 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -100.38 118.07 35.87 Favored 'General case' 0 CA--C 1.564 1.486 0 C-N-CA 123.913 0.885 . . . . 0.0 112.805 -174.489 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -155.15 143.2 20.11 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 -170.147 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 17.9 mp0 -85.18 116.17 23.39 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.441 -0.787 . . . . 0.0 110.376 166.405 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 41.2 t -65.08 117.54 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 C-N-CA 123.769 0.828 . . . . 0.0 110.047 177.242 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 118.61 -54.68 0.61 Allowed Glycine 0 N--CA 1.488 2.139 0 N-CA-C 114.675 0.63 . . . . 0.0 114.675 -159.049 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 5.9 mtmp? -80.79 148.02 30.21 Favored 'General case' 0 CA--C 1.566 1.586 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 -173.519 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -98.78 124.13 43.45 Favored 'General case' 0 CA--C 1.568 1.665 0 C-N-CA 123.183 0.593 . . . . 0.0 111.78 178.497 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 9.0 p90 -135.76 145.63 46.79 Favored 'General case' 0 N--CA 1.498 1.967 0 C-N-CA 123.837 0.855 . . . . 0.0 112.024 -171.605 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -79.15 128.29 33.1 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 119.54 -1.975 . . . . 0.0 113.64 177.675 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -73.95 85.53 1.76 Allowed 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 122.238 1.018 . . . . 0.0 112.079 173.267 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -126.46 -55.48 1.43 Allowed 'General case' 0 CA--C 1.567 1.629 0 C-N-CA 124.087 0.955 . . . . 0.0 111.855 176.369 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.1 tt -70.01 137.05 51.05 Favored 'General case' 0 CA--C 1.568 1.658 0 C-N-CA 123.631 0.772 . . . . 0.0 111.855 173.445 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . 0.332 29.1 m 87.69 136.62 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.168 0 C-N-CA 124.897 1.279 . . . . 0.0 110.51 -166.304 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -71.67 81.42 0.52 Allowed Glycine 0 N--CA 1.492 2.417 0 N-CA-C 117.796 1.878 . . . . 0.0 117.796 -172.114 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . 0.253 5.4 tp -108.27 -162.46 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.58 2.103 0 C-N-CA 124.788 1.235 . . . . 0.0 110.881 175.537 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -64.82 129.79 41.09 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 119.744 -1.847 . . . . 0.0 111.952 164.327 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -75.6 65.29 1.78 Allowed 'General case' 0 CA--C 1.575 1.917 0 N-CA-C 114.615 1.339 . . . . 0.0 114.615 -176.542 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 7.4 mpt_? -136.16 135.75 39.45 Favored 'General case' 0 CA--C 1.561 1.378 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 160.447 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 10.3 mtmt -79.55 72.43 6.21 Favored 'General case' 0 CA--C 1.571 1.782 0 O-C-N 121.225 -0.922 . . . . 0.0 113.156 -170.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 73.0 m -80.73 121.1 25.48 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 121.922 0.868 . . . . 0.0 113.038 -164.131 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 7.2 tpt -75.88 111.13 10.92 Favored 'General case' 0 CA--C 1.56 1.331 0 CA-C-O 122.175 0.988 . . . . 0.0 110.522 -170.318 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 93.8 m -120.61 120.61 36.27 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 115.377 -0.828 . . . . 0.0 110.399 -153.501 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 50.9 m -105.79 125.29 50.82 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 171.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.435 HG22 ' SG ' ' A' ' 95' ' ' CYS . 20.4 t -104.61 130.8 54.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 165.794 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 58.7 m -149.94 152.35 34.85 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.455 -1.403 . . . . 0.0 112.871 -178.418 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 52.3 m95 -83.78 118.96 24.26 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.939 -1.1 . . . . 0.0 113.544 -176.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -94.13 67.38 3.61 Favored 'General case' 0 CA--C 1.572 1.819 0 O-C-N 121.594 -0.691 . . . . 0.0 110.101 159.126 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 67.09 -102.63 0.81 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 114.798 0.679 . . . . 0.0 114.798 -176.371 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -80.81 -23.22 39.38 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 116.523 2.045 . . . . 0.0 116.523 169.284 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 60.1 mtpt -98.77 116.15 30.36 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 119.317 0.962 . . . . 0.0 110.182 -174.659 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 29.2 tp -82.83 109.47 16.99 Favored 'General case' 0 CA--C 1.564 1.485 0 O-C-N 121.277 -0.89 . . . . 0.0 110.057 175.438 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 -97.78 131.93 43.85 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.644 0.778 . . . . 0.0 111.538 -174.194 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' CYS . . . . . 0.435 ' SG ' HG22 ' A' ' 86' ' ' VAL . 44.9 t -122.26 128.92 51.71 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.341 0.657 . . . . 0.0 110.744 175.208 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.1 p -110.69 127.6 67.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 166.221 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -109.05 88.62 2.77 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 123.453 0.701 . . . . 0.0 109.665 175.821 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 12.0 ptmm? -97.22 145.19 26.3 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 114.309 1.225 . . . . 0.0 114.309 -172.23 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 159.75 -97.52 0.16 Allowed Glycine 0 N--CA 1.488 2.133 0 O-C-N 121.282 -0.886 . . . . 0.0 112.626 173.092 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -75.2 -47.16 29.63 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 115.125 1.528 . . . . 0.0 115.125 173.788 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 1.6 ttmp? -103.51 131.79 50.33 Favored 'General case' 0 CA--C 1.561 1.38 0 C-N-CA 123.636 0.774 . . . . 0.0 111.77 -161.796 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -77.87 160.38 28.32 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -179.41 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 56.57 21.43 35.08 Favored Glycine 0 N--CA 1.498 2.774 0 N-CA-C 120.722 3.049 . . . . 0.0 120.722 -179.59 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 45.1 ttt180 -96.02 123.21 39.53 Favored 'General case' 0 CA--C 1.563 1.459 0 CA-C-N 118.481 1.14 . . . . 0.0 112.42 -168.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 173.39 -169.78 42.9 Favored Glycine 0 N--CA 1.484 1.887 0 CA-C-O 121.949 0.75 . . . . 0.0 114.558 -176.327 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . 0.253 41.5 p-90 -156.82 157.17 34.47 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 113.804 1.038 . . . . 0.0 113.804 173.536 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 34.5 m -129.63 118.57 22.17 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 123.782 0.833 . . . . 0.0 108.765 176.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 -121.42 130.15 53.42 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.743 -0.598 . . . . 0.0 112.434 -175.823 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 25.4 p90 -144.66 164.86 29.7 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.251 -0.906 . . . . 0.0 112.059 176.477 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 96.3 mt -109.79 127.82 66.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 120.915 -1.116 . . . . 0.0 109.789 175.734 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -102.02 84.54 2.53 Favored 'General case' 0 CA--C 1.567 1.616 0 C-N-CA 123.997 0.919 . . . . 0.0 109.185 163.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 64.84 -98.06 0.28 Allowed Glycine 0 N--CA 1.493 2.442 0 N-CA-C 116.452 1.341 . . . . 0.0 116.452 -179.012 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 41.1 p30 -88.94 -5.46 57.96 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 117.36 2.356 . . . . 0.0 117.36 167.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -114.63 125.53 53.87 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-N 120.874 1.67 . . . . 0.0 111.529 -172.575 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 14.2 tp -86.26 115.13 23.61 Favored 'General case' 0 CA--C 1.563 1.474 0 C-N-CA 123.869 0.867 . . . . 0.0 109.472 169.605 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 51.8 m80 -102.42 121.09 41.65 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.651 0.78 . . . . 0.0 109.029 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 53.6 tp -121.16 119.41 32.28 Favored 'General case' 0 CA--C 1.562 1.433 0 C-N-CA 123.714 0.806 . . . . 0.0 110.005 -176.637 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -100.19 116.55 32.45 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 168.605 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 71.9 mtm -109.76 124.97 52.19 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 118.974 0.806 . . . . 0.0 110.977 -178.723 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 87.4 mtm180 -112.3 137.13 50.86 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 123.963 0.905 . . . . 0.0 110.809 -171.061 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -154.03 129.97 10.21 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.372 -0.83 . . . . 0.0 111.344 168.481 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . 0.273 7.9 mm-40 64.05 9.19 4.47 Favored 'General case' 0 N--CA 1.502 2.125 0 N-CA-C 117.59 2.441 . . . . 0.0 117.59 -175.303 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 99.88 -19.08 54.74 Favored Glycine 0 CA--C 1.556 2.615 0 N-CA-C 117.792 1.877 . . . . 0.0 117.792 -157.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 96.8 t -83.86 124.27 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 CA-C-N 119.7 1.75 . . . . 0.0 109.77 -177.658 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 47.9 m -103.74 119.73 39.51 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 121.108 0.48 . . . . 0.0 111.205 176.779 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 8.8 t -88.94 136.45 33.0 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.656 0.783 . . . . 0.0 112.075 162.476 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -111.23 114.93 28.5 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.718 -0.614 . . . . 0.0 109.832 176.499 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -113.81 140.38 48.36 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.857 0.863 . . . . 0.0 111.545 176.266 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 34.5 t -123.06 134.84 65.0 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 177.566 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -130.24 132.56 46.01 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 123.878 0.871 . . . . 0.0 111.215 -177.273 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 20.2 tptm -98.06 136.11 38.78 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.997 -1.065 . . . . 0.0 112.161 -178.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 67.7 tttt -74.5 118.33 17.33 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.522 -0.737 . . . . 0.0 112.777 179.531 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . 0.254 35.0 m -102.85 -40.79 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 175.067 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 67.0 t60 . . . . . 0 N--CA 1.486 1.351 0 CA-C-N 119.838 1.199 . . . . 0.0 107.95 164.212 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo . . . . . 0 CA--C 1.563 1.967 0 N-CA-C 114.658 0.984 . . . . 0.0 114.658 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 33.0 m -78.73 125.84 38.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -166.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -75.67 97.49 3.82 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.026 -1.046 . . . . 0.0 112.532 -176.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -72.76 1.22 8.9 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 117.981 2.586 . . . . 0.0 117.981 -178.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -51.84 109.51 0.37 Allowed 'General case' 0 CA--C 1.566 1.594 0 N-CA-C 115.716 1.747 . . . . 0.0 115.716 -176.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 161.24 179.05 35.72 Favored Glycine 0 N--CA 1.484 1.894 0 CA-C-O 122.666 1.148 . . . . 0.0 115.94 -178.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -110.92 126.09 54.36 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 114.052 -1.074 . . . . 0.0 108.541 172.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 49.7 m95 -128.94 125.09 36.75 Favored 'General case' 0 CA--C 1.566 1.578 0 C-N-CA 123.358 0.663 . . . . 0.0 109.46 -167.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 16.7 ptpt -89.78 143.95 26.37 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.857 -1.152 . . . . 0.0 112.933 174.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.41 ' SD ' ' OD1' ' A' ' 13' ' ' ASN . 49.1 ttm -75.99 127.87 33.87 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.845 -1.16 . . . . 0.0 112.585 174.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 88.7 mt -87.06 -49.91 7.0 Favored 'General case' 0 CA--C 1.568 1.639 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 171.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 91.9 p -143.46 142.04 31.03 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 119.428 1.013 . . . . 0.0 113.368 -170.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.41 ' OD1' ' SD ' ' A' ' 10' ' ' MET . 2.3 m120 -117.99 93.42 4.13 Favored 'General case' 0 CA--C 1.565 1.527 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 -177.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -77.18 -70.23 0.48 Allowed 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 115.585 1.698 . . . . 0.0 115.585 -165.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -119.08 44.56 2.3 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.907 0.861 . . . . 0.0 111.237 175.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -72.38 -37.53 68.72 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 114.894 1.442 . . . . 0.0 114.894 175.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -50.02 -54.08 22.51 Favored 'General case' 0 CA--C 1.574 1.889 0 N-CA-C 115.288 1.588 . . . . 0.0 115.288 166.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -71.62 -36.94 70.93 Favored 'General case' 0 CA--C 1.574 1.881 0 N-CA-C 115.978 1.844 . . . . 0.0 115.978 175.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -55.09 -49.54 71.44 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 114.84 1.422 . . . . 0.0 114.84 165.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 78.7 mt -60.96 -39.91 91.33 Favored 'General case' 0 CA--C 1.574 1.889 0 N-CA-C 114.819 1.414 . . . . 0.0 114.819 169.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 26.9 ttm180 -51.52 -51.73 52.8 Favored 'General case' 0 N--CA 1.502 2.173 0 N-CA-C 115.467 1.654 . . . . 0.0 115.467 163.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.51 -27.7 62.78 Favored 'General case' 0 CA--C 1.567 1.635 0 N-CA-C 117.908 2.559 . . . . 0.0 117.908 167.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 95.8 mt -81.52 10.92 5.1 Favored 'General case' 0 CA--C 1.573 1.837 0 N-CA-C 115.614 1.709 . . . . 0.0 115.614 167.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.252 0.9 OUTLIER 64.03 40.0 7.47 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 115.434 1.642 . . . . 0.0 115.434 -175.429 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 89.0 t -100.15 151.0 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 CA-C-O 122.379 1.085 . . . . 0.0 110.645 -178.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 9.7 p-10 -74.12 154.39 39.16 Favored 'General case' 0 CA--C 1.568 1.656 0 N-CA-C 115.59 1.7 . . . . 0.0 115.59 -179.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 45.9 t -54.58 -45.72 71.72 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.345 0 N-CA-C 115.059 1.503 . . . . 0.0 115.059 -176.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.33 -47.98 83.41 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 115.922 1.823 . . . . 0.0 115.922 176.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.77 -49.89 75.96 Favored 'General case' 0 CA--C 1.571 1.75 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 168.02 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 56.3 mtp180 -48.55 -55.47 11.0 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 116.302 1.964 . . . . 0.0 116.302 167.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 35.8 tptt -59.32 -50.78 72.67 Favored 'General case' 0 CA--C 1.564 1.504 0 N-CA-C 115.471 1.656 . . . . 0.0 115.471 176.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 22.2 mt -67.86 -45.69 83.64 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.806 0 CA-C-O 118.03 -0.986 . . . . 0.0 112.286 177.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -57.9 -39.89 79.0 Favored 'General case' 0 CA--C 1.565 1.548 0 N-CA-C 117.229 2.307 . . . . 0.0 117.229 170.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -65.94 -28.67 69.09 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 116.411 2.004 . . . . 0.0 116.411 166.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 80.4 mt -72.99 -37.17 67.1 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 115.727 1.751 . . . . 0.0 115.727 165.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 44.2 mt -68.74 141.48 55.23 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 119.45 1.023 . . . . 0.0 113.711 -175.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 39.2 mmtm -112.54 78.99 2.89 Favored Pre-proline 0 CA--C 1.575 1.91 0 CA-C-O 118.411 -0.804 . . . . 0.0 109.934 177.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.409 ' HD2' ' SD ' ' A' ' 10' ' ' MET . 74.1 Cg_endo -75.34 168.4 24.68 Favored 'Trans proline' 0 CA--C 1.562 1.895 0 C-N-CA 122.528 2.152 . . . . 0.0 115.708 -176.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -108.58 127.36 53.88 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.664 -174.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 38.7 mttp -97.6 113.95 25.77 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.563 -0.71 . . . . 0.0 109.651 172.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -98.69 108.26 20.9 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 165.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.3 mp -96.97 120.05 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 177.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 75.4 t -99.67 101.85 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 166.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -104.59 114.02 27.97 Favored 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 123.469 0.708 . . . . 0.0 110.927 -178.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -123.7 74.48 1.27 Allowed 'General case' 0 CA--C 1.569 1.685 0 C-N-CA 123.843 0.857 . . . . 0.0 110.493 177.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.76 -100.37 1.45 Allowed Glycine 0 N--CA 1.489 2.229 0 O-C-N 121.48 -0.762 . . . . 0.0 114.063 177.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -85.22 -33.84 22.14 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 115.218 1.562 . . . . 0.0 115.218 162.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -78.16 114.15 16.78 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-N 120.682 1.583 . . . . 0.0 112.11 -174.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 48.2 ttm -128.29 118.63 23.6 Favored 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 123.43 0.692 . . . . 0.0 109.644 -175.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 52.4 mt -107.02 103.33 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 176.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 73.2 mt -90.39 99.53 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 175.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 70.5 mtt85 -89.42 95.96 10.5 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.467 -0.771 . . . . 0.0 110.673 178.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 49.5 m -88.29 105.08 17.32 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 177.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 12.2 mt -106.01 113.9 27.72 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 123.684 0.793 . . . . 0.0 109.213 -163.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 9.1 t -139.68 155.91 47.11 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.856 0.836 . . . . 0.0 112.434 -166.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 26.9 m -61.57 -40.74 95.83 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 115.745 1.757 . . . . 0.0 115.745 178.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -69.04 -58.13 4.51 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 114.699 1.37 . . . . 0.0 114.699 171.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 26.4 tpt180 -152.15 135.67 16.09 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-N 118.516 0.598 . . . . 0.0 109.863 175.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -73.98 112.42 10.09 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.776 -0.577 . . . . 0.0 109.706 163.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 52.8 t80 -79.29 -61.68 1.93 Allowed 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -167.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.334 49.7 mt 74.5 97.64 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 C-N-CA 123.932 0.893 . . . . 0.0 111.91 167.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 89.0 mtp -100.18 99.42 10.11 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.486 -0.759 . . . . 0.0 109.352 172.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -98.71 114.45 26.97 Favored 'General case' 0 CA--C 1.563 1.479 0 C-N-CA 124.013 0.925 . . . . 0.0 111.663 177.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -156.55 157.17 34.89 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 -168.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 66.1 mt-30 -100.28 127.16 46.63 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.581 -0.7 . . . . 0.0 110.481 165.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 37.3 t -63.53 123.5 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 C-N-CA 124.103 0.961 . . . . 0.0 110.503 178.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 107.67 -43.28 1.73 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 116.199 1.24 . . . . 0.0 116.199 -158.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 76.1 mttt -86.72 152.57 22.42 Favored 'General case' 0 CA--C 1.568 1.642 0 CA-C-N 118.612 1.206 . . . . 0.0 113.489 -172.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -107.92 117.92 35.39 Favored 'General case' 0 CA--C 1.569 1.674 0 C-N-CA 123.469 0.707 . . . . 0.0 111.469 -173.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 8.8 p90 -127.28 151.57 48.57 Favored 'General case' 0 N--CA 1.501 2.108 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 -171.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -80.43 123.89 28.43 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.015 -1.678 . . . . 0.0 114.81 -176.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 . . . . . 0 N--CA 1.502 2.136 0 N-CA-C 115.696 1.739 . . . . 0.0 115.696 177.501 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 99.2 m . . . . . 0 CA--C 1.56 1.328 0 CA-C-O 121.227 0.536 . . . . 0.0 111.033 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -79.51 94.83 5.68 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 122.999 1.38 . . . . 0.0 110.255 -170.04 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 99.5 m -100.0 118.02 35.5 Favored 'General case' 0 N--CA 1.48 1.036 0 O-C-N 121.292 -0.88 . . . . 0.0 110.372 -153.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 25.0 m -112.74 122.53 47.95 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-N 115.102 -0.954 . . . . 0.0 108.504 -174.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 20.7 t -113.26 127.77 70.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 -177.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 60.9 p -131.36 159.21 38.63 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 122.223 1.011 . . . . 0.0 112.609 -175.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 55.5 m95 -92.13 113.76 26.12 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.782 -0.574 . . . . 0.0 110.605 171.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -92.71 73.22 4.99 Favored 'General case' 0 CA--C 1.566 1.58 0 C-N-CA 123.253 0.621 . . . . 0.0 110.291 171.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.05 -94.56 0.18 Allowed Glycine 0 N--CA 1.489 2.187 0 N-CA-C 114.637 0.615 . . . . 0.0 114.637 -171.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -85.39 -38.37 18.79 Favored 'General case' 0 CA--C 1.569 1.676 0 N-CA-C 115.405 1.631 . . . . 0.0 115.405 171.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -93.31 154.65 17.87 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 119.163 0.892 . . . . 0.0 112.733 -167.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 18.5 tp -99.16 109.68 22.34 Favored 'General case' 0 CA--C 1.564 1.504 0 O-C-N 121.04 -1.037 . . . . 0.0 110.273 178.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 31.7 mm-40 -97.48 122.61 40.74 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 123.862 0.865 . . . . 0.0 111.3 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 41.7 t -114.6 131.39 56.71 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.38 0.672 . . . . 0.0 111.609 175.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 15.0 p -117.03 123.59 72.02 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.699 0 C-N-CA 123.174 0.59 . . . . 0.0 109.579 170.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -98.73 97.05 8.34 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 124.033 0.933 . . . . 0.0 109.277 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 30.4 mmtp -81.31 119.72 24.02 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 -168.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -174.3 -121.38 0.62 Allowed Glycine 0 N--CA 1.484 1.861 0 O-C-N 121.994 -0.441 . . . . 0.0 112.425 171.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -87.05 -32.51 19.94 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 116.619 2.081 . . . . 0.0 116.619 -178.497 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 50.7 mttp -89.57 135.73 33.43 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 120.711 1.596 . . . . 0.0 112.756 -165.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -81.09 102.83 10.5 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.742 0.782 . . . . 0.0 112.989 -164.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 82.35 41.75 9.02 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 117.308 1.683 . . . . 0.0 117.308 -168.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 46.9 ttt180 -84.8 118.46 24.48 Favored 'General case' 0 CA--C 1.564 1.503 0 CA-C-N 118.857 1.329 . . . . 0.0 111.121 175.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 170.84 -165.55 38.75 Favored Glycine 0 N--CA 1.484 1.861 0 N-CA-C 114.827 0.691 . . . . 0.0 114.827 -178.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 28.9 p-90 -157.43 157.13 33.4 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 114.6 1.333 . . . . 0.0 114.6 176.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 25.5 m -120.25 122.37 40.74 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 171.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -119.72 133.89 55.44 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 123.187 0.595 . . . . 0.0 111.834 -178.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 19.0 p90 -149.1 174.45 12.32 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 178.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 55.5 mt -116.46 133.13 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.212 -0.93 . . . . 0.0 108.988 176.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -112.13 90.19 3.27 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 123.773 0.829 . . . . 0.0 109.092 163.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 64.49 -104.66 0.95 Allowed Glycine 0 N--CA 1.492 2.4 0 N-CA-C 115.754 1.062 . . . . 0.0 115.754 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 57.3 p30 -84.13 -2.02 56.04 Favored 'General case' 0 CA--C 1.571 1.775 0 N-CA-C 117.86 2.541 . . . . 0.0 117.86 166.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -118.47 135.9 54.11 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-N 120.657 1.572 . . . . 0.0 112.424 -168.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 12.4 tp -94.38 120.91 35.33 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 123.73 0.812 . . . . 0.0 108.969 174.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 37.3 m80 -109.99 120.1 41.4 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -176.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 42.3 tp -121.51 121.53 37.69 Favored 'General case' 0 CA--C 1.56 1.35 0 C-N-CA 123.576 0.75 . . . . 0.0 109.543 -176.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -107.97 117.89 35.32 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.878 -0.513 . . . . 0.0 109.679 168.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 66.9 mtm -110.46 127.41 55.12 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-N 118.61 0.641 . . . . 0.0 111.1 -178.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 69.1 mtp180 -110.88 144.66 39.56 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -179.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -159.36 131.18 6.36 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.187 0.595 . . . . 0.0 111.153 166.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 59.0 38.07 24.32 Favored 'General case' 0 N--CA 1.507 2.402 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 -173.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 75.75 -26.21 1.4 Allowed Glycine 0 CA--C 1.559 2.827 0 N-CA-C 119.597 2.599 . . . . 0.0 119.597 -160.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 86.8 t -81.02 122.79 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 CA-C-N 119.392 1.596 . . . . 0.0 110.571 -163.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 24.1 m -100.9 120.95 40.9 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 122.909 0.484 . . . . 0.0 111.489 -176.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 44.1 t -88.34 139.45 30.48 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.306 0.643 . . . . 0.0 112.242 160.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 44.8 mtpt -109.51 126.2 53.28 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 168.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -123.03 126.14 46.55 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 123.742 0.817 . . . . 0.0 109.543 174.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 72.8 t -109.1 132.57 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 179.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -122.18 153.07 39.27 Favored 'General case' 0 CA--C 1.565 1.558 0 C-N-CA 124.541 1.136 . . . . 0.0 111.442 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 8.9 tmtt? -120.87 136.88 54.82 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.199 -0.938 . . . . 0.0 111.607 175.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -72.5 120.49 18.19 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 33.4 m -101.49 -43.75 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 N-CA-C 113.194 0.812 . . . . 0.0 113.194 174.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 53.7 t-80 . . . . . 0 N--CA 1.485 1.317 0 CA-C-N 119.75 1.159 . . . . 0.0 108.124 168.472 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo . . . . . 0 CA--C 1.566 2.114 0 N-CA-C 115.356 1.252 . . . . 0.0 115.356 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 25.9 m -81.2 140.04 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.468 -0.77 . . . . 0.0 112.56 177.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.5 100.51 10.13 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.514 -1.366 . . . . 0.0 111.459 175.355 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -72.72 -2.24 19.5 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 118.307 2.706 . . . . 0.0 118.307 177.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -56.29 112.27 1.19 Allowed 'General case' 0 CA--C 1.567 1.601 0 N-CA-C 115.945 1.831 . . . . 0.0 115.945 -172.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 155.46 -161.89 30.78 Favored Glycine 0 N--CA 1.486 1.996 0 N-CA-C 115.7 1.04 . . . . 0.0 115.7 178.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -124.13 127.83 48.37 Favored 'General case' 0 CA--C 1.564 1.498 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 -179.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 61.4 m95 -129.0 125.26 37.0 Favored 'General case' 0 CA--C 1.566 1.567 0 C-N-CA 123.273 0.629 . . . . 0.0 109.489 -166.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 24.8 pttm -96.17 141.19 29.83 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.089 -1.007 . . . . 0.0 112.903 177.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.434 ' SD ' ' HD2' ' A' ' 38' ' ' PRO . 32.8 ttm -68.89 125.89 28.04 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-N 120.044 1.293 . . . . 0.0 113.264 176.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 91.9 mt -85.87 -53.97 4.79 Favored 'General case' 0 CA--C 1.565 1.552 0 C-N-CA 123.387 0.675 . . . . 0.0 112.798 166.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 92.7 p -142.88 150.53 39.96 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 119.243 0.929 . . . . 0.0 112.838 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 24.1 p30 -125.92 84.65 2.3 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-O 122.235 1.017 . . . . 0.0 110.665 178.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -93.8 119.07 32.27 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.825 -1.172 . . . . 0.0 110.656 -163.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.281 32.1 t30 62.96 24.45 14.56 Favored 'General case' 0 N--CA 1.503 2.186 0 N-CA-C 116.617 2.08 . . . . 0.0 116.617 -169.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -69.27 -44.68 71.39 Favored 'General case' 0 CA--C 1.567 1.619 0 N-CA-C 115.223 1.564 . . . . 0.0 115.223 178.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -55.99 -39.91 72.53 Favored 'General case' 0 N--CA 1.504 2.257 0 N-CA-C 117.412 2.375 . . . . 0.0 117.412 169.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -65.38 -43.05 91.93 Favored 'General case' 0 CA--C 1.573 1.854 0 CA-C-N 120.252 1.387 . . . . 0.0 114.639 169.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -57.35 -47.83 80.59 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 115.31 1.596 . . . . 0.0 115.31 166.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 90.0 mt -58.25 -43.55 87.92 Favored 'General case' 0 CA--C 1.57 1.744 0 N-CA-C 114.633 1.346 . . . . 0.0 114.633 169.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.25 -49.2 72.63 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 115.639 1.718 . . . . 0.0 115.639 166.475 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.49 -21.25 9.51 Favored 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 118.507 2.78 . . . . 0.0 118.507 163.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 95.9 mt -91.9 15.87 12.19 Favored 'General case' 0 CA--C 1.576 1.959 0 N-CA-C 114.867 1.432 . . . . 0.0 114.867 166.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 60.41 42.72 14.22 Favored 'General case' 0 N--CA 1.502 2.138 0 N-CA-C 116.149 1.907 . . . . 0.0 116.149 -175.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 91.3 t -93.62 140.05 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.091 -1.006 . . . . 0.0 110.179 -179.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 15.1 p30 -65.37 155.59 34.87 Favored 'General case' 0 CA--C 1.572 1.803 0 N-CA-C 115.188 1.551 . . . . 0.0 115.188 171.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 61.6 t -57.78 -41.32 79.38 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.251 0 N-CA-C 114.668 1.358 . . . . 0.0 114.668 179.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.72 -50.73 72.24 Favored 'General case' 0 CA--C 1.565 1.534 0 N-CA-C 116.163 1.912 . . . . 0.0 116.163 172.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 6.1 tt -67.2 -39.08 86.28 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-N 120.637 1.562 . . . . 0.0 115.13 170.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 53.3 mtp180 -49.17 -42.42 39.74 Favored 'General case' 0 N--CA 1.502 2.128 0 N-CA-C 116.551 2.056 . . . . 0.0 116.551 163.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -72.77 -52.15 16.2 Favored 'General case' 0 CA--C 1.567 1.623 0 CA-C-O 118.284 -0.865 . . . . 0.0 113.324 167.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 5.6 mt -80.74 58.16 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.587 2.397 0 CA-C-N 121.107 1.776 . . . . 0.0 111.761 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -172.79 -51.95 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 126.187 1.795 . . . . 0.0 110.415 -178.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -66.53 -36.52 82.88 Favored 'General case' 0 CA--C 1.568 1.655 0 N-CA-C 116.0 1.852 . . . . 0.0 116.0 164.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 91.9 mt -74.53 -30.49 61.79 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 176.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.6 pp -84.27 149.63 25.96 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 119.408 1.004 . . . . 0.0 111.971 167.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp -104.67 94.74 7.68 Favored Pre-proline 0 CA--C 1.57 1.749 0 CA-C-O 118.091 -0.957 . . . . 0.0 108.492 174.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.434 ' HD2' ' SD ' ' A' ' 10' ' ' MET . 88.9 Cg_endo -75.27 172.71 15.82 Favored 'Trans proline' 0 CA--C 1.562 1.911 0 C-N-CA 122.642 2.228 . . . . 0.0 114.694 -175.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -123.95 130.56 52.79 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.663 -171.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 57.2 mttm -98.46 112.67 24.61 Favored 'General case' 0 N--CA 1.485 1.315 0 O-C-N 121.441 -0.787 . . . . 0.0 109.808 177.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -97.09 110.06 22.68 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 166.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 64.8 mt -105.7 116.66 49.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -174.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 63.2 t -99.25 98.75 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 169.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -100.63 115.71 30.84 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 123.725 0.81 . . . . 0.0 110.848 -178.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -125.6 72.95 1.29 Allowed 'General case' 0 CA--C 1.568 1.659 0 O-C-N 121.647 -0.658 . . . . 0.0 111.186 176.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 70.92 -93.52 0.49 Allowed Glycine 0 N--CA 1.49 2.24 0 O-C-N 121.468 -0.77 . . . . 0.0 114.879 178.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -88.2 -38.57 15.18 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 115.307 1.595 . . . . 0.0 115.307 164.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 20.8 t-160 -80.62 110.27 15.95 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 121.218 1.826 . . . . 0.0 111.717 -176.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 45.6 ttm -126.29 121.82 33.73 Favored 'General case' 0 CA--C 1.556 1.2 0 C-N-CA 123.448 0.699 . . . . 0.0 109.733 -172.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 4.6 mp -112.04 97.06 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 -179.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 73.3 mt -89.77 101.59 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 176.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -91.58 98.03 11.41 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.597 -0.689 . . . . 0.0 109.78 -179.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 18.9 m -87.38 104.76 16.74 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 178.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 18.0 mt -103.22 116.66 32.88 Favored 'General case' 0 CA--C 1.557 1.241 0 CA-C-N 115.417 -0.811 . . . . 0.0 109.991 -162.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 31.3 t -128.91 143.64 50.95 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 123.929 0.892 . . . . 0.0 110.535 -177.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.4 m -77.64 49.22 0.73 Allowed 'General case' 0 CA--C 1.586 2.353 0 O-C-N 121.256 -0.902 . . . . 0.0 113.159 171.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -172.53 -66.43 0.02 OUTLIER 'General case' 0 CA--C 1.566 1.587 0 C-N-CA 125.762 1.625 . . . . 0.0 109.082 -179.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -134.34 101.64 5.07 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-N 119.306 0.957 . . . . 0.0 110.299 -174.04 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 -83.15 139.72 33.01 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.515 -0.74 . . . . 0.0 112.6 -178.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -128.56 100.69 5.85 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.41 0.624 . . . . 0.0 109.726 -178.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.6 mt -100.23 112.8 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 -179.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 24.6 mmm -96.05 91.56 6.02 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 175.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -96.55 101.97 13.67 Favored 'General case' 0 CA--C 1.561 1.389 0 C-N-CA 123.977 0.911 . . . . 0.0 111.793 178.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -145.73 151.98 38.86 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 -166.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 23.6 mp0 -93.31 122.44 35.72 Favored 'General case' 0 CA--C 1.566 1.585 0 O-C-N 121.672 -0.643 . . . . 0.0 110.043 166.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 49.0 t -63.57 126.77 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 C-N-CA 123.912 0.885 . . . . 0.0 110.834 177.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 102.28 -38.2 3.31 Favored Glycine 0 CA--C 1.552 2.344 0 N-CA-C 116.752 1.461 . . . . 0.0 116.752 -162.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 11.2 mmpt? -88.34 134.34 33.84 Favored 'General case' 0 CA--C 1.564 1.503 0 CA-C-N 118.981 1.39 . . . . 0.0 112.254 -175.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -88.47 119.87 29.32 Favored 'General case' 0 CA--C 1.566 1.577 0 O-C-N 121.706 -0.622 . . . . 0.0 112.391 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 33.0 p90 -120.07 157.74 28.31 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 113.753 1.019 . . . . 0.0 113.753 -172.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.39 132.17 36.32 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.726 -1.234 . . . . 0.0 113.786 177.448 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 . . . . . 0 N--CA 1.496 1.849 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 168.145 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 95.8 m . . . . . 0 CA--C 1.563 1.461 0 CA-C-O 122.14 0.972 . . . . 0.0 112.238 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -88.09 101.99 14.34 Favored 'General case' 0 CA--C 1.56 1.332 0 C-N-CA 124.486 1.115 . . . . 0.0 110.046 -178.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 87.8 m -97.07 108.78 21.58 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.549 -0.719 . . . . 0.0 111.516 -170.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 53.8 m -91.82 131.62 37.03 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 164.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.4 t -116.76 136.33 54.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 171.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 68.2 m -150.17 148.57 29.1 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.141 -1.599 . . . . 0.0 113.029 -175.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 75.3 m95 -81.23 130.95 35.25 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.906 -1.121 . . . . 0.0 112.99 178.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -137.47 79.38 1.74 Allowed 'General case' 0 CA--C 1.569 1.688 0 C-N-CA 123.425 0.69 . . . . 0.0 110.344 178.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 64.23 76.97 0.25 Allowed Glycine 0 N--CA 1.497 2.71 0 N-CA-C 117.317 1.687 . . . . 0.0 117.317 170.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . 0.265 6.9 m-20 63.57 2.14 1.18 Allowed 'General case' 0 N--CA 1.505 2.286 0 N-CA-C 117.855 2.539 . . . . 0.0 117.855 -167.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 72.5 mttt -134.2 135.63 43.15 Favored 'General case' 0 N--CA 1.485 1.278 0 O-C-N 121.113 -0.992 . . . . 0.0 109.807 -168.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 22.0 tp -95.37 108.78 20.99 Favored 'General case' 0 CA--C 1.56 1.357 0 O-C-N 121.428 -0.795 . . . . 0.0 109.958 178.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 21.0 mm100 -86.46 141.05 29.39 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.371 0.669 . . . . 0.0 111.639 176.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 41.0 t -133.71 135.76 44.23 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.381 0.672 . . . . 0.0 111.329 175.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.7 p -127.99 116.92 44.47 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.647 0 C-N-CA 123.145 0.578 . . . . 0.0 109.576 174.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -93.36 100.46 12.78 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 124.118 0.967 . . . . 0.0 109.93 176.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -91.92 121.11 33.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.437 -0.789 . . . . 0.0 111.72 -169.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 167.81 -105.44 0.23 Allowed Glycine 0 N--CA 1.486 1.979 0 O-C-N 121.319 -0.863 . . . . 0.0 113.995 172.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -85.79 -46.98 10.16 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 115.091 1.515 . . . . 0.0 115.091 -172.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 48.9 mmtm -78.62 134.04 37.22 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 119.688 1.131 . . . . 0.0 112.433 179.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -88.5 109.33 19.96 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.017 -168.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 76.95 41.12 23.66 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 117.47 1.748 . . . . 0.0 117.47 -167.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 53.8 ttt180 -86.2 117.25 24.9 Favored 'General case' 0 CA--C 1.563 1.47 0 CA-C-N 118.316 1.058 . . . . 0.0 110.704 177.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -172.5 -178.45 42.64 Favored Glycine 0 N--CA 1.484 1.872 0 CA-C-O 122.071 0.817 . . . . 0.0 115.093 -176.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 28.3 p-90 -154.94 158.55 39.43 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 172.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 55.6 m -123.75 120.36 32.46 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 170.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -114.13 132.44 56.07 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 123.196 0.598 . . . . 0.0 111.922 179.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 16.4 p90 -148.4 173.07 13.46 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.215 -0.928 . . . . 0.0 113.088 177.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 73.9 mt -114.24 133.66 59.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.226 -0.921 . . . . 0.0 110.052 174.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -111.65 88.98 2.93 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 123.729 0.812 . . . . 0.0 108.895 162.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 65.35 -104.99 1.08 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 115.832 1.093 . . . . 0.0 115.832 -178.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -85.88 -8.34 58.11 Favored 'General case' 0 CA--C 1.571 1.788 0 N-CA-C 117.591 2.441 . . . . 0.0 117.591 168.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 86.9 mt-10 -105.08 135.46 46.39 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 120.316 1.416 . . . . 0.0 112.316 -175.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 15.5 tp -91.79 121.94 33.88 Favored 'General case' 0 CA--C 1.563 1.45 0 C-N-CA 123.861 0.864 . . . . 0.0 109.38 167.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 47.4 m80 -109.52 120.89 43.89 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -179.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 48.3 tp -120.5 116.57 25.67 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.444 0.698 . . . . 0.0 109.677 179.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -98.19 127.9 44.38 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.764 -0.585 . . . . 0.0 109.898 167.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 69.1 mtm -122.85 129.82 52.12 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-N 118.355 0.525 . . . . 0.0 111.241 -175.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 71.9 mtm-85 -117.9 139.32 51.3 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 123.588 0.755 . . . . 0.0 111.233 -174.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -161.75 131.65 4.77 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.68 -0.637 . . . . 0.0 111.279 170.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 55.7 39.09 30.83 Favored 'General case' 0 N--CA 1.507 2.397 0 N-CA-C 115.444 1.646 . . . . 0.0 115.444 -175.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 72.84 -11.76 4.29 Favored Glycine 0 CA--C 1.557 2.682 0 N-CA-C 120.302 2.881 . . . . 0.0 120.302 -163.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 88.1 t -89.28 123.54 41.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 CA-C-N 120.291 2.045 . . . . 0.0 109.608 -171.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 34.7 m -102.77 123.99 47.47 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.302 0.572 . . . . 0.0 111.169 177.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 21.1 t -100.92 146.64 27.11 Favored 'General case' 0 CA--C 1.563 1.462 0 C-N-CA 123.921 0.888 . . . . 0.0 112.079 165.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 7.6 mtpm? -118.49 110.66 17.67 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.669 -0.644 . . . . 0.0 109.541 174.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -103.48 130.09 50.77 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.502 -0.749 . . . . 0.0 110.817 174.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 44.2 t -113.86 129.91 68.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 176.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -123.67 150.86 43.73 Favored 'General case' 0 CA--C 1.567 1.62 0 C-N-CA 124.729 1.211 . . . . 0.0 110.071 179.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.7 tmtt? -122.47 140.95 52.15 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.556 -1.34 . . . . 0.0 111.484 177.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 66.0 tttt -71.08 117.75 12.99 Favored 'General case' 0 CA--C 1.565 1.556 0 N-CA-C 113.523 0.934 . . . . 0.0 113.523 -177.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 5.5 m -82.59 -34.57 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.273 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 168.069 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 44.6 t-80 . . . . . 0 N--CA 1.484 1.255 0 C-N-CA 125.04 1.336 . . . . 0.0 113.305 175.505 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo . . . . . 0 CA--C 1.56 1.82 0 N-CA-C 114.98 1.108 . . . . 0.0 114.98 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 1.8 t -79.05 146.04 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 CA-C-O 121.701 0.763 . . . . 0.0 110.906 -174.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -72.04 97.03 1.82 Allowed 'General case' 0 CA--C 1.568 1.651 0 O-C-N 120.79 -1.194 . . . . 0.0 111.618 173.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 4.5 m-30 -77.92 3.74 13.8 Favored 'General case' 0 CA--C 1.581 2.151 0 N-CA-C 116.471 2.026 . . . . 0.0 116.471 179.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -60.4 111.02 1.41 Allowed 'General case' 0 CA--C 1.564 1.488 0 C-N-CA 125.339 1.456 . . . . 0.0 114.688 -178.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 165.2 177.21 37.48 Favored Glycine 0 N--CA 1.484 1.887 0 N-CA-C 116.319 1.287 . . . . 0.0 116.319 -179.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -108.11 122.35 46.71 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 114.35 -0.925 . . . . 0.0 108.781 173.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 83.7 m95 -120.77 120.18 34.89 Favored 'General case' 0 CA--C 1.562 1.412 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -167.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 62.1 pttt -88.92 136.5 32.98 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.348 -0.845 . . . . 0.0 112.588 176.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 56.3 ttm -77.19 123.47 26.47 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 121.914 0.864 . . . . 0.0 112.139 179.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 84.0 mt -90.97 -60.16 1.98 Allowed 'General case' 0 CA--C 1.565 1.527 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.757 175.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 67.4 p -130.0 119.29 22.93 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.721 -0.612 . . . . 0.0 110.746 176.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -98.01 93.39 6.28 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 123.252 0.621 . . . . 0.0 109.794 165.227 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -97.12 125.26 41.49 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.66 0.784 . . . . 0.0 110.462 -169.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.269 49.2 t30 64.97 15.59 10.06 Favored 'General case' 0 N--CA 1.504 2.272 0 N-CA-C 117.061 2.245 . . . . 0.0 117.061 -172.142 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -61.01 -41.21 96.11 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 116.234 1.939 . . . . 0.0 116.234 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -51.52 -44.78 62.7 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 115.602 1.704 . . . . 0.0 115.602 166.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -68.81 -41.35 78.77 Favored 'General case' 0 CA--C 1.573 1.836 0 N-CA-C 115.228 1.566 . . . . 0.0 115.228 174.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 48.7 t80 -55.27 -49.26 72.52 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 114.47 1.285 . . . . 0.0 114.47 165.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 97.5 mt -61.0 -40.64 94.31 Favored 'General case' 0 CA--C 1.575 1.922 0 N-CA-C 115.001 1.482 . . . . 0.0 115.001 170.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 49.5 ttp180 -53.86 -49.94 67.37 Favored 'General case' 0 N--CA 1.501 2.11 0 N-CA-C 115.647 1.721 . . . . 0.0 115.647 165.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.67 -15.97 9.32 Favored 'General case' 0 CA--C 1.57 1.742 0 N-CA-C 118.409 2.744 . . . . 0.0 118.409 165.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 99.3 mt -98.56 23.48 8.55 Favored 'General case' 0 CA--C 1.575 1.926 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 163.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 69.39 15.16 8.44 Favored 'General case' 0 N--CA 1.507 2.382 0 N-CA-C 117.482 2.401 . . . . 0.0 117.482 -179.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 67.5 t -87.81 141.88 13.71 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.863 0 O-C-N 120.061 -1.65 . . . . 0.0 110.414 -170.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -73.46 155.02 39.69 Favored 'General case' 0 CA--C 1.569 1.687 0 N-CA-C 115.714 1.746 . . . . 0.0 115.714 -177.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 74.6 t -50.88 -45.83 28.79 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.502 0 N-CA-C 115.715 1.746 . . . . 0.0 115.715 -178.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.03 -49.41 77.75 Favored 'General case' 0 CA--C 1.564 1.5 0 N-CA-C 115.434 1.642 . . . . 0.0 115.434 173.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.8 tt -64.49 -44.58 90.5 Favored 'General case' 0 CA--C 1.572 1.794 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 171.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 74.9 mtp180 -45.15 -54.45 6.83 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 115.911 1.819 . . . . 0.0 115.911 164.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -71.84 -37.96 70.21 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 115.461 1.652 . . . . 0.0 115.461 174.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . 0.25 69.2 mt -62.51 -50.2 80.77 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 CA-C-N 121.116 1.78 . . . . 0.0 112.171 173.19 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -56.93 -42.24 79.65 Favored 'General case' 0 CA--C 1.568 1.67 0 N-CA-C 117.772 2.508 . . . . 0.0 117.772 170.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -53.85 -46.09 71.14 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 117.01 2.226 . . . . 0.0 117.01 163.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 92.6 mt -80.56 -18.29 48.81 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 116.025 1.861 . . . . 0.0 116.025 179.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 18.5 mt -73.46 -37.44 65.8 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 115.789 1.774 . . . . 0.0 115.789 173.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 65.5 mmtt 64.76 65.54 1.01 Allowed Pre-proline 0 CA--C 1.577 1.99 0 C-N-CA 124.546 1.139 . . . . 0.0 112.122 -178.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -71.45 135.0 25.59 Favored 'Trans proline' 0 CA--C 1.562 1.913 0 CA-C-N 122.486 1.924 . . . . 0.0 114.765 -165.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -86.67 130.53 34.45 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.832 -0.543 . . . . 0.0 111.897 -175.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 47.9 mttp -93.26 112.72 24.73 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.191 -0.943 . . . . 0.0 110.181 -179.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -94.59 109.44 21.36 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.388 -0.82 . . . . 0.0 109.034 164.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 97.6 mt -102.49 116.35 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 -175.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 54.0 t -98.16 95.95 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 168.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -93.86 108.5 20.28 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 123.876 0.87 . . . . 0.0 110.558 -179.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -113.94 69.31 0.7 Allowed 'General case' 0 CA--C 1.569 1.689 0 O-C-N 121.637 -0.664 . . . . 0.0 111.061 175.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 70.09 -85.39 0.31 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 115.798 1.079 . . . . 0.0 115.798 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -94.65 -40.04 10.02 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 114.903 1.446 . . . . 0.0 114.903 163.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 20.7 t-160 -79.08 107.19 11.66 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 121.216 1.825 . . . . 0.0 111.243 -175.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 41.1 ttm -118.24 120.5 37.85 Favored 'General case' 0 CA--C 1.553 1.064 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -173.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 5.0 mp -106.13 100.49 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 16.4 mm -87.07 101.3 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 176.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -94.71 97.93 10.42 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 18.3 m -91.94 100.39 13.06 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 -176.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 19.9 mt -99.8 132.85 44.89 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-O 121.812 0.815 . . . . 0.0 112.189 -156.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 28.3 t -151.6 145.72 25.31 Favored 'General case' 0 CA--C 1.562 1.425 0 C-N-CA 123.452 0.701 . . . . 0.0 110.97 -176.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.6 t -77.48 54.12 1.13 Allowed 'General case' 0 N--CA 1.505 2.291 0 O-C-N 120.639 -1.288 . . . . 0.0 114.077 165.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -173.2 -67.04 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 124.983 1.313 . . . . 0.0 109.169 -168.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.06 103.83 4.37 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.379 -0.826 . . . . 0.0 110.014 -179.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -88.48 119.54 29.02 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.738 -0.601 . . . . 0.0 110.357 178.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 51.8 m-85 -107.59 110.11 21.91 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 121.336 0.589 . . . . 0.0 110.573 -175.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 25.0 mm -105.95 104.48 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 N-CA-C 108.11 -1.071 . . . . 0.0 108.11 -174.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 11.4 mmm -99.11 90.71 4.69 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.523 -0.735 . . . . 0.0 109.27 175.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -93.35 111.55 23.24 Favored 'General case' 0 CA--C 1.561 1.386 0 C-N-CA 123.429 0.692 . . . . 0.0 111.385 175.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 11.9 p90 -147.13 148.31 31.45 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.831 0.824 . . . . 0.0 112.849 -170.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 23.8 mp0 -87.6 117.15 26.21 Favored 'General case' 0 CA--C 1.561 1.368 0 O-C-N 121.621 -0.674 . . . . 0.0 109.999 168.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 44.0 t -66.99 113.04 2.7 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.794 0 C-N-CA 124.159 0.984 . . . . 0.0 109.609 175.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 123.22 -48.68 0.94 Allowed Glycine 0 CA--C 1.549 2.213 0 N-CA-C 115.14 0.816 . . . . 0.0 115.14 -156.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 58.4 mttm -86.59 151.77 23.17 Favored 'General case' 0 CA--C 1.568 1.66 0 CA-C-N 118.493 1.146 . . . . 0.0 113.476 -175.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -96.8 107.22 19.66 Favored 'General case' 0 CA--C 1.568 1.643 0 C-N-CA 123.275 0.63 . . . . 0.0 110.425 173.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 15.6 p90 -106.92 142.32 36.73 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 113.639 0.978 . . . . 0.0 113.639 -171.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -76.9 110.55 11.61 Favored 'General case' 0 CA--C 1.568 1.669 0 N-CA-C 114.411 1.263 . . . . 0.0 114.411 179.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 . . . . . 0 N--CA 1.497 1.888 0 O-C-N 120.96 -1.087 . . . . 0.0 113.262 173.365 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 72.6 m . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 121.055 0.455 . . . . 0.0 110.05 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 82.5 mmm -79.48 95.75 5.89 Favored 'General case' 0 CA--C 1.563 1.454 0 CA-C-O 121.98 0.895 . . . . 0.0 109.338 170.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 37.8 m -102.65 117.11 33.95 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.114 0.566 . . . . 0.0 110.698 -160.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 92.3 m -95.16 122.43 37.83 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 173.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 22.1 t -109.97 135.79 47.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 170.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 58.0 m -148.55 147.27 28.85 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.265 -1.522 . . . . 0.0 112.481 -176.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 59.9 m95 -79.41 109.06 13.41 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.255 -0.903 . . . . 0.0 111.095 174.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -86.73 76.21 9.53 Favored 'General case' 0 CA--C 1.566 1.572 0 C-N-CA 123.813 0.845 . . . . 0.0 110.429 172.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 64.72 -99.53 0.36 Allowed Glycine 0 N--CA 1.489 2.199 0 N-CA-C 114.433 0.533 . . . . 0.0 114.433 -169.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -84.4 -32.85 23.92 Favored 'General case' 0 CA--C 1.574 1.88 0 N-CA-C 115.705 1.743 . . . . 0.0 115.705 170.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 48.9 mtpt -94.1 150.14 20.6 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 124.125 0.97 . . . . 0.0 112.011 -168.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 24.0 tp -98.46 109.7 22.41 Favored 'General case' 0 CA--C 1.563 1.464 0 O-C-N 120.329 -1.482 . . . . 0.0 110.345 177.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 31.8 mm-40 -96.65 146.4 24.89 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 123.383 0.673 . . . . 0.0 111.909 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 42.6 t -138.74 131.27 28.87 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.316 0.646 . . . . 0.0 111.527 176.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.9 p -113.81 122.01 67.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 166.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -101.95 75.02 1.5 Allowed 'General case' 0 CA--C 1.567 1.609 0 C-N-CA 123.461 0.704 . . . . 0.0 110.299 -178.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -91.17 129.68 37.14 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.011 -1.056 . . . . 0.0 113.427 -170.164 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 164.81 -94.1 0.11 Allowed Glycine 0 N--CA 1.487 2.084 0 O-C-N 121.335 -0.853 . . . . 0.0 112.477 177.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -72.2 -46.67 55.28 Favored 'General case' 0 CA--C 1.572 1.815 0 N-CA-C 115.614 1.709 . . . . 0.0 115.614 178.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -101.26 143.31 31.49 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 119.362 0.983 . . . . 0.0 112.945 -175.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -76.5 155.9 33.41 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.774 -0.579 . . . . 0.0 112.241 165.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 61.95 12.6 36.83 Favored Glycine 0 N--CA 1.497 2.757 0 N-CA-C 120.488 2.955 . . . . 0.0 120.488 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 36.8 ttt180 -88.16 129.11 35.42 Favored 'General case' 0 CA--C 1.564 1.511 0 CA-C-N 119.082 1.441 . . . . 0.0 112.591 -172.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 178.32 -173.27 45.73 Favored Glycine 0 N--CA 1.486 1.972 0 CA-C-O 121.707 0.615 . . . . 0.0 114.052 -175.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . 0.277 44.2 p-90 -159.43 156.8 29.0 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 171.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 58.9 m -129.56 119.13 23.15 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 176.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 16.2 tt0 -122.98 131.58 53.78 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 123.277 0.631 . . . . 0.0 112.202 -174.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 21.8 p90 -148.71 169.12 21.12 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.379 -0.826 . . . . 0.0 112.302 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 96.4 mt -115.53 145.26 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.22 0 CA-C-O 122.998 1.38 . . . . 0.0 111.062 177.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -136.65 90.58 2.56 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 71.42 -111.8 3.84 Favored Glycine 0 N--CA 1.49 2.269 0 O-C-N 121.983 -0.448 . . . . 0.0 114.158 -174.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 16.5 p-10 -94.66 15.36 18.38 Favored 'General case' 0 CA--C 1.576 1.975 0 N-CA-C 116.585 2.069 . . . . 0.0 116.585 167.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -120.65 136.54 54.81 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-N 120.177 1.353 . . . . 0.0 111.946 -171.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 8.6 tp -97.34 123.09 41.04 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 171.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 36.4 m80 -111.65 121.58 45.49 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 -176.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 50.7 tp -128.48 120.78 27.48 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.618 0.767 . . . . 0.0 109.963 -172.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -105.55 113.83 27.64 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.511 -0.743 . . . . 0.0 109.038 170.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . 0.423 ' HB2' ' SG ' ' A' ' 126' ' ' CYS . 63.1 mtm -106.85 131.9 53.42 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-N 118.891 0.769 . . . . 0.0 111.438 -178.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? -114.76 140.88 48.54 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.784 0.834 . . . . 0.0 111.445 -171.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -156.07 129.37 8.18 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 123.207 0.603 . . . . 0.0 111.111 170.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . 0.265 8.7 mm-40 64.8 -0.32 1.02 Allowed 'General case' 0 N--CA 1.504 2.254 0 N-CA-C 118.135 2.643 . . . . 0.0 118.135 -176.252 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 109.69 -24.4 19.74 Favored Glycine 0 CA--C 1.554 2.531 0 N-CA-C 117.096 1.598 . . . . 0.0 117.096 -156.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 93.6 t -78.1 127.71 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 CA-C-N 119.857 1.829 . . . . 0.0 110.115 177.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 45.6 m -106.86 124.67 49.96 Favored 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 123.032 0.533 . . . . 0.0 110.118 173.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . 0.423 ' SG ' ' HB2' ' A' ' 119' ' ' MET . 19.3 p -107.14 142.08 37.38 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-O 121.701 0.762 . . . . 0.0 112.424 168.047 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 60.1 mttp -114.76 111.14 20.8 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.666 -0.646 . . . . 0.0 109.36 -168.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 82.9 mt-30 -105.35 123.84 48.54 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 123.403 0.681 . . . . 0.0 111.178 178.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 79.1 t -111.27 131.47 62.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 176.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -121.67 164.04 18.0 Favored 'General case' 0 CA--C 1.567 1.608 0 CA-C-N 115.113 -0.949 . . . . 0.0 111.474 -178.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 29.3 ttmt -130.57 142.82 50.46 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.065 -1.022 . . . . 0.0 111.984 165.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 59.8 tttt -76.31 120.15 21.17 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.49 -0.756 . . . . 0.0 112.882 -176.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 32.8 m -97.21 -43.41 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.112 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 174.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 72.0 t60 . . . . . 0 N--CA 1.485 1.302 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 169.235 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo . . . . . 0 CA--C 1.561 1.868 0 N-CA-C 115.375 1.26 . . . . 0.0 115.375 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 31.6 m -80.08 156.48 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 CA-C-O 121.934 0.873 . . . . 0.0 112.761 176.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -77.74 113.17 15.33 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.124 -0.985 . . . . 0.0 112.759 176.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -90.28 7.95 35.73 Favored 'General case' 0 CA--C 1.576 1.966 0 N-CA-C 115.389 1.626 . . . . 0.0 115.389 173.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 62.6 m-80 -67.02 110.19 3.28 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 120.262 1.392 . . . . 0.0 113.077 -176.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 169.63 173.81 37.45 Favored Glycine 0 N--CA 1.478 1.441 0 N-CA-C 116.638 1.415 . . . . 0.0 116.638 -177.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 19.5 t80 -104.19 124.53 49.29 Favored 'General case' 0 CA--C 1.563 1.48 0 CA-C-N 113.675 -1.262 . . . . 0.0 108.516 168.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 82.4 m95 -120.82 122.71 40.89 Favored 'General case' 0 CA--C 1.561 1.394 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -169.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -96.08 135.51 37.76 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.579 -0.701 . . . . 0.0 111.449 178.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 53.6 ttm -71.93 124.34 24.67 Favored 'General case' 0 CA--C 1.565 1.524 0 CA-C-O 122.079 0.942 . . . . 0.0 113.058 -178.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 97.5 mt -81.99 -50.14 9.47 Favored 'General case' 0 CA--C 1.567 1.615 0 CA-C-N 115.191 -0.913 . . . . 0.0 112.292 168.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 89.7 p -149.92 126.79 11.1 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 118.727 0.694 . . . . 0.0 111.751 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -99.69 108.77 21.2 Favored 'General case' 0 N--CA 1.494 1.767 0 C-N-CA 122.944 0.497 . . . . 0.0 110.889 162.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -112.26 125.57 54.31 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.503 -0.748 . . . . 0.0 109.803 -172.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.258 5.3 t30 63.53 27.84 15.13 Favored 'General case' 0 N--CA 1.507 2.414 0 N-CA-C 116.325 1.972 . . . . 0.0 116.325 -174.146 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -70.39 -44.97 66.92 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 114.436 1.273 . . . . 0.0 114.436 174.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -53.43 -51.96 60.96 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 116.813 2.153 . . . . 0.0 116.813 174.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.266 1.5 pm0 -76.89 -25.89 53.56 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 116.394 1.998 . . . . 0.0 116.394 178.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 38.6 t80 -54.84 -49.56 70.79 Favored 'General case' 0 N--CA 1.498 1.967 0 CA-C-N 120.797 1.635 . . . . 0.0 114.481 154.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 68.8 mt -61.98 -35.35 78.24 Favored 'General case' 0 CA--C 1.576 1.965 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 170.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 8.7 ttm180 -56.99 -48.1 79.26 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-N 120.415 1.462 . . . . 0.0 114.645 162.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.74 -13.53 24.14 Favored 'General case' 0 CA--C 1.569 1.703 0 N-CA-C 118.414 2.746 . . . . 0.0 118.414 168.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 48.0 mt -90.15 -1.38 57.94 Favored 'General case' 0 CA--C 1.573 1.845 0 N-CA-C 116.071 1.878 . . . . 0.0 116.071 162.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.277 51.6 m-20 63.02 46.54 4.69 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 115.411 1.634 . . . . 0.0 115.411 -166.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 98.7 t -95.26 135.23 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 174.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 5.5 p-10 -64.3 152.08 42.05 Favored 'General case' 0 CA--C 1.566 1.592 0 N-CA-C 115.192 1.552 . . . . 0.0 115.192 178.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.494 HG22 HH11 ' A' ' 30' ' ' ARG 0.262 38.5 t -58.84 -35.47 56.27 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.224 0 N-CA-C 115.719 1.748 . . . . 0.0 115.719 -172.257 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.8 -50.93 69.16 Favored 'General case' 0 CA--C 1.567 1.62 0 N-CA-C 115.969 1.841 . . . . 0.0 115.969 166.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -71.45 -28.41 63.95 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 116.697 2.11 . . . . 0.0 116.697 171.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.494 HH11 HG22 ' A' ' 27' ' ' VAL . 54.2 mtp180 -55.83 -53.53 55.62 Favored 'General case' 0 N--CA 1.498 1.959 0 CA-C-N 120.824 1.647 . . . . 0.0 114.135 162.229 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 48.1 mmtm -64.39 -49.99 69.43 Favored 'General case' 0 CA--C 1.566 1.596 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 170.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 11.9 mt -77.38 62.12 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.323 0 CA-C-O 123.493 1.615 . . . . 0.0 110.974 175.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -176.03 -53.59 0.01 OUTLIER 'General case' 0 CA--C 1.558 1.28 0 C-N-CA 126.752 2.021 . . . . 0.0 110.044 -177.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -71.52 -35.51 70.73 Favored 'General case' 0 CA--C 1.567 1.619 0 N-CA-C 116.04 1.867 . . . . 0.0 116.04 167.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 92.9 mt -71.85 -35.3 69.81 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 115.153 1.538 . . . . 0.0 115.153 177.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.9 pp -88.71 148.94 23.73 Favored 'General case' 0 CA--C 1.566 1.57 0 CA-C-N 118.671 0.669 . . . . 0.0 111.084 169.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 29.0 mmtp -103.94 93.98 5.96 Favored Pre-proline 0 CA--C 1.573 1.827 0 CA-C-O 117.813 -1.089 . . . . 0.0 109.764 178.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -73.82 160.39 43.59 Favored 'Trans proline' 0 CA--C 1.566 2.09 0 C-N-CA 122.49 2.126 . . . . 0.0 115.489 -175.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -104.2 141.96 35.34 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.508 -0.745 . . . . 0.0 110.795 -179.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 41.8 mttp -102.9 115.38 30.48 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.857 -1.152 . . . . 0.0 109.742 171.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -95.36 110.37 22.4 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 163.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 78.7 mt -106.8 128.33 61.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -177.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 93.1 t -106.27 118.41 53.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 106.026 -1.842 . . . . 0.0 106.026 163.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -111.95 113.51 25.86 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 124.147 0.979 . . . . 0.0 109.197 175.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -120.19 68.83 0.85 Allowed 'General case' 0 CA--C 1.567 1.613 0 O-C-N 121.339 -0.85 . . . . 0.0 110.334 174.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.65 -97.39 0.7 Allowed Glycine 0 N--CA 1.488 2.164 0 N-CA-C 114.672 0.629 . . . . 0.0 114.672 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -85.07 -40.45 16.8 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 115.314 1.598 . . . . 0.0 115.314 165.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 18.7 t-160 -77.41 119.97 21.76 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 120.899 1.681 . . . . 0.0 111.781 -178.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.43 ' SD ' HD21 ' A' ' 93' ' ' LEU . 46.5 ttm -133.9 133.98 42.11 Favored 'General case' 0 CA--C 1.557 1.231 0 CA-C-O 121.488 0.661 . . . . 0.0 110.674 -173.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 33.6 mt -118.56 107.76 22.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 24.8 mm -94.24 100.23 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 176.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 68.4 mtt85 -93.85 100.57 12.73 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.135 -0.978 . . . . 0.0 109.201 178.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 16.6 m -88.46 102.12 14.59 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 178.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 48.0 mt -97.78 112.23 24.21 Favored 'General case' 0 CA--C 1.556 1.209 0 C-N-CA 123.841 0.856 . . . . 0.0 109.286 -165.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 46.0 t -130.18 143.48 50.81 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.972 -171.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.1 m -78.96 56.42 1.95 Allowed 'General case' 0 CA--C 1.579 2.089 0 CA-C-O 122.036 0.922 . . . . 0.0 112.715 175.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -168.99 -67.93 0.02 OUTLIER 'General case' 0 CA--C 1.567 1.598 0 C-N-CA 124.999 1.32 . . . . 0.0 109.267 -179.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 32.3 tpt180 -135.78 115.72 13.17 Favored 'General case' 0 CA--C 1.565 1.55 0 C-N-CA 123.777 0.831 . . . . 0.0 109.193 173.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 71.9 m-80 -83.63 125.05 31.43 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.685 -0.634 . . . . 0.0 111.501 178.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 86.2 t80 -110.87 105.99 14.99 Favored 'General case' 0 CA--C 1.567 1.602 0 C-N-CA 123.24 0.616 . . . . 0.0 110.744 -169.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.8 mp -93.38 115.35 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 178.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -107.31 90.98 3.47 Favored 'General case' 0 CA--C 1.568 1.64 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 175.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -102.4 119.6 39.08 Favored 'General case' 0 CA--C 1.565 1.551 0 C-N-CA 124.159 0.984 . . . . 0.0 112.633 -175.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -157.72 154.79 28.81 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 114.784 1.401 . . . . 0.0 114.784 -166.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 25.2 mp0 -92.82 121.7 34.46 Favored 'General case' 0 CA--C 1.564 1.486 0 O-C-N 121.577 -0.702 . . . . 0.0 110.553 166.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 40.0 t -66.25 121.7 15.83 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.808 0 C-N-CA 124.218 1.007 . . . . 0.0 109.915 174.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 117.2 -42.45 1.85 Allowed Glycine 0 CA--C 1.55 2.236 0 N-CA-C 115.729 1.052 . . . . 0.0 115.729 -160.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 55.9 mttm -82.64 144.78 30.05 Favored 'General case' 0 CA--C 1.566 1.564 0 CA-C-N 118.916 1.358 . . . . 0.0 113.557 -174.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -90.95 97.8 11.4 Favored 'General case' 0 CA--C 1.566 1.588 0 CA-C-O 121.349 0.595 . . . . 0.0 110.014 167.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -107.54 151.7 25.23 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 123.999 0.92 . . . . 0.0 113.083 -169.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -77.1 135.36 38.58 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.693 -1.254 . . . . 0.0 112.918 169.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 . . . . . 0 N--CA 1.497 1.919 0 O-C-N 121.428 -0.795 . . . . 0.0 112.886 175.278 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 72.8 m . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.835 0.35 . . . . 0.0 111.856 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 23.5 mmt -68.63 96.16 0.7 Allowed 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 124.576 1.15 . . . . 0.0 111.579 -177.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 89.6 m -111.59 118.09 34.73 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 -162.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 93.8 m -101.85 118.94 37.95 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 176.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.479 HG22 ' SG ' ' A' ' 95' ' ' CYS . 57.1 t -108.73 124.93 65.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 171.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 57.9 m -130.57 151.54 50.93 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 121.935 0.874 . . . . 0.0 111.529 -177.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 28.1 m95 -83.66 116.66 22.74 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.992 -1.067 . . . . 0.0 112.726 176.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -103.77 65.79 0.83 Allowed 'General case' 0 CA--C 1.572 1.805 0 C-N-CA 123.428 0.691 . . . . 0.0 109.909 162.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 58.28 -114.59 5.99 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 115.538 0.975 . . . . 0.0 115.538 -172.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -61.42 -28.22 69.11 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 116.934 2.198 . . . . 0.0 116.934 168.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 63.5 mttm -93.69 120.96 34.61 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-O 122.097 0.951 . . . . 0.0 110.583 -178.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.43 HD21 ' SD ' ' A' ' 49' ' ' MET . 34.7 tp -86.79 107.11 18.14 Favored 'General case' 0 CA--C 1.564 1.515 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 168.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -98.59 132.64 43.84 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 123.27 0.628 . . . . 0.0 111.544 -172.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . 0.479 ' SG ' HG22 ' A' ' 86' ' ' VAL . 35.4 t -128.33 134.97 48.99 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.158 0.583 . . . . 0.0 111.728 -179.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.9 p -115.82 128.91 72.93 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.792 0 C-N-CA 123.151 0.581 . . . . 0.0 109.758 164.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -106.15 108.2 19.59 Favored 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 123.548 0.739 . . . . 0.0 110.4 -178.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 62.1 mttm -101.08 118.45 37.03 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.042 -1.036 . . . . 0.0 110.814 -174.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -178.91 -60.78 0.07 OUTLIER Glycine 0 N--CA 1.491 2.348 0 N-CA-C 116.546 1.379 . . . . 0.0 116.546 -177.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -125.18 -58.76 1.44 Allowed 'General case' 0 N--CA 1.497 1.893 0 CA-C-N 117.872 0.836 . . . . 0.0 111.938 173.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 41.9 mmtm -87.72 151.51 22.86 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-O 122.189 0.995 . . . . 0.0 113.509 -161.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -73.48 -68.92 0.46 Allowed 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 -169.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -78.35 51.46 3.63 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 116.804 1.482 . . . . 0.0 116.804 171.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 21.2 ttt180 -98.35 118.59 35.36 Favored 'General case' 0 CA--C 1.563 1.461 0 CA-C-N 118.659 1.23 . . . . 0.0 114.041 -169.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 177.46 -165.05 34.6 Favored Glycine 0 N--CA 1.482 1.756 0 CA-C-O 121.844 0.691 . . . . 0.0 114.554 178.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 53.2 p-90 -157.81 152.9 25.61 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 173.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 56.6 m -125.59 118.07 24.92 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 174.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -118.6 125.51 49.93 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 123.021 0.528 . . . . 0.0 111.77 -178.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 17.0 p90 -140.62 170.63 15.42 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.491 -0.755 . . . . 0.0 112.631 178.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 77.4 mt -117.57 135.85 56.63 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.031 -1.043 . . . . 0.0 110.006 176.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -121.52 95.81 4.83 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 173.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 71.93 -109.77 2.95 Favored Glycine 0 N--CA 1.491 2.312 0 O-C-N 121.619 -0.675 . . . . 0.0 114.11 -176.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -110.17 38.42 2.43 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 114.338 1.236 . . . . 0.0 114.338 165.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 82.8 mt-10 -132.62 136.17 46.35 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-N 118.891 0.768 . . . . 0.0 111.199 178.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 20.8 tp -90.75 124.71 35.33 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 123.354 0.662 . . . . 0.0 109.785 173.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 51.5 m80 -113.68 117.52 31.79 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 179.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 51.4 tp -126.53 120.02 28.6 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.884 0.873 . . . . 0.0 109.445 -171.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -111.54 110.03 20.26 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 109.389 -0.596 . . . . 0.0 109.389 173.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 71.9 mtm -104.41 127.13 52.03 Favored 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 123.492 0.717 . . . . 0.0 111.028 -179.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 36.9 mtp-105 -114.04 145.58 41.39 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.377 -0.827 . . . . 0.0 112.659 -175.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -149.88 138.91 21.11 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.705 -0.622 . . . . 0.0 112.002 163.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . 0.287 6.0 mm-40 69.58 -76.19 0.06 Allowed 'General case' 0 N--CA 1.503 2.215 0 C-N-CA 124.326 1.05 . . . . 0.0 112.884 -177.436 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -159.78 46.42 0.42 Allowed Glycine 0 CA--C 1.553 2.408 0 CA-C-N 116.042 -0.526 . . . . 0.0 113.202 153.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 72.1 t -133.93 121.8 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 -163.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 16.2 m -101.97 120.91 41.17 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -173.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 26.7 t -84.73 125.5 32.59 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.657 -0.652 . . . . 0.0 111.821 160.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 28.5 mtmm -111.7 109.05 18.72 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 -173.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -117.95 130.6 56.31 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.613 -0.679 . . . . 0.0 111.565 -172.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 39.7 t -116.97 129.25 73.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 N-CA-C 107.969 -1.122 . . . . 0.0 107.969 179.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -122.0 157.55 31.09 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 123.479 0.712 . . . . 0.0 110.71 173.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 75.4 tttt -114.56 141.29 47.93 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.332 -0.855 . . . . 0.0 112.06 172.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 33.9 tttm -76.41 118.04 18.69 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.605 -0.684 . . . . 0.0 112.758 -178.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 33.6 m -103.38 -35.36 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.2 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 175.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 81.7 t60 . . . . . 0 N--CA 1.484 1.239 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 169.063 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo . . . . . 0 CA--C 1.564 1.975 0 N-CA-C 116.175 1.567 . . . . 0.0 116.175 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 34.3 m -69.88 156.65 7.04 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.854 0 CA-C-O 122.216 1.008 . . . . 0.0 113.399 172.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -87.43 116.5 25.58 Favored 'General case' 0 CA--C 1.56 1.334 0 O-C-N 121.129 -0.982 . . . . 0.0 111.249 169.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 11.1 m-30 -80.07 0.95 29.74 Favored 'General case' 0 CA--C 1.578 2.052 0 N-CA-C 115.504 1.668 . . . . 0.0 115.504 163.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 43.7 m-20 -53.01 113.16 1.01 Allowed 'General case' 0 N--CA 1.493 1.689 0 CA-C-N 120.665 1.575 . . . . 0.0 115.044 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 159.92 173.31 28.27 Favored Glycine 0 N--CA 1.481 1.7 0 CA-C-O 122.378 0.988 . . . . 0.0 115.272 -175.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -104.87 126.5 52.01 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 170.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 65.5 m95 -124.37 122.77 38.62 Favored 'General case' 0 CA--C 1.565 1.522 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 -169.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 21.7 pttp -96.35 138.35 34.08 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.555 -0.716 . . . . 0.0 112.054 -178.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 54.9 ttm -69.71 127.82 34.29 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 119.594 1.088 . . . . 0.0 113.91 -178.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 98.2 mt -87.52 -50.69 6.36 Favored 'General case' 0 CA--C 1.567 1.621 0 CA-C-N 115.291 -0.868 . . . . 0.0 112.757 167.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 80.7 p -144.86 144.6 31.2 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 118.984 0.811 . . . . 0.0 112.188 176.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -114.72 101.75 9.37 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.519 0.676 . . . . 0.0 109.745 164.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -101.84 121.67 42.54 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 123.858 0.863 . . . . 0.0 109.691 -171.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.264 27.9 t30 66.51 22.34 10.64 Favored 'General case' 0 N--CA 1.504 2.264 0 N-CA-C 116.971 2.212 . . . . 0.0 116.971 -174.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -66.28 -40.44 90.08 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 116.055 1.872 . . . . 0.0 116.055 177.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -58.45 -41.09 84.36 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 116.074 1.879 . . . . 0.0 116.074 170.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -65.85 -43.0 89.78 Favored 'General case' 0 CA--C 1.571 1.774 0 N-CA-C 114.724 1.379 . . . . 0.0 114.724 170.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -56.87 -47.2 80.98 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 115.137 1.532 . . . . 0.0 115.137 167.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 84.2 mt -61.1 -42.69 98.98 Favored 'General case' 0 CA--C 1.574 1.893 0 N-CA-C 114.618 1.34 . . . . 0.0 114.618 169.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 48.1 ttp180 -53.11 -47.55 68.53 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 115.395 1.628 . . . . 0.0 115.395 164.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.12 -22.71 61.29 Favored 'General case' 0 CA--C 1.568 1.641 0 N-CA-C 118.239 2.681 . . . . 0.0 118.239 166.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 98.5 mt -88.39 11.56 16.53 Favored 'General case' 0 CA--C 1.573 1.849 0 N-CA-C 115.46 1.652 . . . . 0.0 115.46 164.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.25 10.7 m-20 61.34 40.7 13.92 Favored 'General case' 0 CA--C 1.576 1.964 0 N-CA-C 115.493 1.664 . . . . 0.0 115.493 -175.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 91.2 t -94.88 141.89 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.191 -0.943 . . . . 0.0 109.931 -176.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 14.0 p30 -64.48 154.44 35.86 Favored 'General case' 0 CA--C 1.572 1.812 0 N-CA-C 115.82 1.785 . . . . 0.0 115.82 178.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 96.8 t -58.63 -40.84 80.45 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.276 0 N-CA-C 115.127 1.528 . . . . 0.0 115.127 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.58 -50.3 72.34 Favored 'General case' 0 CA--C 1.567 1.631 0 N-CA-C 116.029 1.863 . . . . 0.0 116.029 171.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -71.65 -34.65 69.93 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 115.322 1.601 . . . . 0.0 115.322 172.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 74.3 mtp180 -50.68 -41.71 55.99 Favored 'General case' 0 N--CA 1.503 2.197 0 N-CA-C 116.131 1.9 . . . . 0.0 116.131 160.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp -71.48 -54.05 11.89 Favored 'General case' 0 CA--C 1.567 1.621 0 O-C-N 120.96 -1.088 . . . . 0.0 113.574 166.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 12.0 mt -77.98 60.44 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.509 2.484 0 CA-C-N 120.923 1.692 . . . . 0.0 111.708 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -179.45 -47.29 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 126.701 2.0 . . . . 0.0 110.969 -174.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -64.49 -45.45 87.26 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 115.99 1.848 . . . . 0.0 115.99 158.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 65.2 mt -78.02 -24.94 47.69 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 115.645 1.72 . . . . 0.0 115.645 -175.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.9 pp -96.0 134.61 38.82 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 162.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 62.4 pttt -98.91 102.06 14.09 Favored Pre-proline 0 CA--C 1.574 1.896 0 CA-C-O 117.906 -1.045 . . . . 0.0 110.644 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -73.61 166.03 30.83 Favored 'Trans proline' 0 CA--C 1.565 2.041 0 CA-C-N 123.101 2.143 . . . . 0.0 115.77 -173.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -110.69 136.27 50.02 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.621 -0.674 . . . . 0.0 110.345 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 43.0 mttp -100.51 116.58 32.79 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 120.918 -1.114 . . . . 0.0 109.851 176.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -101.46 109.29 21.08 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 167.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.1 mp -96.06 127.12 48.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 178.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 74.7 t -110.21 106.55 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 164.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -103.69 105.69 15.99 Favored 'General case' 0 CA--C 1.565 1.535 0 C-N-CA 124.361 1.064 . . . . 0.0 109.222 177.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -125.97 87.42 2.68 Favored 'General case' 0 CA--C 1.565 1.532 0 C-N-CA 123.509 0.724 . . . . 0.0 110.061 -176.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 57.36 72.03 0.65 Allowed Glycine 0 N--CA 1.496 2.662 0 N-CA-C 117.106 1.602 . . . . 0.0 117.106 175.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.471 0.6 OUTLIER 65.26 -33.8 0.17 Allowed 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 118.476 2.769 . . . . 0.0 118.476 -166.473 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 15.6 t-160 -73.69 114.78 12.35 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-N 120.62 1.555 . . . . 0.0 111.471 172.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 44.7 ttm -123.35 124.18 42.37 Favored 'General case' 0 CA--C 1.557 1.227 0 C-N-CA 123.707 0.803 . . . . 0.0 109.646 -175.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 43.2 mt -108.46 104.4 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 178.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 17.0 mm -90.39 98.29 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 176.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -90.39 100.82 13.58 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.225 -0.922 . . . . 0.0 109.2 -176.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 28.6 m -88.55 104.49 16.87 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 43.7 mt -103.2 117.38 34.4 Favored 'General case' 0 CA--C 1.557 1.225 0 C-N-CA 123.852 0.861 . . . . 0.0 109.499 -163.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 43.7 t -128.58 143.03 50.88 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.063 0.945 . . . . 0.0 110.453 -165.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . 0.253 12.7 t -77.34 50.83 0.81 Allowed 'General case' 0 N--CA 1.503 2.191 0 N-CA-C 114.55 1.315 . . . . 0.0 114.55 168.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -167.26 -68.64 0.03 OUTLIER 'General case' 0 CA--C 1.568 1.639 0 C-N-CA 125.537 1.535 . . . . 0.0 108.057 -178.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 33.5 ttm105 -151.19 123.14 8.14 Favored 'General case' 0 CA--C 1.565 1.551 0 CA-C-N 118.959 0.8 . . . . 0.0 110.322 -179.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -80.16 139.44 36.79 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 -178.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -114.0 107.36 15.57 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.745 -0.597 . . . . 0.0 109.465 177.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 43.9 mm -100.51 106.5 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -171.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 1.2 mmm -96.24 87.32 4.47 Favored 'General case' 0 CA--C 1.564 1.493 0 CA-C-O 121.638 0.732 . . . . 0.0 110.207 -176.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -100.01 116.99 33.35 Favored 'General case' 0 CA--C 1.562 1.41 0 C-N-CA 123.928 0.891 . . . . 0.0 112.282 -175.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -155.59 153.54 30.28 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 -168.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -95.09 122.95 38.29 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.507 -0.746 . . . . 0.0 111.425 166.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 31.7 t -65.46 121.85 15.29 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.831 0 C-N-CA 124.169 0.987 . . . . 0.0 110.538 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 105.54 -34.57 5.67 Favored Glycine 0 CA--C 1.552 2.389 0 N-CA-C 116.955 1.542 . . . . 0.0 116.955 -162.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 52.4 mttp -95.55 122.96 38.84 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 119.265 1.532 . . . . 0.0 111.454 -171.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -78.9 116.52 19.28 Favored 'General case' 0 CA--C 1.569 1.697 0 O-C-N 121.491 -0.756 . . . . 0.0 112.587 -178.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -124.71 147.83 48.38 Favored 'General case' 0 N--CA 1.496 1.828 0 C-N-CA 123.787 0.835 . . . . 0.0 112.346 -170.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -68.29 127.18 32.01 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 119.91 -1.744 . . . . 0.0 113.92 172.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 . . . . . 0 N--CA 1.5 2.056 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 176.956 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 84.5 m . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 121.235 0.54 . . . . 0.0 111.211 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 79.1 mmm -72.21 103.4 3.33 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 121.979 0.895 . . . . 0.0 110.398 -174.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 85.8 m -107.76 113.6 26.97 Favored 'General case' 0 N--CA 1.48 1.038 0 O-C-N 121.162 -0.961 . . . . 0.0 110.07 -159.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 40.5 m -98.57 121.37 40.42 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 170.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.524 HG22 ' SG ' ' A' ' 95' ' ' CYS . 20.2 t -109.21 126.36 66.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 170.304 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 58.3 m -133.22 144.41 49.78 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 123.627 0.771 . . . . 0.0 111.323 -176.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 8.2 m95 -83.88 122.55 28.87 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.821 -1.174 . . . . 0.0 113.656 179.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -108.58 65.7 0.63 Allowed 'General case' 0 CA--C 1.576 1.964 0 C-N-CA 123.485 0.714 . . . . 0.0 110.424 163.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 67.65 -94.61 0.29 Allowed Glycine 0 N--CA 1.493 2.477 0 N-CA-C 116.322 1.289 . . . . 0.0 116.322 178.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -82.47 -30.52 29.92 Favored 'General case' 0 CA--C 1.573 1.857 0 N-CA-C 115.34 1.607 . . . . 0.0 115.34 165.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 33.8 mtpt -96.24 116.38 28.92 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-N 119.853 1.206 . . . . 0.0 110.434 -171.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 33.6 tp -86.96 110.8 20.27 Favored 'General case' 0 CA--C 1.564 1.509 0 O-C-N 120.992 -1.068 . . . . 0.0 109.711 174.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 18.2 mm100 -103.05 126.01 50.04 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.863 0.865 . . . . 0.0 110.226 -167.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . 0.524 ' SG ' HG22 ' A' ' 86' ' ' VAL . 41.0 t -127.6 129.11 46.7 Favored 'General case' 0 N--CA 1.481 1.083 0 O-C-N 121.822 -0.549 . . . . 0.0 111.417 -175.028 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 12.0 p -109.5 127.59 66.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 162.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -103.93 75.98 1.33 Allowed 'General case' 0 CA--C 1.57 1.712 0 C-N-CA 123.805 0.842 . . . . 0.0 109.263 175.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 15.7 ptpt -84.44 143.91 29.1 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 114.586 1.328 . . . . 0.0 114.586 -166.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 161.66 -114.15 0.59 Allowed Glycine 0 N--CA 1.484 1.884 0 O-C-N 121.663 -0.648 . . . . 0.0 111.949 172.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -80.33 -36.08 34.71 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 115.655 1.724 . . . . 0.0 115.655 175.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 9.4 tppt? -77.02 114.68 16.09 Favored 'General case' 0 CA--C 1.567 1.605 0 CA-C-N 119.559 1.072 . . . . 0.0 111.58 -177.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -74.17 119.46 18.41 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.418 -0.801 . . . . 0.0 112.854 -169.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 68.48 40.83 86.34 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 118.594 2.197 . . . . 0.0 118.594 -172.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 45.7 ttt180 -92.0 130.22 37.79 Favored 'General case' 0 CA--C 1.566 1.572 0 CA-C-N 118.514 1.157 . . . . 0.0 111.854 179.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 179.73 -168.52 38.98 Favored Glycine 0 N--CA 1.484 1.859 0 CA-C-O 122.368 0.982 . . . . 0.0 114.021 175.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 58.2 p-90 -156.62 153.3 28.37 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 122.214 1.007 . . . . 0.0 112.989 174.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 39.8 m -129.71 117.72 20.75 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 176.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -121.29 129.2 53.01 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 123.247 0.619 . . . . 0.0 111.621 -174.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 17.8 p90 -146.78 163.63 35.37 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.025 -1.047 . . . . 0.0 113.339 -174.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 76.0 mt -106.52 143.39 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.298 0 CA-C-O 123.224 1.488 . . . . 0.0 111.654 178.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -137.06 84.97 2.1 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 178.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 72.39 -110.04 3.04 Favored Glycine 0 N--CA 1.489 2.208 0 CA-C-N 116.025 -0.534 . . . . 0.0 114.415 -174.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 55.6 p30 -88.9 7.22 35.5 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 117.473 2.397 . . . . 0.0 117.473 169.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -124.07 137.93 54.51 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-N 120.085 1.311 . . . . 0.0 112.754 -166.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 26.4 tp -97.01 118.65 33.88 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 123.947 0.899 . . . . 0.0 108.984 172.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 34.1 m80 -107.83 123.29 48.35 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.926 0.89 . . . . 0.0 108.977 -176.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 45.4 tp -123.17 121.14 35.21 Favored 'General case' 0 CA--C 1.559 1.323 0 C-N-CA 123.82 0.848 . . . . 0.0 110.004 -172.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -102.13 114.66 28.98 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.594 -0.691 . . . . 0.0 109.296 166.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 73.5 mtm -103.89 126.85 51.31 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-N 118.557 0.617 . . . . 0.0 110.582 175.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 87.0 mtm180 -120.0 134.43 55.25 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 123.837 0.855 . . . . 0.0 110.471 -167.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -162.53 137.22 6.71 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.372 -0.83 . . . . 0.0 112.236 173.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . 0.328 12.1 mt-10 48.68 43.83 20.94 Favored 'General case' 0 N--CA 1.504 2.265 0 N-CA-C 116.156 1.91 . . . . 0.0 116.156 -178.197 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 65.71 26.24 71.99 Favored Glycine 0 CA--C 1.552 2.363 0 N-CA-C 120.609 3.004 . . . . 0.0 120.609 -167.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 87.6 t -130.83 128.36 62.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 CA-C-N 119.605 1.703 . . . . 0.0 109.202 -175.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 52.4 m -106.07 126.11 51.81 Favored 'General case' 0 N--CA 1.496 1.834 0 C-N-CA 123.284 0.634 . . . . 0.0 111.267 176.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 9.2 t -96.67 128.65 43.81 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.698 0.799 . . . . 0.0 111.542 162.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 47.0 mttp -102.02 111.1 23.25 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 121.427 0.632 . . . . 0.0 110.536 176.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 64.2 mt-30 -108.98 126.74 53.42 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.693 0.797 . . . . 0.0 110.767 176.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 47.7 t -114.27 132.0 64.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -126.87 149.6 49.67 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 123.742 0.817 . . . . 0.0 111.329 178.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 75.4 tttt -111.33 140.18 46.11 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.374 -0.829 . . . . 0.0 112.164 175.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 73.0 tttt -74.19 122.93 23.55 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.448 -0.782 . . . . 0.0 113.07 -178.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 31.7 m -109.32 -42.31 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 175.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 50.2 t-80 . . . . . 0 N--CA 1.485 1.309 0 CA-C-N 119.712 1.142 . . . . 0.0 108.268 167.782 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo . . . . . 0 CA--C 1.565 2.028 0 N-CA-C 117.35 2.019 . . . . 0.0 117.35 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 27.6 m -108.98 175.42 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 CA-C-O 122.666 1.222 . . . . 0.0 112.719 174.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -78.14 96.74 5.24 Favored 'General case' 0 CA--C 1.568 1.643 0 O-C-N 120.874 -1.141 . . . . 0.0 113.287 -172.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -78.14 -0.22 27.4 Favored 'General case' 0 N--CA 1.501 2.116 0 N-CA-C 116.334 1.976 . . . . 0.0 116.334 169.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -60.24 116.07 3.97 Favored 'General case' 0 CA--C 1.563 1.47 0 C-N-CA 125.826 1.65 . . . . 0.0 114.343 179.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 163.44 177.99 36.77 Favored Glycine 0 N--CA 1.484 1.879 0 N-CA-C 116.743 1.457 . . . . 0.0 116.743 177.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -106.57 120.07 40.96 Favored 'General case' 0 CA--C 1.563 1.459 0 CA-C-N 113.961 -1.12 . . . . 0.0 108.536 170.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 64.5 m95 -120.03 124.98 47.22 Favored 'General case' 0 CA--C 1.565 1.547 0 C-N-CA 123.882 0.873 . . . . 0.0 108.766 -169.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -95.24 137.06 34.81 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.67 -1.269 . . . . 0.0 112.619 179.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 4.3 ttp -74.86 121.64 22.15 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 122.133 0.968 . . . . 0.0 112.773 179.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 93.4 mt -79.47 -54.65 5.71 Favored 'General case' 0 CA--C 1.566 1.592 0 CA-C-N 115.029 -0.987 . . . . 0.0 112.609 171.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 89.6 p -144.33 151.77 39.82 Favored 'General case' 0 CA--C 1.563 1.45 0 C-N-CA 123.717 0.807 . . . . 0.0 112.624 -173.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -122.64 133.49 54.52 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.43 0.634 . . . . 0.0 110.901 160.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -125.58 117.78 24.3 Favored 'General case' 0 CA--C 1.561 1.367 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 -179.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.292 31.3 t30 68.88 31.65 4.23 Favored 'General case' 0 CA--C 1.579 2.089 0 N-CA-C 117.082 2.253 . . . . 0.0 117.082 -175.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -71.8 -42.97 66.42 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 115.215 1.561 . . . . 0.0 115.215 175.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -47.3 -47.33 25.37 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 116.442 2.015 . . . . 0.0 116.442 166.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -70.26 -38.62 75.15 Favored 'General case' 0 CA--C 1.57 1.736 0 N-CA-C 115.686 1.736 . . . . 0.0 115.686 176.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 81.5 t80 -55.41 -49.4 72.45 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-N 120.519 1.508 . . . . 0.0 114.201 165.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 79.8 mt -59.37 -43.01 92.91 Favored 'General case' 0 CA--C 1.574 1.895 0 N-CA-C 115.493 1.664 . . . . 0.0 115.493 169.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 36.4 ttp180 -51.2 -51.16 56.44 Favored 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 115.325 1.602 . . . . 0.0 115.325 165.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.87 -24.53 52.39 Favored 'General case' 0 CA--C 1.565 1.538 0 N-CA-C 118.364 2.728 . . . . 0.0 118.364 165.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 93.3 mt -87.18 8.91 21.87 Favored 'General case' 0 CA--C 1.575 1.912 0 N-CA-C 115.735 1.754 . . . . 0.0 115.735 167.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.256 25.8 m-20 67.24 41.46 2.52 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 -175.241 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 90.3 t -100.37 141.66 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 121.031 -1.043 . . . . 0.0 110.014 -178.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 12.1 p30 -68.68 159.89 31.28 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 115.887 1.81 . . . . 0.0 115.887 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 65.0 t -58.52 -46.2 89.9 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.256 0 N-CA-C 114.895 1.443 . . . . 0.0 114.895 -179.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.55 -47.4 84.36 Favored 'General case' 0 CA--C 1.57 1.717 0 N-CA-C 116.052 1.871 . . . . 0.0 116.052 173.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.49 -43.83 97.85 Favored 'General case' 0 CA--C 1.574 1.9 0 N-CA-C 114.873 1.434 . . . . 0.0 114.873 169.259 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 77.1 mtp180 -49.92 -50.92 44.55 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 115.569 1.692 . . . . 0.0 115.569 164.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -54.95 -54.15 46.51 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 115.258 1.577 . . . . 0.0 115.258 168.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 34.9 mt -59.73 -53.2 51.71 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 CA-C-N 119.808 1.185 . . . . 0.0 113.162 178.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -61.94 -40.41 95.45 Favored 'General case' 0 CA--C 1.566 1.569 0 N-CA-C 117.529 2.418 . . . . 0.0 117.529 175.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -65.64 -32.08 73.45 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 116.003 1.853 . . . . 0.0 116.003 169.242 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 81.5 mt -72.79 -30.45 64.1 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 116.139 1.903 . . . . 0.0 116.139 170.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 38.6 mt -73.95 139.8 45.12 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 119.539 1.063 . . . . 0.0 113.547 -179.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -110.96 86.01 5.61 Favored Pre-proline 0 CA--C 1.572 1.826 0 CA-C-O 118.299 -0.858 . . . . 0.0 109.723 172.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -76.87 174.02 13.53 Favored 'Trans proline' 0 CA--C 1.563 1.926 0 C-N-CA 122.558 2.172 . . . . 0.0 115.67 -176.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -111.88 130.27 55.89 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.699 -0.625 . . . . 0.0 111.315 178.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 47.6 mttm -90.12 109.93 20.97 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.275 -0.891 . . . . 0.0 110.137 171.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -92.55 110.94 22.37 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 163.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 74.3 mt -109.03 118.35 56.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 107.475 -1.305 . . . . 0.0 107.475 -178.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 72.1 t -100.87 98.48 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 106.676 -1.602 . . . . 0.0 106.676 166.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -90.44 93.0 9.12 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.537 0.684 . . . . 0.0 109.731 174.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -100.33 70.58 1.52 Allowed 'General case' 0 CA--C 1.567 1.624 0 O-C-N 121.478 -0.764 . . . . 0.0 111.403 -177.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 53.56 67.46 2.13 Favored Glycine 0 N--CA 1.496 2.695 0 N-CA-C 117.64 1.816 . . . . 0.0 117.64 176.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.438 0.5 OUTLIER 61.0 8.22 1.82 Allowed 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 119.617 3.192 . . . . 0.0 119.617 -163.579 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 17.5 t-160 -107.48 106.56 17.01 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 121.276 1.853 . . . . 0.0 107.643 161.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 6.6 tpp -109.45 132.19 54.36 Favored 'General case' 0 CA--C 1.556 1.186 0 O-C-N 121.458 -0.776 . . . . 0.0 110.969 -172.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 47.1 mt -116.47 101.87 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 173.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 72.9 mt -99.13 116.31 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 178.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -115.86 103.39 10.59 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 70.4 m -88.42 112.62 23.12 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 172.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 24.0 mt -110.96 119.01 37.64 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.303 -158.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 36.1 t -130.76 153.53 48.93 Favored 'General case' 0 CA--C 1.56 1.346 0 C-N-CA 123.668 0.787 . . . . 0.0 110.529 173.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 70.2 p -80.98 62.32 4.92 Favored 'General case' 0 N--CA 1.504 2.247 0 O-C-N 120.636 -1.29 . . . . 0.0 111.633 163.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -174.06 -68.61 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 125.097 1.359 . . . . 0.0 108.985 -174.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 14.8 ttm180 -146.61 118.08 7.96 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 123.634 0.773 . . . . 0.0 109.103 -173.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -106.11 130.55 53.98 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 123.229 0.612 . . . . 0.0 110.588 -170.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 10.3 t80 -101.45 109.55 21.4 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.544 -0.722 . . . . 0.0 109.871 178.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 41.6 mm -116.67 117.47 55.58 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -169.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 25.4 mmm -126.6 97.54 5.06 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 123.226 0.61 . . . . 0.0 109.77 -175.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -104.84 103.7 13.34 Favored 'General case' 0 CA--C 1.563 1.463 0 C-N-CA 124.06 0.944 . . . . 0.0 111.875 177.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -151.49 154.24 36.17 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 -163.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 17.8 mp0 -84.57 126.53 33.4 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.11 -0.994 . . . . 0.0 111.08 164.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 15.1 t -69.06 114.15 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 174.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 124.88 -46.72 1.07 Allowed Glycine 0 N--CA 1.488 2.146 0 N-CA-C 115.807 1.083 . . . . 0.0 115.807 -160.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 34.9 mtmt -83.74 142.83 30.42 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 118.872 1.336 . . . . 0.0 113.861 -173.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -93.25 95.54 9.43 Favored 'General case' 0 CA--C 1.566 1.58 0 CA-C-O 121.321 0.582 . . . . 0.0 111.252 176.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -104.56 142.14 35.16 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 124.032 0.933 . . . . 0.0 113.058 -170.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -71.58 115.7 11.07 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.164 -1.585 . . . . 0.0 113.46 176.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 . . . . . 0 CA--C 1.564 1.508 0 O-C-N 121.397 -0.814 . . . . 0.0 109.423 165.501 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 72.5 m . . . . . 0 CA--C 1.559 1.31 0 CA-C-O 121.466 0.651 . . . . 0.0 110.866 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 2.4 tpt -75.58 98.66 4.06 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 122.195 0.998 . . . . 0.0 109.638 -176.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 65.3 m -104.72 110.26 22.51 Favored 'General case' 0 N--CA 1.48 1.059 0 O-C-N 121.695 -0.628 . . . . 0.0 110.065 -154.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 54.6 m -88.79 121.82 31.56 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 167.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 22.9 t -110.35 121.51 63.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 165.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 31.8 m -128.08 154.11 46.07 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 122.125 0.964 . . . . 0.0 111.545 -175.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 29.0 m95 -84.69 114.98 22.42 Favored 'General case' 0 CA--C 1.562 1.422 0 O-C-N 121.223 -0.923 . . . . 0.0 111.939 174.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -93.5 70.92 4.3 Favored 'General case' 0 CA--C 1.571 1.783 0 CA-C-O 121.539 0.685 . . . . 0.0 109.57 159.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 61.14 -114.72 6.96 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 114.901 0.72 . . . . 0.0 114.901 -168.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -64.87 -30.56 71.57 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 116.461 2.023 . . . . 0.0 116.461 166.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -86.87 127.81 35.04 Favored 'General case' 0 CA--C 1.561 1.384 0 CA-C-N 119.443 1.019 . . . . 0.0 111.256 -173.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 25.8 tp -92.28 106.56 18.54 Favored 'General case' 0 CA--C 1.566 1.562 0 O-C-N 121.378 -0.826 . . . . 0.0 109.097 176.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 -100.46 128.83 46.41 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 123.658 0.783 . . . . 0.0 111.132 -173.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 40.9 t -124.19 131.64 53.55 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.436 0.694 . . . . 0.0 111.975 -177.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.5 p -120.15 125.65 74.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 C-N-CA 122.979 0.511 . . . . 0.0 109.628 168.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -100.87 90.26 4.14 Favored 'General case' 0 CA--C 1.568 1.657 0 C-N-CA 124.092 0.957 . . . . 0.0 109.58 -176.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -84.88 122.47 29.21 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.66 -1.275 . . . . 0.0 113.525 -166.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -169.76 -130.64 1.23 Allowed Glycine 0 N--CA 1.485 1.947 0 O-C-N 121.593 -0.692 . . . . 0.0 112.157 171.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.68 -16.44 58.49 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 117.157 2.281 . . . . 0.0 117.157 176.165 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 16.7 ttmt -98.82 129.64 45.22 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 119.97 1.259 . . . . 0.0 111.561 -170.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -79.01 128.55 33.4 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.472 -0.767 . . . . 0.0 112.816 -172.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 66.61 34.1 86.53 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 118.975 2.35 . . . . 0.0 118.975 -176.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 36.7 ttt180 -85.92 124.36 32.3 Favored 'General case' 0 CA--C 1.565 1.527 0 CA-C-N 118.734 1.267 . . . . 0.0 111.577 -177.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -179.18 -168.96 39.03 Favored Glycine 0 N--CA 1.486 1.989 0 N-CA-C 115.687 1.035 . . . . 0.0 115.687 -177.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 41.8 p-90 -157.43 155.47 30.53 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.958 0.885 . . . . 0.0 112.898 170.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 97.5 m -126.16 120.47 30.2 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.344 -0.848 . . . . 0.0 108.712 176.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 16.8 tt0 -124.42 124.72 42.95 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.846 -0.534 . . . . 0.0 111.992 -175.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 14.0 p90 -143.17 163.02 34.04 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.079 -1.013 . . . . 0.0 113.227 -177.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 86.1 mt -107.92 133.94 51.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 CA-C-O 122.266 1.031 . . . . 0.0 110.652 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -120.71 85.34 2.38 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 124.525 1.13 . . . . 0.0 108.451 173.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 69.68 -108.06 2.34 Favored Glycine 0 N--CA 1.491 2.315 0 O-C-N 121.584 -0.697 . . . . 0.0 114.752 -175.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 31.6 p-10 -87.96 -5.16 58.68 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 117.427 2.38 . . . . 0.0 117.427 166.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -103.41 139.59 38.59 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-N 120.408 1.458 . . . . 0.0 112.368 -175.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 10.7 tp -101.46 122.08 43.12 Favored 'General case' 0 CA--C 1.562 1.417 0 C-N-CA 123.873 0.869 . . . . 0.0 108.957 169.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 36.9 m80 -109.27 119.87 40.81 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.533 0.733 . . . . 0.0 109.208 -175.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 20.0 tp -114.38 129.86 56.67 Favored 'General case' 0 CA--C 1.56 1.327 0 C-N-CA 123.737 0.815 . . . . 0.0 110.183 -178.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -119.16 108.7 14.99 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.936 -0.478 . . . . 0.0 110.003 169.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 76.8 mtm -97.82 127.49 43.8 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 123.62 0.768 . . . . 0.0 111.515 -176.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 78.7 mtm180 -118.14 135.2 54.37 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 123.329 0.651 . . . . 0.0 111.693 -167.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -160.23 132.89 6.46 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.26 -0.9 . . . . 0.0 111.515 170.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 33.8 mm-40 58.13 36.88 26.24 Favored 'General case' 0 N--CA 1.505 2.3 0 N-CA-C 115.361 1.615 . . . . 0.0 115.361 -177.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 72.9 -8.62 7.56 Favored Glycine 0 CA--C 1.556 2.603 0 N-CA-C 120.399 2.92 . . . . 0.0 120.399 -162.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 97.1 t -92.88 128.23 44.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 CA-C-N 120.137 1.969 . . . . 0.0 109.76 -171.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 37.8 m -105.9 124.25 49.28 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 122.73 0.412 . . . . 0.0 111.5 177.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 11.2 t -95.14 126.21 40.31 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.426 0.69 . . . . 0.0 111.234 162.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -103.4 121.1 42.09 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 123.381 0.672 . . . . 0.0 109.569 -179.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 20.0 mt-30 -126.64 134.24 50.8 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.588 -0.695 . . . . 0.0 111.227 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 57.1 t -115.24 131.07 68.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 -177.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -123.5 149.83 44.69 Favored 'General case' 0 CA--C 1.563 1.478 0 C-N-CA 124.72 1.208 . . . . 0.0 110.232 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 29.6 ttmt -123.61 141.08 52.36 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.789 -1.194 . . . . 0.0 112.153 175.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 70.8 tttt -73.84 123.4 24.13 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 -175.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . 0.255 34.5 m -107.86 -43.07 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 175.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 . . . . . 0 N--CA 1.487 1.414 0 CA-C-N 120.206 1.366 . . . . 0.0 108.312 167.011 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo . . . . . 0 CA--C 1.561 1.859 0 N-CA-C 115.405 1.271 . . . . 0.0 115.405 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 15.6 m -72.58 141.26 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 CA-C-O 121.936 0.874 . . . . 0.0 113.079 178.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -76.25 121.48 23.0 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 -176.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 8.6 m-30 -85.05 8.4 18.04 Favored 'General case' 0 CA--C 1.572 1.807 0 N-CA-C 115.647 1.721 . . . . 0.0 115.647 177.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 27.5 m120 -51.43 121.82 6.93 Favored 'General case' 0 N--CA 1.499 2.004 0 CA-C-N 121.496 1.953 . . . . 0.0 115.082 172.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 160.45 177.88 33.95 Favored Glycine 0 N--CA 1.481 1.685 0 CA-C-O 123.002 1.334 . . . . 0.0 116.031 174.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 14.8 t80 -110.74 128.84 55.89 Favored 'General case' 0 CA--C 1.564 1.491 0 CA-C-N 113.578 -1.311 . . . . 0.0 108.364 165.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 55.3 m95 -126.81 138.51 53.36 Favored 'General case' 0 CA--C 1.573 1.832 0 C-N-CA 123.733 0.813 . . . . 0.0 110.144 -167.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -112.11 137.05 50.71 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 120.678 -1.264 . . . . 0.0 112.633 178.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.45 ' SD ' ' HD2' ' A' ' 38' ' ' PRO . 1.9 ttt -75.0 123.45 25.18 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.454 -1.404 . . . . 0.0 114.281 -175.122 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 97.5 mt -85.92 -52.67 5.58 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 113.688 0.996 . . . . 0.0 113.688 176.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 83.3 p -142.36 148.25 37.61 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 123.671 0.788 . . . . 0.0 112.112 -176.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -126.75 116.73 21.38 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 123.107 0.563 . . . . 0.0 110.078 170.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -112.15 116.05 29.85 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 178.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.293 18.7 t30 69.71 25.47 5.14 Favored 'General case' 0 CA--C 1.579 2.096 0 N-CA-C 117.964 2.579 . . . . 0.0 117.964 177.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 15.7 t80 -63.41 -45.14 92.39 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 115.459 1.651 . . . . 0.0 115.459 170.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -54.68 -40.78 69.47 Favored 'General case' 0 CA--C 1.573 1.836 0 N-CA-C 117.868 2.544 . . . . 0.0 117.868 172.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -74.22 -40.72 62.26 Favored 'General case' 0 CA--C 1.571 1.775 0 N-CA-C 115.264 1.579 . . . . 0.0 115.264 171.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -49.06 -48.92 43.67 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 115.19 1.552 . . . . 0.0 115.19 162.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 88.5 mt -62.06 -40.19 94.94 Favored 'General case' 0 CA--C 1.573 1.835 0 N-CA-C 115.339 1.607 . . . . 0.0 115.339 169.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 46.9 ttp180 -54.0 -50.47 66.52 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 165.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.58 -21.52 53.34 Favored 'General case' 0 CA--C 1.567 1.622 0 N-CA-C 118.223 2.675 . . . . 0.0 118.223 167.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 37.7 mt -90.83 8.53 34.36 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 115.988 1.847 . . . . 0.0 115.988 168.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 69.84 32.94 3.01 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 115.141 1.534 . . . . 0.0 115.141 -177.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 70.3 t -95.36 144.08 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 120.666 -1.271 . . . . 0.0 110.623 -172.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -64.74 152.64 42.04 Favored 'General case' 0 CA--C 1.573 1.835 0 N-CA-C 116.213 1.931 . . . . 0.0 116.213 -176.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . 0.251 56.1 t -58.45 -42.47 84.37 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.156 0 N-CA-C 115.682 1.734 . . . . 0.0 115.682 -179.251 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.05 -51.3 70.65 Favored 'General case' 0 CA--C 1.57 1.72 0 N-CA-C 115.878 1.807 . . . . 0.0 115.878 173.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -54.28 -53.49 53.05 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 114.314 1.227 . . . . 0.0 114.314 166.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 56.3 mtp180 -47.52 -41.57 21.33 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 118.378 2.732 . . . . 0.0 118.378 171.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -75.73 -52.88 9.48 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 174.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 19.9 mt -63.33 -49.75 81.64 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 CA-C-N 119.251 0.932 . . . . 0.0 112.961 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.93 -33.07 74.88 Favored 'General case' 0 CA--C 1.568 1.664 0 N-CA-C 117.821 2.526 . . . . 0.0 117.821 175.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -69.14 -31.27 69.82 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 116.11 1.893 . . . . 0.0 116.11 165.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 79.9 mt -72.25 -36.49 69.08 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 116.075 1.88 . . . . 0.0 116.075 171.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . 0.293 2.5 pp -80.82 152.69 28.1 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-N 120.196 1.362 . . . . 0.0 114.545 -178.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 30.8 mmtp -111.07 99.29 42.54 Favored Pre-proline 0 CA--C 1.572 1.808 0 CA-C-O 118.348 -0.834 . . . . 0.0 108.818 176.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.45 ' HD2' ' SD ' ' A' ' 10' ' ' MET . 91.0 Cg_endo -77.92 176.92 9.42 Favored 'Trans proline' 0 CA--C 1.565 2.032 0 C-N-CA 122.948 2.432 . . . . 0.0 116.025 -175.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -109.98 163.45 13.55 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.969 0.89 . . . . 0.0 112.213 173.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 43.2 mttm -135.46 120.53 18.78 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.099 -1.001 . . . . 0.0 110.123 176.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -100.57 118.57 37.0 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.422 -0.798 . . . . 0.0 109.656 163.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 78.6 mt -113.75 121.42 65.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 177.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 52.9 t -107.09 97.35 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 107.788 -1.189 . . . . 0.0 107.788 167.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -88.48 117.04 27.14 Favored 'General case' 0 CA--C 1.567 1.604 0 C-N-CA 123.454 0.701 . . . . 0.0 110.019 165.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -142.9 102.04 3.95 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.241 -0.912 . . . . 0.0 109.762 -179.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 56.8 62.36 6.45 Favored Glycine 0 N--CA 1.497 2.706 0 N-CA-C 117.409 1.724 . . . . 0.0 117.409 178.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.416 0.6 OUTLIER 59.97 -10.79 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 119.914 3.302 . . . . 0.0 119.914 -165.291 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 12.4 t-80 -88.4 121.93 31.33 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-N 121.192 1.814 . . . . 0.0 110.127 174.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 40.4 ttm -123.58 116.99 24.04 Favored 'General case' 0 CA--C 1.556 1.208 0 CA-C-O 121.553 0.692 . . . . 0.0 110.161 -174.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 27.6 mt -104.13 98.91 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 177.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 72.0 mt -94.23 111.76 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 178.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 41.9 mtt85 -110.27 101.79 10.5 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 178.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.2 m -80.0 120.7 24.54 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 167.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 74.9 mt -124.39 118.21 26.19 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-O 121.649 0.738 . . . . 0.0 109.638 -164.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.47 -3.13 0.2 Allowed 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 117.018 2.229 . . . . 0.0 117.018 -178.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . 0.344 30.3 m 75.4 -62.97 0.43 Allowed 'General case' 0 N--CA 1.505 2.293 0 CA-C-N 121.556 1.98 . . . . 0.0 112.893 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -63.15 -44.44 95.51 Favored 'General case' 0 CA--C 1.571 1.778 0 N-CA-C 115.174 1.546 . . . . 0.0 115.174 165.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 31.4 ttt85 -128.16 130.77 48.59 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 120.081 1.309 . . . . 0.0 110.397 172.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -133.82 135.21 43.65 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.764 -0.585 . . . . 0.0 110.507 176.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -120.0 119.99 35.01 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 170.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 33.9 mm -112.4 104.88 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 174.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 94.4 mtp -110.74 98.71 7.8 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 -179.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -102.01 98.35 8.56 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 123.523 0.729 . . . . 0.0 110.136 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -142.78 156.78 45.03 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -168.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -94.7 131.26 40.7 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.105 -0.997 . . . . 0.0 110.824 166.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 22.0 t -66.85 113.3 2.84 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.776 0 C-N-CA 123.501 0.721 . . . . 0.0 109.978 -179.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 127.4 -55.45 0.75 Allowed Glycine 0 CA--C 1.548 2.109 0 CA-C-O 119.059 -0.856 . . . . 0.0 114.923 -158.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 13.9 pttt -75.76 145.58 40.69 Favored 'General case' 0 CA--C 1.567 1.627 0 N-CA-C 116.286 1.958 . . . . 0.0 116.286 -170.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -95.01 108.85 20.93 Favored 'General case' 0 CA--C 1.567 1.627 0 C-N-CA 123.172 0.589 . . . . 0.0 110.835 174.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -116.02 143.12 45.89 Favored 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 123.666 0.786 . . . . 0.0 112.819 -173.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -70.66 116.24 10.75 Favored 'General case' 0 CA--C 1.569 1.709 0 O-C-N 120.042 -1.661 . . . . 0.0 113.975 175.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.777 0 O-C-N 121.166 -0.959 . . . . 0.0 108.763 167.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 22.1 m . . . . . 0 CA--C 1.562 1.423 0 CA-C-O 122.208 1.004 . . . . 0.0 111.435 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 72.1 mmm -74.05 110.46 8.36 Favored 'General case' 0 CA--C 1.562 1.439 0 C-N-CA 123.744 0.818 . . . . 0.0 109.757 172.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 76.6 m -108.81 116.16 31.46 Favored 'General case' 0 N--CA 1.484 1.256 0 O-C-N 121.668 -0.645 . . . . 0.0 110.714 -161.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 89.8 m -104.68 125.81 51.15 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 176.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.409 HG22 ' SG ' ' A' ' 95' ' ' CYS . 15.4 t -117.85 119.24 60.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 177.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 56.8 m -140.56 150.18 43.35 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 123.341 0.656 . . . . 0.0 112.161 -174.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 90.7 m95 -79.27 119.74 22.76 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.462 -1.399 . . . . 0.0 112.847 177.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -93.55 78.52 4.34 Favored 'General case' 0 CA--C 1.567 1.616 0 O-C-N 121.631 -0.668 . . . . 0.0 109.295 163.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 67.65 -99.27 0.52 Allowed Glycine 0 N--CA 1.49 2.264 0 O-C-N 121.818 -0.551 . . . . 0.0 114.451 -171.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -102.95 -6.05 22.82 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 116.454 2.02 . . . . 0.0 116.454 170.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 35.8 mtmm -97.39 127.59 43.48 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-N 120.539 1.518 . . . . 0.0 110.026 176.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 22.3 tp -84.73 110.15 18.56 Favored 'General case' 0 CA--C 1.564 1.489 0 O-C-N 121.034 -1.041 . . . . 0.0 110.071 174.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -97.39 125.53 42.07 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.693 0.797 . . . . 0.0 110.841 -175.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . 0.409 ' SG ' HG22 ' A' ' 86' ' ' VAL . 39.4 t -114.03 124.33 51.87 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 123.284 0.633 . . . . 0.0 110.154 175.075 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.6 p -107.3 118.47 55.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 166.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -97.97 88.14 4.17 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 174.145 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -99.07 126.74 44.87 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.092 -1.005 . . . . 0.0 112.462 -174.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 166.39 -107.25 0.28 Allowed Glycine 0 N--CA 1.487 2.072 0 O-C-N 121.28 -0.887 . . . . 0.0 112.915 176.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -76.87 -10.22 59.22 Favored 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 117.764 2.505 . . . . 0.0 117.764 -177.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -122.94 142.84 50.37 Favored 'General case' 0 CA--C 1.566 1.563 0 CA-C-N 120.086 1.312 . . . . 0.0 111.294 177.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -81.79 144.32 31.16 Favored 'General case' 0 CA--C 1.563 1.467 0 O-C-N 121.491 -0.756 . . . . 0.0 111.565 173.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 57.63 23.96 51.4 Favored Glycine 0 N--CA 1.498 2.81 0 N-CA-C 120.854 3.102 . . . . 0.0 120.854 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 57.8 ttt180 -85.95 124.8 32.82 Favored 'General case' 0 CA--C 1.565 1.544 0 CA-C-N 118.501 1.151 . . . . 0.0 111.28 -178.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 178.25 -173.67 46.09 Favored Glycine 0 N--CA 1.488 2.119 0 O-C-N 121.341 -0.849 . . . . 0.0 114.852 -178.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . 0.25 16.8 p-90 -155.12 157.77 37.99 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 114.66 1.356 . . . . 0.0 114.66 171.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 31.8 m -123.77 123.7 41.06 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 123.831 0.852 . . . . 0.0 108.842 170.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -123.44 131.99 53.81 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 123.287 0.635 . . . . 0.0 111.882 -176.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 23.4 p90 -150.54 167.08 28.27 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.045 -1.034 . . . . 0.0 113.014 -179.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 89.3 mt -107.94 136.83 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.193 0 O-C-N 120.776 -1.202 . . . . 0.0 110.447 175.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -123.3 97.09 5.25 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 123.578 0.751 . . . . 0.0 109.701 164.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 76.97 -111.3 3.23 Favored Glycine 0 N--CA 1.491 2.316 0 O-C-N 121.275 -0.89 . . . . 0.0 113.9 -176.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -107.37 37.87 2.28 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 164.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -131.65 117.01 18.1 Favored 'General case' 0 CA--C 1.559 1.326 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 -168.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 17.2 tp -87.42 114.4 24.0 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-O 121.755 0.788 . . . . 0.0 109.914 172.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 48.9 m80 -102.66 120.09 39.96 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.972 0.909 . . . . 0.0 109.076 -177.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 49.5 tp -120.31 120.08 35.01 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 123.784 0.834 . . . . 0.0 109.833 -177.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -105.43 116.3 31.71 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.577 -0.702 . . . . 0.0 109.454 168.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 69.3 mtm -108.5 131.13 55.13 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 123.372 0.669 . . . . 0.0 111.023 -178.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 77.6 mtm-85 -115.16 143.87 44.56 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.534 -0.729 . . . . 0.0 111.411 -175.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -149.17 124.07 9.96 Favored 'General case' 0 N--CA 1.484 1.259 0 CA-C-O 121.456 0.646 . . . . 0.0 110.707 166.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 62.0 24.71 14.75 Favored 'General case' 0 CA--C 1.581 2.17 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 -172.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 88.33 -28.96 5.89 Favored Glycine 0 CA--C 1.557 2.694 0 N-CA-C 118.256 2.062 . . . . 0.0 118.256 -158.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 87.4 t -72.19 120.58 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 CA-C-N 119.644 1.722 . . . . 0.0 110.588 -173.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 29.4 m -102.12 123.74 46.5 Favored 'General case' 0 CA--C 1.566 1.573 0 CA-C-O 121.585 0.707 . . . . 0.0 111.484 -173.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 10.7 t -96.0 138.18 34.0 Favored 'General case' 0 CA--C 1.559 1.316 0 C-N-CA 124.3 1.04 . . . . 0.0 111.475 162.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 6.0 mtmt -118.07 124.14 47.36 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.333 -0.854 . . . . 0.0 110.051 179.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -127.24 134.45 50.08 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 123.593 0.757 . . . . 0.0 111.353 -177.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 38.0 t -116.68 132.39 66.52 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.439 ' CZ ' ' SD ' ' A' ' 10' ' ' MET . 38.3 m-85 -126.89 134.84 50.39 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.999 0.92 . . . . 0.0 111.062 -178.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 74.9 tttt -99.89 137.24 38.62 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.636 -1.29 . . . . 0.0 112.446 -179.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -71.56 118.82 14.86 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 179.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 26.8 m -104.04 -40.72 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 174.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 76.9 t60 . . . . . 0 C--O 1.253 1.273 0 CA-C-N 119.629 1.104 . . . . 0.0 108.416 166.275 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo . . . . . 0 CA--C 1.565 2.053 0 N-CA-C 117.061 1.908 . . . . 0.0 117.061 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.1 t -81.9 139.85 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.53 -0.731 . . . . 0.0 110.76 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -67.92 99.41 0.84 Allowed 'General case' 0 CA--C 1.569 1.674 0 O-C-N 121.109 -0.994 . . . . 0.0 113.35 167.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 10.6 m-30 -79.26 5.46 12.28 Favored 'General case' 0 CA--C 1.579 2.086 0 N-CA-C 116.364 1.987 . . . . 0.0 116.364 175.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -60.43 116.09 4.05 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 125.711 1.604 . . . . 0.0 114.616 -176.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 162.89 -177.9 38.8 Favored Glycine 0 N--CA 1.482 1.767 0 N-CA-C 116.646 1.419 . . . . 0.0 116.646 179.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 24.2 t80 -111.25 122.78 48.75 Favored 'General case' 0 CA--C 1.564 1.484 0 CA-C-N 113.514 -1.343 . . . . 0.0 108.138 170.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 83.1 m95 -122.43 125.82 46.64 Favored 'General case' 0 CA--C 1.564 1.497 0 C-N-CA 123.47 0.708 . . . . 0.0 109.93 -167.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -101.21 139.19 37.22 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.111 -0.993 . . . . 0.0 112.816 -179.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.464 ' SD ' ' HD2' ' A' ' 38' ' ' PRO . 42.0 ttm -67.1 126.12 28.19 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-N 120.241 1.382 . . . . 0.0 113.912 -179.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 91.3 mt -85.07 -55.54 4.0 Favored 'General case' 0 CA--C 1.567 1.611 0 CA-C-N 115.723 -0.672 . . . . 0.0 112.55 163.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 99.7 p -138.65 150.25 46.05 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 123.526 0.73 . . . . 0.0 112.773 -177.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -132.76 104.74 6.77 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.683 0.754 . . . . 0.0 109.453 165.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -108.0 124.77 50.66 Favored 'General case' 0 CA--C 1.56 1.357 0 C-N-CA 124.155 0.982 . . . . 0.0 109.487 -170.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.286 33.4 t30 64.87 24.3 12.74 Favored 'General case' 0 N--CA 1.502 2.165 0 N-CA-C 117.105 2.261 . . . . 0.0 117.105 -173.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -68.21 -45.02 74.45 Favored 'General case' 0 CA--C 1.569 1.68 0 N-CA-C 115.271 1.582 . . . . 0.0 115.271 176.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -43.36 -50.5 6.75 Favored 'General case' 0 N--CA 1.501 2.124 0 N-CA-C 117.319 2.341 . . . . 0.0 117.319 164.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -71.68 -38.45 70.61 Favored 'General case' 0 CA--C 1.571 1.752 0 N-CA-C 115.563 1.69 . . . . 0.0 115.563 177.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 73.0 t80 -53.98 -47.52 71.32 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 114.907 1.447 . . . . 0.0 114.907 162.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 72.6 mt -62.17 -42.0 98.85 Favored 'General case' 0 CA--C 1.574 1.871 0 N-CA-C 114.681 1.363 . . . . 0.0 114.681 171.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 26.1 ttt-85 -50.41 -50.74 51.01 Favored 'General case' 0 N--CA 1.501 2.118 0 N-CA-C 115.586 1.699 . . . . 0.0 115.586 163.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.25 -23.2 55.23 Favored 'General case' 0 CA--C 1.566 1.576 0 N-CA-C 118.181 2.66 . . . . 0.0 118.181 167.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 96.1 mt -88.95 13.83 11.9 Favored 'General case' 0 CA--C 1.574 1.901 0 N-CA-C 115.484 1.661 . . . . 0.0 115.484 165.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 60.29 40.59 17.57 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 115.984 1.846 . . . . 0.0 115.984 -174.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 88.9 t -93.65 137.83 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 120.99 -1.069 . . . . 0.0 109.185 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.5 p-10 -66.83 150.24 49.44 Favored 'General case' 0 CA--C 1.567 1.628 0 N-CA-C 115.19 1.552 . . . . 0.0 115.19 178.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 77.5 t -53.31 -41.23 43.01 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.291 0 N-CA-C 116.057 1.873 . . . . 0.0 116.057 -175.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.54 -49.19 78.75 Favored 'General case' 0 CA--C 1.568 1.635 0 N-CA-C 115.726 1.75 . . . . 0.0 115.726 170.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.6 tt -65.53 -41.86 92.62 Favored 'General case' 0 CA--C 1.574 1.887 0 N-CA-C 114.66 1.355 . . . . 0.0 114.66 171.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 74.8 mtp180 -46.85 -52.14 15.0 Favored 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 115.773 1.768 . . . . 0.0 115.773 164.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -65.71 -47.29 75.88 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 114.88 1.437 . . . . 0.0 114.88 171.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 61.4 mt -55.73 -57.98 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 CA-C-N 120.289 1.404 . . . . 0.0 112.766 175.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.27 -36.56 73.46 Favored 'General case' 0 CA--C 1.564 1.49 0 N-CA-C 118.409 2.744 . . . . 0.0 118.409 176.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -73.59 -30.71 63.17 Favored 'General case' 0 CA--C 1.57 1.724 0 N-CA-C 116.017 1.858 . . . . 0.0 116.017 171.051 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 73.8 mt -72.0 -33.54 68.18 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 116.001 1.852 . . . . 0.0 116.001 173.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.9 pp -78.94 150.64 32.02 Favored 'General case' 0 CA--C 1.566 1.588 0 N-CA-C 114.678 1.362 . . . . 0.0 114.678 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -109.52 94.06 15.4 Favored Pre-proline 0 CA--C 1.571 1.784 0 CA-C-O 118.286 -0.864 . . . . 0.0 108.797 176.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.464 ' HD2' ' SD ' ' A' ' 10' ' ' MET . 83.3 Cg_endo -78.44 171.07 17.45 Favored 'Trans proline' 0 CA--C 1.563 1.966 0 C-N-CA 122.806 2.337 . . . . 0.0 114.504 -178.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -116.61 127.7 54.71 Favored 'General case' 0 CA--C 1.56 1.359 0 CA-C-N 114.992 -1.003 . . . . 0.0 110.405 177.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 58.1 mttm -91.15 113.11 25.29 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.088 -1.007 . . . . 0.0 109.739 170.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -94.48 112.41 24.18 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 165.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 63.6 mt -110.86 119.35 59.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 -174.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 95.4 t -101.9 98.98 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 166.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -95.87 113.45 25.08 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 123.316 0.647 . . . . 0.0 110.028 175.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -116.2 64.59 0.7 Allowed 'General case' 0 CA--C 1.569 1.692 0 O-C-N 121.477 -0.765 . . . . 0.0 110.36 171.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 66.3 -97.95 0.35 Allowed Glycine 0 N--CA 1.487 2.07 0 N-CA-C 115.743 1.057 . . . . 0.0 115.743 -179.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -76.86 -41.84 42.43 Favored 'General case' 0 CA--C 1.565 1.541 0 N-CA-C 115.832 1.79 . . . . 0.0 115.832 169.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 13.1 t-160 -84.12 122.85 29.38 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 120.699 1.591 . . . . 0.0 111.429 175.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 8.6 ttp -137.93 131.34 30.75 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-O 122.116 0.96 . . . . 0.0 111.857 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 48.3 mt -115.24 107.84 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 73.1 mt -98.36 106.15 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 173.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 69.8 mtt180 -95.97 103.52 15.41 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.24 -0.912 . . . . 0.0 110.307 174.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 23.7 m -85.49 103.05 14.01 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 175.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.4 mt -104.5 118.32 36.32 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 124.104 0.962 . . . . 0.0 109.189 -166.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 47.1 t -118.84 161.67 19.77 Favored 'General case' 0 CA--C 1.556 1.183 0 CA-C-O 122.27 1.034 . . . . 0.0 111.181 -170.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 70.6 p -65.99 -19.76 65.97 Favored 'General case' 0 N--CA 1.5 2.025 0 N-CA-C 116.191 1.922 . . . . 0.0 116.191 161.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -78.08 -67.9 0.69 Allowed 'General case' 0 CA--C 1.569 1.679 0 CA-C-N 119.477 1.035 . . . . 0.0 112.185 169.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . 0.263 64.9 ttt180 -151.08 -117.15 0.04 OUTLIER 'General case' 0 CA--C 1.577 1.981 0 CA-C-N 120.516 1.507 . . . . 0.0 111.074 163.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 49.6 t-20 -164.48 138.44 5.27 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.178 -1.576 . . . . 0.0 109.237 -168.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 25.7 t80 -98.07 -55.4 2.79 Favored 'General case' 0 N--CA 1.5 2.054 0 N-CA-C 115.455 1.65 . . . . 0.0 115.455 -173.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.332 3.7 mp 62.02 92.7 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 -176.025 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 45.9 mmm -91.54 94.28 9.36 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.007 -1.058 . . . . 0.0 108.718 160.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.8 p30 -100.13 108.76 20.97 Favored 'General case' 0 CA--C 1.559 1.308 0 C-N-CA 123.954 0.902 . . . . 0.0 110.918 176.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 40.6 p90 -147.67 149.3 32.22 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-O 122.546 1.165 . . . . 0.0 114.029 -165.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 16.5 mm-40 -91.75 123.27 35.01 Favored 'General case' 0 CA--C 1.559 1.326 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.739 160.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 66.3 t -62.45 125.18 18.37 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.787 0 C-N-CA 124.109 0.964 . . . . 0.0 110.539 176.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 100.92 -36.66 4.03 Favored Glycine 0 CA--C 1.55 2.278 0 N-CA-C 117.075 1.59 . . . . 0.0 117.075 -167.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 84.5 mttt -81.21 129.88 34.78 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-N 119.775 1.788 . . . . 0.0 112.207 -176.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -88.93 103.69 16.26 Favored 'General case' 0 CA--C 1.566 1.578 0 O-C-N 121.789 -0.569 . . . . 0.0 111.668 -179.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -106.11 147.73 28.63 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -173.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.46 125.34 28.81 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.7 -1.25 . . . . 0.0 112.759 170.145 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 . . . . . 0 N--CA 1.5 2.045 0 CA-C-O 122.66 1.219 . . . . 0.0 113.487 174.85 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 89.2 m . . . . . 0 N--CA 1.489 1.502 0 N-CA-C 111.378 0.14 . . . . 0.0 111.378 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 2.7 mmt -70.83 99.19 1.69 Allowed 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 121.816 0.817 . . . . 0.0 111.123 176.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 64.7 m -114.47 111.37 21.3 Favored 'General case' 0 N--CA 1.483 1.186 0 O-C-N 121.648 -0.657 . . . . 0.0 110.541 -156.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 36.9 m -95.37 129.64 42.44 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 169.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.1 t -108.58 129.2 63.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 163.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 49.4 m -133.89 141.25 47.29 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.291 -0.88 . . . . 0.0 111.109 -175.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 42.6 m95 -78.29 107.74 11.12 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.66 -1.275 . . . . 0.0 110.859 169.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -85.61 74.92 10.2 Favored 'General case' 0 CA--C 1.568 1.645 0 O-C-N 121.362 -0.836 . . . . 0.0 109.822 168.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.95 -98.46 0.36 Allowed Glycine 0 N--CA 1.487 2.086 0 CA-C-N 116.18 -0.464 . . . . 0.0 114.133 -167.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -105.86 -4.05 21.18 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 116.378 1.992 . . . . 0.0 116.378 173.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 41.7 mtpt -103.36 124.98 49.71 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-N 120.327 1.421 . . . . 0.0 109.247 177.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 24.7 tp -84.79 107.48 16.99 Favored 'General case' 0 CA--C 1.563 1.458 0 O-C-N 120.858 -1.151 . . . . 0.0 110.493 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -96.54 131.25 43.35 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.704 0.802 . . . . 0.0 111.065 -175.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 53.8 t -122.67 136.87 55.0 Favored 'General case' 0 N--CA 1.484 1.269 0 O-C-N 121.645 -0.66 . . . . 0.0 111.693 175.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.7 p -127.08 119.46 52.94 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.637 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 171.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 19.2 mp0 -91.93 104.83 17.2 Favored 'General case' 0 CA--C 1.565 1.541 0 C-N-CA 124.001 0.921 . . . . 0.0 109.976 173.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -91.26 131.44 36.77 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.161 -0.962 . . . . 0.0 112.442 -174.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 161.79 -98.37 0.16 Allowed Glycine 0 N--CA 1.485 1.92 0 O-C-N 121.949 -0.469 . . . . 0.0 112.854 168.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -77.41 -51.83 10.14 Favored 'General case' 0 CA--C 1.568 1.652 0 N-CA-C 115.649 1.722 . . . . 0.0 115.649 -177.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 58.3 mttm -99.31 143.03 30.04 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 122.613 1.197 . . . . 0.0 114.058 -160.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -83.95 97.33 9.19 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 122.144 0.973 . . . . 0.0 112.505 -166.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 82.31 41.48 9.23 Favored Glycine 0 N--CA 1.485 1.924 0 N-CA-C 117.443 1.737 . . . . 0.0 117.443 -168.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 64.0 ttt180 -77.25 113.01 14.56 Favored 'General case' 0 CA--C 1.566 1.594 0 CA-C-N 119.561 1.68 . . . . 0.0 110.41 164.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -169.3 177.79 42.77 Favored Glycine 0 N--CA 1.482 1.724 0 CA-C-O 122.184 0.88 . . . . 0.0 113.978 -177.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . 0.257 28.1 p-90 -152.13 158.47 42.99 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 171.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 33.5 m -129.14 118.64 22.77 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 176.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 -120.29 128.85 53.68 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 123.284 0.634 . . . . 0.0 111.79 -176.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 19.6 p90 -148.81 166.91 27.07 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.997 -1.064 . . . . 0.0 112.21 -179.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 96.2 mt -108.16 132.69 55.26 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.121 0 O-C-N 120.677 -1.264 . . . . 0.0 110.369 176.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -112.42 100.91 9.14 Favored 'General case' 0 CA--C 1.566 1.563 0 C-N-CA 123.796 0.838 . . . . 0.0 108.96 162.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 72.04 -109.51 2.85 Favored Glycine 0 N--CA 1.493 2.463 0 O-C-N 121.366 -0.833 . . . . 0.0 114.792 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -109.14 35.4 3.28 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 163.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -131.91 126.26 33.7 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.799 0.84 . . . . 0.0 109.53 -178.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 23.6 tp -88.6 118.45 28.26 Favored 'General case' 0 CA--C 1.56 1.363 0 C-N-CA 124.008 0.923 . . . . 0.0 109.954 173.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 44.8 m80 -105.47 120.83 42.6 Favored 'General case' 0 CA--C 1.56 1.328 0 C-N-CA 123.949 0.9 . . . . 0.0 108.972 -177.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 28.2 tp -119.38 123.81 45.04 Favored 'General case' 0 CA--C 1.561 1.397 0 C-N-CA 124.056 0.942 . . . . 0.0 109.798 -177.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -105.0 123.42 47.77 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.614 -0.679 . . . . 0.0 109.266 165.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 70.0 mtm -115.3 125.21 53.0 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-N 118.896 0.771 . . . . 0.0 110.659 178.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 69.3 mtp180 -112.89 144.64 42.1 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 123.169 0.588 . . . . 0.0 111.881 -178.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -156.89 129.76 7.73 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 123.079 0.551 . . . . 0.0 111.183 166.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 56.32 40.21 29.91 Favored 'General case' 0 N--CA 1.506 2.355 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 -172.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 77.47 -31.12 1.65 Allowed Glycine 0 CA--C 1.558 2.744 0 N-CA-C 119.536 2.575 . . . . 0.0 119.536 -160.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 90.0 t -77.87 123.39 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 CA-C-N 119.15 1.475 . . . . 0.0 111.114 -162.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 34.2 m -104.99 118.11 35.69 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 123.064 0.546 . . . . 0.0 111.629 -171.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 18.1 t -92.22 141.86 28.11 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.495 0.718 . . . . 0.0 112.006 163.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -117.75 118.16 31.3 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 123.348 0.659 . . . . 0.0 110.006 178.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 71.1 mt-30 -119.09 140.98 49.19 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 123.804 0.841 . . . . 0.0 111.695 179.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 25.0 t -128.46 132.56 67.91 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 177.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -126.64 139.86 52.85 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 123.584 0.754 . . . . 0.0 111.425 179.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 22.3 ttmt -99.49 139.73 34.71 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.881 -1.137 . . . . 0.0 112.67 178.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 73.7 tttt -73.66 118.83 17.08 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 178.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 34.2 m -103.03 -43.08 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 173.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 55.5 t-80 . . . . . 0 N--CA 1.484 1.266 0 CA-C-N 119.491 1.041 . . . . 0.0 108.259 168.079 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo . . . . . 0 CA--C 1.575 2.571 0 N-CA-C 114.039 0.746 . . . . 0.0 114.039 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 22.9 t -131.27 139.14 51.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 -175.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -76.89 107.53 9.29 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.641 -1.287 . . . . 0.0 110.76 163.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 15.9 m-30 -80.98 14.79 2.08 Favored 'General case' 0 CA--C 1.582 2.207 0 N-CA-C 115.905 1.817 . . . . 0.0 115.905 173.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -62.68 111.99 2.32 Favored 'General case' 0 CA--C 1.563 1.474 0 C-N-CA 125.667 1.587 . . . . 0.0 115.136 -172.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 161.09 -178.17 37.15 Favored Glycine 0 N--CA 1.486 1.984 0 N-CA-C 116.026 1.17 . . . . 0.0 116.026 178.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -106.29 123.64 48.37 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-N 114.917 -0.642 . . . . 0.0 109.468 174.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 80.6 m95 -121.55 122.08 38.9 Favored 'General case' 0 CA--C 1.561 1.391 0 C-N-CA 123.481 0.712 . . . . 0.0 109.329 -169.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -96.47 140.87 30.48 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.313 -0.867 . . . . 0.0 112.711 176.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 41.9 ttm -69.47 124.23 23.35 Favored 'General case' 0 CA--C 1.569 1.705 0 O-C-N 120.94 -1.1 . . . . 0.0 113.129 176.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 91.9 mt -82.68 -50.29 8.88 Favored 'General case' 0 CA--C 1.564 1.486 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 165.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 87.3 p -151.75 154.53 36.46 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 119.285 0.948 . . . . 0.0 113.274 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -127.37 105.6 8.63 Favored 'General case' 0 CA--C 1.568 1.673 0 C-N-CA 123.64 0.776 . . . . 0.0 110.632 174.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -96.19 129.78 43.41 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 124.608 1.163 . . . . 0.0 109.965 -174.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 34.3 t30 62.39 18.31 10.19 Favored 'General case' 0 N--CA 1.506 2.368 0 N-CA-C 117.048 2.24 . . . . 0.0 117.048 -179.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -65.59 -42.1 92.08 Favored 'General case' 0 CA--C 1.566 1.583 0 N-CA-C 115.832 1.79 . . . . 0.0 115.832 -178.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -58.37 -39.06 78.58 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 116.243 1.942 . . . . 0.0 116.243 168.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -66.19 -45.78 79.62 Favored 'General case' 0 CA--C 1.571 1.78 0 N-CA-C 114.849 1.426 . . . . 0.0 114.849 170.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -52.82 -48.82 66.7 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 115.121 1.526 . . . . 0.0 115.121 165.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 64.5 mt -62.46 -40.73 97.6 Favored 'General case' 0 CA--C 1.57 1.745 0 N-CA-C 114.746 1.387 . . . . 0.0 114.746 171.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 65.1 ttp85 -55.56 -46.68 77.14 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 115.229 1.566 . . . . 0.0 115.229 164.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.1 -18.85 39.09 Favored 'General case' 0 CA--C 1.569 1.681 0 N-CA-C 118.29 2.7 . . . . 0.0 118.29 164.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 92.3 mt -91.83 15.31 13.23 Favored 'General case' 0 CA--C 1.574 1.898 0 N-CA-C 115.265 1.58 . . . . 0.0 115.265 163.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.259 49.7 m-20 66.72 39.86 3.43 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 115.887 1.81 . . . . 0.0 115.887 -177.523 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 65.6 t -99.61 140.9 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 120.815 -1.178 . . . . 0.0 110.489 -177.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 8.3 p-10 -71.33 156.52 39.41 Favored 'General case' 0 CA--C 1.569 1.679 0 N-CA-C 115.265 1.579 . . . . 0.0 115.265 174.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 61.9 t -53.14 -44.95 53.38 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.373 0 N-CA-C 115.27 1.581 . . . . 0.0 115.27 -177.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.57 -49.2 78.49 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 116.101 1.889 . . . . 0.0 116.101 174.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 31.9 tp -65.8 -36.67 84.16 Favored 'General case' 0 CA--C 1.573 1.842 0 N-CA-C 115.777 1.769 . . . . 0.0 115.777 171.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 55.1 mtp180 -51.36 -52.55 44.67 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 115.394 1.627 . . . . 0.0 115.394 160.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -63.13 -43.29 98.78 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 115.679 1.733 . . . . 0.0 115.679 172.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 59.3 mt -55.76 -55.31 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.192 0 CA-C-N 120.276 1.398 . . . . 0.0 112.72 170.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.86 -43.53 94.62 Favored 'General case' 0 CA--C 1.566 1.573 0 N-CA-C 117.294 2.331 . . . . 0.0 117.294 173.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -53.91 -39.97 66.27 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 117.471 2.397 . . . . 0.0 117.471 167.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 80.7 mt -86.27 -13.21 47.39 Favored 'General case' 0 CA--C 1.572 1.815 0 N-CA-C 116.103 1.89 . . . . 0.0 116.103 175.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 37.9 mt -80.07 133.12 36.08 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-N 119.949 1.25 . . . . 0.0 111.314 169.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 29.1 mmtp -101.31 93.04 2.94 Favored Pre-proline 0 CA--C 1.571 1.755 0 CA-C-O 118.045 -0.978 . . . . 0.0 109.705 171.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -72.41 154.3 55.78 Favored 'Trans proline' 0 CA--C 1.563 1.943 0 CA-C-N 122.852 2.054 . . . . 0.0 114.739 177.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -112.3 127.5 56.0 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.685 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 45.8 mttp -95.42 110.06 22.15 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.508 -0.745 . . . . 0.0 109.854 177.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -95.48 104.77 16.68 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.379 -0.826 . . . . 0.0 108.825 166.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 76.0 mt -98.55 118.29 44.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 -173.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 83.4 t -109.86 95.86 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 107.289 -1.375 . . . . 0.0 107.289 176.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -96.34 114.0 25.64 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 123.567 0.747 . . . . 0.0 111.084 177.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -132.16 93.27 3.24 Favored 'General case' 0 CA--C 1.566 1.577 0 C-N-CA 123.401 0.68 . . . . 0.0 110.004 -178.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 53.67 63.68 4.89 Favored Glycine 0 N--CA 1.497 2.756 0 N-CA-C 118.569 2.188 . . . . 0.0 118.569 172.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.471 0.0 OUTLIER 76.71 -34.56 0.22 Allowed 'General case' 0 N--CA 1.501 2.077 0 N-CA-C 117.317 2.34 . . . . 0.0 117.317 -164.423 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 9.4 t-160 -82.4 108.97 16.23 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 120.923 1.692 . . . . 0.0 110.898 178.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 6.5 ttp -121.25 125.1 46.26 Favored 'General case' 0 CA--C 1.556 1.194 0 CA-C-O 122.147 0.975 . . . . 0.0 110.888 -176.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 4.4 mp -110.1 104.43 17.06 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.353 0 N-CA-C 106.53 -1.656 . . . . 0.0 106.53 -178.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 80.0 mt -89.33 96.09 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 174.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 93.1 mtt180 -84.9 97.27 9.67 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.656 -0.652 . . . . 0.0 110.038 -178.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 51.0 m -89.78 101.39 14.08 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.761 0.791 . . . . 0.0 109.312 -178.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 16.1 mt -102.94 120.93 41.5 Favored 'General case' 0 N--CA 1.485 1.312 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.033 -164.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 10.3 t -136.7 146.53 45.98 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.684 -0.635 . . . . 0.0 111.629 -178.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . 0.253 13.7 t -77.73 56.19 1.46 Allowed 'General case' 0 N--CA 1.503 2.181 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 172.179 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -168.81 -67.82 0.02 OUTLIER 'General case' 0 CA--C 1.567 1.623 0 C-N-CA 125.274 1.429 . . . . 0.0 108.517 -177.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 62.9 ttt-85 -136.67 124.75 22.93 Favored 'General case' 0 CA--C 1.565 1.521 0 CA-C-N 118.754 0.706 . . . . 0.0 109.517 172.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 44.1 t-20 -85.26 130.59 34.57 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.78 -0.575 . . . . 0.0 111.038 170.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -95.96 -75.02 0.54 Allowed 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 118.899 -0.572 . . . . 0.0 112.338 -175.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.331 38.5 mt 74.62 108.75 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 C-N-CA 124.261 1.025 . . . . 0.0 111.9 178.28 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 86.9 mtp -104.95 99.22 8.85 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.478 -0.764 . . . . 0.0 109.491 170.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.7 p30 -96.97 108.54 21.28 Favored 'General case' 0 CA--C 1.56 1.365 0 C-N-CA 124.064 0.946 . . . . 0.0 111.935 176.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 35.2 p90 -148.68 151.91 35.75 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-N 119.029 0.831 . . . . 0.0 113.103 -168.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 54.6 mt-30 -89.86 135.23 33.76 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.289 -0.882 . . . . 0.0 110.796 161.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 41.0 t -69.56 109.54 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.28 -0.888 . . . . 0.0 109.305 179.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 128.27 -50.49 0.89 Allowed Glycine 0 CA--C 1.548 2.122 0 CA-C-O 118.542 -1.143 . . . . 0.0 115.904 -162.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 15.3 ptpt -70.41 139.22 51.79 Favored 'General case' 0 CA--C 1.566 1.578 0 CA-C-N 119.8 1.8 . . . . 0.0 115.231 -173.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -97.71 97.42 9.0 Favored 'General case' 0 CA--C 1.566 1.578 0 C-N-CA 123.116 0.566 . . . . 0.0 110.135 175.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -103.92 130.67 51.55 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 -170.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -69.21 111.75 5.35 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.671 -1.268 . . . . 0.0 113.524 175.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 . . . . . 0 N--CA 1.491 1.577 0 O-C-N 121.22 -0.925 . . . . 0.0 110.683 -177.617 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 95.3 m . . . . . 0 N--CA 1.488 1.454 0 CA-C-O 122.416 1.103 . . . . 0.0 111.383 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 23.6 mtp -76.3 100.06 4.99 Favored 'General case' 0 CA--C 1.557 1.25 0 CA-C-O 122.434 1.111 . . . . 0.0 110.622 -170.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 88.5 m -103.23 112.89 25.97 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.329 -158.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 87.1 m -99.7 125.71 45.61 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 174.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 16.9 t -111.6 123.0 67.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 171.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 71.1 m -138.87 148.78 44.1 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.247 -0.908 . . . . 0.0 112.348 -175.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 10.9 m95 -82.79 122.76 28.61 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.68 -1.263 . . . . 0.0 113.694 -179.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -107.57 71.0 0.8 Allowed 'General case' 0 CA--C 1.572 1.815 0 C-N-CA 123.481 0.712 . . . . 0.0 109.737 160.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.24 -103.15 0.75 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 115.669 1.028 . . . . 0.0 115.669 -179.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -80.4 -25.17 39.22 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 116.322 1.971 . . . . 0.0 116.322 165.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -90.62 110.31 21.46 Favored 'General case' 0 N--CA 1.484 1.269 0 CA-C-N 119.861 1.21 . . . . 0.0 111.261 -179.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 32.7 tp -77.93 111.5 13.85 Favored 'General case' 0 CA--C 1.564 1.516 0 O-C-N 121.354 -0.841 . . . . 0.0 109.671 168.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 31.5 mm-40 -100.39 119.44 38.45 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.567 0.747 . . . . 0.0 110.862 -170.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 40.8 t -111.97 128.93 56.31 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.283 0.633 . . . . 0.0 111.068 175.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.1 p -126.83 121.04 57.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 CA-C-O 121.331 0.586 . . . . 0.0 109.845 174.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -100.79 98.8 9.28 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 124.018 0.927 . . . . 0.0 109.777 -174.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 55.4 mttp -90.84 118.06 29.95 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.337 -0.852 . . . . 0.0 112.238 -167.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 178.68 -118.95 0.63 Allowed Glycine 0 N--CA 1.486 2.008 0 O-C-N 121.137 -0.977 . . . . 0.0 113.624 172.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -75.74 -46.84 28.75 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 115.998 1.851 . . . . 0.0 115.998 -174.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 1.7 ttmp? -91.02 130.77 36.9 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 119.173 0.897 . . . . 0.0 112.081 -176.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -74.52 145.08 43.78 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -176.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 62.38 23.29 64.38 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 120.154 2.822 . . . . 0.0 120.154 -178.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 10.5 ttt85 -83.25 120.51 25.92 Favored 'General case' 0 CA--C 1.563 1.444 0 CA-C-N 119.165 1.483 . . . . 0.0 111.615 -179.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 172.99 -165.1 37.31 Favored Glycine 0 N--CA 1.484 1.865 0 CA-C-O 121.921 0.734 . . . . 0.0 114.605 -179.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 49.9 p-90 -157.14 158.09 35.69 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 114.341 1.237 . . . . 0.0 114.341 176.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 62.9 m -127.03 119.12 25.86 Favored 'General case' 0 CA--C 1.567 1.616 0 C-N-CA 124.117 0.967 . . . . 0.0 108.465 174.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -120.89 127.34 51.78 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.795 -0.566 . . . . 0.0 112.296 -175.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 23.6 p90 -142.76 169.75 16.99 Favored 'General case' 0 N--CA 1.499 1.977 0 C-N-CA 123.763 0.825 . . . . 0.0 112.978 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 94.5 mt -113.42 146.11 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.285 0 CA-C-O 123.145 1.45 . . . . 0.0 111.322 176.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -137.37 90.05 2.48 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 177.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 73.39 -119.35 6.59 Favored Glycine 0 N--CA 1.491 2.305 0 O-C-N 121.867 -0.521 . . . . 0.0 114.258 -172.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -91.16 11.44 23.26 Favored 'General case' 0 N--CA 1.5 2.045 0 N-CA-C 116.742 2.127 . . . . 0.0 116.742 165.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 75.8 mt-10 -111.29 138.29 47.95 Favored 'General case' 0 CA--C 1.56 1.34 0 CA-C-N 119.78 1.173 . . . . 0.0 111.999 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 10.4 tp -98.03 125.96 43.23 Favored 'General case' 0 CA--C 1.563 1.454 0 C-N-CA 123.902 0.881 . . . . 0.0 109.148 170.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 45.4 m80 -113.22 123.08 49.35 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.713 0.805 . . . . 0.0 109.126 -175.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 32.4 tp -122.59 122.26 38.43 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.596 0.758 . . . . 0.0 110.218 -174.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -100.51 117.15 34.06 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.715 -0.615 . . . . 0.0 109.589 164.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 74.3 mtm -105.09 125.93 51.52 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-N 118.782 0.719 . . . . 0.0 110.493 175.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 49.0 mtp180 -114.22 140.13 48.82 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.604 -0.685 . . . . 0.0 111.459 -174.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -151.51 126.75 9.91 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.787 -0.571 . . . . 0.0 110.616 167.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 61.72 28.92 17.87 Favored 'General case' 0 N--CA 1.504 2.232 0 N-CA-C 115.375 1.62 . . . . 0.0 115.375 -172.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 82.4 -27.6 3.62 Favored Glycine 0 CA--C 1.558 2.73 0 N-CA-C 118.693 2.237 . . . . 0.0 118.693 -158.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 96.4 t -73.8 119.38 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 CA-C-N 119.221 1.511 . . . . 0.0 110.416 -169.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 59.4 m -106.35 120.74 42.66 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.182 -169.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 6.6 t -97.31 122.8 40.75 Favored 'General case' 0 CA--C 1.558 1.28 0 C-N-CA 124.082 0.953 . . . . 0.0 111.528 170.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 85.6 mttt -96.19 119.62 35.02 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.824 -0.548 . . . . 0.0 110.059 176.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 18.2 mt-30 -119.68 123.4 43.73 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.706 -0.621 . . . . 0.0 110.686 -179.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 47.5 t -105.03 131.78 53.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 -177.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -126.17 149.08 49.24 Favored 'General case' 0 CA--C 1.563 1.455 0 C-N-CA 124.515 1.126 . . . . 0.0 110.511 -178.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 22.2 ttmt -118.62 141.0 49.01 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.94 -1.1 . . . . 0.0 112.002 175.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 61.6 tttt -74.87 126.43 30.93 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 179.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 33.3 m -107.09 -40.7 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 174.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 33.9 m170 . . . . . 0 C--O 1.255 1.354 0 CA-C-N 120.138 1.336 . . . . 0.0 108.784 -177.751 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo . . . . . 0 CA--C 1.575 2.531 0 N-CA-C 114.634 0.974 . . . . 0.0 114.634 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 18.1 m -144.95 153.64 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 120.595 -1.316 . . . . 0.0 110.393 -171.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -73.3 98.64 2.72 Favored 'General case' 0 CA--C 1.569 1.679 0 O-C-N 121.1 -1.0 . . . . 0.0 112.362 174.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 7.4 m-30 -78.95 -9.55 59.55 Favored 'General case' 0 CA--C 1.577 2.012 0 N-CA-C 115.471 1.656 . . . . 0.0 115.471 161.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -57.9 116.36 3.43 Favored 'General case' 0 CA--C 1.564 1.485 0 CA-C-N 120.837 1.653 . . . . 0.0 114.713 -176.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 152.62 -177.59 30.26 Favored Glycine 0 N--CA 1.486 2.028 0 CA-C-O 122.54 1.078 . . . . 0.0 115.711 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -105.42 123.35 47.72 Favored 'General case' 0 CA--C 1.562 1.434 0 CA-C-N 114.638 -0.781 . . . . 0.0 109.514 178.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 72.2 m95 -122.81 126.02 46.59 Favored 'General case' 0 CA--C 1.567 1.605 0 C-N-CA 123.364 0.666 . . . . 0.0 110.004 -170.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 62.2 pttt -95.06 140.16 30.4 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.244 -0.91 . . . . 0.0 113.167 177.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 50.4 ttm -69.73 129.69 40.29 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.638 -1.289 . . . . 0.0 113.626 174.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 87.4 mt -94.4 -58.27 2.25 Favored 'General case' 0 CA--C 1.567 1.611 0 CA-C-N 115.584 -0.735 . . . . 0.0 112.65 170.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 94.2 p -139.48 130.02 25.73 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 119.632 1.106 . . . . 0.0 113.431 -165.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -102.41 81.45 2.06 Favored 'General case' 0 CA--C 1.568 1.671 0 C-N-CA 123.871 0.868 . . . . 0.0 110.277 176.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -93.93 114.61 26.86 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.656 -1.278 . . . . 0.0 111.013 -170.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.272 22.2 t30 63.15 27.09 15.56 Favored 'General case' 0 N--CA 1.506 2.355 0 N-CA-C 116.801 2.148 . . . . 0.0 116.801 -171.138 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -69.94 -49.18 54.43 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 115.18 1.548 . . . . 0.0 115.18 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 90.0 mt-10 -61.35 -35.52 77.66 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 116.506 2.039 . . . . 0.0 116.506 174.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -63.69 -42.99 97.93 Favored 'General case' 0 CA--C 1.576 1.948 0 N-CA-C 115.187 1.551 . . . . 0.0 115.187 167.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 28.2 t80 -56.31 -50.68 70.74 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 115.041 1.496 . . . . 0.0 115.041 165.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.2 mt -61.3 -40.67 95.02 Favored 'General case' 0 CA--C 1.573 1.834 0 N-CA-C 115.191 1.552 . . . . 0.0 115.191 173.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 41.9 ttp85 -51.15 -50.66 58.49 Favored 'General case' 0 CA--C 1.575 1.904 0 N-CA-C 115.086 1.513 . . . . 0.0 115.086 162.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.74 -19.3 58.65 Favored 'General case' 0 CA--C 1.573 1.83 0 N-CA-C 118.462 2.764 . . . . 0.0 118.462 168.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 43.7 mt -86.51 2.08 49.24 Favored 'General case' 0 CA--C 1.572 1.79 0 N-CA-C 116.12 1.896 . . . . 0.0 116.12 165.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 61.04 46.66 8.05 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 115.126 1.528 . . . . 0.0 115.126 -169.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 99.0 t -93.95 135.04 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.403 -0.81 . . . . 0.0 108.838 176.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.0 p-10 -67.91 147.55 52.33 Favored 'General case' 0 CA--C 1.566 1.584 0 N-CA-C 115.504 1.668 . . . . 0.0 115.504 179.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 25.3 t -49.32 -44.98 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.327 0 N-CA-C 115.796 1.776 . . . . 0.0 115.796 -174.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.99 -46.19 88.75 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 116.3 1.963 . . . . 0.0 116.3 173.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.62 -43.69 96.12 Favored 'General case' 0 CA--C 1.572 1.794 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 168.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 27.5 mtm-85 -53.37 -41.1 65.53 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 116.516 2.043 . . . . 0.0 116.516 167.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -68.6 -54.9 13.63 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 168.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 63.1 mt -54.47 -51.62 47.88 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.303 0 CA-C-N 120.435 1.47 . . . . 0.0 113.841 178.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.78 -38.66 91.95 Favored 'General case' 0 CA--C 1.562 1.435 0 N-CA-C 117.642 2.46 . . . . 0.0 117.642 175.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 16.4 t30 -72.44 -30.33 64.49 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 116.395 1.998 . . . . 0.0 116.395 170.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 83.4 mt -75.05 -32.85 61.64 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 115.331 1.604 . . . . 0.0 115.331 172.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 93.6 mt -81.35 142.2 33.27 Favored 'General case' 0 CA--C 1.564 1.505 0 CA-C-N 119.384 0.993 . . . . 0.0 112.139 174.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -106.94 84.89 1.7 Allowed Pre-proline 0 CA--C 1.575 1.917 0 CA-C-O 118.248 -0.882 . . . . 0.0 109.947 175.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -72.94 166.27 30.5 Favored 'Trans proline' 0 CA--C 1.563 1.965 0 C-N-CA 122.537 2.158 . . . . 0.0 116.028 -178.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -111.25 138.83 47.21 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.214 -177.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 58.6 mttm -104.88 111.65 24.48 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.399 -0.813 . . . . 0.0 109.376 173.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 54.9 tt0 -98.74 102.87 14.74 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 171.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 61.3 mt -97.67 123.68 50.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.513 -0.742 . . . . 0.0 109.202 -169.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 88.4 t -102.48 101.93 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 166.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -104.2 108.19 19.45 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 123.706 0.803 . . . . 0.0 110.358 -179.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -112.56 72.32 0.77 Allowed 'General case' 0 CA--C 1.567 1.634 0 O-C-N 121.683 -0.636 . . . . 0.0 110.634 175.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 68.48 -95.65 0.39 Allowed Glycine 0 N--CA 1.489 2.21 0 N-CA-C 115.014 0.766 . . . . 0.0 115.014 -179.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -86.67 -37.09 18.34 Favored 'General case' 0 CA--C 1.566 1.574 0 N-CA-C 115.743 1.757 . . . . 0.0 115.743 166.077 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 20.8 t-160 -80.66 113.66 19.01 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 121.099 1.772 . . . . 0.0 111.463 -178.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 46.6 ttm -130.5 123.19 29.12 Favored 'General case' 0 CA--C 1.555 1.165 0 CA-C-O 121.386 0.612 . . . . 0.0 110.074 -169.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 54.5 mt -115.86 101.22 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 87.9 mt -89.79 90.67 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -77.59 99.01 5.59 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.303 -0.873 . . . . 0.0 110.715 -173.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 29.4 m -97.13 105.64 17.83 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-O 121.803 0.811 . . . . 0.0 109.016 -169.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 22.2 mt -109.49 117.17 33.3 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.991 0.917 . . . . 0.0 110.072 -159.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 19.2 t -133.87 146.55 50.69 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 123.154 0.582 . . . . 0.0 111.976 -174.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 43.5 p -79.92 61.66 3.89 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.122 -0.986 . . . . 0.0 112.631 172.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -169.95 -70.79 0.02 OUTLIER 'General case' 0 CA--C 1.569 1.693 0 C-N-CA 125.648 1.579 . . . . 0.0 107.513 178.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 32.1 mtt180 -139.8 131.5 27.35 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 123.803 0.841 . . . . 0.0 109.648 171.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -85.4 129.14 34.88 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.039 0.447 . . . . 0.0 111.027 176.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -91.35 -77.4 0.42 Allowed 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 123.146 0.579 . . . . 0.0 111.972 -172.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.36 14.9 mt 79.46 108.35 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 C-N-CA 124.216 1.006 . . . . 0.0 110.986 -179.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.76 95.74 6.85 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 123.513 0.725 . . . . 0.0 109.729 177.064 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -101.53 116.34 32.55 Favored 'General case' 0 CA--C 1.564 1.515 0 C-N-CA 124.228 1.011 . . . . 0.0 112.321 -175.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -157.91 156.44 31.33 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 115.07 1.507 . . . . 0.0 115.07 -171.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -104.23 119.24 38.52 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 123.474 0.709 . . . . 0.0 109.857 167.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 54.0 t -61.98 128.9 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 C-N-CA 123.936 0.894 . . . . 0.0 111.674 -178.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 99.74 -37.13 3.67 Favored Glycine 0 CA--C 1.55 2.279 0 N-CA-C 116.704 1.442 . . . . 0.0 116.704 -163.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 77.7 mttt -89.43 129.83 35.88 Favored 'General case' 0 CA--C 1.565 1.539 0 CA-C-N 118.88 1.34 . . . . 0.0 111.746 -172.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -81.84 106.61 13.9 Favored 'General case' 0 CA--C 1.567 1.615 0 O-C-N 121.321 -0.862 . . . . 0.0 111.771 178.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -109.88 148.89 30.72 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 123.856 0.862 . . . . 0.0 112.006 -175.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.62 124.09 23.04 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.2 -1.562 . . . . 0.0 111.73 168.15 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.496 1.84 0 CA-C-N 119.137 0.88 . . . . 0.0 111.612 -174.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 74.1 m . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 1.1 mmt -70.55 98.18 1.43 Allowed 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 122.216 1.008 . . . . 0.0 111.697 -176.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 95.5 m -112.36 114.53 27.31 Favored 'General case' 0 N--CA 1.481 1.115 0 O-C-N 121.51 -0.744 . . . . 0.0 110.452 -157.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 63.0 m -92.79 124.47 36.81 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 168.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.7 t -112.3 130.33 66.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 169.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 74.9 m -134.79 140.34 45.81 Favored 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 123.791 0.836 . . . . 0.0 111.989 -173.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 8.4 m95 -80.98 116.35 20.9 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.457 -1.402 . . . . 0.0 112.874 177.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 38.8 t0 -103.66 67.18 0.89 Allowed 'General case' 0 CA--C 1.576 1.95 0 C-N-CA 124.063 0.945 . . . . 0.0 110.189 164.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 68.08 -105.82 1.53 Allowed Glycine 0 N--CA 1.492 2.418 0 N-CA-C 115.641 1.016 . . . . 0.0 115.641 -179.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -72.87 -30.25 63.83 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 115.123 1.527 . . . . 0.0 115.123 163.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 24.0 mttt -92.78 110.59 22.03 Favored 'General case' 0 CA--C 1.557 1.221 0 CA-C-N 119.443 1.019 . . . . 0.0 111.62 -171.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 29.0 tp -82.07 105.57 13.28 Favored 'General case' 0 CA--C 1.563 1.479 0 O-C-N 120.47 -1.394 . . . . 0.0 110.164 171.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 11.2 mm100 -87.42 145.89 26.1 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 124.51 1.124 . . . . 0.0 110.721 -174.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 42.9 t -143.63 133.47 23.93 Favored 'General case' 0 N--CA 1.484 1.25 0 O-C-N 121.541 -0.724 . . . . 0.0 112.421 178.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.2 p -118.33 123.8 72.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 165.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -104.46 97.09 7.06 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 123.626 0.77 . . . . 0.0 109.427 -178.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -83.42 111.43 19.03 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.761 -1.212 . . . . 0.0 111.425 -170.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 162.56 103.98 0.18 Allowed Glycine 0 N--CA 1.483 1.798 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.898 -172.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . 0.282 42.3 mt-10 69.61 -68.47 0.19 Allowed 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 116.142 1.904 . . . . 0.0 116.142 174.027 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -82.08 129.89 34.93 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 122.153 0.978 . . . . 0.0 111.242 -170.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -67.78 -45.97 73.3 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 116.096 1.887 . . . . 0.0 116.096 -162.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -101.68 54.52 0.78 Allowed Glycine 0 N--CA 1.49 2.286 0 CA-C-O 118.63 -1.095 . . . . 0.0 115.727 164.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.9 ttt-85 -85.25 116.88 23.85 Favored 'General case' 0 CA--C 1.565 1.543 0 CA-C-N 118.844 1.322 . . . . 0.0 112.062 -179.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 178.7 -173.24 45.58 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 115.139 0.816 . . . . 0.0 115.139 -174.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . 0.279 49.6 p-90 -155.48 167.89 28.92 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 123.338 1.542 . . . . 0.0 113.918 174.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 96.0 m -144.93 114.14 7.01 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.147 -1.596 . . . . 0.0 107.81 174.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 45.6 tt0 -114.67 127.56 55.83 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 123.566 0.746 . . . . 0.0 111.444 -173.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 9.6 p90 -148.34 154.85 40.54 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.706 -1.246 . . . . 0.0 113.679 -174.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 94.8 mt -98.84 133.98 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 O-C-N 120.793 -1.192 . . . . 0.0 110.823 176.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -120.09 91.79 3.62 Favored 'General case' 0 CA--C 1.567 1.618 0 C-N-CA 124.291 1.036 . . . . 0.0 108.387 162.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 69.36 -113.17 4.96 Favored Glycine 0 N--CA 1.492 2.402 0 O-C-N 121.238 -0.914 . . . . 0.0 114.927 -177.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -84.54 -8.75 58.81 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 117.423 2.379 . . . . 0.0 117.423 167.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 62.1 mt-10 -99.95 126.56 46.13 Favored 'General case' 0 CA--C 1.56 1.363 0 CA-C-N 120.549 1.522 . . . . 0.0 111.292 -176.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 21.2 tp -89.22 115.5 26.77 Favored 'General case' 0 CA--C 1.563 1.448 0 C-N-CA 124.224 1.01 . . . . 0.0 109.122 164.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 48.7 m80 -101.83 119.09 38.23 Favored 'General case' 0 CA--C 1.556 1.207 0 C-N-CA 123.979 0.911 . . . . 0.0 108.857 -178.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 42.7 tp -113.31 114.76 27.12 Favored 'General case' 0 CA--C 1.557 1.228 0 C-N-CA 123.677 0.791 . . . . 0.0 109.642 179.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -90.04 126.88 35.92 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.906 -0.496 . . . . 0.0 109.74 163.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 75.5 mtm -119.99 127.79 52.94 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-N 118.658 0.663 . . . . 0.0 110.297 176.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 88.0 mtm-85 -114.82 141.26 48.13 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 123.429 0.692 . . . . 0.0 111.326 -174.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -150.29 131.05 14.09 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.676 -0.64 . . . . 0.0 110.931 163.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 54.79 34.4 21.79 Favored 'General case' 0 N--CA 1.507 2.415 0 N-CA-C 116.169 1.914 . . . . 0.0 116.169 -172.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 76.43 -1.29 61.56 Favored Glycine 0 CA--C 1.557 2.709 0 N-CA-C 120.173 2.829 . . . . 0.0 120.173 -165.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 89.6 t -98.7 120.09 47.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 CA-C-N 120.453 2.126 . . . . 0.0 109.49 -173.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 30.7 m -102.88 120.9 41.44 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 123.243 0.617 . . . . 0.0 111.357 -172.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 33.5 t -92.32 140.34 29.7 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 123.384 0.674 . . . . 0.0 112.041 161.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 33.9 mtpt -104.24 114.94 29.53 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.6 -0.688 . . . . 0.0 110.564 164.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -104.48 124.27 48.97 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.334 0.654 . . . . 0.0 110.291 168.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 62.7 t -109.93 132.79 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -127.23 134.96 50.03 Favored 'General case' 0 CA--C 1.561 1.398 0 C-N-CA 124.104 0.962 . . . . 0.0 110.823 -177.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -103.57 137.38 41.72 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.837 -1.165 . . . . 0.0 112.493 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 71.4 tttt -71.35 125.79 27.93 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 177.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 27.7 m -116.24 -40.17 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.128 0 N-CA-C 114.058 1.133 . . . . 0.0 114.058 177.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 50.5 t60 . . . . . 0 N--CA 1.487 1.395 0 CA-C-N 120.47 1.487 . . . . 0.0 108.53 175.229 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo . . . . . 0 CA--C 1.557 1.658 0 CA-C-O 122.604 1.002 . . . . 0.0 113.919 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 27.6 m -78.38 155.16 5.06 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.687 0 CA-C-N 114.71 -1.132 . . . . 0.0 113.262 -174.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -68.93 100.93 1.27 Allowed 'General case' 0 CA--C 1.563 1.453 0 O-C-N 120.93 -1.106 . . . . 0.0 113.93 176.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 4.5 m-30 -70.61 -1.5 11.36 Favored 'General case' 0 CA--C 1.581 2.161 0 N-CA-C 116.871 2.175 . . . . 0.0 116.871 177.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -45.05 111.03 0.28 Allowed 'General case' 0 CA--C 1.566 1.569 0 N-CA-C 116.122 1.897 . . . . 0.0 116.122 173.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 165.96 175.85 36.76 Favored Glycine 0 N--CA 1.484 1.848 0 N-CA-C 116.313 1.285 . . . . 0.0 116.313 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 12.7 t80 -110.19 125.65 53.28 Favored 'General case' 0 CA--C 1.562 1.409 0 CA-C-N 113.952 -1.124 . . . . 0.0 108.657 173.214 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 82.3 m95 -124.67 127.4 47.24 Favored 'General case' 0 CA--C 1.565 1.539 0 C-N-CA 123.49 0.716 . . . . 0.0 109.982 -167.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -97.1 140.37 31.71 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.188 -0.945 . . . . 0.0 112.853 175.368 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 37.4 ttm -70.79 125.08 25.86 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.819 -1.176 . . . . 0.0 113.024 177.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 90.2 mt -84.62 -51.56 6.76 Favored 'General case' 0 CA--C 1.566 1.595 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 167.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 92.3 p -144.52 150.75 38.08 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 118.806 0.73 . . . . 0.0 112.2 177.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -125.84 114.11 18.13 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 123.13 0.572 . . . . 0.0 109.734 165.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -115.25 124.1 50.5 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 123.387 0.675 . . . . 0.0 109.651 -168.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.264 23.4 t30 62.16 25.26 15.11 Favored 'General case' 0 N--CA 1.504 2.251 0 N-CA-C 116.699 2.111 . . . . 0.0 116.699 -172.224 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -67.8 -43.5 79.51 Favored 'General case' 0 CA--C 1.567 1.633 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 175.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -45.96 -50.0 15.22 Favored 'General case' 0 N--CA 1.505 2.324 0 N-CA-C 116.433 2.012 . . . . 0.0 116.433 167.193 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -70.86 -41.01 71.95 Favored 'General case' 0 CA--C 1.57 1.747 0 N-CA-C 115.463 1.653 . . . . 0.0 115.463 178.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -50.84 -49.38 59.03 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 114.9 1.445 . . . . 0.0 114.9 160.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 81.2 mt -62.96 -39.5 94.84 Favored 'General case' 0 CA--C 1.574 1.877 0 N-CA-C 114.866 1.432 . . . . 0.0 114.866 173.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 69.0 ttp85 -52.45 -50.97 61.55 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 115.087 1.514 . . . . 0.0 115.087 164.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.54 -14.88 22.49 Favored 'General case' 0 CA--C 1.572 1.79 0 N-CA-C 118.545 2.794 . . . . 0.0 118.545 167.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 94.8 mt -97.36 16.48 19.95 Favored 'General case' 0 CA--C 1.57 1.742 0 N-CA-C 115.159 1.54 . . . . 0.0 115.159 164.463 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 60.74 45.37 10.14 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 115.547 1.684 . . . . 0.0 115.547 -177.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 98.0 t -99.83 138.24 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.22 -0.925 . . . . 0.0 109.794 -178.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 12.6 p30 -63.68 152.28 39.51 Favored 'General case' 0 CA--C 1.57 1.746 0 N-CA-C 115.112 1.523 . . . . 0.0 115.112 176.124 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . 0.251 78.8 t -58.62 -40.8 80.3 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.303 0 N-CA-C 115.307 1.595 . . . . 0.0 115.307 -177.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.26 -50.18 72.08 Favored 'General case' 0 CA--C 1.567 1.607 0 N-CA-C 115.953 1.834 . . . . 0.0 115.953 168.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 25.4 tp -66.9 -38.82 86.97 Favored 'General case' 0 CA--C 1.573 1.829 0 N-CA-C 116.052 1.871 . . . . 0.0 116.052 171.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 69.6 mtp180 -50.85 -47.87 60.19 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 115.303 1.594 . . . . 0.0 115.303 162.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -65.05 -54.42 30.49 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 170.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 61.6 mt -51.77 -55.66 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.246 0 CA-C-N 120.41 1.459 . . . . 0.0 113.172 175.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.23 -35.89 80.28 Favored 'General case' 0 CA--C 1.563 1.453 0 N-CA-C 118.352 2.723 . . . . 0.0 118.352 176.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -76.16 -33.43 59.37 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 116.018 1.859 . . . . 0.0 116.018 171.117 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 77.2 mt -72.85 -36.54 67.45 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 115.387 1.625 . . . . 0.0 115.387 178.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . 0.262 3.7 pp -93.92 151.94 19.21 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 119.327 0.967 . . . . 0.0 113.208 179.457 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 28.0 mmtp -108.42 93.37 11.48 Favored Pre-proline 0 CA--C 1.574 1.871 0 CA-C-O 118.078 -0.963 . . . . 0.0 110.03 -173.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -75.6 169.37 22.47 Favored 'Trans proline' 0 CA--C 1.565 2.043 0 C-N-CA 122.664 2.243 . . . . 0.0 115.605 -178.001 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -112.67 134.05 54.39 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-N 116.03 -0.532 . . . . 0.0 112.106 -177.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 23.5 mtpp -102.51 113.88 27.6 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.037 -1.04 . . . . 0.0 110.578 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -97.99 109.68 22.39 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.694 -0.629 . . . . 0.0 109.319 167.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 76.2 mt -102.42 120.56 52.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 -179.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 88.9 t -109.85 95.05 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 174.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -86.87 97.13 10.49 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 123.324 0.65 . . . . 0.0 110.362 173.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -102.27 70.46 1.18 Allowed 'General case' 0 CA--C 1.567 1.633 0 C-N-CA 123.556 0.742 . . . . 0.0 111.332 -178.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 57.94 65.8 3.27 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 117.368 1.707 . . . . 0.0 117.368 177.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.478 0.0 OUTLIER 82.07 -36.99 0.1 Allowed 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 116.473 2.027 . . . . 0.0 116.473 -165.235 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 12.3 t-160 -79.81 95.29 5.98 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-N 120.834 1.652 . . . . 0.0 110.513 175.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 4.1 ttp -104.6 119.52 39.19 Favored 'General case' 0 CA--C 1.552 1.052 0 CA-C-O 121.982 0.896 . . . . 0.0 110.094 -175.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 37.4 mt -106.32 101.16 12.05 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.479 0 N-CA-C 106.587 -1.634 . . . . 0.0 106.587 -178.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 88.1 mt -89.3 111.91 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 177.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 90.3 mtt180 -109.6 100.27 9.34 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -174.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 16.8 m -92.99 109.62 21.07 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 39.7 mt -102.64 123.62 46.69 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.349 0.66 . . . . 0.0 110.938 -159.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 10.2 t -151.01 160.51 43.88 Favored 'General case' 0 CA--C 1.571 1.763 0 CA-C-O 121.31 0.576 . . . . 0.0 112.474 -176.001 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.0 t -63.05 -36.07 82.35 Favored 'General case' 0 N--CA 1.504 2.235 0 N-CA-C 117.738 2.496 . . . . 0.0 117.738 175.386 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -76.48 -52.32 10.04 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 175.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.6 tmm_? -149.05 138.03 21.37 Favored 'General case' 0 CA--C 1.56 1.349 0 C-N-CA 124.212 1.005 . . . . 0.0 108.767 -178.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -102.06 114.93 29.48 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 174.172 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -87.54 121.42 29.96 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 122.862 0.465 . . . . 0.0 110.598 -173.204 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 43.2 mm -114.27 101.98 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 -177.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 76.5 mtp -95.28 90.53 5.88 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.126 -0.984 . . . . 0.0 109.132 169.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.6 p30 -95.15 108.17 20.27 Favored 'General case' 0 CA--C 1.561 1.376 0 C-N-CA 123.821 0.849 . . . . 0.0 111.82 178.045 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 29.4 p90 -147.77 142.88 27.1 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 113.844 1.054 . . . . 0.0 113.844 -169.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 17.1 mp0 -79.96 123.46 27.82 Favored 'General case' 0 CA--C 1.563 1.459 0 O-C-N 121.543 -0.723 . . . . 0.0 110.289 162.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 46.9 t -65.98 117.68 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 C-N-CA 123.315 0.646 . . . . 0.0 110.422 -179.204 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 115.44 -45.18 1.34 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 116.006 1.162 . . . . 0.0 116.006 -160.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -82.29 144.15 30.81 Favored 'General case' 0 CA--C 1.567 1.617 0 CA-C-N 118.802 1.301 . . . . 0.0 113.284 -173.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -95.14 111.56 23.38 Favored 'General case' 0 CA--C 1.564 1.504 0 O-C-N 121.76 -0.588 . . . . 0.0 111.481 176.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 22.8 p90 -106.94 142.74 36.07 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 123.33 0.652 . . . . 0.0 112.748 -177.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -71.13 114.2 8.95 Favored 'General case' 0 CA--C 1.567 1.622 0 O-C-N 120.358 -1.464 . . . . 0.0 112.177 170.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 . . . . . 0 CA--C 1.568 1.646 0 CA-C-O 122.125 0.965 . . . . 0.0 111.266 -175.904 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 93.5 m . . . . . 0 N--CA 1.488 1.447 0 CA-C-O 121.469 0.652 . . . . 0.0 111.24 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 80.6 mmm -71.61 103.73 3.11 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 121.714 0.768 . . . . 0.0 110.277 177.223 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 92.1 m -109.56 111.53 23.09 Favored 'General case' 0 N--CA 1.483 1.178 0 O-C-N 121.671 -0.643 . . . . 0.0 110.866 -159.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 95.1 m -94.71 128.24 41.25 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 170.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.9 t -116.41 129.66 72.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 172.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 58.2 m -149.09 157.12 43.14 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.423 -1.423 . . . . 0.0 113.316 -177.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 45.7 m95 -86.84 123.61 32.16 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.751 -1.218 . . . . 0.0 113.775 -174.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -109.35 73.3 0.84 Allowed 'General case' 0 CA--C 1.57 1.712 0 C-N-CA 124.064 0.946 . . . . 0.0 109.356 164.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.0 -125.14 29.68 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 114.637 0.615 . . . . 0.0 114.637 -172.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -61.12 -19.81 61.93 Favored 'General case' 0 N--CA 1.501 2.09 0 N-CA-C 116.526 2.047 . . . . 0.0 116.526 166.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 43.7 mttt -97.15 121.11 38.67 Favored 'General case' 0 CA--C 1.556 1.206 0 CA-C-N 119.554 1.07 . . . . 0.0 111.554 -174.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 24.3 tp -84.68 108.05 17.2 Favored 'General case' 0 CA--C 1.565 1.544 0 O-C-N 121.326 -0.859 . . . . 0.0 109.086 170.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -93.81 132.02 38.62 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.703 0.801 . . . . 0.0 111.036 -176.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 42.1 t -126.96 128.28 46.16 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.213 0.605 . . . . 0.0 111.315 178.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 12.7 p -109.8 118.12 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 168.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 55.7 mt-30 -99.42 73.69 1.87 Allowed 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 123.577 0.751 . . . . 0.0 109.813 178.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -83.96 134.13 34.67 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.577 -1.327 . . . . 0.0 113.781 -169.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 178.46 -85.03 0.07 OUTLIER Glycine 0 N--CA 1.485 1.932 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.955 -177.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -104.16 -58.25 1.91 Allowed 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 177.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -76.88 133.26 39.34 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 119.985 1.266 . . . . 0.0 112.07 -173.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -61.52 -54.73 39.34 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 116.171 1.915 . . . . 0.0 116.171 -167.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -98.67 53.42 1.11 Allowed Glycine 0 N--CA 1.489 2.177 0 N-CA-C 115.97 1.148 . . . . 0.0 115.97 169.223 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 25.7 ttt-85 -87.57 118.62 27.17 Favored 'General case' 0 CA--C 1.563 1.479 0 CA-C-N 118.685 1.243 . . . . 0.0 111.713 179.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 171.18 -168.9 42.02 Favored Glycine 0 N--CA 1.485 1.918 0 CA-C-O 121.892 0.718 . . . . 0.0 114.226 -179.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 38.5 p-90 -155.99 157.07 35.57 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 176.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 83.1 m -125.89 114.21 18.24 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 175.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 41.1 tt0 -117.57 123.01 45.19 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 123.413 0.685 . . . . 0.0 111.142 -175.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 12.5 p90 -144.36 148.58 34.9 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.966 -1.084 . . . . 0.0 113.229 -176.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 94.3 mt -97.3 135.87 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 CA-C-O 122.374 1.083 . . . . 0.0 110.374 177.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -122.9 87.21 2.71 Favored 'General case' 0 CA--C 1.563 1.445 0 CA-C-N 114.214 -1.357 . . . . 0.0 107.781 174.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 70.97 -105.25 1.58 Allowed Glycine 0 N--CA 1.491 2.323 0 O-C-N 121.488 -0.758 . . . . 0.0 114.714 -175.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 54.8 p30 -99.95 7.23 44.97 Favored 'General case' 0 CA--C 1.574 1.898 0 N-CA-C 116.868 2.173 . . . . 0.0 116.868 169.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -115.33 130.11 56.8 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-N 120.43 1.468 . . . . 0.0 111.694 -178.008 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 13.3 tp -90.94 115.56 28.06 Favored 'General case' 0 CA--C 1.561 1.384 0 C-N-CA 124.224 1.01 . . . . 0.0 109.356 170.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 43.4 m80 -102.31 122.45 44.27 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.873 0.869 . . . . 0.0 109.04 -178.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 49.3 tp -122.96 117.63 25.96 Favored 'General case' 0 CA--C 1.56 1.34 0 C-N-CA 123.701 0.801 . . . . 0.0 109.924 -174.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -104.77 107.87 19.05 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 169.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 68.5 mtm -100.18 128.5 46.24 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.881 -0.512 . . . . 0.0 110.682 178.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 68.5 mtp180 -115.03 143.45 45.17 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.656 -0.653 . . . . 0.0 111.868 -178.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -148.34 130.07 15.09 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.601 -0.687 . . . . 0.0 111.567 164.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 58.27 25.6 12.88 Favored 'General case' 0 N--CA 1.506 2.361 0 N-CA-C 115.716 1.746 . . . . 0.0 115.716 -167.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 90.37 -34.04 4.31 Favored Glycine 0 CA--C 1.557 2.685 0 N-CA-C 118.095 1.998 . . . . 0.0 118.095 -159.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 76.5 t -70.49 119.41 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 CA-C-N 119.276 1.538 . . . . 0.0 111.614 -165.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 21.0 m -95.13 123.36 38.58 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.166 0.507 . . . . 0.0 112.091 -173.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 10.4 t -94.03 130.87 40.0 Favored 'General case' 0 CA--C 1.561 1.383 0 C-N-CA 123.518 0.727 . . . . 0.0 110.99 159.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -108.36 111.63 23.65 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.558 -0.713 . . . . 0.0 109.45 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -111.46 132.07 54.75 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 123.612 0.765 . . . . 0.0 111.384 178.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 43.9 t -115.35 130.42 69.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 176.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -126.59 141.63 51.8 Favored 'General case' 0 CA--C 1.563 1.448 0 C-N-CA 124.232 1.013 . . . . 0.0 110.78 -178.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 10.3 tmtt? -110.46 139.7 45.42 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.966 -1.084 . . . . 0.0 112.288 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 37.0 tttp -73.68 117.23 15.21 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 113.464 0.913 . . . . 0.0 113.464 -177.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . 0.263 34.8 m -103.25 -39.28 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.152 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 174.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 38.2 t60 . . . . . 0 N--CA 1.486 1.344 0 CA-C-N 119.863 1.21 . . . . 0.0 107.956 163.654 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo . . . . . 0 CA--C 1.575 2.555 0 N-CA-C 114.877 1.068 . . . . 0.0 114.877 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -152.77 164.56 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 -178.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -87.85 104.67 16.81 Favored 'General case' 0 CA--C 1.567 1.612 0 O-C-N 119.89 -1.756 . . . . 0.0 111.308 167.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -88.73 3.52 50.59 Favored 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 115.808 1.781 . . . . 0.0 115.808 171.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 62.8 m-80 -65.22 114.63 4.83 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 120.93 1.695 . . . . 0.0 113.426 -178.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 168.33 169.04 31.28 Favored Glycine 0 N--CA 1.483 1.767 0 N-CA-C 116.113 1.205 . . . . 0.0 116.113 -176.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -103.19 128.07 50.29 Favored 'General case' 0 CA--C 1.565 1.52 0 CA-C-N 114.125 -1.037 . . . . 0.0 109.251 169.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 63.1 m95 -125.31 128.54 48.38 Favored 'General case' 0 CA--C 1.568 1.65 0 C-N-CA 123.663 0.785 . . . . 0.0 109.361 -170.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -92.73 147.5 22.81 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.753 -1.217 . . . . 0.0 112.831 171.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.412 ' SD ' ' HD2' ' A' ' 38' ' ' PRO . 42.7 ttm -72.64 130.52 40.76 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.723 -1.235 . . . . 0.0 112.528 171.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 83.3 mt -89.08 -53.24 4.67 Favored 'General case' 0 CA--C 1.568 1.636 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.622 163.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 87.3 p -140.4 151.67 45.12 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-N 119.175 0.898 . . . . 0.0 112.784 -176.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -128.75 112.71 14.48 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.744 -0.597 . . . . 0.0 110.21 166.002 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -110.91 122.93 49.11 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.911 0.885 . . . . 0.0 109.252 -172.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.263 27.1 t30 65.36 25.33 12.07 Favored 'General case' 0 N--CA 1.503 2.222 0 N-CA-C 116.901 2.186 . . . . 0.0 116.901 -175.358 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -68.09 -41.43 81.85 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 115.925 1.824 . . . . 0.0 115.925 178.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -58.52 -40.54 83.21 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 116.213 1.931 . . . . 0.0 116.213 170.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -69.63 -40.8 76.32 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 115.031 1.493 . . . . 0.0 115.031 174.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -51.39 -52.18 48.1 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 114.79 1.404 . . . . 0.0 114.79 161.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 75.0 mt -61.25 -40.46 94.15 Favored 'General case' 0 CA--C 1.573 1.851 0 N-CA-C 115.045 1.498 . . . . 0.0 115.045 172.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 45.7 ttp180 -53.95 -50.17 67.07 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 115.366 1.617 . . . . 0.0 115.366 164.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.63 -22.92 48.37 Favored 'General case' 0 CA--C 1.568 1.639 0 N-CA-C 118.172 2.656 . . . . 0.0 118.172 166.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 93.5 mt -85.83 11.84 10.37 Favored 'General case' 0 CA--C 1.574 1.88 0 N-CA-C 115.88 1.807 . . . . 0.0 115.88 165.02 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 60.69 35.82 19.67 Favored 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 115.951 1.834 . . . . 0.0 115.951 -172.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 97.5 t -96.44 138.62 21.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 120.797 -1.189 . . . . 0.0 109.119 -177.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 7.8 p-10 -67.01 154.35 41.41 Favored 'General case' 0 CA--C 1.567 1.615 0 N-CA-C 115.752 1.76 . . . . 0.0 115.752 -178.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 87.8 t -53.34 -43.65 51.93 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.349 0 N-CA-C 115.502 1.667 . . . . 0.0 115.502 -177.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.95 -47.36 83.14 Favored 'General case' 0 CA--C 1.567 1.608 0 N-CA-C 116.264 1.95 . . . . 0.0 116.264 172.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 31.2 tp -75.77 -26.32 57.26 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 116.477 2.028 . . . . 0.0 116.477 171.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 77.4 mtp180 -54.05 -52.65 60.2 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-N 120.695 1.589 . . . . 0.0 114.092 158.09 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 30.9 mmtp -63.38 -51.17 66.99 Favored 'General case' 0 CA--C 1.568 1.637 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 170.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 15.3 mt -78.42 60.98 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.408 0 CA-C-O 123.63 1.681 . . . . 0.0 111.166 178.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -177.07 -56.98 0.01 OUTLIER 'General case' 0 CA--C 1.562 1.429 0 C-N-CA 126.735 2.014 . . . . 0.0 109.139 -174.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -57.74 -42.69 84.46 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 116.504 2.038 . . . . 0.0 116.504 161.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 74.1 mt -79.31 -19.74 49.64 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 116.067 1.877 . . . . 0.0 116.067 -177.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.0 pp -101.91 141.91 34.03 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 118.988 0.813 . . . . 0.0 111.522 171.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 7.0 mtmp? -102.38 100.65 16.29 Favored Pre-proline 0 CA--C 1.572 1.811 0 CA-C-O 117.878 -1.058 . . . . 0.0 110.37 -177.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.412 ' HD2' ' SD ' ' A' ' 10' ' ' MET . 73.6 Cg_endo -75.76 170.18 20.72 Favored 'Trans proline' 0 CA--C 1.566 2.11 0 CA-C-N 122.85 2.054 . . . . 0.0 116.857 -175.09 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -102.52 154.45 19.09 Favored 'General case' 0 CA--C 1.566 1.558 0 CA-C-N 113.983 -1.462 . . . . 0.0 109.988 176.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 21.8 mtpp -128.46 114.06 16.31 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.807 -1.183 . . . . 0.0 109.227 171.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -102.1 103.56 14.14 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 169.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 73.1 mt -98.24 124.72 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 -177.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.466 HG23 HH12 ' A' ' 52' ' ' ARG . 36.6 t -108.57 111.95 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 164.31 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -99.5 101.55 12.82 Favored 'General case' 0 CA--C 1.566 1.561 0 C-N-CA 123.943 0.897 . . . . 0.0 109.117 172.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -121.36 76.39 1.24 Allowed 'General case' 0 CA--C 1.567 1.627 0 C-N-CA 123.219 0.608 . . . . 0.0 111.409 -174.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 57.1 67.23 2.33 Favored Glycine 0 N--CA 1.497 2.723 0 N-CA-C 117.672 1.829 . . . . 0.0 117.672 171.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.488 0.0 OUTLIER 77.81 -43.53 0.4 Allowed 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 116.209 1.929 . . . . 0.0 116.209 -163.204 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 21.1 t-160 -73.56 109.26 6.93 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-N 120.797 1.635 . . . . 0.0 111.168 176.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 2.9 tpp -114.64 124.99 53.24 Favored 'General case' 0 CA--C 1.555 1.171 0 CA-C-O 122.045 0.926 . . . . 0.0 110.111 178.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 19.3 mt -108.63 103.86 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 N-CA-C 105.407 -2.072 . . . . 0.0 105.407 174.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 90.0 mt -93.41 95.16 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 172.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.466 HH12 HG23 ' A' ' 43' ' ' VAL . 63.1 mtt85 -82.68 94.66 7.62 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.345 -0.847 . . . . 0.0 110.003 177.02 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 34.1 m -84.8 109.29 17.97 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.137 -1.061 . . . . 0.0 108.137 172.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 15.3 mt -116.66 107.66 14.97 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 -164.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 36.7 p -116.45 155.5 28.47 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.349 0.66 . . . . 0.0 111.314 -173.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.3 t -68.35 4.16 1.43 Allowed 'General case' 0 CA--C 1.581 2.149 0 N-CA-C 117.992 2.59 . . . . 0.0 117.992 167.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -104.13 -58.86 1.82 Allowed 'General case' 0 CA--C 1.568 1.671 0 CA-C-N 119.619 1.099 . . . . 0.0 111.836 163.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 11.8 ptm180 -140.02 160.62 39.52 Favored 'General case' 0 CA--C 1.568 1.665 0 CA-C-O 122.56 1.172 . . . . 0.0 114.026 175.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -82.49 128.55 34.38 Favored 'General case' 0 CA--C 1.568 1.652 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.333 160.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -95.97 -66.91 0.88 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.592 -0.692 . . . . 0.0 110.92 178.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.359 58.6 mt 69.76 91.35 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 C-N-CA 124.563 1.145 . . . . 0.0 112.893 170.215 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 75.9 mtp -91.57 96.57 10.55 Favored 'General case' 0 CA--C 1.565 1.55 0 O-C-N 121.544 -0.723 . . . . 0.0 109.276 173.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -96.89 113.38 24.92 Favored 'General case' 0 CA--C 1.564 1.517 0 C-N-CA 123.893 0.877 . . . . 0.0 110.108 178.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -153.98 156.15 36.9 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -171.17 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 11.5 mp0 -91.62 126.27 36.65 Favored 'General case' 0 CA--C 1.564 1.505 0 O-C-N 121.403 -0.811 . . . . 0.0 110.286 163.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 41.5 t -67.41 114.69 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 C-N-CA 124.194 0.998 . . . . 0.0 109.381 174.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 119.88 -47.69 1.01 Allowed Glycine 0 N--CA 1.489 2.172 0 N-CA-C 115.58 0.992 . . . . 0.0 115.58 -160.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 85.1 mttt -79.75 141.01 36.72 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-N 118.743 1.272 . . . . 0.0 113.53 -173.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 55.4 tt0 -100.83 100.79 11.49 Favored 'General case' 0 CA--C 1.565 1.532 0 C-N-CA 123.275 0.63 . . . . 0.0 111.164 -178.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -105.96 144.53 32.55 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 -168.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -73.43 103.69 4.17 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.691 -1.255 . . . . 0.0 111.735 173.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.571 1.767 0 N-CA-C 114.534 1.309 . . . . 0.0 114.534 -170.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 88.2 m . . . . . 0 CA--C 1.556 1.187 0 CA-C-O 121.533 0.682 . . . . 0.0 111.134 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 87.7 mmm -73.08 101.55 3.3 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-O 121.878 0.847 . . . . 0.0 110.751 -172.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 92.2 m -109.16 107.1 17.26 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.535 -158.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 64.6 m -92.8 128.68 38.75 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 172.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 18.2 t -112.55 130.67 65.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 167.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 39.5 m -150.74 155.89 40.19 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.589 -1.319 . . . . 0.0 112.853 -175.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 55.8 m95 -86.24 122.47 30.27 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.836 -1.165 . . . . 0.0 113.601 -175.046 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -102.54 67.03 0.99 Allowed 'General case' 0 CA--C 1.574 1.897 0 C-N-CA 123.286 0.634 . . . . 0.0 109.646 157.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 60.87 -104.17 0.62 Allowed Glycine 0 N--CA 1.492 2.387 0 N-CA-C 115.825 1.09 . . . . 0.0 115.825 -175.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -72.46 -27.78 62.52 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 116.357 1.984 . . . . 0.0 116.357 168.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -91.08 115.23 27.85 Favored 'General case' 0 N--CA 1.485 1.294 0 CA-C-N 119.505 1.048 . . . . 0.0 111.301 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 31.4 tp -80.22 110.38 15.59 Favored 'General case' 0 CA--C 1.565 1.555 0 O-C-N 121.401 -0.812 . . . . 0.0 109.207 167.022 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 30.4 mm-40 -101.07 126.05 47.73 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.713 0.805 . . . . 0.0 110.884 -170.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 40.4 t -118.05 128.9 55.21 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.592 0.757 . . . . 0.0 111.058 176.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.6 p -120.67 118.45 56.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 172.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 63.4 mt-30 -103.21 95.47 6.13 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 123.919 0.887 . . . . 0.0 109.339 -175.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 81.4 mttt -85.23 119.98 26.21 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.749 -1.22 . . . . 0.0 112.373 -168.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 176.51 -101.55 0.16 Allowed Glycine 0 N--CA 1.486 2.004 0 O-C-N 121.458 -0.776 . . . . 0.0 114.0 170.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -86.99 -59.35 2.28 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 -173.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 12.3 mptt -75.26 129.81 38.06 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 122.551 1.167 . . . . 0.0 110.945 -179.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 -76.47 -38.16 55.79 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 116.659 2.096 . . . . 0.0 116.659 -157.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -106.18 56.25 0.51 Allowed Glycine 0 N--CA 1.49 2.249 0 CA-C-N 119.258 0.936 . . . . 0.0 114.81 162.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 35.9 ttt180 -87.44 122.06 30.68 Favored 'General case' 0 CA--C 1.567 1.597 0 CA-C-N 118.364 1.082 . . . . 0.0 112.573 -177.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 172.9 -167.1 39.87 Favored Glycine 0 CA--C 1.546 2.019 0 N-CA-C 114.991 0.757 . . . . 0.0 114.991 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . 0.254 34.7 p-90 -155.26 156.03 34.86 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 113.888 1.069 . . . . 0.0 113.888 170.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 91.1 m -127.74 118.43 23.77 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 176.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -122.66 121.23 35.9 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.743 -0.598 . . . . 0.0 111.728 -174.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 21.9 p90 -134.45 165.74 24.47 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.347 -0.846 . . . . 0.0 113.138 178.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 95.4 mt -110.12 132.55 58.12 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.135 -0.978 . . . . 0.0 109.819 175.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -114.47 91.98 3.81 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 123.979 0.912 . . . . 0.0 108.878 168.248 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 71.67 -106.49 1.92 Allowed Glycine 0 N--CA 1.491 2.328 0 O-C-N 121.463 -0.773 . . . . 0.0 114.732 -177.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -108.06 32.76 4.53 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 115.111 1.523 . . . . 0.0 115.111 165.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -129.33 131.46 46.9 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-N 119.073 0.851 . . . . 0.0 110.345 178.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 12.9 tp -95.83 122.08 38.23 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 121.675 0.75 . . . . 0.0 109.531 175.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 41.0 m80 -111.28 117.31 32.8 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -174.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 42.4 tp -119.81 118.71 31.54 Favored 'General case' 0 CA--C 1.561 1.399 0 C-N-CA 123.764 0.826 . . . . 0.0 110.051 -172.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -106.57 107.72 18.86 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.68 -0.638 . . . . 0.0 109.603 171.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 72.9 mtm -99.58 129.92 45.78 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 123.035 0.534 . . . . 0.0 111.072 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 73.4 mtp85 -117.68 141.85 47.91 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.548 -0.72 . . . . 0.0 112.515 -172.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -151.23 133.47 15.31 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 123.187 0.595 . . . . 0.0 111.274 165.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 59.3 20.82 9.01 Favored 'General case' 0 N--CA 1.509 2.484 0 N-CA-C 116.373 1.99 . . . . 0.0 116.373 -173.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 86.91 -18.61 34.42 Favored Glycine 0 CA--C 1.557 2.715 0 N-CA-C 119.018 2.367 . . . . 0.0 119.018 -159.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 87.4 t -81.31 121.27 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 CA-C-N 119.498 1.649 . . . . 0.0 109.869 -174.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 25.0 m -101.75 126.03 48.53 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.217 0.532 . . . . 0.0 111.812 -177.057 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 7.7 t -95.59 125.64 40.32 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.885 0.874 . . . . 0.0 110.919 162.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 51.7 mtpt -105.5 113.25 26.72 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 123.123 0.569 . . . . 0.0 109.815 -177.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 -114.28 136.56 52.83 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.516 -0.74 . . . . 0.0 111.652 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 62.6 t -116.98 130.31 72.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 178.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -124.78 149.87 46.91 Favored 'General case' 0 CA--C 1.565 1.536 0 C-N-CA 124.536 1.134 . . . . 0.0 110.696 -179.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 25.8 ttmt -119.7 141.95 48.93 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.028 -1.045 . . . . 0.0 112.293 175.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 36.5 tttm -74.68 128.56 35.84 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -177.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 29.2 m -111.73 -33.74 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 178.177 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 49.1 t-80 . . . . . 0 N--CA 1.485 1.292 0 CA-C-N 120.569 1.531 . . . . 0.0 109.112 174.215 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_endo . . . . . 0 CA--C 1.56 1.796 0 N-CA-C 115.017 1.122 . . . . 0.0 115.017 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 27.5 t -97.56 -98.31 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.57 1.712 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 -171.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -152.1 79.15 1.25 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.809 -1.182 . . . . 0.0 108.052 160.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -74.46 -11.34 60.21 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 116.514 2.042 . . . . 0.0 116.514 179.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -61.83 108.56 1.04 Allowed 'General case' 0 CA--C 1.563 1.473 0 C-N-CA 125.813 1.645 . . . . 0.0 114.02 -178.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 163.2 -179.27 38.48 Favored Glycine 0 N--CA 1.483 1.802 0 N-CA-C 116.453 1.341 . . . . 0.0 116.453 -179.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -106.92 128.3 54.19 Favored 'General case' 0 CA--C 1.564 1.505 0 CA-C-N 114.035 -1.082 . . . . 0.0 109.234 171.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 73.4 m95 -122.14 143.53 49.49 Favored 'General case' 0 CA--C 1.572 1.808 0 C-N-CA 123.964 0.905 . . . . 0.0 110.102 -169.27 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -111.67 140.39 46.34 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.035 -1.041 . . . . 0.0 112.306 173.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 50.0 ttm -72.08 125.11 26.45 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.099 -1.001 . . . . 0.0 112.93 176.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 86.4 mt -82.62 -47.87 11.59 Favored 'General case' 0 CA--C 1.567 1.609 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 166.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 80.0 p -148.74 147.96 29.44 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 123.496 0.718 . . . . 0.0 112.242 177.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -120.57 105.8 11.16 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 123.133 0.573 . . . . 0.0 109.535 164.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -101.44 125.48 48.08 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.418 -0.801 . . . . 0.0 109.911 -177.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.273 19.5 t30 64.89 18.91 11.69 Favored 'General case' 0 CA--C 1.583 2.213 0 N-CA-C 117.515 2.413 . . . . 0.0 117.515 -177.588 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -65.28 -47.85 75.22 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 115.516 1.673 . . . . 0.0 115.516 176.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -56.72 -35.32 68.42 Favored 'General case' 0 CA--C 1.576 1.97 0 N-CA-C 117.211 2.3 . . . . 0.0 117.211 172.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -68.4 -46.92 68.67 Favored 'General case' 0 CA--C 1.573 1.834 0 N-CA-C 114.79 1.404 . . . . 0.0 114.79 166.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -52.25 -46.98 66.0 Favored 'General case' 0 N--CA 1.501 2.088 0 N-CA-C 115.369 1.618 . . . . 0.0 115.369 167.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 93.1 mt -61.9 -39.86 93.43 Favored 'General case' 0 CA--C 1.573 1.864 0 N-CA-C 115.061 1.504 . . . . 0.0 115.061 170.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 67.4 ttp85 -56.87 -48.48 78.02 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 115.241 1.571 . . . . 0.0 115.241 164.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.2 -19.15 12.5 Favored 'General case' 0 CA--C 1.569 1.706 0 N-CA-C 118.21 2.671 . . . . 0.0 118.21 167.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 84.5 mt -95.22 3.71 54.31 Favored 'General case' 0 CA--C 1.569 1.694 0 N-CA-C 116.078 1.881 . . . . 0.0 116.078 167.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 58.49 46.17 15.39 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 115.452 1.649 . . . . 0.0 115.452 -169.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 70.0 t -90.3 143.07 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.322 -0.861 . . . . 0.0 109.259 178.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -60.3 145.57 47.12 Favored 'General case' 0 CA--C 1.569 1.681 0 N-CA-C 115.556 1.687 . . . . 0.0 115.556 -176.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . 0.272 91.9 t -60.27 -36.01 65.84 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.168 0 N-CA-C 115.137 1.532 . . . . 0.0 115.137 -176.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.27 -55.03 38.33 Favored 'General case' 0 CA--C 1.566 1.584 0 N-CA-C 115.889 1.811 . . . . 0.0 115.889 167.256 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 5.5 tt -65.27 -39.6 92.82 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 115.565 1.691 . . . . 0.0 115.565 171.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 37.7 mtp-105 -46.84 -41.6 15.9 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 117.208 2.299 . . . . 0.0 117.208 165.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -74.67 -54.84 6.65 Favored 'General case' 0 CA--C 1.567 1.608 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 164.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 4.8 mt -80.89 60.78 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.585 2.296 0 CA-C-N 120.395 1.452 . . . . 0.0 111.61 -176.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -176.03 -51.71 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 126.392 1.877 . . . . 0.0 110.157 -176.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -63.23 -41.25 99.07 Favored 'General case' 0 CA--C 1.568 1.651 0 N-CA-C 115.76 1.763 . . . . 0.0 115.76 161.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 84.0 mt -75.03 -28.93 60.65 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 115.792 1.775 . . . . 0.0 115.792 178.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . 0.259 3.1 pp -91.0 152.12 20.8 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 119.462 1.028 . . . . 0.0 112.24 170.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 29.6 mmtp -108.23 91.71 8.52 Favored Pre-proline 0 CA--C 1.572 1.821 0 CA-C-O 118.064 -0.969 . . . . 0.0 109.341 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -77.22 175.73 10.98 Favored 'Trans proline' 0 CA--C 1.563 1.931 0 C-N-CA 122.384 2.056 . . . . 0.0 116.317 -172.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -107.92 155.87 19.83 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 114.985 -1.007 . . . . 0.0 112.392 178.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 40.9 mttp -121.02 119.64 33.09 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.663 -0.648 . . . . 0.0 109.382 169.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -96.73 111.01 23.35 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.463 -0.939 . . . . 0.0 108.463 162.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 74.3 mt -106.81 122.38 60.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 92.9 t -103.92 104.48 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 167.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -112.52 97.57 6.68 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 123.562 0.745 . . . . 0.0 111.159 -176.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -96.58 69.32 2.54 Favored 'General case' 0 CA--C 1.567 1.634 0 O-C-N 120.88 -1.138 . . . . 0.0 110.766 172.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 64.45 -89.7 0.09 OUTLIER Glycine 0 N--CA 1.491 2.328 0 N-CA-C 116.169 1.227 . . . . 0.0 116.169 -178.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.8 p30 -81.84 -39.77 23.46 Favored 'General case' 0 CA--C 1.566 1.573 0 N-CA-C 115.91 1.819 . . . . 0.0 115.91 166.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -80.3 121.74 26.04 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 121.055 1.752 . . . . 0.0 111.893 -178.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 42.2 ttm -130.29 128.48 41.64 Favored 'General case' 0 CA--C 1.556 1.198 0 CA-C-O 121.597 0.713 . . . . 0.0 111.362 -177.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 46.7 mt -113.56 103.37 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 170.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 64.7 mt -92.88 98.8 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 174.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -86.46 98.89 11.28 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.333 -0.854 . . . . 0.0 109.967 174.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 31.9 m -83.57 109.91 17.8 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 172.075 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 53.5 mt -114.79 118.96 35.04 Favored 'General case' 0 CA--C 1.559 1.302 0 C-N-CA 124.005 0.922 . . . . 0.0 109.725 -164.477 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 9.7 p -133.62 155.42 49.71 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.256 0.55 . . . . 0.0 111.923 177.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 26.1 m -80.86 59.29 3.67 Favored 'General case' 0 N--CA 1.505 2.3 0 O-C-N 120.726 -1.234 . . . . 0.0 112.197 169.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -172.42 -64.53 0.02 OUTLIER 'General case' 0 CA--C 1.568 1.654 0 C-N-CA 125.509 1.524 . . . . 0.0 109.25 -179.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 65.5 ttt180 -138.93 140.3 38.26 Favored 'General case' 0 CA--C 1.568 1.639 0 CA-C-N 118.965 0.802 . . . . 0.0 110.81 175.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -110.28 137.7 47.65 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 123.338 0.655 . . . . 0.0 110.487 174.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -91.41 -74.92 0.49 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.657 -0.652 . . . . 0.0 111.375 178.545 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.363 54.3 mt 75.87 93.45 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 C-N-CA 124.368 1.067 . . . . 0.0 110.664 -177.207 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 81.1 mtp -100.29 99.56 10.24 Favored 'General case' 0 CA--C 1.561 1.37 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 174.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -101.32 113.35 26.34 Favored 'General case' 0 CA--C 1.565 1.52 0 C-N-CA 124.123 0.969 . . . . 0.0 111.614 178.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -157.77 158.32 35.04 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.154 -0.966 . . . . 0.0 113.224 -166.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 30.5 tt0 -95.38 130.6 42.11 Favored 'General case' 0 CA--C 1.564 1.485 0 O-C-N 121.123 -0.986 . . . . 0.0 110.822 160.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.3 t -65.25 117.31 5.64 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.813 0 C-N-CA 124.12 0.968 . . . . 0.0 109.535 170.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 115.25 -46.6 1.14 Allowed Glycine 0 CA--C 1.551 2.313 0 N-CA-C 115.667 1.027 . . . . 0.0 115.667 -159.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -82.77 154.49 24.73 Favored 'General case' 0 CA--C 1.567 1.633 0 CA-C-N 118.662 1.231 . . . . 0.0 113.729 -179.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -99.3 130.86 45.62 Favored 'General case' 0 CA--C 1.57 1.736 0 CA-C-O 121.928 0.871 . . . . 0.0 112.268 175.094 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -68.8 157.49 36.34 Favored 'General case' 0 CA--C 1.57 1.716 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 168.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -105.64 108.99 20.8 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.258 -0.901 . . . . 0.0 108.578 132.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 . . . . . 0 N--CA 1.496 1.861 0 O-C-N 120.832 -1.167 . . . . 0.0 110.325 172.447 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 44.9 m . . . . . 0 N--CA 1.487 1.412 0 CA-C-O 120.987 0.422 . . . . 0.0 111.175 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 4.9 mmt -75.32 74.51 2.42 Favored 'General case' 0 CA--C 1.567 1.62 0 CA-C-O 122.345 1.069 . . . . 0.0 111.241 169.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 100.0 m -93.0 130.21 38.65 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.03 -1.044 . . . . 0.0 109.824 -167.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 91.1 m -123.09 134.14 54.26 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 -178.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 16.1 t -120.64 138.23 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 178.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 59.2 m -147.57 150.8 35.16 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.215 -1.553 . . . . 0.0 113.056 -177.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 75.3 m95 -81.85 126.53 31.99 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.04 -1.037 . . . . 0.0 111.808 176.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -106.5 -21.67 13.0 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 118.145 2.646 . . . . 0.0 118.145 -167.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 159.8 -70.77 0.24 Allowed Glycine 0 N--CA 1.493 2.46 0 CA-C-N 121.296 1.862 . . . . 0.0 112.982 -172.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 34.4 m-20 -126.28 32.04 5.29 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 148.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -141.44 146.94 37.13 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.453 -1.404 . . . . 0.0 110.525 -165.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 35.8 tp -100.08 108.02 20.07 Favored 'General case' 0 CA--C 1.561 1.402 0 O-C-N 121.256 -0.903 . . . . 0.0 109.258 172.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 43.5 mm-40 -93.42 131.25 38.78 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 123.205 0.602 . . . . 0.0 111.535 -179.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 39.5 t -123.12 133.1 54.3 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.663 0.785 . . . . 0.0 111.063 173.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.2 p -115.4 127.41 72.98 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.683 0 C-N-CA 123.33 0.652 . . . . 0.0 109.343 169.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -105.6 91.32 3.71 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 124.096 0.958 . . . . 0.0 109.482 -176.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -90.35 126.51 35.89 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.753 -1.217 . . . . 0.0 112.035 -168.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 165.65 -95.16 0.12 Allowed Glycine 0 N--CA 1.489 2.167 0 O-C-N 121.017 -1.052 . . . . 0.0 114.122 172.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -75.05 -48.32 24.57 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 115.7 1.741 . . . . 0.0 115.7 -173.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 43.6 mttp -115.88 151.47 35.25 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 122.488 1.137 . . . . 0.0 113.908 -168.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -75.68 153.52 37.09 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 54.44 36.32 57.89 Favored Glycine 0 N--CA 1.5 2.954 0 N-CA-C 119.949 2.74 . . . . 0.0 119.949 -178.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 32.3 ttt180 -100.53 116.06 31.59 Favored 'General case' 0 CA--C 1.563 1.45 0 C-N-CA 123.861 0.864 . . . . 0.0 111.177 -164.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 178.25 -170.64 42.84 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 115.336 0.894 . . . . 0.0 115.336 -178.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 37.3 p-90 -154.02 151.93 29.93 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 174.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 91.1 m -121.07 121.06 37.1 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.364 -0.835 . . . . 0.0 109.299 173.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -120.8 129.42 53.57 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 123.205 0.602 . . . . 0.0 112.087 -177.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 19.7 p90 -142.96 172.68 12.37 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.995 -1.066 . . . . 0.0 112.836 178.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 72.0 mt -119.86 132.04 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 O-C-N 121.07 -1.019 . . . . 0.0 109.989 175.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -110.19 89.74 3.11 Favored 'General case' 0 CA--C 1.567 1.611 0 C-N-CA 123.847 0.859 . . . . 0.0 108.77 165.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 68.6 -106.99 1.91 Allowed Glycine 0 N--CA 1.492 2.431 0 N-CA-C 115.75 1.06 . . . . 0.0 115.75 179.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 23.4 p-10 -87.79 0.31 55.94 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 117.248 2.314 . . . . 0.0 117.248 167.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -113.13 132.55 55.41 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-N 120.148 1.34 . . . . 0.0 112.116 -173.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 12.3 tp -93.98 124.71 38.17 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 123.726 0.811 . . . . 0.0 109.667 171.046 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 41.4 m80 -114.52 120.96 42.0 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 123.618 0.767 . . . . 0.0 109.078 -176.153 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 38.9 tp -122.99 121.67 36.65 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 123.742 0.817 . . . . 0.0 110.166 -175.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -106.35 113.65 27.3 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.601 -0.687 . . . . 0.0 109.957 169.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 66.9 mtm -105.94 127.99 53.51 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 123.164 0.586 . . . . 0.0 111.151 -178.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 73.4 mtm180 -119.14 134.11 55.39 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 124.064 0.945 . . . . 0.0 110.442 -169.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -156.78 129.42 7.64 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.27 -0.894 . . . . 0.0 111.697 170.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . 0.283 11.4 mt-10 52.55 44.77 29.67 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 115.843 1.794 . . . . 0.0 115.843 -177.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 68.41 12.53 63.81 Favored Glycine 0 CA--C 1.553 2.411 0 N-CA-C 120.713 3.045 . . . . 0.0 120.713 -167.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 92.6 t -113.88 124.96 71.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 CA-C-N 120.017 1.909 . . . . 0.0 108.516 -177.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 80.8 m -105.0 119.2 38.44 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 123.266 0.626 . . . . 0.0 110.389 179.079 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 12.6 t -88.71 138.13 31.69 Favored 'General case' 0 CA--C 1.56 1.363 0 C-N-CA 123.644 0.778 . . . . 0.0 111.735 161.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 48.1 mtpt -115.17 111.21 20.65 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.66 -0.65 . . . . 0.0 109.483 177.135 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -108.08 131.63 54.4 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 123.546 0.738 . . . . 0.0 111.169 176.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 51.6 t -116.58 131.52 68.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 176.15 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -123.08 153.69 39.58 Favored 'General case' 0 CA--C 1.565 1.522 0 C-N-CA 124.724 1.209 . . . . 0.0 110.628 178.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 26.6 ttmt -122.34 145.9 47.82 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.952 -1.092 . . . . 0.0 111.999 170.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 64.9 tttt -76.07 126.33 30.79 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -176.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 34.1 m -104.71 -43.42 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 174.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 68.5 t60 . . . . . 0 N--CA 1.486 1.34 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 168.46 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo . . . . . 0 CA--C 1.568 2.211 0 N-CA-C 118.475 2.452 . . . . 0.0 118.475 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.4 p -178.3 130.34 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 C-N-CA 124.714 1.206 . . . . 0.0 108.92 -174.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -83.68 107.16 15.94 Favored 'General case' 0 CA--C 1.565 1.531 0 O-C-N 121.049 -1.032 . . . . 0.0 112.128 170.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -80.73 1.46 30.17 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 117.578 2.436 . . . . 0.0 117.578 175.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -55.06 113.42 1.35 Allowed 'General case' 0 CA--C 1.567 1.627 0 N-CA-C 115.756 1.761 . . . . 0.0 115.756 -174.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 162.51 177.26 35.38 Favored Glycine 0 N--CA 1.486 2.025 0 N-CA-C 116.184 1.234 . . . . 0.0 116.184 178.191 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -106.16 131.98 52.77 Favored 'General case' 0 CA--C 1.566 1.589 0 CA-C-N 114.388 -0.906 . . . . 0.0 109.312 168.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 78.4 m95 -128.06 129.15 46.18 Favored 'General case' 0 CA--C 1.563 1.479 0 C-N-CA 123.945 0.898 . . . . 0.0 109.542 -167.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.96 143.72 26.54 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.027 -1.046 . . . . 0.0 112.204 169.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 52.1 ttm -75.59 124.64 27.56 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.874 -1.142 . . . . 0.0 112.302 173.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 95.1 mt -82.52 -51.78 7.47 Favored 'General case' 0 CA--C 1.567 1.628 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.473 166.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 91.3 p -139.61 144.63 37.81 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-N 118.955 0.798 . . . . 0.0 112.134 177.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -118.18 89.56 3.15 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 121.763 0.792 . . . . 0.0 109.145 163.366 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -96.27 121.04 37.63 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.857 0.863 . . . . 0.0 110.081 -167.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.269 27.7 t30 66.59 24.73 10.12 Favored 'General case' 0 N--CA 1.503 2.184 0 N-CA-C 116.651 2.093 . . . . 0.0 116.651 -171.368 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -68.34 -44.54 75.09 Favored 'General case' 0 CA--C 1.569 1.676 0 N-CA-C 115.579 1.696 . . . . 0.0 115.579 178.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -53.73 -44.35 69.83 Favored 'General case' 0 N--CA 1.503 2.176 0 N-CA-C 116.632 2.086 . . . . 0.0 116.632 168.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -63.25 -44.74 94.3 Favored 'General case' 0 CA--C 1.573 1.858 0 N-CA-C 114.765 1.395 . . . . 0.0 114.765 174.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 44.4 t80 -54.48 -50.56 67.48 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 115.0 1.482 . . . . 0.0 115.0 166.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 94.2 mt -63.61 -41.38 98.31 Favored 'General case' 0 CA--C 1.571 1.762 0 N-CA-C 115.142 1.534 . . . . 0.0 115.142 174.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 71.5 ttp85 -53.4 -50.63 64.74 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 115.173 1.545 . . . . 0.0 115.173 163.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.08 -16.11 17.44 Favored 'General case' 0 CA--C 1.568 1.665 0 N-CA-C 118.591 2.812 . . . . 0.0 118.591 168.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 35.4 mt -91.92 -0.66 57.5 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 115.919 1.822 . . . . 0.0 115.919 166.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 62.43 61.64 1.23 Allowed 'General case' 0 N--CA 1.494 1.77 0 CA-C-N 119.98 1.264 . . . . 0.0 113.392 -165.026 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 96.1 t -111.48 136.97 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 N-CA-C 107.767 -1.198 . . . . 0.0 107.767 170.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 14.3 p30 -64.02 157.47 25.09 Favored 'General case' 0 CA--C 1.57 1.749 0 N-CA-C 116.094 1.887 . . . . 0.0 116.094 -177.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 43.2 t -56.9 -43.87 81.18 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.301 0 N-CA-C 114.753 1.39 . . . . 0.0 114.753 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.63 -50.52 72.86 Favored 'General case' 0 CA--C 1.564 1.518 0 N-CA-C 115.741 1.756 . . . . 0.0 115.741 172.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.2 tt -69.9 -37.78 76.11 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 115.092 1.515 . . . . 0.0 115.092 172.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 69.9 mtp180 -46.78 -52.87 13.13 Favored 'General case' 0 N--CA 1.502 2.166 0 CA-C-N 121.21 1.823 . . . . 0.0 115.695 161.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -65.91 -50.07 65.77 Favored 'General case' 0 CA--C 1.565 1.532 0 N-CA-C 114.004 1.113 . . . . 0.0 114.004 170.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 9.8 mt -78.99 58.68 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.586 2.346 0 CA-C-N 120.952 1.705 . . . . 0.0 110.831 175.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -174.98 -47.21 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 126.425 1.89 . . . . 0.0 111.131 -178.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -76.2 -30.61 58.08 Favored 'General case' 0 CA--C 1.569 1.682 0 N-CA-C 115.794 1.776 . . . . 0.0 115.794 164.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 96.0 mt -76.56 -36.27 57.73 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 114.925 1.454 . . . . 0.0 114.925 177.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -100.2 148.21 24.88 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 118.759 0.709 . . . . 0.0 111.015 170.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 44.5 mmtm -103.09 95.86 7.25 Favored Pre-proline 0 CA--C 1.573 1.854 0 CA-C-O 117.707 -1.14 . . . . 0.0 110.105 -171.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -73.52 158.49 47.66 Favored 'Trans proline' 0 CA--C 1.564 1.998 0 CA-C-N 123.158 2.164 . . . . 0.0 115.898 -176.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -90.78 160.55 15.72 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-N 115.714 -0.675 . . . . 0.0 112.21 178.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 30.4 mttp -120.96 121.28 37.68 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.018 -1.052 . . . . 0.0 110.016 170.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -103.37 105.66 15.99 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 164.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 76.0 mt -97.85 116.83 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 87.0 t -102.12 93.79 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 173.017 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -93.12 94.13 8.67 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 123.163 0.585 . . . . 0.0 109.712 175.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -101.81 73.93 1.45 Allowed 'General case' 0 CA--C 1.566 1.594 0 O-C-N 121.632 -0.668 . . . . 0.0 110.877 -178.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 57.4 71.49 0.74 Allowed Glycine 0 N--CA 1.494 2.506 0 N-CA-C 116.909 1.524 . . . . 0.0 116.909 179.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.471 0.4 OUTLIER 70.2 -30.37 0.2 Allowed 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 118.257 2.688 . . . . 0.0 118.257 -166.499 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 21.9 t-160 -76.42 99.42 4.87 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-N 120.937 1.699 . . . . 0.0 110.543 170.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 3.8 ttp -116.7 119.06 34.28 Favored 'General case' 0 CA--C 1.552 1.054 0 CA-C-O 121.917 0.865 . . . . 0.0 110.08 -169.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 5.2 mp -107.02 106.91 21.52 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.422 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 -178.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 24.1 mm -88.97 99.58 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 177.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 65.4 mtt-85 -95.07 95.67 8.73 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.498 -0.751 . . . . 0.0 109.591 -179.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 16.3 m -82.6 115.87 21.75 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 169.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 45.9 mt -119.65 114.1 21.68 Favored 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 123.665 0.786 . . . . 0.0 109.04 -164.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.6 t -102.12 -67.13 0.88 Allowed 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -178.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . 0.317 8.8 t 160.47 -61.89 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.165 0 C-N-CA 126.884 2.074 . . . . 0.0 106.821 -171.627 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -77.25 -48.57 17.16 Favored 'General case' 0 CA--C 1.579 2.062 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 161.195 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 3.6 tpm_? -95.02 135.97 35.9 Favored 'General case' 0 CA--C 1.564 1.501 0 CA-C-O 122.434 1.111 . . . . 0.0 113.157 -170.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 47.1 m-80 -121.89 135.51 54.89 Favored 'General case' 0 CA--C 1.568 1.64 0 CA-C-N 114.625 -1.171 . . . . 0.0 108.574 164.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 20.6 m-30 -94.25 -61.0 1.6 Allowed 'General case' 0 N--CA 1.504 2.231 0 O-C-N 120.898 -1.126 . . . . 0.0 113.179 171.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.282 4.3 mm 64.0 57.21 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.429 0 CA-C-N 119.694 1.133 . . . . 0.0 113.606 175.559 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 66.7 mtp -79.61 104.7 10.39 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.007 -1.683 . . . . 0.0 109.69 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -116.56 108.65 16.24 Favored 'General case' 0 CA--C 1.56 1.354 0 C-N-CA 123.739 0.816 . . . . 0.0 110.807 -162.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 20.5 p90 -152.22 145.81 24.95 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -163.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 18.7 mp0 -82.46 124.85 30.44 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.333 -0.854 . . . . 0.0 110.332 159.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 26.0 t -65.88 121.4 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.57 -0.706 . . . . 0.0 110.581 178.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 116.24 -38.85 2.9 Favored Glycine 0 CA--C 1.55 2.26 0 N-CA-C 116.328 1.291 . . . . 0.0 116.328 -160.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -80.89 141.64 34.38 Favored 'General case' 0 CA--C 1.567 1.616 0 CA-C-N 119.397 1.599 . . . . 0.0 114.021 -172.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -96.11 102.35 14.14 Favored 'General case' 0 CA--C 1.568 1.641 0 C-N-CA 123.694 0.798 . . . . 0.0 109.896 171.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -115.41 146.64 41.42 Favored 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 123.883 0.873 . . . . 0.0 113.153 -169.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -70.1 120.77 16.3 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 119.955 -1.716 . . . . 0.0 113.263 171.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 . . . . . 0 N--CA 1.493 1.693 0 O-C-N 121.087 -1.008 . . . . 0.0 110.332 173.334 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 81.2 m . . . . . 0 N--CA 1.486 1.368 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 4.6 tpt -78.45 104.18 8.88 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-O 122.153 0.978 . . . . 0.0 110.16 -172.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 85.7 m -110.43 121.97 46.6 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.926 -155.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 91.7 m -113.44 119.68 38.42 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 -179.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.448 HG22 ' SG ' ' A' ' 95' ' ' CYS . 22.0 t -112.19 119.11 59.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 177.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 65.3 m -140.54 156.86 46.18 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 122.049 0.928 . . . . 0.0 112.513 -173.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 34.5 m95 -84.52 118.76 24.52 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.043 -1.035 . . . . 0.0 112.908 -178.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -99.23 75.25 1.99 Allowed 'General case' 0 CA--C 1.567 1.597 0 C-N-CA 123.494 0.718 . . . . 0.0 109.894 167.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 73.19 -104.97 1.66 Allowed Glycine 0 N--CA 1.487 2.092 0 O-C-N 121.544 -0.723 . . . . 0.0 112.7 -174.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -92.48 -18.19 23.52 Favored 'General case' 0 CA--C 1.573 1.832 0 N-CA-C 115.469 1.655 . . . . 0.0 115.469 167.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 78.7 mttt -91.46 137.59 32.24 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 121.111 1.778 . . . . 0.0 112.07 -174.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 22.8 tp -92.25 109.96 21.34 Favored 'General case' 0 CA--C 1.563 1.457 0 O-C-N 121.324 -0.86 . . . . 0.0 110.017 177.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -99.3 125.72 45.0 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.392 0.677 . . . . 0.0 111.411 -175.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . 0.448 ' SG ' HG22 ' A' ' 86' ' ' VAL . 46.1 t -116.89 131.86 56.85 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.725 0.81 . . . . 0.0 110.803 176.461 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 11.0 p -123.66 123.68 67.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 C-N-CA 122.791 0.437 . . . . 0.0 110.281 169.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 69.3 mt-30 -102.57 108.36 19.62 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 124.25 1.02 . . . . 0.0 110.71 -177.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -96.65 127.01 42.22 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 -169.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 167.62 -110.42 0.39 Allowed Glycine 0 N--CA 1.488 2.146 0 O-C-N 121.419 -0.801 . . . . 0.0 114.189 167.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -75.41 -43.16 51.42 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 115.614 1.709 . . . . 0.0 115.614 -176.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 37.4 mmtm -83.9 138.56 33.11 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-O 121.935 0.874 . . . . 0.0 112.713 179.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -78.77 148.09 33.09 Favored 'General case' 0 CA--C 1.566 1.585 0 CA-C-N 115.663 -0.699 . . . . 0.0 112.096 168.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 61.0 23.65 61.87 Favored Glycine 0 N--CA 1.498 2.774 0 N-CA-C 120.85 3.1 . . . . 0.0 120.85 178.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 46.5 ttt180 -87.5 118.25 26.84 Favored 'General case' 0 CA--C 1.564 1.498 0 CA-C-N 118.78 1.29 . . . . 0.0 111.792 -175.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -178.3 -172.18 42.43 Favored Glycine 0 N--CA 1.486 2.029 0 O-C-N 121.449 -0.782 . . . . 0.0 114.925 -175.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 41.8 p-90 -157.42 151.1 24.12 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 172.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 29.3 m -120.47 120.04 34.74 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 123.604 0.761 . . . . 0.0 109.192 173.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 22.6 tt0 -119.61 135.08 54.95 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 123.316 0.646 . . . . 0.0 112.489 -176.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 20.8 p90 -152.41 168.98 23.7 Favored 'General case' 0 N--CA 1.497 1.899 0 C-N-CA 123.792 0.837 . . . . 0.0 112.535 177.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 63.2 mt -113.65 133.42 59.66 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.168 0 O-C-N 120.557 -1.339 . . . . 0.0 110.119 172.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -107.66 90.36 3.28 Favored 'General case' 0 CA--C 1.566 1.596 0 C-N-CA 123.789 0.836 . . . . 0.0 109.313 164.102 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 70.29 -103.98 1.27 Allowed Glycine 0 N--CA 1.491 2.358 0 N-CA-C 115.388 0.915 . . . . 0.0 115.388 179.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 54.1 p30 -95.51 5.17 52.24 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 117.121 2.267 . . . . 0.0 117.121 167.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 77.6 mt-10 -115.33 133.96 55.55 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 120.321 1.419 . . . . 0.0 112.295 -176.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 11.1 tp -91.73 121.63 33.55 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 123.951 0.9 . . . . 0.0 109.357 173.145 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 39.2 m80 -111.72 119.39 38.47 Favored 'General case' 0 CA--C 1.559 1.3 0 C-N-CA 123.655 0.782 . . . . 0.0 108.939 -176.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 37.8 tp -124.8 121.62 35.1 Favored 'General case' 0 CA--C 1.562 1.437 0 C-N-CA 123.885 0.874 . . . . 0.0 109.618 -174.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -108.53 104.2 13.48 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 172.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 64.5 mtm -98.82 125.2 44.13 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.784 -0.572 . . . . 0.0 111.158 -177.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -107.74 142.36 37.86 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 123.443 0.697 . . . . 0.0 112.277 -175.132 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -152.98 124.73 7.81 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-O 121.635 0.731 . . . . 0.0 110.867 164.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . 0.311 13.8 mt-10 60.58 31.61 20.26 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 116.654 2.094 . . . . 0.0 116.654 -178.103 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 83.07 -15.21 34.23 Favored Glycine 0 CA--C 1.553 2.451 0 N-CA-C 119.167 2.427 . . . . 0.0 119.167 -162.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 86.2 t -86.93 122.97 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 CA-C-N 120.04 1.92 . . . . 0.0 109.516 -176.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 42.8 m -100.56 124.68 46.45 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 121.092 0.472 . . . . 0.0 111.198 176.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 16.1 t -89.72 127.48 35.95 Favored 'General case' 0 CA--C 1.559 1.312 0 C-N-CA 123.239 0.616 . . . . 0.0 111.241 160.07 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp -100.48 107.74 19.53 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 175.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 66.3 mt-30 -103.49 124.38 48.65 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.105 0.562 . . . . 0.0 110.361 175.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 58.1 t -112.08 130.99 64.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 175.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -124.65 155.45 39.15 Favored 'General case' 0 CA--C 1.566 1.575 0 C-N-CA 124.685 1.194 . . . . 0.0 110.763 -179.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -125.89 141.27 52.06 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.811 -1.18 . . . . 0.0 112.492 174.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 43.0 tttm -74.49 125.07 27.78 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 -174.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 35.8 m -108.55 -41.76 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 176.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 47.2 t-80 . . . . . 0 C--O 1.254 1.331 0 CA-C-N 119.932 1.242 . . . . 0.0 108.966 172.651 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo . . . . . 0 CA--C 1.564 2.006 0 N-CA-C 116.711 1.773 . . . . 0.0 116.711 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 32.8 m -76.83 146.26 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 CA-C-N 115.266 -0.879 . . . . 0.0 112.712 177.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -80.94 103.48 10.79 Favored 'General case' 0 CA--C 1.565 1.536 0 O-C-N 120.606 -1.308 . . . . 0.0 111.381 176.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 13.6 m-30 -70.43 -3.43 17.63 Favored 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 117.66 2.466 . . . . 0.0 117.66 172.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -46.5 114.28 0.79 Allowed 'General case' 0 CA--C 1.567 1.62 0 N-CA-C 116.575 2.065 . . . . 0.0 116.575 178.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 157.18 176.01 28.76 Favored Glycine 0 N--CA 1.487 2.08 0 N-CA-C 116.084 1.193 . . . . 0.0 116.084 -179.213 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -104.6 125.05 50.36 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 121.345 0.593 . . . . 0.0 109.514 172.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 68.5 m95 -123.33 124.66 43.45 Favored 'General case' 0 CA--C 1.568 1.659 0 C-N-CA 123.832 0.853 . . . . 0.0 109.11 -171.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 20.7 pttp -102.96 143.09 33.0 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 120.91 -1.119 . . . . 0.0 112.678 179.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.409 ' SD ' ' HD2' ' A' ' 38' ' ' PRO . 34.0 ttm -66.77 127.23 31.68 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.791 -1.193 . . . . 0.0 113.959 -179.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 93.7 mt -86.46 -55.41 3.9 Favored 'General case' 0 CA--C 1.566 1.595 0 C-N-CA 123.41 0.684 . . . . 0.0 112.467 163.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 88.1 p -139.53 149.5 43.98 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 119.023 0.828 . . . . 0.0 112.759 -177.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -124.49 110.88 15.04 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.07 0.548 . . . . 0.0 109.936 164.063 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -109.77 128.16 55.11 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.861 0.864 . . . . 0.0 109.362 -175.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.268 22.6 t30 64.57 23.02 12.79 Favored 'General case' 0 N--CA 1.504 2.229 0 N-CA-C 116.877 2.177 . . . . 0.0 116.877 -176.218 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -66.59 -45.65 78.54 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 115.471 1.656 . . . . 0.0 115.471 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -55.12 -41.42 71.68 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 116.298 1.962 . . . . 0.0 116.298 169.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -67.31 -41.24 85.66 Favored 'General case' 0 CA--C 1.573 1.835 0 N-CA-C 115.528 1.677 . . . . 0.0 115.528 174.011 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -53.98 -51.23 64.57 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 163.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.5 mt -63.41 -42.64 98.77 Favored 'General case' 0 CA--C 1.572 1.811 0 N-CA-C 114.641 1.348 . . . . 0.0 114.641 175.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 29.7 ttp85 -49.88 -49.65 48.7 Favored 'General case' 0 CA--C 1.575 1.938 0 N-CA-C 115.525 1.676 . . . . 0.0 115.525 161.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.04 -24.31 57.84 Favored 'General case' 0 CA--C 1.569 1.678 0 N-CA-C 117.709 2.485 . . . . 0.0 117.709 167.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 88.6 mt -83.52 1.61 41.04 Favored 'General case' 0 CA--C 1.572 1.823 0 N-CA-C 116.172 1.916 . . . . 0.0 116.172 166.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.268 20.8 m-20 64.1 48.36 3.02 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 114.834 1.42 . . . . 0.0 114.834 -168.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 92.6 t -96.58 142.42 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 CA-C-O 122.218 1.009 . . . . 0.0 109.429 175.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 7.5 p-10 -69.7 154.65 41.68 Favored 'General case' 0 CA--C 1.57 1.717 0 N-CA-C 115.305 1.594 . . . . 0.0 115.305 176.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 57.7 t -55.55 -41.24 62.96 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.303 0 N-CA-C 115.399 1.629 . . . . 0.0 115.399 -176.424 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.87 -49.42 76.32 Favored 'General case' 0 CA--C 1.567 1.598 0 N-CA-C 116.09 1.885 . . . . 0.0 116.09 173.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -62.02 -43.46 98.79 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 170.014 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 60.4 mtp180 -46.12 -53.59 10.09 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 116.201 1.926 . . . . 0.0 116.201 162.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 14.2 tptt -65.37 -47.99 74.49 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 115.603 1.705 . . . . 0.0 115.603 173.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 60.9 mt -55.26 -49.7 70.37 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.188 0 CA-C-N 119.806 1.185 . . . . 0.0 113.499 173.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.54 -42.05 92.36 Favored 'General case' 0 CA--C 1.565 1.529 0 N-CA-C 117.339 2.348 . . . . 0.0 117.339 173.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -59.65 -39.87 85.83 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 116.487 2.032 . . . . 0.0 116.487 168.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 89.9 mt -83.06 -16.21 47.88 Favored 'General case' 0 CA--C 1.569 1.681 0 N-CA-C 116.302 1.964 . . . . 0.0 116.302 179.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 69.4 mt -85.43 147.94 26.24 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 120.093 1.315 . . . . 0.0 112.342 171.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -105.21 87.42 1.99 Allowed Pre-proline 0 CA--C 1.574 1.873 0 CA-C-O 118.154 -0.926 . . . . 0.0 109.489 172.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.409 ' HD2' ' SD ' ' A' ' 10' ' ' MET . 60.5 Cg_endo -69.92 174.78 9.14 Favored 'Trans proline' 0 CA--C 1.564 1.992 0 C-N-CA 122.538 2.159 . . . . 0.0 115.423 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -130.36 136.27 48.91 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.545 -1.347 . . . . 0.0 110.806 -176.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 50.2 mttp -103.48 111.65 24.2 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.582 -0.699 . . . . 0.0 109.696 174.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -96.84 101.29 12.85 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 166.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 65.3 mt -93.93 119.15 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -173.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 75.8 t -109.83 95.32 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 177.37 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -99.31 118.46 36.03 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 123.751 0.82 . . . . 0.0 110.329 178.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -133.58 66.38 1.55 Allowed 'General case' 0 CA--C 1.569 1.696 0 O-C-N 121.51 -0.744 . . . . 0.0 111.867 -178.212 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 72.15 81.39 0.34 Allowed Glycine 0 N--CA 1.493 2.448 0 N-CA-C 115.274 0.87 . . . . 0.0 115.274 174.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.458 0.2 OUTLIER 65.66 -41.59 0.34 Allowed 'General case' 0 N--CA 1.502 2.141 0 N-CA-C 117.861 2.541 . . . . 0.0 117.861 -167.903 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 14.3 t-80 -70.55 120.47 16.23 Favored 'General case' 0 CA--C 1.562 1.416 0 O-C-N 120.984 -1.073 . . . . 0.0 111.595 168.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 17.5 ttp -136.87 125.35 23.52 Favored 'General case' 0 CA--C 1.555 1.163 0 CA-C-O 121.841 0.829 . . . . 0.0 110.522 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 23.0 mt -104.43 107.62 22.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 174.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 83.0 mt -86.67 99.71 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 168.307 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -85.05 93.07 8.52 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.51 -0.744 . . . . 0.0 109.863 -178.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 80.7 m -87.84 102.29 14.55 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 -177.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 17.6 mt -105.84 121.22 43.61 Favored 'General case' 0 CA--C 1.557 1.241 0 CA-C-N 114.514 -1.221 . . . . 0.0 109.365 -164.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 27.1 t -132.57 143.96 50.07 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.38 0.672 . . . . 0.0 110.528 -178.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 21.6 m -56.05 -34.77 66.21 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 116.123 1.898 . . . . 0.0 116.123 175.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -79.93 -58.64 3.07 Favored 'General case' 0 CA--C 1.569 1.693 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 175.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 11.9 tpt180 -151.7 127.18 10.04 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-N 119.824 1.193 . . . . 0.0 110.887 177.291 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -76.86 145.14 38.53 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 177.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -95.92 -67.96 0.82 Allowed 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 118.714 -0.66 . . . . 0.0 112.186 178.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.273 11.4 mm 72.52 96.76 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 C-N-CA 124.128 0.971 . . . . 0.0 111.716 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 82.2 mtp -96.25 98.71 10.51 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.02 -1.05 . . . . 0.0 109.568 173.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -100.66 110.57 22.7 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 123.659 0.784 . . . . 0.0 110.183 -179.118 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -150.52 157.45 43.02 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 114.527 1.306 . . . . 0.0 114.527 -167.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -101.08 138.03 38.65 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.586 -0.696 . . . . 0.0 110.312 160.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 92.5 t -67.77 128.18 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.289 -0.882 . . . . 0.0 110.995 -177.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 91.25 -45.7 2.82 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 116.518 1.367 . . . . 0.0 116.518 -165.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 16.7 tttp -67.29 122.49 17.99 Favored 'General case' 0 CA--C 1.571 1.78 0 C-N-CA 125.37 1.468 . . . . 0.0 113.051 178.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -84.43 114.93 22.26 Favored 'General case' 0 CA--C 1.567 1.6 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.888 -176.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -113.17 139.83 48.43 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -169.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -76.97 112.67 13.85 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.154 -0.966 . . . . 0.0 112.496 177.12 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 . . . . . 0 N--CA 1.487 1.392 0 C-N-CA 123.232 0.613 . . . . 0.0 110.334 175.541 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 73.7 m . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 120.931 0.395 . . . . 0.0 111.802 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 15.5 mtp -80.46 98.11 7.4 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-O 121.655 0.74 . . . . 0.0 110.919 177.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 91.2 m -101.46 125.35 48.09 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.658 -0.651 . . . . 0.0 110.7 -167.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 85.3 m -106.3 122.94 47.24 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 176.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 20.6 t -116.19 121.61 67.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 179.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 58.4 m -128.64 139.19 52.38 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 123.829 0.852 . . . . 0.0 111.221 -173.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 2.9 m95 -81.49 122.34 27.41 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.845 -1.16 . . . . 0.0 113.69 179.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -112.32 67.93 0.66 Allowed 'General case' 0 CA--C 1.577 1.996 0 C-N-CA 123.382 0.673 . . . . 0.0 110.632 164.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 69.96 -102.82 1.04 Allowed Glycine 0 N--CA 1.495 2.584 0 N-CA-C 115.968 1.147 . . . . 0.0 115.968 177.456 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -75.47 -28.93 59.44 Favored 'General case' 0 CA--C 1.574 1.878 0 N-CA-C 115.206 1.558 . . . . 0.0 115.206 162.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 29.8 mtpt -98.87 107.42 19.85 Favored 'General case' 0 N--CA 1.484 1.263 0 CA-C-N 119.469 1.031 . . . . 0.0 110.56 -167.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 30.4 tp -80.75 111.06 16.84 Favored 'General case' 0 CA--C 1.563 1.473 0 O-C-N 120.729 -1.232 . . . . 0.0 109.844 173.191 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 -97.55 126.94 43.13 Favored 'General case' 0 CA--C 1.558 1.272 0 C-N-CA 124.011 0.925 . . . . 0.0 110.961 -174.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 41.9 t -127.48 133.88 49.86 Favored 'General case' 0 N--CA 1.481 1.108 0 O-C-N 121.674 -0.641 . . . . 0.0 111.831 -178.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 12.2 p -118.78 128.92 75.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 C-N-CA 123.068 0.547 . . . . 0.0 109.78 168.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -99.96 104.28 15.89 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 123.47 0.708 . . . . 0.0 109.753 178.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -91.25 119.79 31.61 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.059 -1.026 . . . . 0.0 110.676 -173.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -174.41 -70.33 0.05 OUTLIER Glycine 0 N--CA 1.489 2.172 0 N-CA-C 116.022 1.169 . . . . 0.0 116.022 -175.099 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -138.27 -60.45 0.62 Allowed 'General case' 0 N--CA 1.498 1.963 0 CA-C-N 117.755 0.777 . . . . 0.0 111.952 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -72.74 133.04 44.38 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-O 122.231 1.015 . . . . 0.0 111.704 -173.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -68.73 -56.83 6.84 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 115.392 1.627 . . . . 0.0 115.392 -160.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -83.68 44.11 3.26 Favored Glycine 0 CA--C 1.55 2.226 0 N-CA-C 117.728 1.851 . . . . 0.0 117.728 166.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 25.1 ttt180 -85.95 119.04 25.83 Favored 'General case' 0 CA--C 1.566 1.587 0 CA-C-N 119.674 1.737 . . . . 0.0 113.366 -176.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 175.0 -165.84 37.18 Favored Glycine 0 N--CA 1.485 1.906 0 CA-C-O 122.01 0.783 . . . . 0.0 114.73 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 45.3 p-90 -155.66 152.94 29.26 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 172.065 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 81.8 m -119.73 121.38 39.06 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 169.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -121.0 128.52 52.78 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.604 -0.685 . . . . 0.0 111.578 -177.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 16.4 p90 -148.04 155.32 41.36 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.797 -1.19 . . . . 0.0 113.587 -176.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 94.8 mt -94.35 134.46 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.033 -1.042 . . . . 0.0 110.382 174.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -118.4 94.9 4.65 Favored 'General case' 0 CA--C 1.566 1.574 0 CA-C-N 114.897 -1.047 . . . . 0.0 108.441 159.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 69.11 -108.03 2.32 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 115.619 1.008 . . . . 0.0 115.619 -179.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 55.5 p30 -90.18 2.42 55.38 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 117.407 2.373 . . . . 0.0 117.407 168.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -121.24 130.15 53.53 Favored 'General case' 0 N--CA 1.486 1.329 0 CA-C-N 119.827 1.194 . . . . 0.0 111.663 -168.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 18.4 tp -91.64 113.63 25.95 Favored 'General case' 0 CA--C 1.562 1.409 0 C-N-CA 124.424 1.089 . . . . 0.0 109.451 172.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 41.6 m80 -101.16 124.79 47.41 Favored 'General case' 0 CA--C 1.561 1.399 0 C-N-CA 124.33 1.052 . . . . 0.0 108.842 -177.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 43.6 tp -124.99 120.27 31.09 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.824 0.85 . . . . 0.0 110.332 -171.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -105.06 107.02 17.78 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.711 -0.618 . . . . 0.0 109.686 170.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 72.1 mtm -97.72 124.58 42.12 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-N 118.58 0.627 . . . . 0.0 111.131 179.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 84.7 mtm180 -111.55 139.45 46.98 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 123.866 0.866 . . . . 0.0 110.926 -171.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -147.28 132.46 18.36 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.095 -1.003 . . . . 0.0 112.968 167.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . 0.344 24.7 mt-10 65.61 -73.36 0.07 Allowed 'General case' 0 N--CA 1.502 2.126 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 -173.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -160.2 50.3 0.37 Allowed Glycine 0 CA--C 1.552 2.386 0 C-N-CA 123.862 0.744 . . . . 0.0 112.259 157.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 69.0 t -139.96 122.92 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 -163.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 31.3 m -105.47 123.06 47.26 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 122.996 0.518 . . . . 0.0 111.588 -173.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 44.6 t -88.61 128.98 35.59 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.561 -0.712 . . . . 0.0 111.261 159.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -105.39 110.75 23.22 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -179.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 16.4 mt-30 -118.07 139.08 51.74 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 123.559 0.744 . . . . 0.0 111.491 -176.093 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 33.9 t -122.93 131.79 72.61 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 O-C-N 121.478 -0.764 . . . . 0.0 109.042 -178.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -126.48 138.72 53.54 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 124.146 0.978 . . . . 0.0 110.521 -179.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 76.8 tttt -106.89 140.45 39.69 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.643 -1.286 . . . . 0.0 112.654 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 61.8 tttt -73.63 120.74 19.65 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -179.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 35.9 m -104.92 -41.27 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 175.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 52.8 t-80 . . . . . 0 N--CA 1.486 1.354 0 CA-C-N 119.715 1.143 . . . . 0.0 108.143 168.361 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo . . . . . 0 CA--C 1.561 1.846 0 N-CA-C 116.367 1.641 . . . . 0.0 116.367 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 29.1 m -78.78 160.88 4.39 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.929 0 CA-C-O 122.399 1.095 . . . . 0.0 113.405 -177.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -90.99 107.1 18.98 Favored 'General case' 0 CA--C 1.565 1.547 0 O-C-N 121.015 -1.053 . . . . 0.0 112.373 -175.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 6.5 m-30 -83.64 -2.2 55.61 Favored 'General case' 0 CA--C 1.577 1.981 0 N-CA-C 116.152 1.908 . . . . 0.0 116.152 171.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 51.1 m-80 -58.52 114.05 2.28 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-N 121.612 2.006 . . . . 0.0 114.22 -178.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 160.05 -178.03 36.28 Favored Glycine 0 N--CA 1.483 1.833 0 CA-C-O 122.623 1.124 . . . . 0.0 115.896 -177.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 12.7 t80 -113.36 119.43 37.61 Favored 'General case' 0 CA--C 1.565 1.533 0 CA-C-N 114.222 -0.989 . . . . 0.0 108.875 178.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 77.2 m95 -123.01 124.37 42.99 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 123.541 0.737 . . . . 0.0 110.182 -165.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 64.1 pttt -98.68 136.81 38.21 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 120.501 -1.374 . . . . 0.0 113.4 -179.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 11.0 ttp -72.09 125.34 27.02 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-N 119.395 0.998 . . . . 0.0 112.901 177.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 78.6 mt -94.69 -56.29 2.83 Favored 'General case' 0 CA--C 1.564 1.503 0 CA-C-N 115.068 -0.969 . . . . 0.0 112.927 178.119 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 92.4 p -141.54 124.12 15.9 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.724 0.81 . . . . 0.0 110.227 -170.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -113.77 119.12 36.28 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 121.343 0.592 . . . . 0.0 111.327 175.107 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -114.37 126.84 55.45 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.81 0.844 . . . . 0.0 109.148 -176.054 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.265 19.0 t30 66.76 22.17 10.37 Favored 'General case' 0 CA--C 1.582 2.185 0 N-CA-C 116.911 2.189 . . . . 0.0 116.911 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -68.39 -43.39 77.39 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 115.382 1.623 . . . . 0.0 115.382 178.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -53.54 -44.86 69.55 Favored 'General case' 0 N--CA 1.501 2.108 0 N-CA-C 116.348 1.981 . . . . 0.0 116.348 167.006 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -65.64 -43.93 87.96 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 115.103 1.519 . . . . 0.0 115.103 175.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -53.44 -49.04 68.2 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 164.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 77.7 mt -63.47 -42.72 98.6 Favored 'General case' 0 CA--C 1.571 1.759 0 N-CA-C 114.539 1.311 . . . . 0.0 114.539 172.302 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 69.5 ttp85 -54.34 -46.19 72.88 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 115.696 1.739 . . . . 0.0 115.696 166.297 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.98 -31.83 65.45 Favored 'General case' 0 CA--C 1.567 1.63 0 N-CA-C 116.632 2.086 . . . . 0.0 116.632 164.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 82.2 mt -85.88 30.43 0.66 Allowed 'General case' 0 CA--C 1.572 1.818 0 N-CA-C 114.506 1.298 . . . . 0.0 114.506 167.255 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 64.54 17.98 11.14 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 117.023 2.231 . . . . 0.0 117.023 175.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 94.8 t -88.17 142.41 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 120.504 -1.373 . . . . 0.0 110.932 -168.204 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 7.8 p-10 -71.9 156.96 38.69 Favored 'General case' 0 CA--C 1.569 1.677 0 N-CA-C 115.363 1.616 . . . . 0.0 115.363 177.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 49.0 t -53.97 -42.71 55.35 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.407 0 N-CA-C 115.203 1.557 . . . . 0.0 115.203 -176.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.03 -52.4 65.53 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 115.871 1.804 . . . . 0.0 115.871 173.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -59.47 -42.27 91.64 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 115.934 1.827 . . . . 0.0 115.934 169.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 54.0 mtp180 -51.68 -57.53 8.95 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 164.527 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -59.63 -47.34 85.98 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 115.054 1.502 . . . . 0.0 115.054 175.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 64.7 mt -56.05 -57.06 9.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 CA-C-N 119.622 1.101 . . . . 0.0 112.675 172.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.0 -44.1 91.6 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 117.704 2.483 . . . . 0.0 117.704 176.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -67.61 -27.64 67.07 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 116.375 1.991 . . . . 0.0 116.375 172.289 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 88.5 mt -79.81 -31.45 40.66 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 115.686 1.735 . . . . 0.0 115.686 171.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . 0.272 4.1 pp -80.72 145.79 31.37 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-N 120.148 1.34 . . . . 0.0 114.486 -178.344 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -114.29 93.37 31.02 Favored Pre-proline 0 CA--C 1.573 1.843 0 CA-C-O 118.368 -0.825 . . . . 0.0 108.841 -177.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -81.19 166.93 18.15 Favored 'Trans proline' 0 CA--C 1.56 1.817 0 C-N-CA 122.969 2.446 . . . . 0.0 115.083 -174.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -106.0 118.65 37.17 Favored 'General case' 0 N--CA 1.487 1.379 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.303 173.128 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 35.4 mttp -83.33 107.08 15.61 Favored 'General case' 0 N--CA 1.485 1.284 0 O-C-N 121.302 -0.874 . . . . 0.0 110.331 169.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -91.33 113.18 25.37 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 164.327 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 82.7 mt -108.9 122.94 64.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 -177.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 91.3 t -108.3 102.47 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 169.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 42.7 tt0 -98.69 100.55 11.78 Favored 'General case' 0 CA--C 1.565 1.54 0 C-N-CA 123.825 0.85 . . . . 0.0 110.031 175.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -93.91 74.01 4.17 Favored 'General case' 0 CA--C 1.57 1.737 0 O-C-N 121.438 -0.789 . . . . 0.0 110.228 168.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 65.03 -99.0 0.32 Allowed Glycine 0 N--CA 1.492 2.374 0 N-CA-C 115.053 0.781 . . . . 0.0 115.053 -174.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -83.26 -31.36 26.99 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 116.406 2.002 . . . . 0.0 116.406 165.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 22.6 t-160 -80.19 108.72 14.02 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 121.228 1.831 . . . . 0.0 110.915 -177.2 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 45.2 ttm -118.75 123.6 45.23 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 123.511 0.724 . . . . 0.0 110.046 -172.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 35.9 mt -107.36 106.14 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 175.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 33.9 mm -90.7 108.67 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 174.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 67.2 mtt85 -105.66 100.09 9.67 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.654 -0.654 . . . . 0.0 109.464 173.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 59.1 m -89.9 102.74 15.44 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 176.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 15.2 mt -101.08 125.05 47.67 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.367 0.667 . . . . 0.0 111.132 -160.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.4 t -147.88 156.61 42.88 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 122.009 0.909 . . . . 0.0 111.126 179.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 25.2 m -59.57 -38.7 81.83 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 115.3 1.593 . . . . 0.0 115.3 171.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 35.5 t80 -74.54 -53.24 9.83 Favored 'General case' 0 CA--C 1.572 1.82 0 N-CA-C 114.733 1.382 . . . . 0.0 114.733 174.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 71.2 ttt180 -142.85 130.15 21.01 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 119.526 1.057 . . . . 0.0 110.274 174.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 71.5 m-80 -93.5 117.29 29.9 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 166.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 75.6 t80 -105.01 105.43 15.47 Favored 'General case' 0 CA--C 1.566 1.59 0 C-N-CA 123.28 0.632 . . . . 0.0 111.087 -172.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.9 mp -99.19 121.53 49.9 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.833 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -178.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 95.9 mtp -115.39 103.37 10.72 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.568 -0.707 . . . . 0.0 109.369 167.259 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -101.22 112.92 25.54 Favored 'General case' 0 CA--C 1.566 1.577 0 C-N-CA 124.163 0.985 . . . . 0.0 111.806 177.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -153.74 154.28 33.76 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 115.047 1.499 . . . . 0.0 115.047 -166.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 28.0 mp0 -89.24 121.62 31.71 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.445 -0.784 . . . . 0.0 110.671 167.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 37.3 t -66.85 116.11 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 C-N-CA 123.785 0.834 . . . . 0.0 109.512 172.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 121.55 -46.31 1.13 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 115.589 0.996 . . . . 0.0 115.589 -158.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -84.34 145.75 28.08 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 118.726 1.263 . . . . 0.0 113.297 -174.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -91.9 100.34 13.03 Favored 'General case' 0 CA--C 1.568 1.638 0 O-C-N 121.788 -0.57 . . . . 0.0 110.895 173.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -107.63 145.7 32.96 Favored 'General case' 0 N--CA 1.495 1.813 0 C-N-CA 124.073 0.949 . . . . 0.0 113.429 -169.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -68.57 118.79 12.05 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.234 -1.541 . . . . 0.0 114.133 176.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 . . . . . 0 N--CA 1.493 1.697 0 CA-C-O 122.448 1.118 . . . . 0.0 109.672 163.012 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 99.4 m . . . . . 0 N--CA 1.487 1.394 0 CA-C-O 121.77 0.795 . . . . 0.0 112.151 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 3.9 tpt -78.78 107.28 11.37 Favored 'General case' 0 CA--C 1.563 1.472 0 CA-C-O 122.211 1.005 . . . . 0.0 109.822 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 90.4 m -111.8 115.91 29.83 Favored 'General case' 0 N--CA 1.484 1.227 0 O-C-N 121.545 -0.722 . . . . 0.0 110.737 -152.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 50.3 m -89.96 123.53 33.96 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 168.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 59.7 t -108.87 131.8 58.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 166.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 58.7 m -143.36 150.94 39.84 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.771 -1.205 . . . . 0.0 112.676 -175.205 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 20.5 m95 -86.24 120.25 27.39 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 -178.001 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -105.23 62.76 0.69 Allowed 'General case' 0 CA--C 1.58 2.099 0 C-N-CA 123.871 0.868 . . . . 0.0 110.405 158.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 64.5 -98.99 0.3 Allowed Glycine 0 N--CA 1.496 2.634 0 N-CA-C 116.978 1.551 . . . . 0.0 116.978 178.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -68.96 -35.99 77.39 Favored 'General case' 0 CA--C 1.574 1.886 0 N-CA-C 115.121 1.526 . . . . 0.0 115.121 165.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -92.4 124.34 36.38 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.906 0.883 . . . . 0.0 112.073 -176.199 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 22.0 tp -89.99 108.69 19.87 Favored 'General case' 0 CA--C 1.564 1.491 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 166.087 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 30.3 mm-40 -97.95 130.82 44.79 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.709 0.804 . . . . 0.0 110.991 -172.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 42.4 t -127.67 127.92 44.57 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.015 0.526 . . . . 0.0 111.711 -175.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.6 p -115.07 115.21 48.75 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.625 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 169.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -93.59 94.95 8.91 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 123.628 0.771 . . . . 0.0 109.124 179.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 64.8 mttm -88.43 109.39 19.98 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.123 -0.986 . . . . 0.0 112.075 -169.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -179.83 85.37 0.07 OUTLIER Glycine 0 N--CA 1.484 1.871 0 CA-C-N 116.1 -0.5 . . . . 0.0 113.174 177.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . 0.271 29.1 tt0 70.35 -55.25 0.62 Allowed 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 116.697 2.11 . . . . 0.0 116.697 178.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.0 mmmp? -72.94 141.5 47.82 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 114.798 1.407 . . . . 0.0 114.798 -166.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -80.69 94.68 6.41 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.98 0.895 . . . . 0.0 112.526 -164.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 77.37 46.0 10.58 Favored Glycine 0 N--CA 1.486 1.988 0 N-CA-C 117.208 1.643 . . . . 0.0 117.208 -173.317 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 14.8 ttm180 -77.56 121.51 24.0 Favored 'General case' 0 CA--C 1.568 1.654 0 CA-C-N 118.546 1.173 . . . . 0.0 110.725 167.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 177.37 -171.74 44.51 Favored Glycine 0 N--CA 1.486 2.012 0 O-C-N 121.502 -0.749 . . . . 0.0 114.874 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 51.7 p-90 -157.96 154.04 27.13 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 114.125 1.157 . . . . 0.0 114.125 178.095 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 74.1 m -121.95 116.95 25.27 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 171.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 19.2 tt0 -115.7 126.73 54.48 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 123.398 0.679 . . . . 0.0 110.682 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 14.1 p90 -147.18 157.32 43.56 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.685 -1.259 . . . . 0.0 114.089 -175.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 95.8 mt -100.82 128.8 52.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.434 -0.791 . . . . 0.0 110.038 175.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -112.33 100.03 8.48 Favored 'General case' 0 CA--C 1.567 1.611 0 CA-C-N 114.697 -1.138 . . . . 0.0 108.543 160.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 70.53 -106.58 1.89 Allowed Glycine 0 N--CA 1.494 2.5 0 N-CA-C 115.442 0.937 . . . . 0.0 115.442 -179.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -112.43 33.7 4.76 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 114.767 1.395 . . . . 0.0 114.767 162.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -125.7 127.52 46.37 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 124.058 0.943 . . . . 0.0 109.707 177.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 17.0 tp -93.09 115.55 28.19 Favored 'General case' 0 CA--C 1.563 1.461 0 CA-C-O 122.097 0.951 . . . . 0.0 109.412 173.275 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 48.1 m80 -102.6 123.81 47.0 Favored 'General case' 0 CA--C 1.558 1.253 0 C-N-CA 124.17 0.988 . . . . 0.0 108.878 -176.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 43.3 tp -124.56 118.52 26.76 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.508 0.723 . . . . 0.0 109.654 -172.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 82.1 mt-10 -114.05 110.65 20.37 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.75 -0.594 . . . . 0.0 109.764 173.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 68.0 mtm -105.77 125.25 50.77 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 123.591 0.756 . . . . 0.0 110.755 -174.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 54.6 mtp180 -111.22 142.97 42.73 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.584 -0.697 . . . . 0.0 112.338 -177.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -156.52 133.05 10.09 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 123.08 0.552 . . . . 0.0 110.898 161.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 60.7 34.93 19.85 Favored 'General case' 0 N--CA 1.509 2.478 0 N-CA-C 115.339 1.607 . . . . 0.0 115.339 -168.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 67.35 -0.81 7.86 Favored Glycine 0 CA--C 1.561 2.913 0 N-CA-C 119.984 2.753 . . . . 0.0 119.984 -159.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 75.2 t -95.51 114.14 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 CA-C-N 120.81 2.305 . . . . 0.0 109.446 -167.165 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 25.0 m -94.63 118.63 32.0 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 123.094 0.557 . . . . 0.0 111.295 -173.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 13.9 t -91.6 124.65 35.91 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.306 0.642 . . . . 0.0 111.238 162.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -108.55 115.5 30.21 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.192 0.597 . . . . 0.0 109.659 -175.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -124.22 135.43 53.43 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.636 -0.665 . . . . 0.0 111.854 -174.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 61.7 t -112.97 131.62 64.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -125.34 145.13 50.17 Favored 'General case' 0 CA--C 1.563 1.463 0 C-N-CA 124.844 1.258 . . . . 0.0 109.778 179.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 30.3 ttmt -120.25 140.61 50.94 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.651 -1.281 . . . . 0.0 112.804 179.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 54.5 tttt -74.97 115.81 15.0 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -177.106 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 35.0 m -97.21 -40.73 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 174.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 79.5 t60 . . . . . 0 N--CA 1.486 1.343 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 164.628 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_exo . . . . . 0 CA--C 1.561 1.871 0 N-CA-C 116.563 1.717 . . . . 0.0 116.563 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 22.0 m -107.01 176.43 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 CA-C-O 122.248 1.023 . . . . 0.0 112.067 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -79.19 82.21 5.37 Favored 'General case' 0 CA--C 1.569 1.676 0 O-C-N 120.158 -1.589 . . . . 0.0 113.862 -171.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -73.41 -11.71 60.56 Favored 'General case' 0 CA--C 1.576 1.97 0 N-CA-C 115.614 1.709 . . . . 0.0 115.614 167.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -45.78 121.96 3.45 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 115.793 1.775 . . . . 0.0 115.793 168.007 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 154.84 174.39 24.74 Favored Glycine 0 N--CA 1.484 1.876 0 N-CA-C 115.976 1.15 . . . . 0.0 115.976 175.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 17.3 t80 -103.28 121.2 42.22 Favored 'General case' 0 CA--C 1.563 1.449 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 167.032 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 70.4 m95 -120.39 121.5 38.69 Favored 'General case' 0 CA--C 1.562 1.434 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 -170.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 63.7 pttt -89.47 137.74 32.07 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.249 -0.907 . . . . 0.0 112.169 177.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 51.3 ttm -73.38 121.84 21.11 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 122.092 0.949 . . . . 0.0 112.423 176.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 89.6 mt -81.79 -48.13 12.0 Favored 'General case' 0 CA--C 1.568 1.66 0 CA-C-N 115.242 -0.89 . . . . 0.0 113.157 167.252 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 88.6 p -136.55 146.29 45.99 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 119.225 0.92 . . . . 0.0 112.873 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 20.9 p30 -124.45 81.72 1.97 Allowed 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 121.694 0.759 . . . . 0.0 110.709 167.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -94.72 125.56 39.45 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.138 -0.976 . . . . 0.0 111.56 -167.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.257 51.2 t30 59.15 25.16 13.63 Favored 'General case' 0 N--CA 1.503 2.183 0 N-CA-C 116.968 2.21 . . . . 0.0 116.968 -170.453 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -66.97 -40.47 87.47 Favored 'General case' 0 CA--C 1.568 1.643 0 N-CA-C 114.969 1.47 . . . . 0.0 114.969 172.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -52.93 -53.42 49.79 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 115.484 1.661 . . . . 0.0 115.484 172.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -72.08 -37.01 69.69 Favored 'General case' 0 CA--C 1.566 1.565 0 N-CA-C 115.796 1.776 . . . . 0.0 115.796 176.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 61.3 t80 -50.2 -49.96 51.0 Favored 'General case' 0 N--CA 1.499 2.02 0 CA-C-N 120.526 1.512 . . . . 0.0 114.859 161.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 93.9 mt -62.57 -41.47 98.94 Favored 'General case' 0 CA--C 1.57 1.734 0 N-CA-C 115.51 1.67 . . . . 0.0 115.51 171.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 35.2 ttp180 -62.07 -44.85 95.78 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 115.091 1.515 . . . . 0.0 115.091 169.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -49.82 -28.96 7.09 Favored 'General case' 0 CA--C 1.571 1.781 0 N-CA-C 118.234 2.679 . . . . 0.0 118.234 162.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 91.0 mt -86.97 0.68 54.72 Favored 'General case' 0 CA--C 1.569 1.7 0 N-CA-C 116.45 2.019 . . . . 0.0 116.45 168.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 62.32 39.07 12.68 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 115.458 1.651 . . . . 0.0 115.458 -169.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 86.1 t -92.88 140.25 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 CA-C-O 122.195 0.997 . . . . 0.0 109.02 178.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.8 p-10 -67.0 146.05 54.77 Favored 'General case' 0 CA--C 1.567 1.613 0 N-CA-C 116.287 1.958 . . . . 0.0 116.287 -170.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 58.5 t -59.57 -38.75 77.02 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.162 0 N-CA-C 115.622 1.712 . . . . 0.0 115.622 -173.183 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.12 -38.95 84.58 Favored 'General case' 0 CA--C 1.569 1.711 0 N-CA-C 116.412 2.005 . . . . 0.0 116.412 169.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 6.1 tt -65.49 -50.67 64.45 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-N 119.318 0.963 . . . . 0.0 113.553 165.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 35.2 mtp-105 -47.62 -50.35 24.63 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 116.263 1.949 . . . . 0.0 116.263 172.203 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -70.91 -36.29 72.62 Favored 'General case' 0 CA--C 1.564 1.493 0 N-CA-C 115.239 1.57 . . . . 0.0 115.239 174.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 41.0 mt -71.99 -55.78 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.22 0 CA-C-N 122.334 2.334 . . . . 0.0 110.559 174.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -61.14 -23.3 65.43 Favored 'General case' 0 CA--C 1.565 1.54 0 N-CA-C 119.255 3.057 . . . . 0.0 119.255 176.362 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -75.28 -47.59 27.21 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 115.454 1.65 . . . . 0.0 115.454 160.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 97.4 mt -75.25 -25.56 58.14 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 116.29 1.959 . . . . 0.0 116.29 -175.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . 0.25 1.4 pp -96.34 149.89 21.19 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 119.444 1.02 . . . . 0.0 110.397 158.327 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -107.06 92.32 7.6 Favored Pre-proline 0 CA--C 1.574 1.873 0 CA-C-O 117.78 -1.105 . . . . 0.0 109.222 -176.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -72.04 155.85 56.67 Favored 'Trans proline' 0 CA--C 1.562 1.901 0 C-N-CA 122.535 2.157 . . . . 0.0 116.739 -170.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -101.14 136.22 41.34 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.926 -170.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 60.8 mttm -96.02 112.1 23.93 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.123 -0.986 . . . . 0.0 110.19 174.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -94.5 108.13 20.08 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 163.329 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 78.0 mt -103.07 117.14 48.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 -175.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 91.1 t -100.18 93.75 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 173.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -95.31 97.17 9.65 Favored 'General case' 0 CA--C 1.566 1.568 0 CA-C-O 121.395 0.617 . . . . 0.0 110.831 176.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -89.97 79.23 6.61 Favored 'General case' 0 CA--C 1.568 1.666 0 O-C-N 121.275 -0.89 . . . . 0.0 109.815 167.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 65.94 -102.66 0.73 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 114.897 0.719 . . . . 0.0 114.897 -174.176 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -86.07 -23.29 26.77 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 116.531 2.048 . . . . 0.0 116.531 165.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 18.5 t-160 -78.9 108.89 12.69 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 121.602 2.001 . . . . 0.0 111.148 178.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 47.1 ttm -117.64 121.08 39.94 Favored 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 123.676 0.79 . . . . 0.0 109.932 -174.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 29.6 mt -107.41 101.94 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 173.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 78.8 mt -88.89 100.63 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 177.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 62.6 mtt180 -94.5 98.48 10.88 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.774 -0.579 . . . . 0.0 110.251 -179.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 11.4 m -87.6 107.92 18.83 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 177.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 13.5 mt -108.96 120.35 42.26 Favored 'General case' 0 CA--C 1.558 1.273 0 C-N-CA 123.478 0.711 . . . . 0.0 110.486 -160.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 38.7 t -116.45 -93.41 0.5 Allowed 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.147 0.579 . . . . 0.0 110.624 177.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 52.8 m 176.83 -62.18 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.033 0 C-N-CA 126.618 1.967 . . . . 0.0 106.015 -170.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -72.89 -48.63 35.61 Favored 'General case' 0 CA--C 1.573 1.838 0 N-CA-C 115.935 1.828 . . . . 0.0 115.935 176.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 42.7 tpt85 -139.08 124.64 19.44 Favored 'General case' 0 CA--C 1.564 1.492 0 CA-C-N 118.995 0.816 . . . . 0.0 109.755 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -83.46 173.72 11.25 Favored 'General case' 0 CA--C 1.569 1.69 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 169.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -112.9 -76.24 0.59 Allowed 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.337 -0.852 . . . . 0.0 110.196 170.012 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.374 58.5 mt 70.5 85.51 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.127 0 C-N-CA 124.5 1.12 . . . . 0.0 111.678 173.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 94.4 mtp -102.05 102.64 13.16 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.5 p30 -99.96 110.44 22.77 Favored 'General case' 0 CA--C 1.562 1.434 0 C-N-CA 123.899 0.88 . . . . 0.0 112.554 -178.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -155.04 148.78 25.48 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 -168.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 23.1 mp0 -82.65 125.76 31.57 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.219 -0.926 . . . . 0.0 110.667 160.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 13.1 t -66.17 123.34 18.94 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.91 0 O-C-N 121.31 -0.869 . . . . 0.0 110.142 176.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 115.81 -44.26 1.51 Allowed Glycine 0 CA--C 1.55 2.253 0 N-CA-C 115.597 0.999 . . . . 0.0 115.597 -157.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 83.8 mttt -83.6 146.62 28.19 Favored 'General case' 0 CA--C 1.566 1.593 0 CA-C-N 118.822 1.311 . . . . 0.0 114.18 -172.237 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -91.05 103.71 16.38 Favored 'General case' 0 CA--C 1.564 1.51 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.995 167.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 11.1 p90 -102.72 145.49 29.63 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -171.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -78.81 124.67 28.45 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 177.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 . . . . . 0 N--CA 1.487 1.385 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 169.655 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 73.3 m . . . . . 0 CA--C 1.557 1.213 0 CA-C-O 121.713 0.768 . . . . 0.0 111.835 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 12.4 mmt -88.82 90.13 8.28 Favored 'General case' 0 CA--C 1.56 1.33 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 173.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 86.0 m -92.78 122.41 35.14 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.166 -0.958 . . . . 0.0 110.265 -174.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 58.5 m -110.04 122.73 48.26 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.457 HG22 ' SG ' ' A' ' 95' ' ' CYS . 17.8 t -118.0 128.09 75.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 92.0 p -130.6 166.58 20.33 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 122.506 1.146 . . . . 0.0 113.256 -176.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 68.5 m95 -97.19 129.67 44.52 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.615 -0.678 . . . . 0.0 111.932 175.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -126.49 81.84 2.03 Favored 'General case' 0 CA--C 1.567 1.597 0 C-N-CA 123.668 0.787 . . . . 0.0 109.647 177.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 63.21 17.44 59.24 Favored Glycine 0 N--CA 1.496 2.69 0 N-CA-C 121.74 3.456 . . . . 0.0 121.74 172.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . 0.269 0.8 OUTLIER 126.33 -45.41 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.472 0 C-N-CA 127.374 2.269 . . . . 0.0 111.087 -159.543 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 64.3 mttm -77.7 142.21 38.91 Favored 'General case' 0 CA--C 1.562 1.408 0 C-N-CA 123.68 0.792 . . . . 0.0 111.937 -176.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 25.7 tp -97.62 104.1 16.09 Favored 'General case' 0 CA--C 1.564 1.514 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 172.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 32.9 mm-40 -92.57 142.69 27.12 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 123.332 0.653 . . . . 0.0 111.831 -177.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . 0.457 ' SG ' HG22 ' A' ' 86' ' ' VAL . 49.3 t -139.64 136.88 34.78 Favored 'General case' 0 N--CA 1.484 1.238 0 O-C-N 121.441 -0.787 . . . . 0.0 112.127 -178.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.7 p -114.78 129.25 71.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 C-N-CA 123.203 0.601 . . . . 0.0 109.506 162.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -105.95 75.55 1.12 Allowed 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 123.593 0.757 . . . . 0.0 109.687 179.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -86.92 141.07 29.01 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.487 -1.383 . . . . 0.0 113.388 -173.21 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 135.69 -66.93 0.55 Allowed Glycine 0 N--CA 1.491 2.312 0 O-C-N 121.73 -0.606 . . . . 0.0 113.957 -171.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -79.54 -53.54 6.77 Favored 'General case' 0 CA--C 1.57 1.739 0 N-CA-C 115.335 1.606 . . . . 0.0 115.335 -175.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 45.1 mmtm -133.12 160.61 36.72 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-N 119.903 1.228 . . . . 0.0 114.313 -166.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -77.04 137.9 39.25 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.43 175.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 61.6 35.8 91.68 Favored Glycine 0 N--CA 1.496 2.652 0 N-CA-C 118.785 2.274 . . . . 0.0 118.785 -176.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 46.1 ttt180 -96.93 123.95 40.77 Favored 'General case' 0 CA--C 1.561 1.395 0 CA-C-N 118.16 0.98 . . . . 0.0 112.59 -170.095 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 179.92 -169.13 39.81 Favored Glycine 0 N--CA 1.483 1.776 0 CA-C-O 122.129 0.849 . . . . 0.0 114.847 176.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 43.4 p-90 -155.1 156.27 35.51 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 175.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 49.2 m -125.29 118.71 26.56 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 173.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 -118.52 129.81 55.57 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 123.345 0.658 . . . . 0.0 111.07 -178.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 15.3 p90 -150.34 156.72 42.05 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.761 -1.212 . . . . 0.0 113.396 -175.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 73.8 mt -101.44 141.76 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.186 0 CA-C-O 122.697 1.237 . . . . 0.0 111.346 -176.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -139.7 88.25 2.23 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 123.997 0.919 . . . . 0.0 109.12 -177.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 72.29 -112.61 4.1 Favored Glycine 0 N--CA 1.49 2.257 0 CA-C-N 115.87 -0.605 . . . . 0.0 113.755 -173.021 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 54.8 p30 -92.28 7.35 43.11 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 116.78 2.141 . . . . 0.0 116.78 164.034 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -107.87 146.76 31.87 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-N 120.519 1.509 . . . . 0.0 112.526 -174.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 13.8 tp -108.01 118.98 38.17 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 169.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 34.1 m80 -106.51 124.24 49.3 Favored 'General case' 0 CA--C 1.559 1.326 0 C-N-CA 123.713 0.805 . . . . 0.0 109.202 -175.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 20.1 tp -120.49 130.29 54.22 Favored 'General case' 0 CA--C 1.561 1.374 0 C-N-CA 123.8 0.84 . . . . 0.0 109.736 -176.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -117.76 114.51 23.42 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.567 -0.708 . . . . 0.0 109.532 166.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 68.2 mtm -106.81 125.0 50.44 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 123.368 0.667 . . . . 0.0 110.923 -178.224 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 72.7 mtp85 -111.6 140.93 45.81 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 123.381 0.673 . . . . 0.0 112.299 -176.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -159.22 135.18 8.81 Favored 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 123.301 0.64 . . . . 0.0 111.876 167.493 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 60.5 21.7 11.41 Favored 'General case' 0 N--CA 1.506 2.351 0 N-CA-C 115.963 1.838 . . . . 0.0 115.963 -170.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 82.88 -12.47 48.64 Favored Glycine 0 CA--C 1.56 2.858 0 N-CA-C 119.29 2.476 . . . . 0.0 119.29 -158.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 92.3 t -89.11 123.6 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 CA-C-N 120.015 1.908 . . . . 0.0 109.825 -171.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 24.1 m -101.16 120.81 40.78 Favored 'General case' 0 N--CA 1.494 1.773 0 C-N-CA 122.922 0.489 . . . . 0.0 112.092 -178.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 13.3 t -90.64 125.86 35.78 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.576 0.75 . . . . 0.0 111.655 162.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -107.86 113.57 26.89 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -177.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 14.4 mt-30 -121.51 126.97 50.5 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.431 -0.793 . . . . 0.0 110.882 -174.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 58.1 t -110.83 132.87 58.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -179.083 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -124.84 152.7 43.61 Favored 'General case' 0 CA--C 1.563 1.468 0 C-N-CA 124.307 1.043 . . . . 0.0 110.866 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -120.3 139.24 53.02 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.263 -0.898 . . . . 0.0 111.899 174.198 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 73.3 tttt -73.14 120.32 18.61 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.452 -0.78 . . . . 0.0 112.795 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . 0.253 34.7 m -105.81 -40.18 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 173.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 44.6 t60 . . . . . 0 N--CA 1.486 1.365 0 CA-C-N 119.988 1.267 . . . . 0.0 108.192 165.686 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo . . . . . 0 CA--C 1.564 2.008 0 N-CA-C 115.813 1.428 . . . . 0.0 115.813 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 19.0 m -76.52 152.63 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 CA-C-O 122.302 1.049 . . . . 0.0 112.307 165.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -76.74 118.08 19.0 Favored 'General case' 0 CA--C 1.565 1.545 0 O-C-N 121.242 -0.911 . . . . 0.0 113.383 178.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 6.2 m-30 -84.77 8.47 17.07 Favored 'General case' 0 CA--C 1.579 2.065 0 N-CA-C 115.57 1.693 . . . . 0.0 115.57 169.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -57.59 111.99 1.29 Allowed 'General case' 0 CA--C 1.564 1.499 0 N-CA-C 114.916 1.45 . . . . 0.0 114.916 -179.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 164.24 173.29 32.74 Favored Glycine 0 N--CA 1.484 1.862 0 N-CA-C 115.944 1.138 . . . . 0.0 115.944 -178.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -102.69 120.58 40.82 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-N 114.648 -0.776 . . . . 0.0 108.974 172.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 75.6 m95 -119.14 118.64 31.91 Favored 'General case' 0 CA--C 1.566 1.58 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -170.048 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 59.9 pttt -102.72 141.49 35.45 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.144 -0.972 . . . . 0.0 112.76 -176.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 45.6 ttm -66.05 124.78 23.49 Favored 'General case' 0 CA--C 1.569 1.689 0 N-CA-C 115.188 1.551 . . . . 0.0 115.188 -175.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 94.9 mt -88.32 -49.93 6.65 Favored 'General case' 0 CA--C 1.569 1.675 0 CA-C-N 115.128 -0.942 . . . . 0.0 112.986 164.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 87.0 p -136.6 149.56 48.09 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-N 119.143 0.883 . . . . 0.0 112.848 -178.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -135.7 87.24 2.3 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 123.671 0.789 . . . . 0.0 110.175 172.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -98.27 132.7 43.54 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.543 0.737 . . . . 0.0 110.872 -175.406 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.271 41.5 t30 62.75 17.08 9.53 Favored 'General case' 0 N--CA 1.503 2.203 0 N-CA-C 117.588 2.44 . . . . 0.0 117.588 179.757 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -62.4 -46.39 88.83 Favored 'General case' 0 CA--C 1.565 1.551 0 N-CA-C 115.764 1.764 . . . . 0.0 115.764 177.236 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -61.47 -38.93 89.04 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 116.764 2.135 . . . . 0.0 116.764 173.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -65.5 -41.43 93.21 Favored 'General case' 0 CA--C 1.572 1.825 0 CA-C-N 120.684 1.583 . . . . 0.0 114.924 168.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 39.4 t80 -55.0 -50.32 69.3 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 114.754 1.39 . . . . 0.0 114.754 166.048 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 91.9 mt -61.87 -43.4 98.91 Favored 'General case' 0 CA--C 1.571 1.775 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 171.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 20.4 ttm180 -53.12 -47.55 68.58 Favored 'General case' 0 CA--C 1.578 2.037 0 CA-C-N 120.746 1.612 . . . . 0.0 114.896 164.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.46 -19.11 45.19 Favored 'General case' 0 CA--C 1.568 1.647 0 N-CA-C 118.317 2.71 . . . . 0.0 118.317 166.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 95.4 mt -92.73 12.55 23.03 Favored 'General case' 0 CA--C 1.572 1.815 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 164.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 61.25 45.6 8.68 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 115.21 1.559 . . . . 0.0 115.21 -174.511 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 57.4 t -96.85 143.37 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 CA-C-O 122.388 1.09 . . . . 0.0 110.123 -176.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 -71.46 152.74 42.8 Favored 'General case' 0 CA--C 1.569 1.676 0 N-CA-C 115.022 1.49 . . . . 0.0 115.022 177.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 57.8 t -57.37 -41.1 77.8 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.166 0 N-CA-C 115.14 1.533 . . . . 0.0 115.14 -176.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.09 -49.32 78.31 Favored 'General case' 0 CA--C 1.567 1.624 0 N-CA-C 116.296 1.961 . . . . 0.0 116.296 174.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -59.55 -48.19 82.61 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 114.136 1.162 . . . . 0.0 114.136 168.406 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 53.2 mtp180 -50.82 -45.42 59.47 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 117.444 2.387 . . . . 0.0 117.444 168.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -72.5 -51.7 18.91 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-N 119.978 1.263 . . . . 0.0 113.807 172.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 45.2 mt -58.72 -51.5 71.24 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.23 0 CA-C-N 120.498 1.499 . . . . 0.0 113.293 178.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.83 -35.77 82.19 Favored 'General case' 0 CA--C 1.563 1.477 0 N-CA-C 117.76 2.504 . . . . 0.0 117.76 175.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -74.33 -30.82 62.19 Favored 'General case' 0 CA--C 1.571 1.777 0 N-CA-C 116.357 1.984 . . . . 0.0 116.357 169.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 79.4 mt -73.02 -34.38 66.31 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 115.209 1.559 . . . . 0.0 115.209 169.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 81.9 mt -72.5 152.81 41.69 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 119.318 0.963 . . . . 0.0 112.574 169.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -102.65 89.52 1.83 Allowed Pre-proline 0 CA--C 1.57 1.72 0 CA-C-O 118.234 -0.889 . . . . 0.0 109.339 167.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -70.16 168.67 21.42 Favored 'Trans proline' 0 CA--C 1.563 1.964 0 C-N-CA 122.47 2.114 . . . . 0.0 115.399 -179.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -131.95 128.6 38.81 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.905 -169.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -99.79 109.11 21.55 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.161 -0.962 . . . . 0.0 109.822 177.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -93.76 102.74 14.89 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 169.15 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 92.2 mt -94.91 121.38 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -172.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 96.0 t -112.1 93.2 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 107.067 -1.456 . . . . 0.0 107.067 176.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -89.69 115.97 27.45 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 123.72 0.808 . . . . 0.0 110.556 176.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -135.62 70.51 1.43 Allowed 'General case' 0 CA--C 1.569 1.682 0 C-N-CA 123.212 0.605 . . . . 0.0 110.811 -173.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 61.98 81.62 0.09 OUTLIER Glycine 0 N--CA 1.495 2.627 0 N-CA-C 116.488 1.355 . . . . 0.0 116.488 173.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.452 1.1 p30 63.85 -39.02 0.2 Allowed 'General case' 0 N--CA 1.504 2.225 0 N-CA-C 118.332 2.716 . . . . 0.0 118.332 -165.181 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 12.4 t-80 -79.15 121.64 25.26 Favored 'General case' 0 CA--C 1.56 1.346 0 CA-C-N 120.157 1.344 . . . . 0.0 111.406 173.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 11.3 ttp -134.6 129.51 35.07 Favored 'General case' 0 CA--C 1.556 1.204 0 CA-C-O 122.08 0.943 . . . . 0.0 110.979 -179.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 4.4 mp -105.06 113.57 42.45 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.377 0 N-CA-C 107.081 -1.452 . . . . 0.0 107.081 174.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 24.5 mm -89.04 93.57 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 167.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -80.18 96.68 6.63 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.146 -0.971 . . . . 0.0 109.733 -179.036 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 26.3 m -90.24 100.85 13.6 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 -175.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 23.6 mt -105.86 135.13 47.85 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 124.214 1.006 . . . . 0.0 110.491 -164.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 12.5 p -144.26 156.36 44.24 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.136 -0.978 . . . . 0.0 112.597 177.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.6 m -77.75 61.08 2.35 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 120.742 -1.223 . . . . 0.0 112.316 172.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -177.14 -67.55 0.01 OUTLIER 'General case' 0 CA--C 1.568 1.657 0 C-N-CA 126.013 1.725 . . . . 0.0 107.946 -174.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 56.7 ttt85 -144.76 140.94 28.84 Favored 'General case' 0 CA--C 1.565 1.528 0 CA-C-O 121.784 0.802 . . . . 0.0 110.217 177.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -105.18 119.43 39.03 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 175.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 19.3 t80 -81.75 -57.73 3.31 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 114.074 1.139 . . . . 0.0 114.074 -172.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.272 10.4 mm 76.2 95.97 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 C-N-CA 124.071 0.949 . . . . 0.0 111.798 172.395 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 91.1 mtp -97.52 94.2 6.88 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.994 -1.066 . . . . 0.0 109.628 173.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.9 p30 -96.19 111.29 23.39 Favored 'General case' 0 CA--C 1.561 1.38 0 C-N-CA 124.069 0.948 . . . . 0.0 112.136 179.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 20.4 p90 -150.38 158.57 44.31 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 -168.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -95.22 134.19 38.25 Favored 'General case' 0 CA--C 1.563 1.47 0 O-C-N 121.464 -0.773 . . . . 0.0 110.938 164.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 36.4 t -72.53 122.92 26.09 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.807 0 C-N-CA 123.845 0.858 . . . . 0.0 109.431 178.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 104.74 -48.55 0.98 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 115.56 0.984 . . . . 0.0 115.56 -163.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 26.2 tptp -65.14 133.48 51.66 Favored 'General case' 0 CA--C 1.567 1.618 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 176.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -92.48 110.19 21.6 Favored 'General case' 0 CA--C 1.569 1.709 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.139 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -118.99 134.44 55.19 Favored 'General case' 0 N--CA 1.498 1.947 0 C-N-CA 124.092 0.957 . . . . 0.0 112.664 -169.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -73.41 131.78 42.23 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.248 -1.532 . . . . 0.0 114.245 178.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 . . . . . 0 N--CA 1.5 2.068 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 176.819 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 97.8 m . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 121.384 0.611 . . . . 0.0 110.626 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 33.7 mtp -71.2 105.37 3.4 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-O 122.305 1.05 . . . . 0.0 111.799 -179.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 53.8 m -106.13 119.2 38.61 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.638 -161.406 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 87.6 m -94.79 124.68 38.98 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 166.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 57.8 t -105.45 135.95 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 167.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 52.4 m -147.5 146.88 29.66 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.286 -1.509 . . . . 0.0 112.528 -177.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 47.1 m95 -83.94 119.03 24.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.177 -0.952 . . . . 0.0 112.782 178.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -96.13 71.55 2.86 Favored 'General case' 0 CA--C 1.573 1.849 0 C-N-CA 123.061 0.544 . . . . 0.0 109.569 157.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 62.65 -102.83 0.54 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 115.653 1.021 . . . . 0.0 115.653 -175.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -80.77 -22.29 40.26 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 116.312 1.967 . . . . 0.0 116.312 169.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 61.2 mtpt -92.92 121.83 34.67 Favored 'General case' 0 CA--C 1.56 1.349 0 CA-C-N 119.547 1.067 . . . . 0.0 110.499 -177.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 33.0 tp -89.17 106.98 18.79 Favored 'General case' 0 CA--C 1.564 1.492 0 O-C-N 121.407 -0.808 . . . . 0.0 109.345 174.099 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 -96.59 137.21 36.01 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.724 0.81 . . . . 0.0 111.349 -175.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 40.7 t -134.17 128.35 33.86 Favored 'General case' 0 N--CA 1.483 1.189 0 O-C-N 121.732 -0.605 . . . . 0.0 111.742 -177.056 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 11.1 p -122.47 124.1 70.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 C-N-CA 123.284 0.634 . . . . 0.0 109.84 176.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -102.66 106.85 17.57 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 123.855 0.862 . . . . 0.0 110.385 -176.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -101.85 124.12 46.94 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.289 -0.882 . . . . 0.0 111.666 -169.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 177.49 -62.17 0.09 OUTLIER Glycine 0 N--CA 1.494 2.541 0 N-CA-C 117.388 1.715 . . . . 0.0 117.388 178.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -134.12 -58.41 0.85 Allowed 'General case' 0 N--CA 1.496 1.836 0 CA-C-N 117.529 0.664 . . . . 0.0 112.151 178.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 53.8 mttm -79.37 139.78 37.65 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 114.374 1.25 . . . . 0.0 114.374 -176.042 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -80.33 146.98 31.3 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-N 114.638 -1.165 . . . . 0.0 112.705 175.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 65.04 20.3 66.76 Favored Glycine 0 N--CA 1.495 2.59 0 N-CA-C 119.802 2.681 . . . . 0.0 119.802 -173.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 26.6 ttt180 -84.36 118.17 24.06 Favored 'General case' 0 CA--C 1.566 1.577 0 CA-C-N 118.91 1.355 . . . . 0.0 111.654 -177.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 179.29 -171.77 43.7 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 115.298 0.879 . . . . 0.0 115.298 -174.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . 0.259 39.9 p-90 -156.49 155.0 31.24 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 170.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 84.7 m -128.06 116.55 20.18 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 177.192 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -120.26 126.98 51.93 Favored 'General case' 0 N--CA 1.495 1.821 0 C-N-CA 123.545 0.738 . . . . 0.0 111.537 -174.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 16.3 p90 -148.61 155.38 41.0 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 120.893 -1.13 . . . . 0.0 113.364 -178.052 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 90.7 mt -98.1 132.96 41.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.02 -1.05 . . . . 0.0 110.291 177.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -118.79 94.04 4.31 Favored 'General case' 0 CA--C 1.566 1.594 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 162.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 69.07 -112.38 4.52 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 115.396 0.919 . . . . 0.0 115.396 -178.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 16.0 p30 -85.96 -2.42 58.27 Favored 'General case' 0 CA--C 1.572 1.827 0 N-CA-C 117.139 2.274 . . . . 0.0 117.139 166.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 88.2 mt-10 -109.93 128.95 55.69 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-N 120.646 1.566 . . . . 0.0 111.712 -174.142 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 12.2 tp -90.59 116.03 28.17 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.962 0.905 . . . . 0.0 109.421 167.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 57.7 m80 -99.9 122.45 42.84 Favored 'General case' 0 CA--C 1.559 1.295 0 C-N-CA 123.936 0.895 . . . . 0.0 109.422 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 47.6 tp -123.96 119.65 30.21 Favored 'General case' 0 CA--C 1.561 1.368 0 C-N-CA 123.974 0.909 . . . . 0.0 109.878 -174.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -108.74 106.62 16.73 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 171.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 62.0 mtm -99.72 125.83 45.67 Favored 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 123.043 0.537 . . . . 0.0 111.05 -178.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 71.5 mtm180 -114.56 139.41 49.61 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 123.629 0.772 . . . . 0.0 111.551 -168.114 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -155.64 124.6 6.11 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.583 -0.698 . . . . 0.0 110.798 168.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 60.55 36.21 19.95 Favored 'General case' 0 N--CA 1.505 2.32 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 -178.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 78.64 -22.39 3.36 Favored Glycine 0 CA--C 1.554 2.524 0 N-CA-C 119.3 2.48 . . . . 0.0 119.3 -162.006 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 85.7 t -80.15 120.83 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 CA-C-N 119.886 1.843 . . . . 0.0 110.091 -171.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 57.0 m -103.74 118.22 36.2 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 122.923 0.489 . . . . 0.0 111.015 -179.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 37.7 t -84.74 127.79 34.28 Favored 'General case' 0 CA--C 1.559 1.291 0 C-N-CA 123.115 0.566 . . . . 0.0 111.953 162.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 38.2 mtmm -106.21 109.39 21.31 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -179.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -114.69 133.19 56.07 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 123.674 0.79 . . . . 0.0 111.14 179.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 44.7 t -118.06 131.3 71.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 177.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -125.96 138.26 53.75 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 123.328 0.651 . . . . 0.0 111.656 -179.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 29.0 tptp -96.39 137.25 35.74 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.156 -0.965 . . . . 0.0 112.623 178.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 73.1 tttt -70.73 123.6 22.31 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 174.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 24.4 m -107.0 -42.67 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.13 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 173.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 32.8 m80 . . . . . 0 C--O 1.254 1.293 0 CA-C-N 119.601 1.091 . . . . 0.0 108.683 179.256 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo . . . . . 0 CA--C 1.561 1.849 0 N-CA-C 115.728 1.395 . . . . 0.0 115.728 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 33.0 m -75.37 152.91 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 CA-C-O 122.305 1.05 . . . . 0.0 113.121 177.226 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -71.93 113.53 9.06 Favored 'General case' 0 CA--C 1.56 1.365 0 O-C-N 121.328 -0.857 . . . . 0.0 112.212 172.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 6.0 m-30 -77.02 6.38 6.44 Favored 'General case' 0 CA--C 1.582 2.173 0 N-CA-C 116.188 1.922 . . . . 0.0 116.188 173.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -53.51 111.42 0.71 Allowed 'General case' 0 CA--C 1.565 1.532 0 C-N-CA 126.376 1.87 . . . . 0.0 115.597 -178.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 163.1 178.18 36.68 Favored Glycine 0 N--CA 1.482 1.759 0 CA-C-O 123.01 1.339 . . . . 0.0 116.104 177.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -107.76 124.6 50.27 Favored 'General case' 0 CA--C 1.563 1.46 0 CA-C-N 113.869 -1.165 . . . . 0.0 109.088 175.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -118.92 140.92 49.18 Favored 'General case' 0 CA--C 1.569 1.674 0 C-N-CA 123.9 0.88 . . . . 0.0 110.357 -168.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -115.6 133.04 56.42 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.165 -0.959 . . . . 0.0 111.841 176.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 53.9 ttm -71.61 123.83 23.37 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.096 -1.002 . . . . 0.0 113.562 -177.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 94.9 mt -81.19 -53.18 6.6 Favored 'General case' 0 CA--C 1.567 1.626 0 CA-C-N 115.307 -0.861 . . . . 0.0 112.466 169.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 92.4 p -145.65 124.8 12.89 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.662 0.785 . . . . 0.0 111.106 -175.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -103.19 96.21 6.63 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.92 0.867 . . . . 0.0 110.527 166.047 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -99.24 127.05 45.18 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 124.007 0.923 . . . . 0.0 109.592 -171.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 5.9 t30 66.32 23.16 10.76 Favored 'General case' 0 N--CA 1.508 2.443 0 N-CA-C 116.794 2.146 . . . . 0.0 116.794 -174.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -69.08 -46.96 66.47 Favored 'General case' 0 CA--C 1.568 1.656 0 N-CA-C 115.034 1.494 . . . . 0.0 115.034 178.135 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -42.09 -54.42 3.59 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 118.091 2.626 . . . . 0.0 118.091 167.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.28 8.5 pt-20 -75.67 -31.3 59.69 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 116.612 2.079 . . . . 0.0 116.612 176.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 79.5 t80 -55.4 -48.4 74.41 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-N 120.36 1.437 . . . . 0.0 114.569 160.119 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 69.3 mt -60.82 -40.97 94.75 Favored 'General case' 0 CA--C 1.574 1.898 0 N-CA-C 114.887 1.439 . . . . 0.0 114.887 170.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 37.6 ttm-85 -51.73 -50.84 59.77 Favored 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 115.262 1.578 . . . . 0.0 115.262 163.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.32 -25.37 59.24 Favored 'General case' 0 CA--C 1.566 1.574 0 N-CA-C 117.87 2.544 . . . . 0.0 117.87 168.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 97.0 mt -87.58 9.81 19.96 Favored 'General case' 0 CA--C 1.573 1.864 0 N-CA-C 115.656 1.724 . . . . 0.0 115.656 168.243 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 60.54 43.91 12.36 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 115.606 1.706 . . . . 0.0 115.606 -172.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 95.4 t -93.9 138.7 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.193 -0.942 . . . . 0.0 109.231 177.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 13.1 p30 -63.79 150.38 44.78 Favored 'General case' 0 CA--C 1.57 1.731 0 N-CA-C 115.251 1.575 . . . . 0.0 115.251 178.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 88.8 t -56.41 -40.24 66.01 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.22 0 N-CA-C 115.522 1.675 . . . . 0.0 115.522 -177.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.5 -53.69 55.35 Favored 'General case' 0 CA--C 1.568 1.672 0 N-CA-C 115.739 1.755 . . . . 0.0 115.739 169.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 28.9 tp -63.39 -38.28 90.52 Favored 'General case' 0 CA--C 1.571 1.781 0 N-CA-C 116.175 1.917 . . . . 0.0 116.175 171.22 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 34.6 mtp-105 -49.76 -52.05 34.58 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 115.801 1.778 . . . . 0.0 115.801 163.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -64.15 -49.09 73.49 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 114.547 1.314 . . . . 0.0 114.547 172.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 64.6 mt -58.49 -51.98 65.02 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 CA-C-N 119.996 1.271 . . . . 0.0 113.152 176.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.01 -35.82 81.97 Favored 'General case' 0 CA--C 1.563 1.47 0 N-CA-C 117.682 2.475 . . . . 0.0 117.682 175.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -72.23 -31.02 65.45 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 116.049 1.87 . . . . 0.0 116.049 168.115 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 78.3 mt -73.46 -35.15 65.67 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 115.317 1.599 . . . . 0.0 115.317 171.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 86.6 mt -83.22 143.68 30.29 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 119.069 0.85 . . . . 0.0 111.858 175.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 29.9 mmtp -106.05 88.36 3.01 Favored Pre-proline 0 CA--C 1.574 1.903 0 CA-C-O 117.982 -1.009 . . . . 0.0 109.641 176.078 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -73.18 166.41 30.04 Favored 'Trans proline' 0 CA--C 1.564 1.981 0 C-N-CA 122.45 2.1 . . . . 0.0 116.089 -175.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -98.74 155.7 17.21 Favored 'General case' 0 N--CA 1.488 1.425 0 CA-C-O 121.824 0.821 . . . . 0.0 112.373 177.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 65.2 mttt -117.4 121.14 40.27 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.508 -0.745 . . . . 0.0 109.357 164.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -94.61 109.77 21.66 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.104 -0.997 . . . . 0.0 108.594 161.17 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 68.3 mt -102.32 118.76 49.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 N-CA-C 107.424 -1.325 . . . . 0.0 107.424 179.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 57.3 t -111.35 95.43 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 172.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -88.32 97.87 11.28 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 123.519 0.728 . . . . 0.0 110.298 173.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -114.94 88.92 2.97 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 123.452 0.701 . . . . 0.0 109.973 -176.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 57.98 67.68 2.08 Favored Glycine 0 N--CA 1.495 2.607 0 N-CA-C 116.631 1.412 . . . . 0.0 116.631 178.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.477 0.6 OUTLIER 64.26 -25.46 0.08 Allowed 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 119.183 3.031 . . . . 0.0 119.183 -165.08 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 15.7 t-160 -78.09 109.48 12.21 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 121.284 1.856 . . . . 0.0 111.156 174.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 46.3 ttm -110.19 114.06 27.24 Favored 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 123.729 0.812 . . . . 0.0 109.496 -175.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 49.7 mt -100.15 102.59 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 175.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 59.1 mt -95.92 104.73 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 175.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 89.3 mtt180 -90.65 103.52 16.21 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.648 -0.658 . . . . 0.0 109.276 175.036 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 22.1 m -87.36 101.42 13.54 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 5.9 mt -111.96 118.48 35.59 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 124.009 0.924 . . . . 0.0 110.093 -163.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.1 t -99.08 -78.43 0.5 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.45 -0.781 . . . . 0.0 112.614 178.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.7 t 178.58 -61.58 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 125.699 1.6 . . . . 0.0 107.444 -170.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 7.9 p90 -83.89 -41.37 17.5 Favored 'General case' 0 CA--C 1.573 1.865 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 163.082 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 42.1 ttt85 -109.43 143.16 39.4 Favored 'General case' 0 CA--C 1.565 1.537 0 C-N-CA 124.124 0.97 . . . . 0.0 112.083 -168.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 46.1 t-20 -135.4 131.73 36.65 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 123.383 0.673 . . . . 0.0 110.096 175.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 9.2 t80 -124.78 110.24 14.07 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 172.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 87.1 mt -102.29 112.42 35.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -176.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 27.0 mmm -95.83 94.81 7.87 Favored 'General case' 0 CA--C 1.56 1.359 0 C-N-CA 123.628 0.771 . . . . 0.0 109.238 174.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.1 p30 -101.29 100.38 10.89 Favored 'General case' 0 CA--C 1.561 1.377 0 C-N-CA 123.725 0.81 . . . . 0.0 111.616 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -143.96 150.83 38.92 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -166.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -90.44 125.19 35.48 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.977 -1.077 . . . . 0.0 111.81 169.389 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 17.2 t -68.84 119.03 14.0 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.735 0 C-N-CA 123.858 0.863 . . . . 0.0 110.043 179.208 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 111.7 -43.49 1.71 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 115.778 1.071 . . . . 0.0 115.778 -160.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 51.2 mttm -83.71 143.87 29.74 Favored 'General case' 0 CA--C 1.567 1.608 0 CA-C-N 118.884 1.342 . . . . 0.0 113.41 -175.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -92.04 121.07 33.26 Favored 'General case' 0 CA--C 1.567 1.615 0 O-C-N 121.882 -0.511 . . . . 0.0 111.277 172.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 22.5 p90 -120.63 152.25 38.41 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 123.777 0.831 . . . . 0.0 112.668 -176.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -74.2 120.37 19.67 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.183 -1.573 . . . . 0.0 112.181 167.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 . . . . . 0 N--CA 1.492 1.67 0 O-C-N 121.326 -0.859 . . . . 0.0 111.077 169.868 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 85.6 m . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 121.723 0.773 . . . . 0.0 111.741 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 8.9 tpt -79.01 108.67 12.67 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.879 -1.138 . . . . 0.0 110.743 -178.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 97.4 m -119.71 114.57 22.38 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.146 -0.971 . . . . 0.0 111.069 -151.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 52.7 m -92.07 129.95 37.91 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 165.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.6 t -113.43 129.08 69.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 163.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 52.2 m -149.04 156.8 42.77 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.587 -1.32 . . . . 0.0 112.843 -175.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 72.8 m95 -82.23 115.39 21.29 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.89 -1.131 . . . . 0.0 112.308 179.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -84.83 72.99 10.7 Favored 'General case' 0 CA--C 1.569 1.709 0 O-C-N 121.382 -0.824 . . . . 0.0 109.869 163.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 69.42 -98.51 0.59 Allowed Glycine 0 N--CA 1.488 2.125 0 O-C-N 122.188 -0.32 . . . . 0.0 113.646 -167.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -99.95 -14.63 18.62 Favored 'General case' 0 CA--C 1.575 1.916 0 N-CA-C 116.393 1.997 . . . . 0.0 116.393 169.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 48.7 mtpt -92.82 127.33 38.29 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-N 120.407 1.458 . . . . 0.0 110.236 -176.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 26.0 tp -85.03 105.86 16.1 Favored 'General case' 0 CA--C 1.563 1.462 0 O-C-N 120.739 -1.226 . . . . 0.0 110.562 -177.375 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 29.5 mm-40 -95.16 129.34 42.3 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 123.369 0.668 . . . . 0.0 111.478 -177.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 41.4 t -116.35 128.34 55.45 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.666 0.786 . . . . 0.0 110.896 173.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.6 p -118.76 116.72 52.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 173.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 68.7 mt-30 -104.18 98.01 7.88 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 123.84 0.856 . . . . 0.0 109.079 -173.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -91.49 134.89 34.26 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.424 -0.797 . . . . 0.0 113.074 -164.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 160.43 -109.89 0.42 Allowed Glycine 0 N--CA 1.486 2.009 0 O-C-N 121.504 -0.748 . . . . 0.0 113.526 165.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -84.63 -39.08 19.08 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 115.906 1.817 . . . . 0.0 115.906 -175.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 17.8 ttmm -88.6 129.07 35.57 Favored 'General case' 0 CA--C 1.564 1.504 0 CA-C-N 119.5 1.046 . . . . 0.0 112.315 -175.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -76.16 134.13 40.02 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -172.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 61.93 32.97 83.94 Favored Glycine 0 N--CA 1.496 2.637 0 N-CA-C 119.622 2.609 . . . . 0.0 119.622 -177.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 3.9 ttt85 -86.97 119.77 27.53 Favored 'General case' 0 CA--C 1.564 1.515 0 CA-C-N 118.863 1.331 . . . . 0.0 111.264 -179.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -178.62 -171.83 42.32 Favored Glycine 0 N--CA 1.483 1.804 0 CA-C-O 122.102 0.834 . . . . 0.0 114.366 179.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 47.7 p-90 -156.08 156.24 33.98 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 175.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 29.4 m -127.96 119.65 25.95 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 177.004 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -122.72 131.49 53.81 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 -176.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 23.9 p90 -148.87 160.66 43.04 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.202 -0.937 . . . . 0.0 112.184 -179.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 96.1 mt -109.09 135.04 49.2 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.182 0 O-C-N 120.722 -1.236 . . . . 0.0 110.637 178.498 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -122.51 94.52 4.31 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 124.417 1.087 . . . . 0.0 108.156 176.293 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 73.11 -109.56 2.85 Favored Glycine 0 N--CA 1.491 2.34 0 O-C-N 121.494 -0.754 . . . . 0.0 114.024 -174.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -111.55 37.3 2.94 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 114.514 1.301 . . . . 0.0 114.514 164.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 81.3 mt-10 -130.72 130.66 44.09 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.709 0.804 . . . . 0.0 110.642 178.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 15.5 tp -90.85 118.09 29.98 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 123.892 0.877 . . . . 0.0 109.526 173.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 43.1 m80 -106.39 118.76 37.48 Favored 'General case' 0 CA--C 1.559 1.294 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -178.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 46.8 tp -122.24 124.53 44.02 Favored 'General case' 0 CA--C 1.559 1.301 0 C-N-CA 124.078 0.951 . . . . 0.0 109.572 -173.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 77.5 mt-10 -114.03 109.89 19.18 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.547 -0.72 . . . . 0.0 109.661 170.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 68.7 mtm -101.64 127.2 48.49 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 123.336 0.654 . . . . 0.0 110.858 -177.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 54.2 mtp85 -116.83 137.62 52.08 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 123.416 0.687 . . . . 0.0 110.932 -171.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -157.18 129.38 7.29 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.562 -0.711 . . . . 0.0 111.278 170.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . 0.276 22.6 mt-10 57.57 38.37 27.87 Favored 'General case' 0 N--CA 1.502 2.15 0 N-CA-C 115.77 1.767 . . . . 0.0 115.77 -176.256 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 69.14 9.26 60.05 Favored Glycine 0 CA--C 1.555 2.586 0 N-CA-C 120.365 2.906 . . . . 0.0 120.365 -164.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 95.0 t -111.59 125.54 68.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 CA-C-N 119.989 1.894 . . . . 0.0 108.972 -174.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 41.7 m -106.73 123.24 47.85 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 123.137 0.575 . . . . 0.0 111.168 -176.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 22.1 t -94.27 124.2 38.14 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.541 0.736 . . . . 0.0 111.513 164.378 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 48.5 mtpt -99.02 114.74 27.56 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 123.38 0.672 . . . . 0.0 109.65 177.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 20.2 mt-30 -119.78 123.59 44.09 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 123.35 0.66 . . . . 0.0 110.729 -178.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 43.8 t -112.91 130.49 66.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -123.97 147.45 47.74 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 123.595 0.758 . . . . 0.0 110.909 177.327 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -107.02 143.5 35.03 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.222 -0.924 . . . . 0.0 112.24 174.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 64.9 tttt -77.08 124.65 28.1 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 -177.186 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 27.7 m -110.86 -40.22 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 178.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 47.6 t-80 . . . . . 0 N--CA 1.486 1.373 0 CA-C-N 120.474 1.488 . . . . 0.0 108.488 174.824 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo . . . . . 0 CA--C 1.574 2.496 0 N-CA-C 115.867 1.449 . . . . 0.0 115.867 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 16.9 t -151.0 132.06 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 -172.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -75.78 90.09 2.88 Favored 'General case' 0 CA--C 1.569 1.698 0 O-C-N 121.193 -0.942 . . . . 0.0 111.76 172.065 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 10.6 m-30 -70.36 -1.38 10.4 Favored 'General case' 0 CA--C 1.58 2.119 0 N-CA-C 117.834 2.531 . . . . 0.0 117.834 176.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -51.96 123.61 10.8 Favored 'General case' 0 CA--C 1.566 1.594 0 N-CA-C 115.668 1.729 . . . . 0.0 115.668 177.382 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 163.21 176.93 35.73 Favored Glycine 0 N--CA 1.486 1.995 0 N-CA-C 116.153 1.221 . . . . 0.0 116.153 178.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -111.58 121.0 43.97 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 171.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 78.9 m95 -124.71 126.11 45.17 Favored 'General case' 0 CA--C 1.566 1.594 0 C-N-CA 123.297 0.639 . . . . 0.0 110.591 -165.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -96.62 138.97 33.39 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 120.673 -1.267 . . . . 0.0 113.215 177.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 6.5 ttp -74.68 128.41 35.49 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.683 -1.261 . . . . 0.0 114.207 -178.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 91.0 mt -90.39 -50.05 6.18 Favored 'General case' 0 CA--C 1.567 1.617 0 N-CA-C 113.874 1.065 . . . . 0.0 113.874 172.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 91.3 p -139.98 154.81 47.27 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -175.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 24.7 p30 -135.77 81.36 1.88 Allowed 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 124.133 0.973 . . . . 0.0 111.092 173.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -88.67 119.58 29.27 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.102 -0.999 . . . . 0.0 110.144 -174.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.273 41.9 t30 67.95 21.68 8.84 Favored 'General case' 0 N--CA 1.504 2.251 0 N-CA-C 116.821 2.156 . . . . 0.0 116.821 -175.533 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -69.29 -47.14 65.41 Favored 'General case' 0 CA--C 1.568 1.666 0 N-CA-C 115.795 1.776 . . . . 0.0 115.795 178.051 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -46.48 -44.41 17.55 Favored 'General case' 0 N--CA 1.502 2.173 0 N-CA-C 117.534 2.42 . . . . 0.0 117.534 165.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -69.44 -44.79 70.57 Favored 'General case' 0 CA--C 1.57 1.731 0 N-CA-C 114.992 1.479 . . . . 0.0 114.992 172.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -52.94 -47.35 68.14 Favored 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 115.123 1.527 . . . . 0.0 115.123 166.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.7 mt -61.14 -41.63 97.08 Favored 'General case' 0 CA--C 1.571 1.782 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 169.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 44.2 ttp85 -56.62 -45.52 81.47 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 115.36 1.615 . . . . 0.0 115.36 166.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.12 -25.1 60.98 Favored 'General case' 0 CA--C 1.567 1.606 0 N-CA-C 117.827 2.528 . . . . 0.0 117.827 165.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 98.1 mt -89.39 21.79 3.19 Favored 'General case' 0 CA--C 1.573 1.836 0 N-CA-C 115.23 1.567 . . . . 0.0 115.23 164.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 66.9 16.39 10.36 Favored 'General case' 0 N--CA 1.504 2.236 0 N-CA-C 116.682 2.104 . . . . 0.0 116.682 179.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 91.4 t -82.03 136.35 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 120.223 -1.548 . . . . 0.0 110.215 -167.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 13.7 p30 -62.06 152.86 31.45 Favored 'General case' 0 CA--C 1.57 1.727 0 N-CA-C 115.208 1.559 . . . . 0.0 115.208 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 91.5 t -58.7 -38.4 71.53 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.153 0 N-CA-C 115.219 1.563 . . . . 0.0 115.219 -176.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.12 -55.98 27.64 Favored 'General case' 0 CA--C 1.569 1.687 0 N-CA-C 115.448 1.647 . . . . 0.0 115.448 167.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -56.52 -43.29 79.65 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 116.275 1.954 . . . . 0.0 116.275 169.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 37.3 mtp-105 -52.07 -53.06 46.85 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 116.017 1.858 . . . . 0.0 116.017 168.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -66.75 -47.75 71.27 Favored 'General case' 0 CA--C 1.567 1.629 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 174.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 66.1 mt -55.34 -54.87 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 CA-C-N 120.047 1.294 . . . . 0.0 113.266 174.042 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.84 -38.02 89.13 Favored 'General case' 0 CA--C 1.564 1.514 0 N-CA-C 117.635 2.457 . . . . 0.0 117.635 176.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -74.16 -24.11 59.35 Favored 'General case' 0 CA--C 1.571 1.759 0 N-CA-C 116.138 1.903 . . . . 0.0 116.138 171.265 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 73.6 mt -73.2 -37.79 66.34 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 115.405 1.631 . . . . 0.0 115.405 168.255 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.5 pp -84.28 143.92 29.23 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 119.597 1.089 . . . . 0.0 113.923 -178.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm -104.53 101.88 30.58 Favored Pre-proline 0 CA--C 1.572 1.818 0 CA-C-O 117.954 -1.022 . . . . 0.0 109.348 174.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -82.26 172.12 11.96 Favored 'Trans proline' 0 CA--C 1.564 2.014 0 C-N-CA 122.805 2.337 . . . . 0.0 114.778 -176.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -109.2 118.97 38.11 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.278 176.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 52.6 mttm -85.38 108.3 17.78 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.073 -1.017 . . . . 0.0 109.895 172.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -91.89 108.06 19.65 Favored 'General case' 0 CA--C 1.559 1.302 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 164.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 84.9 mt -97.6 114.15 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 -179.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 98.0 t -101.06 97.72 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 168.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -95.66 99.63 11.46 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 123.673 0.789 . . . . 0.0 109.727 175.328 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -106.64 75.25 1.05 Allowed 'General case' 0 CA--C 1.567 1.612 0 C-N-CA 123.557 0.743 . . . . 0.0 110.563 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 57.61 68.24 1.8 Allowed Glycine 0 N--CA 1.494 2.552 0 N-CA-C 117.628 1.811 . . . . 0.0 117.628 177.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.494 0.0 OUTLIER 81.99 -39.24 0.12 Allowed 'General case' 0 N--CA 1.501 2.108 0 N-CA-C 115.837 1.792 . . . . 0.0 115.837 -165.358 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 21.8 t-160 -74.32 100.49 3.77 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 120.677 1.58 . . . . 0.0 111.183 177.327 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 42.5 ttm -113.14 111.26 21.8 Favored 'General case' 0 CA--C 1.552 1.031 0 CA-C-O 121.665 0.745 . . . . 0.0 109.137 -170.191 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 51.8 mt -102.79 103.12 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 -175.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 26.0 mm -89.22 93.72 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 -178.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 61.1 mtt85 -90.45 97.38 11.15 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.232 -0.918 . . . . 0.0 110.099 178.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 14.3 m -89.41 99.19 12.24 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 15.1 mt -93.77 117.36 29.99 Favored 'General case' 0 N--CA 1.484 1.266 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.594 -162.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 42.2 t -133.11 141.27 48.09 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.849 0.859 . . . . 0.0 110.752 -159.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 13.1 t -74.09 39.35 0.11 Allowed 'General case' 0 CA--C 1.581 2.144 0 N-CA-C 116.701 2.112 . . . . 0.0 116.701 172.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -159.52 -65.29 0.08 Allowed 'General case' 0 CA--C 1.567 1.621 0 C-N-CA 124.676 1.19 . . . . 0.0 109.92 178.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 53.4 ttm-85 -140.09 117.52 11.42 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 123.625 0.77 . . . . 0.0 108.942 174.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 72.0 m-80 -76.77 126.99 31.92 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.785 -0.572 . . . . 0.0 111.993 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 40.9 t80 -106.47 100.28 9.82 Favored 'General case' 0 CA--C 1.567 1.606 0 O-C-N 121.645 -0.66 . . . . 0.0 110.724 -172.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 4.1 mp -95.36 111.22 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 C-N-CA 123.73 0.812 . . . . 0.0 109.051 178.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -103.55 94.83 5.67 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 123.413 0.685 . . . . 0.0 109.621 176.672 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -100.38 118.07 35.87 Favored 'General case' 0 CA--C 1.564 1.486 0 C-N-CA 123.913 0.885 . . . . 0.0 112.805 -174.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -155.15 143.2 20.11 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 -170.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 17.9 mp0 -85.18 116.17 23.39 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.441 -0.787 . . . . 0.0 110.376 166.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 41.2 t -65.08 117.54 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 C-N-CA 123.769 0.828 . . . . 0.0 110.047 177.242 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 118.61 -54.68 0.61 Allowed Glycine 0 N--CA 1.488 2.139 0 N-CA-C 114.675 0.63 . . . . 0.0 114.675 -159.049 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 5.9 mtmp? -80.79 148.02 30.21 Favored 'General case' 0 CA--C 1.566 1.586 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 -173.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -98.78 124.13 43.45 Favored 'General case' 0 CA--C 1.568 1.665 0 C-N-CA 123.183 0.593 . . . . 0.0 111.78 178.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 9.0 p90 -135.76 145.63 46.79 Favored 'General case' 0 N--CA 1.498 1.967 0 C-N-CA 123.837 0.855 . . . . 0.0 112.024 -171.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -79.15 128.29 33.1 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 119.54 -1.975 . . . . 0.0 113.64 177.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 . . . . . 0 N--CA 1.493 1.677 0 CA-C-O 122.238 1.018 . . . . 0.0 112.079 173.267 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 73.0 m . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 121.922 0.868 . . . . 0.0 113.038 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 7.2 tpt -75.88 111.13 10.92 Favored 'General case' 0 CA--C 1.56 1.331 0 CA-C-O 122.175 0.988 . . . . 0.0 110.522 -170.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 93.8 m -120.61 120.61 36.27 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 115.377 -0.828 . . . . 0.0 110.399 -153.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 50.9 m -105.79 125.29 50.82 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 171.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.435 HG22 ' SG ' ' A' ' 95' ' ' CYS . 20.4 t -104.61 130.8 54.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 165.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 58.7 m -149.94 152.35 34.85 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.455 -1.403 . . . . 0.0 112.871 -178.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 52.3 m95 -83.78 118.96 24.26 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.939 -1.1 . . . . 0.0 113.544 -176.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -94.13 67.38 3.61 Favored 'General case' 0 CA--C 1.572 1.819 0 O-C-N 121.594 -0.691 . . . . 0.0 110.101 159.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 67.09 -102.63 0.81 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 114.798 0.679 . . . . 0.0 114.798 -176.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -80.81 -23.22 39.38 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 116.523 2.045 . . . . 0.0 116.523 169.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 60.1 mtpt -98.77 116.15 30.36 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 119.317 0.962 . . . . 0.0 110.182 -174.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 29.2 tp -82.83 109.47 16.99 Favored 'General case' 0 CA--C 1.564 1.485 0 O-C-N 121.277 -0.89 . . . . 0.0 110.057 175.438 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 -97.78 131.93 43.85 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.644 0.778 . . . . 0.0 111.538 -174.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . 0.435 ' SG ' HG22 ' A' ' 86' ' ' VAL . 44.9 t -122.26 128.92 51.71 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.341 0.657 . . . . 0.0 110.744 175.208 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.1 p -110.69 127.6 67.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 166.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -109.05 88.62 2.77 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 123.453 0.701 . . . . 0.0 109.665 175.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 12.0 ptmm? -97.22 145.19 26.3 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 114.309 1.225 . . . . 0.0 114.309 -172.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 159.75 -97.52 0.16 Allowed Glycine 0 N--CA 1.488 2.133 0 O-C-N 121.282 -0.886 . . . . 0.0 112.626 173.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -75.2 -47.16 29.63 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 115.125 1.528 . . . . 0.0 115.125 173.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 1.6 ttmp? -103.51 131.79 50.33 Favored 'General case' 0 CA--C 1.561 1.38 0 C-N-CA 123.636 0.774 . . . . 0.0 111.77 -161.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -77.87 160.38 28.32 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -179.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 56.57 21.43 35.08 Favored Glycine 0 N--CA 1.498 2.774 0 N-CA-C 120.722 3.049 . . . . 0.0 120.722 -179.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 45.1 ttt180 -96.02 123.21 39.53 Favored 'General case' 0 CA--C 1.563 1.459 0 CA-C-N 118.481 1.14 . . . . 0.0 112.42 -168.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 173.39 -169.78 42.9 Favored Glycine 0 N--CA 1.484 1.887 0 CA-C-O 121.949 0.75 . . . . 0.0 114.558 -176.327 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . 0.253 41.5 p-90 -156.82 157.17 34.47 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 113.804 1.038 . . . . 0.0 113.804 173.536 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 34.5 m -129.63 118.57 22.17 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 123.782 0.833 . . . . 0.0 108.765 176.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 -121.42 130.15 53.42 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.743 -0.598 . . . . 0.0 112.434 -175.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 25.4 p90 -144.66 164.86 29.7 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.251 -0.906 . . . . 0.0 112.059 176.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 96.3 mt -109.79 127.82 66.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 120.915 -1.116 . . . . 0.0 109.789 175.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -102.02 84.54 2.53 Favored 'General case' 0 CA--C 1.567 1.616 0 C-N-CA 123.997 0.919 . . . . 0.0 109.185 163.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 64.84 -98.06 0.28 Allowed Glycine 0 N--CA 1.493 2.442 0 N-CA-C 116.452 1.341 . . . . 0.0 116.452 -179.012 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 41.1 p30 -88.94 -5.46 57.96 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 117.36 2.356 . . . . 0.0 117.36 167.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -114.63 125.53 53.87 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-N 120.874 1.67 . . . . 0.0 111.529 -172.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 14.2 tp -86.26 115.13 23.61 Favored 'General case' 0 CA--C 1.563 1.474 0 C-N-CA 123.869 0.867 . . . . 0.0 109.472 169.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 51.8 m80 -102.42 121.09 41.65 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.651 0.78 . . . . 0.0 109.029 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 53.6 tp -121.16 119.41 32.28 Favored 'General case' 0 CA--C 1.562 1.433 0 C-N-CA 123.714 0.806 . . . . 0.0 110.005 -176.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -100.19 116.55 32.45 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 168.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 71.9 mtm -109.76 124.97 52.19 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 118.974 0.806 . . . . 0.0 110.977 -178.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 87.4 mtm180 -112.3 137.13 50.86 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 123.963 0.905 . . . . 0.0 110.809 -171.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -154.03 129.97 10.21 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.372 -0.83 . . . . 0.0 111.344 168.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . 0.273 7.9 mm-40 64.05 9.19 4.47 Favored 'General case' 0 N--CA 1.502 2.125 0 N-CA-C 117.59 2.441 . . . . 0.0 117.59 -175.303 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 99.88 -19.08 54.74 Favored Glycine 0 CA--C 1.556 2.615 0 N-CA-C 117.792 1.877 . . . . 0.0 117.792 -157.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 96.8 t -83.86 124.27 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 CA-C-N 119.7 1.75 . . . . 0.0 109.77 -177.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 47.9 m -103.74 119.73 39.51 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 121.108 0.48 . . . . 0.0 111.205 176.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 8.8 t -88.94 136.45 33.0 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.656 0.783 . . . . 0.0 112.075 162.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -111.23 114.93 28.5 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.718 -0.614 . . . . 0.0 109.832 176.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -113.81 140.38 48.36 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.857 0.863 . . . . 0.0 111.545 176.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 34.5 t -123.06 134.84 65.0 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 177.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -130.24 132.56 46.01 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 123.878 0.871 . . . . 0.0 111.215 -177.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 20.2 tptm -98.06 136.11 38.78 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.997 -1.065 . . . . 0.0 112.161 -178.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 67.7 tttt -74.5 118.33 17.33 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.522 -0.737 . . . . 0.0 112.777 179.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . 0.254 35.0 m -102.85 -40.79 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 175.067 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 67.0 t60 . . . . . 0 N--CA 1.486 1.351 0 CA-C-N 119.838 1.199 . . . . 0.0 107.95 164.212 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 67.5 mtt . . . . . 0 CA--C 1.572 1.793 0 CA-C-O 117.852 -1.071 . . . . 0.0 109.792 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.64 130.0 16.44 Favored 'Trans proline' 0 CA--C 1.563 1.967 0 C-N-CA 122.881 2.387 . . . . 0.0 114.658 -175.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 33.0 m -78.73 125.84 38.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -166.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -75.67 97.49 3.82 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.026 -1.046 . . . . 0.0 112.532 -176.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -72.76 1.22 8.9 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 117.981 2.586 . . . . 0.0 117.981 -178.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -51.84 109.51 0.37 Allowed 'General case' 0 CA--C 1.566 1.594 0 N-CA-C 115.716 1.747 . . . . 0.0 115.716 -176.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 161.24 179.05 35.72 Favored Glycine 0 N--CA 1.484 1.894 0 CA-C-O 122.666 1.148 . . . . 0.0 115.94 -178.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -110.92 126.09 54.36 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 114.052 -1.074 . . . . 0.0 108.541 172.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 49.7 m95 -128.94 125.09 36.75 Favored 'General case' 0 CA--C 1.566 1.578 0 C-N-CA 123.358 0.663 . . . . 0.0 109.46 -167.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 16.7 ptpt -89.78 143.95 26.37 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.857 -1.152 . . . . 0.0 112.933 174.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.41 ' SD ' ' OD1' ' A' ' 13' ' ' ASN . 49.1 ttm -75.99 127.87 33.87 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.845 -1.16 . . . . 0.0 112.585 174.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 88.7 mt -87.06 -49.91 7.0 Favored 'General case' 0 CA--C 1.568 1.639 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 171.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 91.9 p -143.46 142.04 31.03 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 119.428 1.013 . . . . 0.0 113.368 -170.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.41 ' OD1' ' SD ' ' A' ' 10' ' ' MET . 2.3 m120 -117.99 93.42 4.13 Favored 'General case' 0 CA--C 1.565 1.527 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 -177.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -77.18 -70.23 0.48 Allowed 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 115.585 1.698 . . . . 0.0 115.585 -165.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -119.08 44.56 2.3 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.907 0.861 . . . . 0.0 111.237 175.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -72.38 -37.53 68.72 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 114.894 1.442 . . . . 0.0 114.894 175.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -50.02 -54.08 22.51 Favored 'General case' 0 CA--C 1.574 1.889 0 N-CA-C 115.288 1.588 . . . . 0.0 115.288 166.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -71.62 -36.94 70.93 Favored 'General case' 0 CA--C 1.574 1.881 0 N-CA-C 115.978 1.844 . . . . 0.0 115.978 175.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -55.09 -49.54 71.44 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 114.84 1.422 . . . . 0.0 114.84 165.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 78.7 mt -60.96 -39.91 91.33 Favored 'General case' 0 CA--C 1.574 1.889 0 N-CA-C 114.819 1.414 . . . . 0.0 114.819 169.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 26.9 ttm180 -51.52 -51.73 52.8 Favored 'General case' 0 N--CA 1.502 2.173 0 N-CA-C 115.467 1.654 . . . . 0.0 115.467 163.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.51 -27.7 62.78 Favored 'General case' 0 CA--C 1.567 1.635 0 N-CA-C 117.908 2.559 . . . . 0.0 117.908 167.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 95.8 mt -81.52 10.92 5.1 Favored 'General case' 0 CA--C 1.573 1.837 0 N-CA-C 115.614 1.709 . . . . 0.0 115.614 167.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.252 0.9 OUTLIER 64.03 40.0 7.47 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 115.434 1.642 . . . . 0.0 115.434 -175.429 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 89.0 t -100.15 151.0 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 CA-C-O 122.379 1.085 . . . . 0.0 110.645 -178.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 9.7 p-10 -74.12 154.39 39.16 Favored 'General case' 0 CA--C 1.568 1.656 0 N-CA-C 115.59 1.7 . . . . 0.0 115.59 -179.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 45.9 t -54.58 -45.72 71.72 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.345 0 N-CA-C 115.059 1.503 . . . . 0.0 115.059 -176.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.33 -47.98 83.41 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 115.922 1.823 . . . . 0.0 115.922 176.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.77 -49.89 75.96 Favored 'General case' 0 CA--C 1.571 1.75 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 168.02 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 56.3 mtp180 -48.55 -55.47 11.0 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 116.302 1.964 . . . . 0.0 116.302 167.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 35.8 tptt -59.32 -50.78 72.67 Favored 'General case' 0 CA--C 1.564 1.504 0 N-CA-C 115.471 1.656 . . . . 0.0 115.471 176.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 22.2 mt -67.86 -45.69 83.64 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.806 0 CA-C-O 118.03 -0.986 . . . . 0.0 112.286 177.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -57.9 -39.89 79.0 Favored 'General case' 0 CA--C 1.565 1.548 0 N-CA-C 117.229 2.307 . . . . 0.0 117.229 170.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -65.94 -28.67 69.09 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 116.411 2.004 . . . . 0.0 116.411 166.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 80.4 mt -72.99 -37.17 67.1 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 115.727 1.751 . . . . 0.0 115.727 165.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 44.2 mt -68.74 141.48 55.23 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 119.45 1.023 . . . . 0.0 113.711 -175.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 39.2 mmtm -112.54 78.99 2.89 Favored Pre-proline 0 CA--C 1.575 1.91 0 CA-C-O 118.411 -0.804 . . . . 0.0 109.934 177.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.409 ' HD2' ' SD ' ' A' ' 10' ' ' MET . 74.1 Cg_endo -75.34 168.4 24.68 Favored 'Trans proline' 0 CA--C 1.562 1.895 0 C-N-CA 122.528 2.152 . . . . 0.0 115.708 -176.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -108.58 127.36 53.88 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.664 -174.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 38.7 mttp -97.6 113.95 25.77 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.563 -0.71 . . . . 0.0 109.651 172.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -98.69 108.26 20.9 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 165.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.3 mp -96.97 120.05 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 177.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 75.4 t -99.67 101.85 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 166.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -104.59 114.02 27.97 Favored 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 123.469 0.708 . . . . 0.0 110.927 -178.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -123.7 74.48 1.27 Allowed 'General case' 0 CA--C 1.569 1.685 0 C-N-CA 123.843 0.857 . . . . 0.0 110.493 177.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.76 -100.37 1.45 Allowed Glycine 0 N--CA 1.489 2.229 0 O-C-N 121.48 -0.762 . . . . 0.0 114.063 177.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -85.22 -33.84 22.14 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 115.218 1.562 . . . . 0.0 115.218 162.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -78.16 114.15 16.78 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-N 120.682 1.583 . . . . 0.0 112.11 -174.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 48.2 ttm -128.29 118.63 23.6 Favored 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 123.43 0.692 . . . . 0.0 109.644 -175.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 52.4 mt -107.02 103.33 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 176.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 73.2 mt -90.39 99.53 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 175.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 70.5 mtt85 -89.42 95.96 10.5 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.467 -0.771 . . . . 0.0 110.673 178.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 49.5 m -88.29 105.08 17.32 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 177.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 12.2 mt -106.01 113.9 27.72 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 123.684 0.793 . . . . 0.0 109.213 -163.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 9.1 t -139.68 155.91 47.11 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.856 0.836 . . . . 0.0 112.434 -166.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 26.9 m -61.57 -40.74 95.83 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 115.745 1.757 . . . . 0.0 115.745 178.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -69.04 -58.13 4.51 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 114.699 1.37 . . . . 0.0 114.699 171.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 26.4 tpt180 -152.15 135.67 16.09 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-N 118.516 0.598 . . . . 0.0 109.863 175.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -73.98 112.42 10.09 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.776 -0.577 . . . . 0.0 109.706 163.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 52.8 t80 -79.29 -61.68 1.93 Allowed 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -167.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.334 49.7 mt 74.5 97.64 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 C-N-CA 123.932 0.893 . . . . 0.0 111.91 167.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 89.0 mtp -100.18 99.42 10.11 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.486 -0.759 . . . . 0.0 109.352 172.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -98.71 114.45 26.97 Favored 'General case' 0 CA--C 1.563 1.479 0 C-N-CA 124.013 0.925 . . . . 0.0 111.663 177.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -156.55 157.17 34.89 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 -168.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 66.1 mt-30 -100.28 127.16 46.63 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.581 -0.7 . . . . 0.0 110.481 165.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 37.3 t -63.53 123.5 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 C-N-CA 124.103 0.961 . . . . 0.0 110.503 178.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 107.67 -43.28 1.73 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 116.199 1.24 . . . . 0.0 116.199 -158.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 76.1 mttt -86.72 152.57 22.42 Favored 'General case' 0 CA--C 1.568 1.642 0 CA-C-N 118.612 1.206 . . . . 0.0 113.489 -172.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -107.92 117.92 35.39 Favored 'General case' 0 CA--C 1.569 1.674 0 C-N-CA 123.469 0.707 . . . . 0.0 111.469 -173.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 8.8 p90 -127.28 151.57 48.57 Favored 'General case' 0 N--CA 1.501 2.108 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 -171.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -80.43 123.89 28.43 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.015 -1.678 . . . . 0.0 114.81 -176.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -85.65 53.1 2.65 Favored 'General case' 0 N--CA 1.502 2.136 0 N-CA-C 115.696 1.739 . . . . 0.0 115.696 177.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 19.2 p30 -83.68 75.19 10.08 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.134 -1.604 . . . . 0.0 112.378 167.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 95.1 mt -127.64 129.96 48.13 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.633 0.73 . . . . 0.0 109.933 -175.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 67.4 p -83.5 59.84 5.32 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 115.472 1.656 . . . . 0.0 115.472 -163.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -153.38 -70.56 0.01 OUTLIER Glycine 0 N--CA 1.491 2.339 0 O-C-N 120.697 -1.252 . . . . 0.0 115.325 -177.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 50.5 mm -77.19 -60.12 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 C-N-CA 123.291 0.636 . . . . 0.0 111.939 -176.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 41.6 t0 -152.94 107.03 3.1 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-N 119.544 1.066 . . . . 0.0 108.219 167.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -81.33 87.45 6.14 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.383 -0.823 . . . . 0.0 112.971 -172.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 7.4 ptm180 -165.27 141.23 5.41 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 123.509 0.724 . . . . 0.0 110.044 -177.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 57.5 mtmt -73.3 80.88 1.35 Allowed 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 114.807 1.41 . . . . 0.0 114.807 -167.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 99.2 m -89.48 126.61 35.65 Favored 'General case' 0 CA--C 1.56 1.328 0 O-C-N 121.814 -0.554 . . . . 0.0 111.033 173.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -79.51 94.83 5.68 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 122.999 1.38 . . . . 0.0 110.255 -170.04 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 99.5 m -100.0 118.02 35.5 Favored 'General case' 0 N--CA 1.48 1.036 0 O-C-N 121.292 -0.88 . . . . 0.0 110.372 -153.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 25.0 m -112.74 122.53 47.95 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-N 115.102 -0.954 . . . . 0.0 108.504 -174.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 20.7 t -113.26 127.77 70.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 -177.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 60.9 p -131.36 159.21 38.63 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 122.223 1.011 . . . . 0.0 112.609 -175.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 55.5 m95 -92.13 113.76 26.12 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.782 -0.574 . . . . 0.0 110.605 171.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -92.71 73.22 4.99 Favored 'General case' 0 CA--C 1.566 1.58 0 C-N-CA 123.253 0.621 . . . . 0.0 110.291 171.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.05 -94.56 0.18 Allowed Glycine 0 N--CA 1.489 2.187 0 N-CA-C 114.637 0.615 . . . . 0.0 114.637 -171.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -85.39 -38.37 18.79 Favored 'General case' 0 CA--C 1.569 1.676 0 N-CA-C 115.405 1.631 . . . . 0.0 115.405 171.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -93.31 154.65 17.87 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 119.163 0.892 . . . . 0.0 112.733 -167.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 18.5 tp -99.16 109.68 22.34 Favored 'General case' 0 CA--C 1.564 1.504 0 O-C-N 121.04 -1.037 . . . . 0.0 110.273 178.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 31.7 mm-40 -97.48 122.61 40.74 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 123.862 0.865 . . . . 0.0 111.3 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 41.7 t -114.6 131.39 56.71 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.38 0.672 . . . . 0.0 111.609 175.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 15.0 p -117.03 123.59 72.02 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.699 0 C-N-CA 123.174 0.59 . . . . 0.0 109.579 170.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -98.73 97.05 8.34 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 124.033 0.933 . . . . 0.0 109.277 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 30.4 mmtp -81.31 119.72 24.02 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 -168.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -174.3 -121.38 0.62 Allowed Glycine 0 N--CA 1.484 1.861 0 O-C-N 121.994 -0.441 . . . . 0.0 112.425 171.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -87.05 -32.51 19.94 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 116.619 2.081 . . . . 0.0 116.619 -178.497 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 50.7 mttp -89.57 135.73 33.43 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 120.711 1.596 . . . . 0.0 112.756 -165.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -81.09 102.83 10.5 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.742 0.782 . . . . 0.0 112.989 -164.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 82.35 41.75 9.02 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 117.308 1.683 . . . . 0.0 117.308 -168.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 46.9 ttt180 -84.8 118.46 24.48 Favored 'General case' 0 CA--C 1.564 1.503 0 CA-C-N 118.857 1.329 . . . . 0.0 111.121 175.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 170.84 -165.55 38.75 Favored Glycine 0 N--CA 1.484 1.861 0 N-CA-C 114.827 0.691 . . . . 0.0 114.827 -178.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 28.9 p-90 -157.43 157.13 33.4 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 114.6 1.333 . . . . 0.0 114.6 176.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 25.5 m -120.25 122.37 40.74 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 171.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -119.72 133.89 55.44 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 123.187 0.595 . . . . 0.0 111.834 -178.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 19.0 p90 -149.1 174.45 12.32 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 178.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 55.5 mt -116.46 133.13 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.212 -0.93 . . . . 0.0 108.988 176.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -112.13 90.19 3.27 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 123.773 0.829 . . . . 0.0 109.092 163.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 64.49 -104.66 0.95 Allowed Glycine 0 N--CA 1.492 2.4 0 N-CA-C 115.754 1.062 . . . . 0.0 115.754 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 57.3 p30 -84.13 -2.02 56.04 Favored 'General case' 0 CA--C 1.571 1.775 0 N-CA-C 117.86 2.541 . . . . 0.0 117.86 166.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -118.47 135.9 54.11 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-N 120.657 1.572 . . . . 0.0 112.424 -168.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 12.4 tp -94.38 120.91 35.33 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 123.73 0.812 . . . . 0.0 108.969 174.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 37.3 m80 -109.99 120.1 41.4 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -176.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 42.3 tp -121.51 121.53 37.69 Favored 'General case' 0 CA--C 1.56 1.35 0 C-N-CA 123.576 0.75 . . . . 0.0 109.543 -176.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -107.97 117.89 35.32 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.878 -0.513 . . . . 0.0 109.679 168.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 66.9 mtm -110.46 127.41 55.12 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-N 118.61 0.641 . . . . 0.0 111.1 -178.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 69.1 mtp180 -110.88 144.66 39.56 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -179.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -159.36 131.18 6.36 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.187 0.595 . . . . 0.0 111.153 166.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 59.0 38.07 24.32 Favored 'General case' 0 N--CA 1.507 2.402 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 -173.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 75.75 -26.21 1.4 Allowed Glycine 0 CA--C 1.559 2.827 0 N-CA-C 119.597 2.599 . . . . 0.0 119.597 -160.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 86.8 t -81.02 122.79 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 CA-C-N 119.392 1.596 . . . . 0.0 110.571 -163.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 24.1 m -100.9 120.95 40.9 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 122.909 0.484 . . . . 0.0 111.489 -176.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 44.1 t -88.34 139.45 30.48 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.306 0.643 . . . . 0.0 112.242 160.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 44.8 mtpt -109.51 126.2 53.28 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 168.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -123.03 126.14 46.55 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 123.742 0.817 . . . . 0.0 109.543 174.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 72.8 t -109.1 132.57 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 179.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -122.18 153.07 39.27 Favored 'General case' 0 CA--C 1.565 1.558 0 C-N-CA 124.541 1.136 . . . . 0.0 111.442 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 8.9 tmtt? -120.87 136.88 54.82 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.199 -0.938 . . . . 0.0 111.607 175.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -72.5 120.49 18.19 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 33.4 m -101.49 -43.75 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 N-CA-C 113.194 0.812 . . . . 0.0 113.194 174.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 53.7 t-80 . . . . . 0 N--CA 1.485 1.317 0 CA-C-N 119.75 1.159 . . . . 0.0 108.124 168.472 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 1.8 mpt? . . . . . 0 CA--C 1.569 1.696 0 CA-C-O 117.92 -1.038 . . . . 0.0 109.601 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -84.66 147.53 10.93 Favored 'Trans proline' 0 CA--C 1.566 2.114 0 C-N-CA 122.472 2.114 . . . . 0.0 115.356 -177.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 25.9 m -81.2 140.04 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.468 -0.77 . . . . 0.0 112.56 177.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.5 100.51 10.13 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.514 -1.366 . . . . 0.0 111.459 175.355 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -72.72 -2.24 19.5 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 118.307 2.706 . . . . 0.0 118.307 177.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -56.29 112.27 1.19 Allowed 'General case' 0 CA--C 1.567 1.601 0 N-CA-C 115.945 1.831 . . . . 0.0 115.945 -172.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 155.46 -161.89 30.78 Favored Glycine 0 N--CA 1.486 1.996 0 N-CA-C 115.7 1.04 . . . . 0.0 115.7 178.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -124.13 127.83 48.37 Favored 'General case' 0 CA--C 1.564 1.498 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 -179.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 61.4 m95 -129.0 125.26 37.0 Favored 'General case' 0 CA--C 1.566 1.567 0 C-N-CA 123.273 0.629 . . . . 0.0 109.489 -166.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 24.8 pttm -96.17 141.19 29.83 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.089 -1.007 . . . . 0.0 112.903 177.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.434 ' SD ' ' HD2' ' A' ' 38' ' ' PRO . 32.8 ttm -68.89 125.89 28.04 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-N 120.044 1.293 . . . . 0.0 113.264 176.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 91.9 mt -85.87 -53.97 4.79 Favored 'General case' 0 CA--C 1.565 1.552 0 C-N-CA 123.387 0.675 . . . . 0.0 112.798 166.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 92.7 p -142.88 150.53 39.96 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 119.243 0.929 . . . . 0.0 112.838 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 24.1 p30 -125.92 84.65 2.3 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-O 122.235 1.017 . . . . 0.0 110.665 178.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -93.8 119.07 32.27 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.825 -1.172 . . . . 0.0 110.656 -163.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.281 32.1 t30 62.96 24.45 14.56 Favored 'General case' 0 N--CA 1.503 2.186 0 N-CA-C 116.617 2.08 . . . . 0.0 116.617 -169.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -69.27 -44.68 71.39 Favored 'General case' 0 CA--C 1.567 1.619 0 N-CA-C 115.223 1.564 . . . . 0.0 115.223 178.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -55.99 -39.91 72.53 Favored 'General case' 0 N--CA 1.504 2.257 0 N-CA-C 117.412 2.375 . . . . 0.0 117.412 169.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -65.38 -43.05 91.93 Favored 'General case' 0 CA--C 1.573 1.854 0 CA-C-N 120.252 1.387 . . . . 0.0 114.639 169.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -57.35 -47.83 80.59 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 115.31 1.596 . . . . 0.0 115.31 166.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 90.0 mt -58.25 -43.55 87.92 Favored 'General case' 0 CA--C 1.57 1.744 0 N-CA-C 114.633 1.346 . . . . 0.0 114.633 169.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.25 -49.2 72.63 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 115.639 1.718 . . . . 0.0 115.639 166.475 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.49 -21.25 9.51 Favored 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 118.507 2.78 . . . . 0.0 118.507 163.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 95.9 mt -91.9 15.87 12.19 Favored 'General case' 0 CA--C 1.576 1.959 0 N-CA-C 114.867 1.432 . . . . 0.0 114.867 166.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 60.41 42.72 14.22 Favored 'General case' 0 N--CA 1.502 2.138 0 N-CA-C 116.149 1.907 . . . . 0.0 116.149 -175.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 91.3 t -93.62 140.05 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.091 -1.006 . . . . 0.0 110.179 -179.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 15.1 p30 -65.37 155.59 34.87 Favored 'General case' 0 CA--C 1.572 1.803 0 N-CA-C 115.188 1.551 . . . . 0.0 115.188 171.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 61.6 t -57.78 -41.32 79.38 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.251 0 N-CA-C 114.668 1.358 . . . . 0.0 114.668 179.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.72 -50.73 72.24 Favored 'General case' 0 CA--C 1.565 1.534 0 N-CA-C 116.163 1.912 . . . . 0.0 116.163 172.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 6.1 tt -67.2 -39.08 86.28 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-N 120.637 1.562 . . . . 0.0 115.13 170.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 53.3 mtp180 -49.17 -42.42 39.74 Favored 'General case' 0 N--CA 1.502 2.128 0 N-CA-C 116.551 2.056 . . . . 0.0 116.551 163.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -72.77 -52.15 16.2 Favored 'General case' 0 CA--C 1.567 1.623 0 CA-C-O 118.284 -0.865 . . . . 0.0 113.324 167.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 5.6 mt -80.74 58.16 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.587 2.397 0 CA-C-N 121.107 1.776 . . . . 0.0 111.761 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -172.79 -51.95 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 126.187 1.795 . . . . 0.0 110.415 -178.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -66.53 -36.52 82.88 Favored 'General case' 0 CA--C 1.568 1.655 0 N-CA-C 116.0 1.852 . . . . 0.0 116.0 164.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 91.9 mt -74.53 -30.49 61.79 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 176.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.6 pp -84.27 149.63 25.96 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 119.408 1.004 . . . . 0.0 111.971 167.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp -104.67 94.74 7.68 Favored Pre-proline 0 CA--C 1.57 1.749 0 CA-C-O 118.091 -0.957 . . . . 0.0 108.492 174.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.434 ' HD2' ' SD ' ' A' ' 10' ' ' MET . 88.9 Cg_endo -75.27 172.71 15.82 Favored 'Trans proline' 0 CA--C 1.562 1.911 0 C-N-CA 122.642 2.228 . . . . 0.0 114.694 -175.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -123.95 130.56 52.79 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.663 -171.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 57.2 mttm -98.46 112.67 24.61 Favored 'General case' 0 N--CA 1.485 1.315 0 O-C-N 121.441 -0.787 . . . . 0.0 109.808 177.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -97.09 110.06 22.68 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 166.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 64.8 mt -105.7 116.66 49.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -174.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 63.2 t -99.25 98.75 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 169.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -100.63 115.71 30.84 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 123.725 0.81 . . . . 0.0 110.848 -178.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -125.6 72.95 1.29 Allowed 'General case' 0 CA--C 1.568 1.659 0 O-C-N 121.647 -0.658 . . . . 0.0 111.186 176.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 70.92 -93.52 0.49 Allowed Glycine 0 N--CA 1.49 2.24 0 O-C-N 121.468 -0.77 . . . . 0.0 114.879 178.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -88.2 -38.57 15.18 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 115.307 1.595 . . . . 0.0 115.307 164.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 20.8 t-160 -80.62 110.27 15.95 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 121.218 1.826 . . . . 0.0 111.717 -176.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 45.6 ttm -126.29 121.82 33.73 Favored 'General case' 0 CA--C 1.556 1.2 0 C-N-CA 123.448 0.699 . . . . 0.0 109.733 -172.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 4.6 mp -112.04 97.06 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 -179.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 73.3 mt -89.77 101.59 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 176.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -91.58 98.03 11.41 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.597 -0.689 . . . . 0.0 109.78 -179.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 18.9 m -87.38 104.76 16.74 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 178.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 18.0 mt -103.22 116.66 32.88 Favored 'General case' 0 CA--C 1.557 1.241 0 CA-C-N 115.417 -0.811 . . . . 0.0 109.991 -162.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 31.3 t -128.91 143.64 50.95 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 123.929 0.892 . . . . 0.0 110.535 -177.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.4 m -77.64 49.22 0.73 Allowed 'General case' 0 CA--C 1.586 2.353 0 O-C-N 121.256 -0.902 . . . . 0.0 113.159 171.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -172.53 -66.43 0.02 OUTLIER 'General case' 0 CA--C 1.566 1.587 0 C-N-CA 125.762 1.625 . . . . 0.0 109.082 -179.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -134.34 101.64 5.07 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-N 119.306 0.957 . . . . 0.0 110.299 -174.04 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 -83.15 139.72 33.01 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.515 -0.74 . . . . 0.0 112.6 -178.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -128.56 100.69 5.85 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.41 0.624 . . . . 0.0 109.726 -178.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.6 mt -100.23 112.8 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 -179.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 24.6 mmm -96.05 91.56 6.02 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 175.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -96.55 101.97 13.67 Favored 'General case' 0 CA--C 1.561 1.389 0 C-N-CA 123.977 0.911 . . . . 0.0 111.793 178.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -145.73 151.98 38.86 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 -166.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 23.6 mp0 -93.31 122.44 35.72 Favored 'General case' 0 CA--C 1.566 1.585 0 O-C-N 121.672 -0.643 . . . . 0.0 110.043 166.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 49.0 t -63.57 126.77 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 C-N-CA 123.912 0.885 . . . . 0.0 110.834 177.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 102.28 -38.2 3.31 Favored Glycine 0 CA--C 1.552 2.344 0 N-CA-C 116.752 1.461 . . . . 0.0 116.752 -162.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 11.2 mmpt? -88.34 134.34 33.84 Favored 'General case' 0 CA--C 1.564 1.503 0 CA-C-N 118.981 1.39 . . . . 0.0 112.254 -175.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -88.47 119.87 29.32 Favored 'General case' 0 CA--C 1.566 1.577 0 O-C-N 121.706 -0.622 . . . . 0.0 112.391 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 33.0 p90 -120.07 157.74 28.31 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 113.753 1.019 . . . . 0.0 113.753 -172.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.39 132.17 36.32 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.726 -1.234 . . . . 0.0 113.786 177.448 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -71.63 -66.05 0.68 Allowed 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 168.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . 0.373 35.6 t0 69.49 -123.6 0.12 Allowed 'General case' 0 CA--C 1.571 1.765 0 C-N-CA 124.588 1.155 . . . . 0.0 113.143 175.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 5.9 tt -85.38 88.14 7.47 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-N 120.101 1.318 . . . . 0.0 109.759 -177.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 74.8 p -87.32 -13.48 43.49 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 117.146 2.276 . . . . 0.0 117.146 -174.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 82.79 -44.0 3.18 Favored Glycine 0 N--CA 1.495 2.607 0 CA-C-N 120.834 1.652 . . . . 0.0 116.56 -166.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 3.6 mp -83.55 -75.0 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.576 1.947 0 C-N-CA 124.493 1.117 . . . . 0.0 109.454 177.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -89.4 -43.56 10.8 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 115.279 1.585 . . . . 0.0 115.279 -174.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.0 t70 64.58 73.09 0.43 Allowed 'General case' 0 CA--C 1.572 1.804 0 C-N-CA 124.444 1.098 . . . . 0.0 113.899 -171.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -155.9 141.94 18.21 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.562 -0.711 . . . . 0.0 112.157 177.241 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -77.99 73.59 4.55 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.147 -0.97 . . . . 0.0 113.132 177.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 95.8 m -92.48 142.47 27.38 Favored 'General case' 0 CA--C 1.563 1.461 0 CA-C-O 122.14 0.972 . . . . 0.0 112.238 176.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -88.09 101.99 14.34 Favored 'General case' 0 CA--C 1.56 1.332 0 C-N-CA 124.486 1.115 . . . . 0.0 110.046 -178.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 87.8 m -97.07 108.78 21.58 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.549 -0.719 . . . . 0.0 111.516 -170.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 53.8 m -91.82 131.62 37.03 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 164.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.4 t -116.76 136.33 54.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 171.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 68.2 m -150.17 148.57 29.1 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.141 -1.599 . . . . 0.0 113.029 -175.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 75.3 m95 -81.23 130.95 35.25 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.906 -1.121 . . . . 0.0 112.99 178.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -137.47 79.38 1.74 Allowed 'General case' 0 CA--C 1.569 1.688 0 C-N-CA 123.425 0.69 . . . . 0.0 110.344 178.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 64.23 76.97 0.25 Allowed Glycine 0 N--CA 1.497 2.71 0 N-CA-C 117.317 1.687 . . . . 0.0 117.317 170.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . 0.265 6.9 m-20 63.57 2.14 1.18 Allowed 'General case' 0 N--CA 1.505 2.286 0 N-CA-C 117.855 2.539 . . . . 0.0 117.855 -167.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 72.5 mttt -134.2 135.63 43.15 Favored 'General case' 0 N--CA 1.485 1.278 0 O-C-N 121.113 -0.992 . . . . 0.0 109.807 -168.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 22.0 tp -95.37 108.78 20.99 Favored 'General case' 0 CA--C 1.56 1.357 0 O-C-N 121.428 -0.795 . . . . 0.0 109.958 178.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 21.0 mm100 -86.46 141.05 29.39 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.371 0.669 . . . . 0.0 111.639 176.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 41.0 t -133.71 135.76 44.23 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.381 0.672 . . . . 0.0 111.329 175.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.7 p -127.99 116.92 44.47 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.647 0 C-N-CA 123.145 0.578 . . . . 0.0 109.576 174.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -93.36 100.46 12.78 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 124.118 0.967 . . . . 0.0 109.93 176.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -91.92 121.11 33.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.437 -0.789 . . . . 0.0 111.72 -169.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 167.81 -105.44 0.23 Allowed Glycine 0 N--CA 1.486 1.979 0 O-C-N 121.319 -0.863 . . . . 0.0 113.995 172.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -85.79 -46.98 10.16 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 115.091 1.515 . . . . 0.0 115.091 -172.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 48.9 mmtm -78.62 134.04 37.22 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 119.688 1.131 . . . . 0.0 112.433 179.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -88.5 109.33 19.96 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.017 -168.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 76.95 41.12 23.66 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 117.47 1.748 . . . . 0.0 117.47 -167.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 53.8 ttt180 -86.2 117.25 24.9 Favored 'General case' 0 CA--C 1.563 1.47 0 CA-C-N 118.316 1.058 . . . . 0.0 110.704 177.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -172.5 -178.45 42.64 Favored Glycine 0 N--CA 1.484 1.872 0 CA-C-O 122.071 0.817 . . . . 0.0 115.093 -176.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 28.3 p-90 -154.94 158.55 39.43 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 172.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 55.6 m -123.75 120.36 32.46 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 170.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -114.13 132.44 56.07 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 123.196 0.598 . . . . 0.0 111.922 179.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 16.4 p90 -148.4 173.07 13.46 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.215 -0.928 . . . . 0.0 113.088 177.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 73.9 mt -114.24 133.66 59.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.226 -0.921 . . . . 0.0 110.052 174.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -111.65 88.98 2.93 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 123.729 0.812 . . . . 0.0 108.895 162.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 65.35 -104.99 1.08 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 115.832 1.093 . . . . 0.0 115.832 -178.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -85.88 -8.34 58.11 Favored 'General case' 0 CA--C 1.571 1.788 0 N-CA-C 117.591 2.441 . . . . 0.0 117.591 168.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 86.9 mt-10 -105.08 135.46 46.39 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 120.316 1.416 . . . . 0.0 112.316 -175.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 15.5 tp -91.79 121.94 33.88 Favored 'General case' 0 CA--C 1.563 1.45 0 C-N-CA 123.861 0.864 . . . . 0.0 109.38 167.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 47.4 m80 -109.52 120.89 43.89 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -179.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 48.3 tp -120.5 116.57 25.67 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.444 0.698 . . . . 0.0 109.677 179.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -98.19 127.9 44.38 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.764 -0.585 . . . . 0.0 109.898 167.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 69.1 mtm -122.85 129.82 52.12 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-N 118.355 0.525 . . . . 0.0 111.241 -175.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 71.9 mtm-85 -117.9 139.32 51.3 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 123.588 0.755 . . . . 0.0 111.233 -174.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -161.75 131.65 4.77 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.68 -0.637 . . . . 0.0 111.279 170.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 55.7 39.09 30.83 Favored 'General case' 0 N--CA 1.507 2.397 0 N-CA-C 115.444 1.646 . . . . 0.0 115.444 -175.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 72.84 -11.76 4.29 Favored Glycine 0 CA--C 1.557 2.682 0 N-CA-C 120.302 2.881 . . . . 0.0 120.302 -163.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 88.1 t -89.28 123.54 41.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 CA-C-N 120.291 2.045 . . . . 0.0 109.608 -171.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 34.7 m -102.77 123.99 47.47 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.302 0.572 . . . . 0.0 111.169 177.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 21.1 t -100.92 146.64 27.11 Favored 'General case' 0 CA--C 1.563 1.462 0 C-N-CA 123.921 0.888 . . . . 0.0 112.079 165.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 7.6 mtpm? -118.49 110.66 17.67 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.669 -0.644 . . . . 0.0 109.541 174.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -103.48 130.09 50.77 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.502 -0.749 . . . . 0.0 110.817 174.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 44.2 t -113.86 129.91 68.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 176.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -123.67 150.86 43.73 Favored 'General case' 0 CA--C 1.567 1.62 0 C-N-CA 124.729 1.211 . . . . 0.0 110.071 179.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.7 tmtt? -122.47 140.95 52.15 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.556 -1.34 . . . . 0.0 111.484 177.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 66.0 tttt -71.08 117.75 12.99 Favored 'General case' 0 CA--C 1.565 1.556 0 N-CA-C 113.523 0.934 . . . . 0.0 113.523 -177.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 5.5 m -82.59 -34.57 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.273 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 168.069 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 44.6 t-80 . . . . . 0 N--CA 1.484 1.255 0 C-N-CA 125.04 1.336 . . . . 0.0 113.305 175.505 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 66.1 mtt . . . . . 0 CA--C 1.57 1.718 0 CA-C-O 118.123 -0.942 . . . . 0.0 109.532 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -73.58 139.21 27.98 Favored 'Trans proline' 0 CA--C 1.56 1.82 0 C-N-CA 122.54 2.16 . . . . 0.0 114.98 -174.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 1.8 t -79.05 146.04 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 CA-C-O 121.701 0.763 . . . . 0.0 110.906 -174.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -72.04 97.03 1.82 Allowed 'General case' 0 CA--C 1.568 1.651 0 O-C-N 120.79 -1.194 . . . . 0.0 111.618 173.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 4.5 m-30 -77.92 3.74 13.8 Favored 'General case' 0 CA--C 1.581 2.151 0 N-CA-C 116.471 2.026 . . . . 0.0 116.471 179.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -60.4 111.02 1.41 Allowed 'General case' 0 CA--C 1.564 1.488 0 C-N-CA 125.339 1.456 . . . . 0.0 114.688 -178.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 165.2 177.21 37.48 Favored Glycine 0 N--CA 1.484 1.887 0 N-CA-C 116.319 1.287 . . . . 0.0 116.319 -179.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -108.11 122.35 46.71 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 114.35 -0.925 . . . . 0.0 108.781 173.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 83.7 m95 -120.77 120.18 34.89 Favored 'General case' 0 CA--C 1.562 1.412 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -167.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 62.1 pttt -88.92 136.5 32.98 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.348 -0.845 . . . . 0.0 112.588 176.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 56.3 ttm -77.19 123.47 26.47 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 121.914 0.864 . . . . 0.0 112.139 179.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 84.0 mt -90.97 -60.16 1.98 Allowed 'General case' 0 CA--C 1.565 1.527 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.757 175.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 67.4 p -130.0 119.29 22.93 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.721 -0.612 . . . . 0.0 110.746 176.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -98.01 93.39 6.28 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 123.252 0.621 . . . . 0.0 109.794 165.227 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -97.12 125.26 41.49 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.66 0.784 . . . . 0.0 110.462 -169.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.269 49.2 t30 64.97 15.59 10.06 Favored 'General case' 0 N--CA 1.504 2.272 0 N-CA-C 117.061 2.245 . . . . 0.0 117.061 -172.142 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -61.01 -41.21 96.11 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 116.234 1.939 . . . . 0.0 116.234 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -51.52 -44.78 62.7 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 115.602 1.704 . . . . 0.0 115.602 166.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -68.81 -41.35 78.77 Favored 'General case' 0 CA--C 1.573 1.836 0 N-CA-C 115.228 1.566 . . . . 0.0 115.228 174.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 48.7 t80 -55.27 -49.26 72.52 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 114.47 1.285 . . . . 0.0 114.47 165.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 97.5 mt -61.0 -40.64 94.31 Favored 'General case' 0 CA--C 1.575 1.922 0 N-CA-C 115.001 1.482 . . . . 0.0 115.001 170.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 49.5 ttp180 -53.86 -49.94 67.37 Favored 'General case' 0 N--CA 1.501 2.11 0 N-CA-C 115.647 1.721 . . . . 0.0 115.647 165.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.67 -15.97 9.32 Favored 'General case' 0 CA--C 1.57 1.742 0 N-CA-C 118.409 2.744 . . . . 0.0 118.409 165.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 99.3 mt -98.56 23.48 8.55 Favored 'General case' 0 CA--C 1.575 1.926 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 163.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 69.39 15.16 8.44 Favored 'General case' 0 N--CA 1.507 2.382 0 N-CA-C 117.482 2.401 . . . . 0.0 117.482 -179.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 67.5 t -87.81 141.88 13.71 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.863 0 O-C-N 120.061 -1.65 . . . . 0.0 110.414 -170.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -73.46 155.02 39.69 Favored 'General case' 0 CA--C 1.569 1.687 0 N-CA-C 115.714 1.746 . . . . 0.0 115.714 -177.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 74.6 t -50.88 -45.83 28.79 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.502 0 N-CA-C 115.715 1.746 . . . . 0.0 115.715 -178.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.03 -49.41 77.75 Favored 'General case' 0 CA--C 1.564 1.5 0 N-CA-C 115.434 1.642 . . . . 0.0 115.434 173.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.8 tt -64.49 -44.58 90.5 Favored 'General case' 0 CA--C 1.572 1.794 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 171.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 74.9 mtp180 -45.15 -54.45 6.83 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 115.911 1.819 . . . . 0.0 115.911 164.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -71.84 -37.96 70.21 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 115.461 1.652 . . . . 0.0 115.461 174.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . 0.25 69.2 mt -62.51 -50.2 80.77 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 CA-C-N 121.116 1.78 . . . . 0.0 112.171 173.19 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -56.93 -42.24 79.65 Favored 'General case' 0 CA--C 1.568 1.67 0 N-CA-C 117.772 2.508 . . . . 0.0 117.772 170.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -53.85 -46.09 71.14 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 117.01 2.226 . . . . 0.0 117.01 163.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 92.6 mt -80.56 -18.29 48.81 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 116.025 1.861 . . . . 0.0 116.025 179.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 18.5 mt -73.46 -37.44 65.8 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 115.789 1.774 . . . . 0.0 115.789 173.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 65.5 mmtt 64.76 65.54 1.01 Allowed Pre-proline 0 CA--C 1.577 1.99 0 C-N-CA 124.546 1.139 . . . . 0.0 112.122 -178.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -71.45 135.0 25.59 Favored 'Trans proline' 0 CA--C 1.562 1.913 0 CA-C-N 122.486 1.924 . . . . 0.0 114.765 -165.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -86.67 130.53 34.45 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.832 -0.543 . . . . 0.0 111.897 -175.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 47.9 mttp -93.26 112.72 24.73 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.191 -0.943 . . . . 0.0 110.181 -179.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -94.59 109.44 21.36 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.388 -0.82 . . . . 0.0 109.034 164.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 97.6 mt -102.49 116.35 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 -175.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 54.0 t -98.16 95.95 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 168.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -93.86 108.5 20.28 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 123.876 0.87 . . . . 0.0 110.558 -179.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -113.94 69.31 0.7 Allowed 'General case' 0 CA--C 1.569 1.689 0 O-C-N 121.637 -0.664 . . . . 0.0 111.061 175.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 70.09 -85.39 0.31 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 115.798 1.079 . . . . 0.0 115.798 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -94.65 -40.04 10.02 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 114.903 1.446 . . . . 0.0 114.903 163.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 20.7 t-160 -79.08 107.19 11.66 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 121.216 1.825 . . . . 0.0 111.243 -175.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 41.1 ttm -118.24 120.5 37.85 Favored 'General case' 0 CA--C 1.553 1.064 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -173.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 5.0 mp -106.13 100.49 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 16.4 mm -87.07 101.3 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 176.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -94.71 97.93 10.42 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 18.3 m -91.94 100.39 13.06 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 -176.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 19.9 mt -99.8 132.85 44.89 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-O 121.812 0.815 . . . . 0.0 112.189 -156.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 28.3 t -151.6 145.72 25.31 Favored 'General case' 0 CA--C 1.562 1.425 0 C-N-CA 123.452 0.701 . . . . 0.0 110.97 -176.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.6 t -77.48 54.12 1.13 Allowed 'General case' 0 N--CA 1.505 2.291 0 O-C-N 120.639 -1.288 . . . . 0.0 114.077 165.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -173.2 -67.04 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 124.983 1.313 . . . . 0.0 109.169 -168.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.06 103.83 4.37 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.379 -0.826 . . . . 0.0 110.014 -179.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -88.48 119.54 29.02 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.738 -0.601 . . . . 0.0 110.357 178.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 51.8 m-85 -107.59 110.11 21.91 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 121.336 0.589 . . . . 0.0 110.573 -175.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 25.0 mm -105.95 104.48 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 N-CA-C 108.11 -1.071 . . . . 0.0 108.11 -174.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 11.4 mmm -99.11 90.71 4.69 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.523 -0.735 . . . . 0.0 109.27 175.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -93.35 111.55 23.24 Favored 'General case' 0 CA--C 1.561 1.386 0 C-N-CA 123.429 0.692 . . . . 0.0 111.385 175.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 11.9 p90 -147.13 148.31 31.45 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.831 0.824 . . . . 0.0 112.849 -170.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 23.8 mp0 -87.6 117.15 26.21 Favored 'General case' 0 CA--C 1.561 1.368 0 O-C-N 121.621 -0.674 . . . . 0.0 109.999 168.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 44.0 t -66.99 113.04 2.7 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.794 0 C-N-CA 124.159 0.984 . . . . 0.0 109.609 175.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 123.22 -48.68 0.94 Allowed Glycine 0 CA--C 1.549 2.213 0 N-CA-C 115.14 0.816 . . . . 0.0 115.14 -156.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 58.4 mttm -86.59 151.77 23.17 Favored 'General case' 0 CA--C 1.568 1.66 0 CA-C-N 118.493 1.146 . . . . 0.0 113.476 -175.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -96.8 107.22 19.66 Favored 'General case' 0 CA--C 1.568 1.643 0 C-N-CA 123.275 0.63 . . . . 0.0 110.425 173.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 15.6 p90 -106.92 142.32 36.73 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 113.639 0.978 . . . . 0.0 113.639 -171.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -76.9 110.55 11.61 Favored 'General case' 0 CA--C 1.568 1.669 0 N-CA-C 114.411 1.263 . . . . 0.0 114.411 179.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -81.08 62.0 4.87 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.96 -1.087 . . . . 0.0 113.262 173.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -84.2 -44.21 14.16 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.877 -1.139 . . . . 0.0 113.86 164.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -103.99 -54.87 2.47 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-N 119.113 0.87 . . . . 0.0 112.058 169.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 48.3 p -79.75 84.99 5.48 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-N 119.682 1.128 . . . . 0.0 113.239 -172.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -177.09 161.97 29.89 Favored Glycine 0 N--CA 1.488 2.119 0 O-C-N 121.349 -0.845 . . . . 0.0 114.935 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 2.6 mp -66.64 -61.48 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.292 0 C-N-CA 123.555 0.742 . . . . 0.0 111.842 -175.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -104.17 93.21 4.71 Favored 'General case' 0 CA--C 1.561 1.392 0 O-C-N 120.895 -1.128 . . . . 0.0 108.065 155.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -75.45 63.65 1.49 Allowed 'General case' 0 CA--C 1.573 1.851 0 N-CA-C 115.929 1.826 . . . . 0.0 115.929 -173.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 76.3 mtt180 -108.11 52.01 0.73 Allowed 'General case' 0 CA--C 1.575 1.935 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -177.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . 0.254 62.1 mttp 61.88 81.6 0.19 Allowed 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 115.453 1.649 . . . . 0.0 115.453 175.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 72.6 m -121.6 127.89 51.37 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.363 0.665 . . . . 0.0 110.05 166.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 82.5 mmm -79.48 95.75 5.89 Favored 'General case' 0 CA--C 1.563 1.454 0 CA-C-O 121.98 0.895 . . . . 0.0 109.338 170.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 37.8 m -102.65 117.11 33.95 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.114 0.566 . . . . 0.0 110.698 -160.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 92.3 m -95.16 122.43 37.83 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 173.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 22.1 t -109.97 135.79 47.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 170.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 58.0 m -148.55 147.27 28.85 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.265 -1.522 . . . . 0.0 112.481 -176.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 59.9 m95 -79.41 109.06 13.41 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.255 -0.903 . . . . 0.0 111.095 174.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -86.73 76.21 9.53 Favored 'General case' 0 CA--C 1.566 1.572 0 C-N-CA 123.813 0.845 . . . . 0.0 110.429 172.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 64.72 -99.53 0.36 Allowed Glycine 0 N--CA 1.489 2.199 0 N-CA-C 114.433 0.533 . . . . 0.0 114.433 -169.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -84.4 -32.85 23.92 Favored 'General case' 0 CA--C 1.574 1.88 0 N-CA-C 115.705 1.743 . . . . 0.0 115.705 170.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 48.9 mtpt -94.1 150.14 20.6 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 124.125 0.97 . . . . 0.0 112.011 -168.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 24.0 tp -98.46 109.7 22.41 Favored 'General case' 0 CA--C 1.563 1.464 0 O-C-N 120.329 -1.482 . . . . 0.0 110.345 177.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 31.8 mm-40 -96.65 146.4 24.89 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 123.383 0.673 . . . . 0.0 111.909 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 42.6 t -138.74 131.27 28.87 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.316 0.646 . . . . 0.0 111.527 176.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.9 p -113.81 122.01 67.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 166.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -101.95 75.02 1.5 Allowed 'General case' 0 CA--C 1.567 1.609 0 C-N-CA 123.461 0.704 . . . . 0.0 110.299 -178.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -91.17 129.68 37.14 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.011 -1.056 . . . . 0.0 113.427 -170.164 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 164.81 -94.1 0.11 Allowed Glycine 0 N--CA 1.487 2.084 0 O-C-N 121.335 -0.853 . . . . 0.0 112.477 177.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -72.2 -46.67 55.28 Favored 'General case' 0 CA--C 1.572 1.815 0 N-CA-C 115.614 1.709 . . . . 0.0 115.614 178.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -101.26 143.31 31.49 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 119.362 0.983 . . . . 0.0 112.945 -175.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -76.5 155.9 33.41 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.774 -0.579 . . . . 0.0 112.241 165.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 61.95 12.6 36.83 Favored Glycine 0 N--CA 1.497 2.757 0 N-CA-C 120.488 2.955 . . . . 0.0 120.488 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 36.8 ttt180 -88.16 129.11 35.42 Favored 'General case' 0 CA--C 1.564 1.511 0 CA-C-N 119.082 1.441 . . . . 0.0 112.591 -172.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 178.32 -173.27 45.73 Favored Glycine 0 N--CA 1.486 1.972 0 CA-C-O 121.707 0.615 . . . . 0.0 114.052 -175.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . 0.277 44.2 p-90 -159.43 156.8 29.0 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 171.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 58.9 m -129.56 119.13 23.15 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 176.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 16.2 tt0 -122.98 131.58 53.78 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 123.277 0.631 . . . . 0.0 112.202 -174.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 21.8 p90 -148.71 169.12 21.12 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.379 -0.826 . . . . 0.0 112.302 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 96.4 mt -115.53 145.26 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.22 0 CA-C-O 122.998 1.38 . . . . 0.0 111.062 177.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -136.65 90.58 2.56 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 71.42 -111.8 3.84 Favored Glycine 0 N--CA 1.49 2.269 0 O-C-N 121.983 -0.448 . . . . 0.0 114.158 -174.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 16.5 p-10 -94.66 15.36 18.38 Favored 'General case' 0 CA--C 1.576 1.975 0 N-CA-C 116.585 2.069 . . . . 0.0 116.585 167.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -120.65 136.54 54.81 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-N 120.177 1.353 . . . . 0.0 111.946 -171.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 8.6 tp -97.34 123.09 41.04 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 171.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 36.4 m80 -111.65 121.58 45.49 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 -176.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 50.7 tp -128.48 120.78 27.48 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.618 0.767 . . . . 0.0 109.963 -172.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -105.55 113.83 27.64 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.511 -0.743 . . . . 0.0 109.038 170.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . 0.423 ' HB2' ' SG ' ' A' ' 126' ' ' CYS . 63.1 mtm -106.85 131.9 53.42 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-N 118.891 0.769 . . . . 0.0 111.438 -178.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? -114.76 140.88 48.54 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.784 0.834 . . . . 0.0 111.445 -171.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -156.07 129.37 8.18 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 123.207 0.603 . . . . 0.0 111.111 170.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . 0.265 8.7 mm-40 64.8 -0.32 1.02 Allowed 'General case' 0 N--CA 1.504 2.254 0 N-CA-C 118.135 2.643 . . . . 0.0 118.135 -176.252 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 109.69 -24.4 19.74 Favored Glycine 0 CA--C 1.554 2.531 0 N-CA-C 117.096 1.598 . . . . 0.0 117.096 -156.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 93.6 t -78.1 127.71 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 CA-C-N 119.857 1.829 . . . . 0.0 110.115 177.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 45.6 m -106.86 124.67 49.96 Favored 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 123.032 0.533 . . . . 0.0 110.118 173.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . 0.423 ' SG ' ' HB2' ' A' ' 119' ' ' MET . 19.3 p -107.14 142.08 37.38 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-O 121.701 0.762 . . . . 0.0 112.424 168.047 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 60.1 mttp -114.76 111.14 20.8 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.666 -0.646 . . . . 0.0 109.36 -168.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 82.9 mt-30 -105.35 123.84 48.54 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 123.403 0.681 . . . . 0.0 111.178 178.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 79.1 t -111.27 131.47 62.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 176.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -121.67 164.04 18.0 Favored 'General case' 0 CA--C 1.567 1.608 0 CA-C-N 115.113 -0.949 . . . . 0.0 111.474 -178.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 29.3 ttmt -130.57 142.82 50.46 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.065 -1.022 . . . . 0.0 111.984 165.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 59.8 tttt -76.31 120.15 21.17 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.49 -0.756 . . . . 0.0 112.882 -176.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 32.8 m -97.21 -43.41 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.112 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 174.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 72.0 t60 . . . . . 0 N--CA 1.485 1.302 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 169.235 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 81.6 mtp . . . . . 0 CA--C 1.57 1.75 0 CA-C-O 118.33 -0.843 . . . . 0.0 110.238 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -84.17 136.91 7.0 Favored 'Trans proline' 0 CA--C 1.561 1.868 0 C-N-CA 122.301 2.0 . . . . 0.0 115.375 -176.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 31.6 m -80.08 156.48 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 CA-C-O 121.934 0.873 . . . . 0.0 112.761 176.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -77.74 113.17 15.33 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.124 -0.985 . . . . 0.0 112.759 176.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -90.28 7.95 35.73 Favored 'General case' 0 CA--C 1.576 1.966 0 N-CA-C 115.389 1.626 . . . . 0.0 115.389 173.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 62.6 m-80 -67.02 110.19 3.28 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 120.262 1.392 . . . . 0.0 113.077 -176.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 169.63 173.81 37.45 Favored Glycine 0 N--CA 1.478 1.441 0 N-CA-C 116.638 1.415 . . . . 0.0 116.638 -177.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 19.5 t80 -104.19 124.53 49.29 Favored 'General case' 0 CA--C 1.563 1.48 0 CA-C-N 113.675 -1.262 . . . . 0.0 108.516 168.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 82.4 m95 -120.82 122.71 40.89 Favored 'General case' 0 CA--C 1.561 1.394 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -169.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -96.08 135.51 37.76 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.579 -0.701 . . . . 0.0 111.449 178.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 53.6 ttm -71.93 124.34 24.67 Favored 'General case' 0 CA--C 1.565 1.524 0 CA-C-O 122.079 0.942 . . . . 0.0 113.058 -178.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 97.5 mt -81.99 -50.14 9.47 Favored 'General case' 0 CA--C 1.567 1.615 0 CA-C-N 115.191 -0.913 . . . . 0.0 112.292 168.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 89.7 p -149.92 126.79 11.1 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 118.727 0.694 . . . . 0.0 111.751 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -99.69 108.77 21.2 Favored 'General case' 0 N--CA 1.494 1.767 0 C-N-CA 122.944 0.497 . . . . 0.0 110.889 162.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -112.26 125.57 54.31 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.503 -0.748 . . . . 0.0 109.803 -172.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.258 5.3 t30 63.53 27.84 15.13 Favored 'General case' 0 N--CA 1.507 2.414 0 N-CA-C 116.325 1.972 . . . . 0.0 116.325 -174.146 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -70.39 -44.97 66.92 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 114.436 1.273 . . . . 0.0 114.436 174.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -53.43 -51.96 60.96 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 116.813 2.153 . . . . 0.0 116.813 174.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.266 1.5 pm0 -76.89 -25.89 53.56 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 116.394 1.998 . . . . 0.0 116.394 178.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 38.6 t80 -54.84 -49.56 70.79 Favored 'General case' 0 N--CA 1.498 1.967 0 CA-C-N 120.797 1.635 . . . . 0.0 114.481 154.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 68.8 mt -61.98 -35.35 78.24 Favored 'General case' 0 CA--C 1.576 1.965 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 170.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 8.7 ttm180 -56.99 -48.1 79.26 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-N 120.415 1.462 . . . . 0.0 114.645 162.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.74 -13.53 24.14 Favored 'General case' 0 CA--C 1.569 1.703 0 N-CA-C 118.414 2.746 . . . . 0.0 118.414 168.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 48.0 mt -90.15 -1.38 57.94 Favored 'General case' 0 CA--C 1.573 1.845 0 N-CA-C 116.071 1.878 . . . . 0.0 116.071 162.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.277 51.6 m-20 63.02 46.54 4.69 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 115.411 1.634 . . . . 0.0 115.411 -166.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 98.7 t -95.26 135.23 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 174.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 5.5 p-10 -64.3 152.08 42.05 Favored 'General case' 0 CA--C 1.566 1.592 0 N-CA-C 115.192 1.552 . . . . 0.0 115.192 178.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.494 HG22 HH11 ' A' ' 30' ' ' ARG 0.262 38.5 t -58.84 -35.47 56.27 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.224 0 N-CA-C 115.719 1.748 . . . . 0.0 115.719 -172.257 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.8 -50.93 69.16 Favored 'General case' 0 CA--C 1.567 1.62 0 N-CA-C 115.969 1.841 . . . . 0.0 115.969 166.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -71.45 -28.41 63.95 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 116.697 2.11 . . . . 0.0 116.697 171.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.494 HH11 HG22 ' A' ' 27' ' ' VAL . 54.2 mtp180 -55.83 -53.53 55.62 Favored 'General case' 0 N--CA 1.498 1.959 0 CA-C-N 120.824 1.647 . . . . 0.0 114.135 162.229 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 48.1 mmtm -64.39 -49.99 69.43 Favored 'General case' 0 CA--C 1.566 1.596 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 170.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 11.9 mt -77.38 62.12 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.323 0 CA-C-O 123.493 1.615 . . . . 0.0 110.974 175.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -176.03 -53.59 0.01 OUTLIER 'General case' 0 CA--C 1.558 1.28 0 C-N-CA 126.752 2.021 . . . . 0.0 110.044 -177.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -71.52 -35.51 70.73 Favored 'General case' 0 CA--C 1.567 1.619 0 N-CA-C 116.04 1.867 . . . . 0.0 116.04 167.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 92.9 mt -71.85 -35.3 69.81 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 115.153 1.538 . . . . 0.0 115.153 177.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.9 pp -88.71 148.94 23.73 Favored 'General case' 0 CA--C 1.566 1.57 0 CA-C-N 118.671 0.669 . . . . 0.0 111.084 169.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 29.0 mmtp -103.94 93.98 5.96 Favored Pre-proline 0 CA--C 1.573 1.827 0 CA-C-O 117.813 -1.089 . . . . 0.0 109.764 178.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -73.82 160.39 43.59 Favored 'Trans proline' 0 CA--C 1.566 2.09 0 C-N-CA 122.49 2.126 . . . . 0.0 115.489 -175.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -104.2 141.96 35.34 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.508 -0.745 . . . . 0.0 110.795 -179.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 41.8 mttp -102.9 115.38 30.48 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.857 -1.152 . . . . 0.0 109.742 171.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -95.36 110.37 22.4 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 163.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 78.7 mt -106.8 128.33 61.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -177.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 93.1 t -106.27 118.41 53.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 106.026 -1.842 . . . . 0.0 106.026 163.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -111.95 113.51 25.86 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 124.147 0.979 . . . . 0.0 109.197 175.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -120.19 68.83 0.85 Allowed 'General case' 0 CA--C 1.567 1.613 0 O-C-N 121.339 -0.85 . . . . 0.0 110.334 174.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.65 -97.39 0.7 Allowed Glycine 0 N--CA 1.488 2.164 0 N-CA-C 114.672 0.629 . . . . 0.0 114.672 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -85.07 -40.45 16.8 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 115.314 1.598 . . . . 0.0 115.314 165.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 18.7 t-160 -77.41 119.97 21.76 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 120.899 1.681 . . . . 0.0 111.781 -178.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.43 ' SD ' HD21 ' A' ' 93' ' ' LEU . 46.5 ttm -133.9 133.98 42.11 Favored 'General case' 0 CA--C 1.557 1.231 0 CA-C-O 121.488 0.661 . . . . 0.0 110.674 -173.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 33.6 mt -118.56 107.76 22.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 24.8 mm -94.24 100.23 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 176.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 68.4 mtt85 -93.85 100.57 12.73 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.135 -0.978 . . . . 0.0 109.201 178.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 16.6 m -88.46 102.12 14.59 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 178.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 48.0 mt -97.78 112.23 24.21 Favored 'General case' 0 CA--C 1.556 1.209 0 C-N-CA 123.841 0.856 . . . . 0.0 109.286 -165.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 46.0 t -130.18 143.48 50.81 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.972 -171.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.1 m -78.96 56.42 1.95 Allowed 'General case' 0 CA--C 1.579 2.089 0 CA-C-O 122.036 0.922 . . . . 0.0 112.715 175.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -168.99 -67.93 0.02 OUTLIER 'General case' 0 CA--C 1.567 1.598 0 C-N-CA 124.999 1.32 . . . . 0.0 109.267 -179.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 32.3 tpt180 -135.78 115.72 13.17 Favored 'General case' 0 CA--C 1.565 1.55 0 C-N-CA 123.777 0.831 . . . . 0.0 109.193 173.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 71.9 m-80 -83.63 125.05 31.43 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.685 -0.634 . . . . 0.0 111.501 178.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 86.2 t80 -110.87 105.99 14.99 Favored 'General case' 0 CA--C 1.567 1.602 0 C-N-CA 123.24 0.616 . . . . 0.0 110.744 -169.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.8 mp -93.38 115.35 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 178.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -107.31 90.98 3.47 Favored 'General case' 0 CA--C 1.568 1.64 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 175.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -102.4 119.6 39.08 Favored 'General case' 0 CA--C 1.565 1.551 0 C-N-CA 124.159 0.984 . . . . 0.0 112.633 -175.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -157.72 154.79 28.81 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 114.784 1.401 . . . . 0.0 114.784 -166.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 25.2 mp0 -92.82 121.7 34.46 Favored 'General case' 0 CA--C 1.564 1.486 0 O-C-N 121.577 -0.702 . . . . 0.0 110.553 166.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 40.0 t -66.25 121.7 15.83 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.808 0 C-N-CA 124.218 1.007 . . . . 0.0 109.915 174.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 117.2 -42.45 1.85 Allowed Glycine 0 CA--C 1.55 2.236 0 N-CA-C 115.729 1.052 . . . . 0.0 115.729 -160.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 55.9 mttm -82.64 144.78 30.05 Favored 'General case' 0 CA--C 1.566 1.564 0 CA-C-N 118.916 1.358 . . . . 0.0 113.557 -174.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -90.95 97.8 11.4 Favored 'General case' 0 CA--C 1.566 1.588 0 CA-C-O 121.349 0.595 . . . . 0.0 110.014 167.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -107.54 151.7 25.23 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 123.999 0.92 . . . . 0.0 113.083 -169.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -77.1 135.36 38.58 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.693 -1.254 . . . . 0.0 112.918 169.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -70.98 -69.23 0.38 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.428 -0.795 . . . . 0.0 112.886 175.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 19.0 t70 59.93 55.2 3.92 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 116.854 2.168 . . . . 0.0 116.854 168.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -156.01 158.14 37.34 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.271 -0.893 . . . . 0.0 111.322 177.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 41.0 m -75.63 99.05 4.2 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.759 -1.213 . . . . 0.0 110.735 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 151.87 142.92 3.59 Favored Glycine 0 CA--C 1.547 2.077 0 C-N-CA 123.304 0.478 . . . . 0.0 112.3 -175.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . 0.492 1.3 tp 70.04 -71.57 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.318 0 C-N-CA 124.25 1.02 . . . . 0.0 113.548 -173.185 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -156.96 120.39 4.16 Favored 'General case' 0 CA--C 1.567 1.597 0 N-CA-C 105.343 -2.095 . . . . 0.0 105.343 168.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -74.76 80.5 2.07 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 113.904 1.075 . . . . 0.0 113.904 -176.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 27.1 tpt180 -154.37 151.95 29.64 Favored 'General case' 0 CA--C 1.563 1.481 0 CA-C-O 122.276 1.036 . . . . 0.0 110.722 -170.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 58.1 mtmt -72.48 71.22 0.93 Allowed 'General case' 0 CA--C 1.577 1.985 0 O-C-N 121.153 -0.967 . . . . 0.0 112.8 166.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 72.8 m -87.61 118.63 27.23 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.139 -0.976 . . . . 0.0 111.856 -174.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 23.5 mmt -68.63 96.16 0.7 Allowed 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 124.576 1.15 . . . . 0.0 111.579 -177.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 89.6 m -111.59 118.09 34.73 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 -162.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 93.8 m -101.85 118.94 37.95 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 176.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.479 HG22 ' SG ' ' A' ' 95' ' ' CYS . 57.1 t -108.73 124.93 65.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 171.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 57.9 m -130.57 151.54 50.93 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 121.935 0.874 . . . . 0.0 111.529 -177.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 28.1 m95 -83.66 116.66 22.74 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.992 -1.067 . . . . 0.0 112.726 176.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -103.77 65.79 0.83 Allowed 'General case' 0 CA--C 1.572 1.805 0 C-N-CA 123.428 0.691 . . . . 0.0 109.909 162.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 58.28 -114.59 5.99 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 115.538 0.975 . . . . 0.0 115.538 -172.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -61.42 -28.22 69.11 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 116.934 2.198 . . . . 0.0 116.934 168.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 63.5 mttm -93.69 120.96 34.61 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-O 122.097 0.951 . . . . 0.0 110.583 -178.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.43 HD21 ' SD ' ' A' ' 49' ' ' MET . 34.7 tp -86.79 107.11 18.14 Favored 'General case' 0 CA--C 1.564 1.515 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 168.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -98.59 132.64 43.84 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 123.27 0.628 . . . . 0.0 111.544 -172.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . 0.479 ' SG ' HG22 ' A' ' 86' ' ' VAL . 35.4 t -128.33 134.97 48.99 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.158 0.583 . . . . 0.0 111.728 -179.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.9 p -115.82 128.91 72.93 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.792 0 C-N-CA 123.151 0.581 . . . . 0.0 109.758 164.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -106.15 108.2 19.59 Favored 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 123.548 0.739 . . . . 0.0 110.4 -178.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 62.1 mttm -101.08 118.45 37.03 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.042 -1.036 . . . . 0.0 110.814 -174.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -178.91 -60.78 0.07 OUTLIER Glycine 0 N--CA 1.491 2.348 0 N-CA-C 116.546 1.379 . . . . 0.0 116.546 -177.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -125.18 -58.76 1.44 Allowed 'General case' 0 N--CA 1.497 1.893 0 CA-C-N 117.872 0.836 . . . . 0.0 111.938 173.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 41.9 mmtm -87.72 151.51 22.86 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-O 122.189 0.995 . . . . 0.0 113.509 -161.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -73.48 -68.92 0.46 Allowed 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 -169.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -78.35 51.46 3.63 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 116.804 1.482 . . . . 0.0 116.804 171.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 21.2 ttt180 -98.35 118.59 35.36 Favored 'General case' 0 CA--C 1.563 1.461 0 CA-C-N 118.659 1.23 . . . . 0.0 114.041 -169.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 177.46 -165.05 34.6 Favored Glycine 0 N--CA 1.482 1.756 0 CA-C-O 121.844 0.691 . . . . 0.0 114.554 178.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 53.2 p-90 -157.81 152.9 25.61 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 173.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 56.6 m -125.59 118.07 24.92 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 174.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -118.6 125.51 49.93 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 123.021 0.528 . . . . 0.0 111.77 -178.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 17.0 p90 -140.62 170.63 15.42 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.491 -0.755 . . . . 0.0 112.631 178.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 77.4 mt -117.57 135.85 56.63 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.031 -1.043 . . . . 0.0 110.006 176.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -121.52 95.81 4.83 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 173.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 71.93 -109.77 2.95 Favored Glycine 0 N--CA 1.491 2.312 0 O-C-N 121.619 -0.675 . . . . 0.0 114.11 -176.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -110.17 38.42 2.43 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 114.338 1.236 . . . . 0.0 114.338 165.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 82.8 mt-10 -132.62 136.17 46.35 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-N 118.891 0.768 . . . . 0.0 111.199 178.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 20.8 tp -90.75 124.71 35.33 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 123.354 0.662 . . . . 0.0 109.785 173.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 51.5 m80 -113.68 117.52 31.79 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 179.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 51.4 tp -126.53 120.02 28.6 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.884 0.873 . . . . 0.0 109.445 -171.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -111.54 110.03 20.26 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 109.389 -0.596 . . . . 0.0 109.389 173.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 71.9 mtm -104.41 127.13 52.03 Favored 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 123.492 0.717 . . . . 0.0 111.028 -179.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 36.9 mtp-105 -114.04 145.58 41.39 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.377 -0.827 . . . . 0.0 112.659 -175.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -149.88 138.91 21.11 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.705 -0.622 . . . . 0.0 112.002 163.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . 0.287 6.0 mm-40 69.58 -76.19 0.06 Allowed 'General case' 0 N--CA 1.503 2.215 0 C-N-CA 124.326 1.05 . . . . 0.0 112.884 -177.436 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -159.78 46.42 0.42 Allowed Glycine 0 CA--C 1.553 2.408 0 CA-C-N 116.042 -0.526 . . . . 0.0 113.202 153.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 72.1 t -133.93 121.8 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 -163.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 16.2 m -101.97 120.91 41.17 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -173.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 26.7 t -84.73 125.5 32.59 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.657 -0.652 . . . . 0.0 111.821 160.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 28.5 mtmm -111.7 109.05 18.72 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 -173.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -117.95 130.6 56.31 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.613 -0.679 . . . . 0.0 111.565 -172.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 39.7 t -116.97 129.25 73.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 N-CA-C 107.969 -1.122 . . . . 0.0 107.969 179.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -122.0 157.55 31.09 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 123.479 0.712 . . . . 0.0 110.71 173.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 75.4 tttt -114.56 141.29 47.93 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.332 -0.855 . . . . 0.0 112.06 172.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 33.9 tttm -76.41 118.04 18.69 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.605 -0.684 . . . . 0.0 112.758 -178.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 33.6 m -103.38 -35.36 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.2 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 175.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 81.7 t60 . . . . . 0 N--CA 1.484 1.239 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 169.063 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 62.8 mtt . . . . . 0 CA--C 1.572 1.806 0 CA-C-O 118.583 -0.722 . . . . 0.0 112.074 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -73.98 168.76 24.01 Favored 'Trans proline' 0 CA--C 1.564 1.975 0 C-N-CA 122.445 2.097 . . . . 0.0 116.175 176.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 34.3 m -69.88 156.65 7.04 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.854 0 CA-C-O 122.216 1.008 . . . . 0.0 113.399 172.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -87.43 116.5 25.58 Favored 'General case' 0 CA--C 1.56 1.334 0 O-C-N 121.129 -0.982 . . . . 0.0 111.249 169.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 11.1 m-30 -80.07 0.95 29.74 Favored 'General case' 0 CA--C 1.578 2.052 0 N-CA-C 115.504 1.668 . . . . 0.0 115.504 163.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 43.7 m-20 -53.01 113.16 1.01 Allowed 'General case' 0 N--CA 1.493 1.689 0 CA-C-N 120.665 1.575 . . . . 0.0 115.044 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 159.92 173.31 28.27 Favored Glycine 0 N--CA 1.481 1.7 0 CA-C-O 122.378 0.988 . . . . 0.0 115.272 -175.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -104.87 126.5 52.01 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 170.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 65.5 m95 -124.37 122.77 38.62 Favored 'General case' 0 CA--C 1.565 1.522 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 -169.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 21.7 pttp -96.35 138.35 34.08 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.555 -0.716 . . . . 0.0 112.054 -178.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 54.9 ttm -69.71 127.82 34.29 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 119.594 1.088 . . . . 0.0 113.91 -178.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 98.2 mt -87.52 -50.69 6.36 Favored 'General case' 0 CA--C 1.567 1.621 0 CA-C-N 115.291 -0.868 . . . . 0.0 112.757 167.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 80.7 p -144.86 144.6 31.2 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 118.984 0.811 . . . . 0.0 112.188 176.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -114.72 101.75 9.37 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.519 0.676 . . . . 0.0 109.745 164.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -101.84 121.67 42.54 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 123.858 0.863 . . . . 0.0 109.691 -171.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.264 27.9 t30 66.51 22.34 10.64 Favored 'General case' 0 N--CA 1.504 2.264 0 N-CA-C 116.971 2.212 . . . . 0.0 116.971 -174.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -66.28 -40.44 90.08 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 116.055 1.872 . . . . 0.0 116.055 177.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -58.45 -41.09 84.36 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 116.074 1.879 . . . . 0.0 116.074 170.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -65.85 -43.0 89.78 Favored 'General case' 0 CA--C 1.571 1.774 0 N-CA-C 114.724 1.379 . . . . 0.0 114.724 170.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -56.87 -47.2 80.98 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 115.137 1.532 . . . . 0.0 115.137 167.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 84.2 mt -61.1 -42.69 98.98 Favored 'General case' 0 CA--C 1.574 1.893 0 N-CA-C 114.618 1.34 . . . . 0.0 114.618 169.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 48.1 ttp180 -53.11 -47.55 68.53 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 115.395 1.628 . . . . 0.0 115.395 164.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.12 -22.71 61.29 Favored 'General case' 0 CA--C 1.568 1.641 0 N-CA-C 118.239 2.681 . . . . 0.0 118.239 166.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 98.5 mt -88.39 11.56 16.53 Favored 'General case' 0 CA--C 1.573 1.849 0 N-CA-C 115.46 1.652 . . . . 0.0 115.46 164.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.25 10.7 m-20 61.34 40.7 13.92 Favored 'General case' 0 CA--C 1.576 1.964 0 N-CA-C 115.493 1.664 . . . . 0.0 115.493 -175.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 91.2 t -94.88 141.89 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.191 -0.943 . . . . 0.0 109.931 -176.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 14.0 p30 -64.48 154.44 35.86 Favored 'General case' 0 CA--C 1.572 1.812 0 N-CA-C 115.82 1.785 . . . . 0.0 115.82 178.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 96.8 t -58.63 -40.84 80.45 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.276 0 N-CA-C 115.127 1.528 . . . . 0.0 115.127 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.58 -50.3 72.34 Favored 'General case' 0 CA--C 1.567 1.631 0 N-CA-C 116.029 1.863 . . . . 0.0 116.029 171.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -71.65 -34.65 69.93 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 115.322 1.601 . . . . 0.0 115.322 172.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 74.3 mtp180 -50.68 -41.71 55.99 Favored 'General case' 0 N--CA 1.503 2.197 0 N-CA-C 116.131 1.9 . . . . 0.0 116.131 160.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp -71.48 -54.05 11.89 Favored 'General case' 0 CA--C 1.567 1.621 0 O-C-N 120.96 -1.088 . . . . 0.0 113.574 166.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 12.0 mt -77.98 60.44 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.509 2.484 0 CA-C-N 120.923 1.692 . . . . 0.0 111.708 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -179.45 -47.29 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 126.701 2.0 . . . . 0.0 110.969 -174.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -64.49 -45.45 87.26 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 115.99 1.848 . . . . 0.0 115.99 158.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 65.2 mt -78.02 -24.94 47.69 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 115.645 1.72 . . . . 0.0 115.645 -175.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.9 pp -96.0 134.61 38.82 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 162.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 62.4 pttt -98.91 102.06 14.09 Favored Pre-proline 0 CA--C 1.574 1.896 0 CA-C-O 117.906 -1.045 . . . . 0.0 110.644 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -73.61 166.03 30.83 Favored 'Trans proline' 0 CA--C 1.565 2.041 0 CA-C-N 123.101 2.143 . . . . 0.0 115.77 -173.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -110.69 136.27 50.02 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.621 -0.674 . . . . 0.0 110.345 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 43.0 mttp -100.51 116.58 32.79 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 120.918 -1.114 . . . . 0.0 109.851 176.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -101.46 109.29 21.08 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 167.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.1 mp -96.06 127.12 48.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 178.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 74.7 t -110.21 106.55 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 164.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -103.69 105.69 15.99 Favored 'General case' 0 CA--C 1.565 1.535 0 C-N-CA 124.361 1.064 . . . . 0.0 109.222 177.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -125.97 87.42 2.68 Favored 'General case' 0 CA--C 1.565 1.532 0 C-N-CA 123.509 0.724 . . . . 0.0 110.061 -176.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 57.36 72.03 0.65 Allowed Glycine 0 N--CA 1.496 2.662 0 N-CA-C 117.106 1.602 . . . . 0.0 117.106 175.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.471 0.6 OUTLIER 65.26 -33.8 0.17 Allowed 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 118.476 2.769 . . . . 0.0 118.476 -166.473 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 15.6 t-160 -73.69 114.78 12.35 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-N 120.62 1.555 . . . . 0.0 111.471 172.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 44.7 ttm -123.35 124.18 42.37 Favored 'General case' 0 CA--C 1.557 1.227 0 C-N-CA 123.707 0.803 . . . . 0.0 109.646 -175.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 43.2 mt -108.46 104.4 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 178.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 17.0 mm -90.39 98.29 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 176.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -90.39 100.82 13.58 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.225 -0.922 . . . . 0.0 109.2 -176.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 28.6 m -88.55 104.49 16.87 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 43.7 mt -103.2 117.38 34.4 Favored 'General case' 0 CA--C 1.557 1.225 0 C-N-CA 123.852 0.861 . . . . 0.0 109.499 -163.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 43.7 t -128.58 143.03 50.88 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.063 0.945 . . . . 0.0 110.453 -165.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . 0.253 12.7 t -77.34 50.83 0.81 Allowed 'General case' 0 N--CA 1.503 2.191 0 N-CA-C 114.55 1.315 . . . . 0.0 114.55 168.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -167.26 -68.64 0.03 OUTLIER 'General case' 0 CA--C 1.568 1.639 0 C-N-CA 125.537 1.535 . . . . 0.0 108.057 -178.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 33.5 ttm105 -151.19 123.14 8.14 Favored 'General case' 0 CA--C 1.565 1.551 0 CA-C-N 118.959 0.8 . . . . 0.0 110.322 -179.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -80.16 139.44 36.79 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 -178.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -114.0 107.36 15.57 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.745 -0.597 . . . . 0.0 109.465 177.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 43.9 mm -100.51 106.5 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -171.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 1.2 mmm -96.24 87.32 4.47 Favored 'General case' 0 CA--C 1.564 1.493 0 CA-C-O 121.638 0.732 . . . . 0.0 110.207 -176.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -100.01 116.99 33.35 Favored 'General case' 0 CA--C 1.562 1.41 0 C-N-CA 123.928 0.891 . . . . 0.0 112.282 -175.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -155.59 153.54 30.28 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 -168.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -95.09 122.95 38.29 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.507 -0.746 . . . . 0.0 111.425 166.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 31.7 t -65.46 121.85 15.29 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.831 0 C-N-CA 124.169 0.987 . . . . 0.0 110.538 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 105.54 -34.57 5.67 Favored Glycine 0 CA--C 1.552 2.389 0 N-CA-C 116.955 1.542 . . . . 0.0 116.955 -162.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 52.4 mttp -95.55 122.96 38.84 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 119.265 1.532 . . . . 0.0 111.454 -171.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -78.9 116.52 19.28 Favored 'General case' 0 CA--C 1.569 1.697 0 O-C-N 121.491 -0.756 . . . . 0.0 112.587 -178.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -124.71 147.83 48.38 Favored 'General case' 0 N--CA 1.496 1.828 0 C-N-CA 123.787 0.835 . . . . 0.0 112.346 -170.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -68.29 127.18 32.01 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 119.91 -1.744 . . . . 0.0 113.92 172.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -77.03 61.15 1.94 Allowed 'General case' 0 N--CA 1.5 2.056 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 176.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -90.59 74.41 6.75 Favored 'General case' 0 CA--C 1.568 1.667 0 O-C-N 120.481 -1.387 . . . . 0.0 111.69 -174.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 92.3 mt -125.29 140.06 53.16 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 121.573 0.702 . . . . 0.0 110.897 -174.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 34.4 p -92.64 98.34 11.37 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.899 -1.126 . . . . 0.0 111.284 -175.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 173.21 -76.54 0.09 OUTLIER Glycine 0 N--CA 1.486 1.976 0 N-CA-C 115.663 1.025 . . . . 0.0 115.663 173.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 49.6 mm -74.33 -65.98 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 CA-C-N 117.413 0.606 . . . . 0.0 112.144 -173.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -108.74 -52.2 2.79 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-N 119.276 0.944 . . . . 0.0 113.354 174.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.271 13.9 t70 63.34 66.11 0.73 Allowed 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 114.452 1.278 . . . . 0.0 114.452 -171.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 19.6 ttp85 -147.2 141.03 25.77 Favored 'General case' 0 CA--C 1.562 1.426 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 173.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? -75.16 71.84 2.21 Favored 'General case' 0 CA--C 1.572 1.805 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 -172.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 84.5 m -87.13 122.74 31.35 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.585 -0.697 . . . . 0.0 111.211 -178.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 79.1 mmm -72.21 103.4 3.33 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 121.979 0.895 . . . . 0.0 110.398 -174.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 85.8 m -107.76 113.6 26.97 Favored 'General case' 0 N--CA 1.48 1.038 0 O-C-N 121.162 -0.961 . . . . 0.0 110.07 -159.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 40.5 m -98.57 121.37 40.42 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 170.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.524 HG22 ' SG ' ' A' ' 95' ' ' CYS . 20.2 t -109.21 126.36 66.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 170.304 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 58.3 m -133.22 144.41 49.78 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 123.627 0.771 . . . . 0.0 111.323 -176.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 8.2 m95 -83.88 122.55 28.87 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.821 -1.174 . . . . 0.0 113.656 179.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -108.58 65.7 0.63 Allowed 'General case' 0 CA--C 1.576 1.964 0 C-N-CA 123.485 0.714 . . . . 0.0 110.424 163.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 67.65 -94.61 0.29 Allowed Glycine 0 N--CA 1.493 2.477 0 N-CA-C 116.322 1.289 . . . . 0.0 116.322 178.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -82.47 -30.52 29.92 Favored 'General case' 0 CA--C 1.573 1.857 0 N-CA-C 115.34 1.607 . . . . 0.0 115.34 165.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 33.8 mtpt -96.24 116.38 28.92 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-N 119.853 1.206 . . . . 0.0 110.434 -171.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 33.6 tp -86.96 110.8 20.27 Favored 'General case' 0 CA--C 1.564 1.509 0 O-C-N 120.992 -1.068 . . . . 0.0 109.711 174.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 18.2 mm100 -103.05 126.01 50.04 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.863 0.865 . . . . 0.0 110.226 -167.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . 0.524 ' SG ' HG22 ' A' ' 86' ' ' VAL . 41.0 t -127.6 129.11 46.7 Favored 'General case' 0 N--CA 1.481 1.083 0 O-C-N 121.822 -0.549 . . . . 0.0 111.417 -175.028 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 12.0 p -109.5 127.59 66.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 162.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -103.93 75.98 1.33 Allowed 'General case' 0 CA--C 1.57 1.712 0 C-N-CA 123.805 0.842 . . . . 0.0 109.263 175.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 15.7 ptpt -84.44 143.91 29.1 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 114.586 1.328 . . . . 0.0 114.586 -166.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 161.66 -114.15 0.59 Allowed Glycine 0 N--CA 1.484 1.884 0 O-C-N 121.663 -0.648 . . . . 0.0 111.949 172.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -80.33 -36.08 34.71 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 115.655 1.724 . . . . 0.0 115.655 175.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 9.4 tppt? -77.02 114.68 16.09 Favored 'General case' 0 CA--C 1.567 1.605 0 CA-C-N 119.559 1.072 . . . . 0.0 111.58 -177.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -74.17 119.46 18.41 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.418 -0.801 . . . . 0.0 112.854 -169.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 68.48 40.83 86.34 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 118.594 2.197 . . . . 0.0 118.594 -172.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 45.7 ttt180 -92.0 130.22 37.79 Favored 'General case' 0 CA--C 1.566 1.572 0 CA-C-N 118.514 1.157 . . . . 0.0 111.854 179.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 179.73 -168.52 38.98 Favored Glycine 0 N--CA 1.484 1.859 0 CA-C-O 122.368 0.982 . . . . 0.0 114.021 175.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 58.2 p-90 -156.62 153.3 28.37 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 122.214 1.007 . . . . 0.0 112.989 174.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 39.8 m -129.71 117.72 20.75 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 176.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -121.29 129.2 53.01 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 123.247 0.619 . . . . 0.0 111.621 -174.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 17.8 p90 -146.78 163.63 35.37 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.025 -1.047 . . . . 0.0 113.339 -174.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 76.0 mt -106.52 143.39 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.298 0 CA-C-O 123.224 1.488 . . . . 0.0 111.654 178.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -137.06 84.97 2.1 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 178.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 72.39 -110.04 3.04 Favored Glycine 0 N--CA 1.489 2.208 0 CA-C-N 116.025 -0.534 . . . . 0.0 114.415 -174.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 55.6 p30 -88.9 7.22 35.5 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 117.473 2.397 . . . . 0.0 117.473 169.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -124.07 137.93 54.51 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-N 120.085 1.311 . . . . 0.0 112.754 -166.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 26.4 tp -97.01 118.65 33.88 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 123.947 0.899 . . . . 0.0 108.984 172.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 34.1 m80 -107.83 123.29 48.35 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.926 0.89 . . . . 0.0 108.977 -176.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 45.4 tp -123.17 121.14 35.21 Favored 'General case' 0 CA--C 1.559 1.323 0 C-N-CA 123.82 0.848 . . . . 0.0 110.004 -172.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -102.13 114.66 28.98 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.594 -0.691 . . . . 0.0 109.296 166.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 73.5 mtm -103.89 126.85 51.31 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-N 118.557 0.617 . . . . 0.0 110.582 175.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 87.0 mtm180 -120.0 134.43 55.25 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 123.837 0.855 . . . . 0.0 110.471 -167.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -162.53 137.22 6.71 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.372 -0.83 . . . . 0.0 112.236 173.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . 0.328 12.1 mt-10 48.68 43.83 20.94 Favored 'General case' 0 N--CA 1.504 2.265 0 N-CA-C 116.156 1.91 . . . . 0.0 116.156 -178.197 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 65.71 26.24 71.99 Favored Glycine 0 CA--C 1.552 2.363 0 N-CA-C 120.609 3.004 . . . . 0.0 120.609 -167.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 87.6 t -130.83 128.36 62.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 CA-C-N 119.605 1.703 . . . . 0.0 109.202 -175.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 52.4 m -106.07 126.11 51.81 Favored 'General case' 0 N--CA 1.496 1.834 0 C-N-CA 123.284 0.634 . . . . 0.0 111.267 176.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 9.2 t -96.67 128.65 43.81 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.698 0.799 . . . . 0.0 111.542 162.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 47.0 mttp -102.02 111.1 23.25 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 121.427 0.632 . . . . 0.0 110.536 176.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 64.2 mt-30 -108.98 126.74 53.42 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.693 0.797 . . . . 0.0 110.767 176.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 47.7 t -114.27 132.0 64.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -126.87 149.6 49.67 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 123.742 0.817 . . . . 0.0 111.329 178.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 75.4 tttt -111.33 140.18 46.11 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.374 -0.829 . . . . 0.0 112.164 175.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 73.0 tttt -74.19 122.93 23.55 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.448 -0.782 . . . . 0.0 113.07 -178.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 31.7 m -109.32 -42.31 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 175.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 50.2 t-80 . . . . . 0 N--CA 1.485 1.309 0 CA-C-N 119.712 1.142 . . . . 0.0 108.268 167.782 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 72.3 mtm . . . . . 0 CA--C 1.575 1.928 0 CA-C-O 118.525 -0.75 . . . . 0.0 110.924 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -89.98 163.17 4.92 Favored 'Trans proline' 0 CA--C 1.565 2.028 0 N-CA-C 117.35 2.019 . . . . 0.0 117.35 -173.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 27.6 m -108.98 175.42 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 CA-C-O 122.666 1.222 . . . . 0.0 112.719 174.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -78.14 96.74 5.24 Favored 'General case' 0 CA--C 1.568 1.643 0 O-C-N 120.874 -1.141 . . . . 0.0 113.287 -172.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -78.14 -0.22 27.4 Favored 'General case' 0 N--CA 1.501 2.116 0 N-CA-C 116.334 1.976 . . . . 0.0 116.334 169.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -60.24 116.07 3.97 Favored 'General case' 0 CA--C 1.563 1.47 0 C-N-CA 125.826 1.65 . . . . 0.0 114.343 179.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 163.44 177.99 36.77 Favored Glycine 0 N--CA 1.484 1.879 0 N-CA-C 116.743 1.457 . . . . 0.0 116.743 177.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -106.57 120.07 40.96 Favored 'General case' 0 CA--C 1.563 1.459 0 CA-C-N 113.961 -1.12 . . . . 0.0 108.536 170.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 64.5 m95 -120.03 124.98 47.22 Favored 'General case' 0 CA--C 1.565 1.547 0 C-N-CA 123.882 0.873 . . . . 0.0 108.766 -169.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -95.24 137.06 34.81 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.67 -1.269 . . . . 0.0 112.619 179.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 4.3 ttp -74.86 121.64 22.15 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 122.133 0.968 . . . . 0.0 112.773 179.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 93.4 mt -79.47 -54.65 5.71 Favored 'General case' 0 CA--C 1.566 1.592 0 CA-C-N 115.029 -0.987 . . . . 0.0 112.609 171.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 89.6 p -144.33 151.77 39.82 Favored 'General case' 0 CA--C 1.563 1.45 0 C-N-CA 123.717 0.807 . . . . 0.0 112.624 -173.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -122.64 133.49 54.52 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.43 0.634 . . . . 0.0 110.901 160.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -125.58 117.78 24.3 Favored 'General case' 0 CA--C 1.561 1.367 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 -179.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.292 31.3 t30 68.88 31.65 4.23 Favored 'General case' 0 CA--C 1.579 2.089 0 N-CA-C 117.082 2.253 . . . . 0.0 117.082 -175.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -71.8 -42.97 66.42 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 115.215 1.561 . . . . 0.0 115.215 175.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -47.3 -47.33 25.37 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 116.442 2.015 . . . . 0.0 116.442 166.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -70.26 -38.62 75.15 Favored 'General case' 0 CA--C 1.57 1.736 0 N-CA-C 115.686 1.736 . . . . 0.0 115.686 176.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 81.5 t80 -55.41 -49.4 72.45 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-N 120.519 1.508 . . . . 0.0 114.201 165.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 79.8 mt -59.37 -43.01 92.91 Favored 'General case' 0 CA--C 1.574 1.895 0 N-CA-C 115.493 1.664 . . . . 0.0 115.493 169.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 36.4 ttp180 -51.2 -51.16 56.44 Favored 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 115.325 1.602 . . . . 0.0 115.325 165.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.87 -24.53 52.39 Favored 'General case' 0 CA--C 1.565 1.538 0 N-CA-C 118.364 2.728 . . . . 0.0 118.364 165.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 93.3 mt -87.18 8.91 21.87 Favored 'General case' 0 CA--C 1.575 1.912 0 N-CA-C 115.735 1.754 . . . . 0.0 115.735 167.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.256 25.8 m-20 67.24 41.46 2.52 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 -175.241 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 90.3 t -100.37 141.66 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 121.031 -1.043 . . . . 0.0 110.014 -178.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 12.1 p30 -68.68 159.89 31.28 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 115.887 1.81 . . . . 0.0 115.887 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 65.0 t -58.52 -46.2 89.9 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.256 0 N-CA-C 114.895 1.443 . . . . 0.0 114.895 -179.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.55 -47.4 84.36 Favored 'General case' 0 CA--C 1.57 1.717 0 N-CA-C 116.052 1.871 . . . . 0.0 116.052 173.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.49 -43.83 97.85 Favored 'General case' 0 CA--C 1.574 1.9 0 N-CA-C 114.873 1.434 . . . . 0.0 114.873 169.259 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 77.1 mtp180 -49.92 -50.92 44.55 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 115.569 1.692 . . . . 0.0 115.569 164.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -54.95 -54.15 46.51 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 115.258 1.577 . . . . 0.0 115.258 168.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 34.9 mt -59.73 -53.2 51.71 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 CA-C-N 119.808 1.185 . . . . 0.0 113.162 178.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -61.94 -40.41 95.45 Favored 'General case' 0 CA--C 1.566 1.569 0 N-CA-C 117.529 2.418 . . . . 0.0 117.529 175.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -65.64 -32.08 73.45 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 116.003 1.853 . . . . 0.0 116.003 169.242 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 81.5 mt -72.79 -30.45 64.1 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 116.139 1.903 . . . . 0.0 116.139 170.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 38.6 mt -73.95 139.8 45.12 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 119.539 1.063 . . . . 0.0 113.547 -179.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -110.96 86.01 5.61 Favored Pre-proline 0 CA--C 1.572 1.826 0 CA-C-O 118.299 -0.858 . . . . 0.0 109.723 172.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -76.87 174.02 13.53 Favored 'Trans proline' 0 CA--C 1.563 1.926 0 C-N-CA 122.558 2.172 . . . . 0.0 115.67 -176.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -111.88 130.27 55.89 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.699 -0.625 . . . . 0.0 111.315 178.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 47.6 mttm -90.12 109.93 20.97 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.275 -0.891 . . . . 0.0 110.137 171.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -92.55 110.94 22.37 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 163.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 74.3 mt -109.03 118.35 56.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 107.475 -1.305 . . . . 0.0 107.475 -178.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 72.1 t -100.87 98.48 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 106.676 -1.602 . . . . 0.0 106.676 166.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -90.44 93.0 9.12 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.537 0.684 . . . . 0.0 109.731 174.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -100.33 70.58 1.52 Allowed 'General case' 0 CA--C 1.567 1.624 0 O-C-N 121.478 -0.764 . . . . 0.0 111.403 -177.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 53.56 67.46 2.13 Favored Glycine 0 N--CA 1.496 2.695 0 N-CA-C 117.64 1.816 . . . . 0.0 117.64 176.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.438 0.5 OUTLIER 61.0 8.22 1.82 Allowed 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 119.617 3.192 . . . . 0.0 119.617 -163.579 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 17.5 t-160 -107.48 106.56 17.01 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 121.276 1.853 . . . . 0.0 107.643 161.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 6.6 tpp -109.45 132.19 54.36 Favored 'General case' 0 CA--C 1.556 1.186 0 O-C-N 121.458 -0.776 . . . . 0.0 110.969 -172.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 47.1 mt -116.47 101.87 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 173.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 72.9 mt -99.13 116.31 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 178.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -115.86 103.39 10.59 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 70.4 m -88.42 112.62 23.12 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 172.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 24.0 mt -110.96 119.01 37.64 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.303 -158.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 36.1 t -130.76 153.53 48.93 Favored 'General case' 0 CA--C 1.56 1.346 0 C-N-CA 123.668 0.787 . . . . 0.0 110.529 173.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 70.2 p -80.98 62.32 4.92 Favored 'General case' 0 N--CA 1.504 2.247 0 O-C-N 120.636 -1.29 . . . . 0.0 111.633 163.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -174.06 -68.61 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 125.097 1.359 . . . . 0.0 108.985 -174.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 14.8 ttm180 -146.61 118.08 7.96 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 123.634 0.773 . . . . 0.0 109.103 -173.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -106.11 130.55 53.98 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 123.229 0.612 . . . . 0.0 110.588 -170.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 10.3 t80 -101.45 109.55 21.4 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.544 -0.722 . . . . 0.0 109.871 178.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 41.6 mm -116.67 117.47 55.58 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -169.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 25.4 mmm -126.6 97.54 5.06 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 123.226 0.61 . . . . 0.0 109.77 -175.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -104.84 103.7 13.34 Favored 'General case' 0 CA--C 1.563 1.463 0 C-N-CA 124.06 0.944 . . . . 0.0 111.875 177.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -151.49 154.24 36.17 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 -163.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 17.8 mp0 -84.57 126.53 33.4 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.11 -0.994 . . . . 0.0 111.08 164.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 15.1 t -69.06 114.15 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 174.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 124.88 -46.72 1.07 Allowed Glycine 0 N--CA 1.488 2.146 0 N-CA-C 115.807 1.083 . . . . 0.0 115.807 -160.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 34.9 mtmt -83.74 142.83 30.42 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 118.872 1.336 . . . . 0.0 113.861 -173.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -93.25 95.54 9.43 Favored 'General case' 0 CA--C 1.566 1.58 0 CA-C-O 121.321 0.582 . . . . 0.0 111.252 176.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -104.56 142.14 35.16 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 124.032 0.933 . . . . 0.0 113.058 -170.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -71.58 115.7 11.07 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.164 -1.585 . . . . 0.0 113.46 176.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -81.97 100.34 9.63 Favored 'General case' 0 CA--C 1.564 1.508 0 O-C-N 121.397 -0.814 . . . . 0.0 109.423 165.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -109.2 92.23 3.97 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 123.736 0.815 . . . . 0.0 110.601 179.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . 0.278 2.2 tt 57.16 74.98 0.39 Allowed 'General case' 0 N--CA 1.498 1.968 0 C-N-CA 124.783 1.233 . . . . 0.0 113.906 -170.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 28.5 m -90.06 3.62 52.72 Favored 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 116.095 1.887 . . . . 0.0 116.095 -173.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 138.84 -73.55 0.41 Allowed Glycine 0 N--CA 1.487 2.037 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 -164.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 47.3 mm -86.28 173.55 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.587 2.396 0 CA-C-O 122.3 1.048 . . . . 0.0 109.801 164.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 -67.04 68.74 0.07 Allowed 'General case' 0 CA--C 1.576 1.965 0 N-CA-C 117.404 2.372 . . . . 0.0 117.404 -177.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -83.95 98.85 10.03 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.048 -1.033 . . . . 0.0 110.486 171.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 -89.57 78.03 7.12 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.065 -1.022 . . . . 0.0 111.648 -178.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . 0.254 52.2 mtmt 54.81 57.25 5.83 Favored 'General case' 0 N--CA 1.5 2.072 0 N-CA-C 115.711 1.745 . . . . 0.0 115.711 -173.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 72.5 m -86.07 113.9 22.51 Favored 'General case' 0 CA--C 1.559 1.31 0 O-C-N 121.082 -1.011 . . . . 0.0 110.866 178.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 2.4 tpt -75.58 98.66 4.06 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 122.195 0.998 . . . . 0.0 109.638 -176.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 65.3 m -104.72 110.26 22.51 Favored 'General case' 0 N--CA 1.48 1.059 0 O-C-N 121.695 -0.628 . . . . 0.0 110.065 -154.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 54.6 m -88.79 121.82 31.56 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 167.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 22.9 t -110.35 121.51 63.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 165.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 31.8 m -128.08 154.11 46.07 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 122.125 0.964 . . . . 0.0 111.545 -175.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 29.0 m95 -84.69 114.98 22.42 Favored 'General case' 0 CA--C 1.562 1.422 0 O-C-N 121.223 -0.923 . . . . 0.0 111.939 174.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -93.5 70.92 4.3 Favored 'General case' 0 CA--C 1.571 1.783 0 CA-C-O 121.539 0.685 . . . . 0.0 109.57 159.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 61.14 -114.72 6.96 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 114.901 0.72 . . . . 0.0 114.901 -168.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -64.87 -30.56 71.57 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 116.461 2.023 . . . . 0.0 116.461 166.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -86.87 127.81 35.04 Favored 'General case' 0 CA--C 1.561 1.384 0 CA-C-N 119.443 1.019 . . . . 0.0 111.256 -173.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 25.8 tp -92.28 106.56 18.54 Favored 'General case' 0 CA--C 1.566 1.562 0 O-C-N 121.378 -0.826 . . . . 0.0 109.097 176.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 -100.46 128.83 46.41 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 123.658 0.783 . . . . 0.0 111.132 -173.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 40.9 t -124.19 131.64 53.55 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.436 0.694 . . . . 0.0 111.975 -177.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.5 p -120.15 125.65 74.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 C-N-CA 122.979 0.511 . . . . 0.0 109.628 168.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -100.87 90.26 4.14 Favored 'General case' 0 CA--C 1.568 1.657 0 C-N-CA 124.092 0.957 . . . . 0.0 109.58 -176.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -84.88 122.47 29.21 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.66 -1.275 . . . . 0.0 113.525 -166.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -169.76 -130.64 1.23 Allowed Glycine 0 N--CA 1.485 1.947 0 O-C-N 121.593 -0.692 . . . . 0.0 112.157 171.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.68 -16.44 58.49 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 117.157 2.281 . . . . 0.0 117.157 176.165 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 16.7 ttmt -98.82 129.64 45.22 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 119.97 1.259 . . . . 0.0 111.561 -170.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -79.01 128.55 33.4 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.472 -0.767 . . . . 0.0 112.816 -172.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 66.61 34.1 86.53 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 118.975 2.35 . . . . 0.0 118.975 -176.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 36.7 ttt180 -85.92 124.36 32.3 Favored 'General case' 0 CA--C 1.565 1.527 0 CA-C-N 118.734 1.267 . . . . 0.0 111.577 -177.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -179.18 -168.96 39.03 Favored Glycine 0 N--CA 1.486 1.989 0 N-CA-C 115.687 1.035 . . . . 0.0 115.687 -177.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 41.8 p-90 -157.43 155.47 30.53 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.958 0.885 . . . . 0.0 112.898 170.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 97.5 m -126.16 120.47 30.2 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.344 -0.848 . . . . 0.0 108.712 176.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 16.8 tt0 -124.42 124.72 42.95 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.846 -0.534 . . . . 0.0 111.992 -175.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 14.0 p90 -143.17 163.02 34.04 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.079 -1.013 . . . . 0.0 113.227 -177.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 86.1 mt -107.92 133.94 51.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 CA-C-O 122.266 1.031 . . . . 0.0 110.652 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -120.71 85.34 2.38 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 124.525 1.13 . . . . 0.0 108.451 173.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 69.68 -108.06 2.34 Favored Glycine 0 N--CA 1.491 2.315 0 O-C-N 121.584 -0.697 . . . . 0.0 114.752 -175.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 31.6 p-10 -87.96 -5.16 58.68 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 117.427 2.38 . . . . 0.0 117.427 166.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -103.41 139.59 38.59 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-N 120.408 1.458 . . . . 0.0 112.368 -175.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 10.7 tp -101.46 122.08 43.12 Favored 'General case' 0 CA--C 1.562 1.417 0 C-N-CA 123.873 0.869 . . . . 0.0 108.957 169.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 36.9 m80 -109.27 119.87 40.81 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.533 0.733 . . . . 0.0 109.208 -175.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 20.0 tp -114.38 129.86 56.67 Favored 'General case' 0 CA--C 1.56 1.327 0 C-N-CA 123.737 0.815 . . . . 0.0 110.183 -178.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -119.16 108.7 14.99 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.936 -0.478 . . . . 0.0 110.003 169.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 76.8 mtm -97.82 127.49 43.8 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 123.62 0.768 . . . . 0.0 111.515 -176.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 78.7 mtm180 -118.14 135.2 54.37 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 123.329 0.651 . . . . 0.0 111.693 -167.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -160.23 132.89 6.46 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.26 -0.9 . . . . 0.0 111.515 170.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 33.8 mm-40 58.13 36.88 26.24 Favored 'General case' 0 N--CA 1.505 2.3 0 N-CA-C 115.361 1.615 . . . . 0.0 115.361 -177.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 72.9 -8.62 7.56 Favored Glycine 0 CA--C 1.556 2.603 0 N-CA-C 120.399 2.92 . . . . 0.0 120.399 -162.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 97.1 t -92.88 128.23 44.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 CA-C-N 120.137 1.969 . . . . 0.0 109.76 -171.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 37.8 m -105.9 124.25 49.28 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 122.73 0.412 . . . . 0.0 111.5 177.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 11.2 t -95.14 126.21 40.31 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.426 0.69 . . . . 0.0 111.234 162.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -103.4 121.1 42.09 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 123.381 0.672 . . . . 0.0 109.569 -179.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 20.0 mt-30 -126.64 134.24 50.8 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.588 -0.695 . . . . 0.0 111.227 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 57.1 t -115.24 131.07 68.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 -177.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -123.5 149.83 44.69 Favored 'General case' 0 CA--C 1.563 1.478 0 C-N-CA 124.72 1.208 . . . . 0.0 110.232 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 29.6 ttmt -123.61 141.08 52.36 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.789 -1.194 . . . . 0.0 112.153 175.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 70.8 tttt -73.84 123.4 24.13 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 -175.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . 0.255 34.5 m -107.86 -43.07 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 175.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 . . . . . 0 N--CA 1.487 1.414 0 CA-C-N 120.206 1.366 . . . . 0.0 108.312 167.011 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 26.6 ttt . . . . . 0 CA--C 1.571 1.78 0 CA-C-O 118.269 -0.872 . . . . 0.0 109.871 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -75.71 134.51 16.75 Favored 'Trans proline' 0 CA--C 1.561 1.859 0 C-N-CA 122.507 2.138 . . . . 0.0 115.405 -173.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 15.6 m -72.58 141.26 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 CA-C-O 121.936 0.874 . . . . 0.0 113.079 178.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -76.25 121.48 23.0 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 -176.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 8.6 m-30 -85.05 8.4 18.04 Favored 'General case' 0 CA--C 1.572 1.807 0 N-CA-C 115.647 1.721 . . . . 0.0 115.647 177.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 27.5 m120 -51.43 121.82 6.93 Favored 'General case' 0 N--CA 1.499 2.004 0 CA-C-N 121.496 1.953 . . . . 0.0 115.082 172.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 160.45 177.88 33.95 Favored Glycine 0 N--CA 1.481 1.685 0 CA-C-O 123.002 1.334 . . . . 0.0 116.031 174.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 14.8 t80 -110.74 128.84 55.89 Favored 'General case' 0 CA--C 1.564 1.491 0 CA-C-N 113.578 -1.311 . . . . 0.0 108.364 165.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 55.3 m95 -126.81 138.51 53.36 Favored 'General case' 0 CA--C 1.573 1.832 0 C-N-CA 123.733 0.813 . . . . 0.0 110.144 -167.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -112.11 137.05 50.71 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 120.678 -1.264 . . . . 0.0 112.633 178.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.45 ' SD ' ' HD2' ' A' ' 38' ' ' PRO . 1.9 ttt -75.0 123.45 25.18 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.454 -1.404 . . . . 0.0 114.281 -175.122 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 97.5 mt -85.92 -52.67 5.58 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 113.688 0.996 . . . . 0.0 113.688 176.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 83.3 p -142.36 148.25 37.61 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 123.671 0.788 . . . . 0.0 112.112 -176.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -126.75 116.73 21.38 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 123.107 0.563 . . . . 0.0 110.078 170.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -112.15 116.05 29.85 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 178.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.293 18.7 t30 69.71 25.47 5.14 Favored 'General case' 0 CA--C 1.579 2.096 0 N-CA-C 117.964 2.579 . . . . 0.0 117.964 177.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 15.7 t80 -63.41 -45.14 92.39 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 115.459 1.651 . . . . 0.0 115.459 170.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -54.68 -40.78 69.47 Favored 'General case' 0 CA--C 1.573 1.836 0 N-CA-C 117.868 2.544 . . . . 0.0 117.868 172.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -74.22 -40.72 62.26 Favored 'General case' 0 CA--C 1.571 1.775 0 N-CA-C 115.264 1.579 . . . . 0.0 115.264 171.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -49.06 -48.92 43.67 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 115.19 1.552 . . . . 0.0 115.19 162.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 88.5 mt -62.06 -40.19 94.94 Favored 'General case' 0 CA--C 1.573 1.835 0 N-CA-C 115.339 1.607 . . . . 0.0 115.339 169.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 46.9 ttp180 -54.0 -50.47 66.52 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 165.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.58 -21.52 53.34 Favored 'General case' 0 CA--C 1.567 1.622 0 N-CA-C 118.223 2.675 . . . . 0.0 118.223 167.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 37.7 mt -90.83 8.53 34.36 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 115.988 1.847 . . . . 0.0 115.988 168.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 69.84 32.94 3.01 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 115.141 1.534 . . . . 0.0 115.141 -177.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 70.3 t -95.36 144.08 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 120.666 -1.271 . . . . 0.0 110.623 -172.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -64.74 152.64 42.04 Favored 'General case' 0 CA--C 1.573 1.835 0 N-CA-C 116.213 1.931 . . . . 0.0 116.213 -176.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . 0.251 56.1 t -58.45 -42.47 84.37 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.156 0 N-CA-C 115.682 1.734 . . . . 0.0 115.682 -179.251 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.05 -51.3 70.65 Favored 'General case' 0 CA--C 1.57 1.72 0 N-CA-C 115.878 1.807 . . . . 0.0 115.878 173.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -54.28 -53.49 53.05 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 114.314 1.227 . . . . 0.0 114.314 166.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 56.3 mtp180 -47.52 -41.57 21.33 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 118.378 2.732 . . . . 0.0 118.378 171.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -75.73 -52.88 9.48 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 174.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 19.9 mt -63.33 -49.75 81.64 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 CA-C-N 119.251 0.932 . . . . 0.0 112.961 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.93 -33.07 74.88 Favored 'General case' 0 CA--C 1.568 1.664 0 N-CA-C 117.821 2.526 . . . . 0.0 117.821 175.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -69.14 -31.27 69.82 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 116.11 1.893 . . . . 0.0 116.11 165.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 79.9 mt -72.25 -36.49 69.08 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 116.075 1.88 . . . . 0.0 116.075 171.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . 0.293 2.5 pp -80.82 152.69 28.1 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-N 120.196 1.362 . . . . 0.0 114.545 -178.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 30.8 mmtp -111.07 99.29 42.54 Favored Pre-proline 0 CA--C 1.572 1.808 0 CA-C-O 118.348 -0.834 . . . . 0.0 108.818 176.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.45 ' HD2' ' SD ' ' A' ' 10' ' ' MET . 91.0 Cg_endo -77.92 176.92 9.42 Favored 'Trans proline' 0 CA--C 1.565 2.032 0 C-N-CA 122.948 2.432 . . . . 0.0 116.025 -175.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -109.98 163.45 13.55 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.969 0.89 . . . . 0.0 112.213 173.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 43.2 mttm -135.46 120.53 18.78 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.099 -1.001 . . . . 0.0 110.123 176.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -100.57 118.57 37.0 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.422 -0.798 . . . . 0.0 109.656 163.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 78.6 mt -113.75 121.42 65.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 177.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 52.9 t -107.09 97.35 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 107.788 -1.189 . . . . 0.0 107.788 167.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -88.48 117.04 27.14 Favored 'General case' 0 CA--C 1.567 1.604 0 C-N-CA 123.454 0.701 . . . . 0.0 110.019 165.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -142.9 102.04 3.95 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.241 -0.912 . . . . 0.0 109.762 -179.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 56.8 62.36 6.45 Favored Glycine 0 N--CA 1.497 2.706 0 N-CA-C 117.409 1.724 . . . . 0.0 117.409 178.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.416 0.6 OUTLIER 59.97 -10.79 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 119.914 3.302 . . . . 0.0 119.914 -165.291 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 12.4 t-80 -88.4 121.93 31.33 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-N 121.192 1.814 . . . . 0.0 110.127 174.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 40.4 ttm -123.58 116.99 24.04 Favored 'General case' 0 CA--C 1.556 1.208 0 CA-C-O 121.553 0.692 . . . . 0.0 110.161 -174.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 27.6 mt -104.13 98.91 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 177.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 72.0 mt -94.23 111.76 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 178.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 41.9 mtt85 -110.27 101.79 10.5 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 178.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.2 m -80.0 120.7 24.54 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 167.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 74.9 mt -124.39 118.21 26.19 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-O 121.649 0.738 . . . . 0.0 109.638 -164.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.47 -3.13 0.2 Allowed 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 117.018 2.229 . . . . 0.0 117.018 -178.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . 0.344 30.3 m 75.4 -62.97 0.43 Allowed 'General case' 0 N--CA 1.505 2.293 0 CA-C-N 121.556 1.98 . . . . 0.0 112.893 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -63.15 -44.44 95.51 Favored 'General case' 0 CA--C 1.571 1.778 0 N-CA-C 115.174 1.546 . . . . 0.0 115.174 165.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 31.4 ttt85 -128.16 130.77 48.59 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 120.081 1.309 . . . . 0.0 110.397 172.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -133.82 135.21 43.65 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.764 -0.585 . . . . 0.0 110.507 176.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -120.0 119.99 35.01 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 170.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 33.9 mm -112.4 104.88 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 174.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 94.4 mtp -110.74 98.71 7.8 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 -179.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -102.01 98.35 8.56 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 123.523 0.729 . . . . 0.0 110.136 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -142.78 156.78 45.03 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -168.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -94.7 131.26 40.7 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.105 -0.997 . . . . 0.0 110.824 166.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 22.0 t -66.85 113.3 2.84 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.776 0 C-N-CA 123.501 0.721 . . . . 0.0 109.978 -179.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 127.4 -55.45 0.75 Allowed Glycine 0 CA--C 1.548 2.109 0 CA-C-O 119.059 -0.856 . . . . 0.0 114.923 -158.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 13.9 pttt -75.76 145.58 40.69 Favored 'General case' 0 CA--C 1.567 1.627 0 N-CA-C 116.286 1.958 . . . . 0.0 116.286 -170.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -95.01 108.85 20.93 Favored 'General case' 0 CA--C 1.567 1.627 0 C-N-CA 123.172 0.589 . . . . 0.0 110.835 174.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -116.02 143.12 45.89 Favored 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 123.666 0.786 . . . . 0.0 112.819 -173.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -70.66 116.24 10.75 Favored 'General case' 0 CA--C 1.569 1.709 0 O-C-N 120.042 -1.661 . . . . 0.0 113.975 175.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -71.62 99.85 2.17 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.166 -0.959 . . . . 0.0 108.763 167.316 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . 0.28 3.4 p30 -119.27 -159.75 0.78 Allowed 'General case' 0 CA--C 1.568 1.647 0 N-CA-C 113.369 0.878 . . . . 0.0 113.369 -156.132 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 72.5 mt 55.33 60.0 3.63 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 -171.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . 0.438 4.1 t 55.58 -1.7 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.222 0 N-CA-C 120.696 3.591 . . . . 0.0 120.696 -165.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 88.91 146.26 12.75 Favored Glycine 0 N--CA 1.487 2.079 0 CA-C-N 120.774 1.624 . . . . 0.0 115.453 -174.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 31.7 mt -90.05 -56.48 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.175 0 O-C-N 122.104 -0.645 . . . . 0.0 111.06 178.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -87.94 -66.99 0.86 Allowed 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 119.962 1.255 . . . . 0.0 113.173 171.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -99.07 -101.88 0.22 Allowed 'General case' 0 CA--C 1.566 1.587 0 CA-C-N 119.445 1.02 . . . . 0.0 110.401 175.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . 0.282 39.6 ttt85 -140.83 -124.43 0.1 Allowed 'General case' 0 CA--C 1.567 1.633 0 CA-C-N 119.935 1.243 . . . . 0.0 110.081 -176.126 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -106.33 121.68 44.72 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 120.644 1.565 . . . . 0.0 111.974 -168.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 22.1 m -134.96 132.03 37.91 Favored 'General case' 0 CA--C 1.562 1.423 0 CA-C-O 122.208 1.004 . . . . 0.0 111.435 177.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 72.1 mmm -74.05 110.46 8.36 Favored 'General case' 0 CA--C 1.562 1.439 0 C-N-CA 123.744 0.818 . . . . 0.0 109.757 172.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 76.6 m -108.81 116.16 31.46 Favored 'General case' 0 N--CA 1.484 1.256 0 O-C-N 121.668 -0.645 . . . . 0.0 110.714 -161.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 89.8 m -104.68 125.81 51.15 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 176.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.409 HG22 ' SG ' ' A' ' 95' ' ' CYS . 15.4 t -117.85 119.24 60.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 177.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 56.8 m -140.56 150.18 43.35 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 123.341 0.656 . . . . 0.0 112.161 -174.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 90.7 m95 -79.27 119.74 22.76 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.462 -1.399 . . . . 0.0 112.847 177.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -93.55 78.52 4.34 Favored 'General case' 0 CA--C 1.567 1.616 0 O-C-N 121.631 -0.668 . . . . 0.0 109.295 163.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 67.65 -99.27 0.52 Allowed Glycine 0 N--CA 1.49 2.264 0 O-C-N 121.818 -0.551 . . . . 0.0 114.451 -171.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -102.95 -6.05 22.82 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 116.454 2.02 . . . . 0.0 116.454 170.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 35.8 mtmm -97.39 127.59 43.48 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-N 120.539 1.518 . . . . 0.0 110.026 176.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 22.3 tp -84.73 110.15 18.56 Favored 'General case' 0 CA--C 1.564 1.489 0 O-C-N 121.034 -1.041 . . . . 0.0 110.071 174.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -97.39 125.53 42.07 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.693 0.797 . . . . 0.0 110.841 -175.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . 0.409 ' SG ' HG22 ' A' ' 86' ' ' VAL . 39.4 t -114.03 124.33 51.87 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 123.284 0.633 . . . . 0.0 110.154 175.075 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.6 p -107.3 118.47 55.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 166.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -97.97 88.14 4.17 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 174.145 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -99.07 126.74 44.87 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.092 -1.005 . . . . 0.0 112.462 -174.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 166.39 -107.25 0.28 Allowed Glycine 0 N--CA 1.487 2.072 0 O-C-N 121.28 -0.887 . . . . 0.0 112.915 176.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -76.87 -10.22 59.22 Favored 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 117.764 2.505 . . . . 0.0 117.764 -177.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -122.94 142.84 50.37 Favored 'General case' 0 CA--C 1.566 1.563 0 CA-C-N 120.086 1.312 . . . . 0.0 111.294 177.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -81.79 144.32 31.16 Favored 'General case' 0 CA--C 1.563 1.467 0 O-C-N 121.491 -0.756 . . . . 0.0 111.565 173.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 57.63 23.96 51.4 Favored Glycine 0 N--CA 1.498 2.81 0 N-CA-C 120.854 3.102 . . . . 0.0 120.854 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 57.8 ttt180 -85.95 124.8 32.82 Favored 'General case' 0 CA--C 1.565 1.544 0 CA-C-N 118.501 1.151 . . . . 0.0 111.28 -178.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 178.25 -173.67 46.09 Favored Glycine 0 N--CA 1.488 2.119 0 O-C-N 121.341 -0.849 . . . . 0.0 114.852 -178.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . 0.25 16.8 p-90 -155.12 157.77 37.99 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 114.66 1.356 . . . . 0.0 114.66 171.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 31.8 m -123.77 123.7 41.06 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 123.831 0.852 . . . . 0.0 108.842 170.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -123.44 131.99 53.81 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 123.287 0.635 . . . . 0.0 111.882 -176.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 23.4 p90 -150.54 167.08 28.27 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.045 -1.034 . . . . 0.0 113.014 -179.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 89.3 mt -107.94 136.83 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.193 0 O-C-N 120.776 -1.202 . . . . 0.0 110.447 175.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -123.3 97.09 5.25 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 123.578 0.751 . . . . 0.0 109.701 164.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 76.97 -111.3 3.23 Favored Glycine 0 N--CA 1.491 2.316 0 O-C-N 121.275 -0.89 . . . . 0.0 113.9 -176.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -107.37 37.87 2.28 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 164.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -131.65 117.01 18.1 Favored 'General case' 0 CA--C 1.559 1.326 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 -168.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 17.2 tp -87.42 114.4 24.0 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-O 121.755 0.788 . . . . 0.0 109.914 172.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 48.9 m80 -102.66 120.09 39.96 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.972 0.909 . . . . 0.0 109.076 -177.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 49.5 tp -120.31 120.08 35.01 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 123.784 0.834 . . . . 0.0 109.833 -177.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -105.43 116.3 31.71 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.577 -0.702 . . . . 0.0 109.454 168.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 69.3 mtm -108.5 131.13 55.13 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 123.372 0.669 . . . . 0.0 111.023 -178.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 77.6 mtm-85 -115.16 143.87 44.56 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.534 -0.729 . . . . 0.0 111.411 -175.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -149.17 124.07 9.96 Favored 'General case' 0 N--CA 1.484 1.259 0 CA-C-O 121.456 0.646 . . . . 0.0 110.707 166.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 62.0 24.71 14.75 Favored 'General case' 0 CA--C 1.581 2.17 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 -172.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 88.33 -28.96 5.89 Favored Glycine 0 CA--C 1.557 2.694 0 N-CA-C 118.256 2.062 . . . . 0.0 118.256 -158.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 87.4 t -72.19 120.58 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 CA-C-N 119.644 1.722 . . . . 0.0 110.588 -173.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 29.4 m -102.12 123.74 46.5 Favored 'General case' 0 CA--C 1.566 1.573 0 CA-C-O 121.585 0.707 . . . . 0.0 111.484 -173.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 10.7 t -96.0 138.18 34.0 Favored 'General case' 0 CA--C 1.559 1.316 0 C-N-CA 124.3 1.04 . . . . 0.0 111.475 162.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 6.0 mtmt -118.07 124.14 47.36 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.333 -0.854 . . . . 0.0 110.051 179.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -127.24 134.45 50.08 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 123.593 0.757 . . . . 0.0 111.353 -177.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 38.0 t -116.68 132.39 66.52 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.439 ' CZ ' ' SD ' ' A' ' 10' ' ' MET . 38.3 m-85 -126.89 134.84 50.39 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.999 0.92 . . . . 0.0 111.062 -178.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 74.9 tttt -99.89 137.24 38.62 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.636 -1.29 . . . . 0.0 112.446 -179.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -71.56 118.82 14.86 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 179.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 26.8 m -104.04 -40.72 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 174.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 76.9 t60 . . . . . 0 C--O 1.253 1.273 0 CA-C-N 119.629 1.104 . . . . 0.0 108.416 166.275 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.57 1.747 0 CA-C-O 117.636 -1.174 . . . . 0.0 109.382 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -78.78 168.12 21.41 Favored 'Trans proline' 0 CA--C 1.565 2.053 0 C-N-CA 122.555 2.17 . . . . 0.0 117.061 -172.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.1 t -81.9 139.85 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.53 -0.731 . . . . 0.0 110.76 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -67.92 99.41 0.84 Allowed 'General case' 0 CA--C 1.569 1.674 0 O-C-N 121.109 -0.994 . . . . 0.0 113.35 167.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 10.6 m-30 -79.26 5.46 12.28 Favored 'General case' 0 CA--C 1.579 2.086 0 N-CA-C 116.364 1.987 . . . . 0.0 116.364 175.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -60.43 116.09 4.05 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 125.711 1.604 . . . . 0.0 114.616 -176.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 162.89 -177.9 38.8 Favored Glycine 0 N--CA 1.482 1.767 0 N-CA-C 116.646 1.419 . . . . 0.0 116.646 179.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 24.2 t80 -111.25 122.78 48.75 Favored 'General case' 0 CA--C 1.564 1.484 0 CA-C-N 113.514 -1.343 . . . . 0.0 108.138 170.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 83.1 m95 -122.43 125.82 46.64 Favored 'General case' 0 CA--C 1.564 1.497 0 C-N-CA 123.47 0.708 . . . . 0.0 109.93 -167.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -101.21 139.19 37.22 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.111 -0.993 . . . . 0.0 112.816 -179.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.464 ' SD ' ' HD2' ' A' ' 38' ' ' PRO . 42.0 ttm -67.1 126.12 28.19 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-N 120.241 1.382 . . . . 0.0 113.912 -179.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 91.3 mt -85.07 -55.54 4.0 Favored 'General case' 0 CA--C 1.567 1.611 0 CA-C-N 115.723 -0.672 . . . . 0.0 112.55 163.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 99.7 p -138.65 150.25 46.05 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 123.526 0.73 . . . . 0.0 112.773 -177.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -132.76 104.74 6.77 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.683 0.754 . . . . 0.0 109.453 165.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -108.0 124.77 50.66 Favored 'General case' 0 CA--C 1.56 1.357 0 C-N-CA 124.155 0.982 . . . . 0.0 109.487 -170.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.286 33.4 t30 64.87 24.3 12.74 Favored 'General case' 0 N--CA 1.502 2.165 0 N-CA-C 117.105 2.261 . . . . 0.0 117.105 -173.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -68.21 -45.02 74.45 Favored 'General case' 0 CA--C 1.569 1.68 0 N-CA-C 115.271 1.582 . . . . 0.0 115.271 176.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -43.36 -50.5 6.75 Favored 'General case' 0 N--CA 1.501 2.124 0 N-CA-C 117.319 2.341 . . . . 0.0 117.319 164.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -71.68 -38.45 70.61 Favored 'General case' 0 CA--C 1.571 1.752 0 N-CA-C 115.563 1.69 . . . . 0.0 115.563 177.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 73.0 t80 -53.98 -47.52 71.32 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 114.907 1.447 . . . . 0.0 114.907 162.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 72.6 mt -62.17 -42.0 98.85 Favored 'General case' 0 CA--C 1.574 1.871 0 N-CA-C 114.681 1.363 . . . . 0.0 114.681 171.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 26.1 ttt-85 -50.41 -50.74 51.01 Favored 'General case' 0 N--CA 1.501 2.118 0 N-CA-C 115.586 1.699 . . . . 0.0 115.586 163.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.25 -23.2 55.23 Favored 'General case' 0 CA--C 1.566 1.576 0 N-CA-C 118.181 2.66 . . . . 0.0 118.181 167.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 96.1 mt -88.95 13.83 11.9 Favored 'General case' 0 CA--C 1.574 1.901 0 N-CA-C 115.484 1.661 . . . . 0.0 115.484 165.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 60.29 40.59 17.57 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 115.984 1.846 . . . . 0.0 115.984 -174.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 88.9 t -93.65 137.83 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 120.99 -1.069 . . . . 0.0 109.185 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.5 p-10 -66.83 150.24 49.44 Favored 'General case' 0 CA--C 1.567 1.628 0 N-CA-C 115.19 1.552 . . . . 0.0 115.19 178.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 77.5 t -53.31 -41.23 43.01 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.291 0 N-CA-C 116.057 1.873 . . . . 0.0 116.057 -175.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.54 -49.19 78.75 Favored 'General case' 0 CA--C 1.568 1.635 0 N-CA-C 115.726 1.75 . . . . 0.0 115.726 170.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.6 tt -65.53 -41.86 92.62 Favored 'General case' 0 CA--C 1.574 1.887 0 N-CA-C 114.66 1.355 . . . . 0.0 114.66 171.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 74.8 mtp180 -46.85 -52.14 15.0 Favored 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 115.773 1.768 . . . . 0.0 115.773 164.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -65.71 -47.29 75.88 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 114.88 1.437 . . . . 0.0 114.88 171.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 61.4 mt -55.73 -57.98 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 CA-C-N 120.289 1.404 . . . . 0.0 112.766 175.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.27 -36.56 73.46 Favored 'General case' 0 CA--C 1.564 1.49 0 N-CA-C 118.409 2.744 . . . . 0.0 118.409 176.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -73.59 -30.71 63.17 Favored 'General case' 0 CA--C 1.57 1.724 0 N-CA-C 116.017 1.858 . . . . 0.0 116.017 171.051 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 73.8 mt -72.0 -33.54 68.18 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 116.001 1.852 . . . . 0.0 116.001 173.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.9 pp -78.94 150.64 32.02 Favored 'General case' 0 CA--C 1.566 1.588 0 N-CA-C 114.678 1.362 . . . . 0.0 114.678 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -109.52 94.06 15.4 Favored Pre-proline 0 CA--C 1.571 1.784 0 CA-C-O 118.286 -0.864 . . . . 0.0 108.797 176.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.464 ' HD2' ' SD ' ' A' ' 10' ' ' MET . 83.3 Cg_endo -78.44 171.07 17.45 Favored 'Trans proline' 0 CA--C 1.563 1.966 0 C-N-CA 122.806 2.337 . . . . 0.0 114.504 -178.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -116.61 127.7 54.71 Favored 'General case' 0 CA--C 1.56 1.359 0 CA-C-N 114.992 -1.003 . . . . 0.0 110.405 177.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 58.1 mttm -91.15 113.11 25.29 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.088 -1.007 . . . . 0.0 109.739 170.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -94.48 112.41 24.18 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 165.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 63.6 mt -110.86 119.35 59.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 -174.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 95.4 t -101.9 98.98 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 166.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -95.87 113.45 25.08 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 123.316 0.647 . . . . 0.0 110.028 175.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -116.2 64.59 0.7 Allowed 'General case' 0 CA--C 1.569 1.692 0 O-C-N 121.477 -0.765 . . . . 0.0 110.36 171.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 66.3 -97.95 0.35 Allowed Glycine 0 N--CA 1.487 2.07 0 N-CA-C 115.743 1.057 . . . . 0.0 115.743 -179.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -76.86 -41.84 42.43 Favored 'General case' 0 CA--C 1.565 1.541 0 N-CA-C 115.832 1.79 . . . . 0.0 115.832 169.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 13.1 t-160 -84.12 122.85 29.38 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 120.699 1.591 . . . . 0.0 111.429 175.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 8.6 ttp -137.93 131.34 30.75 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-O 122.116 0.96 . . . . 0.0 111.857 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 48.3 mt -115.24 107.84 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 73.1 mt -98.36 106.15 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 173.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 69.8 mtt180 -95.97 103.52 15.41 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.24 -0.912 . . . . 0.0 110.307 174.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 23.7 m -85.49 103.05 14.01 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 175.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.4 mt -104.5 118.32 36.32 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 124.104 0.962 . . . . 0.0 109.189 -166.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 47.1 t -118.84 161.67 19.77 Favored 'General case' 0 CA--C 1.556 1.183 0 CA-C-O 122.27 1.034 . . . . 0.0 111.181 -170.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 70.6 p -65.99 -19.76 65.97 Favored 'General case' 0 N--CA 1.5 2.025 0 N-CA-C 116.191 1.922 . . . . 0.0 116.191 161.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -78.08 -67.9 0.69 Allowed 'General case' 0 CA--C 1.569 1.679 0 CA-C-N 119.477 1.035 . . . . 0.0 112.185 169.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . 0.263 64.9 ttt180 -151.08 -117.15 0.04 OUTLIER 'General case' 0 CA--C 1.577 1.981 0 CA-C-N 120.516 1.507 . . . . 0.0 111.074 163.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 49.6 t-20 -164.48 138.44 5.27 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.178 -1.576 . . . . 0.0 109.237 -168.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 25.7 t80 -98.07 -55.4 2.79 Favored 'General case' 0 N--CA 1.5 2.054 0 N-CA-C 115.455 1.65 . . . . 0.0 115.455 -173.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.332 3.7 mp 62.02 92.7 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 -176.025 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 45.9 mmm -91.54 94.28 9.36 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.007 -1.058 . . . . 0.0 108.718 160.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.8 p30 -100.13 108.76 20.97 Favored 'General case' 0 CA--C 1.559 1.308 0 C-N-CA 123.954 0.902 . . . . 0.0 110.918 176.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 40.6 p90 -147.67 149.3 32.22 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-O 122.546 1.165 . . . . 0.0 114.029 -165.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 16.5 mm-40 -91.75 123.27 35.01 Favored 'General case' 0 CA--C 1.559 1.326 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.739 160.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 66.3 t -62.45 125.18 18.37 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.787 0 C-N-CA 124.109 0.964 . . . . 0.0 110.539 176.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 100.92 -36.66 4.03 Favored Glycine 0 CA--C 1.55 2.278 0 N-CA-C 117.075 1.59 . . . . 0.0 117.075 -167.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 84.5 mttt -81.21 129.88 34.78 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-N 119.775 1.788 . . . . 0.0 112.207 -176.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -88.93 103.69 16.26 Favored 'General case' 0 CA--C 1.566 1.578 0 O-C-N 121.789 -0.569 . . . . 0.0 111.668 -179.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -106.11 147.73 28.63 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -173.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.46 125.34 28.81 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.7 -1.25 . . . . 0.0 112.759 170.145 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -76.41 68.34 2.74 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 122.66 1.219 . . . . 0.0 113.487 174.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -81.85 104.53 12.29 Favored 'General case' 0 CA--C 1.564 1.505 0 O-C-N 120.644 -1.285 . . . . 0.0 112.258 -169.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.7 tp 69.57 49.25 0.57 Allowed 'General case' 0 N--CA 1.503 2.202 0 N-CA-C 114.586 1.328 . . . . 0.0 114.586 178.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 12.4 t -93.95 -8.13 40.96 Favored 'General case' 0 N--CA 1.5 2.073 0 N-CA-C 118.716 2.858 . . . . 0.0 118.716 -171.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 90.24 165.04 40.28 Favored Glycine 0 CA--C 1.552 2.384 0 CA-C-N 121.122 1.783 . . . . 0.0 115.811 -169.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . 0.43 1.7 mp 68.79 -87.58 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.351 0 C-N-CA 124.387 1.075 . . . . 0.0 111.294 176.4 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -78.64 -40.87 32.97 Favored 'General case' 0 CA--C 1.57 1.723 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 163.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.6 t70 58.12 58.18 3.66 Favored 'General case' 0 CA--C 1.572 1.825 0 N-CA-C 115.289 1.589 . . . . 0.0 115.289 176.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.1 ttp85 -148.26 144.35 27.59 Favored 'General case' 0 CA--C 1.565 1.545 0 C-N-CA 123.212 0.605 . . . . 0.0 110.059 -169.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 61.3 mtpt -71.28 82.14 0.75 Allowed 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -177.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 89.2 m -93.27 127.11 38.73 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 123.128 0.571 . . . . 0.0 111.378 178.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 2.7 mmt -70.83 99.19 1.69 Allowed 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 121.816 0.817 . . . . 0.0 111.123 176.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 64.7 m -114.47 111.37 21.3 Favored 'General case' 0 N--CA 1.483 1.186 0 O-C-N 121.648 -0.657 . . . . 0.0 110.541 -156.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 36.9 m -95.37 129.64 42.44 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 169.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.1 t -108.58 129.2 63.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 163.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 49.4 m -133.89 141.25 47.29 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.291 -0.88 . . . . 0.0 111.109 -175.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 42.6 m95 -78.29 107.74 11.12 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.66 -1.275 . . . . 0.0 110.859 169.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -85.61 74.92 10.2 Favored 'General case' 0 CA--C 1.568 1.645 0 O-C-N 121.362 -0.836 . . . . 0.0 109.822 168.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.95 -98.46 0.36 Allowed Glycine 0 N--CA 1.487 2.086 0 CA-C-N 116.18 -0.464 . . . . 0.0 114.133 -167.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -105.86 -4.05 21.18 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 116.378 1.992 . . . . 0.0 116.378 173.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 41.7 mtpt -103.36 124.98 49.71 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-N 120.327 1.421 . . . . 0.0 109.247 177.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 24.7 tp -84.79 107.48 16.99 Favored 'General case' 0 CA--C 1.563 1.458 0 O-C-N 120.858 -1.151 . . . . 0.0 110.493 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -96.54 131.25 43.35 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.704 0.802 . . . . 0.0 111.065 -175.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 53.8 t -122.67 136.87 55.0 Favored 'General case' 0 N--CA 1.484 1.269 0 O-C-N 121.645 -0.66 . . . . 0.0 111.693 175.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.7 p -127.08 119.46 52.94 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.637 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 171.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 19.2 mp0 -91.93 104.83 17.2 Favored 'General case' 0 CA--C 1.565 1.541 0 C-N-CA 124.001 0.921 . . . . 0.0 109.976 173.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -91.26 131.44 36.77 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.161 -0.962 . . . . 0.0 112.442 -174.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 161.79 -98.37 0.16 Allowed Glycine 0 N--CA 1.485 1.92 0 O-C-N 121.949 -0.469 . . . . 0.0 112.854 168.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -77.41 -51.83 10.14 Favored 'General case' 0 CA--C 1.568 1.652 0 N-CA-C 115.649 1.722 . . . . 0.0 115.649 -177.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 58.3 mttm -99.31 143.03 30.04 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 122.613 1.197 . . . . 0.0 114.058 -160.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -83.95 97.33 9.19 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 122.144 0.973 . . . . 0.0 112.505 -166.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 82.31 41.48 9.23 Favored Glycine 0 N--CA 1.485 1.924 0 N-CA-C 117.443 1.737 . . . . 0.0 117.443 -168.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 64.0 ttt180 -77.25 113.01 14.56 Favored 'General case' 0 CA--C 1.566 1.594 0 CA-C-N 119.561 1.68 . . . . 0.0 110.41 164.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -169.3 177.79 42.77 Favored Glycine 0 N--CA 1.482 1.724 0 CA-C-O 122.184 0.88 . . . . 0.0 113.978 -177.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . 0.257 28.1 p-90 -152.13 158.47 42.99 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 171.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 33.5 m -129.14 118.64 22.77 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 176.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 -120.29 128.85 53.68 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 123.284 0.634 . . . . 0.0 111.79 -176.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 19.6 p90 -148.81 166.91 27.07 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.997 -1.064 . . . . 0.0 112.21 -179.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 96.2 mt -108.16 132.69 55.26 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.121 0 O-C-N 120.677 -1.264 . . . . 0.0 110.369 176.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -112.42 100.91 9.14 Favored 'General case' 0 CA--C 1.566 1.563 0 C-N-CA 123.796 0.838 . . . . 0.0 108.96 162.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 72.04 -109.51 2.85 Favored Glycine 0 N--CA 1.493 2.463 0 O-C-N 121.366 -0.833 . . . . 0.0 114.792 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -109.14 35.4 3.28 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 163.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -131.91 126.26 33.7 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.799 0.84 . . . . 0.0 109.53 -178.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 23.6 tp -88.6 118.45 28.26 Favored 'General case' 0 CA--C 1.56 1.363 0 C-N-CA 124.008 0.923 . . . . 0.0 109.954 173.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 44.8 m80 -105.47 120.83 42.6 Favored 'General case' 0 CA--C 1.56 1.328 0 C-N-CA 123.949 0.9 . . . . 0.0 108.972 -177.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 28.2 tp -119.38 123.81 45.04 Favored 'General case' 0 CA--C 1.561 1.397 0 C-N-CA 124.056 0.942 . . . . 0.0 109.798 -177.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -105.0 123.42 47.77 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.614 -0.679 . . . . 0.0 109.266 165.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 70.0 mtm -115.3 125.21 53.0 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-N 118.896 0.771 . . . . 0.0 110.659 178.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 69.3 mtp180 -112.89 144.64 42.1 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 123.169 0.588 . . . . 0.0 111.881 -178.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -156.89 129.76 7.73 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 123.079 0.551 . . . . 0.0 111.183 166.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 56.32 40.21 29.91 Favored 'General case' 0 N--CA 1.506 2.355 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 -172.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 77.47 -31.12 1.65 Allowed Glycine 0 CA--C 1.558 2.744 0 N-CA-C 119.536 2.575 . . . . 0.0 119.536 -160.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 90.0 t -77.87 123.39 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 CA-C-N 119.15 1.475 . . . . 0.0 111.114 -162.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 34.2 m -104.99 118.11 35.69 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 123.064 0.546 . . . . 0.0 111.629 -171.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 18.1 t -92.22 141.86 28.11 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.495 0.718 . . . . 0.0 112.006 163.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -117.75 118.16 31.3 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 123.348 0.659 . . . . 0.0 110.006 178.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 71.1 mt-30 -119.09 140.98 49.19 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 123.804 0.841 . . . . 0.0 111.695 179.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 25.0 t -128.46 132.56 67.91 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 177.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -126.64 139.86 52.85 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 123.584 0.754 . . . . 0.0 111.425 179.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 22.3 ttmt -99.49 139.73 34.71 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.881 -1.137 . . . . 0.0 112.67 178.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 73.7 tttt -73.66 118.83 17.08 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 178.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 34.2 m -103.03 -43.08 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 173.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 55.5 t-80 . . . . . 0 N--CA 1.484 1.266 0 CA-C-N 119.491 1.041 . . . . 0.0 108.259 168.079 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 26.7 ptt? . . . . . 0 CA--C 1.575 1.936 0 N-CA-C 113.7 1.0 . . . . 0.0 113.7 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -80.72 -137.97 0.02 OUTLIER 'Trans proline' 0 CA--C 1.575 2.571 0 C-N-CA 122.355 2.037 . . . . 0.0 114.039 173.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 22.9 t -131.27 139.14 51.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 -175.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -76.89 107.53 9.29 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.641 -1.287 . . . . 0.0 110.76 163.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 15.9 m-30 -80.98 14.79 2.08 Favored 'General case' 0 CA--C 1.582 2.207 0 N-CA-C 115.905 1.817 . . . . 0.0 115.905 173.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -62.68 111.99 2.32 Favored 'General case' 0 CA--C 1.563 1.474 0 C-N-CA 125.667 1.587 . . . . 0.0 115.136 -172.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 161.09 -178.17 37.15 Favored Glycine 0 N--CA 1.486 1.984 0 N-CA-C 116.026 1.17 . . . . 0.0 116.026 178.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -106.29 123.64 48.37 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-N 114.917 -0.642 . . . . 0.0 109.468 174.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 80.6 m95 -121.55 122.08 38.9 Favored 'General case' 0 CA--C 1.561 1.391 0 C-N-CA 123.481 0.712 . . . . 0.0 109.329 -169.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -96.47 140.87 30.48 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.313 -0.867 . . . . 0.0 112.711 176.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 41.9 ttm -69.47 124.23 23.35 Favored 'General case' 0 CA--C 1.569 1.705 0 O-C-N 120.94 -1.1 . . . . 0.0 113.129 176.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 91.9 mt -82.68 -50.29 8.88 Favored 'General case' 0 CA--C 1.564 1.486 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 165.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 87.3 p -151.75 154.53 36.46 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 119.285 0.948 . . . . 0.0 113.274 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -127.37 105.6 8.63 Favored 'General case' 0 CA--C 1.568 1.673 0 C-N-CA 123.64 0.776 . . . . 0.0 110.632 174.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -96.19 129.78 43.41 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 124.608 1.163 . . . . 0.0 109.965 -174.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 34.3 t30 62.39 18.31 10.19 Favored 'General case' 0 N--CA 1.506 2.368 0 N-CA-C 117.048 2.24 . . . . 0.0 117.048 -179.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -65.59 -42.1 92.08 Favored 'General case' 0 CA--C 1.566 1.583 0 N-CA-C 115.832 1.79 . . . . 0.0 115.832 -178.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -58.37 -39.06 78.58 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 116.243 1.942 . . . . 0.0 116.243 168.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -66.19 -45.78 79.62 Favored 'General case' 0 CA--C 1.571 1.78 0 N-CA-C 114.849 1.426 . . . . 0.0 114.849 170.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -52.82 -48.82 66.7 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 115.121 1.526 . . . . 0.0 115.121 165.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 64.5 mt -62.46 -40.73 97.6 Favored 'General case' 0 CA--C 1.57 1.745 0 N-CA-C 114.746 1.387 . . . . 0.0 114.746 171.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 65.1 ttp85 -55.56 -46.68 77.14 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 115.229 1.566 . . . . 0.0 115.229 164.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.1 -18.85 39.09 Favored 'General case' 0 CA--C 1.569 1.681 0 N-CA-C 118.29 2.7 . . . . 0.0 118.29 164.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 92.3 mt -91.83 15.31 13.23 Favored 'General case' 0 CA--C 1.574 1.898 0 N-CA-C 115.265 1.58 . . . . 0.0 115.265 163.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.259 49.7 m-20 66.72 39.86 3.43 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 115.887 1.81 . . . . 0.0 115.887 -177.523 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 65.6 t -99.61 140.9 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 120.815 -1.178 . . . . 0.0 110.489 -177.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 8.3 p-10 -71.33 156.52 39.41 Favored 'General case' 0 CA--C 1.569 1.679 0 N-CA-C 115.265 1.579 . . . . 0.0 115.265 174.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 61.9 t -53.14 -44.95 53.38 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.373 0 N-CA-C 115.27 1.581 . . . . 0.0 115.27 -177.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.57 -49.2 78.49 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 116.101 1.889 . . . . 0.0 116.101 174.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 31.9 tp -65.8 -36.67 84.16 Favored 'General case' 0 CA--C 1.573 1.842 0 N-CA-C 115.777 1.769 . . . . 0.0 115.777 171.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 55.1 mtp180 -51.36 -52.55 44.67 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 115.394 1.627 . . . . 0.0 115.394 160.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -63.13 -43.29 98.78 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 115.679 1.733 . . . . 0.0 115.679 172.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 59.3 mt -55.76 -55.31 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.192 0 CA-C-N 120.276 1.398 . . . . 0.0 112.72 170.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.86 -43.53 94.62 Favored 'General case' 0 CA--C 1.566 1.573 0 N-CA-C 117.294 2.331 . . . . 0.0 117.294 173.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -53.91 -39.97 66.27 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 117.471 2.397 . . . . 0.0 117.471 167.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 80.7 mt -86.27 -13.21 47.39 Favored 'General case' 0 CA--C 1.572 1.815 0 N-CA-C 116.103 1.89 . . . . 0.0 116.103 175.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 37.9 mt -80.07 133.12 36.08 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-N 119.949 1.25 . . . . 0.0 111.314 169.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 29.1 mmtp -101.31 93.04 2.94 Favored Pre-proline 0 CA--C 1.571 1.755 0 CA-C-O 118.045 -0.978 . . . . 0.0 109.705 171.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -72.41 154.3 55.78 Favored 'Trans proline' 0 CA--C 1.563 1.943 0 CA-C-N 122.852 2.054 . . . . 0.0 114.739 177.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -112.3 127.5 56.0 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.685 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 45.8 mttp -95.42 110.06 22.15 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.508 -0.745 . . . . 0.0 109.854 177.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -95.48 104.77 16.68 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.379 -0.826 . . . . 0.0 108.825 166.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 76.0 mt -98.55 118.29 44.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 -173.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 83.4 t -109.86 95.86 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 107.289 -1.375 . . . . 0.0 107.289 176.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -96.34 114.0 25.64 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 123.567 0.747 . . . . 0.0 111.084 177.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -132.16 93.27 3.24 Favored 'General case' 0 CA--C 1.566 1.577 0 C-N-CA 123.401 0.68 . . . . 0.0 110.004 -178.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 53.67 63.68 4.89 Favored Glycine 0 N--CA 1.497 2.756 0 N-CA-C 118.569 2.188 . . . . 0.0 118.569 172.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.471 0.0 OUTLIER 76.71 -34.56 0.22 Allowed 'General case' 0 N--CA 1.501 2.077 0 N-CA-C 117.317 2.34 . . . . 0.0 117.317 -164.423 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 9.4 t-160 -82.4 108.97 16.23 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 120.923 1.692 . . . . 0.0 110.898 178.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 6.5 ttp -121.25 125.1 46.26 Favored 'General case' 0 CA--C 1.556 1.194 0 CA-C-O 122.147 0.975 . . . . 0.0 110.888 -176.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 4.4 mp -110.1 104.43 17.06 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.353 0 N-CA-C 106.53 -1.656 . . . . 0.0 106.53 -178.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 80.0 mt -89.33 96.09 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 174.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 93.1 mtt180 -84.9 97.27 9.67 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.656 -0.652 . . . . 0.0 110.038 -178.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 51.0 m -89.78 101.39 14.08 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.761 0.791 . . . . 0.0 109.312 -178.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 16.1 mt -102.94 120.93 41.5 Favored 'General case' 0 N--CA 1.485 1.312 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.033 -164.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 10.3 t -136.7 146.53 45.98 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.684 -0.635 . . . . 0.0 111.629 -178.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . 0.253 13.7 t -77.73 56.19 1.46 Allowed 'General case' 0 N--CA 1.503 2.181 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 172.179 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -168.81 -67.82 0.02 OUTLIER 'General case' 0 CA--C 1.567 1.623 0 C-N-CA 125.274 1.429 . . . . 0.0 108.517 -177.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 62.9 ttt-85 -136.67 124.75 22.93 Favored 'General case' 0 CA--C 1.565 1.521 0 CA-C-N 118.754 0.706 . . . . 0.0 109.517 172.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 44.1 t-20 -85.26 130.59 34.57 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.78 -0.575 . . . . 0.0 111.038 170.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -95.96 -75.02 0.54 Allowed 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 118.899 -0.572 . . . . 0.0 112.338 -175.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.331 38.5 mt 74.62 108.75 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 C-N-CA 124.261 1.025 . . . . 0.0 111.9 178.28 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 86.9 mtp -104.95 99.22 8.85 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.478 -0.764 . . . . 0.0 109.491 170.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.7 p30 -96.97 108.54 21.28 Favored 'General case' 0 CA--C 1.56 1.365 0 C-N-CA 124.064 0.946 . . . . 0.0 111.935 176.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 35.2 p90 -148.68 151.91 35.75 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-N 119.029 0.831 . . . . 0.0 113.103 -168.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 54.6 mt-30 -89.86 135.23 33.76 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.289 -0.882 . . . . 0.0 110.796 161.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 41.0 t -69.56 109.54 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.28 -0.888 . . . . 0.0 109.305 179.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 128.27 -50.49 0.89 Allowed Glycine 0 CA--C 1.548 2.122 0 CA-C-O 118.542 -1.143 . . . . 0.0 115.904 -162.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 15.3 ptpt -70.41 139.22 51.79 Favored 'General case' 0 CA--C 1.566 1.578 0 CA-C-N 119.8 1.8 . . . . 0.0 115.231 -173.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -97.71 97.42 9.0 Favored 'General case' 0 CA--C 1.566 1.578 0 C-N-CA 123.116 0.566 . . . . 0.0 110.135 175.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -103.92 130.67 51.55 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 -170.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -69.21 111.75 5.35 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.671 -1.268 . . . . 0.0 113.524 175.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -81.88 92.83 6.77 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.22 -0.925 . . . . 0.0 110.683 -177.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.2 p30 -120.06 114.52 22.11 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 123.632 0.773 . . . . 0.0 111.702 -172.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . 0.291 12.0 tp 62.55 51.78 3.12 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 115.098 1.518 . . . . 0.0 115.098 -172.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 97.1 m -162.59 100.67 1.04 Allowed 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 106.139 -1.8 . . . . 0.0 106.139 177.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 122.36 -146.71 16.87 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 115.258 0.863 . . . . 0.0 115.258 177.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . 0.251 5.2 mp -108.83 -87.01 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 -175.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -85.08 65.63 9.33 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 120.266 1.394 . . . . 0.0 111.147 171.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.265 2.4 p30 -78.45 -70.79 0.47 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.38 -0.825 . . . . 0.0 112.523 -172.075 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . 0.252 6.6 tpm_? 53.27 36.95 24.04 Favored 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 118.635 2.828 . . . . 0.0 118.635 160.264 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . 0.261 99.6 mttt 60.44 40.23 17.49 Favored 'General case' 0 N--CA 1.501 2.099 0 N-CA-C 115.84 1.793 . . . . 0.0 115.84 -171.625 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 95.3 m -78.98 116.21 19.15 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.441 -1.412 . . . . 0.0 111.383 178.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 23.6 mtp -76.3 100.06 4.99 Favored 'General case' 0 CA--C 1.557 1.25 0 CA-C-O 122.434 1.111 . . . . 0.0 110.622 -170.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 88.5 m -103.23 112.89 25.97 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.329 -158.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 87.1 m -99.7 125.71 45.61 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 174.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 16.9 t -111.6 123.0 67.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 171.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 71.1 m -138.87 148.78 44.1 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.247 -0.908 . . . . 0.0 112.348 -175.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 10.9 m95 -82.79 122.76 28.61 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.68 -1.263 . . . . 0.0 113.694 -179.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -107.57 71.0 0.8 Allowed 'General case' 0 CA--C 1.572 1.815 0 C-N-CA 123.481 0.712 . . . . 0.0 109.737 160.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.24 -103.15 0.75 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 115.669 1.028 . . . . 0.0 115.669 -179.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -80.4 -25.17 39.22 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 116.322 1.971 . . . . 0.0 116.322 165.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -90.62 110.31 21.46 Favored 'General case' 0 N--CA 1.484 1.269 0 CA-C-N 119.861 1.21 . . . . 0.0 111.261 -179.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 32.7 tp -77.93 111.5 13.85 Favored 'General case' 0 CA--C 1.564 1.516 0 O-C-N 121.354 -0.841 . . . . 0.0 109.671 168.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 31.5 mm-40 -100.39 119.44 38.45 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.567 0.747 . . . . 0.0 110.862 -170.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 40.8 t -111.97 128.93 56.31 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.283 0.633 . . . . 0.0 111.068 175.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.1 p -126.83 121.04 57.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 CA-C-O 121.331 0.586 . . . . 0.0 109.845 174.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -100.79 98.8 9.28 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 124.018 0.927 . . . . 0.0 109.777 -174.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 55.4 mttp -90.84 118.06 29.95 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.337 -0.852 . . . . 0.0 112.238 -167.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 178.68 -118.95 0.63 Allowed Glycine 0 N--CA 1.486 2.008 0 O-C-N 121.137 -0.977 . . . . 0.0 113.624 172.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -75.74 -46.84 28.75 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 115.998 1.851 . . . . 0.0 115.998 -174.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 1.7 ttmp? -91.02 130.77 36.9 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 119.173 0.897 . . . . 0.0 112.081 -176.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -74.52 145.08 43.78 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -176.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 62.38 23.29 64.38 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 120.154 2.822 . . . . 0.0 120.154 -178.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 10.5 ttt85 -83.25 120.51 25.92 Favored 'General case' 0 CA--C 1.563 1.444 0 CA-C-N 119.165 1.483 . . . . 0.0 111.615 -179.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 172.99 -165.1 37.31 Favored Glycine 0 N--CA 1.484 1.865 0 CA-C-O 121.921 0.734 . . . . 0.0 114.605 -179.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 49.9 p-90 -157.14 158.09 35.69 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 114.341 1.237 . . . . 0.0 114.341 176.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 62.9 m -127.03 119.12 25.86 Favored 'General case' 0 CA--C 1.567 1.616 0 C-N-CA 124.117 0.967 . . . . 0.0 108.465 174.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -120.89 127.34 51.78 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.795 -0.566 . . . . 0.0 112.296 -175.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 23.6 p90 -142.76 169.75 16.99 Favored 'General case' 0 N--CA 1.499 1.977 0 C-N-CA 123.763 0.825 . . . . 0.0 112.978 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 94.5 mt -113.42 146.11 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.285 0 CA-C-O 123.145 1.45 . . . . 0.0 111.322 176.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -137.37 90.05 2.48 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 177.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 73.39 -119.35 6.59 Favored Glycine 0 N--CA 1.491 2.305 0 O-C-N 121.867 -0.521 . . . . 0.0 114.258 -172.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -91.16 11.44 23.26 Favored 'General case' 0 N--CA 1.5 2.045 0 N-CA-C 116.742 2.127 . . . . 0.0 116.742 165.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 75.8 mt-10 -111.29 138.29 47.95 Favored 'General case' 0 CA--C 1.56 1.34 0 CA-C-N 119.78 1.173 . . . . 0.0 111.999 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 10.4 tp -98.03 125.96 43.23 Favored 'General case' 0 CA--C 1.563 1.454 0 C-N-CA 123.902 0.881 . . . . 0.0 109.148 170.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 45.4 m80 -113.22 123.08 49.35 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.713 0.805 . . . . 0.0 109.126 -175.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 32.4 tp -122.59 122.26 38.43 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.596 0.758 . . . . 0.0 110.218 -174.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -100.51 117.15 34.06 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.715 -0.615 . . . . 0.0 109.589 164.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 74.3 mtm -105.09 125.93 51.52 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-N 118.782 0.719 . . . . 0.0 110.493 175.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 49.0 mtp180 -114.22 140.13 48.82 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.604 -0.685 . . . . 0.0 111.459 -174.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -151.51 126.75 9.91 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.787 -0.571 . . . . 0.0 110.616 167.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 61.72 28.92 17.87 Favored 'General case' 0 N--CA 1.504 2.232 0 N-CA-C 115.375 1.62 . . . . 0.0 115.375 -172.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 82.4 -27.6 3.62 Favored Glycine 0 CA--C 1.558 2.73 0 N-CA-C 118.693 2.237 . . . . 0.0 118.693 -158.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 96.4 t -73.8 119.38 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 CA-C-N 119.221 1.511 . . . . 0.0 110.416 -169.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 59.4 m -106.35 120.74 42.66 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.182 -169.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 6.6 t -97.31 122.8 40.75 Favored 'General case' 0 CA--C 1.558 1.28 0 C-N-CA 124.082 0.953 . . . . 0.0 111.528 170.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 85.6 mttt -96.19 119.62 35.02 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.824 -0.548 . . . . 0.0 110.059 176.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 18.2 mt-30 -119.68 123.4 43.73 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.706 -0.621 . . . . 0.0 110.686 -179.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 47.5 t -105.03 131.78 53.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 -177.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -126.17 149.08 49.24 Favored 'General case' 0 CA--C 1.563 1.455 0 C-N-CA 124.515 1.126 . . . . 0.0 110.511 -178.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 22.2 ttmt -118.62 141.0 49.01 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.94 -1.1 . . . . 0.0 112.002 175.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 61.6 tttt -74.87 126.43 30.93 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 179.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 33.3 m -107.09 -40.7 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 174.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 33.9 m170 . . . . . 0 C--O 1.255 1.354 0 CA-C-N 120.138 1.336 . . . . 0.0 108.784 -177.751 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.576 1.978 0 N-CA-C 113.834 1.05 . . . . 0.0 113.834 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -78.15 -122.12 0.01 OUTLIER 'Trans proline' 0 CA--C 1.575 2.531 0 C-N-CA 122.612 2.208 . . . . 0.0 114.634 -178.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 18.1 m -144.95 153.64 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 120.595 -1.316 . . . . 0.0 110.393 -171.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -73.3 98.64 2.72 Favored 'General case' 0 CA--C 1.569 1.679 0 O-C-N 121.1 -1.0 . . . . 0.0 112.362 174.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 7.4 m-30 -78.95 -9.55 59.55 Favored 'General case' 0 CA--C 1.577 2.012 0 N-CA-C 115.471 1.656 . . . . 0.0 115.471 161.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -57.9 116.36 3.43 Favored 'General case' 0 CA--C 1.564 1.485 0 CA-C-N 120.837 1.653 . . . . 0.0 114.713 -176.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 152.62 -177.59 30.26 Favored Glycine 0 N--CA 1.486 2.028 0 CA-C-O 122.54 1.078 . . . . 0.0 115.711 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -105.42 123.35 47.72 Favored 'General case' 0 CA--C 1.562 1.434 0 CA-C-N 114.638 -0.781 . . . . 0.0 109.514 178.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 72.2 m95 -122.81 126.02 46.59 Favored 'General case' 0 CA--C 1.567 1.605 0 C-N-CA 123.364 0.666 . . . . 0.0 110.004 -170.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 62.2 pttt -95.06 140.16 30.4 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.244 -0.91 . . . . 0.0 113.167 177.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 50.4 ttm -69.73 129.69 40.29 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.638 -1.289 . . . . 0.0 113.626 174.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 87.4 mt -94.4 -58.27 2.25 Favored 'General case' 0 CA--C 1.567 1.611 0 CA-C-N 115.584 -0.735 . . . . 0.0 112.65 170.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 94.2 p -139.48 130.02 25.73 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 119.632 1.106 . . . . 0.0 113.431 -165.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -102.41 81.45 2.06 Favored 'General case' 0 CA--C 1.568 1.671 0 C-N-CA 123.871 0.868 . . . . 0.0 110.277 176.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -93.93 114.61 26.86 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.656 -1.278 . . . . 0.0 111.013 -170.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.272 22.2 t30 63.15 27.09 15.56 Favored 'General case' 0 N--CA 1.506 2.355 0 N-CA-C 116.801 2.148 . . . . 0.0 116.801 -171.138 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -69.94 -49.18 54.43 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 115.18 1.548 . . . . 0.0 115.18 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 90.0 mt-10 -61.35 -35.52 77.66 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 116.506 2.039 . . . . 0.0 116.506 174.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -63.69 -42.99 97.93 Favored 'General case' 0 CA--C 1.576 1.948 0 N-CA-C 115.187 1.551 . . . . 0.0 115.187 167.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 28.2 t80 -56.31 -50.68 70.74 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 115.041 1.496 . . . . 0.0 115.041 165.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.2 mt -61.3 -40.67 95.02 Favored 'General case' 0 CA--C 1.573 1.834 0 N-CA-C 115.191 1.552 . . . . 0.0 115.191 173.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 41.9 ttp85 -51.15 -50.66 58.49 Favored 'General case' 0 CA--C 1.575 1.904 0 N-CA-C 115.086 1.513 . . . . 0.0 115.086 162.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.74 -19.3 58.65 Favored 'General case' 0 CA--C 1.573 1.83 0 N-CA-C 118.462 2.764 . . . . 0.0 118.462 168.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 43.7 mt -86.51 2.08 49.24 Favored 'General case' 0 CA--C 1.572 1.79 0 N-CA-C 116.12 1.896 . . . . 0.0 116.12 165.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 61.04 46.66 8.05 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 115.126 1.528 . . . . 0.0 115.126 -169.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 99.0 t -93.95 135.04 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.403 -0.81 . . . . 0.0 108.838 176.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.0 p-10 -67.91 147.55 52.33 Favored 'General case' 0 CA--C 1.566 1.584 0 N-CA-C 115.504 1.668 . . . . 0.0 115.504 179.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 25.3 t -49.32 -44.98 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.327 0 N-CA-C 115.796 1.776 . . . . 0.0 115.796 -174.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.99 -46.19 88.75 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 116.3 1.963 . . . . 0.0 116.3 173.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.62 -43.69 96.12 Favored 'General case' 0 CA--C 1.572 1.794 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 168.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 27.5 mtm-85 -53.37 -41.1 65.53 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 116.516 2.043 . . . . 0.0 116.516 167.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -68.6 -54.9 13.63 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 168.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 63.1 mt -54.47 -51.62 47.88 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.303 0 CA-C-N 120.435 1.47 . . . . 0.0 113.841 178.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.78 -38.66 91.95 Favored 'General case' 0 CA--C 1.562 1.435 0 N-CA-C 117.642 2.46 . . . . 0.0 117.642 175.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 16.4 t30 -72.44 -30.33 64.49 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 116.395 1.998 . . . . 0.0 116.395 170.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 83.4 mt -75.05 -32.85 61.64 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 115.331 1.604 . . . . 0.0 115.331 172.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 93.6 mt -81.35 142.2 33.27 Favored 'General case' 0 CA--C 1.564 1.505 0 CA-C-N 119.384 0.993 . . . . 0.0 112.139 174.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -106.94 84.89 1.7 Allowed Pre-proline 0 CA--C 1.575 1.917 0 CA-C-O 118.248 -0.882 . . . . 0.0 109.947 175.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -72.94 166.27 30.5 Favored 'Trans proline' 0 CA--C 1.563 1.965 0 C-N-CA 122.537 2.158 . . . . 0.0 116.028 -178.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -111.25 138.83 47.21 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.214 -177.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 58.6 mttm -104.88 111.65 24.48 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.399 -0.813 . . . . 0.0 109.376 173.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 54.9 tt0 -98.74 102.87 14.74 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 171.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 61.3 mt -97.67 123.68 50.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.513 -0.742 . . . . 0.0 109.202 -169.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 88.4 t -102.48 101.93 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 166.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -104.2 108.19 19.45 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 123.706 0.803 . . . . 0.0 110.358 -179.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -112.56 72.32 0.77 Allowed 'General case' 0 CA--C 1.567 1.634 0 O-C-N 121.683 -0.636 . . . . 0.0 110.634 175.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 68.48 -95.65 0.39 Allowed Glycine 0 N--CA 1.489 2.21 0 N-CA-C 115.014 0.766 . . . . 0.0 115.014 -179.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -86.67 -37.09 18.34 Favored 'General case' 0 CA--C 1.566 1.574 0 N-CA-C 115.743 1.757 . . . . 0.0 115.743 166.077 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 20.8 t-160 -80.66 113.66 19.01 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 121.099 1.772 . . . . 0.0 111.463 -178.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 46.6 ttm -130.5 123.19 29.12 Favored 'General case' 0 CA--C 1.555 1.165 0 CA-C-O 121.386 0.612 . . . . 0.0 110.074 -169.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 54.5 mt -115.86 101.22 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 87.9 mt -89.79 90.67 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -77.59 99.01 5.59 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.303 -0.873 . . . . 0.0 110.715 -173.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 29.4 m -97.13 105.64 17.83 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-O 121.803 0.811 . . . . 0.0 109.016 -169.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 22.2 mt -109.49 117.17 33.3 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.991 0.917 . . . . 0.0 110.072 -159.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 19.2 t -133.87 146.55 50.69 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 123.154 0.582 . . . . 0.0 111.976 -174.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 43.5 p -79.92 61.66 3.89 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.122 -0.986 . . . . 0.0 112.631 172.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -169.95 -70.79 0.02 OUTLIER 'General case' 0 CA--C 1.569 1.693 0 C-N-CA 125.648 1.579 . . . . 0.0 107.513 178.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 32.1 mtt180 -139.8 131.5 27.35 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 123.803 0.841 . . . . 0.0 109.648 171.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -85.4 129.14 34.88 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.039 0.447 . . . . 0.0 111.027 176.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -91.35 -77.4 0.42 Allowed 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 123.146 0.579 . . . . 0.0 111.972 -172.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.36 14.9 mt 79.46 108.35 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 C-N-CA 124.216 1.006 . . . . 0.0 110.986 -179.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.76 95.74 6.85 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 123.513 0.725 . . . . 0.0 109.729 177.064 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -101.53 116.34 32.55 Favored 'General case' 0 CA--C 1.564 1.515 0 C-N-CA 124.228 1.011 . . . . 0.0 112.321 -175.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -157.91 156.44 31.33 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 115.07 1.507 . . . . 0.0 115.07 -171.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -104.23 119.24 38.52 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 123.474 0.709 . . . . 0.0 109.857 167.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 54.0 t -61.98 128.9 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 C-N-CA 123.936 0.894 . . . . 0.0 111.674 -178.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 99.74 -37.13 3.67 Favored Glycine 0 CA--C 1.55 2.279 0 N-CA-C 116.704 1.442 . . . . 0.0 116.704 -163.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 77.7 mttt -89.43 129.83 35.88 Favored 'General case' 0 CA--C 1.565 1.539 0 CA-C-N 118.88 1.34 . . . . 0.0 111.746 -172.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -81.84 106.61 13.9 Favored 'General case' 0 CA--C 1.567 1.615 0 O-C-N 121.321 -0.862 . . . . 0.0 111.771 178.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -109.88 148.89 30.72 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 123.856 0.862 . . . . 0.0 112.006 -175.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.62 124.09 23.04 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.2 -1.562 . . . . 0.0 111.73 168.15 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -74.13 89.9 2.01 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-N 119.137 0.88 . . . . 0.0 111.612 -174.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -86.3 166.37 15.7 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 117.708 2.485 . . . . 0.0 117.708 -139.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . 0.338 2.9 tt 74.79 -76.54 0.06 Allowed 'General case' 0 N--CA 1.499 1.994 0 C-N-CA 124.87 1.268 . . . . 0.0 112.135 -176.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 39.0 p -128.18 -47.33 1.34 Allowed 'General case' 0 N--CA 1.5 2.036 0 C-N-CA 124.345 1.058 . . . . 0.0 111.565 168.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 101.4 -127.12 9.13 Favored Glycine 0 CA--C 1.54 1.626 0 C-N-CA 123.695 0.664 . . . . 0.0 111.467 -177.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 54.1 mt -84.6 -59.74 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 CA-C-O 119.15 -0.452 . . . . 0.0 110.449 172.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . 0.252 26.5 t70 -100.21 -91.9 0.29 Allowed 'General case' 0 CA--C 1.568 1.652 0 CA-C-O 118.052 -0.975 . . . . 0.0 109.453 172.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -154.2 71.29 0.84 Allowed 'General case' 0 N--CA 1.498 1.964 0 CA-C-N 121.118 1.781 . . . . 0.0 112.399 178.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.14 134.2 3.44 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.226 -0.921 . . . . 0.0 110.46 174.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 72.1 mttt -85.66 93.25 8.79 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.38 -0.825 . . . . 0.0 111.155 -176.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 74.1 m -92.47 135.21 34.24 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 -167.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 1.1 mmt -70.55 98.18 1.43 Allowed 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 122.216 1.008 . . . . 0.0 111.697 -176.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 95.5 m -112.36 114.53 27.31 Favored 'General case' 0 N--CA 1.481 1.115 0 O-C-N 121.51 -0.744 . . . . 0.0 110.452 -157.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 63.0 m -92.79 124.47 36.81 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 168.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.7 t -112.3 130.33 66.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 169.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 74.9 m -134.79 140.34 45.81 Favored 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 123.791 0.836 . . . . 0.0 111.989 -173.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 8.4 m95 -80.98 116.35 20.9 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.457 -1.402 . . . . 0.0 112.874 177.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 38.8 t0 -103.66 67.18 0.89 Allowed 'General case' 0 CA--C 1.576 1.95 0 C-N-CA 124.063 0.945 . . . . 0.0 110.189 164.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 68.08 -105.82 1.53 Allowed Glycine 0 N--CA 1.492 2.418 0 N-CA-C 115.641 1.016 . . . . 0.0 115.641 -179.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -72.87 -30.25 63.83 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 115.123 1.527 . . . . 0.0 115.123 163.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 24.0 mttt -92.78 110.59 22.03 Favored 'General case' 0 CA--C 1.557 1.221 0 CA-C-N 119.443 1.019 . . . . 0.0 111.62 -171.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 29.0 tp -82.07 105.57 13.28 Favored 'General case' 0 CA--C 1.563 1.479 0 O-C-N 120.47 -1.394 . . . . 0.0 110.164 171.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 11.2 mm100 -87.42 145.89 26.1 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 124.51 1.124 . . . . 0.0 110.721 -174.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 42.9 t -143.63 133.47 23.93 Favored 'General case' 0 N--CA 1.484 1.25 0 O-C-N 121.541 -0.724 . . . . 0.0 112.421 178.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.2 p -118.33 123.8 72.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 165.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -104.46 97.09 7.06 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 123.626 0.77 . . . . 0.0 109.427 -178.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -83.42 111.43 19.03 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.761 -1.212 . . . . 0.0 111.425 -170.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 162.56 103.98 0.18 Allowed Glycine 0 N--CA 1.483 1.798 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.898 -172.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . 0.282 42.3 mt-10 69.61 -68.47 0.19 Allowed 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 116.142 1.904 . . . . 0.0 116.142 174.027 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -82.08 129.89 34.93 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 122.153 0.978 . . . . 0.0 111.242 -170.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -67.78 -45.97 73.3 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 116.096 1.887 . . . . 0.0 116.096 -162.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -101.68 54.52 0.78 Allowed Glycine 0 N--CA 1.49 2.286 0 CA-C-O 118.63 -1.095 . . . . 0.0 115.727 164.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.9 ttt-85 -85.25 116.88 23.85 Favored 'General case' 0 CA--C 1.565 1.543 0 CA-C-N 118.844 1.322 . . . . 0.0 112.062 -179.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 178.7 -173.24 45.58 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 115.139 0.816 . . . . 0.0 115.139 -174.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . 0.279 49.6 p-90 -155.48 167.89 28.92 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 123.338 1.542 . . . . 0.0 113.918 174.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 96.0 m -144.93 114.14 7.01 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.147 -1.596 . . . . 0.0 107.81 174.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 45.6 tt0 -114.67 127.56 55.83 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 123.566 0.746 . . . . 0.0 111.444 -173.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 9.6 p90 -148.34 154.85 40.54 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.706 -1.246 . . . . 0.0 113.679 -174.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 94.8 mt -98.84 133.98 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 O-C-N 120.793 -1.192 . . . . 0.0 110.823 176.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -120.09 91.79 3.62 Favored 'General case' 0 CA--C 1.567 1.618 0 C-N-CA 124.291 1.036 . . . . 0.0 108.387 162.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 69.36 -113.17 4.96 Favored Glycine 0 N--CA 1.492 2.402 0 O-C-N 121.238 -0.914 . . . . 0.0 114.927 -177.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -84.54 -8.75 58.81 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 117.423 2.379 . . . . 0.0 117.423 167.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 62.1 mt-10 -99.95 126.56 46.13 Favored 'General case' 0 CA--C 1.56 1.363 0 CA-C-N 120.549 1.522 . . . . 0.0 111.292 -176.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 21.2 tp -89.22 115.5 26.77 Favored 'General case' 0 CA--C 1.563 1.448 0 C-N-CA 124.224 1.01 . . . . 0.0 109.122 164.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 48.7 m80 -101.83 119.09 38.23 Favored 'General case' 0 CA--C 1.556 1.207 0 C-N-CA 123.979 0.911 . . . . 0.0 108.857 -178.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 42.7 tp -113.31 114.76 27.12 Favored 'General case' 0 CA--C 1.557 1.228 0 C-N-CA 123.677 0.791 . . . . 0.0 109.642 179.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -90.04 126.88 35.92 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.906 -0.496 . . . . 0.0 109.74 163.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 75.5 mtm -119.99 127.79 52.94 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-N 118.658 0.663 . . . . 0.0 110.297 176.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 88.0 mtm-85 -114.82 141.26 48.13 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 123.429 0.692 . . . . 0.0 111.326 -174.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -150.29 131.05 14.09 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.676 -0.64 . . . . 0.0 110.931 163.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 54.79 34.4 21.79 Favored 'General case' 0 N--CA 1.507 2.415 0 N-CA-C 116.169 1.914 . . . . 0.0 116.169 -172.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 76.43 -1.29 61.56 Favored Glycine 0 CA--C 1.557 2.709 0 N-CA-C 120.173 2.829 . . . . 0.0 120.173 -165.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 89.6 t -98.7 120.09 47.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 CA-C-N 120.453 2.126 . . . . 0.0 109.49 -173.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 30.7 m -102.88 120.9 41.44 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 123.243 0.617 . . . . 0.0 111.357 -172.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 33.5 t -92.32 140.34 29.7 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 123.384 0.674 . . . . 0.0 112.041 161.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 33.9 mtpt -104.24 114.94 29.53 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.6 -0.688 . . . . 0.0 110.564 164.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -104.48 124.27 48.97 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.334 0.654 . . . . 0.0 110.291 168.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 62.7 t -109.93 132.79 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -127.23 134.96 50.03 Favored 'General case' 0 CA--C 1.561 1.398 0 C-N-CA 124.104 0.962 . . . . 0.0 110.823 -177.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -103.57 137.38 41.72 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.837 -1.165 . . . . 0.0 112.493 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 71.4 tttt -71.35 125.79 27.93 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 177.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 27.7 m -116.24 -40.17 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.128 0 N-CA-C 114.058 1.133 . . . . 0.0 114.058 177.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 50.5 t60 . . . . . 0 N--CA 1.487 1.395 0 CA-C-N 120.47 1.487 . . . . 0.0 108.53 175.229 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 CA--C 1.571 1.781 0 CA-C-O 118.201 -0.904 . . . . 0.0 109.671 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -79.93 105.86 1.86 Allowed 'Trans proline' 0 C--N 1.371 1.727 0 C-N-CA 122.395 2.063 . . . . 0.0 113.919 -177.005 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 27.6 m -78.38 155.16 5.06 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.687 0 CA-C-N 114.71 -1.132 . . . . 0.0 113.262 -174.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -68.93 100.93 1.27 Allowed 'General case' 0 CA--C 1.563 1.453 0 O-C-N 120.93 -1.106 . . . . 0.0 113.93 176.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 4.5 m-30 -70.61 -1.5 11.36 Favored 'General case' 0 CA--C 1.581 2.161 0 N-CA-C 116.871 2.175 . . . . 0.0 116.871 177.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -45.05 111.03 0.28 Allowed 'General case' 0 CA--C 1.566 1.569 0 N-CA-C 116.122 1.897 . . . . 0.0 116.122 173.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 165.96 175.85 36.76 Favored Glycine 0 N--CA 1.484 1.848 0 N-CA-C 116.313 1.285 . . . . 0.0 116.313 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 12.7 t80 -110.19 125.65 53.28 Favored 'General case' 0 CA--C 1.562 1.409 0 CA-C-N 113.952 -1.124 . . . . 0.0 108.657 173.214 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 82.3 m95 -124.67 127.4 47.24 Favored 'General case' 0 CA--C 1.565 1.539 0 C-N-CA 123.49 0.716 . . . . 0.0 109.982 -167.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -97.1 140.37 31.71 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.188 -0.945 . . . . 0.0 112.853 175.368 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 37.4 ttm -70.79 125.08 25.86 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.819 -1.176 . . . . 0.0 113.024 177.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 90.2 mt -84.62 -51.56 6.76 Favored 'General case' 0 CA--C 1.566 1.595 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 167.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 92.3 p -144.52 150.75 38.08 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 118.806 0.73 . . . . 0.0 112.2 177.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -125.84 114.11 18.13 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 123.13 0.572 . . . . 0.0 109.734 165.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -115.25 124.1 50.5 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 123.387 0.675 . . . . 0.0 109.651 -168.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.264 23.4 t30 62.16 25.26 15.11 Favored 'General case' 0 N--CA 1.504 2.251 0 N-CA-C 116.699 2.111 . . . . 0.0 116.699 -172.224 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -67.8 -43.5 79.51 Favored 'General case' 0 CA--C 1.567 1.633 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 175.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -45.96 -50.0 15.22 Favored 'General case' 0 N--CA 1.505 2.324 0 N-CA-C 116.433 2.012 . . . . 0.0 116.433 167.193 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -70.86 -41.01 71.95 Favored 'General case' 0 CA--C 1.57 1.747 0 N-CA-C 115.463 1.653 . . . . 0.0 115.463 178.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -50.84 -49.38 59.03 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 114.9 1.445 . . . . 0.0 114.9 160.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 81.2 mt -62.96 -39.5 94.84 Favored 'General case' 0 CA--C 1.574 1.877 0 N-CA-C 114.866 1.432 . . . . 0.0 114.866 173.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 69.0 ttp85 -52.45 -50.97 61.55 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 115.087 1.514 . . . . 0.0 115.087 164.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.54 -14.88 22.49 Favored 'General case' 0 CA--C 1.572 1.79 0 N-CA-C 118.545 2.794 . . . . 0.0 118.545 167.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 94.8 mt -97.36 16.48 19.95 Favored 'General case' 0 CA--C 1.57 1.742 0 N-CA-C 115.159 1.54 . . . . 0.0 115.159 164.463 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 60.74 45.37 10.14 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 115.547 1.684 . . . . 0.0 115.547 -177.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 98.0 t -99.83 138.24 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.22 -0.925 . . . . 0.0 109.794 -178.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 12.6 p30 -63.68 152.28 39.51 Favored 'General case' 0 CA--C 1.57 1.746 0 N-CA-C 115.112 1.523 . . . . 0.0 115.112 176.124 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . 0.251 78.8 t -58.62 -40.8 80.3 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.303 0 N-CA-C 115.307 1.595 . . . . 0.0 115.307 -177.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.26 -50.18 72.08 Favored 'General case' 0 CA--C 1.567 1.607 0 N-CA-C 115.953 1.834 . . . . 0.0 115.953 168.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 25.4 tp -66.9 -38.82 86.97 Favored 'General case' 0 CA--C 1.573 1.829 0 N-CA-C 116.052 1.871 . . . . 0.0 116.052 171.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 69.6 mtp180 -50.85 -47.87 60.19 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 115.303 1.594 . . . . 0.0 115.303 162.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -65.05 -54.42 30.49 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 170.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 61.6 mt -51.77 -55.66 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.246 0 CA-C-N 120.41 1.459 . . . . 0.0 113.172 175.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.23 -35.89 80.28 Favored 'General case' 0 CA--C 1.563 1.453 0 N-CA-C 118.352 2.723 . . . . 0.0 118.352 176.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -76.16 -33.43 59.37 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 116.018 1.859 . . . . 0.0 116.018 171.117 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 77.2 mt -72.85 -36.54 67.45 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 115.387 1.625 . . . . 0.0 115.387 178.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . 0.262 3.7 pp -93.92 151.94 19.21 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 119.327 0.967 . . . . 0.0 113.208 179.457 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 28.0 mmtp -108.42 93.37 11.48 Favored Pre-proline 0 CA--C 1.574 1.871 0 CA-C-O 118.078 -0.963 . . . . 0.0 110.03 -173.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -75.6 169.37 22.47 Favored 'Trans proline' 0 CA--C 1.565 2.043 0 C-N-CA 122.664 2.243 . . . . 0.0 115.605 -178.001 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -112.67 134.05 54.39 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-N 116.03 -0.532 . . . . 0.0 112.106 -177.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 23.5 mtpp -102.51 113.88 27.6 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.037 -1.04 . . . . 0.0 110.578 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -97.99 109.68 22.39 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.694 -0.629 . . . . 0.0 109.319 167.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 76.2 mt -102.42 120.56 52.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 -179.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 88.9 t -109.85 95.05 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 174.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -86.87 97.13 10.49 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 123.324 0.65 . . . . 0.0 110.362 173.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -102.27 70.46 1.18 Allowed 'General case' 0 CA--C 1.567 1.633 0 C-N-CA 123.556 0.742 . . . . 0.0 111.332 -178.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 57.94 65.8 3.27 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 117.368 1.707 . . . . 0.0 117.368 177.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.478 0.0 OUTLIER 82.07 -36.99 0.1 Allowed 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 116.473 2.027 . . . . 0.0 116.473 -165.235 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 12.3 t-160 -79.81 95.29 5.98 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-N 120.834 1.652 . . . . 0.0 110.513 175.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 4.1 ttp -104.6 119.52 39.19 Favored 'General case' 0 CA--C 1.552 1.052 0 CA-C-O 121.982 0.896 . . . . 0.0 110.094 -175.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 37.4 mt -106.32 101.16 12.05 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.479 0 N-CA-C 106.587 -1.634 . . . . 0.0 106.587 -178.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 88.1 mt -89.3 111.91 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 177.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 90.3 mtt180 -109.6 100.27 9.34 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -174.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 16.8 m -92.99 109.62 21.07 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 39.7 mt -102.64 123.62 46.69 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.349 0.66 . . . . 0.0 110.938 -159.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 10.2 t -151.01 160.51 43.88 Favored 'General case' 0 CA--C 1.571 1.763 0 CA-C-O 121.31 0.576 . . . . 0.0 112.474 -176.001 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.0 t -63.05 -36.07 82.35 Favored 'General case' 0 N--CA 1.504 2.235 0 N-CA-C 117.738 2.496 . . . . 0.0 117.738 175.386 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -76.48 -52.32 10.04 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 175.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.6 tmm_? -149.05 138.03 21.37 Favored 'General case' 0 CA--C 1.56 1.349 0 C-N-CA 124.212 1.005 . . . . 0.0 108.767 -178.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -102.06 114.93 29.48 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 174.172 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -87.54 121.42 29.96 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 122.862 0.465 . . . . 0.0 110.598 -173.204 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 43.2 mm -114.27 101.98 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 -177.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 76.5 mtp -95.28 90.53 5.88 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.126 -0.984 . . . . 0.0 109.132 169.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.6 p30 -95.15 108.17 20.27 Favored 'General case' 0 CA--C 1.561 1.376 0 C-N-CA 123.821 0.849 . . . . 0.0 111.82 178.045 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 29.4 p90 -147.77 142.88 27.1 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 113.844 1.054 . . . . 0.0 113.844 -169.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 17.1 mp0 -79.96 123.46 27.82 Favored 'General case' 0 CA--C 1.563 1.459 0 O-C-N 121.543 -0.723 . . . . 0.0 110.289 162.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 46.9 t -65.98 117.68 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 C-N-CA 123.315 0.646 . . . . 0.0 110.422 -179.204 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 115.44 -45.18 1.34 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 116.006 1.162 . . . . 0.0 116.006 -160.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -82.29 144.15 30.81 Favored 'General case' 0 CA--C 1.567 1.617 0 CA-C-N 118.802 1.301 . . . . 0.0 113.284 -173.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -95.14 111.56 23.38 Favored 'General case' 0 CA--C 1.564 1.504 0 O-C-N 121.76 -0.588 . . . . 0.0 111.481 176.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 22.8 p90 -106.94 142.74 36.07 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 123.33 0.652 . . . . 0.0 112.748 -177.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -71.13 114.2 8.95 Favored 'General case' 0 CA--C 1.567 1.622 0 O-C-N 120.358 -1.464 . . . . 0.0 112.177 170.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -79.85 80.33 6.26 Favored 'General case' 0 CA--C 1.568 1.646 0 CA-C-O 122.125 0.965 . . . . 0.0 111.266 -175.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -112.18 -38.9 4.6 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 124.033 0.933 . . . . 0.0 113.479 176.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.1 pp -69.53 102.33 1.8 Allowed 'General case' 0 CA--C 1.567 1.608 0 CA-C-N 120.308 1.413 . . . . 0.0 111.768 173.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . 0.254 30.4 p 74.45 122.0 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.014 0 C-N-CA 124.308 1.043 . . . . 0.0 112.911 -177.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -140.41 177.38 20.76 Favored Glycine 0 N--CA 1.49 2.259 0 CA-C-O 122.353 0.974 . . . . 0.0 115.078 -179.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 50.2 mm -82.71 -79.69 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 170.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 40.6 t0 -87.48 167.03 14.34 Favored 'General case' 0 CA--C 1.575 1.918 0 CA-C-O 121.818 0.818 . . . . 0.0 110.089 152.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -75.83 78.57 2.75 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.318 -1.489 . . . . 0.0 112.191 177.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 8.0 tpm_? -136.02 114.44 11.71 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.692 0.797 . . . . 0.0 109.357 -170.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 55.5 mtmt -74.87 127.92 34.35 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 123.127 0.571 . . . . 0.0 111.981 178.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 93.5 m -136.69 124.69 22.82 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 121.469 0.652 . . . . 0.0 111.24 179.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 80.6 mmm -71.61 103.73 3.11 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 121.714 0.768 . . . . 0.0 110.277 177.223 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 92.1 m -109.56 111.53 23.09 Favored 'General case' 0 N--CA 1.483 1.178 0 O-C-N 121.671 -0.643 . . . . 0.0 110.866 -159.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 95.1 m -94.71 128.24 41.25 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 170.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.9 t -116.41 129.66 72.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 172.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 58.2 m -149.09 157.12 43.14 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.423 -1.423 . . . . 0.0 113.316 -177.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 45.7 m95 -86.84 123.61 32.16 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.751 -1.218 . . . . 0.0 113.775 -174.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -109.35 73.3 0.84 Allowed 'General case' 0 CA--C 1.57 1.712 0 C-N-CA 124.064 0.946 . . . . 0.0 109.356 164.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.0 -125.14 29.68 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 114.637 0.615 . . . . 0.0 114.637 -172.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -61.12 -19.81 61.93 Favored 'General case' 0 N--CA 1.501 2.09 0 N-CA-C 116.526 2.047 . . . . 0.0 116.526 166.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 43.7 mttt -97.15 121.11 38.67 Favored 'General case' 0 CA--C 1.556 1.206 0 CA-C-N 119.554 1.07 . . . . 0.0 111.554 -174.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 24.3 tp -84.68 108.05 17.2 Favored 'General case' 0 CA--C 1.565 1.544 0 O-C-N 121.326 -0.859 . . . . 0.0 109.086 170.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -93.81 132.02 38.62 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.703 0.801 . . . . 0.0 111.036 -176.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 42.1 t -126.96 128.28 46.16 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.213 0.605 . . . . 0.0 111.315 178.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 12.7 p -109.8 118.12 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 168.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 55.7 mt-30 -99.42 73.69 1.87 Allowed 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 123.577 0.751 . . . . 0.0 109.813 178.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -83.96 134.13 34.67 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.577 -1.327 . . . . 0.0 113.781 -169.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 178.46 -85.03 0.07 OUTLIER Glycine 0 N--CA 1.485 1.932 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.955 -177.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -104.16 -58.25 1.91 Allowed 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 177.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -76.88 133.26 39.34 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 119.985 1.266 . . . . 0.0 112.07 -173.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -61.52 -54.73 39.34 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 116.171 1.915 . . . . 0.0 116.171 -167.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -98.67 53.42 1.11 Allowed Glycine 0 N--CA 1.489 2.177 0 N-CA-C 115.97 1.148 . . . . 0.0 115.97 169.223 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 25.7 ttt-85 -87.57 118.62 27.17 Favored 'General case' 0 CA--C 1.563 1.479 0 CA-C-N 118.685 1.243 . . . . 0.0 111.713 179.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 171.18 -168.9 42.02 Favored Glycine 0 N--CA 1.485 1.918 0 CA-C-O 121.892 0.718 . . . . 0.0 114.226 -179.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 38.5 p-90 -155.99 157.07 35.57 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 176.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 83.1 m -125.89 114.21 18.24 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 175.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 41.1 tt0 -117.57 123.01 45.19 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 123.413 0.685 . . . . 0.0 111.142 -175.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 12.5 p90 -144.36 148.58 34.9 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.966 -1.084 . . . . 0.0 113.229 -176.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 94.3 mt -97.3 135.87 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 CA-C-O 122.374 1.083 . . . . 0.0 110.374 177.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -122.9 87.21 2.71 Favored 'General case' 0 CA--C 1.563 1.445 0 CA-C-N 114.214 -1.357 . . . . 0.0 107.781 174.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 70.97 -105.25 1.58 Allowed Glycine 0 N--CA 1.491 2.323 0 O-C-N 121.488 -0.758 . . . . 0.0 114.714 -175.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 54.8 p30 -99.95 7.23 44.97 Favored 'General case' 0 CA--C 1.574 1.898 0 N-CA-C 116.868 2.173 . . . . 0.0 116.868 169.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -115.33 130.11 56.8 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-N 120.43 1.468 . . . . 0.0 111.694 -178.008 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 13.3 tp -90.94 115.56 28.06 Favored 'General case' 0 CA--C 1.561 1.384 0 C-N-CA 124.224 1.01 . . . . 0.0 109.356 170.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 43.4 m80 -102.31 122.45 44.27 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.873 0.869 . . . . 0.0 109.04 -178.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 49.3 tp -122.96 117.63 25.96 Favored 'General case' 0 CA--C 1.56 1.34 0 C-N-CA 123.701 0.801 . . . . 0.0 109.924 -174.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -104.77 107.87 19.05 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 169.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 68.5 mtm -100.18 128.5 46.24 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.881 -0.512 . . . . 0.0 110.682 178.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 68.5 mtp180 -115.03 143.45 45.17 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.656 -0.653 . . . . 0.0 111.868 -178.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -148.34 130.07 15.09 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.601 -0.687 . . . . 0.0 111.567 164.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 58.27 25.6 12.88 Favored 'General case' 0 N--CA 1.506 2.361 0 N-CA-C 115.716 1.746 . . . . 0.0 115.716 -167.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 90.37 -34.04 4.31 Favored Glycine 0 CA--C 1.557 2.685 0 N-CA-C 118.095 1.998 . . . . 0.0 118.095 -159.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 76.5 t -70.49 119.41 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 CA-C-N 119.276 1.538 . . . . 0.0 111.614 -165.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 21.0 m -95.13 123.36 38.58 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.166 0.507 . . . . 0.0 112.091 -173.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 10.4 t -94.03 130.87 40.0 Favored 'General case' 0 CA--C 1.561 1.383 0 C-N-CA 123.518 0.727 . . . . 0.0 110.99 159.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -108.36 111.63 23.65 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.558 -0.713 . . . . 0.0 109.45 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -111.46 132.07 54.75 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 123.612 0.765 . . . . 0.0 111.384 178.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 43.9 t -115.35 130.42 69.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 176.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -126.59 141.63 51.8 Favored 'General case' 0 CA--C 1.563 1.448 0 C-N-CA 124.232 1.013 . . . . 0.0 110.78 -178.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 10.3 tmtt? -110.46 139.7 45.42 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.966 -1.084 . . . . 0.0 112.288 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 37.0 tttp -73.68 117.23 15.21 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 113.464 0.913 . . . . 0.0 113.464 -177.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . 0.263 34.8 m -103.25 -39.28 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.152 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 174.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 38.2 t60 . . . . . 0 N--CA 1.486 1.344 0 CA-C-N 119.863 1.21 . . . . 0.0 107.956 163.654 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 56.7 mtm . . . . . 0 CA--C 1.575 1.921 0 CA-C-O 118.559 -0.734 . . . . 0.0 112.633 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -72.28 -99.07 0.01 OUTLIER 'Trans proline' 0 CA--C 1.575 2.555 0 C-N-CA 122.906 2.404 . . . . 0.0 114.877 179.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -152.77 164.56 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 -178.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -87.85 104.67 16.81 Favored 'General case' 0 CA--C 1.567 1.612 0 O-C-N 119.89 -1.756 . . . . 0.0 111.308 167.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -88.73 3.52 50.59 Favored 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 115.808 1.781 . . . . 0.0 115.808 171.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 62.8 m-80 -65.22 114.63 4.83 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 120.93 1.695 . . . . 0.0 113.426 -178.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 168.33 169.04 31.28 Favored Glycine 0 N--CA 1.483 1.767 0 N-CA-C 116.113 1.205 . . . . 0.0 116.113 -176.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -103.19 128.07 50.29 Favored 'General case' 0 CA--C 1.565 1.52 0 CA-C-N 114.125 -1.037 . . . . 0.0 109.251 169.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 63.1 m95 -125.31 128.54 48.38 Favored 'General case' 0 CA--C 1.568 1.65 0 C-N-CA 123.663 0.785 . . . . 0.0 109.361 -170.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -92.73 147.5 22.81 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.753 -1.217 . . . . 0.0 112.831 171.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.412 ' SD ' ' HD2' ' A' ' 38' ' ' PRO . 42.7 ttm -72.64 130.52 40.76 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.723 -1.235 . . . . 0.0 112.528 171.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 83.3 mt -89.08 -53.24 4.67 Favored 'General case' 0 CA--C 1.568 1.636 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.622 163.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 87.3 p -140.4 151.67 45.12 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-N 119.175 0.898 . . . . 0.0 112.784 -176.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -128.75 112.71 14.48 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.744 -0.597 . . . . 0.0 110.21 166.002 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -110.91 122.93 49.11 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.911 0.885 . . . . 0.0 109.252 -172.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.263 27.1 t30 65.36 25.33 12.07 Favored 'General case' 0 N--CA 1.503 2.222 0 N-CA-C 116.901 2.186 . . . . 0.0 116.901 -175.358 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -68.09 -41.43 81.85 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 115.925 1.824 . . . . 0.0 115.925 178.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -58.52 -40.54 83.21 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 116.213 1.931 . . . . 0.0 116.213 170.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -69.63 -40.8 76.32 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 115.031 1.493 . . . . 0.0 115.031 174.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -51.39 -52.18 48.1 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 114.79 1.404 . . . . 0.0 114.79 161.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 75.0 mt -61.25 -40.46 94.15 Favored 'General case' 0 CA--C 1.573 1.851 0 N-CA-C 115.045 1.498 . . . . 0.0 115.045 172.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 45.7 ttp180 -53.95 -50.17 67.07 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 115.366 1.617 . . . . 0.0 115.366 164.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.63 -22.92 48.37 Favored 'General case' 0 CA--C 1.568 1.639 0 N-CA-C 118.172 2.656 . . . . 0.0 118.172 166.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 93.5 mt -85.83 11.84 10.37 Favored 'General case' 0 CA--C 1.574 1.88 0 N-CA-C 115.88 1.807 . . . . 0.0 115.88 165.02 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 60.69 35.82 19.67 Favored 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 115.951 1.834 . . . . 0.0 115.951 -172.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 97.5 t -96.44 138.62 21.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 120.797 -1.189 . . . . 0.0 109.119 -177.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 7.8 p-10 -67.01 154.35 41.41 Favored 'General case' 0 CA--C 1.567 1.615 0 N-CA-C 115.752 1.76 . . . . 0.0 115.752 -178.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 87.8 t -53.34 -43.65 51.93 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.349 0 N-CA-C 115.502 1.667 . . . . 0.0 115.502 -177.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.95 -47.36 83.14 Favored 'General case' 0 CA--C 1.567 1.608 0 N-CA-C 116.264 1.95 . . . . 0.0 116.264 172.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 31.2 tp -75.77 -26.32 57.26 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 116.477 2.028 . . . . 0.0 116.477 171.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 77.4 mtp180 -54.05 -52.65 60.2 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-N 120.695 1.589 . . . . 0.0 114.092 158.09 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 30.9 mmtp -63.38 -51.17 66.99 Favored 'General case' 0 CA--C 1.568 1.637 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 170.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 15.3 mt -78.42 60.98 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.408 0 CA-C-O 123.63 1.681 . . . . 0.0 111.166 178.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -177.07 -56.98 0.01 OUTLIER 'General case' 0 CA--C 1.562 1.429 0 C-N-CA 126.735 2.014 . . . . 0.0 109.139 -174.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -57.74 -42.69 84.46 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 116.504 2.038 . . . . 0.0 116.504 161.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 74.1 mt -79.31 -19.74 49.64 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 116.067 1.877 . . . . 0.0 116.067 -177.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.0 pp -101.91 141.91 34.03 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 118.988 0.813 . . . . 0.0 111.522 171.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 7.0 mtmp? -102.38 100.65 16.29 Favored Pre-proline 0 CA--C 1.572 1.811 0 CA-C-O 117.878 -1.058 . . . . 0.0 110.37 -177.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.412 ' HD2' ' SD ' ' A' ' 10' ' ' MET . 73.6 Cg_endo -75.76 170.18 20.72 Favored 'Trans proline' 0 CA--C 1.566 2.11 0 CA-C-N 122.85 2.054 . . . . 0.0 116.857 -175.09 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -102.52 154.45 19.09 Favored 'General case' 0 CA--C 1.566 1.558 0 CA-C-N 113.983 -1.462 . . . . 0.0 109.988 176.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 21.8 mtpp -128.46 114.06 16.31 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.807 -1.183 . . . . 0.0 109.227 171.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -102.1 103.56 14.14 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 169.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 73.1 mt -98.24 124.72 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 -177.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.466 HG23 HH12 ' A' ' 52' ' ' ARG . 36.6 t -108.57 111.95 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 164.31 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -99.5 101.55 12.82 Favored 'General case' 0 CA--C 1.566 1.561 0 C-N-CA 123.943 0.897 . . . . 0.0 109.117 172.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -121.36 76.39 1.24 Allowed 'General case' 0 CA--C 1.567 1.627 0 C-N-CA 123.219 0.608 . . . . 0.0 111.409 -174.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 57.1 67.23 2.33 Favored Glycine 0 N--CA 1.497 2.723 0 N-CA-C 117.672 1.829 . . . . 0.0 117.672 171.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.488 0.0 OUTLIER 77.81 -43.53 0.4 Allowed 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 116.209 1.929 . . . . 0.0 116.209 -163.204 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 21.1 t-160 -73.56 109.26 6.93 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-N 120.797 1.635 . . . . 0.0 111.168 176.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 2.9 tpp -114.64 124.99 53.24 Favored 'General case' 0 CA--C 1.555 1.171 0 CA-C-O 122.045 0.926 . . . . 0.0 110.111 178.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 19.3 mt -108.63 103.86 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 N-CA-C 105.407 -2.072 . . . . 0.0 105.407 174.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 90.0 mt -93.41 95.16 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 172.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.466 HH12 HG23 ' A' ' 43' ' ' VAL . 63.1 mtt85 -82.68 94.66 7.62 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.345 -0.847 . . . . 0.0 110.003 177.02 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 34.1 m -84.8 109.29 17.97 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.137 -1.061 . . . . 0.0 108.137 172.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 15.3 mt -116.66 107.66 14.97 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 -164.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 36.7 p -116.45 155.5 28.47 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.349 0.66 . . . . 0.0 111.314 -173.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.3 t -68.35 4.16 1.43 Allowed 'General case' 0 CA--C 1.581 2.149 0 N-CA-C 117.992 2.59 . . . . 0.0 117.992 167.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -104.13 -58.86 1.82 Allowed 'General case' 0 CA--C 1.568 1.671 0 CA-C-N 119.619 1.099 . . . . 0.0 111.836 163.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 11.8 ptm180 -140.02 160.62 39.52 Favored 'General case' 0 CA--C 1.568 1.665 0 CA-C-O 122.56 1.172 . . . . 0.0 114.026 175.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -82.49 128.55 34.38 Favored 'General case' 0 CA--C 1.568 1.652 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.333 160.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -95.97 -66.91 0.88 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.592 -0.692 . . . . 0.0 110.92 178.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.359 58.6 mt 69.76 91.35 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 C-N-CA 124.563 1.145 . . . . 0.0 112.893 170.215 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 75.9 mtp -91.57 96.57 10.55 Favored 'General case' 0 CA--C 1.565 1.55 0 O-C-N 121.544 -0.723 . . . . 0.0 109.276 173.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -96.89 113.38 24.92 Favored 'General case' 0 CA--C 1.564 1.517 0 C-N-CA 123.893 0.877 . . . . 0.0 110.108 178.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -153.98 156.15 36.9 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -171.17 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 11.5 mp0 -91.62 126.27 36.65 Favored 'General case' 0 CA--C 1.564 1.505 0 O-C-N 121.403 -0.811 . . . . 0.0 110.286 163.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 41.5 t -67.41 114.69 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 C-N-CA 124.194 0.998 . . . . 0.0 109.381 174.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 119.88 -47.69 1.01 Allowed Glycine 0 N--CA 1.489 2.172 0 N-CA-C 115.58 0.992 . . . . 0.0 115.58 -160.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 85.1 mttt -79.75 141.01 36.72 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-N 118.743 1.272 . . . . 0.0 113.53 -173.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 55.4 tt0 -100.83 100.79 11.49 Favored 'General case' 0 CA--C 1.565 1.532 0 C-N-CA 123.275 0.63 . . . . 0.0 111.164 -178.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -105.96 144.53 32.55 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 -168.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -73.43 103.69 4.17 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.691 -1.255 . . . . 0.0 111.735 173.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -85.41 66.1 9.52 Favored 'General case' 0 CA--C 1.571 1.767 0 N-CA-C 114.534 1.309 . . . . 0.0 114.534 -170.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -77.37 -52.19 9.57 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 115.176 1.547 . . . . 0.0 115.176 -177.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 93.7 mt -81.2 -162.31 0.49 Allowed 'General case' 0 CA--C 1.576 1.953 0 CA-C-N 119.591 1.087 . . . . 0.0 111.907 177.088 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . 0.381 22.6 m 67.91 37.48 3.09 Favored 'General case' 0 N--CA 1.507 2.407 0 N-CA-C 115.489 1.663 . . . . 0.0 115.489 178.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 62.9 -128.25 39.91 Favored Glycine 0 N--CA 1.489 2.224 0 O-C-N 120.204 -1.56 . . . . 0.0 116.25 175.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . 0.513 0.0 OUTLIER 58.32 -83.84 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 N-CA-C 115.82 1.785 . . . . 0.0 115.82 171.169 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -158.37 99.21 1.6 Allowed 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 105.041 -2.207 . . . . 0.0 105.041 170.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -74.65 83.85 2.08 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 115.021 1.489 . . . . 0.0 115.021 -160.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 86.6 mtt-85 -145.34 149.04 34.07 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 124.615 1.166 . . . . 0.0 108.73 -171.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 57.2 mtmt -74.44 73.91 1.9 Allowed 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.362 -1.461 . . . . 0.0 114.362 -177.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 88.2 m -94.54 126.59 39.92 Favored 'General case' 0 CA--C 1.556 1.187 0 O-C-N 121.446 -0.784 . . . . 0.0 111.134 -179.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 87.7 mmm -73.08 101.55 3.3 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-O 121.878 0.847 . . . . 0.0 110.751 -172.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 92.2 m -109.16 107.1 17.26 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.535 -158.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 64.6 m -92.8 128.68 38.75 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 172.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 18.2 t -112.55 130.67 65.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 167.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 39.5 m -150.74 155.89 40.19 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.589 -1.319 . . . . 0.0 112.853 -175.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 55.8 m95 -86.24 122.47 30.27 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.836 -1.165 . . . . 0.0 113.601 -175.046 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -102.54 67.03 0.99 Allowed 'General case' 0 CA--C 1.574 1.897 0 C-N-CA 123.286 0.634 . . . . 0.0 109.646 157.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 60.87 -104.17 0.62 Allowed Glycine 0 N--CA 1.492 2.387 0 N-CA-C 115.825 1.09 . . . . 0.0 115.825 -175.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -72.46 -27.78 62.52 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 116.357 1.984 . . . . 0.0 116.357 168.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -91.08 115.23 27.85 Favored 'General case' 0 N--CA 1.485 1.294 0 CA-C-N 119.505 1.048 . . . . 0.0 111.301 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 31.4 tp -80.22 110.38 15.59 Favored 'General case' 0 CA--C 1.565 1.555 0 O-C-N 121.401 -0.812 . . . . 0.0 109.207 167.022 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 30.4 mm-40 -101.07 126.05 47.73 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.713 0.805 . . . . 0.0 110.884 -170.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 40.4 t -118.05 128.9 55.21 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.592 0.757 . . . . 0.0 111.058 176.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.6 p -120.67 118.45 56.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 172.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 63.4 mt-30 -103.21 95.47 6.13 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 123.919 0.887 . . . . 0.0 109.339 -175.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 81.4 mttt -85.23 119.98 26.21 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.749 -1.22 . . . . 0.0 112.373 -168.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 176.51 -101.55 0.16 Allowed Glycine 0 N--CA 1.486 2.004 0 O-C-N 121.458 -0.776 . . . . 0.0 114.0 170.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -86.99 -59.35 2.28 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 -173.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 12.3 mptt -75.26 129.81 38.06 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 122.551 1.167 . . . . 0.0 110.945 -179.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 -76.47 -38.16 55.79 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 116.659 2.096 . . . . 0.0 116.659 -157.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -106.18 56.25 0.51 Allowed Glycine 0 N--CA 1.49 2.249 0 CA-C-N 119.258 0.936 . . . . 0.0 114.81 162.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 35.9 ttt180 -87.44 122.06 30.68 Favored 'General case' 0 CA--C 1.567 1.597 0 CA-C-N 118.364 1.082 . . . . 0.0 112.573 -177.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 172.9 -167.1 39.87 Favored Glycine 0 CA--C 1.546 2.019 0 N-CA-C 114.991 0.757 . . . . 0.0 114.991 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . 0.254 34.7 p-90 -155.26 156.03 34.86 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 113.888 1.069 . . . . 0.0 113.888 170.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 91.1 m -127.74 118.43 23.77 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 176.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -122.66 121.23 35.9 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.743 -0.598 . . . . 0.0 111.728 -174.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 21.9 p90 -134.45 165.74 24.47 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.347 -0.846 . . . . 0.0 113.138 178.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 95.4 mt -110.12 132.55 58.12 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.135 -0.978 . . . . 0.0 109.819 175.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -114.47 91.98 3.81 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 123.979 0.912 . . . . 0.0 108.878 168.248 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 71.67 -106.49 1.92 Allowed Glycine 0 N--CA 1.491 2.328 0 O-C-N 121.463 -0.773 . . . . 0.0 114.732 -177.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -108.06 32.76 4.53 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 115.111 1.523 . . . . 0.0 115.111 165.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -129.33 131.46 46.9 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-N 119.073 0.851 . . . . 0.0 110.345 178.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 12.9 tp -95.83 122.08 38.23 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 121.675 0.75 . . . . 0.0 109.531 175.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 41.0 m80 -111.28 117.31 32.8 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -174.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 42.4 tp -119.81 118.71 31.54 Favored 'General case' 0 CA--C 1.561 1.399 0 C-N-CA 123.764 0.826 . . . . 0.0 110.051 -172.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -106.57 107.72 18.86 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.68 -0.638 . . . . 0.0 109.603 171.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 72.9 mtm -99.58 129.92 45.78 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 123.035 0.534 . . . . 0.0 111.072 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 73.4 mtp85 -117.68 141.85 47.91 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.548 -0.72 . . . . 0.0 112.515 -172.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -151.23 133.47 15.31 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 123.187 0.595 . . . . 0.0 111.274 165.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 59.3 20.82 9.01 Favored 'General case' 0 N--CA 1.509 2.484 0 N-CA-C 116.373 1.99 . . . . 0.0 116.373 -173.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 86.91 -18.61 34.42 Favored Glycine 0 CA--C 1.557 2.715 0 N-CA-C 119.018 2.367 . . . . 0.0 119.018 -159.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 87.4 t -81.31 121.27 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 CA-C-N 119.498 1.649 . . . . 0.0 109.869 -174.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 25.0 m -101.75 126.03 48.53 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.217 0.532 . . . . 0.0 111.812 -177.057 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 7.7 t -95.59 125.64 40.32 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.885 0.874 . . . . 0.0 110.919 162.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 51.7 mtpt -105.5 113.25 26.72 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 123.123 0.569 . . . . 0.0 109.815 -177.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 -114.28 136.56 52.83 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.516 -0.74 . . . . 0.0 111.652 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 62.6 t -116.98 130.31 72.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 178.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -124.78 149.87 46.91 Favored 'General case' 0 CA--C 1.565 1.536 0 C-N-CA 124.536 1.134 . . . . 0.0 110.696 -179.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 25.8 ttmt -119.7 141.95 48.93 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.028 -1.045 . . . . 0.0 112.293 175.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 36.5 tttm -74.68 128.56 35.84 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -177.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 29.2 m -111.73 -33.74 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 178.177 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 49.1 t-80 . . . . . 0 N--CA 1.485 1.292 0 CA-C-N 120.569 1.531 . . . . 0.0 109.112 174.215 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 59.8 mtt . . . . . 0 CA--C 1.569 1.675 0 CA-C-O 118.508 -0.758 . . . . 0.0 111.936 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_endo -67.72 128.82 18.63 Favored 'Trans proline' 0 CA--C 1.56 1.796 0 C-N-CA 122.467 2.112 . . . . 0.0 115.017 171.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 27.5 t -97.56 -98.31 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.57 1.712 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 -171.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -152.1 79.15 1.25 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.809 -1.182 . . . . 0.0 108.052 160.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -74.46 -11.34 60.21 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 116.514 2.042 . . . . 0.0 116.514 179.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -61.83 108.56 1.04 Allowed 'General case' 0 CA--C 1.563 1.473 0 C-N-CA 125.813 1.645 . . . . 0.0 114.02 -178.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 163.2 -179.27 38.48 Favored Glycine 0 N--CA 1.483 1.802 0 N-CA-C 116.453 1.341 . . . . 0.0 116.453 -179.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -106.92 128.3 54.19 Favored 'General case' 0 CA--C 1.564 1.505 0 CA-C-N 114.035 -1.082 . . . . 0.0 109.234 171.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 73.4 m95 -122.14 143.53 49.49 Favored 'General case' 0 CA--C 1.572 1.808 0 C-N-CA 123.964 0.905 . . . . 0.0 110.102 -169.27 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -111.67 140.39 46.34 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.035 -1.041 . . . . 0.0 112.306 173.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 50.0 ttm -72.08 125.11 26.45 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.099 -1.001 . . . . 0.0 112.93 176.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 86.4 mt -82.62 -47.87 11.59 Favored 'General case' 0 CA--C 1.567 1.609 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 166.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 80.0 p -148.74 147.96 29.44 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 123.496 0.718 . . . . 0.0 112.242 177.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -120.57 105.8 11.16 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 123.133 0.573 . . . . 0.0 109.535 164.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -101.44 125.48 48.08 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.418 -0.801 . . . . 0.0 109.911 -177.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.273 19.5 t30 64.89 18.91 11.69 Favored 'General case' 0 CA--C 1.583 2.213 0 N-CA-C 117.515 2.413 . . . . 0.0 117.515 -177.588 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -65.28 -47.85 75.22 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 115.516 1.673 . . . . 0.0 115.516 176.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -56.72 -35.32 68.42 Favored 'General case' 0 CA--C 1.576 1.97 0 N-CA-C 117.211 2.3 . . . . 0.0 117.211 172.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -68.4 -46.92 68.67 Favored 'General case' 0 CA--C 1.573 1.834 0 N-CA-C 114.79 1.404 . . . . 0.0 114.79 166.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -52.25 -46.98 66.0 Favored 'General case' 0 N--CA 1.501 2.088 0 N-CA-C 115.369 1.618 . . . . 0.0 115.369 167.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 93.1 mt -61.9 -39.86 93.43 Favored 'General case' 0 CA--C 1.573 1.864 0 N-CA-C 115.061 1.504 . . . . 0.0 115.061 170.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 67.4 ttp85 -56.87 -48.48 78.02 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 115.241 1.571 . . . . 0.0 115.241 164.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.2 -19.15 12.5 Favored 'General case' 0 CA--C 1.569 1.706 0 N-CA-C 118.21 2.671 . . . . 0.0 118.21 167.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 84.5 mt -95.22 3.71 54.31 Favored 'General case' 0 CA--C 1.569 1.694 0 N-CA-C 116.078 1.881 . . . . 0.0 116.078 167.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 58.49 46.17 15.39 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 115.452 1.649 . . . . 0.0 115.452 -169.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 70.0 t -90.3 143.07 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.322 -0.861 . . . . 0.0 109.259 178.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -60.3 145.57 47.12 Favored 'General case' 0 CA--C 1.569 1.681 0 N-CA-C 115.556 1.687 . . . . 0.0 115.556 -176.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . 0.272 91.9 t -60.27 -36.01 65.84 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.168 0 N-CA-C 115.137 1.532 . . . . 0.0 115.137 -176.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.27 -55.03 38.33 Favored 'General case' 0 CA--C 1.566 1.584 0 N-CA-C 115.889 1.811 . . . . 0.0 115.889 167.256 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 5.5 tt -65.27 -39.6 92.82 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 115.565 1.691 . . . . 0.0 115.565 171.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 37.7 mtp-105 -46.84 -41.6 15.9 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 117.208 2.299 . . . . 0.0 117.208 165.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -74.67 -54.84 6.65 Favored 'General case' 0 CA--C 1.567 1.608 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 164.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 4.8 mt -80.89 60.78 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.585 2.296 0 CA-C-N 120.395 1.452 . . . . 0.0 111.61 -176.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -176.03 -51.71 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 126.392 1.877 . . . . 0.0 110.157 -176.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -63.23 -41.25 99.07 Favored 'General case' 0 CA--C 1.568 1.651 0 N-CA-C 115.76 1.763 . . . . 0.0 115.76 161.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 84.0 mt -75.03 -28.93 60.65 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 115.792 1.775 . . . . 0.0 115.792 178.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . 0.259 3.1 pp -91.0 152.12 20.8 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 119.462 1.028 . . . . 0.0 112.24 170.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 29.6 mmtp -108.23 91.71 8.52 Favored Pre-proline 0 CA--C 1.572 1.821 0 CA-C-O 118.064 -0.969 . . . . 0.0 109.341 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -77.22 175.73 10.98 Favored 'Trans proline' 0 CA--C 1.563 1.931 0 C-N-CA 122.384 2.056 . . . . 0.0 116.317 -172.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -107.92 155.87 19.83 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 114.985 -1.007 . . . . 0.0 112.392 178.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 40.9 mttp -121.02 119.64 33.09 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.663 -0.648 . . . . 0.0 109.382 169.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -96.73 111.01 23.35 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.463 -0.939 . . . . 0.0 108.463 162.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 74.3 mt -106.81 122.38 60.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 92.9 t -103.92 104.48 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 167.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -112.52 97.57 6.68 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 123.562 0.745 . . . . 0.0 111.159 -176.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -96.58 69.32 2.54 Favored 'General case' 0 CA--C 1.567 1.634 0 O-C-N 120.88 -1.138 . . . . 0.0 110.766 172.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 64.45 -89.7 0.09 OUTLIER Glycine 0 N--CA 1.491 2.328 0 N-CA-C 116.169 1.227 . . . . 0.0 116.169 -178.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.8 p30 -81.84 -39.77 23.46 Favored 'General case' 0 CA--C 1.566 1.573 0 N-CA-C 115.91 1.819 . . . . 0.0 115.91 166.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -80.3 121.74 26.04 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 121.055 1.752 . . . . 0.0 111.893 -178.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 42.2 ttm -130.29 128.48 41.64 Favored 'General case' 0 CA--C 1.556 1.198 0 CA-C-O 121.597 0.713 . . . . 0.0 111.362 -177.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 46.7 mt -113.56 103.37 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 170.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 64.7 mt -92.88 98.8 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 174.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -86.46 98.89 11.28 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.333 -0.854 . . . . 0.0 109.967 174.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 31.9 m -83.57 109.91 17.8 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 172.075 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 53.5 mt -114.79 118.96 35.04 Favored 'General case' 0 CA--C 1.559 1.302 0 C-N-CA 124.005 0.922 . . . . 0.0 109.725 -164.477 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 9.7 p -133.62 155.42 49.71 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.256 0.55 . . . . 0.0 111.923 177.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 26.1 m -80.86 59.29 3.67 Favored 'General case' 0 N--CA 1.505 2.3 0 O-C-N 120.726 -1.234 . . . . 0.0 112.197 169.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -172.42 -64.53 0.02 OUTLIER 'General case' 0 CA--C 1.568 1.654 0 C-N-CA 125.509 1.524 . . . . 0.0 109.25 -179.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 65.5 ttt180 -138.93 140.3 38.26 Favored 'General case' 0 CA--C 1.568 1.639 0 CA-C-N 118.965 0.802 . . . . 0.0 110.81 175.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -110.28 137.7 47.65 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 123.338 0.655 . . . . 0.0 110.487 174.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -91.41 -74.92 0.49 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.657 -0.652 . . . . 0.0 111.375 178.545 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.363 54.3 mt 75.87 93.45 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 C-N-CA 124.368 1.067 . . . . 0.0 110.664 -177.207 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 81.1 mtp -100.29 99.56 10.24 Favored 'General case' 0 CA--C 1.561 1.37 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 174.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -101.32 113.35 26.34 Favored 'General case' 0 CA--C 1.565 1.52 0 C-N-CA 124.123 0.969 . . . . 0.0 111.614 178.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -157.77 158.32 35.04 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.154 -0.966 . . . . 0.0 113.224 -166.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 30.5 tt0 -95.38 130.6 42.11 Favored 'General case' 0 CA--C 1.564 1.485 0 O-C-N 121.123 -0.986 . . . . 0.0 110.822 160.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.3 t -65.25 117.31 5.64 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.813 0 C-N-CA 124.12 0.968 . . . . 0.0 109.535 170.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 115.25 -46.6 1.14 Allowed Glycine 0 CA--C 1.551 2.313 0 N-CA-C 115.667 1.027 . . . . 0.0 115.667 -159.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -82.77 154.49 24.73 Favored 'General case' 0 CA--C 1.567 1.633 0 CA-C-N 118.662 1.231 . . . . 0.0 113.729 -179.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -99.3 130.86 45.62 Favored 'General case' 0 CA--C 1.57 1.736 0 CA-C-O 121.928 0.871 . . . . 0.0 112.268 175.094 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -68.8 157.49 36.34 Favored 'General case' 0 CA--C 1.57 1.716 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 168.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -105.64 108.99 20.8 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.258 -0.901 . . . . 0.0 108.578 132.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -79.93 86.76 5.41 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.832 -1.167 . . . . 0.0 110.325 172.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -66.77 -63.69 1.01 Allowed 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 -171.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 95.4 mt -139.83 153.08 46.98 Favored 'General case' 0 CA--C 1.568 1.657 0 CA-C-N 118.894 0.77 . . . . 0.0 111.02 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . 0.298 22.5 m 84.85 118.59 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.116 0 C-N-CA 124.614 1.165 . . . . 0.0 113.39 166.323 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 151.8 -97.72 0.18 Allowed Glycine 0 N--CA 1.486 2.005 0 O-C-N 121.77 -0.581 . . . . 0.0 112.301 169.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 17.0 mm -129.05 -67.39 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 163.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . 0.264 33.8 p30 -51.36 -63.54 1.1 Allowed 'General case' 0 CA--C 1.564 1.503 0 N-CA-C 118.593 2.812 . . . . 0.0 118.593 -175.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.3 t70 70.17 153.93 0.12 Allowed 'General case' 0 CA--C 1.577 1.995 0 N-CA-C 114.853 1.427 . . . . 0.0 114.853 173.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . 0.304 0.9 OUTLIER 73.17 64.86 0.1 Allowed 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 174.183 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 47.9 mtmt 54.2 61.29 3.11 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 116.506 2.039 . . . . 0.0 116.506 169.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 44.9 m -80.84 125.7 30.42 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.141 -0.975 . . . . 0.0 111.175 174.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 4.9 mmt -75.32 74.51 2.42 Favored 'General case' 0 CA--C 1.567 1.62 0 CA-C-O 122.345 1.069 . . . . 0.0 111.241 169.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 100.0 m -93.0 130.21 38.65 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.03 -1.044 . . . . 0.0 109.824 -167.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 91.1 m -123.09 134.14 54.26 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 -178.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 16.1 t -120.64 138.23 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 178.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 59.2 m -147.57 150.8 35.16 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.215 -1.553 . . . . 0.0 113.056 -177.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 75.3 m95 -81.85 126.53 31.99 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.04 -1.037 . . . . 0.0 111.808 176.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -106.5 -21.67 13.0 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 118.145 2.646 . . . . 0.0 118.145 -167.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 159.8 -70.77 0.24 Allowed Glycine 0 N--CA 1.493 2.46 0 CA-C-N 121.296 1.862 . . . . 0.0 112.982 -172.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 34.4 m-20 -126.28 32.04 5.29 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 148.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -141.44 146.94 37.13 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.453 -1.404 . . . . 0.0 110.525 -165.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 35.8 tp -100.08 108.02 20.07 Favored 'General case' 0 CA--C 1.561 1.402 0 O-C-N 121.256 -0.903 . . . . 0.0 109.258 172.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 43.5 mm-40 -93.42 131.25 38.78 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 123.205 0.602 . . . . 0.0 111.535 -179.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 39.5 t -123.12 133.1 54.3 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.663 0.785 . . . . 0.0 111.063 173.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.2 p -115.4 127.41 72.98 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.683 0 C-N-CA 123.33 0.652 . . . . 0.0 109.343 169.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -105.6 91.32 3.71 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 124.096 0.958 . . . . 0.0 109.482 -176.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -90.35 126.51 35.89 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.753 -1.217 . . . . 0.0 112.035 -168.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 165.65 -95.16 0.12 Allowed Glycine 0 N--CA 1.489 2.167 0 O-C-N 121.017 -1.052 . . . . 0.0 114.122 172.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -75.05 -48.32 24.57 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 115.7 1.741 . . . . 0.0 115.7 -173.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 43.6 mttp -115.88 151.47 35.25 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 122.488 1.137 . . . . 0.0 113.908 -168.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -75.68 153.52 37.09 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 54.44 36.32 57.89 Favored Glycine 0 N--CA 1.5 2.954 0 N-CA-C 119.949 2.74 . . . . 0.0 119.949 -178.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 32.3 ttt180 -100.53 116.06 31.59 Favored 'General case' 0 CA--C 1.563 1.45 0 C-N-CA 123.861 0.864 . . . . 0.0 111.177 -164.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 178.25 -170.64 42.84 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 115.336 0.894 . . . . 0.0 115.336 -178.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 37.3 p-90 -154.02 151.93 29.93 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 174.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 91.1 m -121.07 121.06 37.1 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.364 -0.835 . . . . 0.0 109.299 173.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -120.8 129.42 53.57 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 123.205 0.602 . . . . 0.0 112.087 -177.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 19.7 p90 -142.96 172.68 12.37 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.995 -1.066 . . . . 0.0 112.836 178.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 72.0 mt -119.86 132.04 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 O-C-N 121.07 -1.019 . . . . 0.0 109.989 175.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -110.19 89.74 3.11 Favored 'General case' 0 CA--C 1.567 1.611 0 C-N-CA 123.847 0.859 . . . . 0.0 108.77 165.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 68.6 -106.99 1.91 Allowed Glycine 0 N--CA 1.492 2.431 0 N-CA-C 115.75 1.06 . . . . 0.0 115.75 179.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 23.4 p-10 -87.79 0.31 55.94 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 117.248 2.314 . . . . 0.0 117.248 167.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -113.13 132.55 55.41 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-N 120.148 1.34 . . . . 0.0 112.116 -173.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 12.3 tp -93.98 124.71 38.17 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 123.726 0.811 . . . . 0.0 109.667 171.046 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 41.4 m80 -114.52 120.96 42.0 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 123.618 0.767 . . . . 0.0 109.078 -176.153 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 38.9 tp -122.99 121.67 36.65 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 123.742 0.817 . . . . 0.0 110.166 -175.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -106.35 113.65 27.3 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.601 -0.687 . . . . 0.0 109.957 169.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 66.9 mtm -105.94 127.99 53.51 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 123.164 0.586 . . . . 0.0 111.151 -178.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 73.4 mtm180 -119.14 134.11 55.39 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 124.064 0.945 . . . . 0.0 110.442 -169.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -156.78 129.42 7.64 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.27 -0.894 . . . . 0.0 111.697 170.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . 0.283 11.4 mt-10 52.55 44.77 29.67 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 115.843 1.794 . . . . 0.0 115.843 -177.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 68.41 12.53 63.81 Favored Glycine 0 CA--C 1.553 2.411 0 N-CA-C 120.713 3.045 . . . . 0.0 120.713 -167.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 92.6 t -113.88 124.96 71.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 CA-C-N 120.017 1.909 . . . . 0.0 108.516 -177.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 80.8 m -105.0 119.2 38.44 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 123.266 0.626 . . . . 0.0 110.389 179.079 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 12.6 t -88.71 138.13 31.69 Favored 'General case' 0 CA--C 1.56 1.363 0 C-N-CA 123.644 0.778 . . . . 0.0 111.735 161.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 48.1 mtpt -115.17 111.21 20.65 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.66 -0.65 . . . . 0.0 109.483 177.135 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -108.08 131.63 54.4 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 123.546 0.738 . . . . 0.0 111.169 176.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 51.6 t -116.58 131.52 68.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 176.15 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -123.08 153.69 39.58 Favored 'General case' 0 CA--C 1.565 1.522 0 C-N-CA 124.724 1.209 . . . . 0.0 110.628 178.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 26.6 ttmt -122.34 145.9 47.82 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.952 -1.092 . . . . 0.0 111.999 170.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 64.9 tttt -76.07 126.33 30.79 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -176.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 34.1 m -104.71 -43.42 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 174.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 68.5 t60 . . . . . 0 N--CA 1.486 1.34 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 168.46 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 74.2 mtp . . . . . 0 CA--C 1.573 1.827 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.505 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -62.89 -85.39 0.01 OUTLIER 'Trans proline' 0 CA--C 1.568 2.211 0 N-CA-C 118.475 2.452 . . . . 0.0 118.475 -174.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.4 p -178.3 130.34 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 C-N-CA 124.714 1.206 . . . . 0.0 108.92 -174.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -83.68 107.16 15.94 Favored 'General case' 0 CA--C 1.565 1.531 0 O-C-N 121.049 -1.032 . . . . 0.0 112.128 170.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -80.73 1.46 30.17 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 117.578 2.436 . . . . 0.0 117.578 175.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -55.06 113.42 1.35 Allowed 'General case' 0 CA--C 1.567 1.627 0 N-CA-C 115.756 1.761 . . . . 0.0 115.756 -174.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 162.51 177.26 35.38 Favored Glycine 0 N--CA 1.486 2.025 0 N-CA-C 116.184 1.234 . . . . 0.0 116.184 178.191 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -106.16 131.98 52.77 Favored 'General case' 0 CA--C 1.566 1.589 0 CA-C-N 114.388 -0.906 . . . . 0.0 109.312 168.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 78.4 m95 -128.06 129.15 46.18 Favored 'General case' 0 CA--C 1.563 1.479 0 C-N-CA 123.945 0.898 . . . . 0.0 109.542 -167.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.96 143.72 26.54 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.027 -1.046 . . . . 0.0 112.204 169.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 52.1 ttm -75.59 124.64 27.56 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.874 -1.142 . . . . 0.0 112.302 173.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 95.1 mt -82.52 -51.78 7.47 Favored 'General case' 0 CA--C 1.567 1.628 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.473 166.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 91.3 p -139.61 144.63 37.81 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-N 118.955 0.798 . . . . 0.0 112.134 177.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -118.18 89.56 3.15 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 121.763 0.792 . . . . 0.0 109.145 163.366 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -96.27 121.04 37.63 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.857 0.863 . . . . 0.0 110.081 -167.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.269 27.7 t30 66.59 24.73 10.12 Favored 'General case' 0 N--CA 1.503 2.184 0 N-CA-C 116.651 2.093 . . . . 0.0 116.651 -171.368 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -68.34 -44.54 75.09 Favored 'General case' 0 CA--C 1.569 1.676 0 N-CA-C 115.579 1.696 . . . . 0.0 115.579 178.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -53.73 -44.35 69.83 Favored 'General case' 0 N--CA 1.503 2.176 0 N-CA-C 116.632 2.086 . . . . 0.0 116.632 168.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -63.25 -44.74 94.3 Favored 'General case' 0 CA--C 1.573 1.858 0 N-CA-C 114.765 1.395 . . . . 0.0 114.765 174.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 44.4 t80 -54.48 -50.56 67.48 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 115.0 1.482 . . . . 0.0 115.0 166.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 94.2 mt -63.61 -41.38 98.31 Favored 'General case' 0 CA--C 1.571 1.762 0 N-CA-C 115.142 1.534 . . . . 0.0 115.142 174.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 71.5 ttp85 -53.4 -50.63 64.74 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 115.173 1.545 . . . . 0.0 115.173 163.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.08 -16.11 17.44 Favored 'General case' 0 CA--C 1.568 1.665 0 N-CA-C 118.591 2.812 . . . . 0.0 118.591 168.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 35.4 mt -91.92 -0.66 57.5 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 115.919 1.822 . . . . 0.0 115.919 166.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 62.43 61.64 1.23 Allowed 'General case' 0 N--CA 1.494 1.77 0 CA-C-N 119.98 1.264 . . . . 0.0 113.392 -165.026 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 96.1 t -111.48 136.97 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 N-CA-C 107.767 -1.198 . . . . 0.0 107.767 170.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 14.3 p30 -64.02 157.47 25.09 Favored 'General case' 0 CA--C 1.57 1.749 0 N-CA-C 116.094 1.887 . . . . 0.0 116.094 -177.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 43.2 t -56.9 -43.87 81.18 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.301 0 N-CA-C 114.753 1.39 . . . . 0.0 114.753 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.63 -50.52 72.86 Favored 'General case' 0 CA--C 1.564 1.518 0 N-CA-C 115.741 1.756 . . . . 0.0 115.741 172.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.2 tt -69.9 -37.78 76.11 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 115.092 1.515 . . . . 0.0 115.092 172.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 69.9 mtp180 -46.78 -52.87 13.13 Favored 'General case' 0 N--CA 1.502 2.166 0 CA-C-N 121.21 1.823 . . . . 0.0 115.695 161.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -65.91 -50.07 65.77 Favored 'General case' 0 CA--C 1.565 1.532 0 N-CA-C 114.004 1.113 . . . . 0.0 114.004 170.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 9.8 mt -78.99 58.68 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.586 2.346 0 CA-C-N 120.952 1.705 . . . . 0.0 110.831 175.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -174.98 -47.21 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 126.425 1.89 . . . . 0.0 111.131 -178.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -76.2 -30.61 58.08 Favored 'General case' 0 CA--C 1.569 1.682 0 N-CA-C 115.794 1.776 . . . . 0.0 115.794 164.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 96.0 mt -76.56 -36.27 57.73 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 114.925 1.454 . . . . 0.0 114.925 177.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -100.2 148.21 24.88 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 118.759 0.709 . . . . 0.0 111.015 170.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 44.5 mmtm -103.09 95.86 7.25 Favored Pre-proline 0 CA--C 1.573 1.854 0 CA-C-O 117.707 -1.14 . . . . 0.0 110.105 -171.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -73.52 158.49 47.66 Favored 'Trans proline' 0 CA--C 1.564 1.998 0 CA-C-N 123.158 2.164 . . . . 0.0 115.898 -176.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -90.78 160.55 15.72 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-N 115.714 -0.675 . . . . 0.0 112.21 178.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 30.4 mttp -120.96 121.28 37.68 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.018 -1.052 . . . . 0.0 110.016 170.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -103.37 105.66 15.99 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 164.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 76.0 mt -97.85 116.83 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 87.0 t -102.12 93.79 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 173.017 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -93.12 94.13 8.67 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 123.163 0.585 . . . . 0.0 109.712 175.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -101.81 73.93 1.45 Allowed 'General case' 0 CA--C 1.566 1.594 0 O-C-N 121.632 -0.668 . . . . 0.0 110.877 -178.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 57.4 71.49 0.74 Allowed Glycine 0 N--CA 1.494 2.506 0 N-CA-C 116.909 1.524 . . . . 0.0 116.909 179.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.471 0.4 OUTLIER 70.2 -30.37 0.2 Allowed 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 118.257 2.688 . . . . 0.0 118.257 -166.499 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 21.9 t-160 -76.42 99.42 4.87 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-N 120.937 1.699 . . . . 0.0 110.543 170.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 3.8 ttp -116.7 119.06 34.28 Favored 'General case' 0 CA--C 1.552 1.054 0 CA-C-O 121.917 0.865 . . . . 0.0 110.08 -169.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 5.2 mp -107.02 106.91 21.52 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.422 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 -178.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 24.1 mm -88.97 99.58 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 177.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 65.4 mtt-85 -95.07 95.67 8.73 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.498 -0.751 . . . . 0.0 109.591 -179.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 16.3 m -82.6 115.87 21.75 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 169.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 45.9 mt -119.65 114.1 21.68 Favored 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 123.665 0.786 . . . . 0.0 109.04 -164.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.6 t -102.12 -67.13 0.88 Allowed 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -178.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . 0.317 8.8 t 160.47 -61.89 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.165 0 C-N-CA 126.884 2.074 . . . . 0.0 106.821 -171.627 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -77.25 -48.57 17.16 Favored 'General case' 0 CA--C 1.579 2.062 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 161.195 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 3.6 tpm_? -95.02 135.97 35.9 Favored 'General case' 0 CA--C 1.564 1.501 0 CA-C-O 122.434 1.111 . . . . 0.0 113.157 -170.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 47.1 m-80 -121.89 135.51 54.89 Favored 'General case' 0 CA--C 1.568 1.64 0 CA-C-N 114.625 -1.171 . . . . 0.0 108.574 164.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 20.6 m-30 -94.25 -61.0 1.6 Allowed 'General case' 0 N--CA 1.504 2.231 0 O-C-N 120.898 -1.126 . . . . 0.0 113.179 171.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.282 4.3 mm 64.0 57.21 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.429 0 CA-C-N 119.694 1.133 . . . . 0.0 113.606 175.559 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 66.7 mtp -79.61 104.7 10.39 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.007 -1.683 . . . . 0.0 109.69 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -116.56 108.65 16.24 Favored 'General case' 0 CA--C 1.56 1.354 0 C-N-CA 123.739 0.816 . . . . 0.0 110.807 -162.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 20.5 p90 -152.22 145.81 24.95 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -163.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 18.7 mp0 -82.46 124.85 30.44 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.333 -0.854 . . . . 0.0 110.332 159.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 26.0 t -65.88 121.4 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.57 -0.706 . . . . 0.0 110.581 178.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 116.24 -38.85 2.9 Favored Glycine 0 CA--C 1.55 2.26 0 N-CA-C 116.328 1.291 . . . . 0.0 116.328 -160.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -80.89 141.64 34.38 Favored 'General case' 0 CA--C 1.567 1.616 0 CA-C-N 119.397 1.599 . . . . 0.0 114.021 -172.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -96.11 102.35 14.14 Favored 'General case' 0 CA--C 1.568 1.641 0 C-N-CA 123.694 0.798 . . . . 0.0 109.896 171.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -115.41 146.64 41.42 Favored 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 123.883 0.873 . . . . 0.0 113.153 -169.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -70.1 120.77 16.3 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 119.955 -1.716 . . . . 0.0 113.263 171.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -78.1 81.0 4.51 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.087 -1.008 . . . . 0.0 110.332 173.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -104.48 57.19 0.71 Allowed 'General case' 0 CA--C 1.575 1.923 0 CA-C-O 122.083 0.944 . . . . 0.0 111.59 173.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 6.5 tt -133.97 124.03 25.62 Favored 'General case' 0 CA--C 1.567 1.606 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 175.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 11.3 t -90.88 145.18 24.96 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 121.994 0.902 . . . . 0.0 113.383 -178.147 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 156.31 -61.41 0.35 Allowed Glycine 0 N--CA 1.49 2.295 0 O-C-N 121.637 -0.665 . . . . 0.0 111.629 -170.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 48.2 mm -69.06 158.2 6.11 Favored 'Isoleucine or valine' 0 CA--C 1.587 2.379 0 O-C-N 122.557 -0.378 . . . . 0.0 110.117 140.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -36.96 -52.06 0.94 Allowed 'General case' 0 N--CA 1.504 2.243 0 N-CA-C 118.335 2.717 . . . . 0.0 118.335 178.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.1 t0 74.25 116.43 0.06 Allowed 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 124.571 1.148 . . . . 0.0 113.618 177.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 -132.38 54.62 1.93 Allowed 'General case' 0 CA--C 1.571 1.769 0 O-C-N 121.59 -0.694 . . . . 0.0 111.618 158.085 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . 0.258 9.7 mtpm? 43.25 57.47 3.78 Favored 'General case' 0 N--CA 1.503 2.181 0 N-CA-C 116.922 2.193 . . . . 0.0 116.922 -178.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 81.2 m -86.3 127.71 34.82 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.43 -0.794 . . . . 0.0 113.036 -164.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 4.6 tpt -78.45 104.18 8.88 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-O 122.153 0.978 . . . . 0.0 110.16 -172.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 85.7 m -110.43 121.97 46.6 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.926 -155.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 91.7 m -113.44 119.68 38.42 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 -179.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.448 HG22 ' SG ' ' A' ' 95' ' ' CYS . 22.0 t -112.19 119.11 59.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 177.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 65.3 m -140.54 156.86 46.18 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 122.049 0.928 . . . . 0.0 112.513 -173.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 34.5 m95 -84.52 118.76 24.52 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.043 -1.035 . . . . 0.0 112.908 -178.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -99.23 75.25 1.99 Allowed 'General case' 0 CA--C 1.567 1.597 0 C-N-CA 123.494 0.718 . . . . 0.0 109.894 167.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 73.19 -104.97 1.66 Allowed Glycine 0 N--CA 1.487 2.092 0 O-C-N 121.544 -0.723 . . . . 0.0 112.7 -174.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -92.48 -18.19 23.52 Favored 'General case' 0 CA--C 1.573 1.832 0 N-CA-C 115.469 1.655 . . . . 0.0 115.469 167.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 78.7 mttt -91.46 137.59 32.24 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 121.111 1.778 . . . . 0.0 112.07 -174.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 22.8 tp -92.25 109.96 21.34 Favored 'General case' 0 CA--C 1.563 1.457 0 O-C-N 121.324 -0.86 . . . . 0.0 110.017 177.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -99.3 125.72 45.0 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.392 0.677 . . . . 0.0 111.411 -175.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . 0.448 ' SG ' HG22 ' A' ' 86' ' ' VAL . 46.1 t -116.89 131.86 56.85 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.725 0.81 . . . . 0.0 110.803 176.461 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 11.0 p -123.66 123.68 67.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 C-N-CA 122.791 0.437 . . . . 0.0 110.281 169.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 69.3 mt-30 -102.57 108.36 19.62 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 124.25 1.02 . . . . 0.0 110.71 -177.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -96.65 127.01 42.22 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 -169.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 167.62 -110.42 0.39 Allowed Glycine 0 N--CA 1.488 2.146 0 O-C-N 121.419 -0.801 . . . . 0.0 114.189 167.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -75.41 -43.16 51.42 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 115.614 1.709 . . . . 0.0 115.614 -176.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 37.4 mmtm -83.9 138.56 33.11 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-O 121.935 0.874 . . . . 0.0 112.713 179.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -78.77 148.09 33.09 Favored 'General case' 0 CA--C 1.566 1.585 0 CA-C-N 115.663 -0.699 . . . . 0.0 112.096 168.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 61.0 23.65 61.87 Favored Glycine 0 N--CA 1.498 2.774 0 N-CA-C 120.85 3.1 . . . . 0.0 120.85 178.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 46.5 ttt180 -87.5 118.25 26.84 Favored 'General case' 0 CA--C 1.564 1.498 0 CA-C-N 118.78 1.29 . . . . 0.0 111.792 -175.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -178.3 -172.18 42.43 Favored Glycine 0 N--CA 1.486 2.029 0 O-C-N 121.449 -0.782 . . . . 0.0 114.925 -175.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 41.8 p-90 -157.42 151.1 24.12 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 172.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 29.3 m -120.47 120.04 34.74 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 123.604 0.761 . . . . 0.0 109.192 173.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 22.6 tt0 -119.61 135.08 54.95 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 123.316 0.646 . . . . 0.0 112.489 -176.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 20.8 p90 -152.41 168.98 23.7 Favored 'General case' 0 N--CA 1.497 1.899 0 C-N-CA 123.792 0.837 . . . . 0.0 112.535 177.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 63.2 mt -113.65 133.42 59.66 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.168 0 O-C-N 120.557 -1.339 . . . . 0.0 110.119 172.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -107.66 90.36 3.28 Favored 'General case' 0 CA--C 1.566 1.596 0 C-N-CA 123.789 0.836 . . . . 0.0 109.313 164.102 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 70.29 -103.98 1.27 Allowed Glycine 0 N--CA 1.491 2.358 0 N-CA-C 115.388 0.915 . . . . 0.0 115.388 179.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 54.1 p30 -95.51 5.17 52.24 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 117.121 2.267 . . . . 0.0 117.121 167.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 77.6 mt-10 -115.33 133.96 55.55 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 120.321 1.419 . . . . 0.0 112.295 -176.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 11.1 tp -91.73 121.63 33.55 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 123.951 0.9 . . . . 0.0 109.357 173.145 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 39.2 m80 -111.72 119.39 38.47 Favored 'General case' 0 CA--C 1.559 1.3 0 C-N-CA 123.655 0.782 . . . . 0.0 108.939 -176.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 37.8 tp -124.8 121.62 35.1 Favored 'General case' 0 CA--C 1.562 1.437 0 C-N-CA 123.885 0.874 . . . . 0.0 109.618 -174.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -108.53 104.2 13.48 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 172.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 64.5 mtm -98.82 125.2 44.13 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.784 -0.572 . . . . 0.0 111.158 -177.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -107.74 142.36 37.86 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 123.443 0.697 . . . . 0.0 112.277 -175.132 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -152.98 124.73 7.81 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-O 121.635 0.731 . . . . 0.0 110.867 164.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . 0.311 13.8 mt-10 60.58 31.61 20.26 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 116.654 2.094 . . . . 0.0 116.654 -178.103 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 83.07 -15.21 34.23 Favored Glycine 0 CA--C 1.553 2.451 0 N-CA-C 119.167 2.427 . . . . 0.0 119.167 -162.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 86.2 t -86.93 122.97 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 CA-C-N 120.04 1.92 . . . . 0.0 109.516 -176.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 42.8 m -100.56 124.68 46.45 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 121.092 0.472 . . . . 0.0 111.198 176.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 16.1 t -89.72 127.48 35.95 Favored 'General case' 0 CA--C 1.559 1.312 0 C-N-CA 123.239 0.616 . . . . 0.0 111.241 160.07 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp -100.48 107.74 19.53 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 175.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 66.3 mt-30 -103.49 124.38 48.65 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.105 0.562 . . . . 0.0 110.361 175.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 58.1 t -112.08 130.99 64.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 175.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -124.65 155.45 39.15 Favored 'General case' 0 CA--C 1.566 1.575 0 C-N-CA 124.685 1.194 . . . . 0.0 110.763 -179.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -125.89 141.27 52.06 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.811 -1.18 . . . . 0.0 112.492 174.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 43.0 tttm -74.49 125.07 27.78 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 -174.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 35.8 m -108.55 -41.76 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 176.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 47.2 t-80 . . . . . 0 C--O 1.254 1.331 0 CA-C-N 119.932 1.242 . . . . 0.0 108.966 172.651 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 79.3 mtp . . . . . 0 CA--C 1.573 1.84 0 CA-C-O 118.544 -0.741 . . . . 0.0 112.182 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -74.15 168.45 24.78 Favored 'Trans proline' 0 CA--C 1.564 2.006 0 C-N-CA 122.333 2.022 . . . . 0.0 116.711 176.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 32.8 m -76.83 146.26 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 CA-C-N 115.266 -0.879 . . . . 0.0 112.712 177.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -80.94 103.48 10.79 Favored 'General case' 0 CA--C 1.565 1.536 0 O-C-N 120.606 -1.308 . . . . 0.0 111.381 176.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 13.6 m-30 -70.43 -3.43 17.63 Favored 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 117.66 2.466 . . . . 0.0 117.66 172.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -46.5 114.28 0.79 Allowed 'General case' 0 CA--C 1.567 1.62 0 N-CA-C 116.575 2.065 . . . . 0.0 116.575 178.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 157.18 176.01 28.76 Favored Glycine 0 N--CA 1.487 2.08 0 N-CA-C 116.084 1.193 . . . . 0.0 116.084 -179.213 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -104.6 125.05 50.36 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 121.345 0.593 . . . . 0.0 109.514 172.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 68.5 m95 -123.33 124.66 43.45 Favored 'General case' 0 CA--C 1.568 1.659 0 C-N-CA 123.832 0.853 . . . . 0.0 109.11 -171.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 20.7 pttp -102.96 143.09 33.0 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 120.91 -1.119 . . . . 0.0 112.678 179.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.409 ' SD ' ' HD2' ' A' ' 38' ' ' PRO . 34.0 ttm -66.77 127.23 31.68 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.791 -1.193 . . . . 0.0 113.959 -179.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 93.7 mt -86.46 -55.41 3.9 Favored 'General case' 0 CA--C 1.566 1.595 0 C-N-CA 123.41 0.684 . . . . 0.0 112.467 163.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 88.1 p -139.53 149.5 43.98 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 119.023 0.828 . . . . 0.0 112.759 -177.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -124.49 110.88 15.04 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.07 0.548 . . . . 0.0 109.936 164.063 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -109.77 128.16 55.11 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.861 0.864 . . . . 0.0 109.362 -175.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.268 22.6 t30 64.57 23.02 12.79 Favored 'General case' 0 N--CA 1.504 2.229 0 N-CA-C 116.877 2.177 . . . . 0.0 116.877 -176.218 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -66.59 -45.65 78.54 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 115.471 1.656 . . . . 0.0 115.471 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -55.12 -41.42 71.68 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 116.298 1.962 . . . . 0.0 116.298 169.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -67.31 -41.24 85.66 Favored 'General case' 0 CA--C 1.573 1.835 0 N-CA-C 115.528 1.677 . . . . 0.0 115.528 174.011 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -53.98 -51.23 64.57 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 163.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.5 mt -63.41 -42.64 98.77 Favored 'General case' 0 CA--C 1.572 1.811 0 N-CA-C 114.641 1.348 . . . . 0.0 114.641 175.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 29.7 ttp85 -49.88 -49.65 48.7 Favored 'General case' 0 CA--C 1.575 1.938 0 N-CA-C 115.525 1.676 . . . . 0.0 115.525 161.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.04 -24.31 57.84 Favored 'General case' 0 CA--C 1.569 1.678 0 N-CA-C 117.709 2.485 . . . . 0.0 117.709 167.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 88.6 mt -83.52 1.61 41.04 Favored 'General case' 0 CA--C 1.572 1.823 0 N-CA-C 116.172 1.916 . . . . 0.0 116.172 166.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.268 20.8 m-20 64.1 48.36 3.02 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 114.834 1.42 . . . . 0.0 114.834 -168.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 92.6 t -96.58 142.42 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 CA-C-O 122.218 1.009 . . . . 0.0 109.429 175.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 7.5 p-10 -69.7 154.65 41.68 Favored 'General case' 0 CA--C 1.57 1.717 0 N-CA-C 115.305 1.594 . . . . 0.0 115.305 176.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 57.7 t -55.55 -41.24 62.96 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.303 0 N-CA-C 115.399 1.629 . . . . 0.0 115.399 -176.424 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.87 -49.42 76.32 Favored 'General case' 0 CA--C 1.567 1.598 0 N-CA-C 116.09 1.885 . . . . 0.0 116.09 173.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -62.02 -43.46 98.79 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 170.014 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 60.4 mtp180 -46.12 -53.59 10.09 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 116.201 1.926 . . . . 0.0 116.201 162.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 14.2 tptt -65.37 -47.99 74.49 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 115.603 1.705 . . . . 0.0 115.603 173.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 60.9 mt -55.26 -49.7 70.37 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.188 0 CA-C-N 119.806 1.185 . . . . 0.0 113.499 173.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.54 -42.05 92.36 Favored 'General case' 0 CA--C 1.565 1.529 0 N-CA-C 117.339 2.348 . . . . 0.0 117.339 173.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -59.65 -39.87 85.83 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 116.487 2.032 . . . . 0.0 116.487 168.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 89.9 mt -83.06 -16.21 47.88 Favored 'General case' 0 CA--C 1.569 1.681 0 N-CA-C 116.302 1.964 . . . . 0.0 116.302 179.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 69.4 mt -85.43 147.94 26.24 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 120.093 1.315 . . . . 0.0 112.342 171.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -105.21 87.42 1.99 Allowed Pre-proline 0 CA--C 1.574 1.873 0 CA-C-O 118.154 -0.926 . . . . 0.0 109.489 172.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.409 ' HD2' ' SD ' ' A' ' 10' ' ' MET . 60.5 Cg_endo -69.92 174.78 9.14 Favored 'Trans proline' 0 CA--C 1.564 1.992 0 C-N-CA 122.538 2.159 . . . . 0.0 115.423 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -130.36 136.27 48.91 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.545 -1.347 . . . . 0.0 110.806 -176.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 50.2 mttp -103.48 111.65 24.2 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.582 -0.699 . . . . 0.0 109.696 174.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -96.84 101.29 12.85 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 166.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 65.3 mt -93.93 119.15 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -173.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 75.8 t -109.83 95.32 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 177.37 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -99.31 118.46 36.03 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 123.751 0.82 . . . . 0.0 110.329 178.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -133.58 66.38 1.55 Allowed 'General case' 0 CA--C 1.569 1.696 0 O-C-N 121.51 -0.744 . . . . 0.0 111.867 -178.212 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 72.15 81.39 0.34 Allowed Glycine 0 N--CA 1.493 2.448 0 N-CA-C 115.274 0.87 . . . . 0.0 115.274 174.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.458 0.2 OUTLIER 65.66 -41.59 0.34 Allowed 'General case' 0 N--CA 1.502 2.141 0 N-CA-C 117.861 2.541 . . . . 0.0 117.861 -167.903 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 14.3 t-80 -70.55 120.47 16.23 Favored 'General case' 0 CA--C 1.562 1.416 0 O-C-N 120.984 -1.073 . . . . 0.0 111.595 168.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 17.5 ttp -136.87 125.35 23.52 Favored 'General case' 0 CA--C 1.555 1.163 0 CA-C-O 121.841 0.829 . . . . 0.0 110.522 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 23.0 mt -104.43 107.62 22.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 174.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 83.0 mt -86.67 99.71 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 168.307 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -85.05 93.07 8.52 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.51 -0.744 . . . . 0.0 109.863 -178.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 80.7 m -87.84 102.29 14.55 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 -177.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 17.6 mt -105.84 121.22 43.61 Favored 'General case' 0 CA--C 1.557 1.241 0 CA-C-N 114.514 -1.221 . . . . 0.0 109.365 -164.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 27.1 t -132.57 143.96 50.07 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.38 0.672 . . . . 0.0 110.528 -178.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 21.6 m -56.05 -34.77 66.21 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 116.123 1.898 . . . . 0.0 116.123 175.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -79.93 -58.64 3.07 Favored 'General case' 0 CA--C 1.569 1.693 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 175.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 11.9 tpt180 -151.7 127.18 10.04 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-N 119.824 1.193 . . . . 0.0 110.887 177.291 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -76.86 145.14 38.53 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 177.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -95.92 -67.96 0.82 Allowed 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 118.714 -0.66 . . . . 0.0 112.186 178.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.273 11.4 mm 72.52 96.76 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 C-N-CA 124.128 0.971 . . . . 0.0 111.716 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 82.2 mtp -96.25 98.71 10.51 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.02 -1.05 . . . . 0.0 109.568 173.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -100.66 110.57 22.7 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 123.659 0.784 . . . . 0.0 110.183 -179.118 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -150.52 157.45 43.02 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 114.527 1.306 . . . . 0.0 114.527 -167.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -101.08 138.03 38.65 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.586 -0.696 . . . . 0.0 110.312 160.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 92.5 t -67.77 128.18 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.289 -0.882 . . . . 0.0 110.995 -177.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 91.25 -45.7 2.82 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 116.518 1.367 . . . . 0.0 116.518 -165.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 16.7 tttp -67.29 122.49 17.99 Favored 'General case' 0 CA--C 1.571 1.78 0 C-N-CA 125.37 1.468 . . . . 0.0 113.051 178.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -84.43 114.93 22.26 Favored 'General case' 0 CA--C 1.567 1.6 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.888 -176.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -113.17 139.83 48.43 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -169.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -76.97 112.67 13.85 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.154 -0.966 . . . . 0.0 112.496 177.12 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -90.88 111.22 22.54 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.232 0.613 . . . . 0.0 110.334 175.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -85.12 178.99 7.34 Favored 'General case' 0 CA--C 1.574 1.896 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -178.57 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 5.4 tt -64.49 -26.26 68.35 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 118.653 2.834 . . . . 0.0 118.653 -160.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 53.9 m -71.14 90.44 0.88 Allowed 'General case' 0 N--CA 1.499 1.988 0 CA-C-N 120.529 1.513 . . . . 0.0 110.82 170.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 160.58 68.06 0.02 OUTLIER Glycine 0 N--CA 1.483 1.779 0 CA-C-N 115.6 -0.727 . . . . 0.0 113.483 -175.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . 0.364 4.0 mp 68.36 -86.11 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 C-N-CA 124.087 0.955 . . . . 0.0 110.099 -174.35 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 48.5 p-10 -157.76 58.02 0.48 Allowed 'General case' 0 CA--C 1.57 1.74 0 C-N-CA 124.39 1.076 . . . . 0.0 111.081 170.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -85.1 91.96 8.24 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.48 -1.387 . . . . 0.0 110.408 178.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 35.7 ttm105 -81.58 67.95 7.74 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.813 -1.18 . . . . 0.0 113.237 -173.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . 0.262 61.5 mttm 56.31 60.28 3.24 Favored 'General case' 0 N--CA 1.501 2.099 0 N-CA-C 114.265 1.209 . . . . 0.0 114.265 -170.208 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 73.7 m -92.9 125.85 37.7 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.608 -0.683 . . . . 0.0 111.802 -173.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 15.5 mtp -80.46 98.11 7.4 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-O 121.655 0.74 . . . . 0.0 110.919 177.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 91.2 m -101.46 125.35 48.09 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.658 -0.651 . . . . 0.0 110.7 -167.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 85.3 m -106.3 122.94 47.24 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 176.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 20.6 t -116.19 121.61 67.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 179.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 58.4 m -128.64 139.19 52.38 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 123.829 0.852 . . . . 0.0 111.221 -173.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 2.9 m95 -81.49 122.34 27.41 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.845 -1.16 . . . . 0.0 113.69 179.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -112.32 67.93 0.66 Allowed 'General case' 0 CA--C 1.577 1.996 0 C-N-CA 123.382 0.673 . . . . 0.0 110.632 164.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 69.96 -102.82 1.04 Allowed Glycine 0 N--CA 1.495 2.584 0 N-CA-C 115.968 1.147 . . . . 0.0 115.968 177.456 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -75.47 -28.93 59.44 Favored 'General case' 0 CA--C 1.574 1.878 0 N-CA-C 115.206 1.558 . . . . 0.0 115.206 162.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 29.8 mtpt -98.87 107.42 19.85 Favored 'General case' 0 N--CA 1.484 1.263 0 CA-C-N 119.469 1.031 . . . . 0.0 110.56 -167.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 30.4 tp -80.75 111.06 16.84 Favored 'General case' 0 CA--C 1.563 1.473 0 O-C-N 120.729 -1.232 . . . . 0.0 109.844 173.191 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 -97.55 126.94 43.13 Favored 'General case' 0 CA--C 1.558 1.272 0 C-N-CA 124.011 0.925 . . . . 0.0 110.961 -174.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 41.9 t -127.48 133.88 49.86 Favored 'General case' 0 N--CA 1.481 1.108 0 O-C-N 121.674 -0.641 . . . . 0.0 111.831 -178.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 12.2 p -118.78 128.92 75.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 C-N-CA 123.068 0.547 . . . . 0.0 109.78 168.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -99.96 104.28 15.89 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 123.47 0.708 . . . . 0.0 109.753 178.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -91.25 119.79 31.61 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.059 -1.026 . . . . 0.0 110.676 -173.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -174.41 -70.33 0.05 OUTLIER Glycine 0 N--CA 1.489 2.172 0 N-CA-C 116.022 1.169 . . . . 0.0 116.022 -175.099 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -138.27 -60.45 0.62 Allowed 'General case' 0 N--CA 1.498 1.963 0 CA-C-N 117.755 0.777 . . . . 0.0 111.952 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -72.74 133.04 44.38 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-O 122.231 1.015 . . . . 0.0 111.704 -173.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -68.73 -56.83 6.84 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 115.392 1.627 . . . . 0.0 115.392 -160.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -83.68 44.11 3.26 Favored Glycine 0 CA--C 1.55 2.226 0 N-CA-C 117.728 1.851 . . . . 0.0 117.728 166.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 25.1 ttt180 -85.95 119.04 25.83 Favored 'General case' 0 CA--C 1.566 1.587 0 CA-C-N 119.674 1.737 . . . . 0.0 113.366 -176.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 175.0 -165.84 37.18 Favored Glycine 0 N--CA 1.485 1.906 0 CA-C-O 122.01 0.783 . . . . 0.0 114.73 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 45.3 p-90 -155.66 152.94 29.26 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 172.065 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 81.8 m -119.73 121.38 39.06 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 169.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -121.0 128.52 52.78 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.604 -0.685 . . . . 0.0 111.578 -177.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 16.4 p90 -148.04 155.32 41.36 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.797 -1.19 . . . . 0.0 113.587 -176.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 94.8 mt -94.35 134.46 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.033 -1.042 . . . . 0.0 110.382 174.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -118.4 94.9 4.65 Favored 'General case' 0 CA--C 1.566 1.574 0 CA-C-N 114.897 -1.047 . . . . 0.0 108.441 159.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 69.11 -108.03 2.32 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 115.619 1.008 . . . . 0.0 115.619 -179.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 55.5 p30 -90.18 2.42 55.38 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 117.407 2.373 . . . . 0.0 117.407 168.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -121.24 130.15 53.53 Favored 'General case' 0 N--CA 1.486 1.329 0 CA-C-N 119.827 1.194 . . . . 0.0 111.663 -168.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 18.4 tp -91.64 113.63 25.95 Favored 'General case' 0 CA--C 1.562 1.409 0 C-N-CA 124.424 1.089 . . . . 0.0 109.451 172.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 41.6 m80 -101.16 124.79 47.41 Favored 'General case' 0 CA--C 1.561 1.399 0 C-N-CA 124.33 1.052 . . . . 0.0 108.842 -177.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 43.6 tp -124.99 120.27 31.09 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.824 0.85 . . . . 0.0 110.332 -171.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -105.06 107.02 17.78 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.711 -0.618 . . . . 0.0 109.686 170.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 72.1 mtm -97.72 124.58 42.12 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-N 118.58 0.627 . . . . 0.0 111.131 179.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 84.7 mtm180 -111.55 139.45 46.98 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 123.866 0.866 . . . . 0.0 110.926 -171.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -147.28 132.46 18.36 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.095 -1.003 . . . . 0.0 112.968 167.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . 0.344 24.7 mt-10 65.61 -73.36 0.07 Allowed 'General case' 0 N--CA 1.502 2.126 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 -173.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -160.2 50.3 0.37 Allowed Glycine 0 CA--C 1.552 2.386 0 C-N-CA 123.862 0.744 . . . . 0.0 112.259 157.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 69.0 t -139.96 122.92 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 -163.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 31.3 m -105.47 123.06 47.26 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 122.996 0.518 . . . . 0.0 111.588 -173.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 44.6 t -88.61 128.98 35.59 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.561 -0.712 . . . . 0.0 111.261 159.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -105.39 110.75 23.22 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -179.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 16.4 mt-30 -118.07 139.08 51.74 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 123.559 0.744 . . . . 0.0 111.491 -176.093 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 33.9 t -122.93 131.79 72.61 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 O-C-N 121.478 -0.764 . . . . 0.0 109.042 -178.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -126.48 138.72 53.54 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 124.146 0.978 . . . . 0.0 110.521 -179.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 76.8 tttt -106.89 140.45 39.69 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.643 -1.286 . . . . 0.0 112.654 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 61.8 tttt -73.63 120.74 19.65 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -179.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 35.9 m -104.92 -41.27 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 175.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 52.8 t-80 . . . . . 0 N--CA 1.486 1.354 0 CA-C-N 119.715 1.143 . . . . 0.0 108.143 168.361 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 68.1 mtt . . . . . 0 CA--C 1.571 1.776 0 CA-C-O 118.385 -0.817 . . . . 0.0 111.755 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.34 161.11 40.99 Favored 'Trans proline' 0 CA--C 1.561 1.846 0 C-N-CA 122.239 1.959 . . . . 0.0 116.367 178.142 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 29.1 m -78.78 160.88 4.39 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.929 0 CA-C-O 122.399 1.095 . . . . 0.0 113.405 -177.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -90.99 107.1 18.98 Favored 'General case' 0 CA--C 1.565 1.547 0 O-C-N 121.015 -1.053 . . . . 0.0 112.373 -175.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 6.5 m-30 -83.64 -2.2 55.61 Favored 'General case' 0 CA--C 1.577 1.981 0 N-CA-C 116.152 1.908 . . . . 0.0 116.152 171.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 51.1 m-80 -58.52 114.05 2.28 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-N 121.612 2.006 . . . . 0.0 114.22 -178.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 160.05 -178.03 36.28 Favored Glycine 0 N--CA 1.483 1.833 0 CA-C-O 122.623 1.124 . . . . 0.0 115.896 -177.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 12.7 t80 -113.36 119.43 37.61 Favored 'General case' 0 CA--C 1.565 1.533 0 CA-C-N 114.222 -0.989 . . . . 0.0 108.875 178.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 77.2 m95 -123.01 124.37 42.99 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 123.541 0.737 . . . . 0.0 110.182 -165.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 64.1 pttt -98.68 136.81 38.21 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 120.501 -1.374 . . . . 0.0 113.4 -179.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 11.0 ttp -72.09 125.34 27.02 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-N 119.395 0.998 . . . . 0.0 112.901 177.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 78.6 mt -94.69 -56.29 2.83 Favored 'General case' 0 CA--C 1.564 1.503 0 CA-C-N 115.068 -0.969 . . . . 0.0 112.927 178.119 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 92.4 p -141.54 124.12 15.9 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.724 0.81 . . . . 0.0 110.227 -170.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -113.77 119.12 36.28 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 121.343 0.592 . . . . 0.0 111.327 175.107 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -114.37 126.84 55.45 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.81 0.844 . . . . 0.0 109.148 -176.054 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.265 19.0 t30 66.76 22.17 10.37 Favored 'General case' 0 CA--C 1.582 2.185 0 N-CA-C 116.911 2.189 . . . . 0.0 116.911 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -68.39 -43.39 77.39 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 115.382 1.623 . . . . 0.0 115.382 178.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -53.54 -44.86 69.55 Favored 'General case' 0 N--CA 1.501 2.108 0 N-CA-C 116.348 1.981 . . . . 0.0 116.348 167.006 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -65.64 -43.93 87.96 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 115.103 1.519 . . . . 0.0 115.103 175.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -53.44 -49.04 68.2 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 164.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 77.7 mt -63.47 -42.72 98.6 Favored 'General case' 0 CA--C 1.571 1.759 0 N-CA-C 114.539 1.311 . . . . 0.0 114.539 172.302 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 69.5 ttp85 -54.34 -46.19 72.88 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 115.696 1.739 . . . . 0.0 115.696 166.297 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.98 -31.83 65.45 Favored 'General case' 0 CA--C 1.567 1.63 0 N-CA-C 116.632 2.086 . . . . 0.0 116.632 164.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 82.2 mt -85.88 30.43 0.66 Allowed 'General case' 0 CA--C 1.572 1.818 0 N-CA-C 114.506 1.298 . . . . 0.0 114.506 167.255 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 64.54 17.98 11.14 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 117.023 2.231 . . . . 0.0 117.023 175.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 94.8 t -88.17 142.41 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 120.504 -1.373 . . . . 0.0 110.932 -168.204 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 7.8 p-10 -71.9 156.96 38.69 Favored 'General case' 0 CA--C 1.569 1.677 0 N-CA-C 115.363 1.616 . . . . 0.0 115.363 177.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 49.0 t -53.97 -42.71 55.35 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.407 0 N-CA-C 115.203 1.557 . . . . 0.0 115.203 -176.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.03 -52.4 65.53 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 115.871 1.804 . . . . 0.0 115.871 173.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -59.47 -42.27 91.64 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 115.934 1.827 . . . . 0.0 115.934 169.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 54.0 mtp180 -51.68 -57.53 8.95 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 164.527 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -59.63 -47.34 85.98 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 115.054 1.502 . . . . 0.0 115.054 175.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 64.7 mt -56.05 -57.06 9.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 CA-C-N 119.622 1.101 . . . . 0.0 112.675 172.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.0 -44.1 91.6 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 117.704 2.483 . . . . 0.0 117.704 176.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -67.61 -27.64 67.07 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 116.375 1.991 . . . . 0.0 116.375 172.289 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 88.5 mt -79.81 -31.45 40.66 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 115.686 1.735 . . . . 0.0 115.686 171.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . 0.272 4.1 pp -80.72 145.79 31.37 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-N 120.148 1.34 . . . . 0.0 114.486 -178.344 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -114.29 93.37 31.02 Favored Pre-proline 0 CA--C 1.573 1.843 0 CA-C-O 118.368 -0.825 . . . . 0.0 108.841 -177.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -81.19 166.93 18.15 Favored 'Trans proline' 0 CA--C 1.56 1.817 0 C-N-CA 122.969 2.446 . . . . 0.0 115.083 -174.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -106.0 118.65 37.17 Favored 'General case' 0 N--CA 1.487 1.379 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.303 173.128 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 35.4 mttp -83.33 107.08 15.61 Favored 'General case' 0 N--CA 1.485 1.284 0 O-C-N 121.302 -0.874 . . . . 0.0 110.331 169.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -91.33 113.18 25.37 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 164.327 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 82.7 mt -108.9 122.94 64.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 -177.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 91.3 t -108.3 102.47 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 169.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 42.7 tt0 -98.69 100.55 11.78 Favored 'General case' 0 CA--C 1.565 1.54 0 C-N-CA 123.825 0.85 . . . . 0.0 110.031 175.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -93.91 74.01 4.17 Favored 'General case' 0 CA--C 1.57 1.737 0 O-C-N 121.438 -0.789 . . . . 0.0 110.228 168.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 65.03 -99.0 0.32 Allowed Glycine 0 N--CA 1.492 2.374 0 N-CA-C 115.053 0.781 . . . . 0.0 115.053 -174.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -83.26 -31.36 26.99 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 116.406 2.002 . . . . 0.0 116.406 165.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 22.6 t-160 -80.19 108.72 14.02 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 121.228 1.831 . . . . 0.0 110.915 -177.2 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 45.2 ttm -118.75 123.6 45.23 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 123.511 0.724 . . . . 0.0 110.046 -172.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 35.9 mt -107.36 106.14 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 175.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 33.9 mm -90.7 108.67 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 174.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 67.2 mtt85 -105.66 100.09 9.67 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.654 -0.654 . . . . 0.0 109.464 173.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 59.1 m -89.9 102.74 15.44 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 176.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 15.2 mt -101.08 125.05 47.67 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.367 0.667 . . . . 0.0 111.132 -160.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.4 t -147.88 156.61 42.88 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 122.009 0.909 . . . . 0.0 111.126 179.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 25.2 m -59.57 -38.7 81.83 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 115.3 1.593 . . . . 0.0 115.3 171.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 35.5 t80 -74.54 -53.24 9.83 Favored 'General case' 0 CA--C 1.572 1.82 0 N-CA-C 114.733 1.382 . . . . 0.0 114.733 174.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 71.2 ttt180 -142.85 130.15 21.01 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 119.526 1.057 . . . . 0.0 110.274 174.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 71.5 m-80 -93.5 117.29 29.9 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 166.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 75.6 t80 -105.01 105.43 15.47 Favored 'General case' 0 CA--C 1.566 1.59 0 C-N-CA 123.28 0.632 . . . . 0.0 111.087 -172.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.9 mp -99.19 121.53 49.9 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.833 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -178.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 95.9 mtp -115.39 103.37 10.72 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.568 -0.707 . . . . 0.0 109.369 167.259 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -101.22 112.92 25.54 Favored 'General case' 0 CA--C 1.566 1.577 0 C-N-CA 124.163 0.985 . . . . 0.0 111.806 177.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -153.74 154.28 33.76 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 115.047 1.499 . . . . 0.0 115.047 -166.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 28.0 mp0 -89.24 121.62 31.71 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.445 -0.784 . . . . 0.0 110.671 167.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 37.3 t -66.85 116.11 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 C-N-CA 123.785 0.834 . . . . 0.0 109.512 172.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 121.55 -46.31 1.13 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 115.589 0.996 . . . . 0.0 115.589 -158.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -84.34 145.75 28.08 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 118.726 1.263 . . . . 0.0 113.297 -174.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -91.9 100.34 13.03 Favored 'General case' 0 CA--C 1.568 1.638 0 O-C-N 121.788 -0.57 . . . . 0.0 110.895 173.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -107.63 145.7 32.96 Favored 'General case' 0 N--CA 1.495 1.813 0 C-N-CA 124.073 0.949 . . . . 0.0 113.429 -169.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -68.57 118.79 12.05 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.234 -1.541 . . . . 0.0 114.133 176.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -75.71 85.13 2.72 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 122.448 1.118 . . . . 0.0 109.672 163.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -134.07 126.28 29.79 Favored 'General case' 0 CA--C 1.558 1.276 0 CA-C-N 114.421 -1.263 . . . . 0.0 107.765 -173.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . 0.322 2.6 mm? 71.63 -61.87 0.48 Allowed 'General case' 0 N--CA 1.502 2.131 0 C-N-CA 123.59 0.756 . . . . 0.0 112.347 -166.673 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 7.2 t -77.52 58.1 1.68 Allowed 'General case' 0 CA--C 1.578 2.023 0 N-CA-C 114.455 1.28 . . . . 0.0 114.455 166.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -132.81 176.07 19.68 Favored Glycine 0 N--CA 1.488 2.134 0 O-C-N 120.512 -1.368 . . . . 0.0 113.937 172.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 46.2 mm -101.19 -67.81 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 122.302 -0.528 . . . . 0.0 110.77 -177.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 51.2 t0 -96.82 160.75 14.19 Favored 'General case' 0 CA--C 1.569 1.691 0 CA-C-O 122.317 1.056 . . . . 0.0 112.328 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -63.98 152.1 40.99 Favored 'General case' 0 CA--C 1.57 1.731 0 N-CA-C 114.347 1.24 . . . . 0.0 114.347 178.412 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . 0.323 0.0 OUTLIER 82.44 121.02 0.05 OUTLIER 'General case' 0 N--CA 1.498 1.931 0 C-N-CA 124.863 1.265 . . . . 0.0 111.656 -169.38 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? -79.01 128.34 33.13 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.506 0.723 . . . . 0.0 112.717 -169.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 99.4 m -101.27 117.18 34.45 Favored 'General case' 0 N--CA 1.487 1.394 0 CA-C-O 121.77 0.795 . . . . 0.0 112.151 -177.222 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 3.9 tpt -78.78 107.28 11.37 Favored 'General case' 0 CA--C 1.563 1.472 0 CA-C-O 122.211 1.005 . . . . 0.0 109.822 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 90.4 m -111.8 115.91 29.83 Favored 'General case' 0 N--CA 1.484 1.227 0 O-C-N 121.545 -0.722 . . . . 0.0 110.737 -152.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 50.3 m -89.96 123.53 33.96 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 168.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 59.7 t -108.87 131.8 58.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 166.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 58.7 m -143.36 150.94 39.84 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.771 -1.205 . . . . 0.0 112.676 -175.205 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 20.5 m95 -86.24 120.25 27.39 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 -178.001 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -105.23 62.76 0.69 Allowed 'General case' 0 CA--C 1.58 2.099 0 C-N-CA 123.871 0.868 . . . . 0.0 110.405 158.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 64.5 -98.99 0.3 Allowed Glycine 0 N--CA 1.496 2.634 0 N-CA-C 116.978 1.551 . . . . 0.0 116.978 178.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -68.96 -35.99 77.39 Favored 'General case' 0 CA--C 1.574 1.886 0 N-CA-C 115.121 1.526 . . . . 0.0 115.121 165.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -92.4 124.34 36.38 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.906 0.883 . . . . 0.0 112.073 -176.199 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 22.0 tp -89.99 108.69 19.87 Favored 'General case' 0 CA--C 1.564 1.491 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 166.087 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 30.3 mm-40 -97.95 130.82 44.79 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.709 0.804 . . . . 0.0 110.991 -172.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 42.4 t -127.67 127.92 44.57 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.015 0.526 . . . . 0.0 111.711 -175.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.6 p -115.07 115.21 48.75 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.625 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 169.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -93.59 94.95 8.91 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 123.628 0.771 . . . . 0.0 109.124 179.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 64.8 mttm -88.43 109.39 19.98 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.123 -0.986 . . . . 0.0 112.075 -169.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -179.83 85.37 0.07 OUTLIER Glycine 0 N--CA 1.484 1.871 0 CA-C-N 116.1 -0.5 . . . . 0.0 113.174 177.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . 0.271 29.1 tt0 70.35 -55.25 0.62 Allowed 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 116.697 2.11 . . . . 0.0 116.697 178.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.0 mmmp? -72.94 141.5 47.82 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 114.798 1.407 . . . . 0.0 114.798 -166.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -80.69 94.68 6.41 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.98 0.895 . . . . 0.0 112.526 -164.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 77.37 46.0 10.58 Favored Glycine 0 N--CA 1.486 1.988 0 N-CA-C 117.208 1.643 . . . . 0.0 117.208 -173.317 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 14.8 ttm180 -77.56 121.51 24.0 Favored 'General case' 0 CA--C 1.568 1.654 0 CA-C-N 118.546 1.173 . . . . 0.0 110.725 167.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 177.37 -171.74 44.51 Favored Glycine 0 N--CA 1.486 2.012 0 O-C-N 121.502 -0.749 . . . . 0.0 114.874 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 51.7 p-90 -157.96 154.04 27.13 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 114.125 1.157 . . . . 0.0 114.125 178.095 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 74.1 m -121.95 116.95 25.27 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 171.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 19.2 tt0 -115.7 126.73 54.48 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 123.398 0.679 . . . . 0.0 110.682 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 14.1 p90 -147.18 157.32 43.56 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.685 -1.259 . . . . 0.0 114.089 -175.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 95.8 mt -100.82 128.8 52.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.434 -0.791 . . . . 0.0 110.038 175.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -112.33 100.03 8.48 Favored 'General case' 0 CA--C 1.567 1.611 0 CA-C-N 114.697 -1.138 . . . . 0.0 108.543 160.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 70.53 -106.58 1.89 Allowed Glycine 0 N--CA 1.494 2.5 0 N-CA-C 115.442 0.937 . . . . 0.0 115.442 -179.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -112.43 33.7 4.76 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 114.767 1.395 . . . . 0.0 114.767 162.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -125.7 127.52 46.37 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 124.058 0.943 . . . . 0.0 109.707 177.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 17.0 tp -93.09 115.55 28.19 Favored 'General case' 0 CA--C 1.563 1.461 0 CA-C-O 122.097 0.951 . . . . 0.0 109.412 173.275 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 48.1 m80 -102.6 123.81 47.0 Favored 'General case' 0 CA--C 1.558 1.253 0 C-N-CA 124.17 0.988 . . . . 0.0 108.878 -176.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 43.3 tp -124.56 118.52 26.76 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.508 0.723 . . . . 0.0 109.654 -172.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 82.1 mt-10 -114.05 110.65 20.37 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.75 -0.594 . . . . 0.0 109.764 173.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 68.0 mtm -105.77 125.25 50.77 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 123.591 0.756 . . . . 0.0 110.755 -174.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 54.6 mtp180 -111.22 142.97 42.73 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.584 -0.697 . . . . 0.0 112.338 -177.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -156.52 133.05 10.09 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 123.08 0.552 . . . . 0.0 110.898 161.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 60.7 34.93 19.85 Favored 'General case' 0 N--CA 1.509 2.478 0 N-CA-C 115.339 1.607 . . . . 0.0 115.339 -168.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 67.35 -0.81 7.86 Favored Glycine 0 CA--C 1.561 2.913 0 N-CA-C 119.984 2.753 . . . . 0.0 119.984 -159.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 75.2 t -95.51 114.14 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 CA-C-N 120.81 2.305 . . . . 0.0 109.446 -167.165 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 25.0 m -94.63 118.63 32.0 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 123.094 0.557 . . . . 0.0 111.295 -173.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 13.9 t -91.6 124.65 35.91 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.306 0.642 . . . . 0.0 111.238 162.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -108.55 115.5 30.21 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.192 0.597 . . . . 0.0 109.659 -175.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -124.22 135.43 53.43 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.636 -0.665 . . . . 0.0 111.854 -174.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 61.7 t -112.97 131.62 64.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -125.34 145.13 50.17 Favored 'General case' 0 CA--C 1.563 1.463 0 C-N-CA 124.844 1.258 . . . . 0.0 109.778 179.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 30.3 ttmt -120.25 140.61 50.94 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.651 -1.281 . . . . 0.0 112.804 179.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 54.5 tttt -74.97 115.81 15.0 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -177.106 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 35.0 m -97.21 -40.73 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 174.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 79.5 t60 . . . . . 0 N--CA 1.486 1.343 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 164.628 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 65.6 mtt . . . . . 0 CA--C 1.569 1.674 0 CA-C-O 118.499 -0.762 . . . . 0.0 109.759 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_exo -64.45 117.51 4.55 Favored 'Trans proline' 0 CA--C 1.561 1.871 0 C-N-CA 122.725 2.283 . . . . 0.0 116.563 -178.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 22.0 m -107.01 176.43 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 CA-C-O 122.248 1.023 . . . . 0.0 112.067 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -79.19 82.21 5.37 Favored 'General case' 0 CA--C 1.569 1.676 0 O-C-N 120.158 -1.589 . . . . 0.0 113.862 -171.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -73.41 -11.71 60.56 Favored 'General case' 0 CA--C 1.576 1.97 0 N-CA-C 115.614 1.709 . . . . 0.0 115.614 167.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -45.78 121.96 3.45 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 115.793 1.775 . . . . 0.0 115.793 168.007 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 154.84 174.39 24.74 Favored Glycine 0 N--CA 1.484 1.876 0 N-CA-C 115.976 1.15 . . . . 0.0 115.976 175.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 17.3 t80 -103.28 121.2 42.22 Favored 'General case' 0 CA--C 1.563 1.449 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 167.032 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 70.4 m95 -120.39 121.5 38.69 Favored 'General case' 0 CA--C 1.562 1.434 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 -170.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 63.7 pttt -89.47 137.74 32.07 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.249 -0.907 . . . . 0.0 112.169 177.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 51.3 ttm -73.38 121.84 21.11 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 122.092 0.949 . . . . 0.0 112.423 176.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 89.6 mt -81.79 -48.13 12.0 Favored 'General case' 0 CA--C 1.568 1.66 0 CA-C-N 115.242 -0.89 . . . . 0.0 113.157 167.252 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 88.6 p -136.55 146.29 45.99 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 119.225 0.92 . . . . 0.0 112.873 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 20.9 p30 -124.45 81.72 1.97 Allowed 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 121.694 0.759 . . . . 0.0 110.709 167.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -94.72 125.56 39.45 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.138 -0.976 . . . . 0.0 111.56 -167.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.257 51.2 t30 59.15 25.16 13.63 Favored 'General case' 0 N--CA 1.503 2.183 0 N-CA-C 116.968 2.21 . . . . 0.0 116.968 -170.453 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -66.97 -40.47 87.47 Favored 'General case' 0 CA--C 1.568 1.643 0 N-CA-C 114.969 1.47 . . . . 0.0 114.969 172.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -52.93 -53.42 49.79 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 115.484 1.661 . . . . 0.0 115.484 172.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -72.08 -37.01 69.69 Favored 'General case' 0 CA--C 1.566 1.565 0 N-CA-C 115.796 1.776 . . . . 0.0 115.796 176.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 61.3 t80 -50.2 -49.96 51.0 Favored 'General case' 0 N--CA 1.499 2.02 0 CA-C-N 120.526 1.512 . . . . 0.0 114.859 161.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 93.9 mt -62.57 -41.47 98.94 Favored 'General case' 0 CA--C 1.57 1.734 0 N-CA-C 115.51 1.67 . . . . 0.0 115.51 171.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 35.2 ttp180 -62.07 -44.85 95.78 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 115.091 1.515 . . . . 0.0 115.091 169.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -49.82 -28.96 7.09 Favored 'General case' 0 CA--C 1.571 1.781 0 N-CA-C 118.234 2.679 . . . . 0.0 118.234 162.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 91.0 mt -86.97 0.68 54.72 Favored 'General case' 0 CA--C 1.569 1.7 0 N-CA-C 116.45 2.019 . . . . 0.0 116.45 168.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 62.32 39.07 12.68 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 115.458 1.651 . . . . 0.0 115.458 -169.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 86.1 t -92.88 140.25 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 CA-C-O 122.195 0.997 . . . . 0.0 109.02 178.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.8 p-10 -67.0 146.05 54.77 Favored 'General case' 0 CA--C 1.567 1.613 0 N-CA-C 116.287 1.958 . . . . 0.0 116.287 -170.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 58.5 t -59.57 -38.75 77.02 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.162 0 N-CA-C 115.622 1.712 . . . . 0.0 115.622 -173.183 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.12 -38.95 84.58 Favored 'General case' 0 CA--C 1.569 1.711 0 N-CA-C 116.412 2.005 . . . . 0.0 116.412 169.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 6.1 tt -65.49 -50.67 64.45 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-N 119.318 0.963 . . . . 0.0 113.553 165.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 35.2 mtp-105 -47.62 -50.35 24.63 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 116.263 1.949 . . . . 0.0 116.263 172.203 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -70.91 -36.29 72.62 Favored 'General case' 0 CA--C 1.564 1.493 0 N-CA-C 115.239 1.57 . . . . 0.0 115.239 174.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 41.0 mt -71.99 -55.78 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.22 0 CA-C-N 122.334 2.334 . . . . 0.0 110.559 174.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -61.14 -23.3 65.43 Favored 'General case' 0 CA--C 1.565 1.54 0 N-CA-C 119.255 3.057 . . . . 0.0 119.255 176.362 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -75.28 -47.59 27.21 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 115.454 1.65 . . . . 0.0 115.454 160.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 97.4 mt -75.25 -25.56 58.14 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 116.29 1.959 . . . . 0.0 116.29 -175.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . 0.25 1.4 pp -96.34 149.89 21.19 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 119.444 1.02 . . . . 0.0 110.397 158.327 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -107.06 92.32 7.6 Favored Pre-proline 0 CA--C 1.574 1.873 0 CA-C-O 117.78 -1.105 . . . . 0.0 109.222 -176.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -72.04 155.85 56.67 Favored 'Trans proline' 0 CA--C 1.562 1.901 0 C-N-CA 122.535 2.157 . . . . 0.0 116.739 -170.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -101.14 136.22 41.34 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.926 -170.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 60.8 mttm -96.02 112.1 23.93 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.123 -0.986 . . . . 0.0 110.19 174.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -94.5 108.13 20.08 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 163.329 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 78.0 mt -103.07 117.14 48.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 -175.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 91.1 t -100.18 93.75 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 173.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -95.31 97.17 9.65 Favored 'General case' 0 CA--C 1.566 1.568 0 CA-C-O 121.395 0.617 . . . . 0.0 110.831 176.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -89.97 79.23 6.61 Favored 'General case' 0 CA--C 1.568 1.666 0 O-C-N 121.275 -0.89 . . . . 0.0 109.815 167.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 65.94 -102.66 0.73 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 114.897 0.719 . . . . 0.0 114.897 -174.176 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -86.07 -23.29 26.77 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 116.531 2.048 . . . . 0.0 116.531 165.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 18.5 t-160 -78.9 108.89 12.69 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 121.602 2.001 . . . . 0.0 111.148 178.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 47.1 ttm -117.64 121.08 39.94 Favored 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 123.676 0.79 . . . . 0.0 109.932 -174.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 29.6 mt -107.41 101.94 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 173.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 78.8 mt -88.89 100.63 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 177.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 62.6 mtt180 -94.5 98.48 10.88 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.774 -0.579 . . . . 0.0 110.251 -179.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 11.4 m -87.6 107.92 18.83 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 177.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 13.5 mt -108.96 120.35 42.26 Favored 'General case' 0 CA--C 1.558 1.273 0 C-N-CA 123.478 0.711 . . . . 0.0 110.486 -160.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 38.7 t -116.45 -93.41 0.5 Allowed 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.147 0.579 . . . . 0.0 110.624 177.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 52.8 m 176.83 -62.18 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.033 0 C-N-CA 126.618 1.967 . . . . 0.0 106.015 -170.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -72.89 -48.63 35.61 Favored 'General case' 0 CA--C 1.573 1.838 0 N-CA-C 115.935 1.828 . . . . 0.0 115.935 176.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 42.7 tpt85 -139.08 124.64 19.44 Favored 'General case' 0 CA--C 1.564 1.492 0 CA-C-N 118.995 0.816 . . . . 0.0 109.755 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -83.46 173.72 11.25 Favored 'General case' 0 CA--C 1.569 1.69 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 169.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -112.9 -76.24 0.59 Allowed 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.337 -0.852 . . . . 0.0 110.196 170.012 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.374 58.5 mt 70.5 85.51 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.127 0 C-N-CA 124.5 1.12 . . . . 0.0 111.678 173.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 94.4 mtp -102.05 102.64 13.16 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.5 p30 -99.96 110.44 22.77 Favored 'General case' 0 CA--C 1.562 1.434 0 C-N-CA 123.899 0.88 . . . . 0.0 112.554 -178.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -155.04 148.78 25.48 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 -168.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 23.1 mp0 -82.65 125.76 31.57 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.219 -0.926 . . . . 0.0 110.667 160.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 13.1 t -66.17 123.34 18.94 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.91 0 O-C-N 121.31 -0.869 . . . . 0.0 110.142 176.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 115.81 -44.26 1.51 Allowed Glycine 0 CA--C 1.55 2.253 0 N-CA-C 115.597 0.999 . . . . 0.0 115.597 -157.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 83.8 mttt -83.6 146.62 28.19 Favored 'General case' 0 CA--C 1.566 1.593 0 CA-C-N 118.822 1.311 . . . . 0.0 114.18 -172.237 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -91.05 103.71 16.38 Favored 'General case' 0 CA--C 1.564 1.51 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.995 167.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 11.1 p90 -102.72 145.49 29.63 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -171.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -78.81 124.67 28.45 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 177.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -117.1 100.96 8.08 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 169.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -125.06 109.91 13.51 Favored 'General case' 0 CA--C 1.563 1.462 0 C-N-CA 123.35 0.66 . . . . 0.0 109.645 173.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 19.2 tp -150.26 -114.63 0.05 Allowed 'General case' 0 CA--C 1.57 1.74 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 172.522 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 85.5 m -162.63 113.35 1.5 Allowed 'General case' 0 N--CA 1.498 1.935 0 O-C-N 119.934 -1.729 . . . . 0.0 107.153 172.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 165.78 -83.06 0.1 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 115.555 0.982 . . . . 0.0 115.555 178.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.474 HG23 ' H ' ' A' ' 78' ' ' ASP 0.294 18.8 tt -130.16 -96.04 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 -170.254 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.474 ' H ' HG23 ' A' ' 77' ' ' ILE . 36.0 t0 -80.17 71.52 6.93 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.998 0.904 . . . . 0.0 110.92 168.661 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 46.9 m-20 -150.53 -1.67 0.38 Allowed 'General case' 0 CA--C 1.573 1.841 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 -164.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 72.0 ttt-85 -95.8 73.06 3.08 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-N 121.004 1.729 . . . . 0.0 110.475 177.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 10.2 mtmp? 43.44 65.38 1.0 Allowed 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 116.278 1.955 . . . . 0.0 116.278 -170.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 73.3 m -100.79 126.09 47.34 Favored 'General case' 0 CA--C 1.557 1.213 0 CA-C-O 121.713 0.768 . . . . 0.0 111.835 -174.321 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 12.4 mmt -88.82 90.13 8.28 Favored 'General case' 0 CA--C 1.56 1.33 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 173.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 86.0 m -92.78 122.41 35.14 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.166 -0.958 . . . . 0.0 110.265 -174.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 58.5 m -110.04 122.73 48.26 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.457 HG22 ' SG ' ' A' ' 95' ' ' CYS . 17.8 t -118.0 128.09 75.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 92.0 p -130.6 166.58 20.33 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 122.506 1.146 . . . . 0.0 113.256 -176.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 68.5 m95 -97.19 129.67 44.52 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.615 -0.678 . . . . 0.0 111.932 175.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -126.49 81.84 2.03 Favored 'General case' 0 CA--C 1.567 1.597 0 C-N-CA 123.668 0.787 . . . . 0.0 109.647 177.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 63.21 17.44 59.24 Favored Glycine 0 N--CA 1.496 2.69 0 N-CA-C 121.74 3.456 . . . . 0.0 121.74 172.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . 0.269 0.8 OUTLIER 126.33 -45.41 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.472 0 C-N-CA 127.374 2.269 . . . . 0.0 111.087 -159.543 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 64.3 mttm -77.7 142.21 38.91 Favored 'General case' 0 CA--C 1.562 1.408 0 C-N-CA 123.68 0.792 . . . . 0.0 111.937 -176.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 25.7 tp -97.62 104.1 16.09 Favored 'General case' 0 CA--C 1.564 1.514 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 172.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 32.9 mm-40 -92.57 142.69 27.12 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 123.332 0.653 . . . . 0.0 111.831 -177.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . 0.457 ' SG ' HG22 ' A' ' 86' ' ' VAL . 49.3 t -139.64 136.88 34.78 Favored 'General case' 0 N--CA 1.484 1.238 0 O-C-N 121.441 -0.787 . . . . 0.0 112.127 -178.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.7 p -114.78 129.25 71.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 C-N-CA 123.203 0.601 . . . . 0.0 109.506 162.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -105.95 75.55 1.12 Allowed 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 123.593 0.757 . . . . 0.0 109.687 179.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -86.92 141.07 29.01 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.487 -1.383 . . . . 0.0 113.388 -173.21 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 135.69 -66.93 0.55 Allowed Glycine 0 N--CA 1.491 2.312 0 O-C-N 121.73 -0.606 . . . . 0.0 113.957 -171.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -79.54 -53.54 6.77 Favored 'General case' 0 CA--C 1.57 1.739 0 N-CA-C 115.335 1.606 . . . . 0.0 115.335 -175.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 45.1 mmtm -133.12 160.61 36.72 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-N 119.903 1.228 . . . . 0.0 114.313 -166.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -77.04 137.9 39.25 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.43 175.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 61.6 35.8 91.68 Favored Glycine 0 N--CA 1.496 2.652 0 N-CA-C 118.785 2.274 . . . . 0.0 118.785 -176.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 46.1 ttt180 -96.93 123.95 40.77 Favored 'General case' 0 CA--C 1.561 1.395 0 CA-C-N 118.16 0.98 . . . . 0.0 112.59 -170.095 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 179.92 -169.13 39.81 Favored Glycine 0 N--CA 1.483 1.776 0 CA-C-O 122.129 0.849 . . . . 0.0 114.847 176.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 43.4 p-90 -155.1 156.27 35.51 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 175.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 49.2 m -125.29 118.71 26.56 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 173.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 -118.52 129.81 55.57 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 123.345 0.658 . . . . 0.0 111.07 -178.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 15.3 p90 -150.34 156.72 42.05 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.761 -1.212 . . . . 0.0 113.396 -175.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 73.8 mt -101.44 141.76 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.186 0 CA-C-O 122.697 1.237 . . . . 0.0 111.346 -176.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -139.7 88.25 2.23 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 123.997 0.919 . . . . 0.0 109.12 -177.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 72.29 -112.61 4.1 Favored Glycine 0 N--CA 1.49 2.257 0 CA-C-N 115.87 -0.605 . . . . 0.0 113.755 -173.021 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 54.8 p30 -92.28 7.35 43.11 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 116.78 2.141 . . . . 0.0 116.78 164.034 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -107.87 146.76 31.87 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-N 120.519 1.509 . . . . 0.0 112.526 -174.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 13.8 tp -108.01 118.98 38.17 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 169.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 34.1 m80 -106.51 124.24 49.3 Favored 'General case' 0 CA--C 1.559 1.326 0 C-N-CA 123.713 0.805 . . . . 0.0 109.202 -175.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 20.1 tp -120.49 130.29 54.22 Favored 'General case' 0 CA--C 1.561 1.374 0 C-N-CA 123.8 0.84 . . . . 0.0 109.736 -176.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -117.76 114.51 23.42 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.567 -0.708 . . . . 0.0 109.532 166.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 68.2 mtm -106.81 125.0 50.44 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 123.368 0.667 . . . . 0.0 110.923 -178.224 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 72.7 mtp85 -111.6 140.93 45.81 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 123.381 0.673 . . . . 0.0 112.299 -176.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -159.22 135.18 8.81 Favored 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 123.301 0.64 . . . . 0.0 111.876 167.493 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 60.5 21.7 11.41 Favored 'General case' 0 N--CA 1.506 2.351 0 N-CA-C 115.963 1.838 . . . . 0.0 115.963 -170.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 82.88 -12.47 48.64 Favored Glycine 0 CA--C 1.56 2.858 0 N-CA-C 119.29 2.476 . . . . 0.0 119.29 -158.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 92.3 t -89.11 123.6 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 CA-C-N 120.015 1.908 . . . . 0.0 109.825 -171.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 24.1 m -101.16 120.81 40.78 Favored 'General case' 0 N--CA 1.494 1.773 0 C-N-CA 122.922 0.489 . . . . 0.0 112.092 -178.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 13.3 t -90.64 125.86 35.78 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.576 0.75 . . . . 0.0 111.655 162.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -107.86 113.57 26.89 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -177.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 14.4 mt-30 -121.51 126.97 50.5 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.431 -0.793 . . . . 0.0 110.882 -174.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 58.1 t -110.83 132.87 58.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -179.083 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -124.84 152.7 43.61 Favored 'General case' 0 CA--C 1.563 1.468 0 C-N-CA 124.307 1.043 . . . . 0.0 110.866 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -120.3 139.24 53.02 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.263 -0.898 . . . . 0.0 111.899 174.198 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 73.3 tttt -73.14 120.32 18.61 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.452 -0.78 . . . . 0.0 112.795 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . 0.253 34.7 m -105.81 -40.18 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 173.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 44.6 t60 . . . . . 0 N--CA 1.486 1.365 0 CA-C-N 119.988 1.267 . . . . 0.0 108.192 165.686 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 17.9 ptp . . . . . 0 CA--C 1.575 1.904 0 CA-C-O 119.063 -0.494 . . . . 0.0 112.255 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -88.89 166.29 5.88 Favored 'Trans proline' 0 CA--C 1.564 2.008 0 C-N-CA 122.574 2.183 . . . . 0.0 115.813 -176.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 19.0 m -76.52 152.63 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 CA-C-O 122.302 1.049 . . . . 0.0 112.307 165.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -76.74 118.08 19.0 Favored 'General case' 0 CA--C 1.565 1.545 0 O-C-N 121.242 -0.911 . . . . 0.0 113.383 178.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 6.2 m-30 -84.77 8.47 17.07 Favored 'General case' 0 CA--C 1.579 2.065 0 N-CA-C 115.57 1.693 . . . . 0.0 115.57 169.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -57.59 111.99 1.29 Allowed 'General case' 0 CA--C 1.564 1.499 0 N-CA-C 114.916 1.45 . . . . 0.0 114.916 -179.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 164.24 173.29 32.74 Favored Glycine 0 N--CA 1.484 1.862 0 N-CA-C 115.944 1.138 . . . . 0.0 115.944 -178.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -102.69 120.58 40.82 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-N 114.648 -0.776 . . . . 0.0 108.974 172.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 75.6 m95 -119.14 118.64 31.91 Favored 'General case' 0 CA--C 1.566 1.58 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -170.048 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 59.9 pttt -102.72 141.49 35.45 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.144 -0.972 . . . . 0.0 112.76 -176.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 45.6 ttm -66.05 124.78 23.49 Favored 'General case' 0 CA--C 1.569 1.689 0 N-CA-C 115.188 1.551 . . . . 0.0 115.188 -175.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 94.9 mt -88.32 -49.93 6.65 Favored 'General case' 0 CA--C 1.569 1.675 0 CA-C-N 115.128 -0.942 . . . . 0.0 112.986 164.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 87.0 p -136.6 149.56 48.09 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-N 119.143 0.883 . . . . 0.0 112.848 -178.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -135.7 87.24 2.3 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 123.671 0.789 . . . . 0.0 110.175 172.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -98.27 132.7 43.54 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.543 0.737 . . . . 0.0 110.872 -175.406 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.271 41.5 t30 62.75 17.08 9.53 Favored 'General case' 0 N--CA 1.503 2.203 0 N-CA-C 117.588 2.44 . . . . 0.0 117.588 179.757 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -62.4 -46.39 88.83 Favored 'General case' 0 CA--C 1.565 1.551 0 N-CA-C 115.764 1.764 . . . . 0.0 115.764 177.236 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -61.47 -38.93 89.04 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 116.764 2.135 . . . . 0.0 116.764 173.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -65.5 -41.43 93.21 Favored 'General case' 0 CA--C 1.572 1.825 0 CA-C-N 120.684 1.583 . . . . 0.0 114.924 168.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 39.4 t80 -55.0 -50.32 69.3 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 114.754 1.39 . . . . 0.0 114.754 166.048 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 91.9 mt -61.87 -43.4 98.91 Favored 'General case' 0 CA--C 1.571 1.775 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 171.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 20.4 ttm180 -53.12 -47.55 68.58 Favored 'General case' 0 CA--C 1.578 2.037 0 CA-C-N 120.746 1.612 . . . . 0.0 114.896 164.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.46 -19.11 45.19 Favored 'General case' 0 CA--C 1.568 1.647 0 N-CA-C 118.317 2.71 . . . . 0.0 118.317 166.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 95.4 mt -92.73 12.55 23.03 Favored 'General case' 0 CA--C 1.572 1.815 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 164.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 61.25 45.6 8.68 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 115.21 1.559 . . . . 0.0 115.21 -174.511 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 57.4 t -96.85 143.37 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 CA-C-O 122.388 1.09 . . . . 0.0 110.123 -176.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 -71.46 152.74 42.8 Favored 'General case' 0 CA--C 1.569 1.676 0 N-CA-C 115.022 1.49 . . . . 0.0 115.022 177.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 57.8 t -57.37 -41.1 77.8 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.166 0 N-CA-C 115.14 1.533 . . . . 0.0 115.14 -176.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.09 -49.32 78.31 Favored 'General case' 0 CA--C 1.567 1.624 0 N-CA-C 116.296 1.961 . . . . 0.0 116.296 174.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -59.55 -48.19 82.61 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 114.136 1.162 . . . . 0.0 114.136 168.406 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 53.2 mtp180 -50.82 -45.42 59.47 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 117.444 2.387 . . . . 0.0 117.444 168.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -72.5 -51.7 18.91 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-N 119.978 1.263 . . . . 0.0 113.807 172.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 45.2 mt -58.72 -51.5 71.24 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.23 0 CA-C-N 120.498 1.499 . . . . 0.0 113.293 178.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.83 -35.77 82.19 Favored 'General case' 0 CA--C 1.563 1.477 0 N-CA-C 117.76 2.504 . . . . 0.0 117.76 175.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -74.33 -30.82 62.19 Favored 'General case' 0 CA--C 1.571 1.777 0 N-CA-C 116.357 1.984 . . . . 0.0 116.357 169.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 79.4 mt -73.02 -34.38 66.31 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 115.209 1.559 . . . . 0.0 115.209 169.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 81.9 mt -72.5 152.81 41.69 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 119.318 0.963 . . . . 0.0 112.574 169.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -102.65 89.52 1.83 Allowed Pre-proline 0 CA--C 1.57 1.72 0 CA-C-O 118.234 -0.889 . . . . 0.0 109.339 167.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -70.16 168.67 21.42 Favored 'Trans proline' 0 CA--C 1.563 1.964 0 C-N-CA 122.47 2.114 . . . . 0.0 115.399 -179.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -131.95 128.6 38.81 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.905 -169.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -99.79 109.11 21.55 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.161 -0.962 . . . . 0.0 109.822 177.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -93.76 102.74 14.89 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 169.15 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 92.2 mt -94.91 121.38 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -172.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 96.0 t -112.1 93.2 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 107.067 -1.456 . . . . 0.0 107.067 176.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -89.69 115.97 27.45 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 123.72 0.808 . . . . 0.0 110.556 176.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -135.62 70.51 1.43 Allowed 'General case' 0 CA--C 1.569 1.682 0 C-N-CA 123.212 0.605 . . . . 0.0 110.811 -173.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 61.98 81.62 0.09 OUTLIER Glycine 0 N--CA 1.495 2.627 0 N-CA-C 116.488 1.355 . . . . 0.0 116.488 173.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.452 1.1 p30 63.85 -39.02 0.2 Allowed 'General case' 0 N--CA 1.504 2.225 0 N-CA-C 118.332 2.716 . . . . 0.0 118.332 -165.181 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 12.4 t-80 -79.15 121.64 25.26 Favored 'General case' 0 CA--C 1.56 1.346 0 CA-C-N 120.157 1.344 . . . . 0.0 111.406 173.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 11.3 ttp -134.6 129.51 35.07 Favored 'General case' 0 CA--C 1.556 1.204 0 CA-C-O 122.08 0.943 . . . . 0.0 110.979 -179.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 4.4 mp -105.06 113.57 42.45 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.377 0 N-CA-C 107.081 -1.452 . . . . 0.0 107.081 174.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 24.5 mm -89.04 93.57 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 167.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -80.18 96.68 6.63 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.146 -0.971 . . . . 0.0 109.733 -179.036 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 26.3 m -90.24 100.85 13.6 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 -175.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 23.6 mt -105.86 135.13 47.85 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 124.214 1.006 . . . . 0.0 110.491 -164.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 12.5 p -144.26 156.36 44.24 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.136 -0.978 . . . . 0.0 112.597 177.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.6 m -77.75 61.08 2.35 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 120.742 -1.223 . . . . 0.0 112.316 172.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -177.14 -67.55 0.01 OUTLIER 'General case' 0 CA--C 1.568 1.657 0 C-N-CA 126.013 1.725 . . . . 0.0 107.946 -174.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 56.7 ttt85 -144.76 140.94 28.84 Favored 'General case' 0 CA--C 1.565 1.528 0 CA-C-O 121.784 0.802 . . . . 0.0 110.217 177.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -105.18 119.43 39.03 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 175.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 19.3 t80 -81.75 -57.73 3.31 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 114.074 1.139 . . . . 0.0 114.074 -172.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.272 10.4 mm 76.2 95.97 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 C-N-CA 124.071 0.949 . . . . 0.0 111.798 172.395 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 91.1 mtp -97.52 94.2 6.88 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.994 -1.066 . . . . 0.0 109.628 173.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.9 p30 -96.19 111.29 23.39 Favored 'General case' 0 CA--C 1.561 1.38 0 C-N-CA 124.069 0.948 . . . . 0.0 112.136 179.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 20.4 p90 -150.38 158.57 44.31 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 -168.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -95.22 134.19 38.25 Favored 'General case' 0 CA--C 1.563 1.47 0 O-C-N 121.464 -0.773 . . . . 0.0 110.938 164.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 36.4 t -72.53 122.92 26.09 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.807 0 C-N-CA 123.845 0.858 . . . . 0.0 109.431 178.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 104.74 -48.55 0.98 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 115.56 0.984 . . . . 0.0 115.56 -163.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 26.2 tptp -65.14 133.48 51.66 Favored 'General case' 0 CA--C 1.567 1.618 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 176.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -92.48 110.19 21.6 Favored 'General case' 0 CA--C 1.569 1.709 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.139 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -118.99 134.44 55.19 Favored 'General case' 0 N--CA 1.498 1.947 0 C-N-CA 124.092 0.957 . . . . 0.0 112.664 -169.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -73.41 131.78 42.23 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.248 -1.532 . . . . 0.0 114.245 178.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -77.09 61.65 2.07 Favored 'General case' 0 N--CA 1.5 2.068 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 176.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -87.49 62.54 7.18 Favored 'General case' 0 CA--C 1.57 1.748 0 O-C-N 120.029 -1.67 . . . . 0.0 112.628 -177.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 48.3 tp -148.17 118.35 7.28 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.209 -0.932 . . . . 0.0 110.746 -159.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 94.7 m -74.33 135.07 42.52 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -173.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 150.91 -63.17 0.4 Allowed Glycine 0 N--CA 1.488 2.143 0 CA-C-O 119.51 -0.606 . . . . 0.0 114.575 179.363 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 65.4 mt -80.91 -78.99 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 178.122 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -132.68 141.44 48.6 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-N 119.522 1.055 . . . . 0.0 110.192 167.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -91.25 67.79 5.85 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.041 -1.037 . . . . 0.0 112.803 178.505 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.3 ttp180 -150.5 115.09 5.21 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 168.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.13 149.08 43.32 Favored 'General case' 0 CA--C 1.565 1.528 0 N-CA-C 116.355 1.983 . . . . 0.0 116.355 -168.702 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 97.8 m -139.3 127.92 23.15 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.626 179.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 33.7 mtp -71.2 105.37 3.4 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-O 122.305 1.05 . . . . 0.0 111.799 -179.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 53.8 m -106.13 119.2 38.61 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.638 -161.406 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 87.6 m -94.79 124.68 38.98 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 166.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 57.8 t -105.45 135.95 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 167.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 52.4 m -147.5 146.88 29.66 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.286 -1.509 . . . . 0.0 112.528 -177.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 47.1 m95 -83.94 119.03 24.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.177 -0.952 . . . . 0.0 112.782 178.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -96.13 71.55 2.86 Favored 'General case' 0 CA--C 1.573 1.849 0 C-N-CA 123.061 0.544 . . . . 0.0 109.569 157.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 62.65 -102.83 0.54 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 115.653 1.021 . . . . 0.0 115.653 -175.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -80.77 -22.29 40.26 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 116.312 1.967 . . . . 0.0 116.312 169.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 61.2 mtpt -92.92 121.83 34.67 Favored 'General case' 0 CA--C 1.56 1.349 0 CA-C-N 119.547 1.067 . . . . 0.0 110.499 -177.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 33.0 tp -89.17 106.98 18.79 Favored 'General case' 0 CA--C 1.564 1.492 0 O-C-N 121.407 -0.808 . . . . 0.0 109.345 174.099 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 -96.59 137.21 36.01 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.724 0.81 . . . . 0.0 111.349 -175.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 40.7 t -134.17 128.35 33.86 Favored 'General case' 0 N--CA 1.483 1.189 0 O-C-N 121.732 -0.605 . . . . 0.0 111.742 -177.056 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 11.1 p -122.47 124.1 70.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 C-N-CA 123.284 0.634 . . . . 0.0 109.84 176.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -102.66 106.85 17.57 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 123.855 0.862 . . . . 0.0 110.385 -176.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -101.85 124.12 46.94 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.289 -0.882 . . . . 0.0 111.666 -169.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 177.49 -62.17 0.09 OUTLIER Glycine 0 N--CA 1.494 2.541 0 N-CA-C 117.388 1.715 . . . . 0.0 117.388 178.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -134.12 -58.41 0.85 Allowed 'General case' 0 N--CA 1.496 1.836 0 CA-C-N 117.529 0.664 . . . . 0.0 112.151 178.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 53.8 mttm -79.37 139.78 37.65 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 114.374 1.25 . . . . 0.0 114.374 -176.042 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -80.33 146.98 31.3 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-N 114.638 -1.165 . . . . 0.0 112.705 175.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 65.04 20.3 66.76 Favored Glycine 0 N--CA 1.495 2.59 0 N-CA-C 119.802 2.681 . . . . 0.0 119.802 -173.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 26.6 ttt180 -84.36 118.17 24.06 Favored 'General case' 0 CA--C 1.566 1.577 0 CA-C-N 118.91 1.355 . . . . 0.0 111.654 -177.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 179.29 -171.77 43.7 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 115.298 0.879 . . . . 0.0 115.298 -174.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . 0.259 39.9 p-90 -156.49 155.0 31.24 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 170.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 84.7 m -128.06 116.55 20.18 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 177.192 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -120.26 126.98 51.93 Favored 'General case' 0 N--CA 1.495 1.821 0 C-N-CA 123.545 0.738 . . . . 0.0 111.537 -174.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 16.3 p90 -148.61 155.38 41.0 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 120.893 -1.13 . . . . 0.0 113.364 -178.052 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 90.7 mt -98.1 132.96 41.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.02 -1.05 . . . . 0.0 110.291 177.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -118.79 94.04 4.31 Favored 'General case' 0 CA--C 1.566 1.594 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 162.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 69.07 -112.38 4.52 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 115.396 0.919 . . . . 0.0 115.396 -178.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 16.0 p30 -85.96 -2.42 58.27 Favored 'General case' 0 CA--C 1.572 1.827 0 N-CA-C 117.139 2.274 . . . . 0.0 117.139 166.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 88.2 mt-10 -109.93 128.95 55.69 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-N 120.646 1.566 . . . . 0.0 111.712 -174.142 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 12.2 tp -90.59 116.03 28.17 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.962 0.905 . . . . 0.0 109.421 167.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 57.7 m80 -99.9 122.45 42.84 Favored 'General case' 0 CA--C 1.559 1.295 0 C-N-CA 123.936 0.895 . . . . 0.0 109.422 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 47.6 tp -123.96 119.65 30.21 Favored 'General case' 0 CA--C 1.561 1.368 0 C-N-CA 123.974 0.909 . . . . 0.0 109.878 -174.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -108.74 106.62 16.73 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 171.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 62.0 mtm -99.72 125.83 45.67 Favored 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 123.043 0.537 . . . . 0.0 111.05 -178.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 71.5 mtm180 -114.56 139.41 49.61 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 123.629 0.772 . . . . 0.0 111.551 -168.114 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -155.64 124.6 6.11 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.583 -0.698 . . . . 0.0 110.798 168.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 60.55 36.21 19.95 Favored 'General case' 0 N--CA 1.505 2.32 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 -178.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 78.64 -22.39 3.36 Favored Glycine 0 CA--C 1.554 2.524 0 N-CA-C 119.3 2.48 . . . . 0.0 119.3 -162.006 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 85.7 t -80.15 120.83 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 CA-C-N 119.886 1.843 . . . . 0.0 110.091 -171.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 57.0 m -103.74 118.22 36.2 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 122.923 0.489 . . . . 0.0 111.015 -179.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 37.7 t -84.74 127.79 34.28 Favored 'General case' 0 CA--C 1.559 1.291 0 C-N-CA 123.115 0.566 . . . . 0.0 111.953 162.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 38.2 mtmm -106.21 109.39 21.31 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -179.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -114.69 133.19 56.07 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 123.674 0.79 . . . . 0.0 111.14 179.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 44.7 t -118.06 131.3 71.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 177.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -125.96 138.26 53.75 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 123.328 0.651 . . . . 0.0 111.656 -179.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 29.0 tptp -96.39 137.25 35.74 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.156 -0.965 . . . . 0.0 112.623 178.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 73.1 tttt -70.73 123.6 22.31 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 174.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 24.4 m -107.0 -42.67 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.13 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 173.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 32.8 m80 . . . . . 0 C--O 1.254 1.293 0 CA-C-N 119.601 1.091 . . . . 0.0 108.683 179.256 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 60.4 mtt . . . . . 0 CA--C 1.571 1.785 0 CA-C-O 118.59 -0.719 . . . . 0.0 112.156 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -75.97 139.45 21.87 Favored 'Trans proline' 0 CA--C 1.561 1.849 0 C-N-CA 122.428 2.085 . . . . 0.0 115.728 179.331 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 33.0 m -75.37 152.91 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 CA-C-O 122.305 1.05 . . . . 0.0 113.121 177.226 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -71.93 113.53 9.06 Favored 'General case' 0 CA--C 1.56 1.365 0 O-C-N 121.328 -0.857 . . . . 0.0 112.212 172.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 6.0 m-30 -77.02 6.38 6.44 Favored 'General case' 0 CA--C 1.582 2.173 0 N-CA-C 116.188 1.922 . . . . 0.0 116.188 173.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -53.51 111.42 0.71 Allowed 'General case' 0 CA--C 1.565 1.532 0 C-N-CA 126.376 1.87 . . . . 0.0 115.597 -178.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 163.1 178.18 36.68 Favored Glycine 0 N--CA 1.482 1.759 0 CA-C-O 123.01 1.339 . . . . 0.0 116.104 177.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -107.76 124.6 50.27 Favored 'General case' 0 CA--C 1.563 1.46 0 CA-C-N 113.869 -1.165 . . . . 0.0 109.088 175.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -118.92 140.92 49.18 Favored 'General case' 0 CA--C 1.569 1.674 0 C-N-CA 123.9 0.88 . . . . 0.0 110.357 -168.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -115.6 133.04 56.42 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.165 -0.959 . . . . 0.0 111.841 176.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 53.9 ttm -71.61 123.83 23.37 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.096 -1.002 . . . . 0.0 113.562 -177.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 94.9 mt -81.19 -53.18 6.6 Favored 'General case' 0 CA--C 1.567 1.626 0 CA-C-N 115.307 -0.861 . . . . 0.0 112.466 169.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 92.4 p -145.65 124.8 12.89 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.662 0.785 . . . . 0.0 111.106 -175.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -103.19 96.21 6.63 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.92 0.867 . . . . 0.0 110.527 166.047 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -99.24 127.05 45.18 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 124.007 0.923 . . . . 0.0 109.592 -171.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 5.9 t30 66.32 23.16 10.76 Favored 'General case' 0 N--CA 1.508 2.443 0 N-CA-C 116.794 2.146 . . . . 0.0 116.794 -174.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -69.08 -46.96 66.47 Favored 'General case' 0 CA--C 1.568 1.656 0 N-CA-C 115.034 1.494 . . . . 0.0 115.034 178.135 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -42.09 -54.42 3.59 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 118.091 2.626 . . . . 0.0 118.091 167.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.28 8.5 pt-20 -75.67 -31.3 59.69 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 116.612 2.079 . . . . 0.0 116.612 176.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 79.5 t80 -55.4 -48.4 74.41 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-N 120.36 1.437 . . . . 0.0 114.569 160.119 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 69.3 mt -60.82 -40.97 94.75 Favored 'General case' 0 CA--C 1.574 1.898 0 N-CA-C 114.887 1.439 . . . . 0.0 114.887 170.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 37.6 ttm-85 -51.73 -50.84 59.77 Favored 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 115.262 1.578 . . . . 0.0 115.262 163.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.32 -25.37 59.24 Favored 'General case' 0 CA--C 1.566 1.574 0 N-CA-C 117.87 2.544 . . . . 0.0 117.87 168.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 97.0 mt -87.58 9.81 19.96 Favored 'General case' 0 CA--C 1.573 1.864 0 N-CA-C 115.656 1.724 . . . . 0.0 115.656 168.243 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 60.54 43.91 12.36 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 115.606 1.706 . . . . 0.0 115.606 -172.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 95.4 t -93.9 138.7 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.193 -0.942 . . . . 0.0 109.231 177.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 13.1 p30 -63.79 150.38 44.78 Favored 'General case' 0 CA--C 1.57 1.731 0 N-CA-C 115.251 1.575 . . . . 0.0 115.251 178.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 88.8 t -56.41 -40.24 66.01 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.22 0 N-CA-C 115.522 1.675 . . . . 0.0 115.522 -177.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.5 -53.69 55.35 Favored 'General case' 0 CA--C 1.568 1.672 0 N-CA-C 115.739 1.755 . . . . 0.0 115.739 169.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 28.9 tp -63.39 -38.28 90.52 Favored 'General case' 0 CA--C 1.571 1.781 0 N-CA-C 116.175 1.917 . . . . 0.0 116.175 171.22 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 34.6 mtp-105 -49.76 -52.05 34.58 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 115.801 1.778 . . . . 0.0 115.801 163.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -64.15 -49.09 73.49 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 114.547 1.314 . . . . 0.0 114.547 172.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 64.6 mt -58.49 -51.98 65.02 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 CA-C-N 119.996 1.271 . . . . 0.0 113.152 176.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.01 -35.82 81.97 Favored 'General case' 0 CA--C 1.563 1.47 0 N-CA-C 117.682 2.475 . . . . 0.0 117.682 175.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -72.23 -31.02 65.45 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 116.049 1.87 . . . . 0.0 116.049 168.115 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 78.3 mt -73.46 -35.15 65.67 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 115.317 1.599 . . . . 0.0 115.317 171.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 86.6 mt -83.22 143.68 30.29 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 119.069 0.85 . . . . 0.0 111.858 175.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 29.9 mmtp -106.05 88.36 3.01 Favored Pre-proline 0 CA--C 1.574 1.903 0 CA-C-O 117.982 -1.009 . . . . 0.0 109.641 176.078 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -73.18 166.41 30.04 Favored 'Trans proline' 0 CA--C 1.564 1.981 0 C-N-CA 122.45 2.1 . . . . 0.0 116.089 -175.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -98.74 155.7 17.21 Favored 'General case' 0 N--CA 1.488 1.425 0 CA-C-O 121.824 0.821 . . . . 0.0 112.373 177.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 65.2 mttt -117.4 121.14 40.27 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.508 -0.745 . . . . 0.0 109.357 164.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -94.61 109.77 21.66 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.104 -0.997 . . . . 0.0 108.594 161.17 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 68.3 mt -102.32 118.76 49.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 N-CA-C 107.424 -1.325 . . . . 0.0 107.424 179.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 57.3 t -111.35 95.43 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 172.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -88.32 97.87 11.28 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 123.519 0.728 . . . . 0.0 110.298 173.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -114.94 88.92 2.97 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 123.452 0.701 . . . . 0.0 109.973 -176.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 57.98 67.68 2.08 Favored Glycine 0 N--CA 1.495 2.607 0 N-CA-C 116.631 1.412 . . . . 0.0 116.631 178.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.477 0.6 OUTLIER 64.26 -25.46 0.08 Allowed 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 119.183 3.031 . . . . 0.0 119.183 -165.08 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 15.7 t-160 -78.09 109.48 12.21 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 121.284 1.856 . . . . 0.0 111.156 174.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 46.3 ttm -110.19 114.06 27.24 Favored 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 123.729 0.812 . . . . 0.0 109.496 -175.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 49.7 mt -100.15 102.59 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 175.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 59.1 mt -95.92 104.73 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 175.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 89.3 mtt180 -90.65 103.52 16.21 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.648 -0.658 . . . . 0.0 109.276 175.036 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 22.1 m -87.36 101.42 13.54 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 5.9 mt -111.96 118.48 35.59 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 124.009 0.924 . . . . 0.0 110.093 -163.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.1 t -99.08 -78.43 0.5 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.45 -0.781 . . . . 0.0 112.614 178.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.7 t 178.58 -61.58 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 125.699 1.6 . . . . 0.0 107.444 -170.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 7.9 p90 -83.89 -41.37 17.5 Favored 'General case' 0 CA--C 1.573 1.865 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 163.082 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 42.1 ttt85 -109.43 143.16 39.4 Favored 'General case' 0 CA--C 1.565 1.537 0 C-N-CA 124.124 0.97 . . . . 0.0 112.083 -168.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 46.1 t-20 -135.4 131.73 36.65 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 123.383 0.673 . . . . 0.0 110.096 175.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 9.2 t80 -124.78 110.24 14.07 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 172.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 87.1 mt -102.29 112.42 35.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -176.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 27.0 mmm -95.83 94.81 7.87 Favored 'General case' 0 CA--C 1.56 1.359 0 C-N-CA 123.628 0.771 . . . . 0.0 109.238 174.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.1 p30 -101.29 100.38 10.89 Favored 'General case' 0 CA--C 1.561 1.377 0 C-N-CA 123.725 0.81 . . . . 0.0 111.616 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -143.96 150.83 38.92 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -166.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -90.44 125.19 35.48 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.977 -1.077 . . . . 0.0 111.81 169.389 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 17.2 t -68.84 119.03 14.0 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.735 0 C-N-CA 123.858 0.863 . . . . 0.0 110.043 179.208 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 111.7 -43.49 1.71 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 115.778 1.071 . . . . 0.0 115.778 -160.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 51.2 mttm -83.71 143.87 29.74 Favored 'General case' 0 CA--C 1.567 1.608 0 CA-C-N 118.884 1.342 . . . . 0.0 113.41 -175.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -92.04 121.07 33.26 Favored 'General case' 0 CA--C 1.567 1.615 0 O-C-N 121.882 -0.511 . . . . 0.0 111.277 172.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 22.5 p90 -120.63 152.25 38.41 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 123.777 0.831 . . . . 0.0 112.668 -176.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -74.2 120.37 19.67 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.183 -1.573 . . . . 0.0 112.181 167.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -71.93 86.93 1.01 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.326 -0.859 . . . . 0.0 111.077 169.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 52.5 p-10 -90.46 -62.38 1.47 Allowed 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 114.346 1.239 . . . . 0.0 114.346 -173.165 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -85.63 74.51 10.26 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-N 119.297 0.953 . . . . 0.0 110.75 178.002 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 40.9 p -88.16 91.08 8.64 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.371 -0.831 . . . . 0.0 110.917 -175.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -73.62 34.61 0.84 Allowed Glycine 0 N--CA 1.498 2.794 0 N-CA-C 118.78 2.272 . . . . 0.0 118.78 173.362 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 38.8 mm -145.82 -69.52 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.575 1.906 0 N-CA-C 105.88 -1.896 . . . . 0.0 105.88 173.302 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -88.4 146.05 25.46 Favored 'General case' 0 CA--C 1.569 1.673 0 C-N-CA 124.198 0.999 . . . . 0.0 113.209 -176.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -86.99 145.3 26.55 Favored 'General case' 0 CA--C 1.572 1.818 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.353 161.122 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . 0.281 10.0 tpt180 94.44 126.21 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.182 0 C-N-CA 125.586 1.554 . . . . 0.0 111.74 -175.423 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 7.9 mptt -75.97 144.24 41.08 Favored 'General case' 0 CA--C 1.566 1.583 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 176.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 85.6 m -132.67 129.74 39.21 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-O 121.723 0.773 . . . . 0.0 111.741 -177.151 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 8.9 tpt -79.01 108.67 12.67 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.879 -1.138 . . . . 0.0 110.743 -178.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 97.4 m -119.71 114.57 22.38 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.146 -0.971 . . . . 0.0 111.069 -151.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 52.7 m -92.07 129.95 37.91 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 165.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.6 t -113.43 129.08 69.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 163.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 52.2 m -149.04 156.8 42.77 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.587 -1.32 . . . . 0.0 112.843 -175.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 72.8 m95 -82.23 115.39 21.29 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.89 -1.131 . . . . 0.0 112.308 179.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -84.83 72.99 10.7 Favored 'General case' 0 CA--C 1.569 1.709 0 O-C-N 121.382 -0.824 . . . . 0.0 109.869 163.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 69.42 -98.51 0.59 Allowed Glycine 0 N--CA 1.488 2.125 0 O-C-N 122.188 -0.32 . . . . 0.0 113.646 -167.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -99.95 -14.63 18.62 Favored 'General case' 0 CA--C 1.575 1.916 0 N-CA-C 116.393 1.997 . . . . 0.0 116.393 169.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 48.7 mtpt -92.82 127.33 38.29 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-N 120.407 1.458 . . . . 0.0 110.236 -176.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 26.0 tp -85.03 105.86 16.1 Favored 'General case' 0 CA--C 1.563 1.462 0 O-C-N 120.739 -1.226 . . . . 0.0 110.562 -177.375 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 29.5 mm-40 -95.16 129.34 42.3 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 123.369 0.668 . . . . 0.0 111.478 -177.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 41.4 t -116.35 128.34 55.45 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.666 0.786 . . . . 0.0 110.896 173.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.6 p -118.76 116.72 52.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 173.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 68.7 mt-30 -104.18 98.01 7.88 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 123.84 0.856 . . . . 0.0 109.079 -173.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -91.49 134.89 34.26 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.424 -0.797 . . . . 0.0 113.074 -164.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 160.43 -109.89 0.42 Allowed Glycine 0 N--CA 1.486 2.009 0 O-C-N 121.504 -0.748 . . . . 0.0 113.526 165.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -84.63 -39.08 19.08 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 115.906 1.817 . . . . 0.0 115.906 -175.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 17.8 ttmm -88.6 129.07 35.57 Favored 'General case' 0 CA--C 1.564 1.504 0 CA-C-N 119.5 1.046 . . . . 0.0 112.315 -175.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -76.16 134.13 40.02 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -172.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 61.93 32.97 83.94 Favored Glycine 0 N--CA 1.496 2.637 0 N-CA-C 119.622 2.609 . . . . 0.0 119.622 -177.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 3.9 ttt85 -86.97 119.77 27.53 Favored 'General case' 0 CA--C 1.564 1.515 0 CA-C-N 118.863 1.331 . . . . 0.0 111.264 -179.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -178.62 -171.83 42.32 Favored Glycine 0 N--CA 1.483 1.804 0 CA-C-O 122.102 0.834 . . . . 0.0 114.366 179.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 47.7 p-90 -156.08 156.24 33.98 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 175.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 29.4 m -127.96 119.65 25.95 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 177.004 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -122.72 131.49 53.81 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 -176.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 23.9 p90 -148.87 160.66 43.04 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.202 -0.937 . . . . 0.0 112.184 -179.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 96.1 mt -109.09 135.04 49.2 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.182 0 O-C-N 120.722 -1.236 . . . . 0.0 110.637 178.498 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -122.51 94.52 4.31 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 124.417 1.087 . . . . 0.0 108.156 176.293 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 73.11 -109.56 2.85 Favored Glycine 0 N--CA 1.491 2.34 0 O-C-N 121.494 -0.754 . . . . 0.0 114.024 -174.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -111.55 37.3 2.94 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 114.514 1.301 . . . . 0.0 114.514 164.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 81.3 mt-10 -130.72 130.66 44.09 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.709 0.804 . . . . 0.0 110.642 178.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 15.5 tp -90.85 118.09 29.98 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 123.892 0.877 . . . . 0.0 109.526 173.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 43.1 m80 -106.39 118.76 37.48 Favored 'General case' 0 CA--C 1.559 1.294 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -178.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 46.8 tp -122.24 124.53 44.02 Favored 'General case' 0 CA--C 1.559 1.301 0 C-N-CA 124.078 0.951 . . . . 0.0 109.572 -173.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 77.5 mt-10 -114.03 109.89 19.18 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.547 -0.72 . . . . 0.0 109.661 170.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 68.7 mtm -101.64 127.2 48.49 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 123.336 0.654 . . . . 0.0 110.858 -177.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 54.2 mtp85 -116.83 137.62 52.08 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 123.416 0.687 . . . . 0.0 110.932 -171.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -157.18 129.38 7.29 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.562 -0.711 . . . . 0.0 111.278 170.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . 0.276 22.6 mt-10 57.57 38.37 27.87 Favored 'General case' 0 N--CA 1.502 2.15 0 N-CA-C 115.77 1.767 . . . . 0.0 115.77 -176.256 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 69.14 9.26 60.05 Favored Glycine 0 CA--C 1.555 2.586 0 N-CA-C 120.365 2.906 . . . . 0.0 120.365 -164.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 95.0 t -111.59 125.54 68.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 CA-C-N 119.989 1.894 . . . . 0.0 108.972 -174.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 41.7 m -106.73 123.24 47.85 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 123.137 0.575 . . . . 0.0 111.168 -176.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 22.1 t -94.27 124.2 38.14 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.541 0.736 . . . . 0.0 111.513 164.378 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 48.5 mtpt -99.02 114.74 27.56 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 123.38 0.672 . . . . 0.0 109.65 177.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 20.2 mt-30 -119.78 123.59 44.09 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 123.35 0.66 . . . . 0.0 110.729 -178.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 43.8 t -112.91 130.49 66.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -123.97 147.45 47.74 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 123.595 0.758 . . . . 0.0 110.909 177.327 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -107.02 143.5 35.03 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.222 -0.924 . . . . 0.0 112.24 174.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 64.9 tttt -77.08 124.65 28.1 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 -177.186 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 27.7 m -110.86 -40.22 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 178.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 47.6 t-80 . . . . . 0 N--CA 1.486 1.373 0 CA-C-N 120.474 1.488 . . . . 0.0 108.488 174.824 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 0' ' ' MET . . . . . . . . . . . . 0.291 68.5 mtt . . . . . 0 CA--C 1.573 1.839 0 CA-C-O 116.764 -1.588 . . . . 0.0 114.339 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -65.19 -105.41 0.0 OUTLIER 'Trans proline' 0 CA--C 1.574 2.496 0 C-N-CA 123.734 2.956 . . . . 0.0 115.867 173.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 16.9 t -151.0 132.06 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 -172.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -75.78 90.09 2.88 Favored 'General case' 0 CA--C 1.569 1.698 0 O-C-N 121.193 -0.942 . . . . 0.0 111.76 172.065 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 10.6 m-30 -70.36 -1.38 10.4 Favored 'General case' 0 CA--C 1.58 2.119 0 N-CA-C 117.834 2.531 . . . . 0.0 117.834 176.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -51.96 123.61 10.8 Favored 'General case' 0 CA--C 1.566 1.594 0 N-CA-C 115.668 1.729 . . . . 0.0 115.668 177.382 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 163.21 176.93 35.73 Favored Glycine 0 N--CA 1.486 1.995 0 N-CA-C 116.153 1.221 . . . . 0.0 116.153 178.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -111.58 121.0 43.97 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 171.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 78.9 m95 -124.71 126.11 45.17 Favored 'General case' 0 CA--C 1.566 1.594 0 C-N-CA 123.297 0.639 . . . . 0.0 110.591 -165.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -96.62 138.97 33.39 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 120.673 -1.267 . . . . 0.0 113.215 177.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 6.5 ttp -74.68 128.41 35.49 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.683 -1.261 . . . . 0.0 114.207 -178.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 91.0 mt -90.39 -50.05 6.18 Favored 'General case' 0 CA--C 1.567 1.617 0 N-CA-C 113.874 1.065 . . . . 0.0 113.874 172.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 91.3 p -139.98 154.81 47.27 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -175.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 24.7 p30 -135.77 81.36 1.88 Allowed 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 124.133 0.973 . . . . 0.0 111.092 173.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -88.67 119.58 29.27 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.102 -0.999 . . . . 0.0 110.144 -174.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.273 41.9 t30 67.95 21.68 8.84 Favored 'General case' 0 N--CA 1.504 2.251 0 N-CA-C 116.821 2.156 . . . . 0.0 116.821 -175.533 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -69.29 -47.14 65.41 Favored 'General case' 0 CA--C 1.568 1.666 0 N-CA-C 115.795 1.776 . . . . 0.0 115.795 178.051 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -46.48 -44.41 17.55 Favored 'General case' 0 N--CA 1.502 2.173 0 N-CA-C 117.534 2.42 . . . . 0.0 117.534 165.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -69.44 -44.79 70.57 Favored 'General case' 0 CA--C 1.57 1.731 0 N-CA-C 114.992 1.479 . . . . 0.0 114.992 172.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -52.94 -47.35 68.14 Favored 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 115.123 1.527 . . . . 0.0 115.123 166.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.7 mt -61.14 -41.63 97.08 Favored 'General case' 0 CA--C 1.571 1.782 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 169.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 44.2 ttp85 -56.62 -45.52 81.47 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 115.36 1.615 . . . . 0.0 115.36 166.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.12 -25.1 60.98 Favored 'General case' 0 CA--C 1.567 1.606 0 N-CA-C 117.827 2.528 . . . . 0.0 117.827 165.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 98.1 mt -89.39 21.79 3.19 Favored 'General case' 0 CA--C 1.573 1.836 0 N-CA-C 115.23 1.567 . . . . 0.0 115.23 164.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 66.9 16.39 10.36 Favored 'General case' 0 N--CA 1.504 2.236 0 N-CA-C 116.682 2.104 . . . . 0.0 116.682 179.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 91.4 t -82.03 136.35 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 120.223 -1.548 . . . . 0.0 110.215 -167.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 13.7 p30 -62.06 152.86 31.45 Favored 'General case' 0 CA--C 1.57 1.727 0 N-CA-C 115.208 1.559 . . . . 0.0 115.208 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 91.5 t -58.7 -38.4 71.53 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.153 0 N-CA-C 115.219 1.563 . . . . 0.0 115.219 -176.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.12 -55.98 27.64 Favored 'General case' 0 CA--C 1.569 1.687 0 N-CA-C 115.448 1.647 . . . . 0.0 115.448 167.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -56.52 -43.29 79.65 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 116.275 1.954 . . . . 0.0 116.275 169.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 37.3 mtp-105 -52.07 -53.06 46.85 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 116.017 1.858 . . . . 0.0 116.017 168.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -66.75 -47.75 71.27 Favored 'General case' 0 CA--C 1.567 1.629 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 174.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 66.1 mt -55.34 -54.87 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 CA-C-N 120.047 1.294 . . . . 0.0 113.266 174.042 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.84 -38.02 89.13 Favored 'General case' 0 CA--C 1.564 1.514 0 N-CA-C 117.635 2.457 . . . . 0.0 117.635 176.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -74.16 -24.11 59.35 Favored 'General case' 0 CA--C 1.571 1.759 0 N-CA-C 116.138 1.903 . . . . 0.0 116.138 171.265 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 73.6 mt -73.2 -37.79 66.34 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 115.405 1.631 . . . . 0.0 115.405 168.255 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.5 pp -84.28 143.92 29.23 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 119.597 1.089 . . . . 0.0 113.923 -178.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm -104.53 101.88 30.58 Favored Pre-proline 0 CA--C 1.572 1.818 0 CA-C-O 117.954 -1.022 . . . . 0.0 109.348 174.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -82.26 172.12 11.96 Favored 'Trans proline' 0 CA--C 1.564 2.014 0 C-N-CA 122.805 2.337 . . . . 0.0 114.778 -176.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -109.2 118.97 38.11 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.278 176.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 52.6 mttm -85.38 108.3 17.78 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.073 -1.017 . . . . 0.0 109.895 172.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -91.89 108.06 19.65 Favored 'General case' 0 CA--C 1.559 1.302 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 164.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 84.9 mt -97.6 114.15 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 -179.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 98.0 t -101.06 97.72 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 168.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -95.66 99.63 11.46 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 123.673 0.789 . . . . 0.0 109.727 175.328 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -106.64 75.25 1.05 Allowed 'General case' 0 CA--C 1.567 1.612 0 C-N-CA 123.557 0.743 . . . . 0.0 110.563 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 57.61 68.24 1.8 Allowed Glycine 0 N--CA 1.494 2.552 0 N-CA-C 117.628 1.811 . . . . 0.0 117.628 177.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.494 0.0 OUTLIER 81.99 -39.24 0.12 Allowed 'General case' 0 N--CA 1.501 2.108 0 N-CA-C 115.837 1.792 . . . . 0.0 115.837 -165.358 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 21.8 t-160 -74.32 100.49 3.77 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 120.677 1.58 . . . . 0.0 111.183 177.327 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 42.5 ttm -113.14 111.26 21.8 Favored 'General case' 0 CA--C 1.552 1.031 0 CA-C-O 121.665 0.745 . . . . 0.0 109.137 -170.191 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 51.8 mt -102.79 103.12 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 -175.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 26.0 mm -89.22 93.72 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 -178.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 61.1 mtt85 -90.45 97.38 11.15 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.232 -0.918 . . . . 0.0 110.099 178.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 14.3 m -89.41 99.19 12.24 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 15.1 mt -93.77 117.36 29.99 Favored 'General case' 0 N--CA 1.484 1.266 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.594 -162.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 42.2 t -133.11 141.27 48.09 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.849 0.859 . . . . 0.0 110.752 -159.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 13.1 t -74.09 39.35 0.11 Allowed 'General case' 0 CA--C 1.581 2.144 0 N-CA-C 116.701 2.112 . . . . 0.0 116.701 172.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -159.52 -65.29 0.08 Allowed 'General case' 0 CA--C 1.567 1.621 0 C-N-CA 124.676 1.19 . . . . 0.0 109.92 178.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 53.4 ttm-85 -140.09 117.52 11.42 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 123.625 0.77 . . . . 0.0 108.942 174.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 72.0 m-80 -76.77 126.99 31.92 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.785 -0.572 . . . . 0.0 111.993 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 40.9 t80 -106.47 100.28 9.82 Favored 'General case' 0 CA--C 1.567 1.606 0 O-C-N 121.645 -0.66 . . . . 0.0 110.724 -172.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 4.1 mp -95.36 111.22 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 C-N-CA 123.73 0.812 . . . . 0.0 109.051 178.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -103.55 94.83 5.67 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 123.413 0.685 . . . . 0.0 109.621 176.672 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -100.38 118.07 35.87 Favored 'General case' 0 CA--C 1.564 1.486 0 C-N-CA 123.913 0.885 . . . . 0.0 112.805 -174.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -155.15 143.2 20.11 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 -170.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 17.9 mp0 -85.18 116.17 23.39 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.441 -0.787 . . . . 0.0 110.376 166.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 41.2 t -65.08 117.54 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 C-N-CA 123.769 0.828 . . . . 0.0 110.047 177.242 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 118.61 -54.68 0.61 Allowed Glycine 0 N--CA 1.488 2.139 0 N-CA-C 114.675 0.63 . . . . 0.0 114.675 -159.049 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 5.9 mtmp? -80.79 148.02 30.21 Favored 'General case' 0 CA--C 1.566 1.586 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 -173.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -98.78 124.13 43.45 Favored 'General case' 0 CA--C 1.568 1.665 0 C-N-CA 123.183 0.593 . . . . 0.0 111.78 178.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 9.0 p90 -135.76 145.63 46.79 Favored 'General case' 0 N--CA 1.498 1.967 0 C-N-CA 123.837 0.855 . . . . 0.0 112.024 -171.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -79.15 128.29 33.1 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 119.54 -1.975 . . . . 0.0 113.64 177.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -73.95 85.53 1.76 Allowed 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 122.238 1.018 . . . . 0.0 112.079 173.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -126.46 -55.48 1.43 Allowed 'General case' 0 CA--C 1.567 1.629 0 C-N-CA 124.087 0.955 . . . . 0.0 111.855 176.369 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.1 tt -70.01 137.05 51.05 Favored 'General case' 0 CA--C 1.568 1.658 0 C-N-CA 123.631 0.772 . . . . 0.0 111.855 173.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . 0.332 29.1 m 87.69 136.62 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.168 0 C-N-CA 124.897 1.279 . . . . 0.0 110.51 -166.304 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -71.67 81.42 0.52 Allowed Glycine 0 N--CA 1.492 2.417 0 N-CA-C 117.796 1.878 . . . . 0.0 117.796 -172.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . 0.253 5.4 tp -108.27 -162.46 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.58 2.103 0 C-N-CA 124.788 1.235 . . . . 0.0 110.881 175.537 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -64.82 129.79 41.09 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 119.744 -1.847 . . . . 0.0 111.952 164.327 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -75.6 65.29 1.78 Allowed 'General case' 0 CA--C 1.575 1.917 0 N-CA-C 114.615 1.339 . . . . 0.0 114.615 -176.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 7.4 mpt_? -136.16 135.75 39.45 Favored 'General case' 0 CA--C 1.561 1.378 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 160.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 10.3 mtmt -79.55 72.43 6.21 Favored 'General case' 0 CA--C 1.571 1.782 0 O-C-N 121.225 -0.922 . . . . 0.0 113.156 -170.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 73.0 m -80.73 121.1 25.48 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 121.922 0.868 . . . . 0.0 113.038 -164.131 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 7.2 tpt -75.88 111.13 10.92 Favored 'General case' 0 CA--C 1.56 1.331 0 CA-C-O 122.175 0.988 . . . . 0.0 110.522 -170.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 93.8 m -120.61 120.61 36.27 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 115.377 -0.828 . . . . 0.0 110.399 -153.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 50.9 m -105.79 125.29 50.82 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 171.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.435 HG22 ' SG ' ' A' ' 95' ' ' CYS . 20.4 t -104.61 130.8 54.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 165.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 58.7 m -149.94 152.35 34.85 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.455 -1.403 . . . . 0.0 112.871 -178.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 52.3 m95 -83.78 118.96 24.26 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.939 -1.1 . . . . 0.0 113.544 -176.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -94.13 67.38 3.61 Favored 'General case' 0 CA--C 1.572 1.819 0 O-C-N 121.594 -0.691 . . . . 0.0 110.101 159.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 67.09 -102.63 0.81 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 114.798 0.679 . . . . 0.0 114.798 -176.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -80.81 -23.22 39.38 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 116.523 2.045 . . . . 0.0 116.523 169.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 60.1 mtpt -98.77 116.15 30.36 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 119.317 0.962 . . . . 0.0 110.182 -174.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 29.2 tp -82.83 109.47 16.99 Favored 'General case' 0 CA--C 1.564 1.485 0 O-C-N 121.277 -0.89 . . . . 0.0 110.057 175.438 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 -97.78 131.93 43.85 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.644 0.778 . . . . 0.0 111.538 -174.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . 0.435 ' SG ' HG22 ' A' ' 86' ' ' VAL . 44.9 t -122.26 128.92 51.71 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.341 0.657 . . . . 0.0 110.744 175.208 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.1 p -110.69 127.6 67.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 166.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -109.05 88.62 2.77 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 123.453 0.701 . . . . 0.0 109.665 175.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 12.0 ptmm? -97.22 145.19 26.3 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 114.309 1.225 . . . . 0.0 114.309 -172.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 159.75 -97.52 0.16 Allowed Glycine 0 N--CA 1.488 2.133 0 O-C-N 121.282 -0.886 . . . . 0.0 112.626 173.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -75.2 -47.16 29.63 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 115.125 1.528 . . . . 0.0 115.125 173.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 1.6 ttmp? -103.51 131.79 50.33 Favored 'General case' 0 CA--C 1.561 1.38 0 C-N-CA 123.636 0.774 . . . . 0.0 111.77 -161.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -77.87 160.38 28.32 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -179.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 56.57 21.43 35.08 Favored Glycine 0 N--CA 1.498 2.774 0 N-CA-C 120.722 3.049 . . . . 0.0 120.722 -179.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 45.1 ttt180 -96.02 123.21 39.53 Favored 'General case' 0 CA--C 1.563 1.459 0 CA-C-N 118.481 1.14 . . . . 0.0 112.42 -168.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 173.39 -169.78 42.9 Favored Glycine 0 N--CA 1.484 1.887 0 CA-C-O 121.949 0.75 . . . . 0.0 114.558 -176.327 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . 0.253 41.5 p-90 -156.82 157.17 34.47 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 113.804 1.038 . . . . 0.0 113.804 173.536 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 34.5 m -129.63 118.57 22.17 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 123.782 0.833 . . . . 0.0 108.765 176.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 -121.42 130.15 53.42 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.743 -0.598 . . . . 0.0 112.434 -175.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 25.4 p90 -144.66 164.86 29.7 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.251 -0.906 . . . . 0.0 112.059 176.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 96.3 mt -109.79 127.82 66.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 120.915 -1.116 . . . . 0.0 109.789 175.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -102.02 84.54 2.53 Favored 'General case' 0 CA--C 1.567 1.616 0 C-N-CA 123.997 0.919 . . . . 0.0 109.185 163.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 64.84 -98.06 0.28 Allowed Glycine 0 N--CA 1.493 2.442 0 N-CA-C 116.452 1.341 . . . . 0.0 116.452 -179.012 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 41.1 p30 -88.94 -5.46 57.96 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 117.36 2.356 . . . . 0.0 117.36 167.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -114.63 125.53 53.87 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-N 120.874 1.67 . . . . 0.0 111.529 -172.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 14.2 tp -86.26 115.13 23.61 Favored 'General case' 0 CA--C 1.563 1.474 0 C-N-CA 123.869 0.867 . . . . 0.0 109.472 169.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 51.8 m80 -102.42 121.09 41.65 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.651 0.78 . . . . 0.0 109.029 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 53.6 tp -121.16 119.41 32.28 Favored 'General case' 0 CA--C 1.562 1.433 0 C-N-CA 123.714 0.806 . . . . 0.0 110.005 -176.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -100.19 116.55 32.45 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 168.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 71.9 mtm -109.76 124.97 52.19 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 118.974 0.806 . . . . 0.0 110.977 -178.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 87.4 mtm180 -112.3 137.13 50.86 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 123.963 0.905 . . . . 0.0 110.809 -171.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -154.03 129.97 10.21 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.372 -0.83 . . . . 0.0 111.344 168.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . 0.273 7.9 mm-40 64.05 9.19 4.47 Favored 'General case' 0 N--CA 1.502 2.125 0 N-CA-C 117.59 2.441 . . . . 0.0 117.59 -175.303 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 99.88 -19.08 54.74 Favored Glycine 0 CA--C 1.556 2.615 0 N-CA-C 117.792 1.877 . . . . 0.0 117.792 -157.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 96.8 t -83.86 124.27 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 CA-C-N 119.7 1.75 . . . . 0.0 109.77 -177.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 47.9 m -103.74 119.73 39.51 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 121.108 0.48 . . . . 0.0 111.205 176.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 8.8 t -88.94 136.45 33.0 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.656 0.783 . . . . 0.0 112.075 162.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -111.23 114.93 28.5 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.718 -0.614 . . . . 0.0 109.832 176.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -113.81 140.38 48.36 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.857 0.863 . . . . 0.0 111.545 176.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 34.5 t -123.06 134.84 65.0 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 177.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -130.24 132.56 46.01 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 123.878 0.871 . . . . 0.0 111.215 -177.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 20.2 tptm -98.06 136.11 38.78 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.997 -1.065 . . . . 0.0 112.161 -178.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 67.7 tttt -74.5 118.33 17.33 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.522 -0.737 . . . . 0.0 112.777 179.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . 0.254 35.0 m -102.85 -40.79 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 175.067 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 67.0 t60 . . . . . 0 N--CA 1.486 1.351 0 CA-C-N 119.838 1.199 . . . . 0.0 107.95 164.212 . . . . . . . . 0 0 . 1 stop_ save_